// Reference=MNI
// Meister I, 2005: Musicians
// Subjects=12
-36	-23	59
-21	-6	61
-6	-3	55
24	3	61
3	0	61
-51	-27	48
-30	-33	49
-24	-52	58
-15	-58	53
-30	-35	57
-21	-43	66
39	-51	51
21	-61	56
12	-65	50
-9	2	41
-36	-4	42
-18	-3	61
6	-3	58
27	-4	53
6	11	44
-36	-26	40
-39	-26	54
-30	-41	63
-25	-53	47
-39	-47	44
39	-47	52
15	-49	61
36	-57	33
-33	0	58
-3	-3	55
-30	0	55
-6	-3	55

// Meister I, 2005: Non-Musicians
// Subjects=12
-36	-20	56
-30	-6	56
-27	0	55
-6	-9	47
24	-6	61
-33	-35	60
-33	-32	51
-24	-71	34
-24	-56	50
-30	-47	58
-33	-44	55
-33	-42	38
33	-47	49
21	-60	42
36	-42	44
-39	-18	53
-27	-3	53
-9	-3	53
0	8	47
24	-3	64
-36	-32	57
-33	-38	63
-39	-38	54
-30	-50	58
-9	-58	55
-24	-71	34
15	-58	61
12	-70	50
36	-41	49
-27	8	52
-3	6	60
3	6	60
-33	0	58
-3	-3	55
-30	0	55
-6	-3	55

// Milham M P, 2005: Congruent and Incongruent vs. Neutral
// Milham M P, 2005: Incongruent vs. Congruent
// Subjects=18
38	-68	-22
12	-28	-6
4	-12	-2
-14	-28	-2
14	6	-2
-22	-56	-6
-6	-86	0
-34	14	-14
-38	-72	0
-30	-80	8
38	-82	14
10	-78	10
66	-50	10
50	-50	22
18	-68	28
28	-62	46
-54	-48	22
-34	-54	22
-16	-68	28
-30	-62	40
-14	-68	54
-46	-30	40
-32	22	2
-44	46	22
-46	18	26
-30	26	54
-44	6	52
-28	42	2
30	22	2
34	18	18
32	38	20
36	58	30
28	46	44
44	24	48
-2	32	36
-2	14	38
0	14	54
12	22	36
34	-32	-24
-12	-24	16
8	-16	-4
-40	-50	-12
-26	-78	-12
-18	-54	-8
34	-78	-8
50	-50	-16
56	-38	-4
2	-70	2
24	-64	6
-26	-66	34
-32	-48	38
2	-54	36
54	-46	26
34	-50	36
-30	56	2
-36	16	6
-42	6	32
36	28	-6
40	14	26
6	20	28
-4	14	48

// Vink M, 2005: Go/Stop and Go Only
// Vink M, 2005: Go/Stop > Go Only
// Vink M, 2005: Parametric Analysis
// Vink M, 2005: Correct vs. Incorrect Stop
// Subjects=20
-22	5	-4
22	5	-4
42	-23	56
2	-3	56
-18	10	0
18	10	-4
-6	1	60
-42	18	-4
-18	10	0
18	10	-4
-6	10	48
-42	18	-4
-22	10	-4
22	10	-4

// Seurinck R, 2005: Hands, Fixed-Paced
// Seurinck R, 2005: Hands, Self-Paced
// Seurinck R, 2005: Tools, Fixed-Paced
// Seurinck R, 2005: Tools, Self-Paced
// Seurinck R, 2005: Tools, Fixed-Paced > Self-Paced
// Seurinck R, 2005: Tools, Self-Paced > Fixed-Paced
// Seurinck R, 2005: Fixed-Paced, Hands > Tools
// Seurinck R, 2005: Fixed-Paced, Tools > Hands
// Seurinck R, 2005: Self-Paced, Button Press Hand, Right > Left
// Seurinck R, 2005: Self-Paced, Button Press Hand, Left > Right
// Subjects=24
29.85	5.89	52.59
-19.76	4.11	59.22
-50.44	11.73	27.61
56.39	9.05	15.97
25.83	-48.8	64.8
40.63	-31.48	42.66
-19.62	-44.06	60.62
-39.33	-31.86	42.94
46.81	-74.23	9.81
-46.11	-72.43	11.21
46.81	-74.23	9.81
38.07	-85.94	-0.09
-44.08	-75.59	0.28
-35.4	-86.2	1.18
27.71	5.99	53.74
-19.89	3.18	49.23
12.93	-50.56	69.67
34.38	-39.62	59.26
-26	-48.78	67.92
-28.26	-44.09	60.77
-24.11	3.89	57.07
32.08	6.42	58.1
-23.85	-53.23	66.08
-47.94	-29.45	46.21
28.03	-50.72	67.19
40.79	-35.75	54.29
-41.92	-73.35	1.14
-29.06	-85.08	-10.24
31.45	-80.41	-9.49
42.31	-84.31	-5.93
-24.09	4.1	59.29
32.02	8.13	53.45
-10.87	-57.44	66.28
-50.06	-24.79	50.27
17.22	-56.28	65.68
40.66	-35.63	44.19
-24.68	-67.12	-2.01
-22.52	-67.11	-2.04
13.63	46.85	-25.14
4.03	35.74	-17.16
48.93	-65.72	8.93
51.12	-72.09	9.52
-48.29	-74.78	9.24
21.39	-63.89	52.92
29.3	-61.71	-4.58
32.46	-59.03	-10.5
-24.71	-62.97	-3.54
-26.98	-53.92	-10
-34.83	-16.25	60.37
47.24	-12.98	56.4
38.64	-16	59.09

// Wraga M, 2005: Object Task, Activations
// Wraga M, 2005: Object Task, Deactivations
// Wraga M, 2005: Self Task, Activations
// Wraga M, 2005: Self Task, Deactivations
// Wraga M, 2005: Object - Self
// Wraga M, 2005: Self - Object
// Subjects=11
-10.97	-57.11	58.4
-2.28	-55.6	62.59
27.93	-60.16	58.04
-37.2	8.43	49
-58.38	-50.19	-14.31
10.12	-70.76	14.57
-2.89	-97.37	6.22
-6.82	-20.07	52.42
-42.03	-18.38	3.55
-50.64	-5.03	9.1
-19.82	-93.66	35.27
-20	-100.54	19.15
14.25	64.59	26.88
-15.9	53.2	33
-20.18	44.78	35.03
4.92	35.35	-32.82
-7.93	40.6	-21.91
61.11	-60.2	32.83
66.42	-52.09	27.45
27.28	-98.95	-.86
-32.96	16.54	43.64
-50.47	18.11	26.98
28.01	-55.18	65.39
5.62	38.42	22.89
-2.92	35.92	31.13
-7.52	41.48	10.49
35.31	24.48	-24.42
-55.08	-54.12	-10.62
22.31	66.85	-18.3
44.08	-34.71	-26.56
-55.27	-34.75	-21.5
-28.86	-97.77	3.34
-11.36	-100.51	19
57.2	5.91	-6.15
-57.7	-7.9	47.6
-6.75	-2.02	61.84
-16.42	-14.09	-20.84
-33.81	-23.7	-30.8
-3.45	54.93	-6.6
-58.04	-29	17.2
-46.25	-30.75	9.33
40.6	-16.38	43.41
49.37	-11.05	53.94
40.68	-11.4	50.76
61.13	-64.45	33.25
-57.78	-61.03	30.45
-62.36	-50.91	12.72
26.68	-19.23	-32.27
64.59	-9.55	-22.67
-62.63	-2.61	1.22
-58.48	0.52	-11.49
-32.91	-.58	44.22
-55.08	10.5	3.16
61.25	-32.91	49.17
44.5	51.63	24.29
-45.82	-29.76	42.84
35.36	24.9	-19.98
10.42	-89.3	34.33
44.97	-29.13	44.59
-28.26	-44.09	60.77
1.91	-18.25	59.94
23.16	38.22	42.78
-58.03	-75.98	8.4
-46.35	-6.39	5.8
65.93	-36.06	-7.74

// Ford K A, 2005: Late preparatory period comparison: Anti vs. Pro
// Ford K A, 2005: Late preparatory period comparison: Correct Anti vs. Error 
// Anti
// Ford K A, 2005: Late preparatory period comparison: Error Anti vs. Correct 
// Anti
// Ford K A, 2005: Saccade period comparison: Pro vs. Anti
// Ford K A, 2005: Saccade period comparison: Error Anti vs. Correct Anti
// Subjects=10
-26.26	-2.03	53.28
23.99	-.42	55.91
-26.66	46.5	20.22
9.01	6.98	56.58
9.83	17.62	28.91
-26.18	-48.44	44.9
-18.63	-68.57	45.39
10.25	-65.94	49.3
27.82	56.51	20.98
9.85	22.19	32.99
3.64	12.15	55.09
-21.04	28.58	49.54
24.93	25.68	49.25
-3.7	-73.23	38.92
-40	-52.24	52.07
-2.71	-53.13	37.22
44.33	-64.74	34.31
5.78	-32.82	37.65
-14.59	23.5	52.12
-30.62	23.41	52.31
23.82	31.94	47.63
37.72	26.56	45.69
2.43	16.23	39.15

// MacDonald III A W, 2005: Patients with Schizophrenia
// Subjects=18
-43.66	16.7	21.8
45.11	12.46	27.83
35.29	59.73	20.63
-37.49	46.03	1.42
51.25	34.93	1.34
-45.94	21.75	4.67
24.65	57.98	26.47
-34.28	53.8	5.2
55.6	23.67	6.69
-8.62	60.64	8.79
33.14	60.69	19.46
54.51	23.49	4.49
-37.5	42.69	-.53

// MacDonald III A W, 2005: Patients with Nonschizophrenia Psychosis
// Subjects=12
-25.68	41.25	7.27
33.21	27.39	15.56
56.66	14.88	2.96
24.65	57.98	26.47
55.6	23.67	6.69
-8.62	60.64	8.79
33.14	60.69	19.46
54.51	23.49	4.49
-37.5	42.69	-.53

// MacDonald III A W, 2005: Normal Subjects
// Subjects=28
-27.69	57.92	30.42
46.1	27.01	23.25
-41.49	18.11	26.12
47.41	11.99	49.03
-41.43	14.31	32.01
24.65	57.98	26.47
-34.28	53.8	5.2
55.6	23.67	6.69
-8.62	60.64	8.79
33.14	60.69	19.46
54.51	23.49	4.49
-37.5	42.69	-.53

// Holmes A J, 2005: Schizophrenic Patients
// Subjects=7
42.91	49.17	34.81
48.34	29.2	37.54
-33.5	-68.86	56.74
4.46	56.86	41.3
42.93	32.88	30.6
-37.91	-62.52	42.87
69.65	-20.66	10.25
-63.86	-20.86	19.6
56.36	50.17	-22.31

// Holmes A J, 2005: Depressed Patients
// Subjects=10
42.91	49.17	34.81
-33.5	-68.86	56.74
4.46	56.86	41.3
42.93	32.88	30.6
-37.91	-62.52	42.87
69.65	-20.66	10.25
-63.86	-20.86	19.6
56.36	50.17	-22.31

// Holmes A J, 2005: Normal Subjects
// Subjects=9
42.91	49.17	34.81
48.34	29.2	37.54
-33.5	-68.86	56.74
4.46	56.86	41.3
42.93	32.88	30.6
69.65	-20.66	10.25
-63.86	-20.86	19.6
56.36	50.17	-22.31

// Habel U, 2005: Sadness - Gender Discrimination
// Habel U, 2005: Happiness - Gender Discrimination
// Habel U, 2005: Sadness - Happiness
// Habel U, 2005: Happiness - Sadness
// Subjects=26
-22.21	29.34	42.19
-42.55	40.06	-25.75
-12.04	61.8	-1.53
-9.61	63.89	20.63
-57.42	-6.17	-14.2
-57.23	-33.2	-4.81
-45.98	-58.32	24.38
-31.73	11.82	-29.87
-4.9	-64.56	24.3
-27.25	-19.86	-24.57
-35.87	-10.97	-20.82
-27.06	10.08	-2.88
27.36	-41.46	16.98
-39.93	-28.67	-3.31
-24.39	35.72	41.6
-3.53	36.77	-17.13
16.91	-36.67	45.82
-2.77	-49.45	25.01
-57.57	-11.67	-27.1
-45.74	-69.63	41.18
19.28	-39.46	61.74
-31.53	-32.64	-23.23
33.07	18.43	-31.63
-31.72	16.28	-28.07
-5.37	41.39	9.34
-37.6	-27.42	9.97
50.94	-23.06	5.79
-67.85	-20.94	12.09
25.22	28.68	32.49
-13.39	-15.3	46.46
44	-22.15	-30.04
15.92	-46.27	-33.9
-23	-40.03	-33.85

// Goldin P R, 2005: Sad > Neutral Film
// Goldin P R, 2005: Amusing > Neutral Film
// Goldin P R, 2005: Subject-Specific Regression Analysis Using Sadness Rating
// Goldin P R, 2005: Subject-Specific Regression Analysis Using Amusement 
// Rating
// Subjects=13
1.05	62.35	16.34
1.58	15.11	66.02
44.74	25.15	-14.5
-51.38	28.43	-4.75
49.1	-6.89	-16.32
57.93	-36.93	7.29
69.7	-49.89	3.78
-47	-11.09	-7.06
-5.93	-64.24	31.5
-2.87	-77.82	6.95
-10.44	-70.01	-1.42
-14.78	-58.66	-5.67
17.03	-3.91	-16.2
-16.09	-6.22	-15.63
-2.99	-25.32	11.47
-3.1	-5.57	5.36
-6.22	-62.92	-6.53
-2.93	41.29	47.15
-5.99	21.87	57.73
65.49	-40.43	16.41
69.75	-36.18	16.01
37.43	-19.3	-10.69
-14.89	-5.99	1.07
-6.45	58.79	12.26
57.76	27.2	10.83
-58.4	-69.01	15.77
65.53	-52.06	17.39
61.25	-44.43	20.14
-2.74	-59.99	31.1
29.1	-86.31	-9.43
-19.06	-58.77	-6.73
45.09	-83.3	-13.21
41.93	-69.69	-2.05
53.73	-82.31	-1.13
-22.49	-7.23	-14.35
-3.1	-6.63	5.45
-58.73	9.95	4.69
-46.83	14.82	25.34
-5.99	21.87	57.73
1.38	41.66	51.53
1.56	18.28	65.75
5.36	50.75	17.26
53.46	13.8	3.08
-18.8	-51.63	30.59
-58.28	-67.72	32.39
-58.76	-6.85	-6.16
53.68	-53.16	4.23
61.03	-25.88	-1.48
33.23	-30.62	-5.23
-6.25	-1.74	13.99
-3.03	-25.66	7.04
5.51	2.82	16.82

// Breitenstein C, 2005: Learning > Baseline, Activations
// Breitenstein C, 2005: Non-Learning > Baseline, Activations
// Breitenstein C, 2005: (Learning > Baseline) > (Non-Learning > Baseline), 
// Activations
// Breitenstein C, 2005: Learning > Baseline, Deactivations
// Breitenstein C, 2005: Non-Learning > Baseline, Deactivations
// Breitenstein C, 2005: (Learning > Baseline) > (Non-Learning > Baseline), 
// Deactivations
// Subjects=14
-63.68	-24.3	-1.1
-60.49	-11.52	-2.42
-63.84	-28.73	-14.1
69.15	-20.95	-7.05
62.57	-8.52	-11.53
56.2	-14.3	-4.13
-38.08	25.91	-16.59
-51.12	45.01	-18.25
-34.94	41.56	-21.55
-60.41	12.06	8.7
-11.44	31.3	39.58
39.74	29.69	-14.92
11.1	36.83	28.56
33.23	-62.48	-35.95
-63.69	-11.22	0.97
-37.89	33.85	-.57
-47.47	-27.43	-1.06
69.1	-8.19	-8.31
72.43	-20.63	-3.78
-47.78	19.5	-15.79
-54.09	20.72	-2.35
-1.7	38.03	42.11
-11.55	37.06	32.28
53.15	13.39	16.72
43.4	19.74	16.25
-18.41	-31.45	-11.25
-31.33	-31.19	-7.69
-28.3	-22.85	-22.01
11.03	-35.86	8.86
10.88	-30.41	-1.76
-14.57	35.41	49.31
-11.42	47.88	44.66
-14.37	-5.75	56.74
8.18	19.54	50.49
8.23	6.78	51.75
27.66	0.15	48.72
33.99	5.62	37.98
37.46	-9.07	52.82
-40.74	-35.42	16.42
-47.29	-39.26	10.19
-2.35	49.62	-6.09
52.96	-60.23	-12.98
50.23	-59.69	27.36
-31.44	-48.39	-19.43

// Denslow S, 2005: TMS
// Denslow S, 2005: Volitional Movement
// Subjects=11
-32	-20	68
-32	-34	68
-18	4	68
10	16	64
6	24	26
-28	-40	70
-50	-48	52
-20	-2	-10
8	-20	-6
4	-66	-18
-58	-28	14
64	-30	18
56	14	-14
-40	-12	62
-40	-34	62
-26	-12	70
-4	2	54
-30	-40	68
-50	-44	52
-40	36	28
-30	52	-10
32	52	-6
-46	48	2
50	46	4
-22	-8	-6
-6	-16	4
26	2	-20
8	-68	-14
-64	-30	6
64	-38	6
58	8	2

// Bonner-Jackson A, 2005: Schizophrenics Patients
// Subjects=17
-52.48	17.08	-13.82
-45.04	36.5	-11.07
-50.24	24.81	3.35
-54.39	27.13	19.93
46.95	22.59	-6.5
-50.01	10.66	26.84
-35.34	16.55	-8.4
-5.06	36.96	46.42
-45.96	44.64	11.68
-31.06	51.79	6.44
5.86	16.36	68.1
44.68	43.21	-14.9
45.17	19.66	38.37
-20.89	-95.13	18.65
-2.93	28.09	41.56
3.62	31.7	60.14
-45.58	8.97	45.89
39.46	19.12	-9.47
12.78	5.13	-9.11
19.24	56.12	16.65
-47.86	6.44	27.17
-3.82	-105.23	10.38
46.92	-20.53	-27.42
-35.74	-13.92	65.54
38.72	-85.11	-8.53
0.45	12.3	57.35
-20	-93.67	-3.79
-52.89	-26.6	54.53
20.64	-98.54	-1.62
41.63	19.56	-3.96
-48.9	4.49	29.57
-32.48	-56.17	55.66
47.27	20.47	34.93
-5.25	-27.68	-5.03
-42.7	-58.08	-23.24
25.55	-76.64	-49.23
-49.05	27.16	19.87
50.87	-45.81	58.3
-36.14	-83.96	-14.45
37.95	-4.05	62.75
40.66	-61.81	-23.89
-49.79	1.97	52.1
-32.08	20.43	0.16
33.04	-38.05	-32.48
-56.66	10.34	-4.28
3.73	-47.29	43.35
-42.19	-20.9	58.39
26.02	-91.56	5.54
1.52	7.91	55.47
32.13	-59.49	-20.64
-22.15	-91.65	-5.05
-39.37	-74.29	-13
1.11	-78.68	-32.05
-55.26	3.91	36.39
-33.56	-57.32	54.65
-34.2	-54.14	-28.13
31.5	-4.43	58.39
39.77	-75.42	-7.12
0.94	-45.27	-40.43
50.6	5.23	43.98
25.5	-68.36	-52.16
-17.02	-23.52	-5.25
-27.8	16.06	-1.75
-16.13	-70.38	-47.05
7.64	-64.24	-11.04
9.77	-20.39	5.34
60.98	14.19	7.42
31.56	-58.76	43.99
-45.44	-84.02	26.92
3.71	-42	42.91
17.4	-40.72	16.99
51.39	-11.93	0.8
-56.26	-65.65	17.7

// Bonner-Jackson A, 2005: Normals
// Subjects=26
-49.14	25.07	6.66
-12.35	20.14	63.53
-40.17	10.83	55.71
19.04	-34.93	-45.97
-64.85	-56.27	15.89
6.88	8.11	57.62
-50.46	34.56	-22
-55.31	-2.15	26.86
-46.72	23.6	42.44
-39.42	43.76	27.29
-40.68	28.67	-2.66
-27.8	-27.87	-19.25
-41.65	-45.04	-19.89
39.13	-28.11	68.1
30.66	6.64	-46.24
-25.79	-43.4	-41.39
-.61	6.92	56.69
-22.15	-95.97	-5.8
25.95	-90.14	-3.5
-51.11	13.66	24.37
-45.38	-30.61	57.01
-35.1	-79.81	-15.93
34.26	-63.96	-23.63
-43.81	28.28	6.33
-37.33	-57.7	-18.87
-25.59	8.04	4.47
-29.27	-61.61	53.85
-42.24	-3.81	59.19
48.24	35.91	28.05
35.26	19.86	0.55
-3.09	-26.35	-1.82
35.92	-57.87	55.02
13.9	-77.89	-36.73
-5.24	-80.32	-25.15
0.54	-44.94	46.53
5.84	-21.22	50.06
-46.95	-18.24	-3.11
-10.25	-63.63	25.92
12.09	-44.81	19.62
40.58	-6.68	-12.9
1.19	23.23	19.62
3.8	-81.73	38.43
-2.14	46.04	12.17
36.74	-61.49	21.86
-30.64	-47.09	21.42
-15.35	-40.32	66.4
52.72	-34.45	26.1
5.19	36.89	-10.57
55.72	-14.57	7.67
14.64	-50.37	71.36
24.16	-28.28	67.17
45.29	-13.12	41.12
-57.4	-33.51	20.59
-42.23	-75.2	30.6
-55.09	-53.62	35.63
18.23	52.4	23.67
-25.52	-48.32	-8.64
21.5	-46.89	-8.19
-40.25	-17.4	34.66
-32.15	-4.46	-18.94
22.74	26.3	43.65
-26.53	40.21	35.24
21.68	-91.22	-3.36
-44.32	-28.49	56.82
-24.3	-91.75	-6.13
-27.14	-57.28	54.58
-45.54	-4.86	45.93
-36.25	-63.07	-19.55
34.22	-56.73	-26.47
39.73	-74.71	-11.64
51.6	8.95	36.97
40.08	-40.3	47.92
-.65	7.64	52.17
-29.48	-81.35	18.71
-28.32	-3.47	62.35
12.91	-27.65	-6.36
22.32	-70.4	-50.83
37.89	1.95	57.78
-26.65	-8.26	0.28
5.37	-75.48	-32.37
-13.79	-27.64	-3.82
32.55	-68.32	30.28
-28.84	19.65	3.54
16.12	-3.43	3.84
36.34	18.9	1.74
17.64	2.43	65.78
26.32	-66.48	54.73
42.87	38.88	25.64
3.19	-37.54	-23.26
-44.75	28.5	23.05
-20.07	-22.97	15.93
56.06	-16.6	50.21
-49.16	-14.71	-12.31
48.13	-13.61	-6.82
14.49	-39.85	55.98
59.14	-51.93	19.68
-65.8	-45.13	36.16
55.93	-30.03	27.92
-51.8	-68.14	40.16
1.17	27.37	18.16
-5.93	-33.52	43.42
-1.54	-86.08	37.74
13.07	-38.09	10.13
-37.87	-86.29	38.18
-48.91	-34.06	12.73
-16.75	-51.41	19.39
-17.52	-42.88	61.07
7.38	34.16	-4.79
-61.62	-69.2	13.6
39.77	-21.55	15.13
1.43	-5.09	38.72
4.82	-19.65	56.63

// De Luca M, 2005: Multiple Sclerosis Patients
// Subjects=14
44	-3	52
-2	-3	53
-45	-34	55
-34	-27	49
-38	-14	56

// De Luca M, 2005: Control Subjects
// Subjects=7
-2	-7	52
-41	-18	56
-39	-24	54
-43	-9	48

// Rodriguez-Fornells A, 2005: Monolingual Subjects
// Subjects=11
36	-84	-16
-32	-28	-20
-28	-68	36
0	8	44
-56	12	36
-24	-52	-40
28	-68	-36

// Rodriguez-Fornells A, 2005: Bilingual Subjects
// Subjects=11
-36	-84	-8
32	-84	-16
-32	-60	42
4	4	48
-56	8	36
-36	-64	-28
36	-64	-36

// Kerns J G, 2005: Normal Subjects
// Subjects=13
3.5	19.5	39.98
-28.39	1.3	55.26
48.75	-46.71	60.63
-38.34	27.39	21.96
46.07	30.01	20.77
61.34	-47.97	29.36
-60.59	-46.47	18.37
42.64	51.89	1.13
19.42	-30.99	5
-59.58	-52.61	7.72
-15.93	-14.45	1.79
54.44	27.12	-3.62
-47.15	26.89	-11.36
1.36	19.48	40.01
-31.59	5.77	58.26
-26.12	-55.5	49.96
5.96	-59.54	49.93
55.08	-55.19	46.77
-43.49	6.36	39.39
54.72	14.72	28.64
-44.78	26.04	18.8
55.6	13.81	3.06
0.3	-60.63	8.82
52.29	20.42	-7.5
-38.56	19.62	-9.73
-56.45	-57.76	-4.15
5.56	23.14	31.84
-26.03	-53.5	62.05
49.81	-45.73	59.42
-63.9	-22.34	14.15
-6.22	-21.11	11.16
28.91	-3.61	0.36
40.46	7.52	-21.89
5.57	22.08	31.93
0.32	-67.06	8.24
19.2	5.25	-8.07
-56.46	-56.79	-5.35
24.48	12.26	-14.3
-.51	-18.45	58.82
36.86	-30.55	50.48

// Kerns J G, 2005: Schizophrenia Patients
// Subjects=13
-13.39	-34.45	45.81
-33.91	3.78	32.81
40.83	16.84	29.74
-38.39	28.02	16.33
40.67	29.38	13.07
44.86	30.75	2.87
24.7	-10.69	5.47
-10.58	-10.02	3.59
-57.47	-45.2	7.07
65.37	-31.77	4.54
-46.06	27.15	-8.05
44.74	31.75	-11.71
3.52	16.41	41.35
3.92	-65.13	60.45
36.71	10.69	47.03
9.92	27.28	43.71
62.4	-40.31	32.05
49.36	12.23	24.45
42.96	7.96	24.88
54.46	16.38	-4.95
5.56	23.14	31.84
-26.03	-53.5	62.05
49.81	-45.73	59.42
-63.9	-22.34	14.15
-6.22	-21.11	11.16
28.91	-3.61	0.36
40.46	7.52	-21.89
5.57	22.08	31.93
0.32	-67.06	8.24
19.2	5.25	-8.07
-56.46	-56.79	-5.35
24.48	12.26	-14.3
-.51	-18.45	58.82
36.86	-30.55	50.48

// Riecker A, 2005: Syllable Repetition vs. Passive Listening
// Subjects=8
-3	6	63
-54	-18	36
51	-15	33
-63	12	18
-39	12	0
-24	-3	3
27	-6	0
-12	-18	0
15	-21	3
-21	-60	-24
24	-60	-24
-21	-60	-57
18	-63	-57

// Jeong B S, 2005: Schizophrenic Patients
// Subjects=10
39.68	18.33	-21.64
-28	15.47	8.93
4.59	-76.07	3.98
37.51	-2.17	57.74
-23.81	-19.02	76.14
-17.32	-27.71	74.65
-17.84	17.66	43.28

// Jeong B S, 2005: Control Subjects
// Subjects=10
-2.32	44.3	-5.57
-17.83	14.47	43.59
-17.36	-64.05	64.8
-40.1	-42.65	65.31
-46.79	-25.64	52.53
-27.3	-15.37	57.91
-21.43	-63.71	-.16
-10.99	-56.15	57.19
54.86	5.62	-20.64
-17.84	17.66	43.28

// Caldwell J A, 2005: Pilots
// Subjects=8
-40	58	12
-48	20	0
-2	18	40
-38	-66	38
-18	0	10
-42	-64	-46
42	0	28
24	62	-10
28	8	64
28	-72	52
12	6	4

// Caldwell J A, 2005: Fatigue-Resistant Non-Pilots
// Subjects=10
-56	14	30
-52	-4	28
-12	-10	60
-20	-74	24
-30	-34	-20
34	36	24
32	28	4
28	-78	24
16	-20	10

// Caldwell J A, 2005: Fatigue-Vulnerable Non-Pilots
// Subjects=10
-42	-14	44
-44	34	0
-8	10	42
-28	-82	26
-28	-16	-24
48	24	20
36	6	-20
34	-76	26
20	-8	-4

// Gotlib I H, 2005: Sad - Neutral Faces, Depressed > Controls
// Gotlib I H, 2005: Sad - Neutral Faces, Controls > Depressed
// Gotlib I H, 2005: Happy - Neutral Faces, Depressed > Controls
// Gotlib I H, 2005: Happy - Neutral Faces, Controls > Depressed
// Subjects=18
-14.41	15.38	-27.15
50.5	-3.43	-25.28
60.4	20.92	-6.56
-7.83	33.67	-15.63
-27.42	42.34	-25.12
42.76	28.48	52.38
62.22	-6.76	-38.59
-42.01	11.27	10.7

// Keedwell P A, 2005: Depressed Subjects
// Subjects=12
11.6	55.5	-4.39
-37.59	46.06	-11.96
2.5	-24.81	31.44
-42.36	2.56	45.27
16.25	-86.65	-12.6
0.3	40.43	49.41
-27.5	-49.96	11.59
37.77	-13.59	35.67
-33.9	-8.19	29.35
-15.94	-89.27	-29.85
-26.26	-35.04	39.32
-.61	-29.34	41.89
51.3	4.73	-3.94
48.51	-27.19	37.8
37.44	-42.28	-18.8
46.29	9.26	41.46
62.17	-15.24	12.11
49.21	29.43	12.97
12.54	50.97	-21.87
-25.41	37.39	39.93
-41.84	46.29	-8.58
11.57	54.19	-7.63
51.3	18.99	1.56

// Keedwell P A, 2005: Control Subjects
// Subjects=12
11.6	55.5	-4.39
-37.59	46.06	-11.96
2.5	-24.81	31.44
-42.36	2.56	45.27
16.25	-86.65	-12.6
0.3	40.43	49.41
-27.5	-49.96	11.59
37.77	-13.59	35.67
-33.9	-8.19	29.35
-15.94	-89.27	-29.85
-26.26	-35.04	39.32
-.61	-29.34	41.89
51.3	4.73	-3.94
48.51	-27.19	37.8
37.44	-42.28	-18.8
46.29	9.26	41.46
62.17	-15.24	12.11
49.21	29.43	12.97
12.54	50.97	-21.87
-25.41	37.39	39.93
-41.84	46.29	-8.58
37.49	-31.82	-7.41
-42.94	33.97	-16.46
-4.49	64.75	-7.22

// Manoach D S, 2005: Spatial > Shape WM Conjunction
// Manoach D S, 2005: Spatial > Shape WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape > Spatial WM Conjunction
// Manoach D S, 2005: Shape > Spatial WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape > Spatial WM, Schizophrenics > Controls
// Manoach D S, 2005: Spatial WM Conjunction
// Manoach D S, 2005: Spatial WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape WM Conjunction
// Manoach D S, 2005: Shape WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape WM, Schizophrenics > Controls
// Subjects=12
-10.88	-59.67	65.38
-27.09	-56.54	65.34
18.35	-62.45	68.51
30.96	7.17	54.69
47.01	-85.85	23.28
53.75	-41.23	52.37
56.27	12.47	6.67
-23.82	-66.1	66.23
-7.57	-65.73	69.28
59.49	-59.89	-9.76
11.89	-68.85	69.26
-40.87	19.44	17.72
-50.8	30.93	3.3
-44.35	-61.2	-17.95
-27.99	8.98	8.45
47.13	3.72	51.39
-31.6	25.93	-16.7
-17.46	-76.9	53.75
-40.36	-45.69	44.32
-27.41	-75.3	36.95
-27.41	3.46	52.69
-47.24	3.78	22.74
-44.11	32.51	19.84
31.06	-74.16	45.92
37.34	-78.88	29.48
36.43	25.86	-21.21
36.65	24.23	-4.25
34.24	7.49	57.96
8.13	22.42	46.84
59.59	13.11	13.27
53.09	39.23	17.52
49.65	47.55	3.31
-23.88	-60.03	62.27
18.07	-57.94	47.9
40.53	-30.08	34.68
63.02	21.06	29.24
53.22	-48.48	9.39
56.35	-52.59	-.34
-31.6	25.93	-16.7
-44.06	19.74	21.1
-50.32	5.01	36.12
-30.66	6.64	52.43
-1.54	19.51	50.66
-8.18	24.93	40.15
-30.62	-71.81	40.02
-30.73	-75.93	30.34
-30.64	-55.54	41.77
-47.6	-71.09	-20.27
-34.4	-98.83	-7.67
-11.83	-11.04	0.07
-44.48	49.47	-5.36
-30.92	-83.87	14.32
11.37	22.43	46.79
36.41	29.05	-21.53
49.95	13.69	20.1
49.73	38.28	7.59
43.27	54.84	12.78
37.46	-64.87	41.54
33.72	-101.47	-5.21
23.91	-102.12	-11.7
40.67	10.39	54.2
17.32	-7.75	-.75
49.62	-67.56	-22.28
37.33	-75.69	29.16
-24.92	30.71	-.48
-30.91	-18.19	28
-11.62	-45.51	10.2
-24.72	-43.3	0.12
-17.61	-28.72	52.34
-17.77	2.87	45.86
30.45	-39.3	5.51
33.66	3.13	11.34
20.79	0.52	18.54
33.94	8.5	34.34
34.13	-19.59	43.84
1.46	24.34	33.32
-51.09	15.67	-22.08
-43.59	6.91	55.98
59.21	23.38	-14.63
50.36	6.93	51.02

// Surguladze S, 2005: Happy Faces, Normals > Depressed
// Surguladze S, 2005: Sad Faces, Depressed > Normals
// Subjects=14
-31.84	-83.64	-10.63
37.58	-73.7	-12.26
24.53	12.77	-7.65
32.15	-62.58	-19.26
-25.67	5.07	-6.43
-25.83	-1	-29.89

// Yoo S S, 2005: Schizophrenics
// Subjects=10
6	14	49
46	36	15
-46	15	25
26	15	58
-26	16	53
40	51	1
8	26	23
34	-56	53
-34	-55	53
-28	-93	10
24	-83	-8
44	-55	-16
-44	-51	-16
32	23	-8
-34	15	-7
42	-57	-22
-40	-67	-17
6	31	44
-32	-1	53
24	17	36
-42	-73	13
-7	-72	42
-38	-48	-18
-22	-4	4
30	29	-1
-32	29	-3
12	-76	-15
-8	-78	-16
4	-58	-29
-4	-46	-31
14	-49	-31
-14	-48	-33
40	49	1
46	-34	57

// Yoo S S, 2005: Normals
// Subjects=10
4	31	44
6	14	48
26	14	38
48	15	18
-44	11	31
30	14	53
-32	8	51
12	26	23
34	-56	42
-34	-56	51
24	-91	3
-18	-97	3
48	-57	-16
-40	-51	-14
24	6	-4
-22	8	-4
36	21	-9
-30	27	-6
39	-57	-22
-38	-57	-21
2	-58	-29
0	-58	-31
6	31	44
-32	-1	53
24	17	36
-42	-73	13
-7	-72	42
-38	-48	-18
-22	-4	4
30	29	-1
-32	29	-3
12	-76	-15
-8	-78	-16
4	-58	-29
-4	-46	-31
14	-49	-31
-14	-48	-33
40	49	1
46	-34	57

// Audoin B, 2005: Multiple Sclerosis Patients
// Subjects=9
-43.14	32.85	11.95
-52.73	30.45	21.31
-54.99	24.3	13
-54.99	24.3	13
-54.16	34.44	-4.83
-1.99	51.15	21.76
-41.11	63.59	7.75
-.6	40.37	44.1
-2.61	38.21	55.55
-28.85	51.14	34.55
-61.17	1.37	32.18
-30.57	-22.18	54.16
8.55	70.05	5.15
63.81	24.4	7.6
61.6	32.8	5.69
68.17	15.91	8.37
20.76	-77.39	0.48
28.98	-81.64	-33.98
43.19	-91.29	-23.18

// Audoin B, 2005: Control Subjects
// Subjects=18
-18.65	18.56	64.49
-28.42	18.22	61.33
-37.3	3.24	39.43
-51.57	22.36	26.58
-37.03	5.32	61.63
-2.71	23.24	44.71
-45.12	6.77	20.17
-63.57	19.26	17
-62.71	18.67	-.88
-36.63	33.08	14.06
-59.37	30.35	9.11
-58.55	27.32	-11.89
-41.36	-27.64	53.76
-40.34	-42.29	46.23
-7.46	-48.53	81.02
-28.21	-42.61	65.1
-28.13	-49.64	70.28
-32.58	-56.12	58.67
-47.73	-10.8	-18.39
-43.49	-5.89	-23.43
-70.44	-15.45	-20.91
-49.75	-50.27	-15.57
-38	-71.99	-30.43
-27.14	-79.19	-27.66
15.46	22.91	28.74
2.55	9.04	30.33
52.15	7.42	21.81
62.43	38.59	-12.83
60.12	38.5	-25.11
50.3	59.64	-28.15
48.25	60.46	-19.23
41.79	65	-16.21
75.81	-30.52	4.99
78.07	-22.14	14.2
73.72	-37.66	9.09
40.69	0.27	-31.08
46.75	-59.34	8.33
59.29	-38.39	-20.85
74.27	-12.06	-27.07
47.43	-33.87	-17.73
42.87	-8.33	-31.39
6.77	-91.26	2.09
47.67	8.39	9.46
17.96	-74.07	36.05
37.64	-71.62	-30.64
-43.14	32.85	11.95
-52.73	30.45	21.31
-54.99	24.3	13
-54.99	24.3	13
-54.16	34.44	-4.83
-1.99	51.15	21.76
-41.11	63.59	7.75
-.6	40.37	44.1
-2.61	38.21	55.55
-28.85	51.14	34.55
-61.17	1.37	32.18
-30.57	-22.18	54.16
8.55	70.05	5.15
63.81	24.4	7.6
61.6	32.8	5.69
68.17	15.91	8.37
20.76	-77.39	0.48
28.98	-81.64	-33.98
43.19	-91.29	-23.18

// Mu Q, 2005: Sleep Deprivation-Resilient Subjects
// Subjects=10
-56	14	30
-30	26	-4
-12	10	60
-20	-74	24
34	36	24
40	12	-6
28	-78	24
-46	-64	-32
-60	14	22
-46	38	18
-12	0	40
-52	-46	18
-44	-2	54
26	-76	44
-52	-2	50
-2	32	22
-8	40	54
-18	-68	-38
-4	-72	46
-60	-64	23
-38	-62	-38
18	-8	62
32	-54	40
-44	14	16
-16	-12	68
-30	-8	-6
-32	-66	-28
10	30	6
28	-60	46
36	-60	2
30	-50	-38

// Mu Q, 2005: Sleep Deprivation-Vulnerable Subjects
// Subjects=10
-42	26	24
-32	46	-8
-28	-82	26
38	16	38
34	-76	26
-42	2	18
-44	-2	54
26	-76	44
-52	-2	50
-2	32	22
-8	40	54
-18	-68	-38
-4	-72	46
-56	4	36
-30	-80	24
42	24	38
32	16	2
4	12	54
38	-76	44
-44	14	16
-16	-12	68
-30	-8	-6
-32	-66	-28
10	30	6
28	-60	46
36	-60	2
30	-50	-38

// Napadow V, 2005: Manual, Increases
// Napadow V, 2005: Manual, Decreases
// Napadow V, 2005: Sensory Control, Increases
// Napadow V, 2005: 2-Hz Electroacupuncture, Increases
// Napadow V, 2005: 2-Hz Electroacupuncture, Decreases
// Napadow V, 2005: 100-Hz Electroacupuncture, Increases
// Napadow V, 2005: 100-Hz Electroacupuncture, Decreases
// Subjects=13
41.71	5.01	0.61
-38.5	10.36	-5.61
37.56	-20.13	6.11
-37.39	-2.32	-4.56
6.56	-11.69	7.99
-5.2	-15.02	7.29
33.06	64.32	11.35
-26.74	59.99	15.74
56.52	45.28	-2.94
-55.58	45.64	11.7
57.05	-32.77	33.71
-57.25	-33.02	40.62
56.93	-25.16	21.92
-55.24	-25.58	26.59
-17.21	-9.03	-24.3
19.18	-14.81	-19.77
-17.2	-13.26	-23.95
-4.41	29.26	-12.05
-5.49	68.69	2.5
2.98	50.37	-15.02
-2.37	50.25	-16.06
6.52	53.9	30.37
-4.31	52.29	10.55
32.89	19.65	-29.51
-52.5	13.57	-17.98
-10.41	45.56	47.99
-61.53	-37.45	38.81
56.86	-22.68	12.79
-64.91	-16.29	23.69
37.26	27.31	-13.48
6.69	19.34	37.73
-6.18	14.44	30.48
3.61	-3.51	45.25
36.35	15.73	2
-34.22	19.28	-.83
40.6	-.97	-7.8
-39.49	-4.19	-1.03
-21.3	1.72	4.95
4.4	-4.21	8.5
27.81	61.97	22.76
-20.28	61.6	22.23
5.49	59.69	36.59
-.79	31.36	42.38
63.18	19.29	18.12
-55.51	14.46	7.62
60.31	-42.01	37.79
-53.04	-42.4	29.09
3.11	-25.2	-28.76
-3.53	-37.36	76.06
53.74	-25.1	23.07
-46.71	-25.7	24.27
-16.14	-9.02	-24.31
28.84	-17.58	-15.19
4.2	22.25	-7.1
6.35	11.43	-9.56
5.04	63.87	-19.52
-1.22	66.51	1.52
3.01	34.25	-17.01
-1.26	34.22	-16.96
-25.92	15.61	-35.19
-2.94	15.86	34.78
37.4	15.56	-.23
-32.97	-16.16	8.82
29.92	61.64	18.3
-38.61	59.77	0.28
5.74	15.08	51.48
-.64	16.44	55.9
57.88	13.17	22.04
-41.43	30.86	39.54
50.73	-44.98	41.5
-55.15	-43.3	31.42
-8.88	-36.34	76.03
61.24	-24.8	26.3
-53.13	-25.82	23.24
-20.46	-2.87	-27.01
37.2	49.68	-13.12
-34.4	37.2	-16.83
2	30.44	-11.1
-2.82	-49.93	23.57
5.37	-10.69	-6.58
-1.35	64.09	-16.12
6.27	65.59	2.63
-1.23	65.29	-.61
2.97	41.48	-19.85
-1.3	41.45	-19.8
43.5	12.34	-42.4
-43	11.28	-34.63

// Nebel K, 2005: Event-Related Design with Continuous fMRI Acquisition
// Nebel K, 2005: Sparse fMRI
// Subjects=13
-4.98	-88.14	13.18
10.15	-96.8	11.54
1.5	-99.06	10.79
1.52	-94.5	13.7
-13.36	-82.9	35.22
-17.73	-85.46	31.07
-7.01	-101.35	21.25
-13.46	-94.57	25.17
12.35	-85.53	17.11
23.24	-93.59	22.21
21.13	-98.71	24.99
23.34	-82.98	32.36
-7.29	-61.87	7.26
-5.18	-92.89	-3.15
-9.53	-71.21	-.74
-11.82	-75.45	-11.49
-9.61	-80.55	-8.78
5.5	-82.84	-11.05
33.69	-92.96	-6.05
42.36	-90.49	-3.08
-13.5	-99.24	21.15
24.93	-53.32	-6.46
-20.37	-57.32	-.81
-11.82	-49.2	-6.24
8.26	-87.08	35.27
34.17	-82.73	34.39
19.03	-96.07	30.37
17.01	-81.86	44.69
21.3	-84.28	41.49
-6.8	-82.25	41.77
-19.82	-89.3	35.96
-9.01	-93.62	35.09
-11.16	-86.94	37.82
42.34	-73.16	-1.43
-2.86	-75.26	12.99
10.13	-72.88	14.78
-18.37	-27.85	-7.12
18.72	-67.74	11.88
-11.89	-38.77	-9.51
31.81	-67.83	21.75
18.98	-73.42	31.49
22.72	-36.21	-6.99
42.17	-60.16	-11.68
44.38	-64.2	-9.07
16.98	-73.35	43.84
16.88	-74.08	36.07
9.82	-33.61	-1.43
12.34	-90	15.31
5.78	-92.77	8.98
-4.93	-83.36	18.31
-15.8	-97	10.88
-11.43	-98.8	14.35
16.53	-74.55	8.11
1.27	-88.71	-4.79
1.32	-92.76	-2.15
-9.55	-88.85	-5.72
6.03	-87.61	29.75
10.29	-92.47	23.44
19	-87.56	29.53
-.64	-74.84	17.4
-9.2	-100.5	18.96
-18.25	-91.53	-10.91
25.01	-58.23	-1.49
22.8	-53.12	-4.2
22.89	-62.28	1.19
-20.31	-62.33	3.05
29.25	-77.43	-11.99
-29.04	-69.57	-5.05
-35.57	-68.84	-8.37
-19.82	-91.54	35.06
8.25	-84.95	35.06
-15.86	-65.74	12.27
-7.2	-69.96	12.54
8.13	-73.87	27.24
-33.53	-58.82	-16.12
-39.9	-66.73	-8.51
-35.65	-65.11	-14.35
-15.43	-80.05	42.82

// Volle E, 2005: MemG Delay One, 1 Square vs. Fixation
// Volle E, 2005: MemG Delay One, 3 Square vs. 1 Square
// Volle E, 2005: MemG Delay One, 5 Square vs. 3 Square
// Volle E, 2005: MemG Delay Two vs. MemG Delay One
// Volle E, 2005: MemG Delay Two vs. VisG Delay Two
// Subjects=11
-33	-3	60
-21	6	57
12	15	39
-45	-12	54
30	-6	63
-18	0	63
-27	-3	48
-9	12	51
15	-57	60
48	42	27
39	57	18
6	24	36
-3	27	33
-42	3	48
-21	3	54
-6	-3	63
-3	12	51
9	-66	54
-6	-66	57
-33	-39	45
-42	27	42
-51	15	36
-33	30	-3
0	39	42
-9	39	-3
-39	-24	63
39	-24	51
-12	-27	69
-6	-15	48
57	-30	27
-54	-36	42
-42	-18	15
57	-21	48
-51	-21	42
48	-12	9
-48	-6	9
-12	15	0
9	33	36
9	39	18

// Hui K K S, 2005: Normals Who Experienced Deqi Only
// Subjects=11
27.67	-7.62	-23.82
-24.72	-2.73	-24.74
37.42	-22.65	-12.64
-17.16	-17.23	-20.27
19.02	-3.24	-35.24
-26.92	-8.88	-35.35
3.31	-1.13	7.14
-.94	-2.05	9.5
3.29	3.1	6.79
-.98	3.07	6.84
9.55	8.11	-11.55
-4.31	10.57	-6.02
5.18	33.46	-13.62
-.12	31.66	-8.95
2.03	36.24	-4.9
-5.39	37.85	2.86
3.23	46.33	15.43
3.58	-12.57	38.21
-.69	-12.59	38.26
6.86	-38.18	36.97
-.64	-35.14	35.69
4.76	-40.05	40.5
8.88	-51.52	15.76
-3.88	-57.51	21.99
-3.89	-52.14	22.65
-40.68	8.86	-11.03
27.53	13.99	-33.44
-26.99	10.15	-36.95
2.88	69.06	-21.04
-21.51	57.68	-.85
5.11	32.77	-22.49
-2.36	41.53	-18.68
4.11	18.05	-20.13
-1.14	5.84	-12.35
16.05	15.69	3.35
-6.39	15.56	3.62
18.32	-29.14	1.51
-9.44	-31.25	4.24
61.35	-32.48	36.98
-37.91	-38.4	52
5.85	-8.98	56.84
-2.6	-13.55	67.36
12.83	-19.71	-13.71
-3.24	-21.29	-18.97
5.25	-33.9	-31.4
-4.41	-31.13	-35.98
6.26	-19.17	-33.76
-.13	-24.5	-33.24
1.12	-40.13	-15.21
-.85	-58.23	-1.4
3.38	-75.09	-13.42
-.9	-75.21	-14.48
5.34	-76.88	-36.71
3.18	-67.29	-36.38
10.57	-68.19	-48.65
2.05	-58.04	-40.49
-2.19	-51.12	-33.21
1	-47.93	-33.52
28.8	-34.47	-27.16
-7.4	-39.92	-11.79
17.2	-52.72	-14.34
-15.92	-52.83	-12.84
17.23	-88.64	-24.71
-14.78	-91.58	-18.52
20.35	-82.96	-34.15
-11.72	-76.64	-32.08
14.92	-83.85	-45.16
-9.59	-73.37	-31.26
11.7	-64.24	-38.96
-14.13	-56.42	-59.39
7.42	-70.95	-42.81
-5.54	-59.28	-55.91
-22.59	-42.41	-42.63
40.54	-41.09	-31.2
-28.91	-34.9	-27.57
38.4	-41.19	-32.28
-21.43	-46.92	-32.23
40.54	-47.69	-33.99
-37.52	-42.16	-38.02
-32.14	-72.5	-45.57
22.29	-68.46	-53.23
-37.57	-49.27	-47.46
30.83	-38.83	-42.43
-36.49	-52.44	-47.2
3.22	-53.75	-26.36
11.75	-60.38	-30.36
-19.26	-50.96	-29.68
6.03	-43.36	66.41
-5.77	-31.89	64.47
65.51	-20.46	27.01
-65	-12.83	13.37
3.25	-23.74	-9.92
-1.02	-22.62	-8.85
4.12	32.4	-13.52
-9.85	65.61	-9.46
6.25	18.06	-20.15
4.15	12.93	-17.47
3.21	-82.35	-38.46
15.94	11.23	-13
-19.3	-5.18	-15.68
-1.19	34.99	-6.99
-1.05	6.7	-1.27
3.5	0.84	32.62
3.52	-23.11	25.71
-1.71	-38.49	33.75
5.75	-60.62	22.14
-1.86	-48.75	11.19
37.36	20.68	-2.89
-33.11	16.45	3.85
53.33	14.63	-13.71
-54.56	11.07	-8.83
5.11	68.95	-8.79
-1.21	66.6	2.63
-.2	28.68	-19.85
-8.43	-10.98	4.76
-7.45	14.49	3.72
21.32	13.81	-7.7
-22.45	9.66	-2.39
-7.29	-8	15.65
7.62	-11.68	7.98
-5.19	-11.67	9.24
-10.48	-25.45	10.45
60.13	-23.03	21.71
-57.37	-19.96	30.61
58.2	-33.05	43.76
-48.8	-34	27.22
43.13	9.76	48.15
3.3	-75.95	-24.5
-.98	-75.98	-24.45
3.29	-72.78	-24.77
-.99	-72.8	-24.72
11.92	-61.93	-9.05
-8.4	-62.3	-12.13
9.8	-78.31	-14.34
-9.49	-78.94	-20.76
6.54	-84.39	-23.83
-6.27	-85.35	-21.37
9.77	-88.43	-21.3
-3.07	-88.76	-24.47
-16.07	-70.84	-39.21
10.62	-64.33	-40.06
-8.66	-51.76	-40.89
30.95	-40.89	-27.76
37.49	-66.94	-21.19
-24.46	-68.2	-18.14
41.76	-69.2	-23.28
-45.84	-76.07	-21.7
29.9	-75.85	-39.31
-30.94	-86.53	-34.37
33.06	-77.4	-45.91
-22.51	-77.73	-45.24
26.62	-61.32	-43.84
-25.74	-68.15	-44.9
-18.27	-59.47	-43.48
-13.88	-67.05	-31.74
-6.41	-80.29	-38.52

// Hui K K S, 2005: Normals Who Experienced Deqi and Pain
// Subjects=4
37.12	11.5	-38.91
-36.63	-0.02	-43.79
9.45	67.46	-.91
-4.43	64.21	-.48
3.03	14.61	-23.17
58.23	-55.77	38.97
41.53	-48.54	-45.08
27.67	-20.82	-29.4
2.25	26.41	19.34
2.38	11.32	30.64
-.77	-4.65	30.9
2.49	2.57	41.41
-.72	2.47	40.34
4.65	-43.37	25.17
0.35	-40.31	23.84
49.03	14.35	-16.99
9.61	65.83	19.3
-4.33	65.24	12.82
-3.43	22.86	-26.02
22.48	5.95	0.75
61.21	-22.94	22.8
-61.72	-18.56	21.62
52.88	-41.62	43.42
4.77	8.44	62.08
-2.64	-4.03	66.56
0.16	-65.34	-10.86
-14.51	-64.63	27.17
14.06	-88.32	-20.24
-11.6	-91.9	-22.99
-11.63	-84.5	-23.61
7.47	-77.04	-38.96
12.59	-59.52	-60.56
36.25	-34.77	-31.68
47.02	-48.02	-25.11
37.55	-78.49	-19.11
-42.68	-76.48	-27.27
-33.3	-49.25	-47.51
-30.14	-43.14	-51.4

// Miura N, 2005: Ancient vs. Rest
// Miura N, 2005: Modern vs. Rest
// Miura N, 2005: Ancient vs. Modern
// Miura N, 2005: Modern vs. Ancient
// Subjects=30
-54	-4	44
-44	2	38
-26	-68	46
-20	-100	0
-62	-26	0
-46	0	50
-30	-64	44
-22	-98	0
16	-90	-8
-44	0	30
-54	14	8
4	-78	6

// Mo L, 2005: Living Things vs. Baseline
// Mo L, 2005: Non-Living Things vs. Baseline
// Mo L, 2005: Non-Living - Living Things
// Subjects=8
-46.84	20.2	26
-44.9	40.16	8.69
-27.21	-68.97	41.06
-21.15	-89.07	-13.08
2.6	4.74	55.73
23.75	-89.69	-11.32
-45.51	2.08	53.16
-41.34	-2.26	37.86
1.51	6.77	54.45
-46.83	20.28	27.11
-46	39.81	4.27
-50.28	25.44	-2.28
-26.15	-69.05	39.94
-25.44	-86.98	-13.21
23.76	-91.81	-11.14
-9.38	-99.75	-14.55
2.01	52.44	-1.8

// Anand A, 2005: Depressed Patients
// Subjects=15
-29.44	-5.84	-23.68
33.21	-3.49	-24.98
-22.61	-8.64	3.38
27.18	3.11	11.45
-13.99	-8.82	1.01
16.26	-9.77	0.59
-46.04	-9.52	29.64
51.09	14.11	24.52
-7.2	54.82	38.3
16.59	53.94	39.1
-39.99	16.83	1.15
48.46	23.75	-10
-9.38	27.29	30.97
10.14	-6.03	29.46

// Anand A, 2005: Healthy Subjects
// Subjects=15
-25.14	-8.16	-25.76
28.95	-7.45	-21.15
-20.41	1.46	7.94
27.12	3.76	6.91
-9.69	-13.37	-1.98
11.91	-13.29	-2.35
-46.18	17.92	24.68
55.33	22.33	20.28
-5.26	64.11	22.78
5.55	64.15	22.59
-46.26	-8.96	12.78
50.93	-4.57	8.45
11.96	43.99	13.27
-.45	-25.24	42.74
16.77	8.21	43.62

// Harvey P O, 2005: Depressed Patients
// Subjects=10
42	-51	48
-36	-51	36
-6	24	39
-45	18	27
51	15	24
-36	48	15
33	6	48
39	45	21
-45	12	33
-36	42	12
-3	24	39

// Harvey P O, 2005: Healthy Subjects
// Subjects=10
-33	-45	42
-12	-69	48
15	-60	42
51	-30	36
42	-63	36
9	39	33
-45	18	21
-39	45	6
39	45	9
48	39	24
-45	12	33
-36	42	12
-3	24	39

// Tremblay L K, 2005: Interaction Between Mood and Drug, Depressed Patients 
// vs. Healthy Subjects, Decreases
// Tremblay L K, 2005: Interaction Between Mood and Drug, Depressed Patients 
// vs. Healthy Subjects, Increases
// Tremblay L K, 2005: Mood, Healthy Subjects > Depressed Patients
// Tremblay L K, 2005: Mood, Depressed Patients > Healthy Subjects
// Tremblay L K, 2005: Predrug > Postdrug
// Tremblay L K, 2005: Postdrug > Predrug
// Subjects=12
45.84	55.08	0.82
-12.87	14.75	-6.27
13.85	13.85	-6.5
18.1	13.62	-9.88
-22.68	42.38	-19.63
5.98	-19.76	68.89
-52.56	12.97	-25.74
38.32	4.17	-23.82
-8.7	71.93	3.38
-2.08	43.39	19.08
29.72	36.52	-17.51
27.6	34.48	-16.2
-33.75	-8.76	49.47
21.29	17.87	-10.27
-29.93	8.47	-3.32
-5.33	5.53	-2.24
15.99	4	-10.16
-33.21	14.28	-10.46
17.99	2.64	-27.92
4.25	-2.5	-10.6
-5.09	-86.43	-7.91
33.31	49.28	37.14
57.67	30.74	1.61
7.92	-31.66	38.64
14.56	-45.77	62.05
-9.25	19.13	50.19
-16.74	-15.15	34.2
-10.8	25.08	-10.51
12.71	17.56	-13.49
14.85	14.31	-14.36
9.58	21.57	-2.64
20.2	17.69	-12.47

// Vitali P, 2005: Tools vs. Rest
// Vitali P, 2005: Animals vs. Rest
// Vitali P, 2005: Tools > Animals
// Subjects=10
-28	2	52
-54	4	36
-44	32	12
-52	16	32
-38	18	28
-30	46	4
-30	24	-4
-48	28	16
-48	16	-8
-52	12	12
-32	8	12
-30	-46	44
-44	-54	0
-46	-56	-12
-42	-64	-8
-36	-68	-4
-24	-76	36
-8	18	44
-16	-18	-12
-16	-12	4
-12	20	16
28	-8	32
18	0	52
40	36	16
40	24	-12
30	20	8
14	30	24
0	16	4
-40	-6	32
-28	0	48
-12	22	44
-40	20	28
-30	22	-4
-40	36	0
-40	6	24
-38	-66	-8
-24	-48	-16
-28	-80	24
-28	-58	32
-32	-78	0
-22	-76	44
-26	-42	44
-6	10	36
-6	-24	4
-16	-6	20
36	44	24
40	36	16
42	30	-8
30	20	-8
26	-54	8
24	-52	4
12	22	28
22	-20	16
22	14	8
24	10	4
-34	4	40
-4	26	56
-10	30	48
-46	34	-4
-52	26	12
-40	-60	44
-50	0	8
-40	-62	0
-48	-56	-12
-36	-78	40
-22	-76	40
30	-6	32
10	30	48
50	34	-12
40	36	-8
30	-54	28
38	-52	8
22	-40	32
28	36	12
26	-26	28
26	-30	-8

// Floyer-Lea A, 2005: Normals, Short-Term Learning Group
// Subjects=15
42	18	44
-28	-44	70
-38	-22	58
34	-28	60
2	4	32
-34	-80	-34
28	-56	-34
26	2	6
14	-18	6
-34	-10	66
-42	-30	64
-16	-64	62

// Floyer-Lea A, 2005: Normals, Long-Term Learning Group
// Subjects=7
-20	-16	72
-32	-30	62
28	-10	16

// Kitada R, 2005: No-Estimation vs. Baseline
// Kitada R, 2005: Estimation vs. No-Estimation
// Kitada R, 2005: Negatively Graded Activity during Estimation within areas 
// activated by No-Estimation vs. Baseline
// Kitada R, 2005: More NGA in Estimation than No-Estimation within areas 
// activated by No-Estimation vs. Baseline
// Kitada R, 2005: NGA during Estimation within the areas activated by 
// Estimation vs. No-Estimation
// Kitada R, 2005: More NGA in Estimation than No-Estimation within areas 
// activated by Estimation vs. No-Estimation
// Subjects=14
-60	-22	44
-58	-20	18
58	-22	18
-58	10	-2
50	14	10
-34	52	20
36	54	10
-30	52	-14
44	48	-8
-2	-2	64
2	10	56
-46	-12	58
58	6	40
-44	-44	62
60	-32	50
-6	-76	52
16	-74	38
-20	2	0
18	0	20
-42	-72	-28
20	-72	-22
-64	-16	12
-32	20	-2
30	24	4
-44	28	28
44	34	22
36	58	-4
-4	18	46
6	24	44
-46	6	28
60	18	26
-44	-42	40
38	-66	52
10	-80	-48
-36	-10	10
58	-6	6
-34	-10	10
64	-6	4
50	36	12
52	38	12

// Mendrek A, 2005: Schizophrenia Patients
// Subjects=12
-44	24	24
40	32	28
28	0	52
-32	4	52
44	-44	44
-24	-68	40
28	-60	40
-52	-44	52
-68	-40	0
28	-68	-36
-36	-64	-36
-16	0	12
8	0	12
-4	48	-12
-8	-56	4
40	-28	8
-40	-28	16
-48	-36	60
-24	-76	-20
-4	-4	72
12	36	-8
32	-68	-28

// Mendrek A, 2005: Normal Subjects
// Subjects=12
-44	-4	36
44	28	24
32	-4	60
-40	48	20
40	-56	48
36	-68	40
-32	-72	44
-40	-52	44
-36	-60	-40
40	-64	-36
4	-16	12
-8	-20	12
-12	48	-12
-8	-48	20
-4	32	-4
52	-16	8
44	12	-40
-32	-36	-20
-48	-36	60
-24	-76	-20
-4	-4	72
12	36	-8
32	-68	-28

// Poldrack R A, 2005: Single-Task SRT vs. Rest, Pre-Training
// Poldrack R A, 2005: Single-Task SRT vs. Rest, Post-Training
// Poldrack R A, 2005: Dual-Task SRT vs. Single-Task SRT, Pre-Training
// Poldrack R A, 2005: Dual-Task SRT vs. Single-Task SRT, Post-Training
// Poldrack R A, 2005: Dual-Task SRT vs. Single-Task SRT, Pre-Training vs. 
// Post-Training
// Subjects=13
18	-54	15
-42	-81	0
-27	-48	48
-12	6	9
24	-54	-18
39	-42	36
60	3	15
-36	-27	51
-48	-30	42
0	-3	54
18	-48	-18
-12	-6	9
39	-45	51
60	-30	6
66	-30	12
-36	0	27
6	-36	-12
3	-78	-27
-42	-51	6
27	-84	6
-54	-33	12
63	-30	12
-42	9	30
33	-81	12
-27	-78	12
36	30	42
30	-78	45
-18	-75	51
6	-66	51

// Puttemans V, 2005: Exclusive Learning-Related Decreases (PRE > MID)
// Puttemans V, 2005: Exclusive Automatization-Related Decreases (MID > POST)
// Puttemans V, 2005: Learning- and Automatization-Related Decreases (PRE > 
// MID)
// Puttemans V, 2005: Learning- and Automatization-Related Decreases (MID > 
// POST)
// Puttemans V, 2005: Temporary Increased Activation (MID > PRE)
// Puttemans V, 2005: Temporary Increased Activation (MID > POST)
// Puttemans V, 2005: Sustained Increased Activation (MID > PRE)
// Subjects=11
48	40	4
-44	42	8
54	8	22
60	-40	40
0	-10	70
0	8	50
-48	16	-4
38	20	4
0	8	50
-48	16	-4
20	-32	76
-14	-32	76
28	-86	34
-10	-86	38
2	-24	44
-4	-22	46
20	-32	76
-14	-32	76
28	-86	34
-10	-86	38
2	-24	44
-4	-22	46
30	-2	-8
-28	-14	2
22	-24	-30
24	-42	-24

// Van Boven R W, 2005: Normals, Group 1 (Right Hand Test)
// Subjects=10
-39	-38.66	48.69
47.53	-34	46.19
0.37	16.99	49.15
-42.49	5.68	30.52
-38.96	-20.63	61.68
17.16	-59.66	-21.57
-50.89	-36.76	33.06
64.53	-29.38	35.57

// Van Boven R W, 2005: Normals, Group 1 (Left Hand Test)
// Subjects=10
-42.21	-38.68	48.73
53.96	-35.99	47.4
-.62	-.91	51.78
-38.19	2.62	31.84
49.74	-18.95	61.63
-18.1	-53.27	-18.35
-58.37	-33.54	33.99
65.64	-34.49	38.22

// Zhang M, 2005: Normals, Group 1
// Subjects=20
-52.89	-36.54	49.79
-62.86	-20.39	11.75
52.92	-35.65	51.84
-36.85	-0.01	66.61
-56.28	4.42	43.05
4.72	15.59	58.14
-63	11.07	5.76
65.2	14.76	0.64
65.33	19.47	20.31
52.23	19.74	-16.36
23.53	-64.45	-29.04

// Zhang M, 2005: Normals, Group 2
// Subjects=22
-21.95	-9.32	54.96
29.32	-7.07	51.95
-40.3	0.74	35.36
46.24	1.01	31
38.94	-29.02	42.53
-29.36	-40.55	50.97
-14.42	-70.29	36.56
44.41	-60.54	47.34

// Bedwell J S, 2005: Brain regions significantly active during encoding 
// period
// Bedwell J S, 2005: Brain regions significantly active during maintenance 
// period
// Bedwell J S, 2005: Brain regions significantly active during retrieval 
// period
// Subjects=14
34.01	-91.63	19.59
-29.05	-69.68	-6.16
33.7	-75.32	-1.07
-35.72	48.2	3.58
-31.53	42.82	-8.29
-21.8	-70.43	54.3
34.38	-57.15	55.39
-57.88	9.35	36.94
25.49	12.16	50.93
36.29	21.97	52.01
13.87	-23.56	-20.42
-2.91	33.79	31.34
16.62	23.54	35.38
-11.61	-10.44	17.94
11.77	5.33	-9.8
-16.27	7.78	-5.08
20.36	8.24	-13.59
12.04	-91.11	-8.1
-33.42	-83.18	-12.59
-13.77	-95.8	0.64
-46.14	-84.65	6.82
8.41	-87.1	46.47
-46.48	55.07	8.69
-58.17	24.7	17.49
55.27	36.05	17.8
-42.39	38.01	-13.23
-17.41	-62.24	61.26
-34.97	-33.77	45.29
-11.34	23.31	45.97
23.33	1.2	48.69
-20.03	38.27	45.76
-46.31	-65.17	-2.95
50.88	-57.49	-6.49
-20.85	-6.22	-28.27
18.13	-3.23	-21.38
-27	-27.77	-5.86
12.39	-7.53	36.29
-2.85	29.85	35.09
11.78	20.74	-5.72
-16.14	17.53	7.4
-20.62	19.57	-5.05
29.15	-67.21	-17.48
-39.89	-78.74	-10.68
41.87	56.8	-12.04
-50.55	17.49	20.32
37.64	21.38	-11.82
-33.71	25.17	-13.23
-5.07	40.38	32.97
3.64	38.69	37.47
-30.66	-49.16	41.14
1.18	39.7	13.88
-31.35	-20.34	-6.52
5.38	-13.73	-6.68

// Bristow D, 2005: Voluntary Blinking > Fixation
// Bristow D, 2005: Fixation > Voluntary Blinking
// Bristow D, 2005: (FV - FN) - (BV - BN), Interaction 1
// Bristow D, 2005: (BV - FV) - (BN - FN), Interaction 2
// Bristow D, 2005: Blinking, Visual Stimulation - External Darkenings, Visual 
// Stimulation
// Bristow D, 2005: External Darkenings, Visual Stimulation - Fixation, Visual 
// Stimulation
// Bristow D, 2005: Fixation, Visual Stimulation - External Darkenings, Visual 
// Stimulation
// Subjects=14
9	-66	-21
-9	-69	-21
3	-75	18
-6	-75	9
21	-69	12
-21	-63	0
51	-6	42
-51	-9	45
6	-9	72
-3	-6	63
63	3	15
-60	0	18
66	-30	9
24	3	6
-27	-9	6
30	-93	-3
-33	-87	-15
-45	-72	-9
48	-27	45
-42	-33	63
30	-72	18
-30	-87	12
48	-60	-15
45	-69	-9
-54	-48	-9
42	-27	42
-42	-39	36
33	-72	30
-27	-69	57
6	-75	24
-6	-75	9
9	-66	-21
-9	-66	-21
63	3	12
-60	3	9
45	-12	39
-48	-15	42
0	-6	63
-6	0	45
3	-75	18
-3	-75	12
45	6	0
24	3	3
-27	-9	6
6	-75	24
-21	-63	0
48	-48	33
-51	-60	33
-39	-48	-6
-45	-81	-9
48	-57	-15
33	-72	30
-18	-69	51
45	-27	42
-63	-27	30

// Dalton K M, 2005: Emotional Faces and Neutral Faces, Controls > Autistic 
// Subjects
// Dalton K M, 2005: Emotional Faces and Neutral Faces, Autistic Subjects > 
// Controls
// Dalton K M, 2005: Familiar Faces and Unfamiliar Faces, Controls > Autistic 
// Subjects
// Dalton K M, 2005: Familiar Faces and Unfamiliar Faces, Autistic Subjects > 
// Controls
// Dalton K M, 2005: Group x Familiarity Interaction, Controls > Autistic 
// Subjects
// Subjects=11
35.47	-59.16	-2.86
-40.42	-59.87	-5.27
16.48	-87.51	17.58
-5.99	-94.59	10.62
46.2	11.58	30.12
-24.79	38.22	-18.14
-22.55	-8.97	-23.13
52.49	-55.51	-12.28
-25.39	-67.81	0.8
-33.95	-76.75	-3.93
7.79	-81.36	1.55
23.36	-2.53	-26.43
31.22	-79.87	-8.88
20.56	-81.79	-5.25

// Fiebach C J, 2005: Long vs. Short Object
// Fiebach C J, 2005: Long vs. Short Subject
// Subjects=14
-45.93	24.03	6.71
49.16	24.52	4.46
-48.11	19.19	-.66
-56.42	10.62	26.92
-56.53	-27.81	-2.2
-54.26	-47.29	7.21
49.21	-17.83	-6.48
-17.99	-16.95	10.94
-19.91	-52.06	25.06
21.78	-59.38	22.97
-13.27	-63.97	49.4

// Katzir T, 2005: Blend > Plus-Minus
// Katzir T, 2005: Non-Blend > Plus-Minus
// Katzir T, 2005: Object Identity > Plus-Minus
// Katzir T, 2005: (Blend and Non-Blend) > Object Identity, with reaction time 
// as a covariate
// Subjects=12
-39	-69	-12
-51	15	33
33	-93	-3
33	30	-12
-3	36	45
-6	-21	-6
30	-33	0
-27	-60	42
12	3	0
45	24	27
42	3	27
33	-93	-3
12	18	45
-33	-84	-15
-45	21	24
33	21	0
-30	-60	45
-36	-12	-33
27	-33	-3
21	-6	15
0	-45	-21
-60	-45	-3
51	36	30
-42	-72	-12
21	-99	-3
-36	24	-9
27	-33	-3
42	36	-12
-3	39	45
57	33	18
-30	-27	-12
9	24	51
-57	9	9
0	18	45
-9	-9	12
-30	21	-3
33	27	-12

// Kemeny S, 2005: Syllable Generation vs. Rest, ASSIST
// Kemeny S, 2005: Sentence Construction vs. Rest, ASSIST
// Kemeny S, 2005: Sentence Construction vs. Syllable Generation, ASSIST
// Kemeny S, 2005: Syllable Generation vs. Rest, BOLD
// Kemeny S, 2005: Sentence Construction vs. Rest, BOLD
// Kemeny S, 2005: Sentence Construction vs. Syllable Generation, BOLD
// Subjects=6
50	-12	46
-48	-18	44
40	-30	18
-38	-30	18
66	-14	8
-64	-26	8
42	14	10
-40	14	10
-46	6	30
-48	28	-4
50	-14	46
-48	-18	46
38	-30	16
-38	-30	16
52	-34	6
-62	-38	14
-58	-48	22
-14	-16	10
38	18	-2
-50	16	8
-46	0	44
-48	34	4
-62	-52	22
-6	-18	6
54	9	-21
-51	6	-21
-39	6	-9
-39	33	-12
33	39	-3
-21	48	-9
-54	-3	-12
6	3	66
-42	-42	12
12	-63	-24
-15	-63	-24
51	12	-27
-57	-6	-24
-36	15	-6
-48	27	-12
-21	39	0
-51	0	12
-3	6	66
45	-33	-6
-45	-36	3
12	-63	-24
-15	-63	-21
33	24	-24
-48	21	-18
36	15	-3
-36	15	-3
-48	21	-12
-3	12	63
54	-39	-3
-54	-39	0
27	-81	-30
-6	-51	-36

// Lange G, 2005: CFS Patients - Study 1
// Subjects=6
-56.83	11.37	35.6
-48.57	23.8	7.33
-46.44	17.01	3.49
-32.78	13.53	57.39
-.42	13.23	52.38
-23.99	-68.51	51.91
-36.9	-52.84	59.54
-2.69	18.98	45.13
37.86	37.28	9.01
66.09	9.94	13.48
36.33	0.39	50.79
23.66	-8.42	72.04
27.94	-58.99	59.04
51.41	-32.71	40.36
6.02	8.59	48.25

// Lange G, 2005: Controls - Study 1
// Subjects=7
-45.99	11.62	37.63
-57.1	9.3	13.4
-43.59	6.91	55.98
-4.42	-63.15	62.25
32.17	-57.47	52.1

// Lange G, 2005: CFS Patients - Study 2
// Subjects=19
-50.65	35.36	16.31
-46.13	7.29	25.73
-41.89	39.52	25.83
-52.86	21.87	9.84
-26.3	18.98	57.86
-46.13	7.29	25.73
-26.43	10.39	46.38
-22.15	31.99	47.53
-21.83	-57.56	54.15
-32.66	-57.8	52.12
-21.83	-57.56	54.15
-.64	28.04	38.59
46.52	48.36	12.25
51.09	29.42	27.49
37.96	53.32	19.75
46.52	48.36	12.25
27.69	18.96	54.7
51.09	29.42	27.49
3.79	29.95	47.29
27.69	18.96	54.7
32.14	-53.32	50.57
38.61	-55.63	48.45
32.14	-53.32	50.57
5.86	24.88	38.8
9.85	39.93	15.95

// Lange G, 2005: Controls - Study 2
// Subjects=18
-48.22	11.09	32.12
-26.43	10.39	46.38
-.47	21.64	50.43
51.14	23.24	30.34
36.27	13.05	48.41
10.64	-59.16	58.24

// Bestmann S, 2005: Activity evoked by suprathreshold rTMS over the left PMd
// Bestmann S, 2005: Conjunction Analysis Finger Tapping Suprathreshold rTMS
// Bestmann S, 2005: Activity evoked by subthreshold rTMS over the left PMd
// Bestmann S, 2005: Differences in Activity between Supra- and Subthreshold 
// rTMS over left PMd
// Subjects=9
-40	-11	54
-49	2	17
-45	-25	15
-50	-52	3
-14	-17	8
-11	-4	18
-27	-11	3
-6	-59	-20
-3	-20	-2
3	-5	55
3	4	44
43	-3	49
42	7	26
54	0	13
50	-22	15
12	-14	8
12	0	14
6	-25	-6
5	55	-15
-50	0	12
-45	-27	16
-50	-53	3
-12	-17	5
-26	-11	3
-5	-19	-3
2	-5	53
3	5	44
53	1	14
53	-22	15
13	-2	15
5	-55	-15
-52	-3	15
-47	-23	14
-48	-53	4
-19	-15	4
-1	-6	52
3	6	43
53	-1	11
49	-26	16
12	-16	9
-37	-10	53
-51	5	12
-50	-51	3
-10	-5	19
-48	-24	16
3	-5	55
2	5	47
43	-8	52
41	7	26
13	0	15
51	-20	14
5	-55	-14

// Baciu M, 2005: Rhyme vs. Visual Detection
// Baciu M, 2005: Word Fluency vs. Fixation
// Subjects=10
-48	-59	-7
-48	-47	-12
-42	31	2
-51	13	21
-24	-60	36
-24	-58	44
-50	-33	20
-44	45	16
-36	-71	32
-51	6	37
-51	9	18
-48	24	17
-48	-52	-4
-35	-78	-3
-24	-64	33
-20	-72	44
-16	-85	12

// Fu C H Y, 2005: Schizophrenic Patients with Acute Psychosis
// Subjects=9
-39.4	13.21	17.58
-24.38	24.9	29.81
10.86	31.46	28.86
-31	9.52	-3.39
-30.95	-8.63	-4.1
-29.77	-21.77	4.79
25.56	-10.63	-21.31
40.83	-56.84	-.89
-.78	-81.58	-.56
21.32	19.35	-4.82
14.01	10.02	12.77
13.89	59.34	17.56
9.78	51.17	36.14
60.29	-4.94	49.18
18.21	25.82	10.29
-7.07	-36.49	32.53
-19.93	-44.57	25.55
-23.04	-40.39	38.62
18.25	-24.36	-5.58
-12.96	31.41	-11.01
18.11	9.39	-9.52
13.92	23.42	7.19
-5.28	13.79	8.22
12.95	6.84	13.05
-11.62	3.52	13.61
3.47	-56.63	5.1
-27.54	11.14	31
-37.26	41.83	29.65
43.94	14.68	15.39
48.07	17.65	-1.64
-36.34	15.03	-.45
29.9	28.46	2.12
-27.71	19.28	12.48
-62.73	-30.11	23.71
-50.74	-34.16	52.91
27.85	9.59	5.96

// Fu C H Y, 2005: Schizophrenic Patients in Remission
// Subjects=10
-39.4	13.21	17.58
-24.38	24.9	29.81
10.86	31.46	28.86
-11.43	14.21	41.71
-21.06	-49.67	14.84
53.55	26.8	19.83
56.8	25.05	24.4
52.42	23.99	11.16
-28.72	14.33	17.36
54.47	20.86	-1.98
-36.15	-2.8	16.66
-67.06	-59.26	5.02
-59.32	-31.21	50.53
15.12	-33.47	0.8
12.88	6.15	4.19
-6.34	2.87	4.69
-9.46	0.45	14.96
13.16	-76.67	6.67
-27.54	11.14	31
-37.26	41.83	29.65
43.94	14.68	15.39
48.07	17.65	-1.64
-36.34	15.03	-.45
29.9	28.46	2.12
-27.71	19.28	12.48
-62.73	-30.11	23.71
-50.74	-34.16	52.91
27.85	9.59	5.96

// Fu C H Y, 2005: Normal Subjects
// Subjects=11
-39.4	13.21	17.58
-24.38	24.9	29.81
10.86	31.46	28.86
-7.24	27.72	37.18
18.21	25.82	10.29
-7.07	-36.49	32.53
-19.93	-44.57	25.55
-23.04	-40.39	38.62
18.25	-24.36	-5.58
-12.96	31.41	-11.01
18.11	9.39	-9.52
13.92	23.42	7.19
-5.28	13.79	8.22
12.95	6.84	13.05
-11.62	3.52	13.61
3.47	-56.63	5.1
-11.43	14.21	41.71
-21.06	-49.67	14.84
53.55	26.8	19.83
56.8	25.05	24.4
52.42	23.99	11.16
-28.72	14.33	17.36
54.47	20.86	-1.98
-36.15	-2.8	16.66
-67.06	-59.26	5.02
-59.32	-31.21	50.53
15.12	-33.47	0.8
12.88	6.15	4.19
-6.34	2.87	4.69
-9.46	0.45	14.96
13.16	-76.67	6.67

// Reiss J P, 2005: Implicit Learners
// Subjects=8
-18.23	3.54	-13.08
-22.49	8.09	-8.95
-22.56	16.2	-14.09
24.53	8.37	-9.51

// Reiss J P, 2005: Implicit Non-Learners
// Subjects=7
-22.49	8.09	-8.95

// Grandjean D, 2005: Angry/Neutral + Neutral/Angry vs. Neutral/Neutral
// Grandjean D, 2005: Angry Speech vs. Neutral Speech
// Subjects=15
63	-30	6
-60	-24	0
27	-87	24
-33	-72	36
-54	24	21
-45	-15	-6
60	-15	0
18	45	6
6	12	21
-60	12	0
-51	-30	12
42	6	-18
63	-24	39
-27	42	27
-21	12	6

// Meyer M E, 2005: Laughter > Speech
// Meyer M E, 2005: Speech > Laughter
// Meyer M E, 2005: Laughter > Sounds
// Meyer M E, 2005: Sounds > Laughter
// Meyer M E, 2005: Laughter vs. Sounds and Speech vs. Sounds
// Subjects=12
-48.95	-24.54	11.93
31.45	-11.54	48.95
53.61	8.74	20.23
51.45	-11.25	9.67
60.2	-35.55	24.99
-44.72	21.18	24.78
-41.7	22.57	1.21
-61.87	-12.44	4.38
-48.81	-64.81	14.2
53.55	-21.52	0.47
56.78	-14.65	6.55
44.07	-36.67	11.88
40.8	-60.44	-6.16
-45.61	-33.01	25.99
-45.82	-63.76	-13.81
-28.99	34.57	-9.98
40.97	-32.23	28.28
-58.67	-4.76	7.04
-45.68	-75.5	-.56
-36.09	-82.3	-6.79
44.03	-32.7	8.21
63.12	-1.12	1.99
31.13	-53.35	-9.99

// Wildgruber D, 2005: Emotion Identification vs. Rest
// Wildgruber D, 2005: Vowel Identification vs. Rest
// Wildgruber D, 2005: Emotion Identification vs. Vowel Identification
// Wildgruber D, 2005: Vowel Identification vs. Emotion Identification
// Subjects=10
3	9	57
-48	9	30
51	33	15
-45	30	-12
48	36	-18
-45	-9	18
45	3	24
39	-51	48
-60	-45	9
48	-45	6
-36	-3	-15
45	15	-30
-6	-27	-3
6	-21	0
-30	-60	-27
42	-63	-33
-6	-72	-30
3	9	51
-54	6	30
42	0	33
-57	0	21
57	3	18
-21	-63	48
27	-54	57
-60	-30	9
51	-42	6
-39	-9	-18
54	3	-15
-6	-24	-3
9	-21	6
-33	-54	-33
48	-66	-33
-3	-72	-24
48	33	-15
48	-42	3
-54	6	33
-48	-39	54
27	-66	39

// Aron A, 2005: Picture of Beloved - Neutral Picture
// Aron A, 2005: Passionate Love Scale Correlation
// Aron A, 2005: Correlation with a Longer Relationship
// Aron A, 2005: Correlation with a Shorter Relationship
// Subjects=17
-16	1	22
12	11	14
18	-18	22
14	-4	22
30	-52	4
2	-15	-9
8	6	14
0	-1	17
-40	52	1
-51	-60	3
-28	-2	-7
42	-2	2
4	36	28
9	-50	15
18	-65	18
12	-70	40
-22	-38	9

// Strangman G, 2005: Implicit Learning, Increases
// Strangman G, 2005: Implicit Learning, Decreases
// Strangman G, 2005: Verbalizable Rule Learning, Increases
// Strangman G, 2005: Verbalizable Rule Learning, Decreases
// Strangman G, 2005: Implicit Learning vs. Verbalizable Rule Learning
// Strangman G, 2005: Verbalizable Rule Learning vs. Implicit Learning
// Subjects=9
-52.36	21.62	3.64
22.05	-77.5	50.13
4.79	-72.63	32.08
8.09	-84.79	39.75
68.41	-11.46	-8.35
14.91	14.91	-6.6
-19.3	-2.98	-14.75
-39.41	-70.32	-16.68
24.71	-69.94	-17.44
-35.26	-44.12	-22.27
42.52	40.74	-19.12
-35.49	46.88	-15.4
27.94	47.85	32.86
-25.39	34.3	41.3
-58.29	-28.29	46.93
-15.61	-104.5	7.11
-61.99	-16.98	-13.08
-15.79	-41.6	8.52
7.52	11.41	3.81
1.2	-76.68	-19.95
44.67	30.98	-21.68
-39.7	8.99	-23.32
14.67	59.61	-20.39
18.01	64.34	-.75
68.6	-17.23	13.32
-61.86	-1.35	10.14
68.6	-17.23	13.32
51.9	-60.41	48.36
-31.82	-88.97	-10.74
1.33	-75.31	-2.23
68.69	-47.1	12.48
-39.7	8.99	-23.32
54.33	-3.65	-30.03
-52.25	-56.31	-13.24
37.52	-58.94	-14.05
18.05	-9.96	-25.74
21.21	64.36	-.79
-22.62	63.84	-3.59
-35.45	13.24	-23.73
24.71	-69.94	-17.44
28.2	19.79	55.29
-5	32.02	51.29

// Fitzgerald K D, 2005: OCD Patients
// Subjects=8
-3	36	-6
3	24	-9
9	30	-9
-3	18	48
-21	6	57
-15	3	63
51	3	39
48	21	39
57	15	30
48	21	-21
57	18	-15
36	20	-21
-27	27	-6
-45	12	46
-51	24	-6
60	-45	-6
51	-54	3
-3	30	-6
3	9	48
-15	9	12
12	12	9
-3	15	12
12	18	9
-6	0	12
9	0	12
12	12	6
3	-3	15

// Fitzgerald K D, 2005: Normals
// Subjects=7
-3	18	33
9	33	36
9	12	45
6	9	48
15	3	69
-6	0	66
6	0	66
48	18	30
45	27	33
48	9	-24
36	15	-12
36	-9	-18
-42	24	-9
-3	30	-6
3	9	48
0	0	54
-6	-3	57
-6	0	12
9	0	12
12	12	6
3	-3	15

// Knutson B, 2005: Main Effect of Valence (Activations)
// Knutson B, 2005: Main Effect of Valence (Deactivations)
// Knutson B, 2005: Main Effect of Magnitude (Activations)
// Knutson B, 2005: Main Effect of Magnitude (Deactivations)
// Knutson B, 2005: Main Effect of Probability (Activations)
// Knutson B, 2005: Main Effect of Probability (Deactivations)
// Knutson B, 2005: Interaction of Valence by Magnitude
// Knutson B, 2005: Interaction of Valence by Magnitude and Probability
// Subjects=14
1.48	-3.44	46.39
-10.74	12.56	-7.23
12.77	12.7	-7.51
41.98	28.61	44.35
-22.68	43.44	-19.72
24.34	43.81	-19.17
-39.67	56.6	0.56
40.49	58.3	1.73
1.27	27.34	31.54
1.46	5.11	46.79
-31.05	21.15	-4.37
33.13	22.14	2.62
-10.72	12.73	-5.01
12.79	12.87	-5.29
-6.4	8.87	-.28
8.56	8.96	-.46
1.27	-12.26	14.79
1.07	-18.72	-13.66
-.26	48.86	-20.43
5.06	56.38	-20.01
-3.45	55.61	-15.38
5.06	55.32	-19.92
-22.47	-12.52	-13.91
2.54	-47.52	26.65
1.34	28.03	40.4
-.6	-7.25	52.31
-31.02	20.35	-.96
-10.67	9.99	0.79
17.1	14.38	0.11
21.32	9.41	-9.56
-43.98	49.63	-6.61
-3.41	51.64	-11.7
5.17	48.78	-8.22
-3.21	42.69	10.23
2.35	27.44	32.64
-2.85	4.74	42.41
-14.99	12.7	-4.96
15.98	16.06	-5.6
-11.55	-4.6	18.75
8.75	-4.48	18.51
-19.26	11.62	-4.82
18.12	16.07	-5.62
1.27	-13.32	14.88
-3.15	51.04	21.8
2.2	47.9	22
17.3	3.23	21.11

// Nakao T, 2005: OCD Patients
// Subjects=24
50	18	-6
42	48	18
46	12	26
44	38	22
-46	8	32
-42	26	18
-48	14	22
-6	18	44
-4	14	52
6	22	38
34	18	0
-10	-8	12
-12	-16	4
-14	-14	16
26	-60	42
34	-52	42
54	-40	44
-26	-66	44
-44	-38	44
-30	-82	20
36	-60	-26
28	-74	-24
-40	-60	-22
32	-10	56
8	28	30
-2	30	38
-8	28	32
12	-2	12
32	6	-40
-26	2	-28
4	-14	-14

// Nakao T, 2005: Normals
// Subjects=14
42	14	-8
34	20	-2
36	20	-10
52	14	34
44	16	28
42	6	52
36	56	14
38	42	30
-50	12	32
-44	28	16
-44	10	24
-2	26	40
-6	20	46
6	28	32
16	0	14
-16	-2	12
-8	-20	6
32	-64	50
34	-50	40
-26	-62	54
-20	-70	52
-34	-54	54
-34	-88	8
-28	-80	22
38	-54	-20
34	-68	-30
42	-58	-32
32	-10	56
8	28	30
-2	30	38
-8	28	32
12	-2	12
32	6	-40
-26	2	-28
4	-14	-14

// Schienle A, 2005: OCD-Relevant > Neutral, OCD Patients
// Schienle A, 2005: OCD-Relevant > Disgust, OCD Patients
// Schienle A, 2005: OCD-Relevant > Fear, OCD Patients
// Schienle A, 2005: Digust > Neutral, OCD Patients
// Schienle A, 2005: Fear > Neutral, OCD Patients
// Schienle A, 2005: OCD-Relevant > Neutral, OCD Patients > Normals
// Schienle A, 2005: Disgust > Neutral, OCD Patients > Normals
// Schienle A, 2005: Fear > Neutral, OCD Patients > Normals
// Schienle A, 2005: OCD-Relevant > Neutral, Unmedicated > Medicated OCD 
// Patients
// Subjects=5
-45	24	-21
-45	27	-21
48	21	-12
-21	3	48
15	66	27
42	15	-12
-30	18	-21
54	-33	48
-36	-69	39
30	-69	48
-9	6	3
-12	-6	3
3	-27	3
18	-66	51
-15	57	15
51	-33	48
-45	-66	51
45	-69	48
-15	8	12
-27	-63	54
21	-69	51
30	12	63
51	-33	45
-39	-69	45
30	-69	48
-15	9	12
-6	-9	12
21	-102	-3
30	-99	-3
-27	-102	-6
-39	36	-18
-33	-27	18
39	-3	3
-63	-24	27
27	-63	45
57	-69	6
42	-81	-3
-36	30	-9
-30	51	-12
48	24	-12
-27	6	66
54	-33	57
-18	24	0
18	-30	12
-39	18	-12
-51	-36	24
66	-27	18
-36	-27	21
39	-18	9
36	12	3
-18	9	24

// Viard A, 2005: OCD Patients
// Subjects=12
-28	60	4
-64	-40	16
8	-48	64
-28	-44	56
12	-84	28
28	24	-12
-48	-52	32
-16	-48	64
24	-56	32
12	-44	32
-8	-44	32
-20	-44	36
-8	-48	12
4	-40	24
20	-32	8
12	-24	4
-16	-32	8
-20	-32	60
-8	-24	56
12	-36	64
8	-32	60
12	-24	56
12	64	-4
-16	60	20
-52	28	4

// Viard A, 2005: Normals
// Subjects=15
-28	60	4
-64	-40	16
8	-48	64
-28	-44	56
12	-84	28
28	24	-12
-48	-52	32
-16	-48	64
24	-56	32

// Kuhtz-Buschbeck J P, 2005: Urge to Void vs. Withholding
// Kuhtz-Buschbeck J P, 2005: Contraction vs. Rest
// Subjects=22
-15	-3	66
0	3	51
0	-12	60
60	-42	48
63	-45	39
-54	9	0
-42	3	-6
-51	12	-6
63	9	12
42	15	-9
60	15	-3
-42	48	-6
-30	-72	-27
-3	-18	0
18	-24	9
3	-18	-30
3	-27	-12
6	-18	57
-6	-6	42
57	-39	21
45	9	-9
-9	-9	75
-12	-12	9

// van den Huevel O A, 2005: OCD Patients
// Subjects=22
-44	38	30
48	38	30
10	24	42
-24	12	52
24	6	54
-2	-56	54
8	-58	52
-30	-48	46
38	-42	44
-32	22	-4
-38	-78	32
32	42	14
24	-14	54
-14	20	34
-10	-64	22
10	-78	44
-52	-28	32
8	16	6
-26	16	-6
-36	52	8
38	54	8
-44	32	34
-42	32	28
38	40	34
-30	36	46
30	24	46
58	16	6
-6	34	28
6	34	24
-6	28	36
6	20	44
26	-2	50
-34	16	56
28	4	52
-24	16	50
-2	-62	52
2	-54	52
-50	-42	40
56	-40	40
-32	20	-4
34	20	-6
-16	-6	4
-26	-24	-22
-14	-4	-4
-8	-22	-26
-40	-72	38
-32	40	4
-2	18	32
9	26	26
-50	24	-10
-46	24	0
50	24	-2
58	20	8
-44	0	-32
-24	-24	-24
24	-18	-26
-4	-26	-20

// van den Huevel O A, 2005: Normals
// Subjects=22
-40	30	28
48	34	34
-20	-6	50
24	-12	52
-22	10	58
22	16	50
-22	20	48
8	24	48
-6	-54	48
-12	-62	22
10	-58	48
-26	-44	48
52	-40	46
-28	18	-2
28	26	0
12	12	0
-10	8	-2
-42	-76	30
38	-78	32
32	42	14
24	-14	54
-14	20	34
-10	-64	22
10	-78	44
-52	-28	32
8	16	6
-26	16	-6
-24	52	2
38	50	-4
34	62	4
32	52	6
-44	38	24
-30	42	4
44	32	32
-40	28	44
28	24	50
-10	22	34
6	22	40
18	-10	58
-22	6	58
26	8	50
-10	-54	48
8	-60	52
50	-42	54
-32	20	-4
34	22	-4
-18	4	16
-42	-70	36
-32	40	4
-2	18	32
9	26	26
-50	24	-10
-46	24	0
50	24	-2
58	20	8
-44	0	-32
-24	-24	-24
24	-18	-26
-4	-26	-20

// Phan K L, 2005: Suppress vs. Fixation
// Phan K L, 2005: Maintain vs. Fixation
// Phan K L, 2005: Conjunction Analysis (Maintain > Fixation) + (Suppress > 
// Fixation)
// Phan K L, 2005: Suppress > Maintain
// Phan K L, 2005: Maintain > Suppress
// Phan K L, 2005: Negative correlation with intensity of negative emotion
// Phan K L, 2005: Positive correlation with intensity of negative emotion
// Subjects=14
8	-84	-6
2	14	54
-14	62	32
42	34	2
-42	28	-6
38	28	0
-32	-4	-24
26	2	-24
42	28	-16
-40	54	16
-8	18	40
-10	52	18
12	58	2
10	-84	-2
8	62	34
54	38	8
38	26	6
-36	20	2
-28	0	-28
16	0	-28
2	6	-6
-48	20	28
-8	-2	-2
-38	54	20
8	64	8
-6	-90	-16
50	22	-12
52	44	14
8	64	30
-18	-4	-20
12	42	54
6	28	52
40	22	44
52	32	-10
52	30	-8
56	24	4
34	54	12
-8	20	44
6	36	36
0	12	-2
-42	20	28
-14	-6	-8
8	28	34
48	12	-10
-44	18	42
54	20	38
-43	50	10
36	52	12
48	-76	4
-40	34	42
42	28	14
-26	6	-26

// Tham W W P, 2005: English Homophone Matching vs. Fixation
// Tham W W P, 2005: Mandarin Homophone Matching vs. Fixation
// Subjects=6
-48	8	34
-40	28	24
-40	28	24
-30	-62	44
-28	-82	-14
-30	-90	-4
44	8	30
40	32	28
42	-54	44
14	-76	14
26	-88	-4
-44	10	36
-30	40	8
-42	32	38
-4	16	40
-46	-38	32
-44	-62	-14
-42	-84	2
44	4	34
12	10	50
36	38	12
12	18	38
40	-40	28
22	-92	-6
48	-70	-8

// Lee J H, 2005: 2D Smoking Images > 2D Non-Smoking Images
// Lee J H, 2005: 3D Smoking Images > 3D Non-Smoking Images
// Subjects=8
8.75	54.85	42.53
29.71	8.97	-29.7
-22.97	5.45	67.11
0.31	16.39	41.39
-23.76	47.75	-18.95
38.7	33.37	37.3
-38.65	-17.5	-35.61
-34.16	55	20.71
46.85	-5.9	-30.88
4.49	-90.06	-14.41
47.63	-68.09	45.7
-53.25	-16.11	11.28
17.12	66.22	23.64
-40.27	-91.25	1.82

// Xu J, 2005: Significant Load Sensitive Activity
// Subjects=8
-48.34	11.32	23.13
-24.17	7.83	53.32
-.44	8.77	50.58
-27.42	-67.75	37.32
51.4	-59.07	34

// Johnson-Frey S H, 2005: Tool, No Go, Right > Move, No Go, Right
// Johnson-Frey S H, 2005: Tool, Go, Right > Tool, No Go, Right
// Johnson-Frey S H, 2005: Tool, No Go, Left > Move, No Go, Left
// Johnson-Frey S H, 2005: Tool, Go, Left > Tool, No Go, Left
// Johnson-Frey S H, 2005: (Tool, No Go, Right > Move, No Go, Right) + (Tool, 
// No Go, Left > Move, No Go, Left)
// Subjects=13
-50.77	-51.98	-10.9
-39.02	-48.18	63.6
-52.91	19.32	5.61
-52.4	-26.15	35.87
-61.39	-22.19	9.86
-9.18	38.62	48.9
-9.64	-42.5	-3.58
-34.81	-14.36	-22.74
-39.98	-7.2	-3.19
-48.08	-74.28	25.99
-26.17	-4.11	63.5
-39.98	-7.2	-3.19
-11.58	52.16	33.03
-64.86	-9.72	-5.88
-65.34	-24.92	38.21
-50.39	-37.06	22.35
-35.16	-10.03	35.1
-26.29	-24.71	49.85
-50.39	-37.06	22.35
52.85	1.33	-8.98
24.75	-59.03	-21.58
31.15	1.59	-16.48
53.14	-39.22	5.11
42.26	-.45	7.06
59.28	34.84	-6.8
42.79	-5.22	47.87
-37.18	-25.37	43.38
-53.79	-64.53	4.28
69.56	-23.36	24.55
35.91	-46.51	8.37
50.51	-14.27	-26.45
65	-55.75	-.18
56.05	28.35	-7.22
-52.89	-51.68	-7.54
-46.8	36.21	-20.82
-62.5	-33.35	5.38
-11.58	48.86	32.24
-43.43	-48.81	57.01
-44.36	-1.04	-5.97
-61.99	-20.79	47.83
-34.77	-68.34	54.31
-56.24	18.58	-2.11
-24.33	34	46.25
-30.58	-38.65	50.19
67	-29.57	-7.28
46.17	45.77	-15.5
-46.52	41.58	2.18
-41.59	-28.24	35.9
-3.66	-48.45	-44.55
-46.55	-39.62	-16.68
-31.48	58.54	-.88
-67.82	-53.57	7.47
-6.67	-63.78	55.63
-46.71	53.3	-10.18
-53.93	-64.55	-7.37
-33.25	49.43	28.07
-31.26	52.55	15.4
44.11	-11.1	65.24
48.51	41.6	-2.81
-43.43	-47.75	56.91
-32.64	-67.48	51.95
-44.47	38.63	-6.53
-41.39	36.33	-19.8
-31.68	37.32	-21.19
-52.68	11.2	22.1
-9.42	52.16	32.99
-44.47	39.69	-6.64
-54.1	21.78	-2.46
-51.77	-55.72	-4.91
-62.54	-36.95	1.26
-33.4	-29.4	0.01
-42.16	-1.89	-3.68
71.38	-24.78	-2.23
30.34	4.73	5.64

// Amir N, 2005: Disgust - Neutral, Phobics > Normals
// Subjects=11
6	17	25
-8	42	16
12	39	13
-12	-9	23
-4	22	6
-30	-13	14
2	-60	12
38	37	9
-26	-39	-5
10	-32	26
8	-38	15
-42	-12	-4
44	-30	27
2	-58	-2
24	27	6
-20	32	15
-44	39	0
-36	35	4
-42	40	15
44	-61	29
-38	-61	21
28	-73	20
-44	-36	9
-34	-53	27
-12	33	-2
6	30	11
24	26	10
-50	9	24
34	19	-13
38	21	-6
18	43	-4
-34	-81	11
40	-60	7
14	-37	31
-18	-53	28
-18	-65	25
-22	-21	10
-14	-8	2
-22	-21	10
12	-10	0

// Creem-Regehr S H, 2005: Tools > Scrambled Tools, Viewing
// Creem-Regehr S H, 2005: Scrambled Tools > Tools, Viewing
// Creem-Regehr S H, 2005: Shapes > Scrambled Shapes, Viewing
// Creem-Regehr S H, 2005: Scrambled Shapes > Shapes, Viewing
// Creem-Regehr S H, 2005: Tools > Shapes, Viewing
// Creem-Regehr S H, 2005: Tools > Scrambled Tools, Imagined Grasping
// Creem-Regehr S H, 2005: Scrambled Tools > Tools, Imagined Grasping
// Creem-Regehr S H, 2005: Shapes > Scrambled Shapes, Imagined Grasping
// Creem-Regehr S H, 2005: Scrambled Shapes > Shapes, Imagined Grasping
// Creem-Regehr S H, 2005: Tools > Shapes, Imagined Grasping
// Creem-Regehr S H, 2005: Finger Clenching > Rest
// Subjects=12
-44	-50	-18
-34	-44	-22
52	-62	-2
44	-66	-4
38	-42	-22
48	-62	18
-42	-28	56
28	-46	60
-54	0	26
-8	20	48
20	-92	18
-20	-84	-12
-14	-96	10
28	-78	-14
-44	-68	-6
-16	-86	-14
16	-96	12
-28	-78	-16
-36	-48	-22
-42	-74	-6
-40	-34	-18
44	-62	2
44	-38	-18
46	-66	-6
40	-50	12
-40	-52	58
-20	-62	62
-26	-10	60
24	-8	60
-10	2	64
42	-40	64
-52	4	8
12	6	56
-16	10	4
-14	-84	-18
24	-84	24
12	-90	18
-14	-98	12
-10	-88	22
-42	-60	-6
48	-62	-6
-26	-10	62
-14	0	62
26	-10	56
-56	6	30
-44	-48	58
-34	-48	64
-56	-34	40
-46	-2	46
-8	20	42
12	12	44
-6	10	50
22	-94	18
26	-78	-12
-16	-86	-14
-24	-80	-10
-8	-64	36
-18	-96	16
-54	-10	-6
-46	-8	-24
56	-6	-6
-54	-66	20
20	-52	28
-60	-44	4
-42	-68	26
-38	-46	-20
12	-56	-16
-8	-62	-18
-52	-28	46
-36	-30	60
36	-24	64
44	-18	52
-4	-10	54
6	-6	48
-60	-32	24
22	-20	4

// Kozel F A, 2005: Normals, Model Building Group
// Subjects=30
-3	21	48
9	18	42
9	-3	66
36	27	0
48	15	-9
51	24	-6
-9	-3	6
12	0	9
12	3	-3
27	51	33
36	42	21
33	45	33
60	-45	21
66	-48	12
-57	-42	30
-57	-51	39
-30	12	9
-30	21	6

// Kozel F A, 2005: Normals, Model Testing Group
// Subjects=31
3	18	60
15	36	21
15	21	66
45	39	-6
42	24	-9
57	15	12
-45	36	-6
-36	42	-12
-51	21	-3
-57	-51	33
-48	-54	33
60	-54	33
-12	9	6
12	6	9

// Phan K L, 2005: Lie > Truth
// Phan K L, 2005: Lie > Recognition
// Subjects=14
-54	12	4
-48	16	-6
-52	16	16
60	14	-2
66	-44	-4
-58	-56	8
-6	40	50
56	18	36
-36	16	42
-44	-66	14
-44	-26	32
-42	22	-22
60	18	18
-54	-40	2
62	-34	-2
-48	-56	6
-2	20	50
-4	36	50
-40	4	44

// Schienle A, 2005: Spider Phobics
// Subjects=10
-18	102	9
24	3	-27
0	-9	12
-48	24	-9
15	6	69
-24	-78	-18
-27	0	-18
27	0	-21
-48	-63	9
21	0	-27
-54	33	-3
-30	-63	-15
-24	-6	-18
24	-3	-21
-51	-69	12
57	-66	9
-24	-9	-9
-24	-9	-12
21	-3	-18
60	0	3
3	12	66
-15	-105	-3
24	-105	0
-54	-27	27
3	27	33
3	6	66
18	-81	54
15	3	-27
51	-57	18
15	-18	-6
60	-66	3
-30	0	-12
-30	0	-18
27	3	-21
24	-9	69
27	-39	3
-27	-75	-12
42	-48	-21
-27	-6	-15
-27	-6	-15
21	0	-18
39	0	15
-30	-6	-21
-39	-18	-24
9	-54	30
51	-57	45

// Schienle A, 2005: Normals
// Subjects=13
-15	-105	-9
-51	-66	33
54	-57	42
12	-102	0
-18	-3	-21
54	-72	3
48	-45	-24
15	-18	-6
60	-66	3
-30	0	-12
-30	0	-18
27	3	-21
24	-9	69
27	-39	3
-27	-75	-12
42	-48	-21
-27	-6	-15
-27	-6	-15
21	0	-18
39	0	15
-30	-6	-21
-39	-18	-24
9	-54	30
51	-57	45

// Langleben D D, 2005: Lie > Repeat Distracter
// Langleben D D, 2005: Truth > Lie
// Langleben D D, 2005: Lie > Truth
// Subjects=26
34	22	-8
37	19	-11
56	26	17
56	12	3
37	19	-1
51	15	-14
8	34	40
12	31	35
16	18	51
7	21	36
56	-52	36
48	-48	50
59	-45	32
56	-50	17
42	-60	47
-30	14	-14
-26	11	-17
-38	16	3
-34	16	3
-42	-32	42
-37	-34	39
-37	-34	46
-24	-13	52
-26	-13	52
-26	-12	63
-12	-13	49
-4	-2	30
-24	-52	58
-12	-50	54
-12	20	21
63	-22	31
63	-22	27
63	-24	23
30	-50	58
24	-50	54
4	-2	44
4	-2	41
4	-60	-18
7	-63	-20
7	-59	-21
-15	-52	-24
-22	-49	-35
-56	6	26
-53	1	22
-53	-3	22
-26	-7	8
-30	-7	8
-12	-25	12
26	-4	66
30	-8	63
30	-13	56
37	-17	52
60	10	26
63	5	22
42	-7	8
63	1	22
34	-8	4
38	-11	8
-50	20	14
-4	34	44
-38	12	48
-38	34	-12

// Nunez J M, 2005: False > True
// Nunez J M, 2005: Autobiographical > Non-Autobiographical
// Nunez J M, 2005: False, Autobiographical > True, Autobiographical
// Subjects=20
-10	20	41
16	-5	19
-20	-1	26
-57	14	12
-20	11	16
-42	4	43
34	42	20
34	32	24
4	-51	27
22	45	37
57	-51	36
-42	-62	34
-2	12	51
-57	14	12
22	46	20
20	-3	22
50	19	32
52	14	9
-36	0	41

// Hennenlotter A, 2005: Smile Observation - Neutral Observation
// Hennenlotter A, 2005: Smile Execution - Fixation
// Hennenlotter A, 2005: (Smile Observation - Neutral Observation) + (Smile 
// Execution - Fixation)
// Subjects=12
56	8	40
-52	-26	32
-60	-18	24
58	-34	22
-42	-68	4
-34	-96	-2
60	8	6
48	-62	0
44	-74	-6
52	-40	-2
46	-26	-6
-52	26	-8
-38	16	-10
36	34	-12
-42	-52	-20
-24	-8	-22
22	-6	-26
-52	8	-36
-40	14	-36
36	14	-44
2	14	62
-4	4	52
-46	-2	56
-54	0	44
-44	-10	34
-58	6	8
46	-4	54
56	2	48
46	-10	36
62	8	12
68	-28	22
-60	-38	20
-22	0	18
20	-66	10
-10	-70	8
-46	-4	2
-12	-18	-2
10	-24	-2
20	-4	-10
-24	-4	-12
40	10	-12
-10	-60	-28
12	-56	-28
56	8	40
60	-32	18
60	8	6
-40	14	-10

// Holsen L M, 2005: Food > Non-Food, Pre-Meal
// Holsen L M, 2005: Food > Non-Food, Post-Meal
// Holsen L M, 2005: Stimulus x Motivational State Interaction
// Holsen L M, 2005: Non-Food > Food, Pre-Meal
// Holsen L M, 2005: Non-Food > Food, Post-Meal
// Subjects=9
5.11	57.95	-13.45
-1.32	61.08	-13.64
-30.07	35.53	-11.16
-7.55	67.33	12.68
25.31	-63.68	63.43
24.69	-56.9	-14.08
-23.41	-54.02	-13.77
63.12	-10.98	-1.64
27.92	-56.63	-10.79
-29.76	-56.72	-6.78
15.9	-2.4	-24.12
19.16	-11.64	-20.04
3.05	53.25	-5.22
-36.51	35.24	-14.41
27.63	35.88	-11.85
-7.48	63.62	19.68
-39.62	23.04	-6.66
43.66	22.77	-17.63
-39.69	22.27	-16.63
18.09	-12.79	-21.05
2.47	-11.95	32.59
-42.6	-63.65	-12.74
53.43	21.2	2.46
12.27	16.32	66.91
-20.16	51.88	34.19
56.83	-62.54	-7.28
11.72	4.06	-9
-13.29	-29.02	60.97
56.98	5.01	40.58
-3.6	-21.59	73.62
57.2	-32.28	53.74
-48.63	-36.6	48.63
21.43	-47.66	-18.16
37.35	-38.82	-29.12
44.1	-61.59	6.17
40.65	-44.38	-18.66
-39.5	-51.46	-20.49
2.52	24.83	54.04
-17.09	68.05	22.76
37.4	-44.91	-25.27
-39.47	-51.2	-17.16

// Simmons W K, 2005: Foods > Locations
// Simmons W K, 2005: Locations > Foods
// Subjects=9
36	-6	9
-21	33	-18
-18	45	-6
48	-45	-12
48	-66	-9
-48	-60	-18
-21	-39	-12
27	-42	-15

// Castriota-Scanderbeg A, 2005: Sommeliers
// Subjects=7
58	0	6
62	16	14
-34	12	-6
-32	28	-4
46	48	12
-34	40	32
-46	40	2
-28	0	2
-38	6	-6
-28	28	-6
-38	36	14
58	16	26
40	40	24
-28	4	12
44	24	-10
28	58	14
-28	-12	-16
-50	36	0

// Castriota-Scanderbeg A, 2005: Controls
// Subjects=7
52	10	2
58	18	2
44	24	-6
28	64	14
-50	36	6
-22	-8	-18
-38	6	-6
-28	28	-6
-38	36	14
58	16	26
40	40	24
-28	4	12
44	24	-10
28	58	14
-28	-12	-16
-50	36	0

// Goekoop R, 2005: Elderly Males, Placebo
// Subjects=14
42	-84	-8
-8	-88	-4
-14	-86	-10
-40	-56	-18
10	-96	-4
40	-54	-20
24	-30	-26
-32	-28	-6
26	-58	42
36	4	30
-38	42	28
-26	32	-6
16	-18	6
-18	-18	6
34	34	14
-28	-58	40
8	12	44
46	20	42
-30	-58	34
-36	12	42
2	46	44
-44	34	-2
-28	-64	0
46	-60	40
-34	18	4
30	4	56
-52	18	30
10	12	48
-38	-74	-4
44	18	42
-42	36	-4
36	40	-6
40	-58	46
44	18	42
-38	10	44
0	48	42
-42	36	-4

// Goekoop R, 2005: Elderly Males, Raloxifene
// Subjects=14
42	-84	-8
-8	-88	-4
-14	-86	-10
-40	-56	-18
10	-96	-4
40	-54	-20
24	-30	-26
-32	-28	-6
26	-58	42
36	4	30
-38	42	28
-26	32	-6
16	-18	6
-18	-18	6
34	34	14
-28	-58	40
8	12	44
46	20	42
-44	40	6
-30	-58	34
-48	-70	12
-4	44	44
46	20	42
-30	-58	34
-36	12	42
2	46	44
-44	34	-2
-28	-64	0
46	-60	40
30	40	-6
22	-82	-4
36	4	44
42	-42	68
-38	-74	-4
44	18	42
-42	36	-4
36	40	-6
40	-58	46
44	18	42
-38	10	44
0	48	42
-42	36	-4

// Kikuchi S, 2005: Pickled Plums > Red Balls
// Subjects=13
-48	18	-18
54	14	-16
44	10	2
-36	48	-10
36	48	-8
-54	10	22

// Achim A M, 2005: Encoding for Both Items and Associations Relative to 
// Baseline
// Achim A M, 2005: Both Item Recognition and Associative Recognition Relative 
// to Baseline
// Achim A M, 2005: Associative Encoding > Item Encoding
// Achim A M, 2005: Associative Recognition > Item Recognition
// Achim A M, 2005: Item Recognition > Associative Recognition
// Achim A M, 2005: New Item Recognition > Old Item Recognition
// Achim A M, 2005: (Associative > Item at Encoding) + (Associative > Item at 
// Recognition)
// Achim A M, 2005: (Item > Associative at Encoding) + (Item > Associative at 
// Recognition)
// Subjects=18
-38	24	20
-42	-4	12
-28	-6	-6
-30	-12	-28
-30	-14	-26
-12	-18	-20
-10	-20	10
-10	-24	46
-36	-28	56
-18	-30	-2
-28	-64	-14
34	38	36
46	30	26
34	24	4
54	6	30
2	2	52
8	2	4
52	0	42
42	-2	14
26	-2	-22
20	-4	-2
42	-10	-30
34	-14	64
10	-16	10
20	-16	-20
62	-30	26
22	-50	-20
-22	34	-16
-40	22	24
-10	4	0
-2	-4	56
-22	-12	4
-24	-12	-22
-36	-18	-24
-12	-20	10
-28	-20	72
-30	-24	6
-32	-24	-22
-46	-34	46
-32	-48	-20
-32	-52	48
32	62	0
30	58	-12
36	52	12
32	22	2
12	4	2
28	-2	-12
38	-4	60
38	-4	10
22	-28	0
46	-34	48
28	-56	-12
-24	36	52
24	58	-10
26	36	36
30	30	-4
6	8	40
6	2	54
14	-24	44
28	-26	-16
2	-58	42
-44	22	26
-32	-54	48
28	-62	46
-8	56	16
-22	12	32
-28	-10	-22
16	48	24
4	44	-18
32	20	38
16	2	30
28	-4	-24
20	-14	-30
56	-28	26
-26	-8	-8
-36	-24	-26
32	-2	-16
-6	12	46
-28	-10	56
30	24	-2
-16	-10	-18
-32	-14	-28
22	-8	-16
20	-10	-26

// Sadato N, 2005: Hearing Signers
// Subjects=9
-46	14	-4
-48	12	34
-44	8	48
-48	-2	42
-2	2	64
-4	16	64
-62	-16	6
-56	-4	-6
-60	-32	6
62	-24	2
42	10	32
42	0	56
-2	6	66
-4	20	52
-40	12	32
-28	4	62
-36	30	16
30	-62	48
38	-48	56
-30	-56	52
-46	-34	40
46	-60	-6
30	-74	24
-44	-66	-8
-54	-62	2
-62	-20	4
-58	-10	4
-54	-24	10

// Sadato N, 2005: Hearing Non Signers
// Subjects=10
-46	14	-4
-48	12	34
-44	8	48
-48	-2	42
-2	2	64
-4	16	64
-62	-16	6
-56	-4	-6
-60	-32	6
62	-24	2

// Sadato N, 2005: Deaf Subjects
// Subjects=7
0	6	66
8	24	46
-48	14	20
-36	0	50
-30	28	-2
48	32	2
46	46	16
36	-56	48
40	-46	56
-26	-62	54
-26	-48	48
-30	-54	52
-20	-76	40
54	-58	0
-60	-18	2
62	-10	0
-48	-70	4
-50	-56	6
-34	-64	-30
-62	-20	4
-58	-10	4
-54	-24	10

// Cox S M L, 2005: Reward vs. Negative Feedback
// Subjects=22
0	44	-8
-16	42	-18
-18	38	-20
-44	32	12
-26	34	44
-22	4	48
26	28	50
2	0	46
-4	-18	40
-16	8	-12
28	0	-10
-10	-10	18
-60	-12	2
62	2	-4
-54	-62	-20
0	-40	-34
-28	-54	-22
2	-50	16
-14	-66	-2
-26	-82	40
32	-74	32
28	-92	-18
-38	-16	50
24	-22	56
58	0	36
-46	-12	32
2	-36	52
-22	-60	42

// Ernst M, 2005: Adults
// Subjects=14
-14	-2	-10
20	-2	-14
-14	12	-8
10	16	-8
-46	-28	60
-34	-56	62
-14	10	-6
10	16	-8
2	10	0
26	-60	-22
18	-78	-14
10	-86	4
-20	-30	-16
50	-40	56
42	-46	52
-54	10	36
4	-10	10
0	-78	34
-10	-52	-4
2	-22	12
-16	20	-4
-26	-4	-14
-42	30	12
10	-64	12
-14	-4	-8
28	-2	-10
-2	6	-6
6	6	-8
-48	-28	58
-44	-50	56
8	-46	36
2	-28	36
-2	34	26
0	22	28
2	34	44
-6	-66	34
48	14	44
44	-72	34
-30	18	-8
26	24	-12
52	18	30
-8	-18	-4
2	-28	-4
32	0	-20
12	-82	-22
28	-84	0
26	-62	-24
-20	2	-12
26	-6	-14
-16	4	-12
16	8	-12
36	-12	-14
40	-26	-14
8	-64	60
-16	20	-4
-8	-60	66
-14	-66	62
-28	-4	-14
32	4	-16
32	-20	-22
-24	-4	-14
20	-4	-14
-16	4	-12
20	4	-8
10	-66	12
8	-86	4
6	-46	6
28	-62	-20
-26	-4	-14
-46	-28	60
-40	34	10
4	-6	8
20	-6	-16
-38	-74	-22
30	0	-12
24	-62	-20
-44	-48	58
-50	-30	56
10	-90	2
-22	-2	-12
26	-6	-14
18	8	-12
34	-12	-16
40	-26	-14
32	-20	-22

// Ernst M, 2005: Adolescents
// Subjects=16
-14	-2	-10
20	-2	-14
-14	12	-8
10	16	-8
-46	-28	60
-34	-56	62
-14	10	-6
10	16	-8
2	10	0
26	-60	-22
18	-78	-14
10	-86	4
-20	-30	-16
50	-40	56
42	-46	52
-54	10	36
4	-10	10
0	-78	34
-10	-52	-4
2	-22	12
-16	20	-4
-26	-4	-14
-42	30	12
10	-64	12
-14	-4	-8
28	-2	-10
-2	6	-6
6	6	-8
-48	-28	58
-44	-50	56
8	-46	36
2	-28	36
-2	34	26
0	22	28
2	34	44
-6	-66	34
48	14	44
44	-72	34
-30	18	-8
26	24	-12
52	18	30
-8	-18	-4
2	-28	-4
32	0	-20
12	-82	-22
28	-84	0
26	-62	-24
-20	2	-12
26	-6	-14
-16	4	-12
16	8	-12
36	-12	-14
40	-26	-14
8	-64	60
-16	20	-4
-8	-60	66
-14	-66	62
-28	-4	-14
32	4	-16
32	-20	-22
-14	-4	-8
20	-2	-14
-12	12	-6
10	4	-6
-46	-28	60
-36	-20	62
-26	-62	64
-14	12	-4
10	4	-6
10	14	-6
18	-78	-16
0	-40	22
42	-46	54
-6	-12	26
-16	-32	16
-4	32	28
0	-24	36
6	-42	36
-14	18	-6
14	6	-10
-6	-54	68
22	-66	60
-8	34	34

// Uncapher M R, 2005: Delay Invariant Memory Effects Associated with 
// Recollection
// Uncapher M R, 2005: Delay Selective Long Delay Memory Effects Associated 
// with Recollection
// Uncapher M R, 2005: Short Delay Memory Effects Associated with Recollection
// Uncapher M R, 2005: Delay Invariant Memory Effects Associated with 
// Familiarity
// Uncapher M R, 2005: Delay Selective Short Delay Memory Effects Associated 
// with Familiarity
// Subjects=18
-18	30	57
0	12	57
-45	3	54
-42	18	27
-45	33	6
57	15	30
57	21	15
39	-6	63
-48	-6	30
-21	-15	-15
-48	-63	-24
-60	-45	3
30	-63	57
-42	-69	36
-48	39	-3
45	45	-6
-6	15	54
-39	-63	-15
30	-24	-24
-60	-18	45
54	-6	48
48	-3	24
-48	-6	30

// Fenker D B, 2005: Emotional, Remember vs. Emotional, Know
// Fenker D B, 2005: Neutral, Remember vs. Neutral, Know
// Fenker D B, 2005: Emotional, Remember vs. Neutral, Remember
// Fenker D B, 2005: Emotional, Know vs. Neutral, Know
// Fenker D B, 2005: Remember vs. New
// Fenker D B, 2005: Know vs. New
// Subjects=20
15	12	-21
-27	12	-21
-9	42	54
-39	9	60
-33	33	12
-9	54	-9
63	-9	-21
-57	-54	0
66	-42	-12
51	-66	21
33	-27	9
-54	-15	-15
-66	-30	-12
-57	-39	12
54	3	9
42	-6	42
69	-18	21
-39	-69	36
-39	-72	51
6	-66	21
27	-93	21
36	-81	24
-24	-78	3
-33	-93	3
-36	-81	15
6	-93	27
-6	-96	21
18	-87	-24
-21	-96	-6
-12	-6	-18
33	-18	-12
33	6	-30
-33	-27	-15
-36	-18	-24
0	-39	39
24	-72	-39
45	18	27
9	51	-9
6	60	3
48	36	18
24	21	51
-60	6	9
-21	57	33
-6	51	-15
51	-6	-18
-45	9	-36
-42	-39	9
-54	-9	-18
33	-72	33
24	-54	39
-30	-84	42
-39	-81	18
6	48	6
-3	-12	45
-3	42	3
-3	-12	9
24	-9	-15
27	-48	-15
-36	-39	-21
27	-33	0
27	-21	-9
-9	-39	3
-33	-18	-11
36	-72	-51
24	-36	-33
15	-45	-51
27	-30	-27
15	-33	0
30	-78	-15
-24	-90	-12
-33	-69	-9
39	-18	69
-15	-84	15
30	6	-21
24	-93	-6
39	-9	27
-9	-9	9
45	51	15
-42	12	48
-15	18	-18
-21	60	6
39	-3	30
63	-48	-3
-63	-24	-3
-63	-48	-9
-36	-42	-21
9	-72	-15
-42	-63	33
39	-63	42
15	-84	39
-3	-78	30
18	-48	51
9	3	39
-9	-39	39
-21	-33	-3
30	0	-12
-18	3	-24
-9	-30	6
3	-18	9
36	9	3
-12	-57	-48
15	15	69
33	-33	42

// Ferretti A, 2005: Erotic > Sport Video Clips
// Ferretti A, 2005: Regression Analysis with Penile Turgidity (Video Clips)
// Ferretti A, 2005: Erotic > Sport Pictures
// Ferretti A, 2005: Onset of Erection > No Erection (Erotic Video Clips)
// Ferretti A, 2005: Sustained Erection > No Erection (Erotic Video Clips)
// Subjects=9
29.4	-52.42	43.48
-31.49	-51.47	47.45
58.1	-29.67	32.32
-46.58	-29.87	39.12
48.3	7.99	24.82
-48.93	7.5	27.09
53.68	-19.1	18.11
-52.13	-21.04	16.14
43.81	29.86	5.19
-40.58	29.61	9.53
42.82	-.1	3.26
-42.65	-.44	6.5
3.35	-12.77	8.12
0.12	-9.78	5.67
28.16	-89.35	6.45
-27.4	-92.86	7.38
5.21	27.2	-11.98
-1.2	23.9	-12.75
48.27	-61.54	-7.27
-47.89	-66.34	-5.76
4.23	-1.53	-11.79
-1.13	0.47	-13.02
19.24	-18.53	-12.77
-18.16	-17.61	-11.3
48.16	-53.93	-19.06
-46.96	-53.53	-19.11
23.39	-2.27	-23.1
-22.57	-1.49	-22.64
26.22	-54.3	47.02
-21.88	-56.96	44.45
54.9	-28.46	34.49
-54.12	-24.97	34.33
48.33	3.85	26.28
-48.91	5.47	28.38
54.76	-20.06	19.29
-54.27	-18.86	17.1
44.87	28.64	3.05
-43.79	30.65	9.48
44.95	0.97	3.14
-41.58	-2.63	5.55
2.3	-13.74	9.33
0.15	-11.64	9.17
29.24	-92.52	6.7
29.24	-91.37	7.72
6.28	26.06	-13.02
-3.36	25.84	-15.12
47.21	-67	-9.03
-50.02	-68.56	-6.67
3.16	1.72	-10.94
4.23	0.59	-11.97
20.32	-21.69	-12.52
-19.22	-20.87	-12.13
47.11	-62.49	-19.44
-45.9	-59.07	-22.01
22.33	-3.25	-21.9
-23.36	-1.92	13.09
26.25	-55.19	49.33
-25.05	-57.7	49.01
59.15	-29.84	30.1
-48.73	-29.97	38.04
52.62	7.39	30.39
-51.06	2.11	26.45
45.96	33.3	8.22
24.98	-89.11	9.81
-27.39	-92.77	8.49
47.2	-61.54	-7.26
-43.6	-65.09	-3.68
21.42	-24.69	-10.05
-23.41	-30.96	-4.55
41.74	-54.06	-20.09
-44.8	-54.41	-16.83
23.44	-6.16	-18.32
-24.62	-9.44	-15.26
57.97	-20.04	19.25
-52.1	-23.96	19.73
41.77	-3.19	4.64
-40.49	-1.23	9.88
5.22	26.14	-11.9
-2.28	27.07	-13
4.22	0.5	-13.08
-3.27	1.51	-13.08
21.24	-1.31	-24.28
-19.36	-3.67	-23.61
56.89	-21.19	18.24
-53.2	-22.11	16.24
41.77	-3.19	4.64
-41.56	-5.63	8.03
2.02	26.21	-10.75
-3.32	25.12	-10.6
22.31	-.16	-23.27
-21.49	-2.54	-22.57

// Nieuwenhuis S, 2005: Positive Feedback > Negative Feedback
// Subjects=14
4.25	48.03	9.7
0.9	43.29	-9.94
22.65	46.22	39.75
0.4	-27.73	35.06
-13.87	9.97	0.83
18.18	9.02	-.57
-31.95	-74.93	-21.95

// Nieuwenhuis S, 2005: Outcome, +60 Cents vs. -40 Cents
// Nieuwenhuis S, 2005: Outcome, +30 Cents vs. -20 Cents
// Nieuwenhuis S, 2005: Outcome, No Gain vs. No Loss
// Nieuwenhuis S, 2005: Expectation Related Activation, Win vs. Lose
// Nieuwenhuis S, 2005: Expectation Related Activation, Lose vs. Win
// Subjects=14
21.36	8.78	-3.93
-7.46	5.6	-1.11
-13.94	1.62	-10.73
-49.64	-50.27	50.9
-.68	-33.37	31.08
0.52	-27.59	50.65
-4.92	13.07	54
-18.75	10.33	61.08
11.91	-59.9	-10.33
-39.62	-56.09	-39.06
21.36	8.78	-3.93
-13.94	1.62	-10.73
21.36	8.78	-3.93
-7.46	5.6	-1.11
-13.94	1.62	-10.73
-49.64	-50.27	50.9
-.68	-33.37	31.08
0.52	-27.59	50.65
-18.75	10.33	61.08
-39.62	-56.09	-39.06
0.52	-27.59	50.65
16.58	-42.56	48.38
4.36	-43.02	-11.66
-36.45	16.12	-13.92
-.68	-33.37	31.08
-4.92	13.07	54

// Prince S E, 2005: Encoding > Retrieval
// Prince S E, 2005: Retrieval > Encoding
// Prince S E, 2005: Semantic, (Encoding + Retrieval) > Perceptual, (Encoding 
// + Retrieval)
// Prince S E, 2005: Perceptual, (Encoding + Retrieval) > Semantic (Encoding + 
// Retrieval)
// Subjects=14
-51.92	37.2	1.58
-59.43	17.92	2.5
-35.82	-11.62	-16.27
-2.88	35.07	33.45
-22.88	-61.71	55.7
-19.63	11.29	-13.21
-40.17	-66.58	-29.81
-31.71	54.65	-19.54
-48.41	33.76	22.03
-19.24	-41.6	6.58
-34.91	-71.61	42.31
-51.02	-38.1	57.2
-43.63	-67.81	37.6
-34.82	-70.89	50.09
30.93	-60.85	39.01
-43.84	-74.89	19.26
-27.93	-73.72	-3.54
-48.74	29.14	-4.4
-24.16	29.38	-26.13
-35.53	-21.55	3.75
-15.29	28.95	-8.31
-23.67	3.47	6.68
25.67	10.83	-20.66
-19.66	-1.03	-18.72
-19.56	-60.46	-22.92
-44.27	-75.88	-14.25
34.48	-47.61	65.65
-22.93	-70.84	49.88
17.3	-26.55	-6.74
0.92	49.84	-3.93

// Yonelinas A P, 2005: Remember Responses > High Confidence Familiarity 
// Responses
// Yonelinas A P, 2005: Familiarity Confidence, Increasing with Familiarity 1 
// to 4
// Yonelinas A P, 2005: Familiarity Confidence, Decreasing with Familiarity 4 
// to 1
// Subjects=16
-6	54	-6
9	63	21
-30	39	-12
24	30	-15
63	3	27
-3	-54	6
0	-45	30
60	-24	15
-54	-27	18
-21	-42	63
36	-36	60
-45	-21	39
54	-12	48
-42	-54	15
-54	-42	21
-45	-3	-3
54	-69	9
57	-48	3
-54	-63	0
66	-39	-3
-24	-21	-21
30	-21	-21
-15	-51	-15
15	-60	-15
-45	-6	12
18	-3	12
-36	57	-3
-48	24	21
-6	30	42
-33	-60	36
39	-51	36
36	-66	48
9	-72	36
-6	-24	24
-33	15	-6
9	15	3
21	15	6
27	9	39
6	51	-12
3	30	-9
6	0	39
-9	-96	6
-48	-69	0
-18	-18	-21
-45	-27	18
30	-51	-30

// Connolly J D, 2005: Prosaccade vs. Fixation
// Subjects=5
27.13	-4.34	46.17
-27.35	-9.95	47.27
4.76	-3.79	55.3
36.88	-45.78	46.19
-26.19	-51.87	41.85

// Dresel C, 2005: Whistling vs. Voluntary Breathing
// Dresel C, 2005: Early Activated Areas During Whistling
// Dresel C, 2005: Late Activated Areas During Whistling
// Subjects=15
-52.62	-5.92	22.67
-22.66	-71.44	-13.94
-60.32	-.39	13.29
-43.84	-8.14	32.82
-60.29	-2.31	15.72
-5.81	-43.99	-42.72
-11.87	-17.84	-3.74
-19.64	-17.91	64.76
-60.11	-6.49	28.46
-41.9	-30.52	11.47
-9.33	-103.67	8.07
-62.33	-6.91	24.05
-22.91	-1.04	-18.66
-35.5	-78.21	-5.21
-31.33	-18.01	-4.51
-22.73	-2.98	-5.02
1.47	11.27	31.25
-.36	3.87	55.55
20.5	-65.12	-17.54
58.5	-2.31	9.21
51.09	-1.19	21.56
58.53	-2.1	11.43
27.15	-71.5	-5.82
4.99	-39.59	-42.21
14.16	-34.55	-.29
23.3	-96.47	25.85
26.92	-5.35	-10.12
65.21	-6.05	26.28
35.68	-20.86	-4.25
28.97	-.75	-18.45
-2.51	12.68	58.07
3.95	27.9	59.82
-35.5	-78.21	-5.21
-.2	2.88	67.97
-22.8	0.85	-9.89
-41.67	-10.26	33
44.43	-80.26	-8.61
24.72	5.28	-11.13
-45.64	-13.1	60.24
-18.73	29.61	-24.01
-45.74	-60.91	42.56
-60.62	-23.4	-14.68
-55.44	-52.02	46.33
-26.49	34	46.29
-23.05	-60.11	-41.95
65.37	-51.88	29.69
22.54	-56.16	-25.19
1.74	-55.63	38.99
56.93	-44.93	47.07
29.88	-.49	53.22

// Dalton K M, 2005: Threat vs. Safety
// Dalton K M, 2005: Threat - Safety, Correlated with Self-Reported Anxiety
// Subjects=17
-29.12	48.6	-21.19
-39.47	27.93	15.23
-39.15	10.32	49.05
-19.1	41.85	28.33
-43.9	13.07	-11.35
36.4	22.84	11.44
29.66	38.04	-25.44
-25.87	32.67	-21.01
-38.32	38.65	29.93
-40.59	15.26	2.92
15.93	-5.31	-20.53
-18.59	-19.82	70.3

// Griffiths D, 2005: Bladder Infusion vs. Rest
// Subjects=6
34	10	16
-34	10	16
0	12	44
9	-6	5
-9	-6	5
0	-32	-10
-47	-32	30
52	-28	26
1	-48	-30
0	-54	0

// Ogawa H, 2005: 1 M NaCl - Deionized Water, Normals
// Subjects=11
-52	26	4
-60	-18	24
-44	2	36
46	-6	12
-38	-8	12
-48	-6	16
46	-6	12
-38	-8	12

// Botvinick M M, 2005: Painful - Non-Painful Facial Expressions
// Botvinick M M, 2005: Painful - Non-Painful Thermal Stimulation
// Subjects=12
0	4	19
-42	18	2
53	0	-5
-18	-2	8
18	-2	19
6	-5	14
68	-40	16
0	11	55
-18	-65	-17
45	-50	-18
-39	-75	7
50	-78	4
-45	-73	6
45	-50	-13
68	-40	13
-24	-6	-12
-27	11	-18
6	22	27
-30	-10	28
33	6	11
-24	-3	6
24	4	16
15	7	13
53	-34	24
12	3	58
-30	-74	-29
3	-22	29
42	36	23

// Hao J, 2005: Alzheimer's Disease Patients
// Subjects=13
-36	-42	62
-20	-104	0
32	-66	50
34	-94	6
38	-48	44
44	50	-4
-48	42	20
-36	60	12
44	-64	-14
30	26	2
30	-68	56
12	-66	60
56	-60	-14
34	4	60
46	8	28
56	14	34
-52	-68	-60
-60	-52	-14
-46	34	24
50	38	26
4	22	38
8	14	44

// Hao J, 2005: Normals
// Subjects=13
-26	-68	44
-32	-56	50
-50	-32	50
32	-60	48
32	-6	64
56	16	2
-16	-14	14
18	0	18
14	-6	12
42	56	8
50	46	14
32	-92	4
52	14	42
28	-56	50
-52	-66	-10
-44	-78	-4
-36	-58	-16
-18	-18	16
-14	-26	-4
-12	-16	6
-32	22	2
-40	14	6
28	-20	-6

// Jackson P L, 2005: Painful Stimuli vs. Neutral Stimuli
// Subjects=15
-42	-44	56
40	-50	56
8	26	40
-10	18	44
18	2	6
-18	2	4
-42	14	-4
32	18	6
-24	-72	-28
42	-66	-34
12	-70	58
-26	-72	38
58	16	24
-64	16	14
42	44	26
-44	42	10
8	18	52
56	-54	-14
-52	8	32
-28	0	52

// O'Boyle M W, 2005: Mathematically-Gifted Male Adolescents
// Subjects=6
33	-60	42
-36	-63	54
27	-12	54
-27	-12	51
18	-75	45
-18	-81	36
9	21	36
-12	15	48
-42	-63	-3
-12	21	-9
45	9	33
45	39	21
42	-60	-21
21	27	15
-33	-54	27
-36	-12	39

// O'Boyle M W, 2005: Control Male Adolescents
// Subjects=6
36	-57	51
-42	-48	42
21	-9	45
-21	3	45
54	9	30
18	-72	51
42	-60	-21
21	27	15
-33	-54	27
-36	-12	39

// Stark R, 2005: Sadomasochists (SM)
// Subjects=12
-15	-9	-21
33	-60	-15
-21	-3	-15
15	-30	0
-18	-27	-9
-21	-3	-18
30	-3	-15
12	3	-6
12	3	-6
9	-27	-3
-3	33	-24
-21	-3	-24
12	48	27
0	48	-18
33	0	51
36	-27	-9
-48	-75	12
36	-27	-9
-18	-6	-18
27	3	-27
6	0	-3
-15	-18	18
12	-18	15
6	-30	-15
-15	18	-12
12	48	30
-33	6	12
39	-72	-3
-15	21	-9
15	-18	18
9	-27	-12
-3	33	33
-33	6	12
-15	18	-12
-33	18	-21
-30	-39	-6
39	12	-15
9	3	-6

// Stark R, 2005: Non-Sadomasochists (NonSM)
// Subjects=12
3	-96	-6
30	-6	-15
54	-60	3
24	9	-12
24	6	-18
12	3	-6
9	-27	-3
0	-30	-6
6	-27	-3
12	3	-6
12	3	-6
9	-27	-3
21	6	-12
-6	0	-15
6	-27	-9
-21	-3	-24
12	48	27
54	-69	3
-15	18	-12
0	-54	27
9	30	21
-3	33	33
-33	6	12
-15	18	-12
21	15	-12
-33	18	-21
-30	-39	-6
39	12	-15
9	3	-6

// Bengtsson S L, 2005: Conjunction Analysis of Rhythmic Sequence - Rest
// Bengtsson S L, 2005: Conjunction Analysis of Isochronous Rhythym - Rest
// Bengtsson S L, 2005: Conjunction Analysis of Rhythmic Sequence - 
// Isochronous Rhythym
// Subjects=7
-8	-4	56
-60	-4	36
-56	-12	44
-56	4	0
-52	-44	16
-24	-4	-8
-8	-64	-24
-32	-64	-32
32	-60	-32
-16	-12	16
12	-12	16
-8	-4	56
-44	-12	52
-56	0	-4
-56	-28	16
-8	-64	-20
8	-72	-20
-32	-64	-28
32	-60	-32
-8	0	56
-52	-40	20
4	-64	-16
-36	-38	-32
28	-44	-40
40	-56	-32

// Garraux G, 2005: [Timing vs. Order Manipulation] - [Self-initiated vs. 
// Visually-triggered]
// Garraux G, 2005: [Order vs. Timing Manipulation] - [Visually-triggered vs. 
// Self-initiated]
// Garraux G, 2005: Second-level Conjunction Analysis of the PPI Results
// Subjects=11
34	0	-2
12	-82	-34
-30	-4	60
-30	-4	48
-58	10	10
-46	8	8
-34	44	12
-38	16	0
-58	-24	44
-46	-34	38
-40	-48	40
18	6	56
42	48	14
40	14	0
50	-24	36
50	-34	40
38	-54	44
2	8	60
-10	10	46
8	12	44
8	20	46
-16	-12	6
18	-54	-32
32	-66	-42

// Kuchinke L, 2005: Words > Nonwords
// Kuchinke L, 2005: Nonwords > Words
// Kuchinke L, 2005: Emotional > Neutral Words
// Kuchinke L, 2005: Neutral > Emotional Words
// Kuchinke L, 2005: Negative > Neutral Words
// Kuchinke L, 2005: Neutral > Negative Words
// Kuchinke L, 2005: Positive > Neutral Words
// Kuchinke L, 2005: Neutral > Positive Words
// Kuchinke L, 2005: Positive > Negative Words
// Subjects=20
-36	27	45
-15	57	9
-48	-69	30
-63	-21	-24
-63	-54	-9
-39	-69	42
-21	39	42
-39	-78	36
-12	57	39
-6	-30	33
-6	27	-18
54	-63	18
42	-69	33
12	-57	27
-42	27	0
-60	-9	-6
-9	3	60
-45	-51	-18
33	27	-6
51	24	21
24	-9	-21
27	15	15
-3	42	-24
-54	21	9
51	27	12
-18	42	9
33	63	0
39	-45	6
54	27	9
-24	-54	15
-27	-33	-21
-15	-3	-21
-18	42	9
15	39	21
39	-54	9
9	57	0
12	-57	3
27	-21	-12
27	-60	18
-3	42	-24
-45	6	-36
48	6	-30
12	48	51
39	57	9
-24	-63	18
0	39	-3
15	-54	0
30	-21	-12

// Lanius R A, 2005: Dissociative PTSD Patients
// Subjects=11
10	-18	0
-14	-16	4
-10	-2	0
0	-20	-6
0	24	22
2	10	32
3	16	30
2	-2	34
0	-48	4
-24	-86	38
4	-16	30
2	30	26
4	-46	4
-52	12	-6
10	8	38
12	22	34
58	-30	0
2	-4	32
4	10	26

// Lanius R A, 2005: Flashback PTSD Patients
// Subjects=11
-38	24	-2
2	20	36
28	-46	-4
0	18	36
3	16	30
0	6	38
0	-46	10
-1	-20	42
-4	-12	38
-6	32	32
26	56	-4
48	4	42
-28	48	-8
-26	52	-6
-18	64	-10
-50	0	36
58	-44	42
42	-52	50
-62	-32	22
-60	-48	26
8	-80	10

// Lanius R A, 2005: Normals
// Subjects=10
10	-18	0
-14	-16	4
-16	-10	0
40	-18	20
2	20	36
2	10	32
12	8	38
0	-18	46
-4	40	22
32	0	-20
-16	-36	0
30	40	-10
-16	62	-6
-8	62	4
-42	2	36
-42	10	30
-22	46	-10
-40	-10	46
24	-62	54
12	-68	28
-4	-38	48
40	-54	16
-38	-56	16
26	-84	40
4	-16	30
2	30	26
4	-46	4
-52	12	-6
10	8	38
12	22	34
58	-30	0
2	-4	32
4	10	26

// Strakowski S M, 2005: Bipolar
// Subjects=16
-26.25	-96.48	15.48
58.77	-17.32	-14.44
58.77	-17.32	-14.44

// Strakowski S M, 2005: Healthy Controls
// Subjects=16
-1.1	-57.46	-32.69
63.05	-30.41	-18.97
-60.8	-38.76	-5.7
-52.52	11.19	-21.13
-22.43	-0.03	-3.81
24.5	69.64	12.11
-17.68	-91.77	20.56
67.33	-21.5	-14.19
3.65	-92.07	14.76
67.08	-24.07	-47.43
-26.69	-4.29	-3.4

// Altshuler L L, 2005: Bipolar Disorder
// Subjects=11
39.49	40.32	3.25
-2.95	-.69	27.25
37.26	32.77	-11.7
-4.97	-17.11	35.34
24.69	-34.99	-5.88
39.49	40.32	3.25
-2.95	-.69	27.25

// Altshuler L L, 2005: Healthy Controls
// Subjects=13
39.4	30.66	-11.55
41.61	31.36	-2.71
-.72	-10.74	34.76
26.83	-30.57	-4.04
37.26	32.77	-11.7
-4.97	-17.11	35.34
24.69	-34.99	-5.88

// Liebenthal E, 2005: Phonemic - Nonphonemic
// Subjects=25
-63.03	-7.93	-6.02
-58.62	-31.71	2.61
-13.77	-15.33	4.07
19.35	-17.41	1.63
10.94	12.6	32.67
-.79	-47.69	11.09
16.15	-75.62	-21.33

// Bondi M W, 2005: APOE e4 Genotype Subjects
// Subjects=10
41.88	-68.01	-7.77
-.47	-64.15	45.93
-30.63	16.72	48.41
-48.08	39.25	11.04
3.44	33.16	37.72
3.28	-25.6	-6.42
-.43	-28.6	65.25
58.66	7.89	-18.79
12.13	-13.66	37.09
-26.38	-84.65	3.33
33.43	-67.03	5.63
-22.1	-40.61	21.9
-1.36	71.66	-14.52
41.58	38.76	-3.34
16.4	-40.04	25.87
-35.11	-38.17	-.46
24.85	-32.21	16.19
-48.03	-56.88	-21.05
37.55	-72.95	-16.22
8.21	-62.73	63.55
-5.26	-73.89	-24.58
-26.29	17.43	57.22
3.44	33.16	37.72

// Bondi M W, 2005: APOE e3 Genotype Subjects
// Subjects=10
-48.03	-56.88	-21.05
37.55	-72.95	-16.22
8.21	-62.73	63.55
-5.26	-73.89	-24.58
-26.29	17.43	57.22
3.44	33.16	37.72

// Canli T, 2005: (Negative - Neutral) Masked With (Neutral - Fixation), 5-HTT 
// Short Variant > 5-HTT Long Variant
// Canli T, 2005: (Positive - Neutral) Masked With (Neutral - Fixation), 5-HTT 
// Short Variant > 5-HTT Long Variant
// Canli T, 2005: (Positive - Neutral) Masked With (Neutral - Fixation), 5-HTT 
// Long Variant > 5-HTT Short Variant
// Subjects=13
-40	8	-14
-28	-32	18
30	-6	-8
36	-2	42
26	-8	48
52	-56	-8
32	-58	64
6	4	4
10	18	42
-8	48	30
-54	-56	38
-40	14	40
-34	12	54
-44	12	32
-44	18	14
-6	-50	40
-40	-46	62
8	46	34
16	-38	56

// Malisza K L, 2005: Fetal Alcohol Spectrum Disorders (FASD) Children
// Subjects=9
32	48	-16
24	58	-8
28	48	-16
-34	52	0
-54	22	32
-54	36	16
26	54	-8
-48	26	18
-58	24	18
-24	64	-10
24	56	-10
30	52	-16
-54	20	34
-36	32	22
-40	8	28
24	-68	44
28	-78	34
-66	-20	24
20	46	4
-42	12	28
22	-4	50
-28	4	26
10	4	66
-24	54	14
-32	0	58
30	-62	38
14	-24	64

// Malisza K L, 2005: Fetal Alcohol Spectrum Disorders (FASD) Adults
// Subjects=10
-24	54	22
34	48	32
12	-34	64
-6	16	40
44	-44	44
-50	-54	44
-46	-40	42
62	-30	2
-60	-54	0
-64	-32	18
-46	-14	10
38	62	-2
-28	66	0
-30	56	22
-42	50	10
42	56	2
-40	30	12
8	-6	62
-44	-40	44
62	-10	2
46	50	14
-18	6	58
-46	-4	54
-48	-6	34
22	-70	40
-14	-82	40
30	-84	22
-36	18	22
-16	8	56
-52	2	44
-42	0	36
-18	66	10
-16	62	-2
-24	-12	58
-30	50	34
24	-76	46

// Malisza K L, 2005: Healthy Children
// Subjects=14
62	14	-16
-50	-26	2
-40	-12	10
20	68	20
-22	-6	64
-40	-14	12
6	-6	56
40	-54	38
-32	-66	48
58	-54	-10
22	-88	34
44	-4	54
24	-22	28
24	0	52
-44	4	30
28	58	16
34	50	24
-30	52	30
12	-10	62
16	-78	46
-8	-60	48
40	-4	54
42	-4	34
-42	-6	54
-46	0	50

// Malisza K L, 2005: Healthy Adults
// Subjects=9
-22	18	58
54	-44	52
20	-72	48
-4	-32	44
12	8	62
-4	2	64
-40	48	22
26	0	44
-36	54	-18
54	42	10
48	4	36
-38	-52	52
-54	-54	42
-34	56	-2
-44	30	-8
-44	-44	22
-62	-52	14
-52	44	4
4	6	60
-8	8	60
-10	12	52
-28	34	34
-40	-46	10
-38	22	30
56	4	40
24	-78	34
38	6	34
-40	0	36
62	-56	18
32	-16	18

// Seung Y, 2005: Non-Musicians > Musicians
// Seung Y, 2005: Musicians > Non-Musicians
// Seung Y, 2005: Distorted Tunes Test > Music Listening
// Seung Y, 2005: Music Listening > Distorted Tunes Test
// Seung Y, 2005: (Musicians vs. Non-Musicians) x (LIS vs. DTT)
// Subjects=5
-2	-44	46
2	-62	4
14	-66	23
-50	-39	41
55	-47	0
51	9	10
-36	-1	5
48	-16	-15
24	-2	0
-4	21	44
-50	-16	46
-7	24	34
-46	-31	56
-41	-70	40
4	-58	12
-8	-32	69
-49	-16	50

// Ochsner K N, 2005: Normals, Experiment 1
// Subjects=17
-6	32	30
0	56	-4
-2	56	20
-8	40	34
2	52	-10
-8	52	16
2	48	4
0	-56	30

// Ochsner K N, 2005: Normals, Experiment 2
// Subjects=16
-12	48	36
-10	52	4
-12	28	52
18	38	44
-4	12	-16
-38	10	48
0	-54	24
-8	-52	28
-8	-64	14
-48	-68	22
-60	-56	20
-56	-48	-4
-66	-38	2
-60	-6	-18
-52	-8	-20
-62	-24	-10
-48	4	-36
-42	20	-30
52	-62	22
56	-70	26
60	-62	20
62	-10	-18
12	-76	-10
26	42	4
36	42	10
46	-54	44
-18	22	56
-12	40	42
8	32	32
-12	26	40
-8	20	36
18	24	28
-6	12	-16
34	26	-2
-12	-18	72
-36	-10	44
-10	2	66
-4	6	62
-6	16	50
-20	32	28
-38	0	24
-34	24	24
10	-22	66
22	18	40
46	18	22
34	22	20
42	26	18
-12	-64	62
-10	-48	66
-54	-34	48
-48	-44	44
24	-64	58
-32	-4	26
48	14	-30
40	10	-40
46	-16	-22
24	-4	-10
16	-56	14
-42	-8	22
-44	-12	24
18	-22	50
16	-34	50
-26	-34	44
20	16	-12
38	-22	12
-30	-4	-22
-8	-52	66
-20	-88	-6
-38	-46	-22
36	-50	-20
-54	0	-26
-54	-10	-20
46	0	-34
46	-16	-18
6	-32	-32

// Killgore W D, 2005: Adolescents
// Subjects=8
-36	-62	-16
40	-74	-10
-36	30	-16
-16	-18	-20
-52	10	8
-44	-32	32
-54	-48	8
42	4	20
2	-24	-12
30	-50	50
42	-28	22
42	22	12
54	-10	-4
28	-4	0
-50	-68	0
46	-66	-10
-28	-22	-12
-34	28	-18
30	-68	-44
-56	-30	2
8	-52	-38
-2	30	0
-16	-54	-24
8	-36	-28
26	-8	14
-18	30	18
18	48	-14
52	-58	28
64	-34	-8
-6	-56	22
8	32	20
2	-22	-28
-8	-12	20
-28	42	38
-48	-6	4
-14	24	28
10	-16	10
0	-56	-12
30	-50	-38
4	-60	48
2	28	60
-64	-20	20
58	-30	-14
0	-74	-48
-24	24	58
2	-42	28
-2	16	26
-46	24	30
28	-48	-12
-34	-62	-6
26	-42	18
12	28	10
44	-26	26
36	-66	18
-8	-50	-40
-32	-54	20
32	-6	6
-32	38	4
44	-4	12
-8	42	-2
-44	-4	0
-24	-28	8
28	32	10
-28	-24	-6
-40	-60	-18
44	-64	-26
48	-34	2
-22	-52	40
26	-48	52
66	-26	18
-56	12	-6
42	10	30
38	-66	14
-40	34	-16
2	-30	-14
-56	-30	8
58	-54	4
48	-70	32
42	-62	-30
2	-76	26
2	36	12
32	-2	-28
6	-2	56
-50	-64	-8
16	-54	-42
-44	-42	44
-18	-20	70
30	-64	50
6	18	-8
2	30	14
4	-64	-8
40	-58	-28
-34	-62	-14
30	-54	48
-24	42	-14
-42	-58	-30
60	-36	50
40	10	32
48	-64	-10
-42	-68	-6
36	-54	-24
-52	20	12
44	-58	16
-46	36	2
16	-12	0
-6	-70	-32
18	-72	-38
-14	48	42
32	14	-10
-12	38	10
50	-34	10
-8	64	20
-28	8	16
8	50	26
-10	-34	36
38	6	-50
48	-24	20
50	14	-38
-30	18	-20
10	-46	70
20	-52	-26
38	-60	60
-30	-88	-4
-6	-10	56
-12	16	22
-6	-38	8
22	-62	32
-46	-64	-36
-46	-68	-4
-52	16	32
0	-42	-10
-16	-60	30
10	10	66
10	-40	8
32	8	46
54	6	-26
36	-70	50
8	-30	2
-30	-78	30
-56	-68	-2
32	60	18
38	-22	-12
-54	10	2
-38	30	-18
28	6	50
36	-60	14
2	30	30
-12	-50	-20
4	26	10
-36	-66	0
2	38	14
18	-52	-24
-50	-66	4
-10	-50	-24
30	-70	-42
40	-18	66
-10	-16	42
34	-34	48
-44	-48	44

// Killgore W D, 2005: Adults
// Subjects=13
-36	-62	-16
40	-74	-10
-36	30	-16
-16	-18	-20
-52	10	8
-44	-32	32
-54	-48	8
42	4	20
2	-24	-12
30	-50	50
42	-28	22
42	22	12
54	-10	-4
28	-4	0
-50	-68	0
46	-66	-10
-28	-22	-12
-34	28	-18
30	-68	-44
-56	-30	2
8	-52	-38
-2	30	0
-16	-54	-24
8	-36	-28
26	-8	14
-18	30	18
4	-60	48
2	28	60
-64	-20	20
58	-30	-14
0	-74	-48
-24	24	58
2	-42	28
-2	16	26
-46	24	30
28	-48	-12
-34	-62	-6
26	-42	18
12	28	10
44	-26	26
36	-66	18
-8	-50	-40
-32	-54	20
32	-6	6
-32	38	4
44	-4	12
-8	42	-2
-44	-4	0
-24	-28	8
28	32	10
-28	-24	-6
-40	-60	-18
44	-64	-26
48	-34	2
-22	-52	40
26	-48	52
66	-26	18
-56	12	-6
42	10	30
38	-66	14
-40	34	-16
2	-30	-14
-56	-30	8
58	-54	4
48	-70	32
42	-62	-30
2	-76	26
2	36	12
32	-2	-28
6	-2	56
-50	-64	-8
16	-54	-42
-44	-42	44
-18	-20	70
30	-64	50
6	18	-8
2	30	14
4	-64	-8
40	-58	-28
-34	-62	-14
30	-54	48
-24	42	-14
-42	-58	-30
60	-36	50
40	10	32
48	-64	-10
-42	-68	-6
36	-54	-24
-52	20	12
44	-58	16
-46	36	2
16	-12	0
-6	-70	-32
18	-72	-38
-14	48	42
32	14	-10
-12	38	10
50	-34	10
-8	64	20
-28	8	16
8	50	26
-10	-34	36
38	6	-50
48	-24	20
50	14	-38
-30	18	-20
10	-46	70
20	-52	-26
38	-60	60
-30	-88	-4
-6	-10	56
-12	16	22
-6	-38	8
22	-62	32
-46	-64	-36
-46	-68	-4
-52	16	32
0	-42	-10
-16	-60	30
10	10	66
10	-40	8
32	8	46
54	6	-26
36	-70	50
8	-30	2
-30	-78	30
-56	-68	-2
32	60	18
38	-22	-12
-54	10	2
-38	30	-18
28	6	50
36	-60	14
2	30	30
-12	-50	-20
4	26	10
-36	-66	0

// Pariente J, 2005: Alzheimer's Disease (AD) Patients
// Subjects=12
30	-20	-12
-24	-32	0
16	-62	34
-12	-58	40
22	-62	62
-18	-60	58
46	16	46
46	48	-8
-24	58	-8
44	-66	42
-48	-58	48
-10	-80	-30
26	-16	-16
58	4	-22
38	22	-34
-32	12	-36
42	-56	-8
26	-18	-18
-58	18	0
-48	-56	44
44	-76	32

// Pariente J, 2005: Normals
// Subjects=17
32	-16	-10
8	-44	-16
-35	14	-28
-36	-60	-10
24	-16	-14
60	4	-20
54	-60	12
-10	-40	48
6	-78	2
30	-60	-20
30	-20	-12
-24	-32	0
16	-62	34
-12	-58	40
22	-62	62
-18	-60	58
46	16	46
46	48	-8
-24	58	-8
44	-66	42
-48	-58	48
-10	-80	-30
26	-16	-16
58	4	-22
38	22	-34
-32	12	-36
42	-56	-8
26	-18	-18
-58	18	0
-48	-56	44

// de Zubicaray G I, 2005: Correct Responses > Incorrect Responses
// de Zubicaray G I, 2005: Low Frequency > High Frequency, Correct Responses
// de Zubicaray G I, 2005: Second Presentation > First Presentation, Correct 
// Responses
// de Zubicaray G I, 2005: Second Presentation < First Presentation, Correct 
// Responses
// de Zubicaray G I, 2005: Unstudied Words > Studied Words, Correct Responses
// de Zubicaray G I, 2005: Studied Words > Second Presentation Words, Correct 
// Responses
// Subjects=14
-45	27	-12
-48	36	15
0	6	60
-48	-3	54
-51	-45	6
-48	-66	-12
-42	39	9
3	-78	42
39	-63	24
-45	24	-9
-57	15	21
-48	0	51
-3	6	57
-51	-45	6
-33	-60	45
-42	-3	54
-30	51	3
-48	18	36
-48	45	-3
-51	3	27
-3	9	57
-12	45	-15
33	-90	6
-30	-96	12
-36	27	-3
33	21	3
-30	-63	57
-36	24	-3
33	24	3
36	24	-9
-12	51	-15
-3	9	57
-30	-96	12
24	-102	3

// Kuhnen C M, 2005: Outcome Following Stock Choice, Gain vs. Loss, 
// Activations
// Kuhnen C M, 2005: Outcome Following Stock Choice, Gain vs. Loss, 
// Deactivations
// Kuhnen C M, 2005: Market Outcome, Chosent Stock vs. Unchosen Stock Value
// Kuhnen C M, 2005: Uncertainty Negative Correlation with Bilateral Anterior 
// Cingulate Foci
// Subjects=19
-2.32	60.71	-4.67
-2.32	52.96	-8.48
24.38	38.69	-16.51
12.76	13.67	-8.71
-12.88	9.2	-9.15
0.29	3.02	33.59
0.5	-30.05	46.4
-1.77	-32.49	28.79
-40.61	21.61	2.39
41.7	22.44	5.84
-2.28	61.05	-.24
-2.36	52.53	-14.02
-6.41	21.9	3.09
8.55	21.99	2.91
-20.35	10.39	-6.94
0.14	-5.21	9.75
5.66	21.97	44.21
-2.89	21.92	44.31

// Coricelli G, 2005: Choose Trials:  Financial Gain > Financial Loss
// Coricelli G, 2005: Unobtained Outcome vs Obtained Outcome, Partial Choose 
// Condition
// Coricelli G, 2005: Outcome of Unselectected Gamble vs Outcom of Selected 
// Gamble, Complete Choose Condition
// Coricelli G, 2005: Partial Choose Condition:  Actual Losses >  Unobtained 
// Outcome
// Coricelli G, 2005: mOFC Activity Correlating with Level of Experienced 
// Regret
// Coricelli G, 2005: Complete Choice Activity:  -50 and +50 Obtained > -200 
// or +200 Forgone
// Coricelli G, 2005: Choose Partial Feedback:  Minimizing Future 
// Disappointment vs Maximization of Expected Values
// Coricelli G, 2005: Activity Preceding Choice of Maximal Expected Values in 
// the Partial Choose Condition
// Coricelli G, 2005: Activity Preceding Choice of Maximal Expected Values in 
// the Complete Choose Condition
// Coricelli G, 2005: Influence of Cumulative Experience of Regret (CR) on 
// Choice-Related Activity
// Coricelli G, 2005: Influence of Immediately Prior Experience of Regret 
// (t-1) on Choice
// Coricelli G, 2005: Choose Complete Feedback:  Minimizing Future Regret vs 
// Maximization of Expected Values
// Subjects=15
8	18	0
6	18	12
12	24	8
2	-34	-20
-60	4	8
-4	0	-8
-42	0	-20
10	24	34
-14	0	6
42	42	-18
54	-50	36
-8	32	-14
-10	30	-12
8	32	24
30	-10	-12
18	-14	-6
-12	-16	-8
-12	-10	46
-34	-20	62
14	-28	54
18	36	8
42	-52	52
-38	-76	-6
-20	-31	6
-28	-28	-52
24	-56	50
32	2	-26
-6	-4	32
68	-12	20
-38	-42	40
-10	40	-24
-8	-4	-24
46	28	38
42	26	-16
54	-58	48
-2	32	28
-6	-16	-16

// Huettel S A, 2005: Task-Related Activation Increased Amplitude with 
// Increasing Uncertainty
// Huettel S A, 2005: Task-Related Activation that was Uncertainty Independent
// Huettel S A, 2005: Task-Related Activation without Significant Effects of 
// Uncertainty or Intercept
// Subjects=12
35	26	4
-30	20	5
61	13	16
55	10	35
-44	-4	36
17	-13	9
43	-50	46
-25	-64	50
29	-70	48
-16	-77	48
-5	9	40
1	0	56
-47	-3	9
42	-5	64
-25	-5	52
-41	-12	51
-30	-17	65
-12	-20	7
-59	-29	26
-54	-31	43
-40	-42	54
-56	-51	20
51	-67	-1
46	-77	-5
-38	-83	-6
-27	-92	25
35	-96	2
-25	-100	0
38	54	18
41	44	28
9	20	37
23	4	55
-61	3	30
37	0	51
53	-28	42
25	-54	-23
-33	-60	-18
-35	-71	-13
37	-81	28
30	-88	-15

// Specht K, 2005: One Frequency Component > Rest
// Specht K, 2005: Two Frequency Component > Rest
// Specht K, 2005: Three Frequency Component > Rest
// Specht K, 2005: Four Frequency Component > Rest
// Specht K, 2005: Four Frequency Component vs. One Frequency Component
// Subjects=5
69.35	-30.34	7.32
-71.03	-21.6	16.69
-66.86	-22.73	4.4
69.38	-25.77	10.23
-15.4	-71.03	47.53
-66.81	-22.31	8.84
64.87	-6.41	-.57
1.77	14.61	55.57
-66.88	-18.47	3.98
69.34	-26.08	6.9
6.04	13.15	51.16
-11.75	-13.71	5.94
31.27	-67.52	-20.85
-50.6	21.54	17.68
6.06	9.96	51.47
-62.67	-7.28	-2.8

// Protopopescu X, 2005: Differential BOLD activity in the luteal vs. 
// follicular phases for negative go vs. neutral go
// Protopopescu X, 2005: Differential BOLD activity in the luteal vs. 
// follicular phases for negative no-go vs. neutral no-go
// Subjects=12
3	51	-81
-45	36	-12
39	36	-18
0	3	39
-45	-3	3
-15	57	-15
-6	42	-18

// Crinion J, 2005: Healthy Controls
// Subjects=18
-60	-48	8
-54	-38	2
-60	-8	-14
-58	-6	-18
-58	8	-20
50	-34	-8
58	-4	22
54	10	-28
54	10	-24
-46	10	18
-56	20	16
-56	28	4
-56	26	-2
-42	28	-14
-46	0	50
56	-10	42
-36	-42	-28
-30	-36	-22
38	-38	-28
-46	6	52
46	-18	64
-30	-36	-22
38	-38	-28
-60	-48	8
-54	-38	2
-60	-10	-14
-58	-6	-18
-54	8	-26
54	10	-28
-46	10	18
-56	20	16
-56	28	4
-56	26	-2
-46	0	50
56	-10	42
-36	-42	-28
-30	-36	-22
38	-38	-28
-42	8	20
16	-80	-40

// Crinion J, 2005: Temporal Aphasic Patients
// Subjects=8
-58	-6	-18
52	-32	-10
56	0	-22
54	10	-28
54	10	-28
-56	26	-2
-42	28	-14
-46	0	50
-60	-48	8
-54	-38	2
-60	-10	-14
-58	-6	-18
-54	8	-26
54	10	-28
-46	10	18
-56	20	16
-56	28	4
-56	26	-2
-46	0	50
56	-10	42
-36	-42	-28
-30	-36	-22
38	-38	-28
-60	-48	8
-50	-40	0
-62	-6	-16
-62	-6	-18
-58	10	-18
48	-36	-8
58	-4	22
-48	8	18
-56	20	16
-56	30	6
-36	-42	-28
62	-8	-16
-46	-56	6
-42	8	20
16	-80	-40
64	-10	-14
-50	-44	0
16	-80	-40
-42	8	20

// Crinion J, 2005: Control Aphasic Patients
// Subjects=9
-60	-48	8
-50	-40	-2
-60	-8	-14
-58	-6	-18
-58	8	-20
50	-32	-10
60	-2	-24
54	10	-28
56	12	-24
-46	8	18
-56	20	16
-56	30	6
-56	26	-2
-42	28	-14
-42	-6	46
-36	-42	-28
-46	6	52
46	-18	64
-30	-36	-22
38	-38	-28
-60	-48	8
-50	-40	0
-62	-6	-16
-62	-6	-18
-58	10	-18
48	-36	-8
58	-4	22
-48	8	18
-56	20	16
-56	30	6
-36	-42	-28
62	-8	-16
-46	-56	6
-42	8	20
16	-80	-40
64	-10	-14
-50	-44	0
16	-80	-40
-42	8	20

// Rinne T, 2005: (Sound Attention + Picture Attention) vs. Infrequent Tones 
// at Irregular Intervals
// Subjects=12
-56	-18	4
58	-18	4

// Remijnse P L, 2005: Reward Main Effect, Correct Response (CR) > Baseline 
// (BL)
// Remijnse P L, 2005: Main Effect of Punishment, PENS + PRE + FRE > Baseline 
// (BL)
// Remijnse P L, 2005: Main Effect of Punishment Excluding Reversal Events, 
// PENS + PRE > Baseline (BL)
// Remijnse P L, 2005: Conjunction Analysis of Reward (CR > BL) and Punishment 
// (PENS + PRE > BL)
// Remijnse P L, 2005: Interaction Analysis: Reward (CR > BL) > Punishment 
// (PENS + PRE > BL)
// Remijnse P L, 2005: Interaction Analysis: Punishment (PENS + PRE > BL) > 
// Reward (CR > BL)
// Remijnse P L, 2005: Main Effect of Affective Switching (FRE > BL)
// Remijnse P L, 2005: The Dissociation of Stimulus-Punishment Association and 
// Affective Switching (FRE > PENS + PRE)
// Subjects=27
-15	36	-15
-30	51	-15
-39	39	15
-45	3	27
-30	-60	48
-51	-39	51
-27	-93	-12
30	-96	-12
-6	15	3
6	18	6
12	6	-9
-18	42	-15
-33	54	-12
-27	24	-9
-24	-96	-15
-18	42	-15
-42	45	-18
-27	24	-6
-24	-96	-15
-18	39	-15
-36	54	-12
-27	-93	-12
-6	12	-6
-42	45	-18
-36	51	9
-30	51	-15
-48	18	6
-48	6	24
-30	24	-12
30	18	-9
-48	33	33
-33	51	30
-36	51	9
-3	30	48
-3	33	33
-27	-90	-9
-27	57	6
27	57	6
30	51	-3
-45	42	-9
18	15	-18
-48	3	18
60	9	33
57	15	12
-33	18	6
33	21	9
-33	45	33
-36	51	9
42	33	42
-3	27	42
0	30	30
-57	-42	27
-33	-24	12
-48	-63	-6
-6	3	54
15	-66	51
48	-36	39
-15	-48	-24

// Hsu M, 2005: Ambiguity > Risk
// Hsu M, 2005: Risk > Ambiguity
// Hsu M, 2005: Gamble > Certain
// Hsu M, 2005: Certain > Gamble
// Hsu M, 2005: Positive Correlation with Expected Value of Decisions in Risk 
// Condition of Card-Deck Treatment
// Hsu M, 2005: Positive Correlation with Expected Value of Decisions in 
// Knowledge Treatment
// Subjects=16
51	33	-6
54	18	-21
-54	-60	42
-45	-54	33
-9	48	39
-12	63	21
54	-54	36
54	-63	30
18	54	18
12	54	30
12	27	57
36	18	42
42	9	45
60	-36	-3
63	-27	-6
51	-24	-9
-39	-9	-15
39	6	-27
42	15	-24
54	27	6
-54	36	-6
-15	-15	-15
-21	-6	-18
33	-6	-27
0	-6	6
9	6	6
-12	6	0
12	-60	-3
9	-78	3
-12	-75	15
-15	-72	51
-3	9	45
12	-75	51
21	-84	39
-42	-75	30
18	-78	-12
0	-81	-3
-9	-21	48
-18	-12	51
-30	-27	54
-33	15	21
-6	15	-3
15	-90	12
33	6	21
27	12	21
-51	-66	6
-51	-57	3
42	-24	60
-15	-75	9
9	24	54
12	39	51
9	12	54
60	-33	3
57	-42	3
-51	-72	30
-42	-78	33
-66	-30	-9
-9	-18	18
-9	-3	18
15	6	3
48	24	-15
54	39	-3
39	24	-15
-9	45	9
-3	57	33
-9	39	30
-6	48	27
3	-42	-6
60	-57	30
60	-51	39
-6	27	42
-45	42	6
21	48	27
18	57	33
33	-87	15
39	-84	9
-9	12	3
-6	3	6
-24	-63	51

// Choo W C, 2005: Rested Wakefulness, 2-Back > 1-Back
// Choo W C, 2005: Rested Wakefulness, 2-Back > 1-Back (Deactivation)
// Choo W C, 2005: Sleep Deprivation Related Increase
// Choo W C, 2005: Sleep Deprivation Related Decrease
// Choo W C, 2005: State Effect: Sleep Deprivation Related Increase
// Choo W C, 2005: State Effect: Sleep Deprivation Related Decrease
// Choo W C, 2005: Load by State Interaction
// Subjects=12
-47.92	13.5	22.12
38.64	37.08	30.3
-.78	28.19	42.65
-32.63	-48.91	39.44
34.75	-62.17	40.89
6.02	-66.6	54.98
-15.79	-18.54	17.74
-6.38	55.16	20.37
-6.23	36.99	33.05
-29.41	-84.98	26.82
21.81	-79.9	19.11
-7.36	-18.63	2.04
-29.45	-82.15	22.12
32.52	-81.87	20.27
20.77	-78.51	23.47
21.85	-78.42	24.56
-62.97	-18.33	-2.92
-35.08	12.61	23.16
26.58	55.85	-1.25
33.04	28.94	-5.76

// Strangman G, 2005: Sleep Deprived > Normal Sleep, SpaceDock vs. Fixation
// Strangman G, 2005: Normal Sleep > Sleep Deprived, SpaceDock vs. Fixation
// Strangman G, 2005: Normal Sleep < Sleep Deprived, SpaceDock vs. Fixation
// Subjects=6
45.22	10.32	41.39
61.15	-54.26	3.13
38.99	-58.17	37.16
-39.15	-59.92	21.48
51.66	-59.63	17.07
9.56	-11.53	-17.71
26.1	-62.19	27.61
38.99	-58.17	37.16
9.56	-11.53	-17.71

// Tyler L K, 2005: (All Regulars - Baseline) - (All Irregulars - Baseline)
// Tyler L K, 2005: (Real Regulars - Baseline) - (Real Irregulars - Baseline)
// Tyler L K, 2005: (Regulars - Baseline) - (Additional Phonemes - Baseline)
// Subjects=18
-46	-26	8
-56	-24	10
-56	-48	8
58	-14	2
58	-28	4
62	-6	10
46	-42	34
38	-44	42
-48	-28	8
-56	-20	10
-66	-30	4
60	-18	4
60	-26	8
46	-28	-4
-4	18	34
-44	-32	6
-34	-28	10
-58	-28	2
38	-28	10
50	-16	4

// Crockford D N, 2005: Healthy Controls
// Subjects=10
-7.89	-61.39	54.7
7.05	-61.48	52.31
-41.06	-58.68	51.51
46.56	-58.24	49.35
-28.35	-90.52	23.92
35.79	-92.08	25.55
-15.63	-84.96	12.16
12.11	-78.62	9.08
-11.52	-64.64	-.74
12.04	-72.79	1.9
-37.08	-92.46	-.35
35.55	-85.85	-3.97
-20.15	-46.89	-4.37
-24.41	-65.4	-9.45

// Crockford D N, 2005: Pathological Gamblers
// Subjects=10
-7.89	-61.39	54.7
7.05	-61.48	52.31
-41.06	-58.68	51.51
46.56	-58.24	49.35
-52.21	16.65	21.9
-7.55	63.99	10.73
-28.35	-90.52	23.92
35.79	-92.08	25.55
-15.63	-84.96	12.16
12.11	-78.62	9.08
-11.52	-64.64	-.74
12.04	-72.79	1.9
-37.08	-92.46	-.35
35.55	-85.85	-3.97
-20.15	-46.89	-4.37
-24.41	-65.4	-9.45
22.61	-69.52	-11.88

// Brooks J C W, 2005: Face
// Brooks J C W, 2005: Hand
// Brooks J C W, 2005: Foot
// Subjects=14
-36	24	-6
38	16	2
-38	4	4
40	12	-4
-38	-10	10
-56	-18	14
62	-26	14
-26	4	-8
28	12	-8
44	20	-10
-12	-8	4
16	-10	4
4	-16	4
-14	-16	4
58	-32	20
-32	22	0
38	16	0
-36	12	0
38	12	2
-38	-16	8
64	-26	14
-22	8	-10
24	12	-6
46	24	-12
12	-8	4
6	-16	-2
-58	-28	14
56	-28	18
-34	22	-4
38	14	0
-40	8	-2
-38	-18	8
-56	-10	4
-22	14	-6
26	16	-2
46	22	-12

// Binder J R, 2005: Nonword > Fixation
// Binder J R, 2005: Fixation > Nonword
// Binder J R, 2005: Positive Correlation between Reading Activation and 
// Response Time
// Binder J R, 2005: Negative Correlation between Reading Activation and 
// Response Time
// Binder J R, 2005: Irregular > Regular
// Binder J R, 2005: Regular > Nonword
// Binder J R, 2005: Nonword > Regular
// Binder J R, 2005: Irregular > Nonword
// Binder J R, 2005: Nonword > Irregular
// Binder J R, 2005: Positive Correlation between Reading Activation and 
// Imageability Ratings
// Binder J R, 2005: Negative Correlation between Reading Activation and 
// Imageability Ratings
// Subjects=24
-3.77	2.93	60.41
-6.2	16.38	28.09
-8.19	-8.49	36.89
-6.13	1.75	31.54
17.33	14.58	30.2
6.63	9.94	26.25
11.86	23.12	17.28
-43.59	5.33	26.1
-22.01	-5.61	47.95
-50.25	9.32	-4.27
-51.24	26.55	12.14
-49.23	31.87	-1.71
-41.53	22.09	22.44
-52.42	45.14	5.02
59.04	-7.89	24.91
45.06	9.75	20.25
53.7	8.54	31.4
31.43	-3	49.35
50.19	14.15	-5.83
47.01	28.74	4.13
-36.37	24.64	-.14
29.93	12.34	0.13
-55.29	-8.49	27.39
-46.66	-14.18	35.57
-59.66	-13.86	13.39
-57.3	-8.27	44.12
-67.22	-11.5	3.25
-55.51	-8.6	-1.59
-31.88	-11.58	12.88
63.21	-5.63	12.41
55.95	-8.91	39.53
52.86	-15.39	52.38
37.97	-19.19	59.56
19.76	-27.39	51.53
-23.99	-64.38	45.1
-26.23	-80.82	25.32
-33.64	-50.52	46.28
-43.36	-39.54	37.66
-26	-64.16	61.83
-18.55	-79.78	51.9
-36.74	-54.97	57.84
28.44	-66.63	52.49
28.26	-71.78	27.28
33.72	-55.23	48.13
18.79	-75.84	44.45
-36.14	-25.69	9.65
-38.38	-21.27	-1.84
-47.82	-41.54	12.23
57.75	-11.27	-4.9
51.47	-29.74	4.53
-40.56	-53.58	-20.3
-27.47	-95.83	-3.52
-14.65	-101.21	-5.45
-37.17	-86.8	-9.74
-3.89	-86.11	9.89
-21.86	-79.85	37.45
-22.29	-71.1	-14.58
-16.88	-67.04	-3.83
-2.9	-106.77	-9.58
23.84	-97.55	-2.85
29.14	-88.09	-4.82
13.2	-76.24	12.21
43.05	-83.43	-.91
30.32	-82.48	12.54
37.63	-90.84	-13.61
20.83	-79.05	30.2
49.27	-55.7	-14.46
36.53	-62.58	-5.93
8.79	-66.72	-1.92
49.33	-75.88	-13.88
50.33	-44.78	-10.93
7.78	-100.19	-8.02
-42.55	-67.45	-6.84
-36.48	-8.34	-27.48
33.14	-12.9	-10.06
33.02	-3.1	-20.92
62.15	-67.08	-11.42
-15.91	-15.42	2.98
-19.09	-4.1	12.11
-26.65	10.4	7.63
-30.89	-1.43	6.44
16.13	-20.86	-1.39
19.34	-1.04	6.95
30.12	-26.35	8.95
24.78	-12.04	15.62
-17.04	-56.7	-21.42
-33.04	-72.91	-23.22
-28.96	-33.13	-32.18
-24.43	-89.86	-23.02
22.48	-51.09	-21.23
34.22	-57.79	-26.38
15.96	-65.44	-41.14
30.86	-26.43	-33.43
24.73	-74.08	-15.98
24.41	-56.56	-50.9
2.21	-57.47	-19.35
-6.36	-20.37	-6.75
-56.12	-66.4	35.6
-46.45	-72.43	39.34
49.59	-57.82	26.98
45.49	-74.79	41.83
61.41	-64.81	31.89
-25.35	24.87	43.21
-20.38	57.31	8.09
-36.03	18.29	41.65
-20.01	34.76	46.78
-29.01	52	-4.75
29.81	52.87	1.19
24.83	29.14	38.93
20.21	59.5	5.21
43.11	16.1	47.62
19.12	49.37	-1.74
36.73	25.21	55.85
-30.1	10.01	-24.64
-11.85	37.3	-3.71
-7.6	22.81	-12.58
36.17	44.65	-9.34
-5.9	-54.12	38.46
11.11	-58.22	25.22
6.9	-43.3	39.63
-30.85	-40.52	-3.66
-34.46	14.59	-33.89
-21.07	-21.23	24.72
-22.1	-38.41	22.83
-10.23	-67.86	26.28
-1.71	8.78	53.21
-8.26	15.03	38.26
-8.4	26.69	23.9
-2.87	26.49	48.39
15.45	16.16	64.66
8.85	18.56	41.11
11.88	25.49	20.42
-32.73	-2.75	44.49
-52.19	5.82	19.46
-56.57	13.48	8.83
-43.84	17.02	-1.65
-42.6	16.62	20.68
53.81	-8.92	39.56
29.28	-2.04	48.18
49.38	9.23	26.93
36.64	-.99	33.51
48.03	18.37	-6.16
62.01	14.91	2.89
50.25	23.64	6.76
44.74	26.21	-14.59
36.44	24.41	18
45.07	27.43	28.8
-34.17	13.19	3.03
32.07	15.7	2.05
-27.2	-62.28	44.96
-37.98	-44.63	40.26
-27.29	-46.76	39.2
-36.68	-66.43	61.03
-18.48	-80.23	59.75
-19.59	-87.27	51.43
-46.34	-53.71	61.19
-37.86	-54.34	52.22
-49.73	-38.09	43.19
-55.15	-30.1	37.01
44.29	-42.02	39.09
29.41	-75.4	35.37
28.47	-63.03	57.77
30.51	-60.79	45.29
40.22	-55.39	59.22
15.68	-81.43	55
27.43	-80.39	53.66
28.43	-87.67	41.99
19.9	-67.74	52.68
-30.53	-94.31	16.46
-37.16	-77.91	-4.91
-24.1	-79.84	24.09
-28.28	-94.24	30.92
-54.28	-78.27	-8.03
-23.97	-86.12	39.12
40	-88.34	18.49
-43.67	-58.11	-9.84
55.44	18.79	-15.2
-12.78	5.83	2.28
-7.39	-15.63	-.44
16.07	-.6	-.86
12.86	-11.62	-5.47
2.14	-25.23	-15.36
2.25	-23.06	-1.04
-42.5	1.19	27.55
30.37	-80.91	19.1
-9.21	-56.31	24.18
-16.8	-9.15	29.23
-31.72	-39.61	21.92
-19.94	-43.6	24.35
-32.95	-42.39	-.13
-29.62	-22.34	24.91
-17.96	4.17	22.55
14.11	1.19	22.44
23.81	-42.88	15.98
22.74	-15.42	27.07
-8.32	15.48	30.42
2.53	10.66	49.65
8.85	18.56	41.11
4.5	25.42	33.9
-42.36	0.36	44.34
-43.59	6.38	26.01
-52.21	10.05	19.11
-53.12	3.93	36.36
-49.17	13.81	-1.32
-54.5	27.07	5.44
-43.82	22.65	2.34
-51.27	36.15	12.45
-37.27	17.63	19.42
47.22	11.16	24.56
55.9	10.38	41.26
48.17	25.28	14.45
42.73	25.37	2.24
46.98	15.19	-5.88
53.58	28.2	24.18
35.18	24.55	-7.65
-28.89	20.28	-2.09
-30.93	12.49	7.51
32.02	14.04	-5.61
-24.01	-70.09	40
-40	-54.44	51.14
-51.85	-41.19	44.59
-34.79	-46.98	37.07
-28.15	-62.14	60.57
-5.28	-21.42	-6.67
4.37	-25.33	-3.11
1.01	-26.98	-24.12
-46.48	-70.57	35.84
-47.7	-64.46	18.61
-49.78	-57.27	29.19
-48.61	-84.76	31.48
-41.06	-83.94	41.36
52.78	-61.31	22.77
45.49	-75.85	41.92
56.13	-70.75	38.02
52.29	-11.44	-20.44
-24.32	29.99	40.53
-37.1	18.28	41.66
27	27.21	41.29
-7.57	26.41	-7.31
-2.29	22.5	-17.08
-13	49.64	-9.2
-11.85	49.45	1.96
-7.56	38.64	-.53
5.23	37.23	-6.13
9.51	15.34	-14.38
-31.99	-36.9	-11.76
-21.33	-34.89	-14.28
-11.41	-55.87	16.36
-3.73	-57.02	42.02
-15.57	-50.29	33.78
-8.08	-100.69	14.51
-6.89	-99.4	31.11
-.61	-72.21	24.3
2.55	-57.3	24.13
7.94	-35.89	39
14.2	-51.65	13.48
5.84	-47.54	40
16.58	-98.63	25.2
-7.26	17.6	30.23
3.69	6.06	58.95
6.7	20.57	39.85
-50.91	-7.35	41.74
-48.72	3.12	53.11
-32.7	-2.41	48.92
-44.66	5.32	26.11
-52.37	11.68	-1.1
-50.29	38.56	2.2
-51.25	36.32	14.66
-38.31	18.93	22.66
39.97	-15.09	43.58
43.06	-6.41	31.66
62.31	1.53	36.35
33.57	-1.84	50.35
47.21	10.99	22.35
48.03	16.17	-7.09
60.02	21.98	25.74
46.01	30.56	14.03
47.12	38.65	22.26
41.74	48.14	21.53
-27.82	19.14	-3.12
-35.22	22.15	8.98
33.13	17.74	0.76
-22.88	-69.4	48.85
-35.8	-48.59	43.91
-46.54	-39.3	41.03
-51.8	-38.48	52.17
45.37	-37.52	42.05
32.7	-61.32	52
19.9	-74.26	51
29.37	-72.49	31.78
32.56	-50.63	38.84
13.57	-63.58	65.79
26.24	-84.85	37.32
24.23	-59.46	63.09
46.61	-48.92	59.72
-26.4	-96.88	-3.45
-29.5	-89.27	12.68
-27.31	-82.06	23.2
-14.36	-79.55	40.69
-41.43	-76.79	-3.84
43.1	-89.43	4.05
34.67	-84.94	21.62
-51.12	-66.7	-10.15
67.29	2.28	-9.49
-8.43	-16.44	2.98
7.54	-13.68	-4.12
10.86	-14.66	10.42
-6.37	-19.4	-7.94
-0.01	-25.42	-17.55
-42.7	-54.74	-21.29
-44.33	-69.24	39.05
-48.77	-67.72	17.78
-50.79	-88.45	25.12
48.63	-66.57	37.76
48.5	-52.62	25.44
-15.71	30.64	48.19
-12.6	34.03	36.72
-39.2	15.35	45.28
-26.38	21.95	46.81
-40.77	26.58	-15.87
-8.66	28.43	-8.58
-12.96	43.55	-5.34
-20.27	-33.82	-14.38
-30.96	-35.03	-15.27
-10.34	-52.52	18.3
-5.98	-48.29	31.28
-5.94	3.72	57.02
5.8	8.02	56.53
-27.35	-6.7	48.11
-49.8	-8.06	46.25
-41.41	-9.64	25.1
-49.98	3.26	27.46
-53.32	4.07	10.7
-36.96	-37.47	36.3
-15.28	-69.21	64.36
-49.68	-39.7	50.02
35.85	-54.16	48.02
40.06	-43.82	43.75
25.23	-64.54	52.35
31.73	-63.56	64.46
28.31	-66.86	35.79
38.89	-38.33	32.16
-23.17	-98.8	-1.09
-36.04	-89.54	-3.95
-45.75	-60.87	-4.01
-21.81	-68.34	48.75
-33.66	-49.63	43.97
-59.36	-53.64	35.68
-49.76	-58.16	31.49
-48.6	-70.32	39.19
59.18	-56.96	23.45
47.41	-60.54	19.42
61.4	-46.23	38.14
42.3	-74.64	44.08
60.41	-68.44	40.01
46.61	-57.72	56
43.28	-57.89	40.44
43.44	-68.4	55.81
55.51	-16.79	-21.14
60.08	-51.01	3.98
54.34	-5.77	-29.86
51.58	-48.43	10.55
69.46	-20.51	-15.41
56.39	7.65	-35.47
-27.95	52.98	-5.96
-29.66	34.36	42.46
-41.38	23.63	42.38
40.88	26.15	40.11
32.34	36.04	44.95
40.8	36.3	33.68
26.99	23.87	39.34
20.35	46.69	18.55
23.33	55.4	-6.75
19.34	52.83	29.2
23.69	38.22	32.6
22.81	30.33	54.46
12.66	52.17	-6.36
-28.78	-38.99	-11.62
-7	-52.18	36.08
-7.07	-70.56	18.66
-3.69	-70.94	40.96
-15.64	-51.06	23.81
-.5	-51.29	47.08
9.02	-49.97	35.71
10.01	-53.02	23.68
-9.29	13.16	41.77
-3.84	7.71	53.32
-8.39	28.97	25.94
9.93	17.51	41.19
45.12	1.63	25.39
51.66	-.31	41.09
-55.43	13.12	17.77
-48.16	18.68	-7.31
-48.07	28.42	8.6
-43.66	13.36	19.85
-36.33	29.46	7.26

// Sabsevitz D S, 2005: Concrete > Abstract
// Sabsevitz D S, 2005: Abstract > Concrete
// Subjects=28
-27.85	-23.98	-24.04
-25.59	-39.14	-13.87
-59.75	-52.21	-14.62
-46.93	-55.39	-15.61
23.42	-5.18	-19.51
27.7	-15.02	-23.2
28.83	-27.53	-19.93
-28.23	-79.46	43.07
-31.53	-66.16	36.41
-38.9	-72.75	48.2
40.05	-59.3	36.13
46.49	-68.87	35.75
49.7	-44.64	45.94
-22.61	27.75	-16.17
-43.86	43.17	6.2
-38.41	31.11	14.95
-18.83	13.96	52.97
-10.85	19.1	-18.93
29.77	28.23	-14.58
40.41	37.73	-16.62
31.34	15.86	45.54
49.16	35.44	8.01
46.9	49.54	-2.07
-13.54	-54.74	17.41
7.77	-53.01	10.33
2.61	-62.16	30.11
-51.42	6	-19.59
-47.99	-30.05	-4.34
-65.94	-52.13	14.44
-61.76	-48.65	4.07
50.06	9.52	-24.4
51.28	-13.05	-13.6
51.17	-.96	-22.42
-45	23.73	-11.12
-52.34	17.48	5.1
-8.46	55.75	28.16

// van Veen V, 2005: Semantically Incongruent > Congruent
// van Veen V, 2005: Response-Incongruent > Semantically Incongruent
// Subjects=14
38.71	38.91	40.18
40.7	56.13	28.67
-35.02	31.96	39.38
8.83	23.84	40.67
55.1	-51.67	50.93
-46.4	-54.31	53.43
40.77	30.41	26.37
-35.2	27.87	14.07
-61.88	4.99	9.61
2.28	31.07	24.53
64.37	-53.01	5.21
-42.56	-14.81	13.28
-15.83	-10.17	15.93

// Koelsch S, 2005: Irregular Chords > Regular Chords, All Adults
// Koelsch S, 2005: Irregular Chords > Regular Chords, All Children
// Subjects=3
-58.33	12.61	3
-48.62	27.85	4.69
-43.41	17.7	-12.32
-52.66	4.72	21.62
-54.97	-34.69	2.02
-62.29	-49.32	18.16
57.33	12.37	5.54
48.62	33.72	4.7
51.65	21.22	-14.29
47.89	3.47	25.63
55.22	-32.18	-.1
63	-49.09	13.77
63	-49.09	13.77
-45.58	20.88	-12.6
58.4	13.33	4.31
57.24	21.53	0.15
48.41	21.21	-14.23
48.99	5.8	27.62
50.84	-30.38	-3.57
55.41	-41.67	13.16

// Kensinger E A, 2005: Accurate Emotional Word-Picture Identification > 
// Control
// Kensinger E A, 2005: Accurate Nuetral Word-Picture Identification > Control
// Kensinger E A, 2005: Accurate Emotional Word-Only Identification > Control
// Kensinger E A, 2005: Accurate Neutral Word-Only Identification > Control
// Kensinger E A, 2005: Accurate Retrieval of Emotional Items (Emotional 
// Corect Attributions > Emotional Misattributions)
// Kensinger E A, 2005: Accurate Retrieval of Neutral Items (Neutral Corect 
// Attributions > Emotional Misattributions)
// Subjects=16
-44	48	-13
-35	-26	59
-53	-20	18
-36	-65	42
-39	-41	57
18	-3	-17
-30	-9	61
-27	-37	-7
-9	-6	50
-35	-20	62
-48	-23	51
-33	-36	43
-35	-64	-2
18	-97	-1
-3	-31	24
-27	-6	-15
24	9	9
-12	34	-7
-30	37	42
45	-9	53
54	-18	51
-9	-50	44
62	-43	10
47	-49	0
62	0	-10
45	12	-33
50	-1	-22
-56	-6	-22
20	-18	-18
-27	-9	-22
21	-12	-22
29	33	29
47	-51	22
48	-22	29
-41	2	-10
-56	-21	-20
27	-5	8
-15	48	36
39	36	18
36	39	21
35	6	11
-32	-42	26
45	-39	32
18	-24	37
-59	-21	-16
50	-50	-5
-21	-6	-18
24	9	13
5	-3	-9
-35	43	-17
-35	13	-21
48	-50	0
-56	-54	25
-41	-61	-14
41	-70	-12
-41	-71	40
15	-2	-20

// Stephan T, 2005: Galvanic Vestibular Stimulation (GVS) > Rest, All 
// Stimulation Frequencies (Activations)
// Stephan T, 2005: GVS > Rest, All Stimulation Frequencies (Deactivations)
// Stephan T, 2005: Linear BOLD Increase with Frequency, Correlation
// Stephan T, 2005: Linear BOLD Increase with Frequency (Excluding 5.0 Hz), 
// Correlation
// Stephan T, 2005: Linear BOLD Decrease with Frequency, Correlation
// Stephan T, 2005: Linear BOLD Decrease with Frequency (Excluding 5.0 Hz), 
// Correlation
// Stephan T, 2005: Linear BOLD Increase with Stimulation Reciprocal (1/f), 
// Correlation
// Stephan T, 2005: Linear BOLD Decrease with Stimulation Reciprocal (1/f), 
// Correlation
// Subjects=10
56	-28	24
54	4	4
40	2	-6
42	40	0
52	2	44
-16	-14	6
-58	-22	22
-52	2	2
-36	0	-2
-46	4	36
-42	36	0
22	2	0
-30	-50	50
-18	-70	-28
30	-64	-28
56	-58	-2
-4	-2	62
6	6	56
-6	6	34
-10	-16	40
34	-50	46
12	-26	48
-54	-58	2
6	-34	-34
-50	-58	-28
6	-34	-34
6	-50	42
10	-58	56
-24	-90	22
8	-56	22
-16	-62	8
-24	-18	-24
62	-4	-20
48	0	-42
40	12	-40
44	-22	66
26	30	48
20	50	42
-4	60	-8
-42	-26	64
-32	-18	72
48	-64	26
24	-94	10
30	-32	-20
28	-22	-22
-40	16	-38
-62	-2	-20
-42	-36	24
18	-16	18
4	-46	-16
0	-66	-24
32	-26	10
-42	-38	22
-20	-18	2
10	-2	8
2	-32	46
34	-28	14
-18	2	-32
-32	-70	-16
-24	4	-38
-22	2	-38
34	-50	68
-34	-68	-16
-18	-20	4
20	-18	16
-44	-36	22
10	-80	10
0	-44	-6

// Birbaumer N, 2005: Healthy Controls
// Subjects=10
-36	3	-12
36	12	-15
-3	9	39
-3	33	-3
3	18	39
-24	30	-12
-60	-27	33
51	-42	24
12	3	69
-27	3	-18
27	3	-27
-36	57	-3
0	57	-9
21	6	-18
-51	-45	15
-18	6	-24
33	-6	15
3	30	3
15	24	-12

// Birbaumer N, 2005: Criminal Psychopaths
// Subjects=10
21	6	-18
-51	-45	15
-18	6	-24
33	-6	15
3	30	3
15	24	-12

// Kong J, 2005: Addition Without Carrying vs. Rest
// Kong J, 2005: Adding With Carrying vs. Rest
// Kong J, 2005: Subtraction Without Borrowing vs. Rest
// Kong J, 2005: Subtraction With Borrowing vs. Rest
// Kong J, 2005: Main Effect of Arithmetic Type (subtraction vs addition)
// Kong J, 2005: Main Effect of Procedure Complexity (with carrying/borrowing 
// vs. without carrying/borrowing)
// Subjects=16
-9	12	42
-21	-3	45
33	-93	-3
-30	-90	0
-27	12	0
-6	12	42
-42	9	30
48	12	27
-24	-3	45
-42	-78	0
-45	-66	-15
-15	-93	-12
15	-96	-6
-21	-33	-3
-27	24	3
33	21	0
-39	-51	-30
-30	-72	-21
-39	-54	-30
-9	12	42
-27	-60	-48
33	-60	42
-24	-72	30
-42	9	30
45	15	24
45	-75	-15
-12	-96	-15
-42	-72	-9
33	33	-6
-27	24	0
-6	12	42
-42	12	24
-24	-6	45
-27	-75	42
30	-54	45
-24	-69	36
-45	-69	-9
-30	24	0
30	24	0
-12	-9	0
-39	21	24
-24	-72	39
-27	-60	51
-12	-75	45
48	-39	51
-3	15	51
6	21	42
-45	9	27
-24	-78	36

// Rivera S M, 2005: Mental Arithmetic, Increases with Age
// Rivera S M, 2005: Mental Arithmetic, Decreases with Age
// Subjects=17
-53	-68	7
-51	-37	46
-16	59	19
-10	-4	-5
-32	-33	-2
-10	-20	-17
-32	1	-13

// Kadosh R C, 2005: Numerical vs. Size
// Kadosh R C, 2005: Numerical vs. Luminance
// Kadosh R C, 2005: Luminance vs. Numerical
// Kadosh R C, 2005: Size vs. Numerical
// Kadosh R C, 2005: Size vs. Luminance
// Kadosh R C, 2005: Luminance vs. size
// Kadosh R C, 2005: Numerical Distance
// Kadosh R C, 2005: Luminance Distance
// Kadosh R C, 2005: Size Distance
// Kadosh R C, 2005: Numerical Distance (IPS)
// Kadosh R C, 2005: Luminance Distance (IPS)
// Kadosh R C, 2005: Size Distance (IPS)
// Subjects=15
56.88	-43.28	7.83
29.45	-61.77	46.5
37.62	-55.71	0.17
40.88	5.2	30.71
-25.06	-56.72	47.82
-25.16	-12.68	53.05
-39.04	-41.29	42.22
55.82	-45.4	8.02
33.2	8.65	7.09
-25.06	-53.38	49.77
-26.35	-82.11	8.7
-52.18	3.7	19.64
-28.34	-16.85	54.55
-26.26	-4.23	52.35
-34.72	-39.61	49.84
-33.88	-2.47	34.45
44.17	-74.02	10.55
43.89	-45.16	-15.28
-40.32	-4.97	30.27
40.96	-70.87	10.33
48.18	-46.02	-13.03
-24.21	-86.49	6.81
-52.12	3.25	27.48
-37.35	14.57	7.41
25.72	-40.87	-13.2
29.44	-63	44.37
60.12	-39.66	13.07
39.77	-57.82	0.32
-24	-53.54	47.54
-37.13	1.48	30.81
41.74	-44.2	-16.45
38.74	-59.59	4.95
-44.52	-.97	41.13
26.24	-54.13	49.24
-24	-53.54	47.54
-22.99	-66.2	35.2
28.36	-55.43	45.98
-25.08	-51.44	47.37

// Nakao T, 2005: Obsessive Compulsive Disorder (OCD) Patients
// Subjects=10
48	26	26
-40	26	18
-36	2	44
-40	38	6
-40	12	-8
22	-60	42
40	-50	46
-20	-64	52
-48	-36	40
10	-76	-20
38	-60	-22
22	-74	-18
30	66	8
54	12	34
-50	4	36
6	24	42
-6	16	46
34	18	-2
58	-36	44
24	-58	58
-28	-58	52
-60	-28	34
-48	-40	46
-34	-86	14
26	-68	-24
-32	58	-4
-50	22	-4
-44	16	46
-54	-62	22
-66	-28	-8
-10	-70	52
28	-82	-30
-42	16	48
-34	58	-8
-44	28	-14
48	-66	40
-42	-72	36
-10	-60	26
22	-84	-34
8	-86	-26
44	46	-2
54	10	40
24	10	-8
-28	10	6
-30	4	-36
-58	-60	2
-64	-28	10
62	-44	30
-64	-32	34
-34	-60	48
-4	-70	50
-26	-86	32
22	-60	56
-44	-66	-38
-20	-70	-34
32	12	42
18	56	20
18	46	0
14	-42	34
-26	-40	36
-18	-6	40
24	-28	-18
64	-16	-14
26	-34	38
-18	-28	-16
54	-10	34
-36	48	18
-2	24	22
20	0	12
18	-30	-2
-12	-26	-2
-40	-10	-14
-64	-30	-2
-58	-42	0
32	-82	32
42	-82	4
16	-90	18
-16	-66	2
16	-58	-20
-42	-48	-24

// Nakao T, 2005: Healthy Controls
// Subjects=13
48	26	26
-40	26	18
-36	2	44
-40	38	6
-40	12	-8
22	-60	42
40	-50	46
-20	-64	52
-48	-36	40
10	-76	-20
38	-60	-22
22	-74	-18
-32	58	-4
-50	22	-4
-44	16	46
-54	-62	22
-66	-28	-8
-10	-70	52
28	-82	-30

// Pelphrey K A, 2005: Autism
// Subjects=10
49	-79	18
-38	-66	3
-42	19	-1
35	5	0

// Pelphrey K A, 2005: Healthy Controls
// Subjects=9
49	-51	11
63	-54	0
52	-37	37
-53	-40	42
46	23	32
56	16	11
7	26	35

// Peuskens H, 2005: biological motion - scrambled point light motion
// Peuskens H, 2005: localization of motion-sensitive regions
// Subjects=6
54	-69	6
-48	-69	3
45	-60	-18
-39	-69	-21
57	-48	12
45	-69	6
-48	-75	0

// Ansari D, 2005: Children
// Subjects=12
56.23	-47.72	60.62
9.93	26.31	44.91
44.08	9.62	32.54
-62.89	7.78	18.31
53.53	10.08	10.08
18.2	13.59	3.51
39.5	13.03	-5.61
30.9	23.38	-8.61

// Ansari D, 2005: Healthy Controls
// Subjects=12
-53.99	-11.54	56.63
36.84	-40.66	43.53
-32.61	-34.39	48.26
-52.04	9.56	40.34
-33	32.88	23.66
28.28	-71.61	29.49
-17.64	-71.54	34.48
-42.45	-33.5	19.3
63.32	-26.53	17.5
-38.45	28.48	8.48
50.24	12.55	0.99
-21.09	-68.67	3.05

// Kaufmann L, 2005: Numerical comparison > null events
// Kaufmann L, 2005: Physical comparison > null events
// Kaufmann L, 2005: Numerical comparison > physical comparison
// Kaufmann L, 2005: Both Tasks (Distance 1 > Distance 4, only neutral trials)
// Kaufmann L, 2005: Numerical comparison (Distance 1 > Distance 4, only 
// neutral trials)
// Kaufmann L, 2005: Physical comparison (Distance 1 > Distance 4, only 
// neutral trials)
// Kaufmann L, 2005: Both tasks (incongruent trials > congruent trials)
// Kaufmann L, 2005: Numerical comparison (incongruent trials > congruent 
// trials)
// Subjects=17
52	4	28
0	-4	60
32	-16	64
-56	0	24
-60	-16	24
-48	-20	60
24	-56	56
-24	-64	60
44	-32	44
20	4	28
-24	16	16
40	-80	-8
-44	-72	-8
8	-56	-4
36	-16	64
28	-60	56
-8	-4	68
-32	-52	52
-60	-24	48
36	-80	-8
-40	-84	-8
24	4	52
20	4	28
-48	-12	28
-24	-32	36
-36	-8	24
-4	8	48
12	-16	40
-24	-60	52
-48	-32	44
16	-44	52
28	-44	48
40	-36	40
-36	0	16
24	4	20
28	0	16
20	-48	52
32	-40	20
-28	-24	20
-28	-56	48
-36	-20	56
-48	-28	44
44	-32	56
40	-40	60
20	-80	40
44	8	28
44	36	16
-36	-84	20
-28	-68	36
0	28	36
-32	24	-4
-44	36	-4
36	-24	56
32	-48	56
24	-44	40
44	16	-4
28	24	0

// Venkatraman V, 2005: Symbolic Exact Addition > Control
// Venkatraman V, 2005: Symbolic Approximate Addition > Control
// Venkatraman V, 2005: Nonsymbolic Exact Addition > Control
// Venkatraman V, 2005: Nonsymbolic Approximate Addition > Control
// Venkatraman V, 2005: Conjunction (symbolic and nonsymbolic addition, exact 
// and approximate)
// Venkatraman V, 2005: Nonsymbolic-symbolic (collapsed across exact and 
// approximate addition)
// Subjects=10
-44.64	7.69	29.26
-50.76	-35.47	49.67
-28.28	-61.23	44.88
3.64	12.15	55.09
51.79	-38.54	42.06
-2.77	9.91	54.24
-44.62	3.46	29.61
-50.81	-35.99	43.03
-31.49	-58.08	44.66
-35.24	18.64	4.81
48.63	-38.05	48.75
29.94	19.03	4.03
-2.88	19.8	44.49
-42.49	4.53	29.5
-47.53	-35.2	52.96
-31.52	-58.33	41.33
-35.28	18.3	0.38
-44.78	30.44	20.66
-51.16	-56.04	-9.93
32.57	-51.6	40.03
32.03	18.53	-2.64
51.38	39.65	21.01
54.58	-46.07	-14.21
-6	11.84	51.88
-44.69	7.18	22.61
-54	-35.83	45.28
-28.33	-61.83	37.13
-28.81	19.99	7.97
-38.4	38.85	18.76
-52.25	-53.05	-12.4
38.65	10.85	21.34
51.79	-31.94	44.85
29.34	-58.48	33.96
32.1	22.56	8.17
44.94	42.61	18.61
54.55	-43.15	-17.8
-44.63	4.52	29.52
-50.76	-35.47	49.67
-28.28	-61.23	44.88
3.63	13.21	55
48.61	-38.31	45.42
0.27	28.02	40.42
-38.17	-1.53	33.3
-31.58	-62.28	31.63
-28.85	28.37	6.15
-38.3	20.16	24.79
35.48	8.97	24.88
42.26	-43.12	52.59
32.6	-64.55	37.77
34.25	29.34	13.15
51.51	21.21	30.36

// Costantini M, 2005: Possible hand movements vs possible scissors movements
// Costantini M, 2005: Impossible hand movements vs impossible scissors 
// movements
// Costantini M, 2005: Observation of impossible vs possible hand movements
// Subjects=13
-52	8	20
56	-24	48
52	-36	40
-40	-32	40
56	-36	48
-56	-48	0
56	-56	4
-12	-20	0
56	12	28
-28	-24	64
-60	4	24
-36	-36	64
44	-36	64
-64	-20	24
64	-16	20
-52	-40	28
56	-36	36
32	-44	56
-56	-28	16
52	-28	16
-52	-60	8
48	-56	8
48	-60	-12
-48	-80	8
-64	-20	28
60	-20	32
-52	-24	32
64	-28	40
32	-44	56
-60	-28	16
52	-68	4
48	-60	-12
40	-88	4

// Michels L, 2005: classic point-light walker
// Michels L, 2005: classic point-light walker static
// Michels L, 2005: sequential position walker
// Michels L, 2005: sequential position walker static
// Subjects=4
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6

// Zentgraf K, 2005: Observation for motor imagery > rest
// Zentgraf K, 2005: Observation for evaluation > rest
// Zentgraf K, 2005: Observation for motor imagery > observation for 
// evaluation
// Zentgraf K, 2005: Observation for evaluation > Observation for motor 
// imagery
// Subjects=10
30	-6	57
48	30	15
-39	39	33
-36	-54	63
60	-30	33
33	-42	45
-45	-57	-30
-33	-75	27
-24	-63	-54
12	-60	-42
-21	0	9
21	21	-3
60	12	36
42	24	-3
-42	-3	60
-54	12	24
24	-57	60
-57	-33	27
42	-48	-30
-39	-87	-3
-21	-39	-45
-12	12	27
-33	42	21
-18	3	72
-54	12	0
-6	-3	60
-57	-39	42
-12	-60	-3
24	-36	18
-12	-36	18
0	24	66
0	24	66

// den Ouden H E M, 2005: IC (ICPM + ICnoPM) > PC (PCPM + PCnoPM)
// den Ouden H E M, 2005: PC (PCPM + PCnoPM) > IC (ICPM + ICnoPM)
// den Ouden H E M, 2005: PM (ICPM + PCPM) > noPM (ICnoPM + PCnoPM)
// den Ouden H E M, 2005: ICnoPM - PCnoPM
// den Ouden H E M, 2005: PC x PM
// Subjects=11
0	-48	33
-57	-57	18
51	-48	24
-9	63	12
-42	18	-39
39	21	-33
-42	-72	36
48	-75	36
-57	-30	36
-3	-60	51
48	-45	45
27	63	6
3	-42	24
-57	-57	21
57	-66	27
-9	69	15
-36	12	-30
30	18	-27
-45	-69	36
48	-72	39
-3	48	30

// Shin L M, 2005: PTSD
// Subjects=13
22	4	-14
18	-6	-20
-20	-8	-18
14	48	8
0	46	-10
4	-38	70
-12	52	-10
16	38	22
22	2	-14
22	0	-26
40	-72	-40
-12	-52	38
-10	38	-12
16	38	22
-12	52	-10
16	48	20

// Shin L M, 2005: Healthy Control
// Subjects=13
18	-6	-18
-16	-6	-18
-2	38	-10
-6	38	12
-6	24	20
14	48	20
-28	-8	-18
22	-8	-26
-38	-82	20
-58	-22	-18
20	-68	-46
10	-12	52
22	2	-14
22	0	-26
40	-72	-40
-12	-52	38
-10	38	-12
16	38	22
-12	52	-10
16	48	20

// Kim J, 2005: Appropriateness of facial affect > Gender matching task
// Kim J, 2005: Appropriateness of facial affect > Gender matching task + 
// Resting
// Subjects=14
-46.19	15.83	-30.51
-53.54	22.7	-9.82
-3.12	-4.69	3.05
-3.02	43.61	35.8
12	44.3	43.38
-.78	25.99	41.72
3.45	33.24	38.83

// Mitchell J P, 2005: Mentalizing > Nonmentalizing
// Mitchell J P, 2005: Nonmentalizing > Mentalizing
// Subjects=18
-9	51	36
-45	12	18
-36	6	51
-24	-3	-27
45	-6	-15
-30	-18	6
0	-21	48
-24	-42	69
24	-57	69
-51	-48	3
57	-51	9
-9	-102	12
9	-96	15
-39	-63	-3
51	-57	-12
-24	-69	39
-30	-87	6
36	-87	0

// Bryant R A, 2005: PTSD
// Subjects=14
51.66	-30.84	60.34
-47.7	-39.7	62.91
-56.79	-19.03	31.88
29.15	69.58	10.44
49.32	7.23	54.37
42.1	45.39	3.65
46	20.4	-34.28
61.6	-59.13	-13.23
-65.28	-52.89	37.62
-.32	0.88	58.08
26.84	-25.64	-20.44
-25.18	3.54	-26.92
7.38	0.44	-15.96
55.74	-12.93	45.05
-47.67	-32.9	66.72
-54.8	1.63	23.08
1.06	-55.3	-14.82
0.94	-38.7	-20.94

// Bryant R A, 2005: Controls
// Subjects=14
6.38	-78.42	59.09
3.6	-102.76	5.52
12.03	-99.93	-10.59
-52.03	-37.59	62.77
68.76	-25.64	46.09
13.97	25.32	-2.85
7.49	-86.31	-25.31
-24.95	16.26	-5.77
66.01	22.49	9.99
50.36	46.98	-25.78
22.98	63.12	33.6
72.49	-14.68	2.36
-7.46	0.34	6.71
0.85	28.49	-14.14
55.74	-12.93	45.05
-47.67	-32.9	66.72
-54.8	1.63	23.08
1.06	-55.3	-14.82
0.94	-38.7	-20.94

// Sakamoto H, 2005: PTSD
// Subjects=16
-13.75	-43.68	-4.71

// Sakamoto H, 2005: Healthy Control
// Subjects=16
48.71	-53.65	53.4
31.49	-11.12	54.49
-28.19	-75.78	49.45
-28.33	-13.42	57.6
-34.97	25.87	43.23
-15.86	18.1	23.59

// Allen P P, 2005: Activation Whilst Listening to and Evaluating the Source 
// of Speech
// Allen P P, 2005: Self > Alien
// Allen P P, 2005: Alien > Self
// Allen P P, 2005: Distorted > Undistorted
// Allen P P, 2005: Undistorted > Distorted
// Allen P P, 2005: Emotional > Neutral
// Allen P P, 2005: Source x Distortion Interaction
// Allen P P, 2005: Correct > Misattributions
// Allen P P, 2005: Distorted Self-Speech, Correct > Misattributions
// Subjects=11
50.29	-18.8	-5.3
-47.92	-21.62	8.33
-51.19	-28.92	-3.28
-36.22	-56.21	-13.44
38.41	28.17	-2.41
-41.62	22.29	11.27
4.44	18.22	23.35
7.84	-58.84	17.5
7.95	-61.07	29.96
0.11	-40.68	-8.46
-1.05	-18.48	-10.31
-37.49	21.91	-7.71
4.4	26.59	21.53
53.52	-26.27	-5.83
-46.9	-29.87	-2.14
-5.09	-69.97	-1.49
45.88	21.53	-6.4
-35.33	22.1	-5.52
5.5	26.86	24.84
-49.03	-34.2	-2.87
-53.27	-42.68	-2.11
-41.26	-35.56	33.96
-21.92	-74.99	31.47
-49.12	-23	-9.38
-49.16	-19.02	-13.06
54.45	-11.17	-17.14
17.26	-58.64	-8.27
44.93	20.52	8.19
8.77	15.5	29.1
-37.59	27.4	-19.32
5.24	40.66	-3.08
-33.38	31.14	-26.37

// Small D M, 2005: BR > BO
// Small D M, 2005: FR > FO
// Small D M, 2005: LO > LR
// Small D M, 2005: CR > CO
// Small D M, 2005: CO > CR
// Small D M, 2005: (CO > CR) vs. (LO > LR + BO > BR + FO > FR)
// Subjects=11
3	33	3
-3	27	21
18	12	9
57	-9	-6
-3	-27	51
-3	3	15
-6	0	-3
48	36	-18
24	-18	-12
-57	18	-3
54	15	-3
-45	-9	-3
51	-12	0
66	-24	15
-36	9	3
-30	24	-3
-3	-3	15
-6	0	-6
-36	12	0
-45	-9	-3
39	15	-18

// Stevens M C, 2005: Target Stimulus > Baseline, Placebo > E2
// Stevens M C, 2005: Distractor Stimulus > Baseline, Placebo > E2
// Stevens M C, 2005: Target Stimulus > Baseline, E2 > Placebo
// Stevens M C, 2005: Distractor Stimulus > Baseline, E2 > Placebo
// Stevens M C, 2005: Standard Stimulus > Baseline, E2 > Placebo
// Subjects=8
-16	-72	60
16	0	16
-60	-52	-6
36	-68	54
-48	-80	12
16	-4	-6
-52	-52	48
-20	-72	54
20	-84	30
-56	-16	48
-12	44	36
20	-84	42
20	44	30
-56	-64	12

// David S P, 2005: Smokers
// Subjects=9
1	44	-5
-14	56	28
14	-78	-17
8	56	-12
-6	50	0
-14	56	28
32	-86	-20
-6	-82	-12

// Canessa N, 2005: Descriptive Reasoning vs. Baseline
// Canessa N, 2005: Social-Exchange (SE) vs. Baseline
// Canessa N, 2005: Social-Exchange (SE) > Descriptive Reasoning (DES)
// Canessa N, 2005: Descriptive Reasoning (DES) > Social-Exchange (SE)
// Subjects=12
-10	32	32
2	36	32
-4	28	44
10	26	40
-4	16	56
-44	14	44
-42	18	32
-8	14	64
38	46	20
34	56	24
-54	-70	16
-38	-48	24
-48	-68	36
-46	-66	40
-46	-52	44
-6	-78	40
2	-68	36
-4	-80	36
-4	28	32
4	36	32
-4	40	36
4	42	44
-6	30	44
6	32	52
-6	14	68
10	16	56
-42	20	36
-28	18	44
-42	6	56
46	6	44
48	14	32
-40	36	12
-50	38	20
-52	-62	28
-46	-64	32
-44	-64	40
46	-64	28
46	-58	32
52	-56	36
46	-68	40
-14	8	12
-8	44	52
8	44	52
-8	40	56
8	38	56
-40	32	16
40	6	40
46	-60	32
50	-60	36
-16	10	12
4	38	32
-6	30	44
-6	34	56
-44	14	44
-42	18	32
-44	-58	32
-50	-66	36
-44	-64	40
-42	-66	44

// Dietz N A, 2005: All Conditions vs. Fixation
// Dietz N A, 2005: Main Effect of Word-Type: Pseudowords > Real Words
// Dietz N A, 2005: Main Effect of Response-Modality: Aloud > Silent
// Dietz N A, 2005: Aloud Real Word Reading > All Silent Reading and Aloud 
// Pseudoword Reading
// Subjects=16
-56.81	6.05	36.12
-41.19	-47.56	-21.59
-47.55	-61.96	-14.45
-39.87	-81.83	-9.26
-60.23	20	24.72
-46.19	11.23	21.98
-28.34	-51.2	53.63
10.46	21.55	60.34
-62.51	-.61	11.11
-53.65	-2.21	27.92
62.8	1.96	8.72
56.54	0.31	25.8
-54.27	16.07	-17.58
-65.84	-14.42	1.32
-64.66	-26.76	7.01
60.38	7.63	-10.85
62.77	-26.73	0.35
-18.84	-8.42	-40.41
-11.95	-29.41	-12.68
-35.7	-67.65	-18.58
18.42	-71.09	-12.43
5.52	-18.11	3.84
-20.63	9.68	-7.43
-22.61	-77.62	-11.09

// Grewe T, 2005: N-OS vs. N-SO
// Subjects=16
-33.17	22.37	-2.22
-54.42	16.92	11.87
-.94	37.56	26.25
-39.25	12.64	37.7
48.14	30.48	12.9
41.66	23.07	0.21
50.26	13.87	4.23

// Han S, 2005: Healthy Controls, Shape Experiment
// Subjects=16
16.76	-90.32	23.11
61.01	-22.66	32.48
-67.6	-33.31	29
55.04	5.9	-6.11
27.61	-83.38	27.85
-55.88	-57.47	11.02

// Han S, 2005: Healthy Controls, Vertical Lines Experiment
// Subjects=13
5.69	-81.38	4.49
-28.28	-59.5	56.69
3.72	-89.82	17.68

// Pouthas V, 2005: (Short Standard + Short Nonstandards + Long Standard + 
// Long Nonstandards) > Controls, p<0.01
// Pouthas V, 2005: (Short Standard + Short Nonstandards + Long Standard + 
// Long Nonstandards) > Controls, p<0.0001
// Pouthas V, 2005: (Long Standard + Long Nonstandards) > (Short Standard + 
// Short Nonstandards), p<0.01
// Pouthas V, 2005: (Long Standard + Long Nonstandards) > (Short Standard + 
// Short Nonstandards), p<0.0001
// Pouthas V, 2005: (Long Standard + Long Nonstandards) > (Short Standard + 
// Short Nonstandards), p<0.0003
// Subjects=6
-33	24	0
39	-42	39
3	6	60
3	24	48
33	18	0
39	33	15
-51	0	48
27	3	51
9	12	12
6	12	57
12	30	27
51	12	15
-51	-3	48
51	9	42
12	18	15
6	12	57
51	12	15
-51	-3	48
51	9	42
12	18	15

// Konishi S, 2005: Dimension change (DC) minus Dimension repeat (DR)
// Konishi S, 2005: Control minus release
// Subjects=31
8.42	19.18	69.57
-46.11	12.91	28.54
-19.67	5.9	66.88
-10.99	-79.1	52.73
-56.51	-3.78	57.26
-16.42	-87.43	-36
37.6	-50.04	-29.41
5.46	-32.77	-3.68
-43.3	-23.75	72.46
-30.42	-59.4	57.84
-31.33	56.39	10.54
62.06	-66.65	21.12
-18.52	-49.82	-23.99

// Meister I, 2005: Novel > Repeated 1-day (Activations)
// Meister I, 2005: Novel > Repeated 6-week (Activations)
// Meister I, 2005: Comparison of retention intervals for naming novel vs. 
// repeated pictures, 1-day > 6-week
// Subjects=10
30	-90	-3
48	-60	-15
-39	-75	-12
-48	-63	-15
-45	-84	0
-51	9	39
-36	30	12
39	-65	-9
45	-72	-9
-42	-72	-18
-56	26	-4
42	-69	-15
-27	-93	-9
-45	-72	-18
-33	-69	-15
-39	15	15
-36	6	24

// Mohanty A, 2005: Healthy Controls
// Subjects=17
-53.75	-36.8	-25.12
66.61	-8.2	-23.35
60.15	34.71	-10.71
-53.98	37.96	-10.26
0.97	38.55	-8.4
33.2	-99.58	5.31
43.74	-84.11	15.28
-57.85	-40.56	17.34
62.32	38.59	17.87
-32.72	25.19	19.35
55.98	24.59	-3.18
47.44	45.53	-4.53
30.78	-17.64	0.06
-20.03	5.07	-.96
-22.01	-28.57	1.37
-47.28	-51.91	2.74
-32.72	25.19	19.35
66.61	-8.2	-23.35
33.19	-97.48	5.16
43.74	-84.11	15.28
-57.84	-40.43	19.55

// Mohanty A, 2005: Schizotypy
// Subjects=17
-41.05	-42.99	-24.77
32.84	-21.09	-22.27
-20.06	4.22	-14.81
7.27	47.01	-9.02
-64.23	-39.33	3.97
-66.26	-57.85	11.91
-56.12	51.09	-2.27
43.23	45.75	-.27
53.93	28.42	25.27
-11.36	-33.33	25.45
-55.6	-57.83	45.14
55.98	24.59	-3.18
47.44	45.53	-4.53
30.78	-17.64	0.06
-20.03	5.07	-.96
-22.01	-28.57	1.37
-47.28	-51.91	2.74
-32.72	25.19	19.35
66.61	-8.2	-23.35
33.19	-97.48	5.16
43.74	-84.11	15.28
-57.84	-40.43	19.55

// Kimmerly D S, 2005: Increased activation during baroreceptor unloading 
// covarying with mild lower body negative pressure
// Kimmerly D S, 2005: Decreased activation during baroreceptor unloading 
// covarying with mild lower body pressure (LBNP)
// Kimmerly D S, 2005: Increased activation during higher heart rates 
// covarying with mild LBNP
// Kimmerly D S, 2005: Decreased activation during higher heart rates 
// covarying with mild LBNP
// Kimmerly D S, 2005: Increased activation during baroreceptor unloading 
// covarying with moderate LBNP
// Kimmerly D S, 2005: Decreased activation during baroreceptor unloading 
// covarying with moderate LBNP
// Kimmerly D S, 2005: Increased activation during higher heart rates 
// covarying with moderate LBNP
// Kimmerly D S, 2005: Decreased activation during higher heart rates 
// covarying with moderate LBNP
// Subjects=6
-42	36	20
44	0	54
52	18	28
6	-54	70
6	-78	52
-40	12	-6
-46	12	10
32	28	20
18	46	10
-8	24	24
44	48	-12
34	-22	13
40	-12	34
44	-22	60
-14	-52	-25
18	46	12
-22	0	-26
-12	-20	12
46	0	0
30	54	0
-42	38	24
48	4	50
58	20	26
-60	-16	42
8	-58	68
5	-78	50
-38	14	-6
30	22	12
16	54	6
13	-46	30
-26	-2	-18
6	-14	14
46	44	-10
36	-34	18
22	60	16
-8	-6	46
46	-6	54
44	-18	56
-28	-50	-36
44	-8	-2
4	44	2
-22	-6	-20
26	-2	-26
-6	-16	12
2	-32	-14

// Khalfa S, 2005: Minor - Major
// Khalfa S, 2005: Mode - Tempo
// Subjects=13
1.3	55.94	26.84
-15.24	53.39	0.48
-18.05	63.18	36.53
24.38	-.17	45.44
-60.03	11.67	38.98
31.06	-8.47	59.6

// Koelsch S, 2005: Unpleasant > Pleasant (Both Blocks)
// Koelsch S, 2005: Pleasant > Unpleasant (Both Blocks)
// Koelsch S, 2005: Unpleasant > Pleasant (2nd Block Only)
// Koelsch S, 2005: Pleasant > Unpleasant (2nd Block Only)
// Subjects=11
-28.9	-15.01	-18.09
-25.62	-27.43	-13.74
-49.36	11.84	-26.8
27.73	-14.67	-18.77
24.58	-27.3	-16.56
40.39	8.95	-30.93
-38.24	-25.36	14.11
-38.52	33.25	1.39
-29.92	20.7	3.46
50.39	-15.57	8.93
40.56	33.73	0.44
37.37	24.02	-.94
-19.32	-5.44	-19
16.99	-5.48	-22.76
-51.2	-2.69	5.67
-54.51	10.52	-2.09
-9.7	6.76	-13.45
53.53	2.42	7.38
53.49	5.34	3.79
11.71	7.23	-9.27

// Zambreanu L, 2005: Heat/Capsaicin > No Heat/Capsaicin
// Subjects=12
-18	-60	-28
-10	-28	-18
0	-34	-4
-46	-24	4
-10	-30	6
8	-28	8
38	-26	8
-64	-26	10
62	-40	10
2	44	14
-8	-40	36
4	-58	66
22	62	10
0	2	70
-2	-30	78

// Haist F, 2005: Autism Spectrum Disorders (ASD)
// Subjects=8
52.94	-25.62	57.69
44.34	-32.79	48.36
43.24	-43	40.3
38.6	-75.4	-20.49
38.57	-75.65	-23.82
34.39	-84.6	-15.21
44.34	-32.79	48.36
49.41	1.83	27.55
-42.51	5.42	27.19
-33.21	50.55	4.34
41.88	12.18	24.54
-54.25	-2.14	26.85
-32.02	16.63	6.06
38.98	-9.84	56.53
44.11	-4.38	30.36
-40.3	-1.54	33.33
32.47	-7.65	44.15
-5.91	-1.48	58.58
37.91	-36.26	45.38
27.31	-58.52	47.37
-24.98	-55.87	58.89
42.09	-36.11	33.05
22.99	-72.18	36.29
-19.75	-72.44	36.81
35.61	-85.16	4.9
-33.83	-75.55	11.58
50.43	-69.01	-7.78
42.92	-66.06	-10.17
-37.26	-58.08	-9.92
38.6	-75.4	-20.49
11.92	-18	8.46
-9.42	-26.59	9.42
-23.44	7.16	6.75
37.5	-74.6	-23.89
-42.4	18.68	47.27
-10.18	-5.82	57.87
31.15	27.09	25.64
6.83	-6.66	45.48
5.73	-7.01	41.06
-3.94	0.16	38.34
-42.87	4.99	-19.61
44.11	-4.38	30.36
-43.43	2.55	45.29
59.89	12.87	4.2
5.91	-84.17	34.15
-1.59	-78.93	33.8
-1.72	-80.3	16.07
37.82	-87.72	12.89
-20.91	-90.99	17.19
7.85	-92.82	4.74
-7.23	-75.44	-3.23
-32.79	-90.14	1.64
22.62	-68.38	-10.86
-15.84	-72.84	-10.04
50.28	-9.03	-2.77
50.18	10.81	-7.78
47.29	-70.55	0.19
16.13	-49.38	-12.38
-12.73	-46.38	-12.3
29.85	-14.92	-22.12
-25.73	-14.19	-21.54
25.56	-7.37	-20.47
-22.52	-8.63	-18.7
36.09	-1.19	-37.84
-31.24	1.58	-37.3
32.03	-49.51	-29.28
-27.73	-61.16	-23.15
-6.36	-46.77	-17.92
-42.75	53.46	15.36
-9.07	-93.24	28.39
-6	-89.21	11.29
59.05	-63.79	3.95
12.05	-94.71	-6.3
-9.24	-89.58	6.9
35.57	-85.59	-.64
40.85	-80.79	-7.8
30.06	-89.54	-23.67

// Haist F, 2005: Healthy Controls
// Subjects=8
52.94	-25.62	57.69
44.34	-32.79	48.36
43.24	-43	40.3
38.6	-75.4	-20.49
38.57	-75.65	-23.82
49.41	1.83	27.55
-42.51	5.42	27.19
42.26	-13.54	63.49
32.5	-5.19	48.41
-31.65	1.82	48.56
42.87	31.14	21.82
49.25	35.32	20.28
-33.21	50.55	4.34
-33.22	56.98	4.92
41.88	12.18	24.54
-54.25	-2.14	26.85
5.64	21.8	41.99
-2.9	20.69	42.18
-8.32	15.48	30.42
16.23	18.63	27.64
46.57	-24.09	64.33
-53.02	-20.31	39.51
-51.95	-41.08	32.31
27.37	-64.44	53.44
-28.19	-63.63	55.12
22.03	-69.93	51.73
-7.92	-60.59	51.29
-51.86	-44.62	41.53
61.22	-46.97	14.78
64.39	-47.3	10.31
-53.18	-41.66	11.19
38.87	-87.97	9.55
48.28	-68.05	-8.95
-39.39	-62.4	-10.65
-32.94	-69.68	-9
33.17	14.91	5.45
-32.02	16.63	6.06
16.19	-16.92	8.32
-12.72	-1.23	7.33
-16	19.9	5.6
23.62	-3.13	7.08
-.99	-55.2	-17.27
6.47	-75.22	-29.06
43.82	-63.36	-30.48
-25.64	-55.06	-27.04
44.34	-32.79	48.36
49.41	1.83	27.55
-42.51	5.42	27.19
-33.21	50.55	4.34
41.88	12.18	24.54
-54.25	-2.14	26.85
-32.02	16.63	6.06
38.98	-9.84	56.53
44.11	-4.38	30.36
-40.3	-1.54	33.33
32.47	-7.65	44.15
-5.91	-1.48	58.58
37.91	-36.26	45.38
27.31	-58.52	47.37
-24.98	-55.87	58.89
42.09	-36.11	33.05
22.99	-72.18	36.29
-19.75	-72.44	36.81
35.61	-85.16	4.9
-33.83	-75.55	11.58
50.43	-69.01	-7.78
42.92	-66.06	-10.17
-37.26	-58.08	-9.92
38.6	-75.4	-20.49
11.92	-18	8.46
-9.42	-26.59	9.42
-23.44	7.16	6.75
37.5	-74.6	-23.89
-26.26	-3.17	52.26
-43.43	2.55	45.29
-53.16	9.04	33.7
-34.27	49.48	4.44
56.85	8.04	24.72
-48.91	7.75	30.42
-51.03	8.97	32.57
3.65	-4.22	49.77
-3.9	12.65	48.45
11.14	-1.81	52.83
11.35	-22.73	71.31
-51.91	-20.93	45.12
48.65	-35.68	51.9
-6.87	-61.82	49.15
30.41	-75.02	26.41
65.47	-47.2	11.41
-42.44	-46.62	14.83
50.56	-73.18	7.07
32.12	15.07	7.68
-30.93	17.95	9.28
-40.52	5.03	8.24
-9.49	-13.01	6.05
25.69	9.4	3.77
7.56	-76.01	-25.66
44.11	-4.38	30.36
-43.43	2.55	45.29
59.89	12.87	4.2
5.91	-84.17	34.15
-1.59	-78.93	33.8
-1.72	-80.3	16.07
37.82	-87.72	12.89
-20.91	-90.99	17.19
7.85	-92.82	4.74
-7.23	-75.44	-3.23
-32.79	-90.14	1.64
22.62	-68.38	-10.86
-15.84	-72.84	-10.04
50.28	-9.03	-2.77
50.18	10.81	-7.78
47.29	-70.55	0.19
16.13	-49.38	-12.38
-12.73	-46.38	-12.3
29.85	-14.92	-22.12
-25.73	-14.19	-21.54
25.56	-7.37	-20.47
-22.52	-8.63	-18.7
36.09	-1.19	-37.84
-31.24	1.58	-37.3
32.03	-49.51	-29.28
-27.73	-61.16	-23.15
-6.36	-46.77	-17.92
47.31	21.96	40.39
-48.01	34.48	18.13
55.5	29.24	-3.81
-56.55	21.4	14.86
-51.35	26.49	-2.35
38.82	23.57	48.15
4.33	52.23	22.73
66.64	-15.45	36.61
-42.19	-19.76	59.41
-3.8	-64.31	30.36
51.72	-69.95	21.28
-45.55	-63.13	21.82
40.97	-58.64	17.11
-45.58	-60.22	18.23
67.31	-11.81	-12.77
-56.75	3.94	-18.24
25.68	-33.64	-16.04
-27.77	-40.73	-20.41
40.75	-64.21	-13.65
-27.72	-42.41	-14.69
-37.18	-22.18	13.83
0.08	-73.94	-25.75
2.09	-66.41	-38.67

// Valera E M, 2005: 2-back - X-task, ADHD
// Valera E M, 2005: 2-back - X-task, Healthy Controls
// Valera E M, 2005: 2-back - X-task, Healthy Controls > ADHD
// Valera E M, 2005: 2-back - X-task, Healthy Controls > ADHD, No LD subjects
// Subjects=15
-36	-60	54
39	21	-3
39	36	30
6	-78	-33
33	-57	-36
-12	-6	9
3	33	42
15	-12	6
-27	-69	-36
-33	27	-6
-27	-69	42
9	-75	-24
15	-81	12
57	-54	-18
-27	-66	-21
-33	-90	-3
-33	-57	-15

// Pantano P, 2005: Multiple Sclerosis (MS)
// Subjects=18
-45.82	-14.45	45.81
-47.8	-27.35	57.2
-36.44	-9.7	-64.64
-.35	6.1	56.45
-11.89	-11.45	-4.37
-11.7	-8.94	11.06
-58.39	14.32	-1.65
-18.42	-58.87	-17.5
47.14	7.02	52.19
36.56	-43.86	59.64
34.27	0.05	58.7
63.09	13.92	33.3
36.56	-43.86	59.64
14.21	-4.59	10.19
62.49	21.47	-12.26
51.79	5.79	-7.16
20.47	-58.74	-18.17
-.99	-70.85	-8.76
-39.28	-14.01	50.14
-55.76	-28.16	26.04
-51.08	-34.16	53.45
-62.28	10.94	31.25
-.39	8.02	54.02
-26.91	-.9	6.05
-16.14	-16.37	0.67
-51.6	-18.34	16.04
50.32	-22.93	41.65
44.94	-29.33	42.37
67.21	1.54	15.41
67.31	12.15	25.56
40.78	-4.08	60.12
40.92	-47.89	62.21
24.84	-.38	-2.73
14.21	-3.53	10.09
62.57	18.8	-6.39
20.45	-56.71	-19.49
3.36	-52.02	-2.86
56.63	9.75	34.95
69.64	-19.44	32.01
53.09	6.39	10.69
12.64	-16.61	53.99
60.98	-17.45	30.84
42.84	-16.91	49.02
60.96	-20.85	28.93
43.01	-37.46	58.9
-36.96	-9.47	64.21
60.98	-19.58	31.05
61.03	-13.74	36.07

// Pantano P, 2005: Healthy Controls (HC)
// Subjects=9
-33.82	-11.35	55.38
-27.27	-35.99	55.47
-41.25	-35.53	61.26
-62.29	-5.53	27.28
-49.12	8.08	45.88
-.29	7.68	61.89
33.17	-13.24	54.43
45.08	-31.59	52.68
5.04	7.18	56.25
17.34	-66.74	-11.72
7.55	-71.65	-17.8
9.6	-70.24	-25.81
-46.91	-4.68	47.1
-43.57	-12.65	53.44
-52.21	-31.28	49.82
-49.11	5.95	46.09
-1.44	8.22	56.26
39.66	-14.28	54.42
46.12	-35.19	48.54
10.48	1.99	57.79
31.35	-74.55	-15.67
6.53	-52.53	-8.46
9.77	-59.11	-10.11

// Mitchell R L C, 2005: Congruent > Neutral (Color Modality)
// Mitchell R L C, 2005: Congruent > Neutral (Number Modality)
// Mitchell R L C, 2005: Congruent > Neutral (Shape Modality)
// Mitchell R L C, 2005: Incongruent > Neutral (Color Modality)
// Mitchell R L C, 2005: Incongruent > Neutral (Number Modality)
// Mitchell R L C, 2005: Incongruent > Neutral (Shape Modality)
// Mitchell R L C, 2005: Congruent (number > color) > Neutral (number > 
// color), Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (number > shape) > Neutral (number > 
// shape), Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (shape > color) > Neutral (shape > color), 
// Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (shape > number) > Neutral (shape > 
// number), Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (number > shape) > Neutral (number > 
// shape), After exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (shape > color) > Neutral (shape > color), 
// After exclusion of task difficulty effects
// Subjects=15
-10.91	-7.38	73.65
-7.54	-39.27	76.75
-24.35	-60.27	25.32
-17.94	-87.02	14.41
-8.42	-78.66	-0.02
0.97	-58.16	-22.38
-17.32	-13.47	77.72
-57.05	-19.84	11.8
50.44	-12.22	52.91
43.75	-36.76	31.92
52.65	-.23	-25.63
-44.74	-5.01	-36.95
21.39	-44.23	56.58
18.29	-36.61	69.32
-1.44	-51.94	44.28
26.83	-51.99	-26.79
-28.2	-35.3	-17.42
-28.04	-66.9	-10.94
39.82	-48.45	-24
-27.6	-80.05	20.61
36.32	-70.09	-48.69
-30.74	15.9	48.15
-17.74	6.37	48.87
-27.21	-60.66	55.67
-24.05	-71.16	46.57
-56.77	-24.35	32.41
-24.05	-84.23	44.5
-50.36	27.66	37.24
49.32	45.05	-23.33
29.8	51.05	-26.95
16.76	60.27	-31.01
-35.02	40.94	-28.21
40.85	-70.31	52.1
-27.77	-91.18	4.91
40.04	-82.92	-13.87
-40.95	-79.7	-9.45
-34.97	-40.7	-40.3
49.37	-79.31	-44.64
-22.07	-34.58	-44.49
40.85	-70.31	52.1
-56.77	-24.35	32.41
-24.05	-84.23	44.5
40.85	-70.31	52.1
-27.77	-91.18	4.91
40.04	-82.92	-13.87
-40.95	-79.7	-9.45
-34.97	-40.7	-40.3
49.37	-79.31	-44.64
-22.07	-34.58	-44.49
40.85	-70.31	52.1
44.14	-45.86	60.83
-68.9	-43.69	9.88
-44.2	-12.97	4.17
-55.97	-18.77	11.67
-14.19	-3.34	71.06
1.8	-50.86	44.12
30.14	-70.06	-25.06
24.05	-94.49	0.99
-55.97	-18.77	11.67
-14.19	-3.34	71.06
1.8	-50.86	44.12

// Chen S H A, 2005: Encoding > Finger Tapping (within telencephalon and 
// diencephalon)
// Chen S H A, 2005: Maintenance > Finger Tapping (within telencephalon and 
// diencephalon)
// Chen S H A, 2005: Retrieval > Finger Tapping (within telencephalon and 
// diencephalon)
// Chen S H A, 2005: Encoding > Finger Tapping (below diencephalon)
// Chen S H A, 2005: Maintenance > Finger Tapping (below diencephalon)
// Chen S H A, 2005: Retrieval > Finger Tapping (below diencephalon)
// Subjects=15
-48.49	-83.88	-7.79
-50.74	-62.72	-10.96
-56.1	-75.5	-9.61
-48.39	-84.22	0.09
-66.9	10.87	7.8
-53.45	5.83	45.05
-59.84	-5.58	49.65
-53.54	2.98	37.49
-20.45	-36.05	-2.91
-27	-38.72	-8.14
-22.76	-38.26	-14.98
-33.55	-31.61	-12.09
-29.11	-31.83	-3.18
-4.75	9.92	51.66
-.52	14.74	45.51
-8.83	11.67	70.61
-.32	10.77	60.47
27.07	-33.76	-3.95
29.15	-34.37	-10.65
20.48	-9.42	-7.36
47.22	-0.01	57.36
61.18	-.58	50.46
63.21	3.91	41.01
38.67	2.81	65.07
31.79	-103	12.91
27.56	-101.23	20.65
69.15	6.47	-.8
-11.28	10.65	48.34
-2.64	12.81	47.98
-64.62	12.87	17.65
-56.15	8.36	3.39
-58.06	11.29	23.3
-38.1	29	-18.01
-41.41	-44.42	46.46
-18.53	10.34	-12.02
-9.91	12.39	-13.49
-50.69	-64.54	-7.42
31.1	27.53	-14.56
13.87	14.71	-13
-3.02	37.32	23.15
-9.24	25.03	41.28
-4.78	6.42	48.65
-55.91	13.42	23.05
-64.57	13.29	22.09
-16.1	-13.93	3.79
-36.99	2.34	64.17
-46.63	14.49	-11.95
54.85	14.33	-19.26
48.51	12.05	-8.85
7.85	-16.86	17.12
-18.74	-30.65	-37.09
-10.12	-26.37	-37.66
-25.23	-37.26	-38.57
37.56	-70.01	-36.4
50.87	-91.5	-14.33
41.82	-61.7	-39.53
41.96	-72.67	-30.61
31	-45.47	-37.59
1.07	-84.75	-19.75
28.74	-80.11	-52.06
-16.45	-26.41	-26.34
20.16	-77.49	-46.57
-1.11	-87.09	-21.72

// Soeda A, 2005: Traumatic Brain Injury (TBI)
// Subjects=5
-59.42	21.22	3.29
-50.5	8.02	22.37
44.58	12.82	22.52
57.77	14.53	40.06
49.03	9.41	31.75
40.78	-62.11	47.93
12.58	11.36	54.59

// Soeda A, 2005: Healthy Controls
// Subjects=11
4.01	5.36	59.81
3.76	25.39	44.38
-24.3	-92.69	22.93
-32.56	-59.2	60.1
38.5	-76.13	35.91
51.68	-50.4	57.79
38.58	-66.79	43.95
-46.36	48.24	16.08
-46.21	23.13	23.05
-50.38	13.31	33.05
55.11	-70.21	-16.51
61.59	-57.01	-13.44
40.67	2.74	52.72
53.05	42.21	14.99
44.35	57.07	13.66
-28.39	-3.47	58.99

// Thomas R J, 2005: Pre-treatment: n-back > baseline
// Thomas R J, 2005: Post-treatment: n-back > baseline
// Thomas R J, 2005: Pre-treatment > Post-treatment: n-back > baseline
// Subjects=3
52.68	-1.87	34.52
39.01	-61.25	38.54
37.41	51.91	15.68
34.57	-4.72	40.54
2.53	7.32	47.7
-1.58	-4.2	64.33
-18.58	-70.26	51.11
-37.29	10.77	13.3
-46.58	-46.33	32.69
-42.6	26.48	24.31
-42.6	26.48	24.31
-45.85	-67.36	-19.08
-59.65	-33.58	6.12
34.73	-67.88	35.8
13.14	7.75	38.62
-4.88	0.3	53.95
-16.49	-71.82	44.52
-29.37	-17.57	59.08
-47.92	6.9	19.32
-60.02	31.84	-14.97
-63.94	-38.09	3.21
-42.6	26.48	24.31
49.38	4.74	23.96
51.39	-11.93	0.8
42.28	-60.55	47.36
39.56	19.09	3.91
18.77	-14.57	66.08
-27.09	-58.97	60.29
-46.79	-40.82	7.7
-56.2	-43.13	33.65

// Lieberman M D, 2005: In-Group > Out-Group
// Lieberman M D, 2005: Out-Group > In-Group
// Lieberman M D, 2005: African-American > Caucasian-American
// Lieberman M D, 2005: Perceptual Encoding > Verbal Encoding (African 
// American Targets)
// Lieberman M D, 2005: Verbal Encoding > Perceptual Encoding 
// (African-American Targets)
// Subjects=20
46.79	-52.44	13.25
61.73	-31.95	2.01
41.55	17.22	-45.1
35.08	19.53	-42.97
-35.71	-16.31	-9.09
37.62	26.7	-12.35
20.21	27.93	-21.14
41.96	-23.46	-20.91
11.65	-23.98	-24.82
18.08	-10.13	-26.3
57.24	25.89	0.84

// Amedi A, 2005: Negative Correlation between Visual Imagery (VI) and Visual 
// Imagery Questionnaire (VVIQ)
// Amedi A, 2005: Positive Correlation between VI and VVIQ
// Subjects=9
-61.89	-8.3	2.92
-38.3	-20.5	8.13
-51.21	-10.43	1.86
-48.06	-8.81	-5.01
56.66	-1.67	-4.58
55.53	13.13	-5.81
-64.12	-3.71	-6.37
66.49	-34.51	10.33
63.36	-38.16	18.48
-54.16	-52.86	17.72
42.93	-37.36	3.03
-44.54	-52.81	17.6
-5.04	-74.92	3.39
4.64	-91.78	4.69
-25.48	-74.21	-13.16
-50.05	-68.81	-9.99
-49.03	-59.46	-13.02
54.54	-37.69	-16.03
-13.61	-58.68	7.7
-3.83	-72.31	23.23
-30.97	-28.6	-14.7
32.1	-29.02	-12.04
51.18	30.99	-8.37
-31.08	35.07	-3.31

// Mazard A, 2005: Imagery - Baseline
// Mazard A, 2005: Perception - Baseline
// Mazard A, 2005: Imagery (Objects) - Imagery (Non-Objects), p<0.001
// Mazard A, 2005: Imagery (Objects) - Imagery (Non-Objects), p<0.05
// Mazard A, 2005: Perception (Objects) - Perception (Non-Objects)
// Mazard A, 2005: Perception (Non-Objects) - Perception (Objects)
// Mazard A, 2005: Imagery (Objects) - Imagery (Non-Objects), Left vs Right 
// Lateralization
// Mazard A, 2005: Perception (Objects) - Perception (Non-Objects), Left vs 
// Right Lateralization
// Subjects=15
-48	-58	-10
50	-58	-16
-6	-84	2
-16	-76	10
36	-50	38
36	-54	48
32	-68	46
-44	-46	42
-28	-74	28
-24	-76	42
-30	-66	52
-32	-52	40
32	0	52
-32	0	52
-54	28	28
-46	24	24
46	32	20
8	14	50
14	30	26
-10	26	38
-6	14	48
40	26	-4
-36	20	-4
-34	22	6
0	-36	-14
-14	-10	2
-14	-2	-4
-8	-10	10
16	-8	10
6	-26	-4
-18	2	14
16	0	-4
24	-96	-2
-8	-86	-2
10	-94	4
30	-74	40
34	-78	28
22	-30	-2
-20	-32	-4
-56	-48	-14
50	-56	-12
-46	-72	-10
-34	-74	-12
-18	-98	-2
-26	-82	20
34	-58	-18
-24	-92	10
34	-54	50
-40	-48	42
-30	-68	56
-32	0	54
6	18	44
-4	14	48
-50	4	36
54	10	24
32	-6	46
34	2	54
-56	14	22
10	-12	8
-10	-18	10
-52	8	16
-52	36	20
-54	6	36
64	4	36
-60	-14	18
-60	-28	48
-66	-28	30
-44	-38	36
6	-76	8
-16	-30	6
-50	-54	-14
6	-80	0
14	-94	4
4	-90	4
-12	-98	0
-28	-72	-12
-32	-58	-20
-50	-54	-14
-58	-60	-8
38	-68	-18
18	-86	26
-44	-76	20
8	-44	60
-46	30	16
-50	6	20
22	-64	50
-56	-22	30
-46	-50	50
-38	-50	38
-52	8	24
-46	4	30
-48	36	22
-24	2	42
-48	-54	-14
-46	-72	-8
-42	-62	-10
-62	-56	2
-52	-46	48
-26	-64	48
-50	6	24
-40	18	28
30	30	26
-62	12	8
2	-88	2
-34	-80	26
-48	-54	-14
-26	-88	-10

// Cannon T D, 2005: Maintenance and Manipulation
// Cannon T D, 2005: Memory Set
// Subjects=11
1.66	-59.82	46.65
52.45	24.25	14.48
46.91	45.23	-2.82
49.43	-14.46	23.34
2.48	7.94	42.08
20.3	15.46	-0.02
-17.09	15.32	1.54
-32.1	24.58	-1.3
29.3	-5.13	49.56
-31.65	-4.78	45.77
-46.78	3.28	27.42
-3.71	-53.51	46.19
50.36	21.41	19.21
-43.68	31.85	24.99
2.46	11.03	40.7
19.33	-1.12	5.84
-17.01	-8.03	2.38
29.27	0.07	48
-21.89	-37.33	50.61

// Laurens K R, 2005: Schizophrenic Subjects
// Subjects=29
-52	8	-20
52	12	-12
-36	24	0
48	20	-8
-36	20	4
36	20	0
8	28	32
-8	-4	48
-56	-40	16
60	-44	4
-60	-44	24
64	-32	32
-56	16	20
44	12	24
40	4	40
24	0	-24
20	-12	-16
44	16	-20
36	28	-16
44	0	0
8	48	8
0	-36	24
44	-64	12
-32	-68	52
40	-60	48
-4	-64	48
16	-76	52
-56	-48	48
42	-56	48
44	16	44
-12	44	32
16	56	28
-56	16	36
-44	20	48
-52	20	24
-64	-44	12
-68	-36	0
56	-36	4
56	-12	-8

// Laurens K R, 2005: Control Subjects
// Subjects=28
-24	-4	-24
20	-8	-16
-28	-20	-12
32	-20	-12
-52	12	-16
56	8	-12
-36	20	-12
36	16	-4
-36	16	-12
40	8	-12
0	32	28
4	28	36
-4	4	36
0	-36	28
-64	-36	20
56	-40	4
-60	-48	24
64	-28	32
64	-48	-8
-36	-64	52
36	-60	48
-4	-60	48
8	-76	36
-36	-56	40
36	-60	44
-48	4	36
52	16	28
48	4	48
16	52	28
24	0	-24
20	-12	-16
44	16	-20
36	28	-16
44	0	0
8	48	8
0	-36	24
44	-64	12
-32	-68	52
40	-60	48
-4	-64	48
16	-76	52
-56	-48	48
42	-56	48
44	16	44
-12	44	32
16	56	28

// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity on Day 
// 1, Decreased Intensity
// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity on Day 
// 1, Increased Intensity
// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity with 
// Extended Practice, Decreased Intensity
// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity with 
// Extended Practice, Increased Intensity
// Parsons M W, 2005: Increased MR Signal Intensity for Transfer Conditions
// Parsons M W, 2005: Increased MR Signal Intensity in the New Sequence
// Parsons M W, 2005: Increased MR Signal Intensity in the New Map
// Subjects=12
-5.88	6.52	65.71
-22.01	2.05	50.66
-52.12	8.79	30.36
-43	47.55	-19.83
-38.28	7.22	22.53
-52.23	18.59	19.51
-46.75	-29.39	17.89
-40.09	-27.83	51.14
-54.08	-21.29	40.72
-20.72	-64.81	52.91
-41.24	-38.64	35.33
41.17	-13.72	61.29
20.9	-12.35	66.99
55.78	4.69	22.78
29.3	0.42	52.44
60.17	-18.29	28
13.57	-49.32	71.29
39.03	-36.88	50.99
43.22	-79.43	23.29
25.58	-39.06	-31.2
0.01	34.17	9.79
-4.4	38.15	-7.22
1.48	-30.9	35.31
0.28	-82.8	-2.7
-25.66	42.47	9.39
-16.49	-72.88	44.61
-40.04	-47.13	49.41
-61.77	-11.41	17.67
-28.51	-88.89	3.71
-11.69	4.95	4.57
-4.23	-65.51	-26.41
-20.27	-59.17	-25.64
-13.98	-47.22	-36.75
24.63	30.34	13.18
24.07	-66.55	40.27
38.96	-37.56	42.13
12.88	10.55	6.05
13	-14.57	11.5
-51.92	-58.34	29.3
-9.07	-98.78	25.51
48.52	-57.82	26.99
-37.02	1.53	45.3
-3.87	12.91	51.77
-46.81	17.2	28.48
-6.12	16.1	38.15
-29.28	-62.75	52.83
-38.99	-45.09	48.12
-12.75	-66.36	-22.89
38.86	5.33	46.34
6.81	14.03	51.55
41.92	18.16	32.96
25.67	36.61	11.53
7.8	13.26	41.57
20.94	-61.39	52.14
44.38	-40.02	51.19
31.47	-83.82	22.67
34.82	-75.74	44.26
12.17	-85.76	13.02
15	13.65	4.65
-11.28	-5.03	54.47
-22.98	-12.24	58.56
-32.06	48.07	13.46
-23.21	-93.77	-4.86
-38.15	-87	1.44
-14.85	-15.5	1.86
-8.46	10.77	10.74
21.87	0.89	59.17
54.65	12.8	17.65
13.19	-12.6	36.98
29.14	-88.09	-4.82
40.87	-70.67	-.84
53.81	-77.05	11.81
9.81	-19.96	10.88
40.62	-51.32	-25.88
24.45	-29.81	-35.3
-27.27	-75.11	30.42

// Piefke M, 2005: Increased Brain Activity Common to All Memory Conditions 
// Across Males and Females
// Piefke M, 2005: Males > Females, All Conditions
// Piefke M, 2005: Males > Females, CP + CN
// Piefke M, 2005: Males > Females, RP + RN
// Piefke M, 2005: Males > Females, RP + CP
// Piefke M, 2005: Males > Females, RN + CN
// Piefke M, 2005: Females > Males, All Conditions
// Piefke M, 2005: Females > Males, CP + CN
// Piefke M, 2005: Females > Males, RP + RN
// Piefke M, 2005: Females > Males, RP + CP
// Piefke M, 2005: Females > Males, RN + CN
// Subjects=10
-10	62	28
-50	32	-10
40	18	20
-46	22	20
-42	6	52
-2	12	56
54	16	-32
-52	14	-34
60	0	-24
-56	2	-24
-24	-20	-18
-30	-54	48
-6	-56	4
36	-64	-24
-28	-66	-18
46	-82	2
-42	-78	4
14	-82	-42
-12	-38	-14
-14	-36	-16
-14	-38	-14
-12	-38	-16
-14	-38	-14
48	44	8
44	2	4
48	44	8
44	2	4
48	42	6
46	44	10
48	44	8
44	2	4

// Ragland J D, 2005: Schizophrenics
// Subjects=14
-45.75	13.86	26.52
-37.36	-36.04	-14
-54.14	-54.89	19
22.73	-37.51	16.66
5.4	-66.42	-25.32
-7.32	-30.26	3.02
-32.98	-43.79	-4.48
-32.92	-60.71	-3.06
-2.7	-66.25	32.74
-33.14	6.25	-4.21
5.63	19.42	38.85
-32.76	-85.4	7.93
18.28	-17.42	1.64
-28.25	-56.57	50.07
31.55	-91.76	30.03
-20.21	-22.22	-1.97
39.76	-64.5	-3.58
-37.38	16.43	3.91
-62.98	12.39	9
22.79	-89.64	3.19
-7.27	-7.74	18.97
43.8	34.17	5.95
17.94	53.8	-13.25
-24.31	-86.38	-5.47
5.78	-31.67	38.67
5.6	45.49	45.58
31.06	48.16	22.76
57.12	-44.06	39.12
-49.86	-2.06	41.29
-2.91	15.14	39.3
5.68	15.54	43.63
-28.52	-85.72	3.45
-28.25	-56.57	50.07
39.73	-64.85	-8.01
-50.06	13.49	22.14
-7.35	-13	6.03
9.7	-9.01	1.04
39.54	21.12	2.63
-49.85	-23.89	34.19
56.89	10.59	30.08
48.53	-22.62	41.88
18.52	-89.67	3.24
-7.44	12.38	3.9
9.89	41.28	45.89
26.68	60.14	12.89
-24.8	53.54	-12.73
40.06	-61.42	36.31
5.73	-36.59	30.16
43.8	34.17	5.95
52.87	-48.31	39.52
-3.12	-9.09	1.19
-45.59	-2.03	41.23
-28.47	-89.61	8.23
27.2	-88.24	20.86
-36.92	3.62	58.5
35.87	-47.39	53.02
-49.78	-23.21	43.06
-11.13	0.91	76.28
-23.96	-43.17	57.82
-7.28	-3.51	18.61
1.53	-84.17	20.82
-15.58	-88.84	16.94
-32.78	-89.97	3.85
18.52	-89.67	3.24
-54.05	-14.43	46.83
31.5	-87.88	25.24
-32.61	-79.46	29.74
-49.96	5.72	31.71
65.16	20.93	-2.11
-23.93	-60.43	54.8
-15.72	-59.58	10.03
-33.17	-67.68	-38.16
48.21	35.57	23.62
18.62	-88.64	16.53
-28.23	-16.79	69.04
-62.91	-4.53	10.42
14.47	-30.25	56.29

// Ragland J D, 2005: Normals
// Subjects=14
-41.88	31.61	-19.62
-20.48	49.68	-8
-41.59	17.09	12.82
-7.32	-30.26	3.02
-32.98	-43.79	-4.48
-32.92	-60.71	-3.06
48.37	19.68	38.33
52.53	31.71	28.36
5.63	-90.43	-5.47
-33.14	6.25	-4.21
18.53	-93.9	3.59
14.01	-8.64	5.42
-24.02	-52.66	45.23
-11.62	-13.03	6.08
60.93	17.02	2.73
-49.97	9.95	31.36
31.53	-56.9	40.49
-50.14	25.84	16.65
10.02	16.25	52.45
1	-23.81	-24.39
22.79	-89.64	3.19
-7.27	-7.74	18.97
43.8	34.17	5.95
17.94	53.8	-13.25
-24.31	-86.38	-5.47
5.78	-31.67	38.67
5.6	45.49	45.58
31.06	48.16	22.76
57.12	-44.06	39.12
-49.86	-2.06	41.29
-2.91	15.14	39.3
18.52	-89.67	3.24
-46.09	49.87	-3.26
-24.01	-56.89	45.59
-7.43	-18.26	-6.91
56.87	14.82	29.72
5.74	16.22	52.5
-28.91	20.02	-5.41
-11.72	3.55	0.23
18.52	-89.67	3.24
-7.44	12.38	3.9
9.89	41.28	45.89
26.68	60.14	12.89
-24.8	53.54	-12.73
40.06	-61.42	36.31
5.73	-36.59	30.16
43.8	34.17	5.95
52.87	-48.31	39.52
-3.12	-9.09	1.19
-45.59	-2.03	41.23
-37.12	-81.88	-1.24
5.66	19.77	43.28
-41.44	5.43	27.18
-50.45	53.39	-12.43
-20.19	-26.45	-1.62
-28.33	-44.23	44.57
14.02	-12.87	5.77
52.48	26.79	19.85
31.57	-60.79	45.28
39.51	20.77	-1.8
31.49	8.6	61.76
-28.9	24.59	-1.34
35.24	-36.29	-23.73
52.69	7.02	39.35
-6.9	13.63	75.16
-7.28	-3.51	18.61
1.53	-84.17	20.82
-15.58	-88.84	16.94
39.87	-85.31	2.63
52.52	27.14	24.28
-11.61	-8.45	10.16
-54.39	30.38	20.77
-2.61	9.43	75.47
-32.47	-51.68	58.63
-33.17	-67.68	-38.16
48.21	35.57	23.62
18.62	-88.64	16.53
-28.23	-16.79	69.04
-62.91	-4.53	10.42
14.47	-30.25	56.29

// Tan H Y, 2005: Comparisons > Schizophrenics, Maintenance of Letters
// Tan H Y, 2005: Schizophrenics > Comparisons, Maintenance of Letters
// Tan H Y, 2005: Comparisons > Schizophrenics, Manipulation Plus Maintenance 
// of Letters
// Tan H Y, 2005: Schizophrenics > Comparisons, Manipulation Plus Maintenance 
// of Letters
// Tan H Y, 2005: Comparisons > Schizophrenics, Manipulation Plus Maintenance 
// > Maintenance of Letters
// Tan H Y, 2005: Schizophrenics > Comparisons, Manipulation Plus Maintenance 
// > Maintenance of Letters
// Subjects=11
-43.54	13.5	35.45
49.39	14.77	29.81
-14.74	-17.65	15.42
-57.56	14.33	19.93
58.9	16.97	16.14
-48.71	1.01	53.28
35.35	15.35	10.97
-46.43	-50.25	50.86
-48.57	-50.26	50.89
-43.69	39.42	26.58
44.93	40.32	16.57
-9.23	17.1	51.48
9.96	22.25	47.48
35.2	30.27	-2.55
-26.79	24.26	-5.79
-56.4	7.54	28.29
61.06	17.24	19.43
-0.04	63.23	14.05
-53.96	-42.01	48.03
57.22	-40.91	52.24
-44.74	38.53	28.9
-7.06	14.12	53.94
-56.4	7.54	28.29
-57.2	-39.11	44.48

// Tieleman A, 2005: Semantic Self-Paced vs. Perceptual Self-Paced
// Tieleman A, 2005: Semantic Fixed-Paced vs. Perceptual Fixed-Paced
// Tieleman A, 2005: Self-Paced > Fixed-Paced, Semantic vs. Perceptual
// Tieleman A, 2005: Greater Task-Related Deactivation During Fixed-Paced 
// Compared to Self-Paced, Semantic
// Subjects=22
-52.95	29.96	4.56
-38.24	33.49	-27.42
-54.92	22.58	17.65
-46.2	21.01	23.26
-.49	25.89	50.01
3.82	41.11	51.79
-.5	41.09	51.87
-.65	30.17	38.38
37.49	31.18	-21.76
35.26	36.18	-25.58
-51.05	9.39	-20.33
-37.74	24.05	9.37
-52.83	10.06	9.89
-52.78	-42.13	2.72
46.1	15.7	-27.1
-27.21	-17.32	-20.34
-24.96	-25.41	-15.09
-27.16	-32.31	-19.98
-18.58	-14.1	-20.8
-37.9	-47.14	-17.21
20.38	-14.61	-16.93
-9.26	-92.2	15.9
-12.08	93.27	2.08
-7.23	-81.12	8.05
-37.91	-47.24	-18.32
-2.77	-71.35	20.45
14.47	-90.2	13.06
14.55	-89.57	19.72
16.59	-67.54	14.14
-7.27	-61.76	8.37
-48.46	21.34	15.42
-40.22	24.94	-15.33
-54.9	23.86	19.76
-50.24	5.64	42.78
-.37	21.3	58.31
5.86	27.11	39.7
-6.99	23.53	48.11
38.26	30.41	38.82
50.56	24.41	-14.59
-48.91	18.01	-20.1
-39.9	15.32	8.02
-57.13	-36.83	2.27
-11.48	-94.85	10.6
-22.47	-92.95	-2.85
-20.29	-93.9	-1.67
-42.16	-52.16	-13.27
5.38	-51.99	-14.1
14.61	-92.45	23.36
9.64	-80.88	-24.76
37.6	-58.75	-30.79
-24.94	-27.43	-13.77
-20.77	-17.61	-23.78
-33.71	-21.91	-23.13
-50.21	-68.56	29.95
-42.51	10.82	-28.46
20.42	-14.3	-13.6
-.48	-75.82	29.82
-16	-47.11	4.83
14.43	-86.15	10.42
22.99	-57.19	9.65
-25.09	-28.57	-25.98
22.51	-21.4	-20.78
-56.74	-62.4	27.21
-52.36	-69.63	30.09
-50.23	-69.83	27.83
-20.06	40.19	43.33
-9.18	-69.68	27.12
18.9	-65.33	26.21
-9.29	-61.8	19.62
18.58	-51.24	4.65

// Lacourse M G, 2005: Novel, Move vs. Rest
// Lacourse M G, 2005: Novel, Image vs. Rest
// Lacourse M G, 2005: Skilled, Move vs. Rest
// Lacourse M G, 2005: Skilled, Image vs. Rest
// Lacourse M G, 2005: Novel, Image > Move
// Lacourse M G, 2005: Novel, Move > Image
// Lacourse M G, 2005: Skilled, Image > Move
// Lacourse M G, 2005: Skilled, Move > Image
// Lacourse M G, 2005: Novel > Skilled, Move
// Lacourse M G, 2005: Novel > Skilled, Image
// Subjects=54
-26	-4	58
-32	-18	48
40	32	26
34	-18	54
6	2	56
-6	-6	52
-42	-32	44
-24	-56	58
-36	-40	50
48	-34	44
20	-58	58
40	-44	52
-22	-56	-28
20	-56	-28
4	-62	-20
-32	-20	-6
-14	-20	8
10	-16	-8
-22	-4	58
-36	-20	52
34	24	-2
28	-8	52
4	0	58
2	-8	50
-50	-24	32
-42	-30	42
34	-50	42
-6	-50	-18
18	-56	-22
2	-62	-18
20	0	14
-24	-4	12
-14	-20	8
14	-20	8
-56	8	22
-26	-12	52
54	10	12
28	-10	54
2	-2	62
-10	-26	44
-38	-28	46
-32	-48	52
38	-54	48
-20	-56	-24
20	-56	-26
4	-62	-16
22	-8	22
-28	-2	-8
30	-4	8
-16	-22	6
18	-14	10
-46	12	6
-36	-20	52
38	36	20
32	-14	50
0	2	58
8	18	40
-52	-4	40
-18	-66	54
-42	-46	48
48	-38	40
-34	-52	-32
24	-64	-24
-2	-50	-10
20	-4	16
-28	-14	-2
-16	-10	8
-10	18	4
18	18	4
-38	12	12
-34	-24	54
-4	-18	46
-10	-14	58
6	0	44
6	-8	50
10	-10	58
-32	-38	48
-50	-26	30
50	-26	32
30	-26	44
-48	-22	12
6	-62	-20
-16	-22	2
10	-16	-10
-20	18	48
-52	22	22
-36	16	42
-50	-40	32
-48	-56	18
-32	-24	56
-6	-8	48
-8	-26	46
-46	-28	26
-12	-60	22
-42	0	14
52	-24	18
44	-14	0
-44	-12	2
54	-36	22
12	-36	14
-16	-22	4
2	-62	-16
-26	4	50
-42	8	42
-2	12	50
-40	32	22
-32	30	-8
32	-12	42
46	8	30
32	36	12
46	24	-6
-44	-34	32
10	-60	50
18	-32	34
32	-46	48
-44	-62	-6
16	-10	-2
-8	-24	0
-22	0	56
-4	8	52
26	-8	54
38	14	4
-34	-48	44
40	-40	44
54	-24	18
22	-36	4

// Ongur D, 2005: Recognition of Previously Seen Pairs
// Subjects=15
42	-24	-16
-46	-24	-18
8	46	-2
-18	28	-2
-8	44	-10
22	6	18
42	18	-40
-36	2	-6
42	-56	-2
56	-58	10
26	-52	14
4	22	30
30	26	36
-44	30	6
20	-46	26
8	-22	28
-6	-26	10

// Britton J C, 2006: Nonsocial (Positive + Negative) > Nonsocial Neutral
// Britton J C, 2006: Nonsocial Positive (Appetite) > Nonsocial Neutral
// Britton J C, 2006: Nonsocial Negative (Disgust) > Nonsocial Neutral
// Britton J C, 2006: Social (Positive + Negative) > Social Neutral
// Britton J C, 2006: Social Positive (Joy) > Social Neutral
// Britton J C, 2006: Social Negative (Sadness) > Social Neutral
// Britton J C, 2006: Social > Nonsocial, Emotion (Positive + Negative)
// Britton J C, 2006: Social > Nonsocial, Positive
// Britton J C, 2006: Social > Nonsocial, Negative
// Britton J C, 2006: Nonsocial > Social, Emotion (Positive + Negative)
// Britton J C, 2006: Nonsocial > Social, Positive
// Britton J C, 2006: Nonsocial > Social, Negative
// Britton J C, 2006: Positive > Neutral
// Britton J C, 2006: Negative > Neutral
// Subjects=12
18	-75	-15
18	-99	6
-36	-24	0
24	-9	15
24	-75	-18
-3	-81	-6
-36	-24	0
33	-15	6
-12	21	33
-9	-9	12
21	-99	3
33	-15	15
-18	-9	-21
-33	-87	-18
39	-87	-18
-48	-12	-12
45	-27	-9
15	-24	45
3	-3	3
-21	9	-15
21	-9	-6
33	-15	-18
-33	-12	-21
36	-90	-15
-33	-87	-15
42	6	-21
15	60	-12
15	-18	42
-9	6	0
0	-3	3
30	-6	-15
33	-18	-21
6	12	3
-48	-12	-9
9	18	33
15	-24	45
3	-3	3
-15	3	-12
39	-12	-27
57	-21	-15
15	-27	36
18	-12	-18
-9	3	-6
36	-87	-15
51	-57	-3
12	-24	36
30	-3	-15
-6	6	-6
24	-21	-24
-9	-81	-9
-9	30	21
-9	-18	36
15	-9	-18
-9	3	-6
18	-21	-21
-6	15	51
6	33	42
-36	-24	0
54	-18	12
15	-75	-15
15	-75	-15
-9	-90	-9
-18	-63	-9
-39	-9	12
54	-15	15
18	-102	-9
15	-99	6
-15	-66	-9
33	18	0
18	-93	9
-48	-3	-18
21	-24	48
3	-6	6
33	-6	15
-18	-84	9
6	-3	0
-21	-6	-21
-15	3	-12

// Cunnington R, 2006: Observation > Self-Selection Movements
// Cunnington R, 2006: Self-Selection > Observation Movements
// Cunnington R, 2006: Self-Selection and Observation Movements
// Subjects=14
58	-26	30
-52	-24	18
34	-50	56
-36	-34	66
48	-4	46
-46	-70	0
54	-72	6
34	-76	32
-14	-98	-2
26	-98	-4
38	32	30
-36	34	30
-20	60	6
44	20	52
-34	40	46
-4	26	54
-2	-22	20
-6	8	16
20	6	8
0	6	50
64	12	28
-44	6	30
-26	-4	52
14	-96	6
32	-68	44
-26	-70	54

// Hlushchuk Y, 2006: Normals, Group 1
// Subjects=10
54.96	-19.06	45.97
53.72	-26.33	20.94
-50.77	-21.3	54.06
-44.64	-20.83	18.27
-63.89	7.19	27.29
-8.85	-62.48	-14.34
-31.01	-46.55	-26.57
-21.9	-75.88	33.77
40.08	-18.3	57.23
20.98	-59.91	57.59
27.41	-49.84	63.36

// Hlushchuk Y, 2006: Normals, Group 2
// Subjects=10
43.3	-19.25	58.39
-44.33	-19.86	58.33
26.25	-23.32	62.27
-28.29	-20.73	59.33

// Soros P, 2006: Vowel Sound vs. Rest
// Soros P, 2006: Vowel Sound vs. Oral Movement
// Soros P, 2006: Consonant-Vowel Sound vs. Vowel Sound
// Soros P, 2006: Consonant-Vowel-Consonant-Vowel Sound vs. Consonant-Vowel 
// Sound
// Soros P, 2006: Consonant-Vowel-Consonant-Vowel Sound vs. Vowel Sound
// Subjects=9
-2	6	60
6	-2	66
-8	12	34
4	12	34
-2	0	34
4	8	34
60	-4	42
48	-12	44
-44	-6	0
44	2	-6
-24	6	-4
22	-2	2
-22	-6	-2
20	0	0
-12	-14	8
12	14	6
-10	-20	6
10	-20	8
-50	-18	-2
44	4	-14
-38	-26	10
-58	4	-10
-18	-66	-28
-12	-68	-22
-14	-68	-24
14	-68	-24
-8	-18	-6
8	-18	-6
-2	52	26
-4	62	14
2	54	8
-36	-30	14
48	-32	16
-46	-28	10
38	-30	12
-60	-34	4
70	24	0
28	-10	12
-52	-16	6
-50	28	-12
-38	-24	4
36	-24	14
-18	-26	20
-18	-20	24
-38	-24	8
36	-26	10
-64	-18	-8
64	-6	-8
-58	-8	-18
-22	-64	-28
22	-62	-28
-16	-64	-22
12	-72	-22
-18	-66	-24
16	-68	-24
-28	-62	-34
26	-62	-32
-22	-62	-26
26	-62	-26
-18	-56	-24
18	-62	-24

// Drobyshevsky A, 2006: Verb Generation
// Drobyshevsky A, 2006: Working Memory
// Drobyshevsky A, 2006: Emotional Pictures
// Subjects=31
53.48	17.31	7.25
57.9	-33.93	4.8
1.55	7.19	59.99
-41.14	-49.67	44.06
48.68	-43.08	52.52
-43.49	7.41	39.3
55.92	2.89	40.77
-48.02	14.68	9.75
51.35	16.24	7.36
-32.7	1.99	50.79
37.85	4.87	54.19
-29.98	57.34	9.31
37.3	62.86	5.85
2.56	10.92	52.98
-23.97	-62	48.25
22.01	-66.84	50.35
-37.94	-53	42.08
43.29	-50.14	44.25
-20.29	-32.94	-16.69
26.75	-34.69	-15.96
-35.22	-44.83	-17.75
37.43	-47.82	-21.68
-10.49	-83.72	-13.65
17.34	-83.13	-8.45
-44.65	-70.38	-3.23
51.5	-64.6	-5.93
-44.55	4.23	39.58
53.75	9.05	38.05
-43.78	19.82	7.04
50.24	29.01	7.42
-7.56	62.85	9.71
15.99	63.33	13.86

// Mechelli A, 2006: Naming > Fixation
// Mechelli A, 2006: Positive Linear Effect of Relevance, Artifacts
// Mechelli A, 2006: Positive Linear Effect of Relevance, Artifacts > Animals
// Mechelli A, 2006: Artifacts > Animals, Relevance Unmatched, Low, Medium, 
// and High
// Mechelli A, 2006: Artifacts > Animals, Relevance Matched, Low and Medium
// Mechelli A, 2006: Artifacts > Animals, Relevance Matched, Medium
// Subjects=12
-50	-8	46
50	-10	38
-54	-2	18
54	-4	24
-2	12	46
2	12	46
-54	-46	10
66	-34	8
-56	12	-8
-28	-96	2
18	-98	-4
-40	-62	-20
46	-62	-18
-44	-52	-18
44	-50	-20
-28	-74	26
30	-74	26
-28	-60	44
28	-68	44
-14	-26	-16
-40	-48	-28
38	-56	-32
-28	-52	-14
32	-50	-16
-29	-92	4
34	-82	10
6	-88	-16
18	-84	-24
-28	-52	-14
32	-50	-16
-28	-52	-14
-26	-36	-24
32	-50	-16
28	-42	-22
-28	-52	-16
30	-48	-18
28	-44	-22
-28	-52	-14
32	-50	-16
28	-42	-22

// Pierno A C, 2006: Action vs. No Action
// Pierno A C, 2006: Interaction Between Type of Observed Behaviour and 
// Distractor
// Subjects=14
-40	-12	62
-48	-10	36
42	-8	34
56	28	28
-54	-44	12
54	-32	8
-28	-44	64
26	-42	58
-48	-36	26
50	-27	26
-50	-74	6
48	-74	8
28	-82	30
-49	34	11
-47	7	25
54	-6	52
58	-7	27

// Saccuman M C, 2006: Verbs vs. Nouns
// Saccuman M C, 2006: Nouns vs. Verbs
// Saccuman M C, 2006: Manipulable vs. Non-Manipulable Items
// Saccuman M C, 2006: Non-Manipulable vs. Manipulable Items
// Saccuman M C, 2006: Interaction Between Word Class and Semantic Reference
// Saccuman M C, 2006: Manipulable Verbs vs. Manipulable Nouns
// Saccuman M C, 2006: Manipulable Nouns vs. Manipulable Verbs
// Saccuman M C, 2006: Non-Manipulable Verbs vs. Non-Manipulable Nouns
// Saccuman M C, 2006: Non-Manipulable Nouns vs. Non-Manipulable Verbs
// Saccuman M C, 2006: Manipulable Verbs vs. Non-Manipulable Verbs
// Saccuman M C, 2006: Non-Manipulable Verbs vs. Manipulable Verbs
// Saccuman M C, 2006: Manipulable Nouns vs. Non-Manipulable Nouns
// Saccuman M C, 2006: Non-Manipulable Nouns vs. Manipulable Nouns
// Saccuman M C, 2006: Positive Correlations with Increase in Response Time
// Subjects=13
-44	-46	44
-12	-78	-40
50	-54	-20
14	-80	16
10	-40	24
22	10	0
-56	-4	32
-56	6	24
-32	-58	60
-42	-40	56
-42	-38	36
-56	-16	28
-48	-54	-24
-44	-70	-16
40	-44	56
64	-24	0
60	-22	20
0	-38	16
-56	-4	32
-56	6	24
-32	-58	60
-42	-40	56
-42	-38	36
-56	-16	28
-48	-54	-24
-44	-70	-16
40	-44	56
64	-24	0
60	-22	20
0	-38	16
-32	-42	-24
-16	-64	4
-40	-86	20
24	-64	-24
20	-62	12
34	-90	12
10	-54	-8
-36	-22	44
-52	-68	0
-22	-90	-16
-26	-92	-4
-28	-86	4
-32	-74	-40
-12	-62	32
10	-64	32
6	-54	28
38	6	32
40	-10	44
50	-48	0
54	-68	8
34	-92	0
34	-86	8
26	-50	-24
24	-78	-20
28	-66	-35
-42	-44	44
-28	-88	4
-12	-78	-40
50	-54	-20
12	-82	20
10	-38	20
22	10	-4
-38	-54	44
56	-70	4
12	-80	20
22	4	-12
-32	-56	56
-42	-40	36
-32	-42	40
-44	-70	16
36	-44	56
-22	-56	-8
-16	-64	4
-14	-62	32
50	-44	0
14	-52	48
8	-66	36
52	-72	4
18	62	12
-28	-4	36
-26	-54	60
-52	-40	40
-30	-62	20
-62	-34	0
-50	-66	-4
-10	-70	32
54	-6	20
42	-22	36
50	-24	-8
4	-56	20
4	-36	20
-16	-60	4
-12	-40	-20
-30	-50	-24
-38	-80	8
36	-88	12
26	-80	-20
-44	20	-4
-42	-80	-4
-38	-82	-20
48	-70	-20

// de Diego Balaguer R, 2006: Regular Inflection > Regular Repetition
// de Diego Balaguer R, 2006: Irregular Inflection > Irregular Repetition
// de Diego Balaguer R, 2006: Nonce Inflection > Nonce Repetition
// de Diego Balaguer R, 2006: Irregular Inflection > Regular Inflection
// de Diego Balaguer R, 2006: Regular Inflection > Irregular Inflection
// de Diego Balaguer R, 2006: Regular Inflection > Nonce Inflection
// de Diego Balaguer R, 2006: Nonce Inflection > Regular Inflection
// de Diego Balaguer R, 2006: Irregular Inflection > Nonce Inflection
// de Diego Balaguer R, 2006: Nonce Inflection > Irregular Inflection
// Subjects=12
32	-48	0
36	-24	60
-48	8	0
-16	-52	-36
-48	36	12
-36	20	16
-24	-56	-44
20	-24	68
-48	16	12
-12	-52	-32
28	-24	56
-40	24	12
-56	24	16
-44	24	20
40	16	24
48	40	16
-28	-12	-20
-44	8	-4
-4	-36	44
-48	-24	12
-28	-28	-28
8	-56	8
48	-48	12
60	-48	4
0	44	-4
-48	16	24
-52	36	8
-48	48	4
-28	-68	32
-28	-60	-44
48	16	20
44	48	12
44	-36	52
-4	-36	44
-40	-24	8
8	-60	12
60	-48	8
64	32	8
28	-36	-32
0	60	-4
-48	12	8
-48	48	4
-36	-64	52
-40	-64	-40
48	16	20
40	-40	40

// Riecker A, 2006: Syllable Repetition vs. Passive Listening
// Subjects=8
3	6	63
-42	-15	36
36	-15	39
-12	-18	0
12	-21	6
-24	-3	3
27	-6	0
-12	18	9
-39	12	6
-24	-63	-21
21	-54	-24
-21	-67	-54
24	-60	-57

// Johnson M R, 2006: Controls
// Subjects=18
-47.31	14.21	19.47
1.67	18.25	48.49
18.28	-60.74	63.86
-18.3	2.22	4.47
-27.23	-66.29	52.86
54.82	21.78	-20
-38.08	59.82	-9.86
-65.84	-13.36	1.22
-18.52	0.56	-13.29
42.95	60.1	-11.26
36.69	53.03	5.23
43.52	11.86	23.76
-47.31	14.21	19.47
42.99	60.41	-7.93
-31.6	59.84	-9.97
-27.15	-74.49	57.03
54.78	21.47	-23.33
-18.3	2.22	4.47
-50.84	32.85	0.87
-40.62	10.37	35.42
-37.74	-46	-4.99
-62.52	13.53	13.07
23.55	-7.46	-21.06
49.7	44.67	6.96
-14.84	-79.33	4.64
-62.12	-11.94	39.11
-61.93	-29.09	50.89
46.65	-34.88	5.91
-40.11	-49.35	62.61
-41.01	28.19	7.89
-37.36	-12.48	32.02
7.51	-28.17	-12.01
-2.62	53.07	-26.6
58	45.39	-20.15
-47.35	13.9	16.14
-15.19	65.81	7.09
-2.61	52	-26.5
42.74	58.54	-27.92
-2.01	-15.7	7.09
20.31	-9.6	-20.79
-31.2	-42.26	0.13
-31.2	-42.26	0.13
20.31	-9.6	-20.79
-37.85	17.79	-.1
36.76	21.77	3.84
-58.64	-30.89	54.38
37.41	-52.11	40.27
-62.06	-10.36	44.56
-21.99	-2.28	-32
33.57	-32.57	-3.06
64.98	1.01	9.9
-31.1	1.19	17.12
20.89	8.9	27.8
-52.38	7.96	44.82
36.69	53.03	5.23
1.72	18.56	51.82
-27.29	-53.64	50.49
52.67	18.58	-19.65
-18.3	2.22	4.47
40.25	11.64	21.59
-18.49	-2.53	-11.86
55.64	14.73	42.31
-44.06	11.03	19.73
-30.46	-69.5	53.23
1.72	18.56	51.82
36.53	55.07	-7.3
-18.29	0.09	4.68
54.82	21.78	-20
40.25	11.64	21.59
-21.78	-.72	-15.35
55.64	14.73	42.31
33.04	-3.67	-38.4
-59.44	-53.28	-12.87
2.02	-74.39	56.53
-41.32	59.81	-9.8
-47.3	11.02	19.78
1.66	21.44	48.17
-34.8	60.14	-6.58
36.53	28.82	-12.54
-18.26	3.6	7.7
54.82	21.78	-20
-7.75	-74.73	53.37
39.75	60.4	-7.88
-47.31	14.21	19.47
-33.63	-67.92	58.74
1.66	21.44	48.17
36.47	60.08	-11.15
-34.87	56.33	-12.93
54.75	21.26	-25.55
-65.91	-8.35	-2.64
-18.26	3.6	7.7

// Johnson M R, 2006: Schizophrenics
// Subjects=18
-47.31	14.21	19.47
1.67	18.25	48.49
18.28	-60.74	63.86
-18.3	2.22	4.47
-27.23	-66.29	52.86
54.82	21.78	-20
-38.08	59.82	-9.86
-65.84	-13.36	1.22
-18.52	0.56	-13.29
42.95	60.1	-11.26
36.69	53.03	5.23
43.52	11.86	23.76
-47.31	14.21	19.47
42.99	60.41	-7.93
-31.6	59.84	-9.97
-27.15	-74.49	57.03
54.78	21.47	-23.33
-18.3	2.22	4.47
-50.84	32.85	0.87
-40.62	10.37	35.42
-37.74	-46	-4.99
-62.52	13.53	13.07
23.55	-7.46	-21.06
49.7	44.67	6.96
-14.84	-79.33	4.64
-62.12	-11.94	39.11
-61.93	-29.09	50.89
46.65	-34.88	5.91
-40.11	-49.35	62.61
-41.01	28.19	7.89
-37.36	-12.48	32.02
7.51	-28.17	-12.01
-2.62	53.07	-26.6
58	45.39	-20.15
-47.35	13.9	16.14
-15.19	65.81	7.09
-2.61	52	-26.5
42.74	58.54	-27.92
-2.01	-15.7	7.09
20.31	-9.6	-20.79
-31.2	-42.26	0.13
-31.2	-42.26	0.13
20.31	-9.6	-20.79
-37.85	17.79	-.1
36.76	21.77	3.84
-58.64	-30.89	54.38
37.41	-52.11	40.27
-62.06	-10.36	44.56
-21.99	-2.28	-32
33.57	-32.57	-3.06
64.98	1.01	9.9
-31.1	1.19	17.12
20.89	8.9	27.8
-50.02	-44.14	49.94
-8.09	17.9	45.33
-27.45	25.04	53.91
-47.19	5.26	27.07
37.53	-60	47.78
10.44	-15.14	-33.52
-40.27	-5.64	59.41
-31.32	24.72	4.71
-55.57	-1.52	46.94
-34.59	31.09	4.13
58.97	-32.68	40.23
-46.8	-47.63	46.87
33.33	35.71	-7.57
54.98	-38.3	-19.66
-31.32	24.72	4.71
-47.18	2.07	27.39
34.27	-56.82	47.52
-50.02	-44.14	49.94

// Mochizuki-Kawai H, 2006: Mirror vs. Normal Reading, First Run
// Mochizuki-Kawai H, 2006: Mirror vs. Normal Reading, Second Run
// Mochizuki-Kawai H, 2006: Mirror vs. Normal Reading, Third Run
// Subjects=15
34.17	8.04	52.31
56.46	11.69	21.31
48.71	-71.74	-9.52
34.19	-56.38	40.75
3.17	-76.44	-22.85
-2.73	20.9	42.7
-28.4	-60.44	46.7
-39.46	-67.87	25.21
53.13	19.78	16.08
29.7	5.82	40.28
50.85	-64.28	-10.3
35.81	-84.44	-6.93
32.11	-51.4	48.14
-7.04	18.76	42.98
-44.04	6.77	20.15
-28.39	-62.56	46.91
-41.93	-84.4	-2.24
46.58	11.58	9.16
48.62	26.06	3.21
44.38	-68.56	-9.76
23.52	-61.96	50.45
-28.63	3.48	41.5
-37.51	7.21	24.47
-44.11	-80.16	-2.63
-43.7	-34.42	38.78
-32.92	-76.15	28.16

// Shapiro K A, 2006: Nouns > Verbs
// Shapiro K A, 2006: Verbs > Nouns
// Subjects=10
-36	-42	-16
-22	59	23
24	-17	-19
-46	6	40
-32	-57	64
-57	-40	9
38	-48	48

// Hirshorn E A, 2006: Switch - Free Generation
// Hirshorn E A, 2006: Switch - Free Generation (Clustered Responses)
// Hirshorn E A, 2006: Free Generation - Switch
// Hirshorn E A, 2006: Free Generation (Clustered Responses) - Switch
// Subjects=10
-42	3	66
-18	48	-6
-39	24	18
-3	-57	63
-57	-57	54
-3	-66	60
-3	-72	0
48	24	54
48	24	42
48	42	30
3	51	-15
39	57	3
36	42	-9
12	-27	-27
42	-51	45
-12	21	63
-30	54	18
-51	45	9
-54	21	39
-33	18	51
-39	-3	51
15	54	-3
-33	27	6
-39	-24	33
-33	-63	21
-18	-21	15
-39	-39	36
-39	-66	39
-12	-66	51
39	45	39
36	51	15
15	33	48
66	-33	21
51	-30	-18
36	-54	42
48	-60	-33
-18	57	18
-6	57	0
-3	36	-3
-3	30	21
-39	-27	30
-57	-24	42
-57	-24	15
-45	0	-3
-63	-27	30
-36	-78	9
45	24	15
3	-15	12
54	-18	42
69	-15	12
48	-27	6
24	-102	9
-3	60	-12
-63	0	-12
-24	-36	18
-21	-24	-9
-27	-27	-18
-30	-42	-24
-36	-51	-15
-24	-54	-12
-15	-63	0
-6	-75	-9
-9	-90	3
-24	-90	27
27	-27	75
3	-33	30
18	-42	27
48	-21	63
45	-12	21
54	-3	-33
63	-3	9
30	-9	-30
30	-15	-12
30	-30	-15
39	-66	-12
12	-78	30
9	-96	3

// Tremblay P, 2006: Word Reading vs. Fixation
// Tremblay P, 2006: Word Generation, Subcategory vs. Fixation
// Tremblay P, 2006: Word Generation, Category vs. Fixation
// Subjects=12
-52	-8	25
-46	-17	39
47	-10	35
-1	-2	58
-55	-7	24
-48	-16	41
46	-11	35
-45	4	35
-2	-1	58
-2	4	57
-46	33	10
-56	-7	23
-47	-17	40
44	-13	35
-42	3	27
-2	-1	58
-2	4	57
-51	32	9

// Camchong J, 2006: Schizophrenic Patients
// Subjects=14
49.47	12.28	38.94
-48.84	11.7	40.12
29.28	5.7	51.99
-10.23	-78.87	21.62
17.77	-62.13	56.7
-9.95	-59.49	65.72

// Camchong J, 2006: Normals
// Subjects=14
0.4	10.73	50.79
49.47	12.28	38.94
-48.84	11.7	40.12
29.28	5.7	51.99
-26.3	5.2	50.44
-10.23	-78.87	21.62
17.77	-62.13	56.7
-9.95	-59.49	65.72
36.45	45.36	27.4
30.97	57.07	14.21
-38.54	56.14	8.39
23.6	7.62	8.4
37.43	20.22	4.96
-34.17	19.79	5.82
-11.57	-15.77	11.89

// Dalton K M, 2006: Controls > Autistic Subjects and Siblings, All Faces
// Dalton K M, 2006: Controls and Siblings > Autistic Subjects, All Faces
// Dalton K M, 2006: Autistic Subjects > Controls, All Faces
// Subjects=10
24.82	-81.94	-7.52
-34.02	-68.72	-10.18
21.22	-2.62	-27.51

// Meisenzahl E M, 2006: Schizophrenic Patients
// Subjects=12
-9.69	-11.14	-1.08
24.78	12.28	-5.1
31.11	25.4	-14.35
-31.59	27.1	-15.69
27.09	2.48	4.79
51.1	20.81	27.22
-31.41	54.7	3.98
-27.16	14.77	-10.07
44.97	-33.48	43.9
48.91	22.72	24.83
56.23	22.04	5.72
49.01	-36.71	20.62
39.72	16.41	-19.21
14.43	-23.76	23.29
-62.59	-5.59	3.76
-64.56	-19.45	16.37
-53.79	-24.08	12.16
56.24	-9.63	-.11
-29.3	32.4	-5.05
-11.65	-57.84	4.7
18.58	-60.06	2.16
34.25	-40.55	49.27

// Meisenzahl E M, 2006: Normals
// Subjects=12
-52.11	22.67	-16.03
-47.96	-39.44	42.72
-43.49	-40.51	53.95
53.17	15.73	18.73
56.26	26.61	8.63
-11.74	-9.25	7.73
-9.65	4.48	5.22
7.64	-18.42	0.47
-41.78	5.38	28.09
37.46	22.26	-25.36
-48.39	28.44	22.56
51.47	-37.72	44.21
-66.53	-38.83	27.28
36.54	-57.15	55.35
-37.95	52.04	-1.24
-35.66	47.56	8.12
-43.82	16.09	39.39
-1.02	41.61	11.48
-27.22	23.07	-13.13
3.46	38.41	22.93
-34.8	-48.89	55.75
-47.85	-38.61	51.6
-31.56	27.31	-13.47
-51.07	24.59	-18.48
-28.68	22.83	41.83
-43.88	15.67	34.95
50.94	27.21	15.39
34.27	-55.75	47.41
42.85	-49.65	43.3
-5.31	37.44	13.09
-3.07	24.89	16.54
7.98	-25.7	25.84
39.73	20.87	-17.41
9.96	33.11	23.34
-11.79	-3.07	4.88
7.63	-11.93	0.95
-44.33	18.83	-0.09
33.14	49.56	-20.14
-2.66	21.42	48.25
-11.04	-66.34	51.47
58.25	18.78	-6.32
-56.19	19	2.34
-2.84	29.96	36.2
-9.69	-11.14	-1.08
24.78	12.28	-5.1
31.11	25.4	-14.35
-31.59	27.1	-15.69
27.09	2.48	4.79
51.1	20.81	27.22
-31.41	54.7	3.98
-27.16	14.77	-10.07
44.97	-33.48	43.9
48.91	22.72	24.83
56.23	22.04	5.72
49.01	-36.71	20.62
39.72	16.41	-19.21
14.43	-23.76	23.29
-62.59	-5.59	3.76
-64.56	-19.45	16.37
-53.79	-24.08	12.16
56.24	-9.63	-.11

// Schaefer H S, 2006: Social Interaction Analysis
// Schaefer H S, 2006: Facial Stimuli Analysis
// Schaefer H S, 2006: Erotic Stimuli Analysis
// Subjects=9
-22.44	54.81	17.24
-11.44	32.87	49.07
-45.74	13.94	27.63
-40.38	0.95	24.2
-27.6	-3.81	16.64
-33.05	-13.75	-1.42
26.81	-6.54	3.98
21.59	-7.57	18.62
11.87	-10.86	4.51
-32.04	-18.66	-9.94
-29.81	-37.51	-6.16
66.46	-44.71	2.26
-56.26	-46.99	25.05
46.1	-55.29	-8.88
-5.01	-44.91	19.83
-49.71	-65.3	35.44
-1.97	46.7	34.42
-50.3	38.47	1.09
-6.13	30.27	42.53
-47.83	3.44	29.65
-37.4	20.66	3.55
42.69	6.28	-10.66
9.74	-20.64	2.01
21.56	-78.16	-13.37
-8.68	62.24	1.96
-23.48	60.52	22.35
35.13	50.44	-3.13
10.64	43.49	5.55
11.87	33.07	22.02
-27.59	39.14	35.34
-5.15	31.62	32.37
54.42	31.35	-3.98
42.02	12.58	43.46
61.01	5.73	8.13
2.5	-2.89	39.64
-45.59	26.49	52.22
38.47	23.31	3.57
-34.14	18.99	9.23
-6.39	-8.65	-6.61
-55.62	12.29	-6.69
-27.17	-38.88	58.61
-41.19	-44.64	40.3
41.06	-50.04	32
4.67	-48.66	25.61
2.67	-69.22	35.16
4.51	-76.69	-6.61

// Tan H Y, 2006: High-Performing Schizophrenics
// Subjects=8
-55	15	10
-45	37	-7

// Tan H Y, 2006: Low-Performing Schizophrenics
// Subjects=7
-55	15	10
-30	14	-2

// Tan H Y, 2006: High-Performing Normals
// Subjects=14
44	23	27
-45	37	-7

// Tan H Y, 2006: Low-Performing Normals
// Subjects=12
44	23	27
-30	14	-2

// Beauregard M, 2006: Depressed Patients
// Subjects=12
4	17	19
41	-9	-25
26	-6	-14
34	8	3
2	46	21
44	3	-27
-22	-12	-11

// Beauregard M, 2006: Normals
// Subjects=12
4	17	19
41	-9	-25
26	-6	-14
34	8	3
-6	49	10
-43	17	-13

// Voets N L, 2006: Left Temporal Lobe Epileptic (LTLE) Subjects
// Subjects=12
4	-56	52
-64	-36	22
62	-22	14
24	30	44
-8	58	32
2	58	32
12	-32	4
-10	-80	4
2	-86	-6
-34	18	-6
0	18	36
-44	36	8

// Voets N L, 2006: Normals
// Subjects=12
-40	0	26
-40	4	-12
-56	-4	36
-4	16	40
34	16	-2
14	-100	-8
-30	-84	-12
8	16	36
20	-94	2
-26	-64	42
-28	-10	4
30	-4	0
-10	6	42
-10	-96	-8
44	24	-12
-44	20	-12
16	-16	2
-14	-26	14
-38	48	14
-34	16	-8
34	16	-2
0	18	36

// Moriguchi Y, 2006: Main Effects of ToM Animated Stimuli, Conjunction of 
// Alexithmia Subjects and Normals
// Subjects=14
50	-31	0
42	-61	-9
53	-48	13
50	9	-24
40	4	-34
24	-5	-17
-24	-91	-2
-14	-79	-30
-57	-52	16
-65	-48	17
16	-81	-31
-53	24	14
8	-11	4
6	-52	43
-6	-50	41
-42	9	31
-44	4	44
12	63	17
10	62	30
6	49	44
-57	-6	-11
-49	-28	60
6	-23	-2
10	13	62
-42	-21	-24
69	-20	30
-4	30	-22
-34	-7	-30
-10	-15	4

// Porubska K, 2006: Food vs. Non-Food
// Porubska K, 2006: Activations Modulated by the Subjective Feeling of 
// Appetite
// Subjects=12
-30	30	-18
-48	-12	6
42	-12	12
39	6	-12
54	-6	18
-45	-3	9
39	-18	6
-48	-15	3
27	-12	-3
-30	-15	3

// Takahashi M, 2006: Normal Men
// Subjects=11
-4	-76	2
-44	-78	10
28	-22	-18
22	2	-14
-30	12	-8
0	-14	-10
-8	-90	10
-40	-8	48
-18	-10	38
-42	4	12
-32	-28	-4
-4	-26	6
12	2	18
-8	-14	-12
10	-64	-30
22	2	-14
-32	-6	30
-32	14	12
34	-18	-4
-4	-12	-12
10	-62	-30
30	-94	-16
-10	4	2
28	-92	-14
52	-62	34
-4	-28	2

// Takahashi M, 2006: Normal Women
// Subjects=11
28	-92	-16
-44	6	50
-8	2	0
6	-38	-6
-16	-92	-14
-48	4	50
-44	-66	34
-6	-30	0
-12	2	2
16	-82	-22
22	2	-14
-32	-6	30
-32	14	12
34	-18	-4
-4	-12	-12
10	-62	-30
30	-94	-16
-10	4	2
28	-92	-14
52	-62	34
-4	-28	2

// Allen P P, 2006: 2-Back > 0-Back, Sham Depletion
// Allen P P, 2006: 2-Back > 0-Back, Acute Tryptophan Depletion
// Allen P P, 2006: N-Back, Sham Depletion > Acute Tryptophan Depletion
// Allen P P, 2006: N-Back, Acute Tryptophan Depletion > Sham Depletion
// Allen P P, 2006: Letter Fluency > Baseline, Sham Depletion
// Allen P P, 2006: Letter Fluency > Baseline, Acute Tryptophan Depletion
// Allen P P, 2006: Letter Fluency, Sham Depletion > Acute Tryptophan 
// Depletion
// Subjects=10
47.52	-46.14	40.52
-41.57	34.86	22.48
43.92	35.37	21.46
-25.02	-66.24	48.61
0.36	16.91	48.04
5.58	24.45	35.08
-44.76	30.61	22.87
-44.84	13.3	5.37
35.73	1.68	54.49
-.48	-57.63	47.61
0.31	16.39	41.39
8.8	20.24	35.4
39.66	43.18	26.43
-6.02	-55.32	22.94
0.42	13.1	53.93
-37.36	37.55	15.52
-44.81	18.04	11.66
-53.46	8.07	-6.36
5.52	27.11	28.17
0.31	16.39	41.39
0.38	12.68	48.39
5.53	23.94	28.43
-41.53	10.03	17.87
-44.85	29.67	10.69
-22.05	21.43	53.49
0.33	12.16	41.75
-25.09	-9.8	62.84
0.56	-50.23	46.98
-2.83	12.66	48.43

// Bartolo A, 2006: Funny vs. Neutral Cartoons
// Bartolo A, 2006: Brain Regions in which Stimuli-Related BOLD Signal was 
// Significant for Humor Appreciation
// Subjects=21
-35.74	-52.66	-18.94
-33.97	11.19	-36.49
-33.42	-80.95	-11.7
-62.89	-12.23	-21.35
-58.67	2.36	-26.23
-54.23	16.39	-14.25
-42.32	-45.75	-25.11
-50.77	-73.88	-15.46
-50.9	-45.26	-19.41
7.52	-87.16	-22.98
31.27	-47.85	-17.19
37.28	21.97	-39.89
55.78	31.79	-27.73
33.48	-62.74	-15.76
52.87	-71.9	-23.02
56.21	-68.93	-14.41
-33.45	-80.09	-14.02
-53.23	24.59	-18.44
-56.15	-60.61	-11.08
-31.82	19.91	-35.15
-62.87	-10.96	-19.24
-50.77	-73.88	-15.46
-18.6	-5.49	-20.54
-58.42	-23.08	-11.39
-58.67	2.36	-26.23
-42.3	-45.55	-22.89
-54.41	6.32	-30.06
7.52	-87.16	-22.98
33.45	-47.64	-15.01
60.34	-18.93	-19.43
31.32	-62.74	-15.72
50.17	14.91	-47.26
55.84	27.85	-23.98
18.38	-34.2	-8.24

// Bird G, 2006: Autism Patients
// Subjects=16
46	-48	-20
44	-68	-14
62	-54	-4
-42	-78	-14
-50	-76	-2
28	-46	-12
2	-84	-6
16	-100	8
34	-82	20
-26	-46	-12
-10	-96	-2
-30	-88	22
30	-46	-16
-28	-42	-18
-44	-56	-16

// Bird G, 2006: Normals
// Subjects=16
44	-50	-20
46	-74	-10
-44	-54	-18
-42	-82	-10
-50	-70	2
28	-46	-10
28	-52	-8
2	-82	-6
20	-56	16
34	-88	24
-26	-48	-10
-30	-90	26
44	-46	-20
44	-78	-8
-44	-52	-20
30	-44	-12
-28	-46	-12
-44	-56	-16

// Dapretto M, 2006: Autism Patients
// Subjects=10
-52	-16	38
46	-6	20
-62	2	22
56	-2	14
-46	-16	30
-34	-38	52
-44	-50	-14
34	-50	-12
-8	-72	4
10	-80	2
-26	-66	-4
26	-66	0
-20	-12	-8
20	-4	-12
-34	-68	-16
28	-52	-20
54	8	6
12	20	34
-50	10	12
56	10	14
-36	-2	14
26	14	12
-22	-6	-8
30	-4	-16
-40	-14	-12
36	-18	-8
10	6	6
30	-24	0
-32	-32	6
-26	-10	-10
22	-10	-8
-48	-52	-14
36	-64	-12
-18	-80	-10
6	-76	2
-32	-62	-6
36	-74	-4
-22	-40	-2
30	-48	-16

// Dapretto M, 2006: Normals
// Subjects=10
-44	-6	44
42	-16	34
-42	-8	38
48	0	20
2	0	60
12	20	34
-36	40	26
50	0	40
-50	8	10
54	10	8
-40	20	2
42	36	8
-36	-4	10
36	2	4
-42	-18	38
58	-12	20
-52	4	2
48	12	-4
28	4	-24
-34	-62	-18
30	-62	-16
-18	-78	-12
6	-74	-4
-44	-64	-4
40	-70	-4
-18	-10	-8
18	-8	-8
-36	-12	-8
32	-12	-8
16	4	8
-28	-10	8
20	-4	8
-14	-24	14
4	-18	12
-30	-58	-22
26	-66	-20
54	8	6
12	20	34
-50	10	12
56	10	14
-36	-2	14
26	14	12
-22	-6	-8
30	-4	-16
-40	-14	-12
36	-18	-8
10	6	6
30	-24	0
-32	-32	6
-52	12	4
52	10	12
-52	36	2
42	26	2
30	34	2
-18	-8	-12
-38	-76	-12
32	-52	-12
-18	-78	-8
10	-82	-8
-34	-84	2
36	-70	-4
-42	-60	-14
30	-68	-14

// Ethofer T, 2006: Affective Prosody > Emotional Word Content
// Ethofer T, 2006: Emotional Word Content > Affective Prosody
// Subjects=24
-36	42	6
39	42	6
66	-42	3
-21	36	51
-48	9	-39
-48	30	-6

// Ethofer T, 2006: Happy and Angry > Neutral
// Subjects=24
60	-21	3
-54	-12	0

// Fliessbach K, 2006: Encoding, Abstract > Concrete
// Fliessbach K, 2006: Subsequent Memory Effect
// Fliessbach K, 2006: Recognition, Abstract > Concrete
// Fliessbach K, 2006: Recognition, Concrete > Abstract
// Fliessbach K, 2006: Recognition, Old/New Effect
// Fliessbach K, 2006: Old/New Effect for Concrete Words After Inclusive 
// Masking With Encoding, Concrete > Abstract
// Subjects=21
-52.97	24.33	1.75
55.29	29.67	18.43
-50.43	10.77	28.82
49.51	25.68	-12.45
-53.16	18.52	-14.48
-50.82	27.53	1.4
-36.98	-76.42	48.43
-52.17	-63.81	46.32
50.48	-67.71	44.96
47.13	-6.16	49.01
-2	74.11	26.21
-17.89	-50.57	25.37
-44.07	-12.03	14.16
-43.49	-63.47	49.5
-58.82	-43.19	37.67
7.31	41.48	-13.3
1.01	42.81	1.25
7.39	12.56	-12.68
-40.12	42.14	-3.59
17.27	-21.24	-7.26
-8.05	-59.48	32.81
8.21	-62.3	36.18
-18.47	-60.35	-21.83
-1.47	-35.77	44.92
5.05	-28.85	49.73
4.07	41.47	-13.24
-5.63	41.64	-10.85

// Kraut M A, 2006: Threatening - Non-Threatening
// Kraut M A, 2006: Non-Threatening - Threatening
// Kraut M A, 2006: Animal > Objects
// Subjects=18
44	-40	8
18	21	-8
26	25	-11
28	17	-9
32	-72	46
36	-52	-26
-32	9	35
-36	2	39
38	51	7
-57	-31	5
-34	44	-11
-30	44	-11
-32	23	23
-22	-83	41
57	-15	4
-65	-37	-2
-50	-39	0
-12	12	47
0	16	49
-63	-14	-3
-57	5	-9
-12	-5	9

// Mitchell R L C, 2006: Congruent Semantic vs. Prosody Only
// Mitchell R L C, 2006: Incongruent Semantic vs. Prosody Only
// Subjects=28
-53.18	31.49	-13.52
-65.53	-39.45	20.6
71.4	-19.15	0.57
-62.74	0.92	-6.97
-47.47	21.78	8.63
-53.1	35.41	-6.06
-47.88	27.49	-22.18
42.66	12.01	-43.48
-56.24	-18.62	-9.63
61.35	-4.14	-22.03
-34.85	-11.38	-25.28
-18.37	-14.77	-5.05

// Sacco K, 2006: Experimental Normals
// Subjects=6
50.45	9.15	25.81
61.28	-15.65	34.46
55.86	3.35	32.93
4.78	-4.68	57.61
7.81	13.35	42.68
42.9	1.82	14.25
61.23	-12.82	29.76
60.18	-15.91	31.15
4.92	-36.14	63.59
43.24	-30.94	44.87
-14.32	-41.8	60.94
17.49	-84.84	10.65
29.11	-77.34	-3.49
20.45	-64.33	-13.41
-53.22	5.1	24
-53.25	4.76	19.56
-53.03	-8.25	44.07
-56.37	2.42	30.95
-.55	-7.88	57.94
-1.74	4.12	48.02
-40.45	-1.94	14.4
-30.9	-31.17	-6.67
-52.99	-8.96	48.59
-40.14	-21.83	46.18
-7.93	-36.47	60.42
-30.35	-56.16	55.64
-52.98	-31.94	40.48
-7.05	-61.5	25.71
-11.57	-64.1	-7.48
4.87	-16.85	65.32
33.7	-10.33	64.44
-40.1	-11.46	56.46
0.6	-16.88	65.37
-52.04	2.96	37.54
-54.08	-22.43	39.7
-30.29	-51.16	65.25
-40.03	-37.18	54.16
-66.99	-43.08	21.5
17.48	-88.27	7.6
37.6	-73.57	-10.6
10.87	-57.36	-4.96
21.52	-67.58	-14.26

// Sacco K, 2006: Control Normals
// Subjects=6
50.45	9.15	25.81
61.28	-15.65	34.46
55.86	3.35	32.93
4.78	-4.68	57.61
7.81	13.35	42.68
42.9	1.82	14.25
61.23	-12.82	29.76
60.18	-15.91	31.15
4.92	-36.14	63.59
43.24	-30.94	44.87
-14.32	-41.8	60.94
17.49	-84.84	10.65
29.11	-77.34	-3.49
20.45	-64.33	-13.41
-53.22	5.1	24
-53.25	4.76	19.56
-53.03	-8.25	44.07
-56.37	2.42	30.95
-.55	-7.88	57.94
-1.74	4.12	48.02
-40.45	-1.94	14.4
-30.9	-31.17	-6.67
-52.99	-8.96	48.59
-40.14	-21.83	46.18
-7.93	-36.47	60.42
-30.35	-56.16	55.64
-52.98	-31.94	40.48
-7.05	-61.5	25.71
-11.57	-64.1	-7.48

// Smeets P A M, 2006: Men
// Subjects=12
-20	-8	-4
-16	-2	0
-35	-6	2
-34	-16	38
-14	12	66
22	32	-4
-6	26	-4
34	4	10
-24	6	8
-8	-80	20
-40	-8	36
-20	-90	16
-54	-34	54
-42	-46	62
0	26	46
-2	-4	-6
-14	-2	-2
6	26	46

// Smeets P A M, 2006: Women
// Subjects=12
44	-14	48
56	-2	32
66	-30	12
30	-16	-6
54	-10	8
-42	-16	48
2	-4	-4
-18	-6	-22
-2	-4	-6
-14	-2	-2
6	26	46

// Uher R, 2006: Food > Non-Food
// Uher R, 2006: Taste: Chocolate Milk
// Uher R, 2006: Taste: Chicken Broth
// Uher R, 2006: Taste: Both, Fasting vs. Satiation
// Uher R, 2006: Taste: Chocolate, Fasting vs. Satiation
// Uher R, 2006: Taste: Chicken, Fasting vs. Satiation
// Uher R, 2006: Food: Women > Men
// Uher R, 2006: Taste: Both, Women > Men
// Uher R, 2006: Taste: Chicken, Women > Men
// Subjects=8
-41.53	-66.9	-13.59
36.41	-55.06	-18.83
32.3	-77.49	-5.75
36.86	-54.75	40.25
-37.35	13.43	6.39
-41.4	-1.81	30.02
20.44	-62.22	-13.58
-6.32	18.44	13.42
20.27	-3.55	-11.81
8.63	-2.42	3.84
-34.17	13.19	3.03
-44.66	-17.74	16.89
-37.39	46	14.81
-48.93	10.84	29.04
-48.67	-42.57	40.21
44.24	-10.75	44.28
-41.62	17.89	9.41
51.4	14.56	13.08
-44.56	-12.4	30.94
8.88	28.76	49.18
32.27	-82.24	-12.04
-34.08	-67.2	-18.11
-49.29	23.53	-13.28
5.57	39.69	39.38
-39.59	13.44	-6.97

// Rektor I, 2006: Dots vs. Fixation
// Rektor I, 2006: Alphabet vs. Fixation
// Subjects=10
-51	-27	42
-54	9	15
-42	-30	39
-33	-36	60
-60	-24	30
-9	-30	45
-33	-27	57
-12	-15	0
0	-9	60
36	-93	-6
60	-27	33
-57	-21	36
-36	-24	57
-24	-18	60
-12	-21	6
-30	-39	57
-3	-15	51
42	-36	48
63	-12	30
21	-6	69

// Bohland J W, 2006: Simple Syllable, Go vs. Fixation
// Bohland J W, 2006: Simple Sequence, Go vs. Fixation
// Bohland J W, 2006: Complex Syllable, Go vs. Fixation
// Bohland J W, 2006: Complex Sequence, Go vs. Fixation
// Bohland J W, 2006: Go > NoGo
// Bohland J W, 2006: Complex Sequence > Simple Sequence
// Bohland J W, 2006: Complex Syllable > Simple Syllable
// Bohland J W, 2006: Syllable Complexity x Sequence Complexity
// Subjects=13
-46	-10	60
56	6	40
-54	-12	40
-62	-4	24
60	-4	30
-42	-24	12
66	-10	12
-32	20	0
40	10	6
38	24	2
38	-22	8
-62	-8	6
-54	-4	4
56	-26	8
-56	8	-6
64	6	2
50	4	-8
48	14	18
-34	36	12
-32	46	12
-2	-2	68
-2	6	50
4	4	70
-4	14	40
-12	2	10
-24	2	-10
-20	12	4
18	10	6
32	-6	-2
24	4	-4
-8	-20	-2
12	-22	0
14	-12	6
20	-16	10
8	-6	4
-26	-60	-22
40	-56	-26
34	-62	-24
24	-56	-20
36	-54	-54
-44	-60	-20
-44	-18	64
-34	-6	54
48	6	32
56	8	32
-54	-10	40
-62	-4	22
64	-10	14
66	-4	24
56	-6	34
-48	-26	14
-64	-12	12
-50	2	6
54	-14	12
38	-6	14
-34	8	8
-34	-4	8
42	8	-14
-66	-24	8
-40	-2	-14
70	-26	8
-54	10	-6
64	6	2
-46	6	28
-54	14	32
-38	24	2
40	26	4
50	20	0
-36	40	32
-26	46	20
56	-8	54
0	0	66
-6	10	52
-6	14	42
-8	-12	42
8	-12	40
-28	-52	52
-52	-36	50
40	-48	48
42	-44	46
-60	-40	30
-46	-30	32
-22	2	6
-30	-8	-4
-28	-16	10
32	-6	-2
24	4	6
-10	-16	0
14	-16	4
-20	-60	-22
20	-60	-20
40	-68	-22
44	-54	-28
36	-54	-54
16	-62	-44
38	-40	-50
56	6	40
50	-14	60
-52	-12	40
-62	-4	24
68	-6	26
56	-8	38
-42	-24	12
-52	0	4
68	-8	12
-44	4	0
36	-22	6
-64	-10	6
-66	-22	8
-64	-30	12
58	-12	6
66	-22	8
50	-24	12
70	-30	16
-52	8	-4
64	6	2
-36	26	2
-38	32	14
2	0	66
-2	14	42
-58	-38	28
-24	0	-8
-22	4	6
20	8	6
32	-16	-2
32	-4	-4
30	-4	8
24	2	-6
-10	-16	4
14	-16	2
-28	-60	-24
20	-56	-20
46	-56	-28
36	-52	-56
-46	-60	-20
-60	0	30
62	-4	42
56	8	40
-54	-10	44
60	-4	32
68	-4	22
-44	-24	14
-34	24	0
-40	14	4
40	24	0
-62	-12	8
-64	-30	12
52	-24	10
60	-14	8
64	-28	2
64	8	0
-54	12	0
-48	10	28
50	20	-6
-56	16	30
-46	28	24
-30	-6	50
-42	46	20
0	0	70
-2	18	38
-28	-52	50
-52	-38	54
-48	-36	46
34	-56	52
-12	0	10
12	2	8
-22	-2	6
32	-20	0
-10	-14	6
14	-12	6
8	-20	0
22	-22	-2
-28	-62	-28
-14	-62	-18
22	-62	-20
34	-62	-26
8	-68	-20
42	-54	-28
38	-52	-56
36	-40	-52
20	-64	-46
4	-46	-16
4	-56	-24
-46	-60	-20
-54	-12	40
-44	-24	12
-64	-8	20
-62	-6	4
-48	-16	2
-50	10	-6
-60	-30	12
-44	6	-2
-48	-14	60
60	-12	10
64	8	0
62	-4	28
50	-22	12
12	-16	4
46	-14	0
0	-6	12
10	0	10
68	-26	4
-10	-16	4
-24	0	-8
-20	4	2
30	0	-6
40	8	4
-10	-14	16
20	8	4
14	-16	16
34	-12	-2
48	2	-10
32	-66	-22
20	-58	-18
-26	-60	-22
-14	-60	-16
-8	-58	-2
0	0	68
2	-6	72
0	2	50
2	-4	52
2	18	40
-4	-14	78
38	-48	-56
22	-60	-20
32	-60	-26
-34	-56	-32
36	-54	-56
26	-32	-46
6	-74	-38
16	-70	-48
30	-62	-56
36	-44	-54
-44	-58	-10
6	-68	-18
30	-38	-50
4	-80	-18
-24	-64	-22
-48	-64	-22
22	-82	-18
-16	-62	-16
-30	-78	-22
-22	-84	-22
6	-88	-10
36	-38	-40
0	6	56
8	30	34
-2	18	46
0	2	68
0	-6	70
-2	22	36
-48	4	30
-56	-8	46
-50	28	24
-54	16	32
-50	-6	54
-54	6	42
-32	-4	64
-42	-2	44
-32	-4	52
-58	10	20
-26	-6	50
0	-6	12
-8	-2	10
18	-8	20
-32	22	4
-42	16	6
-48	14	2
-48	20	-6
40	22	2
50	20	-2
-30	-54	58
-26	-60	56
-30	-48	46
-48	-32	46
-26	-68	38
-52	-34	52
26	-64	64
32	-56	52
0	18	46
0	4	62
0	0	70
4	24	38
50	22	-6
42	20	-12
38	26	0
38	24	-6
-26	-62	52
-30	-54	52
-48	-40	52
-20	-66	66
-38	-44	44
-34	26	0
-34	22	4
-50	12	0
22	-76	-20
26	-62	-18
0	16	48
-8	8	62
2	34	36
8	26	34
0	16	66
2	14	32
-6	24	28
34	22	-8
38	44	24
52	20	-4
40	20	10
52	34	26
58	24	14
-42	30	24
-30	24	6
-42	46	22
-36	16	-8
-58	14	18
-52	16	14
-44	14	4
-62	6	28
-40	12	26
-52	10	44
-50	4	36
42	-50	-30
28	-52	-24
32	-52	-28
36	-56	-28
-2	-72	-8
14	-66	-12
42	-72	-28
2	-56	-32
14	-58	-20
14	-54	-14
16	-6	14
-10	0	10
10	-2	12
-4	-10	14
8	-8	2
-30	-52	50
-40	-44	54
-52	-40	56
-36	-48	42
-24	-72	46
-18	-68	64
34	2	58
34	2	38
34	4	44
44	12	38
34	0	48
-44	-58	-16
-32	0	52
-38	0	62
-38	-4	42

// Finger E C, 2006: Moral = Social with Audience > Social without Audience = 
// Neutral
// Finger E C, 2006: Moral > Social = Neutral
// Finger E C, 2006: Moral and Social > Neutral
// Finger E C, 2006: Audience > No Audience
// Subjects=16
-1.88	53.19	49.48
-44.93	24.41	-2.25
79.97	1.96	-28.57
-64.19	13.12	-8.89
-74.69	-53.1	-11.02
0.02	79.24	28.32
-9.02	3.93	73.77
-67.33	-62.08	-31.54
-74.5	-51.21	13.35
-21.52	1.61	-24.03

// Lepage M, 2006: Associative Encoding vs. Item Encoding, Conjunction 
// Analysis
// Lepage M, 2006: Associative Encoding vs. Item Encoding, Interaction, 
// Normals > Schizophrenia Patients
// Lepage M, 2006: Associative Recognition vs. Item Recognition, Conjunction 
// Analysis
// Lepage M, 2006: Associative Recognition vs. Item Recognition, Interaction, 
// Normals > Schizophrenia Patients
// Subjects=15
-26	26	10
-30	-8	58
-30	-52	-14
16	14	-2
4	-4	56
52	-66	12
-56	14	34
-2	12	32
-12	0	4
-4	-4	42
-30	-10	0
-30	-18	64
-2	-54	30
60	-18	26
24	-44	-22
60	-46	14
18	-52	-18
-38	22	24
-42	0	38
-18	-58	2
-42	-60	48
-18	-72	60
-10	-76	42
-10	-78	10
-10	-88	-4
32	24	-2
6	6	56
34	4	62
10	-58	8
24	-70	-12
14	-72	18
18	-72	48
34	-72	32
20	-76	-10
30	-76	44
-40	28	20
-30	-50	48
-28	-64	46
-44	-62	-8
28	26	-4
2	18	48
4	-38	26
30	-58	48
34	-74	52
4	-76	-16

// Ohnishi T, 2006: Maze vs. Control
// Ohnishi T, 2006: Good Navigators > Poor Navigators
// Ohnishi T, 2006: Poor Navigators > Good Navigators
// Ohnishi T, 2006: Positive Correlation between Task Performance and Brain 
// Activity
// Ohnishi T, 2006: Negative Correlation between Task Performance and Brain 
// Activity
// Ohnishi T, 2006: Positive Correlation with SDQ-S
// Ohnishi T, 2006: Negative Correlation with SDQ-S
// Subjects=28
-26	-30	-25
-20	-35	-4
-14	-58	7
-16	-65	51
-8	-91	3
-14	-61	53
-36	-39	41
-44	-63	-22
-44	-81	10
-3	-35	-3
34	-38	-27
21	-37	-5
20	-57	19
16	-65	53
16	-97	3
30	-56	53
36	-45	41
32	-59	-17
50	-68	-5
12	-80	-8
3	-22	-4
51	16	26
-16	-29	-5
16	-35	-3
-8	-54	52
10	-52	49
59	-48	45
-16	-30	-9
-20	-29	-4
44	-58	53
-17	-33	-6
-26	-32	-2
20	-31	-5
28	-32	-3
-40	-69	50
41	-50	48

// Ries M L, 2006: Normal Elderly Subjects
// Subjects=14
8	-74	32
10	-52	32
-8	-80	28
-56	-62	16
48	-54	28
58	-56	24
48	-58	14
8	-62	14
-8	-54	28
8	-58	24
10	58	24
-12	58	8
-10	48	42
8	-60	24
4	-66	22

// Ries M L, 2006: Mild Cognitive Impairment Patients
// Subjects=14
-52	-58	42
6	-74	36
46	-62	46
-10	44	4
-8	50	18
2	58	10
-6	-54	28
-10	-56	0
-28	16	-22
-24	4	-18
-4	-10	34

// Tang J, 2006: Numerical > Physical
// Tang J, 2006: Numerical Task Conflict Trials > Numerical Task Non-Conflict 
// Trials
// Tang J, 2006: Physical Task Conflict Trials > Physical Task Non-Conflict 
// Trials
// Tang J, 2006: Numerical Task Error Trials > Numerical Task Correct Trials
// Tang J, 2006: Physical Task Error Trials > Physical Task Correct Trials
// Tang J, 2006: Conjunction by Masking Across Tasks (Error Trials > Correct 
// Trials)
// Subjects=18
51.04	11.57	20.29
-37.97	19.09	-9.19
51.29	-78.5	21.36
45	-35.51	45.22
25.65	-62.16	48.19
36.46	-53.31	50.49
55.15	-55.66	-10.1
50.86	-64.18	-9.19
-21.82	-64.04	53.67
42.83	-37.75	44.36
36.47	-44.49	52.98
-9.11	19.48	50.79
16.34	-2.66	7.73
20.59	8.84	4.27
9.66	7.87	-5.53
18.94	23.62	47.66
-22.59	-16.19	3
39.52	55.45	-26.43
38.07	-79.35	1.5
-46.48	-52.17	-13.2
48.97	14.42	27.89
-42.19	34.04	1.73
4.6	-42.06	11.82
56.15	-26.73	-10.74
-33.76	18.27	-18.15
-33.98	8.96	-37.39
-53.69	-46.31	15.48
46.22	29.71	-15.04
60.54	24.19	5.44
37.3	15.59	-39.26
7.62	-14.16	0.05
-3.18	-14.2	0.23
-18.44	-83.1	-24.06
1.14	30.67	9.17
5.19	-23.9	-23.6
-52.54	2.36	30.81
39.7	-5.59	-24.88
-48.43	17.19	16.95
-26.85	37.89	19.02
-62.15	-28.52	34.03
58.65	-41.66	13.1
55.1	-27.59	-8.4
58.22	26.23	-7.05
35.41	20.85	-17.34
-35.92	18.27	-18.11
-16.3	-78.84	-24.52
5.02	-39.39	-39.99
58.62	-41.87	10.88
56.15	-26.73	-10.74
-33.76	18.27	-18.15
-53.69	-46.31	15.48
46.22	29.71	-15.04

// de Leeuw R, 2006: Painful Heat vs. Continuous Warm Stimulus
// Subjects=9
35.31	42.38	16.51
50.45	10.29	26.83
58.02	-23.84	25.15
51.27	11.07	-4.47
38.51	12.65	3.35
-35.24	12.12	3.13
2.5	5.92	43.36
5.39	37.8	15
0.04	37.77	15.07
7.58	-1.19	5.98
9.78	-14.76	9.32
-11.59	-14.88	9.58
-35.79	-19.89	57.12
-36.26	-66.5	-22.61
4.87	-71.86	42.05
13.21	-79.41	12.48

// Abler B, 2006: Increasing Probability at Expectation Phase
// Abler B, 2006: Reward Prediction Error at Outcome Phase
// Subjects=11
10.6	0.25	-18.24
-8.89	9.75	-18.85
10.77	-1.7	-4.6
-8.47	-19.98	7.62
4.13	-58.77	-29.1
14	14.58	-2.91
-5.59	6.88	-15.26
-63.7	-30.99	-3.8
-30.79	38.55	49.27

// Huettel S A, 2006: Decisions Involving Ambiguity > Decisions Involving Risk
// Subjects=13
39	16	33
51	16	45
40	6	44
41	19	9
-36	-57	50

// Preuschoff K, 2006: Win > Loss
// Preuschoff K, 2006: Activation for Expected Reward, Immediate
// Preuschoff K, 2006: Activation for Expected Reward, Delayed
// Preuschoff K, 2006: Activation for Reward Variance, Immediate
// Preuschoff K, 2006: Deactivation for Reward Variance, Immediate
// Preuschoff K, 2006: Activation for Reward Variance, Delayed
// Preuschoff K, 2006: Deactivation for Reward Variance, Delayed
// Subjects=19
-5.13	-18.73	14.29
14.08	-14.47	12.6
16.09	-17.95	-4.98
-22.42	-16.41	-9.13
-9.6	2.25	-3.03
13.9	5.65	-2.47
14	4.47	9.89
29.99	-17.86	-5.14
-2.19	-24.71	-22.04
-34.12	-37.88	-10.54
25.73	-33.04	-8.28
-6.32	-22.23	-3.25
2.54	-37.58	31.4
-.74	-20.77	28.91
-1.81	27.55	48.29
-45.9	25.52	12.16
50.36	22.55	20.23
-34.07	-4.45	8.96
-26.77	20.12	-4.33
52.6	4.93	26.14
-47.94	4.53	16.18
-54.23	-59.09	5.97
-33.81	-75.29	14.9
61.16	-42.11	8.8
41.81	-61.03	-13.93
21.82	-64.5	25.63
5.66	-88.94	-0.02
19.16	-44.65	-34
-3.14	-49.93	-17.69
-26.63	-8.09	2.49
25.77	-5.14	8.33
-11.78	4.01	-7.61
13.86	6.28	-8.1
18.23	-22.33	-6.86
3.08	-26.6	-33.1
-4.32	-20.33	-20.16
-1.2	34.82	-9.2
-46.54	-59.02	33.76
-33.83	12.38	47.7
20.63	32	48.77
-1.78	30.01	52.54
-11.76	42.73	11.44
-45.76	-37.89	4.1
25.14	-75.34	36.53
-13.97	-41.59	-32.76
-37.33	-70.91	-24.46
25.81	-87.19	-20.47
35.22	-34.35	-26.13
10.88	-84.74	-14.93
-46.17	7.29	-30.91
-24.75	23.34	-18.01
-4.45	24.51	-18.34
-16.04	-24.37	-16.34
-33.18	19.02	-4.17
37.37	15.22	-4.66
-17.11	-31.06	-20.22
20.28	-23.18	-17.97
62.12	-11.36	7.32
41.97	-23.05	23.03
-55.5	-7.37	0.53
10.72	-33.64	-14.75
3.08	23.93	-12.8
38.99	-32.82	48.42
44.33	-21.87	51.9
-8.04	-25.53	50.58
-1.2	23.9	-12.75
8.79	-65.57	-.9
-34.31	53.46	0.77
-30.99	23.95	4.32
34.18	27.52	3.27
-9.62	-2.32	-7.11
13.89	-2.18	-7.39
2.25	-15.32	2.77
2.13	-18.8	-14.78
-39.18	-6.39	39.3
-14.78	-30.14	5.32
0.11	-15.33	2.79
-0.01	-18.81	-14.76

// Yacubian J, 2006: Normals Group 1
// Subjects=42
-12	3	0
12	6	0
-33	21	-6
33	24	-6
-39	57	3
36	60	-3
-12	15	-3
15	15	-6
3	51	-6
12	9	-3
-12	6	-3
36	63	0
12	9	-3
-12	9	-3
48	39	-18
-45	45	-15
-12	6	-3
12	9	-3
-12	3	-3
12	9	-3
-27	-3	-18
30	-3	-12
-27	-3	-18
27	0	-18

// Yacubian J, 2006: Normals Group 2
// Subjects=24
12	9	-3
-12	6	-3
-12	6	-3
12	9	-3
-24	-3	-15
27	-3	-18

// Wagner G, 2006: Control Subjects
// Subjects=16
53.14	15.52	16.51
5.85	21.58	38
-48.74	19.26	-6.78
-12.08	48.42	-6.93

// Wagner G, 2006: Unipolar Depressed Patients
// Subjects=16
-56.01	23.64	17.56
-39.06	29.93	-8
-7.16	27.71	35.38
-48.74	19.26	-6.78
-12.08	48.42	-6.93

// Remijnse P L, 2006: OCD Patients
// Subjects=20
45	42	-18
27	-63	45
33	-93	0
-24	-99	-12
36	51	-12
15	36	-15
36	-93	-12
-36	-93	-3
6	18	3
39	51	-3
45	39	27
33	21	-3
27	-63	45
36	-96	0
30	51	-15
30	54	15
-30	54	6
-45	36	27
33	18	6
-18	18	-15
36	54	-3
-31	60	6
33	45	33
-42	33	42
36	27	3
-33	21	6

// Remijnse P L, 2006: Normals
// Subjects=27
36	54	-12
15	36	-15
45	42	21
30	-63	48
36	-93	-9
-33	-96	-12
6	18	6
-6	15	6
-12	6	-9
36	51	-12
15	36	-15
36	-93	-12
-36	-93	-3
6	18	3
33	54	-12
18	42	-15
30	24	-12
33	-93	-9
-33	-96	-12
-18	18	-15
36	51	9
-30	60	9
33	45	33
-42	33	42
33	18	6
-33	21	9
0	30	33
-18	18	-15
36	54	-3
-31	60	6
33	45	33
-42	33	42
36	27	3
-33	21	6

// Seseke S, 2006: Activations during Relaxation and Contraction
// Seseke S, 2006: Relaxation > Contraction
// Seseke S, 2006: Contraction > Relaxation
// Subjects=11
-1.22	-24.68	-35.44
7.52	-22.66	-10.06
-5.32	-23.96	-12.03
31.05	-53.06	-20.05
-25.6	-50.23	-19.63
7.53	-39.03	-15.38
9.74	-15.19	3.79
-8.44	-4.46	6.44
26.79	7.47	6.15
-23.43	6.11	6.84
53.53	7.88	9.15
-50.1	4.26	12.88
51.56	-51.86	7.5
1.46	-81.68	11.69
58.03	-31.42	23.55
-54.16	-29.8	26.93
0.33	12.16	41.75
-.61	-7.34	51.2
16.64	-23.3	63.49
-15.44	-23.66	61.66
1.49	16.45	55.87
2.27	35.38	25.28
17.2	54.93	29.04
45.09	25.49	31.19
43.78	19.66	-2.87
-34.2	20.59	2.4
42.12	2.61	52.1
53.95	-43.73	43.59
53.95	-43.73	43.59
-52.91	-48.77	43.01
2.74	-25.58	62.73
0.08	-49.74	-15.51
44.33	-70.2	32.54
-36.91	-69.88	30.1
-6.1	-41.83	18.47
33.34	-16.3	14.76
-29.74	-17.02	11.08

// Epstein J, 2006: Normals > Depressed, Positive
// Epstein J, 2006: Neutral > Positive, Depressed
// Epstein J, 2006: Positive > Neutral, Normals
// Epstein J, 2006: Normals > Depressed, Positive - Neutral
// Subjects=10
15	6	-3
-15	15	-6
15	6	-3
-15	15	-6
15	6	-3
-15	15	-6
15	9	-3
-18	9	-6

// Kerns J G, 2006: Incongruent, Activations
// Kerns J G, 2006: Regions on Conflict Trials Predicting Good Behavioral 
// Adjustments
// Kerns J G, 2006: Regions Active during Good Adjustment Trials for Both iI 
// and iC
// Subjects=26
-6.01	8.49	49.93
-45.34	-49.99	54.17
45.48	-34.21	57.38
-41.51	35.46	30.24
36.48	43.5	30.9
-1.82	13.12	40.58
-45.82	32.89	24.93
-54.21	9.21	35.93

// Meschyan G, 2006: Spanish vs. English
// Meschyan G, 2006: Spanish vs. Rest
// Meschyan G, 2006: English vs. Spanish
// Meschyan G, 2006: English vs. Rest
// Subjects=12
7.92	5.66	53.36
12.1	15.75	45.77
1.44	9.34	46.43
26.8	13.1	10.14
37.49	11.04	10.19
-58.67	-6.96	6.11
-54.39	-15.74	2.34
7.85	13.78	48.22
3.69	8.26	59.88
-.58	6.12	60.11
28.92	12.94	7.9
35.33	12.98	7.82
-58.75	7.5	0.44
-56.54	3.97	9.63
-56.58	5.74	5.02
46.56	-45.04	54.93
55.04	-50.07	44.11
-28.33	-75.03	31.55
-26.17	-72.56	35.77
46.52	-56.47	44.74
55.04	-52.36	42.07
-24.11	-71.12	26.71
-13.34	-79	33.94
52.99	-49.23	55.21
40.16	-47.19	55.19
-25.18	-66.72	28.58
-32.62	-66.43	33.1
-11.26	-68.59	30.81
-17.71	-73.37	24.59

// Rubia K, 2006: Adult Normals
// Subjects=23
34.91	57.99	-29.41
5.19	64.35	0.51
35.14	57.13	0.77
-48.01	29.02	16.35
-9.77	43.31	-8.7
-48.88	-24.91	20.89
28.07	-15.56	24.8
-9.29	-63.68	11.42
-22.53	12.06	-12.63
-37.25	-65.65	-11.52
12.31	-77.7	34.65
-51.32	27.97	3.1
-39.32	-35.4	8.27
33.94	50.21	-19.82
55.64	10.98	7.75
-38.5	35.71	5.65
-25.43	7.55	25.7
32.18	-4.05	8.17
8.7	-3.93	11.77
33.45	-52.51	14.45
29.92	49.58	13.73
48.34	-10.33	21.89
4.67	-3.59	44.13
-44.54	-22	30.63
22.57	2.58	12.18
4.67	-3.59	44.13
-10.37	-78.12	3.72
5.2	52.29	-4.05
-29.93	41.39	9.53
-33.16	8.19	-6.6
-52.02	-28.65	27.93
-18.03	26.54	22.91
27.79	-3.07	-6.36
4.88	-73.89	43.34
43.86	-63.02	-26.05
16.18	23.58	22.76
35.27	22.23	3.7
-41.1	-29.44	57.98
5.2	52.29	-4.05
43.56	55.81	-17.05
-37.55	52.04	-3.54
5.51	-82.83	-17.26
-37.05	-43.87	22.34
-62.93	-17.91	2.62
51.48	-1.05	17.73
-44.56	-24.46	26.38
47.03	22.31	3.56
-29.89	41.82	15.07
4.24	-13.59	-16.36
63.37	-35.87	20.52
35.78	-49.39	40.93
8.61	-43.25	-15.04
20.04	43.52	-22.45
47.1	-59.31	-19.71
-3.11	-88.05	-28.99
54.76	-20.06	19.29
55.91	9.32	41.35
44.01	-13.15	13.26
31.79	46.77	-22.85
-20.41	52.57	1.8
16.03	13.23	-.9
-9.3	-36.31	21.39
43.67	52.52	-4.51
-37.1	20.4	41.49
1.4	25.37	47.32
-48.83	-61.81	11.71
4.41	-24.99	1.32
-29.39	-67.21	36.48
31.96	-23.96	-29.19
39.56	-55.56	-25.51

// Rubia K, 2006: Adolescent Normals
// Subjects=29
39.36	23.63	-19.88
-26.53	-37.78	3.87
-9.4	-8.81	19.08
20.51	-4.41	18.37
-58.69	-16.02	-.93
8.77	-55.89	0.52
-53.05	-7.36	41.77
-.41	68.18	-32.08
32.39	-39.23	21.15
31.21	-56.84	0.01
52.6	-14.79	18.87
-54.26	-19.83	18.29
-32.54	-40.31	54.33
6.84	-12.03	44.82
5.2	52.29	-4.05
-29.93	41.39	9.53
-33.16	8.19	-6.6
-52.02	-28.65	27.93
-18.03	26.54	22.91
27.79	-3.07	-6.36
4.88	-73.89	43.34
43.86	-63.02	-26.05
16.18	23.58	22.76
35.27	22.23	3.7
-41.1	-29.44	57.98
5.2	52.29	-4.05
43.56	55.81	-17.05
-37.55	52.04	-3.54
5.51	-82.83	-17.26
-37.05	-43.87	22.34
-62.93	-17.91	2.62
51.48	-1.05	17.73
-44.56	-24.46	26.38
47.03	22.31	3.56
-29.89	41.82	15.07
4.24	-13.59	-16.36
63.37	-35.87	20.52
35.78	-49.39	40.93
8.61	-43.25	-15.04
20.04	43.52	-22.45
47.1	-59.31	-19.71
-3.11	-88.05	-28.99
54.76	-20.06	19.29
55.91	9.32	41.35
44.01	-13.15	13.26
31.79	46.77	-22.85
-20.41	52.57	1.8
16.03	13.23	-.9
-9.3	-36.31	21.39
43.67	52.52	-4.51
-37.1	20.4	41.49
1.4	25.37	47.32
-48.83	-61.81	11.71
4.41	-24.99	1.32
-29.39	-67.21	36.48
31.96	-23.96	-29.19
39.56	-55.56	-25.51

// Wittfoth M, 2006: Motion-Based: Incompatible > Compatible
// Wittfoth M, 2006: Location-Based: Incompatible > Compatible
// Wittfoth M, 2006: Motion-Based + Location-Based: Incompatible > Compatible
// Wittfoth M, 2006: Conflict-Based Activity of the Motion-Based Simon
// Wittfoth M, 2006: Conflict-Based Activity of the Location-Based Simon
// Subjects=20
1.92	6.94	65.29
3.91	14.41	53.31
-.6	20.7	40.44
-13.03	-57.45	66.31
1.41	-68.01	9.96
-5.06	-82.17	8.11
-61.94	-26.96	50.68
-68.93	-19.88	12
78.08	-17.67	16
10.08	-86.37	8.27
-37.8	-69.37	-13.89
-29.21	-63.16	-16.89
14.35	-85.61	4.76
-4.85	-89.33	23.39
34.25	2.07	57.38
27.85	-1.69	63.46
55.29	-66.63	-1.18
40.86	-35.24	59.84
-4.68	6.08	56.52
34.15	-76.35	33.76
10.08	-86.37	8.27
-.68	-83.87	12.69
5.72	-76.82	7.4
-2.52	8.22	56.28
3.9	15.48	53.21
-15.24	-53.41	63.71
1.41	-68.01	9.96
-61.94	-26.96	50.68
4.07	9.07	65.04
-68.93	-19.88	12
-.6	20.7	40.44
-37.8	-69.37	-13.89
-29.21	-63.16	-16.89
-4.85	-89.33	23.39
-24.01	-1.87	64.36
53.1	-66.84	-3.36
34.15	-76.35	33.76
44.26	-69.49	-19.75

// Knutson K M, 2006: Attitude Congruent - Attitude Incongruent
// Knutson K M, 2006: Attitude Congruent - Classification
// Knutson K M, 2006: Attitude Incongruent - Attitude Congruent
// Knutson K M, 2006: Attitude Incongruent - Classification
// Subjects=30
-20.85	11.32	-24.4
53.21	0.73	19.09
39.73	25.23	-16.72
-33.75	29.22	-15.87
-53.78	21.94	22.17
-7.15	27.81	36.49
-46.72	51.07	-11.08
5.88	25.08	41.02
-28.3	-61.84	54.68
-33.71	29.53	-12.54
-53.67	18.41	30.36
56.36	33.92	17.99

// Husain F T, 2006: Category - Auditory, Tones
// Husain F T, 2006: Category - Auditory, Tonal Contours
// Husain F T, 2006: Category - Auditory, Vowels
// Husain F T, 2006: Category - Auditory, Syllables
// Husain F T, 2006: Category - Auditory, All (Pooled)
// Husain F T, 2006: Category - Auditory, Tones + Vowels
// Husain F T, 2006: Category - Auditory, Tonal Contours + Syllables
// Husain F T, 2006: Category - Auditory, Tones + Tonal Contours
// Husain F T, 2006: Category - Auditory, Vowels + Syllables
// Subjects=12
-45	33	24
48	15	30
-27	-66	54
30	-63	45
33	48	18
6	-69	45
-54	-51	-12
0	18	57
-39	-57	51
6	-78	-15
-51	33	18
-27	-54	48
-24	18	0
-45	18	27
6	-27	0
9	33	42
12	-3	21
-42	-42	48
18	9	3
33	51	18
54	18	33
12	-45	-27
45	3	42
-3	-15	0
-48	-48	48
0	24	54
-30	27	0
-36	54	15
-51	33	15
-36	-63	45
39	51	12
-33	-60	48
-45	33	21
-30	27	0
36	51	15
-3	24	51
51	15	30
-48	18	24
54	15	33
-30	-57	48
33	51	18
42	3	54
30	-63	48
-36	3	54
-6	27	48
-45	-51	51
0	24	54
33	-93	-12
-51	33	15
39	51	12
-51	15	27
36	-72	51
-39	-57	51
-42	36	24
39	3	54
-33	30	-3
30	48	24
-27	12	54
-3	21	54
-39	39	0
42	-45	51
33	-63	42
-30	30	0
-6	-18	0
36	51	15
-45	-51	48
0	27	51
57	12	27
-51	15	27

// Husain F T, 2006: Category - Auditory, Tones
// Husain F T, 2006: Category - Auditory, Tonal Contours
// Husain F T, 2006: Category - Auditory, Vowels
// Husain F T, 2006: Category - Auditory, Syllables
// Subjects=12
-42	9	18
-54	-27	0
3	-21	-24
27	3	9
-21	-3	18
-48	12	-18
24	-30	48
57	6	3
60	-18	30
54	-39	30
-57	-21	9
-27	-24	60
48	12	33
63	-45	-9
-57	-3	45
36	-42	57
9	-24	-12
27	-60	54
24	45	36
33	-69	33
51	-51	45
51	-30	33
0	3	63
60	-24	6

// Smolka M N, 2006: Smoking-Related Pictures > Fixation, Correlated with FTND 
// Scores
// Smolka M N, 2006: Smoking-Related Pictures > Fixation Correlated with 
// Cue-Induced Craving Scores
// Subjects=10
48	0	39
33	-18	63
3	-6	42
-6	-12	45
-45	-12	39
-39	-9	39
-3	-87	12
9	-81	12
27	-21	-27
33	-36	-18
-60	-33	30
-30	-6	63
-27	-15	-30
-51	-30	51
3	-24	-18
-12	-18	-15
-30	-15	-18
-24	-6	-18
-45	-9	-30
-21	-18	-21
30	-63	12
27	-24	-24
30	-36	-15
27	-3	-15
45	-9	-33
27	-15	-21
-30	-42	-15
-24	-60	9
-33	-63	21
27	-57	-21
-18	-96	0
45	-69	21
-9	-72	-45
30	-63	-9
15	-84	9

// Golestani N, 2006: Read, English - Rest
// Golestani N, 2006: Read, French - Rest
// Golestani N, 2006: Sentences, English - Rest
// Golestani N, 2006: Sentences, French - Rest
// Golestani N, 2006: Sentences, English vs. Read, English
// Golestani N, 2006: Sentences, French vs. Read, French
// Golestani N, 2006: Sentences vs. Read, French - English
// Golestani N, 2006: Read, Five - Three
// Golestani N, 2006: Sentences, Five - Three
// Golestani N, 2006: Correlation between English Sentences - Read Subtraction 
// and Toefl Scores
// Subjects=12
-56	0	44
-28	-88	0
32	-84	4
-48	-64	-12
40	-72	-20
-24	-8	4
-48	-16	56
-32	-88	4
32	-84	4
-48	-64	-12
40	-76	-16
-48	12	20
-36	24	8
-48	24	24
-56	-4	36
-8	4	60
28	-60	48
-32	-84	0
32	-84	4
20	-60	-24
-44	-60	-12
40	-76	-12
-52	-36	52
-36	-56	52
-52	8	20
-52	-4	48
-12	4	60
28	-56	48
-28	-88	0
32	-84	4
36	-72	-20
-44	-60	-12
40	-76	-12
-52	8	16
-40	24	4
-44	28	24
-12	8	56
32	-52	44
-52	-44	56
-36	-52	48
36	-84	4
32	-60	-20
-52	8	16
-44	28	4
-52	32	20
-12	8	60
28	-52	36
-48	4	16
-20	-4	12
0	44	12
-20	-92	8
-44	-76	-12
-24	-92	16
32	-84	16
-8	12	-8
-28	-84	28

// Hoeft F, 2006: Dyslexic Participants
// Subjects=10
-4.75	17.58	53.15
-50.7	15.28	8.21
-47.96	-1.18	50.13
-56.04	3.67	10.57
-62.27	0.09	30.08
-28.72	-98.96	13.54
27.34	-101.82	2.78
-2.58	15.46	53.32
-42.29	19.07	-9.11
44.14	15.02	-11.31
69.36	2.5	14.16
-33.55	-20.66	-9.81
-28.75	-99.17	11.32
31.72	-99.16	8.05
16.32	-15.95	3.44
-39.62	25.05	31.71
23.01	49.09	32.75
-52.24	-46.8	44.64
-37.14	-46.95	42.15
45.12	-59.76	49.86
64.89	-48.93	-7.57

// Hoeft F, 2006: Age-Matched Participants
// Subjects=10
50.41	51.75	-20.65
-46.56	9.59	-6.98
-9.4	24.95	28.96
3.65	29.98	36.09
46.09	19.96	-27.52
-26.14	-64.06	53.74
40.87	-59.26	55.49
-33.1	-99.39	9.17
31.81	-100.67	14.92
-7.52	-87.65	-15.96
5.51	-53.18	-3.9
-2.58	15.46	53.32
-42.29	19.07	-9.11
44.14	15.02	-11.31
69.36	2.5	14.16
-33.55	-20.66	-9.81
-28.75	-99.17	11.32
31.72	-99.16	8.05
16.32	-15.95	3.44
-39.62	25.05	31.71
23.01	49.09	32.75
-52.24	-46.8	44.64
-37.14	-46.95	42.15
45.12	-59.76	49.86
64.89	-48.93	-7.57

// Hoeft F, 2006: Reading-Matched Participants
// Subjects=10
-.45	15.26	51.06
-54.11	28.27	-1.98
-64.54	6.91	22.72
-41.65	3.02	37.29
10.24	29.77	44.96
10.01	35.66	27.57
37.57	25.22	-16.69
42.06	21.06	-4.02
-46.63	10.14	-12.64
-46.45	-56.33	-11.67
48.63	-55.99	-13.32
-33.24	-97.14	-1.13
29.56	-99.17	8.08
-20.65	2.99	-10.13
33.42	12.31	-5.25
-9.61	-16.04	3.89
-11.97	-54.7	-19.14
46.45	-71.41	-17.36
-2.58	15.46	53.32
-42.29	19.07	-9.11
44.14	15.02	-11.31
69.36	2.5	14.16
-33.55	-20.66	-9.81
-28.75	-99.17	11.32
31.72	-99.16	8.05
16.32	-15.95	3.44

// Schmahl C, 2006: Borderline Personality Disorder (BPD) Patients
// Subjects=12
-5.26	-15.7	-1.58
10.76	-12.43	-2.03
1.49	10.91	52.99
-43.63	-21.42	10.5
55.74	-11.05	11.83
-30.95	16.64	6.04
-18.16	9.85	-.22
20.35	7.17	2.9
33.16	16.93	4.17
-46.54	-38.25	40.94
48.6	-47.19	40.59
-56.41	8.51	27.09
46.22	3.04	29.72
41.78	25.5	17.85
-30.96	56.07	20.58
41.73	46.91	19.4
-5.26	-15.7	-1.58
7.56	-15.63	-1.73
-43.33	-11.82	52.07
2.52	12.77	49.48
-46.83	-18.1	12.49
52.48	-8.33	6.06
-37.39	16.34	2.8
-24.53	0.3	0.65
20.36	7.26	4.01
36.35	15.73	2
-33.65	-63.8	39.59
46.43	-47.46	37.3
-51.1	1.68	20.91
42.97	2.59	24.22
-40.44	31.15	29.47
36.5	31.53	27.44

// Schmahl C, 2006: Normals
// Subjects=12
-5.26	-15.7	-1.58
-1.74	10.63	49.71
-53.19	-20.96	17.26
60.14	-19.6	24.77
-34.16	16.62	6.08
-11.67	7.41	8.83
20.31	10.09	-.69
36.38	20.47	8.3
-36.88	-50.88	41.89
53.93	-37.39	43.06
46.19	2.78	26.39
-37.34	43.26	20.61
39.71	34.98	30.46
-1.74	10.63	49.71
-52.12	-24.22	16.41
59.08	-19.61	24.78
-30.96	17.69	5.96
-20.26	6.84	2.28
23.52	10.1	-.72
36.37	18.1	5.15
-40.12	-41.38	41.13
34.74	-56.79	41.56
14.46	-64.32	42.42
-46.76	-.95	27.77
52.52	5.22	16.08
-34.2	49.11	13.4
42.72	52.74	12.21

// Yokoyama S, 2006: Japanese and English vs. Controls
// Yokoyama S, 2006: Japanese vs. Control
// Yokoyama S, 2006: English vs. Control
// Yokoyama S, 2006: English vs. Japanese
// Yokoyama S, 2006: Japanese, Active vs. Control
// Yokoyama S, 2006: Japanese, Passive vs. Control
// Yokoyama S, 2006: English, Active vs. Control
// Yokoyama S, 2006: English, Passive vs. Control
// Yokoyama S, 2006: Japanese, Passive vs. Active
// Yokoyama S, 2006: English, Passive vs. Active
// Subjects=36
-46	8	30
-6	8	56
-44	46	-10
-60	-38	-4
-34	-58	46
6	16	52
44	46	-18
34	-58	46
12	-80	-26
-42	24	-18
-56	26	-2
-42	24	18
-42	24	18
-56	-38	-2
-56	-38	-2
-48	-56	48
-40	-58	30
-12	-102	0
14	-84	-30
34	-78	-30
-50	26	20
-50	20	-4
-46	6	30
-48	4	50
-36	-60	48
-10	-92	-6
14	-80	-16
48	-68	-28
-28	-92	-8
-6	-82	-28
-32	-76	-22
-42	24	-18
-44	22	-32
-56	26	-2
-40	22	22
-48	4	50
-54	-38	-2
-58	-50	12
-38	-56	28
-40	-64	38
14	-84	-30
34	-78	30
-44	28	-18
-42	22	28
-54	30	10
-44	8	42
-38	12	52
-40	18	42
-6	6	68
-2	46	36
4	32	48
-62	-42	0
-56	-28	-10
-32	28	-12
-40	-56	-12
-42	-58	30
-38	-70	48
-48	-60	48
14	-82	-32
34	-82	-26
-50	22	-2
-50	8	46
-8	26	44
-36	0	40
-52	-40	-2
32	-74	-32
8	-82	-26
-4	-82	-24
-44	24	-6
-46	22	-18
-48	6	38
-4	6	68
-8	-88	-2
12	-84	-22
-28	-74	46
-52	34	14
-52	20	30
-32	18	-4
-50	20	-10
-6	-88	0

// Carlsson K, 2006: Uncorrelated > Correlated
// Carlsson K, 2006: Correlated > Uncorrelated
// Carlsson K, 2006: Uncorrelated High > Correlated High
// Carlsson K, 2006: Correlated High > Uncorrelated High
// Carlsson K, 2006: Uncorrelated Low > Correlated Low
// Carlsson K, 2006: Correlated Low > Uncorrelated Low
// Carlsson K, 2006: High > Low
// Carlsson K, 2006: Low > High
// Subjects=9
26	48	-4
36	24	2
-30	18	6
28	20	64
-34	8	58
52	18	48
58	18	16
42	12	22
-30	-54	40
46	-48	50
58	-54	18
42	-52	-44
6	52	-2
38	-22	-4
-40	-16	6
54	-14	14
-50	-20	18
-48	-24	62
-54	-36	56
36	-18	-20
-22	-10	-18
6	-86	20
6	-48	-8
26	46	-4
-30	26	10
-30	10	0
-36	10	60
24	-16	76
12	-12	54
-4	-26	60
-40	-80	40
-8	-18	-28
-36	56	-8
-50	46	-10
42	-2	-14
-44	-6	-12
44	-14	6
-44	-22	10
-16	-14	-20
-12	-80	14
-28	-64	-8
-10	-48	-12
50	14	52
42	10	24
22	20	60
44	6	40
32	22	-2
48	-54	58
38	-52	50
40	-52	-46
10	48	0
-60	0	26
-60	-6	24
52	-10	16
-64	-20	30
-52	-22	56
-34	-24	34
-38	-26	60
-40	-16	52
10	-100	22
10	-82	22
-28	-14	-20
38	-16	-18
-10	-52	-20
-34	24	-12
34	18	-16
-2	52	12
2	38	20
8	16	40
8	6	40
-10	0	42
-10	-16	44
50	26	-6
-50	30	0
36	12	6
-34	10	-4
46	-16	0
-40	-18	-6
42	-22	20
-42	-26	24
-28	-30	64
-42	-26	66
6	-32	-28
10	-24	-10
2	-86	10
-14	-58	-20
16	-46	-18
10	-64	-44
16	42	-20
-18	48	-18

// Diedrichsen J, 2006: Congruency Effect for Spatial Cues
// Diedrichsen J, 2006: Congruency Effect for Symbolic Cues
// Diedrichsen J, 2006: Symbolic > Spatial
// Subjects=15
-18	-80	54
10	-84	46
16	-72	62
28	-70	60
-6	-84	-28
-12	-78	-32
-16	-80	56
-8	-78	56
-16	-88	42
-26	-60	56
18	-78	54
12	-74	60
-10	22	46
0	28	46
-26	-70	40
-36	-50	38
-26	60	-6
-32	44	-12
-36	52	-6
-40	-2	32
-50	2	38
32	-90	-10
38	-78	-18
-22	-98	-10
-28	-88	-29

// Yoon H W, 2006: Picture > Fixation
// Yoon H W, 2006: Chinese Character > Fixation
// Yoon H W, 2006: Chinese Character > Picture
// Yoon H W, 2006: Picture > Chinese Character
// Subjects=14
-41.59	-55.44	-16.78
43.93	-69.91	-18.78
-47.87	22.82	32.49
-50.07	-61.33	-9.5
52.48	-63.34	-17.2
-22.34	-28.75	-3.63
-47.89	20.36	28.23
39.4	30.66	-11.55
44.42	-49.45	53.1
-2.89	30.63	46.93
22.61	-5.79	14
-7.09	-16.95	37.58
-43.43	-15.05	37.84
-4.9	18.79	59.09
41.81	-65.35	-14.68
-28.7	-67.88	-13.66

// Denkova E, 2006: Autobiographical vs. Semantic
// Denkova E, 2006: Autobiographical vs. Unknown
// Denkova E, 2006: Semantic vs. Unknown
// Denkova E, 2006: (Autobiographical, Faces vs. Semantic, Faces) vs. 
// (Autobiographical, Names vs. Semantic, Names)
// Denkova E, 2006: (Autobiographical, Names vs. Semantic, Names) vs. 
// (Autobiographical, Faces vs. Semantic, Faces)
// Denkova E, 2006: (Semantic, Faces vs. Unknown, Male Faces) vs. (Semantic, 
// Names vs. Unknown, Male Names)
// Denkova E, 2006: (Semantic, Names vs. Unknown, Male Names) vs. (Semantic, 
// Faces vs. Unknown, Male Faces)
// Subjects=12
-38	-84	28
-32	-82	38
-10	-58	8
-6	-52	0
-6	32	28
-26	12	58
-6	-64	44
-30	-34	-20
-20	-38	-18
-22	22	44
-40	50	16
-48	16	-2
-6	-40	36
-26	-18	-28
-46	28	2
-2	-52	10
-6	-52	2
-46	-72	28
-36	-78	40
-40	52	16
-6	28	46
-60	-38	-16
38	38	30
14	-2	-2
16	-2	12
2	66	20
-10	70	12
34	14	-6
-8	52	-18
-12	8	10
44	54	14
-26	-32	-22
24	-30	-22
-38	-78	44
-52	-68	34
32	44	0
-24	60	14
6	28	46
-2	-40	34
-36	24	-4
42	-72	44
-40	44	-10
-62	-28	-16
20	-14	66
-20	-30	-24
-46	-60	-16
-32	-34	16

// Eickhoff S B, 2006: Main Effect of Anal Canal Stimulation
// Eickhoff S B, 2006: Main Effect of Rectal Stimulation
// Subjects=8
-54	-12	18
6	-22	-6
-42	2	-6
-62	4	10
-2	-12	4
-6	-28	6
20	6	6
-44	-12	4

// Saito Y, 2006: Spontaneous Singing > Synchronized Singing
// Saito Y, 2006: Synchronized Singing > Spontaneous Singing
// Saito Y, 2006: Spontaneous Speaking > Synchronized Speaking
// Saito Y, 2006: Synchronized Speaking > Spontaneous Speaking
// Saito Y, 2006: Spontaneous Singing > Spontaneous Speaking
// Saito Y, 2006: Synchronized Singing > Synchronized Speaking
// Subjects=20
-33.75	40.17	-13.59
-46.18	-35.75	13.18
44.53	-32.45	9.07
-56.9	-25.28	22.42
55.47	-17.13	23.06
-44.43	27.99	-5.48
-50.66	-33.62	1.84
-58.91	-48.27	29.21
55.51	18.15	33.01
49.47	31.95	-14.19
3.6	29.67	32.76
57.39	-21.12	3.25
55.6	7.93	38.51
44.09	25.55	-13.47
3.6	23.08	31.17
66.13	-28.01	9.39
53.05	-1.57	5.87
50.69	3.45	-9.15
-52.53	-19.43	27.37

// Juckel G, 2006: Schizophrenic Patients
// Subjects=10
-15.25	10.66	-8.74
-18.5	7.25	-10.59

// Juckel G, 2006: Normals
// Subjects=10
-21.72	7.45	-8.31
10.67	7.35	-11.1
-24.91	7.75	-4.93
-11.96	10.98	-5.47
10.75	11.27	-3.64
-41	-1.26	2.96
-33.88	-54.49	41.72
-27.7	-77.48	13.64
7.49	-24.98	-12.33
-15.25	10.66	-8.74
-15.3	12.48	-12.28
10.67	7.35	-11.1
-15.3	12.48	-12.28
20.44	20.88	-4.76
-44.39	22.78	-3.84
-50.78	1.59	-.52
-52.71	-31.73	10.66
-50.56	-53.72	4.95
53.13	-60.05	0.45
-44.18	-16.16	4.49
-24.88	-24.78	-8.43
30.36	-48.74	-3.64
36.9	-45.01	1.48
-14.83	-62.85	8.61
24.07	-65.91	8.25
-17.92	-86.91	15.52
-18.13	-25.02	11.65
7.49	-15.2	-11.05
-18.5	7.25	-10.59

// Kumari V, 2006: Violent Schizophrenia
// Subjects=12
57.76	10.06	38.26
-50.53	7.81	20.15
-48.55	10.83	6.38
-50.69	19.75	10.01
43.98	58.63	-15.62
37.72	51.55	0.88
42.12	60.9	8.84
12.38	25.21	42.01
-30.45	-53.02	57.21
-43.53	-51.77	48.34
53.53	6.42	45.41
61.98	4.99	29.72
38.51	1.67	52.86
-43.59	-21.58	49.84
-23.85	-54.3	66.19
53.77	-33.37	56.07
-43.41	-37.76	60.4
38.75	-43.65	61.82
3.19	-77.4	-21.63
9.57	-58.44	-25.86
22.48	-58.81	-30.53
-30.71	15.04	50.48
44.87	12.77	44.93
8.41	-59.68	52.72
-30.75	16.96	48.05
31.9	21.44	46.54
8.44	-59.48	54.94
51.61	-46.56	52.93
60.21	-44.61	50.35
40.41	33.61	38.46
42.97	-48.72	53.29
48.62	47.96	7.77
-65.57	-37.53	18.17
-46.44	1.71	0.52
29.12	3.68	-5.45
16.13	-11.87	-10.41

// Kumari V, 2006: Non-violent Schizophrenia
// Subjects=13
-45.81	8.61	51.37
-34.97	13.32	55.2
55.23	16.07	10.81
23.68	-67.31	62.18
49.52	-43.82	59.42
-21.76	-65.76	58.32
-37.17	17.36	52.6
-48.06	16.7	46.13
35.95	39.15	29.03
50.93	46.88	19.04
-50.57	33.76	22.07
55.23	16.07	10.81
-50.35	28.83	38.24
-7.14	35.57	39.08
8.03	31.58	41.46
27.96	-69.83	57.88
34.32	-75.1	47.08
-49.91	-48.84	57.13
53.75	-42.3	52.47
-43.51	-49.44	50.35
-41.47	-48.13	41.22
36.32	2.52	50.57
49.3	4.9	52.36
-59.11	12.66	26.54
68.33	10.57	20.1
-49.95	-22.9	59.04
-43.51	-36.26	53.53
45.17	-44.04	57.27
51.47	-32.29	44.8
34.42	-50.25	60.31
37.58	-61.09	-32.8
12.75	-55.21	54.45
8.43	-57.35	54.73
60.21	-44.61	50.35
55.57	9.85	36.07
43.06	-56.81	58.57
-65.57	-37.53	18.17
-46.44	1.71	0.52
29.12	3.68	-5.45
-63.46	-37.94	13.7
16.13	-11.87	-10.41

// Kumari V, 2006: Violent Antisocial Personality Disorder
// Subjects=10
51.29	21.09	41.76
32.03	18.02	55.84
53.6	17.88	53.24
3.6	29.67	32.76
7.95	37.54	36.39
-65.27	-39.71	40.8
53.68	-45.05	46.02
-52.24	-41.38	45.22
55.85	-33.99	49.37
-47.74	-44.37	58.89
47.27	-51.04	51.21
6.34	-52.48	61.01
-2.33	-52.72	58.94
46.87	40.01	37.72
-22.13	29.97	48.85
-30.7	19.51	52.28
-17.73	26.14	53.64
46.95	18.74	39.82
49	17.92	30.91
39.53	17.63	51.27
-52.76	33.54	19.89
53.03	48.6	14.35
55.24	29.25	13.99
5.87	40.28	42.87
40.69	-60.61	41.06
58.07	-48.87	50.81
64.51	-38.21	49.64
-2.31	-56.97	59.36
-32.79	9.07	55.59
32.01	13.55	54.04
-61.13	-23.51	30.16
38.45	4.45	48.11
-39.12	-37.96	58.11
60.09	-19.29	45.6
-2.53	13.64	56.86
1.53	22.63	37.97
31.13	-60.9	-30.47
1.58	16.46	40.82
4.16	-63.54	57.66
-48.06	7.98	44.75
1.65	21.33	47.06
6.29	-61.61	55.19
-45.87	8.19	46.93
40.41	33.61	38.46
42.97	-48.72	53.29
48.62	47.96	7.77
55.57	9.85	36.07
43.06	-56.81	58.57
-65.57	-37.53	18.17
-46.44	1.71	0.52
29.12	3.68	-5.45
-50.61	-23.42	7.56
-48.59	-.43	0.77
16.13	-11.87	-10.41

// Kumari V, 2006: Healthy Controls
// Subjects=13
40.54	14.88	44.8
29.79	22.91	50.91
53.43	18.77	39.71
-50.19	8.18	47.01
-28.59	19.1	47.8
-34.99	12.05	53.09
40.31	37.24	31.38
48.74	48.79	16.65
-39.82	46.56	20.62
-46.33	39.74	16.92
-50.73	45.69	11.93
39.75	26.5	-14.61
52.7	22.08	-16.63
1.64	16.87	45.26
5.76	30.74	32.62
14.64	15	47.47
-45.66	-44.98	52.19
17.26	-66.91	66.73
21.48	-71.98	58.2
64.43	-38.84	42.98
57.49	-46.64	5.77
49.45	-46.57	52.97
39.8	66.24	-2.85
38.19	41.9	35.44
38.4	15.08	47.06
53.23	19.44	23.96
-44.5	50.43	-6.58
-50.61	22.5	16.46
41.93	28.84	-12.64
-2.88	30.71	32.77
5.75	32.86	32.4
3.79	25.59	46.6
-16.06	-1.61	9.29
-11.06	-52.31	52.32
10.57	-59.68	52.68
-43.49	-47.1	52.36
-3.44	-82.92	-34.42
44.02	-70.2	-38.73
-29.35	-80.68	-31.96
-31.65	-57.6	-37.57
49.24	6.61	47.71
34.18	4.85	52.62
-43.59	6.91	55.98
-36.1	-17.71	44.85
-54.35	-19.07	54.26
-48.57	1.91	2.78
-61.52	10.78	6.6
-52.62	12.68	26.43
8.2	10.93	50.22
-.41	-4.2	49.62
-6.91	13.21	52.49
59.51	-69.57	-9.92
-61.24	-39.64	18.31
9.53	-63.11	-29.88
24.59	-61.34	-34.79
5.37	-75.05	-19.66
-30.71	15.04	50.48
44.87	12.77	44.93
8.41	-59.68	52.72
-30.75	16.96	48.05
31.9	21.44	46.54
8.44	-59.48	54.94
51.61	-46.56	52.93
-63.46	-37.94	13.7
-50.61	-23.42	7.56
-48.59	-.43	0.77

// Adcock R A, 2006: MID Anticipation: Any Reward vs. +$0
// Adcock R A, 2006: MID Anticipation: +$5 vs. +$0
// Adcock R A, 2006: MID Anticipation: +$5 vs. +$1
// Adcock R A, 2006: MIE Anticipation: Main Effect of Reward Cue Value Across 
// Intervals
// Adcock R A, 2006: MIE Anticipation: Antecedent to Stimulus Onset (Cue)
// Adcock R A, 2006: MIE Anticipation: During Stimulus Presentation
// Adcock R A, 2006: Memory-Related Activation During High Value Cue
// Adcock R A, 2006: Memory-Related Activation During Low Value Cue
// Adcock R A, 2006: Memory-Related Activation During Low Value Stimulus
// Adcock R A, 2006: Memory-Related Activation Main Effect
// Adcock R A, 2006: Memory-Related Activation Antecedent to Stimulus Onset 
// (Cue)
// Adcock R A, 2006: Memory-Related Activation During Stimulus
// Subjects=12
6.41	-14.29	-11.86
-3.21	-15.49	-12.77
-11.76	5.32	-4.38
11.75	8.81	-2.71
9.67	0.59	1.35
-5.28	0.59	2.63
3.4	-22.2	10.02
-.88	-22.22	10.07
19.17	1.65	-13.35
-12.86	1.71	-9.64
-.97	32.82	19.96
31.1	44.1	25.33
33.01	20.94	-12.89
-34.27	13.22	-10.36
-33.11	23.05	6.65
19.6	-67.57	13.64
-21.43	-66.64	-39.5
6.41	-14.29	-11.86
-3.21	-15.49	-12.77
11.7	3.89	-11.22
-10.69	5.33	-4.39
39.72	-44.07	-.83
8.56	11.07	-.63
8.62	-.39	2.56
-5.28	1.64	2.55
3.41	-17.71	12.99
-.87	-19.94	12.11
19.18	0.59	-13.26
-12.86	0.57	-10.66
-44.94	19.93	-5.22
-1	39.08	18.32
33.02	19.88	-12.81
-35.33	12.24	-9.15
-21.43	-66.64	-39.5
-3.21	-13.29	-11.84
11.71	5.03	-10.2
36.45	-34.83	-4.91
-26.66	-21.63	-7.52
-4.31	16.03	-4.25
3.37	-13.65	10.42
49.14	20.92	-.81
-47.07	16.74	-4.93
0.05	40.06	17.11
7.31	66.39	-.8
-36.39	10.12	-8.96
19.59	-65.45	13.46
-9.61	-21.96	-13.27
-11.84	4.55	-14.35
21.35	-14.37	-14.26
35.21	-23.43	-22.58
35.46	-48.33	-.42
-36.17	-44.7	-2.13
18.21	-4.99	-2.74
23.53	17.85	3.09
42.66	-10.53	-21.52
39.62	-25.29	-5.75
-26.47	-28.46	14.24
-31.93	-31.81	-1.03
40.58	-30.8	-22.02
-64.01	9.46	12.6
-39.36	-35.74	3.84
5.62	-41.05	13.81
9.86	-78.77	-6.5
35.18	-39.18	-33.53
-13.91	-27.78	-19.42
-35.32	-37.06	-27.32
41.7	-77.55	-34.84
11.62	-55.15	-45.3
-8.53	-23.01	-13.19
-10.77	5.61	-14.45
26.67	-11.34	-16.81
34.14	-23.44	-22.57
34.39	-49.39	-.32
-37.23	-47.96	-2.96
-64.01	8.41	12.69
-39.35	-36.8	3.93
35.18	-39.18	-33.53
-35.32	-37.06	-27.32
10.8	-73.53	-21.44
-39.46	-59.83	-18.67
-32.98	-78.91	-18.26
-9.6	-20.81	-12.25
-9.7	5.62	-14.46
21.37	-16.4	-12.97
16.12	-5.54	4.02
25.7	16	6.56
15.01	-1.58	0.35
-14.97	-1.3	-7.13
41.78	-30.57	-5.33
-31.91	-32.7	1.27
-4.2	-33.39	-10.14
-5.16	-78.4	-14.16
-5.35	-13.3	-11.81
14.96	-16.44	-12.9
8.48	11.36	-10.69
23.42	-12.93	-23.33
-20.39	-12.05	-21.78
30.05	-33.64	-2.71
-8.54	9.91	-.34
-33.01	-1.18	9.79
39.39	44.75	-8.27
-53.51	37.22	-1
45.94	28.73	4.15
6.53	25.38	19.38
9.79	12.79	21.51
56.99	-13.65	33.22
-57.39	-12.48	31.09
-63.79	-38.75	22.22
8.85	-56.17	10.58
28.75	-48.19	-39.39
-8.55	-46.24	-24.63
23.35	-16.96	-34.14
8.7	14.81	20.24
-44.69	-8.22	16.09
-54.48	-36.4	-17.12
30.07	-46.67	-6.08
-35.13	-43.89	-5.56
8.47	11.27	-11.8
22.44	-10.93	-11.21
9.77	14.82	20.23
-61.72	6.7	31.77
48.39	-14.21	26.68
-4.28	-11.09	-10.89
8.48	11.36	-10.69
20.13	-12.66	-33.35
-11.77	11.84	-2.69
13.92	-9.5	-5.66
-29.87	-16.19	-5.71
9.77	14.82	20.23
-61.73	6.62	30.66
-47.89	-7.1	17.15
48.38	-14.3	25.57
-51.28	-33.12	-16.31
-33	-41.76	-5.76

// Chang L, 2006: THC+ Users
// Subjects=12
12	60	9
-27	-54	63
27	-54	-51
-39	-33	54
-21	-75	36
-15	-75	-6
-21	0	-24
24	-42	42
-12	60	9
6	12	51
6	-54	66
-18	-75	36
21	-66	-12
6	12	51
30	3	54
48	9	24
-27	0	57
33	-72	30
33	-48	60
-27	-42	66
12	-72	-3
-39	-66	-3
45	-63	-3
-30	-63	-27
9	-42	-48
42	-21	30
-42	15	-12
33	-72	30
-15	-75	-6
15	-78	-39
36	-36	27
15	54	36
-12	-75	-3

// Chang L, 2006: THC- Users
// Subjects=12
-21	-3	63
-36	21	-3
27	3	51
3	-48	69
30	-60	-18
-27	-6	30
30	-48	33
39	15	-27
-18	-78	-6
24	-42	42
-12	60	9
6	12	51
6	-54	66
-18	-75	36
21	-66	-12
12	18	54
45	-33	36
-33	-57	-39
24	-54	60
-39	-42	54
-6	60	12
39	-66	-33
45	-36	33
36	-36	27
15	54	36
-12	-75	-3

// Chang L, 2006: Normals
// Subjects=19
-21	-3	63
-36	21	-3
27	3	51
3	-48	69
30	-60	-18
-27	-6	30
30	-48	33
39	15	-27
-18	-78	-6
12	60	9
-27	-54	63
27	-54	-51
-39	-33	54
-21	-75	36
-15	-75	-6
-21	0	-24
27	-57	57
-24	-45	51
21	6	57
24	-54	60
-39	-42	54
-6	60	12
39	-66	-33
45	-36	33
42	-21	30
-42	15	-12
33	-72	30
-15	-75	-6
15	-78	-39

// Jager G, 2006: Novel Set > Contrasl Task, STERN
// Jager G, 2006: Tones, SAT > Rest
// Jager G, 2006: Tones, SAT - Dots, SAT
// Subjects=10
42	5	28
34	-59	44
6	5	56
-34	-63	44
42	-67	-12
-46	13	36
-2	13	48
-58	-31	4
58	-23	8
-46	21	-4
-58	-27	0
58	-31	8
-6	-67	8
-2	-83	32

// Deeley Q, 2006: Psychopathic Subjects
// Subjects=6
35.32	-67.3	-25.59
32.24	-85.84	-17.31
-41.6	-71.99	-24.32
-32.96	-83.06	-16.8
-41.18	-18.24	51.46
28.96	-78.97	-24.54
35.4	-74.19	-18.33
-41.23	-18.75	44.82
43.75	17.11	-8.24
28.27	-67.29	30.25
43.87	-67.25	-25.7
35.36	-62.56	-19.3
-37.25	-78.85	-17.1
-37.16	-77.91	-4.91
-36.93	-27.19	45.47
35.49	-85.39	-11.81
-6.2	-94.53	-16.14
-29.86	-67.69	-24.81
-32.7	-14.47	44.36
27.96	-73.8	-12.7
35.54	-84.88	-5.16
27.92	-74.23	-18.24
39.61	-71.5	-25.29
24.73	-78.48	-17.84
-41.46	-82.68	-11.16
35.87	-61.65	47.53
8.91	4.81	42.26
-21.82	-66.22	48.57

// Deeley Q, 2006: Normals
// Subjects=9
35.32	-67.3	-25.59
32.24	-85.84	-17.31
-41.6	-71.99	-24.32
-32.96	-83.06	-16.8
-41.18	-18.24	51.46
28.96	-78.97	-24.54
35.4	-74.19	-18.33
-41.23	-18.75	44.82
43.93	19	16.14
32.56	-58.38	35.03
-41.18	-18.24	51.46
35.32	-67.3	-25.59
-41.48	-78.45	-11.51
24.8	-85.45	-11.68
5.8	5.82	55.6
35.49	-85.39	-11.81
-6.2	-94.53	-16.14
-29.86	-67.69	-24.81
-32.7	-14.47	44.36
27.96	-73.8	-12.7
35.54	-84.88	-5.16
27.92	-74.23	-18.24
35.42	-78.42	-17.97
27.9	-83.21	-24.18
-21.99	-71.28	24.47
-32.63	-18.19	51.36
-37.47	-57.05	-37.89
-17.97	-90.37	-16.36
-29.89	-60.29	-25.43
-6.17	-77.72	-5.29
-22.43	8.77	-0.08

// Eickhoff S B, 2006: Left Anodal, Right Cathodal Stimulation > Rest
// Eickhoff S B, 2006: Right Anodal, Left Cathodal Stimulation > Rest
// Subjects=11
38	-26	20
60	-6	8
36	-4	-20
-46	-20	16
-38	-22	20
40	-26	22
-42	-6	-6
-48	-36	26

// McBride D, 2006: Expectant Smokers
// Subjects=10
-4	30	24
-4	40	8
0	56	22
-8	60	-14
-36	12	2
-2	-16	36
50	-34	2
-8	-58	36
4	-58	36
-2	-6	6
-56	2	34
56	6	35
-26	-14	54
26	-14	56
-38	-6	16
38	-2	15
-40	-45	58
36	-44	52
-57	-26	38
54	-27	42
-26	-58	55
27	-58	58
-22	-81	38
25	-80	41
-33	-85	10
35	-82	10
-26	-52	-13
30	-56	-13
-48	-68	-2
53	-61	-6
-16	-8	26
-4	30	12
-10	24	30
6	46	8
0	58	20
2	32	32
-8	60	-14
-30	36	42
20	58	34
-4	-24	26
58	-56	24
6	-74	32
-4	-74	26
-8	-58	36
-2	28	18
10	-20	26
18	-10	-10
-8	-58	36
50	-32	2

// McBride D, 2006: Non-Expectant Smokers
// Subjects=10
-4	30	24
-4	40	8
0	56	22
-8	60	-14
-36	12	2
-2	-16	36
50	-34	2
-8	-58	36
4	-58	36
-2	-6	6
-56	2	34
56	6	35
-26	-14	54
26	-14	56
-38	-6	16
38	-2	15
-40	-45	58
36	-44	52
-57	-26	38
54	-27	42
-26	-58	55
27	-58	58
-22	-81	38
25	-80	41
-33	-85	10
35	-82	10
-26	-52	-13
30	-56	-13
-48	-68	-2
53	-61	-6
54	-36	4
-2	28	18
10	-20	26
18	-10	-10
-8	-58	36
50	-32	2

// Mohamed F B, 2006: Guilty Subjects
// Subjects=6
-17	-83	-6
-35	-85	8
39	-9	19
28	-47	-10
-38	15	17
-52	-1	15
-52	-9	12
6	39	-5
-20	-18	23
36	-48	45
-56	15	25
-4	54	38
6	-5	13
0	-88	-4
-6	4	9
-14	-20	20

// Mohamed F B, 2006: Non-Guilty Subjects
// Subjects=5
30	-27	-2
-20	-56	56
46	-79	21
2	-44	56
50	-4	41
-14	-45	35
12	-59	62
0	-62	9
-16	17	-9
-22	19	-3
20	-50	54
-64	-22	-16
-48	-40	48
-4	-26	33
42	-1	37

// Goekoop R, 2006: Correct Recognition of Familiar Faces Averaged Across Pre- 
// and Post-Treatment of Both Groups
// Goekoop R, 2006: Interaction Between Activation Levels of Raloxifene and 
// Placebo Groups at Pre- and Post-Treatment
// Subjects=14
2	-82	4
-31	-73	-10
-30	-72	-12
25	-35	-2
-23	-38	2
50	8	-3
48	10	-2
-40	4	0
0	-40	60
36	-62	40
-38	-62	39
-35	10	55
40	0	0
43	28	40
-40	28	42
-39	-10	54
-42	-23	55
-26	-38	-2
52	22	16

// Jackson P L, 2006: Pain Related Sites of Activation
// Jackson P L, 2006: Self vs. Other
// Jackson P L, 2006: Others vs. Self
// Subjects=18
-6	24	39
6	21	42
33	21	0
-30	18	3
60	12	24
-48	9	3
-21	9	0
15	6	0
-12	-12	0
63	-18	36
-60	-21	33
42	-45	51
-30	-51	54
-36	-48	-39
42	3	-6
-42	3	-6
-42	-3	12
0	0	36
-21	-15	3
-63	-24	36
66	-27	42
63	-30	27
30	-36	63
-15	-54	66
51	18	48
48	-57	27
-45	-60	27
-51	-69	39
-12	-60	36
3	-66	39

// Mostofsky S H, 2006: Normal Children
// Subjects=11
51.56	-27.21	53.26
-43.43	-18.2	62.95
23.21	-48.94	29
43.02	-28.64	61.39
-49.94	-29.38	58.56
26.82	-63.05	-30.18
-27.11	-75.69	-24.65
12.39	14.37	40.85
47.34	-26.5	61.1
36.44	-27.26	53.52
27.96	-41.35	64.02

// Mostofsky S H, 2006: Children with Attention-Deficit / Hyperactivity 
// Disorder (ADHD)
// Subjects=11
-52.16	-15.56	57.23
12.02	-80.37	-8.04
-16.1	-85.04	-10.46
8.23	14.43	53.24
51.59	-12.76	58.55
-55.63	-.87	42.39
18.64	-95.68	0.08
-22.81	-60.47	-22.87
-16.1	-85.04	-10.46
8.15	8.39	45.99
47.34	-26.5	61.1
36.44	-27.26	53.52
27.96	-41.35	64.02

// Santel S, 2006: Anorexia Nervosa Patients
// Subjects=13
-50	-28	26
12	-82	-8
27	-91	-6
30	-77	-21
-18	-96	-3
-18	-86	-21
-24	-93	-2
24	-79	-14
18	-93	13

// Santel S, 2006: Normals
// Subjects=10
-50	-28	26
12	-82	-8
18	-93	0
30	-90	10
-12	-99	0
-12	-91	-8
21	-91	-3
33	-71	-17
-15	-96	-3
15	19	27
-33	40	-12
-48	-10	-15

// Xiao Z, 2006: Water-Related Images > Neutral Scene Images
// Xiao Z, 2006: Drug-Related Images > Neutral Scene Images
// Subjects=14
4.05	41.37	-14.35
-54.97	24.4	14.11
50.9	28.07	13.06
-28.63	-83.99	24.38
-46.38	-66.75	-8.4
41.16	-78.25	-9.87
-28.02	-76.57	-11.1
30.27	-70.19	-14.96
2.27	-82.74	-9.88

// Dimitrova A, 2006: Activation in Finger Movement
// Dimitrova A, 2006: Activation in Foot Movement
// Dimitrova A, 2006: Activation in Tongue Movement
// Subjects=12
6	-60	-24
8	-74	-44
14	-38	-24
28	-46	-30
24	-46	-20
40	-54	-26
-2	-72	-44
-6	-64	-20
-46	-60	-30
-28	-50	-24
-6	-38	-42
18	-34	-24
28	-34	-30
8	-66	-36
16	-60	-26

// Staresina B P, 2006: Increasing Activation Across Subsequent Memory 
// Conditions
// Staresina B P, 2006: Free Recall-Specific Network (Conjunction/Masking 
// Analysis)
// Staresina B P, 2006: Successful Word/Color Binding
// Subjects=16
-51	18	18
21	-21	-21
-66	-45	-9
-33	21	-3
42	-39	-27
-51	30	9
-24	-15	-18
-3	-51	18
-39	-54	57
-45	21	21
-51	21	30
-39	15	57
-30	30	48
-18	54	33
-30	21	-3
3	51	42
-39	-54	57
-57	-54	30
-36	-69	42
54	-60	39
39	-57	42
-3	-51	15
-60	-54	-3
-66	-48	-9
-48	-33	-18
42	-39	-30
-3	0	6
-15	0	18
-30	-6	-36

// Calhoun V D, 2006: Normals > Schizophrenic Patients
// Calhoun V D, 2006: Schizophrenic Patients > Normals
// Subjects=15
-56.42	18.4	-15.53
-56.37	18.71	-12.2
1.93	15.76	67.78
-56.16	-30	-5.14
-50.58	-24.28	9.88
-62.71	14.31	-1.57
-44.42	14.92	-7.55
1.89	11.09	63.76
-53.76	-23.87	14.38
-38.13	60.57	-13.29
-49.98	-60.3	49.3
1.25	-50.55	1.52
-2.94	24.77	26.63
-57.72	-45.21	38.97
-16.47	3.03	-21.41
-16.48	7.28	-21.83
-3.23	1.86	-.23
-3.09	-55.13	-1.32
-.98	-2.93	5.81
-7.34	28.59	21.84
-55.5	-59.03	40.3
64.7	7.65	-10.93
52.72	18.89	-16.32
8.48	11.94	72.53
64.67	3.08	-13.84
62.79	-13.45	4.64
58.4	-1.97	1.34
50.97	-15.2	9.5
17.07	11.56	67.94
56.39	-12.85	11.41
45.05	6.47	57.88
65.23	-32.19	22.14
1.27	-53.74	1.83
3.57	22.87	28.95
65.23	-45.27	20.07
20.35	-.58	-16.08
20.27	5.39	-21.15
22.54	-1.42	-13.79
3.34	-2.92	5.73
-15.3	-65.94	55.99
-28.51	-85.29	33.47
-23.93	-.18	70.92
-32.84	-81.05	33.13
-23.91	-4.44	71.34
-37.17	-78.94	32.99
-32.9	-81.46	28.69
-37.13	-74.27	37.01
-43.48	-14.16	60.31
-26.18	0.25	64.19
-4.41	-32.44	69.29
30	-79.48	46.47
27.82	-81.82	44.5
29.76	19.41	47.89
47.11	-76.31	33.54
47.1	-72.05	33.12
31.88	-93.56	22.06
44.97	-73.98	35.59
27.88	-72.59	51.43
34.1	15.17	48.24
4.18	-26.23	66.29

// Coan J A, 2006: Threatened - Safe, No Hand Holding
// Coan J A, 2006: No Hand Holding, Threatened > Hand Holding with Spouse, 
// Threatened
// Coan J A, 2006: No Hand Holding, Threatened > Hand Holding with Stranger, 
// Threatened
// Coan J A, 2006: Hand Holding with Stranger > Hand Holding with Spouse, 
// Threatened
// Coan J A, 2006: Negative Correlations between WDAS and Threat-Related 
// Activation during Hand Holding with Spouse
// Coan J A, 2006: Positive Correlation between Shock Pain Ratings and 
// Threat-Related Activation
// Subjects=16
5.71	11.48	46.2
-9.09	-2.3	62.03
11.26	-2.81	67.41
-11.91	42.24	-8.59
4.13	47.88	-5.9
35.39	39.89	25.64
-40.28	-.14	37.67
13.67	48.31	-14.97
-37.36	39.75	16.45
40.58	18.58	-2.75
-28.9	22.39	-2.27
9.67	9.31	3.96
-9.42	-.27	19.48
-7.47	5.52	-2.21
30.96	5.32	-8.22
-10.53	-12.76	9.39
2.16	-13	-8.58
4.38	-28.59	-3.95
11.07	-55.3	21.63
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
54.76	-26.66	16.5
-11.91	42.24	-8.59
-7.47	5.52	-2.21
4.38	-28.59	-3.95
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
-11.91	42.24	-8.59
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
35.39	39.89	25.64
-9.09	-2.3	62.03
40.58	18.58	-2.75
2.16	-13	-8.58
40.58	18.58	-2.75
2.16	-13	-8.58

// Assaf M, 2006: Schizophrenic Patients
// Subjects=16
11.32	7.88	40.39
8.33	23.98	63.5
-11.49	53.95	40.7
-8.91	59.92	-10.36
-43.56	-2.77	55.82
-51.12	36.19	-20.74
58.03	36.89	-19.31
-37.46	28.35	32.47
-49.88	-49.69	59.45
1.61	-53.38	28.68
-69.12	-36.64	-6.51
-31.84	8.76	-39.65
33.04	2.92	-36.81
-5.38	-4.63	-.67
4.35	-4.6	-.84
-11.88	18.2	2.78
17.22	14.49	-4.07
-21.83	-4.33	-19.47
30.11	-32.01	-19.86
-5.53	-9.07	-13.68
-14.41	0.52	55
14.59	11.39	43.34
4.13	16.8	-13.04
-32.59	-13.5	66.78
52.7	38.45	-13.77
33.8	28.29	27.9
-34.18	-84.09	12.16
54.83	63.44	-10.68
-48.01	9.01	-36.04
29.79	6.1	-37.07
-31.5	-9.47	-16.56
30.33	-42.36	-4.27
-39.27	-57.7	42.13
47.1	-54.51	36.98

// Assaf M, 2006: Normals
// Subjects=16
-1.86	37.95	29.79
-2.34	41.97	-7.58
-41.3	47.9	-10.86
61.49	29.74	-4.09
-43.75	11.19	44.36
53.08	39.13	16.41
-55.5	-52.44	41.89
47.08	-49.2	36.46
11.55	-57.21	44.58
-65.82	-49.29	-4.19
-30.69	9.28	-34.12
61.27	-11.25	-29.17
-5.38	-11.22	-2.26
10.74	7.87	-5.55
-2.12	-23.12	-3.38
-14.41	0.52	55
14.59	11.39	43.34
4.13	16.8	-13.04
-32.59	-13.5	66.78
52.7	38.45	-13.77
33.8	28.29	27.9
-34.18	-84.09	12.16
54.83	63.44	-10.68
-48.01	9.01	-36.04
29.79	6.1	-37.07
-31.5	-9.47	-16.56
30.33	-42.36	-4.27
-39.27	-57.7	42.13
47.1	-54.51	36.98

// Ongur D, 2006: Normals
// Subjects=15
20	-66	42
-38	-58	34
36	14	-6
-56	34	-14
4	26	56
52	18	2
-30	20	56
-6	-28	6
0	4	28
54	-38	-16
32	-22	-28
-38	-24	-22
36	-60	46
-10	18	38
32	-48	52
-30	-58	62
28	-50	52

// Ongur D, 2006: Schizophrenic Patients
// Subjects=15
32	40	-16
0	4	70
64	-12	-22
-58	-8	-4
36	-60	46
-10	18	38
22	-40	66
36	14	0
-34	30	-8
44	4	40
28	-50	52

// Ragland J D, 2006: Normals
// Subjects=13
-45	9	29
-45	22	17
-38	13	43
-22	7	55
30	-16	49
-4	21	43
-4	-36	27
-34	-52	47
-15	-44	-15
49	-26	-5
-55	12	25
-51	26	21
-34	11	55
-4	24	43
-41	-52	54
-15	-59	62
19	-56	36
-15	-88	-6
30	-80	1
-4	-52	-28
41	-64	-34
30	-29	5
22	-37	-5
-51	-19	-12
51	-26	-5
41	-58	10
-45	15	10
-49	13	40
-45	30	21
-38	10	51
38	21	43
-11	-3	19
-41	-56	50
26	-63	-20

// Ragland J D, 2006: Schizophrenic Patients
// Subjects=13
-30	17	47
-11	0	7
11	-8	0
49	-26	-5
-26	-64	44
49	-26	-5
-30	17	47
-19	2	48
41	20	36
-34	19	3
8	21	43
0	-32	27
-11	0	7
26	-25	1
22	-37	-2
-8	-60	40
-34	-75	37
-45	-56	43
45	-41	50
-8	-77	-13
30	-29	5
22	-37	-5
-51	-19	-12
51	-26	-5
41	-58	10
49	11	3
-49	4	3
19	-42	39
-55	-4	-3

// Weiss A P, 2006: Schizophrenia Patients
// Subjects=16
37.83	23.9	3.61
22.82	59.75	20.49
42	62.2	-.25
16.85	-56.85	36.61
57.91	-52.25	37.7
-30.82	-60.19	26.55
-28.69	-60.39	24.29
-36.1	-63.01	-49.28
-.42	-32.68	43.48
-31.84	10.99	-38.75
28.91	56.86	-10.7
-25.12	67.52	-8.6
61.37	24.45	-14.77
50.37	36.13	-26.95
-13.33	-47.62	45.18
4.2	-28.26	67.61
56.88	1.29	-32.58
70.23	-39.54	-10.83
-48.91	-66.27	-37.54
-9.59	0.54	8.97
-4.31	-11.94	81.83
4.05	-5.27	60.86
-36.29	14.4	-47.97
56.84	3.21	-35.01
-7.42	-1.58	9.14
3.76	25.39	44.38
48.7	28.81	9.66
-55.26	-4.03	-14.45
-49	44.71	-21.62
-29.6	13.75	-32.34
33.09	14.18	-31.21
31.56	56.15	27.42
15.14	-40.36	75.35
-6.83	15.96	58.94
-4.31	-11.94	81.83
-44.55	-68.17	-35.18
-11.86	12.88	3.31
-5.57	11.45	-12.35
48.7	28.81	9.66
-48.98	47.04	-19.61
35.34	12.68	-24.37
31.56	56.15	27.42
-4.76	24.06	53.63
-44.56	-66.05	-35.39
-9.71	10.55	1.26

// Weiss A P, 2006: Normals
// Subjects=16
3.53	41.16	29.38
42.13	21.58	1.53
24.98	68.47	21.83
44.46	51.32	20.96
44.18	57.95	0.13
24.63	61.52	-6.61
6.18	-55.85	47.9
16.85	-56.85	36.61
-2.43	-55.67	50.27
51.26	-53.51	24.49
57.86	-52.66	33.26
-67.53	-44.8	32.37
-65.49	-56.68	20.07
-59.06	-50.48	17.1
57.1	-18.94	-19.37
63.65	-29.35	-16.21
-61.69	-32.12	-16.04
37.83	23.9	3.61
22.82	59.75	20.49
42	62.2	-.25
16.85	-56.85	36.61
57.91	-52.25	37.7
-28.69	-60.39	24.29
9.98	21.21	22.28
-8.76	-30.43	68.05
56.95	-2.55	-27.72
-33.95	-60.87	-49.53
-35.83	15.6	-12.24
-36.1	-63.01	-49.28
-36.29	14.4	-47.97
56.84	3.21	-35.01
-7.42	-1.58	9.14
48.7	28.81	9.66
-48.98	47.04	-19.61
35.34	12.68	-24.37
31.56	56.15	27.42
-4.76	24.06	53.63
-44.56	-66.05	-35.39
-9.71	10.55	1.26

// Assaf M, 2006: Correct Recall
// Assaf M, 2006: Correct No Recall
// Assaf M, 2006: Correct Associated
// Assaf M, 2006: Correct Non Associated
// Assaf M, 2006: Correct Recall > No Recall
// Assaf M, 2006: Correct Associated > Non Associated
// Assaf M, 2006: Correct Non Associated > Associated
// Subjects=18
-1.63	23.24	44.69
-4.95	28.13	39.78
-37.06	-15.72	54.75
-44.03	10.17	22.05
-47.62	23.93	-2.78
36.52	23.3	-14.24
-46.78	-28.83	52.85
-30.54	-50.46	50.23
-59.35	-46.07	-4.62
-24.41	-96.82	13.25
33.78	-88.93	2.52
-8.62	-4.65	-.62
10.94	-10.34	6.34
-11.96	10.98	-5.47
17.32	11.92	2.9
-1.59	24.62	47.91
-37.11	-12.84	51.1
-44.06	6.67	19.04
-46.54	19.58	-3.49
46.32	22.79	-8.75
-43.66	-33.04	42.01
40.69	-44.13	45.03
-24	-56.5	54.08
37.6	-49.59	55.71
-24.36	-99.7	16.9
40.37	-93.61	9.59
-14.96	-18.94	7.63
14.21	-8.95	9.5
-11.88	8.31	0.4
8.05	22.96	41.19
-5.1	30.28	28.36
-42.51	-6.27	52.79
-39.68	14.75	24.89
-44.31	21.17	1.92
36.6	29.34	-6.99
-33.94	-33.01	41.84
40.75	-40.42	50.27
-27.36	-47.57	46.53
34.22	-47.35	45.46
-53.96	-49.45	-6.62
74.82	-33.09	11.98
-27.8	-94.68	1.89
46.8	-90.7	5.83
-15.07	-13.18	0.34
7.65	-16.18	1.37
13.94	14.16	-7.35
1.02	-18.41	-10.63
4.93	24.95	51.13
-1.65	27.5	44.27
-33.74	-5.3	62.63
-52.55	12.14	32.09
36.41	56.37	-16.39
-44.33	24.36	1.6
36.51	25.42	-14.45
-33.88	-35.89	45.49
37.51	-47.03	48.73
-30.6	-47.58	46.59
34.31	-46.72	52.12
-52.93	-56.35	-11.56
-37.41	-80.7	14.12
46.87	-90.19	11.38
-15.08	-9.99	0.02
7.6	-14.37	-2.17
17.17	10.78	-9.31
-1.74	37.72	38.78
-2.33	45.36	-5.67
-43.8	14.06	40.71
-44.57	34.6	-15.1
39.71	25.12	-17.83
-55.57	-46.37	37.93
-66.22	53.88	-14.39
-5.38	-4.63	-.67
17.32	11.92	2.9
-12.01	45.64	-2.17
-8.04	-36.42	38.37
-40.28	-47.3	50.09
-65.8	-54.6	-3.67
21.11	-4.75	42.59
20.92	18.99	32.4
-11.4	21.73	40.52

// Heinze S, 2006: Normals
// Subjects=15
31.55	37.44	22.55
16.6	40.87	37.03
-60.58	-38.4	-14.32
33.68	-37.16	5.24
-42.46	30.9	-20.37
29.45	35.72	27.24
29.99	-48.87	52.41
38.54	-37.55	46.66
-60.58	-38.4	-14.32
-42.46	30.9	-20.37
40.84	-70.41	50.99
34.48	-68.44	60.99
60.55	-62.23	-11.79
48.61	-58.32	-15.33
-60.47	-49.68	-8.73
55.32	-77.37	-1.23
40.84	-70.41	50.99
16.09	-34.08	-18.3
9.6	-87.78	-29.68

// Heinze S, 2006: Schizophrenic Patients
// Subjects=18
32.2	-59.5	53.42
49.28	-35.8	41.82
-.63	26.98	38.7
9.96	33.11	23.34
27.77	-88.72	39.58
-28.35	-60.02	51.14
33.68	-37.16	5.24
-42.46	30.9	-20.37
46.94	2.27	35.85
30.06	-59.3	55.68
-28.35	-60.02	51.14
-.63	26.98	38.7
-42.46	30.9	-20.37
-50.66	-66.46	-4.99
-64.87	-33.85	-11.34
14.06	70.9	13.93
-16.27	70.17	7.8
-28.43	10.46	58.74
62.97	-63.54	8.47
-17.43	-62.45	59.04
40.84	-70.41	50.99
16.09	-34.08	-18.3
9.6	-87.78	-29.68

// Kensinger E A, 2006: Pictures Corresponding with Subsequent Item-and-Source 
// Memory
// Kensinger E A, 2006: Words Corresponding with Subsequent Item-and-Source 
// Memory
// Kensinger E A, 2006: All Items Corresponding with Subsequent 
// Item-and-Source Memory
// Kensinger E A, 2006: Pictures Corresponding with Subsequent Item-Not-Source 
// Memory
// Kensinger E A, 2006: Words Corresponding with Subsequent Item-Not-Source 
// Memory
// Kensinger E A, 2006: All Items Corresponding with Item-Not-Source Memory
// Subjects=21
-30	11	51
45	46	-12
-24	26	-11
41	15	-23
45	-9	-9
-30	-12	-12
39	-21	-12
45	-24	-19
6	-17	12
22	-47	60
46	3	4
32	15	-21
-52	-35	-3
-30	-12	-15
-9	10	61
24	-47	55
39	13	-28
-36	-15	-14
15	-35	-6
-18	-6	-5
-15	48	31
-48	37	-13
-35	-65	7
42	-65	-8
30	-73	-11
-21	-10	-23
28	-1	-23
-40	-81	8
33	44	-2
17	-4	39
2	18	17
-36	-62	-20
35	-76	-10
-37	-12	-26
30	3	-20
35	-75	-20
-3	20	43
-42	31	29
33	35	1
-27	-63	28
45	-67	6
24	-79	-9
36	-76	-11
42	-64	-2
-27	-73	-1
-30	-82	-6
-36	-62	-17
-37	-10	-25
30	-4	-23
-42	-78	12
42	-78	7
15	-79	-6
18	-98	10
-6	-51	-25

// Blair K, 2006: Moderated by Decision Form:  RewRew > PunPun
// Blair K, 2006: Moderated by Decision Form:  RewRew> RewPun
// Blair K, 2006: Moderated by Decision Form:  RewPun > PunPun
// Blair K, 2006: Moderated by Decision Form:  PunPun > RewRew
// Blair K, 2006: Moderated by Decision Form:  PunPun > RewPun
// Blair K, 2006: Main Effect of Between-object Reinforcement Level 
// Difference, All Trials
// Blair K, 2006: Main Effect of Decision Form (Excluding RewPun):  RewRew > 
// PunPun
// Blair K, 2006: Main Effect of Decision Form (Excluding RewPun):  PunPun > 
// RewRew
// Blair K, 2006: Main Effect of Between-object Reinforcement Level Difference 
// (Excluding RewPun)
// Subjects=21
0.88	55.1	-8.7
28.77	-6.21	-19.49
-62.78	-28.42	18
-56.21	-76.14	19.69
67.61	-63.65	4.95
-29.33	-62.21	46.09
0.88	55.1	-8.7
28.77	-6.21	-19.49
-62.78	-28.42	18
-56.21	-76.14	19.69
67.61	-63.65	4.95
-29.33	-62.21	46.09
0.88	55.1	-8.7
28.77	-6.21	-19.49
-62.78	-28.42	18
-56.21	-76.14	19.69
-29.33	-62.21	46.09
4.6	22.05	45.33
53.72	28.51	41.99
-40.62	17.21	0.53
39.51	21.83	-1.89
47.66	-53.49	55.63
-48.93	-82.55	-8.85
4.6	22.05	45.33
53.72	28.51	41.99
-40.62	17.21	0.53
39.51	21.83	-1.89
47.66	-53.49	55.63
-48.93	-82.55	-8.85
2.3	15.92	21.34
-36.09	13.2	30.93
7.32	52.22	-5.19
34.13	-3.81	-16.41
33.03	-3.01	-19.81
-26.58	-40.49	-3.71
71.88	-30.7	17.76
-46.52	-79.71	27.69
20.88	-66.39	42.52
11.01	23.14	45.16
-54.23	-28.29	19
-40.45	-64.53	-10.46
-30.47	-51.98	40.79
-1.96	20.47	25.46
-35.02	12.15	31
48.34	-76.17	-3.81

// Daselaar S M, 2006: Oldness Related Increase, Recollection
// Daselaar S M, 2006: Oldness Related Increase, Familiarity
// Daselaar S M, 2006: Oldness Related Decrease, Familiarity
// Daselaar S M, 2006: Exponential > Linear, Recollection
// Daselaar S M, 2006: Linear > Exponential, Familiarity Related Increase
// Daselaar S M, 2006: Young > Old, Recollection
// Daselaar S M, 2006: Old > Young, Familiarity Related Decrease
// Daselaar S M, 2006: Young > Old, Familiarity Related Decrease
// Subjects=12
-23	-26	-9
-53	-57	38
-4	-55	17
0	-2	35
0	49	19
-34	-23	57
4	-85	-2
30	-49	-20
-38	-76	28
4	-35	44
-26	-1	-26
49	-41	-17
-49	-19	-18
45	12	10
-19	12	13
-19	-27	4
-30	-80	8
34	-57	-35
-45	-6	35
53	5	28
-30	52	8
4	21	41
15	-67	56
-38	-29	15
-23	-26	-9
-53	-57	38
-4	-55	17
0	-2	35
0	49	19
-34	-23	57
4	-85	-2
30	-49	-20
-38	-76	28
4	-35	44
-23	-26	-9
-53	-57	38
-4	-55	17
0	-2	35
0	49	19
-34	-23	57
4	-85	-2
30	-49	-20
-26	-1	-26
49	-41	-17
-49	-19	-18
-45	-6	35
53	5	28
-30	52	8
4	21	41
15	-67	56
-38	-29	15

// Daselaar S M, 2006: Brain Regions Associated with Recollection
// Daselaar S M, 2006: Brain Regions Associated with Familiarity
// Daselaar S M, 2006: Brain Regions Associated with Novelty
// Subjects=14
-26	-26	-11
30	-23	-11
-4	-43	20
0	-23	33
-45	-65	31
-27	14	-20
34	17	-20
0	-81	-2
-4	59	-3
-4	-43	20
-45	-65	31
-34	-41	-8
0	-31	44
-15	-68	34
-38	80	32
15	-58	17
0	30	12
-34	-41	-8
-38	80	32
15	-58	17
-19	-8	-16
27	-4	-27
30	15	-4
-64	-11	-3
-45	-23	-18
49	-22	5
-11	-52	62
4	17	41
-49	2	31
56	5	28
45	38	19
30	13	52
-11	-42	-23
27	-4	-27

// Montaldi D, 2006: Linear Increases in Familiarity F1 to F3
// Montaldi D, 2006: Linear Decreases in Familiarity F1 to F3
// Montaldi D, 2006: Linear Increases in Familiarity M to F3
// Montaldi D, 2006: Linear Decreases in Familiarity M to F3
// Montaldi D, 2006: Recollected > F3
// Montaldi D, 2006: F3 > Recollected
// Subjects=13
-51	18	-12
-36	24	-9
-54	18	21
-45	9	33
48	21	-12
3	48	6
-39	-72	39
-3	-81	45
-9	-12	6
0	-45	15
-63	-45	-3
66	-24	-15
-51	-60	21
-3	48	6
0	-45	15
-33	-3	-36
36	-9	-33
42	-36	24
42	-24	12
-33	-15	15
-39	3	18
24	15	30
-42	-45	12
42	-66	15
-57	-18	3
-30	-60	-6
33	-72	-6
-18	-90	0
-30	24	-12
-48	15	39
-30	63	6
-39	-51	48
-42	-66	42
9	-75	48
-15	-12	15
-3	-42	27
-12	9	0
15	9	3
-6	-18	-6
-63	-42	-3
-9	-75	48
-30	0	-33
30	-3	-36
-33	-12	24
48	-21	21
33	-30	24
36	-48	24
18	-48	12
-45	-3	-24
-60	-21	3
-45	-42	21
-48	27	-15
42	24	-21
-3	48	12
-42	-72	30
-12	-33	-3
21	-33	-3
-33	-12	0
-39	-75	-9

// Uncapher M R, 2006: Memory Effects for Items in which Once Source Feature 
// was Remembered (Location or Color)
// Uncapher M R, 2006: Memory Effects for Items in which Both Source Features 
// were Remembered (Location and Color)
// Uncapher M R, 2006: Items Remembered > Items Forgotten (Regardless of 
// Source Accuracy)
// Subjects=20
-45	21	-3
3	-60	15
-33	-54	18
-60	-45	15
-57	-36	-9
-45	24	-9
-48	27	9
-48	18	27
-48	-9	24
21	-42	48
24	-72	27
-48	6	33
-24	-3	-30
24	-93	30
-27	-96	15

// Gizewski E R, 2006: Men
// Subjects=22
-6	38	-12
30	32	-12
-30	-9	-20
27	-21	-18
-3	-17	9
3	-12	39
-42	-6	6
45	-7	-1
-9	36	-15
10	33	-17
-30	-9	-21
31	-16	-21
-6	-18	9
6	-6	36
-42	-3	3
43	-4	3

// Gizewski E R, 2006: Women
// Subjects=25
-6	38	-12
30	32	-12
-30	-9	-20
27	-21	-18
-3	-17	9
3	-12	39
-42	-6	6
45	-7	-1
-9	36	-15
10	33	-17
-30	-9	-21
31	-16	-21
-6	-18	9
6	-6	36
-42	-3	3
43	-4	3
2	1	31
-9	36	-21
-42	-3	-3
42	0	-1

// Kirsch P, 2006: Monetary > Verbal, All Subjects and Both Substances
// Subjects=8
-12	9	-15
12	9	-12
-9	-15	3
6	-21	3
-21	0	-12
27	-6	-12
-21	0	3
15	12	-6
-30	30	-9
51	21	-15
-6	12	36
6	24	27
-45	3	3
39	12	-6
12	-21	-9
-36	-18	51
51	-3	48
60	-15	27
-57	12	-3
54	-30	-6
-24	-51	60
-60	-21	24
-24	-66	3
42	-75	24
9	-72	51

// Bohlhalter S, 2006: Tic Generation > Baseline
// Bohlhalter S, 2006: Tic Imitation > Baseline
// Subjects=10
12.66	11.98	61.25
-8.91	16.58	65.64
10.22	9.9	39.08
-9.19	7.91	41.85
-30.72	-4.72	45.71
-26.44	34.41	50.73
42.63	3.42	36.93
47.18	-12.33	51.86
59.83	-25.62	23.82
-58.96	-32.22	28.74
48.63	2.04	-1.13
27.07	4.51	3.47
22.74	-21.86	-2.81
-40.01	-.81	-3.82
-37.84	-16.11	-6.83
-26.84	-10.16	10.32
-18.29	-21.8	0.12
-40.11	-56.28	-22.99
-33.55	-60.09	-18.24
6.19	16.42	63.16
8.15	8.39	45.99
-5	20.06	33.85
-42.49	31.76	-22.69
-42.09	39.13	10.19
-22.11	19.12	47.69
45.1	-9.59	58.35
47.19	-14.46	52.07
44.94	-21.68	43.86
32.35	-43.05	68.6
-39.11	-11.6	64.46
-67.68	-19.69	25.41
-25.98	-38.79	71.41
66.36	-25.19	28.15
-48.09	-27.3	34.79
44.12	7.16	-15.01
27.07	4.51	3.47
-46.48	12.34	-.53
-26.84	-10.16	10.32
13.94	-18.68	-14.18
-7.64	-18.55	-11.59
-1.06	-74.66	-15.11
31.21	-51.56	-22.43
-27.07	-53.48	-16.76

// Dresel C, 2006: Nomals
// Subjects=13
-48	-10	24
-56	-6	18
-16	-60	-24
-10	-18	-2
-16	10	-4
20	-60	-26
62	-6	14
48	-4	24
12	-14	0
26	-10	-2
-8	-22	74
-54	-34	54
-56	14	12
-14	-34	-20
8	-34	76
54	-32	52
-40	-62	-12
-24	-68	-22
-38	-34	64
38	-34	64
30	-58	-42
-64	-6	22
-42	-12	34
54	-2	26
44	-10	44

// Dresel C, 2006: Blepharospasm (BLEPH) Patients
// Subjects=13
-18	-60	-18
-50	-8	32
-52	-4	16
-18	10	-10
-10	-24	74
-2	8	34
-38	4	-4
-22	-12	-2
16	-60	-20
58	-4	34
38	10	0
12	-12	-6
58	0	12
24	2	-6
4	-14	60
-8	-22	74
-54	-34	54
-56	14	12
-14	-34	-20
8	-34	76
54	-32	52
-40	-62	-12
-24	-68	-22
-60	-4	14
-38	-16	14
56	-4	28

// Dresel C, 2006: Meige's Syndrome Patients
// Subjects=13
-54	-6	22
-46	-14	36
-16	-60	-50
-18	-14	-4
52	-10	36
24	-64	-24
54	-10	50
-38	-34	64
38	-34	64
30	-58	-42
-64	-6	22
-42	-12	34
54	-2	26
44	-10	44
-4	-6	70
-60	-58	-8
44	-42	62
62	-38	36

// Kim H, 2006: Reward Receipt
// Kim H, 2006: Successful Avoidance of a Monetary Loss
// Kim H, 2006: Reward Receipt > Successful Avoidance of a Monetary Loss
// Kim H, 2006: Reward Expectation: Expected Reward Increase
// Kim H, 2006: Reward Expectation: Expected Reward Decrease
// Kim H, 2006: Prediction Error on Reward Trials
// Kim H, 2006: Prediction Error on Avoidance Trials
// Kim H, 2006: Prediction Error on Reward Trials > Prediction Error on 
// Avoidance Trials
// Subjects=16
0	33	-18
0	33	-18
15	18	9
-6	30	-21
-36	27	-21
-42	21	33
48	33	33
6	27	36
-15	6	-15
15	6	-15
0	30	18
-24	30	48
-39	12	-9
39	15	-3
-3	-24	0
0	36	15
0	-27	-27
-12	6	-15
15	6	-15

// Little D M, 2006: Classification > Fixation
// Little D M, 2006: Feedback > Fixation
// Little D M, 2006: Classification > Feedback
// Little D M, 2006: Feedback > Classification
// Little D M, 2006: Classification: Early > Late
// Little D M, 2006: Feedback: Early > Late
// Little D M, 2006: Fixation: Early > Late
// Subjects=18
-44	10	0
30	28	-8
4	34	38
-48	6	36
26	6	48
24	-24	8
-16	-8	0
4	-18	12
44	-50	54
-28	-84	28
34	-70	28
-44	-60	-16
46	-62	-20
22	-66	22
48	40	14
-4	30	38
-56	4	34
32	4	44
-10	14	8
22	26	4
-24	-30	-6
34	-72	26
-24	-54	-22
-30	20	-2
30	44	24
-4	-8	48
8	4	32
-58	8	26
60	12	24
-20	12	-2
18	10	-2
-14	-14	0
6	-18	8
-42	-32	42
60	-18	44
-56	-66	22
-24	-10	-20
30	-12	-24
-50	-66	12
-26	56	22
-24	14	2
12	-74	-2
-34	27	4

// Brown M R G, 2006: Prosaccade Response > Fixation
// Brown M R G, 2006: Fixation > Prosaccade Response
// Brown M R G, 2006: Antisaccade Response > Fixation
// Brown M R G, 2006: Fixation > Antisaccade Response
// Brown M R G, 2006: Nogo Response > Fixation
// Brown M R G, 2006: Fixation > Nogo Response
// Brown M R G, 2006: Antisaccade Response > Prosaccade Response
// Brown M R G, 2006: Antisaccade Response > Nogo Response
// Brown M R G, 2006: Nogo Response > Antisaccade Response
// Brown M R G, 2006: Nogo Response > Prosaccade Response
// Brown M R G, 2006: Prosaccade Response > Nogo Response
// Brown M R G, 2006: Prosaccade Instruction > Fixation
// Brown M R G, 2006: Antisaccade Instruction > Fixation
// Brown M R G, 2006: Nogo Instruction > Fixation
// Brown M R G, 2006: Fixation > Nogo Instruction
// Brown M R G, 2006: Antisaccade Instuction > Nogo Instruction
// Brown M R G, 2006: Prosaccade Instruction > Nogo Instruction
// Subjects=10
39.98	0.39	51.2
-39.12	-1.39	48.91
37.52	48.62	28.23
-36.24	50.13	26.72
53.57	6.11	13.76
-37.3	6.28	10.33
1.56	1.74	58.22
1.36	13.94	37.13
40.12	-43.22	51.51
-36.84	-42.79	50.13
22.01	-64.73	50.18
-20.74	-64.99	50.69
62.47	-36.28	42.87
14.37	-28.99	45.04
3.81	-66.24	46.05
18.71	-83.3	30.58
-17.63	-82.46	30.93
-3.1	50.5	28.53
0.03	28.88	10.24
48.56	-60.74	30.58
-45.47	-62.36	31.79
8.17	-31.29	70.95
-2.79	-42.98	30.79
38.91	1.45	51.12
-34.83	-.14	50.99
34.27	53.72	25.6
-35.19	51.02	24.4
56.77	8.24	13.55
-44.78	9.49	11.26
2.62	6.06	58.96
1.32	18	34.55
41.16	-40.21	49.02
-37.92	-41.83	48.94
22.01	-65.79	50.27
-20.72	-64.81	52.91
63.49	-34.59	37.14
-58.5	-18.45	22.69
1.42	-23.84	30.26
1.7	-60.54	51.17
19.78	-83.2	31.68
-15.48	-83.41	32.1
20.45	1.6	13.41
-19.09	-1.9	13.04
-2	50.84	32.95
45.37	-61.73	31.81
-49.71	-67.5	34.5
-1.72	-48.44	29.01
36.75	4.52	49.78
-40.21	2.74	47.46
35.33	51.44	23.55
-35.22	49.62	20.06
46.1	3.95	14.03
-51.17	7.51	13.73
4.77	5.1	60.13
2.43	12.89	37.2
42.21	-39.23	47.81
-37.91	-42.8	50.14
24.16	-65.69	51.35
-22.88	-65.08	49.61
61.37	-33.37	39.29
-60.53	-20.61	36.27
5.73	-23.47	34.64
1.69	-58.42	51
28.32	-81.04	31.4
-21.88	-82.22	34.3
-13.7	2.96	20.38
2.18	53.19	21.56
26.12	0.65	55.8
-29.47	0.06	53.14
-2.75	10.17	57.56
-.83	18.87	32.28
34.76	-41.22	50.29
-29.31	-42.23	56.69
22.01	-64.73	50.18
-19.65	-59.26	55.77
33.66	-77.83	31.07
-6.96	-77.1	30.36
64.49	-19.95	33.67
-20.83	-27.55	53.13
-.7	-22.54	33.52
-.43	-53.86	55.1
-15.89	3.71	13.65
36.8	-.42	54.65
-28.39	0.16	54.24
35.36	54.96	27.72
-32.99	48.37	31.29
0.47	5.96	57.88
1.32	19.06	34.47
37.95	-40.23	49.05
-28.23	-49.8	55.08
18.82	-66.78	51.5
-19.64	-62.44	56.04
20.86	-84.17	32.86
-18.71	-80.35	30.77
-2.9	-19.98	25.52
4.91	-61.57	51.22
1.62	-82.17	32.92
-15.87	-3.99	13.18
9.93	37.31	49.56
43.23	-60.69	31.75
-49.72	-67.59	33.4
-.62	-53.63	30.55
27.02	24.21	43.78
-13.85	33.29	13.37
50.62	-51.64	24.22
36.86	-24.03	52.17
0.49	-33.39	44.45
0.74	-48.43	70.24
0.49	-53.2	36.07
-16.87	-1.03	24.09
15.52	-83.14	32.84
-13.36	-78.11	31.63
-27.76	39.55	13.01
27.67	68.17	6.63
32.53	-52.12	33.39
-30.55	-52.75	30.82
26.2	-62.22	41
-22.96	-62.6	40.48
29.32	-70.8	26.07
-48.6	-36.35	51.95
4.59	-27.51	23.84
0.64	-68.12	49.59
-27.48	3.99	34.95
-14.95	36.28	10.9
-22.31	23.17	21.01
7.49	33.07	8.69
25.04	-45.65	35.16
-31.54	-50.85	41.82
22.98	-58.01	40.68
-21.87	-59.08	44.63
-29.42	-74.07	30.36
3.52	-23.11	25.71
-3.61	-66.74	53.99
-2.59	-85.91	39.97
31.51	-46.07	42.93
24.08	-62.06	43.24
-15.53	-65.27	32.81
1.38	-24.27	24.72
3.76	-68.95	38.47
33.63	-3.36	58.28
-30.44	-3.32	64.59
-52.12	-25.27	16.49
28.15	3.95	43.23
-28.5	3.44	41.69
-10.03	-69.07	52.02
-4.67	-65.6	55.02

// Grimm S, 2006: unPV > unPJ
// Grimm S, 2006: unPJ > unPV
// Grimm S, 2006: exPV > exPJ
// Grimm S, 2006: exPJ > exPV
// Grimm S, 2006: Conjunction Analysis (unPV > unPJ) vs. (exPV > exPJ)
// Grimm S, 2006: Exclusive Masking Analysis (unPV > unPJ) vs. (exPV > exPJ)
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Valence: unPV > unPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Valence: exPV > exPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Valence: unPJ > unPV
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Intensity: unPJ > unPV
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Intensity: exPJ > exPV
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Recog: unPV > unPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Recog: exPV > exPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Recog: exPJ > exPV
// Grimm S, 2006: Positive Valenced Pictures Showing Positive Correlation in 
// unPV > exPV
// Grimm S, 2006: Positive Valenced Pictures showing Positive Correlation in 
// exPV
// Grimm S, 2006: Negative Valenced Pictures Showing Positive Correlation in 
// unPV
// Grimm S, 2006: Positive Valenced Pictures Showing Negative Correlation in 
// unPJ
// Grimm S, 2006: Negative Valenced Pictures Showing Negative Correlation in 
// unPJ
// Subjects=29
12	64	16
10	46	48
46	14	48
-38	32	38
30	54	-6
-32	58	0
4	58	40
24	18	-24
-14	-8	-18
56	28	-6
44	-58	38
-44	-68	46
44	-10	44
-44	2	32
-6	8	48
30	-48	-10
-8	-58	4
-2	-10	56
12	-20	-10
-12	-18	8
0	-58	-30
36	26	48
-38	36	38
28	48	24
-30	56	8
4	26	20
0	-54	36
22	4	-24
60	-58	2
-56	-42	48
42	2	-30
-4	-4	-14
54	4	28
-42	10	32
30	34	-14
-48	32	-10
28	-62	-12
-30	-82	32
40	24	46
-40	34	38
26	46	30
4	-66	36
56	-56	28
-40	-60	36
6	66	16
12	60	2
6	46	52
50	26	36
-36	16	56
-38	54	4
16	2	-18
-14	-8	-16
54	26	-6
-58	-64	24
42	-62	-22
-18	14	14
-4	56	14
-28	36	20
46	26	14
-44	24	20
48	40	-10
4	30	52
46	4	14
12	44	10
26	20	42
46	-10	26
8	18	48
8	18	48
-24	48	16
-22	48	16
16	3	19
-36	-9	57
50	26	16

// Addis D R, 2006: Successful Encoding > Baseline Triad
// Addis D R, 2006: Zero Link > One Link > Two Link
// Addis D R, 2006: Two Link > One Link > Zero Link
// Addis D R, 2006: One Link + Two Link > Zero Link
// Subjects=12
-64.68	12.46	13.21
44.23	29.89	-1.57
50.88	33.39	12.53
-11.37	20.87	42.85
-7.16	27.71	35.38
5.85	27	38.59
-16.11	-16.16	2.89
11.94	-12.02	-.24
-16.15	-31.78	-3.41
-45.73	-33.49	48.81
38.58	-42.66	49.4
-44.37	-56.94	-18.37
-48.48	-69.64	-4.71
-37.88	-65.63	-19.86
20.31	-82.94	-35.95
-60.4	24.17	11.98
46.44	34.67	3.52
-52.44	9.68	40.17
33.34	58.77	-2
20.37	60.85	-1.99
-46.03	9.18	34.51
-4.95	-27.67	28.49
40.52	-69.51	26.25
-11.82	-80.98	-13.18
-13.78	44.18	28.26
-37.08	-11.46	54.33
-11.82	-4.35	2.77
-22.91	-9.86	-21.15
-42.32	12.28	-12.92
-39.33	-72.36	34.62
-13.5	-47.8	31.75
-2.54	-26.96	47.43
-47.82	-31.81	55.4
51.52	-30.81	49.13
-57.77	-39.03	36.12
61.13	-57.86	34.84
18.6	-83.98	-1.08
-1.02	-44.8	-5.74
11.89	-51.76	-11.99
46.81	25.36	30.21
5.62	-4.21	14.78
64.67	-5.74	-16.33
36.24	-51.67	33.53
-11.59	-92.39	2.51

// Britton J C, 2006: Faces - Fixation
// Britton J C, 2006: IAPS - Fixation
// Britton J C, 2006: Emotional Faces - Neutral Faces
// Britton J C, 2006: (Emotional Faces > Emotional IAPS) - Neutral
// Britton J C, 2006: Emotional IAPS - Neutral IAPS
// Britton J C, 2006: (Emotional IAPS > Emotional Faces) - Neutral
// Britton J C, 2006: Faces, Happy - Neutral
// Britton J C, 2006: Faces, Sad - Neutral
// Britton J C, 2006: Faces, Anger - Neutral
// Britton J C, 2006: Faces, Fear - Neutral
// Britton J C, 2006: Faces > IAPS, Happy - Neutral
// Britton J C, 2006: Faces > IAPS, Sad - Neutral
// Britton J C, 2006: Faces > IAPS, Anger - Neutral
// Britton J C, 2006: Faces > IAPS, Fear - Neutral
// Britton J C, 2006: IAPS, Happy - Neutral
// Britton J C, 2006: IAPS, Sad - Neutral
// Britton J C, 2006: IAPS, Anger - Neutral
// Britton J C, 2006: IAPS, Fear - Neutral
// Britton J C, 2006: IAPS > Faces, Sad - Neutral
// Britton J C, 2006: IAPS > Faces, Fear - Neutral
// Subjects=12
-21	-6	-18
24	-6	-15
-24	-30	-3
15	30	-3
0	45	-24
30	-78	-15
-21	-6	-15
24	-3	-15
15	30	-6
3	45	-21
-33	-60	-15
60	-39	6
-66	-6	9
-39	18	-9
0	30	30
69	-21	15
-66	-9	12
-27	6	12
-3	30	30
12	-75	12
30	-93	-15
36	-78	0
63	-18	9
-63	-15	6
-30	6	9
63	-27	12
51	12	-3
-42	21	-21
0	30	30
9	51	9
0	-72	24
33	-3	-24
-21	-21	-12
-63	-6	12
57	-24	12
-39	18	-9
-15	60	-12
-18	-27	-9
60	-33	0
-36	15	6
3	18	21
0	6	30
57	-18	3
-60	-15	6
-39	3	12
54	12	-6
-39	24	0
-3	36	30
0	30	-12
-60	-6	12
57	-15	6
3	27	-3
66	-33	9
-45	-9	0
-39	-9	9
0	30	30
54	-75	-3
-45	-72	-30
0	-90	0
-21	-12	-12
-42	24	6
-12	69	6
-18	-27	-3
9	-90	-3
30	-90	-15
9	-93	-3
0	-72	-15

// Dolcos F, 2006: Emotional - Scrambled Pictures
// Dolcos F, 2006: Neutral - Scrambled Pictures
// Dolcos F, 2006: Emotional - Neutral Pictures
// Subjects=15
50.27	43.53	16.24
-35.15	33.84	22.49
50.78	-52.21	44.34
-54.99	-52.59	48.93
5.76	-26.47	37.12
20.25	27	-2.1
57.7	32.14	5.96
-52.43	29.74	-1.5
3.03	13.56	-23.08
43.86	-11.35	-4.73
24.49	-.78	-17.67
-22.51	-4.23	-16.84
30.96	-14.4	-15.48
-24.59	-12.36	-11.67
1.02	0.57	-11.93
3.3	-14.42	0.45
50.27	43.53	16.24
-35.15	33.84	22.49
50.78	-52.21	44.34
-54.99	-52.59	48.93
5.76	-26.47	37.12
20.25	27	-2.1
57.7	32.14	5.96
-52.43	29.74	-1.5
3.03	13.56	-23.08
43.86	-11.35	-4.73
24.49	-.78	-17.67
-22.51	-4.23	-16.84
30.96	-14.4	-15.48
-24.59	-12.36	-11.67
1.02	0.57	-11.93
3.3	-14.42	0.45
50.27	43.53	16.24
50.78	-52.21	44.34
20.25	27	-2.1
57.7	32.14	5.96
-22.51	-4.23	-16.84
30.96	-14.4	-15.48
-24.59	-12.36	-11.67
24.49	-.78	-17.67

// Platek S M, 2006: Unfamiliar > Scrambled Faces
// Platek S M, 2006: Familiar > Unfamiliar Faces
// Platek S M, 2006: Self > Unfamiliar Faces
// Platek S M, 2006: Familiar > Self Faces
// Platek S M, 2006: Self > Familiar Faces
// Subjects=12
30	-84	-6
0	10	48
24	-34	0
26	-48	42
-8	-44	30
36	-4	56
42	-6	-14
-32	18	4
-20	-58	-36
50	-46	0
-50	-38	44
-40	-2	44
-34	40	22
54	-22	48
-22	-76	-26
58	-48	24
-12	8	-2
12	8	-2
16	-28	10
56	12	-6
-2	24	-2
-52	4	-16
26	34	34
6	48	-12
50	-62	40
-58	-6	-4
20	16	56
26	-12	46

// Garrett A S, 2006: Aversive vs. Neutral Pictures
// Garrett A S, 2006: Activation During Negative Emotion Ratings Following 
// Aversive Pictures vs. Neutral Pictures
// Garrett A S, 2006: Areas of Activation Significantly Correlated with 
// Ratings of Negative Emotions
// Subjects=9
-48	-77	15
-36	-72	-3
-40	-66	-8
-50	-62	-2
-48	-54	6
51	-64	3
42	-74	-8
30	-78	24
46	-67	-10
40	-44	-26
50	-56	1
55	-48	19
-22	3	-17
20	-2	-10
-14	-31	-5
-30	-16	-16
22	-10	-15
6	-32	-12
4	-15	4
2	-2	-5
26	13	-4
-24	11	-6
12	12	1
-16	17	-1
38	11	-4
40	29	-10
-34	25	-8
26	26	-15
-38	34	-15
4	-70	-32
-6	-78	-10
4	-82	-4
4	-29	1
-14	-22	-7
-2	-4	-7
50	36	-14
30	48	-6
48	36	-5
48	21	1
4	-71	-30
32	-42	-26
16	-20	-12
-14	-16	-9
8	-19	8
-6	-11	8
26	52	-18
50	32	-17
-36	-7	56
-32	-13	47
-28	9	59
-8	12	49
6	12	40
2	23	32
-8	9	33

// Beblo T, 2006: Borderline Personality Disorder (BPD) Patients
// Subjects=20
-23.41	-9.86	24.8
-33.47	11.64	2.68
-36.83	-17.69	-12.29
36.01	-9.65	23.77
26.08	-15.6	6.6
45.44	12.22	4.64
-1	-64.36	-8.29
-7.55	-56.19	-12.34
9.83	-64.12	-6.25
-36.97	43.66	-10.52
12.8	-19.1	-18.6
6.32	-25.71	-20.08
3.01	-26.24	-25.57
-16.94	-51.5	15.37
-23.35	-57.59	19.44
-26.53	-70.26	21.87
20.19	-75.78	40.67
-13.35	-31.35	46.93
29.01	-34.35	-21.85
32.65	-66.4	2.55
35.91	-56.4	5.99
4.36	-49.35	-8.74
71.69	-38.86	19.33
55.4	-32.96	14.54
40.27	-91.04	2.62
-50.73	8.49	4.4
-56.17	14.75	2.76
-33.5	11.43	0.46
52.7	45.04	-12.18
45.22	35.75	-7.77
48.21	44.84	-25.53
64.72	13.28	-8.12
46.49	12.02	2.4
55.14	25.23	5.43
14.51	-99.77	14
13.27	-91.13	3.08
-38.21	-5.74	-33.62
33.31	-6.06	-18
36.42	53.18	-16.07

// Beblo T, 2006: Normals
// Subjects=21
4.36	-49.35	-8.74
71.69	-38.86	19.33
55.4	-32.96	14.54
40.27	-91.04	2.62
-50.73	8.49	4.4
-56.17	14.75	2.76
-33.5	11.43	0.46
52.7	45.04	-12.18
45.22	35.75	-7.77
48.21	44.84	-25.53
64.72	13.28	-8.12
46.49	12.02	2.4
55.14	25.23	5.43
14.51	-99.77	14
13.27	-91.13	3.08
-38.21	-5.74	-33.62
33.31	-6.06	-18
36.42	53.18	-16.07

// Bermpohl F, 2006: Expected vs. Unexpected Picture
// Bermpohl F, 2006: Emotional vs. Neutral
// Bermpohl F, 2006: Expected Positive vs. Expected Neutral
// Bermpohl F, 2006: Expected Negative vs. Expected Neutral
// Bermpohl F, 2006: Expected Emotional vs. Unexpected Emotional
// Bermpohl F, 2006: Expected Neutral vs. Unexpected Neutral
// Subjects=17
12	64	20
-44	20	52
-28	-28	-8
32	-16	-20
-28	-20	0
-20	-28	-4
16	-4	12
-52	20	-16
-56	-56	-20
52	16	-20
40	-52	-24
-40	-60	-20
40	-52	-24
-60	-60	36
-40	-60	-24
12	-76	-20
-8	-88	-4
16	-84	-4
-4	56	20
48	8	20
-24	-8	-20
24	-4	-24
-28	-12	-20
28	-12	-20
16	-4	8
-8	-28	-12
44	12	12
-48	-80	12
56	-64	0
-52	-56	-24
44	-48	-24
-52	-60	-28
44	-56	-28
-4	-92	4
4	-68	-4
-8	64	24
-20	-8	-20
28	-4	-28
-4	-28	-12
40	56	8
-64	0	20
-68	-28	16
60	-28	0
-48	-40	36
48	-40	36
0	-28	36
-8	60	20
-56	32	-8
24	0	-28
-28	-32	-8
32	-16	-20
-28	-16	-8
-16	-12	8
24	-28	0
8	-36	-20
-52	16	-16
52	16	-16
-40	-56	-24
40	-52	-24
-36	-72	-24
12	-72	-20
-8	-76	-12
16	-84	-4
-48	52	-8
48	52	-4
-28	-24	-4
16	-4	12
-40	-60	-20
52	-52	-20
-60	-60	40
56	-60	44
-4	-84	16
4	-88	0

// Grosbras M H, 2006: Hand, Neutral > Concentric Circles
// Grosbras M H, 2006: Hand, Angry > Concentric Circles
// Grosbras M H, 2006: Face, Neutral > Concentric Circles
// Grosbras M H, 2006: Face, Angry > Concentric Circles
// Subjects=10
-24	-8	60
-48	8	28
44	4	36
52	20	24
48	24	20
-52	-28	40
-36	-52	64
-36	-44	52
-28	-52	44
32	-52	56
-12	-76	56
-8	-68	64
-52	-64	0
48	-64	0
60	-56	4
44	-56	8
-44	-80	12
40	-84	-4
-44	-52	-20
44	-48	-20
44	-60	-16
-12	-80	-44
-32	-68	-56
8	-76	-32
-16	-24	8
-24	-8	64
40	-4	64
-56	8	24
44	4	36
56	20	28
52	16	8
48	32	0
0	24	52
-52	-28	40
-36	-36	48
-40	-44	56
32	-60	48
-28	-80	28
-20	-80	44
-28	-60	52
20	-60	68
12	-68	64
-64	-20	32
-48	-64	4
52	-52	4
56	-68	12
56	-4	-12
-40	-80	12
48	-80	4
-44	-52	-20
44	-48	-20
-16	-80	48
-12	-80	-44
16	-48	-48
-16	-24	12
-16	-32	4
24	-8	-12
-44	-4	56
48	4	48
-48	20	24
36	12	32
52	24	28
-56	8	-12
4	44	44
4	12	60
52	-68	12
-48	-48	4
52	-56	8
52	-36	-4
-56	8	-12
56	-4	-12
-48	-80	-12
48	-84	-4
-44	-48	-16
-44	-60	-20
44	-56	-20
-8	-84	-44
-32	-68	-52
-4	-76	-24
8	-84	-40
-28	-4	-16
16	-20	-4
-20	-8	-12
20	-12	-12
-44	28	-4
-40	-4	44
44	4	48
-52	20	28
52	12	24
56	20	28
56	24	20
0	8	56
-52	-60	8
48	-56	8
56	-36	-4
-52	-44	4
52	-52	4
56	-40	0
56	4	-20
-48	-80	-12
48	-84	-4
-44	-56	-20
-40	-68	-24
44	-56	-20
-8	-80	-36
-32	-68	-52
-20	0	12
20	0	0
-20	-8	-12
20	-12	-12
24	-20	-12
-44	28	-8

// Holt D J, 2006: Schizophrenic Patients
// Subjects=15
-22	-8	-14
-22	-24	-14
26	-6	-16
-36	-36	-17
42	-42	-16
-22	-24	-14
-22	-16	-14
26	-6	-16
28	-16	-12
-40	-42	-20
40	-42	-16
-20	-8	-16
-22	-24	-14
-16	-4	-18
-22	-20	-10
30	-4	-16
24	-18	-12
-42	-44	-18
40	-40	-20
-22	-22	-12
30	-4	-26
28	0	-24
-30	-4	-26
28	2	-22
26	2	-24

// Holt D J, 2006: Normals
// Subjects=16
-34	-18	-22
24	-8	-20
-38	-47	-15
42	-42	-20
-22	-24	-14
22	-8	-20
22	-20	-12
-40	-46	-20
40	-46	-16
-24	-12	-16
-22	-24	-14
-28	-10	-18
-32	-20	-10
28	-8	-20
24	-22	-10
-40	-44	-20
38	-38	-17
-22	-22	-12
28	0	-24
-18	2	-18
24	0	-18
26	2	-24

// Ischebeck A, 2006: Multiplication Untrained vs. Number Matching
// Ischebeck A, 2006: Multiplication Trained vs. Number Matching
// Ischebeck A, 2006: Subtraction Untrained vs. Number Matching
// Ischebeck A, 2006: Subtraction Trained vs. Number Matching
// Ischebeck A, 2006: Multiplication Untrained vs. Trained
// Ischebeck A, 2006: Subtraction Untrained vs. Trained
// Ischebeck A, 2006: Multiplication Trained vs. Untrained
// Ischebeck A, 2006: Subtraction Trained vs. Multiplication Trained
// Ischebeck A, 2006: Subtraction Untrained vs. Multiplication Untrained
// Subjects=12
33	18	3
9	-6	63
57	3	21
-18	9	3
-30	24	6
54	-42	45
-33	-57	39
51	-57	-9
27	-96	3
-3	-57	-36
-21	-96	3
-3	-69	-6
-27	-60	-30
33	33	6
27	-3	21
51	3	33
18	-3	57
-15	3	18
-27	21	6
30	-51	45
-24	-60	54
57	-45	-9
36	-93	-3
27	-72	33
-24	-96	6
57	3	21
36	18	3
42	42	6
48	24	27
18	-15	0
27	3	57
9	0	60
21	9	9
-51	30	27
-45	15	3
-15	-3	3
-33	-6	54
33	-81	30
-33	-63	36
27	-90	-9
9	-81	15
33	-51	-33
-21	-96	3
-24	-75	12
-12	-75	-18
0	-48	-24
21	3	45
36	0	51
39	15	30
0	27	48
42	42	3
33	18	3
-42	30	33
-33	33	0
48	-57	39
-30	-63	36
45	-66	-21
6	-30	-6
18	-84	9
-27	-63	-24
-3	9	51
-51	6	-27
-18	-21	15
42	-45	45
-33	-66	39
-33	21	-3
48	6	33
24	-63	51
-42	-39	39
-48	-66	39
-12	-75	15
42	-69	-12
12	-69	45
-33	-78	24
-18	-81	-9

// Jacobsen T, 2006: Aesthetic vs. Symmetry
// Jacobsen T, 2006: Symmetry vs. Aesthetic
// Jacobsen T, 2006: Beautiful vs. Not Beautiful
// Jacobsen T, 2006: Parametric Effects of Complexity for Aesthetic Judgments
// Jacobsen T, 2006: Parametric Effects of Complexity for Symmetry Judgments
// Jacobsen T, 2006: Condition Specific Effects of Complexity for Aesthetic 
// Judgments
// Jacobsen T, 2006: Condition Specific Effects of Complexity for Symmetry 
// Judgments
// Subjects=15
2.32	28.24	29.22
2.15	60.5	19.83
24.62	51.12	20.36
2.56	-14.35	42.83
-2.75	-45.81	35.49
-48.14	18.85	-5.1
50.14	26.84	-6.89
-45.12	0.52	-35.93
50.72	-55.01	35.65
-42.21	-58.48	40.35
-18.55	-53.46	61.96
25.3	-56.11	65.03
-31.46	-84.05	39.03
-25.21	5.46	53.75
28.12	13.56	43.54
-51.03	6.77	31.64
-25.36	-74.07	2.44
-5.99	-82.53	15.19
3.23	59.54	21.01
-31.45	-86.17	39.21
-41.49	12.66	24.34
34.56	-82.8	8.05
15.37	-90.14	11.12
-22.14	-83.82	-.13
-25.44	-58.46	-2.22
28.03	-68.72	-1.97
37.68	-77.12	-1.38
-22.1	-93.34	0.67
-28.63	-61.66	-1.91
31.2	-52.58	-0.02
18.53	-92.84	3.51
34.02	37.86	-14.32
47.05	33.56	11.54
44.1	6.54	33.91

// Junghofer M, 2006: High > Low Arousal of Picture Presentation
// Junghofer M, 2006: Right > Left Side of Picture Presentation
// Junghofer M, 2006: Fast > Slow Rate of Picture Presentation
// Junghofer M, 2006: Slow > Fast Rate of Picture Presentation
// Subjects=18
-42	-72	-3
-28	-64	35
-46	-66	11
-44	-74	0
-46	-64	9
-26	-78	28
-14	-88	-2
46	-77	9
22	-66	38
46	-75	9
44	-78	1
48	-72	4
22	-76	30
18	-87	1
44	-76	4
20	-66	33
46	-66	0
-38	-57	32
50	-62	38
-40	-58	43
-28	-80	22
51	-58	38
34	-73	24
-26	-76	-6
24	-77	19
-6	-54	52
22	-58	49
-8	-72	28
24	-75	18
-2	-83	12
20	-75	15

// Kim S W, 2006: Erotic Scenes - Sports HIghlights
// Subjects=10
10	-60	58
-58	-42	36
10	-90	24
28	-6	68
60	24	14
38	57	-8
-34	50	-6
-3	-4	41
-12	8	6
10	8	6
60	12	0
4	24	6
38	-10	8

// Kranz F, 2006: Face-Responsive Regions
// Subjects=10
-37.2	-79.68	-11.34
40.49	-78.64	-11.65
-38.22	-49.29	-20.13
40.98	-50.56	-20.26
-51.04	-45.97	8.85
50.67	-41.41	6.41
-15.84	-7.87	-12.26
18.77	-7.22	-13.83
-31.93	-47.55	47.35
35.07	-49.16	45.26
2.3	-9.89	11.01
-11.5	1.35	14.46
14.8	1.15	15.07
-40.02	6.55	31.98
44.62	5.65	30.63
-20.71	6.4	-.69
23.86	6.2	-.29
1.94	19.62	45.9
-34.42	21.73	1.98
38.79	20.92	1.54
2.03	63.14	-8.05

// Lawrence E J, 2006: Social Perception > Non Social Labeling
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Personal 
// Distress, Positive Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Personal 
// Distress, Negative Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Social 
// Skills, Positive Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Social 
// Skills, Negative Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Overlap on the 
// Trait Task, Positive Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Overlap on the 
// Trait Task, Negative Correlation
// Subjects=12
-49.01	23.19	23.55
-48.99	-45.83	-1.89
55.69	31.21	21.67
1.45	12.68	48.38
39.36	-29.09	-41.11
27.61	44.51	-10.35
28.09	32.93	46.38
-6.38	29.9	10.23
-13.61	11.56	35.27
-18.17	13.03	-.49
-10.5	39.16	34.03
32.22	-4.76	12.69
66.27	-30.22	-16.79
55.64	30.7	15.02
40.03	-17.75	50.49
16.33	32.86	46.52
-37	17.11	54.03
-13.86	29.86	10.32
-30.07	39.94	-9.3
24.5	45.43	1.88
5.69	45.29	56.75
16.05	34.35	10.71
27.71	36.74	-.78
24.85	-57.48	6.04
-18.02	-1.89	13.03
-53.23	-25.79	9.86
-32.88	-40.56	9.75
-29.91	13.04	0.76
61.19	-36.31	15
51.34	26.02	9.89
-48.61	-46.29	47.21
-37.05	-56.99	17.87

// Ponseti J, 2006: (Preferred, Sexual Pictures + Non-Preferred, Sexual 
// Pictures) > Non-Sexual Pictures
// Ponseti J, 2006: Preferred Sexual Pictures > Non-Preferred Sexual Pictures
// Subjects=12
-48	-70	-6
-46	-36	60
-62	-24	40
-22	-66	60
64	-20	38
34	-54	62
24	-64	60
0	38	8
-8	54	0
4	56	8
0	-10	8
2	0	-2
4	-30	14
2	0	0
2	-26	2
0	-8	4
52	10	30
-46	6	32
26	-66	56
24	-68	60
16	-70	64
32	-80	30
-14	-66	64
-20	-80	48
-10	-82	50

// Ricciardi E, 2006: Tactile, 1-Back vs. Rest
// Ricciardi E, 2006: Visual, 1-Back vs. Rest
// Ricciardi E, 2006: Tactile Maintenance vs. Rest
// Ricciardi E, 2006: Visual Maintenance vs. Rest
// Ricciardi E, 2006: Overlapping
// Ricciardi E, 2006: Tactile Maintenance > Visual Maintenance, Interaction
// Ricciardi E, 2006: Visual Maintenance > Tactile Maintenance, Interaction
// Subjects=6
23.35	58.83	-3.69
13.66	78.95	-4.15
-21.52	53.19	-3.82
2.42	31.46	43.45
1.49	9.85	53.08
-25.07	-.83	68.78
-.5	-9.57	63.65
37.84	3.64	52.07
33.3	43.65	33.15
40.6	49.56	12.5
44.6	61.02	-18.62
-46.92	41.35	24.23
-25.71	69.42	13.82
-2.03	19.78	16.6
53.58	8.4	15.8
40.42	36.67	-16.53
-54.29	12.84	27.82
-43.98	53.94	-5.86
44.84	18.43	-5.01
-35.24	27.44	8.53
-39.44	2.92	8.41
39.05	-14.62	63.62
-36.79	-19.21	65.99
58.07	-19.01	32.55
-15.34	-30.38	71.14
-54.1	-18.2	39.34
9.3	-30.6	79.8
57.1	-40.97	37.74
-57.47	-22.13	16.29
18.81	-65.72	51.41
23.96	-72.15	22.9
6.05	-48.74	65.75
-20.81	-81.07	35.31
-7.82	-82.63	55.37
27.43	-48.52	66.6
-24.97	-63.53	56.19
-43.82	-21.28	-15.16
50.48	-64.1	0.73
46.91	-11.9	-25.91
-54.31	-59.95	-5.11
-42.31	-77.03	20.72
64.2	-8.69	0.38
41.45	18.73	-28.42
-50.35	18.15	-13.93
50.31	-46.09	-14.16
-41.62	-44.7	-15.45
20.67	-104.89	-1.09
-12.56	-88.59	-7.65
-22.13	-71.68	5.54
-28.46	-104.92	2.83
1.48	-92.43	10.36
0.51	-80.4	28.32
-42.29	-80.2	20.99
16.2	-22.38	6.54
-9.47	-22.7	4.64
10.82	1.45	12.41
-12.67	-1.77	14.07
16.95	-49.75	-44.7
37.53	-66.6	-16.76
20.43	-54.64	-11.99
-20.27	-44.83	-19.03
-37.47	-57.05	-37.89
8.05	12.49	72.86
0.39	14.96	50.43
32.55	-.19	58.03
46.1	33.61	26.04
52.64	9.76	33.54
37.25	54.68	-3.51
-46.11	54.1	-3.61
-35.92	-3.66	46.84
-53.16	11.24	34.63
-35.25	44.96	14.87
9.52	38.57	-2.95
-8.53	29.72	8.04
-16.23	52.71	-10.53
6.6	29.4	30.19
55.82	12.78	31.02
43.63	35.63	-16.48
-52.48	19.28	-12.89
-57.49	13.87	27.77
-29.89	22.1	7.8
58.79	11.46	-.13
-50.19	12.12	4.41
5.96	-22.13	65.75
42.15	-17.91	48.25
-58.54	-21	17.32
16.77	-74.65	59.99
30.38	-72.02	23.93
2.86	-57.3	65.39
-5.73	-83.04	49.8
-22.84	-63.51	56.17
34.78	-43.25	51.57
55.96	-27.49	33.28
-38.95	-44.75	52.55
43.03	-73.74	0.51
-46.76	-66.79	2.07
-34.93	-85.76	3.53
49.44	-49.5	10.67
31.05	-43.21	-16.41
-34.11	-60.86	-18.65
14.09	-80.23	-12
6.9	-101.48	16.63
16.41	-81.68	10.4
-4.91	-76.89	19.17
14	8.87	11.76
35.38	-82.1	-24.35
31.87	53.17	-8.89
13.72	76.21	1.65
-18.33	53.12	-4.97
10.5	56.3	-7.79
3.55	15.61	44.77
-25.08	-.91	67.67
-.52	-10.79	61.53
30.47	-1.89	63.77
40.6	48.5	12.59
-46.92	40.29	24.32
-25.71	69.42	13.82
37.54	0.56	12.18
-33.1	27.45	8.51
-42.63	6.33	11.5
57.79	7.74	6.89
21	-26.73	73.77
-38.93	-20.37	65
58.06	-19.1	31.44
-14.26	-31.34	72.33
-54.12	-16.17	38.06
-64.98	-9.32	17.53
57.12	-43	39.03
25.16	-59.77	45.26
0.69	-55.46	61.91
-20.81	-81.07	35.31
27.41	-45.44	65.22
18.94	-69.89	66.26
-34.55	-43.35	70.22
44.4	-34.3	56.29
-48.92	-63.81	-.39
53.67	-49.99	3.97
-45.53	-73.96	19.39
41.45	17.67	-28.33
-8.29	-84.17	-5.84
1.5	-94.37	12.75
-17.81	-72.28	11.12
29.3	-83.12	18.18
-31.78	-99.45	-8.74
16.2	-22.38	6.54
-5.22	-27.33	-.6
-12.67	-1.86	12.96
16.96	-50.8	-44.61
41.69	-49.11	-24.96
17.18	-48.49	-14.7
-20.24	-46.68	-15.53
-35.35	-56.06	-39.11
-12.97	55.44	-2.99
9.1	11.18	69.61
-.38	-21.48	74.69
33.64	1.04	60.14
45.01	35.64	24.77
51.56	9.67	32.45
35.11	55.73	-3.57
13.85	53.46	10.25
-37.54	55.47	-.48
-28.37	-.73	56.54
-32.87	17.79	34.96
14.98	29.94	8.86
-7.44	25.58	9.49
7.67	28.35	30.27
27.05	2.46	37.79
-39.72	31.88	-16.32
-54.33	12.41	22.28
-55.6	22.41	0.27
-29.89	26.42	8.56
54.53	8.35	1.3
-65.98	-16.3	23.71
15.7	-73.6	59.91
2.84	-49.81	65.87
-21.73	-67.48	59.83
6.03	-82.97	49.66
33.71	-44.31	51.68
56	-32.6	35.94
-36.82	-44.73	52.52
52.91	-62.14	39.57
45.16	-71.53	1.41
33.56	-71.12	21.58
-45.67	-63.36	5.12
65.35	-24.28	5.02
26.87	-59.81	-10.51
11.99	-83.16	-8.38
-17.94	-92.23	-12.86
5.83	-101.49	16.64
29.5	-84.32	43.93
-19.84	-75.49	24.8
20.46	-31.24	1.66
-2.99	-15.38	16.21
20.46	-31.24	1.66
26.69	-60.55	-33.87
-30.84	-66.75	-12.61
26.6	54.96	1.05
2.63	1.83	59.32
3.76	-20.63	57.84
29.35	-1.27	58.15
52.54	9.79	20.16
41.64	36.11	3.58
-40.71	49.19	1.2
-48.94	16.21	29.71
7.69	16.47	27.92
-5.24	31.74	20.1
-17.2	50.47	1.93
44.42	-27.53	61.3
44.42	-27.53	61.3
-47.52	-25.17	58.81
7.09	-66.59	54.97
6.07	-47.42	68.98
-13.2	-87.4	49.14
31.58	-46.44	51.88
27.25	-69.07	34.87
-33.5	-44.66	66.97
-39.04	-45.6	41.47
-12.74	-43.21	-12.56
-46.76	-66.88	0.96
32.26	-68.06	-7.65
-33.07	-51.25	-18.35
-22.26	-86.16	-16.66
1.33	-79.71	-4.09
-1.91	-58.15	-.28
9	-99.7	12
4.88	-95.9	34.03
-21.68	-71.37	64.62
-7.03	-86.59	17.77
5.78	-2.01	50.68
31.53	1.37	64.6
40.35	46.99	-20.74
-50.05	35.5	31.45
62.09	8.11	11.27
-57.54	7.9	19.35
-37.91	-14.19	62.24
47.59	-21.34	58.51
56.97	-20.42	28.22
-57.32	-21.65	36.32
-51.1	-14.86	13.38
6.06	-29.9	75.32
6.91	-25.61	48.18
26.17	-63.7	35.55
-19.71	-58.81	47.93
-2.5	-79.51	53.93
35.93	-42.38	62.64
12.62	-61.25	82.33
-31.38	-45.87	64.82
34.67	-34.5	40.81
24.54	-32.13	-23.96
-18.12	-42.53	-17.02
50.44	-53.52	-.16
-60.77	-58.22	-9.64
-59.87	8.12	-5.18
36.52	-68.21	-9.92
-24.26	-73.8	5.75
2.72	-101.62	28.96
-31.44	-86.08	40.31
-11.34	-96.82	9.76
-5.15	-54.11	-2.82
-25.38	-91.93	-8.33
-3.04	-21.44	6.69
-11.52	-2.05	24.12
-28.93	-69.14	-43.66
17.19	-49.46	-13.5
21.2	-44.52	-46.3
-27.93	-47.81	-43.23
15.32	33.46	54.29
14.96	50.55	13.83
-2.42	52.99	-21.87
-7.01	14.72	61.69
-32.71	17.22	55.08
-36.09	16.55	32.88
-11.83	50.76	5.19
1.97	33.35	-14.69
14.11	24.25	31.65
47.39	-44.26	23.63
51.43	-20.31	2.62
24.75	-47.5	-2.6

// Marjoram D, 2006: High Risk- (HR-)
// Subjects=12
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
12.74	-46.49	55.83
60.88	-67.39	13.37
-62.22	-57.52	22.34
36.29	-37.12	39.93
-13.38	-16.26	47.68
-20.19	11.84	27.08
29.63	18.47	37.9
-44.16	-24.77	4.22
12.14	46.4	27.59
33.65	-46.18	0.53
-13.75	33.44	28.2
-12.06	-71.8	-29.77
21.09	-21.32	37.51

// Marjoram D, 2006: High Risk+ (HR+)
// Subjects=12
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
67.27	-54.91	8.67
6.28	-55.12	55.67
-62.4	-59.93	8.01
36.29	-37.12	39.93
-13.38	-16.26	47.68
-20.19	11.84	27.08
29.63	18.47	37.9

// Marjoram D, 2006: High Risk+Ever (HR+Ever)
// Subjects=6
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
63.03	-60.89	13.81
-2.83	-64.11	17.49
37.82	54.51	9.55
38.11	31.5	27.51
39.94	-51.97	-15.81
29.53	23.17	30.72

// Marjoram D, 2006: High Risk+Now (HR+Now)
// Subjects=6
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
51.2	-40.86	22.12
-.24	-46.64	54.94
-65.7	-58.23	3.42
-37.16	-74.48	34.79
-50.26	-70.03	25.61
58.63	-72.48	4.95
37.82	54.51	9.55
38.11	31.5	27.51
39.94	-51.97	-15.81
-44.16	-24.77	4.22
12.14	46.4	27.59
33.65	-46.18	0.53
-13.75	33.44	28.2
-12.06	-71.8	-29.77

// Marjoram D, 2006: High Risk Ill (HRill)
// Subjects=5
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
69.28	-37.45	0.18
29.53	23.17	30.72
21.09	-21.32	37.51

// Marjoram D, 2006: Normals
// Subjects=13
-4.62	-44.94	50.37
56.72	-38.84	31.91
-62.36	-57.5	11.13

// Tanaka M, 2006: Chronic Fatigue Patients
// Subjects=6
9	-84	-3
-45	-9	54
-27	-57	57
24	-87	9
-21	-87	-9
57	-24	15
-39	-21	6
54	-21	12
-54	-33	18

// Tanaka M, 2006: Normals
// Subjects=7
9	-84	-3
-45	-9	54
-27	-57	57
24	-87	9
-21	-87	-9
57	-24	15
-39	-21	6
-54	-33	18

// Vollm B A, 2006: Theory of Mind (ToM) vs. Physical Causality (PC1) Strip 
// (processing ToM stimuli)
// Vollm B A, 2006: Empathy vs. Physical Causality 2 (PC2) Strip (processing 
// empathy stimuli)
// Vollm B A, 2006: Conjunction, ToM + Empathy (common activations associated 
// with processing ToM and empathy stimuli)
// Vollm B A, 2006: Interaction, (ToM-PC1 Strip) vs. (Empathy-PC2 Strip) (incr 
// activation processing ToM than empathy)
// Vollm B A, 2006: (Empathy- PC2 Strip) vs. (ToM- PC1 Strip) (areas more 
// activated in processing empathy than ToM)
// Subjects=13
-48	28	-17
-59	-57	22
-59	-21	-7
-50	-7	-27
0	-51	25
-36	-45	-18
-15	-102	0
-15	-89	-26
18	49	-8
45	-78	18
62	6	-5
62	-15	-17
39	-72	-32
-9	37	51
-50	-57	17
-45	10	-31
-12	-52	3
-30	-80	-26
48	4	-33
57	3	-21
27	-96	8
18	-83	-26
-21	35	51
-53	-57	19
-53	-9	-18
-50	-4	-30
-27	-96	10
-21	-102	-2
-9	-52	3
-30	-80	-26
15	37	51
6	8	-16
53	-60	17
59	-12	-15
18	-101	11
42	-87	4
21	-83	-26
-39	55	3
48	46	-7
62	3	-5
3	-89	29
-21	-1	-15
9	53	14
24	13	24
6	-22	34
42	-76	1

// Moulier V, 2006: BOLD Signal Correlated Positively with Plethysmographic 
// Signal (Lag=0)
// Moulier V, 2006: BOLD Signal Correlated Positively with Plethysmographic 
// Signal, (Lag=-20)
// Moulier V, 2006: BOLD Signal Correlated Negatively with Plethysmographic 
// Signal (Lag=0)
// Moulier V, 2006: (Women, Swimsuit - Women, Clothed) - (Children, Swimsuit - 
// Children, Clothed)
// Moulier V, 2006: (Women, Clothed - Women, Swimsuit) - (Children, Clothed - 
// Children, Swimsuit)
// Moulier V, 2006: BOLD Signal Correlated Positively with Plethysmographic 
// Signal, (Lag=+10)
// Subjects=10
15	63	-3
3	42	24
6	63	-3
27	57	-3
-27	63	21
12	-3	72
18	-15	57
42	30	42
36	45	33
30	33	48
27	-3	66
-33	30	45
-45	42	-9
36	18	-12
48	9	-6
-48	15	-6
-57	3	6
-9	-18	72
-33	-12	54
-36	18	0
-42	-15	-3
-45	-3	3
39	3	-9
3	18	36
3	30	33
0	-30	54
-54	-33	27
-63	-36	30
0	-69	51
60	-3	0
18	-15	12
-57	12	3
15	63	-3
-33	33	45
27	-3	69
3	21	63
45	15	-6
-45	-3	6
36	18	9
0	36	24
3	18	36
12	-9	48
-30	-84	15
39	-81	0
-36	-69	-18
36	-54	-15
39	-72	-15
-51	15	-6
-36	-42	60
3	-45	-21
-12	-12	15
3	-9	0
51	24	27
63	-6	36
0	48	-9
6	42	42
-30	39	-6
-6	-42	45
-3	-54	66
-6	42	-6
3	-45	21
18	-51	6
-9	-30	36
3	-72	3
27	-87	-3
-30	-21	18
-33	-21	-15
-27	-36	0
33	-33	-6
-24	-42	-15
-15	-51	-21
9	-63	-18
-9	-27	-15
42	-66	-15
48	-69	-9
-27	-84	6
-42	-63	-9
39	-81	-6
-36	-78	3
24	-63	48
39	-45	66
-27	-69	48
-18	-54	69
-45	-39	54
-39	-42	45
-51	-33	42
-57	-27	30
33	-48	54
-6	-81	39
33	6	30
39	21	0
30	24	9
-21	9	21
24	-30	15
0	-21	12
6	-9	-3
3	9	6
15	-63	21
-48	-69	24
-51	-33	3
0	-27	54
-9	-42	69
9	-39	72

// Perner J, 2006: False Belief > "False" Photo
// Perner J, 2006: False Belief > Temporal Change
// Perner J, 2006: False Sign > Temporal Change
// Subjects=19
54	-57	27
48	-21	-9
-48	-57	30
39	-30	12
9	-54	33
-15	54	36
51	-66	27
-45	-57	27
54	-18	-12
-60	-6	-18
-60	-36	-3
-18	30	54
54	18	15
-42	-63	36
-54	-42	-6

// Chen C H, 2006: Sadness, Manic > Depressed and Normals
// Chen C H, 2006: Fear, Manic and Depressed > Normals
// Chen C H, 2006: Happiness, Depressed > Manic and Normals
// Chen C H, 2006: Implicit, Sadness > Explicit, Sadness; Manic > Depressed 
// and Normals
// Chen C H, 2006: Implicit, Sadness > Explicit, Sadness
// Chen C H, 2006: Implicit, Fear > Explicit, Fear
// Chen C H, 2006: Implicit, Happiness > Explicit, Happiness
// Subjects=8
-28	-56	-8
-40	-2	32
-52	-8	38
-42	-38	4
20	-14	-22
-12	20	4
26	2	-4
-8	-24	4
-4	-28	-20
-14	38	46
58	-10	12
-32	-10	34
-20	30	-8
-52	-26	-8
-24	-58	14
16	-72	-8
12	10	40
-8	-36	36
-20	-4	12
10	-16	12
-12	28	46
-54	-16	-16
-58	-18	4
-6	2	44
-34	8	-4
-28	-34	-1
-28	-2	-16
56	-46	24
54	-44	20
8	-64	2
-6	24	0
20	-28	14
0	-48	-12
2	-20	-20
-34	-48	26
-28	-36	40
14	8	26
-28	-30	22
-8	2	18

// Roth R M, 2006: Bipolar Patients
// Subjects=11
34	-62	-27
44	28	8
10	3	50
18	-37	-32
-20	-63	14
-24	-26	-9
-30	-65	-9
-34	-77	6
-18	-66	9
14	-48	-25
16	-67	-19
-36	-13	23
-32	50	-3
63	-1	26
-46	-28	-14

// Roth R M, 2006: Normals
// Subjects=11
44	24	10
42	-58	-39
-46	-5	52
-22	-55	-12
44	28	8
10	3	50
18	-37	-32
-20	-63	14
-24	-26	-9
-30	-65	-9
-34	-77	6

// Kronhaus D M, 2006: Bipolar Disorder
// Subjects=10
27.73	-37.74	-27.99
56.59	10.85	-7.86
-20.56	42.22	-21.87
-12.06	29.7	-33.18
-2.33	25.41	-20.67
-20.5	40.62	-15.05
-30.79	-55.24	-1.31
-29.02	43.11	-9.58
-23.59	34.14	-2.2
-11.2	-47.12	46.85
-20.56	42.22	-21.87
-20.5	40.62	-15.05

// Kronhaus D M, 2006: Healthy Controls
// Subjects=11
-30.79	-55.24	-1.31
-29.02	43.11	-9.58
-34.49	41.71	-27.24
37.49	-36.22	-9.27
-23.59	34.14	-2.2
-11.2	-47.12	46.85
6.97	-74.39	36.66
7.74	-57.67	5.14
-31.59	-61.3	30.43
-30.79	-55.24	-1.31
-29.02	43.11	-9.58
-23.59	34.14	-2.2
-11.2	-47.12	46.85
-20.56	42.22	-21.87
-20.5	40.62	-15.05

// Baumgartner T, 2006: Pictures with Music > Fixation
// Baumgartner T, 2006: Pictures Without Music > Fixation
// Baumgartner T, 2006: Pictures Without Music > Pictures With Music
// Baumgartner T, 2006: Pictures With Music > Pictures Without Music
// Subjects=9
48	0	40
-44	12	-28
52	-20	-4
56	-4	-20
-32	4	-40
-40	-8	-36
-20	-4	-28
20	-24	-24
-24	-8	-24
32	-28	-12
-20	-4	-24
-28	-96	8
28	-92	16
12	-92	-16
-26	-100	0
-24	-88	-24
24	-87	-24
-4	-26	-8
40	-56	-36
8	-32	-32
52	8	32
-52	32	20
-20	-32	-8
20	-28	-12
-40	-80	0
28	-92	16
-12	-96	-16
12	-96	-16
-20	-100	0
-24	-88	-24
22	-86	-20
-48	-64	-28
24	-88	-28
52	24	28
48	44	8
-4	28	52
0	44	-16
52	0	44
56	-20	-4
60	-24	4
36	12	-32
56	-28	8
-64	-28	8
-56	-16	0
56	0	-20
64	-16	-12
40	12	-44
-52	8	-28
16	-8	-32
24	-16	-20
-26	-20	-28
-17	-4	-20
24	-8	-24
-24	-20	-16
-32	-20	-32
-40	-8	-32
35	-2	-36
-36	-8	12
8	-44	16
-8	16	0
-16	4	24
4	-24	-36
8	-40	-12

// Brambati S M, 2006: Dyslexic Patients
// Subjects=13
-46	18	10
-46	24	14
40	16	14
42	3	29
50	13	22
52	18	14
50	10	36
50	4	40
52	12	36
-50	16	7
-46	24	14
-38	-58	47
-59	-45	32
52	24	17
52	15	21
4	14	47
52	-45	2
22	-77	-26
14	-80	-23
12	-77	-30
-42	14	18
46	7	18
-46	19	6
-32	24	10
-51	-42	21
-30	-69	-13
-38	-49	-14
-42	-65	-10
34	51	5
26	49	1
14	-52	-21
-36	-69	-13
-46	20	6
-51	25	2
-16	-5	52
-16	4	47
-53	-40	20
-55	-55	18
-40	-26	-12
-37	-49	-14
-40	-57	-14
46	-35	-8
40	-27	-5

// Brambati S M, 2006: Healthy Controls
// Subjects=11
-54	8	7
-46	22	6
-44	13	18
-30	27	-4
-34	15	-7
-38	11	-7
-30	15	4
-2	3	62
-10	12	43
-4	8	51
-62	-44	13
-46	9	-7
-54	-46	6
-57	-29	-2
-55	-2	-10
-38	-49	-14
-40	-57	-14
-52	-40	24
40	17	25
32	24	6
44	32	10
36	21	-4
34	33	-8
48	25	25
48	36	24
36	46	16
36	39	-5
48	17	36
40	6	37
6	14	51
54	-35	2
-44	18	14
-48	16	4
-40	23	-8
-36	-2	7
-4	-1	63
-2	14	47
-57	-31	-2
-62	-39	6
-48	-41	2
-48	41	2
-54	-48	4
-38	-49	-14
36	13	22
40	15	25
38	33	6
42	32	10
34	35	-2
40	17	-11
34	47	5
36	51	1
-38	3	29
-48	5	33
-48	23	3
-36	24	13
-44	22	21
-40	16	18
-38	30	2
-30	4	4
-32	16	-1
-24	4	0
-4	5	58
-6	10	51
-52	-40	20
-62	-46	13
-38	-49	-14
-40	-60	-14
-24	-54	40
-30	-56	47
-44	-38	46
-50	-37	35
32	22	6
44	29	6
42	32	10
40	34	13
34	19	-4
38	17	-4
36	23	-11
46	17	-1
34	38	16
6	9	59
4	14	54
-46	19	6
-32	24	10
-51	-42	21
-30	-69	-13
-38	-49	-14
-42	-65	-10
34	51	5
26	49	1
14	-52	-21
-36	-69	-13
-46	20	6
-51	25	2
-16	-5	52
-16	4	47
-53	-40	20
-55	-55	18
-40	-26	-12
-37	-49	-14
-40	-57	-14
46	-35	-8
40	-27	-5

// Fu C H Y, 2006: Self Undistorted > Self Distorted Feedback
// Fu C H Y, 2006: Self Distorted > Self Undistorted Feedback
// Fu C H Y, 2006: Self Undistorted > Alien Undistorted Feedback
// Fu C H Y, 2006: Alien Undistorted > Self Undistorted Feedback
// Fu C H Y, 2006: Self Distorted > Alien Undistorted Feedback
// Fu C H Y, 2006: Alien Undistorted > Self Distorted Feedback
// Fu C H Y, 2006: Self Undistorted Feedback> Rest
// Fu C H Y, 2006: Self Distorted Feedback> Rest
// Fu C H Y, 2006: Alien Undistorted Feedback > Rest
// Fu C H Y, 2006: Alien Distorted Feedback > Rest
// Fu C H Y, 2006: Self Distorted Correct Responses > Self Distorted 
// Misattribution Responses
// Subjects=13
-37.58	9.97	-24.55
-37.54	10.4	-19.01
-55.56	-13.52	-10.1
-16.91	-25.66	8.32
57.84	-11.47	6.27
-33.34	31.57	-20.83
-29.02	32.11	-14.23
-55.51	-27.26	-8.95
-21.13	-76.76	-5.19
-10.78	25.25	-8.29
35.17	25.52	-8.84
-64.03	-23.71	-3.57
5.36	-6.38	-5.82
-2.91	-79.39	0.39
-59.78	-3.08	1.34
39.85	-69.1	5.73
-59.73	-16.83	2.49
-10.42	-57.77	5.36
-52.1	-58.02	5.86
-21.31	-2.85	0.88
-55.47	-2.63	6.83
13.17	-68.84	11.59
13.22	-68.32	18.24
-32.94	-11.5	14
-59.6	-15.46	20.22
-5.98	-51.63	29.33
62.04	-2.35	-.12
57.87	-18.87	6.89
12.87	-48.94	-20.18
-21.1	-84.16	-4.57
43.72	11.4	-13.33
-59.83	-3.6	-5.31
8.76	-58.17	-1.52
62.09	-30.36	-4.47
31.26	-71.78	-.64
-6.32	-26.54	-4
54.66	-29.89	2.27
-6.04	-85.24	7.61
27.97	-37.45	3.21
17.34	-51.26	4.49
1.45	-89.43	7.88
17.07	19.58	-1.45
-48.93	-47.43	4.93
-59.73	-16.83	2.49
-59.71	-12.17	7.68
-48.89	-47	10.47
13.13	-57.21	10.62
39.9	-70.79	11.45
17.13	15.78	4.45
1.39	-61.51	11.11
23.78	-46.57	9.6
-59.67	-8.49	14.06
-14.58	-64.26	18.22
17.18	16.3	11.1
1.29	-21.87	14.48
13.22	-68.32	18.24
-20.91	-84.39	19.98
17.27	-8.02	13.13
-59.6	-15.46	20.22
1.45	-52.1	22.59
19.53	-14.47	25.92
-59.54	-18.12	27.13
61.97	-9.64	-11.78
1.29	-72.39	-5.82
-55.46	-16.8	2.44
47.14	-19.36	1.48
62.14	-18.84	6.84
35.69	-74.53	18.5
62.19	-18.33	13.48
-55.71	-.71	-23.44
-55.59	-7.17	-10.63
-59.59	-18.63	20.48
-59.5	-28.69	28.02
12.92	-2.22	6.01
-6.65	12.81	-31.83
-49.37	6.21	-30.79
-52.5	-.69	-23.48
-17.17	-18.46	-22.4
-55.67	-.28	-17.9
8.28	45.57	-22.48
54.37	7.78	-19.84
8.33	31.82	-21.33
0.95	4.28	-18.94
-17.08	-31.78	-15.7
-59.74	-38.92	-7.92
-55.62	0.23	-11.25
61.95	-3.3	-12.31
62.06	-33.96	-9.74
-41.64	-20.84	-9.65
-3.23	-6.86	-11.26
1.35	-76.19	0.08
-59.72	-34.26	-2.74
-55.57	0.66	-5.71
-41.81	35.64	-8.81
62.09	-30.36	-4.47
66.3	-12.36	-6.02
43.82	-2.98	-6.55
8.57	1.38	-2.05
62.05	-5.53	0.14
-55.52	1.17	0.93
-10.6	-9.13	1.28
12.88	-2.65	0.47
-37.49	36.17	-2.21
-63.93	-38	4.31
66.42	-18.82	6.78
-59.72	-9	7.41
-63.89	-37.58	9.85
-41.56	-5.72	6.93
62.2	-21.5	13.75
-3.14	20.4	10.99
-52.21	-2.1	13.44
58.01	-42.68	15.57
13.23	-70.44	18.42
-59.56	-24.98	21.02
62.24	-21.07	19.29
-14.67	-14.68	26.33
5.69	-28.3	27.24
9.07	-76.92	31.27
-59.46	-38.21	28.81
-49.37	-20.11	-40.85
-37.48	-42.79	-32.39
46.8	-5.27	-36.5
57.51	-11.55	-36.1
-49.49	37.94	-33.45
43.64	-4.86	-30.93
-41.93	30.04	-26.18
46.78	27.39	-26.98
51.15	-0.07	-24.72
-44.92	-28.14	-21.27
61.91	-17.98	-23.34
62.08	-63.45	-19.53
-37.32	-59.82	-18.7
-10.81	7.39	-19.06
-60.04	27.18	-20.16
62.15	-70.43	-13.37
57.71	-27.1	-16.96
-33.13	-24.47	-16.13
-3.24	-3.69	-11.53
-6.64	49.16	-15.92
61.85	22.08	-14.44
-59.83	-3.6	-5.31
-3.08	-33.92	-3.42
-59.88	8.03	-6.28
-33.22	25.11	-8.02
-55.53	-9.92	-4.83
5.41	-5.87	0.82
-48.96	-40.03	4.31
-59.85	14.89	-.17
0.96	40.63	-3.03
-55.33	-51.7	5.36
19.29	-2.61	0.39
-14.8	-19.3	7.76
8.51	33.71	3.04
47.07	9.62	4.62
-52.15	-19.02	14.85
-55.5	20.09	11.61
-41.35	-36.5	21.77
8.71	7.16	17.54
-45.11	9.41	-31.1
34.98	38.96	-27.81
12.91	-59.52	-19.3
51.13	7.33	-25.34
-49.32	6.73	-24.14
57.71	-27.1	-16.96
-45.08	27.27	-20.33
-52.49	7.14	-18.56
8.63	-34.28	-9.1
-64.02	-38.95	-7.87
-48.95	-66.35	-5.75
35.05	46.24	-16.15
57.79	-33.99	-9.69
-55.6	-4	-10.9
-14.9	-17.08	-4.69
46.89	32.99	-9.6
-41.79	28.23	-8.19
57.7	1.34	-7.07
-55.57	0.66	-5.71
5.51	-44.45	-2.63
43.75	29.26	-2.56
57.85	-25.64	1.88
8.76	-43.91	3.98
-37.44	33.43	3.6
-55.4	-19.55	8.24
-21.21	-19.34	7.83
54.58	16.52	10.65
-52.14	-22.19	15.12
5.48	13.48	17.04
-14.72	-15.19	19.68
-59.56	-24.98	21.02
-59.51	-24.46	27.66
-45.11	9.41	-31.1
54.46	-27.55	-22.46
-49.32	6.73	-24.14
8.57	-31.62	-16.01
57.74	-34.5	-16.34
51.08	32.08	-21.84
8.63	-48.54	-14.59
-52.34	-31.99	-15.28
5.51	-70.77	-12.69
46.88	10.9	-20.02
-55.68	3.94	-18.26
-3.21	-10.03	-11
12.91	-34.26	-9.15
-59.76	-34.69	-8.28
-52.39	-3.98	-10.94
-55.37	-54.33	-1.11
51.17	33.02	-9.65
54.48	5.55	-7.39
62.09	-30.36	-4.47
1.33	-71.96	-.28
-59.82	-6.77	-5.04
8.62	-5.85	0.78
51.22	33.53	-3.01
-3.15	-2.74	0.66
62.18	-39.36	2.98
-59.78	-3.08	1.34
-6.3	-5.51	6.5
54.54	12.83	4.27
66.43	-21.99	7.05
-59.68	-19.57	8.3
8.61	20.47	10.84
54.59	13.35	10.91
-55.3	-32.78	16.04
35.44	3.09	17.57
5.65	-31.99	20.85
-55.24	-38.7	22.12
1.59	-76.97	31.36
9.07	-76.92	31.27
-55.19	-38.18	28.76
1.34	-86.14	-4.67
66.35	-26.11	-4.87
57.73	6.08	-.78
66.43	-32.99	2.4
5.67	-75.65	6.67
66.44	-25.16	7.32
-59.69	-16.4	8.03
62.27	-38.42	15.17
-55.24	-38.7	22.12
-59.58	-32.81	16.1
-59.51	-38.72	22.17
-59.47	-36.09	28.64

// Harenski C L, 2006: Watch, Moral > Number Discrimination
// Harenski C L, 2006: Watch, Non-moral > Number Discrimination
// Harenski C L, 2006: Watch, Moral > Watch, Non-moral
// Harenski C L, 2006: Watch, Non-moral > Watch, Moral
// Harenski C L, 2006: Decrease, Moral > Number Discrimination
// Harenski C L, 2006: Decrease, Non-moral > Number Discrimination
// Harenski C L, 2006: Decrease, Moral > Watch, Moral
// Harenski C L, 2006: Decrease, Moral > Decrease, Non-moral
// Harenski C L, 2006: Decrease, Non-moral > Decrease, Moral
// Subjects=10
63	27	9
-21	-6	-15
-12	39	54
-9	30	63
9	57	18
9	69	21
30	-45	-12
-15	54	39
3	-63	15
-6	51	21
-9	27	63
18	-3	-27
-51	-66	30
-15	-45	24
-39	39	39
42	30	-18
-54	27	0
60	36	15
12	66	30
-12	66	27
-18	54	39
-9	36	60
12	27	66
-30	-93	21
51	-66	15
-45	-81	18
15	-99	3
0	39	54
63	27	9
15	18	69
-24	0	-27
42	33	-18
33	-81	18
42	-48	-27
-45	-84	6
-12	-102	12
0	-87	-12
45	14	-3
3	17	-8
-39	17	-8
-30	47	17
-12	18	60
-12	23	49
-3	9	55
6	-72	33
-6	60	6
0	51	-3
-12	15	66
-21	48	21
42	33	30
-27	39	33
-36	15	48
3	36	-3
-51	-66	9
57	-66	9
39	-63	21
-45	33	-18
45	-33	45

// Lee T W, 2006: Imitation > View, Angry Faces
// Lee T W, 2006: Imitation >  View, Sad Faces
// Lee T W, 2006: Imitation > View, Happy Faces
// Lee T W, 2006: Imitation > View, Chewing Faces
// Lee T W, 2006: Imitation > View, Licking Faces
// Lee T W, 2006: Associated Conjunction of Imitation of Ingestive Expressions 
// > View
// Lee T W, 2006: Imitation > View, Angry Faces (Excluding Chew and Lick 
// Imitation)
// Lee T W, 2006: Imitation > View, Sad Faces (Excluding Chew and Lick 
// Imitation)
// Lee T W, 2006: Imitation > View, Happy Faces (Excluding Chew and Lick 
// Imitation)
// Lee T W, 2006: View, Angry Faces > View, Neutral Faces
// Lee T W, 2006: View, Sad Faces > View, Neutral Faces
// Lee T W, 2006: View, Happy Faces > View, Neutral Faces
// Lee T W, 2006: View, Chewing Faces > View, Neutral Faces
// Lee T W, 2006: View, Licking Faces > View, Neutral Faces
// Lee T W, 2006: Activations Associated with Facial Movements, Chewing Faces
// Lee T W, 2006: Activations Associated with Facial Movements, Licking Faces
// Lee T W, 2006: Activations Associated with Facial Movements, Conjunction of 
// Ingestive Expressions
// Lee T W, 2006: Selective Correlations with Facial Movements During 
// Imitation, Angry Face
// Lee T W, 2006: Selective Correlations with Facial Movements During 
// Imitation, Sad Face
// Lee T W, 2006: Selective Correlations with Facial Movements During 
// Imitation, Happy Face
// Subjects=18
-53	-7	36
53	-4	36
59	4	8
3	19	35
3	0	55
-53	-33	32
-18	-55	3
-39	-3	6
-48	-1	41
56	-10	39
50	13	35
59	7	13
0	8	44
6	9	60
-50	-7	36
45	-10	36
65	-25	21
59	12	8
0	-3	55
24	3	3
-50	-7	31
53	-2	25
59	3	8
59	-21	40
6	13	35
0	0	55
39	-5	14
-50	-7	28
56	-2	28
50	-8	11
53	-29	54
0	0	53
-42	-6	6
36	-5	11
-53	-7	31
53	-4	28
62	-21	37
6	3	55
39	16	-26
-42	-6	3
39	0	0
-45	-9	45
42	-13	39
-53	-11	12
-45	11	-4
56	9	11
56	8	36
3	19	35
3	0	55
-53	-33	32
-45	11	-6
-18	-55	3
-39	-3	6
36	9	8
-48	-1	41
56	-16	37
-50	7	7
59	9	13
50	13	35
0	8	44
6	9	60
-39	-41	55
-50	6	0
-45	-9	45
48	-4	42
65	-25	21
-48	16	-4
59	12	8
0	13	32
0	-3	55
-59	-31	24
-48	14	-6
24	3	3
-42	-7	31
12	-7	45
-3	58	-5
-33	22	-24
42	-19	-24
45	19	35
59	-54	19
56	-10	-17
67	1	19
-6	-64	58
-53	-48	30
-50	2	-28
-50	-7	28
56	-2	25
3	0	55
-18	-64	58
53	-28	26
59	-58	8
-39	-62	-12
-42	-50	-10
45	-56	-15
33	-76	-9
-42	-84	15
-45	-17	4
45	8	-5
-27	-3	3
-50	-7	25
53	-7	36
-18	-64	56
53	-28	24
39	19	-31
59	8	-5
53	-69	12
-45	-50	-15
36	-56	-15
24	-70	-4
-42	-87	7
-45	-76	-6
30	-81	18
48	-77	-1
-50	-37	18
45	-8	14
-56	-10	31
56	-2	28
-18	-61	53
-53	-52	8
59	11	-6
59	-64	9
-48	-47	-15
42	-50	-18
-48	-78	4
-30	-87	15
30	-81	18
-33	-82	-11
45	-79	-1
-48	-37	18
45	-8	14
-45	-12	45
45	-4	44
-53	-19	23
53	-28	21
-21	64	2
18	67	8
9	6	66
-57	6	5
56	7	13
3	55	-15
-3	0	53
-48	-65	36
-39	-56	-12
-37	3	5
47	8	-5
-24	0	-8
21	12	8
-56	-21	43
-12	-2	69
9	3	66
-30	20	-14
59	15	2
-3	46	-12
3	34	-9
3	0	58
6	-42	33
-45	-35	54
48	-62	34
42	16	-24
21	-13	-20
45	9	0
-45	-16	39
39	-16	37
42	-4	33
-53	-8	11
-59	-19	20
56	9	8
9	6	60
-6	-16	39
6	-36	40
50	-56	36
56	-28	26
-45	13	-26
39	16	-34
-65	-33	-11
-45	-67	9
53	-32	7
59	-36	-13
-39	-56	-12
42	-56	-12
-21	-95	13
-21	-82	-6
50	-69	9
42	0	6
-15	12	13
21	21	3
-24	6	5
27	0	0
-21	-4	-15

// Mathiak K, 2006: (Passive/Dead + Preparation/Search) > (Potential Danger + 
// Under Attack + Active Fighting)
// Mathiak K, 2006: (Potential Danger + Under Attack + Active Fighting) > 
// (Passive/Dead + Preparation/Search)
// Subjects=13
14	38	-2
-50	-60	54
44	-40	-6
36	-52	24
-26	56	-16
-38	-2	6
-40	-30	-18
54	-54	48
54	-58	-24
-2	-56	56
60	-32	18
-56	-38	36
-2	-12	40

// Petrella J R, 2006: Normals > MCI Patients, Encoding
// Petrella J R, 2006: Normals > MCI Patients, Retrieval
// Petrella J R, 2006: MCI Patients > Normals, Retrieval
// Subjects=20
-16	3	66
24	7	57
-44	18	19
-6	29	41
-22	-44	-16
40	13	29
-6	27	45
-46	12	36
32	23	-5
-48	15	-6
-34	-10	-13
34	-14	36
-26	5	18

// Aron A R, 2006: Go - Null Event
// Aron A R, 2006: Stop - Go
// Aron A R, 2006: Stop Inhibit - Stop Respond
// Subjects=5
24	-100	-6
-22	-102	-14
-42	-28	46
-14	-12	-6
-28	-10	0
-16	-14	6
-24	2	8
-26	-8	8
-18	-6	-4
-14	-20	-8
-10	-16	-12
-26	-20	4
-26	-18	10
20	10	-2
28	2	-4
30	14	-4
42	48	14
-34	-62	-36
-6	-6	58
-10	4	44
-20	-6	48
68	-44	8
34	26	0
36	22	0
44	22	-4
44	12	8
52	38	-6
54	14	0
42	20	-10
6	20	50
6	8	70
8	20	34
18	-104	4
-40	16	-6
-56	-28	8
-46	-38	18
22	-30	-6
12	-26	0
16	4	-6
6	-26	-2
6	-20	4
10	-14	-4
18	12	-8
12	-18	2
18	-22	-2
6	-20	-12
-6	-22	4
-8	-16	0
34	40	30
8	-20	30
-26	-98	-10
-20	-26	-10
48	2	50
14	-42	48
36	-48	46
10	-42	52
18	-104	2
-18	-108	0
-26	-10	2
-34	-16	-6
-34	-6	-18
-16	-54	14
-30	22	56
42	-22	52
22	-8	12
20	4	12
24	-2	2
-2	40	-18
-10	-28	70

// David N, 2006: 1PP > 3PP
// David N, 2006: 3PP > 1PP
// David N, 2006: ACT > PAS
// David N, 2006: PAS > ACT
// David N, 2006: ACT Using 1PP as a Search Volume
// David N, 2006: Common for ACT and 1PP
// David N, 2006: Common for PAS and 3PP
// Subjects=13
-2	44	-8
-62	-20	-14
-56	-64	30
-28	-4	-12
-4	-24	44
54	6	-32
-32	34	-12
20	36	52
-12	-50	8
6	-10	48
-8	-52	30
-6	-88	30
-48	-10	-8
-34	-56	56
-44	8	34
88	2	54
2	-36	-40
18	-26	14
34	22	2
-36	22	2
4	16	46
-18	-22	12
40	56	6
32	-64	-50
-14	46	10
-10	40	46
-8	58	20
4	-56	-50
14	46	22
50	-72	2
-50	-58	16
6	-54	50
28	-78	40
-38	-46	-18
44	4	50
-52	22	34
-36	0	62
28	-82	12
58	-38	54
44	-52	54
-14	46	10
-10	40	46
-14	-48	10
-14	-32	74
0	-28	46
10	56	32
-14	46	10
-10	40	46
-8	58	20
50	-72	2
-50	-58	16
6	-54	50
28	-78	40
44	4	50
16	-62	36
-52	22	34
46	18	36

// Daw N D, 2006: Activations Correlated to Number of Points Received
// Daw N D, 2006: Regions Correlated to Probability Assigned by Model
// Daw N D, 2006: Exploration > Exploit
// Daw N D, 2006: Prediction Error
// Subjects=14
3	30	-21
-3	45	-18
45	36	-15
-3	33	-6
27	57	6
-29	-33	45
39	-36	42
-57	3	36
3	9	51
21	-54	-30
18	-57	-51
9	12	-9
9	0	18

// Bingel U, 2006: Main Effect of Painful Laser-Stimulation
// Bingel U, 2006: Right Hand, Placebo > Nonplacebo
// Bingel U, 2006: Left Hand, Placebo > Nonplacebo
// Bingel U, 2006: Right Hand, Co-players of Placebo Analgesia
// Bingel U, 2006: Left Hand, Co-Players of Placebo Analgesia
// Subjects=19
42	-42	48
57	-21	21
63	-51	12
39	-6	0
3	30	39
6	39	9
9	-18	9
18	-3	-15
30	-63	-33
18	12	-3
-54	-42	48
-60	-15	15
-60	-36	12
-39	6	3
-3	18	48
-6	42	12
-12	-9	0
-18	-3	-15
-33	-72	-21
-15	15	0
3	42	-18
-3	39	-18
15	-6	-21
3	-21	-3
0	-12	-9
-18	-12	-21

// Fukui H, 2006: Human - Computer
// Subjects=16
-8	43	35
-57	-51	28

// Johnson S C, 2006: Activations in Novel Drawings Relative to Previously 
// Learned, Normals
// Johnson S C, 2006: Previously Learned vs. Novel Drawings, Normals
// Johnson S C, 2006: Elderly Normals vs. Mild Cognitive Impairment, Novel 
// Drawings
// Johnson S C, 2006: Elderly Normals vs. Mild Cognitive Impairment, 
// Previously Learned
// Subjects=14
-34	-44	-28
30	-44	-26
-44	34	8
24	-4	-24
-25	-8	-22
-12	22	46
58	-58	28
58	-18	-18
8	-76	36
2	-28	26
36	18	52
8	52	54
-36	-54	32
-54	22	30
40	-68	-24
22	-8	-26
24	-26	-10
16	-72	28
12	-52	16

// Smith Y R, 2006: Working Memory (4-sec Delay) - Working Memory (1-sec 
// Delay), Pre-Therapy
// Smith Y R, 2006: Working Memory (4-sec Delay) - Working Memory (1-sec 
// Delay), Post-Therapy, Hormone > Placebo
// Subjects=10
-42	6	29
-44	30	25
45	4	31
-5	14	47
-31	-70	43
27	-61	48
-12	-75	-14
25	-75	-17
-39	24	32
-44	20	15
40	11	18

// Becerra L R, 2006: Morphine > Saline
// Subjects=8
21.01	35.54	-26.07
-20.2	35.19	-25.81
7.45	19.08	17.31
33.83	36.86	28.14
-34.85	36.28	28.59
24.39	-22.28	-23.24
-16.82	-22.63	-22.98
22.53	-24.31	64.59
11.63	6.52	-16.26
-9.51	6.27	-17.23
21.19	-7.06	-15.39
-20.03	-7.68	-19.54
0.03	-3.37	-21.07
-17.88	-4.47	-2.02
28.61	-1.85	-.25
-12.58	-20.02	-15.41
9.67	-20.65	5.59
-5.12	-20.84	4.58
-1.97	-33.72	-16.76
14.97	-51.06	-26.77
-9.34	-49.3	-28.96

// Kong J, 2006: High Pain > Low Pain
// Kong J, 2006: Pain Intensity Evaluation > Target Matching
// Subjects=16
14	-42	72
66	-22	22
-66	-26	20
4	2	46
20	-70	-2
36	-20	16
-36	-16	14
-52	10	-4
-32	0	2
-14	-8	8
16	-14	8
0	-48	-26
-8	-78	18
-28	52	16
-30	20	8
-12	16	56
-14	74	52
-32	-80	34
42	14	2
36	32	4
14	-98	-6

// Maihofner C, 2006: Heat Pain Stimulation - Non Painful Stimulation
// Maihofner C, 2006: Impact Pain Stimulation - Non Painful Stimulation
// Maihofner C, 2006: Impact Pain Stimulation - Heat Pain Stimulation
// Subjects=14
-34.75	-20.14	53.78
-31.56	-17.04	52.37
-30.38	-58.7	50.27
38	-51.86	50.03
-43.6	-20.11	13.73
56.85	-20.56	12.62
-47.77	-24.48	26.41
52.89	-34.85	48.43
-41.4	11.4	35.6
48.35	7.36	30.45
-38.51	46.54	8.08
42.87	38.88	25.64
-2.73	14.74	61.64
8.88	30.96	50.11
-28.82	22.11	7.79
38.49	20.14	3.84
-2.9	15.23	40.41
5.63	12.91	37.16
-33.67	-18.91	55.9
-41.23	-5.55	50.4
51.68	3.21	45.25
-30.37	-59.67	51.47
36.95	-58.21	50.57
-54.27	-22.11	16.25
17.34	-20.46	17.52
-50.99	-24.67	24.24
59.27	-40.61	42.15
-50.17	15.64	8.58
52.54	9.79	20.16
-29.78	29.82	25
39.62	42.84	22
-4.95	25.93	55.15
8.92	25.84	52.77
-48.06	15.31	4.12
41.73	13.99	6.55
-48.06	15.31	4.12
40.83	-20.57	13.92
-.84	26.44	33.87
4.55	12.73	34.96
-54.27	-23.26	15.23
60.06	-18.26	14.62
-49.89	-31.98	25.95
52.68	-25.02	24.19
54.68	10.95	21.15
-31.83	-23.12	14.97
36.39	26.01	11.18

// Hampton A N, 2006: Prior Correct Activity
// Hampton A N, 2006: Posterior Correct - Prior Correct Activity
// Hampton A N, 2006: State-Based > Standard RL
// Hampton A N, 2006: Prior Incorrect Activity
// Hampton A N, 2006: Switch - Stay Activity
// Subjects=16
6	57	-6
33	-15	-18
-9	66	21
6	66	24
0	39	-6
0	33	-24
-9	-57	24
-6	54	24
-24	3	-9
18	3	-15
-12	51	-15
6	45	-9
39	36	33
48	15	9
6	21	45
-3	24	30
51	21	3
-39	18	-12

// Pessiglione M, 2006: Reward Prediction Error, Positive Correlations
// Pessiglione M, 2006: Punishment Prediction Error, Negative Correlations
// Pessiglione M, 2006: Stimulus Related Activity, Go/NoGo
// Pessiglione M, 2006: Stimulus Related Activity, (Go/NoGo Gain) - (Go/NoGo 
// Neutral)
// Pessiglione M, 2006: Stimulus Related Activity, (Go/NoGo Loss) - (Go/NoGo 
// Neutral)
// Subjects=39
-30	-10	-2
-10	12	-8
40	24	-8
-30	-6	0
26	-48	30
-12	-22	6
-38	-26	56
-6	-10	56
-42	-4	14
44	0	10
-12	10	-10
30	28	-6

// Cerasa A, 2006: Parkinson's Disease Patients
// Subjects=10
-30.4	-22	67.58
-62.56	-20.69	3.01
60.72	-21.55	9.96
-2.55	-7.29	51.09
-44.14	38.89	19.21
52.74	32.17	-12.03
-54.07	26.35	0.45
60.04	-2.17	45.03
-43.94	38.21	34.96
-11.79	-11.79	3.5
27	-73.71	-17.92
-22.62	-75.49	-11.3
-28.22	-26.24	67.97
-60.25	-23.89	14.49
57.48	-21.56	10.02
10.45	6.14	56.26
-28.97	28.31	20
62.56	20.92	-6.6
31.26	-73.04	-22.54
30.26	-62.64	-14.59
14.43	-68.61	14.28
-7.26	-70.38	8.1
34.01	-91.63	19.59
-7.18	-74.21	12.96
25.26	-62.95	16.9
4.03	10.99	62.61
54.88	27.72	-13.87
-62.59	-2.29	4.55
39.9	21.05	-3.99
-9.41	-74.74	7.45
26.99	14.83	-.91
12.08	-21.93	8.58
-13.96	-79.71	-11.03
18.6	-25.95	11.11
-7.52	-16.55	-1.7
31.28	-69.64	-20.64

// Cerasa A, 2006: Healthy Controls
// Subjects=11
-43.4	-22.35	64.48
71.57	-18.97	14
-13.38	10	52.92
25.59	-60.45	43.54
64.99	15.25	12.97
-11.59	22.5	25.88
20.42	-49.27	-20.23
-56.66	-16.93	42.88
9.68	-56.54	-17.09
20.76	-51.13	5.72
-22.27	-99.15	11.21
-7.21	-74.42	10.74
14.4	-78.7	9.68
4.03	10.99	62.61
54.88	27.72	-13.87
-62.59	-2.29	4.55
39.9	21.05	-3.99
-9.41	-74.74	7.45
26.99	14.83	-.91
12.08	-21.93	8.58
-13.96	-79.71	-11.03
18.6	-25.95	11.11
-7.52	-16.55	-1.7
31.28	-69.64	-20.64

// Eckert T, 2006: Parkinson's Disease Patients
// Subjects=9
-26	-28	60
-4	-12	60
-60	8	6
36	-12	60
56	16	-8
64	-24	20
48	-36	48
16	-56	-28
4	-68	-20
-28	-64	-32
-40	-28	60
0	-8	64
-60	4	6
32	-12	64
64	-28	24
48	-40	52
20	-56	-28
4	-68	-20
-24	-68	-32
24	0	64
32	4	56
40	0	40
-32	-52	60
-40	-20	56
-52	-24	36
0	4	60
36	-8	60
-60	-20	20
16	-72	56
-28	-64	-28
4	-68	-20
12	-60	-24
-40	-40	48
-40	-44	60
-36	-44	68
-48	-64	44
-40	-76	32
28	-32	64
12	-24	60
28	-44	72
16	-48	-48
-32	-16	64
0	4	64
4	-68	-16
16	-68	-24
-20	-72	-28
-36	-48	64
-40	-40	44
28	-28	68
16	-48	-48

// Eckert T, 2006: Healthy Controls
// Subjects=9
-40	-25	60
-4	-20	56
32	-24	68
-60	-20	40
-60	4	20
-56	-4	44
20	-52	-44
-40	-20	56
-52	-24	36
0	4	60
36	-8	60
-60	-20	20
16	-72	56
-28	-64	-28
4	-68	-20
12	-60	-24
-40	-40	48
-40	-44	60
-36	-44	68
-48	-64	44
-40	-76	32
28	-32	64
12	-24	60
28	-44	72
16	-48	-48
-32	-16	64
0	4	64
4	-68	-16
16	-68	-24
-20	-72	-28
-36	-48	64
-40	-40	44
28	-28	68
16	-48	-48

// Durston S, 2006: Healthy Controls
// Subjects=11
-57.54	-19.84	57.75
26.58	-50.57	-45.98
44.06	22.05	-16.48
-38.03	20.8	-13.84
5.42	45.68	8.73
-7.43	46.46	17.84
-37.85	48.4	5.84
49.02	19.19	33.02
-45.81	12.97	52.06
31.17	60.89	-2.18
-63.18	-47.87	33.72
60.82	5.43	22.98
-16.3	-29.63	-14.82
-37.76	-31.86	-3.03
-38.03	20.8	-13.84
-7.43	46.46	17.84
-45.81	12.97	52.06
31.17	60.89	-2.18
-63.18	-47.87	33.72
44.06	22.05	-16.48
49.02	19.19	33.02
-45.81	12.97	52.06
-63.18	-47.87	33.72

// Durston S, 2006: Unaffected Siblings
// Subjects=11
-57.77	-16.08	40.57
44.2	-51.31	-20.43
-58.33	1.66	0.73
48.7	20.1	8.28
5.42	45.68	8.73
-28.05	-23.21	-2.93
56.96	-53.44	47.92
48.15	0.64	-39.09
39.74	34.05	-14.23
-3.17	-14.1	1.34
44.06	22.05	-16.48
49.02	19.19	33.02
-45.81	12.97	52.06
-63.18	-47.87	33.72

// Durston S, 2006: Siblings with Attention Deficit/Hyperactivity Disorder
// Subjects=11
-57.6	-20.25	53.31
22.61	-54.58	-19.74
53.42	25.25	40.19
49.38	-36.14	49.7
-38.03	20.8	-13.84
-7.43	46.46	17.84
-45.81	12.97	52.06
31.17	60.89	-2.18
-63.18	-47.87	33.72

// Evers E A, 2006: NoGO Inhibition vs. Go, Experimental Session
// Subjects=13
48	-46	36
52	-52	42
52	-54	30
48	34	22
30	52	24
52	10	6
2	26	42
0	34	40
20	18	58
-34	-60	54
-58	-50	38
-28	-72	50
-30	26	-6
-48	10	42
-40	30	28
60	-36	-6
60	-26	-12

// Hermann D, 2006: Alcohol Dependent Subjects
// Subjects=10
-9	45	39
-54	21	21
-27	15	42
-39	48	-12
-6	-33	27
-21	-39	-3
33	-39	-3
-12	-60	30
12	-60	39
-9	-54	33
21	-27	3

// Hermann D, 2006: Healthy Controls
// Subjects=10
-9	45	39
-54	21	21
-27	15	42
-39	48	-12
-6	-33	27
-21	-39	-3
33	-39	-3
-12	-60	30
12	-60	39
-9	-54	33
42	54	6
-36	-3	30

// Passamonti L, 2006: MAO-A (+) Subjects
// Subjects=12
43	16	-10
33	20	-16
53	15	-5
49	-34	53
37	-55	58
61	-41	27
11	-8	18
-13	-8	18
3	-22	12
11	-66	-3
-17	-68	8
33	-55	47
53	20	19
37	19	-2

// Passamonti L, 2006: MAO-A (-) Subjects
// Subjects=12
11	-66	-3
-17	-68	8
33	-55	47
53	20	19
37	19	-2

// Peelen M V, 2006: Group-Average Activation for the Biological Motion 
// Display
// Subjects=17
48.31	-72.11	-6.38
56.87	-52.17	3
62.32	-40.02	21.99
39.55	-41.47	-22.23
37.53	-72.06	-18.53
16.39	-100.6	-.28
-43.56	-73.46	-1.87
-58.4	-38.29	27.69

// Saur D, 2006: Aphasic Patients
// Subjects=14
-51	36	-9
-48	27	18
36	24	-9
54	30	21
6	27	42
-51	30	-9
-48	24	18
-63	-39	0
-39	-63	24
-51	12	-21
48	18	-27
-51	27	-9
-48	27	18
-57	-45	0
-57	0	-15
-6	15	51
33	21	-9
51	30	21
33	21	-9
9	18	48
-33	24	-3
36	-84	9
36	30	-12
33	21	-9
-42	21	-6
-6	9	57
-48	-48	-12
-42	-45	-18
-42	12	24
33	24	-3
-63	-51	3
-57	-12	-12
-30	21	-3
36	30	-12
-9	33	42
-45	36	-9
-57	15	9
48	21	3
0	18	39
39	24	0

// Saur D, 2006: Healthy Controls
// Subjects=14
-60	-45	3
-42	12	24
-45	24	-6
33	24	-6
54	27	21
-57	-9	-15
-42	-45	-18
-36	-66	24
9	18	48
-42	-45	-18
-42	12	24
33	24	-3
-63	-51	3
-57	-12	-12
-30	21	-3
36	30	-12
-9	33	42
-45	36	-9

// Beaver J D, 2006: Appetizing - Bland
// Beaver J D, 2006: Appetizing - Disgusting
// Beaver J D, 2006: Appetizing - Nonfood
// Beaver J D, 2006: Disgusting - Bland
// Beaver J D, 2006: Disgusting - Appetizing
// Beaver J D, 2006: Disgusting - Nonfood
// Subjects=12
8	10	-12
-8	16	-12
52	-12	14
-24	-4	62
-34	-32	28
36	-30	30
24	-26	-20
14	-40	4
-58	-40	6
42	-30	-24
-32	22	36
16	-84	26
46	-70	40
-10	-20	32
14	-42	30
-10	-46	-16
-36	42	-10
-42	-4	44
40	-30	-26
-52	-40	10
58	-34	16
-42	-66	22
66	-46	-12
-30	26	40
-38	50	-8
40	-26	-8
34	10	46
-40	16	38
64	-28	18
32	-26	-26
-44	12	-32
-44	-54	10
-50	-32	6
-40	-28	-24
8	-90	8
8	-48	46
-14	52	8
18	52	6
-40	32	32
44	30	40
16	26	-14
12	12	-16
-38	-18	30
48	-20	42
50	-34	52
18	-18	-22
-18	-44	2
14	-40	4
-28	-60	36
36	26	-6
22	36	-14
20	0	-26
32	18	8
24	44	-8
52	-38	54
-8	-76	-2
16	-84	4

// Wiech K, 2006: Main Effect of Pain
// Wiech K, 2006: Externally-Controlled - Self-Controlled
// Wiech K, 2006: Self-Controlled - Externally-Controlled
// Wiech K, 2006: Self-Controlled - Externally-Controlled, Correlated with 
// Belief in Self-Control
// Subjects=12
57	0	3
-39	-18	15
-42	3	-9
-36	0	9
-54	-18	12
-15	6	0
15	6	-3
12	9	15
-51	-24	27
51	-45	33
51	42	-9
24	30	-15
-24	39	-9
-21	21	-6
-57	-42	36
0	31	2
27	30	-15
45	33	-12
27	45	0
-45	33	-15
-27	30	-15
-15	45	-15
-54	-21	-24
9	33	3
15	-87	-36
-3	45	36
9	12	54
-3	15	48
-9	12	42
33	33	39
30	42	42
39	39	39
27	51	33
45	45	30
48	51	12
-39	54	21
-12	-6	63
-48	-36	45
45	-36	54
54	-33	33
48	-33	45
-45	-27	21
51	6	12
-60	-30	21
-36	12	9
-12	27	51
15	-66	-12
27	-60	-24
36	48	21
33	57	15
24	18	60
-15	-96	0
-45	-72	-21
42	-72	9
-6	-18	69
27	-21	63
15	-66	66
-6	-24	33
-12	-27	9

// Desai R, 2006: Generate Regular Verbs - Read Regular Present Tense Verbs
// Desai R, 2006: Generate Regular Verbs - Read Regular Present Tense Verbs 
// (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Read Irregular Present Tense 
// Verbs
// Desai R, 2006: Generate Irregular Verbs - Read Irregular Present Tense 
// Verbs (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Phonologically Matched)
// Desai R, 2006: Areas Correlated with Response Time Across Conditions
// Desai R, 2006: Areas Correlated with Response Time Across Conditions 
// (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Phonologically Mismatched)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Phonologically Mismatched) (Deactivations)
// Desai R, 2006: (Read Irregular - Read Regular) Past Tense Verbs 
// (Phonologically Mismatched) (Deactivations)
// Subjects=25
-51.09	3.97	22.95
3.58	12.69	48.36
-24.55	13.33	4.02
-51.16	-60.45	-11.79
-56.21	-31.07	38.22
47.33	-4.19	32.54
-33.68	-44.34	43.53
42.66	20.19	-9.6
-27.16	-65.11	49.66
46.02	-56.15	-19.96
-47.08	24.31	-3.34
48.62	-34.88	48.48
68.42	-7.06	-6.49
-45.82	-25.38	0.82
-4.1	18.25	24.56
-38.22	-96.49	-11.15
44.08	-29.98	15.78
27.41	-65.16	57.96
-21.19	-4.91	15.55
61.1	-36.11	3.83
51.32	34.56	10.29
-56.17	-62.51	30.81
49.63	-64.08	28.62
-5.85	-60.12	43.42
-4.5	47.06	-15.77
-32.05	-26.49	-14.86
-52.15	5.19	25.09
-32.04	15.32	2.82
-41.22	-43.84	36.88
-37.04	-6.38	39.27
-13.37	6.39	64.69
13.99	3.24	7.77
-6.18	0.18	24.98
-22.98	-72.71	33.52
48.06	15.37	-3.68
-12.8	0.11	-2.81
30.41	-65.08	31.15
-2.18	-20.31	-20.18
-16.82	-69.79	1.98
-64.7	-36.07	43.19
43.07	-5.19	33.79
-41.57	-56.33	-14.48
-47.97	-22.22	0.58
28.48	-64.09	57.86
50.32	29.87	18.5
-30.55	-93.42	14.15
-9	-89.21	39.2
45.39	-3.29	58.14
33.39	-87.18	-7.18
-5.04	-32.05	20.98
27.56	44	-17
3.58	12.61	47.25
-22.2	26.49	36.34
58.14	-54.51	27.72
-55.02	-66.13	38.91
8.6	4.9	2.11
-32.57	-54.91	44.4
-50.04	8.12	21.48
35.85	-62.96	44.29
38.44	26.23	-0.02
50.5	6.4	31.62
-29.45	-75.55	24.91
-44.7	-55.58	-4.47
-50.29	31.95	-.59
-46.65	-2.04	41.25
-11.58	-26.86	6.12
-56.49	-16.47	6.88
68.77	-36.3	28.3
6.48	2.86	3.42
-39.02	-50.89	41.91
38.03	-62.52	49.81
-46.72	2.74	34.16
46.9	14.42	-15.85
36.7	-3.65	40.43
50.37	28.18	24.22
-8.32	31.94	36.84
-29.46	-74.49	24.82
-6.32	-18.88	-1.3
-46.03	32.95	-1.84
-4.96	12.73	49.57
35.23	21.81	-1.84
-14.88	6.16	6.74
14.99	9.17	1.68
-42.39	0.1	41.02
5.44	-25.33	-3.12
0.22	26.37	32.75
14.43	5.67	66.66
-47.11	15.26	-10.38
-40.08	-50.81	43.03
19.42	-54.05	-4.22
49.43	5.25	30.61
-11.61	-56.78	-9.21
35.31	54.53	22.18
58.94	-23.26	5.01
43.29	-52.34	43.32
35.28	-63.41	-30.38
-60.72	-.66	18.99
-12.8	-82.28	-36.05
-46.91	24.97	18.91
2.48	-28.32	27.27
10.37	-43.8	74.2
-51.14	-59.13	-8.56
51.15	44.91	-7.31
-11.04	-50.87	67.24
25.45	49.7	-11.87
44.88	-16.26	-13.26
-31.18	56.05	-7.29
8.13	-87.7	43.34
-6.78	-24.69	75.03
-28.87	-34.48	-22.03
-42.57	-8.38	13.85
-41.7	-2.77	-10.05
-50.02	9.43	24.71
-33.64	-55.97	44.51
50.49	6.32	30.51
37.35	28.25	-1.29
-37.05	0.13	40.95
35.85	-64.02	44.38
11.88	10.09	13.91
-3.1	-19.83	-.14
-49.1	-55.75	-20.02
-30.53	-74.5	24.83
-9.38	30.97	38.05
3.57	14.72	47.07
-52.25	-17.84	2.49
-50.86	-7.89	48.48
-57.63	-10.56	0.83
58.76	-7.54	-11.92
-40.36	-36.21	11.7

// Dreher J C, 2006: Error Prediction at S1: P=0.5 $20 > P=0.25 $20
// Dreher J C, 2006: Error Prediction at S2: $20 in Slot A > $20 in Slot B
// Dreher J C, 2006: Reward Uncertainty During the Delay: P=0.5 $20 > P=0.25 
// $20
// Dreher J C, 2006: Conjunction Error Prediction at S1 and S2
// Dreher J C, 2006: Error Prediction at S2 (No Reward): P=0.75 $0 > P=0.5 $0
// Dreher J C, 2006: Error Prediction at S2 (No Reward): P=0.5 $0 > P=0.75 $0
// Subjects=31
-4	-23	-15
-46	19	30
-38	34	0
42	23	-19
-46	8	57
38	11	53
-11	27	19
4	15	27
-4	23	65
-42	-49	42
27	-61	42
8	-19	-15
-8	-15	-15
-34	27	34
-38	27	4
27	27	-15
-11	15	61
-53	15	8
-49	-42	57
-39	-20	59
-4	-19	-15
-4	-8	-11
23	8	-11
-30	0	-11
0	-23	-15
-42	23	34
-53	19	-8
42	23	-8
-11	8	65
-46	-27	38
30	-57	57
-38	27	0
-8	15	8
-11	-46	11
-30	-15	68
-4	-8	46
-30	15	46
-46	23	8
42	23	4
23	30	38
15	61	-8
46	-42	-4
-38	-46	-8
-57	-30	30
42	-38	30

// Grinband J, 2006: Unmodulated Regressor Activations
// Grinband J, 2006: Uncertainty Regressor Activations
// Subjects=10
2	38	38
-2	40	38
40	22	4
-36	24	4
14	10	8
-16	6	8
8	-12	-4
-2	-12	-2
28	10	58
-34	4	58
38	24	8
-40	24	10
46	16	26
-40	24	34
42	-62	4
-48	-68	-6
36	-28	46
-44	-40	48
2	38	40
-8	36	36
36	26	8
-30	22	12
12	4	-6
-16	6	-4
6	-14	10
-8	-16	10

// Huettel S A, 2006: Decision Phase Activity to Response Selection in the 
// Absence of Behavioral Risk
// Huettel S A, 2006: Decision Phase Activity Modulated by Behavioral Risk
// Huettel S A, 2006: Reward Phase Activity Modulated by Reward Delivery or 
// Omission w/in Behavioral Risk Condition
// Huettel S A, 2006: Reward Phase Activity Modulated by Reward Delivery or 
// Omission w/in Reward Risk Condition
// Subjects=11
-42	46	25
-25	11	4
0	7	46
0	7	46
25	7	7
53	4	7
-49	0	7
-21	0	11
-60	0	39
-46	-4	35
-28	-11	7
-35	-21	60
-53	-28	21
-53	-28	53
-39	-39	53
-56	-42	-21
35	-63	-21
-25	-67	53
-32	-67	-18
7	-70	53
0	-77	-21
0	-77	-21
28	60	7
-39	53	4
-4	28	39
4	28	39
42	28	39
39	21	0
-35	18	0
32	14	60
-21	14	63
18	0	4
14	-25	18
0	-28	32
0	-28	32
49	-56	46
-35	-63	46
-35	-70	-32
11	-77	49
-43	41	-7
-51	22	-15
1	7	-8
-1	7	-8
58	2	-5
62	-18	11
-63	-30	-11
-33	-38	70
7	-43	44
-7	-43	44
22	-61	-22
-48	-74	35
44	-83	-15
-33	-96	-14
11	-106	0
-6	57	1
6	57	1
21	38	49
-25	28	51
45	-41	-16
-8	-55	30
36	-89	-12
23	-101	-3

// Yoshida W, 2006: Goal-Search Task - Visuomotor Task, Activations
// Yoshida W, 2006: Correlation between Evoked Activity and Back-Track 
// Probability
// Yoshida W, 2006: Correlation between Evoked Activity and Expected Hidden 
// Current Position Entropy
// Subjects=13
34	55	5
40	52	-3
2	30	32
34	-51	55
32	-61	46
13	-46	55
3	-12	-10
16	-4	-6
2	31	33
26	-60	53
-24	-52	47
18	65	10
-8	42	29
-12	38	-7

// van Leijenhorst L, 2006: Healthy Young Adults
// Subjects=14
22	50	-14
8	14	56
34	28	0
42	30	18
-30	-2	38
-42	4	32
0	6	20
28	-74	34
26	-64	46
-22	-68	44
-20	-74	34
48	-40	52
-14	-104	6
-24	-86	8
-26	-84	-10
22	-98	2
16	58	20
-36	-28	16
-66	-32	28
58	-24	24
58	-64	8
-58	-68	8
-52	-72	32
12	46	-10
-24	-24	58
-46	-80	34
-34	20	-6
36	24	-10
48	24	36
-46	18	30
36	12	58
44	6	40
12	26	60
64	-46	-12
46	-56	48
-50	-46	48
-44	-58	50
4	50	-10
-4	50	-16
20	38	18
-20	12	-20
-34	-42	22
-22	6	68
-22	18	50
22	28	36
-12	22	4
48	-18	44
66	-4	26
54	-18	54
-26	-46	56
62	0	-8
68	-18	0
20	-8	-24
-12	-60	14
-48	-76	10
-60	-30	14
-22	0	-12
-44	-36	-24
-40	-84	36
-20	-90	40

// van Leijenhorst L, 2006: Healthy Children
// Subjects=12
2	14	44
-8	62	36
28	-34	12
6	-14	34
8	14	36
-2	8	24
18	-94	32
-2	-90	34
-44	-68	34
40	22	-12
-2	46	42
8	46	44
40	46	-12
-20	-2	38
-6	20	8
12	-40	44
-66	-26	32
-10	-82	20

// Yokoyama S, 2006: Passive vs. Active
// Yokoyama S, 2006: Passive vs. Nouns
// Subjects=28
-42	38	-4
-40	28	-2
-40	30	-12
-48	4	44
-10	-94	-2
-58	-38	4
-62	-28	0
-52	-2	40

// Feinstein J S, 2006: Action Selection: Uncertain > Certain
// Feinstein J S, 2006: Action Selection > Outcome
// Subjects=16
-46.91	37.03	23.48
45.01	36.69	24.68
35.3	18.18	6.27
-33.07	15.74	8.37

// Nakic M, 2006: High Negative > Neutral Words
// Nakic M, 2006: Low Frequency > High Frequency Words
// Nakic M, 2006: High Frequency Neutral Words > Low-Frequency Neutral Words
// Subjects=13
-60.92	-11.52	-11.32
-46.58	-66.05	25.43
49.02	-5.54	-26.47
11.63	45.99	-3.6
-1.74	-64.01	20.28
-32.1	30.12	1.58
28.77	28.91	-5.71
-7.07	0.83	47.24
47.56	-22.74	54.17
42.14	-34.54	39.61
41.27	-46.75	60.72
-44.33	-48.38	47.34

// Bedny M, 2006: Words (Nouns + Verbs) > Non-words
// Bedny M, 2006: Non-words > Words (Nouns + Verbs)
// Bedny M, 2006: Verbs > Nouns
// Bedny M, 2006: Positive Correlation between Imageability Ratings and Words 
// (Nouns + Verbs) Activations
// Bedny M, 2006: Negative Correlation between Imageability Ratings and Words 
// (Nouns + Verbs) Activations
// Bedny M, 2006: Interaction between Imageability and Grammatical Class
// Subjects=13
-57	-48	0
-48	33	3
3	21	54
27	-66	9
-15	-90	0
39	15	0
-60	-30	36
-39	33	39
9	-54	42
-60	-24	-24
-60	-30	39
33	-12	9
15	30	57
45	-66	48
-45	-66	-9
-24	-3	-24
-54	-6	6
-9	-36	21
-27	-78	39
-21	18	54
45	-69	24
-30	-99	-3
15	-90	-3
-54	15	-6
-60	-51	0

// Marangolo P, 2006: Noun-from-Verb Derivation > Verb Repetition
// Marangolo P, 2006: Noun-from-Adjective Derivation > Adjective Repetition
// Marangolo P, 2006: Verb-from-Noun Generation > Noun Repetition
// Marangolo P, 2006: Verb Inflection > Verb Repetition
// Marangolo P, 2006: Adjective Inflection > Adjective Repetition
// Marangolo P, 2006: Noun Inflection > Noun Repetition
// Marangolo P, 2006: Noun-from-Verb Derivation > Verb Inflection
// Marangolo P, 2006: Noun-from-Adjective Derivation > Adjective Inflection
// Marangolo P, 2006: Verb Inflection > Verb Derivation
// Marangolo P, 2006: Adjective Inflection > Adjective Derivation
// Marangolo P, 2006: Noun Inflection > Verb-from-Noun Generation
// Subjects=10
-53	28	24
-59	13	21
-44	55	3
-50	13	30
-32	22	3
-41	-48	42
-38	-63	39
-35	-69	54
-29	-63	51
66	22	18
50	13	24
41	34	18
35	-72	45
35	-72	51
20	4	24
-44	28	-1
-53	13	18
-35	25	-1
-38	10	36
-38	-54	51
-26	-69	54
-35	-63	39
-32	-60	45
35	-57	48
32	-54	45
-5	13	60
-59	-39	3
-56	-33	3
20	4	24
-20	7	3
-53	28	30
-53	16	21
-41	10	30
-50	43	6
-53	4	18
-59	13	21
-44	55	3
-35	10	36
-50	-3	48
-44	-42	48
-29	-69	51
-38	-72	45
-11	-18	69
-11	-9	78
-47	-57	-13
47	-6	57
-5	-27	57
-38	-72	24
-53	-69	27
32	-84	15
26	-96	15
-38	19	-1
8	25	27
2	7	42
52	4	-12
-41	34	3
-56	19	33
-50	10	30
-47	37	21
-32	-57	39
-32	-66	48
56	19	24
47	19	27
20	4	18
-47	31	21
-47	10	18
-38	4	30
-38	13	36
-44	43	18
-38	-54	54
-35	-63	39
-32	-63	45
38	-54	48
-5	13	60
-44	-72	24
-50	-72	26
-2	-2	42
-38	-72	20
-46	-74	20
2	10	42

// Stringaris A K, 2006: Literal Followed by Irrelevant (IRL) > Metaphoric 
// Followed by Irrelevant (IRM)
// Stringaris A K, 2006: Metaphoric Followed by Irrelevant (IRM) > Literal 
// Followed by Irrelevant (IRL)
// Stringaris A K, 2006: Literal Followed by Relevant (RL) > Metaphoric 
// Followed by Relevant (RM)
// Stringaris A K, 2006: Metaphoric Followed by Relevant (RM) > Literal 
// Followed by Relevant (RL)
// Subjects=12
-25.2	-80.18	19.67
24.75	-21.18	7.46
51.48	-61.52	-7.31
32.56	-70.44	30.46
-32.59	-55.08	42.19
-10.1	-57.69	47.72
1.62	-33.84	52.28
-29.4	-26.63	52.03
-29.96	-52.26	-31.68
-10.55	-74.46	-17.78
39.39	28.29	-14.7
-32.56	-50.42	47.37
55.35	-5.22	-36.61
44.03	-70.02	-6.51
31.95	28.68	-9.07
-53.16	-8.56	26.26
-2.87	-52.61	-38.65
-32.88	-77.88	-4.96
46.85	32.57	-15.14
-41.38	8.31	36.97

// Uchiyama H, 2006: Reading S1 > Baseline
// Uchiyama H, 2006: Sarcasm Detection: Sarcastic plus Non-Sarcastic Responses 
// minus Unconnected
// Subjects=20
-2	2	70
8	16	46
-6	18	38
2	-36	28
-46	0	48
34	8	58
-60	-12	40
-58	-14	14
-46	-18	44
46	40	32
38	48	22
-34	30	-24
26	36	-20
-42	6	30
-56	28	14
-58	0	-16
-54	-8	-20
-54	-38	0
58	12	-14
-16	-74	24
-38	-84	-6
28	-98	-12
40	-82	-4
-14	-94	-12
10	-94	-4
-40	-66	-30
36	-70	-26
0	-54	-38
-10	-28	-6
22	-28	-2
-22	-6	-2
20	-10	-2
12	-6	10
-10	-16	8
26	-2	-18
-34	-10	-20
-6	16	58
-6	44	42
-8	60	28
-60	22	12
-56	24	-6
-46	18	-10
-52	8	-30
-56	-10	-12
-56	-28	-2
28	-82	-34

// Aziz-Zadeh L, 2006: Metaphorical Phrases > Literal Phrases
// Aziz-Zadeh L, 2006: Observation > Rest
// Aziz-Zadeh L, 2006: Reading > Rest
// Aziz-Zadeh L, 2006: Observe Foot > Rest
// Aziz-Zadeh L, 2006: Observe Hand > Rest
// Aziz-Zadeh L, 2006: Observe Mouth > Rest
// Subjects=12
-48	18	-16
44	-82	16
6	-92	-2
-42	-58	-16
44	-52	-18
-34	-44	46
28	-56	48
-54	-32	30
52	0	48
54	4	28
-52	4	30
-36	-90	-8
28	-96	6
-40	6	32
-44	20	18
-54	32	-6
28	22	18
-26	-30	-8
6	-92	-4
-54	-32	30
-40	6	28
50	12	26
26	-90	16
-30	-6	46
54	2	38
-58	0	28
26	-84	18
-20	-30	-4
60	2	42
-54	4	26
-34	0	-34
-32	-56	-58

// Lee S S, 2006: Literal > Rest
// Lee S S, 2006: Nonliteral > Rest
// Lee S S, 2006: Nonliteral > Literal
// Subjects=12
-65.08	-20.21	0.6
-62.87	-30.42	5.9
-58.59	-21.6	9.57
-48.04	14.42	6.43
-52.14	-43.05	6.83
-43.98	25.42	-16.85
-48.2	19.39	-11.83
24.65	-52.93	-17.76
-3.11	-48.53	-13.34
-7.24	-77.82	-6.38
56.81	-18.79	8.01
50.41	-23.06	8.44
54.55	-20	-7.48
58.79	-5	-6.55
58.74	3.29	-9.48
-54.15	6.55	42.84
-56.43	11.68	26.83
-56.29	-2.27	39.15
-4.92	9.81	53.16
41.62	13.93	-7.94
48.03	24.88	-4.48
-62.89	-28.48	3.5
-60.7	-34.47	8.44
-50.04	-21.55	9.47
-43.77	-27.28	-10.2
58.84	-8.89	-1.77
44.02	-27.33	8.87
48.17	-21.98	-5.01
61.15	-31.28	11.24
-43.46	0.1	41.03
-54.33	22.27	25.91
-56.43	22.6	30.37
7.98	-92.59	21.45
-7.01	-81.93	22.96
-5.6	86.24	-4.54
7.17	94.6	-7.62
-43.51	36.9	49.1
-56.19	-34.16	39.59
-50.32	19.55	-9.59
-37.56	23.34	-16.75
-2.85	17.94	47.99
-52.2	24.39	25.71
-47.44	-58.46	54.91
-63.06	-8.19	-9.35

// Henderson L A, 2006: Superficial Pain vs Deep Pain
// Subjects=19
5	50	-4
6	-20	60
-6	-41	52
38	11	4

// Kounios J, 2006: Insight preparation> Noninsight preparation
// Kounios J, 2006: Noninsight preparation > Insight preparation
// Subjects=20
-50.91	-63.42	18.56
-3.29	45.18	1.1
-1.68	-45.81	35.48
56.97	-63.29	10.62
-25.68	-7.16	-13.21
-65.1	-33.58	-7.2
-30.58	-102.48	7.11

// Mackiewicz K L, 2006: Anticipation and Picture Periods: Aversive > Neutral
// Mackiewicz K L, 2006: Regression of delayed aversive memory (d') on 
// aversive-neutral contrast for picture period
// Mackiewicz K L, 2006: Regression of delayed aversive memory (Pr) on 
// aversive-neutral contrast for picture period
// Subjects=30
21.32	-2.65	-14.13
-19.29	-2.9	-13.64
31	-22.86	-14.77
-29.9	-23.05	-11.83
24.48	-6.41	-21.65
-21.5	-2.62	-23.67
23.41	-6.41	-21.64
-22.57	-2.63	-23.66

// Sergerie K, 2006: Encoding: Fearful Remembered vs. Forgotten
// Sergerie K, 2006: Encoding: Neutral Remembered > Forgotten
// Sergerie K, 2006: Encoding: Fearful Remembered > Neutral Remembered
// Sergerie K, 2006: Recognition: Fearful Remembered > Forgotten
// Sergerie K, 2006: Recognition: Neutral Remembered > Forgotten
// Sergerie K, 2006: Recognition: Fearful Remembered > Neutral Remembered
// Subjects=18
-34	-54	42
38	-56	50
34	-62	36
30	2	-34
-38	-90	0
-42	-76	-12
-36	-54	-18
-44	-56	-16
-14	14	-10
-14	-18	-14
36	-56	48
28	-92	10
46	-82	-6
48	-66	4
-32	34	10
-36	38	4
30	0	-34
42	-4	34
-4	-50	12
-38	-78	42
-38	-58	-20
-50	-58	-18
-38	-80	-16
-24	-8	-20
14	38	4
20	-44	28
20	-66	50
48	-38	32
56	-38	0
16	-48	-12
8	-4	10
20	-10	-14
-12	52	24
-36	14	24
-10	46	-14
-4	42	-10
-42	32	8
-22	-76	46
-64	-16	0
-48	12	-30
-28	-48	-18
-14	6	-8
42	46	-6
2	38	14
14	-68	10
36	-64	48
26	-16	-4
-40	8	-30
-20	-4	-12
-14	-8	-24
-16	-34	10

// Wagner G, 2006: Planning > CC1
// Wagner G, 2006: Planning > CC2
// Subjects=17
23.27	14.92	46.21
-24.24	10.61	48.56
3.67	30.19	38.31
10.68	-51.19	63.05
-6.62	-56.88	60.55
45.03	-37.43	47.66
-34.75	-44.11	60.88
55.15	41.7	9.4
-37.96	54.16	-1.45
33.2	24.89	-19.94
-9.18	-86.15	23.14
-22.1	8.28	46.52
8.05	31.68	42.57
36.53	-61.61	53.55
-34.77	-46.45	58.87
8.46	-59.37	56.05
-8.81	-57.1	58.36
-48.51	43.98	16.54
-44.37	50.3	3.52
35.32	30.01	-22.72
23.01	-19.79	19.39

// Kennedy D P, 2006: Autism (ASD)
// Subjects=12
-42.12	-37.74	60.92
-53.17	11.16	33.52
12.02	-93.9	-9.71
-30.71	-88.53	-5.21
28.87	-47.96	-22.68
-43.79	5.47	0.44
-4.11	-11.5	11.44
8.75	-10.02	15.63
17.73	-84.56	41.85
42.07	-74.75	15.1
47.51	-2.3	56.92
-34.58	-35.95	69.6
59.27	-19.75	50.44
12.42	-80.99	47.19
55.09	-45.16	52.62
-51.76	-30.39	60.41
59.27	-19.75	50.44
3.78	-41.32	51.77
46.58	-36.06	60.87
-59.46	-27.21	33.47
21.88	-6.69	57.58
-4.49	41.6	-17.54
16.93	21.38	-19.44
42.07	-73.69	15.01

// Kennedy D P, 2006: Healthy Controls
// Subjects=14
-46.41	-32.48	60.52
43.39	-50.17	57.63
54.78	8.72	33.6
-30.77	-85.79	-11.02
50.4	-80.27	-15.76
34.31	-64.59	-18
-.88	-9.11	14.55
34.23	19.23	6.19
0.34	-49.28	17.9
2.86	-36.44	73.67
-.17	55.35	-5.36
-0.07	13.51	-9.66
-42.22	-73.97	32.73
54.92	-64.56	21.9
58.86	-3.17	3.33
54.4	-.68	-19.13
-1.29	54.74	-13.1
-18.42	6.06	-35.59
38.3	12.71	-23.42
55.09	-45.24	51.51
59.27	-19.75	50.44
3.78	-41.32	51.77
46.58	-36.06	60.87
-59.46	-27.21	33.47
21.88	-6.69	57.58
-4.49	41.6	-17.54
16.93	21.38	-19.44
42.07	-73.69	15.01

// Schmitz N, 2006: Autism Group
// Subjects=10
-29.34	48.56	-4.41
37.87	43.87	10.6
-2.85	-6.29	27.46
3.15	42.71	0.1
-54.73	-52.59	17.24
-50.23	-46.87	32.28
-.58	16.45	40.86
3.47	27.56	21.76
-61.67	7.41	-6.51
59.25	13.8	-13.68
-26.3	-67.43	40.63
21.41	-60.49	54.82
-37.96	20.26	-8.19
54.8	39.11	-18.35
55.76	-25.9	44.09
36.37	-32.14	47.28
44.99	-19.14	48.09
36.49	-33.44	56.37
35.62	6.04	-3.55
-39.33	-13.26	46.7
-41.44	-26.03	48
-2.83	-6.08	29.68
-5.13	10.31	21.38
-2.84	4.77	30.85
-29.35	52.82	-4.83
-31.66	45.18	-17.48
-42.2	-7.62	-7.6
38.48	-19.37	45.98
-2.48	-29.73	52.19

// Schmitz N, 2006: Healthy Controls
// Subjects=12
-7.13	-91.34	13.54
-11.6	-96.85	0.71
-17.98	-96.04	9.71
5.97	-37.75	34.91
-43.55	-54.11	46.33
-50.09	-47.96	43.59
55.79	-40.99	43.34
60.03	-48.19	35.02
53.56	-52.47	35.55
42.7	14.89	44.76
44.58	21.54	23.9
40.68	-43.17	43.82
53.55	-28.45	39.9
9.71	1.7	-2.68
-1.11	5.91	-2.91
-5.5	1.02	-9.08
-26.77	-11.87	14.97
-18.17	-1.2	13.77
-27.06	3.49	-4.47
-24.87	-5.02	-3.67
57.5	-64.08	3.02
48.91	-70.28	6.02
-50.24	-22.85	36.63
-2.64	12.81	47.98
3.84	6.24	46.28
-29.35	52.82	-4.83
-31.66	45.18	-17.48
-42.2	-7.62	-7.6
38.48	-19.37	45.98
-2.48	-29.73	52.19

// Gomot M, 2006: Deviant > Standard, Activations common to both groups
// Gomot M, 2006: Novel > Standard, Activations common to both groups
// Gomot M, 2006: Deviant > Standard, Typically Developing Controls > 
// High-Functioning Autism (HFA) Patients
// Gomot M, 2006: Novel > Standard, Typically Developing Controls > HFA 
// Patients
// Subjects=12
62.63	-22.35	-10.17
52.05	-32.73	5.61
67.36	-32.39	19.88
-66.83	-22.52	6.62
-50.88	-16.68	-12.15
-48.02	-34.43	38.86
4.77	-25.51	28.11
7.69	-11.51	5.39
20.69	-2.44	9.87
6.26	-57.46	53.66
62.72	19.94	5.82
42.89	-66.88	42.76
20.27	1.03	-21.84
37.76	-69.62	-20.75
-29.02	-93.49	-8.29
-54.07	37.3	2.73
62.62	-20.22	-10.38
46.71	-35.53	10.46
71.72	-36.43	22.45
-66.82	-26.77	7.04
-39.61	-37.23	19.94
-52.51	-32.4	26.41
-60.74	11.8	-17.05
3.65	-23.59	25.7
48.44	36.72	-9.04
62.72	19.94	5.82
58.12	14.55	-17.1
12.82	12.78	-10.55
9.86	-15.76	5.77
-11.36	18.74	43.06
45.1	-40.2	52.41
-54.1	37.09	0.51
-11.32	36.59	50.26
-12.76	24	19.03
-27.41	53.39	-21.73
-32.6	27.62	-10.13
-44.97	-41.3	22.68
7.5	-52.3	-17.47
46.76	-39.57	13.1
30.88	33.52	-30.84
-14.92	21.87	19.28
22.69	56.58	9.6

// Wang A T, 2006: Autism Spectrum Disorders (ASD) Group
// Subjects=18
-38.93	-25.83	63.23
-30.4	-8.35	68.35
-54.49	20.55	3.76
-58.74	27.39	9.92
50.19	22.95	-2.11
37.27	26.25	-13.39
48.28	-20.79	10.5
-58.59	-26	7.71
61.12	-29.34	8.84
-62.85	-34.65	6.25
61.03	-19.28	1.31
-52.22	-28.59	1.16
61.07	-29.85	2.2
-69.31	-37.32	-.14
65.35	-34.23	0.28
-46.2	4.83	-35.17
43.6	1.31	-33.67
-46.2	11.35	-33.48
47.9	12.6	-25.75
-41.12	-15.44	60.15
43.8	25.37	2.22
-49.98	-25.26	16.47
-50.08	-30.69	1.31
43.74	-3.83	-17.63
47.87	1.34	-33.72
-7.48	62.56	19.77
-43.23	-19.51	62.75
54.52	21.38	4.67
-56.62	27.23	7.68
52.31	27.2	-2.49
-50.36	25.72	-12.34
47.93	41.46	-10.33
-49.99	-27.55	14.43
48.28	-20.79	10.5
-60.72	-23.72	9.77
46.11	-21.14	6.1
-67.12	-36.79	6.48
54.62	-19.32	1.39
-56.49	-26.33	3.25
54.64	-27.95	-.12
-58.58	-43.43	2.48
60.93	-24.71	-13.85
-67.02	-55.48	12.51
-61.04	-2.86	-23.2
-41.12	-19.84	58.29
-56.61	23	8.04
52.29	27.02	-4.7
47.93	41.46	-10.33
-36.9	-20.33	51.59
-49.69	-20.06	56.18
-60.91	16.11	1.97
-58.77	29.33	7.53
43.84	23.6	6.83
-50.36	25.72	-12.34
47.93	32.66	-14.05
46.15	-20.8	10.53
-62.92	-13.33	6.69
48.23	-14.78	5.54
-62.99	-11.9	-2.35
61.03	-19.28	1.31
-56.42	-40.96	6.71
63.2	-27.73	1.99
-65.16	-21.06	-10.47
52.39	-11.56	-8.16
-56.77	-7.24	-25.11
43.6	1.31	-33.67
-52.57	7.42	-28.62
47.9	12.6	-25.75
-2.89	24.12	45.24
-30.41	-8.52	66.14
-51.84	-20.25	53.99
43.84	23.6	6.83
-45.84	-20.09	0.37
-47.92	-32.62	3.68
-46.05	-6.83	-20.81
-4.93	22.85	56.52
-47.5	-23.94	60.94
-54.49	18.44	3.93
-39.48	19.04	10.4
-48.17	26.25	-5.72
35.15	26.41	-11.15
52.57	-22.87	10.63
-65.01	-19.52	9.47
65.36	-23.14	6.04
-65.1	-20.38	-1.61
54.6	-19.49	-.83
-60.81	-26.87	-3.35
-69.32	-33.09	-.5
54.55	-17.89	-7.65
41.43	0.96	-38.08
-48.31	11.68	-29.03
47.93	4.14	-25.04
-50.01	-38.81	6.45
39.31	1.11	-35.84
35.02	9.72	-34.28
47.92	3.97	-27.25
41.63	29.42	-.32
-58.33	-14.45	46.88
-65.13	-5.4	-.64
56.71	-11.02	-1.56
-67.26	-22.85	-5.84
50.2	-7.68	-12.92
-48.26	7.79	-24.24
52.25	11.19	-16.76

// Wang A T, 2006: Typically Developing (TD) Group
// Subjects=18
-5.45	68.06	8.13
-9.52	56.89	29.19
-5.02	26.39	47.31
-2.78	14.23	54.99
41.9	-24.88	13.15
-52.14	-32.13	10.38
52.48	-12.81	3.1
-62.88	-28.31	5.72
65.29	-15.02	0.9
-65.06	-24.44	0.96
56.85	-38.17	5.17
-65.06	-30.95	-.72
52.34	-12.07	-14.81
-50.45	-1.54	-34.58
-50.43	11.84	-26.79
52.25	11.19	-16.76
-41.12	-15.44	60.15
43.8	25.37	2.22
-49.98	-25.26	16.47
-50.08	-30.69	1.31
43.74	-3.83	-17.63
47.87	1.34	-33.72
-.98	56.94	29.09
1.06	60.32	17.63
-7	17	63.73
50.41	-23.06	8.44
56.8	-21.08	5.97
-60.78	-22.12	2.95
54.6	-12.97	0.85
-60.72	-32.53	6.05
-67.22	-29.02	-3.09
54.45	-10.11	-17.23
-50.45	-1.54	-34.58
-50.43	11.84	-26.79
-41.12	-19.84	58.29
-56.61	23	8.04
52.29	27.02	-4.7
47.93	41.46	-10.33
-.73	26.59	49.47
-15.93	54.73	29.44
-5.45	68.06	8.13
-.66	14.07	52.75
3.48	25.93	40.56
-45.41	-17.75	58.16
-52.26	21.59	17.03
-56.71	15.28	-9.16
-47.85	-31.94	12.54
52.48	-12.81	3.1
-65.09	-18.09	0.43
50.38	-23.4	4.01
-62.8	-45.06	9.35
63.09	-6.92	-4.21
-56.73	1.91	-16.96
60.93	-9.39	-8.44
-50.4	1.09	-28.11
-41.94	11.2	-35.75
50.1	11.01	-18.95
-2.89	24.12	45.24
-30.41	-8.52	66.14
-51.84	-20.25	53.99
43.84	23.6	6.83
-45.84	-20.09	0.37
-47.92	-32.62	3.68
-46.05	-6.83	-20.81
-9.3	37.28	50.9
-4.9	23.19	60.96
3.46	27.87	38.16
-43.69	21.82	19.14
56.62	27.56	1.89
-56.77	34.49	-8.54
54.44	20.52	-6.41
46.18	-29.26	11.24
-45.73	-32.09	10.3
48.23	-16.9	5.72
-58.65	-20	2.74
54.57	-11.03	-1.54
-65.07	-26.72	-1.08
56.87	-40.11	7.56
-56.58	-25.07	-8.01
52.34	-12.07	-14.81
-48.33	-1.7	-36.83
43.56	2.03	-38.19
-50.43	11.84	-26.79
47.91	10.48	-25.57
-50.01	-38.81	6.45
39.31	1.11	-35.84
35.02	9.72	-34.28

// Williams J H, 2006: ASD
// Subjects=16
41.8	-53.46	-12.33
27.02	-87.84	-1.47
50.86	-31.55	63.79
31.24	-68.61	-.9
54.83	-63.3	10.65
-55.01	-54.96	45.78
47.96	3.34	-21.63
22.37	-19.28	-22.78
22.52	30.59	16.53
-20.47	-1.9	-28.21
-41.74	-1	-14.66
-19.68	-16.74	68.94
-28.74	9.76	13.29
-30.57	13.98	54.22
-45.57	-79.85	12.07
66.65	-14.22	38.74
18.74	-3.91	66.3
-28.68	36.77	32.21
-46.01	45.18	4.94
20.81	-53.96	38.14
-55.01	-54.96	45.78
-7.63	37.95	-9.39
31.19	35.18	33.89
39.81	12.94	34.54
-22.03	10.68	52.16
-19.68	-16.74	68.94
-37.01	0.48	45.39
-45.5	-8.83	49.61
-28.29	-48.2	48.25

// Williams J H, 2006: Controls
// Subjects=15
41.8	-53.46	-12.33
27.02	-87.84	-1.47
50.86	-31.55	63.79
31.24	-68.61	-.9
54.83	-63.3	10.65
-55.01	-54.96	45.78
47.96	3.34	-21.63
22.37	-19.28	-22.78
22.52	30.59	16.53
-20.47	-1.9	-28.21
-41.74	-1	-14.66
-19.68	-16.74	68.94
-28.74	9.76	13.29
-30.57	13.98	54.22
-45.57	-79.85	12.07
64.45	-23.63	27.28
38.02	-31.8	61.73
64.56	-14.86	44.39
20.4	57.07	28.83
40.05	-25.24	50
60.3	-30.12	40.14
-22.27	49.92	36.61
20.81	-53.96	38.14
-55.01	-54.96	45.78
-7.63	37.95	-9.39
31.19	35.18	33.89
39.81	12.94	34.54
-22.03	10.68	52.16
-19.68	-16.74	68.94
-37.01	0.48	45.39
-45.5	-8.83	49.61
-28.29	-48.2	48.25

// Castelli F, 2006: Estimating Numerosity: In space and time
// Castelli F, 2006: Difficulty Effect While Estimating Numerosity: In Space
// Castelli F, 2006: Difficulty Effect While Estimating Numerosity: In Time
// Subjects=12
33	-78	24
24	-90	21
33	-78	15
-21	-90	27
-24	-48	48
-33	-51	54
33	-57	51
-57	-39	45
27	-42	48
21	-51	42
24	-42	42

// Cross E S, 2006: Observing and Simulating Rehearsed Movements > Observing 
// and Simulating Unrehearsed Movements
// Cross E S, 2006: Changes in BOLD Magnitude vs Dance Observation, 
// Uncorrected
// Cross E S, 2006: Simulation of Rehearsed Movements>Simulation of Control 
// Movements, Uncorrected
// Cross E S, 2006: Observation of Rehearsed Movements>Modulated Observation 
// of Control Movement, Uncorrected
// Subjects=10
30	-75	-21
21	-33	-9
-12	-30	24
0	-6	57
-3	6	54
-9	12	42
-36	0	45
-48	12	21
-54	6	33
27	-69	54
-33	-48	66
45	-48	18
66	-15	30
63	-18	39
-36	-36	42
36	24	0
33	-87	21
-18	-99	-3
-30	24	0
-18	12	0
-18	3	0
36	-75	-21
-18	-30	-3
57	-30	36
51	-45	9
57	-36	21
-48	-39	15
-48	-42	9
-42	18	15
-3	15	30
27	-54	33
-6	9	69
-51	9	36
-57	6	12
48	-51	21
-42	18	27
-54	12	33
-12	-87	-12
-9	-27	-18
-12	-96	-6
-9	-48	-3
18	-24	6
-18	-66	21
21	-60	24
-9	-18	33
36	-72	-6
21	0	9
24	-87	15
-6	-66	57
12	-75	-33
-42	-69	-24
30	-81	-24
60	-21	48
-9	-81	45
-51	6	30
-21	-33	-12
-57	-27	36

// Kana R K, 2006: High-Imagery - Fixation, Control > Autism
// Kana R K, 2006: High-Imagery - Fixation, Austism > Control
// Kana R K, 2006: Low-Imagery - Fixation, Control > Autism
// Kana R K, 2006: Low-Imagery - Fixation, Autism > Control
// Subjects=12
-34	20	-18
-42	24	-2
-52	16	2
48	18	2
-46	24	38
-48	12	46
24	46	-2
-8	8	58
14	18	66
-50	-54	28
-44	-74	36
0	28	30
-10	-8	8
-18	-84	-16
-4	28	32
-26	-2	54
44	-8	52
-20	-56	60
30	-48	60
0	-50	18
18	-60	24
-22	-56	22
18	-78	44
-18	-84	-16
20	-88	-10
26	-84	16

// Piazza M, 2006: Estimation > Matching
// Piazza M, 2006: Counting > Matching
// Piazza M, 2006: Counting > Estimation
// Subjects=10
48	42	14
50	8	34
54	14	12
52	-48	50
54	-36	50
50	-56	54
0	24	48
-2	30	42
4	14	54
-54	4	38
-52	-8	46
-60	6	16
32	-10	56
52	4	34
6	-8	66
52	-46	48
46	-50	52
60	-40	32
-40	-36	38
-38	-48	46
46	42	16
42	42	26
42	34	36
8	-8	66
-6	-4	62
-50	-10	48
-36	-10	42
26	-12	58
28	-14	48
40	-12	48

// Ansari D, 2006: Number Change Effect
// Ansari D, 2006: Area Change Effect
// Ansari D, 2006: Common Activation across Number and Area
// Subjects=16
33.78	-39.23	62.4
-26.04	-43.73	64.58
15.66	-58.62	60.89
-15.31	-57.5	64.5
-11.43	-68.18	8.47
26.24	-62.93	45.52
-31.93	19.77	19.18
28.06	-89.24	-5.83

// Ansari D, 2006: Children
// Subjects=9
47.08	31.62	13.93
-51.25	21	9.26
-26.17	-58.22	42.38
-35.82	-46.56	42.63

// Ansari D, 2006: Healthy Controls
// Subjects=9
-32.56	-48.14	49.41
35.85	-46.5	50.72
6.71	31.66	45.61
-.92	27.87	24.83
16.21	23.92	27.2
0.34	-17.42	30.85
-35.16	20.55	15.8
-35.82	-46.56	42.63

// Ansari D, 2006: Main effect of congruity (incongruent > congruent)
// Ansari D, 2006: Main effect of distance (small > large)
// Ansari D, 2006: Interaction of congruity and distance effects
// Ansari D, 2006: Main effect of distance in the neutral condition 
// (small>large)
// Subjects=14
11.22	-32.9	49.86
-20.86	-33.35	46.92
54.98	-36.5	40.74
6.85	-20.75	42.2
10.92	23.34	34
5.44	46.06	25.46
-23.44	46.69	22.4
26.75	51.05	19.22
42.8	34.85	14.82
-27.7	36.89	19.92
-12.44	-36.78	29.27
30.22	-21.98	24.19
22.67	-17.25	17.19
6.56	-6.15	10.87
-5.25	-9.02	2.32
34.19	13.34	-1.12
-32.02	1.31	0.65
34	45.35	-13.84
-22.57	14.97	-16.22
-24.65	-7.5	-17.65
-26.94	23.87	-24.72
31.53	-12.89	59.1
-11.11	-46.1	60.15
38.99	-26.22	51.21
2.49	15.69	45.89
-31.61	-34.01	39.3
13.06	28.81	35.74
31.34	0.46	39.03
21.34	45.93	8.56
-16.04	40.42	9.46
-32.05	15.23	1.71
13.2	8.35	46.38
56.78	0.67	11.95
-23.6	44.97	0.24
-35.74	-45.79	52.6
-11.15	-79.53	40.65
38.93	-42.22	36.94
5.67	14.39	42.61
29.38	-76.8	31.03
-47.84	-16.45	20.17
-16.8	-64.07	7.07

// Cantlon J F, 2006: Healthy Controls
// Subjects=12
43	-47	59
-31	-66	62
32	-70	-14
-34	-47	-19
-27	-72	-7
35	-79	38
-40	-60	60
18	-63	63
-10	-74	62

// Cantlon J F, 2006: Children
// Subjects=8
45	-44	62
18	-53	65
-56	2	62
-21	1	62
0	-14	57
-62	-28	25
46	28	20
-39	-78	4
-41	-88	13
45	-71	-11
17	39	11
15	28	62
37	-38	-1
35	-79	38
-40	-60	60
18	-63	63
-10	-74	62

// Liu X, 2006: All Number Comparison Tasks vs. Baseline
// Liu X, 2006: Incongruent vs. Congruent
// Liu X, 2006: DIstance of 18 vs. Distance of 27
// Subjects=12
-34	-48	44
26	-56	42
-44	-66	-16
44	-82	-10
24	-12	54
-48	4	38
-24	-8	58
28	-58	-30
2	-48	-34
-20	6	10
-16	-10	2
22	-12	18
8	-20	-14
44	34	22
-32	40	12
36	48	4
-40	-4	32
-44	30	20
48	12	8
12	20	30
12	6	54
40	-4	48
-22	-6	54
34	22	4
-24	-56	38
30	-58	44
-26	-86	2
34	-82	10
-28	-76	28
30	54	20
56	18	-4
12	14	38
-48	12	0
48	-54	38
8	-12	4

// Wiese H, 2006: Traumatic Brain Injury Patients
// Subjects=18
-37.18	-7.83	47.25
-43.58	-2.87	54.71
-21.89	-2.17	61
-.39	8.02	54.02
-4.98	11.45	33.59
14.53	12.04	38.8
10.09	16.61	30.58
-41.57	-25.9	37.91
-28.53	-20.88	45.03
49.14	-22.6	33.79
65.22	-12.53	25.8
-60.04	-21.27	31.04
-48.09	-25.07	35.69
59.06	-26.53	48.58
-46.4	-2.34	3.16
-31.32	3.89	0.05
33.54	4.43	2.25
-37.75	-23.04	-.54
-18.16	-17.57	10.91
25.03	-19.75	8.15
-20.42	-3	6.14
-60.11	12.11	32.22
55.11	13.01	1.03
64.77	14.76	-3.79
38.56	8.57	57.78
40.55	10.63	45.22
51.31	16.84	42.18
-62.39	13.4	23.16
54.99	16.43	-8.27
-9.21	14.29	41.22
-.49	8.35	46.14
12.28	11.3	31.07
-36.85	-32.76	67.64
56.73	-23.43	35.99
67.57	-20.95	38.92
-57.88	-21.27	31
-24.01	-33.65	57.42
59.07	-28.66	48.79
-35.73	25.14	-1.98
40	21.78	3.78
60.84	-34.86	16.88
53.12	-41.55	3.1
-29.2	16.76	-.14
37.87	8.9	3.97

// Wiese H, 2006: Healthy Controls
// Subjects=18
-41.3	-10.75	62.17
-34.85	-2.22	61.22
58.39	11.1	3.41
-24.21	-7.79	47.02
34.23	-.26	55.37
-11.02	7.1	67.74
1.59	14.33	41.03
12.69	8.89	62.67
-4.86	12.39	43.58
7.76	35.02	20.95
-58.09	-21.76	14.24
-52.2	-18.11	53
63.02	-28.15	19.54
69.66	-18.17	34.12
-60.07	-21.48	28.82
-48.47	-.56	10.86
56.62	-34.14	24.72
-39.97	-9.32	-2.98
42.19	2.33	2.31
-13.85	-22.02	9.03
-39.16	-2.13	62.41
-55.8	6.6	30.45
-52.61	0.78	25.37
55.16	8.96	3.67
47.13	8.08	52.08
46.5	24.14	5.68
-2.71	18.88	44.02
12.69	11.13	63.57
-11.42	11.74	37.03
-49.96	-14.18	60.42
67.51	-20.3	34.37
63.31	-22.68	43.64
-30.51	-36.01	55.53
30.18	-55.17	65.35
-42.13	19.15	3.2
-35.8	25.69	-7.64
46.34	1.1	-11.09
-53.03	7.44	-6.66
58.78	-40.73	23.1
-13.93	-20.41	3.27
-20.31	-13.12	12.75
-28.5	24.18	56.26
-39.38	25.75	50.69
7.49	20.94	-3.42

// Wiese H, 2006: Subgroup of Traumatic Brain Injury Patients, Right-Lesioned
// Subjects=9
7.49	20.94	-3.42

// Wiese H, 2006: Subgroup of raumatic Brain Injury Patients, Left-Lesioned
// Subjects=9
-28.5	24.18	56.26
-39.38	25.75	50.69

// Jatzko Alexander, 2006: PTSD >control, film - baseline
// Jatzko Alexander, 2006: Control >PTSD, film - baseline
// Subjects=10
33	-15	51
21	57	18
48	-51	3
-36	-33	-24
36	15	-27
-36	9	-24

// Williams L M, 2006: PTSD
// Subjects=13
-42	-56	62
38	-42	36
-56	-30	-26
44	-60	-14
-50	-36	-2
38	-60	0
-14	-62	60
24	-76	30
-6	-70	44
24	-56	54
-46	-34	6
48	-20	50
52	-8	52
-8	-76	12
-28	-90	22
24	-76	30

// Williams L M, 2006: Healthy Control
// Subjects=13
-46	8	46
40	14	30
-44	-38	-26
40	-78	42
-6	-70	44
24	-56	54
-46	-34	6
48	-20	50
52	-8	52
-8	-76	12
-28	-90	22
24	-76	30

// Kobayashi C, 2006: ToM > non ToM (monolingual)
// Kobayashi C, 2006: ToM versus non-ToM bilingual L1 (Japanese)
// Kobayashi C, 2006: ToM versus non-ToM bilingual L2 (English)
// Kobayashi C, 2006: Conjunction among three groups
// Kobayashi C, 2006: Conjunction between American and Japanese L1 (Japanese)
// Kobayashi C, 2006: Conjunction between American and Japanese L2 (English)
// Kobayashi C, 2006: Conjunction between Japanese L1 and L2
// Kobayashi C, 2006: Monolingual (English) minus bilingual L1(Japanese)
// Kobayashi C, 2006: Bilingual L1 (Japanese) minus monolingual (English)
// Kobayashi C, 2006: Monolingual (English) minus Bilingual L2 (English)
// Kobayashi C, 2006: Bilingual L2 (English) minus monolingual (English)
// Kobayashi C, 2006: Bilingual L1(Japanese) minus L2 (English)
// Kobayashi C, 2006: Bilingual L2 (English) minus L1 (Japanese)
// Subjects=32
42	5	55
50	-42	19
32	34	32
26	-61	18
18	30	24
-22	30	22
20	24	23
34	25	26
16	44	20
8	21	-4
2	-52	-26
18	44	16
16	28	23
22	40	20
18	28	24
34	28	24
-40	-14	-1
-12	-60	44
60	-44	20
-53	-40	21
-12	-54	41
32	-55	23
18	30	24
-48	-30	27
-40	-16	-1
-40	2	9
24	40	18
34	28	24
18	18	24
10	25	-3
18	42	20
18	27	26
57	-44	21
-34	6	13
-40	-16	-3
36	-7	8
53	-17	-23
14	-42	-25
51	-32	24
-48	-32	16
16	42	31
24	14	-23
12	-5	43
34	-5	11
14	-42	11
-22	-44	42
50	40	24
-44	44	20
16	40	38
-46	-7	-27
42	18	-36
12	13	-16
10	21	-3
2	-52	-28
53	34	-4
-6	11	-11
24	53	-1
-26	23	23
36	24	28
-59	-21	43
-8	3	16

// Astur R S, 2006: Controls > Patients
// Subjects=12
-65.82	-9.85	4.23
32.97	12.18	-41.09
29.78	2.7	-38.98
26.7	-11.37	-28.57
-66.05	-15.98	-15.33
36.16	-1.3	-47.66
-27.66	26.78	38.06
-56.41	34.87	-11.56
-14.77	54.69	37.32

// Liu L, 2006: Pinyin-naming (tone-change) > control
// Liu L, 2006: Pinyin-naming (vowel-change) > control
// Liu L, 2006: Character-naming (tone-change) > control
// Liu L, 2006: Character-naming (vowel-change) > control
// Liu L, 2006: Pinyin-naming (tone-change) > pinyin-naming (vowel-change)
// Liu L, 2006: Pinyin-naming (vowel-change) > pinyin-naming (tone-change)
// Liu L, 2006: Character-naming (tone-change) > character-naming 
// (vowel-change)
// Liu L, 2006: Character-naming (vowel-change) > character-naming 
// (tone-change)
// Subjects=10
-61.41	11.61	15.48
42.31	5.39	12.09
25.26	-62.95	16.9
-24.88	-24.78	-8.43
3.81	14.75	45.44
-43.83	-49.6	25.72
10.11	9.07	30.2
-48.57	-50.6	-7.72
-46.09	-21.95	23.02
29.11	-20.44	-10.9
40.22	1.55	16.99
-33.09	11.25	32.96
7.86	23.74	26.55
29.42	-88.2	-.84
-37.21	-9.21	44.02
16.87	-54.52	38.62
8.22	4.55	50.85
42.4	10.48	20.55
19.08	-60.68	41.43
29.49	-85.45	5.61
33.33	-19.03	-18.96
-35.51	4.91	11.22
-45.74	-54.32	44.15
9.84	35.47	14.15
8.01	-36.44	25.78
-40	42.97	5.29
42.5	6.85	27.63
-37.87	-25.04	-10.43
29.39	-88.41	-3.06
-39.45	-49.17	30.09
35.75	-34.58	-1.77
12.21	23.96	28.69
-65.71	7.35	15.98
-46.37	-67.82	-8.29
-13.84	33.88	21.43
45.35	26.91	0.94
9.96	-45.65	7.6
-11.51	8.89	29.47
-48.81	60.3	-4.12
-58.12	-44.93	7.57
-52.61	-63.84	11.59
50.6	29.08	-10.57
-24.8	-34.04	-4.16
-54.72	2.25	29.74
-43.73	5.87	44.88

// Xu Y, 2006: Chinese
// Subjects=20
-11.19	2.43	68.35
-48.69	1.18	55.5
28.31	-6.48	59.72
-14.21	-28.54	81.01
63.26	-11.72	16.26
-11.12	-64.93	50.57
21.01	-49.7	65.66
-54.27	-24.31	15.32
44.94	-55.18	-21.14

// Xu Y, 2006: Thai
// Subjects=20
-35.99	10.97	43.38
-41.69	10.51	-3.36
5.79	21.14	61.01
-21.93	-14.61	55.4
24.76	22.91	27.18
-4.96	-64.2	18.1
-44.71	-27.06	6.52
-45.67	-45.75	12.56
-13.26	-83.69	42.14
-31.71	-94.37	1.98
5.4	-71.88	-27.1

// Bangert M, 2006: (Acoustic vs. Rest, Pianists) > (Acoustic vs. Rest, 
// Non-Musicians)
// Bangert M, 2006: (Motion-Related vs. Rest, Pianists) > (Motion-Related vs. 
// Rest, Non-Musicians)
// Bangert M, 2006: Auditory-Motor Conjunction Analysis: Pianists > 
// Non-Musicians
// Subjects=7
68.05	-36.36	-11.11
8.47	3.12	70.04
26.85	61.94	-2.21
-50.7	-32.86	-1.59
-59.52	-2.47	-8.93
-47.48	-4.58	2.28
-55.77	6.81	32.67
-52.83	10.06	9.89
-43.64	-39.43	42.64
-55.65	-27.33	34.92
71.35	-32.64	-5.93
36.66	-24.88	-12.83
40.58	-10	42.78
53.59	-3.05	47.47
5.12	-8.67	58.94
58.54	34.14	20.17
53.51	-46.29	32.7
14.68	-6.59	46.24
8.02	-12.32	31.23
-59.09	-46.33	15.57
-52.85	8.79	7.77
-47.24	31.2	28.99
-52.42	1.06	39.9
-14.9	-50.19	6.24
71.35	-32.64	-5.93
53.54	-42.79	35.72
-55.88	-46.53	13.3
-59.29	-42.36	0.62
-50.7	-32.86	-1.59
-50.11	3.28	51.97
-52.48	3.94	36.26
-52.83	10.06	9.89
-43.69	-43.14	37.41

// Bense S, 2006: Leftward OKN vs. Rest
// Bense S, 2006: Rightward OKN vs. Rest
// Bense S, 2006: Leftward OKN vs. Rest, Deactivation
// Bense S, 2006: Rightward OKN vs. Rest, Deactivation
// Bense S, 2006: Rightward vs Leftward OKN
// Bense S, 2006: Leftward vs Rightward OKN
// Bense S, 2006: Laterality Effects
// Subjects=15
-6	-88	-10
20	-96	14
-42	-78	4
46	-66	-2
-60	-40	44
-30	-58	62
24	-54	54
38	-36	38
40	4	44
24	-4	50
-44	-2	56
-28	-6	48
8	8	54
-40	42	4
46	52	0
42	48	28
36	18	6
46	6	24
-44	6	20
-52	6	30
-30	18	3
-14	-20	42
-12	30	-2
-6	-90	-12
20	-94	14
-50	-74	-8
46	-68	-2
-44	-36	30
-30	-56	60
62	-32	42
36	-32	42
44	4	46
44	-6	52
-30	-4	50
-52	2	44
12	6	56
-10	14	46
-44	50	8
44	42	-4
40	48	20
62	16	2
62	16	8
-60	16	10
-44	4	20
-14	-20	46
58	-16	48
26	-60	20
-22	-50	8
0	-30	12
24	32	42
18	-46	72
18	-40	64
-20	-42	74
44	-2	-12
-38	-24	2
26	-44	22
-4	-6	22
26	32	36
20	-42	64
-22	-24	66
42	-14	0
-38	-20	4
17	18	31
14	-90	30
-28	-86	16
-22	-70	60
17	-19	31
-4	-74	14
32	-78	16
40	4	60
46	-58	-4

// Dehaene-Lambertz G, 2006: Healthy Controls, Experiment 1
// Subjects=10
48.69	-28.15	-2.63
66.01	-23.42	1.09
44.67	-47.78	17.31
-54.95	-32.36	4.03
-50.99	0.03	-17.17
-63.39	-57.08	15.59
-50.77	19.12	3.35
-15.94	-18.21	15.42
9.9	-10.03	9.68
53.04	-36.65	-1.86
39.9	-20.51	-12.2
-63.6	-32.39	4.18
-55.07	-15.76	-2.09
66.06	-36.19	2.35
53.2	-48.58	8.28
57.21	-11.52	-8.9
-55.06	-20.01	-1.67
-63.55	-45.15	5.45
-33.49	19.18	3.05
48.76	-31.99	2.23
52.96	-15.38	-3.97
-59.4	-15.77	-2.01
-63.48	-48.99	10.31
65.91	-11.08	-4.61
61.64	-23.85	-3.28
-59.43	-7.26	-2.86
-59.38	-20.03	-1.59

// Dehaene-Lambertz G, 2006: Healthy Controls, Experiment 2
// Subjects=15
-66.96	-14.74	-1.99
-60.37	-43.43	0.74
-57.13	-43.42	0.68
-63.76	17.81	1.46
-67.02	-11.86	-5.63
-63.61	-43.44	0.8
-60.37	-43.43	0.74
-67	-15.05	-5.32
-60.41	-10.9	4.24
-63.62	-40.25	0.48
-40.78	-35.73	13.09
-60.3	-39.62	7.08
-66.98	-44.39	-9.14
65.87	-11.39	-7.94
-63.58	-30.05	6.19

// Carreiras M, 2006: Lexical Decision, Low Frequency Words (LFW) > High 
// Frequency Words (HFW)
// Carreiras M, 2006: Interaction with Task, LFW > HFW
// Carreiras M, 2006: Lexical Decision-LFW, High Frequency Syllables (HFS) > 
// Low Frequency Syllables (LFS)
// Carreiras M, 2006: Reading Aloud-All words, LFS > HFS
// Carreiras M, 2006: Reading Aloud-HFW, LFS > HFS
// Subjects=16
-46	18	22
-4	22	42
-2	10	58
-46	18	22
-4	22	42
-2	10	58
-42	-12	-32
-40	-12	-32
-40	16	14

// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs1049353
// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs806377
// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs806380
// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs6454674
// Subjects=19
-36.4	-5.32	-2.09
-32.75	-2.39	0.97
-30.47	-31.86	7.88
-27.91	-20.71	11.37
-37.9	-35.37	12.72
-39.29	2.93	13.98
-31.19	-19.12	15.74
-39.04	-35.24	17.18
-2.38	-25.95	-6.33
28	1.03	-5.59
26.95	-.81	-3.19
19.43	-10.96	1.09
19.56	-6.71	5.19
20.66	-5.83	9.57
30.06	3.03	13.18
6.4	-19.92	-15.85
-10.27	-11.75	-11.89
6.21	-18.94	-11.47
-6.5	-9.16	-7.69
0.67	-5.05	-4.77
-17.27	-10.45	-4.11
0.79	-5.09	-2.53
-20.25	-7.33	-2.1
2.15	-18.57	1.93
4.42	-17.69	6.29
9.47	-14.99	10.46
5.52	-4.88	-12.64
1.68	-26.66	-6.31
4.48	4.38	-5.6
4.47	-22.05	-3.38
3.95	7.51	-3.63
4.34	-10.36	-2.13
5.98	13.38	-.8
-10.35	8.53	-.2
25.81	-30.91	2.69
10.29	13.86	3.57
20.6	-27.53	6.93
16.54	9.9	8.29
15.92	-24.36	11.18
14.35	-23.5	15.58

// Chou T L, 2006: Related Words > Baseline
// Chou T L, 2006: Unrelated Words > Baseline
// Chou T L, 2006: Related Words > Unrelated Words
// Chou T L, 2006: Correlation between Activation and Higher Semantic 
// Association in Related Word Pairs
// Chou T L, 2006: Correlation between Activation and Lower Semantic 
// Association in Related Word Pairs
// Chou T L, 2006: Correlation between Activation and Increasing Age in 
// Related Words
// Chou T L, 2006: Correlation between Activation and Increasing Age in 
// Unrelated Words
// Chou T L, 2006: Correlation between Deactivation and Age in Related Words
// Chou T L, 2006: Correlation between Deactivation and Age in Unrelated Words
// Chou T L, 2006: Correlation between Activation and Increasing Accuracy in 
// Related Words, p<0.001
// Chou T L, 2006: Correlation between Activation and Increasing Accuracy in 
// Related Words, p<0.005
// Chou T L, 2006: Correlation between Activation and Decreasing Accuracy in 
// Related Words
// Chou T L, 2006: Correlation between Activation and Longer Response Time in 
// Unrelated Words
// Subjects=35
-53.51	10.84	41.2
36.58	25.94	-8.9
-4.94	30.36	40.68
-41.17	-38.64	-17.99
4.73	-70.67	15.77
-21.54	-29.57	-2.41
-34.82	31.55	-13.84
36.53	28.82	-12.54
-4.92	23.98	41.31
-53.81	-41.72	7.18
17.69	-70.62	15.55
-22.87	-39.71	61.36
47.24	1.26	59.48
-56.92	-16.67	22.69
59.03	-2.72	50.71
-24.77	-26.18	-.45
10.71	-18.59	-13.01
-30.52	-63.43	49.27
-30.69	25.03	53.97
-4.9	-32.78	31.24
-17.5	-66.26	52.69
53.26	-52.52	12.03
50.44	-57.07	43.9
-34.76	61.52	-3.36
37.01	37.88	26.89
-41.36	-47.3	50.1
-55.97	-45.02	6.42
-56.22	18.79	0.11
-46.89	-29.66	43.97
-30.75	-4.93	43.49
-56.02	-51.92	1.51
-40.34	-16.04	51.48
27.78	14.16	60.77
1.91	56.77	-10.24
61.63	-19.5	-2.59
7.89	-46.09	14.41
58.45	-22.39	1.12
-59.44	-11.73	-4.65
-65.66	-25.08	13.58
14.66	-3.39	45.93
-8.03	-13.36	43.94
-63.03	-42.37	46.62
71.29	-24.34	-8.99
11.96	41.76	12.37

// de Zubicaray G I, 2006: Primed > Unprimed
// Subjects=13
-48	27	30
-21	57	18
-6	24	48

// Fassbender C, 2006: Cue-Related Activations
// Fassbender C, 2006: Cued and Un-cued Correct Responses to Incongruent 
// Stimuli
// Subjects=15
-55.38	16.97	26.37
-40.45	14.52	20.83
38.64	23.97	25.82
43.02	10.76	33.57
26.13	-.32	56.99
-42.43	5.13	37.25
34.79	-50.74	51.09
-34.64	-49.84	55.15
-49.69	-37.67	48.73
-21.85	-58.82	47.95
32.2	-48.86	-7.03
9.78	26.97	25.9
13.12	-13.37	27.01
-32.06	21.75	3.4
33.08	23.82	-3.1
32.4	12.52	43.58
-47.82	8.99	32.53
52.62	19.45	34.96
-50.03	25.81	30.03
53.55	24.6	18.9
-41.56	34.95	23.59
-32.63	2.67	59.65
44.94	37.07	15.73
-41.69	48.98	12.38
26.6	56.02	0.97
3.49	26.01	41.66
-1.91	35.24	37.61
-46.53	-24.87	48.74
37.98	-50.89	48.83
-35.72	-37.87	58.62
-36.82	-54.68	47.78
24.21	-57.43	61.81
54.92	-38.15	33.07
11.36	-57.76	58.64
25.16	-67.43	42.56
-8.97	-60.43	53.52
-.49	-54.46	47.34
32.19	-46.83	-8.32
-36.17	-52.44	-5.95
-47.86	-57.28	1.29
49.27	11.29	12.26
-35.2	13.61	8.58
30.96	19.67	-1.61
-27.83	23.46	-2.37
11.8	11.52	4.87
0.04	-17.16	-7.09

// Foerde K, 2006: ST correct > DT correct, Probe trials
// Foerde K, 2006: ST > DT, Training trials
// Foerde K, 2006: DT > ST, Training trials
// Foerde K, 2006: Bold activity vs. Accuracy, Probe task
// Foerde K, 2006: Bold activity vs. Declarative knowledge, Probe task
// Subjects=14
8	-66	0
-6	-72	4
-10	-70	10
-2	-64	38
4	-62	4
-4	-66	6
16	-8	26
6	14	-10
10	-22	14
10	6	-10
10	4	-2
24	-28	10
-6	-22	14
-16	-14	0
-18	-24	16
-14	-14	4
-18	-12	28
-16	-6	24
-12	32	58
-10	38	52
-14	62	28
-6	62	20
-22	64	20
-12	66	22
-6	8	52
42	0	36
-8	10	44
0	6	52
8	20	28
-54	-8	54
56	-42	20
54	-2	-4
70	-28	28
48	-48	8
54	-2	0
66	-38	14
-62	-2	4
-58	4	-6
-48	-6	2
-56	-54	8
-54	-50	10
-60	-6	-4
-6	-60	-6
6	-58	-14
14	-74	-18
10	-74	-16
8	-64	-14
-6	-72	10
36	46	32
36	50	32
30	48	22
40	52	24
36	52	24
34	52	12
-40	-30	44
-56	-32	46
-54	-32	50
-50	-36	52
-50	-32	52
-38	-34	44
28	-18	-18
-30	-18	0
22	-16	-20
-22	-16	-20

// Helmchen C, 2006: External vs. Internal, Activations
// Helmchen C, 2006: External = Internal, Activations
// Subjects=16
-30	-32	60
-34	-30	58
-60	-22	28
-62	-20	24
-40	-18	18
46	-14	18
54	-18	18
-32	6	6
-30	10	6
-32	14	4
-34	8	0
-32	32	-2
-36	8	-4
34	16	4
36	38	-4
40	30	0
-36	-14	10
38	-14	14

// Miotto E C, 2006: Related-Nonstructured Words, Post-Training > Pre-Training
// Miotto E C, 2006: Unrelated Words, Post-Training > Pre-Training
// Subjects=15
-46.91	22.77	17.98
-46.01	19.92	-5.21
-45.66	11.46	36.76
63.22	13.11	20.87
63.13	23.17	13.34
-.36	-65.24	59.4
-25.13	-93.67	24.15
-52.2	-67.85	-11.16
-48.08	-68.31	-31.24
-49.06	33.59	20.44
-32.16	59.1	4.73
-48.16	23.08	-5.45
63.22	13.11	20.87
47.34	11.3	40.16
19.72	-68.49	29.33
19.54	-81.37	0.3
-20.01	-78.44	0.51

// Paulus M P, 2006: High Probability Prospects > Low Probability Prospects
// Paulus M P, 2006: High Reward Prospects > Low Reward Prospects
// Subjects=16
16.7	-77.54	50.2
-.74	9.95	40.83
46	5.12	1.67
-40.49	36.1	24.6
39.96	-78.91	16.59
-22.85	-75.74	49.39
-26.02	-56.67	62.32
-41.68	9.54	-2.16
-2.09	1.49	0.29
59	-20.38	14.81
46.47	-53.64	40.04
-21.13	25.44	36.42
60.77	18.65	-17.48
-49.03	-7.79	8.3
-4.09	2.94	19.15
0.22	-19.67	15.42
40.12	-58.62	45
28.09	32.93	46.38
-58.25	-51.01	42.14
-37.06	26.37	49.91
-22.79	-68.54	59.93
-37.48	18.74	-7.44
-55.22	-50.59	19.77
-37.88	-71.06	42.47
-44.23	-52.9	57.75
32.57	5.44	62.01
3.08	45.93	-3.49
-49.23	26.33	-4.6

// Wood G, 2006: Small Decade Distance > Large Decade Distance, p<0.001
// Wood G, 2006: Small Decade Distance > Large Decade Distance, p<0.0001
// Wood G, 2006: Unit-Decade Compatibility
// Wood G, 2006: Decade Distance > Unit-Decade Compatibility, p<0.001
// Wood G, 2006: Decade Distance > Unit-Decade Compatibility, P<0.0001
// Wood G, 2006: Decade Distance < Unit-Decade Compatibility
// Wood G, 2006: Decade Distance and Unit-Decade Compatibility (conjunction)
// Subjects=14
10.71	-72.88	60.71
49.25	5.55	47.81
52.71	21.02	-16.53
40.87	-48.31	57.77
44.88	-35.27	36.24
-32.7	-44.94	51.96
-28.6	-87.08	25.81
-2.87	-19.57	23.17
-41.65	11.84	39.77
-24.2	1.03	49.51
53.01	24.37	7.79
49.31	-33.36	44.94
-20.1	-101.27	11.38
49.31	-33.36	44.94
-20.1	-101.27	11.38
32.09	-58.1	45.44
-37.05	-58.34	46.64
-38.04	20.7	-14.95
-6.78	-75.56	44.47
5.4	-71.55	-16.65
40.6	-85.36	28.94
52.93	19.38	0.44
18.79	2.82	31.79
-7.15	-54.24	19.95
6.28	-13.57	63.88
49.37	-32.95	49.38
45.27	-46.61	64.25

// Melcher T, 2006: Word-oddballs (Word-oddball vs. Oddball control condition)
// Melcher T, 2006: Stroop-incongruency (Stroop-incongruency vs. 
// Stroop-congruency)
// Melcher T, 2006: Word-oddball in contrast with stroop incongruency 
// (Word-oddball>Stroop-incongruency)
// Melcher T, 2006: Stroop-incongruency in contrast with word oddball (Stroop 
// incongruency>Word oddball)
// Melcher T, 2006: Color-oddballs (Color-oddballs vs. Oddball control)
// Melcher T, 2006: Color-oddball in contrast with Word-oddball 
// (Color-oddball>Word-oddball)
// Melcher T, 2006: Word-oddball in contrast with color-oddball 
// (Word-oddball>Color-oddball)
// Subjects=9
42	6	24
-36	12	27
54	30	15
54	36	3
39	3	-30
-33	3	-39
-42	-66	-15
24	-60	51
-21	-57	42
33	-72	24
-36	-75	18
36	-90	-6
-21	-93	-3
42	12	9
-42	-18	9
-54	9	33
-39	-3	27
-30	-15	45
-48	-24	36
15	9	42
-45	3	0
-42	-18	66
24	-21	12
6	-87	39
-6	-75	42
24	-42	-45
36	-63	18
42	6	3
-39	-15	6
-60	6	36
-51	0	36
-18	-24	57
-45	-21	42
42	6	27
-33	9	27
54	30	12
54	33	-6
42	0	-33
-30	3	-39
-42	-66	-15
24	-60	51
-30	-48	57
33	-69	24
-27	-66	24
36	-93	-9
-27	-87	-9
42	15	9
-39	-3	27
-51	9	33
-33	9	27
-42	-9	45
18	6	39
-51	-9	-9
-45	-21	51
21	-18	18
6	-87	42
-12	-87	39
18	-45	-42
36	-63	18
-39	-18	9
-24	-27	48
-45	-21	51
9	30	60
-9	39	48
-57	18	15
-42	33	-15
-12	36	21
-6	0	9
-39	12	-33
42	12	-33
-60	-48	0
57	-45	0
-9	-18	3
9	-12	9
9	-72	48
-18	-63	36
-9	-51	6
39	-57	-30
42	6	24
-39	6	21
60	21	6
-39	3	27
0	18	48
-51	-54	-15
-36	-75	-18
36	-54	45
-30	-69	45
-39	-69	27
48	-81	0
-30	-84	-9
12	-6	-3
9	27	54
-3	39	48
-36	36	18
-36	39	-24
-15	42	9
-33	27	-27
54	-9	-30
-54	-48	-9
54	-45	-3
-9	-18	-9
6	-15	18
9	-63	48
-3	-63	48
-18	-51	-6
24	-57	-42
-54	-48	-9
-21	-81	39
-36	-60	30
39	12	9
-33	3	-33
42	0	-33
-30	-18	48
-45	-18	15
48	-36	-27
-39	-3	24

// Kaufmann L, 2006: Numerical Comparison > Fixation
// Kaufmann L, 2006: Numerical Comparison Close Distance > Numerical 
// Comparison Far Distance
// Kaufmann L, 2006: Physical Comparison > Fixation
// Kaufmann L, 2006: Physical Comparison Close Distance > Physical Comparison 
// Far Distance
// Kaufmann L, 2006: Physical Comparison (maximal interference>minimal 
// interference)
// Subjects=17
-6.87	14.58	55.72
10.37	13.17	51.08
-28.16	-55.38	66.37
5.65	17.9	21.56
48.31	58.75	-14.58
-20.06	-40.8	26.69
73.51	-18.39	-2.9
45.18	-39.58	59.07
-61.9	-58.43	47.07
-53.63	-24	24.48
1.16	-70.94	-9.91
26.97	-58.61	-17.18
-37.93	-63.82	-23.4
48.66	54.75	11.58
1.63	21.23	45.95
-6.8	10.75	60.58
1.46	-23.81	23.52
23.15	-40.64	25.93
-46.29	46.64	21.84
45.27	-12.7	70.98
45	23.59	57.31
-32.6	-17.96	64.98
45.26	-43.42	63.93
-57.41	-39.63	64.19
-28.18	-51.12	65.95
5.52	-69.55	-6.76
-37.93	-63.82	-23.4
39.85	-63.54	-24.75
1.17	-1.97	4.55
48.88	13.79	21.23
-38.1	54.19	-12.66
-28.92	-64.28	5.63
-11.78	-78.43	-8.95

// Pekkola J, 2006: ATT_VOWELS vs. Baseline
// Pekkola J, 2006: ATT_CIRCLES vs. Baseline
// Pekkola J, 2006: ATT_CIRCLES > ATT_VOWELS
// Subjects=10
-13.58	-94.69	-3.78
37.34	28.16	-2.4
-37.4	20.66	3.55
-34.68	-43.58	53.51
50.8	-40.95	52.31
-9.24	11.56	48.6
67.63	-32.67	20.2
-59.52	-35.46	23.01
-41.33	-83.51	5.64
46.27	11.21	39.07
-51.85	-5.99	59.48
-23.79	-53.52	75.41
50.81	-43.07	52.49
-.63	15.47	57.09
64.43	-34.81	20.42
65.51	-36.92	20.58
14.65	-66.83	64.94
24.61	60.89	22.88
31.47	2.89	56.66

// Stevens M C, 2006: Single-tone > Two-tone
// Subjects=20
0	0	60
-52	-4	40
-48	-56	8
-56	-44	44
36	-20	-16
44	-36	-28
-28	-76	32
20	-76	36
-44	-88	8
44	-80	8
-24	12	8
24	-4	0
-24	-56	-20
28	-56	-20

// Lie C H, 2006: Original Wisconsin Sorting Test (A) - High level Baseline 
// (HLB)
// Lie C H, 2006: Non-Randomized Wisconsin Card Sorting Test (B) - HLB
// Lie C H, 2006: Pseudo-Randomized Wisconsin Card Sorting Task (C) - HLB
// Lie C H, 2006: Conjunction analysis [(A-HLB) * (B-HLB) * C-HLB)]
// Subjects=12
-40	-60	-12
46	-48	38
38	46	22
6	30	42
-26	32	-4
-2	-36	24
-44	-46	-2
-14	-2	20
38	24	-8
-42	-54	50
32	-64	52
32	-72	-30
-32	54	14
60	18	14
-12	-14	42
8	28	40
-2	-34	20
30	0	64
-38	16	-4
-24	-70	38
32	-68	54
38	-86	-8
26	-74	-48
-42	24	38
-28	-60	-38
50	12	22
12	16	46
8	-78	-40
-53	-54	18
32	-64	52
-28	-70	52
26	-74	-50
-52	10	34
50	12	24
-30	20	0
-4	18	50
32	26	-8

// Lotze M, 2006: Body referred movements - Isolated hand movements
// Lotze M, 2006: Expressive gestures - Body referred movements
// Lotze M, 2006: Main effect of isolated hand movement
// Lotze M, 2006: Main effect of body referred movement
// Lotze M, 2006: Main effect of expressive gestures
// Subjects=20
-48	-57	15
54	-57	9
60	-39	3
57	27	3
-45	-60	24
-60	-48	12
-51	-21	33
-54	21	-9
51	-63	0
-45	-72	0
39	-51	-21
-42	-48	-21
30	-78	-18
-30	-60	-21
48	12	30
-51	9	24
48	15	24
-48	12	24
42	0	48
36	-57	54
-21	-66	45
36	-45	54
-60	-30	42
-60	-30	33
51	-66	-3
-42	-75	3
39	-48	-24
-42	-48	-21
42	3	39
36	-48	-24
-39	-66	-21
-51	0	48
51	18	24
-45	9	27
51	18	24
-45	12	24
36	-51	57
-33	-45	60
-45	-33	45
36	-48	54
-45	-33	42
12	-27	-9
54	27	-9
51	-69	-3
45	-72	-9
-45	-78	-6
42	-66	-24
-39	-60	-30
-54	-51	6
42	-51	-21
-39	-48	-24
54	-42	6
51	21	24
-45	15	24
51	18	27
-48	12	27
-45	24	-12
51	36	-6
51	6	42
48	9	33
-48	0	48
-45	3	36
-63	-48	24
12	-30	-6
0	12	60
54	12	-27
-30	9	-24
30	-57	54
66	-33	21
-66	-39	18
21	-3	-18
-18	-3	-21

// Crone E A, 2006: Blocked Task: Bivalent - Univalent
// Crone E A, 2006: Mixed Task: Bivalent - Univalent
// Crone E A, 2006: Univalent Switching - Repetitions
// Crone E A, 2006: Bivalent Switches - Repetitions
// Subjects=21
18	28	30
-22	-28	22
-2	20	36
20	34	6
-38	16	30
-44	16	10
14	28	30
34	24	-2
-32	-4	54
-40	-8	40
24	2	64
26	-2	46
-36	52	12
-4	20	42
24	-48	22
-4	8	60
10	16	46
-30	-58	46
-40	-44	44
34	-56	40
-22	-2	42
38	-82	-10
-32	30	16
-14	48	34
-32	36	38
-28	-6	52
42	-8	32
-26	36	20
-12	8	60
4	2	62
-8	-16	66
-32	-52	52
18	-60	50
-24	-42	2
-6	-62	34
-42	-42	42
-62	-40	-16
-48	-32	-8
-38	8	-16
48	-34	-18
62	0	-12
-58	-22	42
26	-30	64
32	-30	54
-13	7	13

// Forstmann B U, 2006: (df2 U df3) > df1
// Subjects=22
10.28	-68.86	52.89
-4.04	28.71	35.95
34.78	-72.83	40.67

// Gruber O, 2006: Target with advance preparation vs Baseline
// Gruber O, 2006: Target with advance preparation vs Cue
// Subjects=12
-24.74	-98.14	-12.38
48.67	-67.69	-12.16
-45.68	-32.01	53.15
5.79	22.23	33.46
-23.95	-4.75	68.01
-21.86	-61.51	-33.99
18.17	-60.95	-30.24
-28.91	-105.84	-2.59
-36.87	-17.56	69.5
5.7	17.14	25
-36.87	-17.56	69.5
-20.56	-59.84	-16.24
14.01	-59.72	-16.84

// Liu X, 2006: Incongruent > Neutral trials
// Liu X, 2006: 1 word > 4 word blocks across incongruent and neutral trials
// Subjects=14
-54	22	30
34	64	12
-52	16	16
-40	-60	40
-40	-52	20
-60	-48	-8
-6	-100	-14
36	40	12
50	24	26
54	10	16
48	28	8
4	22	40
-8	4	36
36	-46	54
8	-62	54
0	-94	0
0	-94	28
28	-80	10
30	-70	-20
48	-38	16
-52	-36	16
48	-20	-6
-52	-40	-2
-50	-56	6
-32	-30	0
44	-54	2
40	0	-22
28	-40	-42
22	-54	-44
-22	-80	-38
-2	-22	-16

// Chen J L, 2006: 0 dB > Silence
// Chen J L, 2006: BOLD Covariation with parametric rhythm
// Subjects=12
63.19	-14.69	5.36
-65	-23.75	9.82
-71.39	-23.62	12.12
-58.72	-7.48	-.54
-18.33	-7.35	-30.01
22.45	-53.63	-26.59
-54.04	-3.34	52.59
-60.62	-33.61	19.52
69.68	-35.8	7.06
20.84	17.68	70.04
27.16	16.86	58.89
-24.13	16.56	59.5

// Ecker C, 2006: 0 degree angular disparity > Baseline
// Ecker C, 2006: 100 degree angular disparity > Baseline
// Ecker C, 2006: 100 degree angular disparity > 20 degree angular disparity
// Ecker C, 2006: 60 degree angular disparity > 0 degree angular disparity
// Subjects=10
-36.91	-18.21	51.41
-21.99	-6.49	50.26
5.73	9.54	48.6
27.7	21.25	-8.4
-18.1	-19.21	-4.48
-36.91	-18.21	51.41
47.15	-62.06	-13.9
-41.45	-73.71	-5.22
-21.99	-71.28	24.47
32.48	-63.55	23.19
-21.93	-62.93	36.03
32.55	-55.21	34.76
35.71	-6.15	49.57
55.76	11.12	23.35
-44.7	14.75	24.2

// Halari R, 2006: Subgroup of Normals, Men
// Subjects=9
44	-20	-6
0	-38	42
50	-10	2
-22	26	38
-36	12	42
4	12	48
54	-60	28
52	-58	38
60	-50	32
-40	-44	46
-30	-4	56
14	-88	-10
-16	-86	0
32	-52	52
4	12	54
-2	0	62
-34	-76	22
-32	-82	2
34	-70	22
-36	-4	52
32	-62	52
26	-54	62
-2	60	16
8	58	16
52	-40	12
54	-52	18
66	-38	22
-44	-58	24
-60	-36	0
4	-8	64
-2	14	54
10	14	58
6	28	30
-50	0	48
-52	8	34
-52	14	20
6	-32	8
-4	-36	0
2	-16	6
-4	-72	-10
6	-70	-8
-18	8	1
0	-58	30
-8	-48	38
10	-48	16
-16	56	-4
8	62	6
56	-58	8
46	-52	16
42	-74	2
-18	-32	-16
-22	-28	-4
-30	-38	-16
-52	-58	38
-42	-66	42
-56	-56	28

// Halari R, 2006: Subgroup of Normals, Women
// Subjects=10
16	-12	60
-20	34	40
-12	-44	44
40	-56	50
-32	-78	-12
18	-88	2
-46	-28	44
46	12	22
54	32	14
-28	-78	12
-38	-78	10
-34	-78	-2
-38	-40	56
12	-52	62
16	-58	58
-12	-48	34
-52	-10	28
-42	18	-6
-12	4	20
44	18	-12
-6	-48	32
10	-48	38
-44	-58	32
-40	-64	38
62	-18	18
52	-18	16
54	-6	8

// Hugdahl K, 2006: Normals
// Subjects=11
25.63	-72.15	44.7
-19.64	-47.46	58.71
40.29	13.01	24.82
-43.09	24.44	13.9

// Hugdahl K, 2006: Subgroup of Normals, Females
// Subjects=5
28.89	-60.03	47.93
40.16	25.15	16.89
25.65	-76.41	45.12
-39.79	24.87	18.28
44.46	29.42	16.4
-19.69	-55.53	52.79

// Hugdahl K, 2006: Subgroup of Normals, Males
// Subjects=6
28.89	-60.03	47.93
40.16	25.15	16.89
25.67	-67.48	48.72
-27.33	-47.36	48.75

// Keehner M, 2006: Mental rotation > 0 degrees rotation
// Keehner M, 2006: Mental rotation > Perspective taking
// Subjects=14
42	-44	57
30	-59	44
-42	-45	38
56	-21	45
-48	-33	49
-30	-58	61
53	-41	52
48	39	20
27	-73	56
50	13	32

// Ochsner K N, 2006: Pain > Warm
// Ochsner K N, 2006: Anxiety Sensitivity Index (ASI) Regression for (Pain > 
// Warm)
// Ochsner K N, 2006: Fear of Pain Questionnaire (FPQ) Regression for (Pain > 
// Warm)
// Subjects=13
0	-12	68
44	32	24
54	4	52
48	8	36
38	42	2
6	8	36
-2	-28	34
28	16	0
42	0	10
38	-22	12
44	-32	26
-70	2	2
54	-38	12
54	-36	32
66	-46	40
-42	-68	40
-20	0	14
-8	-2	6
16	-6	14
-10	48	0
-14	40	0
30	40	-8
38	42	-8
32	48	-10

// Song G H, 2006: Healthy Controls
// Subjects=12
-1.73	20.66	55.56
-8.26	19.34	39.01
55.66	15.55	11.83
-30.9	50.16	26.65
-38.59	51.23	-.11
36.25	28.96	-5.8
-8.43	-12.04	4.84
-24.51	-1.64	3.04
-49.81	-21.35	39.56
-59.55	-17.15	25.93
65.66	-30.97	42.38
-29.85	-67.6	-23.7
29.87	-14.66	-18.79
4.75	-54.4	33.9
3.03	43.22	-11.07
-5.03	25.16	45.18
55.68	17.93	14.98
-34.09	50.31	28.91
-40.64	54.27	11.92
39.51	19.72	-1.71
-5.23	-15.36	2.86
-18.07	0.85	7.22
-49.62	-43.5	55.91
2.21	-42.15	-13.94
29.86	-11.49	-19.06
7.97	-54.21	36.07
1.98	46.73	-6.89
10.97	23.86	40.64
58.88	19	14.85
49.25	42.98	22.99
36.3	47.08	8.3
36.36	20.21	4.97
26.82	0.06	6.77
62.51	-35.85	48.4
-23.52	-18.95	-14.48
-1.73	-48.52	27.9

// Song G H, 2006: IBS Patients
// Subjects=12
2.5	20.26	49.96
55.58	12.5	-.18
-32.04	21.92	5.61
-14.8	-11.65	10.46
-18.05	1.11	10.54
-46.53	-20.56	49.49
51.9	-46.15	53.85
-37.3	-65.11	-18.25
-24.58	-14.47	-11.49
1.57	-37.7	43.68
0.89	54.12	-7.5
1.41	16.74	45.81
52.32	19.62	-4.08
-37.4	19.51	2.53
-11.61	-11.8	8.21
69.71	-16.8	18.84
-1.92	-73.64	-7.91
29.97	-26.84	-11.08
6.93	-40.76	44.99
-2.33	44.07	-13.31
42.99	22.56	34.81
38.33	52.58	-3.34
39.48	20.52	-5.13
-46.52	-26.99	48.91
-36.76	-49.59	58.5

// Szaflarski J P, 2006: Healthy controls
// Subjects=10
-32.63	-20.3	51.54
34.7	-19.9	50.73
-32.62	-20.22	52.65
34.7	-19.9	50.73

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 1
// Subjects=1
34.68	-19.01	48.43
-34.97	1.66	33
37.82	-3.13	47.06
-38.1	0.3	43.18

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 2
// Subjects=1
-24.07	-32.23	47.98
-38.32	1.24	14.11

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 3
// Subjects=1
35.74	-24.55	45.53
-29.54	-9.42	40.55
-32.84	-20.33	23.66

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 4
// Subjects=1
58.98	3.57	21.72
27.82	41.19	15.58

// Baliki M N, 2006: Healthy Controls
// Subjects=11
-2	-18	8
4	-20	10
16	12	8
24	8	-2
-24	14	-2
-12	16	8
46	-2	-14
46	-8	-2
-10	-94	-18
-32	-88	-20
0	18	34
2	12	46
18	28	58
-30	18	6
-48	22	-16
-46	4	-2

// Baliki M N, 2006: Subgroup of [Patients], Group 1
// Subjects=13
10	22	28
-12	40	0
18	60	12
26	42	22
54	16	-4
48	-2	16
56	-20	36
56	12	-8
56	-36	28
46	-20	28
-32	-18	58
-32	-26	52
-2	-70	-14
0	3	46
2	-2	54
4	-28	46
-14	58	28
-16	48	0
20	58	8
6	44	6
22	48	30
-28	32	26
18	-6	-30
-10	-2	-26
-10	-20	4
-14	-28	2
12	-28	4
6	4	-6
-22	4	-2
4	-2	50
4	18	28
10	-36	24
-30	-26	58
-28	-18	62
-46	-18	52
54	18	-8
54	-4	36
-12	-26	40
50	-30	44
62	-28	22
56	-40	24

// Baliki M N, 2006: Subgroup of [Patients], Group 2
// Subjects=11
-6	24	24
0	36	-12
0	32	-6
-12	58	20
12	60	22
-10	34	42
50	-64	30
-48	-70	-2
-32	-60	-38
-2	-90	-16
36	18	6
50	4	8
12	-60	28
62	-36	24
40	-58	54
34	40	32
4	4	48
-36	14	-4

// Tsukamoto T, 2006: True Feedback - Rest
// Tsukamoto T, 2006: False Feedback - Rest
// Tsukamoto T, 2006: True Feedback - False Feedback
// Subjects=20
9.82	-12.78	3.23
5.71	-30.9	16.3
-5.16	10.1	19.16
39.93	23.49	-.87
-2.37	1.71	67
57.3	17.58	3.9
-56.67	1.57	45.53
45.06	-60.18	45.42
-58.68	-32.27	51.15
-46.51	3.42	-4.13
-.18	1.92	69.18
-55	8.89	8.92
-22.64	15.18	5.5
11.96	8.92	5.53
-9.83	11.85	-7.83
9.9	-10.03	9.68
-9.54	-18.81	8.64
11.97	-1.93	4.37
52.72	11.24	-17.8
57.63	-32.43	20.05
59.92	16.66	39.81
-58.88	-.98	41.34
60.15	-27.59	48.67
-9.57	-27.74	5.04
12.16	-28.96	13.76

// Wang A T, 2006: Normal Adults
// Subjects=12
-50.5	-37.89	13.47
65.92	-21.92	-5.78
-12.27	53.55	-20.88
-37.64	-25.5	7.54
-44.08	-36.16	8.71
-26.93	-67.75	-8.63
35.71	-67.73	-11.94
-20.37	-80.28	-5.26
-52.65	-77.23	6.19
-48.37	-35.97	11
63.91	-38.32	2.6
-70	-44.97	7.78
63.7	-28.93	-11.77
-26.88	-65.21	-4.4
24.92	-65.44	-9.74
-5.05	-85.36	8.43
-16	-77.72	-1.11
-9.37	-94.09	7.12
-35.29	-96.31	7.79
40.23	-37.78	9.67
42.53	-45.45	19.36
-50.41	13.11	30.83
-61.62	14.42	-.48
-3.21	63.29	13.86
-14.1	64.75	7.18
-69.99	-40.51	9.58
-13.78	-86.02	1.92
-9.31	-93.68	11.57
-15.68	-92.87	20.56
46.82	-43.52	16.85
-52.88	19.53	7.83
40.15	18.56	15.3
31.61	21.49	24.13
-7.46	59.43	18.8
-46.17	-31.29	14.98
66.08	-11.96	8.92
48.99	-45.64	17.02
-9.76	58.39	7.73
-7.56	65.19	11.5
-50.69	19.75	10.01
46.82	-43.52	16.85
-29.06	-67.55	-6.37
33.53	-70.08	-13.91
-37.64	-25.5	7.54
27	-59.46	-14.85
-50.89	27.01	-4.15
-59.3	-17.28	4.86
59.55	-21.11	3.21
-65.95	-5.37	-5.17
55.21	-23.46	1.28
-70.13	-26.24	1.45
57.23	-9.19	-6.89
-65.94	-22.8	-7.93
59.34	-9.6	-11.37
-52.65	-77.23	6.19
51.03	-68.35	3.55
-48.89	17.05	-18.89
46.11	14.64	-26.99
-15.92	-90.28	2.38
9.94	-88.47	-2.72
-22.55	-82.62	-7.23
35.71	-67.73	-11.94
-44.22	-65.68	-8.54
46.45	-65.99	-16.78
-13.6	-95.61	14.07
12.27	-93.81	8.97
-13.55	-101.79	16.92
-24.27	-101.2	23.77
27.65	-94.01	28.9
-57.13	-21.52	5.24
48.76	-23.28	3.61
-70.11	-23.9	3.46
51.02	-42.21	7.69
-59.26	-30.04	6.12
61.73	-31.95	2.01
-63.74	-24.71	-5.54
52.9	-13.66	-8.62
-48.5	-63.15	-4.23
48.95	-74.33	8.66
-57.47	8.72	-15.68
46.11	14.64	-26.99
-13.76	-90.27	2.34
14.3	-83.79	1.22
-26.91	-65.41	-6.62
42.24	-67.3	-7.61
-31.28	-65.84	-10.99
46.47	-57.06	-13.18
-11.46	-97.94	12.02
10.08	-94.03	6.79
-26.51	-101.83	17.15
-37.39	-89.32	13.85
33.92	-84.6	14.41
53.04	22.45	10.22
57.21	19.09	-2.97
48.4	30.99	-12.96
55.57	9.85	36.07
-57.14	-19.4	5.03
48.78	-23.07	5.83
-56.97	-46.63	12.2
55.19	-17.08	0.65
-67.88	-43.04	5.31
59.6	-33.87	4.47
-61.51	-28.54	-.71
66.04	-36.39	0.13
-48.35	-70.83	5.49
42.4	-70.51	3.91
-59.6	6.8	-13.21
46.11	14.64	-26.99
-15.97	-86.23	-.26
5.51	-82.73	-9.94
-26.87	-82.64	-7.16
46.5	-56.85	-10.96
-31.34	-59.67	-13.84
50.84	-63.22	-10.4
-13.65	-98.16	9.84
10.08	-94.03	6.79
-22.17	-99.48	19.08
10.3	-98.95	22.96
-46.11	-85.51	9.14
25.54	-91.48	33.17
46.57	29.01	11.92
-48.83	24.06	-12.86
53.37	11.76	33.68
-54.83	25.44	25.21
-65.76	-17.09	7.19
44.48	-27.34	6.33
-70.08	-23.7	5.68
55.2	-21.33	1.07
-68	-26.44	-.81
57.4	-31.96	2.08
-65.74	-45.37	3.26
46.53	-36.88	-3.97
-50.53	-66.59	5.1
-46.8	5.59	-26.75
41.73	7.62	-32.94
-22.45	-79.66	1.44
20.72	-73.34	-2.16
-24.68	-89.01	-6.56
31.43	-80.51	-10.6
-46.5	-51.22	-14.41
46.47	-57.06	-13.18
-27.26	-2.43	-21.81
24.56	-2.45	-24.93
-5.02	-93.87	9.27
10.13	-93.61	11.23
-26.55	-99.91	14.72
25.36	-97.19	18.05
-43.93	-89.75	9.53
31.74	-84.82	12.23
57.22	23.55	-1.17
41.83	32.47	-19.72
55.58	7.72	36.29
22.91	-66.53	1.61
27.09	-67.56	-9.57
-20.73	-1.99	-17.48
-48.8	22.14	-10.43
-31.04	-85.87	4.44

// Wang A T, 2006: Normal Children
// Subjects=12
-37.64	-25.5	7.54
-44.08	-36.16	8.71
-26.93	-67.75	-8.63
35.71	-67.73	-11.94
-20.37	-80.28	-5.26
-52.65	-77.23	6.19
-48.37	-35.97	11
63.91	-38.32	2.6
-70	-44.97	7.78
63.7	-28.93	-11.77
-26.88	-65.21	-4.4
24.92	-65.44	-9.74
-5.05	-85.36	8.43
-16	-77.72	-1.11
-9.37	-94.09	7.12
-35.29	-96.31	7.79
40.23	-37.78	9.67
42.53	-45.45	19.36
-50.41	13.11	30.83
-61.62	14.42	-.48
-3.21	63.29	13.86
-14.1	64.75	7.18
-69.99	-40.51	9.58
-13.78	-86.02	1.92
-9.31	-93.68	11.57
-15.68	-92.87	20.56
46.82	-43.52	16.85
-52.88	19.53	7.83
40.15	18.56	15.3
31.61	21.49	24.13
-7.46	59.43	18.8
-46.17	-31.29	14.98
66.08	-11.96	8.92
48.99	-45.64	17.02
-9.76	58.39	7.73
-7.56	65.19	11.5
-50.69	19.75	10.01
46.82	-43.52	16.85
-29.06	-67.55	-6.37
33.53	-70.08	-13.91
-37.64	-25.5	7.54
27.01	-61.59	-14.64
-.86	51.57	26.18
-48.48	-21.49	5.09
48.78	-36.25	2.65
27	-59.46	-14.85
-50.89	27.01	-4.15
-61.4	-25.59	7.96
48.8	-18.61	7.63
-65.89	-11.54	-2.32
66	-19.17	0.67
-61.37	-42.81	7.42
59.59	-38.34	2.67
-57.17	-32.78	-.37
59.55	-34.29	0.03
48.87	-74.95	2
-57.48	10.85	-15.89
50.53	11.02	-19.98
-11.74	-84.71	-7.21
22.86	-84.38	-5.59
-37.7	-82.88	-9.19
46.5	-50.26	-9.37
-42.22	-53.74	-18.72
46.47	-57.06	-13.18
-11.45	-100.07	12.23
3.62	-85.12	10.5
-15.6	-100.96	25.84
16.72	-97.22	18.2
-50.51	-79.56	4.15
-61.59	23.34	3.12
-50.91	24.67	-6.16
59.37	-11.51	-8.94
-5.19	53.68	26.05
-9.74	69.44	11.12
-54.95	-19.18	7.21
46.68	-29.25	8.72
-61.5	-21.95	0.87
46.65	-38.17	5.12
-67.69	-54.76	17.67
63.87	-27.69	1.55
-63.58	-45.36	3.23
57.43	-38.34	2.71
-44.09	-69.11	0.76
48.85	-70.7	1.58
-55.53	7.07	-33.47
33.04	11.63	-35.43
-24.65	-90.93	-4.13
-15.91	-94.53	2.8
-44.27	-52.92	-9.8
42.18	-50.28	-9.29
-40.03	-53.53	-16.54
42.17	-54.74	-11.09
-4.94	-99.84	14.34
10.09	-96.15	7
-20.06	-102.02	14.81
10.34	-96.41	27.19
-52.8	-76.14	-5.12
42.52	-80.52	11.62
-59.07	-41.76	18.48
-61.42	22.46	16.65
3.57	54.54	34.78
-5.19	53.68	26.05
-7.54	67.53	13.51
-70.07	-27.95	6.1
46.75	-41.81	12.2
-65.9	-18.13	-3.91
59.68	-39.84	9.55
-63.36	-56.88	17.81
61.67	-23.65	-1.06
-52.76	-47.45	3.25
52.89	-11.54	-8.83
48.86	-72.82	1.79
-44.75	11.36	-34.08
-22.47	-88.59	-2.16
22.92	-83.97	-1.15
-35.53	-63.11	-4.46
37.93	-62.85	-5.74
-46.5	-51.22	-14.41
42.14	-48.36	-11.72
-11.42	-99.86	14.45
8.02	-97.66	13.91
-20	-101.6	19.25
16.68	-95.3	15.77
-41.97	-73.77	-3.3
42.45	-76.69	6.76
-55.04	19.52	7.87
52.99	28.62	7.37
-51.01	37.02	-11.86
-5.22	55.6	23.62
-9.73	65.18	11.54
9.65	69.09	6.34
-61.42	-21.33	7.54
66.06	-14.29	6.91
-63.54	-38.56	7.04
48.94	-41.59	14.38
53.05	-30.06	-.27
-61.73	0.41	-12.54
-58.99	-63.04	20.58
53.32	-63.05	14.19
48.85	-70.7	1.58
-44.05	-73.15	3.4
48.24	5.72	-30.63
-18.15	-88.57	-2.24
5.75	-85.32	8.24
-33.35	-82.66	-7.04
44.42	-62.83	-5.85
-42.17	-51.2	-14.49
40	-52.62	-11.27
-2.89	-94.07	7.01
20.95	-95.7	11.25
-9.17	-101.36	21.29
8.16	-96.63	25.01
31.71	-78.44	11.6
-56.79	9.45	38.03
-42.04	-63.34	-6.57
-48.27	-83.39	8.97
42.3	-66.88	-3.17
-50.51	-55.53	8.49
43.92	-.88	-32.14
48.86	-72.82	1.79
20.87	-89.73	6.18
10.17	-95.53	13.66
-28.86	-83.53	6.41
-35.27	-93.98	9.8
42.29	-64.75	-3.38
-48.8	22.14	-10.43
-31.04	-85.87	4.44

// Sweet L H, 2006: Relapse-remitting Multiple Sclerosis (RRMS)
// Subjects=15
1.53	-8.47	50.15
1.53	-8.47	50.15
32.48	7.84	51.78
-29.5	7.47	52.52
49.44	-6.72	27.15
-46.74	-7.3	28.31
39.66	61.93	34.89
-37.27	61.46	35.81
37.68	-47.46	10.63
-34.99	-47.89	11.5
12.87	22.53	9.51
-10.64	22.39	9.79
56.89	-6.93	23.74
18.86	52.18	-34.31
-17.48	51.96	-33.87
46.33	32.76	56.22
6.86	11.2	56.25
-22.99	-37.59	47.3
-49.81	-19.06	41.6
54.51	39.95	10.91
39.66	22.32	18.14
-3.83	11.13	56.38
1.32	-7.26	24.41
1.32	-7.26	24.41
-20.18	42.91	28.25
-34.37	17.73	-20.77
-3.83	11.13	56.38
47.16	35.74	25.85
1.06	-3.4	-8.26
1.06	-3.4	-8.26
51.32	4.9	-1.72
-49.13	4.3	-.52
12.86	-13.82	-6.4

// Sweet L H, 2006: Healthy Controls (HC)
// Subjects=15
1.53	-8.47	50.15
1.53	-8.47	50.15
32.48	7.84	51.78
-29.5	7.47	52.52
49.44	-6.72	27.15
-46.74	-7.3	28.31
39.66	61.93	34.89
-37.27	61.46	35.81
37.68	-47.46	10.63
-34.99	-47.89	11.5
12.87	22.53	9.51
-10.64	22.39	9.79
56.89	-6.93	23.74
18.86	52.18	-34.31
-17.48	51.96	-33.87
46.33	32.76	56.22
6.86	11.2	56.25
-22.99	-37.59	47.3
-49.81	-19.06	41.6
54.51	39.95	10.91
39.66	22.32	18.14
-3.83	11.13	56.38
1.32	-7.26	24.41
1.32	-7.26	24.41
-20.18	42.91	28.25
-34.37	17.73	-20.77
-3.83	11.13	56.38
1.49	-7.75	45.63
1.49	-7.75	45.63
32.48	7.84	51.78
-29.5	7.47	52.52
-46.8	45.89	41.69
47.16	35.74	25.85
1.06	-3.4	-8.26
1.06	-3.4	-8.26
-43.93	-33.39	-34.22
51.32	4.9	-1.72
-49.13	4.3	-.52
1.12	15.86	6.86
1.12	15.86	6.86
12.86	-13.82	-6.4
46.33	32.76	56.22
18.86	52.18	-34.31
-17.48	51.96	-33.87

// Albuquerque R, 2006: Burning Mouth Disorder (BMD)
// Subjects=8
3.92	28.73	28.61
-20.41	-66.55	23.49
11.66	-69.53	23.38
-13.17	-19.61	10.55
10.33	-16.3	10.01
41.32	28.96	28.16
40.37	8.23	35.48
-18.43	-67.11	2.33
6.94	-73.13	-36.49
5.62	29.52	27.63
47.25	10.51	-.36
2.82	1.61	55.09
41.57	-36.62	48.6

// Albuquerque R, 2006: Healthy Controls
// Subjects=8
3.92	28.73	28.61
-20.41	-66.55	23.49
11.66	-69.53	23.38
-13.17	-19.61	10.55
10.33	-16.3	10.01
41.32	28.96	28.16
40.37	8.23	35.48
-18.43	-67.11	2.33
6.94	-73.13	-36.49
16.47	-62.47	-28.91
5.99	57.31	-9.39
-26.99	-54.73	-34.97
-12.53	-16.25	12.61
31.41	6.01	8.9
1.39	43.62	25.94
11.6	-11.98	10.63
44.07	7.44	30.49
36.57	36.4	25.69
55.15	-40.12	33.79

// Roelofs A, 2006: Incongruent > Congruent
// Subjects=12
-8.03	19.62	70.21
-5.86	6.78	69.03
-19.89	-.22	48.59
-22.32	54.87	31.73
-48.03	16.71	8.47
58.83	33.89	14.72
-51.9	-37.31	39.8
48.64	-36.82	50.88
0.07	25.97	13.83
-3.02	35.95	33.1
-7.38	41.58	23.76

// Kesler S R, 2006: Turner Syndrome
// Subjects=15
-46.36	39.53	14.7
-23.96	-68.31	54.13
47.24	-46.89	49.67
18.41	4.37	2.51
-48.63	-58.67	-13.64
10.02	33.53	27.78
-43.56	-41.03	48.4
46.54	41.98	12.88
27.7	-54.27	40.65
-46.34	-76.33	-7.45
-23.94	-65.97	56.14
32.21	-65.98	52.94
-48.28	9.61	27.78
-21.78	-77.97	53.93
42.79	-46.77	39.65
-31.36	-49.99	-13.67
3.77	27.62	45.28
-4.83	6	44.21
-43.81	-5.7	35.94
-48.74	-3.7	-11.23
-45.98	-37.49	29.04
-5.5	39.28	-1.66
48.89	42.28	27.38
-43.88	15.67	34.95
8.07	-74.29	22.8
-35.68	-2.93	-3.69
26.76	25.18	-16.5
8.01	-5.83	31.71
-41.89	2.32	18.31
5.92	-22.75	34.54
32.05	-2.61	53.4
-11.62	33.24	25.94
28.91	28.38	-16.85

// Kesler S R, 2006: Healthy Controls
// Subjects=15
-4.83	6	44.21
-43.81	-5.7	35.94
-48.74	-3.7	-11.23
-45.98	-37.49	29.04
-5.5	39.28	-1.66
48.89	42.28	27.38
-43.88	15.67	34.95
8.07	-74.29	22.8
32.05	-2.61	53.4
-11.62	33.24	25.94
28.91	28.38	-16.85

// Knops A, 2006: (NL2 - NL1) and (LL2 - LL1)
// Knops A, 2006: LCL2 - LCL1
// Knops A, 2006: LIL2 - LIL1
// Knops A, 2006: NCL2 - NCL1
// Knops A, 2006: NIL2 - NIL1
// Subjects=13
-25.3	48.63	-26.9
-7.1	29.29	40.82
0.55	25.58	46.66
-46.25	30.48	21.2
-41.44	14.46	56.32
-46.6	47.54	-2.89
56.27	42.02	12.71
48.68	37.43	9.93
31.96	17.5	50.29
35.57	23.16	-4.12
40.67	-46.47	43.02
-37.13	-42.49	43.95
45.21	-56.91	57.42
-33.16	-81.21	8.5
0.99	-51.46	-19.68
-16.22	-80.45	-18.76
44.45	29.32	15.29
-53.79	35.01	24.24
5.85	32.53	40.28
-33.43	-84.35	-13.6
-28.54	-64.77	34.81
40.67	-46.47	43.02
5.22	-21.46	-20.48
-46.23	35.04	24.11
-53.47	12.21	44.42
32.01	18.98	54.62
56.39	38.59	22.01
48.53	57.11	2.38
30.91	62.21	-22.47
-24.07	-62.55	46.84
36.31	-46.8	39.77
-50.41	27.35	33.91
31.98	10.05	51.02
-42.32	47.25	-6.3
40.74	-49.24	47.78
-37.16	-33.98	43.11
-28.19	-59.94	63.46
31.9	17.08	45.85
53.03	42.01	12.77
35.51	64.31	-.35
-50.52	4.62	20.47
-2.79	32.5	40.43
-42.37	55.65	-8.25
40.61	-67.72	33.92
49.43	-57.62	49.58
-41.99	-60.8	-2.34
-20.55	-2.87	-3.95
5.33	-45.82	-16.95

// Wallentin M, 2006: Space > Nonspace
// Wallentin M, 2006: Nonspace > Space
// Wallentin M, 2006: Positive Correlation between Space and Nonspace > Rest 
// and Reaction Time
// Wallentin M, 2006: Negative Correlation between Space and Nonspace > Rest 
// and Reaction time
// Wallentin M, 2006: Positive Correlation between Space > Nonspace and 
// Reaction time
// Wallentin M, 2006: Positive Correlation between Nonspace > Space and 
// Reaction time
// Subjects=20
24	10	66
-56	-66	0
-42	-64	18
62	-58	-8
-16	-64	22
20	-64	22
-36	-82	32
40	-84	32
-38	-40	52
46	-40	60
26	-68	28
22	-74	58
-12	-68	62
-12	-60	50
10	-58	64
6	-74	56
2	36	-24
-6	56	38
4	60	28
-36	30	-18
-6	32	56
-58	-6	-34
-56	-12	-26
62	-16	-28
-46	6	-40
8	-46	30
54	-62	36
-32	-36	-28
-32	58	20
32	52	28
-36	38	36
-46	14	22
-42	18	-4
42	20	-6
46	8	46
0	36	36
-4	18	46
0	16	66
-34	26	0
-50	18	-14
-28	0	50
18	-64	22
6	-66	10
-34	-78	26
42	-76	22
-8	-78	44
2	-50	56
-2	-86	4
8	54	-8
-18	32	-8
18	38	-8
52	-12	36
30	-22	70
62	-12	-8
-56	-16	6
66	-22	6
-44	-32	16
-14	-46	74
18	-38	74
-28	0	-16
-28	-12	8
28	-8	2
-20	-60	16
-26	-74	20
30	-88	28
-26	10	-26

// Sol-Padulls C, 2006: Memory dysfunction patients
// Subjects=39
-37.59	20.83	20.89
-39.87	-80.76	-9.36
46.4	-53.22	-18.04
40.35	-10.59	24.91
-24.06	-64.67	47.05
-.52	14.74	45.51
40.2	21.1	19.53

// Sol-Padulls C, 2006: Subgroup of Memory dysfunction patients, Real rTMS
// Subjects=20
-5.09	36.87	29.95
46.9	16.2	35.59
-37.13	-61.09	40.19
42.86	-49.55	44.41
57.08	22.51	-12.27
46.44	45.61	5.8
40.34	44.04	35.19
8.02	35.83	41.04

// Sol-Padulls C, 2006: Subgroup of Memory dysfunction patients, Sham rTMS
// Subjects=19
-5.09	36.87	29.95
46.9	16.2	35.59

// Mitchell J P, 2006: Similar > dissimilar
// Mitchell J P, 2006: Dissimilar > similar
// Subjects=15
18	57	9
51	3	24
-3	3	36
12	-66	-6
9	-90	24
-24	-66	24
-9	45	42

// Callan D E, 2006: Conjunction: Passive Listening to singing of the song 
// lyrics and Covert singing of the song lyrics
// Subjects=16
-60.71	7.65	-15.51
55.94	18.8	-17.48
-53.07	7.13	-9.99
54.96	11.87	-11.18
67.18	-26.09	6.94
-57.98	-35.17	20.05
69.46	-35.03	14.51
51.61	-39.97	54.52
-33.68	16.67	-12.38
48.41	25.57	-13.54
-53.48	3.39	41.93
-39.52	-8.13	32.75
-.18	4.15	70.08
58.8	11.99	35.81
-35.59	-73.41	-11.28
29.19	-77.85	-16.43
-13.81	-95.04	-2.79
25.05	-95.11	-5.69
5.62	-77.54	-.37
-24.9	-65.48	-18.97
39.93	-69.51	-19.68
-18.72	-73.17	-44.09

// Chen F, 2006: Abacus Expert Group
// Subjects=7
17.06	14.75	67.62
70.36	-45.1	-1.32
66.04	-60.42	-4.22
55.35	-59.62	4.85
-70.37	-30.24	-18.32
-57.46	-24.02	-21.4
-67.72	-52.85	15.24
-65.71	-60.47	2.52
-57.35	-51.67	-18.67
27.71	9.28	54.53
21.39	12.64	67.76
21.65	-55.43	74.49
-28.07	-57.94	73.34
-28.33	10.13	66.61
-5.29	-38.98	-.64
27.71	9.28	54.53
23.83	-53.09	76.46
19.34	-69.66	60.25
22.96	-103.32	-1.48
27.12	-89.24	-11.91
-28.39	9.71	62.17
-15.23	-69.78	60.85
-19.48	-64.92	67.16
-22.47	-101.77	-5.34
-26.92	-91.77	-12.98
-2.69	-92.62	22.55

// Chen F, 2006: Non-expert control group
// Subjects=7
1.68	19.41	49.49
51.63	-31.05	58.12
-37.07	5.01	58.3
-45.58	-35.64	60.23
-56.53	-21.42	52.28
1.7	21.75	51.5
5.8	35.41	36.63
1.29	18.63	18.2
3.52	8.21	21.44
53.86	-32.75	62.73
62.3	-18.87	50.01
-30.56	11.83	62
-52.68	18.86	23.58
-33.63	26.86	-6.67
-48.57	45.69	11.89
-16.12	-54.53	-5.64
-49.99	-29.69	55.23
-32.63	-55.37	55.24
-32.75	-54.07	46.14
32.07	20.56	60.07
3.67	35.61	38.89
1.67	23.67	49.07
29.91	-60.44	43.47
-28.37	12.04	64.18
-57.02	16.51	21.65
-57.32	20.81	-1.19
-21.78	-59.37	57.69
-45.84	-28.8	41.63
-13.7	-107.29	4.02

// Peters L, 2006: Words-Digits
// Peters L, 2006: Dots-Digits
// Peters L, 2006: Dots-Words
// Peters L, 2006: Digits-Dots
// Peters L, 2006: Words-Dots
// Peters L, 2006: Digits-Fixation
// Peters L, 2006: Words-Fixation
// Peters L, 2006: Dots-Fixation
// Subjects=22
-20	-95	-8
24	-100	-6
14	-68	68
-26	-98	-2
-2	-76	-30
0	16	52
34	22	6
-40	14	2
30	-4	66
50	2	36
-24	-4	66
26	44	14
36	-86	28
-2	-78	-30
34	18	4
30	-2	62
-26	-66	-28
-38	16	4
30	-54	-36
-48	-82	4
-24	-6	64
8	16	52
-52	-70	40
60	-26	22
2	50	-10
60	-66	34
-4	-56	20
-4	-94	28
4	-76	34
2	50	-10
-68	-50	12
60	-64	34
60	-28	24
28	-54	-24
-8	14	46
-50	-38	56
-48	-78	-14
38	-48	56
-32	20	8
36	-66	-24
-50	-72	-16
-32	-66	66
0	12	52
-48	6	38
-28	32	8
48	8	24
34	24	4
38	-52	54
36	50	34
2	-72	-24
2	16	50
36	20	6
38	52	34
-30	22	8
50	6	36
-52	6	40
-38	56	22

// Kukolja J, 2006: (Right Imagined Stimuli (RI) + Left Imagined Stimuli (LI) 
// > Right Visual Stimuli (RV) + Left Visual Stimuli (LV))
// Kukolja J, 2006: (RV + LV > RI + LI)
// Kukolja J, 2006: (LV + RV > Catch Trials (2CT))
// Kukolja J, 2006: (RI + LI > 2CT)
// Kukolja J, 2006: (LV > CT)
// Kukolja J, 2006: (RV > CT)
// Kukolja J, 2006: (LV > CT), masked with (RV > CT)
// Kukolja J, 2006: (RV > CT), masked with (LV > CT)
// Kukolja J, 2006: (LI > CT)
// Kukolja J, 2006: (RI > CT)
// Kukolja J, 2006: (LI > CT), masked with (RI > CT)
// Kukolja J, 2006: (RI > CT) masked with (LI > CT)
// Kukolja J, 2006: (LV > RV)
// Kukolja J, 2006: (RV > LV)
// Kukolja J, 2006: (RI > LI)
// Subjects=20
-28	-60	46
-40	-48	48
46	-42	50
-26	-2	52
28	4	56
-50	4	30
52	10	26
-6	12	48
8	18	46
-30	20	2
43	22	-2
-16	-68	24
14	-62	26
-30	-64	-28
32	-64	-32
8	58	24
8	34	2
48	-76	6
-44	-72	4
38	-82	26
20	-64	62
-34	-62	54
-28	-58	48
32	-60	48
-26	0	56
28	4	58
-52	8	32
52	12	30
8	18	46
-28	18	2
34	22	-2
-16	-62	22
16	-62	26
-30	-64	-28
36	-68	-26
32	-74	34
18	-66	64
38	-82	24
14	-62	66
-30	-60	46
34	-76	34
22	-74	54
40	-84	14
14	-62	66
-30	-60	46
-26	-56	46
44	-44	48
-26	0	56
26	8	60
-46	4	34
48	6	32
10	18	46
-28	22	0
34	22	-2
-16	-62	22
16	-62	26
-28	-62	-28
36	-70	-26
-28	-58	50
24	-64	58
-26	6	48
28	0	56
-48	20	30
48	34	26
-38	56	12
8	18	46
34	22	-4
16	-62	26
-32	-64	-28
34	-66	-28
44	-40	50
-44	-38	46
-24	4	32
26	10	60
-2	20	42
10	24	46
-28	22	0
34	24	2
6	-64	56
-38	56	12
-38	4	32
-28	-54	54
24	-60	58
-24	-76	42
20	-74	-14
-18	-94	26
-34	-50	64
-28	-76	52
-58	-42	44
-46	-68	-6
22	-34	68
22	-16	-10
-14	-46	34
-12	44	48
12	60	32
-28	-64	-12
38	-88	-6
-26	-80	-32
38	-78	-32

// Suchan B, 2006: Simultaneous matrix rotation > Simultaneous 3-D cube 
// rotation
// Suchan B, 2006: Simultaneous 3-D cube rotation > Simultaneous matrix 
// rotation
// Suchan B, 2006: Successive matrix rotation > Successive 3-D cube rotation
// Subjects=11
58.17	38.99	-8.31
13.98	33.07	-.25
-8.64	27.99	4
-43.95	5.27	27.02
64.58	-.94	-22.4
54.92	-.45	-16.68
65.33	-14.99	33.88
53.71	-28.37	52.21
-46.74	-34.04	54.49
-52.18	-44.15	49.98
-27.08	-44.42	68.63
-14.05	-50.45	72.36
-34.42	55.29	21.91
-40.82	46.01	26.29
14.97	-19.71	66.58
-37.02	-8.82	59.67
17.48	-89.72	-4.97
11.08	-92.41	1.01
-1.75	-96.95	10.64

// Wilson K D, 2006: Object recognition > Baseline, p<0.001
// Wilson K D, 2006: Object recognition > Baseline, p<0.040
// Wilson K D, 2006: Object recognition > Baseline, p<0.003
// Wilson K D, 2006: Object recognition > Baseline, p<0.019
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.001
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.008
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.040
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.002
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.001
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.029
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.013
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.002
// Subjects=7
41	-60	-30
-26	-98	-15
-30	-71	-30
19	-94	-20
38	-86	10
26	-86	-25
38	-52	55
19	-4	55
30	-94	10
19	-94	-10
-30	-90	15
34	-90	15
-38	-60	-30
-38	-64	55
26	-75	50
45	-68	-25

// Aramaki Y, 2006: Parallel
// Aramaki Y, 2006: Mirror
// Aramaki Y, 2006: Parallel - Mirror
// Aramaki Y, 2006: Phase Transition
// Aramaki Y, 2006: Asymmetric Activation, Phase Transition
// Aramaki Y, 2006: Asymmetric Activation, Parallel
// Aramaki Y, 2006: Asymmetric Activation, Mirror
// Subjects=15
32	-28	58
30	-16	68
-42	-28	58
-60	4	28
-58	-2	38
-48	-38	52
0	2	64
6	-8	66
-8	-4	72
56	12	14
42	16	6
24	-4	8
-26	-6	12
-18	-20	8
14	-18	10
22	-66	-20
-26	-54	-22
-2	-72	-18
34	-28	58
30	-14	68
-42	-26	58
-2	-10	56
-54	-26	12
-16	-54	-18
26	-58	-22
-4	2	60
6	4	60
8	-8	62
10	0	38
-30	-20	60
-30	-12	58
34	-14	54
32	-44	54
46	-2	12
-54	2	26
24	-10	0
24	10	2
10	-10	16
-22	-12	2
-22	0	2
-14	-16	18
4	-54	-18
28	-46	-30
-34	-52	-28
10	18	60
-8	14	58
24	12	58
44	2	44
10	36	26
-8	14	44
58	12	24
32	48	-4
30	18	-6
6	-24	26
-8	-34	24
-6	18	18
-40	16	0
-54	8	20
-40	-8	38
42	-44	54
-44	-46	46
-30	42	22
8	-8	0
-6	-12	-2
8	-18	-12
-18	-62	-40
28	4	62
28	2	50
54	10	22
48	-32	50
44	46	10
54	-42	46
22	58	14
32	-26	54
32	-12	62
-8	-4	70
-28	-56	-18
30	-28	62
-52	-40	16

// Lehericy S, 2006: Simple - Rest
// Lehericy S, 2006: Scale - Rest
// Lehericy S, 2006: Complex - Rest
// Lehericy S, 2006: Complex - Simple
// Lehericy S, 2006: Complex - Scale
// Lehericy S, 2006: Scale - Simple
// Subjects=12
-40	-14	50
-2	-4	56
-42	-26	22
-34	0	0
28	4	14
-18	-2	12
12	2	0
-14	-16	8
-44	-24	56
-2	-2	56
-6	2	46
-46	6	6
-48	-20	28
-22	16	4
22	18	6
-18	14	4
-20	2	0
-14	-16	-2
-14	-16	2
-36	-22	56
-6	-4	54
-2	0	52
-26	-8	52
28	-2	40
-10	6	42
16	8	38
-60	10	24
50	16	12
34	30	16
-52	-20	32
-46	-26	52
-20	-66	62
30	-64	52
-32	-40	46
40	-50	44
-10	-66	56
-24	-20	14
-24	4	0
26	10	16
-14	14	4
20	12	20
-18	-10	2
20	-6	0
-12	-12	-4
10	-12	-6
-14	-12	10
-36	-22	58
-2	-4	50
-4	2	48
-30	-10	58
34	0	62
-8	8	38
14	6	38
-56	8	32
54	-10	30
32	48	18
-52	-26	38
56	-20	36
-44	-30	50
46	-40	58
-14	-62	68
24	-64	56
-32	-38	48
34	-42	48
-8	-64	54
-28	20	8
-24	14	12
18	10	2
8	16	10
-12	-2	16
-14	4	4
16	6	4
-12	-12	-4
14	-12	-4
-10	-10	12
10	-2	10
0	6	52
-14	0	52
38	-4	46
38	28	16
-44	-36	48
34	-44	48
-28	-60	58
26	-66	56
-26	-54	48
-8	-64	54
26	12	14
-18	-24	22
10	-12	-6
-14	-14	12
8	-16	18
-34	-28	60
-4	-6	52
-24	-10	62
-36	-46	66
-30	8	4
14	12	2
14	12	2

// Rand-Giovannetti E, 2006: First Successful Encoding > Fixation
// Subjects=12
-39	21	27
-33	9	27
-45	36	3
-42	24	18
36	33	6
39	15	27
-12	-21	0
-21	-30	-9
9	-27	-6
-30	-54	39
-45	-30	48
36	-72	18
54	-18	24
48	-24	33
-33	-81	-6
42	-75	-3
9	-90	-12

// Riecker A, 2006: Younger Subjects
// Subjects=10
3	15	51
-36	-21	54
-9	18	9
-12	-21	6
-21	6	9
33	-51	-54
-3	12	54
-39	-24	57
-12	-18	6
30	-54	-51
-12	18	6
-21	6	3

// Riecker A, 2006: Older Subjects
// Subjects=10
3	12	51
-45	-21	51
39	-24	54
39	0	54
-15	21	6
-9	-18	6
-18	9	6
36	-54	-51
-3	15	51
-42	-24	54
-9	-18	9
27	-54	-51
-12	18	9
-18	6	6

// Ashwin C, 2007: Autistic Group
// Subjects=13
42	-48	14
-22	3	-17
2	18	-16
-8	26	-12
10	34	21
0	26	21
40	-48	14
65	-15	3
-54	-22	6
-46	-22	12

// Ashwin C, 2007: Control Group
// Subjects=13
36	-86	-18
-24	5	-15
-16	-6	-11
20	-8	-13
-4	54	38
-22	3	-17
2	18	-16
-8	26	-12
10	34	21
0	26	21
40	-48	14
65	-15	3
-54	-22	6
-46	-22	12
38	-68	-18
-36	-62	-22
54	-39	-2
-11	-4	-8
34	-4	-8
4	34	30

// Schneider F, 2007: 0-Back vs. Fixation, Normals > Schizophrenics
// Schneider F, 2007: 0-Back vs. Fixation, Schizophrenics > Normals
// Schneider F, 2007: 2-Back vs. 0-Back, Normals > Schizophrenics
// Schneider F, 2007: 2-Back vs. 0-Back, Schizophrenics > Normals
// Subjects=48
26	6	-8
-28	20	-12
50	-36	8
-28	-34	0
-6	-4	-6
-16	2	12
42	-26	48
-30	-42	66
34	-34	68
50	-6	34
6	-32	56
-8	-70	54
42	-28	46
40	14	-12
36	-24	10
44	-72	8

// Weiss E M, 2007: Schizophrenic Patients
// Subjects=8
-43.94	-2.28	26.64
-40.11	44.38	-2.69
48.49	22.9	-7.68
44.66	13.44	29.18
33.33	66.32	-1.63
48.5	38.31	-3.6
-26.69	-72.57	8.65
-34.99	-48.11	41.11
31.9	-72.62	27.83
-59.58	33.15	-6.85
-59.25	-54.06	1.77
61.79	-62.14	0.51
-28.56	-68.17	32.9
-30.95	-89.6	10.41
31.7	-87.26	9.11
31.99	-80.72	33.11
-44.37	9.81	-4.8
-35.12	5.59	41.4
-39.91	41.47	12.16
-44.06	14.32	20.52
37.96	38.01	16.78
3.43	27.25	18.43
46.96	-40.25	28.85
5.31	-3.3	-9.95
-54.73	-4.44	27.04
-5.14	-57.61	6.8
-50.82	1.27	-3.85
46.62	-34.02	3.59
55.08	-4.73	-5.06
-11.45	-89.12	14.51
-20.1	-87.02	14.45
12.36	-82.14	19.02
-42.09	-22.09	-1.68
35.71	-23.95	-2.82
9.67	23.28	-1.45
-18.37	58.56	10.1
-33.41	35.11	12.68
51.3	-11.65	36.03
59.61	-7.52	10.83
-11.72	33.58	18.06
-.76	8.51	24.84
9.95	31.95	22.34
14.38	4.31	25
7.95	-10.61	26.58
23.18	-36.08	28.84
-43.89	-47.88	21.07
-59.55	4.98	-9.67
53.35	-64.97	16.62
63.64	-.97	-11.18
-20.07	-95.53	15.29
-35.25	-12.88	27.54
-59.06	-35.17	20.07
-33.63	44.4	-2.8
7.48	31.78	-2.26
40.36	-91.48	9.38

// Weiss E M, 2007: Controls
// Subjects=8
-48.25	13.11	30.8
53.11	12.02	13.49
39.78	39.88	-9.21
48.98	28.76	32.07
-4.99	17.94	34.06
-2.97	38.8	27.48
-50.23	-33.69	35.46
64.21	-44.86	24.53
46.95	-38.12	28.64
-32.86	-54.9	37.26
-63.48	-44.63	11
-28.71	-95.56	15.44
36.28	-72.19	32.19
-33.62	24.73	-6.46
-35.12	5.59	41.4
-39.91	41.47	12.16
-44.06	14.32	20.52
37.96	38.01	16.78
3.43	27.25	18.43
46.96	-40.25	28.85
5.31	-3.3	-9.95
-54.73	-4.44	27.04
-5.14	-57.61	6.8
-50.82	1.27	-3.85
46.62	-34.02	3.59
55.08	-4.73	-5.06
-11.45	-89.12	14.51
-20.1	-87.02	14.45
12.36	-82.14	19.02
-42.09	-22.09	-1.68
35.71	-23.95	-2.82
9.67	23.28	-1.45
-50.67	15.49	10.43
-3.1	39.99	17.28
1.01	42.81	1.25
5.79	24.36	33.25
13.9	46.69	-3.84
-50.7	-30.63	-.69
-67.94	-41.33	0.66
-41.63	-55.87	27.42
70.33	-19.05	1.7
-43.75	-31.54	35.14
-11.21	-50.15	40.91
-16.22	12.55	0.05
-24.79	-6.62	2.09
20.55	17.35	3.43
-37.91	33.75	-1.68
-48.28	4.09	26.09
-20.33	57.88	25.89
53.04	31.16	11.6
53.2	-59.53	6
16.56	-50.21	15.79
8.15	-76.96	28.66
-29.06	28.75	13.23
48.47	9.61	-11.97
26.81	24.43	-13.06

// Basho S, 2007: Overall Effects for Category-Driven Word Generation
// Basho S, 2007: Factor-Specific Effects for Paced
// Basho S, 2007: Factor-Specific Effects for Unpaced
// Basho S, 2007: Factor-Specific Effects for Overt
// Basho S, 2007: Factor-Specific Effects for Covert
// Basho S, 2007: Paced > Unpaced
// Basho S, 2007: Covert > Overt
// Subjects=12
-13	-17	15
-16	-6	13
-34	17	17
-4	17	39
-24	2	52
-9	-58	-2
-14	-9	17
-5	15	37
2	-30	-8
-9	-54	7
-38	28	15
-40	13	15
-24	6	49
-34	-17	17
-43	30	15
-42	17	24
5	26	25
-38	24	22
-24	4	52
56	-34	17
7	15	-5
33	4	50
29	-90	0
-47	9	39
-27	0	10
51	-15	10
-7	6	66
-2	-64	-17
-9	-11	30
7	15	39
22	-52	66
-43	-21	-3
-14	-7	54
5	24	-10
14	54	-12
40	-58	47
33	-45	64
-27	-19	-18

// Chikazoe J, 2007: Antisaccade - Control Saccade
// Subjects=24
24	-6	54
36	18	-4
-34	18	-4
36	-2	50
52	16	20
-34	-6	50
-26	-6	60
38	36	26
-22	-2	46
-46	6	40
42	56	10
32	22	36
-4	36	28
-4	24	36
10	32	28
12	18	36
2	-10	40
0	2	56
14	36	4
8	20	60
8	-68	56
-28	-58	54
46	-46	46
-6	-56	50
-16	-46	50
-18	-68	52
54	-42	34
-54	-46	44
-62	-36	38
-4	-62	62
58	-30	52
20	-70	40
20	-52	50
-62	-24	36
-10	-78	40
44	-32	40
64	-22	32
-10	-34	0
58	-44	20
46	-54	16
56	-54	4
-40	-80	8
36	-76	26
-30	-76	24
-2	-20	10
26	-36	-42
-6	-2	0
4	-34	2
28	-60	-24
-6	-22	-18
10	0	-2
32	-50	-46
14	-26	-10
-36	-66	-20

// Dichter G S, 2007: Subjects with Autism Spectrum Disorder (ASD)
// Subjects=17
42	28	23
40	24	0
50	7	27
-31	26	5
10	22	41
29	-71	42
-23	-61	43
31	-78	-2
36	-39	42
-33	-65	-3
31	-79	25
-29	-85	-2

// Dichter G S, 2007: Neurotypical Controls
// Subjects=17
47	30	13
49	8	32
-43	0	33
35	1	53
3	21	44
7	18	30
33	-64	45
-29	-59	45
45	16	12
54	25	25
-38	27	21
17	-18	43
21	-98	17
-23	80	0
-29	-84	7
26	27	0

// Jardri R, 2007: Passive Speech Listening (UFV - GT)
// Jardri R, 2007: Voice Familiarity Processing (FV - UFV)
// Jardri R, 2007: Intelligible Speech (UFV - RTV)
// Jardri R, 2007: Self-Other Distinction (UFV - SGV)
// Subjects=12
-49.81	-13.6	43.37
-3.86	4.19	49.15
-55.47	-24.63	-2.48
-56.59	-10.89	-3.62
46.47	-31.72	48.24
-55.42	-25.18	4.26
-50.07	-16.34	7.91
52.78	-12.99	42.14
6.82	4.25	49.03
57.8	-23.96	-3.84
58.82	-10.2	-5
57.85	-24.5	2.9
52.21	5.31	-24.07
-48.74	-13.6	43.36
-1.66	2.69	57.06
-45.96	16.03	-.42
-49.05	-32.17	-4.15
0.17	31.4	28.98
46.46	-31.8	47.13
-48.02	22.34	12.45
51.71	-12.99	42.15
4.75	2.73	56.99
51.4	-31.57	-5.36
-60.61	-12.67	28.92
-59.62	-3.57	22.57
5.84	-2.55	57.42
-.89	53.39	38.3
-3.18	54.04	19.32
-33.19	39.72	1.9
-33.2	25.37	-4.7
0.38	-55.37	21.76
-2.18	36.9	4.01
25.58	-13.8	-21.05
1.5	-53.79	28.31
0.17	33.6	29.91
-46.6	-61.91	23.96
47.52	-29.68	46.94
-59.77	10.2	8.03
-10.7	-59.54	-31.29
-16.88	-1.2	21.88
-9.46	-17.16	7.52
63.35	-11.92	27.43
3.38	53.42	38.25
5.37	54.09	19.21
2.52	-55.36	21.73
4.24	36.94	3.94
2.31	33.61	29.89
49.57	-61.33	22.81
12.81	-59.4	-31.57
19.45	-.98	21.44
11.91	-17.03	7.26

// Parris B A, 2007: Normals, Group 1
// Subjects=22
-.69	25.5	34.36
-31.53	28.58	-11.36
-44.13	24.75	17.25
-26.47	3.49	41.46
-39.86	35.3	15.01
-59.61	11.05	-13.63
-34.99	-48.11	41.11
-.75	-81.09	7.93
0.39	-30.3	23.06
-36.06	-58.34	-45.26
-33.6	-74.65	-24.64
-9.55	-16.69	8.43
48.36	19.73	-18.57
58.42	22.26	7.9
37.55	29.47	-17.11
41.87	-54.8	-34.62
13.96	12.14	-6.03
18.26	21.83	-5.94
-16.35	13.74	-10.15
3.34	-6.21	4.94
-9.81	5.47	-7.2
-35.9	-60.39	-32.74
-.64	24.75	37.8
3.36	-11.53	5.46
18.29	10.03	-5.89

// Parris B A, 2007: Normals, Group 2
// Subjects=22
-9.81	5.47	-7.2
-35.9	-60.39	-32.74
-.64	24.75	37.8
3.36	-11.53	5.46
18.29	10.03	-5.89

// Aparicio M, 2007: Hearing Subjects
// Subjects=12
-52	20	18
44	26	6
-36	-20	60
-2	-2	68
-50	-22	-16
-62	-42	-2
-24	-94	-20
20	-86	30
62	-6	20
-4	-14	12
-50	14	-10
68	-16	30
56	-14	30
30	28	56
10	-40	16
-48	6	24
-56	-46	-4
-4	38	-10
66	-22	34
12	-26	74
26	-26	74
2	-92	10
8	-76	-2
-48	8	24
58	26	20
-26	64	43
10	24	46
30	-78	28
32	-70	40
28	-64	-32

// Aparicio M, 2007: Deaf Subjects
// Subjects=12
-46	36	6
10	12	-4
-6	6	54
18	32	26
-44	-50	-24
-24	-94	-16
14	-78	-42
32	-68	-44
-30	-72	-46
62	-6	20
-4	-14	12
-50	14	-10
68	-16	30
56	-14	30
30	28	56
10	-40	16
-48	38	10
64	20	16
52	26	-12
10	26	48
-48	-56	-24
-26	-66	42
26	-68	-36
-4	38	-10
66	-22	34
12	-26	74
26	-26	74
2	-92	10
8	-76	-2
-48	8	24
58	26	20
-26	64	43
10	24	46
30	-78	28
32	-70	40
28	-64	-32

// Caseras X, 2007: Women > Men, Disgusting vs. Neutral Pictures
// Subjects=17
-30.21	38.56	-27.03
-25.98	38.08	-33.73
-41.88	27.29	-20.37
-26.01	58.68	-28.76
-41.96	14.29	-37.12
-45.1	6.24	-30.84

// Habel U, 2007: Explicit Emotion Recognition
// Habel U, 2007: Implicit Face Processing
// Habel U, 2007: Explicit Emotion Recognition - Implicit Face Processing
// Subjects=14
-10	-54	-18
-4	-24	-10
4	-26	-10
14	-18	-8
-18	-26	-8
20	4	-14
-52	16	-24
-20	0	-20
40	20	-22
-44	20	-24
42	-58	-22
-10	-56	-18
-26	-56	-18
-12	-24	-10
20	-28	-8
-20	4	-18
18	4	-18
46	18	-18
38	28	-28
-28	-58	-16
38	-40	-20
-2	-24	-12
48	18	-20
-50	14	-24
-16	-2	-12
-40	20	-22

// Sommer M, 2007: Conjunction of True and False Belief
// Sommer M, 2007: False Belief > True Belief
// Sommer M, 2007: True Belief > False Belief
// Subjects=16
-22	8	66
-42	32	28
-52	14	0
-52	-50	48
56	-50	42
-6	-72	56
-2	-90	14
-8	16	46
42	4	58
46	28	40
34	64	6
34	-54	24
64	-54	-4
38	-64	46
4	-74	52
0	56	26

// Goldstein R Z, 2007: All Words > Fixation
// Goldstein R Z, 2007: Fixation > All Words
// Goldstein R Z, 2007: Positive Correlations Between Drug > Neutral Contrasts 
// With Drug > Neutral Percent Correct
// Goldstein R Z, 2007: Negative Correlations Between Drug Contrasts With Drug 
// Ratings
// Subjects=14
3	6	51
48	3	15
-33	42	15
-42	3	42
21	-63	48
-39	-36	48
24	-69	-9
21	-54	-21
9	0	15
9	-12	18
6	51	-9
3	36	6
3	54	0
33	-30	24
-33	-18	18
-18	-42	-3
-9	-78	24
6	51	-9
12	45	-6
-6	24	-3
-6	42	-12
0	39	-9
24	-45	-6
12	15	42
9	21	51
-15	15	27
21	-63	-24

// Gu X, 2007: Rating Painful Pictures vs. Counting Neutral Pictures
// Gu X, 2007: Rating Painful Cartoons vs. Counting Neutral Cartoons
// Gu X, 2007: Rating vs. Counting Painful Pictures
// Gu X, 2007: Rating vs. Counting Painful Cartoons
// Subjects=12
-5.12	29.01	26.25
-2.74	27.39	43.18
46.5	41.67	9.55
-48.83	49.25	-7.51
41.96	25.75	-11.21
19.31	21.63	-8.18
12.14	36.52	25.21
-.52	30.04	48.48
58.4	37.46	9.76
-53.75	-70.85	5.58
-47.97	-40.61	41.71
-21.78	-63.73	57
-64.21	-19.08	43.22
-5.22	31.58	19.27
8.2	26.23	53.19
42.34	45.03	22.73
39.73	20.87	-17.41
20.61	11.18	6.28
-.97	44.15	15.71
-2.65	36.83	52.33
-48.56	-53.79	-7.4
-64.24	-19.29	41

// Jobard G, 2007: Reading > Listening
// Jobard G, 2007: Listening > Reading
// Jobard G, 2007: Conjunction of Reading and Listening Irrespective of the 
// Linguistic Complexity
// Jobard G, 2007: Reading > Listening, Text - Words
// Jobard G, 2007: Listening > Reading, Text - Words
// Jobard G, 2007: Reading > Listening, Text - Sentences
// Jobard G, 2007: Reading > Listening, Sentences - Words
// Jobard G, 2007: Text - Words
// Jobard G, 2007: Text - Sentences
// Jobard G, 2007: Sentences - Words
// Subjects=10
-16	-94	-6
24	-90	-4
-40	-72	-18
-26	-84	20
32	-78	22
-48	-52	-12
38	-44	-22
-28	-62	52
28	-68	62
-52	0	34
-22	-32	-2
26	-30	0
-52	-20	6
-60	-36	16
-44	-4	-14
-24	-44	-12
56	-14	0
66	-18	0
58	0	-8
62	-40	6
-56	-74	16
24	-48	14
-40	-36	64
44	20	20
-14	-42	14
8	-44	-16
-56	-48	6
-50	-44	-10
-48	-56	-12
52	-42	14
-48	2	54
-58	30	2
-46	26	16
-42	6	28
46	28	-4
60	28	-2
58	-6	44
46	6	58
0	8	58
32	-62	-28
-26	-68	-26
0	-36	-4
-14	-30	-6
-2	-56	-36
-12	-98	-2
-24	-82	-14
16	-88	4
24	-94	8
16	-62	-8
24	-30	-2
44	-20	8
-14	100	0
-28	-90	0
28	-94	6
-10	-86	2
-14	-92	-8
14	-76	8
14	-70	-6
-42	4	50
-46	4	54
-48	-52	20
-58	-56	-2
-50	-66	20
-58	-8	-16
-56	-16	-12
-54	-36	-6
-22	-42	-12
56	12	-24
-48	-54	20
-18	-42	-18
-30	-40	-18
-24	-50	-16
-56	-8	-14
-58	-56	-2
54	12	-22
6	-36	-8

// Szameitat A J, 2007: Imagery > Fixation
// Szameitat A J, 2007: Whole Body Movements - Fixation
// Szameitat A J, 2007: Upper Extremity Movements - Fixation
// Szameitat A J, 2007: Whole Body - Upper Extremity Movements
// Szameitat A J, 2007: Upper Extremity - Whole Body Movements
// Subjects=15
6	6	49
-4	10	47
32	-7	50
-26	-7	63
-42	-45	61
-30	-47	67
-63	-43	39
18	-3	19
22	-4	4
-36	23	-5
-48	12	-1
10	-5	51
-6	-7	59
32	-7	50
-26	-7	63
-42	-49	60
-28	-47	67
-46	-40	54
22	-4	4
20	-3	17
-36	23	-3
-40	14	5
-48	12	-1
-4	10	47
12	3	66
32	-7	50
-26	-7	63
-42	-45	61
-32	-47	67
-63	-43	39
59	-36	50
63	-29	46
51	-23	40
20	-5	19
20	-2	4
-36	23	-6
-12	-30	53
-18	-30	60
-16	-43	63
-8	-48	10
4	-19	54
65	-14	30
53	-18	36
51	-25	53
-61	-14	34
-67	-14	27
40	-38	63
32	-40	50

// Wessa M, 2007: Emotional Go/NoGo vs. Control Go/NoGo, Bipolar Patients > 
// Healthy Subjects
// Wessa M, 2007: Emotional Distractors vs. Neutral Distractors (NoGo), 
// Bipolar Patients > Healthy Subjects
// Subjects=17
60	-60	8
64	-40	-12
52	-40	8
32	60	0
-20	60	0
-4	24	28
8	-44	44
-32	-24	24
-8	-4	20
-12	12	24

// Wong S W, 2007: 35% Maximum Contraction - 5% Maximum Contraction, 
// Deactivations
// Wong S W, 2007: Right and Left Hand, 35% Trials, Activations
// Wong S W, 2007: Right and Left Hand, 35% Trials, Deactivations
// Subjects=17
0	48	-2
-50	-62	40
-18	58	26
-42	4	8
38	2	14
32	14	2
-22	-14	6
14	-18	8
30	-2	0
4	-2	62
6	6	48
32	-2	64
-30	26	24
28	38	22
-54	4	8
50	6	14
-26	-58	44
34	-42	46
28	-54	42
-40	0	32
50	-28	48
60	-32	24
-28	-54	-26
16	-46	-28
-2	-62	-24
8	-26	-12
-26	-92	-6
34	-86	-4
0	46	-4
-2	58	-4
-10	40	54
-38	-74	44
42	-82	24
12	-40	62
36	12	-22
-8	-40	44
2	-52	34
8	-68	18
-4	-84	24
6	-78	30
-24	-82	42
42	-82	24
-10	-54	2
14	-48	0

// Engels A S, 2007: High Anxious Apprehension Subjects
// Subjects=11
-44	20	16
-50	-38	0
-30	-58	44

// Engels A S, 2007: High Anxious Arousal Subjects
// Subjects=13
54	-16	-18

// Engels A S, 2007: Normals
// Subjects=18
20	-82	-18
-46	28	-2
-2	54	10
-54	-52	22

// Toyomura A, 2007: TAF vs. Non-TAF
// Subjects=12
62	-22	22
56	14	32
36	30	-2
-52	8	38
52	-10	-2
32	-42	44

// Vance A, 2007: ADHD Children
// Subjects=12
-18	-92	38
-24	-74	50
-38	-56	48
24	-70	32
32	-90	28
36	-40	50
18	-12	22

// Vance A, 2007: Normal Children
// Subjects=12
24	-70	34
28	-84	42
32	-90	30
-16	-88	36
40	-88	-16
-28	-80	2
-26	-86	14
44	-54	-22
-44	-76	-18
48	-28	36
36	-42	50
-40	-46	48
-30	-60	50
36	0	32
54	8	16
40	0	48
48	30	16
54	24	30
-36	38	-14
42	-72	-34
42	-86	-34
44	-52	-40
56	-74	-22
24	-70	32
32	-90	28
36	-40	50
18	-12	22

// Begliomini C, 2007: Grasping Small > Reaching Small
// Begliomini C, 2007: Grasping Large > Reaching Large
// Begliomini C, 2007: Grasping Small > Grasping Large
// Subjects=12
-33.87	-12.83	51.05
-50.11	-16.39	48.31
-33.8	-31.97	52.94
-33.88	-29.3	47.07
23.66	-54.78	-21.98
17.27	-53.01	-14.2
-43.46	-15.12	61.52
-50.22	-10.63	41.02
23.67	-51.38	-20.08
-37.14	-42.59	42.84

// Creem-Regehr S H, 2007: Hand vs. Fixation
// Creem-Regehr S H, 2007: Viewer vs. Fixation
// Creem-Regehr S H, 2007: Hand Degree vs. Hand Zero
// Creem-Regehr S H, 2007: Viewer Degree vs. Viewer Zero
// Creem-Regehr S H, 2007: Hand Degree vs. Viewer Degree
// Creem-Regehr S H, 2007: Hand vs. Fixation, Event-Related Design
// Creem-Regehr S H, 2007: Viewer vs. Fixation, Event-Related Design
// Creem-Regehr S H, 2007: Hand Rotation, Right Hand vs. Left Hand
// Creem-Regehr S H, 2007: Hand Rotation, Left Hand vs. Right Hand
// Creem-Regehr S H, 2007: Hand vs. Viewer, Event-Related Design
// Creem-Regehr S H, 2007: Viewer vs. Hand, Event-Related Design
// Creem-Regehr S H, 2007: Effect of Degree on Hand
// Subjects=18
-38	-88	-4
30	-88	-6
-30	-6	62
-4	-80	-20
12	-80	-24
4	-74	-16
-38	-40	40
-34	30	0
-26	32	6
-54	2	30
-4	10	48
-20	-72	50
30	-32	-2
28	-64	52
32	-68	26
-40	-88	-4
30	-88	-10
8	-70	-24
-6	-24	-8
32	-54	56
28	-64	44
28	-34	0
-26	-32	-6
-36	-30	34
34	-74	26
-34	-78	14
-14	-62	54
38	-74	16
52	-72	16
-18	-76	30
-42	-82	16
-22	42	4
-28	-36	30
12	-48	50
16	-68	60
-22	-60	-28
-42	12	4
-28	-8	62
-26	-16	48
-26	-46	62
-14	-52	62
38	-52	-34
34	-88	-8
-32	-6	60
-38	-90	-4
-32	-54	-24
-4	10	48
-20	-74	50
-34	-58	56
-22	12	-4
-26	18	2
30	-64	50
-54	4	34
-14	-12	18
-20	-32	4
-22	-20	-8
34	-88	-10
-34	-62	52
-20	-72	50
-26	-76	18
-32	-6	60
28	-2	58
-6	10	46
-32	-52	-24
-20	-32	2
-30	-84	-22
22	-32	12
46	-60	-34
-40	-26	50
10	-60	-16
52	-12	50
-8	-66	-18
38	-20	14
10	-8	46
-36	-50	64
-42	-40	54
28	-50	-30
26	-74	-10
-24	2	62
-22	-68	54
-10	-72	44
24	-68	54
30	0	54
32	-68	28
44	-50	46

// Gowen E, 2007: Eye-Hand Tracing vs. Fixation
// Gowen E, 2007: Eye-Hand Drawing vs. Fixation
// Gowen E, 2007: All Eye Conditions vs. All Hand Conditions
// Gowen E, 2007: All Hand Conditions vs. All Eye Conditions
// Gowen E, 2007: All Tracing vs. Drawing Conditions
// Gowen E, 2007: Hand Tracing vs. Hand Drawing
// Gowen E, 2007: Eye Drawing vs. Eye Tracing
// Gowen E, 2007: Eye-Hand Drawing vs. Eye-Hand Tracing
// Gowen E, 2007: Independent Tracing vs. Coordinated Tracing
// Gowen E, 2007: Independent Drawing vs. Coordinated Drawing
// Subjects=10
4	-62	-16
2	-74	-36
-26	-18	58
-34	-28	62
52	6	-2
48	-2	2
4	-62	-16
4	-72	-38
-28	-26	70
12	-64	-50
-4	-22	48
-36	-30	50
-34	-28	62
-10	-80	10
-8	-92	12
-44	52	10
-52	36	18
-58	14	10
-44	40	26
-62	-50	44
-44	-68	30
50	8	40
46	-12	46
60	-30	8
56	-22	-2
26	14	0
-38	-30	60
50	-40	16
-26	-18	68
-44	-28	58
8	-74	-46
4	-70	-34
10	-72	-50
4	-68	-26
4	-66	-22
68	-14	30
-46	-70	6
-42	-82	20
14	-84	0
-8	-76	-8
24	-96	0
-34	-80	8
-40	-82	20
-26	-48	60
-60	-10	40
-54	-2	42
50	-64	-32
42	-72	-14
-2	14	48
8	12	44
22	-2	54
22	-2	54
-6	-70	58
18	-76	50
22	-72	32
42	36	34
30	24	-20
-32	38	38
60	-50	22
48	-76	32
-6	-96	28
-40	-72	-30
-2	8	56
-20	18	56
24	28	56
14	30	34
-38	34	28

// Koch K, 2007: Schizophrenia Patients
// Subjects=13
-38.15	-51.24	-38.09
-.69	29.86	35.05
-58.53	14.35	-12.85
-.41	24.28	55.77
48.23	23.15	-27.87
48.93	27.28	27.74
45.08	-46.89	49.71
-32.61	-55.26	56.35
14.82	-40.52	50.72
-9.45	-72.82	5.02
-26.33	-80.82	35.24
-1.4	40.93	-18.7
60.51	2.08	-1.34
51.39	-71.18	30.72
-24.42	43.16	40.86
44.81	-5.18	36.62
-54.36	-52.02	46.31
14.82	-40.52	50.72
-26.33	-80.82	35.24
-11.61	-72.83	5.06
20.77	-64.21	3.65
-1.4	40.93	-18.7
51.4	-70.01	31.72
60.56	2.39	1.99
-11.18	-29.12	47.79
-54.36	-52.02	46.31
14.63	1.82	44.29

// Koch K, 2007: Normals
// Subjects=13
14.04	-82.47	-19.08
-38.03	-67.84	-31.96
16.81	-98.72	25.07
46.78	31.74	29.58
46.93	16.41	37.81
-48.55	26.14	9.34
-.58	27.4	43.14
55.79	-44.29	42.55
-9.45	-72.82	5.02
-26.33	-80.82	35.24
-1.4	40.93	-18.7
60.51	2.08	-1.34
51.39	-71.18	30.72
-24.42	43.16	40.86
44.81	-5.18	36.62
-54.36	-52.02	46.31
14.82	-40.52	50.72
-26.33	-80.82	35.24
-11.61	-72.83	5.06
20.77	-64.21	3.65
-1.4	40.93	-18.7
51.4	-70.01	31.72
60.56	2.39	1.99
-11.18	-29.12	47.79
-54.36	-52.02	46.31
14.63	1.82	44.29

// Lagopoulos J, 2007: Bipolar Disorder Patients
// Subjects=10
-46	28	4
52	8	-18
-54	-36	4
38	-90	-2
10	14	4
-40	-84	-8
46	28	0
-44	24	0
-10	-98	6
-54	-8	0
4	52	0
14	16	6
-50	12	-2
-34	44	-2
12	20	10
14	-18	8
26	2	10
40	-14	46
-42	-10	46
44	24	6
8	-32	-12
40	26	6
38	42	32
20	-72	32
14	62	34
10	42	12
10	56	6

// Lagopoulos J, 2007: Healthy Controls
// Subjects=10
-24	-50	-18
-4	-80	-2
46	24	-2
-40	20	-2
48	30	4
34	46	36
12	-82	36
4	-40	-6
10	-96	-6
42	-70	-6
-18	-94	-6
44	26	0
56	-50	32
8	-98	0
-12	-98	0
26	-26	6
-52	-44	0
46	-52	6
-44	-30	6
36	-86	6
44	48	32
-6	-62	32
16	-78	32
6	4	-6
-55	-26	12
-32	45	12
9	40	12
12	60	36
-12	67	14
14	-20	14
22	2	16
14	-78	34
-8	-60	32
35	-14	48
-38	-12	46
44	24	6
8	-32	-12
40	26	6
38	42	32
20	-72	32
14	62	34
10	42	12
10	56	6

// Mallol R, 2007: Parkinson's Disease Patients
// Subjects=13
-41.46	-20.71	47.47
-24.1	-4.72	56.8
-37.08	-11.46	54.33
29.9	1.85	55.23
45.16	-41.91	57.06
44.95	-35.82	41.89
53.55	-27.38	39.79
22.71	-17.71	-4.34
30.17	0.19	-8.48
44.33	-10.94	-2.02
11.69	29.9	-11.11
-3.18	41.6	11.52
-41.93	-24.25	9.73
10.6	-72.65	51.73
-22.71	-18.19	-6.88
18.52	-.32	9.7
5.9	27.42	43.03
42.64	7.88	38.73
-.49	-43.09	35.54
7.63	-11.93	0.95

// Mallol R, 2007: Normals
// Subjects=11
-34.89	-24.43	53.33
-32.69	-31.76	55.14
-34.73	-41.78	62.89
8.19	5.4	48.53
-2.59	-1.02	49.35
-2.66	10.47	45.97
-29.01	-13.56	8.46
60.48	14.95	-1.49
55.19	-2.84	3.72
61.19	-31.2	44.52
53.56	-33.87	39.31
65.28	-20.83	28.86
58.76	5.09	30.89
-53.53	-39.64	29.38
-64.33	-39.68	29.57
32.26	-43.67	61.94
20.7	2.02	11.67
22.71	-17.71	-4.34
30.17	0.19	-8.48
44.33	-10.94	-2.02
11.69	29.9	-11.11
-3.18	41.6	11.52
-41.93	-24.25	9.73
10.6	-72.65	51.73
-22.71	-18.19	-6.88
18.52	-.32	9.7
5.9	27.42	43.03
42.64	7.88	38.73
-.49	-43.09	35.54
7.63	-11.93	0.95

// Milner T E, 2007: Simple Grip vs. Rest
// Milner T E, 2007: Complex Grip vs. Rest
// Milner T E, 2007: Complex Grip vs. Simple Grip
// Subjects=17
-42	-22	48
18	-54	-18
-36	-20	56
20	-56	-20
14	-62	-54
-14	-22	6
-44	0	4
-34	-32	60
-50	-26	14
-40	-42	60
68	-26	20

// Ogino Y, 2007: Pain vs. Rest
// Ogino Y, 2007: Fear vs. Rest
// Ogino Y, 2007: Pain vs. Fear
// Subjects=10
40	8	-8
36	-4	12
64	-32	36
52	6	8
8	10	52
4	14	32
8	-6	48
34	-52	60
-34	-50	52
-24	-62	-56
-12	-74	-48
4	-64	-48
48	-70	-4
-54	-66	-16
-20	4	-16
-4	8	40
2	-32	-4
-10	-74	-40
44	-80	-12
42	-60	-24
52	-78	0
58	-32	16
18	-48	72
-62	-26	20
-58	-48	48
-54	-34	52
42	-6	-12
8	-54	-56
-26	-50	-48
-14	-56	-48

// Sowell E R, 2007: Children with Heavy Prenatal Alcohol Exposure
// Subjects=11
-52	-22	0
62	-2	-8
-42	46	20
-68	-24	8
-66	-22	8

// Sowell E R, 2007: Control Children
// Subjects=16
-60	-24	6
-42	46	20
-68	-24	8
14	18	-22
36	-4	44
-40	48	20
-64	-22	8
-66	-22	8

// Sowell E R, 2007: IQ-Matched Control Children
// Subjects=11
14	18	-22
36	-4	44
-40	48	20
-64	-22	8

// Stoeter P, 2007: Somatoform Pain Disorder Patients
// Subjects=17
-34	12	6
-6	50	42
-60	-8	-4
-56	-40	16
-22	-28	-22
-4	-32	6
-26	-16	10
24	58	0
62	-6	-6
28	-2	-28
52	-68	30
-52	-2	48
0	60	36
-18	2	66
-30	-50	16
-31	-30	-24
-14	-56	-14
44	34	36
8	14	66
44	-22	46
6	-48	40
24	-74	10
-46	44	2
-34	-4	16
-8	10	4
18	-30	8
-22	6	34
-44	0	34
-38	2	-38
-10	2	38
-48	42	10
-46	-40	14
-44	-18	12
0	-56	20
2	64	6
-10	56	36
-62	-22	30
-24	-28	20
-28	16	-4
24	62	0
52	36	18
-52	-42	28
-20	96	24
-2	-64	48
-2	-14	12
30	-20	22
18	-36	6
34	-48	42
32	-76	42
16	-22	18
-38	-22	20
-42	-62	-8
-28	-54	66
22	56	-4
42	-70	-6
28	-48	68
-60	-8	-4
58	-14	0
-60	-6	-4

// Stoeter P, 2007: Normals
// Subjects=17
-34	12	6
-6	50	42
-60	-8	-4
-56	-40	16
-22	-28	-22
-4	-32	6
-26	-16	10
24	58	0
62	-6	-6
28	-2	-28
52	-68	30
-52	-2	48
0	60	36
-18	2	66
-30	-50	16
-31	-30	-24
-14	-56	-14
44	34	36
8	14	66
44	-22	46
6	-48	40
24	-74	10
-46	44	2
-34	-4	16
-8	10	4
18	-30	8
-22	6	34
-44	0	34
-38	2	-38
-10	52	24
-26	-46	-4
-4	-10	34
-24	-24	34
16	52	28
34	30	-14
56	34	8
30	-16	-10
12	-2	36
28	-20	38
-54	6	18
-14	-14	14
-36	-80	-42
48	42	-2
-52	-42	28
-20	96	24
-2	-64	48
-2	-14	12
30	-20	22
18	-36	6
34	-48	42
32	-76	42
16	-22	18
-38	-22	20
-42	-62	-8
-28	-54	66
22	56	-4
42	-70	-6
28	-48	68

// Wang Y, 2007: Language Switching vs. Language Non-Switching
// Wang Y, 2007: Forward Switching vs. L2 Non-Switching
// Wang Y, 2007: Backward Switching vs. L1 Non-Switching
// Wang Y, 2007: Forward Switching vs. Backward Switching
// Wang Y, 2007: Backward Switching vs. Forward Switching
// Subjects=12
-15	43	39
-18	51	25
18	45	34
15	-18	48
15	23	-4
0	25	43
0	47	14
0	40	-12
-12	-1	47
-42	-59	39
-65	-26	1
65	-16	20
27	-41	-3
-24	-66	-35
-3	-17	9
0	29	46
0	39	26
-62	-36	34
36	59	5
39	50	9
3	43	-12
-62	-29	1
18	-89	27
39	2	50
-24	-48	-23
33	-85	-3
3	-73	-4

// Wrase J, 2007: Alcoholic Subjects
// Subjects=16
-40	20	-4
4	-15	4
-16	12	-4
32	-23	-2
4	23	2
-40	19	-4
-4	-15	5
-16	12	-4
-36	51	1
20	4	0
-4	-19	1
32	-77	22
8	-50	10
-63	-31	-5
63	-38	13
4	-27	5
-36	-85	8
-21	-69	22
-36	-65	22

// Wrase J, 2007: Normals
// Subjects=16
-16	11	-7
12	8	-4
-16	12	-4
32	-23	-2
4	23	2
-20	15	-7
20	11	-7
-12	4	0
-16	12	-4
-36	51	1
4	-27	5
-36	-85	8
-21	-69	22
-36	-65	22

// Addis D R, 2007: Event Construction > Semantic Retrieval
// Addis D R, 2007: Event Elaboration > Visual Imagery
// Addis D R, 2007: Future Event Construction > Past Event Construction
// Addis D R, 2007: Future Event Elaboration > Past Event Elaboration
// Addis D R, 2007: Construction > Elaboration
// Addis D R, 2007: Elaboration > Construction
// Subjects=14
-22.81	-21.14	-15.55
61.1	-23.1	39.24
61.2	-39.81	44.25
-13.34	-69.62	39.51
40.31	-80.95	7.22
-1.32	67.81	-6.79
-5.18	55.91	26.95
25.27	41.11	39.1
-3.61	42.74	-22.2
-3.53	49.95	-13.95
-3.4	10.39	-12.28
3.02	36.25	-11.59
-2.68	-9.4	40.09
-22.84	-19.12	-16.87
-18.31	-36.15	-4.06
31.39	-35.97	-4.92
-36.11	13.52	-34.44
-56.39	-9.87	-19.46
73.28	-8.15	-19.6
-11.22	-38.14	43.08
3.64	-49.95	19.34
-7.05	-50.22	28.52
-11.21	-51.22	41.01
-47.96	-53.68	39.64
51.51	-51.65	44.47
-26.59	-99.16	11.28
-3.54	-57.39	-36.95
11.55	-55.42	-39.64
5.42	64.28	12.49
-43.88	11.31	34.26
56.21	39.37	7.37
39.8	54.23	-5.03
53.28	20.92	28.3
-41.79	7.51	27.88
-22.98	13.75	-21.24
55.09	41.29	4.96
62.43	32	-14.42
-18.52	49.77	-3.59
44.19	-22.93	-15.4
56.29	-37.7	-1.81
6.29	-50.66	57.47
-42.16	-60.98	-15.76
38.01	-55.74	1.4
-32.89	-77	30.49
-13.86	-91	-5.43
-16.1	-74.09	-8.19
48.79	-51.45	0.79
-39.96	-54.07	-10.88
42.42	-76.89	4.54
25.68	-57.6	51.1
23.62	-50.29	60.5
29.88	-65	40.56
-30.98	-84.39	8.77
42.29	-66.99	-4.28
-33.19	-90.23	3.79
35.93	-85.74	2.16
-15.94	-88.25	1.06
-13.42	-85.55	29.88
-22.89	64.75	-3.88
-35.28	31.76	34.33
-35.91	54.4	-10.48
58.12	29.86	-14.13
-6.74	-44.64	53.73
-57.68	-53.72	39.81
-33.8	-61.96	-38.22
39.58	-54.67	-44.67

// Ahrens K, 2007: Conventional Metaphor Sentences vs. Literal Sentences
// Ahrens K, 2007: Anomalous Metaphor Sentences vs. Literal Sentences
// Ahrens K, 2007: Anomalous Metaphor Sentences vs. Conventional Metaphor 
// Sentences
// Subjects=8
58.75	-25.23	-20.47
-2.81	11.77	50.74
3.53	32.96	48.89
-45.55	7.11	49.39
-52.11	18.74	35.11
-52.16	22.62	30.32
-44.02	35.99	-17.73
-50.08	24.24	23.47
54.77	19.55	36.04
43.6	36.52	-18.78
50.38	22.72	22.44
-54.57	30.79	-1.56
56.58	27.22	-2.54
54.41	22.47	-8.81
-34.72	-13.29	59.9
46.26	4.52	35.17
44.06	21.43	33.78
1.24	44.6	34.55
-2.84	11.43	46.31
9.71	57	28.96
-58.89	12.64	-15.6
56.56	15.96	-10.52
-60.73	-45.73	0.46
60.9	-25.05	-18.28
56.63	-27.19	-18.05
-45.92	-49.47	-21.7
-28.66	-93.78	-18.18
37.61	-88.81	-14.9
50.39	-76.04	-16.11
-2.82	7.2	46.66
-46.02	30.84	-1.66
37.31	24.48	-8.78
5.72	31.37	55.69
7.81	30.87	49.01
-49.96	16.63	35.26
-50.1	26.18	21.08
52.65	15.3	36.42
50.45	21.29	31.48
-52.22	24.22	23.5
-46	31.01	0.55
-50.09	13.15	17.71
-54.55	30.96	0.65
-52.47	32.57	-6.2
-36.9	-7.13	57.17
-45.54	5	49.57
48.4	2.42	35.32
-48.05	-51.6	-21.49
25.2	-75.8	44.38

// Altmann C F, 2007: Sheep vs. Barking Dog
// Altmann C F, 2007: Left vs. Right Sound Localization
// Altmann C F, 2007: Sound Pattern and Localization
// Altmann C F, 2007: Sound Pattern > Localization
// Altmann C F, 2007: Localization > Sound Pattern
// Subjects=17
-56.44	3.68	-12.28
-67.33	-22.95	10.04
56.84	5.56	-17.87
70.58	-20.92	3.45
-71.31	-20.24	11.74
68.38	-37.33	14.08
-63.41	-28.19	11.16
69.57	-25.08	8.48
-66	-1.38	-8.48
58.09	-1.38	-14.18
77.31	-25.18	-3.41
33.77	-47.79	34.98
38.88	36.99	-12.61
-45.3	-27.86	50.49
35.36	-24.97	45.92

// Dick F, 2007: Language vs. Tones
// Dick F, 2007: Environmental Sound vs. Tones
// Dick F, 2007: Language vs. Environmental Sound
// Dick F, 2007: Environmental Sound vs. Language
// Subjects=12
-56	22	26
-46	28	18
-44	18	26
-38	12	36
56	34	0
38	30	12
-28	-48	-10
-40	-74	14
-56	-12	6
-40	-60	12
-52	-60	-12
-46	-32	0
56	-12	-4
46	-48	-16
52	-18	-4
58	-6	-6
46	-72	20
38	-26	-18
64	-32	0
-46	30	12
-46	40	-12
-40	42	-12
44	12	30
52	40	8
56	36	6
50	42	-6
-50	-44	12
-40	-44	-16
-38	-42	-18
-46	-60	-12
-46	-68	-10
-38	-26	-22
-44	-72	18
-44	-14	-4
-28	6	-28
-52	-26	8
-58	-6	-12
-28	-2	-18
62	-6	0
50	-36	12
40	-36	8
38	-62	-18
56	6	-16
50	-66	-4
-64	-26	0
-32	-44	-10
-56	-38	6
46	-60	-12
46	-54	-12
56	-14	-6
40	-48	-18
38	-38	-24
50	-66	-16
58	6	-4
44	10	32
50	28	20
56	-30	14
58	-42	20
64	-20	14
64	-42	12

// Fusar-Poli P, 2007: N-Back, Positive Correlation
// Fusar-Poli P, 2007: Random Movement Generation, Positive Correlation
// Fusar-Poli P, 2007: Overt Letter Fluency, Positive Correlation
// Fusar-Poli P, 2007: Spatial Objects Location, Positive Correlation
// Fusar-Poli P, 2007: N-Back, Negative Correlation
// Fusar-Poli P, 2007: Random Movement Generation, Negative Correlation
// Fusar-Poli P, 2007: Overt Letter Fluency, Negative Correlation
// Fusar-Poli P, 2007: Spatial Objects Location, Negative Correlation
// Subjects=10
-53.14	-53.37	11.06
40	-10.35	49.87
5.68	9.02	41.95
-10.84	15.85	-19.77
-25.6	49.76	21.05
5.21	23.86	-13.93
-10.91	47.02	-15.69
8.67	6.73	12
-18.04	30.77	22.55
-17.93	24.31	35.36
-5.96	-46.98	34.51
-56.72	-45.19	-34.2
5.15	39.72	-15.26
43.9	-59.33	-19.67
39.81	-72.79	-.65
-32.91	-33.16	9.13
16.5	-75.28	24.36
63.37	-11.67	30.75
-6.18	-25.08	14.83
-32.77	-31.7	27.96
27.7	-44.68	-35.21
-48.8	-28.46	30.1
-41.23	-30.81	40.25
-10.54	-26.05	2.7
39.35	23.46	-22.1
8.75	-66	-6.44
-13.67	-70.37	-5.82
20.25	12.74	-7.6
24.87	-52.91	10.12
-36.85	-34.07	52.74
55.61	13.9	4.16
59	-36.84	8.38
63.28	-12.61	18.57

// Gur R C, 2007: Target Green Circles > Standard Red Circles
// Gur R C, 2007: Novel > Standard Red Circles
// Subjects=36
-54.12	-15.11	37.97
-45.43	-26.72	52.22
-45.46	-27.07	47.79
-3.04	-21.44	6.69
5.52	-16.81	10.66
-3.08	-30.58	-1.47
-11.6	0.35	13.88
57.11	-22.22	46.21
61.35	-13.74	45.45
40.05	-13.18	54.57
-.65	3.15	49.21
5.76	3.19	49.13
-.69	2.81	44.77
5.72	2.85	44.7
-54.3	5.01	22.9
-54.27	5.35	27.33
-67.24	-.67	5.68
-32.95	-8.24	14.84
-32.98	-8.58	10.41
-2.9	-68.3	6.15
-2.87	-67.96	10.59
18.62	-62.23	27.7
-23.94	-56.2	54.45
-28.22	-56.23	54.5
35.57	-50.47	13.14
43.96	0.68	13.21
31.57	-78.39	37.83
35.7	-84.31	15.97
31.56	-65.36	41.2
26.84	-48	-9.27
26.97	-64.24	1.01
-28.73	-48.34	-8.61
-28.71	-52.57	-8.25
-24.09	-79.75	25.2
-24.08	-83.98	25.56
10.02	-76	15.57
-7.09	-71.87	15.42
-7.35	-4.2	9.75
48.34	10.54	30.18
44.26	-70.88	23.67

// Kobayashi C, 2007: Adults
// Subjects=16
-59	-27	7
10	52	34
40	47	5
28	21	-8
6	-3	26
55	-8	-6
18	52	-6
28	15	25
-8	-80	22
-6	-22	58
17	-3	-12
60	24	21
62	-54	3
26	-95	-4
-12	-86	-6
4	56	23
-16	-4	-10
38	40	31
52	-30	32
14	-94	21
64	-49	26
-63	-47	23
61	8	1
36	5	-20
-2	-79	13
24	50	-13
-21	-11	-7
-61	-6	-3
50	-9	-12
-14	-2	-5
40	36	-15
42	11	-9
-65	-34	1
-42	-55	21
61	-52	17
-34	5	-17
-57	20	17

// Kobayashi C, 2007: Children
// Subjects=12
-59	-27	7
10	52	34
40	47	5
28	21	-8
6	-3	26
55	-8	-6
18	52	-6
28	15	25
-8	-80	22
-6	-22	58
17	-3	-12
60	24	21
62	-54	3
26	-95	-4
-12	-86	-6
4	56	23
-16	-4	-10
38	40	31
52	-30	32
14	-94	21
64	-49	26
-63	-47	23
61	8	1
36	5	-20
-2	-79	13
24	50	-13
-21	-11	-7
-61	-6	-3
50	-9	-12
-14	-2	-5
40	36	-15
42	11	-9
-44	14	12
-65	-34	1
-42	-55	21
61	-52	17
-34	5	-17
-57	20	17

// Malhi G S, 2007: Normals
// Subjects=10
-24.5	53.37	26.31
54.63	15.98	17.38
-43.8	28.36	7.44
-34.81	-21.89	45.01
-40.23	-27.09	33.24
-2.81	-6.89	43.38
66.55	-48.17	12.59
-59.85	-1.57	-6.59
-52.03	-58.4	14.81
-40.4	-24.49	11.83
-50.12	4	9.55
21.48	-58.15	-16.17
51.42	-64.32	-15.99
51.4	-70.03	-21.09
-13.7	-21.16	11.25
24.62	-54.33	-22.1
12.65	53.14	-7.55
-9.81	56.18	-7.55
-6.63	41.59	-17.52
-16.76	-49.38	18.11
41.09	-27.69	45.74
60.99	-4.3	2.28
-21.39	-21.23	-16.54
-24.76	-10.81	-32.99
-18.27	-12.21	-24.02
-18.1	-56.62	-20.3
-13.8	-51.85	-14.06
-38.57	49.2	1.17
-40.74	44.44	-5.1
37.65	11.53	30.22
41.04	-19.49	41.7
37.83	-36.05	34.21
29.93	5.74	-2.66
-20.17	-60.26	-12.16
-21.14	-85.64	-10.02
32.57	-40.69	43.58
30.46	-66.76	36.87
34.62	-73.4	19.53
-9.14	-88.46	21.3
-3.85	-91.23	12.55
5.8	-80.97	20.5
-21.32	-55.66	-21.46
-27.33	-82.23	20.99
-21.11	-87.5	-6.52
-4.95	-95.98	6.27
26.97	-84.04	-7.37
-56.41	4.19	26.34
-56.39	-28.56	15.7
-59.8	3.35	1.91
-20.28	-19.74	-11.1
24.55	-28.7	-20.9
-18.11	-36.9	-13.03
-57.36	-26.48	28.92
16.19	-64.19	-11.14
22.49	-58.66	-22.83
-34.11	-8.13	2.58

// Malhi G S, 2007: Bipolar Patients
// Subjects=10
-51.98	-24.96	34.31
-52.03	-25.47	27.66
-38.03	-19.88	43.76
-53.1	-60.69	12.78
-46.84	-52.25	-2.49
-45.67	-69.96	2.32
-40.58	-3.31	-3.32
-35.14	-7.71	8.13
-40.33	-78.64	-.35
-28.43	-85.92	14.62
-9.53	-32.19	-7.95
-32	-10.66	-2.81
-13.74	-35.93	-.9
-11.64	-33	-4.51
15.3	-53.59	15.86
-16.08	-21.54	-21.04
29.84	-21.52	-24.91
-36.57	4.98	-34.18
25.56	-22.77	-26.99
-21.46	-23.06	-26.42
42.84	-66.91	-21.25
42.86	-78.71	-22.49
-49.06	-72.92	-21.92
21.35	-37.43	-23.48
-46.91	-71.68	-19.82
38.62	-81.74	-19.96
48.11	-64.31	-29.34
-38.57	49.2	1.17
-40.74	44.44	-5.1
37.65	11.53	30.22
41.04	-19.49	41.7
37.83	-36.05	34.21
29.93	5.74	-2.66
-20.17	-60.26	-12.16
-21.14	-85.64	-10.02
32.57	-40.69	43.58
30.46	-66.76	36.87
34.62	-73.4	19.53
-9.14	-88.46	21.3
-3.85	-91.23	12.55
5.8	-80.97	20.5
-21.32	-55.66	-21.46
-27.33	-82.23	20.99
-21.11	-87.5	-6.52
-4.95	-95.98	6.27
26.97	-84.04	-7.37
-56.41	4.19	26.34
-56.39	-28.56	15.7
-59.8	3.35	1.91
-20.28	-19.74	-11.1
24.55	-28.7	-20.9
-18.11	-36.9	-13.03
-57.36	-26.48	28.92
16.19	-64.19	-11.14
22.49	-58.66	-22.83
-34.11	-8.13	2.58

// Soderlund H, 2007: Word Encoding, Alcohol = Placebo
// Soderlund H, 2007: Word Encoding, Alcohol NOT= Placebo
// Soderlund H, 2007: Phrase-Word Pair Encoding, Alcohol = Placebo
// Soderlund H, 2007: Phrase-Word Pair Encoding, Alcohol NOT= Placebo
// Soderlund H, 2007: Object Pair Encoding, Alcohol = Placebo
// Soderlund H, 2007: Object Pair Encoding, Alcohol NOT= Placebo
// Soderlund H, 2007: Face-Name Pair Encoding, Alcohol NOT= Placebo
// Subjects=12
-46.02	28.64	-2.6
-8.36	50.18	38.66
-3.91	25.68	51.81
-34.91	15.47	46.34
-50.16	26.72	14.34
52.53	-34.22	1.54
40.42	45.47	-12.81
4.72	21.13	61.02
-36.3	-55.93	-23.5
0.72	-59.6	63.37
-25.33	-94.67	-2.53
-18.95	-4.93	28.9
-43.43	-30.37	32.43
25.62	-45.15	-27.34
14.54	-92.07	41.4
-46.04	23.98	-7.78
-41.73	28.83	-.43
-37.21	-76.31	-11.74
-40.26	4.43	41.75
-3.89	20.39	52.26
-43.13	-47	65.05
10.19	-46.74	49.92
45.26	-38.72	26.54
-3.84	14.31	56.11
47.02	37.62	8.97
39.54	-45.87	-24.09
-37.28	-48.47	-9.61
32.19	-47.89	-8.23
-29.38	-59.46	40.29
-56.4	-68.25	-2.16
-29.69	-74.69	-5.27
16.35	-96.54	-2.85
57.67	8.74	-7.69
-46.74	-4.04	29.15
-17.72	-20.81	43.6
10.1	-25.76	45.93
-.75	-37.4	20.27
-14.57	10.47	48.75
52.27	17.97	-11.75
1.6	-39.56	47.19
61.2	-32.88	18.06
50.56	-43.44	20.18

// Wang A T, 2007: Autistic Subjects
// Subjects=18
-8	50	30
0	52	28
-64	-28	0
50	2	-4
-56	-36	0
40	-64	20
-66	-32	10
52	-26	10
-56	-30	2
56	-6	-2
-60	-54	10
54	-50	4
48	-62	6
-52	-64	18
52	-60	20
52	2	-8
-40	-62	-16
36	-46	-14
-34	-70	-14
36	-60	-8
-24	-82	-2
12	-86	0
-46	-84	10
34	-82	8
-30	-92	4
14	-90	-4
-18	-94	12
18	-88	10
-8	52	32
4	58	14
34	2	36
40	12	38
-50	14	26
52	16	16
-52	20	18
40	30	0
-40	-32	14
54	-24	6
-54	-20	4
50	-20	2
-56	-46	6
54	-2	-8
-46	-62	10
46	-62	6
-44	-60	20
-56	6	-10
40	10	-26
-40	-50	-10
40	-54	-10
-32	-78	-8
28	-76	-10
-22	-80	-8
16	-80	0
-46	-84	8
40	-74	4
-28	-86	-6
20	-88	2
-8	-92	10
16	-92	12
-30	-70	-26
2	50	20
-6	58	22
-52	-18	10
-60	-24	2
56	-8	-2
48	-10	-14
10	-78	-22
-52	-20	10
-60	-22	6
56	-8	-2
48	-12	-8
0	-90	20
0	-80	10
-10	-76	-22
10	-78	-28
10	42	36
-8	56	26
-4	58	18

// Wang A T, 2007: Controls
// Subjects=18
4	42	12
-6	64	12
14	50	-4
-58	-24	6
48	-21	10
-64	-20	2
56	-10	0
-8	50	30
0	52	28
-64	-28	0
50	2	-4
-56	-36	0
40	-64	20
-10	58	28
2	50	20
-2	62	18
48	2	34
-58	18	16
32	14	22
-56	22	20
50	24	10
-44	22	-10
-48	-30	8
48	-24	6
-60	-22	2
54	-8	-2
-58	-4	-8
46	-38	2
50	-60	10
-48	-66	14
38	-70	16
-42	16	-18
38	16	-20
-40	-44	-14
38	-48	-14
-32	-80	-8
26	-74	-10
-26	-78	-6
24	-80	0
-32	-88	8
28	-82	4
-36	-84	-4
38	-76	-2
-12	-94	20
10	-90	14
-28	-74	-28
12	-80	-20
-6	40	48
-6	52	30
0	62	20
-44	42	4
-56	16	14
50	18	24
-56	18	8
50	24	16
-48	30	-2
-52	-28	6
52	-20	10
-58	-22	4
50	-10	0
-66	-30	0
54	-6	-4
-54	-68	8
52	-58	10
-48	-66	12
38	-68	12
-46	10	-26
40	14	-20
-44	-48	-12
32	-46	-16
-32	-56	-10
40	-48	-8
-20	-82	-4
22	-78	-2
-32	-86	8
30	-84	8
-34	-82	-4
40	-74	0
-4	-92	12
16	-88	10
-26	-72	-32
16	-66	-20
2	50	20
-6	58	22
-52	-18	10
-60	-24	2
56	-8	-2
48	-10	-14
10	-78	-22
-52	-20	10
-60	-22	6
56	-8	-2
48	-12	-8
0	-90	20
0	-80	10
-10	-76	-22
10	-78	-28
10	42	36
-8	56	26
-4	58	18

// Lawrence N S, 2007: Disgust vs. Neutral, All Subjects
// Lawrence N S, 2007: Disgust vs. Neutral, OCD Patients > Normals
// Lawrence N S, 2007: Disgust vs. Neutral, Normals > OCD Patients
// Lawrence N S, 2007: Fear vs. Neutral, All Subjects
// Subjects=17
-42.52	-73.8	-6.31
51.55	-68.49	-1.15
45	-56.78	-14.32
-59.58	-43.81	11.44
-53.08	-63.78	14.16
-31.76	-85.02	-1.03
25.64	8.8	-3.99
-13.72	-13.75	10.63
-7.41	-5.94	0.98
-42.87	36.86	-6.67
-13.7	-15.7	13.02
36.35	31.13	8.52
-43.71	-55.29	-14.54
46.28	-40.29	19.97

// Roth R M, 2007: Medicated OCD Patients
// Subjects=6
32	31	6
28	26	52
30	-36	55
26	-35	0
24	-87	12
16	-2	4
8	-37	-30
-28	46	25
-10	35	44
-40	21	23
-32	21	-3
-34	15	36
-42	42	-7
-46	-33	-5
-14	-11	-20
-28	-11	-25
-20	-93	5
6	-13	56
42	13	-4
42	-14	62
46	-27	42
65	-35	7
48	-33	9
24	-48	-18
26	-85	10
-44	-4	-2
-12	-72	-3
-6	10	1.4
32	33	-8
-40	21	23
46	-18	60
12	-44	48
2	-76	0
42	-2	-35
42	-50	-26
-52	-31	35
-18	-54	50
-6	-17	14
-12	9	62
-24	-67	-15
-30	-50	-21
28	37	44
10	-16	36
42	-36	-14
59	0	-8
36	-5	-28
14	-23	7
-2	52	-8
-42	-6	-5
-2	-60	-34
-14	24	10

// Roth R M, 2007: Unmedicated OCD Patients
// Subjects=6
32	33	-8
-40	21	23
46	-18	60
12	-44	48
2	-76	0
42	-2	-35
42	-50	-26
-52	-31	35
-18	-54	50
-6	-17	14
-12	9	62
-24	-67	-15
-30	-50	-21
28	37	44
10	-16	36
42	-36	-14
59	0	-8
36	-5	-28
14	-23	7
-2	52	-8
-42	-6	-5
-2	-60	-34
-14	24	10

// Roth R M, 2007: Normals
// Subjects=14
61	19	27
12	2	40
44	-13	61
63	-33	5
46	6	-29
26	-77	13
50	-55	-7
6	-22	-7
-32	35	30
-30	41	-4
-63	-31	0
-48	-52	1
-46	-7	-27
6	-13	56
42	13	-4
42	-14	62
46	-27	42
65	-35	7
48	-33	9
24	-48	-18
26	-85	10
-44	-4	-2
-12	-72	-3
-6	10	1.4

// Tobler P N, 2007: Activations Correlated with Magnitude
// Tobler P N, 2007: Activations Correlated with Probability
// Tobler P N, 2007: Activations Correlated with Expected Value
// Subjects=16
-12	2	6
18	-6	2
12	36	36
50	16	6
-10	4	-4
18	-18	-12
-20	-16	-14
18	18	-14
-2	48	-12
8	58	10
-4	64	8
52	26	-2
28	42	26
-34	48	10
-8	12	6
16	-6	4
-30	34	0
14	46	18
52	28	8

// Yucel M, 2007: OCD Patients
// Subjects=19
2	0	52
4	4	52
-2	8	52
4	2	46
6	0	58
0	0	60
-12	10	40
20	-80	50
20	-10	60
-16	0	12
18	-4	12
34	14	2
22	8	12
48	-4	26
38	-22	56
-32	20	2
-42	-34	34
2	-10	52
-10	-86	40
-60	-6	12
24	-14	60
-34	30	26
-36	-12	4
2	40	26
-26	26	-14
54	-54	-14

// Yucel M, 2007: Normals
// Subjects=19
0	12	48
-8	16	46
4	10	48
-2	4	48
6	0	58
4	6	54
24	-76	32
28	-6	60
-28	0	56
20	-6	58
36	16	22
50	-4	34
36	-62	-26
-16	4	14
34	-58	-14
2	-10	52
-10	-86	40
-60	-6	12
24	-14	60
-34	30	26
-36	-12	4
2	40	26
-26	26	-14
54	-54	-14

// Mochizuki H, 2007: Itching
// Mochizuki H, 2007: Itching > Pain
// Mochizuki H, 2007: Pain
// Mochizuki H, 2007: Pain > Itching
// Subjects=14
-16	-4	64
48	8	8
-48	10	4
-38	-14	-4
8	16	36
2	-38	26
-16	4	6
-38	-14	-4
2	-38	26
-4	-2	58
36	10	6
-42	10	-4
-8	10	40
-18	6	4
50	-22	12
-2	-4	6
-2	-4	6

// Abler B, 2007: Depressed Patients > Normals, Negative - Neutral Picture 
// Expectation
// Abler B, 2007: Depressed Patients > Normals, Negative - Positive Picture 
// Expectation
// Abler B, 2007: Depressed Patients > Normals, Negative - Neutral Picture 
// Presentation
// Abler B, 2007: Depressed Patients > Normals, Positive - Neutral Picture 
// Presentation
// Subjects=12
-21	0	-9
27	-3	-9
-3	-6	69
-51	21	33
24	-3	-6
12	21	33
-3	24	-15

// Matsuo K, 2007: Depressed Patients
// Subjects=15
-30	0	48
40	0	42
-16	0	42
42	4	30
-26	0	48
-6	12	42
-32	34	26
-30	52	16
38	4	28
42	26	28
2	14	48
0	20	40
6	22	34
-34	32	28
-30	52	16

// Matsuo K, 2007: Normals
// Subjects=15
-30	0	46
-44	18	20
-24	10	44
44	54	6
44	34	20
-26	0	44
-34	32	28
-30	52	16

// Walter H, 2007: Depressed Patients
// Subjects=12
-42	-45	48
-18	-72	48
-45	-3	51
0	6	63
-45	27	24
33	-66	-27
-27	-75	30
30	24	3
-18	-72	48
-36	-3	57
0	12	57
33	-66	-30
30	-60	48
30	0	54
-18	6	3
33	21	3
-51	-60	-12
-18	-72	48
-45	27	24
30	-60	48
-51	-60	-12
30	-69	-27
27	0	54
30	21	0
-33	-66	-27
51	3	48
45	39	27
-9	-81	9

// Walter H, 2007: Normals
// Subjects=17
-36	-81	-12
42	-69	-24
-42	-42	45
-51	3	36
-24	69	54
33	-63	54
-51	3	36
21	-66	60
30	-66	-27
30	-3	66
-33	-69	-24
-39	24	0
33	24	3
-21	0	9
42	36	24
-42	24	27
12	-75	-21
-18	-69	57
-51	3	36
24	-66	60
39	39	24
54	12	30
24	-63	6
-39	-42	-36
-66	-15	18
-33	51	18
-33	-39	-42

// Georgiou-Karistianis N, 2007: Normals
// Subjects=17
-46	-44	50
34	-36	56
-4	2	56
10	4	58
-34	-16	56
50	-14	44
-26	4	8
22	12	4
-6	38	14
2	40	10
-4	-36	40
4	-42	28
-8	10	34
0	14	40
36	10	-2
36	20	-4
-36	0	6
48	-30	30
62	-38	14
-62	-38	26
-50	-42	18
-52	-20	42
-28	-10	64
20	-62	50

// Georgiou-Karistianis N, 2007: Huntington's Disease Patients
// Subjects=20
-44	-36	44
58	-36	22
-10	10	36
4	2	50
-54	-22	22
52	-16	24
-8	4	36
10	22	32
28	2	54
-36	-2	8
36	4	8
32	22	4
-30	-50	62
-42	26	38
-4	58	8
0	58	28
-4	-46	22
4	-52	22
-8	10	34
0	14	40
36	10	-2
36	20	-4
-36	0	6
48	-30	30
62	-38	14
-62	-38	26
-50	-42	18
-52	-20	42
-28	-10	64
20	-62	50

// Diamond E L, 2007: Novel vs. Repeated Correlated with AD Assessment Scale 
// Word Recognition
// Diamond E L, 2007: Novel vs. Repeated Correlated with AD Scale Assessment 
// Total Score
// Diamond E L, 2007: Novel vs. Repeated Correlated with Free and Cued 
// Selective Reminding Test-Cued Recall Assessment
// Subjects=29
-41.25	18.77	-12.46
-53.01	-8.82	-8.41
-41.15	-61.5	-21.33
54.79	5.1	-26.19
-56.15	-39.78	-6.42
-5.26	-32.18	3.17
-41.03	-64.92	-12.03
-8.53	-32.4	1.01
-41.26	-15.24	-20.3
-44.48	26.51	-9.81
54.86	3.49	-20.43
-4.92	23.98	41.31
-28.42	33.08	-20.82
-55.97	-38.43	8.01
27	-29.92	-8.81
-57.36	-9.05	-10.56
-40.81	-8.62	16.01
-56.29	-11.27	-11.48
-27.97	-6.22	6.59
-47.34	29.3	20.21
-47.57	-56.64	-14.98
54.93	4.01	-14.88
7.61	-9.91	-.37
-11.82	-36.12	-4.17
-24.44	25.52	35.89

// Fu C H Y, 2007: Differences in Dynamic Range, Normals > Depressed Patients
// Fu C H Y, 2007: Normals > Depressed Patients, Post- vs. Pre-Treatment
// Subjects=19
-18.91	-37.42	21.59
4.83	-52.49	44.89
-8.26	-70.71	3.07
-4.07	-40.82	3.86
-30.76	-49.44	4.89
3.36	-34.69	-0.08
11.92	-21.35	6.51
-6.26	-18.28	6.46
17.22	-18.48	1.75
8.67	-38.25	-5.42
2.23	-29.83	-6.05
2.53	-72.87	15.4
-4.88	-73.29	24.44
-2.62	-71.99	41.03
17.6	-74.93	28.78
-14.46	-75.12	29.16
18.44	-71.78	0.62
-10.37	-70.46	6.42
22.63	-66.01	-7.71

// Haller S, 2007: Simple - Fixation
// Haller S, 2007: Medium - Simple
// Haller S, 2007: Complex - Medium
// Subjects=16
28.06	-84.92	-5.07
28.06	-84.92	-5.07
-39.26	-81.98	-2.32
44.43	-23.04	64.27
-52.03	11.85	42.37
1.46	10.65	49.67
33.73	-49.6	52.12
36.34	25.5	4.53
-59.54	-12.66	28.9
56.94	-9.68	29.55
-23.95	-55.23	53.25
-31	31.53	5.91
-48.04	17.76	8.38
2.48	-28.32	27.27
-37.16	-65.91	-1.12
-43.94	104.98	21.09
49.53	6.79	44.98
4.57	3.89	62.47
27.07	-88.42	4.82
-29.35	-45.92	50.3
31.08	8.7	9.34
40.7	-48.26	-13.87
51.22	22.56	-7.34
49.35	-21.92	9.47
-1.82	-67.03	8.82
-41.33	8.61	43.64
-.27	9.72	59.8
-54.24	-39.46	12.13
34.7	-.31	59.13
46.2	20.38	33.84
-32.03	28.6	9.51
-57.7	-3.15	-5.26
35.28	31.12	8.53
33.66	-49.23	43.17

// Lagopoulos J, 2007: Bipolar Patients
// Subjects=10
-26.65	8.2	6.7
7.47	11.95	-2.93
-3.23	9.6	-4.84
-20.31	-18.85	-13.41
24.64	-31.1	-10.66
-16.02	-16.54	-11.42
13.78	2.16	-20.02
-16.13	2.15	-17.45
-5.52	40.97	-11.9
39.73	45.01	36.31
-26.71	-21	-13.15
11.64	2.15	-19.99

// Lagopoulos J, 2007: Normals
// Subjects=10
7.27	45.1	-14.62
-7.66	43.07	-12.05
39.64	46.26	25.05
-3.14	32.46	15.55
16.36	-48.13	17.62
-9.26	-50.22	20.32
-5.25	-11.22	1.39
-11.88	-.28	-21.75
42.16	-44.15	39.3
-41.19	-40.24	42.16
-5.52	40.97	-11.9
39.73	45.01	36.31
-26.71	-21	-13.15
11.64	2.15	-19.99

// Sheridan M A, 2007: ADHD Adolescent Girls
// Subjects=10
-22	-82	-8
18	-68	50
-22	-62	46
-10	-12	14
-44	28	10
-10	12	36
0	22	50
-42	12	30
-34	-52	-38
28	-50	-28
-14	-68	-16
22	-62	32
-16	-64	30
-10	-10	14
18	-12	18
8	18	44
-38	14	16
42	14	14
-38	14	58
36	-16	56
-24	56	36
38	26	4
48	-36	46

// Sheridan M A, 2007: Normal Adolescent Girls
// Subjects=10
12	-82	-10
-46	-56	-26
38	-42	44
-34	-60	34
16	16	22
30	38	16
-38	36	22
-8	32	16
36	-58	-20
-22	-46	-10
-18	12	14
-12	-18	4
6	-14	2
8	28	20
-32	16	6
38	12	-8
-54	-10	-4
32	42	16
-52	36	4
-48	-26	38
22	-72	-10
38	28	2
38	26	4
48	-36	46

// Koch K, 2007: Males
// Subjects=21
-6	30	56
32	28	-20
-44	14	20
-44	0	22
-60	-20	40
14	-12	40
-8	-50	28
54	2	-20
-58	6	-28
-56	-12	-28
-48	-66	30
54	20	16
-66	-22	4
-38	-22	-2
-26	30	36
34	10	28
-40	-22	62
-42	-10	62
12	38	28
-14	12	40
18	-10	40
16	14	42
-28	-46	6
42	-64	10
-34	-24	40
-26	-44	58
-32	-46	38
30	-40	44
12	-48	46
24	-80	36
-8	-56	-26
20	-26	14
36	-24	24
-4	6	16
46	-64	10
-32	-46	38
-22	-68	36
28	16	-22
-22	-2	-12

// Koch K, 2007: Females
// Subjects=19
-6	30	56
32	28	-20
-44	14	20
-44	0	22
-60	-20	40
14	-12	40
-8	-50	28
54	2	-20
-58	6	-28
-56	-12	-28
-48	-66	30
54	20	16
-66	-22	4
-38	-22	-2
46	-64	10
-32	-46	38
-22	-68	36
28	16	-22
-22	-2	-12

// Ortigue S, 2007: Love > Friend
// Ortigue S, 2007: Passion > Friend
// Ortigue S, 2007: Love > Passion
// Ortigue S, 2007: Passion > Love
// Subjects=36
6	12	0
6	-22	-22
-26	20	-4
36	-4	2
36	-88	-18
-48	-50	-24
34	-18	-28
-40	-8	-34
66	-44	32
-46	26	26
-44	-26	-20
-18	-96	-8
12	-48	-38
-36	-78	-52
6	12	0
-26	20	-4
36	-4	2
-48	-50	-24
64	-52	16
34	-18	-28
-40	-8	-34
66	-44	32
-18	-96	-8
18	-94	-8
-12	-68	-2
12	-48	-38
-36	-78	-52
-48	-50	-24
64	-52	16
-64	-50	22
66	-44	32
36	-88	-18
-56	-70	-2
-40	-8	-34
-44	-26	-20
-6	-42	8
64	2	24
-36	-78	-52

// Baumann O, 2007: Color-Coded Memory-Guided Saccades, 2.0s > 5.5s Retention
// Baumann O, 2007: Color-Coded Memory-Guided Saccades, Re-Ordering > Fixation
// Subjects=13
32.06	-86.79	37.07
56.83	-11.75	46.03
47.39	-39.26	62.36
-31.1	-34.95	9.49
1.53	26.99	38.66
-4.34	-61.47	68.8
-39.69	17.94	24.57

// Eddington K M, 2007: Self + Other Relevance vs. Syllable Counting
// Eddington K M, 2007: Self vs. Other Relevance
// Eddington K M, 2007: Promotion Goal Priming
// Eddington K M, 2007: Prevention Goal Priming
// Subjects=16
-2.12	34.16	9.82
-50.4	24.15	-18.9
4.33	60.94	25.34
-49.71	-59.84	37.21
46.44	-52.92	35.52
-17.86	-52.99	12.85
1.17	48.23	26.44
33.66	6.76	65.24
-50.1	-26.55	-.15
49.26	-23.92	-2.63
-34.24	6.96	-8.72
-37.69	41.78	-26.1
48.89	35.95	-26.6
29.86	-5.95	-16.18
10.57	31.81	-7.97

// Fehr T, 2007: Addition, Complex > Simple
// Fehr T, 2007: Subraction, Complex > Simple
// Fehr T, 2007: Multiplication, Complex > Simple
// Fehr T, 2007: Division, Complex > Simple
// Fehr T, 2007: Conjunction (All Conditions)
// Subjects=11
-2.57	24.28	55.81
10.39	22.09	54.68
8.12	27.84	47.43
-44.11	48.98	23.82
40.33	12.26	28.25
46.66	33.03	20.49
46.57	53.14	17.38
-43.52	-45.08	51.04
-17.45	-64.78	57.03
-28.63	-50.09	31.11
-33.24	-86.19	1.15
27.42	-74.95	14.69
20.89	-81.87	9.88
20.8	-94.61	-0.06
-33.08	-45.61	21.78
-50.74	-49.54	-7.78
55.16	-46.84	-7.61
-44.06	44.93	26.46
-.44	24.08	53.55
3.78	25.49	45.49
-41.84	37.7	29.37
-37.68	55.18	20.85
-28.45	14.72	58.32
48.83	33.04	20.45
48.73	53.15	17.34
46.82	12.28	28.14
42.09	23.5	-.9
-45.65	-44.88	53.3
36.44	-53.51	48.27
-10.95	-66.78	58.24
-30.53	-62.36	49.17
36.42	-71.15	43.3
32.04	-60.64	41.21
-9.94	-7.58	-20.47
-5.1	-10.21	20.04
3.78	25.49	45.49
-39.67	48.76	32.73
-41.84	37.7	29.37
48.83	33.04	20.45
48.93	16.34	25.46
31.35	-69.13	-15.09
-7.46	-35.8	-.92
-3.14	-5.17	4.94
-3.06	-19.85	8.64
3.78	25.49	45.49
-41.78	35.99	34.03
-48.94	51.71	-15.59
-44.09	34.84	21.85
48.82	35.17	20.24
51.08	18.47	25.21
38.57	13.03	59.58
60.78	24.89	24.41
-35.8	25.69	-7.64
-32.65	-73.01	50.26
-10.9	-70.83	60.88
36.44	-75.41	43.72
19.32	-68.7	59.03
3.34	-5.15	4.83
9.89	1.98	11.86
-2.57	24.28	55.81
10.39	22.09	54.68
8.12	27.84	47.43
-43.97	42.37	33.43
48.83	33.04	20.45
51.08	18.47	25.21
60.78	24.89	24.41
36.39	-71.36	41.08

// Milea D, 2007: Decision - Reference 1
// Milea D, 2007: Decision - Prepare
// Milea D, 2007: Prepare - Reference 1
// Milea D, 2007: Execution - Reference 2
// Subjects=12
-27	57	18
36	45	30
-36	0	54
45	9	48
-24	0	57
33	6	57
9	21	39
0	6	57
-39	39	30
30	45	39
27	9	57
48	12	39
-21	9	57
30	9	57
3	34	45
-36	-6	57
42	0	4
-24	0	57
33	0	51
9	6	57
-3	3	57
-24	3	51
27	0	4

// Woodard J L, 2007: Recent > Unfamiliar
// Woodard J L, 2007: Remote > Unfamiliar
// Woodard J L, 2007: Recent > Remote
// Subjects=15
-.7	-50.99	22.07
1.34	48.7	-6.16
-48.05	23.91	-4.41
-17.4	35.15	39.24
26.66	25.34	39.11
-59.3	-41.62	-7.14
-56.48	-13.34	-17.36
-45.48	-69.68	27.95
52.71	-61.75	14.33
26.49	-20.42	-15.93
17.88	8.36	15.77
-10.31	-49.23	51.26
1.53	-50.03	20.52
2.19	47.74	-7.65
-18.73	31.33	45.04
-29.39	16.48	56.22
-6	54.76	13.71
-8.63	47.51	30.3
-63.26	-41.46	-7.45
-46.99	-69.05	26.57
56.25	-61.98	15.2
29.19	-42.71	-20.89
15.01	6.31	17.09
-3.39	-54.83	31.8

// Stark R, 2007: Disgust > Neutral, Parametric Modulators
// Stark R, 2007: Fear > Neutral, Parametric Modulators
// Stark R, 2007: Disgust > Fear, Parametric Modulators
// Stark R, 2007: Fear > Disgust, Parametric Modulators
// Stark R, 2007: Disgust > Neutral
// Stark R, 2007: Disgust > Fear
// Stark R, 2007: Fear > Neutral
// Stark R, 2007: Fear > Disgust
// Subjects=66
18	30	-18
63	-18	27
-63	-24	30
45	-60	-9
-45	-66	-6
36	-87	12
-36	-93	12
39	3	-6
-39	0	-15
54	33	0
-9	-48	33
-42	-60	-18
-51	-69	12
45	-78	3
-15	-96	18
12	-99	18
-27	-45	-18
30	-51	-15
-45	-63	-6
-33	-96	15
21	-102	-6
39	-3	3
-39	-6	6
33	57	6
-48	42	-15
-39	48	-3
42	27	39
-42	27	39
36	15	54
42	-45	-30
63	-51	12
3	-60	42
-45	-72	12
-12	-99	15
-30	33	-15
48	9	24
-63	-24	33
24	-57	57
48	-63	-9
-45	-66	-9
-36	0	-12
33	0	-24
-27	-51	-15
30	-54	-12
-33	-93	12
39	-3	3
-39	-6	6
54	36	6
30	0	-30
48	-66	3
-48	-69	9
9	-93	3
3	48	-6
-48	42	-9
57	30	-6
27	27	48
0	27	-12
-39	12	45
57	-6	-24
57	-48	12
-45	-57	12
42	-48	-24
3	-57	39
-9	-99	12

// Gavazzi C, 2007: Huntington's Disease (HD) Patients
// Subjects=9
-32	-20	56
20	-66	-44
-36	16	8
-20	-16	20
-2	62	4
-4	60	-4
-20	-50	38
48	-40	40
18	-26	54

// Gavazzi C, 2007: Normals
// Subjects=11
-28	-18	54
18	-80	-10
-36	4	2
-20	-16	20
-2	62	4
-4	60	-4
-20	-50	38
48	-40	40
18	-26	54

// Herwig U, 2007: Expectation Negative > Presentation Negative in Conjunction 
// with Main Negative Expectation
// Herwig U, 2007: Expectation Negative > Neutral in Conjunction with 
// Expectation Negative > Positive
// Herwig U, 2007: (Exp Negative > Neutral) + (Exp Negative > Positive) + (Exp 
// Negative > Pres Disgusting)
// Subjects=12
4.35	33.74	17.59
1.39	17.63	43.51
2.52	-29.04	31.79
-28.81	48.51	18.96
31.09	42.96	24.31
-38.4	11.48	8.79
-1.03	-8.45	-4.46
-38.91	-55.32	53.43
15.52	-66.6	40.37
6.49	35.95	18.49
4.55	16.07	36.91
-24.44	44.11	30.43
40.54	10.49	-10.99
-6.37	-8.48	-4.4
-18.2	2.83	-8.56
-13.85	-20.58	-8.87
18.19	-19.42	-10.45
5.43	36.03	19.61
-4.23	-9.52	-4.34

// Hofer A, 2007: Encoding, Faces > Scrambled Faces
// Hofer A, 2007: Correct Recognition, Learned Faces > Scrambled Faces
// Hofer A, 2007: Correct Rejection, Distractor Faces > Scrambled Faces
// Hofer A, 2007: Failed Recognition, Learned Faces > Scrambled Faces
// Hofer A, 2007: False Recognition, Distractor Faces > Scrambled Faces
// Hofer A, 2007: Correct Recognition, Learned Faces > Correct Rejection, 
// Distractor Faces
// Subjects=21
-7.39	33.7	19.1
-7.2	30.69	32.84
5.82	31.15	37.06
-3.07	-23.25	6.73
-11.74	-1.6	9.22
31.3	-59.66	-17.15
40.04	-85.15	-14.77
27.07	-85.2	-14.55
35.37	34.78	-17.59
48.2	25.07	-30.3
57.02	22.1	-16.71
-46.36	-63.35	-6.49
-46.05	-69.79	16.55
-41.31	-.97	63.45
-32.7	7.57	62.46
-50.1	6.68	53.88
-2.73	36.21	45.67
-3.04	42.64	22.62
22.65	-59.69	-17
-41.33	3.28	63.03
5.82	44.33	40.23
1.65	36.64	50.03
48.22	34	-26.7
39.71	30.54	-17.25
18.5	-58.46	-3.6
48.67	-67.69	-12.16
-38.1	21.35	-19.5
-3.13	-23.67	2.29
5.56	-80.19	-5.71
1.35	-79.37	3.24
-41.33	3.28	63.03
-2.82	44.3	40.38
-7.29	38.78	27.56
1.12	-19.81	-2.64
-25.08	-8.8	-21.22
-7.24	39.2	32
5.42	45.68	8.73
-3.24	49.9	8.46
-32.65	-48.98	54.6
-32.82	-50.23	41.28
-46.33	33.15	15.33
-37.58	34.01	24.07

// Marchand W R, 2007: Bipolar Patients
// Subjects=14
-32	-24	46
-6	-8	40
16	18	8
-10	12	-2

// Marchand W R, 2007: Normals
// Subjects=15
-32	-32	62
-54	-26	54
10	-56	-22
22	-8	6
18	-18	6
42	38	24
34	-26	56
56	-16	52
54	-44	46
-28	-88	0
32	-82	14
-8	-54	-22
-32	-24	46
-6	-8	40
16	18	8
-10	12	-2

// Prado J, 2007: Verification: 2-Mismatch > 1-Mismatch > 0-Mismatch
// Prado J, 2007: Falsification: 2-Mismatch > 1-Mismatch > 0-Mismatch
// Prado J, 2007: Affirmative Throughout: 1-Mismatch > 0-Mismatch
// Prado J, 2007: Verification, Hits Only: 2-Mismatch > 1-Mismatch > 
// 0-Mismatch
// Subjects=20
49.96	21.45	22.7
11.4	18.28	48.32
34.23	-57.13	44.19
-8.21	-96.76	12.97
17.51	-89.51	-2.75
-52.61	34.68	32.1
-33.84	-47.59	46.64
49.96	21.45	22.7
11.4	18.28	48.32
34.23	-57.13	44.19
-8.23	-96.97	10.75
23.99	-89.49	-2.86
49.95	24.64	22.38
11.36	17.97	44.99
-30.58	10.56	59.88
34.22	-53.94	43.87
-44.14	35.59	18.42
-40.41	15.22	52.87
-17.71	6.58	51.09
-36.91	-59.43	57.95
-40.32	-29.01	50.52
-30.63	-57.67	41.98
58.66	25.19	27.78
53.39	7.51	34.1
53.11	24.03	15.66
14.56	20.96	42.4
1.6	27.51	44.21
11.19	38.62	36.23
27.74	-53.96	43.98
34.3	-56.61	49.74
34.47	-47.71	64.54
-21.83	25.22	-13.43
46.64	20.82	16.09
8.09	24.34	44.41
42.85	56.08	-19.83
24.14	-97.17	6.86
-24.64	-73.39	-.27
-1.46	-77.23	37.82
-44.09	33.78	21.96
-49.2	14.05	40.81
-43.87	28.85	38.13
-40.16	-49.66	59.28
-33.77	-51.43	51.5
-1.3	-59.61	54
37.56	-49.9	52.38
50.41	-37.61	45.34

// Rothemund Y, 2007: Normal weight subjects
// Subjects=13
-4	14	12
28	-22	-4
-38	18	0
-34	-20	-10
-28	-38	40
-4	44	50
-2	10	68
-2	2	72
32	50	4
54	26	2
-40	-76	2
-50	-32	14
-36	44	12
-32	52	-4
-30	-76	30
38	-54	46
26	-22	-4
-26	-22	-2
18	30	2
54	-70	-4
50	46	10
44	52	16
-44	48	10
34	-18	-8
-30	-22	-2
4	12	12
38	16	0
36	4	-10
2	-40	42
32	-32	42
24	-38	46
30	32	-8
-24	-16	-8
32	54	-6

// Rothemund Y, 2007: Obese subjects
// Subjects=13
-4	14	12
28	-22	-4
-38	18	0
-34	-20	-10
-28	-38	40
-4	44	50
-2	10	68
-2	2	72
32	50	4
54	26	2
-40	-76	2
-50	-32	14
-36	44	12
-32	52	-4
-30	-76	30
38	-54	46
26	-22	-4
-26	-22	-2
18	30	2
-46	-66	-16
46	-64	-14
44	-74	-16
30	-88	-4
34	-20	-8
-26	-30	-8
-24	34	-12
52	-60	-20
40	-82	-16
-44	-80	-14
-38	-86	4
40	-52	-24
-54	-58	-22
64	-44	2
50	24	-10
54	32	0
22	54	34
-40	-70	-8
-8	-94	-4
34	-18	-8
-30	-22	-2
4	12	12
38	16	0
36	4	-10
2	-40	42
32	-32	42
24	-38	46
30	32	-8
-24	-16	-8
32	54	-6

// Suh S, 2007: Embedded Korean vs. Rest
// Suh S, 2007: Embedded English vs. Rest
// Suh S, 2007: Conjoined Korean vs. Rest
// Suh S, 2007: Conjoined English vs. Rest
// Suh S, 2007: Embedded Korean vs. Conjoined Korean
// Suh S, 2007: Embedded Korean vs. Embedded English
// Suh S, 2007: Embedded English vs. Embedded Korean
// Suh S, 2007: Conjoined Korean vs. Conjoined English
// Subjects=16
-38	-50	46
-48	10	36
-6	16	48
20	-90	-12
-24	-92	-14
34	-64	46
-38	15	-4
-44	24	16
-6	24	40
-34	-60	46
-24	-94	-15
36	-58	52
-16	-90	-12
-34	-62	45
-2	10	50
-50	8	30
24	-90	-10
-2	10	60
34	-62	46
12	-90	-10
-38	-52	46
-8	-70	46
-46	16	46
-26	-80	2
8	-85	14
50	-34	46
-60	0	30
-16	-76	6
-34	45	8
4	30	48
-40	24	44
-42	23	-10
62	-10	-20
30	-80	30
-18	-34	50
-18	-70	24
-38	7	10
-30	-68	-2
-32	20	-18

// Carreiras M, 2007: (Lexical Decision + Read) > False Fonts
// Carreiras M, 2007: Lexical Decision > False Fonts
// Carreiras M, 2007: Read > False Fonts
// Carreiras M, 2007: [Lexical Decision-False Fonts] > [Read-False Fonts], 
// Lexical Decision > Read
// Carreiras M, 2007: [Lexical Decision-False Fonts] > [Read-False Fonts], 
// Lexical Decision > False Fonts
// Carreiras M, 2007: [Lexical Decision-False Fonts] > [Read-False Fonts], 
// Read > False Fonts
// Carreiras M, 2007: [Read-False Fonts] > [Lexical Decision-False Fonts], 
// Lexical Decision > Read
// Carreiras M, 2007: [Read-False Fonts] > [Lexical Decision-False Fonts], 
// Lexical Decision > False Fonts
// Carreiras M, 2007: [Read-False Fonts] > [Lexical Decision-False Fonts], 
// Read > False Fonts
// Carreiras M, 2007: Lexical Decision > Read, (Words + Pseudowords + False 
// Fonts)
// Carreiras M, 2007: Lexical Decision > Read, Words
// Carreiras M, 2007: Lexical Decision > Read, Pseudowords
// Carreiras M, 2007: Read > Lexical Decision, (Words + Pseudowords + False 
// Fonts)
// Carreiras M, 2007: Read > Lexical Decision, Words
// Carreiras M, 2007: Read > Lexical Decision, Pseudowords
// Carreiras M, 2007: Pseudowords > Words, (Lexical Decision + Read + False 
// Fonts)
// Carreiras M, 2007: Pseudowords > Words, Lexical Decision
// Carreiras M, 2007: Pseudowords > Words, Read
// Carreiras M, 2007: Pseudowords > False Fonts, (Lexical Decision + Read + 
// False Fonts)
// Carreiras M, 2007: Pseudowords > False Fonts, Lexical Decision
// Carreiras M, 2007: Pseudowords > False Fonts, Read
// Carreiras M, 2007: Words > Pseudowords, (Lexical Decision + Read + False 
// Fonts)
// Carreiras M, 2007: Words > Pseudowords, Lexical Decision
// Carreiras M, 2007: Words > Pseudowords, Read
// Carreiras M, 2007: False Fonts > Pseudowords, (Lexical Decision + Read + 
// False Fonts)
// Carreiras M, 2007: False Fonts > Pseudowords, Lexical Decision
// Carreiras M, 2007: False Fonts > Pseudowords, Read
// Subjects=36
-28	-92	-4
14	-78	16
-40	-66	-12
-42	-42	-20
-52	-40	12
-62	-34	4
-62	-14	6
-52	10	-14
-44	24	-6
-54	12	0
-36	24	0
34	18	4
-44	-34	46
-24	-62	36
-20	-68	44
-26	-52	48
-60	-18	28
-48	6	32
-54	0	42
-46	-6	54
-26	-8	56
-4	4	58
8	6	56
8	18	44
-2	-78	-26
6	-74	-20
25	-68	-24
-28	-62	-24
-24	-6	6
-26	2	-4
-20	6	4
26	10	4
-28	-92	-4
14	-78	16
-40	-66	-12
-42	-42	-20
-52	-40	12
-62	-34	4
-62	-14	6
-52	10	-14
-44	24	-6
-54	12	0
-36	24	0
34	18	4
-44	-34	46
-24	-62	36
-20	-68	44
-26	-52	48
-60	-18	28
-48	6	32
-54	0	42
-46	-6	54
-26	-8	56
-4	4	58
8	6	56
8	18	44
-2	-78	-26
6	-74	-20
25	-68	-24
-28	-62	-24
-24	-6	6
-26	2	-4
-20	6	4
26	10	4
-28	-92	-4
14	-78	16
-40	-66	-12
-42	-42	-20
-52	-40	12
-62	-34	4
-62	-14	6
-52	10	-14
-44	24	-6
-54	12	0
-36	24	0
34	18	4
-44	-34	46
-24	-62	36
-20	-68	44
-26	-52	48
-60	-18	28
-48	6	32
-54	0	42
-46	-6	54
-26	-8	56
-4	4	58
8	6	56
8	18	44
-2	-78	-26
6	-74	-20
25	-68	-24
-28	-62	-24
-24	-6	6
-26	2	-4
-20	6	4
26	10	4
-50	-22	54
34	18	4
-50	-22	54
34	18	4
34	18	4
-62	-14	6
-62	-34	4
56	-28	0
-62	-14	6
-62	-34	4
-62	-14	6
-62	-34	4
56	-28	0
60	-20	46
-52	-28	48
-64	-26	28
-54	-22	18
-34	-32	52
24	-50	-26
2	-48	-32
-4	-12	54
30	-98	-10
6	8	-12
14	12	-16
-6	6	-12
60	-20	46
-52	-28	48
-64	-26	28
-54	-22	18
-34	-32	52
24	-50	-26
2	-48	-32
-4	-12	54
30	-98	-10
6	8	-12
14	12	-16
-6	6	-12
60	-20	46
-52	-28	48
-64	-26	28
-54	-22	18
-34	-32	52
24	-50	-26
2	-48	-32
-4	-12	54
30	-98	-10
6	8	-12
14	12	-16
-6	6	-12
-66	-30	2
-54	-18	0
-52	-12	2
54	-36	6
50	-26	2
52	-12	0
56	12	-14
-58	-4	20
-44	-14	36
-52	-8	46
56	-4	24
46	-12	36
-12	-60	-20
16	-70	-16
-8	-94	0
0	-84	12
-66	-30	2
-54	-18	0
-52	-12	2
54	-36	6
50	-26	2
52	-12	0
56	12	-14
-58	-4	20
-44	-14	36
-52	-8	46
56	-4	24
46	-12	36
-12	-60	-20
16	-70	-16
-8	-94	0
0	-84	12
-66	-30	2
-54	-18	0
-52	-12	2
54	-36	6
50	-26	2
52	-12	0
56	12	-14
-58	-4	20
-44	-14	36
-52	-8	46
56	-4	24
46	-12	36
-12	-60	-20
16	-70	-16
-8	-94	0
0	-84	12
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4

// Curtis V A, 2007: Overall Task Effect, Bipolar Patients > Normals
// Curtis V A, 2007: Overall Task Effect, Normals > Bipolar Patients
// Curtis V A, 2007: Phonetic Tasks > Repetition + Word Form Analysis
// Curtis V A, 2007: Semantic Tasks > Repetition + Word Form Analysis
// Subjects=12
20.42	-83.25	-24.09
-41.3	0.28	43.22
5.66	16.42	41.33
-41.48	10.54	24.52
-44.64	10.95	30.1

// Deeley Q, 2007: Normals
// Subjects=9
39.75	-82.19	-12.13
35.54	-84.88	-5.16
32.09	-71.98	-30.74
32.48	-63.55	23.19
32.57	-62.61	35.38
-32.51	-16.9	67.98
-41.18	-18.24	51.46
43.93	19	16.14
43.89	18.57	10.6
35.49	-85.39	-11.81
-44.7	-74.24	-11.83
39.81	-84.85	-5.22
-17.84	-93.4	-.49
32.19	-86.35	-23.96
-28.95	-53.87	98.92
-36.94	-22.96	45.12
8.85	8.61	36.37
27.99	-82.26	-11.99
27.92	-86.38	-23.91
-36.92	-15.04	51.15
-32.68	-18.7	44.71
-33	-71.42	-17.77
-33	-71.42	-17.77
47.11	-62.49	-19.44
20.53	-85.48	-11.63
39.57	-71.93	-30.83
-37.32	-71.96	-24.37
-29.35	-26.2	57.57
-41.23	-18.75	44.82
51.44	10.58	16.76
47.15	14.79	16.45
32.23	-82.67	-17.58
-33.02	-67.2	-18.13
27.8	-67.77	-31.04
-37.4	-63.93	-30.62
-36.91	-18.21	51.41
-48.78	0.24	43.31
32.28	-85.41	-11.77
35.34	-71.53	-25.24
-41.19	-15.07	51.2
-41.15	-14.64	56.74
-10.47	-94.55	-16.09
-10.47	-94.55	-16.09
-25.51	-86.7	-23.27
-41.58	-63.02	-18.38
-41.46	-94.74	-15.72
-41.63	-63.53	-25.03
32.26	-90.07	-16.96
-33	-71.42	-17.77
-25.39	-94.21	-10.37
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
35.32	-67.3	-25.59
-37.37	-60.33	-25.34
27.94	-78.46	-17.88
32.3	-89.64	-11.42
35.32	-67.3	-25.59
39.68	-74.16	-18.38
32.3	-89.64	-11.42
35.28	-66.67	-31.22
32.26	-90.07	-16.96
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
-37.3	-79.37	-23.75
-22.29	-78.76	-17.28
-10.47	-94.55	-16.09
-37.37	-72.39	-29.91
24.12	85.42	-31.58
-29.74	-86.21	-16.57
-13.65	-89.91	-10.87
-33.11	-56.08	-25.75
-25.46	-86.18	-16.62
-13.62	-98.37	-10.16
47.15	-62.06	-13.9
35.49	-85.39	-11.81
-17.97	-90.37	-16.36
-44.61	-98.56	-9.79
-41.63	-63.53	-25.03
-29.72	-90.44	-16.22
-25.39	-94.21	-10.37
-22.19	-94.2	-10.41
32.3	-89.64	-11.42
20.48	-85.91	-17.17
35.32	-67.3	-25.59
27.95	-82.69	-17.53
-22.19	-94.2	-10.41
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
32.26	-90.07	-16.96
-17.95	-94.6	-16
35.54	-84.88	-5.16
-17.86	-93.66	-3.81
13.06	-69.95	-2.81
-13.62	-98.37	-10.16
39.56	-55.64	-26.62
-41.61	-67.76	-24.67
-37.3	-79.37	-23.75
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
32.26	-90.07	-16.96
-36.91	-18.21	51.41
35.28	-66.67	-31.22
32.3	-89.64	-11.42
39.68	-74.16	-18.38
-36.97	-15.56	44.5
35.32	-67.3	-25.59
32.3	-89.64	-11.42
27.94	-78.46	-17.88
-41.17	-18.15	52.57
-13.62	-98.37	-10.16
-25.46	-86.18	-16.62
47.15	-62.06	-13.9
43.94	-70.96	-18.69
28.3	-74.69	30.87
-33.11	-56.08	-25.75
-29.74	-86.21	-16.57
16.27	-89.74	-11.23
24.76	-85.88	-17.22
31.46	-75.19	24.18
-32.58	-21.99	57.26
-37.37	-72.39	-29.91
-10.47	-94.55	-16.09
-32.93	-78.4	-11.61
-41.63	-63.53	-25.03
-17.97	-90.37	-16.36
-13.62	-98.37	-10.16
55.83	8.47	30.27
-48.71	-18.8	44.91
35.49	-85.39	-11.81
16.27	-89.74	-11.23
27.95	-82.69	-17.53
-6.2	-94.53	-16.14
-22.19	-94.2	-10.41
-22.19	-94.2	-10.41
-37.29	-67.22	-18.08
35.32	-67.3	-25.59
32.3	-89.64	-11.42
20.48	-85.91	-17.17
-25.39	-94.21	-10.37
-29.72	-90.44	-16.22
-13.62	-98.37	-10.16
-17.95	-94.6	-16
-17.86	-93.66	-3.81
-41.61	-67.76	-24.67
32.26	-90.07	-16.96
35.54	-84.88	-5.16
13.13	-69.26	6.05
39.56	-55.64	-26.62
-36.92	-15.04	51.15

// Deeley Q, 2007: Asperger Syndrome (AS) Subjects
// Subjects=9
35.47	-82.22	-12.08
-29.83	-61.89	-18.61
39.78	-77.45	-5.84
32.04	-72.49	-37.39
-33.14	-72.88	-36.61
32.5	-67.78	23.55
39.75	7.86	23.81
58.89	19.09	15.96
51.31	9.21	-.97
35.4	-61.07	-13.85
39.78	-81.85	-7.7
-48.8	4.47	42.96
-44.37	-10.43	56.42
55.71	10.61	16.71
43.82	22.29	3.6
-33	-71.42	-17.77
-33	-71.42	-17.77
47.11	-62.49	-19.44
20.53	-85.48	-11.63
39.57	-71.93	-30.83
-37.32	-71.96	-24.37
-29.35	-26.2	57.57
-41.23	-18.75	44.82
51.44	10.58	16.76
47.15	14.79	16.45
32.23	-82.67	-17.58
-33.02	-67.2	-18.13
27.8	-67.77	-31.04
-37.4	-63.93	-30.62
-36.91	-18.21	51.41
-48.78	0.24	43.31
32.28	-85.41	-11.77
35.34	-71.53	-25.24
-41.19	-15.07	51.2
-41.15	-14.64	56.74
-10.47	-94.55	-16.09
-10.47	-94.55	-16.09
-25.51	-86.7	-23.27
-41.58	-63.02	-18.38
-41.46	-94.74	-15.72
-41.63	-63.53	-25.03
32.26	-90.07	-16.96
-33	-71.42	-17.77
-25.39	-94.21	-10.37
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
35.32	-67.3	-25.59
-37.37	-60.33	-25.34
27.94	-78.46	-17.88
32.3	-89.64	-11.42
35.32	-67.3	-25.59
39.68	-74.16	-18.38
32.3	-89.64	-11.42
35.28	-66.67	-31.22
32.26	-90.07	-16.96
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
-37.3	-79.37	-23.75
-22.29	-78.76	-17.28
-10.47	-94.55	-16.09
-37.37	-72.39	-29.91
24.12	85.42	-31.58
-29.74	-86.21	-16.57
-13.65	-89.91	-10.87
-33.11	-56.08	-25.75
-25.46	-86.18	-16.62
-13.62	-98.37	-10.16
47.15	-62.06	-13.9
35.49	-85.39	-11.81
-17.97	-90.37	-16.36
-44.61	-98.56	-9.79
-41.63	-63.53	-25.03
-29.72	-90.44	-16.22
-25.39	-94.21	-10.37
-22.19	-94.2	-10.41
32.3	-89.64	-11.42
20.48	-85.91	-17.17
35.32	-67.3	-25.59
27.95	-82.69	-17.53
-22.19	-94.2	-10.41
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
32.26	-90.07	-16.96
-17.95	-94.6	-16
35.54	-84.88	-5.16
-17.86	-93.66	-3.81
13.06	-69.95	-2.81
-13.62	-98.37	-10.16
39.56	-55.64	-26.62
-41.61	-67.76	-24.67
-37.3	-79.37	-23.75
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
32.26	-90.07	-16.96
-36.91	-18.21	51.41
35.28	-66.67	-31.22
32.3	-89.64	-11.42
39.68	-74.16	-18.38
-36.97	-15.56	44.5
35.32	-67.3	-25.59
32.3	-89.64	-11.42
27.94	-78.46	-17.88
-41.17	-18.15	52.57
-13.62	-98.37	-10.16
-25.46	-86.18	-16.62
47.15	-62.06	-13.9
43.94	-70.96	-18.69
28.3	-74.69	30.87
-33.11	-56.08	-25.75
-29.74	-86.21	-16.57
16.27	-89.74	-11.23
24.76	-85.88	-17.22
31.46	-75.19	24.18
-32.58	-21.99	57.26
-37.37	-72.39	-29.91
-10.47	-94.55	-16.09
-32.93	-78.4	-11.61
-41.63	-63.53	-25.03
-17.97	-90.37	-16.36
-13.62	-98.37	-10.16
55.83	8.47	30.27
-48.71	-18.8	44.91
35.49	-85.39	-11.81
16.27	-89.74	-11.23
27.95	-82.69	-17.53
-6.2	-94.53	-16.14
-22.19	-94.2	-10.41
-22.19	-94.2	-10.41
-37.29	-67.22	-18.08
35.32	-67.3	-25.59
32.3	-89.64	-11.42
20.48	-85.91	-17.17
-25.39	-94.21	-10.37
-29.72	-90.44	-16.22
-13.62	-98.37	-10.16
-17.95	-94.6	-16
-17.86	-93.66	-3.81
-41.61	-67.76	-24.67
32.26	-90.07	-16.96
35.54	-84.88	-5.16
13.13	-69.26	6.05
39.56	-55.64	-26.62
-36.92	-15.04	51.15

// Ferstl E C, 2007: Emotion > Time/Space
// Ferstl E C, 2007: Time/Space > Emotion
// Ferstl E C, 2007: Space > Emotion/Time
// Ferstl E C, 2007: Time > Emotion/Space
// Ferstl E C, 2007: Emotion/Space > Time
// Subjects=20
-55.57	4	-3.76
-38.95	-78.73	39.78
47.6	-68.43	41.27
15.39	-56.96	27.3
-48.91	13.21	32.19
47.19	26.22	26.65
-52.19	-50.16	-2.61
-55.48	-41.18	-10.01
-29.84	-37.86	-10.59
-35.74	-78.71	39.75
-13.51	-57.65	21
15.41	-60.14	27.56
-58.55	-56.29	1.33
-33.05	-37.87	-10.55
27.9	-40.42	-7.69
-42.9	38.72	-10.17
27.93	-43.34	-4.1

// Geuze E, 2007: Normals
// Subjects=12
12.76	38.93	1.44
9.9	24.91	40.57
-1.86	24.75	39.6
-10.74	37.73	1.81
-5.01	-46.05	18.81
-1.72	-46.24	29.94
-1.68	-45.81	35.48
4.61	-47.05	18.78
42.19	-52.69	38.9
-43.28	-46.43	44.93
49.56	-10.89	42
51.73	-11.68	45.39
50.41	17.61	25.1
-29.79	32.99	24.73
44.75	47.16	-5.19
53.4	17.6	-2.81
57.76	0.88	0.77
-49.9	-58.47	13.68
-41.72	16.86	-3.89
36.36	20.21	4.97
-29.94	18.24	-.79
25.6	-8.09	-15.95
-30.02	-12.28	-23.88
9.9	26.05	41.59
-.79	25.9	40.61
-3.92	-52.39	19.33
-4.93	-43	30.82
0.48	-52.23	34.88
8.9	-50.2	19
40.05	-51.65	38.84
-45.46	-45.73	40.44
51.7	-9.82	41.89
42.16	-16.77	49.27
46.18	19.15	31.71
31.89	49.99	-8.63
-30.86	31.92	24.84
45.81	47.16	-5.2
53.41	15.49	-2.63
57.77	-1.24	0.95
-51.23	-.75	3.27
-48.83	-56.26	14.59
-41.72	16.86	-3.89
41.63	17.36	-4.89
3.27	-14.77	-3.98
-17.07	5.63	0.12

// Geuze E, 2007: PTSD Patients
// Subjects=12
14.9	38.95	1.42
5.6	30.17	40.18
-5.07	30.19	41.41
-10.74	39.94	2.74
0.41	-53.97	26.1
0.41	-43.05	29.65
3.66	-46.92	34.4
-1.69	-45.89	34.37
5.73	-41.08	27.19
45.41	-54.7	40.15
-43.28	-48.63	44
52.8	-12.73	45.46
42.77	40.05	13.27
-36.18	27.66	25.25
46.88	49.37	-4.29
37.32	28.96	-5.81
56.69	-1.33	-.15
-53.36	-5.07	2.55
-49.86	-67.99	14.47
-30.99	23.95	4.32
40.57	18.49	-3.85
-29.95	18.16	-1.9
27.75	-11.25	-15.71
-25.75	-13.31	-23.84
20.35	3.91	2.06
7.77	23.84	40.68
-5.04	19.53	41.19
-.71	-51.23	20.31
-3.86	-42.99	30.81
5.8	-46.91	34.37
-8.1	-45.93	34.45
2.49	-50.15	20.18
42.19	-52.69	38.9
-41.16	-54.25	39.99
42.16	-18.88	49.45
51.48	17.61	25.09
-29.8	35.1	24.56
44.73	46.98	-7.41
53.42	16.63	-1.61
57.78	-1.15	2.06
-51.23	1.45	4.21
-41.71	14.74	-3.71
35.22	18.38	-4.9
-5.27	-14.73	-2.77
7.56	-14.57	-1.82
-28.88	17.11	-1.83
27.71	-10.53	-20.23
-27.88	-17.64	-24.57
-17.06	5.72	1.22
33.15	-7.27	-6.07

// Harrington G S, 2007: Write > Rest
// Harrington G S, 2007: Draw > Rest
// Harrington G S, 2007: Draw > Write
// Subjects=11
-53.23	8.36	24.84
-38.4	38.94	19.87
-20.86	-1.4	60.97
-43.44	-1.93	42.32
-52.15	-66.28	-4.6
-59.51	-20.06	29.52
-21.77	-62.45	56.06
-3.83	3.48	53.68
55.71	11.67	16.62
27.16	3.66	53.3
53.82	5.42	46.16
19.95	-52.97	64.83
36.8	-32.29	41.71
-52.12	6.59	29.43
-46.94	33.43	18.2
-28.02	40.23	-19.39
-24.18	1.78	47.36
-56.36	1.36	31.04
-50.04	-62.13	-6.09
-37.99	-37.05	41.85
-13.2	-58.88	60.13
-31	21.67	2.28
-19.16	6.13	6.79
-2.75	2.42	53.75
55.75	12.1	22.16
52.34	45.14	9.39
28.18	2.01	45.62
52.71	9.39	42.49
52.73	6.3	43.87
59.99	-57.41	-9.98
15.67	-60.74	61.07
36.75	-25.14	37.77
51.41	10.24	12.33
36.37	2.78	-.26
18.21	11.56	4.79
-44.9	37.96	7.76
-24.17	11.73	52.1
-50.01	-62.93	-2.68
-44.43	-29.69	41.31
-10	-54.55	60.84
-33.75	-89.04	16.05
-40.57	15.52	6.25
48.22	14.79	16.44
49.13	46.18	9.34
28.2	3.33	48.86
34.31	51.86	29.11
52.49	-59.91	-14.14
13.55	-58.38	64.24
42.14	-26.8	43.42
36.8	-78.5	22.17
14.03	-16.05	6.04

// Kensinger E A, 2007: Overall Recognition, Neutral + Negative
// Kensinger E A, 2007: Overall Recognition, Negative
// Kensinger E A, 2007: Overall Recognition, Neutral
// Kensinger E A, 2007: Successful Recognition, Negative
// Kensinger E A, 2007: False Recognition, Negative
// Kensinger E A, 2007: Successful Recognition + False Recognition, Neutral
// Kensinger E A, 2007: Successful Recognition, Neutral
// Kensinger E A, 2007: False Recognition, Neutral
// Kensinger E A, 2007: Visually Specific Recognition, Negative + Neutral
// Kensinger E A, 2007: Visually Specific Recognition, Negative
// Kensinger E A, 2007: Visually Specific Recognition, Neutral
// Subjects=19
-48.4	37.16	23.94
-44.14	26.88	17.04
-40.21	63.31	-6.8
-24.28	12.53	46.13
42.23	35.48	12.47
55.21	44.35	14.74
-7.06	27.37	43.25
-2.91	42.51	32.72
-44.44	23.53	-7.28
37.61	32.12	-11.77
-32.66	-51.22	53.7
40.93	-59.91	60.03
-6.61	-68.79	59.48
-4.53	-55.16	55.86
14.9	-57.43	53.51
-43.51	-36.26	53.53
-34.95	-40.15	45.93
38.61	-59.99	47.76
42.93	-49.03	49.96
42.87	-30.84	49.28
-53.86	-58.5	-.12
-48.49	-67.51	-4.92
-18.25	8.06	9.49
-53.64	25.21	34.17
-46.37	41.66	14.49
53.31	21.13	30.52
50.72	39.79	0.7
50.99	19.98	18.34
-34.83	-60.04	51.25
32.24	-56.95	57.65
1.79	-60.74	41.73
-24.03	-46.93	53.13
38.5	-60.82	38.88
42.89	-55.93	45.04
-44.36	-40.47	-14.39
33.79	-57.16	9.46
62.89	-57.57	3.4
-46.3	-53.06	0.33
1.36	0.55	19.99
18.92	-54.17	30.71
-37.89	25.13	-1.95
-18.6	-5.49	-20.54
-11.41	39.16	43.28
48.84	47.39	24.63
-52.16	47.44	-15.12
-46.31	22.41	15.28
-44.72	48.77	-24.34
-35.13	23.02	44.16
-28.72	13.81	37.12
48.68	54.96	13.8
-17.76	10.63	48.45
-44.04	4.65	20.36
-33.67	32.08	-8.31
35.66	36.96	5.72
-59.75	-26.74	52.87
-58.18	-58.52	-0.05
-54	-58.48	-11.33
60.65	-52.68	-1.53
-62.6	-45.02	-4.67
-60.44	-47.24	-5.61
-51.77	-66.67	-7.19
-39.85	-67.48	-5.07
14.26	-86.33	-3.01
1.5	-19.14	27.54
-11.41	27.15	41.11
-7.65	16.42	-4.96
-5.31	6.83	7.15
-50.61	35.67	19.64
-46.46	49.75	9.21
50.9	40.08	15.23
53.31	21.13	30.52
-4.86	25.46	45.64
-2.92	35.92	31.13
-56.31	27.95	-5.27
-46.16	13.67	25.1
37.65	28.07	-9.13
51.03	13.7	20.08
50.72	39.79	0.7
-34.78	-55.27	56.38
36.57	-59.06	57.78
36.36	-60.62	41.13
1.79	-60.74	41.73
-30.51	-46.95	53.25
-41.46	-29.43	46.1
40.59	-27.43	40.02
-42.21	-38.33	-14.64
-18.57	-26.11	-22.98
33.79	-57.16	9.46
62.89	-57.57	3.4
-51.68	-62.75	0.26
-48.52	-60.07	-5.66
31.77	-81.31	15.25
7.84	0.57	19.88
-7.09	-25.34	30.54
18.92	-54.17	30.71
-33.55	23.13	-.7
-18.62	-5.69	-22.76
5.09	33.41	-19.18
-17.92	22.56	38.31
-28.83	27.22	31.31
-64.18	-21	45.65
67.73	-21.94	51.34
67.74	-33.95	49.17
-44.25	-66.95	-10.65
-26.5	-56.88	27.27
53.07	-59.4	-4.1
-31.16	-82.45	-4.86
-39.71	-77.39	3.75
-15.92	-1.64	20.5
-13.83	15.39	18.78
14.1	21.89	6.45
23	-5.65	21.35
18.62	-23.62	13.12
33.88	-68.54	13.95
48.84	47.39	24.63
-52.16	47.44	-15.12
-48.4	37.16	23.94
-44.14	26.88	17.04
-24.28	12.53	46.13
55.21	44.35	14.74
-7.06	27.37	43.25
35.66	36.96	5.72
-32.66	-51.22	53.7
40.93	-59.91	60.03
-34.95	-40.15	45.93
-62.6	-45.02	-4.67
-56.02	-58.51	-0.08
60.65	-52.68	-1.53
14.26	-86.33	-3.01
-5.31	6.83	7.15
-20.2	35.86	31.43
2.88	36.28	-22.79
7.15	57.77	-22.75
7.51	63.77	6.91
33.96	-72.28	19.92
58.9	-32.14	34.57
38.18	-60.98	14.24
54.6	0.45	-41.42
32.02	-84.87	34.64
-43.94	-75.62	11.49
-31.08	-86.18	1.11
2.92	47.54	-17.18
-28.83	-72.37	10.91
14.42	-32.58	20.8
-39.73	-66.55	4.92
11.59	40.12	-16.6
-29.5	30.95	-20.59
-34.71	-68.99	58.86
44.82	-30.27	32.38
-64.75	-16.54	1.52
-41.68	-48.63	24.47
65.01	-21.74	7.66
73.66	-32.66	5.23
-22.79	-27.53	-14.92
-1.4	35.51	-19.28
20.87	-30.64	18.26
-16.48	-1.43	-23.21
-30.87	-80.26	18.45

// Lissek S, 2007: Simple + Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Simple + Complex 1 + Complex 2 > Rest, Non-Dominant Hand
// Lissek S, 2007: Simple > Rest, Dominant Hand
// Lissek S, 2007: Simple > Rest, Non-Dominant Hand
// Lissek S, 2007: Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Complex 1 + Complex 2 > Rest, Non-Dominant Hand
// Lissek S, 2007: Women > Men, Simple + Complex 1 + Complex 2 > Rest, 
// Dominant Hand
// Lissek S, 2007: Women > Men, Simple + Complex 1 + Complex 2 > Rest, 
// Non-Dominant Hand
// Lissek S, 2007: Men > Women, Simple + Complex 1 + Complex 2 > Rest, 
// Non-Dominant Hand
// Lissek S, 2007: Women > Men, Simple > Rest, Dominant Hand
// Lissek S, 2007: Men > Women, Simple > Rest, Dominant Hand
// Lissek S, 2007: Women > Men, Simple > Rest, Non-Dominant Hand
// Lissek S, 2007: Men > Women, Simple > Rest, Non-Dominant Hand
// Lissek S, 2007: Women > Men, Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Men > Women, Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Women > Men, Complex 1 + Complex 2 > Rest, Non-Dominant 
// Hand
// Lissek S, 2007: Men > Women, Complex 1 + Complex 2 > Rest, Non-Dominant 
// Hand
// Lissek S, 2007: Men > Women, Complex 2 > Complex 1, Dominant Hand
// Lissek S, 2007: Women > Men, Complex 2 > Complex 1, Non-Dominant Hand
// Lissek S, 2007: Men > Women, Complex 2 > Complex 1, Non-Dominant Hand
// Subjects=16
-34	-28	56
56	-16	24
-34	-10	60
60	-18	44
0	-2	64
8	0	64
-24	14	62
52	4	50
54	6	44
58	8	38
-32	42	28
-56	4	36
60	10	20
-56	8	20
60	14	12
34	20	-2
0	4	54
32	42	30
-56	-22	48
62	-30	42
-54	-24	42
50	-24	38
-50	-24	18
54	-32	54
66	-20	20
-44	-38	60
42	-36	48
-46	2	2
42	10	-2
60	12	0
-52	6	2
50	8	4
62	-34	20
56	16	-8
-8	8	40
10	10	40
14	-104	6
-18	-16	20
-16	-20	8
14	-4	6
16	-8	6
16	-16	20
-18	-6	-2
16	-4	-6
-26	-2	8
22	8	4
-30	18	4
30	2	12
40	-22	62
-38	-10	60
32	6	66
58	12	4
0	-2	58
36	44	32
-60	8	24
60	10	24
62	10	16
-64	-20	28
54	-20	54
-56	-24	40
40	-22	50
-58	-22	20
62	-26	18
54	-18	18
-40	-40	50
-34	-40	46
-42	4	0
50	-22	22
-52	4	4
-52	-34	14
2	-54	0
-10	12	34
6	12	40
16	-18	6
24	-8	2
20	-6	-2
26	-2	6
-32	-28	56
-24	-22	74
-44	2	10
62	14	12
0	-2	64
-52	-22	52
-56	-22	50
-58	-18	26
-58	-22	18
-48	-24	18
-52	6	2
-4	-6	40
6	-94	-8
-16	-18	2
-28	0	-8
40	-18	60
34	-16	62
0	-2	62
6	0	68
44	-26	62
52	-18	14
-42	2	0
46	-22	18
-58	-22	20
-16	-104	8
18	-104	8
-26	-94	6
18	-18	4
28	-4	-2
-38	-26	58
60	-16	34
-34	-10	58
60	-18	42
52	8	10
0	0	62
10	0	64
-30	-12	68
32	-6	66
-58	6	34
60	10	22
-56	8	18
56	12	12
0	4	54
-58	-20	30
62	-30	42
-40	-28	54
58	-16	24
-38	-46	64
-58	-22	20
40	-40	58
64	-18	20
-44	-38	60
40	32	44
-42	10	-2
50	10	4
-50	-22	18
-52	6	4
62	-34	20
56	16	-8
14	-4	6
-14	-12	0
16	-16	20
-18	-6	-2
18	-2	-2
-26	-2	10
22	6	4
40	-22	62
-56	0	38
30	-14	60
-2	-2	64
8	0	64
-34	-8	62
32	-6	64
-58	6	34
-60	8	22
60	10	24
62	10	16
-64	-20	28
-62	-22	32
42	-36	66
-56	-24	38
40	-34	58
-58	-22	20
-34	-44	54
-24	-54	66
30	-50	64
-46	-38	24
50	-22	22
-52	36	14
2	-54	0
16	-16	8
14	-12	20
18	-4	-2
26	2	6
-34	-34	62
60	-2	10
-42	-26	46
-22	-38	70
-32	-46	64
-62	-48	24
48	-26	16
56	-34	18
-60	-12	12
-4	-46	8
8	-46	16
16	-30	40
-10	-100	6
-24	-98	18
52	0	26
26	-8	-12
-8	-26	0
14	-28	-2
38	-18	38
-44	-12	38
60	-6	34
52	0	10
46	-22	62
20	-38	58
48	-24	14
-44	-26	18
-60	-14	12
-60	-6	8
14	-20	46
-32	-54	28
-12	-30	18
12	-32	22
-18	-40	12
-50	-26	16
-38	-44	52
68	-38	24
-22	-46	54
56	-22	14
14	-28	42
18	-20	30
8	-4	28
60	-6	32
-60	-8	14
-26	-40	58
22	-40	58
-48	-28	18
50	-24	14
-16	2	38
-12	28	48
-20	-2	8
24	2	4
-44	-76	12
-40	-16	56
60	-2	10
62	10	16
-40	-28	46
-34	-34	62
60	-20	36
-36	-46	62
-40	-40	58
-48	-26	16
-62	-46	12
-40	-54	8
48	-70	8
-6	-92	32
20	-88	34
-6	-62	6
-40	-84	4
-42	-72	0
-32	44	38
52	0	26
-8	16	16
16	-14	20
42	-60	28
-22	-44	16
14	-22	30
38	-18	38
62	-10	36
46	-22	62
34	-40	60
-26	-60	18
16	-26	38
22	54	12
-4	-26	-2
4	-26	0
-60	-22	24
-54	2	-6
-32	-54	20
36	-58	20
-14	40	10
-6	-6	24
-32	34	28
-42	46	-14
-16	50	8
-10	-34	16
14	-32	20
-18	-38	12
-14	26	8
-8	2	26
16	-12	32
26	20	-4
18	-78	6
-66	-26	12
-48	-24	-4
52	-28	6
-16	-14	38
0	-18	-2
-34	-8	30
-24	-58	38
36	-70	46
-46	-38	44
22	-46	54
-22	-66	40
30	-74	36
34	-72	28
-22	44	4
-42	46	-6
52	30	20
-2	-4	-6
-12	-36	14

// Liu Y, 2007: English Words > Fixation
// Liu Y, 2007: English Pseudowords > Fixation
// Liu Y, 2007: Learned Chinese Characters > Fixation
// Liu Y, 2007: Novel Chinese Characters > Fixation
// Liu Y, 2007: Learned Chinese Characters > English Words
// Liu Y, 2007: English Words > Learned Chinese Characters
// Subjects=23
-54.1	1.6	47.72
11.81	56.67	24.5
-48.89	9.07	33.65
-52.29	29	16.41
56.57	27.05	-4.76
-62.87	-33.77	3.95
63.18	-26.84	-.31
-39.81	15.62	-33.92
36.09	3.21	-35.98
-58.39	-43.66	27.03
-32.83	-90.57	-3.9
33.43	-92.29	-4.52
-40.56	-46.98	-17.51
39.57	-41.21	-18.91
-51.02	6.85	32.75
59.14	4.14	42.86
-6.01	9.55	49.85
4.65	14.9	49.27
-46.94	29.03	16.34
54.67	25.12	25.54
-43.86	38.77	4.34
-61.78	-32.36	8.28
-36.85	-50.54	46.32
35.83	-52.21	45.62
-31.77	-90.65	-5.02
34.91	87.65	-17.4
-46.91	-54.16	-13.48
46.12	-64.98	-10.3
-51.95	-.5	47.87
44.25	0.42	51.15
-2.83	12.66	48.43
3.58	14.81	48.18
-51.06	16.37	31.95
48.31	19.08	30.58
-38.44	15.45	5.12
34.23	19.23	6.19
-33.57	-60.75	51.6
31.64	-60.1	54.14
-35.79	-52.81	44.27
33.7	-54.34	45.83
-31.73	-92.42	-.41
32.36	-91.15	-3.49
-47.93	-67.91	-12.32
46.09	-66.38	-14.64
-51.98	6.9	47.25
54.86	7.29	42.64
-6.03	10.52	48.65
2.51	14.8	48.19
-56.47	25.51	26.78
50.37	25.9	22.18
-32.07	23.77	2.11
33.11	23.02	0.31
-45.91	28.69	11.9
47.03	32.25	8.3
-30.35	-62.76	52.84
28.4	-61.6	48.73
-33.65	-52.8	44.24
39.03	-53.34	44.57
-31.77	-90.65	-5.02
33.45	-93.18	-2.21
-47.9	-70.91	-9.84
47.18	-61.8	-10.58
-54.2	4.98	36.28
-32.59	-3.41	63.5
44.08	1.88	28.72
-.7	13.64	47.21
3.56	14.64	45.96
-44.76	26.21	21.01
-35.29	51.13	12.12
42.9	32.62	27.27
48.22	24.74	21.18
-29.93	23.87	3.2
32.08	21.24	4.93
-21.71	-63.96	64
29.52	-57.74	57.31
-43.52	-80.78	-.14
-32.78	-91.12	2.83
43.15	-82.32	13.49
-50.08	-59.3	-10.79
50.38	-63.98	-11.55
-16.73	30.01	53.83
-13.7	53.49	40.67
9.67	58.77	24.35
7.74	45.5	45.56
-51.46	36.38	-12.1
45.81	26.22	-14.6
-58.34	-59.61	27.25
-64.95	-47.44	6.23
56	-62.27	23.93
57.97	-45.3	9.1
-48.35	12.31	-34.65
36.04	23.56	-34.34
-8.01	-91.2	27.09
5.88	-92.17	27.01

// Moriguchi Y, 2007: Alexithymia Patients
// Subjects=16
0	6	28
-8	24	40
6	24	16
6	8	52
6	16	48
0	-74	-38
12	-74	-44
-52	18	-6
-58	20	24
-46	34	12
-56	8	32
-56	8	20
-46	52	-12
-32	60	10
56	22	-6
54	28	6
56	8	32
34	40	24
38	28	20
-30	26	0
-38	-6	8
36	20	2
18	-18	-6
-30	-38	48
-42	-44	66
-60	-28	42
-68	-24	30
38	-34	42
34	-52	70
52	-28	44
-68	-26	30
-52	-26	20
62	-20	38
-14	-18	10
8	-26	-4
0	0	40
-8	24	40
2	18	48
-30	-36	-40
-48	44	-12
-56	8	22
-46	34	12
-56	8	32
-34	60	8
54	8	20
56	10	32
42	28	20
-42	-2	4
-32	16	10
-2	-36	-4
-14	-22	-8
-38	-28	58
-42	-46	62
-62	-24	36
-60	-28	42
38	-34	42
38	-48	60
52	-28	44
-54	-32	46
-62	-20	22
62	-20	38
-14	-18	10
4	-32	-4
-20	56	34
-12	60	32
-12	52	44
-14	-64	-32
-18	-50	-24
-10	-54	-28
-4	-70	-20
6	-76	-28
22	-70	-28
-32	-34	-40
-22	-32	-36
-2	-38	-42
-12	2	52
-14	4	56
32	2	-32
-20	12	46
-32	10	58
38	14	2
38	-30	18
48	-24	16
54	26	6
6	26	14
20	42	34
62	-6	-6
60	2	-8
62	-26	-2
-8	38	4

// Moriguchi Y, 2007: Normals
// Subjects=14
-10	2	52
-8	14	48
8	-2	36
12	16	42
-32	-34	-38
26	-64	-28
-54	10	32
-50	44	0
-56	14	2
-46	36	14
-42	36	40
-42	50	16
-44	54	-14
-20	56	34
-34	56	20
56	10	32
56	10	26
50	50	-16
54	32	30
52	48	-8
24	72	4
-30	16	8
-40	-10	0
44	24	12
0	-32	0
-10	-20	-16
6	-18	-22
-2	-38	-42
-40	-50	58
-34	-36	48
-60	-28	42
36	-46	58
52	-28	44
-62	-20	22
68	-36	36
62	-20	36
-14	-14	10
16	-6	12
0	0	40
-8	24	40
2	18	48
-30	-36	-40
-48	44	-12
-56	8	22
-46	34	12
-56	8	32
-34	60	8
54	8	20
56	10	32
42	28	20
-42	-2	4
-32	16	10
-2	-36	-4
-14	-22	-8
-38	-28	58
-42	-46	62
-62	-24	36
-60	-28	42
38	-34	42
38	-48	60
52	-28	44
-54	-32	46
-62	-20	22
62	-20	38
-14	-18	10
4	-32	-4
-20	56	34
-12	60	32
-12	52	44
-14	-64	-32
-18	-50	-24
-10	-54	-28
-4	-70	-20
6	-76	-28
22	-70	-28
-32	-34	-40
-22	-32	-36
-2	-38	-42
-12	2	52
-14	4	56
32	2	-32
-20	12	46
-32	10	58
38	14	2
38	-30	18
48	-24	16
54	26	6
6	26	14
20	42	34
62	-6	-6
60	2	-8
62	-26	-2
-8	38	4

// Scheres A, 2007: Normals
// Subjects=11
11.75	10.92	-2.89
-11.74	6.64	-1.14
33.71	-82.78	35.94
33.13	24.34	3.55
-35.23	21.01	7.96
12.81	10.93	-2.9
-13.87	9.97	0.83
12.88	9.41	5.03
-9.62	3.22	-4.23
-21.36	3.23	-2.98
-42.18	-40.62	51.12
-.2	-36.19	-46.75
7.89	-74.78	17.73
-28.39	-76.69	23.88
33.48	-84.03	5.94
-21.05	-90.25	-.72
33.71	-81.63	36.96
-23.99	-86.38	35.79
-30.04	-47.57	-39.88
-12.97	-47.72	-43.41
-8.46	-82.62	-27.15
1.28	-58.3	-2.54

// Scheres A, 2007: ADHD Patients
// Subjects=11
-23.99	-28.11	59.9
26.21	7.05	69.76
-45.46	-6.2	56.08
-46.48	-18.9	57.16
-12.71	-12.15	3.79
0.17	-12.53	11.48
10.71	-15.06	-8.5
-16.49	-18.04	65.66
17.72	-23.12	65.69
0.1	-29.76	-4.92
-24	-28.2	58.79
21.71	-44.75	19.51
10.34	-46.34	68.84
-7.84	-49.88	66
7.64	-57.64	-8.24
1.17	-64.88	-18.71

// Thompson C K, 2007: Pseudowords vs. Words
// Thompson C K, 2007: Verbs vs. Fixation
// Thompson C K, 2007: Nouns vs. Fixation
// Subjects=17
-47.35	13.9	16.14
65.17	12.24	26.71
-41.21	35.45	-6.27
-47.17	6.53	29.19
49.77	2.46	3.29
-55.71	-15.73	32.66
59.09	-15.38	53.08
47.21	-15.42	53.28
53.79	-20.09	60.36
-37.18	-33.02	41.9
-46.94	-26.78	40.32
-56.38	5.54	-15.38
-50.58	-41.81	6.02
-59.15	-50.04	10.34
-52.57	-71.18	13.44
-8.17	20.57	39.46
4.78	23.81	38.92
11.16	28.53	31.62
14.21	26.02	16.13
-40.89	-67.17	-1.73
-50.71	-72.29	-10.02
52.98	-65.55	-12.45
-11.84	-59.19	-9.73
-18.37	-62.92	-14.86
-34.73	-45.52	-23.02
-59.07	11.81	28.87
-62.12	-11.94	39.11
-31.38	21.01	-.53
-44.22	0	5.13
62.07	7.85	37.28
68.35	8.54	21.42
-55.61	-1.83	43.61
-4.81	11.63	47.01
8.14	14.87	46.47
43.88	3.61	50.34
58.5	-25.27	4.76
71.56	-21.2	13.1
-40.72	-62.63	12.39
-46.8	-29.03	50.63
44.02	-36.91	53.22
61.87	-17.73	16.28
-30.43	-49.63	59.11
17.67	-100.38	7.29
-24.49	-94.15	7.39
-27.56	-79.73	23.94
-31.23	-77.44	-8.72
-41	-75.66	-12.09
36.9	-86.56	-6.73
49.76	-78.53	-13.35
7.64	12.2	6.4
7.49	17.64	-4.22
-2.16	-24.49	-6.61
14.2	-15.64	6.81
36.64	23.06	-5.25
46.61	29.32	15.25
36.47	25.11	-17.78
50.34	-9.65	45.94
-31.36	17.82	-.21
-44.19	-3.09	6.56
-50.76	4.98	1.39
-52.41	-2.13	40.22
-59.1	8.3	25.85
40.23	24.61	22.55
47.2	-5.64	54.56
-4.81	11.63	47.01
40.23	24.61	22.55
58.66	-32.84	15.59
-43.63	-32.84	44.23
-40.21	-36.9	58.02
-33.7	-43.26	58.54
34.26	-63.51	44.82
-27.42	-67.75	37.32
-30.39	-49.31	62.44
-8.3	11.98	27.99
-40.92	-83.86	-7.92
30.56	-94.26	3.1
-21.24	-97.33	7.65
20.95	-100.06	10.56
-37.94	-51.81	-21.23
33.37	-44.97	-20.88
-18.48	0.87	-9.96
-28.21	4.03	-10.11
-5.47	-25.03	-12.1
14.1	-13.07	-.17

// Tunik E, 2007: Velocity-Dependent Perturbation - Null > Position-Dependent 
// Perturbation - Null
// Subjects=15
27	-3	-9
21	18	-3
21	12	-12
-33	-9	-3
-21	3	-3
-21	6	12
24	27	6
-3	-60	24
-3	-12	66
-18	15	-18
3	60	3
-9	57	-3
6	-48	15

// Abler B, 2007: Expectation, High > No Reward, Placebo
// Abler B, 2007: Expectation, High > Low Reward, Placebo
// Abler B, 2007: Outcome, Win > Omission, Placebo
// Abler B, 2007: Expectation, High > No Reward, Olanzapine
// Abler B, 2007: Expectation, High > Low Reward, Olanzapine
// Abler B, 2007: Outcome, Win > Omission, Olanzapine
// Abler B, 2007: Expectation, High > No Reward, Placebo > Olanzapine
// Abler B, 2007: Expectation, High > Low Reward, Placebo > Olanzapine
// Abler B, 2007: Outcome, Win > Omission, Placebo > Olanzapine
// Abler B, 2007: Breath-Holding vs. Normal Breathing, Placebo > Olanzapine
// Subjects=8
12	-24	-15
-12	-24	-21
-6	15	-3
9	15	0
-30	24	-9
-6	12	33
-48	-21	33
21	-45	-21
9	-15	-15
-15	-24	0
-27	27	-6
48	9	3
-33	3	3
-54	9	15
-12	6	42
15	45	15
51	-36	6
-6	-81	9
-21	-84	-9
9	3	-15
18	-15	6
-21	6	0
-21	-27	-9
0	18	33
-6	39	12
-24	36	42
57	-12	-9
9	-75	9
-21	-39	-27
9	12	-6
6	12	42
57	-24	24
18	-57	-27
-12	-3	-6
33	18	-12
-3	-39	30
-9	6	-9
15	-66	-3
15	-72	-27
-3	0	0
-30	27	0
3	15	36
21	-60	0
21	-72	15
-36	24	-15
-51	15	30
54	15	24
36	-12	9

// Cross E S, 2007: Activity during Movement Preparation (NoGo)
// Cross E S, 2007: Activity during Movement Execution (Go)
// Cross E S, 2007: Study Time: Random Increasing (Early > Late) > Block 
// Increasing (Early > Late)
// Cross E S, 2007: Study Time: Block Increasing (Early > Late) > Random 
// Increasing (Early > Late)
// Cross E S, 2007: Movement Time: Random Increasing (Early > Late) > Block 
// Increasing (Early > Late)
// Cross E S, 2007: Movement Time: Block Increasing (Early > Late) > Random 
// Increasing (Early > Late)
// Subjects=13
-34	-94	0
42	-18	68
-24	-60	48
38	-28	48
32	-96	-6
10	-22	0
44	-16	52
-10	-2	56
2	-2	62
-10	-20	8
6	-6	68
-38	-14	62
-56	-10	50
-18	-10	-2
18	2	0
38	18	6
22	-16	74
-44	-30	66
-12	-30	30
-12	-26	46
6	-14	46
-30	26	0
46	22	2
2	-28	-48
-54	-44	8
-4	-32	50
-12	-52	-22
-2	-56	-10
-34	-56	52
40	20	8
42	-44	46
14	-80	16
-14	4	2
-32	-10	60
38	-48	-36
34	-72	48
-42	-86	-8
32	-72	34
-30	24	2
-48	2	16
-40	14	4
58	10	40
-30	-12	50
64	10	12
-10	-24	32
6	20	50
-2	-6	64
-6	6	54
42	42	24
50	0	54
-34	38	24
18	-4	68
42	22	38
-32	-84	20
12	-26	30
52	32	26
-40	46	22
48	4	4
-8	-20	-10
24	-16	72
6	-44	64
46	-84	-4
52	-12	58
-22	-30	48
38	-54	-44
-32	-42	-4
-42	18	50
26	60	24
-40	-18	12
-16	-54	64
16	-48	50
-14	2	40
-60	-22	42
48	-14	12
-26	-4	56
-32	-48	26
30	-48	-10
-30	-68	22
14	-30	30
12	-44	-36
-48	-48	12
64	6	18
-42	-46	50
14	-38	-2
-12	-40	-2
46	-64	-4
-12	-22	50
30	-58	30
-10	-8	60
38	-10	-28
-26	6	20
54	-32	38
52	-68	16
-40	-4	-30
16	30	14
24	-66	-6
46	-8	40
-38	22	6
42	-54	-40
30	-46	66
-44	-70	-22
-22	-66	44
24	-30	-2
-32	-26	54
-32	-34	18
-60	-38	32
-38	-22	-22
46	-4	54
58	-22	54
14	-20	48
60	-32	52
50	-24	62
-46	-48	40
68	-36	34
58	-24	10
42	-62	12
34	-78	-8
-24	-34	-20
12	-54	2
24	6	-22
-56	-52	-14

// Rauch S L, 2007: Implicit Learning > Random, TTM Patients + Normals
// Subjects=10
12	18	10
-14	16	0
6	40	-14
-6	38	-12
10	-32	34
-4	-36	30
40	-14	18
2	-46	-14

// Gamer M, 2007: Regional Activity Differing Between Item Types
// Gamer M, 2007: Brain Activity Correlating with Reaction Time
// Gamer M, 2007: Brain Activity Correlating with Amplitude of the Skin 
// Conductance Responses
// Subjects=14
-48	-42	50
-36	-21	60
-48	-33	60
3	-27	35
45	24	-10
36	27	-5
45	18	0
-39	-51	55
-30	-72	55
-51	18	40
-42	18	-5
-42	51	10
-30	45	40
-33	36	45
-24	-9	65
-36	-9	65
-3	12	55
-3	27	40
6	30	40
51	-48	45
42	-48	60
51	24	-5
45	18	0
48	33	25
39	39	35
36	-69	55
60	-54	-5
66	-42	5
-9	-72	45
6	-75	55
15	-12	5
-39	-54	-30
-36	-60	-40
39	-54	-40
-51	-66	-10
-39	-75	-15
-3	15	45
6	6	55
48	18	-5
57	9	-5
-45	-66	-30
42	-54	-30

// Goossens L, 2007: Spiders vs. Neutral Pictures, Spider Phobics > Normals
// Goossens L, 2007: Spiders vs. Snakes, Spider Phobics > Normals
// Subjects=14
2	-29	1
-4	-15	10
14	-1	11
-2	-40	20
6	23	25
-4	26	24
-6	0	70
12	9	66
40	-67	-15
2	-86	-11
-18	-77	-16
-16	-90	-14
59	13	-7
-40	13	-4
-18	1	-12
-6	-57	64
24	-82	-11
20	-95	-5
32	-67	-12
12	-90	-9
-42	-59	-22
-40	-50	-26
-24	-90	-12
-2	-70	0
2	15	36
-4	23	28
6	19	62
0	6	49
61	10	-2
-51	13	-6
-32	52	25
20	-68	9
-2	-32	24
32	-46	-23
4	-15	10

// Liu X, 2007: Bet > Bank
// Liu X, 2007: Bank > Bet
// Liu X, 2007: Win > Loss
// Liu X, 2007: Loss > Win
// Liu X, 2007: Right > Wrong
// Liu X, 2007: Wrong > Right
// Subjects=15
-4	38	-12
6	16	-8
-26	-2	68
-14	20	8
8	18	6
56	20	0
-48	34	-6
-40	60	-2
20	62	18
32	-8	66
12	28	54
-40	-4	8
34	-18	4
34	30	26
-20	34	-16
-24	32	36
-16	6	52
18	16	4
-20	8	-4
-36	-18	8
36	-18	12
52	34	12
-60	20	20
2	54	30
42	14	-18
-40	16	-14
0	-30	2
40	34	24
-34	56	-12
42	56	-8
22	42	-14
-18	44	-18
24	56	-2
14	18	-2
-20	-4	22
6	52	24
4	20	24
-2	26	-10
54	26	8
0	56	-8
54	14	-14
-36	10	-22

// Mayer J S, 2007: Common Activation, WM Load
// Mayer J S, 2007: Common Activation, Attentional Demand
// Mayer J S, 2007: Common Activation, 2-Way Interaction
// Mayer J S, 2007: Common Activation, 3-Way Interaction
// Mayer J S, 2007: Working Memory Selective, WM Load
// Mayer J S, 2007: Working Memory Selective, 2-Way Interaction
// Mayer J S, 2007: Working Memory Selective, 3-Way Interaction
// Mayer J S, 2007: Attention Selective, Attentional Demand
// Subjects=18
48.38	13.16	36.65
49.26	37.61	22.32
42.79	33.62	12.69
57.89	13.25	23.15
-20.88	-7.11	55.87
32.57	-1.08	60.33
-43.37	-5.56	50.43
44.3	0.85	56.69
-46.65	0.16	42.18
51.6	10.01	36.88
-3.85	10.96	54.16
5.78	13.31	56.09
35.32	18.35	8.49
-29.94	25.9	1.91
-18.51	-62.89	63.87
31.65	-62.21	54.32
-39.04	-39	44.26
37.95	-52.29	44.49
-15.34	-64.35	58.38
-19.72	-72.09	41.24
28.33	-65.63	37.91
-24.18	-92.75	8.45
29.21	-90.66	3.2
-41.46	-78.19	-8.19
-41.49	-61.02	-6.28
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-7.37	-24.18	-.84
8.67	-20.74	0.92
48.38	13.16	36.65
49.26	37.61	22.32
42.79	33.62	12.69
57.89	13.25	23.15
-20.88	-7.11	55.87
32.57	-1.08	60.33
-43.37	-5.56	50.43
44.3	0.85	56.69
-46.65	0.16	42.18
51.6	10.01	36.88
-3.85	10.96	54.16
5.78	13.31	56.09
35.32	18.35	8.49
-29.94	25.9	1.91
-18.51	-62.89	63.87
31.65	-62.21	54.32
-39.04	-39	44.26
37.95	-52.29	44.49
-15.34	-64.35	58.38
-19.72	-72.09	41.24
28.33	-65.63	37.91
-24.18	-92.75	8.45
29.21	-90.66	3.2
-41.46	-78.19	-8.19
-41.49	-61.02	-6.28
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-7.37	-24.18	-.84
8.67	-20.74	0.92
-20.88	-7.11	55.87
-43.37	-5.56	50.43
44.3	0.85	56.69
-46.65	0.16	42.18
51.6	10.01	36.88
-3.85	10.96	54.16
5.78	13.31	56.09
-18.51	-62.89	63.87
31.65	-62.21	54.32
-39.04	-39	44.26
37.95	-52.29	44.49
-15.34	-64.35	58.38
-19.72	-72.09	41.24
28.33	-65.63	37.91
-24.18	-92.75	8.45
29.21	-90.66	3.2
-41.46	-78.19	-8.19
-41.49	-61.02	-6.28
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-46.65	0.16	42.18
-3.85	10.96	54.16
5.78	13.31	56.09
-19.72	-72.09	41.24
28.33	-65.63	37.91
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-41.59	36.81	20.09
-49	25.47	25.58
-54.51	21.53	2.56
-52.94	-34.86	44.07
-49.99	-63.81	-.37
57.78	-47.28	-16.38
-45.85	-51.95	-12.57
55.63	-48.43	-17.37
-52.23	-49.54	-8.24
53.63	-50.42	-1.57
-41.59	36.81	20.09
-49	25.47	25.58
-54.51	21.53	2.56
-52.94	-34.86	44.07
-49.99	-63.81	-.37
57.78	-47.28	-16.38
-45.85	-51.95	-12.57
55.63	-48.43	-17.37
-49	25.47	25.58
-49.99	-63.81	-.37
45.03	28.15	24.28
40.6	36.36	6.91
-21.21	-50.06	-4.09
21.6	-47.01	4.09
-14.74	-56.03	0.8
15.22	-59.82	4.12
19.59	-72.06	10.67

// Straube T, 2007: Spider Phobics
// Subjects=16
4.53	18.02	34.52
33.08	15.11	-5.71
-6.38	0.24	-1.78
32.28	-90.87	-13.55
-28.61	-94.32	-11.44
5.53	-14.53	12.7
-1.88	17.98	34.59
42.69	6.28	-10.66
-6.38	0.24	-1.78
34.41	-86.54	-12.82
-23.24	-92.97	-8.27
7.68	-25.34	10.24

// Straube T, 2007: Normals
// Subjects=15
-3.21	54.84	15.9
-1.88	17.98	34.59
42.69	6.28	-10.66
-6.38	0.24	-1.78
34.41	-86.54	-12.82
-23.24	-92.97	-8.27
7.68	-25.34	10.24

// Wrase J, 2007: Gain Cue > Neutral Cue
// Wrase J, 2007: Loss Cue > Neutral Cue
// Wrase J, 2007: Gain Cue and Gain Outcome > Gain Cue and Nongain Outcome 
// (GG>GN)
// Wrase J, 2007: GG > GN correlated with the probability of faster reaction 
// time in the next trial (pa(GG))
// Wrase J, 2007: GN > GG correlated with the probability of faster reaction 
// time in the next trial (pa(GN))
// Wrase J, 2007: LL > LN correlated with the probability of faster reaction 
// time in the next trial (pa(LL))
// Wrase J, 2007: LN > LL correlated with the probability of faster reaction 
// time in the next trial (pa(LN))
// Subjects=14
-15	6	0
18	6	0
27	-36	9
18	15	12
-21	42	9
24	42	5
39	21	9
-45	21	15
33	27	-6
-21	36	-3
-51	9	24
-30	18	12
30	21	9
-57	3	15
33	-69	27
-21	21	12
9	-30	6
9	-91	15
12	9	0
-12	12	0
-21	9	15
15	0	15
-15	0	15
15	-6	21
15	12	15
-21	18	21
-42	21	15
-45	6	24
36	24	9
-30	54	12
33	54	12
-27	27	14
33	-66	27
0	-6	6
9	-15	9
-27	-6	21
-15	18	18
18	15	18
-12	8	-5
6	42	0
39	54	0
-33	51	0
-39	-6	18
-33	-66	27
-48	-48	27
-30	-87	24
0	-12	12
-18	6	12
27	-12	12
42	-9	3
-15	-6	12
-9	9	-3
-42	33	-6
51	30	0
-12	-81	18
-12	42	9
6	33	9
-45	-6	9
45	-6	15
30	45	-3
6	-36	15
-6	-39	15
-42	-66	33
-48	-60	30
-33	-57	24
-12	3	-3

// Fischer H, 2007: Hits > Misses, Neutral
// Fischer H, 2007: Women > Men, Neutral
// Fischer H, 2007: Men > Women, Neutral
// Subjects=12
-33.22	32.1	26.42
4.13	-17.83	64.34
8.5	-62.35	58.59
16.38	-38.49	3.43
1.12	66.05	20.24

// Ilg R, 2007: (Coherent Explicit + Coherent Implicit + Incoherent) > 
// Pseudowords
// Ilg R, 2007: Coherent Implicit > Incoherent
// Ilg R, 2007: Coherent Implicit > Coherent Explicit
// Subjects=15
0	8	56
0	16	40
-8	26	38
-4	24	30
-52	10	24
54	18	-6
-46	10	32
-34	20	-4
40	20	-2
50	12	30
-28	-70	54
-52	-44	-6
-44	-62	-20
-14	-82	8
10	-70	12
16	-50	4
-2	-14	10
8	-2	6
6	-78	-16
-12	-84	-18
40	-68	-24
-6	4	64
4	2	66
-2	24	26
-52	16	-4
56	10	-8
-24	50	28
-2	-68	60
42	-66	-24
58	-40	24
-52	-56	40
46	-28	-10

// Kramer U M, 2007: High > Low Provocation
// Kramer U M, 2007: High > Low Provocation > (Computer Opponent, Win + 
// Computer Opponent, Loss)
// Kramer U M, 2007: High > Low Provocation, Low Selection
// Kramer U M, 2007: High > Low Selection, High Provocation
// Kramer U M, 2007: Win > Loss
// Kramer U M, 2007: Loss > Win
// Kramer U M, 2007: Win, High Provocation > Win, Low Provocation
// Subjects=15
-6.79	-50.04	63.77
-15.35	-63.38	57.18
0.44	-18.59	43.21
3.51	14.12	39.32
3.35	33.36	26.55
-5.14	19.65	28.91
3.45	7.98	28.68
2.49	-22.78	30.15
39.46	25.8	-5.57
-60.51	-39.1	31.13
26.86	41.16	28.97
-30.98	44.9	13.71
56.63	16.73	-.55
42.97	6.99	26.08
-47.08	19.91	-5.2
-55.32	-40.61	11.13
2.58	-78.88	20.36
-9.45	-18.13	8.71
-8.25	-73.88	3.34
-18.16	-73.68	-34.48
2.56	11	54.09
7.06	-55.93	55.19
3.6	6.26	47.78
-4.95	0.76	46.11
5.59	20.14	34.33
-.97	40.56	23.77
-9.45	-17.07	8.62
6.57	-14.86	8.26
25.67	8.09	0.54
41.58	25.56	-8.92
-29.99	24.33	-4.65
-42.81	18.8	-6.27
28.76	57.43	5.28
24.01	-71.63	29.54
-15.38	-48.32	59.27
8.18	-47.67	65.63
-5.8	-55.21	51.93
-33.61	-24.91	60.86
35.81	-12.86	59.05
-27.36	-4.58	47.93
35.85	-36.55	55.46
-5	14.5	44.96
7.82	4.63	40.06
-.81	25.73	38.39
-8.31	16.63	31.44
20.51	-6.61	17.44
13.97	8.53	7.32
-18.2	15.94	-4.08
-10.53	-11.62	10.41
15.1	-11.64	7.89
-38.39	-15.9	-1.18
-52.45	15.22	-10.32
-58.39	-45.86	26.1
7.57	-50.66	-14.4
-32.51	-19.1	67.05
-12.23	-10.44	67.21
-39	-44.12	46.92
45.41	-47.04	42.85
-12.46	21.23	50.06
40.88	23.86	38.07
-54.38	9.61	13.59
-.86	31.82	34.54
0.59	-57.63	47.6
14.96	4.42	-4.61
-7.44	4.72	1.2
-15.82	-8.94	18.05
-2.34	50.59	-11.63
40.79	-74.78	-12.76
35.28	-67.73	-31.13
-49.02	-18.71	4.76
57.81	-13.93	2.01
19.67	19.99	58.71
18.52	31.19	52.21
10.96	16.03	35.72
-.97	31.76	20.04
7.46	43.73	8.91
7.57	-2.34	4.96
46.98	17.39	-4.95
-24.55	-15.27	-8.08
-23.54	-7.07	-12.13
37.3	4.59	-18.26
-42.74	-56.22	-26.74

// Abutalebi J, 2007: Regular Switches into Italian
// Abutalebi J, 2007: Regular Switches into French
// Abutalebi J, 2007: Irregular Switches into Italian
// Abutalebi J, 2007: Irregular Switches into French
// Abutalebi J, 2007: Conjunction Analysis
// Abutalebi J, 2007: French to Italian > Italian to French, Regular Switches
// Abutalebi J, 2007: Italian to French > French to Italian, Regular Switches
// Abutalebi J, 2007: French to Italian > Italian to French, Irregular 
// Switches
// Abutalebi J, 2007: Italian to French > French to Italian, Irregular 
// Switches
// Subjects=12
-41.8	21.65	29.84
-5.11	56.43	32.5
-3.2	45.85	11.1
-16.21	49.86	8.69
-45.73	-65.17	42.98
-11.25	-48.24	38.48
-43.94	-57.02	15.25
-65.64	-49	10.34
-61.66	-25.33	-12.24
-40.05	-55.86	-18.55
-22.57	-25.86	2.84
-.97	13.54	9.78
-29.02	-10.37	8.14
61.53	25.69	-1.45
57.12	33.77	-6.66
59.63	25.43	18.78
52.99	-8.58	-.16
61.51	-20.43	-12.58
61.59	-32.99	-9.09
61.8	-51.09	3.9
16.16	-5.08	-6.6
31.42	-3.99	4.24
-41.81	17.18	28.04
-7.25	58.76	34.55
-63.54	-40.69	7.25
-55.18	-18.72	-10.76
-61.66	-25.33	-12.24
-44.26	-63.76	-10.97
61.53	25.69	-1.45
61.67	26.73	9.65
63.69	-18.09	-10.6
61.61	-32.78	-6.87
54.8	8.5	-24.29
-57.07	22.68	18.79
-50.8	18.92	1.13
-45.68	-47.32	50.18
-52.27	-41.58	43
-63.8	-23	-10.19
-63.73	-42.14	-8.3
61.77	23.1	16.73
49.25	11.07	49.51
59.89	16.45	37.59
39.76	24.37	-14.4
74.66	-47.41	-3.41
61.59	-32.99	-9.09
56.96	8.5	-24.33
-52.74	27.16	20.52
-52.91	19.32	5.61
-46.19	18.88	23.47
-.39	17.9	56.4
-39.22	-49.63	48.06
-61.66	-25.33	-12.24
-68.02	-35.36	-4.41
61.53	25.69	-1.45
57.18	40.78	-.63
59.63	25.43	18.78
46.85	13.66	31.36
57.76	16.65	39.85
74.66	-47.41	-3.41
70.26	-41.46	-8.4
63.75	-32.98	-9.13
56.96	8.5	-24.33
-50.6	24.83	18.47
-61.66	-25.33	-12.24
-63.77	-46.81	-12.31
61.49	-22.77	-14.59
72.5	-47.42	-3.37
61.62	24.19	5.42
59.52	37.77	13.07
-7.52	8.64	3.65
-5.26	29.04	15.04
14.09	45.92	10.8
-7.12	-56.26	21.27
20.92	-52.12	18.14
53.63	-54.18	40.2
-26.04	-61.1	62.41
-55	-13.01	4.36
54.9	4.86	-17.21
-20.63	18.4	-6.06
-5.08	26.03	28.78
9.75	34.85	7.49
-48.63	1.49	-1.66
-59.25	-32.17	6.33
40.24	-70.52	3.95
-22.84	68.35	0.25
-41.38	-27.74	52.65
-2.56	-52.25	40.97
64.27	-11.6	35.81

// Kroliczak G, 2007: Grasp - Reach
// Kroliczak G, 2007: Pantomimed Grasp - Pantomimed Reach
// Kroliczak G, 2007: Pantomimed Movement - Real Movement
// Subjects=10
-48.71	-31.91	40.43
-36.78	-25.64	65.42
-69.26	-25.8	11.16
-46.56	-23.01	45.24
-12.69	-15.23	5.16
47.52	-34.08	45.08
37.96	-40.14	50.16
17.15	-49.89	-19.04
59.03	13.94	32
44.26	-16.04	44.72
36.89	-29.15	54.83
10.82	-15.01	5.99
36.89	-42.35	49.24
30.07	2.8	14.31
24.05	-72.26	35.17
36.95	-52.75	52.35
6.85	4.6	53.46
46.49	-44.66	45.98
24.07	-84.15	32.82
26.28	-44.99	57.39
52.7	-33.56	23.79
-14.9	-47.88	-17.72
-51.83	-46.48	45.03
-15.88	-19.48	5.56
55.61	-38.83	-17.06
43.09	-62.06	14.02

// Nelson E E, 2007: Successful Change - Successful Go, Pediatric Bipolar 
// Disorder Patients - Normals
// Nelson E E, 2007: Successful Change - Successful Go, Pediatric Bipolar 
// Disorder Patients with ADHD - Normals
// Nelson E E, 2007: Successful Change - Successful Go, Unmedicated Pediatric 
// Bipolar Disorder Patients - Normals
// Nelson E E, 2007: Successful Change - Successful Go, Medicated Pediatric 
// Bipolar Disorder Patients - Normals
// Subjects=10
-32	20	46
36	12	54
-32	-4	60
-32	20	46
40	2	54
46	18	34
-30	-6	62
0	-66	46
-28	-72	40
-8	-8	44
-32	12	20
-28	20	38
-34	0	58
2	-34	66
-32	18	48
10	-66	56

// Ortigue S, 2007: All Primes > Rest
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Composite
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Ease
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Satisfaction
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Frequency
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with PLS
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Emotional Closeness Satisfaction
// Subjects=29
6	-8	10
6	12	0
6	-22	-22
36	-4	2
-26	20	-4
-30	20	-4
-20	20	-4
36	-88	-18
-48	-50	-24
64	-52	16
56	-70	-2
34	-18	-28
-40	-8	-34
-64	-50	22
66	-44	32
-18	62	16
-46	26	26
52	38	22
66	-14	-8
-44	-26	-20
-64	-22	-10
-18	-96	-8
18	-94	-8
16	-76	20
-12	-68	-2
10	-40	20
-6	-42	8
64	2	24
12	-48	-38
-36	-78	-52
6	12	0
6	-22	-22
36	-4	2
-26	20	-4
36	-88	-18
-48	-50	-24
34	-18	-28
-40	-8	-34
-64	-50	22
66	-44	32
-18	62	16
-46	26	26
66	-14	-8
-44	-26	-20
-18	-96	-8
12	-48	-38
-36	-78	-52
-26	20	-4
-26	20	-4
-18	62	16
-26	20	-4
34	-18	-28
-18	62	16
66	-14	-8
-26	20	-4
34	-18	-28
-64	-50	22
-18	62	16
-46	26	26
-18	62	16

// Padula C B, 2007: Working Memory > Vigilance, Marijuana Users > Normals
// Padula C B, 2007: Main Effect for Performance, Positive Relationship
// Padula C B, 2007: Interaction of Group x Performance
// Subjects=17
35.44	-15.57	10.21
10.41	-48.91	76.86
-9.9	-62.24	71.52
67.46	-42.13	-5.77
9.37	-36.56	-52.41
45.52	-50.24	56.5
-58.61	-42.63	-.93
-52.16	-65.31	-5.8
51.52	19.1	30.54
-52.52	37.51	-11.07
-61.76	-42.05	6.86
34.98	0.58	-42.43
-1.13	28.99	-2.03
-23.7	-9.84	-34.2
25.82	-28.84	4.75

// Postle B R, 2007: Location Memory, Rest vs. Rest
// Postle B R, 2007: Object Memory, Rest vs. Rest
// Postle B R, 2007: No Memory, Saccades vs. Rest
// Postle B R, 2007: No Memory, Passive Listening vs. Rest
// Subjects=12
29	14	48
-20	-28	36
13	-29	30
13	36	22
-9	-17	11
-22	-57	3
42	-52	-4
39	-49	-8
-43	-49	-8
-44	-44	-36
-36	10	42
-5	-3	38
47	-7	38
-38	-10	38
31	-48	34
-9	1	26
13	18	26
42	6	26
23	-23	26
-31	-23	23
-47	11	24
38	22	23
54	14	19
-43	27	15
43	34	12
16	14	12
38	-3	7
-58	-26	1
-36	6	-4
46	24	-4
-9	-61	-8
-3	-7	-11
13	7	-12
-31	18	-12
-21	-56	-21
-43	-28	-21
42	14	-21
31	-11	-24
4	-21	-26
38	-26	-31
0	-49	53
21	6	53
39	-21	53
-20	-1	49
-2	-34	49
-2	6	46
-38	-11	42
6	-38	41
45	-9	39
12	-52	37
-6	-5	37
-15	-54	34
5	13	31
-8	-12	31
-12	-50	28
12	-69	24
9	25	24
-51	10	18
-4	-72	17
56	6	16
5	23	16
6	-60	12
-31	-61	6
-44	7	5
-13	-49	4
20	4	4
10	-60	2
42	-29	2
-13	-52	2
-20	15	2
-29	14	0
-6	-8	-1
34	28	-4
16	-9	-4
-14	-7	-4
-51	12	-8
21	-29	-12
-28	27	-12
20	20	-17
-55	-11	-23
20	-44	-26
-22	-48	-26
34	-7	53
-12	-6	49
36	-19	48
-1	20	46
11	2	44
40	1	43
42	-7	40
-47	-23	40
9	-33	37
-5	-7	34
35	-52	31
-20	-22	28
16	-30	27
21	-16	27
-39	0	27
-24	26	22
60	-19	19
47	26	18
-44	22	18
-45	-13	10
-16	2	10
39	-14	8
-16	19	1
-43	28	-1
14	-12	-1
54	-10	-5
-52	-11	-6
-21	-64	-6
37	38	-9
26	-7	-9
-9	-6	-12
9	-15	-15
45	-23	-18
54	3	-21
38	-33	-24
12	-29	-27
-21	-41	-32

// Vandewalle G, 2007: Light Condition Effects During the Performance of the 
// Task, Blue Light > Violet Light
// Vandewalle G, 2007: Light Condition Effects at Light Onset, Blue Light > 
// Green Light
// Vandewalle G, 2007: Light Condition Effects at Light Onset, Violet Light > 
// Green Light
// Subjects=15
-44	42	30
-18	-24	10
-6	-38	-20
6	-30	-16
-28	-38	2
-16	-24	18
16	-4	-18
-22	-22	-10

// Cornier M A, 2007: Eucaloric, Hedonic > Utilitarian
// Subjects=12
30	-3	48
-36	-63	-27
36	-63	-18
6	0	-12
21	-66	54
-27	-27	-9
24	-33	-6

// Filimon F, 2007: Actual Reaching > Passive Viewing
// Filimon F, 2007: Observed Reaching > Passive Viewing
// Filimon F, 2007: Imagined Reaching > Passive Viewing
// Filimon F, 2007: Actual Reaching + Observed Reaching + Imagined Reaching
// Subjects=15
-45	-41	14
-23	-14	14
-33	-18	14
-37	-30	14
-31	-28	14
-30	-37	14
-52	12	13
-21	-2	14
-31	3	6
-48	-47	9
-33	-46	14
-27	-55	14
-57	-38	14
-4	-60	11
-10	0	13
-5	-5	14
-14	-88	14
-45	-72	14
-3	-74	14
-2	-88	14
-11	-81	13
54	-35	13
37	-11	13
34	-38	7
29	-40	11
23	-5	12
26	-52	12
20	-59	14
60	-31	14
7	-64	12
7	2	14
15	-90	14
6	-76	13
5	-86	13
13	-79	13
-14	-92	26
-29	-52	47
-29	-57	64
-23	-6	60
-45	-76	3
-45	-58	12
-6	-62	52
-1	-89	10
20	-91	26
28	-52	49
21	-62	66
48	-72	4
51	-50	11
7	-65	52
-22	-65	62
-29	-51	45
-28	-40	55
-6	-63	57
-59	-37	41
-48	-44	26
-22	-3	61
-26	-12	55
-50	16	15
-5	-1	59
19	-66	61
59	-36	43
8	6	59
-22	-2	62
-24	-61	60
-30	-49	48

// Hassabis D, 2007: Real Memories > Real Objects
// Hassabis D, 2007: New Scene > New Object
// Hassabis D, 2007: Previously Imagined Scene > Previously Imagined Object
// Hassabis D, 2007: Conjunction Analysis (RM - RO + IS - IO + NS - NO)
// Hassabis D, 2007: Recall of Real Episodic Memories > Recall of Previously 
// Imagined Experiences, (RM - RO) > (IS - IO)
// Subjects=21
-3	51	24
3	42	-9
27	36	39
-57	-9	-21
57	-6	-24
-18	-21	-15
18	-24	-12
15	-18	9
-18	-36	-15
24	-33	-18
-3	-57	15
12	-60	12
-3	-54	33
3	-66	39
-48	-78	18
48	-72	27
3	-63	63
3	24	-9
27	27	45
57	-6	-24
21	-24	-12
-18	-36	-15
33	-42	-12
-12	-60	9
12	-57	15
9	-57	48
-48	-78	24
45	-66	24
9	-75	57
-3	45	36
-6	48	-9
-24	24	51
-63	-12	-18
24	-21	-15
-21	-39	-18
27	-36	-18
-9	-48	6
15	-57	9
-9	-42	36
-3	-60	54
-36	-75	30
45	-69	33
3	-66	60
-6	54	27
-3	48	-12
-24	24	51
24	24	48
-63	-9	-18
57	-3	-24
-21	-21	-21
24	-21	-15
-18	-33	-15
21	-33	-18
-6	-54	9
12	-54	9
-3	-39	42
-6	-63	51
6	-66	60
-33	-78	39
48	-72	27
-6	-78	54
-3	63	6
-3	-54	36
3	-63	39

// Jacobsen L K, 2007: Increases in Smokers During Smoking Relative to 
// Non-Smokers
// Jacobsen L K, 2007: Decreases in Smokers During Smoking Relative to 
// Non-Smokers
// Subjects=38
-38.17	-9.34	54.14
20.01	25.76	47.43
37.5	-42.67	49.42
13.8	11.34	65.77
49.75	-40.37	-7.04
50.12	0.7	30.35
-33.85	-33.45	48.61
61.91	12.13	25.66
-59.17	13.31	22
-5.66	2.45	63.62
22.12	12.27	40.89
40.61	5.18	-36.05
21.16	-3.71	-38.2

// Rilling J K, 2007: CC vs. (CD + DC + DD), Psychopathy Positive Correlation
// Rilling J K, 2007: CC vs. (CD + DC + DD), Psychopathy Negative Correlation
// Rilling J K, 2007: CD vs. (CC + DC + DD), Psychopathy Positive Correlation
// Rilling J K, 2007: CD vs. (CD + DC + DD), Psychopathy Negative Correlation
// Rilling J K, 2007: DC vs. (CC + CD + DD), Psychopathy Positive Correlation
// Rilling J K, 2007: DC vs. (CC + CD + DD), Psychopathy Negative Correlation
// Rilling J K, 2007: DD vs. (CC + CD + DC), Psychopathy Positive Correlation
// Rilling J K, 2007: Partner Cooperation - Defect, Psychopathy Positive 
// Correlation
// Rilling J K, 2007: Partner Cooperation - Defect, Psychopathy Negative 
// Correlation
// Rilling J K, 2007: Choice Cooperation - Choice Defect, Psychopathy Positive 
// Correlation
// Rilling J K, 2007: Choice Cooperation - Choice Defect, Psychopathy Negative 
// Correlation
// Subjects=22
5.1	60.07	-13.62
-62.96	-6.1	3.86
-66.01	-31.96	13.87
22.43	26.39	3.5
-34.09	16.25	15.04
-7.2	-3.8	28.67
45.37	-79.25	25.48
2.22	-17.86	-2.6
15.94	0.23	-17.65
41.5	40.11	-13.48
-12.83	23.98	2.99
-2.97	1.26	24.86
-9.37	-31.53	14.3
37.55	-42.22	-4.3
52.65	-68.14	3.27
16.45	-82.39	14.92
-19.96	-72.38	10.04
13.27	-87.61	16.51
-58.76	-30.97	-15.29
55.96	-51.69	23.04
-52	-73.46	12.73
18.37	-79.06	-11.03
18.55	-98.13	3.95
-61.91	-5.21	1.54
-17.11	25.01	2.95
-1.83	-59.5	9.86
26.91	-71.44	-9.54
27.3	-74.01	39.74
15.48	-93.43	23.66
-42.22	-5.84	60.47
7.29	46.33	-12.5
37.18	40.71	-19.06
68.47	-31.72	-8.89
46.03	-69.26	-24.44
13.27	-98.62	11.86

// Rolls E T, 2007: Chocolate Cravers
// Subjects=8
-30	12	0
32	22	0
-4	24	38
-20	42	-4
-12	6	4
-30	44	26
-6	32	-30
-8	22	28
4	30	8
-28	42	-10
-4	16	-12
-2	30	4
14	28	-18
-10	2	14
-8	28	30
34	14	-8
-2	40	2
8	36	-8
30	42	28
-8	28	-20
-6	56	16
-2	24	-28
0	40	-2
6	38	-10

// Rolls E T, 2007: Chocolate Non-Cravers
// Subjects=8
-30	12	0
32	22	0
-4	24	38
-20	42	-4
-12	6	4
-30	44	26
-6	32	-30
-8	22	28
4	30	8
-28	42	-10
-4	16	-12
-2	30	4
14	28	-18
-10	2	14
-8	28	30
34	14	-8
-2	40	2
8	36	-8
30	42	28
-8	28	-20
-6	56	16
-2	24	-28

// Safron A, 2007: Preferred Sexual > Non-Preferred Sexual
// Safron A, 2007: Non-Preferred Sexual > Preferred Sexual
// Safron A, 2007: Preferred Sexual > Sports
// Safron A, 2007: Sports > Preferred Sexual
// Safron A, 2007: Sports > Non-Preferred Sexual
// Safron A, 2007: Non-Preferred Sexual > Sports
// Subjects=11
-28	-85	-5
-32	-84	14
34	-82	-4
-18	-89	1
-21	-89	4
29	-85	24
-22	-83	35
-12	-53	22
12	-56	22
-9	-61	64
31	-41	-2
-27	-24	-1
-19	-15	-1
-19	-23	7
-24	-25	17
-14	7	14
-19	-18	27
9	9	16
18	-17	27
-33	2	18
-29	27	17
-1	26	21
10	20	21
-36	-32	52
-38	-17	58
-39	-43	65
-16	-36	66
-27	-38	65
26	-40	-34
26	-53	-24
-19	19	48
17	1	36
16	23	45
45	21	26
34	-30	63
-4	-90	-3
11	-90	-3
-31	-88	-4
-34	-88	9
27	-90	4
22	-89	9
27	-84	24
-38	-39	56
-1	21	15
-22	-26	5
-14	0	-6
-37	-3	4
-20	-62	7
16	-34	28
56	-26	38
29	-29	64
20	-47	-30
9	-52	11
-31	-32	65
-40	-30	20
40	-68	41
-54	-2	-16
-51	-21	45
-55	-47	11
-24	-34	-14
-12	-17	74
-10	-102	11
-41	-59	-40
-1	-69	39
-52	17	32
58	-43	0
-38	48	11
43	-32	54
-46	-70	-5
26	-85	26

// Stern E R, 2007: Position - Neutral
// Stern E R, 2007: Position - Word
// Stern E R, 2007: Position - Neutral, Positive Correlation with Behavioral 
// Cueing Effect
// Stern E R, 2007: Position - Neutral, Negative Correlation with Behavioral 
// Cueing Effect
// Subjects=14
32	46	-20
22	54	20
-2	6	48
38	-54	48
12	-72	48
-42	-40	48
12	-60	66
-32	-54	66
-36	-60	-30
26	-56	-26
-12	-62	-28
16	-12	16
16	-68	42
-54	-44	44
34	-50	42
52	-66	-10
36	46	40
-56	-64	22
64	-52	-4
12	-78	52
-22	-74	60
16	-62	70
36	-56	58
-42	-56	54
32	-64	32
28	-80	16
38	-92	-14
-22	-96	20
50	-8	34

// Baicy K, 2007: Leptin-Deficient Patients, High Calorie > Low Calorie
// Baicy K, 2007: Leptin Supplement, High Calorie > Low Calorie
// Subjects=3
-36	10	2
-56	-32	18
48	0	0
22	6	-32
-26	-24	-24
62	-24	20
-64	-48	26
-40	-52	-24
18	-66	16
-2	32	-12
-8	28	36
-14	14	48
10	56	12
10	44	46
24	54	-8
-28	44	38
-20	36	46
40	22	56
-2	-46	34
-30	-96	20
-14	-22	-14
6	-36	-32
-50	-52	-40
-32	-60	-38
-50	-64	-34
-2	-74	-46
-34	-80	-38
-20	-82	-32
-6	-82	-26
46	-48	-44
36	-68	-32
44	-76	-42
16	-84	-24

// Eschen A, 2007: Enact - Report
// Eschen A, 2007: Report - Abstract
// Subjects=10
-59.9	-25.66	41.55
-15.3	-50.64	58.95
-19.76	15.06	61.5
-58	-63.76	12.8
-49.87	-48.53	60.46
-26.5	-5.43	37.86
14.9	7.09	66.18

// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 1, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 1, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 2, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 2, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 3, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 3, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 4, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 4, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 5, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 5, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 6, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 6, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 7, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 7, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 8, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 8, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 9, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 9, 7T 
// Scanner
// Subjects=9
-36	-28	70
-52	-20	20
-4	-6	60
16	-56	-24
-44	-30	62
-52	-20	20
-2	-10	62
-14	-20	0
14	-50	-28
-36	-26	70
-48	-24	28
-2	-10	62
-14	-20	8
16	-52	-18
-36	-30	62
-40	-24	19
-4	-4	52
-14	-24	0
22	-52	-28
-44	-24	56
-60	-16	28
-4	-2	58
26	-52	-24
-38	-24	70
-62	-14	28
-2	-2	58
-24	-10	6
18	-48	-22
-34	-18	68
-54	-20	20
-4	-2	56
18	-46	-24
-44	-24	58
-52	-24	22
-8	-4	56
-16	-24	4
14	-52	-18
-38	-32	64
-48	-30	20
-8	-6	52
20	-52	-24
-44	-18	60
-50	-28	20
-10	-2	54
-22	-20	-2
18	-46	-26
-44	-26	60
-58	-22	28
0	-4	58
18	-54	-26
-40	-26	64
-50	-26	18
-2	-4	54
-14	-20	6
18	-50	-28
-42	-20	64
-58	-20	22
-6	-8	52
22	-56	-24
-42	-24	66
-58	-18	18
-6	-10	50
-16	-22	8
24	-54	-28
-46	-12	56
-52	-18	12
20	-54	-20
-46	-18	54
-60	-18	8
-10	-8	52
-14	-22	0
18	-50	-28
-40	-32	64
-2	-2	-46
18	-50	-24
-38	-22	54
-54	-24	22
-6	2	48
-22	-26	6
16	-48	-22

// Herwig U, 2007: Expectation Unpleasant > Neutral
// Herwig U, 2007: Expectation Pleasant > Neutral
// Herwig U, 2007: Expectation Unknown > Neutral
// Herwig U, 2007: (Expectation Unknown + Unpleasant) > (Expectation Pleasant 
// + Neutral)
// Subjects=14
-32.03	22	6.72
-34.2	9.59	-2.25
-32.09	1.6	-9.41
2.24	20.78	15.35
-32.21	7	-22.13
-23.56	-2.92	-13.59
-11.62	-6.43	8.87
11.82	4.03	4.38
15.13	4.02	17.73
-12.72	2.03	8.18
25.66	-18.4	-11.74
-6.44	-16.82	-15.97
-60.55	-27.47	30.16
-32.95	-69.77	-10.11
51.55	-65.15	0.8
25.59	-2.63	-14.18
-23.49	-18.7	-11.15
8.52	-16.73	-16.14
-4.28	60.29	17.69
2.2	22.55	10.74
-1.1	9.53	-5.97
21.32	-2.65	-14.13
-19.23	-18.76	-12.31
-.91	-28.02	3.87
-10.68	-26.37	-15.12
38.65	-70.4	-10.88
51.55	-66.29	-.22
-19.29	-2.9	-13.64
21.38	-18.51	-12.8
5.51	24.83	26.13
7.62	44.3	30.05
49.17	27.86	6.41
-31.04	20.1	-4.28
-36.39	0.26	-12.59
-36.49	10.15	-22.34
21.33	-2.57	-13.02
-12.76	-1.66	1.79
10.76	4.11	5.5
-.96	-19.82	-.16
6.45	-24.86	-10.98
50.48	-63.04	0.64
37.29	6.7	-18.44
-34.07	-63.77	-15.06
51.37	20.82	11.44
40.5	23.27	-10.95
-29.92	21.76	3.37
-37.42	-1.52	-7.97
12.89	2.98	4.46
6.51	-13.26	1.43
8.57	-20.62	-11.36
-50.06	-65.64	-10.26

// Hummel C, 2007: Taste-Disorder Patients vs. Normals
// Hummel C, 2007: Normals vs. Taste-Disorder Patients
// Subjects=8
-3	36	-6
-6	-57	24
15	42	-12
48	-18	9
36	12	0
6	-15	33
39	-39	45
-36	-57	63
36	-81	24
12	-39	42

// Kleber B, 2007: Overt Singing - Imagined Singing
// Kleber B, 2007: Imagined Singing - Overt Singing
// Subjects=16
-57	-12	33
39	-24	39
-54	-9	33
48	-12	36
-39	-30	12
45	-21	12
-45	-21	3
66	-3	-6
-21	-75	9
-9	-42	-24
15	-63	-24
-63	-9	21
63	-6	12
6	-30	-45
18	-24	-3
-9	12	51
42	45	33
-36	30	-12
42	39	-9
9	42	9
-15	45	-6
-48	-57	48
60	-51	45
-33	-75	51
51	27	24
-50	9	42
-39	-69	45
57	-63	24

// Maihofner C, 2007: Acute Pain, Placebo
// Maihofner C, 2007: Acute Pain, ASA
// Maihofner C, 2007: Acute Pain, Parecoxib
// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo
// Maihofner C, 2007: Mechanical Hyperalgesia, ASA
// Maihofner C, 2007: Mechanical Hyperalgesia, Parecoxib
// Maihofner C, 2007: Tactile Stimulation, Placebo
// Maihofner C, 2007: Tactile Stimulation, ASA
// Maihofner C, 2007: Tactile Stimulation, Parecoxib
// Maihofner C, 2007: Acute Pain, Placebo vs. ASA
// Maihofner C, 2007: Acute Pain, Placebo vs. Parecoxib
// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo vs. ASA
// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo vs. Parecoxib
// Maihofner C, 2007: Acute Pain > Mechanical Hyperalgesia, Parecoxib
// Maihofner C, 2007: Mechanical Hyperalgesia > Acute Pain, Parecoxib
// Subjects=14
41.82	-26.18	56.98
53.37	-10.99	8.73
-54.57	-23.88	18.19
52.18	-45.83	48.25
-44.32	-42.73	50.21
40.26	17.94	-2.69
-45.69	15.81	7.73
13.94	26.95	25.3
50.14	5.18	40.64
44.89	46.67	27.08
22.1	53.07	-.97
-35.09	24.4	40.79
40.43	-25.36	58.04
49.64	-28.56	17.16
-54.66	-24.94	19.62
51.1	-45.06	47.3
-44.55	-39.53	50.28
34.88	17.65	6.43
-45.78	15.05	8.91
14.58	25.1	24.66
45.95	7.63	38.26
46.81	49.97	28.34
23.29	54.88	1.66
-46.36	17.82	46.16
39.88	-27.41	54.98
53.69	-27.25	15.89
34.85	-51.57	58.18
-43.26	17.89	4.07
12.22	23.76	22.68
44.46	12.79	41.75
38.58	43.79	26.16
3.5	59.13	0.64
-27.77	13.72	43.72
41.36	-29.86	52.05
30.67	-17.66	56.61
55.17	-24.98	14.79
-54.23	-23.4	20.26
51.57	-46.57	52.55
-43.27	-38.99	48.99
41.27	13.23	2.27
-41.95	13.26	6.01
10.3	22.39	21.7
-1.92	23.11	18.33
1.54	54.93	-5.46
58.65	-2.2	3.58
43.07	48.2	27.75
20.74	52.11	1.81
-35.49	43.24	24.27
40.52	-31.06	53.16
53.09	-15.4	12.23
-53.89	-23.56	22.28
52.43	-45.55	53.24
49.17	-39.28	49.29
39.98	16.33	2.58
-47.07	14.1	7.67
6.22	21.93	20.23
5.09	57.58	-1.71
29.5	12.63	41.04
38.22	45.23	21.36
21.71	52.22	3.24
-21.05	32.1	49.69
42.61	-30.64	47.42
55.31	-11.33	10.97
-55.95	-22.89	18.79
53.27	-44.59	51.81
45.76	-45.47	47.95
40.09	18.02	2.44
-45.39	13.54	3.12
4.71	22.61	18.18
6.15	58.88	-2.94
30.84	15.18	49.17
51.75	11.07	29.87
43.35	49.28	8.59
-35.94	43.81	49.66
42.71	-30.2	46.15
-53.29	-26.22	16.81
58.61	-23.87	17.89
52.92	-47.39	47.25
51.09	-39.21	48.6
50.08	15.11	7.92
5.9	17.14	31.34
10.07	50.19	45.47
46.39	46.37	27.2
55.83	16.66	6.83
7.71	12.22	57.05
42.92	-31.46	45.03
-51.45	-27.56	18.46
57.46	-25.11	21.24
52.16	-46.22	46.05
50.87	-35.28	48.6
-37.69	14.13	4.55
48.15	14.52	7.43
7.21	10.58	33.1
9.94	50.77	41.97
44.2	17.5	36.67
54.78	13.51	7.44
7.4	11.59	57.1
44.66	-29.78	50.11
-53.5	-25.95	17.57
58.18	-22.32	18.66
35.92	-52.6	57.14
43.98	-52.08	49.42
-35.04	19.34	4.19
49.86	14.53	7.3
5.08	16.97	36.05
8.96	49.19	39.44
41.07	38.35	27.15
53.69	15.95	6.13
8.26	4.51	55.01
49.7	-26.93	53.49
56.86	-24.13	13.25
-55.57	-20.37	14.11
51.2	-28.19	53.58
58.2	-25.51	20.04
-49.11	-26.53	17.9
52.85	-44.94	52.85
46.18	19.57	4.02
13.51	26.12	24.25
-4.04	21.48	19.49
39.22	45.41	26.47
42	-31.97	92.14
59.21	-21.19	13.98
-56.82	-24.02	16.67
52.18	-45.83	48.25
41.59	19.51	3.74
13.94	26.95	25.3
-4.39	22.15	15.76
40.97	49.71	18.5
43.14	48.49	9.44
41.37	-28.87	53.86
60.39	-19.62	14.84
-55	-24.53	16.69
53.72	-45.42	54.77
43.19	19.53	3.83
6.44	22.21	21.1
-4.14	19.33	19.23
40.93	49.9	27.97
22.75	54.15	0.5
43.08	-27.58	53.85
54.13	-10.33	10.34
-51.3	-20.24	14.05
40.46	47.31	35.77
42.06	-28.54	59.4
53.93	-45.14	54.3
39.72	48.02	23.01
23.72	53.02	0.92

// Rotshtein P, 2007: Main Effect of Feature Change: Features, Change - 
// Features, Repeat
// Rotshtein P, 2007: Main Effect of Second Order Configured Relations Change: 
// 2nd Change > 2nd Repeat
// Rotshtein P, 2007: Correlation of Behavior and fMRI:  Second-order 
// Configural Relations
// Subjects=14
39	-90	0
45	-75	9
-42	-60	3
42	-54	-21
30	-9	-21
-30	-6	-27
48	-39	36
33	-87	-18
-45	-75	-12
-45	-81	-6
42	-57	-21
45	-54	-21
-33	36	24
18	63	12
-18	18	42
-3	-9	36
33	33	-12
-24	-3	9

// Shibata M, 2007: Literal Sentence
// Shibata M, 2007: Metaphoric Sentence
// Shibata M, 2007: Anomalous Sentence
// Shibata M, 2007: Metaphoric Sentence vs. Literal Sentence
// Shibata M, 2007: Literal Sentence vs. Metaphoric Sentence
// Shibata M, 2007: Metaphoric Sentence vs. Anomalous Sentence
// Shibata M, 2007: Anomalous Sentence vs. Metaphoric Sentence
// Subjects=13
-32	-51	58
34	-59	56
-36	-38	57
12	-44	54
0	7	55
-55	11	20
53	14	18
0	23	36
20	-9	12
-2	-7	17
2	28	47
-8	57	8
-44	28	17
44	24	17
51	26	12
-51	8	9
4	-22	34
-2	23	32
-42	-9	15
-4	-11	13
10	-71	26
-2	8	49
-2	-1	52
55	21	32
-53	5	29
50	18	14
-50	4	7
51	8	1
4	23	30
-6	-23	12
-46	-50	39
-4	50	29
0	52	21
0	61	14
-42	24	14
10	-63	58
10	-46	50
-8	-53	58
-16	-51	65
22	48	34
26	35	41
2	54	23
0	61	12
-40	26	15
-34	-61	25
12	-37	44

// Szameitat A J, 2007: Right - Rest
// Szameitat A J, 2007: Left - Rest
// Subjects=17
-40	38	24
-36	31	30
-28	30	22
-4	-5	59
-12	-3	57
4	2	48
12	9	57
-55	10	0
-57	5	29
-53	5	13
-30	18	5
51	10	11
53	23	-6
46	14	3
-48	-34	55
-38	-38	55
53	-69	20
67	-39	33
67	-44	22
53	-27	40
34	-35	44
30	-43	67
-55	-65	14
-36	29	30
-4	-3	59
-12	3	57
2	2	48
12	7	59
-55	10	1
-57	7	29
-51	5	13
-30	22	4
55	10	5
55	21	-4
46	14	3
-50	-34	55
-38	-38	55
-40	-46	59
57	-63	20
67	-39	30
67	-44	22
51	-25	38
34	-31	42
30	-45	67
-57	-63	14
-50	-72	29
-61	-58	3

// Takahashi T, 2007: Brain Activations in Changing Gum Hardness
// Takahashi T, 2007: Brain Activations in Consistent Gum Hardness
// Takahashi T, 2007: Changing Gum Hardness - Consistent Gum Hardness
// Subjects=15
52	-8	38
-50	-10	32
50	-10	38
-52	-10	24
64	-26	28
50	10	54
-62	-42	8
0	-8	56
-46	40	0

// Neuner I, 2007: Encoding vs. Fixation
// Neuner I, 2007: Immediate Recall vs. Motor Baseline
// Neuner I, 2007: Delayed Recall vs. Motor Baseline
// Neuner I, 2007: Immediate Recall vs. Delayed Recall
// Subjects=15
-34	-62	-32
-46	-68	-10
-26	-62	52
-42	6	30
-2	24	40
-42	2	46
-36	30	-4
36	48	32
28	2	60
-16	-8	14
32	28	-6
16	6	6
-2	-28	-18
-24	-38	-50
22	-40	-50
-2	32	38
36	24	-12
-30	28	-4
26	-94	-6
36	-84	-10
46	-62	-16
0	-38	-46
36	26	-10
0	32	38
-38	-82	-6
-46	-66	-10
-26	-98	-4
40	-82	-10
-30	28	-6
32	12	56
8	-24	-16
16	2	8
-28	0	56
-16	-2	14
24	46	-18
-14	-24	8
10	-20	2
0	-26	64
-20	-16	70
14	-12	10

// Haase L, 2007: Sucrose - Water
// Haase L, 2007: Caffeine - Water
// Subjects=18
-55.35	-9.09	19.63
-55.34	-5.75	21.58
-33.13	17.34	1.55
-34.03	-5.16	13.48
-55.39	-11.72	13.16
-32.01	17.86	8.18
-42.77	35.69	5.7
-7.34	-13.97	7.23
-24.82	42.37	-19.6
-30.11	38.45	-14.75
-42.67	13.65	9.78
-35.34	11.01	-11.28
-60.74	-6.29	15
-55.5	13.49	8.82
-12.68	-16.21	6.36
-5.2	-15.1	6.18
-4.39	50.38	-.44
63.26	-1.86	19.9
42.93	-8.84	14.02
63.26	-1.86	19.9
41.64	21.84	-1.92
41.6	25.82	-5.6
13.9	15.51	1.16
36.17	39.1	-12.22
35.07	40.95	-15.71
43.73	8.14	-14.17
38.6	-2.87	9.11
67.52	-6.41	15.77
14.03	-16.05	6.04
12.97	-17.11	6.14
12.82	43.93	11.06
40.62	-24.91	-14.71
32.32	-23.54	17.61
35.27	-27.23	-16.69
34.36	-38.73	-.1
30.9	-7.34	-20.54
3.13	37.65	-.57
-19.31	-13.01	-20.6
-19.34	-7.81	-22.15
-56.44	-11.55	15.39

// Mobbs D, 2007: Cue, Predator vs. Cue, Yoked Control
// Mobbs D, 2007: Predator - Yoked Control
// Mobbs D, 2007: Yoked Control - Predator
// Mobbs D, 2007: Chase, Predator, High Correlated with a Distal Predator-Prey 
// Distance
// Mobbs D, 2007: Chase, Predator, Low Correlated with a Distal Predator-Prey 
// Distance
// Mobbs D, 2007: Chase, Predator, High Correlated with a Proximal 
// Predator-Prey Distance
// Mobbs D, 2007: Chase, Predator, Low Correlated with a Proximal 
// Predator-Prey Distance
// Mobbs D, 2007: Chase, Predator, High - Chase, Predator, Low
// Mobbs D, 2007: Chase, Predator, Low - Chase, Predator, HIgh
// Mobbs D, 2007: Chase, Predator, High Correlated with Increased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, Low Correlated with Increased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, High Correlated with Decreased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, Low Correlated with Decreased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, High Correlated with Increased Confidence 
// of Escape
// Mobbs D, 2007: Chase, Predator, High Correlated with Decreased Confidence 
// of Escape
// Mobbs D, 2007: Chase, Predator, Low Correlated with Increased Confidence of 
// Escape
// Mobbs D, 2007: Chase, Predator, Low Correlated with Decreased Confidence of 
// Escape
// Subjects=14
13	32	-14
-6	41	22
-8	18	30
-29	48	-6
-4	39	-13
6	49	-19
3	54	-4
40	20	28
3	-25	-7
-2	-28	-8
-5	-63	-13
3	-22	11
-17	2	25
16	-13	20
-5	48	17
3	37	-9
22	-2	-18
28	-6	-27
-8	35	-13
-5	27	-14
32	-4	-24
16	16	2
45	34	-8
-10	38	-11
-31	-2	-25
2	42	6
-3	-33	-15
8	-32	-21
32	4	-13
60	18	8
2	-27	-28
7	20	30
6	-33	-14
5	28	17
8	59	-1
-10	16	13
20	7	10
30	47	27
37	33	9
38	-13	-17
-3	-32	-15
-23	0	-15
-1	51	-1
15	54	20
-35	39	8
31	-4	-23
-32	-73	-14
-1	-26	-19
7	-20	-15
18	58	7
5	42	15
5	42	-13
49	38	11
11	-32	-18
-3	61	12
0	-28	-19
-5	-32	-18
-9	-32	-32
-36	45	-2
-3	-61	-32
29	-57	-28
0	17	26
24	11	1
-45	-66	-8
-20	10	-11
34	-40	-6
-31	24	-4
3	38	-17
23	-2	16
57	-24	-11
42	-76	-13
-39	34	15
35	49	-1
-4	29	-8
-3	48	24
-3	-33	-5
27	7	-16
19	-7	-24
-11	16	-7
17	47	-4
-5	44	30
34	22	-10
2	-29	-19
6	24	28
7	54	28
6	-26	10
-8	-19	4
49	-7	7
-2	34	-20
28	9	-25
12	51	-8
-3	-37	-20
7	41	31

// Jager G, 2007: Associative Learning > Classification
// Subjects=20
-34	-51	-20
-34	-91	12
42	9	32
38	-51	-20
2	29	40
-46	29	24

// de Zubicaray G I, 2007: Hit > Correct Rejection
// de Zubicaray G I, 2007: Correct Rejection > Hit
// de Zubicaray G I, 2007: Hit > Miss
// de Zubicaray G I, 2007: Miss > Hit
// de Zubicaray G I, 2007: Miss > Correct Rejection
// de Zubicaray G I, 2007: Correct Rejection > Miss
// Subjects=16
-51	15	0
-45	33	15
0	42	6
0	3	63
-51	-6	48
51	-6	36
66	-9	-3
51	-18	3
60	6	-12
-57	-18	0
-18	-3	-12
21	-21	-21
-24	-24	-15
33	18	3
-39	-42	42
-6	-33	-6
36	-66	-30
27	30	-18
45	42	-9
24	33	36
27	60	3
24	-9	54
-21	27	42
-30	-12	54
33	-9	51
-9	-6	45
42	15	-36
-51	-3	-18
-51	-54	21
60	-18	-24
30	-3	-27
-30	-6	-27
-36	-24	-15
-33	-42	-6
-33	-15	12
-39	-21	48
-6	-30	57
12	-51	42
-15	-51	63
36	-72	-12
-39	-81	-9
-45	-66	-45
-54	9	12
-57	-3	21
0	15	30
3	42	3
-48	-12	15
-60	-12	-3
66	-6	0
-24	-3	-21
-24	-18	-21
66	-6	21
-42	-42	48
-15	-72	51
-24	-66	45
12	24	60
30	54	15
42	-60	-12
54	-72	-6
24	-87	-12
-30	-93	6
-27	-78	-21
-54	18	24
-42	9	36
39	6	57
3	12	48
-12	9	-3
15	9	-6
-33	-51	39
-33	-72	42
-3	-78	30
15	-72	27
-24	24	42
-30	-12	60
24	33	45
12	51	42
-45	-24	18
-39	0	9
-30	-6	-27
30	-6	-27
63	-9	27
-63	-15	21
-36	-78	-12

// Achim A M, 2007: Associative Encoding vs. Item Oriented Encoding, Normals > 
// FEP
// Achim A M, 2007: Associative Encoding vs. Item Oriented Encoding, FEP + 
// Normals
// Achim A M, 2007: Arbitrary vs. Related Pairs, Normals > FEP
// Achim A M, 2007: Arbitrary vs. Related Pairs, FEP + Normals
// Achim A M, 2007: Subsequent Memory Effect Contrast, FEP > Normals
// Achim A M, 2007: Subsequent Memory Effect Contrast, FEP + Normals
// Subjects=20
-42	16	-24
-50	6	28
50	8	30
-4	-58	14
26	-38	-16
-28	-46	-14
46	-74	22
30	-52	52
-28	-90	2
-32	-2	-36
-36	-10	-40
-30	-14	-32
-28	-28	-18
-18	-34	4
28	4	-38
30	-8	-26
36	-10	-40
-32	10	-28
50	10	-40
52	-4	-12
38	-16	-24
42	-60	4
48	-66	-2
-28	-10	-8
-42	-16	16
-38	-24	16
42	-12	12
38	-12	24
12	-50	-14
6	-64	-16
-40	-82	16
42	-42	-20
-42	-74	-8
-24	-96	8
52	-76	0
6	-18	-2
-48	-6	40
40	-2	-12
46	-12	24
16	-16	-2
-2	-20	22
-46	-24	38
-10	-66	18
-12	48	50
-52	34	16
-34	34	-22
-56	18	26
-40	16	22
-40	4	24
-26	-34	76
50	36	14
22	32	-20
60	14	36
42	12	24
-20	-2	-22
-22	-26	-10
-26	-32	-20
-10	-52	10
36	-12	-34
28	-30	-30
12	-36	-12
-42	-18	-26
-36	-8	20
-14	-30	24
28	-30	26
-28	-60	50
-44	-74	-2
30	-60	16
30	-74	34

// Bjork J M, 2007: Anticipation: No Response, Probability 1.0 vs. Probability 
// 0.5
// Bjork J M, 2007: Anticipation: Response, Probability 1.0 vs. Probability 0
// Bjork J M, 2007: Anticipation: Response, Probability 1.0 vs. Probability 
// 0.5
// Bjork J M, 2007: Anticipation: Response, Probability 0.5 vs. Probability 0
// Bjork J M, 2007: (Response, Probability 1.0 vs. Probability 0) vs. (No 
// Response, Probability 1.0 vs. Probability 0)
// Bjork J M, 2007: (Response, Probability 0.5 vs. Probability 0) vs. (No 
// Response, Probability 0.5 vs. Probability 0)
// Bjork J M, 2007: Reward Notification:  No Response, Probability 1.0 Wins 
// vs. Probability 0 Non-Wins
// Bjork J M, 2007: Reward Notification:  Response, Probability 1.0 Wins vs. 
// Probability 0 Non-Wins
// Bjork J M, 2007: Reward Notification:  Win vs. Non-Win Notifications in all 
// Probability 0.5 Trials
// Subjects=20
-2.37	49.19	-15.97
-26.18	-5.66	61.39
-30.46	-26.63	52.05
-7.03	-6.4	50.08
33.67	-30.48	51.63
49.56	-15.29	40.14
26.24	-9.15	66.66
-26.02	-36.96	69.59
-55.22	-33.07	26.1
-30.87	39.41	25.32
-35.2	-2.85	2.15
53.47	6.14	0.38
-10.74	9.21	-9.18
33.12	5.59	-4.92
28.94	-18.76	-2.83
-7.35	-18.55	3.15
1.24	-63.05	-8.83
-1.22	54.45	-3.04
52.52	-17.84	6.86
-34.77	-19.26	51.48
-10.47	12.04	27.38
29.38	-47.14	43.04
-46.51	-43.36	43.6
17.49	9.61	48.46
-30.93	10.29	6.58
17.06	12.81	-6.45
-14.99	9.45	-5.8
-3.14	-23.52	-6.52
5.46	-59.22	-14.78
-30.46	-26.63	52.05
-42.42	-16.7	30.16
-58.53	-17.65	19.27
13.3	-14.74	50.55
-2.84	-3.98	39.79
22.04	-20.46	72.11
29.42	-25.85	56.87
-21.77	-41.59	64.35
22.04	-41.32	63.83
-58.43	-33.09	26.14
-55.5	-2.97	2.4
61.06	-13.48	7.51
13.07	-71.01	-2.72
-18.75	18.07	64.89
-35.17	1.81	7.34
-26.63	-19.09	-2.16
28.98	-18.33	2.71
13	-62.98	-8.97
-34.79	-22.77	47.31
-14.93	-7.47	-4.38
21.42	-10.43	-4.55
25.68	5.97	0.71
-39.05	-92.96	20.9
-30.91	6.06	6.93
-14.35	-4.73	72.33
33.27	31.34	25.26
-26.51	-38.75	5.06
6.26	54.5	-3.13
-11.82	14.58	-8.5
11.71	12.78	-6.39
-61.83	-37.36	-1.34
66.36	-29.28	-4.61
-42.13	-53.23	53.29
47.61	-52.94	48.89
5.81	-29.34	-96.47
2.47	-4.29	35.3
-28.21	-18.82	70.32
31.63	-19.52	69.69
12.87	-50	-20.1
3.25	32.33	13.26
-2.76	-36.13	36.91
45.47	-62.9	44.18
5.37	31.03	10

// Samanez-Larkin G R, 2007: Younger Adults
// Subjects=12
-.18	59.66	-4.61
-12.98	42.15	-9.68
27.71	27.93	-4.5
-42.8	14.48	-7.02
53.36	14.89	-10.39
-12.82	13.06	-.55
-12.88	12.46	-8.31
8.61	13.87	8.05
25.7	2.89	2.09
-17.07	0.17	-1.66
10.63	-4.92	-14.93
10.77	-10.06	1.11
6.58	-9.23	12.24
-35.97	-7.43	39.35
-8.22	-9.89	32.54
15.18	-17.47	15.07
-16.86	-19.6	17.84
-4.24	-23.87	-10.94
4.48	-41.82	3.85
-1.94	-63.87	-5.38
26.03	-90.34	7.67
31.94	27.45	-11.2
0.26	24.68	38.47
23.38	20.71	-14.99
-36.32	19.61	3.63
-38.55	16.45	-9.47
44.8	16.95	-10.46
11.72	12.86	-5.28
-12.87	12.63	-6.09
-12.81	8.83	-.2
12.86	7.04	1.89
8.6	-19.22	-7.02
-6.26	-46.8	-4.53
42.71	21.85	-1.93
-16.07	13.75	-5.04
-40.64	27.95	1.86
42.68	20.45	-6.27
-18.2	13.74	-5.01
-6.38	15.64	4.73
34.08	29.75	-9.18
-26.76	29.01	0.5
-.14	50.15	-3.81
44.82	21.52	-6.39
16.02	9.8	-3.96
8.55	-2.13	-6.22

// Samanez-Larkin G R, 2007: Older Adults
// Subjects=12
-4.42	55.58	-1.99
31.87	55.28	-9.07
6.25	51.07	-6.19
40.47	49.33	-4.21
25.52	47.13	-3.85
21.56	37.15	32.72
-29.94	30.39	4.88
38.45	22	0.34
-49.07	13.7	10.96
-10.65	9.01	1.99
-12.41	12.94	52.98
17.09	6.55	-4.81
-12.69	3.51	13.63
-53.11	5.15	38.49
12.93	3.32	8.89
13.27	6.92	55.42
-38.08	-.59	45.49
-5.9	0.8	60.61
15.48	-1.18	60.54
17.23	-9.51	7.68
-25.08	-9.71	63.95
-10.49	-15.68	12.98
-8.09	-12.92	48.41
-40.14	-15.23	48.97
4.63	-18.28	33.1
25.69	-21.4	-9.26
-25	-22.06	69.44
21.75	-24.52	33.43
-16.59	-25.66	49.57
-35.81	-34.41	48.3
17.62	-34.09	47.66
38.91	-36.93	36.5
-8.24	-42.99	17.48
-8.15	-44.25	28.73
30.46	-42.64	46
-37.85	-46.6	56.04
-7.97	-46.76	51.24
-20.73	-52.84	56.36
60.11	-58.41	4.6
26.03	-57.41	20.52
17.75	-54.72	56.08
-25.19	-59.15	30.18
-7.89	-65.8	52.84
39.53	30.89	5.15
-32.07	26.06	4.15
45.17	-36.32	16.3
-12.5	-36.33	21.43
47.38	12.79	45.62
-3.41	56.04	-9.84
-8.62	13.46	-9.56
9.55	13.57	-9.78
-3.48	55.27	-19.81
-13.92	13.85	-3.95
12.78	11.64	-7.42
-6.38	15.64	4.73
34.08	29.75	-9.18
-26.76	29.01	0.5
-.14	50.15	-3.81
44.82	21.52	-6.39
16.02	9.8	-3.96
8.55	-2.13	-6.22

// Bonner-Jackson A, 2007: Siblings of Schizophrenic Patients (SIBs)
// Subjects=21
-2.92	30.38	43.6
-47.9	15.88	25.26
43.73	26.8	-6.82
35.25	-74.67	-38.36
-41.82	42.15	-7.12
47.93	45.86	-8.46

// Bonner-Jackson A, 2007: Siblings of Healthy Comparisons (SNCs)
// Subjects=38
-54.62	29.13	-9.23
-21.95	-106.06	15.12
-.61	18.98	61.26
29.33	-102.58	14.23
-46.03	46.07	2.63

// Budhani S, 2007: Punished Reversal Errors > Rewarded Correct Responses
// Budhani S, 2007: Rewarded Correct Responses > Punished Reversal Errors
// Subjects=21
11.17	8.31	59.79
48.36	14.05	34.35
-36.1	25.26	35.49
32.58	2.26	62.28
37.43	22.5	7
-28.81	17.79	7.04
10.73	-19.29	-8.15
-5.26	6.3	7.73
42.22	-45.75	46.12
-31.49	-52.53	47.54
-.21	54.92	-10.9
29.84	-11.66	-21.28
-30.96	-26.23	-11.55
-13.46	-51.68	29.42

// Galvan A, 2007: Greater Activation to Reward
// Galvan A, 2007: Greater Activation to Baseline
// Subjects=7
7.45	6.32	-6.91
-7.51	7.29	-6.82
50.12	34.33	-6.41
48.18	38.57	21.14
47.54	-47.11	41.72
27.8	10.22	0.33
3.53	-4.37	34.17
15.09	7.99	14.05
2.01	34.93	-8.14
-22.21	38.46	39.8
49.09	-4.77	-16.5
18.82	-45.92	59.79
6.58	34.69	29.75
7.39	-47.09	-37.01

// Johnson J D, 2007: Encoding, Scene > Encoding, Sentence
// Johnson J D, 2007: Encoding, Sentence > Encoding, Scene
// Johnson J D, 2007: Recognition, Scene > Fixation
// Johnson J D, 2007: Recognition, Sentence > Fixation
// Johnson J D, 2007: Content Independent Recollection Related Activity
// Subjects=16
24	-81	-12
-18	-72	48
51	-33	-18
51	6	33
-24	-12	57
24	-6	57
-6	54	-9
-60	-9	-21
-63	-24	-6
-3	-57	27
48	15	-12
-39	-3	0
6	-87	24
-54	6	0
-15	45	39
-9	-60	-18
-51	21	0
-51	-63	30
-30	-87	30
-48	-60	-9
-27	-42	-21
-6	60	-6
-21	-24	-21
-42	-78	30
-3	60	0
-42	-33	-21
-54	-57	-21
-36	-42	-30
15	-27	69
33	-24	57
51	-9	45
-24	-6	21
21	-3	24
-15	-39	60
3	-51	21
-9	57	-9
-6	-9	66
54	-72	18
57	-3	-18
-27	-60	15
0	-24	15
33	-93	-3
45	-78	12
57	-60	-18
0	-66	-27
36	-81	33

// Otten L J, 2007: Memory Effects for "Remember" Responses Irrespective of 
// the Probe
// Otten L J, 2007: Memory Effects for "Remember" Responses, Spoken Word Probe
// Otten L J, 2007: Memory Effects for "Remember" Responses, Picture Probe
// Otten L J, 2007: Memory Effects for "Know" Responses, Probe Independent
// Otten L J, 2007: Memory Effects for "Know" Responses, Spoken Word Probe
// Subjects=18
-48	39	-3
33	-39	-3
60	9	36
-6	-66	30
3	27	15
48	-54	27
-21	45	33
57	3	27
39	-84	3
-51	-60	-18
36	-48	54
-3	-45	24
-15	60	30
39	-24	30
-51	-60	18
-39	-57	24
-57	-30	51
30	-51	54
-39	-48	63
42	-42	48
-39	-60	33
-21	-54	51
63	-57	-3
-15	-57	0
39	-9	-27
27	21	27
-30	-72	24

// Flores-Gutierrez E O, 2007: Bach + Mahler - Prodromides
// Flores-Gutierrez E O, 2007: Bach - Prodromides
// Flores-Gutierrez E O, 2007: Mahler - Prodromides
// Flores-Gutierrez E O, 2007: Prodromides - Bach + Mahler
// Flores-Gutierrez E O, 2007: Prodromides - Bach
// Flores-Gutierrez E O, 2007: Prodromides - Mahler
// Flores-Gutierrez E O, 2007: Mahler - Bach (Excitement)
// Flores-Gutierrez E O, 2007: Bach - Mahler (Calmness)
// Flores-Gutierrez E O, 2007: Music - Noise
// Subjects=19
-55	-21	3
-61	-29	7
-42	-73	22
-12	-90	30
-46	-71	20
-34	54	-9
-42	-73	22
-55	-21	1
-61	-29	7
-12	-90	30
8	-6	-11
-34	4	9
-57	12	16
-38	31	4
-44	42	-11
34	31	-7
42	9	16
-50	-59	25
26	58	-1
-57	13	18
-40	29	4
-34	6	9
-30	16	8
-44	42	0.11
-40	21	-16
-50	35	2
-51	3	-10
34	33	-7
42	27	4
42	9	16
36	14	12
65	-34	18
-32	27	-11
-20	3	-15
24	5	-15
30	13	-19
12	-4	-10
36	32	-18
26	58	-1
46	26	-15
-42	29	6
-50	33	6
-32	16	10
-34	6	9
-57	13	18
34	35	-8
67	-43	24
34	29	6
-48	15	0
-32	27	-11
-55	-21	5
-44	13	21
55	-4	-7
63	-21	10
8	-6	-11

// Goldstein R Z, 2007: Normals
// Subjects=12
-41.35	12.51	-21.93
-37.92	7.39	-8.03
-28.33	-3.39	-20.58
42.87	35.46	-22.27
42.96	13.12	-20.06
46.25	43.1	-9.64
46.16	22.71	-21.07
-37.8	54.24	10.86
-18.16	59.06	26.86
33.64	52.24	19.93
4.39	51.51	13.77
4.56	62.64	29.48
7.75	65.53	25.78
-5.49	56.92	3.32
1.09	54.38	10.19
4.23	-18.61	-12.9
7.36	-22.72	-22.63
-11.89	-18.04	-5.96
-15.2	-11.99	-9.86
-5.32	-7.51	2.97
20.62	-10.61	2.84
-35.11	63.28	-30.42
-31.6	-49.63	-32.75
7.42	-71.52	-27.89
4.67	-87.56	7.36
-38.05	19.53	-15.96
33.43	27.72	-1.17
53.1	16.27	13.07
62.63	21.44	-1.05
36.78	21.97	6.06
46.41	14.69	-3.47
-27.96	45.33	18.3
53.38	8.57	34
47.23	1.16	58.37
-5.25	-3.7	9.32
-11.8	-30.49	-1.37
-28.25	-78.34	-29.97
-18.5	-74.8	-27.13
-24.74	-82.84	-9.42
-41.05	-67.25	-14.04
-24.22	-82.29	30.86
-24.31	-92.8	21.82
-27.5	-85.8	27.9
23.36	-60.26	-46.09
33.1	-63.41	-45.94
36.8	-82.93	-13.82
17.26	-90.32	-22.84
39.72	-55.76	-33.36
10.54	-75.63	-37.62
-21.35	56.17	30.56
46.11	35.47	-22.33

// Goldstein R Z, 2007: Cocaine Abusers
// Subjects=16
-41.35	12.51	-21.93
-37.92	7.39	-8.03
-28.33	-3.39	-20.58
42.87	35.46	-22.27
42.96	13.12	-20.06
46.25	43.1	-9.64
46.16	22.71	-21.07
-37.8	54.24	10.86
-18.16	59.06	26.86
33.64	52.24	19.93
4.39	51.51	13.77
4.56	62.64	29.48
7.75	65.53	25.78
-5.49	56.92	3.32
1.09	54.38	10.19
4.23	-18.61	-12.9
7.36	-22.72	-22.63
-11.89	-18.04	-5.96
-15.2	-11.99	-9.86
-5.32	-7.51	2.97
20.62	-10.61	2.84
-35.11	63.28	-30.42
-31.6	-49.63	-32.75
7.42	-71.52	-27.89
4.67	-87.56	7.36
-38.05	19.53	-15.96
33.43	27.72	-1.17
53.1	16.27	13.07
62.63	21.44	-1.05
36.78	21.97	6.06
46.41	14.69	-3.47
-27.96	45.33	18.3
53.38	8.57	34
47.23	1.16	58.37
-5.25	-3.7	9.32
-11.8	-30.49	-1.37
-28.25	-78.34	-29.97
-18.5	-74.8	-27.13
-24.74	-82.84	-9.42
-41.05	-67.25	-14.04
-24.22	-82.29	30.86
-24.31	-92.8	21.82
-27.5	-85.8	27.9
23.36	-60.26	-46.09
33.1	-63.41	-45.94
36.8	-82.93	-13.82
17.26	-90.32	-22.84
39.72	-55.76	-33.36
10.54	-75.63	-37.62
36.75	41.43	7.5
-21.6	67.37	12.65
36.85	48.75	16.86
4.55	65.83	29.16
14.09	67.81	15.36
36.75	41.43	7.5
33.47	64.07	8.68
20.5	64.02	8.9
-11.82	51.45	14.06

// Marsh A A, 2007: Activation Associated with Changes in the Number of 
// Response Options
// Marsh A A, 2007: Activation Associated with Reward Value
// Subjects=18
3.42	30.79	34.57
-36.06	3.69	31.72
42.01	4.75	38.54
-19.85	7.87	56.84
-.94	-3.1	9.59
-19.6	-68.61	58.79
29.51	-61.17	54.25
26.09	-88.68	15.34
-7.52	48.93	8.64
-.71	21.21	48.81
-23.05	1.25	54.08
-42.39	4.5	42.88
29.3	4.73	53.19
-39.36	23.59	27.86
28.74	-1.01	-21.04
-26.74	25.92	1.87
-45.49	-59.27	30.42
-58.32	-48.43	34.12
41.87	-65.89	-7.94

// Murray L J, 2007: Regions Active at the Target Word During Relational 
// Trials Relative to Item Specific Trials
// Subjects=17
-49	10	24
-10	14	56
-52	35	18
-56	-56	0
-32	24	0
-28	-28	-24
46	14	24
32	21	-4
-38	-35	-21
-14	10	7
-35	-52	46
-32	14	56
-52	49	-7
49	38	32
-38	4	56
-38	-42	42
-14	7	66
-14	28	28
-7	10	28
-46	-56	-10
-49	7	56

// Peters J, 2007: Correct > Incorrect Source Encoding, Auditory
// Peters J, 2007: Correct > Incorrect Source Encoding, Picture
// Peters J, 2007: Correct > Incorrect Source Encoding, Auditory Retrieval
// Peters J, 2007: Correct > Incorrect Source Encoding, Picture Retrieval
// Subjects=14
48.75	-51.76	-2.54
-24.82	12.83	3.53
-42.12	-57.37	-11.64
-33.4	-54.59	-5.34
35.89	-33.54	9.33
-55.06	-57.21	-9.19
-3.29	-40.22	-14
-31.07	-46.75	9.53
37.33	11.44	-37.73
20.43	-51.39	-20.02
63.79	-37.03	-6.49
13.86	-12.71	-19.25
-18.29	-52.41	-5.81
-20.59	-53.46	-16.88
39.66	-15.79	-30.59
-42.52	16.25	-27.88
-24.92	-49.22	-17.22
-31.48	-45.4	-21.97
31.29	-44.35	-14.18
54.95	-29.79	-20.5
-31.35	18.98	0.79
-20.95	-18.96	-38.21
70.37	-31.92	1.86
-12.08	-4.09	-17.42

// Sailer U, 2007: Wins vs. Losses, Exploratory Phase
// Sailer U, 2007: Correct vs. Wrong, Exploratory Phase
// Sailer U, 2007: Interaction of Utilitarian and Performance Feedback
// Sailer U, 2007: Wins vs. Losses, Exploratory vs. Proficiency Phase
// Sailer U, 2007: Interaction of Feedback and Learning Phase
// Subjects=38
-54	34	2
-12	68	-10
-6	12	6
-14	44	-12
4	68	0
18	32	-16
2	54	-14
-20	10	-20
-16	20	-10
-48	-6	48
-6	-68	46
-52	12	20
-32	12	68
-50	54	4
-38	-16	42
2	-24	38
0	6	28
60	-56	-20
-56	-6	-12
54	-46	58
12	-16	30
-48	-24	22
-42	30	24
-8	-46	64
28	-58	46
30	-68	62
-12	16	-22
-48	-52	18
-60	-50	0
66	-26	-8
66	-48	-2
66	-8	-6
-64	-42	-18
46	24	-20
-12	-48	18
-10	-2	12
-32	12	68
38	14	64
-54	16	40
-26	40	48
-24	24	34
-40	-62	-14
-52	-72	8
-14	-52	-8
42	-78	0
28	-96	14
36	-78	20
-2	-88	-12
38	-24	34
-26	-68	60
38	-62	58
-12	-70	56
4	-80	52
44	-44	14
-36	-30	-12
-22	-46	-16
18	-26	-12
-48	28	10
-54	32	2
22	38	-12
-14	16	-10
-14	40	-10

// Vilberg K L, 2007: Regions Selectively Sensitive to Familiarity
// Vilberg K L, 2007: Regions Selectively Sensitive to Recollection
// Vilberg K L, 2007: Recollection Sensitive Regions Which are Also Sensitive 
// to Amount of Information Recollected
// Subjects=14
-30	48	-12
-30	45	27
-45	39	12
-54	21	18
-48	3	39
24	3	51
27	6	18
-9	0	15
-27	-15	60
-66	-36	-3
-39	-30	45
-30	-63	45
42	-42	36
33	-54	45
15	-72	60
6	-66	30
-18	33	51
-48	27	33
-36	21	51
36	-27	69
6	9	-3
-15	-3	-15
-36	-9	-36
-51	-57	-21
-24	-87	-21
30	-33	-21
33	-60	57
-36	-78	33
-9	-78	33
33	-24	72
-54	-54	-24
-39	-81	39

// Blair K S, 2007: Negative > Neutral
// Blair K S, 2007: Negative, Incongruent = Congruent > View
// Blair K S, 2007: Negative, View > Congruent = Incongruent
// Blair K S, 2007: Negative, View > Congruent > Incongruent
// Blair K S, 2007: Interaction: Task * Negative Emotion
// Blair K S, 2007: Positive > Neutral
// Blair K S, 2007: Positive, Incongruent = Congruent > View
// Blair K S, 2007: Positive, View > Congruent = Incongruent
// Blair K S, 2007: Positive, View > Congruent > Incongruent
// Blair K S, 2007: Interaction: Task * Positive Emotion
// Subjects=22
-35.4	22.56	-13.36
5.5	52.12	34.99
-19.32	-6.5	-18.91
29.78	-5.74	-27.35
-40.34	-78.82	-2.57
49.43	-73.79	-.68
-32.02	54.04	21.88
43.94	44.43	28.5
21.11	53.39	-18.82
-20.55	49.97	-18.06
36.21	57.14	0.76
-7.3	20.43	25.53
-40.51	-.34	7.58
40.53	23.61	-6.51
-57.47	6.47	28.39
8.85	22.87	41.87
55.15	-37.95	63.16
11.78	-19.46	-10.38
36.21	57.14	0.76
-38.57	20.68	-9.82
-16.76	35.21	52.28
-46.41	-76.4	43.02
4.75	-48.94	35.67
22.36	-8.45	-20.34
-26.86	0.52	-23.88
40.46	60.16	-1.77
52.65	-84.6	-3.15
42.88	40.03	26.65
-28.81	55.11	21.75
34.06	55.89	-1.34
-21.62	47.76	-18.98
-14.92	33.28	13.39
-28.9	24.51	-2.45
38.39	24.66	-6.58
-58.68	7.21	10.5
40.82	7.86	23.8
66.52	-24.31	18.4
33.22	-63.71	-20.29
-15.69	34.16	52.35
1.54	-47.9	35.62
-48.54	-75.27	44.06
37.27	57.06	-.36

// Christoffels I K, 2007: PNvoice > PNnoise
// Christoffels I K, 2007: PNnoise > PNvoice
// Subjects=14
0	8	35
-1	-9	46
2	-17	-31
1	-15	9
37	7	11
49	-9	30
28	-34	-14
29	-54	-13
49	-25	-2
-40	2	9
-42	-21	41
-10	-68	7
-15	-53	-15
-27	-10	5
51	-18	8
57	-30	12
-41	-28	7

// Eippert F, 2007: Decrease - View
// Eippert F, 2007: Increase - View
// Subjects=24
0	18	54
6	24	36
-6	30	27
-45	15	3
-42	21	0
-30	3	57
-60	24	6
-6	30	27
-3	24	30
-45	18	-3
12	-48	9
0	15	57
-6	-39	-18
-24	-33	-6
-6	27	15
30	-63	-24
-6	-12	63
-9	-51	6
15	9	54
-21	-51	12
-27	-57	-24
9	-6	66
21	3	-18
-18	0	-12
-12	9	54
-15	9	60
-30	0	54
15	9	54
15	-3	75
51	9	6
-6	27	15
0	18	30
-6	30	30
-9	33	27
-45	18	-3
-18	12	-15

// Benuzzi F, 2007: Whole Faces vs. Masks
// Benuzzi F, 2007: Upper Faces vs. Masks
// Benuzzi F, 2007: Lower Faces vs. Masks
// Benuzzi F, 2007: Whole Faces vs. Parts of Faces
// Benuzzi F, 2007: Whole Faces vs. Upper Faces
// Benuzzi F, 2007: Whole Faces vs. Lower Faces
// Benuzzi F, 2007: Upper Faces vs. Whole Faces
// Benuzzi F, 2007: Lower Faces vs. Whole Faces
// Subjects=24
48.76	-82.37	-8.47
20.54	-31.96	-7.38
-46.46	-71.73	-15.75
29.57	-105.66	7.61
-46.28	23.68	17.39
20.3	-9.71	-21.9
-15.88	-101.98	3.53
7.63	-87.39	-14
34.26	-49.27	47.89
1.39	-74.7	7.26
-14.01	-88.84	-16.85
48.69	35.3	10.14
-16.37	-3.9	-15.13
-24.67	-88.91	-5.45
29.57	-105.66	7.61
-22.34	-106.25	4.07
3.2	-82.82	-22.22
34.13	-78.69	31.75
9.74	-32	-7.19
34.27	-51.39	48.1
46.49	-60.15	-11.75
-37.86	-72.02	-19.23
-33.67	21.13	-10.59
-26.15	-68.52	51.94
48.47	58.83	-2.27
-53.84	33.54	19.91
53.06	35.73	14.51
-1.31	-65.58	-32.81
56.52	20.93	28.24
39.74	20.97	-16.3
20.58	-31.65	-4.05
-9.77	-82.86	-21.99
10.1	36.38	35.34
-44.04	17.72	22.43
-.62	31.44	40.5
27.16	-73.63	-5.61
12.42	-103.61	18.9
20.24	-8	-26.55
48.04	15.11	-45
-25.18	-8.47	-29.09
-57.76	-67.41	31.08
-62.94	-12.54	-24.68
37.41	6.54	-32.76
5.71	-86.7	5.02
-9.46	-88.23	0.94
53.51	-64.89	28.94
18.13	-7.59	-22.07
12.42	-103.61	18.9
48.52	-51.3	-20.51
-25.02	-12.75	-17.47
-18.57	-5.28	-18.31
45.84	10.43	-48.98
52.82	-55.85	-23.49
12.41	-101.49	18.69
-62.88	-12.13	-20.24
20.24	-8	-26.55
-5.04	-52.42	16.37
-23.02	-8.46	-29.13
45.91	17.54	-41.84
-57.77	-65.29	30.87
-29.47	-16.99	-28.18
50.24	4.48	-43.98
44.5	-17.35	9.82
-7.83	63.22	-9.59
29.51	-103.94	2.96
40.39	-87.98	12.4
42.55	-87.97	12.36
33.52	-58.07	-11.74
-32.92	-87.09	25.88
-50.65	-69.65	-4.68
25.66	-57.7	49.99
50.65	56.81	-.98
7.76	42.68	22.44
56.18	-62.55	-15.04
35.52	21.68	-8.46
-24.06	-64.67	47.05
60.85	18.82	28.37

// Brown M R G, 2007: Preparation, Antisaccade > Preparation, Prosaccade
// Brown M R G, 2007: Preparation, Prosaccade > Preparation, Antisaccade
// Brown M R G, 2007: Response, Antisaccade - Preparation, Antisaccade
// Brown M R G, 2007: Response, Prosaccade - Preparation, Prosaccade
// Subjects=11
30.39	0.59	54.64
31.47	-.37	55.82
1.48	7.57	51.04
0.3	14.02	38.25
35.25	54.98	14.34
53.71	9.77	33.53
56.94	8.9	35.79
50.37	25.9	22.18
38.67	55.03	42.17
40.82	55.13	43.25
18.31	76.23	42.86
22.59	75.28	44
3.42	69.25	50.31
1.16	31.69	18.91
51.31	72.94	24.91
26.13	-2.52	56.06
29.32	-2.67	53.81
1.54	4.82	56.85
54.7	7.86	22.52
56.83	29.79	30.7
39.71	39.29	31.21
33.35	56.31	45.47
32.28	55.16	44.46
19.41	74.38	46.35
21.54	72.1	44.28
1.28	64.75	47.36
48.18	71.49	33.99
50.31	73.62	33.79
-3.9	40.11	59.53
17.53	45.16	67.78
35.69	38.66	64.77

// Burianova H, 2007: All Retrieval Conditions vs. Scrambled Pictures
// Burianova H, 2007: Semantic and Episodic Retrieval vs. Scrambled Picture
// Burianova H, 2007: Autobiographical and Episodic Retrieval vs. Scrambled 
// Picture
// Burianova H, 2007: Autobiographical Retrieval vs. Scrambled Pictures
// Burianova H, 2007: Episodic Retrieval vs. Scrambled Pictures
// Burianova H, 2007: Semantic Retrieval vs. Scrambled Pictures
// Subjects=12
-46.72	29.18	-15.64
52.71	21.02	-16.53
-41.56	16.82	47.12
13.89	17.04	-10.99
-7.43	-13.7	5.86
14.13	-1.92	4.33
-2.95	-72.7	6.02
5.68	48.71	29.72
56.81	48.92	-28.32
-55.11	-58.69	-13.53
65.48	-46.69	39.26
-57.66	-51.38	41.82
-2.98	26.69	24.2
5.45	41.53	10.26
1.47	-58.78	16.89
-42.28	12.59	-9.59
48.47	12.91	-11.17
-33.72	63.44	-5.81
35.68	57.9	11.49
5.21	69.31	-2.57
9.27	64.06	-24.53
39.67	58.72	-14.43
5.72	49.03	33.05
-45.52	-52.66	61.91
-6.65	-69.1	56.15
22.96	48.78	29.42
44.78	25.22	40.34
73.16	-14.5	-30.17

// Chua E F, 2007: Pair Remembered > Pair Forgotten
// Chua E F, 2007: Face Remembered/Pair Remembered > Face Remembered/Pair 
// Forgotten
// Chua E F, 2007: Face Remembered/Pair Remembered > Fixation
// Chua E F, 2007: Face Remembered/ Pair Forgotten > Face Forgotten/Pair 
// Forgotten
// Subjects=18
-22	-4	-18
20	-8	-16
-22	-12	-28
18	-6	-28
-28	-4	-24
-22	-4	-18
20	-8	-16
-22	-32	-6
24	-30	-4
-24	-14	-24

// Dickstein D P, 2007: Normals
// Subjects=22
36	52	-10
38	36	-12
38	36	-12
24	-24	64
22	-90	42
28	-24	46
12	-2	38
14	46	2
-16	-8	28
18	-12	28
34	-2	8
14	46	2
32	-52	22
-20	-12	30
-34	-54	-2
-16	-10	28
36	-66	30
-16	-8	2

// Dickstein D P, 2007: Pediatric Bipolar Patients (PBD Patients)
// Subjects=23
36	52	-10
38	36	-12
38	36	-12
24	-24	64
22	-90	42
28	-24	46
12	-2	38
14	46	2
-16	-8	28
18	-12	28
34	-2	8
14	46	2
32	-52	22
-20	-12	30
-34	-54	-2
-16	-10	28

// Feusner J D, 2007: NSF vs. Gray Ovals, Body Dysmorphic Disorder Patients > 
// Normals
// Feusner J D, 2007: LSF vs. Gray Ovals, Body Dysmorphic Disorder Patients > 
// Normals
// Feusner J D, 2007: HSF vs. Gray Ovals, Body Dysmorphic Disorder Patients > 
// Normals
// Feusner J D, 2007: LSF, Normals > Body Dysmorphic Disorder Patients
// Subjects=12
-62	8	2
-54	18	-2
-30	18	-6
-44	22	-20
-36	-36	54
-42	2	32
-60	8	0
56	-2	36
24	14	50
-56	10	-20
-60	-48	-16
-6	-74	16
22	-88	22
-24	-86	6

// Lee H J, 2007: Deaf Patients
// Subjects=9
-44	-38	14
-50	-4	-10
-54	-36	12
-64	-30	2
-52	-48	10
-52	-62	10
-46	-50	50
52	-10	-10
58	-42	10
52	-38	6
64	-24	-2
54	-28	-12
52	-54	2
52	-40	26
50	-44	36
40	-48	48
-50	-48	-16
-38	-68	-20
42	-50	-14
-12	46	-50
-26	20	4
-28	20	-4
-34	14	4
34	20	0
-40	20	30
-48	22	30
-56	10	16
-44	-4	42
50	26	-12
36	36	38
60	14	24
50	16	28
48	8	18
50	4	42
50	-2	56
42	0	46
-6	-4	60
8	12	50
6	-6	68
-24	-100	-2
-10	-92	-14
16	-104	8
14	-100	-8
22	-96	-6
20	-8	16
-20	2	12
-12	-8	6
24	-62	-28
8	-74	-11
-54	-38	12
-48	-66	6
-50	-64	8
-46	-50	52
58	-42	12
52	-54	0
62	-40	24
-40	-50	-16
-40	-66	-20
42	-50	-14
-38	12	4
34	20	2
-46	-2	42
36	36	38
48	8	16
50	4	42
-6	-6	60
-24	-100	-2
-44	-80	-2
14	-102	14
-20	2	12
-38	-36	10
-64	-30	2
-26	20	-6
-24	20	6
20	-8	16
-26	8	4
10	-64	-26
-42	-36	12
-60	-44	42
-64	-30	2
-38	-28	-4
-48	-6	-10
54	4	-12
58	-40	24
62	16	22
-26	32	-4
-32	30	54
-6	-92	-12
-16	-98	-6
14	-104	12
22	-78	4
-24	-22	22

// Lee H J, 2007: Normals
// Subjects=15
-62	-38	14
-50	-56	4
-42	-50	52
58	-42	10
52	-38	6
56	-26	-4
56	-26	-4
60	-48	0
48	-62	4
36	-56	56
-42	-64	-20
46	-52	-14
44	-56	-24
-46	18	-4
-26	20	2
-30	18	-6
32	20	0
34	26	-10
-36	52	8
-42	18	42
-60	6	10
-52	4	36
44	32	38
36	42	22
54	16	30
44	8	26
48	4	40
-6	-4	60
10	16	38
-24	-100	-2
30	-90	-10
24	6	2
6	-20	6
-24	0	6
-10	-14	4
12	-76	-18
46	-62	4
44	-52	-16
-40	12	2
-6	-6	60
-24	-99	0
-24	-92	-1
28	-88	-10
-62	-36	14
-46	18	-4
-30	18	-6
30	18	-14
-34	56	10
-38	16	28
-44	18	40
-6	4	58
-4	14	50
4	-20	6
-10	-14	6
-42	-36	12
-60	-44	42
-64	-30	2
-38	-28	-4
-48	-6	-10
54	4	-12
58	-40	24
62	16	22
-26	32	-4
-32	30	54
-6	-92	-12
-16	-98	-6
14	-104	12
22	-78	4
-24	-22	22

// Meister I, 2007: Video, Perception > Rest
// Meister I, 2007: Picture, Phonological > Rest
// Meister I, 2007: Picture, Conception > Rest
// Meister I, 2007: Video, Perception > Video, Phonological and Video, 
// Conception
// Subjects=14
30	8	62
44	8	32
46	12	22
34	26	-4
52	40	15
44	58	10
-28	-4	56
-38	18	30
-50	6	20
-60	20	16
-50	40	-16
-4	16	52
26	-58	50
32	-68	40
-30	-46	40
-26	-60	44
40	-44	-20
10	-98	16
44	-72	10
-50	-58	-14
10	-90	0
-12	-74	-50
12	-78	-50
26	-30	0
-16	-24	16
42	56	-10
-4	16	52
-46	6	34
-48	46	8
-48	28	38
-6	38	44
-32	22	-2
-50	-36	50
-52	-64	-16
34	-44	-22
14	-98	12
-32	-88	-18
42	54	-14
-50	-28	50
-50	14	34
-42	0	38
-4	42	58
-28	-50	42
-28	-68	36
-50	-64	-12
-32	-86	-12
16	-102	16
26	8	64
38	-2	48
58	16	14
58	18	6
42	14	24
36	62	12
6	12	52
-28	-4	50
-56	6	42
-52	4	12
-42	46	28
18	-74	58
24	-60	48
44	-76	26
-22	-60	64
-66	-32	32
-48	-46	52
50	-62	-10
-48	-74	-16
-40	-48	-50
16	-24	12
-10	-16	12

// Qin S, 2007: Hit Discontinuous Associations vs. Hit Simultaneous 
// Associations
// Qin S, 2007: Formation of New Memories Including Associations vs. Miss
// Subjects=6
15	39	33
33	30	39
15	48	30
-33	-39	-9
-18	9	12
-21	12	-3
-18	3	-6
21	6	6
27	9	15
15	-60	18
-39	-63	15
-42	-69	27
-33	-81	36
36	-72	-9
30	-90	15
30	-87	-9
-9	-99	3
-30	-93	-6
-24	-33	-3
-18	-36	3
24	-6	-18
21	-27	-9
0	45	-18
-6	60	-12
15	36	-15
-36	-51	-15
-21	-6	-18
0	6	-9
3	60	24
-9	54	24
42	30	12
-42	33	-9
36	33	-15

// Rektorova I, 2007: Normals
// Subjects=8
-6	0	64
-4	6	62
2	10	56
-26	20	2
-62	-10	0
-62	-30	2
-52	10	-4
-48	-10	48
-60	-14	22
-54	-6	16
-24	-94	8
62	-20	2
52	-10	4
58	-4	16
50	-14	40
4	18	38
4	-6	34
42	20	10
28	-74	46
-8	16	38
-10	-12	42
-54	-6	34
-38	-6	52
56	-4	36
44	-2	44
48	-72	-10
30	-6	48
-14	-64	52
16	-18	8
10	-18	6
-8	-18	6
-20	10	-10
6	-76	-6
-2	-78	6
-44	30	8
-50	-72	28
-10	-54	32
-48	-64	46
-52	-14	44
16	-12	10
-4	12	60
26	-62	40
-52	-14	44

// Rektorova I, 2007: Parkinson's Disease Patients
// Subjects=9
-4	12	60
4	8	62
-2	-28	-8
-30	6	4
-40	26	2
-28	18	-2
-46	-24	8
-50	6	-8
-64	-26	2
-52	-14	44
-58	-4	22
-56	-16	16
-18	-96	-2
50	-14	4
66	-12	4
42	-14	48
46	-14	36
8	6	46
6	20	40
4	-8	36
-2	-32	-4
46	8	-4
42	14	0
26	-62	40
-50	-40	2
-50	-66	28
-6	22	44
-12	-18	42
-46	-10	32
-42	-6	56
46	0	46
54	-6	34
26	-76	6
34	-4	46
26	6	0
-16	-56	56
16	-12	10
46	-70	20
48	-56	10
50	-64	28
0	-62	36
-58	-4	22
46	-14	36
-30	6	4
46	8	-4
-6	22	44
6	20	40
-42	-6	56
16	-12	10
26	6	0
50	-14	4
-58	-4	22
-18	-96	-2
-64	-26	2
66	-12	4
-38	-6	52
-44	30	8
-54	-6	16

// Schnell K, 2007: Borderline Personality Disorder (BPD) Patients
// Subjects=6
-39	-7	28
-15	6	63
-18	8	44
65	-38	7
59	-40	16
18	-14	62
6	-6	58
15	53	19
27	53	19
33	34	34
3	17	52
3	12	63
-62	-40	13
9	-45	41
21	-4	39
-15	-4	39
-56	-4	36
62	-10	36
9	-24	51
42	30	15
33	11	41
-30	-23	9
-33	-17	15
21	-16	-19
-59	-25	15
-59	6	-3
-50	-40	13
65	-14	6
56	-18	-9
50	-26	12
24	-66	12
12	-75	18
-6	-83	21
6	-60	20
33	-5	9
21	19	27
62	-24	-11
-45	-14	15
56	-57	22
3	-40	19
59	-39	32
50	-65	34
3	-50	44
15	-45	35
9	-57	30
-6	-80	29
3	-83	26
21	19	27
24	28	29
18	-6	53
53	24	15
-18	-4	-20
-36	-24	-16
-24	-13	-17
-12	-49	5
24	-24	-14
21	-15	-17
56	-57	22
21	-27	37
3	-40	19
21	-29	59
12	-53	47
42	-68	31
-3	-47	44
59	-42	33
50	-65	34
0	-86	26
0	-67	6
9	-83	35
9	-89	27
18	-73	-4
6	-60	17
27	23	23
21	22	22

// Schnell K, 2007: Normals
// Subjects=6
-39	-7	28
-15	6	63
-18	8	44
65	-38	7
59	-40	16
18	-14	62
6	-6	58
15	53	19
27	53	19
33	34	34
3	17	52
3	12	63
-62	-40	13
9	-45	41
-36	25	-16
50	7	30
18	-47	-8
-30	-53	-7
-36	-59	-12
48	-67	1
21	-73	48
36	-71	34
-36	-81	21
-6	-76	-4
45	-76	4
3	-86	24
18	-72	15
-6	-81	12
3	41	-2
39	-31	26

// Simmonds D J, 2007: Go Activations
// Simmonds D J, 2007: No-Go Activations
// Simmonds D J, 2007: Go Activations Negatively Correlated with 
// Intraindividual Coefficient of Variability
// Simmonds D J, 2007: Go Activations Positively Correlated with 
// Intraindividual Coefficient of Variability
// Simmonds D J, 2007: No-Go Activations Negatively Correlated with 
// Intraindividual Coefficient of Variability
// Simmonds D J, 2007: No-Go Activations Positively Correlated with 
// Intraindividual Coefficient of Variability
// Subjects=30
-5	-105.78	8.21
-41.35	-15.53	57.04
-6.91	7.68	50.8
13.75	-70.41	-39.31
3.4	-44.06	1.96
-18.03	-97.52	5.37
44.35	-57.82	-9.71
-2.58	15.46	53.32
11.86	-54.2	-15.11
29.07	-25.11	-14.92
62.89	-35.68	7.96
63.34	-50.96	39.72
-31.32	23.65	4.81
35.74	20.05	8.51
-58.13	-42.8	7.36
24.72	-42.87	-20.94
20.81	-1.51	19.86
20.75	53.88	26.71
-37.3	-20.78	35.08
20.52	-71.5	-16.91
51.63	-9.15	62.67
-18.44	-44.84	-16.64
-13.2	9.11	66.45
-66.53	-38.83	27.28
53.31	-12.78	23.78
22.53	69.58	-.65
14.1	2.23	2.8
18.54	2.01	11.71

// Smits M, 2007: (Lemon + Chocolate) vs. Sweetened Water
// Smits M, 2007: Lemon vs. Sweetened Water
// Smits M, 2007: Chocolate vs. Sweetened Water
// Subjects=7
32	-28	18
50	12	20
-26	-14	30
-62	2	6
-58	-10	8
58	-10	2
52	-52	-16
54	-44	-10
54	-56	-4
-18	-50	-8
28	-84	18
-12	-74	20
32	-28	18
-56	0	26
30	64	2
40	-76	18
46	-72	30
56	-44	-10
58	-10	4
-54	-62	36
46	-66	-8
30	-84	6
18	-80	40
-18	-82	42
40	-68	44
48	-60	42
50	12	20
-14	-74	-6
-16	-78	0
-2	-86	6
-6	-78	20

// David S P, 2007: Smoking-Related Pictures vs. Neutral Pictures, 
// Non-Abstinent
// David S P, 2007: Smoking-Related Pictures - Neutral Pictures, Abstinent
// Subjects=8
44.6	-72.2	-6.61
-44.5	-69.2	-10.4
45.3	-79.3	-11.8
-43.9	-69.5	-16.1

// Livesey A C, 2007: Duration Discrimination > Easy Color Discrimination
// Livesey A C, 2007: Duration Discrimination > Difficult Color Discrimination
// Subjects=10
45.19	50.85	-7.03
-50.96	48.38	-5.14
57.03	-28.9	57.81
2.79	28.34	53.07
0.63	28.33	53.11
38.8	26.36	-4.49
-19.61	7.04	-12.79
15.01	11.94	-8.26
-37.9	25.03	-3.06
-45.59	-68.93	-31.73
-64.18	-36.31	42.68
44.3	21.69	2.6
-45.31	21.79	8.6
-15.27	9.39	-10.86

// Gobbini M I, 2007: False Belief Stories vs. Physical Stories, Activations
// Gobbini M I, 2007: False Belief Stories vs. Physical Stories, Deactivations
// Gobbini M I, 2007: Intentional Movement Animation vs. Random Movement 
// Animation, Activations
// Gobbini M I, 2007: Intentional Movement Animation vs. Random Movement 
// Animation, Deactivations
// Gobbini M I, 2007: Point Light, Biological Motion vs. Point Light, 
// Scrambled Motion, Activations
// Gobbini M I, 2007: Point Light, Biological Motion vs. Point Light, 
// Scrambled Motion, Deactivations
// Subjects=12
-2.23	58.31	5.57
7.58	58.13	30
11.57	62.9	-5.02
-21.26	53.73	30.7
39.35	22.4	-22.01
11.06	29.2	54.69
-55.13	-59.5	28.32
38.17	13.54	-40.21
-52.61	11.31	-33.41
-35.28	-28.97	-19.08
6.76	-13.95	33.83
-10.21	-49.03	35.85
-43.75	35.48	16.88
-43.6	5.16	23.88
56.79	-48.63	-6.22
-50.11	-50.75	-10.39
-26.11	-71.88	44.64
-50.74	-39.62	51.14
-11.44	-93.53	-2.78
9.6	56.95	14.47
-50.18	27.61	12.04
54.47	31.87	2.67
4.71	20.96	58.8
-1.89	43.16	43.63
49.41	11.69	31.19
-48.1	-14.7	-12.32
-59.48	-58.18	18.22
51.6	-44.83	15.83
53.28	5.31	-24.08
-50.41	10.95	-24.48
46.14	-54.86	-3.34
-41.55	-56.07	-11.16
38.56	-56.02	-17.66
10.13	-48.48	41.14
-61.59	-31.53	32.74
49.48	-22.75	26.27
-24.62	24.62	-1.39
19.35	5.65	10.85
7.57	-22.14	-3.41
-28.82	-81.14	-33.73
15.9	-30.92	-35.11
-2.82	-22.38	35.76
46.97	31.56	-.56
40.81	14.38	25.48
49.32	39.35	31.1
64.44	-35.86	20.5
-54.18	-60.78	11.69
49.56	-75.76	15.1
47.28	-70.63	-.92
-45.61	-78.08	7.46
31.57	-64.13	43.33
-42.6	-68.05	-14.6
43.86	-44.36	-18.69
-14.73	-87.81	-11.03
-25.36	-100.47	-8.73
26.75	12.58	3.49
13.91	-71.2	-32.83
-57.38	-9.13	33.04
53.96	-20.58	53.91
-39.27	-30.48	16.78

// Malhi G S, 2007: Euthymic Bipolar Patients
// Subjects=10
50	26	4
-38	22	-4
-46	30	4
-6	-60	14
52	4	-8
-54	-4	-20
-56	-14	-4
-54	0	-10
26	-76	-10
30	-78	-18
22	-60	-38
42	24	-6
48	20	2
-44	20	2
10	50	2
8	48	-6
-6	42	-6
42	6	-24
46	12	-12
-38	-16	-6
18	-70	2
-22	-90	-6
22	-62	-38
28	28	36
-31	44	12
18	6	49
-10	5	49
34	-18	36
20	-24	49
3	21	36
-12	18	36
17	-22	36
-43	-33	33
-43	-30	36
17	-37	7
18	-15	4
21	-15	7
16	-36	14
21	-23	14
-20	7	15
11	43	19
-18	56	16
-19	59	27
27	47	16
27	54	13
-31	53	4
35	-16	61
48	-11	35
-46	-11	35
6	34	16
-7	-6	43
-61	-29	4
17	-54	6
16	-84	-6
12	-73	16
-13	-70	35
11	11	16
-13	17	-1
13	-26	-19
5	-39	-11
13	-33	-11

// Malhi G S, 2007: Normals
// Subjects=10
14	58	20
16	42	34
-12	48	34
-34	22	-6
-38	24	4
-44	20	12
-8	-54	20
40	10	-22
40	6	-12
-42	10	-22
-48	-2	-6
-44	6	-12
-42	-46	6
-38	-62	20
-40	-22	-4
12	2	-4
-8	4	4
14	-40	44
46	26	2
-36	24	6
-32	18	-8
-4	48	38
-2	56	20
60	-6	20
-2	-44	20
64	-30	6
-36	2	-20
-36	2	-30
-46	-60	20
46	-2	-30
-56	-20	-8
-52	-48	2
-40	20	2
-34	-72	-12
-14	-54	-42
32	-66	-30
28	28	36
-31	44	12
18	6	49
-10	5	49
34	-18	36
20	-24	49
3	21	36
-12	18	36
17	-22	36
-43	-33	33
-43	-30	36
17	-37	7
18	-15	4
21	-15	7
16	-36	14
21	-23	14
-20	7	15
11	43	19
-18	56	16
-19	59	27
27	47	16
27	54	13
-31	53	4
35	-16	61
48	-11	35
-46	-11	35
6	34	16
-7	-6	43
-61	-29	4
17	-54	6
16	-84	-6
12	-73	16
-13	-70	35
11	11	16
-13	17	-1
13	-26	-19
5	-39	-11
13	-33	-11

// Saarela M V, 2007: Provoked - Chronic Pain
// Saarela M V, 2007: Pain Intensity Ratings Correlated With Activations Due 
// To Face Stimuli
// Subjects=12
-41.68	20.55	2.49
46.97	24.96	-3.36
-5.14	25.1	30.69
3.65	12.32	57.31
-58.32	-47.29	35.14
-49.8	-1.46	49.04
-60.44	-58.13	32.73
40.52	19.04	-10.59
-8.28	29.11	41.54
-38.57	13.02	-12.52

// Schoning S, 2007: Males
// Subjects=12
-40	-54	62
-36	-50	46
-34	-40	44
36	-64	60
52	-44	58
10	-78	58
4	18	50
-22	-4	60
-20	-14	64
-50	10	28
-36	14	22
-54	10	38
-26	28	-4
-30	24	6
-46	30	32
-36	30	24
34	24	-6
40	34	20
52	30	34
30	-4	62
46	-52	-16
48	-62	-18
-38	-62	-22
-44	-76	-18
-32	-66	-10
30	-92	-4
-6	-80	-32
30	-68	-34
36	-48	-34
30	-42	-34
-28	-66	-12
-48	-42	26
-42	-34	40
-42	-50	58
-28	-66	-10
-38	-30	42
-28	-28	36
42	2	6
-8	-52	-42
-46	-16	58
-30	-30	70
40	20	50
-36	-52	10
-2	60	32
18	12	12

// Schoning S, 2007: Early Follicular Females
// Subjects=12
-42	-54	50
-36	-62	52
-46	-44	52
-44	-30	36
22	-76	54
10	-74	52
30	-60	32
58	-28	34
-30	-6	52
-12	-8	66
-22	-10	64
-24	26	-16
-48	10	22
-58	12	32
-30	26	10
56	10	20
20	2	60
32	-4	64
42	2	32
-36	-56	-24
52	-54	-22
42	-52	20
-40	-84	-10
-38	-70	-34
-44	-56	-34
36	-88	4
44	-82	-10
30	-78	0
-18	-8	0
-18	-30	10
-10	-76	-36
24	-68	-34
30	-62	-40
32	-48	4
-28	-66	-12
-48	-42	26
-42	-34	40
-42	-50	58
-8	-52	-42
-46	-16	58
-30	-30	70
40	20	50
-64	-36	22
-10	-12	62
-34	-48	8
-10	-16	-10
10	36	2
2	40	2
-6	4	32
-14	0	12
10	32	16
6	26	20
6	40	20
38	-72	20
34	-80	30
50	28	30
25	16	28

// Schoning S, 2007: Midluteal Females
// Subjects=12
-28	-80	28
-26	-70	34
-28	-48	34
28	-62	34
34	-52	40
28	-72	44
-8	2	58
-46	12	20
-40	2	44
-24	-4	54
-28	22	-12
-30	30	-12
40	20	4
34	30	0
50	6	48
32	-2	48
56	10	22
10	26	38
6	29	48
-8	2	58
-36	-88	-8
-38	-88	2
-32	-86	-20
32	-56	-36
44	-68	-12
42	-58	-28
-18	-2	8
-30	-60	-40
-42	-66	-32
-42	-58	-38
6	-68	-36
14	-68	-32
-28	-66	-10
-38	-30	42
-28	-28	36
42	2	6
-36	-52	10
-2	60	32
18	12	12
-64	-36	22
-10	-12	62
-34	-48	8
-10	-16	-10
10	36	2
2	40	2
-6	4	32
-14	0	12
10	32	16
6	26	20
6	40	20
38	-72	20
34	-80	30
50	28	30
25	16	28

// Butler T, 2007: Threat - Safety
// Butler T, 2007: Safety - Threat
// Subjects=42
12	12	9
33	27	9
-30	27	9
-15	6	9
48	21	-3
21	6	0
6	-18	9
-9	-9	6
3	30	39
51	-33	36
-69	-24	30
39	9	39
-57	15	3
0	-30	30
27	-99	-6
48	18	27
-30	-21	3
-39	-12	21
45	-66	33
-27	-18	-15
12	-48	3
48	-9	39
30	-15	-18
-3	75	3
-45	-12	36
-12	-81	30
-42	-66	39

// Cheng Y, 2007: Normals
// Subjects=14
-50	-66	-14
46	16	-2
2	-42	-2
46	26	22
-62	-26	28
48	8	40
-38	-4	60
-41	-43	60
-2	15	41
-28	-94	8
-60	-24	34
26	-70	56
-20	-66	60
-4	-34	-15
40	20	-9
-36	16	-1
4	18	45
6	2	54
-6	-12	73
48	8	42
-38	-4	59
32	-16	-30
-28	-30	-18
-34	-92	-12
4	62	6
-34	-12	12
-54	-4	26
50	-14	28
18	-28	30
-34	10	36
-4	-40	38
14	42	50
-14	30	48
36	-54	40
44	18	-12
-40	14	-8
24	-70	2
58	14	0
62	-54	0
-4	-86	18
-60	-26	20
-38	36	30
38	-2	60
48	8	42
2	10	42
12	-64	-40
-34	-92	-12
-20	-76	50
-30	4	64
-24	-78	-24
24	-70	2
58	-52	2
-38	-68	20
-4	-88	20
26	40	-8
-14	58	8
10	60	14
14	34	48
-12	24	52
-4	-36	-20
40	22	-14
-38	16	-8
0	24	30
38	-2	58
-6	-2	74
-38	10	-4
-44	20	4
46	6	38
4	8	44
-26	-52	68
-52	-38	16
46	6	38
4	6	46
-34	-30	66
0	62	4
-24	-84	-8
26	22	56
-26	-84	-8
16	38	46
-8	60	2
26	28	-8
-10	-78	8
38	-14	14
42	-2	42
-40	-22	60
-6	-76	12
-40	22	16
36	-16	18
-50	-18	32
-2	4	42
-42	-86	8
-30	-64	62
-2	-54	64
-42	-82	6
32	-86	10
-42	40	32
30	-60	58
-32	-62	62

// Cheng Y, 2007: Acupuncture Experts
// Subjects=14
-46	-76	-12
22	-26	-8
-22	-26	-12
44	6	30
-52	4	44
38	-52	52
-32	0	66
-14	-98	-10
-20	-28	-8
-54	6	42
-32	2	66
38	28	4
42	0	42
32	-16	-30
-28	-30	-18
-34	-92	-12
4	62	6
-34	-12	12
-54	-4	26
50	-14	28
18	-28	30
-34	10	36
-4	-40	38
14	42	50
-14	30	48
36	-54	40
44	18	-12
-40	14	-8
24	-70	2
58	14	0
62	-54	0
-4	-86	18
-60	-26	20
-38	36	30
38	-2	60
48	8	42
2	10	42
12	-64	-40
-34	-92	-12
-20	-76	50
-30	4	64
-24	-78	-24
24	-70	2
58	-52	2
-38	-68	20
-4	-88	20
26	40	-8
-14	58	8
10	60	14
14	34	48
-12	24	52
-4	-36	-20
40	22	-14
-38	16	-8
0	24	30
38	-2	58
-6	-2	74
-38	10	-4
-44	20	4
46	6	38
4	8	44
-26	-52	68
-52	-38	16
46	6	38
4	6	46
-34	-30	66
0	62	4
-24	-84	-8
26	22	56
-26	-84	-8
16	38	46
-8	60	2
-48	24	2
44	-16	18
-48	-20	20
40	-16	40
58	-22	54
-10	-90	22
16	-82	26
40	-16	40
56	-24	48
42	-88	4
-34	-84	12
16	60	6
-30	-56	56
22	-50	58
16	-30	-6
14	58	6
44	-66	4
18	50	42

// Lamm C, 2007: Observation of Patients Expressing Pain and the First-Hand 
// Experience of Pain
// Lamm C, 2007: Imagine Self > Imagine Other
// Lamm C, 2007: Imagine Other > Imagine Self
// Lamm C, 2007: Empathy Quotient, Other
// Lamm C, 2007: Empathic Concern Index, Other
// Lamm C, 2007: Emotional Contagion, Watching Pain
// Subjects=17
-52	-2	-16
-38	2	-20
-48	-8	-12
0	6	62
0	14	50
42	-2	-18
34	18	6
-38	18	4
-36	26	4
-32	26	-10
50	-44	18
40	-42	4
-10	12	40
44	20	-16
50	6	-14
22	10	-16
26	0	-22
-52	-26	26
-60	-34	24
42	8	-2
-16	-4	14
-30	2	8
-36	8	4
8	0	54
46	-14	56
22	-32	66
-38	-10	-12
-36	36	34
-60	8	2
26	-76	56
38	-68	56
24	-66	64
48	-64	44
26	0	10
-36	-2	12
0	-4	42
-22	-46	-24
14	16	28
30	16	12
44	18	8
-32	-10	10
16	-26	42
6	-4	52
50	-14	44
64	-38	34
-50	-42	36
-56	-44	56

// Martin R, 2007: Saliva Swallow vs. Rest
// Martin R, 2007: Water Swallow vs. Rest
// Martin R, 2007: Shifted Water Swallow vs. Rest
// Martin R, 2007: Water Swallow > Saliva Swallow
// Martin R, 2007: Saliva Swallow > Water Swallow
// Subjects=8
-54.23	-5.31	27.11
-56.26	-3.07	42.56
-54.33	-6.25	14.92
-62.87	-9.56	14.18
60.28	-9.43	46.21
65.46	6.49	31.44
7.9	6.55	51.05
8.04	-.8	66.16
-7.14	10	42.01
7.79	20.75	42.06
-41.32	25.37	51.15
43.13	16.28	49.83
50.88	-41.24	62.37
-61.45	-27.88	52.51
-42.68	2.56	4.01
-21.37	9.75	-1.29
-9.5	-17.59	1.98
5.48	-22.78	2.24
9.18	-74.75	45.59
7.84	-61.04	16.57
-21.97	-88.62	20.34
-33.78	-81.64	15.43
46.32	-81.58	8.93
44.48	-56.59	57.04
-27.07	-48.85	67.25
-3.58	-22.56	74.81
-2.54	-25.01	70.55
66.73	-48.57	34.93
9.98	-78.63	9.1
-18.96	-72	1.07
-25.45	-61.89	-5.28
-14.77	-54.17	-2.7
23.65	-47.85	-7.02
-54.23	-8.57	26.27
-40.08	-.29	63.33
-59.67	-5.23	14.9
53.87	-.66	50.01
-24.11	23.33	64.51
34.62	23.25	58.27
-3.81	3.65	55.89
12.24	5.06	58.93
-7.09	5.06	46.89
12.05	14.09	38.11
-41	-50.42	61.97
56.14	-62.92	42.94
62.55	-48.71	47.25
-12.71	-16.55	1.93
15.11	-4.95	11.79
45.91	15.18	-5.87
-5.74	-70.01	53.17
-31.39	-70.17	53.48
11.03	-69.99	10.6
7.1	-30.24	70.87
25.09	-89.06	24.3
-12.59	-60.33	0.02
16.32	-65.02	5.66
-20.18	-48.29	-8.71
-45.46	-4	57.01
-57.37	-5.7	36.1
-56.39	-8.84	22.97
-62.79	-18.57	21.63
59.12	-7.03	35.99
60.14	7.78	34.74
64.31	-2.03	17.67
-16.52	6.97	72.49
-41.54	42.86	29.62
28.25	24.7	63.79
48.46	18.42	49.59
-.43	-9.85	73.71
-7.05	-2.17	49.73
4.96	-20.39	74.53
-9.28	3.39	39.25
25.04	-29.19	41.59
4.48	26.31	31.59
-45.35	-33.61	59.49
49.79	-41.5	59.06
30.96	-2.34	-10.92
44.9	5.92	-1.73
28.29	-89.04	24.26
10.05	-81.2	17.12
9.12	-74.21	38.85
-1.77	-76.41	11.28
-7.03	-95.39	14.05
-1.46	-73.24	52.28
4.99	-29.91	75.33
26.16	-87.91	25.31
14.14	-56.74	2.76
-9.32	-76.09	2.42
-13.69	-57.34	-2.45
-36.11	39.35	38.77
-46.75	26.6	39.96
50.53	18.81	40.61
48.12	48.97	18.04
8.69	59.71	36.55
51.51	5.81	23.85
40.01	-28.93	43.62
-5.21	50.74	31.88
1.12	55.47	23.61
-43.61	9.47	24.63
-9.24	27.94	53.92
-19.2	14.51	4.97
-10.53	3.7	15.82
-16.76	-72.45	8.89
22.86	-75.75	17.64

// Sanjuan J, 2007: Schizophrenic Patients
// Subjects=10
-60	-24	-2
-54	-12	-12
-24	24	4
28	16	-12
16	-8	38
2	-52	28
4	-36	30
24	-4	-14
52	38	-8
-4	56	-8
38	38	-14
8	54	34

// Sanjuan J, 2007: Normals
// Subjects=10
-62	-16	6
48	0	-14
-60	-38	10
64	-48	12
-34	28	-12

// Sabatinelli D, 2007: Normals, Study 1
// Subjects=22
-4.39	44.92	-2.21
11.71	10.58	-7.32
25.6	-5.89	-15.02
42.93	-62.63	-7.12
51.51	-76.58	-9.39
48.34	3.93	27.39
35.96	-58.5	60.65
62.33	-26.82	27.58
-9.66	10.45	-7.06
-23.56	-6.18	-14.43
-40.42	-63.13	-6.12
-48.94	-77.18	-8.18
-45.7	3.37	28.52
-32.43	-58.91	61.47
-59.49	-27.55	29.04
9.82	21.94	29.67
0.58	-59.91	45.56
29.35	-.21	58.06
-32.11	25.63	-1.39
23.45	-5.98	-16.1
37.6	-72.43	-9.58
43.01	-81.57	-4.41
51.42	19.13	17.16
31.54	-72.13	36.19
19.54	-90.17	-3.42
-2.9	-3.43	33.06
58.11	-19.64	38.17
25.47	35.61	-15.15
-21.43	-6.25	-15.56
-35.06	-72.87	-8.71
-40.34	-82.07	-3.41
-49.03	18.53	18.36
-55.16	-20.32	39.53

// Sabatinelli D, 2007: Normals, Study 2
// Subjects=22
-3.32	42.72	-3.15
-3.23	3	-7.63
5.32	3.05	-7.73
-20.33	-8.1	-12.08
-43.75	-60.03	-20.84
46.02	-59.49	-21.91
-47.88	-71.8	-7.53
50.43	-71.21	-8.71
-23.63	16.11	-15.18
25.52	16.41	-15.77
6.89	-60.99	31.08
2.51	-10.46	38.04
33.8	-49.97	61.07
-28.4	-5.39	51.36
31.44	-5.03	50.64
-22.56	-5.8	-23.4
40.85	-71.98	-4.08
-38.23	-72.46	-3.13
39.76	-80.96	-10
-30.07	12.56	-19.27
9.95	-62.43	12.21
11.06	-9.27	38.96
5.84	-84.94	24.18
2.24	27.38	18.14

// Winston J S, 2007: Attractiveness Judgment > Age Judgment
// Winston J S, 2007: Age Judgment > Attractiveness Judgment
// Winston J S, 2007: Task x Attractiveness Interaction
// Winston J S, 2007: High Attractiveness + Low Attractiveness > Medium 
// Attractiveness
// Subjects=26
-60	-45	9
-48	-42	3
54	-48	27
51	-21	-6
-36	21	-24
-51	24	-6
0	51	18
-6	60	15
3	54	30
-9	27	60
-18	54	39
-18	45	42
3	36	9
0	-18	39
54	0	-36
-24	0	-24
12	-51	18
-9	-54	12
0	60	-6
27	0	-24
60	-42	0
-3	30	-27

// Jabbi M, 2007: Correlation, Personal Distress + Disgusted Faces
// Jabbi M, 2007: Correlation, Fantasy + Disgusted Faces
// Jabbi M, 2007: Correlation, Empathic Concern + Disgusted Faces
// Jabbi M, 2007: Correlation, Perspective Taking + Disgusted Faces
// Jabbi M, 2007: Correlation, Personal Distress + Pleasant Faces
// Jabbi M, 2007: Correlation, Fantasy + Pleasant Faces
// Jabbi M, 2007: Correlation, Perspective Taking + Pleasant Faces
// Jabbi M, 2007: Correlation, Personal Distress + Neutral Faces
// Jabbi M, 2007: Correlation, Fantasy + Neutral Faces
// Jabbi M, 2007: Correlation, Empathic Concern + Neutral Faces
// Jabbi M, 2007: Correlation, Perspective Taking + Neutral Faces
// Jabbi M, 2007: Unpleasant Taste - Neutral Taste + Disgusted Faces - Neutral 
// Faces
// Jabbi M, 2007: Pleasant Taste - Neutral Taste + Pleasant Faces - Neutral 
// Faces
// Subjects=18
20	4	2
-44	26	-10
0	-22	-22
46	38	-4
20	-46	0
-24	-60	2
-10	50	10
-4	32	10
40	34	16
50	2	18
42	-46	22
-60	-52	32
62	-42	36
8	12	26
-6	20	30
-48	10	32
-6	-12	38
-36	-2	42
42	12	38
-46	8	2
30	10	-10
48	22	-22
14	12	-4
-46	34	0
40	-32	2
-10	4	10
50	38	10
40	-50	16
-30	56	18
26	62	22
46	24	32
32	32	36
-12	28	26
0	-36	30
-10	54	32
58	-52	38
-44	14	42
-12	22	38
12	-34	-18
12	4	-16
-36	18	-4
10	-18	26
-32	14	-26
44	12	-18
-10	-2	-16
34	-28	-4
-20	58	-6
-44	16	-2
44	-50	10
-38	50	10
22	60	14
34	34	22
50	24	16
-14	40	22
6	-16	24
26	44	36
42	22	44
12	52	42
2	-38	-34
40	30	22
-38	20	-14
22	-6	0
-4	30	8
-28	0	16
48	-48	20
40	12	40
42	26	44
32	-6	-26
32	14	-18
-54	-10	-16
28	-26	-8
16	16	-14
-12	62	-8
24	48	-2
-30	56	10
-44	32	14
-6	48	8
40	-52	32
-32	28	16
10	-58	20
-10	-56	22
-16	28	24
-6	-30	26
-10	52	34
22	50	34
-44	14	44
40	24	46
10	32	50
-14	20	50
-30	6	50
48	8	-20
42	28	-18
-42	20	-20
-8	-4	-14
-14	60	-10
28	-28	-6
10	28	-4
38	22	48
30	-8	0
52	28	2
18	60	4
40	-48	12
14	28	26
-26	24	18
-18	38	18
10	-46	18
4	-36	32
12	28	50
26	-10	-24
-18	12	-8
24	0	2
46	16	-10
18	14	-10
2	-24	-2
-2	30	8
42	36	12
48	-4	26
32	-20	38
10	-16	44
-4	-16	50
32	16	-20
-24	8	-16
36	36	-14
16	18	-12
52	34	-4
32	34	2
-22	-22	2
40	-52	28
-52	20	12
-38	46	10
38	26	18
-12	24	26
-30	4	50
-38	-62	44
-10	30	46
26	-52	66
42	-48	14
-40	-52	28
-36	16	-24
22	-6	-26
40	30	-16
10	-24	-14
-14	-6	-14
30	-4	-10
-12	60	-6
36	-30	2
-30	18	22
18	56	6
38	-54	32
42	22	46
-14	38	18
-40	-66	42
6	36	50
52	18	-6
-38	24	-10
-44	30	0
-14	12	2
6	6	58
-34	8	-14
28	-18	42

// Keightley M L, 2007: Young Adults
// Subjects=10
12	32	-16
28	44	20
32	56	8
-24	40	44
0	68	4
-4	-4	56
8	24	-12
28	8	0
24	-72	8
-28	-88	28
-4	-52	36
20	-72	24
-20	-72	-12
60	-32	32
-60	-24	32
60	4	-4
-48	-20	4
-16	-44	36
-8	24	40

// Keightley M L, 2007: Older Adults
// Subjects=11
4	52	-4
4	-60	-4
56	-8	28
-60	0	12
-8	16	40
4	-8	40
12	60	12
-52	52	-8
40	28	-8
44	40	16
-48	8	36
24	-28	48
-28	-12	52
-32	8	48
40	-40	20
44	-36	0
-40	-44	4
36	-72	16
-20	-32	4

// Lanius R A, 2007: Post-traumatic Stress Disorder (PTSD) Subjects without 
// Major Depression
// Subjects=11
48	0	2
-32	14	6
16	48	10
36	30	30
-54	6	0
-56	4	22
0	55	-5
4	-54	26
2	32	16
46	42	-2
-46	12	-2
0	26	18
-6	-36	28

// Lanius R A, 2007: Post-traumatic Stress Disorder (PTSD) Subjects with Major 
// Depression
// Subjects=15
2	28	14
-2	-60	28
2	-44	28
50	38	0
-6	56	6
-12	-14	6
-6	52	4
46	40	-2
4	22	20
-2	-60	28
-46	12	-2
0	26	18
-6	-36	28

// Lanius R A, 2007: Control Subjects
// Subjects=16
40	18	6
16	-58	24
52	20	4
50	32	10
46	30	18
26	58	0
2	32	16
46	42	-2
-12	-14	6
-6	52	4
46	40	-2
4	22	20
-2	-60	28

// Pavuluri M N, 2007: Angry Faces vs. Neutral Faces, Pediatric Bipolar 
// Patients > Controls
// Pavuluri M N, 2007: Angry Faces vs. Neutral Faces, Controls > Pediatric 
// Bipolar Patients
// Pavuluri M N, 2007: Happy Faces vs. Neutral Faces, Pediatric Bipolar 
// Patients > Controls
// Pavuluri M N, 2007: Happy Faces vs. Neutral Faces, Controls > Pediatric 
// Bipolar Patients
// Subjects=10
16.24	20.92	29.68
14.97	-28.41	-16.35
36.77	-78.76	18.84
34.58	-74.88	14.08
-13.82	24.83	14.08
-14.62	-47.17	19.01
-36.48	-16.09	-31.29
-52.19	-47.96	-1.68
31.2	51.73	41.42
22.55	62.79	33.9
46.87	50.34	-5.48
10.7	38.63	11.53
14.35	-20.45	45.44
17.99	-12.76	-34.43
38.35	28.63	-10.25
8.77	-99.81	-16.99
14.5	-92.49	35.86
54.77	-41.98	11.09
-18.96	36.79	45.48
-38.7	50.03	-15.63
-32.98	-37.19	-1.69
-20.34	-29.14	-22.58
-23.23	-99.4	-8.85
-26.21	-96.05	21.02
-52.18	-34.76	3.91
-48.73	-80.5	17.74
33.37	32.37	38.56
1.18	27.46	19.27
9.93	-41.74	18.28
33.05	-6.1	-18.43
17.11	-28.31	-15.27
48.15	-14.5	-4.52
17.66	-84.19	32.9
-9.31	37.2	49.8
-27.9	39.23	-4.81
-9.68	44.26	3.48
-11.41	-51.47	18.22
-28.77	-29.05	-6.88
-24.77	-9.84	-34.18
-30.06	20.3	-15.46
-62.64	-62.09	23.05
25.74	62.56	30.54
25.74	62.56	30.54
40.38	53.85	-14.62
33.02	-3.1	-20.92
22.26	-13.88	-35.5
44.76	25.32	-12.28
4.55	-93.86	-8.52
28.29	-79.18	27.9
69.62	-45.2	-4.42
60.04	-63.5	-6.12
-25.21	15.32	57.39
0.06	63.2	27.43
-14.15	64.18	-13.75
-9.48	45.26	30.16
-34.24	-27.02	-21.48
-44.7	-9.45	13.97
-22.04	-101.46	5.81
-22.02	-101.28	8.02
-42.34	-62.05	21.7
-45.58	-83.28	9.02

// Hou C, 2007: PTSD Patients
// Subjects=10
-6	-48	6
-6	9	9
6	9	9
12	-9	0
9	33	30
-42	48	15
39	60	12
69	-18	9
-24	-51	-6
3	48	3
-57	21	24
42	57	15
-42	33	18
-42	48	15
51	-78	21
-54	-45	-15
-33	-36	69
66	-21	9
6	-51	15
28	-20	-18
-21	-24	-18
57	33	15
42	57	6
18	-33	-12

// Hou C, 2007: Normals
// Subjects=7
-15	-24	-6
21	-27	12
-9	-9	15
-33	-12	21
-3	60	24
-3	54	39
45	18	27
-42	33	18
57	-66	-15
-51	-69	6
48	-42	-24
54	-51	-15
51	12	-18
24	-21	-9
-24	-51	-6
3	48	3
-57	21	24
42	57	15
-42	33	18
-42	48	15
51	-78	21
-54	-45	-15
-33	-36	69
66	-21	9
3	-39	24
-3	60	-18
-3	33	39
-12	63	27
-21	63	15
48	39	33
-51	27	-12
15	-30	12
18	-15	18
-66	-42	-3
-24	-15	0
21	-6	3
9	9	6
-9	6	6
18	-99	-15
57	33	15
42	57	6
-3	-6	30
6	-36	24
3	27	60
-42	0	12
42	-33	6
69	-12	9
-12	-27	15
9	9	6
3	3	3
15	-90	9
12	-93	0

// Rauch S L, 2007: Implicit Learning vs. Random, All Subjects
// Rauch S L, 2007: Implicit Learning vs. Random, OCD Patients > Healthy 
// Controls
// Subjects=12
20	16	-6
14	38	-14
-16	38	-12
18	-10	10
20	-12	-16
26	22	-20

// Obleser J, 2007: Voiced and Voiceless Consonants > Spectrally Rotated 
// Analogues
// Obleser J, 2007: Voiced Consonants > Voiceless Consonants
// Obleser J, 2007: Spectrally Rotated Analogues > Voiced and Voiceless 
// Consonants
// Obleser J, 2007: Correlation with Spectral Peak of Consonantal Burst
// Subjects=13
-78	-18	0
26	2	2
0	50	-2
-68	-16	4
78	-4	-4
64	-26	8
-66	-34	22
-66	-50	16
60	14	-4

// Beneventi H, 2007: N-back Main Effect
// Beneventi H, 2007: Facial Expressions > Scrambled Drawings
// Subjects=12
-44	-55	-11
24	-52	43
0	21	43
-28	-56	51
40	40	20
28	24	0
28	7	55
-8	-79	-20
-44	6	44
-32	23	-1
40	-67	-17
-40	36	17
-44	9	25
4	11	62
48	-59	-7
-8	3	62
-32	-83	-16
4	-79	-16
-36	-75	-16
44	-55	-14
-40	39	9
-20	-86	-13
28	-92	4
-28	6	44
40	35	2

// Brown S, 2007: Melody Discrimination > Tone Discrimination
// Brown S, 2007: Harmony Discrimination > Tone Discrimination
// Brown S, 2007: Melody Listening > Rest
// Subjects=11
54.79	4.4	32.85
52.48	17.99	16.12
39.42	52.84	-0.03
43.85	39.09	14.45
48.08	34.2	5.89
-49.87	-4.34	39.25
-56.58	10.14	6.88
54.57	-19.83	-5.26
67.44	-19.24	1.23
63.15	-28.24	-4.66
65.36	-29.66	4.36
-60.8	-22.29	0.73
-54.25	-40.6	11.11
-56.59	-9.75	-2.6
-50.28	0.18	-12.43
-52.41	6.85	-8.5
-67.1	-32.22	10.56
-53.93	-57.07	45.95
5.74	7.42	48.77
52.31	13.99	-8.07
-30.96	-64.7	-27.28
54.79	4.4	32.85
3.65	3.52	53.59
52.46	17.82	13.91
48.22	9.34	14.67
39.44	53.01	2.19
43.84	41.2	14.28
47.94	48.15	-6.43
52.82	-2.7	51.31
50.21	40.73	7.55
44.3	-2.41	55.85
-45.61	-4.49	36.98
-52.27	10.51	11.26
-45.7	5.57	29.45
-43.6	7.36	24.81
-45.85	26.03	18.81
-.67	24.99	56.3
-35.44	53.99	-5.96
65.31	-19.25	1.26
65.37	-31.77	4.54
56.56	11.56	-12.38
-56.51	-22.1	2.9
-52.4	4.74	-8.32
-52.33	-9.9	-4.87
-67.1	-32.22	10.56
-67.04	-40.34	15.7
-52.09	-42.54	13.48
5.66	15.37	41.42
5.5	-23.67	4.55
-37.44	13.63	-4.78
61.06	-21.22	3.7
52.39	-7.16	-6.3
-50.15	-11.66	-.28
-50.06	-21.72	7.25
-58.6	-23.88	7.53
-52.13	-31.96	12.59
-56.31	-42.05	20.18

// Chen C H, 2007: fMRI Correlates of Depressive Symptom Severity at Baseline 
// (Pre-treatment)
// Chen C H, 2007: fMRI Predictors of Symptom Changes After Antidepressant 
// Treatment (Post-treatment)
// Subjects=17
-.14	56.81	-2.99
-1.11	43.89	10.11
-7.54	54.44	-6.11
6.18	48.29	-22.42
-20.25	47.87	-25.57
-10.6	27.1	-4.22
12.75	14.93	17.56
16.82	40.01	-4.16
11.58	25.97	-8.71
21.24	5.61	19.26

// Monterosso J, 2007: Hard Choice > No Choice
// Monterosso J, 2007: Easy Choice > No Choice
// Monterosso J, 2007: Hard Choice > Easy Choice
// Subjects=12
42	37	12
-47	15	33
34	-57	48
-41	39	-2
-34	-54	49
-3	26	42
-31	-55	48
-43	12	33
31	-62	44
43	42	19
-7	27	40

// Ramasubbu R, 2007: Mother > (Friend + Older Unknown Face + Younger Unknown 
// Face)
// Subjects=10
3	42	-6
12	36	-9
45	45	12
-3	-54	27
6	-60	30

// Wittmann M, 2007: Delay Reward vs. Immediate Reward
// Wittmann M, 2007: Delay < 1 Year vs. Delay >= 1 Year
// Subjects=13
-3.88	-53.11	23.85
-54.11	-63.35	19.71
45.04	-11.29	9.74
-41.58	-4.83	4.62
-41.23	-53.87	31.03
-51.78	-65.77	43.31
-.47	-76.21	41.36
-19.25	11.79	-2.61

// Yoo S S, 2007: Sleep Deprived Subjects
// Subjects=14
-3	-90	-9
-12	-87	-18
9	-81	-15
6	9	51
-6	9	48
33	27	0
-30	27	-3
-45	9	30
24	-30	-6
18	-6	-18

// Yoo S S, 2007: Sleep Privileged Subjects
// Subjects=14
-39	-81	-9
-9	-93	-3
-9	-78	-6
3	9	54
6	0	57
42	21	0
48	3	30
60	9	21
45	15	24
-42	3	30
-36	24	0
-33	24	-9
-36	33	-9
-45	18	15
-51	27	18
-33	-9	48
39	-24	51
-27	-66	51
-21	-30	-12
19	-7	-22

// Boettiger C A, 2007: Want/Dont Want - Sooner/Larger, Positive Correlations 
// with ICR
// Boettiger C A, 2007: Want/Dont Want - Sooner/Larger, Negative Correlations 
// with ICR
// Subjects=9
66	-42	44
36	-52	-62
56	-52	-2
68	-50	-12
18	-4	-28
-22	50	44
58	36	-10

// Johnstone T, 2007: Major Depressive Disorder Patients
// Subjects=21
-47	24	0
47	24	0
-42	10	44
44	14	-1
32	46	25
39	-55	41
-57	-18	7
32	46	25

// Johnstone T, 2007: Healthy Controls
// Subjects=18
-47	24	0
-42	10	44
44	14	-1
39	-55	41
-57	-18	7
32	46	25
32	46	25

// Chevrier A D, 2007: Cognitive Go-Phase Activities
// Chevrier A D, 2007: Successful Stop-Phase Activities
// Chevrier A D, 2007: Unsuccessful Stop-Phase Activities
// Subjects=14
-32.68	-0.04	52.07
0.4	15.05	51.54
36.44	45.19	25.18
24.37	58.41	-9.25
-1.22	65.37	0.5
0.81	48.95	-19.33
-35.76	-49.21	49.54
-2.57	-29.67	65.36
1.57	-44.3	40.89
-46.47	-69.34	37.97
47.09	-10.02	-1.54
31.34	-89.59	3.09
-28.49	-90.92	5
-7.33	-78.76	-18.57
24.46	-61.5	-46.03
49.31	15.06	19.75
6.5	4.17	6.66
-.66	-88.04	12.24
49.39	21.37	32.6
7.57	38.24	20.52
-42.17	-27.25	58.92
-58.3	-47.12	37.36
56.03	-45.46	34.79
-4.93	-27.59	37.34
-30.77	-24.35	12.83
0.38	-80.72	10.5
58.91	-31.27	-2.12
36.07	-.3	-40.14

// Devue C, 2007: Intact Own Face > Scrambled
// Devue C, 2007: Intact Own Body > Scrambled
// Devue C, 2007: Intact Faces > Intact Bodies
// Devue C, 2007: Intact Bodies > Intact Faces
// Devue C, 2007: Intact Own Face > Intact Colleague's Face
// Devue C, 2007: Intact Colleague's Face > Intact Own Face
// Devue C, 2007: Intact Own Body > Intact Colleague's Body
// Devue C, 2007: Intact Colleague's Body > Intact Own Body
// Devue C, 2007: Intact Self > Intact Colleague
// Subjects=28
-42	-54	-26
-46	-80	-14
40	-80	-16
42	-52	-22
42	34	6
44	24	0
46	8	44
40	-2	52
10	16	50
6	6	62
-40	-72	-6
-48	-76	2
-44	-68	-20
46	-78	-2
40	-54	-22
8	26	-16
52	-70	-2
42	-76	10
-42	-80	16
34	-54	-10
34	-52	-12
38	22	16
48	32	14
48	-28	18
40	-30	18
68	-22	12
-56	-48	16
-6	-42	56
26	52	2
32	18	-16
12	26	32
-36	36	16
-36	12	-14
43	-48	-10
48	-22	10
16	40	-10
8	32	26
32	14	-12

// Knutson B, 2007: Product + Price > Fixation
// Knutson B, 2007: Price > Fixation
// Knutson B, 2007: Choice > Fixation
// Subjects=26
9.69	38.17	19.38
-9.8	39.71	-13.98
40.58	37.24	4.61
-47.12	40.35	-2.45
-3.07	36.49	26.36
-21.04	31.84	50.38
31.98	23.47	-7.52
-27.88	22.94	-9.02
11.71	13.84	-6.48
-9.65	12.74	-5.02
8.58	6.93	0.83
-11.71	13.58	6.08
-7.49	3.15	-5.36
-1.74	-32.15	33.22
32.87	64.46	-14.31
-13.09	72.9	-11.15
-3.45	63.27	-12.68
5.12	49.32	-14.95
4.16	37.22	-6.12
-8.31	-48.16	5.64
-4.54	66.35	-14.04
-3.44	40.38	-19.68
-19.01	40.6	39.58
-45.8	18.8	21.65
32.95	31.25	-17.1
-35.47	34.99	-17.75
35.31	11.66	4.59
-31.99	11.43	7.61
-39.4	0.1	13.1
-39.3	-14.28	19.89
-51.03	-17.44	21.4
-25.02	-31.03	63.5
1.48	-27.64	36.15
60.21	-33.18	28.13
-50.93	-29.53	30.22
10.23	-37.59	58.07
-7.1	-52.15	22.69
-24.98	-68.01	53.22

// Petrella J R, 2007: Normals
// Subjects=28
-9.01	16.91	57.77
-43.95	16.22	29.3
-51.76	28.56	12.52
46.68	17.83	18.63
-37.01	-10.94	59.88
27.8	-60.03	47.94
-30.55	-51.62	49.23
-35.63	-58.41	-11.65
27.07	-57.88	-9.41
-20.54	-20.31	-6.71
-33.42	-16.43	0.97
-35.56	-29.41	0.05
18.48	-9.35	4.99
31.34	-19.91	-5.39
-11.78	-7.33	5.3
3.28	54.59	12.37
-7.51	63.38	15.04
18.31	63.8	6.72
7.67	33.23	13.29
-1.53	33.41	-30.28
55.06	-11.43	-7.76
-53.96	-12.25	0.91
64.91	-29.06	-1.7
8.27	-50.94	42.9
-6.9	-49.08	40.73
58.86	-47.75	28.27
-64.24	-30.24	38.72
-7.06	31.73	43.94
-11.3	23.62	49.3
18.12	-16.41	-24.56
-5.21	19.57	17.1
-27.17	-19.24	-17.91
-31.39	-54.56	-16.58
-18.55	38.61	-8.09
-48.74	5.02	-9.86
-9.13	-60.55	32.94
-6.78	-55.9	48.12
-.56	-52.32	28.61
14.59	-58.65	28.98
12.55	-63.25	37.32
50.82	19.79	4.92
44.73	16.09	34.52
-7.72	-16.94	-17.35
29.2	-13.23	-2.65
53.08	-28.68	2.95
-39.92	-55.99	-8.45
-29.26	-44.98	-17.57
-37.34	-83.48	18.88
-43.53	-17.87	55.07
-37.28	-43.63	31.74
31.89	-71.66	26.61
-52.48	13.72	37.53
6.3	-50.56	58.58
-8.81	-46.15	60.64
-.56	-47.96	29.3
-2.48	-69.16	43.76
-2.59	-63.41	36.47
12.59	-29.03	47.38

// Petrella J R, 2007: Mild Cognitive Impairment (MCI) Patients
// Subjects=34
-27.06	-54.54	-16.66
23.09	-94.73	10
16.76	-93.61	22.32
27.41	-72.82	14.48
29.28	-73.93	-8.98
-15.94	-92.61	0.37
-44.27	-60.57	-11.29
-41.93	-73.46	0.03
-24.08	-49.47	48.9
-17.5	-48.72	56.56
-24.06	-17.59	56.95
29.92	-55.98	45.27
-16.14	-27.32	-1.61
5.44	-27.45	-4.2
31.31	-30.01	-9.99
-1.06	30.35	5.88
7.63	37.28	10.65
3.25	59.81	10.73
5.84	-12.43	30.16
60.51	15.16	0.73
-55.99	-13.45	11.15
-64.6	-21.99	12.14
55.04	-.69	-7.7
-62.48	-41.96	5.11
65.16	-32.71	16.59
58.83	-33.72	29.12
-7.06	31.73	43.94
-11.3	23.62	49.3
18.12	-16.41	-24.56
-5.21	19.57	17.1
-27.17	-19.24	-17.91
-31.39	-54.56	-16.58
-18.55	38.61	-8.09
-48.74	5.02	-9.86
-9.13	-60.55	32.94
-6.78	-55.9	48.12
-.56	-52.32	28.61
14.59	-58.65	28.98
12.55	-63.25	37.32
50.82	19.79	4.92
44.73	16.09	34.52
-7.72	-16.94	-17.35
29.2	-13.23	-2.65
53.08	-28.68	2.95
-39.92	-55.99	-8.45
-29.26	-44.98	-17.57
-37.34	-83.48	18.88
-43.53	-17.87	55.07
-37.28	-43.63	31.74
31.89	-71.66	26.61
-52.48	13.72	37.53
6.3	-50.56	58.58
-8.81	-46.15	60.64
-.56	-47.96	29.3
-2.48	-69.16	43.76
-2.59	-63.41	36.47
12.59	-29.03	47.38

// Petrella J R, 2007: Alzheimers Disease (AD) Patients
// Subjects=13
29.9	-64.9	41.67
-13.27	-55.92	48.24
31.36	-58.07	-11.7
-39.77	-80.04	-1.59
48.76	20.51	12.72
50.81	15.33	3.12
-24.18	-89.63	32.71
-26.1	-63.75	57.07
-5.34	26.29	8.59
-7.42	35.62	16.67
-5.54	34.61	-5.68
13.98	39.66	1.34
-12.05	21.31	-9.85
-20.64	54.43	0.46
-9.71	12.78	2.16
-7.06	31.73	43.94
-11.3	23.62	49.3
18.12	-16.41	-24.56
-5.21	19.57	17.1
-27.17	-19.24	-17.91
-31.39	-54.56	-16.58
-18.55	38.61	-8.09
-48.74	5.02	-9.86
-9.13	-60.55	32.94
-6.78	-55.9	48.12
-.56	-52.32	28.61
14.59	-58.65	28.98
12.55	-63.25	37.32
50.82	19.79	4.92
44.73	16.09	34.52
-7.72	-16.94	-17.35
29.2	-13.23	-2.65
53.08	-28.68	2.95
-39.92	-55.99	-8.45
-29.26	-44.98	-17.57
-37.34	-83.48	18.88
-43.53	-17.87	55.07
-37.28	-43.63	31.74
31.89	-71.66	26.61
-52.48	13.72	37.53
6.3	-50.56	58.58
-8.81	-46.15	60.64
-.56	-47.96	29.3
-2.48	-69.16	43.76
-2.59	-63.41	36.47
12.59	-29.03	47.38

// Akine Y, 2007: Alcohol Dependent Subjects
// Subjects=9
-33	54	-6
36	54	-6
-51	12	21
51	12	24
-45	21	-6
36	21	0
-6	24	33
-12	-84	39
6	-78	38
-30	-66	36
36	-63	39
-15	-3	12
-18	-30	15
6	-24	15
18	-18	18
15	-3	15
51	30	33
6	24	27
-12	-30	6
-15	21	6
-36	42	3
33	54	0
-48	12	30
51	9	21
-51	24	-6
51	24	0
3	30	30
-6	-81	42
15	-72	39
-27	-72	39
30	-57	39
-18	-33	9
-12	-6	12
18	-3	15
-39	27	18
39	48	12
-33	-24	18
-6	30	18
-15	-24	19
18	3	3

// Akine Y, 2007: Healthy Controls
// Subjects=9
-48	39	-3
39	45	18
-54	9	33
54	27	33
-33	24	-3
60	21	6
-3	18	36
-6	-78	42
12	-72	45
-51	-39	39
-21	-3	6
-9	-12	6
15	0	15
51	30	33
6	24	27
-12	-30	6
-15	21	6
-39	45	15
36	60	0
-51	3	33
54	21	30
-57	9	3
60	18	6
0	21	39
-6	-81	42
3	-81	27
-30	-75	42
48	-36	36
-27	3	-3
-18	-6	21
-15	-6	12
15	-3	24
6	-27	3
27	3	0
-39	27	18
39	48	12
-33	-24	18
-6	30	18
-15	-24	19
18	3	3

// Altamura M, 2007: (3 Letter + 5 Letter + 8 Letter, Long and Short Delay) - 
// Arrow Task
// Altamura M, 2007: 3 Letters, Short Delay - Arrow Task
// Altamura M, 2007: 3 Letters, Long Delay - Arrow Task
// Altamura M, 2007: 5 Letters, Short Delay - Arrow Task
// Altamura M, 2007: 5 Letters, Long Delay - Arrow Task
// Altamura M, 2007: 8 Letters, Short Delay - Arrow Task
// Altamura M, 2007: 8 Letters, Long Delay - Arrow Task
// Altamura M, 2007: Load Effects
// Altamura M, 2007: Delay Effects
// Subjects=18
33	37	20
-41	38	24
-40	21	9
40	30	20
33	18	-1
-10	10	49
7	17	48
40	1	27
-29	10	60
-37	-55	47
44	44	51
21	-66	47
-48	-61	-12
-25	0.2	5
-18	-13	11
10	-3	5
3	-66	-11
-29	-67	-21
-10	-23	28
7	-23	28
-10	9	43
-33	-59	47
-10	10	49
-10	23	37
33	18	4
-51	1	27
-25	4	5
-7	-50	-7
-29	-66	42
-48	-62	-6
33	38	25
-3	-23	28
-10	10	49
-51	5	27
10	-62	-11
33	18	-1
7	-13	17
1	-63	-17
-37	-52	41
40	-47	57
-48	8	16
37	37	14
-48	-54	-7
-10	10	49
7	17	48
-40	-52	41
37	-48	46
-44	10	4
-40	-5	44
25	-7	55
37	14	-1
37	40	20
10	-3	5
44	26	15
21	-66	47
-3	-48	-12
-48	-62	-6
-51	4	21
33	2	27
-10	10	49
-44	10	4
7	34	31
-40	21	9
-44	34	20
40	30	26
44	12	27
-3	-55	-22
21	-59	-17
-55	-41	46
48	-41	46
21	-66	47
10	-18	6
-10	16	43
29	-1	53
-3	-1	60
-44	22	26
10	30	31
21	-66	47
14	-9	17
-14	-13	11
10	-3	5
-44	-45	35
33	-52	52
33	21	-1
37	37	20
44	1	33
-44	-62	-6
-40	-66	-17
-44	22	26
37	37	14
-51	5	27
33	18	-1
-44	-45	35
33	-48	46
1	20	48
-10	10	49
33	-1	55
-37	-5	50
-11	8	54
-52	-8	36
-51	4	21

// Hill S, 2007: Healthy Controls > Family History of Alcohol Dependence
// Subjects=8
63	-36	-6
21	57	9
-48	30	9

// Seymour B, 2007: Aversive Prediction Error
// Seymour B, 2007: Reward Prediction Error
// Seymour B, 2007: Aversive TD Error
// Seymour B, 2007: Appetitive TD Error
// Subjects=24
-16	0	-10
30	18	-12
-16	6	-6
-20	-4	6
10	6	-1
-12	6	-18

// Zaki J, 2007: Self Pain + Other Pain, Common Activations Assessed by Masked 
// Contrast Analysis
// Subjects=13
46	28	20
4	10	40
48	8	40
42	22	-12
28	28	2
28	16	6
30	20	-2
12	-2	10
20	-6	14
16	-10	20

// Hampton A N, 2007: Switch - Stay, Healthy Controls
// Hampton A N, 2007: Stay - Switch, Healthy Controls
// Hampton A N, 2007: Healthy Controls > Amygdala Lesion, Switch - Stay
// Hampton A N, 2007: Expected Reward, Healthy Controls
// Hampton A N, 2007: Expected Reward, Healthy Controls > Amygdala
// Hampton A N, 2007: High Probability Reward > High Probability Punishment, 
// Healthy Controls
// Hampton A N, 2007: High Probability Punishment > High Probability Reward, 
// Healthy Controls
// Subjects=1
-30	21	-9
33	21	-12
-9	21	33
0	18	51
-6	45	21
-30	21	-18
36	21	-18
-9	33	42
6	57	-6
-27	-6	-21
6	57	-3
-3	57	-9
27	52	6

// Kim H, 2007: Normals: Preference First
// Subjects=14
30	-21	-18
42	0	15
15	3	-12
9	6	-9
-60	-15	-27
-39	0	15
-15	27	-15
-18	-12	-6
12	39	21
12	3	-9
-18	27	-15
15	0	-6
-21	0	-9
9	-12	-15
-36	-6	0
-48	-21	21
-45	-27	15
-6	21	-9
-3	24	-21
12	3	-15
0	39	-27
12	15	-3
18	27	-15
9	6	-9
63	-36	-18
63	-33	-21
18	6	-15
-6	24	-12

// Kim H, 2007: Normals: Roundness First
// Subjects=11
-42	36	3
-42	15	0
-27	-39	-33
27	-33	-27
51	18	48
-54	-36	-6
-60	3	21
-45	-6	15
-42	15	0
-15	36	18
12	3	-9
-18	27	-15
12	3	-15
0	39	-27
9	6	-9
63	-36	-18
63	-33	-21
18	6	-15
-6	24	-12

// Langenecker S A, 2007: Major Depressive Disorder Patients
// Subjects=16
50	4	-4
-50	4	-4
54	4	-13
-54	4	-13
50	4	-4
-50	4	-4
3	47	23
-15	57	-4
-48	-27	49
48	-73	22
54	-30	10
-59	-13	6
-43	6	44
59	-15	6
-59	-15	8
-8	55	-1
50	3	37
50	-71	17
-61	-46	33
40	-83	8
-43	-75	-1
13	4	7
-13	24	-8
61	-13	10
45	-13	1
-66	-5	14
63	-30	3
-44	-54	-20
-17	61	-4
63	-50	18
31	-95	-16
-27	-102	-11
-45	-79	-27
-3	22	57
20	57	-3
56	20	27
48	4	26
-21	-1	-16
-4	-62	-7
-3	22	57

// Langenecker S A, 2007: Healthy Controls
// Subjects=17
50	4	-4
-50	4	-4
54	4	-13
-54	4	-13
50	4	-4
-50	4	-4
1	32	1
-50	18	24
40	-23	55
47	-71	0
57	-32	-13
-57	-26	-3
-50	-30	47
-52	-29	-23
-45	-79	-10
27	-96	23
50	12	37
-47	10	41
-45	-29	53
59	-29	-4
-45	-73	17
24	-91	23
41	-79	4
40	-85	-26
-13	24	-8
61	-13	10
45	-13	1
-66	-5	14
63	-30	3
-44	-54	-20
-6	43	0
-50	12	29
45	-71	3
-13	-102	16
20	-102	3
-3	22	57
20	57	-3

// Walsh N D, 2007: Major Depressive Disorder Patients
// Subjects=20
29.11	-62.02	1.91
1.28	-49.5	1.18
53.6	-23.21	6.18
64.5	-43.98	25.64
-44.86	16.38	4
4.71	-48.23	31.15
-41.34	-12.21	33.12
22.58	-41.34	-5.32
10.87	-27.7	7.05
2.16	-57.98	-25.99
-2.11	4.66	0.03
5.5	-9.41	10.04
24.96	-95.89	4.8
-44.55	-81.5	4.39
2.25	-82.3	-23.96
3.53	8.84	39.76
4.53	-27.05	15.99
-39.44	22.73	16.78
-36.11	17.43	30.57
-2.89	35.03	48.79
-31.54	-19.07	53.65
57.83	-32.42	-3.13
17.52	-76.84	17.79
8.02	70.38	-45.75

// Walsh N D, 2007: Healthy Controls
// Subjects=20
29.11	-62.02	1.91
1.28	-49.5	1.18
53.6	-23.21	6.18
64.5	-43.98	25.64
-44.86	16.38	4
4.71	-48.23	31.15
-41.34	-12.21	33.12
22.58	-41.34	-5.32
10.87	-27.7	7.05
2.16	-57.98	-25.99
-2.11	4.66	0.03
5.5	-9.41	10.04

// Bartres-Faz D, 2007: Parkinson's Disease Patients (A1/A2 heterozygous)
// Subjects=8
56	-28	-8
14	-54	-28
-40	-48	46
44	-42	40
22	-8	60
-22	-54	-28
34	-28	44
-24	-14	60
-46	-18	48
14	-16	64
4	-46	18
-34	-14	58

// Bartres-Faz D, 2007: Parkinson's Disease Patients (A2/A2 homozygous)
// Subjects=12
-34	-48	52
-50	-36	36
-34	-14	58
-4	6	52
36	-20	62
14	-16	64
4	-46	18
-34	-14	58

// Plassmann H, 2007: Positive Correlation with Willingness To Pay During 
// Free-Bid Trials
// Plassmann H, 2007: Areas with Increasing Activation with WTP in Free-Bid & 
// Free-Bid > Forced-Bid
// Plassmann H, 2007: Free-Bid > Forced-Bid, when Exposed to the Item
// Plassmann H, 2007: Forced-Bid > Free-Bid, when Exposed to the Item
// Plassmann H, 2007: Free-Bid > Forced-Bid, at Time of Bidding
// Plassmann H, 2007: Forced-Bid > Free-Bid, at Time of Bidding
// Subjects=19
6	30	-17
-4	34	-20
44	44	12
4	30	-18
44	44	18
6	23	-8
6	25	-11
4	38	-20
-26	30	-12
30	28	-15
16	-4	8
2	-14	-18
8	-52	17
3	39	15
-8	-4	-7
8	-6	-3
48	32	13
-12	18	5
-4	7	27
4	1	26
24	-89	-8
-62	-37	20
58	37	22
-10	-58	-1
10	-57	-1
-2	-26	33
6	-69	-20
26	-67	-19
-48	41	13
-32	60	16
22	4	-7
-4	32	22
4	32	24
-8	6	0
26	52	42
-4	-21	7
14	-2	2
-45	9	50
-8	-6	-5
-40	-6	-9

// Yu H, 2007: Parkinson's Disease Patients
// Subjects=8
-42.22	-17.9	55.91
-1.65	-10.34	53.69
4.79	-1.25	60.66
-57.59	6.33	12.79
60.36	-36.03	46.21
-55.36	-31.18	9.22
63.21	-24.3	5.05
-9.46	-16.02	8.54
5.49	-13.81	8.18
34.25	-73.99	-29.48
-23.44	-70.82	-24.62
-44.41	-16.31	49.11
-30.41	-27.18	58.78
57.01	-18.85	34.77
6.82	10.86	51.82
-1.63	-5.77	57.77
6.91	-1.4	58.42
-3.95	9.94	40.87
50.62	5.49	47.3
-56.5	6.51	14.99
57.78	12.05	7.64
-49.87	-36.21	26.31
50.69	-35.55	39.59
-56.41	-32.07	11.54
58.96	-28.47	6.56
47.05	11.56	2.23
-9.47	-18.3	6.5
16.18	-13.75	8.05
19.31	1.96	4.47
23.54	-61.11	-27.09
-24.57	-64.91	-30.68
1.16	-63.9	-19.91

// Yu H, 2007: Healthy Controls
// Subjects=8
-42.25	-11.64	54.27
-53.04	-22.68	36.36
-6.01	11.75	50.78
-4.83	-3.5	59.85
-1.76	2.72	43.68
-44.46	5.18	51.77
47.37	12.7	44.51
-50.88	-.49	47.86
-49.03	11.93	15.57
53.58	12.8	17.66
-50.82	-39.42	39.97
63.42	-30.96	29.03
-53.22	-31.08	10.3
60.02	-22.03	7.13
-39.39	-11.96	8.54
42.9	-16.84	6.89
-12.65	-17.01	9.77
14.05	-13.67	9.18
-26.64	-2.71	3.16
26.79	3.15	5.4
-14.78	2.87	19.28
18.33	3.96	16.58
-23.43	-7.1	1.26
15.08	-67.88	-17.51
-15.96	-65.32	-22.94
-45.46	-16.06	52.45
-3.88	10.62	49.73
8.96	12.01	52.81
-3.76	-3.5	59.84
6.94	-2.2	61.83
-2.86	7.91	42.14
7.8	11.06	40.64
53.81	8.59	45.89
-47.69	-1.7	45.69
54.89	1.03	44.28
40.73	49.79	29.21
-50.1	9.72	14.65
54.6	5.69	8.21
-54.05	-40.75	36.77
61.31	-32.83	32.55
-55.33	-34.18	11.7
62.21	-32.42	10.2
-42.69	7.94	4.68
43.83	16.91	2.93
-11.59	-19.29	7.72
-25.56	-3.68	4.34
-21.29	-3.74	3.18
24.6	-56.79	-26.35
-20.23	-69.66	-23.64
1.19	-60.3	-14.64

// Marco-Pallares J, 2007: Correct Responses > Incorrect Responses
// Subjects=12
36.38	-77.32	-31.46
18.36	-83.55	-14
21.32	7.29	-9.38
-2.83	-20.35	34.47
-5.27	33.59	16.59
-7.52	8.26	-8.02
-3	-29.81	8.5
-6.17	7.92	28.79
-12.85	5.14	-6.58
-47.98	-58.48	-14.22
-57.42	-53.48	10

// Schonberg T, 2007: Healthy Learners
// Subjects=17
18	15	15
18	12	15
18	15	15
18	12	15
-18	-24	39
-33	-18	-30
18	30	24
-3	60	-15
12	-3	36
30	-9	9
18	-30	39
33	-21	-12
36	3	-12
-12	63	-6
-48	3	24
-27	-9	-30
0	45	24
-3	-90	-6

// Schonberg T, 2007: Healthy Non-Learners
// Subjects=12
18	15	15
18	12	15
-18	-24	39
-33	-18	-30
18	30	24
-3	60	-15
12	-3	36
30	-9	9
18	-30	39
33	-21	-12
36	3	-12
-12	63	-6
-48	3	24
-27	-9	-30
0	45	24
-3	-90	-6

// Behrens T E J, 2007: Main Effects of Decide
// Behrens T E J, 2007: Main Effects of Monitor
// Subjects=18
38	-88	-12
-44	-72	-12
28	-96	-2
26	-90	-8
34	-44	-20
-44	-62	-18
-36	-50	-34
60	-40	20
66	-46	16
46	12	-4
42	18	-4
38	20	-14
42	18	-8
6	20	26
4	16	30
2	-8	48
-8	-8	52
2	6	60
4	16	56
0	-8	68
-44	-4	2
-38	-2	6
-34	18	6
-32	14	10
-46	8	0
-28	24	0
-20	2	-2
18	0	-2
-54	-24	14
-48	-26	12
-56	-22	20
-30	-56	52
-34	-54	54
-38	-34	42
8	-22	-4
-8	-18	-4
24	-34	-6
10	-20	2
-12	-20	0
34	28	26
30	30	24
36	46	34
32	48	22
28	54	12
-34	46	24
-32	56	20
6	-24	26
48	-24	16
20	-48	-14
46	-70	0
-4	-72	6
18	-74	-10
-20	-72	-10
36	-52	54
42	-52	40
6	-66	48
8	-46	44
-36	-54	54
50	-42	12
-10	6	-8
16	6	-4
10	-20	-10
12	-22	12
22	-26	-10
-20	-22	-10
44	-4	50
52	6	16
52	14	34
50	36	20
-4	34	6
6	36	10
4	32	24
6	34	44
-28	16	0
-32	14	-10
-32	14	-10
-58	-14	28
-54	2	42
8	-36	24
-56	-50	8

// Forn C, 2007: Healthy Controls
// Subjects=10
40.71	43.01	24.2
42.91	25.05	25.68
31.89	47.88	-8.45
5.73	13.94	50.46
-39.38	28.79	26.31
-24.79	61.37	-7.81
-41.37	6.2	37.15
32.66	-57.35	48.32
-27.19	-56.65	48.95
-35.73	-57.76	49.14

// Forn C, 2007: Relapsing-Remitting Multiple Sclerosis Patients
// Subjects=17
40.8	27.49	29.96
30.36	2.45	51.14
2.54	19.55	54.48
52.36	21.11	1.37
-41.52	23.32	24.56
-57.79	22.85	-7.55
-44.58	3.89	35.15
39.01	-46.91	45.14
0.18	-9.18	13.43
-6.19	25.27	32.92

// Opitz B, 2007: Local Violation Sentences vs. Correct Sentences
// Opitz B, 2007: Long-Distance Violation Sentences vs. Correct Sentences
// Subjects=24
-26.75	-22.49	-18.6
25.57	-10.54	-20.21
-58.39	-19.46	37.27
-55.21	-36.24	26.37
-64.94	-34.15	12.92
64.36	-26.78	14.17
37.23	8.3	-25.27
-36.33	-10.14	-9.49
41.66	-6.5	-10.69
28.81	9.54	-8.54
18.1	-26.96	-25.43
-0.05	-10.44	-16.57
8.9	-82.07	6.06

// Christmann C, 2007: Pain - Baseline
// Christmann C, 2007: Pain - Baseline, Correlation with Pain Intensity Rating
// Christmann C, 2007: Pain - Baseline, Positive Correlation with Pain 
// Unpleasantness Rating
// Christmann C, 2007: Pain - Baseline, Negative Correlation with Pain 
// Unpleasantness Rating
// Subjects=6
-50.07	-10.8	10.8
-54.26	-19.83	18.29
-44.8	-3.88	3.46
-41.47	-16.84	14.55
-32.02	19.97	8.01
-60.7	7.25	25.02
-43.29	-15.79	55.74
-51.86	-12.76	54.47
-31.54	-22.33	52.81
-47.53	-21.99	58.54
-33.63	-18.57	60.33
-13.44	-21.84	43.64
-15.58	-22.91	43.76
-8.2	-1.98	38.57
-9.29	-2.16	36.37
-2.71	-11.41	53.8
-2.74	-16.07	48.61
-.95	-55.92	-12.75
-2.87	-59.16	14.31
11.3	-5.72	71
10.2	-8.19	66.76
19.27	-51.19	-22.3
21.4	-51.26	-23.43
49.43	-27.67	17.76
53.7	-27.64	17.71
49.2	2.94	0.7
44.88	12.26	-2.27
44.87	6.72	-5.15
53.55	-6.21	5.87
-46.8	-16.7	16.83
-50.79	-13.81	54.55
-57.62	-1.67	5.66
-2.72	-14.84	50.74
-49.92	-37.78	19.75
-33.63	-18.57	60.33
-9.25	-2.87	40.89
25.62	-50.7	-30.22
32.07	-62.29	-29.32
-47.55	-21.11	56.24
0.54	-15.27	58.54
-30.41	-26.03	59.8
-9.29	-2.16	36.37
30.94	-45.38	-30.73
-61.77	8.39	26.05
-46.92	0.68	7.57
-67.11	-14.7	16.89
-14.5	-21.77	44.76
-48.92	-25.34	15.35
12.88	-57.57	-21.69
9.16	-10.14	69.17
60.99	6.61	5.83

// Freund W, 2007: Right weak - rest
// Freund W, 2007: Left weak - rest
// Freund W, 2007: Right moderate - rest
// Freund W, 2007: Left moderate - rest
// Freund W, 2007: Right pain - rest
// Freund W, 2007: Left pain - rest
// Freund W, 2007: Right increase
// Freund W, 2007: Left increase
// Freund W, 2007: Right tonic pain early - rest
// Freund W, 2007: Left tonic pain early - rest
// Freund W, 2007: Right tonic pain late - rest
// Freund W, 2007: Left tonic pain late - rest
// Freund W, 2007: Left tonic pain late - tonic pain early
// Freund W, 2007: Right tonic pain early - tonic pain late
// Freund W, 2007: Left tonic pain early - tonic pain late
// Subjects=15
-54	-16	18
52	30	22
62	-12	22
56	-52	46
-30	54	4
56	-18	12
38	-4	-8
42	0	8
-56	-16	36
14	-68	54
42	50	10
-40	40	-4
50	-42	52
-46	-56	48
0	38	36
44	52	12
56	-22	54
56	-20	14
56	-30	48
54	-54	48
-40	-16	16
38	44	-6
40	14	-6
-4	4	18
38	52	2
46	0	8
42	-28	10
-54	6	-2
36	6	38
-24	-42	2
54	-54	48
46	46	4
-2	-2	22
-4	8	12
-38	-12	6
-40	-16	14
42	50	-2
56	22	26
46	0	10
-52	18	-12
10	28	48
20	-34	12
32	-52	2
12	10	16
2	16	72
32	18	-2
-44	-4	8
40	52	20
14	-22	18
8	20	0
64	-18	20
-24	-48	6
-22	18	34
62	-18	18
54	-18	54
18	26	36
38	-10	14
-32	34	12
-6	18	6
8	-56	64
22	-34	12
6	28	-6
-4	12	4
26	-50	72
-16	-52	64

// Longe O A, 2007: Stems (Nouns + Verbs) vs. Baseline
// Longe O A, 2007: Inflections (Nouns + Verbs) vs. Baseline
// Longe O A, 2007: Stems + Inflections vs. Baseline
// Longe O A, 2007: Inflected vs. Stem
// Longe O A, 2007: Inflected Verbs vs. Verb Stems
// Longe O A, 2007: Inflected Nouns vs. Noun Stems
// Longe O A, 2007: Inflected Verbs vs. Inflected Nouns
// Longe O A, 2007: (Inflected Verbs vs. Verb Stems) vs. (Inflected Nouns vs. 
// Noun Stems)
// Subjects=12
-41.49	-19.86	45.15
-58.86	-18.31	39.69
-60.37	16.73	12.72
-46.2	27.6	24.85
7.57	-67.08	-14.89
22.49	-60.93	-30.32
-35.82	-49.98	-24.8
-44.39	-52.69	-18.79
-44.37	-50.35	-16.78
-46.5	-67.69	-18.39
-57.78	-15.01	40.47
-39.34	-18.79	45.01
-50.04	-29.05	50.69
-50.68	28.57	12.5
-41.86	11.35	23.02
-50.7	14.22	8.32
-53.03	30.4	-2.21
-37.99	36.42	-7.54
-33.82	32	-20.62
5.48	-51.26	-6.33
7.53	-76.11	-19.6
18.33	-58.64	-17.03
-57.78	-15.01	40.47
-41.5	-18.79	45.04
-47.9	-20.43	50.92
5.51	-51.06	-4.11
-44.39	-52.69	-18.79
-35.82	-49.98	-24.8
-48.64	-65.36	-16.34
-2.55	20.02	56.23
-41.84	13.68	25.03
-29.22	-11.83	-7.4
-50.7	15.28	8.21
-52.81	26.64	14.97
-60.37	15.67	12.82
-39.89	19.78	9.82
-46.28	10.6	15.32
-25.14	37.76	-16.86
-66.81	-39.85	4.98
-23	20.13	-21.87
-62.65	-22.48	-4.66
-15.48	-65.06	42.46
-13.47	-66.19	30.21
-26.34	-56.8	39.58
-51.58	-62.02	8.03
-42.04	11.06	8.48
-53.76	-42.47	10.62
-48.75	-25.7	-16.9
-23.01	23.32	-22.19

// Hermann D, 2007: Audiovisual Stimulation vs. Baseline, Healthy Controls > 
// Alcohol-Dependent Patients
// Subjects=9
6	-81	9

// Grahn J A, 2007: All Rhythms - Rest
// Grahn J A, 2007: Metric Simple - Metric Complex and Nonmetric
// Subjects=27
-9	6	60
3	6	66
-24	6	9
21	6	6
-54	0	51
54	0	45
30	-66	-27
-30	-66	-24
60	-33	6
-57	-15	9
-57	6	3
27	30	15
-51	3	3
-51	-9	-3
42	-36	18
45	6	-6
30	-21	12
-27	0	-9
-27	0	0
-27	-12	-6
24	0	-9
24	12	6
24	-3	9
-51	33	6
-12	69	18
21	9	-15

// Lamm C, 2007: Reaching Range Predictions/Averaged > Gender Matching
// Lamm C, 2007: Correlation between (Reaching Range Prediction > Baseline 
// Activation) and Visual Imagery Subscale
// Subjects=17
56	-26	50
62	-24	36
60	-26	26
32	-38	42
52	-30	60
-60	-8	22
-62	-30	28
-62	-32	44
14	-70	58
18	-62	60
18	-64	68
16	-54	70
6	-34	52
-6	-26	44
56	12	12
-40	4	2
44	-32	18
-36	-86	36
36	-80	46
46	-80	28
54	4	22
44	-50	44
35	-45	32
-50	-34	-12
-54	-42	6
10	-56	0

// Lieberman M D, 2007: Gender Labeling > Affect Labeling
// Lieberman M D, 2007: Affect Labeling > Gender Labeling
// Subjects=30
-24	0	-24
4	48	-16
6	8	-4
6	26	-8
2	18	32
44	-14	2
-40	-12	8
-8	-64	26
66	-42	14
-56	-22	12
40	6	-18
-40	8	-14
6	-26	-2
10	-54	-12
54	24	-10
48	46	-6
56	18	8

// Schaefer M, 2007: Familiar Brands > Unfamiliar Brands
// Schaefer M, 2007: Sport/Luxury Brands > Unfamiliar Brands
// Schaefer M, 2007: Value Brands > Unfamiliar Brands
// Schaefer M, 2007: Sport/Luxury Brands > Value Brands
// Subjects=14
14	8	50
-8	12	54
32	-36	-6
-8	-58	10
26	-34	34
-10	48	36
-6	10	56
2	30	2
-10	54	12
18	-92	-2
-14	-92	0
22	-58	62
38	-86	-4

// Kaladjian A, 2007: Healthy Controls
// Subjects=21
-8.38	56.21	30.34
-43.86	26.72	38.34
49.41	31.54	-18.63
0.71	55.93	-19.1
-62.6	-29.71	-1.7
58.24	-8.64	-12.57
-49.9	-53.09	57.55
55.68	-56.07	31.39
1.69	-56.05	34.55
-40.86	-66.97	0.49
30.79	-82.72	23.24
49.55	25.99	-9.12

// Kaladjian A, 2007: Schizophrenia Patients
// Subjects=21
-14.91	49.29	25.53
-37.29	17.59	43.61
33.9	32.32	36.46
-33.65	-70.26	56.73
31.1	-72.78	49.15
-1.3	-59.61	54
-27.49	-69.33	31.88
49.55	25.99	-9.12

// Mashal N, 2007: Novel Metaphors > Unrelated Words
// Mashal N, 2007: Conventional Metaphors > Unrelated Words
// Mashal N, 2007: Literal Expressions > Unrelated Words
// Mashal N, 2007: Novel Metaphors > Literal Expressions
// Mashal N, 2007: Conventional Metaphors > Literal Expressions
// Mashal N, 2007: Novel Metaphors > Conventional Metaphors
// Subjects=15
40.61	21.12	2.62
-5.18	-9.39	11.28
-38.51	49.89	10.03
43.72	54.18	3.15
-36.34	20.58	2.43
-48.09	36.97	9
-37.26	39.63	28.72
53.56	26.89	20.94
-41.12	-46.16	48.23
-4.16	36.31	24.16
-53.24	-47.8	0.55
-54.35	12.15	18.96
56.67	18.22	4.91
68.51	-30.24	-3.43
47.15	-21.48	1.65
-52.13	-53.97	3.29
-32.52	-69.71	45.65
45.84	50.68	-1.04
-38.49	48.91	11.23
-42.21	-48.62	43.99
43.71	55.15	1.96
-6.24	-9.31	12.4
-38.47	18.36	1.53
66.36	-31.48	-5.54
39.54	24.38	3.47
-36.21	43.87	28.36
-49.04	10.78	14.55
-43.88	39.65	2.03
56.67	18.22	4.91
-32.52	-69.71	45.65
-41.14	-46.33	46.01
43.78	56.98	11.84
-37.4	50.32	15.56
40.61	21.12	2.62
60	-40.86	-2.45
-54.31	-48.95	-.45
-4.17	-9.98	3.51
56.67	18.22	4.91
-47.94	12.19	18.88
-46.02	39.64	2.06
-35.26	15.21	1.75
-46.97	34.23	14.79
65.51	-50.12	15
43.82	32.15	7.23
-50.01	20.61	31.58
3.36	29.04	25.8
56.13	-23.57	56.37
-53	-57.37	28.12
-46.1	31.04	-12.83
53.59	-28.84	2.2
51.38	25.39	15.52
-46.95	36.6	17.94

// Stringaris A K, 2007: Metaphoric > Literal
// Stringaris A K, 2007: Metaphoric > Non-Meaningful
// Stringaris A K, 2007: Non-Meaningful > Metaphoric
// Stringaris A K, 2007: Literal > Metaphoric
// Stringaris A K, 2007: Literal > Non-Meaningful
// Stringaris A K, 2007: Non-Meaningful > Literal
// Subjects=11
-29.92	-63.89	-30.71
16.25	-85.51	-11.58
-6.31	-14.4	1.67
-45	31.39	-8.41
35.66	-68.19	17.97
-20.88	-82.9	25.43
28.26	-66.32	29.05
-53.08	-7.71	37.34
-29.33	-57.81	47.96
-6.31	-14.4	1.67
-25.41	-89.99	-10.73
-41.5	-74.22	-11.86
47.11	-62.49	-19.44
-33.28	27.86	-13.83
16.32	-52.96	10.22
-10.3	-79.55	12.76
51.45	7.41	17.02
-44.78	21.64	16.94
-13.33	-74.51	36.91
51.49	-65.75	-6.95
13.25	-63.66	23.42
-26.23	-42.35	41.05
35.83	-50.01	46.55
-2.67	-54.9	41.83
13.36	-29.54	51.79
1.5	-2.12	49.62
-41.22	-22.98	45.17
-33.02	-67.2	-18.13
-22.22	-82.48	-10.28
0.75	59.27	-23.54
51.49	-65.75	-6.95
-29.48	-80.21	19.73
9.07	-38.54	45.9
44.21	-6.61	42.82
-53.45	-7.16	-10.66
-22.01	-75.94	19.28
51.41	19.04	16.05
39.92	-2.41	42.51
-18.27	-61.59	-43.3
43.91	-62.5	-19.4
-33.2	19.83	-7.58
35.07	51.96	-11.06
-48.91	-53.78	5.46
-22.05	-80.68	12.99
16.47	-67.88	23.74
58.96	-1	17.64
-29.38	-55.06	42.15
32.65	-57.44	47.21
-2.77	-2.15	49.67
1.74	-53.51	59.51
-41.15	-26.7	52.17

// Vorhold V, 2007: Risk Rating > Letter Decision
// Subjects=13
-6	54	33
-42	33	-21
33	87	-42

// Walter H, 2007: Healthy Controls
// Subjects=17
-15	12	-3
21	18	3
30	-9	69
-39	-78	30
24	-66	60
39	-69	45
-39	-75	-24
33	-60	-48
-42	9	-27
36	18	-30
-9	-36	-9
15	-36	-12
48	0	53
-15	30	54
-39	9	-27

// Walter H, 2007: Schizophrenic Patients
// Subjects=15
-15	12	-3
21	18	3
30	-9	69
-39	-78	30
24	-66	60
39	-69	45
-39	-75	-24
33	-60	-48
-42	9	-27
36	18	-30
-9	-36	-9
15	-36	-12
48	0	53
-15	30	54
-39	9	-27
-45	18	-21
33	18	-24
-6	-45	-6
42	15	-18
-45	27	21
-39	27	18
27	39	-18
36	-63	-63

// Walter H, 2007: Depressed Patients
// Subjects=12
-45	18	-21
33	18	-24
-6	-45	-6
42	15	-18
-45	27	21
-39	27	18
27	39	-18
36	-63	-63

// Dougal S, 2007: Neutral > Control
// Dougal S, 2007: Emotional > Control
// Dougal S, 2007: Neutral > Emotional
// Dougal S, 2007: Emotional > Neutral
// Dougal S, 2007: Emotional and Neutral > Control
// Subjects=14
-17.12	-12.49	-13.98
-34.26	-8.62	-17.45
-33.19	-33.87	-27.61
-32.11	-12.83	-17.12
37.24	-20.13	-35.15
-32.09	-10.46	-13.97
19.23	-12.01	-11.09
-26.66	-34.75	-12
33.19	-36.51	-12.54
-24.62	-9.44	-15.26
-16.04	-10.11	-10.84
-35.34	-12.05	-20.49
-35.49	-5.85	-36.63
-29.95	-11.51	-13.91
-29.95	-11.51	-13.91
-35.34	-12.05	-20.49

// Harvey P O, 2007: Social Hits > Social Misses
// Harvey P O, 2007: Non-Social Hits > Non-Social Misses
// Harvey P O, 2007: Emotional Hits > Emotional Misses
// Harvey P O, 2007: Neutral Hits > Neutral Misses
// Subjects=17
-18	56	22
10	60	34
-44	38	-8
60	18	18
22	-6	-24
-22	-18	-22
-46	-72	-14
26	34	-16
46	12	30
-24	-16	-12
32	-24	-26
46	-62	-16
-32	36	-12
-46	18	26
20	-4	-20
30	-26	-24
-44	-52	-14
-16	58	22
58	6	4
-22	-6	-28
48	-60	-16

// Kensinger E A, 2007: Task-Correct Negative and Neutral > Control
// Kensinger E A, 2007: Task-Correct Negative > Task-Correct Neutral
// Subjects=20
30	56	17
-48	-59	-10
53	-64	-4
-48	-52	-5
27	-50	5
21	-32	-14
-18	-7	-22
-32	-8	-25
-30	-8	-35
36	-21	-20
36	-15	-17
-21	-9	-20
-18	3	-12
-21	5	-15
-12	29	46
-35	41	0
30	-6	28
30	-37	25
56	-61	-2
33	-2	-35
-50	-67	-7
-41	-56	-5
-29	-36	-13
-30	-5	-33
38	-21	-14
33	-4	-25
27	0	6
-3	7	16
6	-25	15
-32	-39	-21

// Miyamoto T, 2007: High-Intensity Clicks, Activations
// Subjects=12
-2	66	16
-6	58	24
28	26	48
-34	18	44
26	32	58
-48	-2	20
-28	2	50
-8	-42	54
36	-70	50
-32	-66	50
-40	-72	34
52	-56	26
-42	-58	34
-10	36	10
4	-42	38

// Anguera J A, 2007: Control group
// Subjects=9
-54	-61	5
53	-62	-4

// Anguera J A, 2007: fMRI group
// Subjects=11
50	25	1
48	13	23
6	5	61
26	3	55
-26	5	55
61	-32	29
-4	-57	54
4	-55	56
54	11	-4
-2	17	25
-24	-26	-12
2	27	-11
61	-8	-13
-38	-50	52
-57	-36	9
10	-74	35
20	-38	-20
24	-44	-12
-36	-14	14
20	-46	2
-54	-61	5
53	-62	-4
-38	-50	52

// Coccaro E F, 2007: Main Effect, Group
// Coccaro E F, 2007: Main Effect, Emotion
// Coccaro E F, 2007: IED (> HC) vs Rest, Angry
// Coccaro E F, 2007: IED (> HC) vs Rest, Disgusted
// Coccaro E F, 2007: IED (> HC) vs Rest, Fearful
// Coccaro E F, 2007: IED (> HC) vs Rest, Happy
// Coccaro E F, 2007: IED (> HC) vs Rest, Neutral
// Coccaro E F, 2007: IED (> HC) vs Rest, Surprised
// Coccaro E F, 2007: IED (> HC) vs Rest, Sad
// Coccaro E F, 2007: HC (> IED) vs Rest, Angry
// Coccaro E F, 2007: HC (> IED) vs Rest, Disgusted
// Coccaro E F, 2007: HC (>IED) vs Rest, Fearful
// Coccaro E F, 2007: HC (> IED) vs Rest, Happy
// Coccaro E F, 2007: HC (> IED) vs Rest, Neutral
// Coccaro E F, 2007: HC (>IED) vs Rest, Surprised
// Coccaro E F, 2007: HC (> IED) vs Rest, Sad
// Subjects=10
52	-80	14
-12	-96	-14
-26	50	26
-46	-84	-4
-36	-6	40
-4	-42	52
-8	0	76
-8	4	-22
36	-60	-44
-68	-44	14
-40	-48	-28
30	-82	26
40	20	50
-40	-74	-20
-8	-16	-34
-10	-98	24
24	-32	24
32	52	-16
-26	-48	62
26	-40	50
-10	10	24
-54	-18	-18
24	-10	-30
28	-62	10
-38	-56	34
10	-62	-6
-44	-58	54
52	26	2
42	-82	-28
46	-18	48
16	-56	34
-18	12	-22
-2	-30	-8
60	-34	12
6	-34	-22
40	-46	-26
-20	-102	2
-6	-16	-2
-22	-28	44
28	-72	-6
-12	-90	-12
26	-44	38
0	-40	-40
-40	-86	-14
6	-36	-14
48	-60	-14
-16	-12	24
-26	4	-10
10	0	-10
6	-12	-20
-44	-54	-16
-12	-36	-24
-10	-70	-2
-4	14	6
-24	-28	26
-32	-62	12
-24	14	14
-18	-106	-8
20	50	18
-34	64	0
-22	52	16
-56	-52	50
-42	26	44
-32	-78	-46
16	44	-4
-20	20	30
34	-6	42
-48	-78	12
10	2	-20
-16	38	40
14	-72	26
-46	-30	-4
20	26	36
-48	-84	16
-26	46	28
-4	-24	-50
18	-14	50
4	56	40
-10	-68	66
-44	-70	22
-16	52	12
-50	28	0
-48	-62	54
-50	-6	-38
16	28	38
-48	54	8
-38	-58	-42
-58	-48	24
4	-42	54
-30	-10	-30
20	12	-24
6	56	46
-46	56	-8
-52	16	12
-60	-50	38
42	-70	36
-10	60	12
-64	-48	2
-26	20	30
50	-4	-32
18	48	16
-54	-78	16
60	-60	14
-22	8	-22
-12	44	-18
34	36	-8
-64	-52	42
48	-80	-6
-6	-8	-4
-6	40	30
-52	20	-24
8	2	-24
-16	46	20
30	-22	-28
-50	-82	16
-20	24	60

// Grabner R H, 2007: Multi-Digit > Single-Digit
// Grabner R H, 2007: Single-Digit > Multi-Digit
// Grabner R H, 2007: Higher > Lower Mathematical Competence
// Subjects=12
36	-68	-26
-28	26	-4
30	30	-2
-36	-42	44
-46	8	30
-42	-66	-30
0	-74	-24
10	26	36
-26	-2	54
-10	16	44
0	-70	10
38	-46	42
24	-28	6
-48	36	28
-10	-22	12
-58	-64	32
-52	-64	28
-50	-54	16
-10	18	56
-6	54	34

// Nieuwland M S, 2007: Referential ambiguity > Referential coherence
// Nieuwland M S, 2007: Referential failure > Referential coherence
// Nieuwland M S, 2007: Semantic anomaly > Semantic coherence
// Nieuwland M S, 2007: Referential ambiguity > Referential failure
// Nieuwland M S, 2007: Referential ambiguity < Referential coherence
// Nieuwland M S, 2007: Referential failure < Referential coherence
// Nieuwland M S, 2007: Semantic anomaly < Semantic coherence
// Nieuwland M S, 2007: Referential ambiguity < Referential failure
// Subjects=22
-6	66	-2
2	64	20
28	28	44
-6	-62	30
-10	-64	44
-2	-64	48
-50	-68	30
50	-62	30
4	-64	46
-40	-60	50
-48	-52	48
-54	-54	42
52	-62	42
-42	10	54
-44	24	0
-46	32	8
-52	14	18
50	32	4
-2	62	24
-2	50	-6
-8	62	-2
-8	-66	22
-16	-68	22
-42	28	-2
-50	26	18
40	32	-8
40	22	12
50	18	18
-30	-12	-14
-44	-6	-20
4	60	-10
-4	18	-14
0	10	-10
6	22	-20
30	30	46
-8	-64	22
8	-56	18
-12	-62	34
-42	24	18
38	24	18

// Kalbfleisch M L, 2007: Areas modulated by task difficulty (Hard > Easy)
// Kalbfleisch M L, 2007: Areas modulated by response correctness (Correct > 
// Incorrect)
// Kalbfleisch M L, 2007: Areas modulated by task difficulty and correctness 
// interaction
// Subjects=14
-39.25	-4.99	54.85
10.38	12.21	52.3
-24.13	8.14	56.65
32.06	12.8	57.47
46.49	48.16	10.03
-48.36	6.76	20.22
-42.3	14.61	-10.91
56.11	16.75	-4.96
41.85	20.56	-20.78
14.96	-69.02	55.78
-17.52	-51.06	54.55
49.31	-42.08	43.56
-40.03	-34.93	-12.77
31.96	-67.85	32.96
-24.56	-102.32	0.35
-37.91	-85.51	-25.74
-5.34	-87.54	-14.88
-7.9	-65.37	-41.69
30.94	8.13	53.47
-46.2	6.77	20.18
58.69	7.86	26.13
-.15	-65.68	57.94
12.77	-75.83	52
6.39	-46.64	66.03
38.66	-50.86	53.58
-28.38	-58.1	48.71
33.98	-87.48	18.06
3.53	-84.68	3.73
-9.54	-64.73	-.26
33.52	-79.96	-16.29
11.6	16.1	-20.94

// Das P, 2007: Conscious, Schizophrenia patients < Control, Amygdala
// Das P, 2007: Conscious, Schizophrenia patients < Control, Medial prefrontal 
// cortices
// Das P, 2007: Conscious, Schizophrenia patients < Control, Thalamus
// Das P, 2007: Conscious, Schizophrenia patients > Control, Visual 
// association cortices
// Das P, 2007: Nonconscious, Schizophrenia patients < Control, Amygdala
// Das P, 2007: Nonconscious, Schizophrenia patients < Control, Medial 
// prefrontal cortices
// Das P, 2007: Nonconscious, Schizophrenia patients > Control, Thalamus
// Das P, 2007: Nonconscious, Schizophrenia patients > Control, Visual 
// association cortices
// Das P, 2007: Nonconscious, Schizophrenia patients > Control, Brainstem 
// (midbrain)
// Subjects=14
32	0	-16
8	54	-12
-6	50	6
-4	28	36
2	-12	4
-2	-10	12
-32	-50	-22
36	-48	-20
-32	-82	-18
30	-72	-14
36	-88	-2
-22	2	-18
22	4	-16
-14	44	12
18	-12	4
-40	-32	-20
48	-82	-2
-46	-82	-4
2	-16	-10

// Gaffrey M S, 2007: Autism Spectrum Disorders (ASD) Patients
// Subjects=10
-47.12	21.69	-9.81
-52.28	24.68	15.65
-48.07	21.82	5.81
-48.2	43.51	-2.7
-41.58	28.17	18.58
-3.87	16.16	52.61
0.53	-4.44	60.98
-9.23	-98.21	5.39
-14.68	-88.44	-5.4
-19.8	-96.01	20.94
9.01	-90.81	16.83
-21.39	-11.37	-12.91
11.94	-76.01	-12.33
-17.73	7.71	54.6
-58.92	0.33	-23.49
55.52	10.75	-8.95
-16.85	-84.39	-7.95
-24.15	-81.41	17.53
0.61	-78.32	41.53
22.66	-75.61	-8.02
30.29	-88.28	6.33
53.89	-15.81	46.82
3.51	-51.8	12.5
9.2	-78.9	47.05

// Gaffrey M S, 2007: Healthy Controls
// Subjects=10
-47.01	28.34	7.48
-4.98	31.13	53.6
-20.46	4.79	-24.31
-10.44	43.1	43.74
-2.91	25	42.94
-7.36	50.64	30.8
-45.65	1.68	34.23
36.22	36.36	-6.42
2.41	33.58	43.27
62.24	-5.76	24.7
13.34	-92.39	23.6
-11.65	0.98	8.25
-8.49	11.48	6.22
32.24	-5.65	14.99
-17.73	7.71	54.6
-58.92	0.33	-23.49
55.52	10.75	-8.95
-16.85	-84.39	-7.95
-24.15	-81.41	17.53
0.61	-78.32	41.53
22.66	-75.61	-8.02
30.29	-88.28	6.33
53.89	-15.81	46.82
3.51	-51.8	12.5
9.2	-78.9	47.05
-25.53	47.19	29.07
0.08	28.25	15.87
31.13	35.64	26.04
27.9	51.91	30.29
10.61	51.95	4.84
7.34	55.65	-2.13
-61.89	-31.36	-6.3
-27.58	-67.28	-5.92
53.68	-64.16	-.42
-31.59	-83.22	22.23
-40.36	-76.79	-3.86
-39.18	-69.06	13.33
-50.97	-70.62	8.02
36.77	-77.7	18.75
-4.81	-46.2	44.47
-52.99	-43.03	34.72
46.44	-44.12	39.25
59.22	-32.41	38.12

// Gur R E, 2007: Patients
// Subjects=16
26	-102	-2
16	-18	2
-6	-20	-14
24	-12	-28
-26	20	12
36	18	0
-36	4	26
50	56	10
28	-98	-4
50	-44	-18
10	-4	20
-10	-8	-26
18	-8	-24
34	-28	-18
-50	16	-18
48	20	-12
0	-27	-5
-51	13	-12
36	19	-18
4	-26	25
12	6	0
-6	2	-2
46	16	10
10	-1	-10
36	58	1
-10	11	-11
28	-6	-11
-24	-8	-13
6	-89	10
48	-67	12
-6	-85	41

// Gur R E, 2007: Healthy Controls
// Subjects=17
38	-82	-18
-46	-84	-20
42	-56	-28
12	-8	14
-12	-10	-26
20	-8	-26
30	-36	-6
-28	20	14
48	28	-2
-40	8	30
48	60	4
28	-98	-4
50	-44	-18
10	-4	20
-10	-8	-26
18	-8	-24
34	-28	-18
-50	16	-18
48	20	-12
0	-27	-5
-51	13	-12
36	19	-18
4	-26	25
12	6	0
-6	2	-2
46	16	10
10	-1	-10
36	58	1
-10	11	-11
28	-6	-11
-24	-8	-13
6	-89	10
48	-67	12
-6	-85	41

// Just M A, 2007: High-Functioning Autism Patients
// Subjects=18
-24	-96	10
30	-74	24
56	-24	52
42	-38	40
-38	-40	38
-58	-30	46
6	28	40
56	22	38
48	44	26
28	6	60
34	22	2
-48	10	32
-24	0	52
-58	14	10
-34	24	2
24	-24	-8
10	-14	10
-20	-28	-2
-12	-20	10

// Just M A, 2007: Healthy Controls
// Subjects=18
-28	-74	30
2	-64	44
4	-86	32
0	14	52
26	2	52
32	26	-2
-42	42	32
-24	-2	54
-32	64	8
-32	28	0
6	-42	0
20	-28	10
-20	-30	8

// Kana R K, 2007: Healthy Controls > Autism Patients, Simple Response 
// Inhibition-Fixation
// Kana R K, 2007: Healthy Controls > Autism Patients, 1-Back 
// Inhibition-Fixation
// Kana R K, 2007: Autism Patients > Healthy Controls, 1-Back 
// Inhibition-Fixation
// Subjects=12
-42	-46	-16
26	-34	-8
16	-48	8
24	0	60
14	-30	42
40	-30	46
-32	-44	56
40	14	10
38	14	-4
-12	-46	0
-4	38	4
-40	-80	34
-16	-54	12
16	-50	10
48	-72	32
-8	-64	32
-28	-4	66
56	8	38

// Manjaly Z M, 2007: Autistic patients
// Subjects=12
-45	-78	3
24	-93	-3
33	-84	12
30	-99	3
30	-66	42
-24	-78	33
39	-78	-12
39	-93	3
-12	-75	3
-24	-30	0
-27	-60	57
33	24	0
9	-72	6
6	-69	-33
39	-81	9
-27	-90	3

// Manjaly Z M, 2007: Control group
// Subjects=12
-45	-78	3
24	-93	-3
33	-84	12
30	-99	3
30	-66	42
-24	-78	33
39	-78	-12
39	-93	3
-12	-75	3
-24	-30	0
-27	-60	57
33	24	0
-12	-72	57
-24	-3	63

// Williams L M, 2007: Paranoid Schizophrenics
// Subjects=13
12.09	27.64	48.12
-25.71	-10.77	-18.48
20.55	19.09	33.13
8.9	27.87	51.48
-36.05	23.58	41.21
43.77	23.97	-2.12
-22.47	-30.12	-21.36
5.25	38.55	-2.9
-30.01	-4.45	-18.96
-6.26	37.7	28.53
12.65	34.48	-14.91
-41.62	5.74	3.74
43.88	2.02	3.06
-41.55	25.17	21.06
-38.17	11.59	37.78
-25.51	-32.83	-1.02
-32.81	23.94	45.6

// Williams L M, 2007: Nonparanoid Schizophrenics
// Subjects=14
5.76	20.79	56.57
-25.71	-10.77	-18.48
13.17	31.07	51.17
31.91	10.73	-20.95
-34.35	22.31	-16.7
-22.48	-25.89	-21.71
27.86	-39.71	-12.21
5.25	38.55	-2.9
-30.01	-4.45	-18.96
-6.26	37.7	28.53
12.65	34.48	-14.91
-41.62	5.74	3.74
43.88	2.02	3.06
-41.55	25.17	21.06
-38.17	11.59	37.78
-25.51	-32.83	-1.02
-32.81	23.94	45.6

// Williams L M, 2007: Healthy controls
// Subjects=13
12.09	27.64	48.12
-25.71	-10.77	-18.48
20.55	19.09	33.13
8.9	27.87	51.48
-36.05	23.58	41.21
43.77	23.97	-2.12
-22.47	-30.12	-21.36
5.76	20.79	56.57
-25.71	-10.77	-18.48
13.17	31.07	51.17
31.91	10.73	-20.95
-34.35	22.31	-16.7
-22.48	-25.89	-21.71
27.86	-39.71	-12.21

// Karunanayaka P R, 2007: Orthopedic Injury Patients > Traumatic Brain Injury 
// Patients
// Karunanayaka P R, 2007: Traumatic Brain Injury Patients > Orthopedic Injury 
// Patients
// Karunanayaka P R, 2007: Negative Correlation between BOLD Activation and 
// NEPSY Verbal-Fluency Scores in All Patients
// Karunanayaka P R, 2007: Correlation between BOLD Activation and DAS Verbal 
// IQ Scores in All Patients
// Subjects=8
-39.27	-23.88	19.58
63.36	-44.76	15.69
-39.06	-43.66	39.07
50.54	-27.23	23.29
24.83	-85.11	-7.25
-56.44	-42.27	3.47
-35.53	58.51	-16.37
-31.1	29.44	-7.29
50.25	13.69	2.01
-48.05	17.68	7.27
45.99	44.65	17.31
-56.54	-25.7	-2.38
46.22	-23.37	18.55
-13.72	36.86	32.03
11.93	37.01	31.72
50.16	8.44	-10.93
54.49	30.98	4.98
-43.64	-7.33	13.78
54.63	-15.89	4.44
-47.77	-27.82	24.46
12.15	-57.41	21.8

// Maruishi M, 2007: Diffuse Axonal Injury Patients
// Subjects=12
-55	18	19
-48	18	18
51	18	19
50	28	19

// Maruishi M, 2007: Healthy Controls
// Subjects=12
-46	1	48
-50	7	22
-46	26	19
-42	-38	39
-46	-35	46
-32	-49	60
48	-41	40

// Newsome M R, 2007: Traumatic Brain Injury Patients
// Subjects=10
24.22	-67	19.56
-8.31	-59.22	12.62
-4.14	-49.4	2.61
25.94	-79.03	-17.38
36.69	-66.23	-18.83
8.79	-47.44	-0.04
0.65	-74.34	34.13
11.02	-79.75	-1.36
-1.84	-48.36	13.68
2.35	-64.69	-.47
13.08	-76.12	-8.48
-3.8	-49.04	29.47
4.62	-41.95	12.93
4.84	-46.88	29.11
-10.16	-72.25	34.11
0.46	-69.21	20.18
2.52	-37.08	19.21
0.45	-60.49	21.56
-6.36	-34.52	1.18
19.48	-85.43	-16.63
0.18	-84.46	-5.2
2.3	-75.95	-6.08
-38.74	18.08	14.46
-31.66	-40.89	49.3
-27.97	17.91	12.05
-38.81	35.09	12.77
-53.64	4.38	29.51
-19.29	53.22	21.85
-32.43	16.85	1.02
-28.1	45.35	7.09
-47.25	5.91	22.53
-12.58	30.88	35.15
-47.25	5.91	22.53
-34.14	11.45	35.2
-53.76	12.26	22.01
-12.61	45.98	35.9
-38.97	31.72	-.34
-31.74	-19.62	47.2
-14.58	-2.95	40.78
-16.78	1.09	38.17
-14.66	11.73	37.08
-23.88	57.71	1.32
-16.63	-17.44	46.73
-20.97	-11.07	46.17
-20.85	-34.26	50.71
-21.6	56.43	10.37
-34.4	51.04	22.33
-60.09	-4.15	30.47
-32.09	-2.55	23.11
-19.25	29.4	19.73
-33.82	-27.72	52.52
-34.25	4.03	24.73
-17.18	65.99	20.55
-12.16	-31.69	54.79
-41.04	54.23	10.92
43.73	21.07	41.89
-19.14	45.54	31.57
-16.76	31.9	46.33
37.48	-3.44	55.63
38.94	37.29	8.99
49.8	24.56	10.06
-31.86	3.57	42.67
-25.27	13.14	52.81
43.34	31.34	13.99
28.77	0.36	50.92
11.38	25.83	48.69
13.66	9.24	54.78
13.53	21.37	46.86
-31.77	10.79	50.92
34.91	15.33	26.92
30.99	-1.34	55.53
52.39	16.84	42.16
-3.89	42.17	40.61
26.82	4.15	68.5
43.4	16.45	15.46
33.01	12.93	47.36
37.05	10.87	25.08
-20.95	26.34	55.92
20.35	-.13	69.04
47.94	4.95	29.97
-29.92	45.71	33.98
30.95	24.6	57.45
20.23	9.88	61.33
22.28	24.36	55.38
33.11	15.89	56.03
-14.68	22.57	38.25
-3.75	21.31	47.16
36.75	52.38	9.78
-29.44	9.91	64.41
43.89	9.13	52.03
50.35	6.82	49.91
32.94	32.08	45.47
-29.41	1.41	65.25
50	15.17	24.44
47.83	32.6	27.23
54.58	8.34	42.96
37.3	6.15	43.47
56.76	4.09	43.35
-19.1	34.9	32.63
-10.47	37.06	32.27
-8.3	43.66	33.82
39.46	-.43	41.85
41	49.64	3.25
34.53	30.06	0.82
56.32	20.54	12.59
41.17	20.28	10.64
56.39	18.83	17.24
25.8	62.14	0.03
43.41	-7.58	11.11
20.1	22.02	53.4
30.24	38.97	4.49
45.54	7.53	11.82
13.58	30.51	52.68
23.92	62.09	22.48
17.61	48	32.95
41.43	-17.18	23.3
63.07	-10.31	26.74
32.32	58.12	2.56
41.23	33.87	18.25
28.18	63.81	17.75
49.97	1.79	19.04
19.71	56.31	29.85
34.92	35.09	31.69
60.78	6.29	20.65
56.48	2.02	21.15
32.5	57.24	16.09
21.96	26.33	30.53
13.28	28.22	28.25
24.05	28.05	25.85
11.25	31.38	39.18
22	28.88	34.76
60.97	-20.74	30.05
11.81	-62.89	64.19
-49.06	-35.19	42.31
7.49	-56.31	65.85
-36.12	-48.53	36.69
29.02	-65.58	57.44
22.57	-67.52	59.98
37.35	-37.22	38.8
18.28	-67.33	62.28
17.93	-65.56	35.21
-5.55	-59.11	59.63
7.41	-56.94	59.19
-31.62	-51.52	50.36
-38.24	-39.41	42.55
-44.58	-60.29	49.2
-45.05	-48.51	14.43
-49.59	-52.32	-3.05
30.96	-82.54	36.67
30.95	-58.51	41.02
20.25	-62.18	48.29
-18.48	-61.07	62.28
37.68	-61.08	59.09
-3.72	-61.59	32.95
31.01	-79.99	40.9
-31.74	-72.12	36.71
39.56	-47.85	39.82
-14.4	-65.06	42.44
-40.42	-61.52	35.81
-42.38	-33.71	57.74
24.59	-75.14	47.25
50.28	-35.26	36.15
24.59	-75.14	47.25
50.28	-35.26	36.15
24.59	-75.14	47.25
35.4	-59.8	50.03
-44.95	-54.27	21.72
11.6	-81.98	43.67
15.95	-81.76	45.81
15.9	-84.3	41.58
-48.92	-34.15	53.41
39.73	-70.62	48.79
-33.61	-52.41	63.92
30.79	-75.07	24.73
48.39	-59.54	52.03

// Newsome M R, 2007: Orthopedic Injury Patients
// Subjects=6
-18.76	13.38	54.92
-18.69	16.13	61.37
-10.05	16.16	61.22
24.44	17.78	53.75
9.24	34.75	52.33
20.13	22.23	55.62
-38.61	34.42	28.52
2.84	22.17	55.92
-38.98	42.56	0.83
-38.4	3.14	38.34
-25.79	20.25	14.02
-27.36	9.3	57.71
-23.87	31.57	-2.82
-21.48	55.13	19.46
-36.66	52.53	15.49
-36.58	18.08	14.42
-23.82	25.39	0.03
-30.32	16.45	-3.46
-36.7	49.99	11.26
-23.59	55.54	23.94
-38.55	6.35	26.82
-25.64	49.77	31.27
-34.27	8.29	24.31
-10.84	21.18	0.23
-36.65	35.1	12.74
24.34	12.7	45.29
-39.01	35.77	-2.98
-15.15	25.63	2.1
-30.27	18.99	0.77
-45.15	20.8	21.02
-34.36	53.58	26.56
-23.73	47.91	11.25
9.09	29.25	39.43
15.76	32.85	54.65
-30.23	30.25	6.38
-31.76	15.25	52.72
-36.12	17.15	50.36
-51.51	10.77	28.84
24.22	-67	19.56
-8.31	-59.22	12.62
-4.14	-49.4	2.61
25.94	-79.03	-17.38
36.69	-66.23	-18.83
8.79	-47.44	-0.04
0.65	-74.34	34.13
11.02	-79.75	-1.36
-1.84	-48.36	13.68
2.35	-64.69	-.47
13.08	-76.12	-8.48
-3.8	-49.04	29.47
4.62	-41.95	12.93
4.84	-46.88	29.11
-10.16	-72.25	34.11
0.46	-69.21	20.18
2.52	-37.08	19.21
0.45	-60.49	21.56
-6.36	-34.52	1.18
19.48	-85.43	-16.63
0.18	-84.46	-5.2
2.3	-75.95	-6.08
-38.74	18.08	14.46
-31.66	-40.89	49.3
-27.97	17.91	12.05
-38.81	35.09	12.77
-53.64	4.38	29.51
-19.29	53.22	21.85
-32.43	16.85	1.02
-28.1	45.35	7.09
-47.25	5.91	22.53
-12.58	30.88	35.15
-47.25	5.91	22.53
-34.14	11.45	35.2
-53.76	12.26	22.01
-12.61	45.98	35.9
-38.97	31.72	-.34
-31.74	-19.62	47.2
-14.58	-2.95	40.78
-16.78	1.09	38.17
-14.66	11.73	37.08
-23.88	57.71	1.32
-16.63	-17.44	46.73
-20.97	-11.07	46.17
-20.85	-34.26	50.71
-21.6	56.43	10.37
-34.4	51.04	22.33
-60.09	-4.15	30.47
-32.09	-2.55	23.11
-19.25	29.4	19.73
-33.82	-27.72	52.52
-34.25	4.03	24.73
-17.18	65.99	20.55
-12.16	-31.69	54.79
-41.04	54.23	10.92
-49.52	40.14	21.42
-8.15	33.85	43.75
-25.29	26.12	53.77
-18.89	23.39	47.21
-36.46	29.97	26.69
-1.67	27.29	42.05
-29.86	22.1	34.08
-32.36	37.04	10.23
-27.34	18.22	61.31
2.86	24.5	57.93
-21.06	18.92	45.45
-30.28	49.6	6.71
-12.18	16.36	63.48
-27.55	14.43	43.76
-29.66	14.84	48.24
-28.21	29.22	-4.76
-36.05	13.31	55.22
-25.89	23.88	6.94
-34.52	50.21	13.45
-26	53.66	3.99
-36.63	52.74	17.71
-31.93	29.31	42.36
-31.76	15.25	52.72
-25.5	26.79	38.02
-42.72	9.71	40
-12.63	21.75	29.34
-25.95	32.18	3.88
-25.96	21.13	0.49
-16.67	15.09	50.23
-49.12	19.03	48.16
-23.61	16	14.4
-6.04	31.32	39.48
-30.08	35.75	19.28
-47.22	12.7	26.34
-49.37	17.16	28.17
-25.34	-7.04	43.61
-6.12	8.8	28.26
-53.65	19.68	32.48
-10.23	5.99	44.3
-27.83	49.56	29.08
-29.9	10.84	28.47
-27.7	15.52	32.45
-25.01	4.17	71.63
-10.44	15.38	29.93
-12.42	12.36	43.71
-36.37	8.69	28.79
-32.3	44.04	16.26
-51.82	41.22	10.15
-41.13	16.41	-3.27
-33.78	-1.15	61.1
-30.42	50.69	-4.6
-12.5	24.91	40.23
32.45	24.09	5.92
39.01	33.45	13.85
32.67	34.46	25.06
47.75	38.56	22.16
41.22	36	18.04
32.62	31.92	20.83
45.76	2.6	27.99
41.22	36	18.04
54.12	15.86	8.61
54.3	28.16	25.32
28.07	41.09	4.32
43.63	31.29	36.4
43.59	11.31	29.41
45.65	8.36	20.7
56.49	21.78	25.91
54.28	34.54	24.69
58.69	17.75	28.52
49.97	-6.93	17.66
19.4	32.13	0.87
17.23	27.66	-.89
41	49.64	3.25
34.53	30.06	0.82
56.32	20.54	12.59
41.17	20.28	10.64
56.39	18.83	17.24
25.8	62.14	0.03
43.41	-7.58	11.11
20.1	22.02	53.4
30.24	38.97	4.49
45.54	7.53	11.82
13.58	30.51	52.68
23.92	62.09	22.48
17.61	48	32.95
41.43	-17.18	23.3
63.07	-10.31	26.74
32.32	58.12	2.56
41.23	33.87	18.25
28.18	63.81	17.75
49.97	1.79	19.04
19.71	56.31	29.85
34.92	35.09	31.69
60.78	6.29	20.65
56.48	2.02	21.15
32.5	57.24	16.09
21.96	26.33	30.53
13.28	28.22	28.25
24.05	28.05	25.85
11.25	31.38	39.18
22	28.88	34.76
60.97	-20.74	30.05
-12.34	-59.29	35.11
-35.89	-57.71	53.28
-40.22	-49.01	54.74
-38.07	-53.47	52.9
-31.52	-63.87	56.06
-27.22	-64.06	53.76
5.22	-72.46	54.04
-1.49	-41.4	42.12
-42.4	-42.64	54.14
-40.46	-59.6	33.38
-10.09	-67.38	40.35
-35.95	-71.31	45.66
-25.01	-70.23	56.58
-42.4	-42.64	54.14
-40.46	-59.6	33.38
-10.09	-67.38	40.35
-35.95	-71.31	45.66
-25.01	-70.23	56.58
-42.83	-65.52	16.07
-3.52	-77.57	45.73
-12.23	-73.76	41.02
-9.94	-48.7	56.43
-51.21	-43.91	40.97
7.5	-65.03	64.47
-51.26	-46.46	36.74
-1.15	-62.93	64.41
-12.31	-39.32	42.1
39.79	-57.03	56.41
30.91	-54.47	38.38
-46.64	-42.03	60.88
-33.55	-45.41	69.95
-40.27	-27.53	54.85
-44.94	-71.7	18.96
15.88	-56.03	45.51
-1.2	-50.17	63.15
-40.66	-52.33	19.21
-34.06	-68.91	25.22
20.42	-69.65	60.23
22.57	-65.39	59.77
-33.98	-72.75	30.09
-42.83	-56.8	17.45
52.72	-46.35	55.13
-16.54	-47.42	47.45
-57.57	-47.36	50.39
-14.15	-63.19	62.42
26.88	-63.25	59.48
48.24	-43.15	43.68
28.77	-67.45	37.46
48.43	-48.28	57.64
-14.3	-53.38	52.49
50.59	-48.28	57.6
-37.99	-28.82	63.91
30.96	-75.95	38.26
-38.59	-66.13	9.34
52.57	-38.67	45.41
36.81	22.18	8.28
20.02	6.09	43.78
-10.55	-22.66	13.52
-6.16	-19.89	19.9
45.45	46.23	12.48
30.24	30.25	3.11
31.08	-2.84	62.4
38.88	39	4.34
15.1	-11.46	-5.95
-12.97	-7.1	-3.66
41.03	49.85	5.47
-8.6	-4.54	0.49
47.81	30.26	25.22
26.29	-21.7	21.77
17.88	-.3	44.44
41.79	0.83	55.13
2.2	-11.09	-1.28
50.07	13.46	29.09
-4.17	-12.41	7.92
-6.31	-16.67	8.38
43.58	6.85	27.61
22.29	6.93	52.62
22.35	5.22	57.27
13.06	-4.05	4.56
-10.7	9.04	8.15
45.75	-1.86	26.19
32.53	55.32	18.52
12.99	-.21	-.3
13.21	-20.44	12.9
6.83	-17.51	21.68
19.84	0.38	28.66
26.52	-.27	44.29
15.13	4.05	-.76
-19.28	-1.41	11.57
26.52	-.27	44.29
24.43	-4.11	49.19
34.95	26.59	32.53
30.86	-11.09	43.05
37.09	15.54	29.1
60.8	10.75	22.45
43.63	24.7	34.81
62.89	5.88	16.17
36.97	16.84	20.01
8.66	-13.41	-3.41
10.97	-14.49	7.87
51.86	41.38	6.12
56.7	10.27	40.5
43.84	-2.12	46.42
26.65	-10.28	52.01
21.93	2.1	23.97
21.96	-10.87	23.01
19.81	-6.41	24.85

// Takarae Y, 2007: Brain activation during visually guided saccades, 
// control>autism
// Takarae Y, 2007: Brain activation during visually guided saccades, 
// autism>control
// Takarae Y, 2007: Brain activation during visual pursuit, control>autism
// Takarae Y, 2007: Brain activation during visual pursuit, autism>control
// Subjects=13
26.17	-9.83	57.79
6.86	2.48	53.64
45.02	31.32	24.01
28.39	-74.89	42.03
4.77	-56.34	36.29
60.03	-65.78	-8.16
30.09	-90.42	-21.36
-38	-12.93	50.98
0.45	-6.36	49.99
-20.8	-49.12	49.36
-9	-66.14	48.42
-47.86	-70.49	-4.3
-14.85	-89.09	-27.65
51.57	16.36	36.35
4.77	18.3	65.72
36.28	63.36	12.51
12.94	45.22	27.68
8.96	-46.26	28.7
58.01	-62.48	7.2
2.25	-16.46	1.75
5.36	13.34	1.44
-42.53	15.11	28.61
-21.48	73.42	10.1
-.89	34.73	30.95
0.33	-25.16	27.03
0.09	-12.24	1.42
-4.26	13.28	1.56
-12.78	-64.5	-26.39
45.34	-12.6	47.77
3.69	24.81	67.41
38.76	28.42	42.17
49.69	-56.79	40.27
2.68	-69.05	37.38
4.56	18.36	38.95
21.49	-77.79	-22.33
-35.85	-6.23	54.86
-5.93	22.47	65.49
-36.09	39.61	42.09
-45.33	-52.1	54.35
0.65	-72.43	48.84
-0.03	48	9.75
0.3	14.11	39.35
0.47	-34.71	41.22
-53.25	-71.03	-10.88
-40.58	-68.1	-29.12
30.5	-53.22	46.88
47.39	-81.58	8.92
-48.92	-63.81	-.39
-8.4	10.23	17.48

// Ansari D, 2007: Small Nonsymbolic > Large Nonsymbolic
// Ansari D, 2007: Large Nonsymbolic > Small Nonsymbolic
// Ansari D, 2007: Conjunction of small nonsymbolic and large nonsymbolic
// Ansari D, 2007: Conjunction of Small and Large symbolic number
// Subjects=13
45.3	-55.81	25.74
11.07	-80.57	11.48
17.45	-58.87	16.28
-41.14	-34.27	50.58
33.69	-42.28	50.39
-16.45	-59.33	54.63
-24.01	-49.23	48.29
28.38	-48.66	50.99
6.78	17.03	49.07
-32.73	3.85	47.28
30.32	7.57	48.48
-41.43	9.91	30.15
48.29	14.42	25.39
30.93	25.92	-3.25

// Piazza M, 2007: Overall fMRI Adaptaion Effect (Activation decrease with 
// repetition of same approximate quantity)
// Piazza M, 2007: Distance-Dependent Recovery from Adaptation across 
// condtions (Far>Close)
// Piazza M, 2007: Notation Change > Number Change
// Piazza M, 2007: Mental Arithmetic > Sentence Comprehension
// Subjects=14
-34	-54	44
-20	-68	42
-32	-64	40
34	-64	54
34	-58	50
46	-46	40
-28	-64	-32
36	-72	-26
-34	-80	-2
24	-80	4
36	-46	-20
-36	-60	-14
-54	24	-30
38	26	20
-14	-2	2
14	-2	0
-34	-62	60
-26	-50	40
-24	-58	58
48	-44	38
54	-40	52
42	-44	52
-36	22	-4
-34	20	6
36	22	6
44	24	-4
-8	12	46
4	12	30
44	28	28
40	4	42
32	-2	60
-30	48	18
44	-52	-38
28	-60	-28
-38	-66	-38
-26	-68	-28
-4	-90	12
28	-42	-8
32	-56	-10
-32	-48	-8
-26	-36	-16
-14	-60	10
-16	-52	2
-45	-48	-48
-30	-39	-39
-21	-60	54
45	-45	45
33	-54	45
30	-72	42

// Baumgaertner A, 2007: sentences (intelligible > reversed)
// Baumgaertner A, 2007: videos (visible > scrambled)
// Baumgaertner A, 2007: sentences (action >  non-action)
// Baumgaertner A, 2007: videos (action > non-action)
// Baumgaertner A, 2007: conjunction (action sentences > non-action sentences 
// AND action videos > non-action videos)
// Subjects=19
-42	-45	-18
-3	9	54
-54	36	9
-45	6	33
48	-69	-3
-48	-72	0
48	15	21
-21	3	57
-48	9	24
-36	33	-15
39	36	-12
-6	-48	6
33	0	54
6	21	51
-51	36	6
-57	12	24
-39	-60	45
6	3	63
36	39	39
42	-33	33
30	-69	-27
-33	57	-6
-42	42	27
-42	-66	-15
-57	-24	36
-51	6	27
-51	9	24
-54	-21	30
-42	-48	54

// Herrington J D, 2007: Walker vs Fixation, Controls > ASD
// Herrington J D, 2007: Randomized walker vs fixation, Controls > ASD
// Subjects=10
40.83	-44.93	-23.07
55.71	-80.79	-20.24
-31.77	-81.61	-14.7
48.86	-67.8	-16.79
41.75	-71.94	-11.9
-31.74	-81.27	-10.27
53.86	-53.89	-13.55
43.65	-68.45	0.06
44.2	-33.31	-10.7
48.33	-49.78	-9.37
-52.21	-45.91	-4.08
-54.02	-41.33	-1.1
-54	-41.16	1.12
-56.66	-37.22	4.17
-39.53	-74.84	-6.26
45.77	-71.23	-3.08
32.32	-84.48	7.11
-40.51	-69.48	6.69
42.96	-82.57	15.75
30.43	-96.47	21.52
28.33	-95.19	25.89
-40.48	-69.14	11.12
51.12	-83.07	-6.61
37.6	-76.35	3.02
-56.63	-36.88	8.6
-58.41	-37.07	13.09
-57.36	-50.68	18.68
-55.19	-51.17	23.16
-40.77	-59.39	32.61
28.73	-87.02	11.82
21.76	-102.15	17.63
-5.44	-113.84	18.92
24.69	-85.67	29.6
-46.05	-57.76	28.07
-37.21	-58.92	36.99
-49.14	-63.39	40.84
-20.42	-55.39	39.84
-21.45	-54.02	45.32
-21.42	-50.95	50.63
-17.37	-38.12	55.09
-13.48	-38.52	60.65
-10.55	-37.33	66.1
54.46	-63.16	31.83
54.49	-62.81	36.26
58.04	-62.54	39.54

// Montgomery K J, 2007: activation evoked during all conditions, 
// communicative hand gestures vs rest
// Montgomery K J, 2007: activation evoked during all conditions, 
// object-directed hand gestures vs rest
// Subjects=14
-34.7	-15.23	62.29
-38.97	-29.52	56.85
58.06	5.11	41.68
-50.96	8.6	41.52
58.86	14.43	10.77
-55.39	-8.37	15.11
63.51	-28.96	41.12
-55.05	-46.67	42.86
50.49	-49.75	7.33
-54.21	-52.32	10.98
52.64	-62.77	3.94
-54.21	-67.64	5.57
41.71	4.93	-.5
-37.42	-3.72	-8.9
5.73	-93.8	5.96
-.71	-93.04	2.63
42.75	-55.71	-27.77
-24.57	-55.05	-27.05
-34.71	-15.4	60.07
-38.97	-29.52	56.85
59.12	5.03	40.55
-50.96	7.54	41.61
57.79	14.42	10.79
-55.39	-10.66	13.08
59.23	-28.98	41.18
-54	-43.49	42.58
50.49	-47.55	8.26
-56.35	-52.33	11.01
51.59	-62.6	6.17
-53.14	-67.63	5.56
41.7	3.78	-1.52
-35.24	-5.48	-4.32
6.85	-88.79	15.57
-3.79	-97.15	18.62
40.62	-55.64	-26.63
-24.55	-55.94	-24.74

// Jonas M, 2007: observation across all stimulus types
// Jonas M, 2007: observation of a color change
// Jonas M, 2007: observation of a moving dot
// Jonas M, 2007: observation of a moving finger
// Jonas M, 2007: observation of a moving finger and dot
// Jonas M, 2007: observation - execution across all stimulus types
// Jonas M, 2007: observation - execution of a color change
// Jonas M, 2007: observation - execution of a moving finger
// Jonas M, 2007: observation - execution of a moving dot
// Jonas M, 2007: observation - execution of a moving finger and dot
// Jonas M, 2007: response to imitation
// Jonas M, 2007: response to control cues
// Jonas M, 2007: finger movement vs color change
// Subjects=17
-51	15	9
48	15	6
-54	-36	48
60	-24	45
33	-36	39
45	-45	54
-39	-51	45
42	-45	54
-57	18	0
51	12	3
-54	-33	48
60	-27	42
-39	-39	36
45	-48	36
48	-42	54
-42	-39	39
-51	-33	48
-39	-48	48
-60	15	3
48	18	6
-57	-33	36
57	-33	39
-39	-42	42
-39	-51	51
39	-48	39
-39	0	12
57	15	3
-57	-21	21
60	-33	39
54	-39	42
-39	0	12
48	15	3
-57	-21	21
66	-33	27
-54	-36	48
54	-39	42
-39	0	9
60	15	3
-57	-24	21
69	-30	27
54	-36	51
-48	6	3
63	15	12
-57	-21	21
66	-18	30
-45	-30	54
51	-33	51
-39	3	9
60	15	3
-57	-24	21
66	-30	24
54	-36	51
54	-72	0
-36	18	9
36	27	0
-27	-57	48
30	-60	42
-54	-36	48
12	21	36
45	6	33
-66	-33	-27

// Kemp A H, 2007: PTSD-depression
// Subjects=8
-10	18	30
10	40	40
28	-2	-28
0	40	44
-2	38	12
14	58	4
-8	26	42
-4	40	8
26	4	-20
-20	2	-20
-10	52	40
30	4	-28
12	60	8
-20	2	-20
10	16	28
14	34	6
2	26	56
-10	52	-14

// Kemp A H, 2007: PTSD-alone
// Subjects=8
0	36	42
-2	52	-4
32	-2	-28
0	40	44
-2	38	12
14	58	4
-8	26	42
-4	40	8
26	4	-20
-20	2	-20
-10	52	40
30	4	-28
12	60	8
32	-4	-20
-10	52	50
10	16	28
14	58	4

// Kemp A H, 2007: Healthy Controls
// Subjects=32
8	26	56
-10	58	8
-26	4	-18
26	-6	-16
32	-4	-20
-10	52	50
10	16	28
-20	2	-20
10	16	28
14	34	6
14	58	4
2	26	56
-10	52	-14

// Scheibel R S, 2007: Traumatic Brain Injury (TBI) Patients
// Subjects=14
-51.38	16.06	39.52
-27.47	-.25	47.45
11.36	23.49	46.68
-8	17.46	52.09
-36.41	32.51	30.92
-6.15	23.9	29.01
-14.23	1.87	69.43
13.29	26.09	28.46
-33.8	-47.28	49.97
-16.43	-40	57.92
-9.92	-61.67	55.47
9.49	-57.55	52.49
44.04	-53.18	51.47
24.62	-66.22	50.85
18.18	-41.8	59.75
31.04	7.79	61.35
13.74	11.99	61.23
43.86	2.34	48.22
15.47	26.31	30.65
33.17	7.59	59.09
-12.39	19.16	47.52
-8.31	23.89	29.05
-51.43	13.52	35.29
-29.57	0.16	51.93
-49.04	-8.83	48.67
2.83	-6.32	49.78
15.72	6.28	46.07
0.57	21.33	47.08
-22.96	-25.14	56.56
-1.19	-39.12	66.54
-40.24	-27.32	57.07
0.55	3.69	42.1
4.61	34.57	27.77
0.8	-16.34	57.53
-3.46	-55.26	54.73
8.71	48.23	12.9
32.48	-26.08	-2.56
8.72	-15.12	1.24
-8.61	-54.92	-10.21
-6.52	-35.77	-12.14
-25.88	-30.75	-3.34
-21.74	-56.21	-23.31
-8.57	-13.05	1.33
-13.24	-70.4	-37.74
17.53	-27.02	11.24
6.58	9.1	7.85
10.89	28.68	10.32
30.31	35.13	9.35
23.78	17.26	2.27
34.79	-22.7	10.51

// Scheibel R S, 2007: Orthopedic Injury (OI) Patients
// Subjects=10
15.47	26.31	30.65
33.17	7.59	59.09
-12.39	19.16	47.52
-8.31	23.89	29.05
-51.43	13.52	35.29
-29.57	0.16	51.93
-49.04	-8.83	48.67
2.83	-6.32	49.78
15.72	6.28	46.07
-25.11	-29.4	57.02
-11.91	-53.84	70.42
-7.76	-24.46	62.96
35.47	-26.43	62.42
13.89	-19.71	66.6
24.75	-41.15	66.3
0.57	21.33	47.08
-22.96	-25.14	56.56
-1.19	-39.12	66.54
-40.24	-27.32	57.07
0.55	3.69	42.1
4.61	34.57	27.77
0.8	-16.34	57.53
-3.46	-55.26	54.73
8.71	48.23	12.9
32.48	-26.08	-2.56
8.72	-15.12	1.24
-8.61	-54.92	-10.21
-6.52	-35.77	-12.14
-25.88	-30.75	-3.34
-21.74	-56.21	-23.31
-8.57	-13.05	1.33
-13.24	-70.4	-37.74

// Thompson J C, 2007: face > radial
// Thompson J C, 2007: hand > radial
// Thompson J C, 2007: All conditions > fixation
// Thompson J C, 2007: Areas active to both Face > Radial and Hand > Radial
// Subjects=11
-16	2	16
-42	14	24
-44	2	8
2	32	48
8	14	56
-54	8	18
-20	-2	12
6	32	52
-46	-8	46
-49	8	2
2	29	52
-18	-2	14

// Wong P C M, 2007: Pre-training tone > pre-training sinewave, all subjects
// Wong P C M, 2007: Post-training tone > post-training sinewave, all subjects
// Wong P C M, 2007: Post-training tone > pre-training tone, all subjects
// Wong P C M, 2007: Successful vs less successful learners (Post-training 
// tone)
// Wong P C M, 2007: Less successful vs less successful learners 
// (post-training tone)
// Subjects=17
62.17	-24.05	8.39
-66.15	-15.81	2.48
46.08	-21.48	1.67
-46.92	-12.52	1.98
-40.46	21.04	22.51
-55.5	-45.84	-15.2
-63.03	22.79	5.9
-56.24	-32.47	33.87
71.64	-12.33	-6.09
68.48	-38.24	-10.57
42.65	-17.21	-25.42
52.5	-67.48	-15.74
50.53	0.15	33.26
39.66	27.86	21.02
14.4	-73.8	29.84
12.88	7.21	4.1
-24.41	-44.63	-2.28
-21.29	-2.6	4.2
-43.58	-1.19	24.41
-30.96	-36.17	-16.29
-56.47	-18.41	9.28
-33.61	-66.72	43.18
-39.95	-32.98	67.18
-50.04	-44.52	1.36
-53.38	13.33	6.58
-60.79	-52.93	-10.08
-62.82	-40.91	7.89
-40.38	-34.18	10.41
58.83	-28.78	-11.25
49.09	-23.52	-24.96
52.59	-.61	23.26
33.09	42.66	6.47
45.92	-6.65	-12.96
42.5	44.97	-19.48
42.54	11.34	-27.81
36.47	-44.52	-6.33
23.66	14.82	18.95
23.42	51.86	2.47
10.8	30.86	21.1
10.72	3.68	-0.04
10.79	53.84	29.21
-5.51	57.52	-4.37
4.83	-66.75	39.39
-21.31	43.36	20.42
-37.24	31.09	28.32
-32.77	0.16	40.9
-34.03	-44.68	-2.16
-40.43	8.18	21.36
-34.21	16.1	-.56
-40.48	-15.4	5.5
-50.38	-1.91	-25.63
-53.41	-33.14	-16.29
-56.16	-44.91	38.26
-53.09	-16.59	32.5
-54.32	-14.97	12.31

// Abutalebi J, 2007: Dialect vs. German
// Abutalebi J, 2007: Pseudowords vs. German
// Abutalebi J, 2007: 1st Run Dialect vs. 1st Run German
// Abutalebi J, 2007: 4th Dialect Run vs. 4th Run German
// Abutalebi J, 2007: 4th Run Pseudowords vs. 4th Run German
// Subjects=12
-38	8	28
-52	10	16
-40	30	12
-44	26	24
-32	30	0
-44	6	36
-24	-50	48
-28	-50	56
-16	-10	-12
-20	2	-16
-50	10	0
-54	-40	8
-42	-68	-4
-40	-62	-12
-18	8	0
-6	-10	12
-2	-18	12
48	34	20
34	-64	56
-4	20	52
-46	6	48
-46	8	36
-52	14	16
-42	18	20
-40	30	8
-30	30	4
-44	40	4
-24	-48	48
-46	-28	48
-44	-30	44
-50	8	4
-52	4	4
-62	-32	4
-34	-58	-12
-46	-52	-12
-40	-76	-4
-22	-74	28
54	22	32
50	26	32
46	34	24
50	26	8
42	32	4
30	-68	56
34	-54	52
40	-56	56
44	-62	-8
-48	2	44
-50	12	36
-46	22	28
-50	14	24
-52	12	20
-40	24	16
-44	28	8
-40	26	-4
-22	-54	44
-22	-64	56
-32	-54	44
-12	2	-12
-14	-4	-12
-24	6	-16
-62	-36	4
-34	-62	-8
-18	12	0
-18	8	12
-20	-6	12
-6	-12	16
-48	6	12
-48	10	20
-42	14	28
-50	8	-4
-4	18	48
-40	4	36
-42	14	28
-52	12	16
-32	32	4
-38	28	12
-44	30	4
-28	-42	48
-22	-54	44
-56	-22	40
-38	-62	-12
-14	-8	16
48	14	32
40	28	4
30	-60	56
-42	18	20
-44	32	4
-40	34	-4
-24	-50	52
-46	-30	44
-50	-50	-8
-20	-74	28
-22	-76	36
30	-70	56
40	-60	56
40	-60	-8

// Bahlmann J, 2007: All Conditions vs. Baseline
// Bahlmann J, 2007: Noncanonical vs. Canonical
// Bahlmann J, 2007: Noncanonical Unambiguous vs. Canonical Unambiguous
// Bahlmann J, 2007: Noncanonical Ambiguous vs. Canonical Ambiguous
// Subjects=12
-56	-32	-16
-48	-60	8
-44	12	20
-8	8	60
36	-80	-28
-40	-52	28
-44	24	28
-40	28	8
-40	-52	28

// Fias W, 2007: (Number comparison-number dimming) - (letter 
// comparison-letter dimming)
// Fias W, 2007: Conjunction of (number comparison-number dimming) and (letter 
// comparison-letter dimming)
// Fias W, 2007: Conjunction of (numcomp-numdim) and (lettercomp-letterdim) 
// and (squarecomp-squaredim)
// Subjects=17
6	-72	-6
-39	-87	-6
-24	-78	-9
-39	-39	36
45	-36	48
-27	-69	39
30	-69	42
-42	3	30
-24	-3	57
27	0	51
-18	-9	72
-6	3	53
12	3	45
-3	-75	10
10	-65	13
-7	-72	5
11	-68	11
-14	-48	-8
9	-56	-1
-24	-50	-16
29	-47	-17
-44	-68	-13
-27	-69	39
30	-69	42
-42	3	30
-3	-75	10
10	-65	13
-7	-72	5
11	-68	11
-14	-48	-8
9	-56	-1
-24	-50	-16
29	-47	-17
-44	-68	-13

// Kadosh R C, 2007: Notation Adaptation
// Kadosh R C, 2007: Quantity Adaptation
// Kadosh R C, 2007: Notation x Adaptation
// Subjects=12
-51.24	-53.64	-20.17
32.55	-59.52	34.01
-34.82	-54.98	29.94
21.96	-49.84	50.04

// Bitan T, 2007: All Spelling Conditions > Simple and Complex Control (Masked 
// by Spelling vs. Fixation)
// Bitan T, 2007: All Rhyming Conditions > Simple and Complex Control (Masked 
// by Rhyming vs. Fixation)
// Bitan T, 2007: Spelling vs. Fixation > Rhyming vs. Fixation
// Bitan T, 2007: Rhyming vs. Fixation > Spelling vs. Fixation
// Bitan T, 2007: Overlap of Language-Specific Activation between the Two 
// Tasks (Masked by Conditions vs. Fixation)
// Bitan T, 2007: Positive Correlation between Accuracy and Activations, 
// Rhyming Conditions vs. Fixation
// Bitan T, 2007: Spelling + Rhyming
// Bitan T, 2007: Spelling (Masked by Spelling > Rhyming)
// Bitan T, 2007: Spelling (Masked by Rhyming > Spelling)
// Bitan T, 2007: Rhyming (Masked by Spelling > Rhyming)
// Bitan T, 2007: Rhyming (Masked by Rhyming > Spelling)
// Bitan T, 2007: Rhyming, O+P- > O-P+
// Subjects=38
-48	36	6
-6	15	48
-54	-39	6
-6	-12	6
-6	-75	6
-57	-51	-12
-30	-57	39
-60	-42	12
-48	15	21
-6	9	60
-9	-87	12
-45	-33	-15
36	33	-6
27	-72	39
-21	-66	54
30	3	54
54	-48	-12
-39	-48	48
-24	3	60
-51	30	9
-45	30	-12
27	0	3
39	36	-9
-36	6	3
-54	-50	-12
-48	21	-15
-6	24	45
-42	6	30
-36	24	0
12	15	3
33	24	0
-6	36	24
-42	39	12
45	36	21
-12	3	12
-27	-60	42
33	-63	51
-30	-54	51
-48	33	9
-24	-63	45
30	-69	45
-39	-48	45
-45	30	12
36	33	-9
6	30	45
42	36	33
60	-12	3
51	6	9
-51	3	48
-51	-24	54
-33	21	6

// Grezes J, 2007: Body Expression vs Scrambled stimuli, Irrespective of 
// Static or Dynamic Stimuli
// Grezes J, 2007: Fearful Body Expressions vs Neutral Whole Body Actions, 
// Irrespective of Static or Dynamic
// Grezes J, 2007: Dynamic vs Static Body Expression, Irrespective of 
// Emotional Content
// Grezes J, 2007: Interaction, Fearful Body Expression and Dynamic 
// Information
// Subjects=16
4	54	28
-2	44	-14
36	32	-20
-46	34	-14
60	-46	16
-54	-50	16
13	-30	0
24	-24	-14
-22	-4	-32
54	14	-26
-32	12	-30
26	10	-28
28	0	-28
44	-52	-22
-40	-56	-18
52	-72	6
-44	-82	4
8	18	66
-12	-52	40
64	-46	24
-58	-54	14
52	-48	12
48	-66	8
50	30	-4
48	-20	-8
34	28	-16
34	4	-24
44	18	-32
-32	14	-32
10	0	70
22	-62	62
-22	-62	62
6	-56	66
34	-46	56
-34	-46	56
44	6	48
-44	6	48
30	-40	48
-30	-40	48
24	-84	28
-24	-84	28
60	-42	30
-60	-42	30
50	28	24
50	30	-12
-16	-24	10
60	-44	16
-60	-44	16
48	-66	8
-48	-66	8
30	-94	8
-30	-94	8
54	-16	-14
44	-50	-22
-44	-50	-22
24	10	-28
-10	-76	-42
54	4	40
60	-36	24
-52	-42	24
-52	-54	20
60	-44	18
50	-44	22

// Lotze M, 2007: Receiving aversive stimuli; parametric modulation
// Lotze M, 2007: Retaliation; parametric modulation
// Lotze M, 2007: Conjunction; retaliation and watching the opponent
// Subjects=14
12	-78	0
-42	-69	6
-15	-54	-15
60	-69	0
57	-29	12
-63	-12	12
66	6	3
-51	9	-3
12	3	39
-24	0	-12
36	0	-3
-33	0	-3
-54	6	-3
60	0	-3
12	-18	0
-6	-15	0
21	-45	-3
9	69	15
18	-84	18
-24	-90	6
12	48	33
54	27	6
-42	33	-9
48	-66	0
-48	-69	6
15	-96	9
-15	-99	15
27	-24	-18
-18	-6	-15

// Bar K J, 2007: Healthy Controls
// Subjects=13
-16.02	-8.95	11.14
58.33	23.76	1.03
48.48	41.39	-5.03
62.7	26.32	5.19
46.36	41.7	-1.66
-40.16	-1.96	-16.03
-55.85	-17.83	21.66
60.94	-16.59	28.51
71.7	-1.56	27.96
32.27	-15.19	68.08
29.77	28.23	50.38
44.36	41.77	10.7
-50.38	-54.5	19.59
-62.85	-23.93	-20.2
4.07	-27.06	57.41
10.05	-67.98	9.81
31.55	-73.09	-.13
3.93	-84.97	35.13
22.71	-18.78	-4.24
20.56	-36.22	-6.96
24.67	-74.96	-31.21
-35.96	-55.38	-36.59
11.91	-60.37	-12.26
-3.17	-62.24	-8.46
48.43	-78.27	-33.52

// Bar K J, 2007: Major depressive disorder
// Subjects=13
-16.02	-8.95	11.14
58.33	23.76	1.03
48.48	41.39	-5.03
62.7	26.32	5.19
46.36	41.7	-1.66
-40.16	-1.96	-16.03
-43.53	-30.94	53
-48.35	-9.51	18.47
-64.73	-1.03	6.7
-66.66	-15.75	21.64
-39.91	6.5	5.54
3.75	31.87	44.86
-11.35	18.85	44.17
-28.5	-5.36	50.22
29.81	19.82	52.33
33.22	35.94	-16.55
42.03	43.81	-1.79
55.33	-53.24	4.22
64.98	-30.77	2.95
50.67	-51.39	-21.65
-6.67	-39.76	59.97
10.57	-33.42	57.93
12.88	-42.16	67.72
-15.19	-50.87	67.94
45.13	-33.4	56.22
65.35	-20.31	34.41
27.09	-53.32	-6.5
27.07	-2.08	1.88
16.3	-16.05	2.33
-35.82	-54.34	-25.49
-44.25	-75.77	-13.14
48.43	-78.27	-33.52

// McCabe C, 2007: MSG > Odor tl
// McCabe C, 2007: NaCl > Odor tl
// McCabe C, 2007: MSGV > Odor tl
// McCabe C, 2007: NaClV > Odor tl
// McCabe C, 2007: Supralinear additivity, MSGV
// McCabe C, 2007: [MSGV - (MSG + V)] - [NaCIV - (NaCl + V)]
// McCabe C, 2007: MSG > Odor tl + NaCl > Odor tl + MSGV > Odot tl
// Subjects=12
34	24	-6
46	22	28
8	6	56
-38	20	20
-38	14	2
-40	22	24
10	6	54
-40	12	0
-2	8	54
-42	42	8
-6	52	-14
10	42	-22
-48	6	-18
-52	-10	42
-40	22	24

// Zhang Y, 2007: Effect of DRD2 rs1076560 genotype on brain activity during 
// working memory, GT > GG
// Zhang Y, 2007: Effect of DRD2 rs2283265 genotype on brain activity during 
// working memory, GT > GG
// Subjects=19
-19.63	24.37	-11.15
21.39	19.95	-14.77
-54.03	38.67	5.95
-31.56	43.68	-10.61
-53.39	8.48	50.39
-10.62	24.97	17.78
-7.55	-10.17	-2.33
-31.27	55.74	15.08
-10.46	-17.57	21.98
-22.53	-17.9	7.65
-54.05	42.93	5.53
12.25	-21.74	22.01
-9.35	-14.06	24.98
-35.31	-50.5	15.58
37.82	22.73	2.61

// Loucks T, 2007: Repetitive Vocalization > Continuous Vocalization
// Loucks T, 2007: Vocalization > Rest
// Loucks T, 2007: Exhalation > Rest
// Loucks T, 2007: Vocalization > Exhalation
// Subjects=12
-9.14	3.79	58.17
-61.71	-27.27	19
-45.58	-6.35	40.48
39.81	-4.66	27.09
61.43	-38.23	45.27
-3.84	-3.3	48.67
42.96	-75.57	-9.38
8.73	-74.98	-12.38
10.86	-1.46	16
-43.7	-2.47	7.79
-45.58	-8.55	39.55
61.42	-38.31	44.16
42.98	-73.11	-5.12
8.73	-73.92	-12.47
23.52	25.51	5.79
69.42	8.81	-7.83
-61.71	-27.27	19
-50.15	-8.31	1.67

// Holzel B K, 2007: Meditators
// Subjects=15
-51	-3	-42
-45	36	-21
36	-84	-42
15	21	-21
-24	-93	-36
-9	63	6
15	66	6
63	6	9
54	-6	-36
-18	-57	-54
-54	0	-39
-24	-30	72
-60	3	15
-27	-18	-30
-48	-21	-30

// Holzel B K, 2007: Non-meditators
// Subjects=15
-51	-3	-42
-45	36	-21
36	-84	-42
15	21	-21
-24	-93	-36
-9	63	6
15	66	6
63	6	9
54	-6	-36
-18	-57	-54
-54	0	-39
-24	-30	72
-60	3	15
-27	-18	-30
-51	-6	-39

// Di Russo F, 2007: Significant activation sites (Group Data)
// Di Russo F, 2007: Significant activation sites (Single Subject Data)
// Di Russo F, 2007: Unseeded source model (Group data)
// Di Russo F, 2007: Unseeded source model (Single subject)
// Subjects=5
11.04	-92.73	-2.32
48.87	-71.66	2.79
39.49	-75.68	29.12
30.35	-75.1	-10
14.5	-93.28	14.48
51.06	-71.44	4.97
32.92	-81.86	20.88
33.53	-74.44	-14.6
-6.2	-94.6	1.52
-44.05	-74.22	3.51
-32.85	-79.99	33.02
-23.59	-79.02	-3.09
-9.23	-91.99	18.12
-47.25	-72.85	6.79
-34.02	-88.37	23.79
-30.12	-82.75	-8.21
13.21	-91.55	-1.36
50.02	-70.07	8.22
34.17	-80.61	34.18
24.91	-74.26	-12.23
12.37	-95.21	16.95
47.79	-68.37	3.61
31.8	-72.29	19.95
24.95	-72.88	-9.01
-7.25	-96.63	2.86
-45.09	-68.49	7.44
-28.59	-86.98	26.92
-42.1	-62.69	-11.11
-6.01	-89.96	16.74
-45.1	-68.59	6.33
-28.63	-90.58	22.79
-38.8	-58.97	-5.93
15.34	-97.28	-5.31
40.17	-74.33	-2.4
6.77	-77.02	5.16
42.36	-67.53	1.37
-8.43	-90.77	-3.31
-36.54	-76.84	-1.96
-5.07	-83.34	7.11
-32.08	-65.9	11.45
5.61	-86.36	-2.86
39.21	-81.06	6.13
9.09	-85.65	16.06
43.41	-71.03	-1.66
-15.91	-89.11	3.38
-38.64	-82.91	2.03
-9.36	-84.21	9.51
-41.79	-76.78	10.45

// Gaab N, 2007: Words with Silence > Silence
// Gaab N, 2007: Words with Recorded Scanner Background Noise (RecSBN) > 
// RecSBN
// Gaab N, 2007: Words with RecSBN > Words with Silence
// Gaab N, 2007: RecSBN > Silence
// Gaab N, 2007: Words with Silence > RecSBN
// Gaab N, 2007: Words with RecSBN > Silence
// Subjects=10
64	-14	10
-60	-18	12
-4	12	44
-2	-28	32
-46	-6	48
62	-26	6
-20	8	4
-64	-42	16
-60	14	8
-66	-24	14
36	-52	-20
-56	-16	8
-42	-34	16
54	-22	14
54	-20	14
-42	-26	16
-18	8	4
26	2	2
62	-14	10
-58	-18	10
2	12	40
-2	88	6

// Gothelf D, 2007: Significant Activations During the Response Inhibition 
// Task in All Subjects
// Gothelf D, 2007: 22q11.2DS Patients > TD and DD Subjects, Go/NoGo vs. Go
// Subjects=9
-7.16	27.71	35.38
35.68	62.26	12.18
31.6	-94.57	-.25
-37.98	29.93	-8.02
65.33	-36.89	29.33
-20.16	-101.68	6.94
-26.72	62.95	34.46
-28.26	-46.22	60.98
-37.08	-47.6	46.7

// Gu X, 2007: Rating Painful Words > Counting Neutral Words
// Gu X, 2007: Rating Painful Words > Counting Painful Words
// Gu X, 2007: Conj. Analysis: (Rating Painful vs. Counting Neutral) vs. 
// (Rating Painful vs. Counting Painful)
// Subjects=10
37.74	12.33	-5.33
50.99	28.69	19.72
-40.04	37.24	1.38
-43.93	-30.66	21.61
-60.13	-8.82	26.45
-28.85	-76.94	8
24.92	-5.28	2.24
42.24	-7.14	4.37
50.97	26.36	17.71
-48.37	-44.68	9.62
-15.58	-16.58	44.38
-52.48	-10.3	33.19
53.28	-12.99	21.56
-64.57	-12.96	16.85
-28.79	-75.35	13.45
37.76	12.43	-4.22
50.96	28.48	17.5
-46.18	-44.47	11.81
-52.48	-10.3	33.19
53.28	-12.99	21.56
-28.85	-76.94	8

// Mitterschiffthaler M T, 2007: Conjunction Analysis: Main Effect of Happy 
// Music, Happy > Neutral
// Mitterschiffthaler M T, 2007: Conjunction Analysis: Main Effect of Sad 
// Music, Sad > Neutral
// Mitterschiffthaler M T, 2007: Conjunction Analysis: Main Effect of Neutral 
// Music, Neutral > Sad and Happy
// Subjects=16
-57.05	-34.08	8.72
50.8	-15.38	-3.93
-20.06	40.19	43.33
-9.73	43.29	6.98
-2.71	-7.37	38.77
-2.64	-24.39	40.45
-11.76	17.96	11.77
9.58	5.12	-11.98
-13.87	-47.31	2.57
-6.61	-19.58	69.18
-11.12	-45.07	49.37
-41.93	-31.9	8.25
53.03	-19.22	0.89
65.81	7.86	-8.73
22.43	-16.5	-25.75
-13.4	-28.48	43.28
-11.21	22.12	56.17
-14.1	-55.56	-16.78
-59.18	-36.01	11.19
-37.48	-28.72	19.06

// Chen C, 2007: Unmatched Numbers > Matched Numbers
// Subjects=20
-29.22	-60.7	66.91
-35.77	-54.65	63.06
-39.09	-45.4	58.84
-55.98	22.79	19.89
-49.53	38.97	20.42
-20.48	-54.86	-8.89
-26.89	-74.03	-6.89
-20.31	-76.57	-0.03

// Kadosh R C, 2007: Main effect of size congruity (incongruent vs. congruent 
// or neutral) for number and size comparisons
// Subjects=14
28.36	-64.15	43.36
-26.12	-53.39	49.78
42.23	-41.26	49.09
-37.96	-34.51	47.22
31.53	-6.37	60.79
-26.2	-4.69	60.19
-3.95	9.94	40.87
3.54	-18.54	29.79
33.24	46.4	27.35
-28.74	46.03	28.09
53.61	8.74	20.23
-48.92	4.32	27.36
37.44	15.99	5.31
-36.26	7.09	6.91
37.44	15.99	5.31
-36.26	7.09	6.91
37.51	-51.45	-13.57
-39.39	-59.15	-9.81
6.81	12.97	51.64

// Price G R, 2007: Group (dyscalculic vs. control) x Distance (close vs. far) 
// Interaction
// Subjects=8
36.97	-47.04	57.44
-37.29	-57.28	-13.33
-13.04	58.01	-11.01

// Cavina-Pratesi C, 2007: Grasp > Reach
// Cavina-Pratesi C, 2007: Size > Pattern
// Subjects=9
-34.71	-24.2	56.35
-36.87	-36.45	49.6
-29.35	-51.38	48.53
43.22	-36.57	40.88
-38	-40.4	39.9
-21.87	-67.88	40.91
-11.25	-86.02	25.58
1.46	-81.68	11.69
6.82	5.31	48.94
50.76	-40.32	46.68
-29.51	-91.56	10.64
-51.1	-68.65	-7.76

// Kadosh R C, 2007: Numerical comparison task for I.S.: Incongruent vs. 
// Congruent
// Kadosh R C, 2007: Triangle comparison task for I.S.: Incongruent vs. 
// Congruent
// Subjects=1
-32.57	-64.77	40.77
-30.54	-58.13	30.15
-42.59	-71.23	-14.33

// Robertson B, 2007: Decreased activation post-treatment, Sad vs. Neutral
// Robertson B, 2007: Decreased activation post-treatment, Attentional targets
// Robertson B, 2007: Increased activation post-treatment, Sad vs. Neutral
// Robertson B, 2007: Increased activation post-treatment, Attentional targets
// Subjects=10
34.23	39.79	-21.43
-2.05	59.45	18.7
8.38	35.96	-15.01
4.29	39.84	3.73
46.39	27.66	-2.51
27.13	-39.93	-1.1
16.22	20.53	3.19
-6.64	-50.84	-24.1
31.48	-60.43	-2.5
31.43	-8.34	3.55
-57.89	-48.69	24.75
34.77	-60.11	0.77
-51.81	32.61	9.88
-32.21	-60.35	1.93
38.83	58.35	4.67
60.76	15.96	20.81
19.73	1.78	20.67
12.78	-71.37	53.8
-1.26	-71.42	54.05

// Zysset S, 2007: Interference-related changes: Incongruent > Neutral
// Zysset S, 2007: Age-related changes: Incongruent > Neutal
// Zysset S, 2007: Reaction time-related changes: Incongruent > Neutral
// Subjects=23
-3.94	19.88	45.61
-23.08	7.59	53.55
-45.78	21.26	25.9
-45.98	35.58	4.63
-32.52	-53.25	52.07
-6.76	-68.45	59.74
-36.36	25.86	1.99
-45.72	-70.39	-3.22
-29.58	-85.64	4.57
-16.97	-21.86	2.42
-10.52	1.67	17.1
-10.47	-80.21	-9.49
-7.07	-55.16	25.17
2.48	23.35	48.59
31.37	7.4	46.25
44.07	12.8	32.27
47.17	28.16	24.25
34.74	-43.59	47.14
12.43	-65.42	55.92
11.95	28.47	31.32
43.8	16.57	-1.5
40.83	-66.7	-4.52
34.52	-88.68	0.74
11.91	-77.41	-16.67
5.79	-51.39	31.4
-7.16	29.63	48.17
-45.67	12.52	36.67
-49.15	26.04	5.46
-16.76	-69.19	9.73
-26.66	-16.09	-4.64
50.52	16.52	38.57
18.41	-53.37	4.66
-32.85	-83	-2.31
56.76	21.36	18.02
37.69	-79.15	-0.09

// Moll J, 2007: Neutral agency > No agency
// Moll J, 2007: Guilt > Neutral agency
// Moll J, 2007: Embarrassment > Neutral agency
// Moll J, 2007: Compassion > Neutral agency
// Moll J, 2007: Disgust > Neutral agency
// Moll J, 2007: Indignation self > Neutral agency
// Moll J, 2007: Indignation other > Neutral agency
// Subjects=12
7.32	12.04	-18.23
24.87	62.22	12.37
58.13	-12.76	-22.24
39.75	19.91	-16.2
-29.47	20.21	-20.65
-2.9	14.13	27.68
13.68	45.03	-21.6
-48.5	9.01	9.92
3.11	69.72	1.91
48.24	56	-21.03
3.17	-11.92	-10.18
69.39	-46.5	6.68
-54.26	7.46	-17.85
-57.93	-34.76	24.49
-60.16	-46.23	16.7
5.28	67.6	2.08
-7.2	18.68	30.67
-48.49	5.82	10.23
-43.94	-61.37	14.56
7.39	71.65	-.6
24.66	-19.26	-21.03
-11.35	-3.05	39.61
13.95	3.32	-8.51
-60.14	-43.89	18.71
56.38	-51.21	2.88
-26.9	55.01	18.44
5.28	-12.22	-13.55
-67.16	-15.13	-17.63
46.37	-78.62	-25.61
-50.36	-25.91	26.85
-43.92	-32.79	21.82
26.84	-5.97	-16.78
-46.26	-60.4	2.18
41.92	36.39	-12.26
-9.29	15.9	35.46
-1.04	34.92	8.79
46.22	1.23	-21.18
55.24	-59.39	-4.13
48.41	47.46	-8.99
7.84	11.52	22.15
31.03	-21.14	-29.92
3.06	14.67	-12.81
5.51	35.46	14.22
0.96	67.58	2.16
24.77	-27.15	-13.53
59.24	37.82	-9.34
56.33	-66.94	-4.53

// Bengtsson S L, 2007: Improvise - Reproduce
// Bengtsson S L, 2007: FreeImp - Rest
// Subjects=11
36.91	45.87	20.5
-24.27	19.11	47.72
-27.33	17.16	61.42
-33.77	4.37	62.79
30.83	19.31	46.77
11.46	19.86	53.76
-34.04	8.88	42.18
-37.22	2.8	46.2
-63.42	-38.69	17.13
49.7	-53.86	-13.55
-37.28	-79.77	24.11
-27.82	-91.49	1.58
43.58	-80.73	9.38
43.5	-84.54	3.04
36.91	45.87	20.5
-27.33	17.16	61.42
-33.77	4.37	62.79
30.83	19.31	46.77
11.46	19.86	53.76
-34.04	8.88	42.18
-37.22	2.8	46.2
49.7	-53.86	-13.55
-37.28	-79.77	24.11
-27.82	-91.49	1.58
43.58	-80.73	9.38
43.5	-84.54	3.04

// Baumann S B, 2007: All motor > Off
// Baumann S B, 2007: All auditory > Off
// Baumann S B, 2007: Involuntary (Motor and auditory condition > Baseline)
// Baumann S B, 2007: Voluntary (Motor and auditory condition > Baseline)
// Baumann S B, 2007: Voluntary (Pianists > Non-musicians)
// Subjects=7
-40	-38	54
-16	-54	-32
24	-8	-8
-26	-8	-10
14	-22	-10
18	-54	66
8	22	30
-34	44	26
50	-12	6
-58	-26	2
-36	-44	36
42	-2	60
54	4	48
22	0	-6
16	-6	74
-32	-56	62
-42	16	22
58	12	12
-52	-8	48
24	-70	-34
-24	-8	48
58	8	-10
-56	12	-10
-46	-30	10
64	-32	8
54	0	48
-54	8	36
-54	10	-6
-56	8	32
34	4	60
61	7	13
8	4	56
24	0	-6
48	8	-12
64	-38	10
62	-35	18
-60	-24	24
54	2	48
-20	8	-6
-34	-14	62
-58	-26	12
46	-40	50
-52	-6	48
22	-68	-34
34	-4	60
-2	6	46

// Mizuno T, 2007: MAJOR - NEUTRAL
// Mizuno T, 2007: MINOR - NEUTRAL
// Mizuno T, 2007: MAJOR - MINOR
// Mizuno T, 2007: MINOR - MAJOR
// Subjects=18
39.75	26.5	-14.61
-34.8	26.23	-13.31
11.3	28.5	42.83
1.64	22.4	46.96
7.84	40.01	28.3
-54.16	16.91	-8.7
-5.38	-14.52	-3.06
49.64	37.66	0.93
-5.38	-14.52	-3.06
11.3	28.5	42.83
-38.04	26.22	-13.26
52.73	23.35	-14.52
4.88	22.41	46.9
-37.04	-22.1	55.38
-27.24	-8.37	63.94
-33.65	-37.42	63.56
7.54	-70.58	-17.9
-4.82	-16.85	40.87
-11.88	-21.23	-5.64
47.29	-24.68	57.56
-8.73	-64.57	-21.58
28.01	-46.46	66.77

// Kawamichi H, 2007: 3D rotation with large angular difference (3DL) > Rest
// Kawamichi H, 2007: 3D rotation with small angular difference (3DS) > Rest
// Kawamichi H, 2007: 2D rotation with large angular difference (2DL) > Rest
// Kawamichi H, 2007: 2D rotation with small angular rotation (2DS) > Rest
// Kawamichi H, 2007: (3DS + 3DL) - (2DS + 2DL)
// Kawamichi H, 2007: 3DL - 3DS
// Kawamichi H, 2007: 2DL - 2DS
// Subjects=12
10	-86	46
-14	-84	44
28	-4	58
-24	-8	50
-42	-74	-32
50	42	24
42	-62	-34
56	10	36
-48	10	24
8	12	48
-50	-48	42
32	-58	34
-30	-66	54
44	-62	-32
-24	-92	20
58	-22	36
-42	-74	-32
34	8	60
42	-38	30
44	-46	62
-30	-70	56
8	-80	52
44	-62	-30
-38	56	22
-42	-74	-32
34	62	14
54	10	34
-44	6	24
32	-68	-32
-24	-8	62
10	-86	46
40	-62	-34
-32	-68	58
-28	-86	12
34	-56	30
42	-42	36
-42	-74	-32
28	-64	36
38	58	10
-24	-10	54
38	12	-4
30	-72	38
30	-82	32
-28	-74	44
28	-12	70
2	-7	72
24	-86	32
14	-88	46
24	-80	52
10	-60	48
56	-54	40
-22	-82	48
-46	-72	-30
22	-12	78
44	-52	42
58	-38	28
46	-50	44

// Kucian K, 2007: Healthy Children
// Subjects=20
21.36	-69.62	49
40.12	-80.17	-7.42
-14.35	-66.87	45.98
21.36	-69.62	49
15.04	-60.75	63.92
40.12	-80.17	-7.42
-14.35	-66.87	45.98
43.8	-39.64	35.57
-40.33	-44.42	46.44
14.17	-25.73	2.2
7.6	-16.5	-1.96
-15	-25.84	2.71
-8.53	-16.03	3.87
31.01	7.58	59.13
4.99	22.07	54.78
-24.64	-86.47	-2.33
-11.66	-96.2	-3.83
-20.69	-.17	70.86
-27.41	0.17	51.89
26.81	28.79	-12.37
-44.52	18.55	-14.63
-38.03	25.16	-13.15
55.02	17.81	-5.04
46.73	37.91	26.73
11.28	-50.46	24.87
11.4	-59.41	32.47
14.63	-49.62	33.69
-8.05	-59.48	32.81
-4.71	-35.79	44.98
-43.64	-39.43	42.64

// Kucian K, 2007: Healthy Adults
// Subjects=20
-46.83	-37.96	47.03
-40.94	-80.66	-8.23
40.69	-44.13	45.03
34.04	-85.9	23.5
23.79	-85.52	-17.82
-34.83	24.86	-16.54
43.45	11.34	18.2
55.37	21.47	22.6
43.31	32.19	11.66
36.49	31.8	-15.08
-44.01	8.15	23.37
24.2	-96.65	12.41
-34.71	-58.49	-23.98
11.28	-50.46	24.87
11.4	-59.41	32.47
14.63	-49.62	33.69
-8.05	-59.48	32.81
-4.71	-35.79	44.98
-43.64	-39.43	42.64

// Schendan H E, 2007: Saccade task: Saccade > Fixation
// Schendan H E, 2007: Object decision task: Intact object > Scrambled
// Schendan H E, 2007: Mental rotation task: Rotation > Control
// Subjects=13
-42	-12	54
48	0	54
30	-54	51
-18	-78	48
-27	-72	24
-15	-93	0
21	-93	12
-30	-78	3
-39	-78	-12
-21	-57	-15
18	-48	0
9	-30	-24
6	-81	-36
-21	-24	-6
-45	30	12
54	33	21
-42	15	30
-45	-6	45
51	-9	42
-24	-21	66
21	-27	66
-30	33	-12
30	42	-12
-30	-3	15
33	-63	60
-12	-36	57
-42	-66	-21
-33	-63	-18
36	-66	-15
18	18	42
-9	-75	-36
6	-60	-39
-30	24	0
36	33	3
-45	6	27
-48	33	27
-27	3	63
24	9	57
9	36	42
-6	18	24
9	6	30
-24	-66	60
33	-75	30
-36	-78	18
-39	-54	-3
-33	-54	-15
-27	-48	-6
30	-42	-9
-42	-33	3
-54	9	-18
24	-21	6
-33	-30	3
18	0	3
3	-24	-12
0	-33	-33
6	-81	-33
30	-72	-33
6	-63	-39

// Hermann A, 2007: Blood-injection-injury (BII) Phobia Patients
// Subjects=9
-15	-30	-6
0	-21	6
3	-21	6
27	-63	54
18	0	-18
-6	-21	6
12	-21	18
-6	48	-15
-9	45	-21
-21	-63	54
27	-63	54
-9	-3	63
-12	15	42
3	57	30
6	57	30
-3	36	-21
12	48	-9
54	24	53

// Hermann A, 2007: Healthy Controls
// Subjects=10
-57	-24	42
18	-81	54
18	-12	-3
-27	39	-21
51	36	-18
30	33	-15
-3	63	24
-24	0	-15
-15	-30	0
6	-24	12
-9	-3	63
-12	15	42
3	57	30
6	57	30
-3	36	-21
12	48	-9
54	24	53

// McClure E B, 2007: General Anxiety Disorder Patients > Healthy Controls: 
// Fearful faces > Happy faces
// Subjects=15
18	-3	-13
30	-6	-8
-12	-6	-8
-8	-5	-12
-16	-8	-6
38	31	-3
36	35	-7
8	5	31
4	49	12
4	6	40
2	6	44

// Meseguer V, 2007: Positive > Neutral (Activations)
// Meseguer V, 2007: Negative > Neutral (Activations)
// Subjects=14
-41.92	24.66	-26.84
-22.61	17.89	-19.81
-30.12	16.36	-25.17
-35.97	15.54	47.46
-38.45	31.82	10.43
32.51	-14.97	45.88
-49.85	-8.57	39.6
36.21	3.27	-21.49
-31.24	12.58	-32.64
61.89	1.56	-18.29
45.27	-57.3	20.29
16.58	-50.22	45.68
-10.32	-74.26	12.32
43.87	-40.93	-15.64
40.78	-73.81	-13.96
-36.29	-40.44	-15.87
-.1	31.91	-5.63
-2.85	-42.53	22.95
32.99	3.16	-22.56
-39.38	-44.8	-3.2
-36.3	29.72	10.58
-24.78	4.33	-29.8
-4.32	18.14	-4.42
18.3	-8.45	7.58
-20.15	-27.17	2.9
-20.14	-7.28	12.39
27.91	6.93	12.87
-6.35	-49.95	-17.65
52.41	21.62	8.01
-42.5	7.71	29.23
-42.79	37.71	4.41
-25.86	15.16	-27.35
-3.88	13.96	51.68
42	5.81	38.46
-28.68	38.88	32.03
41.5	2.78	-28.2
-33.31	4.45	-27.48
-53.07	-44.94	23.73
60.81	2.61	-18.37
48.39	-55.94	10.1
-43.51	-57.54	11.29
-10.4	-70.72	3.1
18.39	-56.89	0.49
-12.36	-45.87	35.61
11.1	-82.42	14.98
44.93	-41.01	-16.76
40.79	-71.53	-11.92
-38.38	-47.68	-13.01
5.19	33.55	-12.52
-7.28	14.09	26.06
-3.92	-37.07	24.74
20.5	-47.27	0.78
14.88	-15.09	-23.05
-37.26	-47.16	-6.38
-16.91	-47.67	-.99
34.51	-30.59	22.64
-46.96	-6.35	-.77
29.84	-.66	-16.62
-30.04	-2.59	-22.46
18.31	-6.16	9.62
-23.38	-23.04	1.48
32.04	3.3	-6.94
5.44	-44.07	-11.59

// Tracy J, 2007: Internal Heartbeat - External Heartbeat
// Tracy J, 2007: Internal Heartbeat - Rest
// Tracy J, 2007: Internal Heartbeat - Rhythmic Neutral Tone
// Tracy J, 2007: Internal Heartbeat - White Noise
// Tracy J, 2007: Internal Heartbeat - Silent Counting
// Subjects=17
51.94	-27.45	40.28
40.36	-57.6	50.29
51.93	-41.59	37.19
54.72	-42.06	43.47
58.73	37.72	35.5
42.25	-26.17	35.05
-22.91	-47.88	39.43

// Wise R G, 2007: Saline: Pain > Warm
// Wise R G, 2007: Midazolam: Pain > Warm
// Wise R G, 2007: Saline: Pain Anticipation > Warm Anticipation
// Subjects=8
2	16	34
10	-2	48
48	4	-10
-2	-2	60
36	8	8
-34	4	4
38	-16	12
-32	-24	6
16	-18	4
-12	-18	2
24	-22	64
26	-32	64
6	-40	-48
-18	-44	-36
-2	2	40
-6	-24	44
6	-26	50
-54	-8	8
56	4	-4
6	-6	70
-26	48	8
38	2	4
-40	-4	-12
-36	-20	10
38	-22	14
10	-16	2
-4	-18	4
34	-26	52
-50	-24	10
54	-18	10
-2	-34	26
18	-42	52
-6	-32	-12
-12	-40	-32
12	-96	-10
2	20	26
-2	-20	44
44	20	-14
56	18	-12
4	0	58
-8	-2	50
48	8	-10
-38	-36	18
-52	-38	16
-66	-34	24
8	-54	64

// Walter M, 2007: Pedophiles
// Subjects=13
-3	-3	-15
3	-30	-18
-27	42	36
60	-51	6
57	27	0
24	-78	6
-33	12	-3
-30	57	24
30	39	51
42	-3	42
-21	-66	15
-6	66	24
12	-45	3
-21	-21	-15

// Walter M, 2007: Controls
// Subjects=14
-3	-3	-15
3	-30	-18
-27	42	36
60	-51	6
57	27	0
24	-78	6
-33	12	-3
-6	66	24
12	-45	3
-21	-21	-15

// Aron A R, 2007: Noncritical Stop > Noncritical Go
// Aron A R, 2007: Critical Stop > Critical Go
// Subjects=15
-40	-44	46
-44	-46	34
-54	-28	0
46	10	-6
52	-24	-4
50	-50	42
-48	36	26
-44	46	24
-50	42	10
-34	-70	-60
-20	-80	-58
-14	-78	-46
14	-8	6
10	-16	-6
8	-22	-12
6	-38	24
-2	-24	30
10	-26	36
-26	-70	-36
-40	-64	-36
-34	-76	-32
38	58	-10
28	52	-12
22	52	-22
-12	-84	-30
-16	-92	-32
42	20	0
56	-30	2
38	-44	46
-2	-20	24
6	-18	28
4	-20	42
-32	22	2
-38	18	-4
-44	16	-10
8	-18	-6
14	4	-4
16	10	8
-14	10	-4
-14	4	8
-14	18	-2
-62	-40	30
-52	-40	14
-68	-34	4
28	-96	0
20	-102	-4
22	-104	10
14	-62	30
6	-78	54
10	-46	46
-32	-70	-56
-34	-72	-64
-16	-14	62
-12	-8	-2
-8	-16	-4
-42	-82	-6
-24	-102	6
-22	-98	-14
-44	44	24
-36	36	24
-42	36	30
-18	-72	-38
-42	-62	-42
-32	-64	-38

// Rubia K, 2007: Adults
// Subjects=26
44.88	29.87	5.18
-46.01	32.07	0.46
10.72	45.41	16.54
-46.83	-62.11	-6.13
36.54	-76.75	-10.32
-22.43	-42.9	-21.4
-9.32	-54.17	10.62
46.97	37.11	2.32
2.08	57.62	10.03
-51.36	31.95	-.58
52.43	-7.78	-.67
-50.93	-27.33	31.15
-59.56	-27.09	21.19
3.63	-47.26	29.96
3.53	-15.37	29.52
1.17	35.12	21.97
46.93	29.02	-5.93
-41.75	45.04	2.67
-3.09	42.92	26.94
-60.87	1.14	1
47.39	-23.39	31.92
24.8	-20.67	14.11
-6.24	-45.57	-2.4
47.39	-23.39	31.92
-10.52	-30.28	3.05
-15.04	20.99	-7.89
33.36	-73.26	-6.11
1.14	-70.68	-24.92
-25.49	-66.72	-12.68
-10.12	-76.61	37.04
43.87	-2.46	0.1
65.2	-2.76	-5.7
-28.67	-25.73	8.46
-28.77	1.76	6.15
9.05	-70.58	30.74
44.24	-51.33	28.72
-36.96	-30.79	40.2
0.98	61.67	7.48
1.18	34.06	22.06
50.41	0	17.66
4.7	-39.51	33.76
4.53	-68.77	-.58
42.99	-77.43	-5.87
-26.68	-22.86	-9.65
-25.61	-22.85	-9.66
-22.31	-9.83	7.05
-22.25	-37.75	3.81
-25.34	-57.44	11.08
23.59	-10.07	-.15
23.79	-12.33	25.69
47.31	-27.51	20
24.88	-57.13	10.47

// Rubia K, 2007: Children
// Subjects=26
50.14	16.98	-10.53
31.92	59.14	-.47
-22.15	18.2	39.27
-41.33	5.48	41.67
40.98	-4.69	40.46
-45.92	5.46	0.46
40.37	4.29	-36.12
5.95	-54.08	51.7
20.44	-84.14	-21.78
46.97	37.11	2.32
-4.18	50.32	26.33
-56.55	-26.93	-4.51
-41.25	-60.73	24.92
51.37	-17.65	-4.29
46.39	-58.89	27.1
3.59	-54.21	22.74
1.17	35.12	21.97
46.93	29.02	-5.93
-41.75	45.04	2.67
-3.09	42.92	26.94
-60.87	1.14	1
47.39	-23.39	31.92
24.8	-20.67	14.11
-6.24	-45.57	-2.4
47.39	-23.39	31.92
-10.52	-30.28	3.05
-15.04	20.99	-7.89
33.36	-73.26	-6.11
1.14	-70.68	-24.92
-25.49	-66.72	-12.68
-10.12	-76.61	37.04
43.87	-2.46	0.1
65.2	-2.76	-5.7
-28.67	-25.73	8.46
-28.77	1.76	6.15
9.05	-70.58	30.74
44.24	-51.33	28.72
-36.96	-30.79	40.2
0.98	61.67	7.48
1.18	34.06	22.06
50.41	0	17.66
4.7	-39.51	33.76
4.53	-68.77	-.58
42.99	-77.43	-5.87
-26.68	-22.86	-9.65
-25.61	-22.85	-9.66
-22.31	-9.83	7.05
-22.25	-37.75	3.81
-25.34	-57.44	11.08
23.59	-10.07	-.15
23.79	-12.33	25.69
47.31	-27.51	20
24.88	-57.13	10.47

// Ertelt D, 2007: Subgroup of stroke patients, Control group
// Subjects=8
-40	-34	32
-6	-10	58
-18	54	22
-34	-14	66
-46	24	-4
-56	12	24
-42	-46	64
12	-48	-14
50	-64	2
62	6	24
-28	4	42
-28	-64	-16
14	6	48
46	-30	-6
38	-24	36
-24	8	-16
-54	-16	16
-6	-6	46
-40	14	28
56	-32	28
60	14	22
52	-24	6
58	16	-4

// Ertelt D, 2007: Subgroup of stroke patients, Experimental group
// Subjects=8
-4	-46	-4
-62	6	12
-24	-38	56
-10	-36	38
-30	-64	38
-26	-38	-34
-40	26	-8
-30	-6	40
-18	-18	-20
-38	-54	-14
-40	6	-12
-14	-54	-42
-10	4	44
-34	-68	-26
54	-36	24
6	-66	2
10	-54	56
14	-52	-50
50	-40	0
30	-42	-28
56	20	-8
-56	-26	52
-34	-52	58
-42	-52	-26
-12	-50	-20
50	10	12
28	-62	-36
-24	8	-16
-54	-16	16
-6	-6	46
-40	14	28
56	-32	28
60	14	22
52	-24	6
58	16	-4

// Lindberg P G, 2007: Stroke patients
// Subjects=5
44.2	-30.14	68.24
60.18	-18.57	53.38
17.16	-22.07	-16.14
-8.68	-21.53	-9.03
14.03	-27.84	-8.79
-18.18	-3.43	12.87
10.92	-7.15	6.02
46.06	15.39	-30.43
-7.73	-1.29	69.63
-31.51	-52.2	-25.78
21.6	-9.83	80.06
31.29	-23.18	74.49
1.69	-.25	45.84
5.05	0.7	55.77
-44.57	29.08	-16.79
47.4	-43.51	62.78
1.76	26.52	56.63
18.16	8.37	68.23
-44.49	-58.94	-28.25
-34.72	-71.67	-27.16
-37.65	48.79	21.48
43.03	39.89	-9.27
-50.36	-18.26	28.33
-37.15	19.69	54.61
56.8	-3.25	45.19
-49.8	-40.35	67.49
-59.79	-25.99	49.43
33.42	-57.73	-19.61
-9.04	-73.45	-47.59
37.13	44.23	37.47
1.74	29.71	56.32
-4.56	17.86	67.68

// Lindberg P G, 2007: Healthy controls
// Subjects=6
63.03	-28.05	20.65
18.26	-7.27	73.14
57.15	-26.9	67.7
21.43	11.88	71.19
14.15	-13.83	3.26
-37.95	-61.8	-24.72
45.99	21.46	-34.39
-53.59	-21.46	28.71
-54.21	29.67	-9.96
-31.51	-52.2	-25.78
21.6	-9.83	80.06
31.29	-23.18	74.49
1.69	-.25	45.84
5.05	0.7	55.77

// Kapreli E, 2007: Fingers > Rest
// Kapreli E, 2007: Knee > Rest
// Kapreli E, 2007: Ankle > Rest
// Kapreli E, 2007: Toes > Rest
// Subjects=18
-38	-26	52
-4	-8	54
-46	-28	18
-28	-2	8
-18	-22	10
38	-24	50
28	-4	10
16	-18	4
22	-52	-24
8	-66	-22
24	-50	-24
16	-68	-48
-40	-28	48
-2	-6	64
-4	-54	-8
-10	-52	-20
-20	-66	-50
-16	-40	64
-2	-24	66
-12	-6	44
-24	-26	64
-40	-28	20
-32	-16	8
-18	-22	10
12	-38	64
0	-24	68
10	-6	42
12	-22	72
30	-26	20
28	-10	16
20	-18	-2
22	-38	-20
20	-32	70
36	-28	24
4	-50	-16
14	-40	-22
20	-50	-50
-12	-34	66
-12	-6	44
-44	-28	20
-32	-14	8
-26	-24	20
-2	-48	-8
-14	-38	-18
-22	-60	-40
-8	-42	66
-4	-26	62
-8	-8	46
-12	-28	76
-34	-24	16
-30	-14	6
6	-38	66
2	-24	68
8	-12	52
10	-24	72
40	-30	20
32	-14	8
18	-22	12
22	-42	-24
52	-28	20
4	-70	-42
12	-40	-22
24	-50	-50
-12	-40	76
-8	-8	48
-46	-28	20
-28	-8	-12
0	-48	-8
-16	-36	-22
-6	-42	68
-4	-18	74
-4	-8	52
-4	-18	74
-56	-34	20
-28	-10	10
-22	-22	22
4	-38	70
0	-26	70
8	-4	44
12	-22	72
34	-24	18
32	-2	6
44	-32	22
4	-46	-8
14	-40	-24
-12	-6	58
-52	-32	20
-28	-10	10
0	-44	-8
-14	-38	-24

// Picchioni M, 2007: Common Activations Associated with Correct Answers
// Picchioni M, 2007: Increased Neural Response Associated with Correct 
// Answers
// Picchioni M, 2007: Decreased Neural Response Associated with Correct 
// Answers
// Picchioni M, 2007: WM Simultaneous > WM 4
// Picchioni M, 2007: WM Simultanous < WM 4
// Picchioni M, 2007: WM Simultaneous > WM 12
// Picchioni M, 2007: WM Simultaneous < WM 12
// Picchioni M, 2007: WM 4 < WM 12
// Picchioni M, 2007: WM 12, Correct > Incorrect
// Subjects=14
-29.75	-83.04	-16.84
27.94	-78.46	-17.88
-22.23	-82.56	-11.39
32.21	-66.38	-13.37
32.33	-84.9	-5.13
-22.21	-73.59	-5.45
8.6	-26.88	-9.72
-30.07	27.88	-13.87
43.69	20.92	-14.13
35.17	24.46	-8.75
-30.01	24.07	-7.97
16.35	-72.42	6.28
12.84	8.98	-.51
-6.29	-18.62	2.03
12.98	-18.08	7.34
20.39	2.05	5.56
16.39	-71.99	11.82
47.23	7.9	23.72
-48.95	7.32	24.88
44.21	-30.81	32.58
-44.57	4.06	37.37
-25.13	-50.81	41.74
32.67	-73.72	43
5.6	20.22	35.43
51.65	5.07	41.75
1.4	12.17	41.73
32.51	-6.17	49.61
-32.6	-14.59	56.64
12.77	-47.77	-32.55
5.23	-20.95	-29.14
-6.36	-51.17	-19.78
-25.67	-32.26	-21.14
-10.44	-77.75	-5.23
20.67	-84.02	7.2
-10.27	-88.01	13.47
20.7	-68.28	18.15
16.51	-79.51	24.71
12.9	42.59	21.21
-10.45	24.36	35.27
-25.17	-27.12	45.33
-2.89	28.52	47.1
-17.54	-40.93	58.67
-13.33	-26.1	57.38
39.54	-63.47	-31.54
-32.99	-74.6	-17.51
-44.71	-71.07	-12.09
47.14	-58.88	-14.17
39.73	-77.96	-12.48
-32.95	-58.85	-6.56
51.48	-61.52	-7.31
-32.79	-76.94	7.22
8.72	-21.28	7.65
27.93	-1.62	12.48
35.69	-39.33	33.39
28.39	-61.69	47.62
35.27	-63.5	-31.49
-41.64	-60.36	-25.29
32.23	-82.67	-17.58
-32.9	-85.8	-10.99
28.06	-84.92	-5.07
-6.27	-38.17	-3.02
-41.34	-76.99	7.32
13.03	-41.77	3.75
8.72	-21.28	7.65
16.28	-41.32	9.25
-17.65	-87.11	25.74
28.36	-78.49	36.76
32.6	-70.01	36
1.16	-62.76	-18.89
-3.07	-62.36	-13.3
12.93	-54.86	-14.11
-10.5	-61.89	-6.56
16.17	-50.1	-7.86
-25.45	-90.41	-16.27
32.23	-82.67	-17.58
-44.71	-71.07	-12.09
47.24	-70	-6.55
-41.41	-73.28	0.32
39.87	-76.51	6.35
24.59	9.05	-.65
8.72	-21.28	7.65
13.12	-40.83	15.93
1.1	62.87	22.99
5.4	-67.48	-25.24
-10.53	-78.69	-17.42
-13.84	-39.16	-15.12
-10.41	-85.15	-4.61
-2.83	-76.33	12.4
-6.41	37.3	9.61
16.02	41.67	8.98
20.3	49.52	13.85
-17.68	-30.24	45.51
-25.09	-34	52.6
20.38	-71.62	-25.06
-18.06	-67.11	-18.31
5.37	-19.5	-10.3
12.67	28.13	-14.38
1	16.86	-7.72
-22.11	-89.02	1.42
13.11	-77.18	0.02
-2.89	-72.53	6.51
55.8	-48.92	3.85
59.05	-48.47	9.36
-10.32	-72.15	12.14
20.7	-68.28	18.15
20.82	-74.74	30.96
5.42	54.6	25.86
5.91	-62.25	42.35
-14.04	-48.87	-44.42
39.56	-55.64	-26.62
43.95	-62.08	-13.86
16.26	-73.36	-5.91
-25.74	24.1	-8.02
-3.33	32.69	-9
5.28	29.03	-2.1
-33.2	33.03	-2
32.07	22.22	3.74
20.72	-87.83	13.1
-5.99	-75.84	19.09
39.58	25.95	10.03
32.1	37.96	14.68
28.36	-78.49	36.76
-17.51	-61.45	54.82
1.72	-61.34	54.59

// Vohn R, 2007: Within-Modal Divided Auditory Attention - Within-Modal 
// Selective Auditory Attention
// Vohn R, 2007: Auditory/Visual Divided Attention (A/V DAC) - Auditory/Visual 
// Selective Attention (A/V SAC)
// Vohn R, 2007: Conjuntion Analysis for Cross-Modal DAC-SAC and Within-modal 
// DAC-SAC
// Vohn R, 2007: Cross-Modal DAC-SAC - Within-Modal DAC-SAC
// Subjects=16
49.03	28.01	35.51
48.83	38.57	22.14
40.12	42.38	17.43
40.69	-49.66	43.34
35.6	14.65	-3.28
35.52	9.67	-10.63
60.58	11.32	5.59
48.57	14.7	-3.51
39.71	29.48	-17.14
31.49	38.09	18
40	57.91	11.41
-24.12	6.01	56.86
-19.74	15.27	63.72
40.74	-49.24	47.78
40.84	-48.52	55.55
5.67	-8.25	17.42
27.08	-13.99	0.82
27.67	22.15	54.38
23.55	11.58	67.82
-15.28	-60.31	58.79
-45.68	-40.73	51.77
14.51	29.37	40.45
-50.84	-3.29	-6.76
-41.83	40.04	31.38
48.88	26.87	23.3
49.03	28.01	35.51
45.16	-48.5	55.47
36.55	-52.68	57.15
35.6	14.65	-3.28
40.17	42.79	21.87
1.77	14.61	55.57
-2.7	25.47	45.61
35.8	42.36	17.51
-49.89	-39.91	60.72
-46.44	45.49	9.63

// Wakusawa K, 2007: (Situational_Irony + Situational_Metaphor) - 
// (Literal_Irony + Literal_Metaphor)
// Wakusawa K, 2007: Situational_Irony - Situational_IronyControl
// Wakusawa K, 2007: Literal_Irony - LIteral_IronyCon
// Subjects=31
-10	58	24
2	46	-14
52	12	-32
52	12	-32
2	46	-14

// Woo S H, 2007: All Conditions > Rest
// Woo S H, 2007: Areas Positively Correlated with Response time change
// Woo S H, 2007: Areas Negatively Correlated with Response Time Increase
// Subjects=10
1.25	-83.39	-5.32
57.9	-41.4	38.87
45.24	51.27	-2.59
-47.89	-30.21	49.64
-44.59	-14.37	58.11
2.35	29.48	19.35
2.17	-30.96	-7.16
2.86	-72.86	38.43
2.16	-4.82	-3.03
1.5	-58.57	19.11
-22.56	49.7	18.89
55.62	4.74	38.82
8.1	-4.04	39.38
-29.42	-.21	-20.87
32.26	-13.5	-17.25
7.15	-.88	50.29
-11.17	-71.74	39.68
-43.87	-68.51	18.63
61.14	-38.1	39.6
-54.43	-31.71	45.42
58.57	-43.35	6.55
10.36	28.47	54.05
49.54	48.95	-4.67

// Kimmerly D S, 2007: BOLD signal changes that corresponded with sex-specific 
// heart rate responses (Activations)
// Kimmerly D S, 2007: BOLD signal changes that corresponded with sex-specific 
// heart rate responses (Deactivations)
// Kimmerly D S, 2007: BOLD signal changes that correspond with sex-specific 
// total muscle sympathetic nerve activity (act)
// Kimmerly D S, 2007: BOLD signal changes that correspond with sex-specific 
// total muscle sympathetic nerve activity(deact)
// Subjects=16
4	18	26
24	0	-22
-2	46	-2
40	14	-2
32	-36	18
-36	8	-6
-4	46	-14

// Kimmerly D S, 2007: 15 and 35 mmHg > 5 mmHg
// Kimmerly D S, 2007: 15 and 35 mmHg < 5 mmHg
// Subjects=11
38	-22	22
4	44	10
-8	40	-6
14	44	-6
2	-16	4
-4	-18	6

// Hale T S, 2007: Forward Digit Span - Baseline, ADHD - Healthy Controls
// Hale T S, 2007: Backward Digit Span - Baseline, Healthy Controls - ADHD
// Hale T S, 2007: Backward Digit Span - Baseline, ADHD - Healthy Controls
// Subjects=10
-39.47	-66.81	25.11
-13.48	-81.6	26.13
-2.9	-2.24	24.82
12.3	-49.81	20.3
24.94	48.5	14.84
57.49	12.45	17.86
17.16	-50.11	62.83
-23.9	-70.02	58.78
-47.79	-31.61	57.62
-30.87	-69.32	20.73
53.37	-25.44	26.16
25.82	-39.02	66.07
-50.08	-65.39	40.84
-44.22	-28.48	-1.01
1.65	-15.87	39.54

// Elzinga B M, 2007: Healthy Controls
// Subjects=14
-40.73	40.15	32.48
-31.51	26.56	-10.04
-47.69	30	-6.74
-53.88	9.2	12.23
-24.59	13.43	21.4
39.7	62.22	-11.42
56.48	33.8	28.09
56.73	15.9	43.3
33.31	26.79	-11.17
46.26	30.02	-11.71
53.18	16.9	19.73
8.05	31.68	42.57
-40.26	-38.38	53.68
47.36	-43.83	59.45
-34.11	14.95	38.22
-30.69	13.02	51.8
-37.56	-55.59	7.16
-47.36	-36.48	5.43
52.99	-66.61	-12.34
37.01	-61.71	6.49
46.67	-45.72	4.75

// Elzinga B M, 2007: Dissociative Patients
// Subjects=13
-37.78	60.93	13.56
-47.25	39.81	29.26
-47.38	48.76	21.65
-34.78	23.04	-13
46.36	60.3	2.11
53.06	48.8	16.58
56.53	21.03	29.35
66.44	6.05	40.75
30.89	13.24	50.73
33.3	29.98	-11.48
36.65	24.23	-4.25
11.34	28.81	46.16
-37.06	-48.56	47.91
-53.28	-45.43	47.88
-53.16	-44.49	57.87
63.5	-37.7	55.21
37.38	-42.54	39.33
50.52	-44.44	52.74
-37.17	22.88	54.29
-20.91	10.18	55.27
-10.78	-62.24	72.35
-4.44	-59.96	61.93
-7.74	-66.98	55.96
21.56	-65.94	65.44
31.24	-66.22	61.94
-5.01	34.2	35.82
1.43	43.8	34.76
56.2	-60.22	-13.03
49.95	-51.99	6.43

// de Lange F P, 2007: Affected & Unaffected > Fixation
// de Lange F P, 2007: Affected > Unaffected
// de Lange F P, 2007: Left Hand > Right Hand
// de Lange F P, 2007: Right Hand > Left Hand
// Subjects=8
38	-36	38
-28	-4	46
-26	4	62
28	0	60
8	44	-24
-12	62	32
-36	48	34
-58	-6	10
-52	-36	-4
68	-28	10
16	-40	70
32	-10	68
-6	-36	64

// Nebel K, 2007: Patients < Controls, Focused Attention
// Nebel K, 2007: Patients < Controls, Divided Attention
// Subjects=6
31.85	40.79	46.86
-40.29	24.42	-20.88
-41.94	29.32	20.12
-50.64	22.29	14.24
31.3	2.73	-4.27
-60.88	-39.62	-38.85
50.29	-52.07	-51.84
48.16	-47.41	-47.78
68.82	-32.16	-35.07
-34.25	-83.89	-77.5
-27.82	-90.87	-83.65

// Kobayashi C, 2007: Bilinguals
// Subjects=12
5.51	24.51	11.94
-53.17	-19.85	-23.01
33.13	62.64	-18.07
35.94	-97.75	-0.01
7.62	71.19	17.38
29.03	71.94	1.25
59.39	28.02	0.59
14.06	73.02	13.72
-25.02	71.54	-0.03
1.87	-57.99	48.18
-46.41	23.81	7.3
-51.18	42.36	-23.59
31.38	-89.64	-16.42
30.98	62.73	-16.92
1.95	-72.68	51.88
71.48	13.15	13.07
-20.92	40.34	-23.91
64.75	25.5	-3.73
33.37	69.93	2.49
5.81	54.11	41.51
41.77	4.64	-30.41
33.08	57.86	-23.2
-53.16	-21.98	-22.8
-.25	-79.58	47
30.91	57.85	-23.16
-20.9	57.98	-18.93
-23.1	55.54	-22.01
1.98	-73.53	54.2
39.63	4.84	-28.15
28.73	55.51	-25.14
37.69	67.71	1.52
-44.44	-8.25	-14.22
-53.15	-24.1	-22.59
48.16	11.69	-35.7
48.59	27.98	0.78
22.52	73.94	0.04
-58.35	18.99	2.37
0.88	34.22	-10.23
63.68	19.01	-4.19
67.36	-54.29	15.33
-67.01	-13.98	-5.42
24.5	15.63	-26.72
71.48	11.02	13.28
-40.32	8.91	-26.07
41.8	7.07	-27.29
65.2	-56.42	15.57
-51.18	16.11	-28.84

// Kobayashi C, 2007: Monolinguals
// Subjects=12
-64.9	-1.21	-6.72
46.15	18.24	-22.87
26.58	53.38	-24.89
69.13	12.85	-1.43
-11.03	-82.71	48.61
39.93	53.04	5.17
3.66	15.84	34.12
64.75	25.5	-3.73
33.37	69.93	2.49
5.81	54.11	41.51
41.77	4.64	-30.41
33.08	57.86	-23.2
-44.44	-8.25	-14.22
-53.15	-24.1	-22.59
48.16	11.69	-35.7
48.59	27.98	0.78
22.52	73.94	0.04
-58.35	18.99	2.37
0.88	34.22	-10.23
67.36	-54.29	15.33
-67.01	-13.98	-5.42
24.5	15.63	-26.72
-58.34	19.1	3.48
-64.91	-5.68	-8.52
52.61	4.99	-27.27

// Wolf R C, 2007: Healthy Controls
// Subjects=16
-36	30	33
-36	30	36
-36	33	33
-36	33	33
-36	27	33
-36	27	33
-39	-42	39
-36	-42	36
-36	-42	36
36	21	48

// Wolf R C, 2007: Pre-Huntington's Disease
// Subjects=16
-36	30	33
-36	30	36

// Wolf R C, 2007: Subgroup of Pre-Huntington's Disease, Far pre-HD
// Subjects=8
-36	33	33
-36	33	33
-39	-42	39
-36	-45	36
39	18	48

// Wolf R C, 2007: Subgroup of Pre-Huntington's Disease, Close pre-HD
// Subjects=8
-36	27	33
-36	27	33
-39	-42	39
-36	-42	36
-36	-42	36
36	21	48
-39	-42	39
-36	-45	36
39	18	48

// Powell H W R, 2007: Healthy Controls (HC)
// Subjects=10
34	-26	-28
26	-22	-20
-28	-28	-16
38	-20	-30
-26	-30	-18
44	-36	-18
-18	-14	-28
-28	-6	-30
-40	-18	-26
-40	-16	-30

// Powell H W R, 2007: Subgroup of Temporal Lobe Epilepsy, Right TLE (RTLE)
// Subjects=10
-30	-10	-36
-34	-34	-18
-40	-20	-26
16	-18	-26
-18	-14	-28
-28	-6	-30
-40	-18	-26
-40	-16	-30

// Powell H W R, 2007: Subgroup of Temporal Lobe Epilepsy, Left TLE (LTLE)
// Subjects=4
34	-24	-16
22	-14	-32
40	-20	-30
40	-32	-24
38	-36	-24
38	-30	-30
34	-26	-28
26	-22	-20
-28	-28	-16
38	-20	-30
-26	-30	-18
44	-36	-18

// Powell H W R, 2007: Healthy Controls (HC)
// Subjects=10
-44	2	24
-40	20	0
-44	-56	12
-52	-26	-6
48	-26	-4
-44	10	20
-50	-34	-6
52	-26	-6
50	22	40
42	12	38

// Powell H W R, 2007: Subgroup of TLE, Right Temporal Lobe Epilepsy (RTLE)
// Subjects=7
-42	14	22
-46	28	-2
-52	-52	6
-56	-30	-12
54	-28	-12
-44	10	20
-50	-34	-6
52	-26	-6
42	12	38
46	-8	14

// Powell H W R, 2007: Subgroup of TLE, Left Temporal Lobe Epilepsy (LTLE)
// Subjects=7
-40	10	12
38	6	18
-44	10	20
-50	-34	-6
52	-26	-6
50	22	40
46	-8	14

// Fan J, 2007: Ready > Relax
// Fan J, 2007: Incongruent > Congruent
// Fan J, 2007: Uncued > Cued
// Fan J, 2007: Response anticipation and response conflict > Baseline
// Subjects=20
32	-78	30
-42	6	32
38	4	34
4	6	6
6	-26	0
4	-4	8
-24	-62	36
-30	36	24
4	62	28
-26	6	50
6	12	52
8	16	38
-52	24	26
22	34	42
-8	24	38
-38	-72	44
-32	42	32
8	-44	50
10	-16	48
6	-30	48
-40	2	32
-40	42	4
-32	36	30
-28	-86	28
-22	-44	-2
30	-78	24
8	24	40
-8	18	38
42	6	34
14	-24	8
26	-60	-2
-22	14	-52
-30	-56	48
56	-42	16
-40	0	36
34	-78	30
42	2	44
4	8	6
-4	14	48
-30	-56	52
-32	44	22
6	-26	2
22	-48	52
20	46	24

// Hessl D, 2007: Fragile X Premutation
// Subjects=12
59.92	-57.74	24.76
1.55	-56.02	23.34
-54.81	-77.24	6.23
1.55	-56.02	23.34
50.92	-82.36	-8.51
-44.15	-91.42	-8.24
53.66	-12.31	51.75
57.28	43.73	8.04
15.99	-4.2	-20.13
-50.12	-8.84	48.69
-28.47	2.5	53.92
-30.62	-45.55	45.27
18.62	36.54	25.1
-48.7	5.33	-6.52
28.86	41.14	-18.11
42.91	-53.6	47.05
-50.66	-23.84	3.12
8.16	-52.84	34.12
59.95	-57.53	26.98
-38	-65.4	-28.84
-39.95	14.91	3.58
-46.23	-53.6	5.99
-33.43	-26.32	-1.41
12.26	-47.89	17.87
55.19	-78.3	-11.23

// Hessl D, 2007: Healthy Controls
// Subjects=13
-40.04	36.18	1.48
65.86	-35.51	-13.4
-44.11	-58.26	1.93
-37.72	-91.81	-12.79
-50.01	-1.42	59.16
55.87	-1.04	57.32
-20.23	-107.73	-.31
48.47	-51.71	-24.95
46.75	26	25.66
15.89	6.02	-25.62
-30.62	-45.55	45.27
18.62	36.54	25.1
-48.7	5.33	-6.52
28.86	41.14	-18.11
42.91	-53.6	47.05
-50.66	-23.84	3.12
8.16	-52.84	34.12
59.95	-57.53	26.98
-38	-65.4	-28.84
-39.95	14.91	3.58
-46.23	-53.6	5.99
-33.43	-26.32	-1.41
12.26	-47.89	17.87
55.19	-78.3	-11.23

// Almor A, 2007: Repeated Name> Pronoun
// Subjects=16
32	-72	44
26	-70	46
38	-72	38
-26	-60	54
-20	-58	50
30	-64	42
-56	-34	-10
-62	-42	2
-50	-36	-18
-50	-38	-14
-54	-34	-14
-62	-36	4

// Santi A, 2007: MOV > BIND, Linear Effect
// Santi A, 2007: MOV, Positive Linear Effect
// Santi A, 2007: BIND, Negative Linear Effect
// Santi A, 2007: MOV & BIND, Postive Linear Effect
// Santi A, 2007: BIND > MOV, Linear Effect
// Santi A, 2007: BIND, Positive Linear Effect
// Santi A, 2007: BIND > MOV
// Santi A, 2007: MOV > BIND
// Subjects=11
-50	32	6
-50	33	8
-39	19	10
-40	-28	-22
44	-22	-26
48	-16	-32
46	-18	-29
42	58	-8
-62	-40	0
-52	14	28
70	-42	0
48	-28	-16
44	-20	24
-34	28	42
6	58	2
59	-3	-14
36	3	-32

// Hoeft F, 2007: NoGo > Go, Healthy Controls (HC) > Fragile X and 
// Developmental Delay > Fragile X
// Hoeft F, 2007: NoGo > Go, Fragile X > HC and Fragile X > DD
// Subjects=10
-24.78	54.7	15.08
48.36	16.44	-19.36
20.46	12.27	-5.03
-52.55	11.08	32.19
40.44	7.56	35.44
9.56	2.78	-13.99
-37.39	2.62	32.77
62.61	-7.15	-8.31
48.65	-13.16	-2.99
-37.91	-18.76	-12.17
33.59	-24.71	0.65
-41.62	-27.38	33.57
40.08	-35.63	-1.74
58.74	-43.16	19.98
18.68	-46.16	13.11
29.38	-60.03	1.97
53	48.39	12.13
-22.31	49.34	37.98
-2.63	39.17	54.34
14.58	7.99	41.44
36.01	36.27	32.67
-45.57	-50.85	58.37
-7.52	-31.85	-4.67
-39.94	25.96	6.97
-.43	-74.35	34.15

// Kaplan J T, 2007: Normals
// Subjects=20
-60	8	20
44	36	10
-44	36	34
46	36	26
6	-2	62
-2	14	32
60	4	28
-54	-32	48
32	-56	42
-60	8	-4
64	4	0
-4	-86	34
36	-4	-4
-36	14	2
-44	6	-4
42	6	-2
24	10	4
-22	14	2

// Fitzgerald P B, 2007: Schizophrenia
// Subjects=3
48.85	-83.88	-1.6
-37.93	20.46	-5.96
-48.24	17.58	32.6
-50.09	4.55	54.09
-43.56	-58.57	44.53
-34.75	-57.29	57.7
-50.06	-47.75	45.81
-7.23	30.48	30.62
12.3	22.46	35.56
-3.04	36.05	21.03
-46.65	17.68	-12.26
-55.22	7.23	-8.84
-20.59	5.64	-4.79
-57.02	16.51	21.65
-37	3.3	62.95
-41.55	10.34	46.65
-54.6	-42.84	29.72
39.86	20.74	-7.32
-41.6	-.92	41.04
-7.09	31.52	41.72
10.17	22.66	37.82
-39.48	11.85	39.74
-33.71	17.52	-14.71
-57.38	7.22	-8.81
-61.27	12.65	26.58
-47.93	-32.64	46.52
-58.96	-40.93	27.36
-43.75	-3.06	41.28
-41.33	-55.81	50.95
-34.95	-58.75	42.16
-46.49	21.06	0.85

// Fitzgerald P B, 2007: Controls
// Subjects=4
-7.23	30.48	30.62
12.3	22.46	35.56
-3.04	36.05	21.03
-46.65	17.68	-12.26
-55.22	7.23	-8.84
-20.59	5.64	-4.79
-57.02	16.51	21.65
-37	3.3	62.95
-41.55	10.34	46.65
-54.6	-42.84	29.72
39.86	20.74	-7.32
-41.6	-.92	41.04
-7.09	31.52	41.72
10.17	22.66	37.82
-39.48	11.85	39.74
-33.71	17.52	-14.71
-57.38	7.22	-8.81
-61.27	12.65	26.58
-47.93	-32.64	46.52
-58.96	-40.93	27.36
-43.75	-3.06	41.28
-41.33	-55.81	50.95
-34.95	-58.75	42.16
-46.49	21.06	0.85

// Ronquillo J, 2007: Dark > Light
// Ronquillo J, 2007: Light > Dark
// Ronquillo J, 2007: Black > White
// Ronquillo J, 2007: (White dark-White light) > (Black dark-Black light)
// Subjects=11
-27.61	-62.08	-7.47
-20.34	-.53	-10.48
11.7	-15.91	-19.6
7.38	22.01	-10.46
-25.75	19.61	-10.99
-29.99	-36.05	-28.58
36.38	-44.32	-17.5
52.36	25.51	3.23
-28.94	20.82	-8.83
12.79	3.01	-8.93
59.77	-13.6	-21.46
-30.02	-14.48	-24.81
-49.24	14.19	-10.27
14.98	-28.33	-15.25
56.75	-36.99	-7.19
23.53	-31.53	-16.19
55.63	-4.59	-.98

// Koshino H, 2008: Autistic Patients
// Subjects=11
-50	22	26
42	8	36
4	8	62
6	22	44
-38	-54	50
52	-44	44
52	-50	-16
-36	-54	-28
-34	-70	-28
-50	12	36
42	42	0
-24	8	-14
42	28	-6
-6	20	48
6	12	24
-4	26	34
-42	-38	26
-58	-38	22
42	-28	24
52	10	-4
46	-26	-6
44	-66	20
-26	-60	-12
-22	-20	-20
-42	-42	-6
-18	-14	26
16	-10	28
4	-14	-12
-2	-22	8
34	28	44
32	-12	56
28	-70	48

// Koshino H, 2008: Controls
// Subjects=11
-34	54	14
-32	2	58
38	24	-12
-2	20	50
-8	-6	62
-36	4	30
6	10	26
-32	-58	42
36	-64	42
58	-44	8
-44	-62	-24
42	-50	-26
-34	-88	-6
-24	6	-14
20	-12	8
-50	12	36
42	42	0
-24	8	-14
42	28	-6
-6	20	48
6	12	24
-4	26	34
-42	-38	26
-58	-38	22
42	-28	24
52	10	-4
46	-26	-6
44	-66	20
-26	-60	-12
-22	-20	-20
-42	-42	-6
-18	-14	26
16	-10	28
4	-14	-12
-2	-22	8
34	28	44
32	-12	56
28	-70	48

// Seghier M L, 2008: Semantic Categorization vs. Perceptual Categorization
// Subjects=50
-50	14	-13
-48	27	15
-45	15	22
-50	-38	3
-30	-65	42
-48	5	47
-3	20	46
42	20	-9
39	54	22
50	-32	2

// Fitzgerald P B, 2008: MDD Patients
// Subjects=13
30	30	2
48	20	36
32	48	18
44	20	34
42	-52	36
-22	-36	-6
20	-36	-6
-40	2	-6
-38	22	-16
30	0	-6
20	-40	50
50	0	22
-44	4	48
28	18	54
50	12	16
6	10	4
6	12	42
34	-8	54
-4	2	60
-2	8	46
-28	-54	48
-28	20	52
-52	24	16
50	-38	34
52	-52	28
18	-66	42
36	-80	24
-38	-62	36
-52	-46	32
-46	-54	28
-58	50	6
18	-10	10
-18	-14	12
42	8	-16
50	-58	20
44	24	48
-42	-32	22

// Fitzgerald P B, 2008: Controls
// Subjects=13
30	30	2
48	20	36
32	48	18
44	20	34
42	-52	36
-44	6	26
-42	38	20
44	36	28
28	18	54
50	12	16
6	10	4
6	12	42
34	-8	54
-4	2	60
-2	8	46
-28	-54	48
-28	20	52
-52	24	16
50	-38	34
52	-52	28
18	-66	42
36	-80	24
-38	-62	36
-52	-46	32
-46	-54	28
-58	50	6
18	-10	10
-18	-14	12
42	8	-16
50	-58	20
44	24	48
-42	-32	22

// Mitterschiffthaler M T, 2008: Depressed Patients
// Subjects=17
-10	32	28
6	-60	42
-52	-72	24
-26	32	4
8	-46	-6
-26	10	58
-5	30	24
2	-60	44

// Mitterschiffthaler M T, 2008: Normals
// Subjects=17
-30	62	14
-5	30	24
2	-60	44

// Dillon D G, 2008: Anticipation; (Reward - No Incentive ) masked with 
// (Reward - Loss)
// Dillon D G, 2008: (Anticipation; Reward - No Incentive) masked with (Reward 
// Anticipation - Reward Outcome Gain)
// Dillon D G, 2008: (Anticipation; Loss - No Incentive) masked with (Loss 
// Anticipation - Loss Outcome Penalty)
// Dillon D G, 2008: Outcome; (Reward - No Incentive) masked with (Reward - 
// Loss)
// Dillon D G, 2008: (Outcome; Reward - No Incentive) masked with (Reward 
// Outcome Gain - Reward Anticipation)
// Dillon D G, 2008: Outcome; (Loss - No Incentive) masked with (Loss - 
// Reward)
// Dillon D G, 2008: (Outcome; Loss - No Incentive) masked with (Loss Outcome 
// - Loss Anticipation)
// Subjects=8
3.66	14.78	34.23
19.22	5.59	-18.91
-28.07	-3.65	-.38
-55.24	22.43	-6.98
66.32	-31.02	23.13
-44.47	-50.02	-24.65
-23.71	-75.6	-12.39
9.83	-93.66	-12.29
13.32	-86.36	8.21
35.63	-84.73	-21.46
6.81	20.65	27.99
-55.24	22.43	-6.98
48.69	11.28	5.8
62.53	3.18	-12.69
49.08	-11	31.53
-64.42	-25	25.88
66.32	-31.02	23.13
6.67	-8.87	10.75
-41.25	-50.21	-26.93
-10.38	24.61	36.86
45.41	22.96	4.69
-.6	21.77	40.33
-23.86	-59.2	-20.73
3.15	-55.81	-20.41
41.87	36.08	-15.59
69.07	-20.4	-12.71
-37.77	-72.46	-12.46
-24.02	-55.99	-32.25
42.02	-67.89	-25.48
-7.62	49.47	4.1
3.74	-30.62	30.88
6.35	52.19	-2.01
-28.39	27.87	-19.19
-50.78	25.61	3.83
38.52	28.65	-26.01
48.32	47.9	-15.75
-41.34	54.18	-12.6
41.97	61.99	-2.47
45.8	24.81	35.88
22.91	56.01	26.46
9.94	63.62	28.17
6.93	33.6	40.16
-68.15	-42.89	-15.99
69.1	-23.49	-11.28
55.78	12.13	-31.39
69.31	-40.53	1.61
52.3	-53.82	21.14
-3.94	-92.8	9.15
-20.77	-62.46	-32.79
19.23	-39.15	-26.81
-61.11	-50.72	26.13
-28.09	-84.74	-18.13
-1.09	52.04	8.21
-58.18	23.53	16.49
49.45	31.85	-15.3
-20.89	48.2	-20.21
-41.35	57.37	-12.92
-40.48	19.06	48.01
-17.32	69.31	10.14
-7.32	56.11	29.21
-6.94	25.01	52.45
56.72	12.6	42.51
-64.89	-47.13	-15.63
59.52	-67.34	-9.02
65.87	-25.63	-11.02
-61.11	-50.72	26.13
-28.07	-87.93	-17.82
-13.77	-77.2	4.41
23.04	-77.61	9.42

// Cooper J C, 2008: Valence Effect
// Cooper J C, 2008: Salience Effect
// Cooper J C, 2008: Interaction Effect of Valence and Salience
// Subjects=12
-10	34	10
-4	28	8
36	-74	36
-22	8	44
-2	-24	2
-34	42	18
38	36	-20
48	40	2
44	-50	38
-10	34	-22
-18	12	-18
-26	-8	62
6	-66	-24
50	-68	-20
-28	14	-4
34	-52	-30
-18	-66	54
-20	-18	66
-30	-58	46
-48	-48	40
-52	-58	42
24	-62	20
-22	-8	-10
-18	-6	-4
56	-28	36
-18	52	0
28	56	-6
18	-18	-2
18	10	18
26	-82	32
-50	6	-24
-20	-64	26
-12	6	8
-54	-46	26
-24	20	36
-10	4	18
-12	-58	26
-32	4	18
38	-30	36
-38	12	16
-6	-22	12
-6	26	14
-26	34	28
-22	-46	-8
10	14	-4
36	10	16
32	-6	48
-26	2	-30
26	-52	-22
42	-50	-26
-20	-76	18
6	-84	6
-42	-76	18
30	16	36
0	-72	18
40	-50	-2
34	34	26
6	-8	64
-34	-92	24
6	-56	14
-10	-72	8
-6	6	-4

// Strohle A, 2008: Normals
// Subjects=10
-18.39	-24.76	-8.55
4.36	-16.51	-1.91
-50.42	-62.46	14.78
-52.66	-69.68	6.57
4.35	51.2	10.44
20.3	39.5	-12.2
-50.91	38.92	-3.09
-44.29	18.08	3.34
54.9	45.36	-8.89
49.62	36.39	-1.19
43.01	55.1	-7.41
14.1	5.53	3.59
20.51	14.81	-.8

// Strohle A, 2008: ADHD Patients
// Subjects=10
46.37	39.57	-1.45
58.14	45.37	-8.95
20.25	63.21	-11.19
-50.91	38.92	-3.09
-44.29	18.08	3.34
54.9	45.36	-8.89
49.62	36.39	-1.19
43.01	55.1	-7.41
14.1	5.53	3.59
20.51	14.81	-.8

// Guroglu B, 2008: Peer vs. Celebrity + Positive vs. Non-Positive
// Subjects=28
6	32	-2
4	20	-4
-2	32	4
-8	6	-6
-6	-10	0
34	2	-34
30	-4	-22
38	8	-22
-28	-4	-26
-28	-12	-8
-32	-4	-12
52	-8	8
58	2	6
32	-22	-4
-44	-26	2
-44	-76	28
-40	-62	20
-50	-64	18

// Payer D E, 2008: Methamphetamine (MA) Dependent Subjects
// Subjects=12
-22	-6	-16
28	28	-6
38	50	0
-56	22	28
-6	18	46
32	-58	44
16	-64	-6
-8	-70	40
-20	-100	18
2	-76	-4
-22	-30	-4
18	-24	-10
18	-14	-10
-16	-10	4
-58	-52	8
38	-50	-22
-42	-46	-26
48	38	-6
64	-48	14
42	-36	38
40	10	-20
54	-66	-2
58	-54	-16
-16	-88	26
-2	16	20

// Payer D E, 2008: Normals
// Subjects=12
-22	-4	18
44	4	26
-46	46	-6
-38	-4	50
0	28	46
-8	12	46
42	-42	24
50	-74	2
-28	-68	40
22	-4	-16
40	-4	50
-48	-46	8
62	-50	14
48	38	-6
64	-48	14
42	-36	38
40	10	-20
54	-66	-2
58	-54	-16
-16	-88	26
-2	16	20

// Brown S, 2008: Glottal Stops > Fixation
// Brown S, 2008: Phonation > Fixation
// Brown S, 2008: Lips > Fixation
// Brown S, 2008: Tongue Movement > Fixation
// Subjects=16
49.09	-5.48	33.22
64.9	11.33	5.51
58.86	10.28	40.46
-2.51	12.68	58.07
-39.51	-10.25	32.96
-55.64	5.62	42.87
-58.16	10.56	15.53
-60.32	-9.11	11.91
-48.31	-33.32	16.34
26.92	-66.68	-23.1
39.72	-61.29	-35.06
-25.05	-67.69	-31.08
-42.41	-63.91	-35.64
-23.12	-82.52	-52.06
49.08	-3.35	33.01
10.42	14.65	55.42
67.03	11.13	3.26
55.58	3.36	35.6
-2.52	14.81	57.86
-41.72	-6.21	30.36
-53.45	5.83	45.05
-62.57	8.76	7.94
56.21	-8.78	-2.43
55.19	-29.09	-1.53
60.5	-8.97	-4.73
58.24	-.99	-11.08
-43.94	-37.35	18.91
-52.86	-18.63	1.52
-58.07	-31.44	14.08
-66.7	-22.65	16.72
-58.43	-3.53	-8.84
26.54	-73.84	-53.76
29.02	-67.08	-27.58
37.63	-65.13	-30.16
14.04	-74.82	-17.59
-27.19	-65.36	-29.03
-7.55	-72.56	-15.21
-37.94	-71.58	-25.99
-23.13	-80.4	-52.27
-36.17	-61.3	-53.93
24.81	-11.53	-7.23
-18.45	-5.51	-9.33
62.94	-12.31	16.85
63.1	-5.64	30.76
69.23	13.58	6.34
67.37	11.5	30.11
-53.54	-7.97	35.21
-60.07	9.13	34.75
-63.47	-10.62	18.84
-4.79	8.55	48.44
-46.42	6.27	3.43
24.75	-3.23	-10.29
27.06	4.4	2.36
-22.63	-2.26	2.75
-20.57	-2.98	-5.06
26.88	-64.76	-25.53
-22.82	-64.93	-24.67
71.58	-3.56	18.08
63.11	-7.76	30.97
67.05	13.47	5.27
-66.59	-6.51	28.57
-55.9	6.94	22.57
-66.78	-6.8	14.03
-2.54	5.88	54.27
-22.65	2	2.33
-20.62	3.2	-7.91
20.42	-71.16	-24.79
-20.64	-69.18	-24.28

// Eyler L T, 2008: Normals
// Subjects=14
-5.05	-34.34	18.94
10.02	-72.66	17.52
-35.21	17.93	9.33
-45.82	-50.64	-9.33
-2.82	24.8	54.11

// Eyler L T, 2008: Schizophrenia/Schizoaffective Disorder Patients
// Subjects=17
-10.37	-45.11	17.68
35.85	-38.75	54.53
35.52	-3.72	25.95
2.66	-53.9	40.57
4.98	49.01	-32.77
52.79	-59.03	24.81
10.02	-72.66	17.52
-35.21	17.93	9.33
-45.82	-50.64	-9.33
-2.82	24.8	54.11

// Koppelstaetter F, 2008: 2 Back - 0 Back, Caffeine
// Koppelstaetter F, 2008: 2 Back - 0 Back, Placebo
// Subjects=15
-7.36	30.61	20.52
-46.34	24.33	12.85
-33.49	49.79	8.99
-53.97	15.06	6.05
-32.87	8.45	48.93
-53.82	17.27	18.15
-19.7	-62.12	51.2
-37.08	-41.01	48.29
-24.59	-77.34	3.49
-33.66	-65.28	-27.81
-3.38	-29.9	-18.38
10.06	22.89	28.84
52.96	32.77	5.84
44.05	59.15	-10.07
52.86	23.22	-4.42
31.95	8.68	47.8
53.16	13.5	17.83
23.59	-65.8	55.31
49.23	-38.35	37.59
35.85	-82	-3.81
44.12	-65.01	-29.16
9.63	-29.54	-15.27
-2.8	24.74	37.84
-42.07	37.11	11.51
-28.57	12.72	48.43
-28.35	-57.89	50.93
-50.03	-33.3	51.11
-6.71	-57.51	53.89
-15.8	-97	10.88
-33.61	-68.16	-24.16
5.84	24.77	37.69
52.96	32.77	5.84
31.89	8.26	43.36
27.77	-58.11	45.51
53.61	-37.92	41.95
23.56	-61.65	53.78
23.1	-96.86	10.21
31.11	-69.83	-34.07

// Noriuchi M, 2008: Own Child vs. Other Child
// Noriuchi M, 2008: Other Child vs. Own Child
// Noriuchi M, 2008: Own Child vs. Other Child, Separation Situation
// Noriuchi M, 2008: Own Child vs. Other Child, Play Situation
// Noriuchi M, 2008: Separation Situation vs. Play Situation, Own Child
// Noriuchi M, 2008: Play Situation vs. Separation Situation, Own Child
// Subjects=13
-30	24	-24
28	22	-24
54	6	28
2	18	62
52	10	48
-38	2	28
58	-66	8
36	24	6
-16	-56	14
-20	6	0
-16	-8	10
-12	-16	6
0	-28	-12
6	-8	-4
22	56	26
32	48	24
32	34	16
68	-14	6
-46	-36	52
-34	-42	68
30	-32	48
-22	-58	50
-26	-34	-22
-22	-44	-8
-14	6	-12
12	8	-12
32	32	-18
-42	14	46
56	28	26
-26	26	52
-20	0	70
26	54	42
0	28	66
58	-64	12
-36	-76	30
44	-70	34
2	-76	56
36	-66	-8
-4	-60	26
2	-34	36
22	6	-10
-26	22	-24
26	26	-22
54	10	46
44	-58	-8
60	-54	-4
62	-40	20
50	-76	-14
-22	12	4
4	-10	-12
-32	24	0
-16	12	56
18	0	78
-4	2	70
4	32	66
56	24	26
-50	56	22
-42	12	42
-32	6	44
-38	22	56
32	52	40
50	24	48
-18	-34	54
64	-8	-12
-52	-34	-2
48	-32	-6
46	-22	-6
54	-16	-8
-60	-62	24
-52	8	0
62	-26	8
-52	-56	-14
61	-60	30
-42	-70	52
-38	-32	38
54	-54	50
-40	-80	42
-6	-78	12
-14	-72	26
-4	-78	52
6	-64	62
2	24	30
12	-44	38
-2	-18	-10
-14	-22	-6
-18	-2	20
-13	-21	-12
-30	-26	54
32	-38	12
34	-58	18
-28	-76	8
-46	-40	30
-6	4	-12

// Watanabe T, 2008: Hits - Correct Rejection (Retrieval Success)
// Subjects=18
-45	27	24
-48	27	6
36	-12	-30
57	0	-24
-36	-3	-18
-51	6	-24
-18	-60	39

// Iaria G, 2008: Emotional Processing - Orientation Discrimination
// Iaria G, 2008: Orientation Discrimination, Positive and Negative - 
// Orientation Discrimination, Neutral
// Subjects=10
-6	34	56
8	36	56
-12	56	34
-14	58	18
-48	46	-12
-40	34	2
40	28	-22
-40	34	2
-4	50	-20
56	-70	18
-24	-34	-22
38	-74	24
-36	-84	26
-26	-10	-14
10	-86	-26
-6	24	64
-44	34	-20
-46	-52	26
46	-48	-22
-60	-56	14
54	-70	-2

// Spence S A, 2008: Lie - Truth
// Spence S A, 2008: Comply - Defy
// Spence S A, 2008: [(Lie - Truth) - (Defy - Comply)]
// Subjects=17
-34	34	6
-30	-86	16
-10	-96	16
-4	-46	-18
32	36	6
60	10	18
20	10	-10
-26	28	4
-46	26	0
-20	-14	-22
2	56	6
2	44	-18
18	-24	-20
-28	44	-16
-58	-26	-4
-8	-98	24
-20	-106	4
-20	-24	6
38	46	-18
62	8	18
38	-86	22
14	-26	8
-42	30	-4
-26	28	4

// Abe N, 2008: Effect of Making Deceptive Responses:  (LT - TR) + (LN - CR)
// Abe N, 2008: True Recognition to True Targets (TR) > False Recognition to 
// False Targets (FR)
// Abe N, 2008: Lie to New Targets (LN) > Correct Rejection to New Targets 
// (CR)
// Abe N, 2008: False Recognition to False Targets > Correct Rejection to New 
// Targets (CR)
// Subjects=20
12	57	-6
33	21	15
24	15	60
42	6	51
24	-3	57
15	-27	0
24	-69	-12
18	-75	39
-45	48	-15
-12	21	57
-30	21	9
-48	9	6
-27	3	60
-54	-6	39
-42	-27	3
-30	-42	45
-27	-57	54
-51	-60	36
-30	-69	30
-9	-78	45
66	-21	-3
0	60	24
0	-45	-42
-48	-9	-15
-60	-18	-12
-51	-54	36
24	15	39
18	-27	3
-12	21	54
-27	21	12
-42	18	39
-27	9	42
-51	-57	36
-33	-69	33
9	6	-9
36	-9	-15
-9	33	-18
-21	27	-24
-42	27	0
-24	18	39
-27	18	12
-12	3	9
-27	-63	54
-18	-63	21

// Suchan B, 2008: Recollection vs. Correct Rejection
// Suchan B, 2008: Familiarity vs. Correct Rejection
// Subjects=10
31.2	-18.83	-16.7
22.34	-7.34	-31.13
-33.78	-9.25	-25.51

// Dunsmoor J E, 2008: Unconditioned Response Diminution
// Subjects=18
0.28	30.69	29.49
54.58	46.58	8.57
-6.5	-69.17	-30.87
19.83	-82.41	-31.06
22.11	-44.18	-25.49
-31.09	36.39	-31.63
-46.18	-25.03	10.83
48.5	-22.5	10.31
-3.43	-16.46	-.53

// Galati G, 2008: Sound > No Sound
// Galati G, 2008: Action vs. Non Action Related Sounds
// Galati G, 2008: Non Action vs. Action Related Sounds
// Galati G, 2008: Mouth > Hand Sounds
// Galati G, 2008: Hand > Mouth Sounds
// Subjects=11
-52	-22	2
-44	-28	4
-58	-18	0
-60	-46	10
-36	-32	42
-58	-20	24
-56	-38	24
-40	-14	56
-4	8	52
60	-14	0
66	-32	10
68	-34	4
56	-40	4
34	-48	46
62	10	20
42	40	26
32	8	58
44	26	14
46	16	30
12	42	54
24	40	52
2	58	12
4	50	8
18	-70	8
8	-68	-12
8	-78	18
-48	34	-10
-54	36	-4
-46	38	-2
-56	10	12
-50	20	20
-60	22	6
-54	-48	4
-54	-42	-2
-64	-30	-12
52	-42	4
56	-30	-2
68	-32	-2
-38	-28	16
-46	-28	18
-50	-12	0
46	-20	6
44	-10	-6
34	-22	16
28	48	44
28	48	22
30	54	34
8	-46	54
14	-48	62
16	-42	48
16	-74	48
24	-72	40
-42	-24	12
-50	-6	0
-40	-30	12
-62	-6	-8
68	-24	-6
62	-28	-8
64	-12	-8
58	-4	-16
-50	38	16
-50	38	24
-42	32	20

// Goldin P R, 2008: Watch, Negative > Watch, Neutral
// Goldin P R, 2008: Reappraise > Watch, Negative
// Goldin P R, 2008: Suppress > Watch, Negative
// Goldin P R, 2008: Watch, Negative > Suppress
// Goldin P R, 2008: Reappraise > Suppress
// Goldin P R, 2008: Suppress > Reappraise
// Subjects=17
-42.99	24.66	-26.83
-36.41	25.35	-4.66
1.07	61.47	18.65
56.96	16.82	41.82
4.75	29.13	68.15
-54.25	10.98	31.32
53.51	32.97	17.09
-50.24	20.32	0.38
56.62	20.96	-.9
-42.23	2.87	63.09
-13.82	66.55	30.66
-54.42	32.33	18.38
8.9	46.53	58.84
-49.93	-78.62	0.87
44.61	24.84	-32.31
38.39	22.45	-7.51
38.11	-39.74	69.09
-46.59	-21.16	41.73
-6.19	-91.18	-14.19
19.19	-5.84	-13.84
-17.15	-2.88	-13.67
-9.52	6.36	8.89
11.88	3.57	12.22
1.24	-30.13	4.02
-3.25	-5.97	-13.57
19.41	-23.42	6.59
-10.79	73.49	9.97
52.21	45.97	-7.41
-53.57	44.37	-4.94
-38.15	11.85	41.1
-29.06	44.89	-14.19
-39.79	47.65	-18.76
-36.52	40.61	-13.75
-39.84	9.73	-41.23
-60.98	7.68	-10.7
-54.73	21.41	-26.42
-65.3	-3.77	-20.84
-60.72	-34.73	5.12
-60.77	-38.5	-2.37
-47.26	-.63	-36.93
-30.55	-62.7	26.08
-42.34	-54.31	25.51
-49.65	-67.96	42.35
8.78	-67.86	-2.94
1.45	24.83	54.05
42.97	15.79	29.8
52.47	25.57	17.72
54.48	42.95	8.43
57.73	23.6	5.56
32.93	51.94	-11.03
-35.47	60.25	-7.6
-47.15	48.89	-2.05
-35.27	20.58	2.42
57.03	-65.95	17.54
67.59	-55.11	5.35
56.94	-74.55	2.65
-60.57	-70.42	11.46
-46.9	-61.73	-15.08
-38.95	-64.47	45.28
-31.39	-77.91	49.67
39	-72.26	33.88
-1.57	-94.08	30.6
0.29	-77.26	0.18
-6.09	-85.76	0.96
-14.04	78.5	6.24
-6.28	67.19	38.32
-50.25	27.98	3.08
-39.3	-15.42	18.87
-39.83	28.56	-31.66
-57.47	-41.85	9.02
-42.87	-7.07	-24.17
-57.97	5.65	-37.33
41.46	18.82	-27.31
4.69	-73.66	18.78
-16.65	-98.71	13.32
19.76	-102.12	21
1.47	-5.72	44.35
1.4	4.51	39.03
1.38	19.66	42.22
-2.3	48.82	-7.02
52.37	35.54	9.08
52.51	14.99	18.61
-6.71	62.74	-19.29
-35.38	53.45	0.78
49.26	25.55	17.76
56.72	9.93	7.83
-46.88	-61.48	-11.76
-64.87	-22.38	27.55
49.46	-74.59	2.73
-38.95	-79.87	38.76
1.17	-19.89	-1.3

// Huh J, 2008: Perfume > Rest
// Subjects=8
10	-2	-6
-36	38	-2
22	-6	-30
-16	0	-14
-38	14	4
58	-46	26
8	-84	16
-24	56	20
8	22	64
0	-28	24
-14	-20	-12
52	-46	10
-22	-64	64
-14	36	56
-56	-36	42
10	18	28
46	-52	8
32	-40	-42
48	-60	26
0	-72	2
8	-24	0
52	-10	20

// Reiss A L, 2008: Normals
// Subjects=12
-42.57	24.65	-29.83
-1.23	-12.46	-15.66
-1.13	-18.32	-9.48
48.26	13.48	-28.03
-16.33	7.36	-9.52
44.04	-9.83	-24.53

// Reiss A L, 2008: Narcoleptic Patients
// Subjects=10
7.59	-8.95	-1.59
55.85	-5.95	-29.6
-51.13	-2.18	-29.27
-16.33	7.36	-9.52
44.04	-9.83	-24.53

// Rosenbaum M, 2008: Placebo Treatment > Initial Weight
// Rosenbaum M, 2008: Initial Weight > Placebo Treatment
// Rosenbaum M, 2008: Leptin Treatment > Placebo Treatment
// Rosenbaum M, 2008: Placebo Treatment > Leptin Treatment
// Subjects=6
8	-14	-18
-10	-54	-4
-18	-10	0
-46	28	-4
18	-84	-4
38	22	34
-52	22	38
58	-2	-18
-32	-24	-12
32	-26	-12
-20	-4	-18
-6	20	-4
-22	38	2
6	26	2
10	-14	34
-6	-24	34
-48	-36	-18
12	6	-12
-40	-58	40
-24	50	-12
-26	-48	2
36	-2	34
-36	-10	36
40	-56	34
14	36	0
-14	36	0
-16	18	38
-6	-46	-14
-22	-2	-12
12	14	-2
52	30	-6
36	-4	34
-34	-52	-2
6	26	40
26	34	-18
-26	44	-12
-38	6	42
-54	-32	-18
-48	-28	44
42	-76	40
-12	6	-10
2	2	4
-2	2	4
-6	-14	-20
-18	-20	34
26	-4	40
12	-44	-22
-14	-40	-20
-26	18	-8
-36	6	-10
20	-84	-4
-6	64	0
-36	58	-6
-28	12	32
32	-74	0
42	-38	0
-42	-26	-18
38	-30	-16
28	-64	28
-20	-50	30
-12	40	38
-44	-4	-10

// Schwartz S, 2008: Humor > Neutral, Normals + Narcoleptic Patients
// Schwartz S, 2008: Humor > Neutral, Normals > Narcoleptic Patients
// Schwartz S, 2008: Humor > Neutral, Narcoleptic Patients > Normals
// Subjects=12
-45	-51	-18
48	-63	-15
-42	18	-3
-39	-87	6
-12	39	45
18	6	-18
-21	-6	-21
12	3	-18
-9	45	15
27	12	-21
42	-78	-6
-27	24	-18
-48	18	15
0	18	36
45	18	-12
12	60	3
57	-33	27
-36	3	-6
-9	-45	33
51	30	3
33	-57	-15
-39	-60	-12
-15	9	-3
33	3	-21

// Bueti D, 2008: Action - Control Action
// Bueti D, 2008: Perception - Control Perception
// Bueti D, 2008: (Action - Control Action) vs. (Perception - Control 
// Perception)
// Bueti D, 2008: Control Perception - Perception
// Subjects=14
-48	45	9
-33	36	27
42	51	6
12	0	60
-3	15	51
45	-39	48
-30	12	-3
24	9	9
24	-9	0
-30	-69	-45
30	-66	-24
-57	12	24
-27	12	-3
21	-6	-9
27	-15	24
42	-60	-36
-48	27	39
12	24	60
-45	12	51
48	-39	45
-36	-54	51
54	-66	-9
-30	-63	-9
24	-66	-9
0	-78	-24
12	-63	-36
-30	-66	-45
12	-93	-33
-51	-66	39
15	30	60
-12	-54	36
21	-69	60

// Ettinger U, 2008: Standard Antisaccade
// Ettinger U, 2008: Standard Saccades
// Ettinger U, 2008: Delayed Saccades
// Ettinger U, 2008: Saccade-by-Delay Interaction
// Subjects=17
-11.02	-70.6	51.89
8.26	14.64	55.46
14.93	-68.17	53.45
16.5	-94.42	2.23
-13.93	8.07	9.42
32.1	10.88	59.9
58.23	16.45	-8.33
32.36	-54.95	67.53
63.25	-38.5	35.13
48.74	46.66	16.86
16.37	-6.81	9.26
49.27	5.75	50.03
-32.59	-50.7	59.26
-11.49	-89.43	11.18
-26.28	6.01	56.9
63.25	-38.5	35.13
32.1	10.88	59.9
-26.28	6.01	56.9
49.27	5.75	50.03
32.36	-54.95	67.53
-32.59	-50.7	59.26
14.93	-68.17	53.45
-11.02	-70.6	51.89
48.74	46.66	16.86
58.23	16.45	-8.33
16.37	-6.81	9.26
8.26	14.64	55.46
-13.93	8.07	9.42
16.5	-94.42	2.23
-11.49	-89.43	11.18
63.25	-38.5	35.13
32.1	10.88	59.9
-26.28	6.01	56.9
49.27	5.75	50.03
32.36	-54.95	67.53
-32.59	-50.7	59.26
14.93	-68.17	53.45
-11.02	-70.6	51.89
48.74	46.66	16.86
58.23	16.45	-8.33
16.37	-6.81	9.26
8.26	14.64	55.46
-13.93	8.07	9.42
16.5	-94.42	2.23
-11.49	-89.43	11.18
63.25	-38.5	35.13
32.1	10.88	59.9
-26.28	6.01	56.9
49.27	5.75	50.03
32.36	-54.95	67.53
-32.59	-50.7	59.26
14.93	-68.17	53.45
-11.02	-70.6	51.89
48.74	46.66	16.86
58.23	16.45	-8.33
16.37	-6.81	9.26
8.26	14.64	55.46
-13.93	8.07	9.42
16.5	-94.42	2.23
-11.49	-89.43	11.18

// Calder A J, 2008: Disgusting - Non-Foods
// Calder A J, 2008: Disgusting - Bland Foods
// Calder A J, 2008: Disgusting - Appetizing Foods
// Calder A J, 2008: Appetizing - Non-Foods
// Calder A J, 2008: Appetizing - Bland Foods
// Calder A J, 2008: Bland - Non-Foods
// Subjects=12
48	10	-10
-14	-2	-6
22	10	44
-14	-2	-8
44	-34	42
-46	4	-26
-52	-10	43
62	-2	24
-46	-12	24
30	0	12
48	-42	36
26	6	60
-42	24	24
20	-80	24
22	30	24

// Driessen M, 2008: T1 vs.T2, ULE vs. RLE
// Subjects=13
9	-49	8
-27	-70	-9
6	-76	-13
42	-29	7
15	-75	12
-47	-12	-2
36	18	13
-3	-93	7
30	41	-2
18	30	30
-27	19	32
-9	19	32
21	2	41
-33	17	49
-24	-50	50
27	17	41
6	-24	-16
-3	-21	-16
39	-74	34
-9	-33	46
9	11	41
-3	10	38
-18	-8	14
57	6	3

// Hanakawa T, 2008: Instructional Cue
// Hanakawa T, 2008: Finger Tapping, Imagery
// Hanakawa T, 2008: Finger Tapping, Movement
// Hanakawa T, 2008: Finger Tapping, Imagery + Finger Tapping, Movement
// Hanakawa T, 2008: Finger Tapping, Movement > Finger Tapping, Imagery
// Hanakawa T, 2008: Finger Tapping, Imagery > Finger Tapping, Movement
// Hanakawa T, 2008: Finger Tapping, Imagery > Instructional Cue
// Hanakawa T, 2008: Delay 1 vs. Delay 2
// Subjects=13
-40	-72	-28
52	14	26
-28	0	62
-32	-56	44
42	-56	58
28	-76	44
-54	10	30
-50	6	42
-2	12	42
-4	10	52
58	-44	34
-56	10	26
-44	-70	-28
6	14	40
-2	2	58
-40	-52	58
-20	4	60
-38	-4	58
-44	14	-12
34	-2	56
56	14	-14
12	-74	50
18	-52	-32
6	-64	-32
-48	-30	46
-36	-26	56
-36	-8	62
-2	2	50
-28	-62	-42
66	-22	12
-26	-10	-2
-28	8	-6
32	-68	56
52	8	-4
-10	-24	-6
-44	-70	-28
6	12	44
-2	-2	54
56	16	-14
32	-68	-36
-46	14	-10
-24	-4	-2
-54	12	26
-56	6	38
-40	-52	58
-28	-66	58
-62	-38	22
20	2	4
14	-76	52
64	-42	28
-36	-6	60
-4	-88	2
34	0	60
-34	-28	64
-48	-28	46
-38	-18	60
-34	-46	64
14	-52	-32
6	-64	-40
56	-26	48
66	-24	10
-2	-10	44
-58	-22	8
-10	-22	4
0	10	58
-16	6	58
42	0	40
30	-60	-18
56	14	-12
-46	14	-16
0	-2	60
6	18	32
46	0	44
32	-6	60
-12	-76	-12
-28	-64	-36
16	-78	-12
-64	-30	26
10	-28	36
-4	-8	58
-8	12	38

// Iseki K, 2008: Gait Observation > Scrambled Gait Observation
// Iseki K, 2008: Stepping Observation > Scrambled Gait Observation
// Iseki K, 2008: Gait Observation > Stepping Observation
// Iseki K, 2008: Virtual Walking > Scrambled Virtual Walking
// Iseki K, 2008: Gait Observation > Scrambled Gait Observation and Virtual 
// Walking > Scrambled Virtual Walking
// Subjects=16
18	-12	64
-8	-10	68
-24	-2	64
-12	-56	64
-50	-34	30
-56	20	6
46	-62	0
30	-94	-2
-46	-78	0
26	-4	-38
-26	-10	-26
48	2	44
-44	0	56
48	8	26
-40	14	28
-36	-54	58
50	-70	-2
-48	-68	8
-38	-44	-26
26	-90	-14
-30	-88	-6
22	-6	58
-24	-8	68
32	-4	46
-30	-6	42
12	-66	64
-16	-62	22
-16	-16	46
38	-80	18
-38	-82	24
-18	-4	-22
6	20	0
-10	22	-2
8	-20	6
32	-6	48
-14	-16	48
-34	-8	52
14	-64	66
-10	-62	62
38	-56	-12
-34	-42	-16
26	-86	-6
-24	-90	-6
-20	-28	-2

// Liu C, 2008: Real Characters > Checkerboard
// Liu C, 2008: Pseudo Characters > Checkerboard
// Liu C, 2008: Artificial Characters > Checkerboard
// Liu C, 2008: Real > Artificial Characters
// Liu C, 2008: Pseudo > Artificial Characters
// Liu C, 2008: Pseudo > Real Characters
// Liu C, 2008: Artificial > Real Characters
// Subjects=14
-46.27	-80.16	-2.59
-47.81	-62.42	49.47
-33.82	-8.5	-28.94
-41.82	16.02	27.04
53.17	-81.63	-.78
-44.09	-84.41	-2.21
-26.26	-62.76	44.65
-52.63	22.46	27.7
-37.96	36.63	-5.32
-22.48	-17.59	10.98
51.01	-81.64	-.74
36.32	-59.87	37.7
22.59	39.38	-2.14
18.57	11.04	16.42
25.04	-15.29	9.95
-43.98	-83.58	6.67
55.34	-75.03	0.78
34.19	-69.45	38.68
15.98	27.48	-14.3
-50.45	24.81	29.68
-60.26	21.92	22.29
-53.61	-12.85	28.97
-64.3	-30.65	34.28
-62.54	-55.55	-2.51
-52.94	-43.27	-9.49
-55.92	-53.43	8.38
-55.72	7.23	37.11
-50.48	20.24	26.77
-46.51	-54.61	-16.32
3.33	-3.02	4.62
14.25	4.44	14.9
37.75	-.75	-7.4
31.1	19.88	-16.05
-46.45	-62.91	-13.26
-50.54	-86.35	0.34
-22.93	35.95	-13.36
-11.82	-4.35	2.77
-26.96	-6.73	1.02
-11.74	35.6	16.74
26.84	19.21	-11.43
28.95	18.81	-15.9
7.62	-8.74	0.63
16.34	15.94	11.49
24.7	54.38	-2.54
14.09	41.56	10.11
34.22	-45.22	45.25
32.2	-48.55	55.7
46.73	-21.18	14.64
24.95	57.32	17.33
27.29	48.79	29.34
56.23	-62.24	-11.71
25.91	-56.28	-15.15
-41.69	-88.06	16.04
-46.1	-79.98	10.84
-29.08	-70.95	-8.28
-35.57	-64.48	-7.68
-20.31	-77.63	0.08
-21.84	-83.92	47.79
-53.78	-75.42	2.67
38.31	-83	19.78
33.53	-60.19	-11.53
37.85	-51.46	-10.22
31.21	-44.97	-20.84
60.53	-57.97	-12.21
42.7	-23.37	37.34
25.91	-61.36	68.28
36.32	-67.52	36.21

// Mehnert U, 2008: Bladder Filling vs. Rest
// Mehnert U, 2008: Combined vs. Rest
// Mehnert U, 2008: Bladder Filling vs. Combined
// Subjects=8
47	12	15
42	35	13
27	12	-13
-50	20	20
-41	37	15
5	29	44
43	10	2
-39	14	-2
-8	-64	29
58	-42	0
58	-41	33
-51	1	7
-54	-28	22
-58	-42	22
13	-73	-25
-5	-75	-23
-20	-65	-26
35	41	26
0	51	5
-34	30	33
-35	-51	31
3	-58	17
49	7	11
45	-23	46
26	-29	61
-32	-29	56
2	-36	55
56	-37	24
51	-48	45
-55	-29	23
-51	-41	36
-35	-51	31
-52	-4	6.8
-10	-53	3
-25	-66	-26
49	29	12
-48	19	19
56	-34	20
7	19	24
8	37	24
28	3	7

// Munzert J, 2008: Motor Imagery > Gymnastic Film
// Munzert J, 2008: Gymnastic Film > Motor Imagery
// Munzert J, 2008: Gymnastic Film and Motor Imagery > Fixation
// Subjects=10
5.57	14.42	29.23
-42.66	-13.73	-.2
43.78	4.25	-9.39
-48.08	4.13	-2.75
-.91	-8.31	11.14
-28.22	-52.97	55.34
27.36	-52.55	55.79
24.61	-19.3	-9.42
3.14	-50.12	-34.47
-24.2	17.99	50.46
26.17	-4.29	60.67
-50.05	6.98	20.46
52.5	5.05	13.86
2.61	0.51	56.08
-18.1	-2.75	1.95
20.35	7.17	2.9
-24.66	-48.25	-35.42
-21.42	-56.69	-34.75
20.18	-60.47	-46.07
-27.29	-37.87	44.03
40.05	-34.04	46.28

// Dannhauser T M, 2008: Amnestic Mild Cognitive Impairment (aMCI) Patients
// Subjects=10
-52.25	18.42	17.29
55.86	-3.25	30.13
-3.13	-46.5	-14.63
-41.63	25.46	11

// Dannhauser T M, 2008: Normals
// Subjects=10
-37.22	26.86	28.68
8.58	-84.26	-36.13
-41.63	25.46	11

// Dohnel K, 2008: Amnestic Mild Cognitive Impairment (aMCI) Patients
// Subjects=16
10	30	22
18	37	33
32	51	16
50	-52	36
6	-35	44

// Dohnel K, 2008: Normals
// Subjects=16
9	38	31
44	-64	42
-14	-74	35

// Foland L C, 2008: Emotion Perception vs. Shape Perception, BD Patients vs. 
// Normals
// Foland L C, 2008: Emotion Labeling vs. Shape Perception, BD Patients vs. 
// Normals
// Foland L C, 2008: Emotion Perception vs. Shape Perception, Normals vs. BD 
// Patients
// Foland L C, 2008: Emotion Labeling vs. Shape Perception, Normals vs. BD 
// Patients
// Subjects=9
-18	-4	-12
-18	-28	-16
-4	-28	6
-16	42	2
8	24	24
-18	-12	-12
-26	-6	-8
-4	-12	10
-32	30	14
-34	28	-8
34	34	-4
36	24	-4
-14	34	18
-34	26	-8
36	30	-10
44	24	-8
-6	34	4
-46	26	28

// Sanchez-Carrion R, 2008: Traumatic Brain Injury Patients
// Subjects=18
34	-6	56
-28	2	54
-50	12	30
-34	-52	42
-28	-68	46
44	-48	44
34	-62	44
32	-6	56
46	2	54
-52	12	38
-50	-2	48
-60	8	16
-34	-56	46
-24	-80	46
-28	-76	40
44	-52	48
34	-66	44
44	-44	38
22	-74	36
-22	-28	-8

// Sanchez-Carrion R, 2008: Healthy Controls
// Subjects=14
24	4	62
-4	6	60
-52	12	26
-34	24	2
-36	44	24
-40	50	8
34	22	4
-42	-46	46
-22	-66	42
-32	-56	48
40	-54	52
44	-46	44
16	-68	56
8	-76	-26
32	-56	-38
-34	-56	-38
-52	10	24
-30	-2	46
-32	-2	56
24	2	62
4	20	44
-34	26	6
42	32	34
40	46	20
52	10	30
-42	50	10
-34	42	20
34	22	4
-20	-68	40
-38	-48	44
44	-46	46
34	-74	36
14	-82	-26
38	-66	-32

// Brune M, 2008: Schizophrenics
// Subjects=9
-46	-44	18
48	-42	20
54	-48	10
46	-64	18
-44	-36	8
-50	-40	12
50	-14	-12
62	-40	4
-60	-40	4
-10	-52	46
14	-54	48
-42	18	24
-16	28	42
6	-30	62
44	-22	20
14	34	-2
12	-28	22
14	-36	24
-20	40	-16
24	-16	20
-16	-20	0
38	12	28
22	24	40
0	-28	54
4	-34	60
46	-24	6
56	-36	-4
-48	-42	34
14	-70	46

// Brune M, 2008: Normals
// Subjects=13
-2	6	20
38	-22	24
-58	-40	16
-56	-68	18
-50	-32	0
62	-6	-16
60	-64	6
46	-70	10
-6	-54	36
34	10	34
40	20	-20
-10	18	16
24	-26	26
4	-28	0
44	-22	20
14	34	-2
12	-28	22
14	-36	24
-20	40	-16
24	-16	20
-16	-20	0
38	12	28
22	24	40
0	-28	54
4	-34	60
46	-24	6
56	-36	-4
-48	-42	34
14	-70	46

// Ghosh S S, 2008: Monosyllables > Passive Viewing
// Ghosh S S, 2008: Bisyllables > Monosyllables
// Subjects=10
-54	2	20
54	-8	48
20	-28	66
-50	14	0
-50	30	18
-40	-28	12
-40	-30	16
60	-2	16
2	18	50
-2	8	62
2	0	76
-32	-20	4
48	12	-2
-4	-42	12
2	-42	10
-50	-10	20
-58	-14	26
-66	-30	20
-4	-56	72
-4	-50	76
2	-56	74
46	-18	4
46	-22	6
-58	-22	12
68	-18	4
64	-26	12
-36	6	-20
-24	6	-20
-52	-54	-28
-8	-64	2
0	-66	8
14	-28	-8
10	-46	4
-12	-2	14
-16	-2	16
10	2	8
-26	-6	-6
-18	0	10
24	4	-6
-16	0	6
18	2	6
-12	-20	-2
-10	-8	6
14	-28	0
6	-8	8
-42	-62	-28
42	-56	-30
30	-78	-26
44	-36	-38
-30	-56	-28
-18	-60	-20
28	-58	-30
8	-66	-20
-28	-38	-54
40	-40	-52
-16	-32	-44
28	-36	-48
24	-34	-46
4	-58	-6
-4	-80	34
2	-84	36
-52	-6	30
-46	-8	54
50	-4	38
-56	16	20
-60	16	32
-6	4	68
8	16	44
54	-2	32
-24	-70	42
-20	-70	48
24	-68	50
-32	-52	50
-62	-2	-10
-66	-18	2
70	-2	-6
70	-28	4
-58	6	-12
-42	-64	-10
18	-92	-12
-38	-50	-24
-40	-44	-24
-22	4	4
26	4	0
22	8	4
-22	0	-4
-30	-84	-20
-8	-80	-32
-30	-60	-28
-32	-56	-26
28	-62	-26
2	-102	-6
14	-66	10
-46	-84	-2
-28	-82	16
-16	-92	-10
34	-88	20
34	-80	-16

// Gomot M, 2008: Novel > Standard Tones, All Subjects
// Gomot M, 2008: Novel > Standard Tones, ASC Patients > Normals
// Gomot M, 2008: Novel > Standard Tones, Normals > ASC Patients
// Gomot M, 2008: Novel > Standard Tones, Positive Correlation Between Signal 
// Change and AQ-Adol Scores
// Subjects=12
-13.94	-13.93	3.75
-47.33	-26.39	10.04
-49.48	-21.94	11.87
65.01	-19.61	7.45
58.69	-36.99	17.12
-58.11	-24.09	12.23
-62.43	-29.53	11.73
-42	-26.89	4.39
44.53	-29.15	9.87
52.28	-29.9	24.38
7.9	33.83	31.15
-37.74	-2.21	4.12
67.43	-47.18	22.47
18.54	-17.65	8.05
-2.72	10.06	41.53
52.86	-22.69	-13.33
10.15	-27.82	26.01
3.73	31.66	42.64
50.88	-18.06	1.94
-2.64	-4.73	44.11
-5.04	23.05	31.32
-31.21	-11.65	6.06
23.02	-70.06	9.8
-58.39	-18.52	-8.48
6.52	-16.5	-1.94
-.43	11	51.48
-41.42	-9.46	53.08
-30.56	-19.95	55.06
-26.29	8.13	56.69
-35.56	52.64	16.58
-40.34	51.43	-19.07
-42.35	51.4	-7.83
-48.67	-54.62	-16.28
-44.38	-47.16	-17.09
32.06	6.21	55.88
23.42	4.06	56.25
36.41	-4.51	55.75
42.9	-0.03	57.44
34.11	1.03	46.28
49.31	-13.7	48.6
65.09	9.49	20.26
-32.84	-59.15	37.68
-34.98	-51.3	41.43
-19.88	7.64	51.03
5.41	19.32	2.37
32.07	6.32	56.99
62.95	9.59	21.41
-.55	7.94	41.7
-18.53	-47.25	60.92
-51.71	-50.95	0.22

// Jogia J, 2008: Bipolar Patients
// Subjects=8
-44	24	24
-38	8	34
40	16	32
-50	-80	2
-32	-54	62
34	-54	48
-54	-40	34
20	-24	0
-36	-54	-24
40	-64	-28
4	6	64
34	58	-8
-42	42	2
4	-18	68
54	-72	0
-28	-28	64
-50	-80	8
-2	-18	10
2	-24	4
12	-4	68
-42	2	50
30	30	-18
28	-24	72
6	-36	28
-26	-22	-20
60	-16	36
-58	-12	-20
4	-16	70
-28	-14	68
2	-34	76
42	32	0
-42	40	0
14	-20	8

// Jogia J, 2008: Normals
// Subjects=12
48	40	14
6	16	44
68	-44	16
-48	44	6
66	-34	-14
-42	-50	-28
12	-4	68
-42	2	50
30	30	-18
28	-24	72
6	-36	28
-26	-22	-20

// Lowell S Y, 2008: Overt Swallowing vs. Rest
// Lowell S Y, 2008: Oral Sensory Stimulation vs. Rest
// Lowell S Y, 2008: Covert Swallowing vs. Rest
// Lowell S Y, 2008: Breath Holding vs. Rest
// Subjects=14
62.2	-3.98	20.09
62.2	4.82	23.81
47.07	5.13	1.65
59.94	5.72	8.15
62.25	-16.67	21.15
15	-19.35	-9.31
15.08	-16.3	2.7
16.09	-.43	1.36
32.08	-9.48	-6.99
-10.59	-17.76	-.23
-20.27	-5.3	-3.39
-23.52	-.29	-7.12
-57.35	-5.45	39.43
-53.11	-8.05	32.9
-53.29	-5.53	10.39
10.64	-53.16	-33.19
8.54	-55.03	-29.66
-13.83	-57.73	-21.37
2.58	0.17	51.65
-4.93	0.93	48.33
-1.83	11.89	38.45
6.76	9.11	43.04
-23.47	-48.1	-19.84
15.03	-1.41	2.57
25.94	-84.68	-1.73
40.72	-49.15	-11.57
-31.98	11.51	8.72
-25.29	-95.39	1.99
10.62	-66.53	-40.99
2.41	-65.27	3.61
55.86	-36.26	16.17
15.51	-.84	64.97
44.92	-56.5	-24.38
-3.09	-34.01	-4.53
-36.31	-2.23	-3.46
-59.66	-13.86	13.39
-46.84	-16.07	11.2
-57.38	-27.79	25.69
-50.88	-7.01	46.17
-50.97	0.77	36.6
-42.52	-15.53	17.8
62.28	-27.25	22.04
64.3	-13.12	11.91
42.9	-6.9	11.63
64.39	-18.77	21.3
61.22	-12.91	28.65
25.75	-64.73	-19.01
42.76	-8.44	-8.31
-21.29	-63.07	-20.84
-31.98	-49.93	-15.13
-42.47	-32.62	17
47.11	-53.68	-15.72
-57.34	-38.37	26.57
-31.65	-92.63	10.75
40.63	-47.89	-22.82
21.51	-29.2	0.36
34.55	-81.83	6.86
-19.17	-19.22	-4.47
-10.27	-19.97	40.1
42.85	-66.74	-19.04
57.99	1.08	30.86
30.03	-16.29	1.41
-31.53	-45.3	44.7
-44.8	-45.6	-13.11
43	-82.8	-6.54
-10.58	-25.34	-1.82
-55.26	-60.87	10.59
51.54	-71.83	-3.1
38.77	-80.2	-0.02
32.19	-62.23	-14.83
36.44	-71.18	-20.82
36.69	-81.81	6.83
-27.74	-45.84	-17.75
-38.37	-69.51	-20.1
-44.66	-68.35	-4.51
0.56	-3.04	65.32
5.9	-5.21	64.33
8.86	12.04	39.43
29.99	3.08	4.25
42.78	9.33	1.35
57.75	16.11	5.07
58.79	2.66	-3.85
-34.08	0.93	9.63
-51.24	11.23	6.73
-29.53	-88.38	10.37
62.27	-38.34	16.28
-6.08	12.12	41.82
-23.34	-84.06	-16.82
26.25	-79.31	40.2
6.86	-15.12	46.19
-53.08	-36.23	26.34
45.31	-10.66	45.37
28.39	-30.88	60.65
-27.45	-89.06	1.49
-27.49	-87.2	-2.02
64.44	-31.46	22.37
4.75	4.93	57.92
-3.77	-3.67	57.62
47.03	4.79	-2.78
60.97	10.84	5.47
54.57	6.49	4.8
28.08	-84.66	-1.75
36.61	-80.47	-3.32
-36.18	-68.99	-13.48
58.19	-34.19	42.74
40.64	-45.61	-20.78
36.34	-45.89	-24.06
49.49	-2.86	35.75

// Redcay E, 2008: Toddlers
// Subjects=10
3.46	8.15	30.9
-47.53	-61.6	41.79
-9.34	-51.08	9.25
12.06	-49.55	13.33
-.52	-69.06	37.42
43.2	-84	19.21
2.32	-46.41	-.2
-40.71	-5.74	-20.96
7.4	34.33	-2.57
3.47	7.09	30.98
-56.5	14.17	17.7
-48.05	13.19	4.3
41.87	11.04	23.52
61.03	22.44	17.88
-14.05	55.35	-4.09
20.15	64.36	-.77
3.3	40.5	22.61
6.15	54.44	-17.63
-31.03	52.04	9.77
28.64	50.69	-13.11
-22.6	28.89	-15.15
41.65	48.25	9.25
16.08	53.35	22.5
16.35	-44.95	17.36
-9.04	-68.77	41.95
-9.08	-102.21	22.45
-17.9	-94.08	-9.35
33.34	-81.09	-11.03
9.55	21.31	-5.96
-27.75	-61.33	-25.37
16.2	-68.5	-11.89
25.6	-.34	-12.14
-30.66	25.18	47.7
29.41	-11.67	61.26
-18.02	36.57	28.76
12.13	3.94	44.53
-35.26	-24.4	-15
-39.67	-6.08	-25.41
-52.09	-59.08	5.95
67.46	-33.33	-2.05
-22.22	-55.02	0.8
24.78	-50.5	-.12
-56.61	-4.46	-3.04
-43.64	-33.65	3.72
67.46	-15.73	5.4
-56.58	-21.73	-6.06
63.06	-8.32	-8.56
-43.77	-8.62	-2.84
54.69	-19.69	10.34
-17.79	-22.64	33.72
-69.19	-32.78	17.32
-9	-33.22	61.27
12.28	-25.32	51.44
42.23	-16	59.24
-21.81	-37.53	61.78
-43.51	-76.29	2.83
-39.27	-32.6	16.96
45.94	-3.14	-8.79
29.07	-72.31	-7.26
-16.92	-77.42	-14.11
-22.09	-89.91	3.73
-16.92	-77.42	-14.11
16.38	-88.62	3.18
-27.76	-57.1	-25.72
12.1	3.6	40.1
-9.12	-18.05	51.08
-9.08	-38.48	48.33
-7.56	48.5	3.1
-39.6	46.28	4.77
50.22	35.36	6.89
-32.08	25.89	1.94
40.77	11.75	19.01
58.81	18.23	4.88
44.8	31.3	-3.86
-26.87	50.96	-4.69
-53.44	-35.59	-20.54
-50.19	-1.08	-1.17
62.04	-16.61	-5.62
50.3	14.21	8.66
-52.24	-12.3	5.37
-34.74	-59.58	39.24
55.02	-64.59	35.29
-45.34	-59.93	49.43
-13.6	-45.48	13.28
-10.27	-92.41	11.61
20.72	-92.23	11.24
-17.86	-89.25	-1.95
19.47	-82.06	-8.56
11.81	12.66	5.89
-32.03	-61.44	-26.43
20.42	-59.13	-14.96
-32.04	4.4	-.72
-18.08	-6.89	3.41
-17.54	-38.65	60.71
-35.77	-29.58	55.7
62.16	6.59	19.2
53.59	5.22	16.07
-40.63	43.44	9.48
41.74	36.08	16.96
41.02	13.26	52.34
-22.51	55.18	8.29
33.31	-67.17	-9.97
-56.68	-21.7	-19.44
62.18	-45.88	1.3
-53.32	-12.39	4.28
50.19	-3.37	-12.17
54.46	-0.08	-11.38
-52.24	-12.3	5.37
60.47	-45.92	55.96
-22.1	-93.34	0.67
-27.52	-85.34	-5.52
36.67	-87.44	2.84
-31.59	-51.45	34.07
38.6	1.53	10.97
14.24	0.36	39.23
-9.03	-19.22	63.44
-9.19	-12.13	45.01
3.8	-29	59.66
-25.11	-19.92	55.88
-4.73	-40.94	57.41
-5.23	-47.22	-10.08
-14.83	-16.3	5.28
20.45	-20.32	5.21

// Redcay E, 2008: 3 Year Olds
// Subjects=10
-17.93	-68.02	-2.62
-26.54	-51.15	-3.93
-48.01	-8.3	1.64
-48.03	-12.87	-2.44
62.12	-15.76	5.46
50.4	-16.54	10.12
-38.19	-34.71	17.12
-20.81	-64.61	41.74
20.72	-51.65	26.79
21.73	-82.96	7.1
-17.79	-69.82	15.37
-27.62	-49.05	-4.1
-21.02	-90.96	3.8
-26.77	46.44	5.73
33.03	56.23	3.1
7.4	34.33	-2.57
3.47	7.09	30.98
-56.5	14.17	17.7
-48.05	13.19	4.3
41.87	11.04	23.52
61.03	22.44	17.88
-14.05	55.35	-4.09
20.15	64.36	-.77
3.3	40.5	22.61
6.15	54.44	-17.63
-31.03	52.04	9.77
28.64	50.69	-13.11
-22.6	28.89	-15.15
41.65	48.25	9.25
16.08	53.35	22.5
16.35	-44.95	17.36
-9.04	-68.77	41.95
-9.08	-102.21	22.45
-17.9	-94.08	-9.35
33.34	-81.09	-11.03
9.55	21.31	-5.96
-27.75	-61.33	-25.37
16.2	-68.5	-11.89
25.6	-.34	-12.14
-30.66	25.18	47.7
29.41	-11.67	61.26
-18.02	36.57	28.76
12.13	3.94	44.53
-35.26	-24.4	-15
-39.67	-6.08	-25.41
-52.09	-59.08	5.95
67.46	-33.33	-2.05
-22.22	-55.02	0.8
24.78	-50.5	-.12
-56.61	-4.46	-3.04
-43.64	-33.65	3.72
67.46	-15.73	5.4
-56.58	-21.73	-6.06
63.06	-8.32	-8.56
-43.77	-8.62	-2.84
54.69	-19.69	10.34
-17.79	-22.64	33.72
-69.19	-32.78	17.32
-9	-33.22	61.27
12.28	-25.32	51.44
42.23	-16	59.24
-21.81	-37.53	61.78
-43.51	-76.29	2.83
-39.27	-32.6	16.96
45.94	-3.14	-8.79
29.07	-72.31	-7.26
-16.92	-77.42	-14.11
-22.09	-89.91	3.73
-16.92	-77.42	-14.11
16.38	-88.62	3.18
-27.76	-57.1	-25.72
12.1	3.6	40.1
-9.12	-18.05	51.08
-9.08	-38.48	48.33
-28.53	24.05	46.66
33.15	-40.28	-20.03
-39.67	-7.13	-25.32
-47.84	-54.91	4.43
66.21	-8.9	-16.35
-23.39	-51.65	-10.62
33.08	-22.3	-21.54
-57.67	-8.79	-3.78
-42.45	-41.16	16.6
63.17	-13.72	4.16
-53.2	-41.91	7.86
53.39	-8.89	-15.09
-43.65	-22.82	6.15
50.41	-19.8	9.28
-17.79	-23.7	33.81
23.8	-56.17	9.29
-25.07	-71.16	40.1
-14.48	-53.37	35.15
-23.29	-67.08	-3.75
16.2	-55.3	-6.31
-40.32	-22.57	22.82
49.43	-6.8	26.05
27.65	61.4	1.62
-9.5	-17.59	1.98
16.19	-20.26	6.37
3.21	29.7	6.79
-15.01	38.94	3.99
-26.93	49.21	-13.46
48.45	10.59	44.67
48.2	35.49	22.51
20.57	41.26	44.65
55.86	-54.92	8.82
29.92	-35.01	-20.43
-59.81	-9.94	-4.78
-59.65	-29.18	7.99
-46.82	-25.76	9.78
-44.35	-65.1	37.59
-25.71	31.04	-.8
-27.54	-81.2	-6.98
-27.42	-84.31	7.78
-13.72	-20.27	8.94
16.25	-20.72	14.21

// Sachdev P, 2008: Anorexia Nervosa Patients
// Subjects=10
8	-68	48
10	-94	-14
-8	-94	-14
-50	14	46
-46	6	30
-42	4	22
54	30	12
-30	-64	48
42	-62	-8
-36	-86	-4
-20	-28	14
18	-80	26
14	-76	0
46	20	20
-36	10	20

// Sachdev P, 2008: Normals
// Subjects=10
56	10	8
62	-20	36
26	-2	48
-32	-54	54
36	-96	-2
-42	-90	-4
12	-22	8
-34	6	20
46	10	24
48	38	16
38	-70	44
-22	-68	56
52	-34	50
-40	-90	-4
44	-64	-16
8	-18	6
-10	50	-4
-22	28	40
18	-80	26
14	-76	0
46	20	20
-36	10	20

// Wong P C M, 2008: Speech in Moderately Loud Noise vs. Quiet
// Wong P C M, 2008: Speech in Loud Noise vs. Quiet
// Wong P C M, 2008: Speech in Loud Noise> Speech in Moderately Loud Noise
// Wong P C M, 2008: Speech in Moderately Loud Noise > Speech in Loud Noise
// Subjects=11
-59.71	-15.52	5.73
-46.74	-40.3	14.35
-46.65	-45.88	24.85
-30.58	0.69	47.53
-34.11	-45.45	-12.13
-21.04	-89.02	1.41
-18.14	39.69	14
-11.38	-65.47	16.05
-5.01	-88.92	1.22
-2.01	21.01	18.73
-18.1	-12.61	-1.69
55.69	-18.25	1.28
65.44	-39.89	9.68
10.95	-43.39	10.6
13.98	-18.76	-1.54
20.36	-2.6	0.38
17.43	-6.4	34.19
23.75	-79.75	-6.57
26.96	9.26	29.42
49.06	-23.78	-28.29
-69.34	-19	2.78
-33.65	-50.6	45.17
-50.01	10.66	26.84
-1.75	20.41	52.23
-46.94	33.43	18.2
-34.17	19.79	5.82
-30.67	-3.51	34.5
-40.58	-42.83	-18.97
-27.28	-60.85	35.92
-11.66	-12.31	1.56
55.69	-18.25	1.28
42.97	-46.88	3.83
39.57	33.43	10.52
49.28	14.72	15.32
46.28	0.38	36.63
30.29	3.97	43.21
11.13	4.62	53.41
20.8	-63.99	32.29
17.25	-14.8	8.13
26.96	-86.33	-9.4
-56.43	-34.53	7.28
-30.95	23.24	8.84
-49.73	-71.02	30.34
-21.49	-4.65	-22.39
-56.78	-11.72	-28.08
-66.36	-8.09	-21.59
-8.23	-52.76	14.95

// Yassa M A, 2008: At-risk Alzheimer's
// Subjects=18
33.58	13.45	6.96
51.53	-55.9	44.89
56.61	-42.96	22.23
62.85	-43.64	3.14
41.87	54.68	-11.83
24.75	-16.41	-13.47
-41.86	-83.88	3.31
23.58	11.79	70.05
-21.7	-10.6	74.15
54.89	25.59	-13.66
46.34	-31.74	-17.92
25.78	-32.75	64.33
-31.1	15.43	20.19
41.97	-8.05	-16.83
31.2	-74.63	-27.99
-24.56	-35.57	13.92
60.68	-8.68	9.81

// Yassa M A, 2008: Healthy Controls
// Subjects=15
35.61	-2.78	-6.04
-6.66	8.49	70.89
-35.16	0.92	37.38
53.16	11.27	16.93
-21.96	-24.59	50.89
58.17	30.27	-9.69
33.59	17.92	8.76
41.89	57.01	-9.82
48.45	52.13	-4.97
32.26	-54.62	59.66
25.87	-63.8	65.16
28.02	-59.54	64.7

// Altshuler L, 2008: Healthy Controls
// Subjects=17
-26.79	0.15	-14.92
24.5	-1.83	-17.58
-52.46	19.54	-9.56
50.13	20.15	-10.79
52.52	20.62	22.59
-26.56	-65.59	-11.64
39.68	-60.96	-12.79
-50.25	13.72	-2.41
48.01	24.71	-6.69
52.55	18.68	24.99
-37.43	44.43	8.25

// Altshuler L, 2008: Bipolar I Depressed
// Subjects=11
-43.94	52.17	-1.25
46.12	27.27	26.57
-39.41	-61.6	-14.06
37.54	-60.97	-12.77
-50.25	13.72	-2.41
48.01	24.71	-6.69
52.55	18.68	24.99
-37.43	44.43	8.25

// Forstmann B U, 2008: Incongruent vs. Neutral
// Forstmann B U, 2008: Congruent vs. Neutral
// Subjects=24
-30	-82	18
-38	-66	46
22	-78	56
54	12	32
66	-56	16
10	-80	4
-30	-84	18
32	-86	18

// Lee T W, 2008: Activation Associated with Interference Effect of Emotion 
// Expression, Overall Interference
// Lee T W, 2008: Activation Associated with Interference Effect of Emotion 
// Expression, Highest 20% Interference
// Lee T W, 2008: Activation Associated with Interference Effect of Emotion 
// Expression, Lowest 20% Interference
// Lee T W, 2008: Discordant > Concordant
// Lee T W, 2008: Activation Associated with Interference Effect of the Simon 
// Task
// Subjects=14
45	-24	48
50	17	-11
-3	9	55
-53	-29	10
65	-40	8
50	-24	-9
-21	-76	-11
-9	-71	31
36	12	-1
6	-32	4
24	-75	-37
39	-29	51
50	26	4
-3	17	52
-65	-43	15
62	-46	8
62	-35	-1
-24	-79	-14
6	-68	42
36	29	-4
12	-29	1
27	-75	-34
53	-12	48
50	20	-11
53	-60	22
56	-43	2
-30	-88	-5
6	-68	31
50	9	-3
8	-20	4
28	-60	-27
-53	13	24
-42	26	-4
48	23	-11
-30	25	37
45	25	26
42	14	55
9	-23	56
27	43	-15
-53	-38	7
-48	-44	-3
39	17	-11
-33	-83	-29
-3	-65	-27
-12	48	22
42	16	38
50	-6	-2
30	-35	-8
45	-53	-20
-9	-71	42
-45	0	-3
-15	17	-6
27	17	-6
-33	-72	-39

// Lissek S, 2008: Deception > Cooperation
// Lissek S, 2008: Deception > Cooperation/Deception
// Lissek S, 2008: Cooperation/Deception > Deception
// Lissek S, 2008: Cooperation/Deception > Cooperation
// Lissek S, 2008: Cooperation > Deception
// Lissek S, 2008: Cooperation > Cooperation/Deception
// Subjects=13
-38.29	26.48	-33.45
-40.24	30.26	-15.86
-44.69	27.08	-26.67
-18.27	54.93	17.18
-20.57	53.89	6.12
-1.11	65.01	9.17
-7.33	18.81	20.57
12.1	23.13	19.81
3.54	8.42	23.66
-4.72	-45.67	42.59
10.34	-57.08	34.5
-41.63	-44.92	29.7
-37.37	-56.37	21.8
42.54	-56.3	18.19
51.13	-63.27	12.01
-41.91	-44.87	7.29
57.07	-3.84	-18.62
61.44	-16.59	-17.44
-15.44	-60.39	46.48
-20.24	65.1	34.14
-13.9	57.49	21.34
-7.45	50.72	17.42
12.05	22.72	15.37
-6.97	-44.17	35.76
-9.43	17.09	25.26
7.85	19.28	24.75
-33.14	-35.08	19.62
-59.35	-43.84	-3.72
-39.68	-42.11	13.7
-50.58	-31.93	8.4
50.44	10.4	-26.64
-11.2	-67.59	38.15
-48.92	32.15	-18.14
-36	20.94	-23.97
-9.16	23.42	47.04
12.58	-41.15	44.09
-48.24	-48.11	18.92
-52.67	-48.95	10.12
51.1	-54.76	11.17
61.72	-51.71	-2.76
61.94	-58.77	13.62
-41.56	-77.24	28.42
-41.89	-57.84	6.33
57.77	-75.18	22.04
52.43	17.88	-38.62
59.16	-8.71	-24.9
-.31	-53.75	47.8
6.2	-46.93	51.5
-40.22	32.6	-13.85
-44.77	30.92	-31.54
-11.28	19.37	49.72
-2.51	-43.12	46.79
-50.42	-43.86	18.54
-57.02	-42.59	9.56
-43.69	-61.74	33.64
46.65	-60.07	0.56
-48.2	-71.92	16.8
51.15	-76.24	11.05
59.89	-57.95	22.54
65.69	-12.74	-22.37
57.18	-18.32	-12.71
-.19	-63.76	55.51
8.42	-61.81	52.93
-16.2	71.75	13.24
12.63	-47.32	46.95
-56.82	-41.13	25.1
-50.61	-38.73	4.59
-50.36	-58.75	20.01
-67.92	-54.3	-.3
59.55	-49.6	-2.93
-48.28	-59.37	13.32
57.77	-75.18	22.04
-61.08	-51.58	28.45
-54.79	-31.11	17.35
1.89	-42.48	53.37
-5.31	63.7	18.34
-32.04	-73.24	13.29
-46.19	-27.04	14.56
-52.34	-59.64	33.58
-39.77	-31.89	8.21
-11.81	67.93	18.03
-61.21	-30.72	21.91
-67.56	-29.7	33.12

// McKay L C, 2008: Breath Holding vs. Rest
// Subjects=8
-42	2	2
-22	8	-4
-32	-18	-2
-8	-20	-16
-4	10	42
-8	20	28
-58	14	16
-48	42	6
-30	50	20
-40	46	24
-4	10	42
-56	-2	40
-64	-40	36
-16	-16	6
-22	-8	-22
-62	2	-8
-66	-24	4
-2	-30	-24
-2	-28	-40
44	20	8
44	4	0
40	-10	-8
26	6	4
32	-14	2
10	-20	-14
8	26	30
2	8	28
58	14	16
46	48	8
44	42	20
4	8	48
58	-2	42
56	-46	54
14	-16	6
22	-8	-20
62	-2	4
62	-22	6
4	-24	-24
2	-22	-42

// Sommer M, 2008: Incompatible > Compatible
// Sommer M, 2008: Cognition Emotion Integration, Emotion x Compatibility
// Subjects=12
-33.63	-10.82	64.14
33.32	37.31	33.68
-7.07	7.43	50.04
50.47	-60.92	0.46
-36.15	-65.39	-8.21
38.53	11.77	5.66
7.49	24.27	4.96
-14.76	-15.62	14.14
50.66	-32.55	37.11
-33.68	-54.2	39.9
18.78	-67.12	47.07
39.76	11.28	26.87
-20.2	45.99	26.88
35.25	46.18	10.61
1.46	7.31	47.72

// Tourville J A, 2008: No Formant Shift vs. Passive Viewing
// Tourville J A, 2008: Formant Shift vs. Passive Viewing
// Tourville J A, 2008: Formant Shift vs. No Formant Shift
// Subjects=11
-48	-8	60
-48	0	30
-56	-10	42
-62	-6	12
48	8	4
54	-8	30
-48	10	-2
-2	8	62
4	20	36
-44	-34	24
46	-26	18
-58	-10	10
-64	-30	14
-52	-34	16
72	-24	6
58	-28	12
-44	6	2
-16	-62	-20
-30	-86	-24
26	-58	-24
-26	-4	4
-24	-6	-4
-8	-14	6
30	8	4
26	-2	-4
14	-12	10
6	-18	8
-44	-8	64
-60	4	8
-52	-14	38
-60	-8	12
44	-18	70
56	-10	30
-60	8	2
-48	10	-2
0	72	72
48	12	2
-40	-30	18
44	-24	18
72	-24	32
-62	-30	14
-62	-22	4
68	-16	8
58	-28	6
64	-10	10
-34	-4	10
-34	-20	8
-18	-62	-20
-2	-78	-14
8	-64	-10
24	-56	-22
28	-58	-54
-30	-6	4
-22	-2	-2
-10	2	10
-8	-14	6
22	2	-2
14	4	10
4	-22	6
-2	-70	16
-22	-42	70
48	-10	44
60	14	34
70	-2	20
58	14	28
56	32	24
-54	-24	14
-66	-38	22
-60	-30	10
-62	-24	10
-60	-62	10
68	-36	18
72	-40	12
68	-16	8
48	-8	-8
56	-10	-4
26	-62	-54
12	-84	40

// Vanderwal T, 2008: (Self-Concept vs. Letter) > (Mother-Concept vs. Letter)
// Vanderwal T, 2008: Self-Concept > Mother-Concept
// Vanderwal T, 2008: Mother-Concept > Self-Concept
// Vanderwal T, 2008: Friends vs. Bumper Cars
// Subjects=17
-8.36	51.32	39.68
-5.28	56.66	25.81
-53.37	23.36	12.43
-47.12	25.03	-7.86
-47.29	23.23	-31.12
-4.92	-51.71	28.21
-50.06	-38.18	0.82
17.41	32.95	47.61
45.71	14.27	-31.44
-14.7	-56.74	5.32
14.24	-72.17	9.63
-18.11	33.35	14.53
13.87	39.37	6.97
7.58	40.61	23.66
-37.29	-45.22	-8.77
27.52	13.9	-34.55
-31.16	4.64	-25.29
-2.3	27.96	-15.31
49.42	-43.16	10.14
61.93	-6.81	-16.48
-49.88	-52.75	18.77
58.68	-3.91	-20.03
55.71	-31.2	-.98
-40.25	-69.07	13.34
-53.16	-53.54	8.84
36.36	-39.12	-19.05
49.13	26.38	0.96
12.85	59.68	22.01
-47.15	34.55	-8.65
-34.11	-38.85	-9.34
7.98	-57.47	35.23
26.59	-1.19	-23.23
-11.6	47.61	33.33

// Wittfoth M, 2008: Incompatible > Compatible
// Wittfoth M, 2008: Error, Compatible > Compatible
// Wittfoth M, 2008: Error, Incompatible > Incompatible
// Wittfoth M, 2008: (Error, Compatible > Compatible) > (Error, Incompatible > 
// Incompatible)
// Wittfoth M, 2008: (Error, Incompatible > Incompatible) > (Error, Compatible 
// > Compatible)
// Wittfoth M, 2008: (Error, Compatible > Compatible) + (Error, Incompatible > 
// Incompatible)
// Wittfoth M, 2008: (Error, Compatible > Compatible) + (Incompatible > 
// Compatible)
// Wittfoth M, 2008: (Error, Incompatible > Incompatible) + (Incompatible > 
// Compatible)
// Subjects=15
55.36	15.94	20.91
58.46	31.29	12.61
56.33	40.31	17.36
64.62	16.91	-15.2
71.2	14.36	-8.34
50.7	-47.89	-18.64
52.95	-58.1	-13.19
-15.17	-55.12	68.36
-41.25	-39.88	60.57
-50.94	-39.71	62.96
-61.9	-26.65	54.01
49.43	-35.72	54.14
-37.66	-78.21	-5.17
-44.09	-82.18	-1.31
60.82	16.38	25.25
35.47	27.86	-11.31
46.35	21.93	-6.42
8.05	31.68	42.57
-.68	32.09	35.95
7.86	24.8	26.44
17.05	15.81	67.52
71.87	-34.22	34.55
-1.1	43.22	5.72
-.86	30.74	21.52
3.43	38.2	20.71
1.53	-14.57	30.45
35.35	18.21	-22.68
-42.3	10.25	-11.6
-9.01	-65.14	41.23
12.6	-65.06	40.86
6.38	-59.82	62.86
0.92	-14.78	-17.71
3.08	-14.77	-17.74
-7.49	-5.39	2.8
-3.12	-22.5	3.3
7.68	-22.46	3.11
60.78	18.3	22.82
62.81	22.79	13.38
58.99	-22.69	43.72
65.43	-22.98	40.28
53.63	-35.58	43.96
51.69	-28.4	63.46
-61.91	-34.41	51.42
-53.34	-29.47	46.3
-66.66	-15.75	21.64
-60.15	-22.1	22.16
-60.42	-64.57	-7.25
-41.94	-82.28	-2.45
58.55	-64.28	0.78
-48.67	-43.67	-14
-42.33	-52.34	-26.7
1.01	-76.44	-22.81
-13.77	48.65	30.06
-14.19	43.3	-4.15
-5.43	38.74	4
-35.14	12.07	41.88
14.34	55.44	32.27
25.05	42.74	22.13
-5.72	35.49	-19.21
5.05	36.39	-21.72
-69.34	-13.11	-18.92
66.62	2.6	-30.63
66.62	2.6	-30.63
-25.05	-15.19	-20.59
14.66	-49.41	35.91
-11.34	-50.03	30.81
-2.68	-43.3	33.36
-41.41	-63.02	42.7
3.8	32.18	48.19
35.41	23.08	-16.44
-46.62	10.24	-11.53
6.04	17.51	51.85
61.91	15.42	26.45
-60.73	-38.03	58.48
64.41	-34.58	42.56
6.04	17.51	51.85
61.43	22.73	-10.12
-46.65	17.68	-12.26

// Cao Q, 2008: Intrinsic Alerting vs. Fixation, Normals > ADHD Children
// Cao Q, 2008: Phasic Alerting vs. Fixation, Normals > ADHD Children
// Cao Q, 2008: Alerting Effect, Normals > ADHD Children
// Subjects=12
11.67	-49.68	56.16
27.35	31.77	31.02
-58.73	-35.98	45.92
27.57	8.25	43.43
26.65	46.24	-20.82
-34.37	27.22	20.2
-18.13	37.37	24.52
21.4	-23.4	61.24
14.78	13.91	58.78
-21.62	4.88	-1.34

// Capek C M, 2008: SR > BP
// Capek C M, 2008: Man > BP
// Capek C M, 2008: DM > BP
// Capek C M, 2008: EP > BP
// Capek C M, 2008: (SR + Man + DM + EP) > BP
// Capek C M, 2008: (Man + DM + EP) > SR
// Capek C M, 2008: SR > (Man + DM + EP)
// Capek C M, 2008: (DM + EP) > Man
// Capek C M, 2008: Man > (DM + EP)
// Capek C M, 2008: DM > EP
// Capek C M, 2008: EP > DM
// Subjects=13
55.58	-6.16	-7.53
-56.46	-21.58	9.54
51.65	0.67	39.89
-2.9	20.69	42.18
47.26	-60.94	0.5
-48.95	-66.35	-5.75
55.91	4.92	39.49
-44.72	18.98	23.85
47.26	-60.94	0.5
-48.95	-66.35	-5.75
-44.48	0.6	47.69
47.19	-58.37	-7.52
-56.45	-38.04	3.12
51.64	9.38	42.51
-41.52	14.51	20.84
1.57	6.22	61.19
47.15	-30.28	-2.07
-56.45	-38.04	3.12
51.66	5.15	42.86
-44.74	26.38	23.23
47.28	-65.17	0.85
-48.95	-66.35	-5.75
-56.51	-14.44	5.6
58.78	-14.95	-11.3
-56.46	-21.58	9.54
-41.52	14.51	20.84
47.15	-54.4	-11.2
-56.58	-10.81	-2.51
51.51	-37.06	6.25
-49	-62.38	-9.43

// Capek C M, 2008: Normals
// Subjects=13
47.15	-30.28	-2.07
-44.62	-65.72	1.96
-33.62	-50.34	48.49
40.07	-45.93	43.93
-48.76	-2.85	44.69
43.99	15.28	23.14
5.75	9.71	50.81
36.41	-46.26	-15.1
13.1	-85.01	-4.9
1.4	-31.76	24.23
-2.9	-7.92	30.09
55.88	-11.8	29.74

// Capek C M, 2008: Deaf Patients
// Subjects=13
55.58	-6.16	-7.53
-56.46	-21.58	9.54
51.65	0.67	39.89
-2.9	20.69	42.18
-10.75	-48	-33.37
51.38	-26.28	-5.8
39.55	17.86	1.79
51.48	-17.51	11.31
-56.42	-25.56	13.22
51.43	26.96	22.08
1.29	19.86	31.05
32.51	-1.76	51.47
-29.46	1.29	55.27
36.78	5.92	54.12

// Falconer E, 2008: PTSD Patients
// Subjects=23
-42	56	4
64	-52	-10
62	-60	18

// Falconer E, 2008: Trauma-Exposed Patients
// Subjects=17
42	14	36
32	-60	46
10	-72	42
42	-60	54
36	4	-20
-36	4	-24
62	-50	-10

// Falconer E, 2008: Normals
// Subjects=23
30	56	-14
44	16	34
-38	58	2
6	32	26
32	-60	46
-32	0	-24

// Gundersen H, 2008: 3-Back, Control Group > 0.08% BAC Group
// Gundersen H, 2008: 2-Back, 0.08% BAC Group > Control Group
// Gundersen H, 2008: 3-Back, 0.02% BAC Group > Control Group
// Gundersen H, 2008: 2-Back, 0.02% BAC Group > Control Group
// Subjects=12
1.37	34.56	27.83
11.24	26.92	37.38
-17.77	-33.26	38.23
7.6	-55.93	-10.39
50.02	-85.38	5.25
46.9	-86.68	14.4
14.61	-97.87	22.78
-1.48	-97.1	31.94
-5.53	19.41	-7.53
7.45	17.33	-7.55
-27.39	-77.32	38.27
-24.02	-69.78	49.79

// Herpertz S C, 2008: Adolescents with Conduct Disorder
// Subjects=22
48	-78	0
-30	-96	3
-30	0	-18
-39	27	-6
30	3	-21
33	27	0
-45	24	-21
45	24	-21
57	33	0
39	33	-6
-42	-18	-21
-30	15	-18
6	54	18
-12	66	21
39	6	30
0	42	-18
-3	51	-9
-3	33	-6
63	-24	33
27	-60	57
-48	24	18
-60	-30	33
-51	-33	42
39	-84	6
-45	-72	-3
24	0	-9
33	-12	-12
33	-18	0
0	57	30

// Herpertz S C, 2008: Healthy Controls
// Subjects=22
-18	-99	-12
39	-72	-12
-21	-3	-15
18	-3	-12
27	0	-27
42	6	33
48	21	21
51	33	-6
3	54	27
-39	36	12
-24	36	-12
-30	33	-6
-54	9	33
-39	6	24
-3	48	-12
-9	57	0
27	-54	54
24	-72	54
-60	-33	30
63	-30	36
-27	24	-9
48	-75	-9
-48	-81	3
45	-3	48
-36	30	-3
-39	27	0
54	30	12
-21	3	-24
-21	-3	-15

// Olsson C J, 2008: Active High Jumpers
// Subjects=12
2	14	66
-2	-6	68
-2	0	60
-30	0	70
-34	-64	-30
-50	-2	54
-40	-2	60
-16	-10	78
52	10	52

// Olsson C J, 2008: Novice High Jumpers
// Subjects=12
-38	-44	50
-8	-90	-6
-6	-90	8
4	-86	18
-12	-100	16
14	-70	-4
14	-80	-6
-64	-28	24
-52	8	16

// Suskauer S J, 2008: Go - Fixation, Between Group Differences in Correlation 
// Between Activation and CV
// Suskauer S J, 2008: No Go - Fixation, Between Group Differences in 
// Correlation Between Activation and CV
// Subjects=25
-61.98	-20.68	48.94
-61.98	-20.68	48.94
55.92	-24.75	56.3
69.57	3	30.91
-11.03	13.58	68.22
16.37	8.49	12.22
65.34	-22.54	33.51
21	33.85	42.13

// Suskauer S J, 2008: Normals (Typically Developing Children)
// Subjects=25
-37.64	-75.88	-3.16
3.72	25.08	41.05
51.07	-81.22	3.7
42.25	50.89	16.55
53.26	-37.22	15
7.63	-64.44	-9.55
26.9	11.98	-8.47
65.14	-35.05	14.58
-9.97	-61.36	-33.08
-26.87	-62.97	-3.5
-24.03	-14.09	59.97
33.63	-64.89	-4.34
1.69	21.64	50.39
-22.9	-39.3	-26.08
12.32	24.79	37.57
56.54	-36.89	18.27
-2.85	-37.96	21.63
-32.75	-13.58	54.46
-24.65	2.07	14.68
-15.75	-48.54	24.02
8.6	-25.49	73.99

// Suskauer S J, 2008: ADHD Patients
// Subjects=25
8.1	18.92	43.83
65.14	-35.05	14.58
-9.97	-61.36	-33.08
-26.87	-62.97	-3.5
-24.03	-14.09	59.97
33.63	-64.89	-4.34
1.69	21.64	50.39
-22.9	-39.3	-26.08
12.32	24.79	37.57
56.54	-36.89	18.27
-2.85	-37.96	21.63
-32.75	-13.58	54.46
-24.65	2.07	14.68
-15.75	-48.54	24.02
8.6	-25.49	73.99

// Morey R A, 2008: Executive Shapes, Activations
// Morey R A, 2008: Emotional > Neutral Pictures, Activations
// Morey R A, 2008: Executive Shapes, Deactivations
// Morey R A, 2008: Emotional > Neutral Pictures, Deactivations
// Morey R A, 2008: Emotional > Neutral Pictures Positively Correlated with 
// Symptom Severity (DTS)
// Morey R A, 2008: Emotional > Neutral Pictures Negatively Correlated with 
// Symptom Severity (DTS)
// Subjects=39
-6	8	40
-50	6	26
48	-32	54
30	-54	54
34	-10	64
-40	-40	58
6	8	48
-40	40	22
-34	20	0
-20	-52	-18
-18	0	8
-16	-8	12
4	58	6
-46	-60	26
-2	-54	42
34	-46	50
-10	2	12
54	20	20
-42	-4	34
2	-44	24
30	-12	-20
4	40	-22
4	62	4
26	26	40
4	8	-12
54	28	2
2	-48	32
54	-50	30
-40	-18	16
58	-18	-12
28	-30	-12
4	8	0
58	2	-6
38	-18	18
4	-16	58
4	2	40
64	-10	28
-58	-8	20
-10	50	0
-4	50	12
-2	36	-2
-50	36	2
10	2	12
-60	-36	42
-36	8	2
-50	-60	26
36	40	22
26	46	-6
-2	36	30
2	30	20
-2	34	16
-24	50	0
-54	12	12
20	-18	6
30	-86	-4
30	-52	60
46	-46	40
6	-66	-28
38	16	2

// Paine P A, 2008: Saline Infusion - Rest
// Paine P A, 2008: Hydrochloric Acid Infusion - Rest
// Paine P A, 2008: Saline Infusion - Hydrochloric Acid
// Subjects=7
-56.45	-9.44	15.22
63.13	-2.09	3.19
63.17	-5.01	6.78
63.22	3.25	17.24
51.65	-15.79	33.47
-53.24	-18.14	12.56
47.37	-7.1	36.13
47	8.85	-5.35
-48.9	3.44	29.66
59.07	-16.35	25.62
-29.89	1.24	-.48
47.38	5.13	42.91
58.95	-13.23	10.86
51.77	-17.85	48.13
59	-3.92	21.23
-53.18	-4.33	25.9
-33.03	-5.84	4.61
39.74	-13.09	14.42
55.85	-3.34	29.03
55.8	-20.4	14.85
51.71	-15.2	41.22
59.01	-12.63	18.62
63.27	-3.89	21.18
63.29	-.46	24.24
59.03	4.08	28.37
59.07	-16.35	25.62
39.86	-60.13	11.67
-56.45	-9.44	15.22
-17.78	-64.19	19.36
-13.4	-67.54	30.75
-17.73	-68.08	24.15
-56.45	-1.69	19.03
-53.18	-4.33	25.9
-48.93	-4.56	22.53

// Sommer I E C, 2008: Attention to Hallucination - Rest
// Sommer I E C, 2008: Silent Word Generation - Rest
// Sommer I E C, 2008: Attention to Hallucination - Silent Word Generation
// Subjects=24
40	-4	4
48	21	28
28	27	-5
44	16	10
51	11	-4
-44	-17	45
-20	-8	67
-55	-37	39
-44	0	4
-32	-4	0
-55	4	11
-12	2	44
8	3	62
-4	-9	48
24	-52	-21
20	-64	-30
-55	-19	16
-20	-59	-24
48	-46	13
51	-37	30
-51	6	33
-56	12	16
36	24	-8
-28	-4	52
36	-4	60
-24	-4	56
32	-4	60
-48	4	32
48	4	32
-36	20	0
36	24	-4
-12	-8	12
12	-8	8
4	8	28
-44	-56	-16
44	-56	-20
-44	-64	-4
52	-36	4
-44	4	-12
52	-36	8
-28	-60	48
32	-64	52
-28	-56	44
48	-44	52
-28	-68	36
28	-92	0
-32	-60	-28
23	-76	-24
51	9	29
40	23	-8
55	12	14
44	1	29
44	2	44
44	12	12
36	16	7
0	3	59
0	26	50
-28	23	-1
-36	4	0
-36	-1	55
44	32	21
-48	-33	42
28	-63	-20

// Haldane M, 2008: 3, 2, 1-back > 0-back, Pre-Treatment
// Haldane M, 2008: Angry vs. Neutral Faces, Pre-Treatment
// Haldane M, 2008: 3, 2, 1-back > 0-back, Post-Lamotrigine Monotherapy > 
// Pre-Treatment
// Haldane M, 2008: Angry Faces, Pre-Treatment > Post-Lamotrigine Monotherapy
// Haldane M, 2008: Angry Faces, Post-Lamotrigine Monotherapy > Pre-Treatment
// Subjects=8
46	8	34
48	-50	52
-36	-56	62
-6	8	52
46	30	40
-4	-82	-16
8	-82	-20
46	-56	-48
-60	8	6
4	26	48
32	-78	-30
-12	50	42
-4	62	22
-6	44	32
-16	44	8
22	22	46
8	62	22
0	38	18
28	42	46
8	-22	16
-4	46	10
-44	-14	34
-60	-38	24
-8	-54	-8
10	36	6
50	-12	-8

// Hassel S, 2008: Happy Faces, Group-by-Condition Interaction
// Hassel S, 2008: Happy Faces, Main Effect of Group
// Hassel S, 2008: Fearful Faces, Main Effect of Group
// Subjects=19
10	20	11
-17	20	14
-46	-56	36
20	14	35
18	-91	-10
49	-53	2
20	-56	42
-14	-96	-11
39	-62	31
36	-64	39
36	-64	36
-30	5	42

// Vinogradov S, 2008: Healthy Controls
// Subjects=8
-9.71	54.34	10.37
-3.25	64.04	10.42
-3.32	54.8	3.49
3.31	46.09	13.21
9.7	66.21	9.99
7.6	58.97	12.98
-6.87	-54.39	41.25
7.59	57.8	11.98
7.52	66	7.81
21.06	27.68	44.98
-2.36	-7.01	65.62
-2.54	-5.06	51.99
1.86	-15.37	56.29
24.64	10.18	-16.1
16.4	-77.71	-2.78
-.67	17.95	33.99
-16.31	9.7	-7.51
-14.02	-.31	0.17
65.35	-20.31	34.41
42.33	-23.95	8.27
44.46	-26.38	5.11
-5.65	36.01	-13.66
5.21	34.24	-10.3
-60.15	7.44	28.2
-53.58	7.03	34.85
48.55	-22.6	-12.14
-53.63	0.12	29.93
-1.04	2.07	1.95

// Vinogradov S, 2008: Schizophrenic Patients
// Subjects=8
22.52	12.61	-12.94
1.73	-33.84	42.44
7.59	57.8	11.98
7.52	66	7.81
21.06	27.68	44.98
-2.36	-7.01	65.62
-2.54	-5.06	51.99
1.86	-15.37	56.29
24.64	10.18	-16.1
16.4	-77.71	-2.78
-.67	17.95	33.99
-16.31	9.7	-7.51
-14.02	-.31	0.17
-41.48	-72.26	35.77
-39.45	-63.41	27.01
-45.88	-69.6	29.98
65.35	-20.31	34.41
42.33	-23.95	8.27
44.46	-26.38	5.11
-7.75	47.37	-6.9
-53.63	0.12	29.93
-1.04	2.07	1.95

// Schnell K, 2008: Interrupted > Uninterrupted Control, Schizophrenia 
// Patients
// Schnell K, 2008: Interrupted Control Correlated with AMDP score, 
// Schizophrenia Patients
// Schnell K, 2008: Interrupted Control Correlated with SAPS score, 
// Schizophrenia Patients
// Schnell K, 2008: Interrupted > Uninterrupted Control Correlated with AMDP, 
// Schizophrenia Patients
// Schnell K, 2008: Interrupted > Uninterrupted Control Correlated with SAPS, 
// Schizophrenia Patients
// Subjects=20
36	24	-9
36	42	27
39	33	33
3	24	48
3	30	42
-33	54	18
-30	63	-3
-27	42	27
-33	27	-9
-33	18	-6
-3	33	27
-6	18	24
12	27	21
-42	0	36
63	-48	21
51	-51	33
51	-45	54
-57	-51	36
-54	-51	48
-63	-54	18
-3	-78	48
15	-75	39
6	-75	42
12	-45	36
-51	-18	42
-57	-15	30
-42	-21	57
51	-48	48
42	-54	42
-45	-51	42
-33	-54	39
45	-69	-18
-57	-12	33
-54	-24	48
-51	-15	39
57	-15	39
-42	-12	-6
-39	-54	40
-45	-54	48
42	-54	42
51	-48	48
48	-69	-15
-6	-27	39
-3	-30	39

// Hutchison E R, 2008: Syllables (30 ms Between + 15 ms Between + 15 ms 
// Within) > Tones
// Hutchison E R, 2008: Tone Different > Syllables (30 ms Between + 15 ms 
// Between + 15 ms Within)
// Hutchison E R, 2008: 30 ms Between > Tone Different
// Hutchison E R, 2008: Tone Different > 30 ms Between
// Hutchison E R, 2008: 15 ms Between > Tone Different
// Hutchison E R, 2008: Tone Different > 15 ms Between
// Hutchison E R, 2008: 15 ms Within > Tone Different
// Hutchison E R, 2008: Tone Different > 15 ms Within
// Hutchison E R, 2008: 15 ms Between > 30 ms Between
// Hutchison E R, 2008: Condition vs. RT Regression
// Subjects=14
-5.09	3.22	14.68
-60.98	-19.36	5.62
31.43	24.46	-8.49
33.04	-45.88	5.31
6.72	-78.04	44.55
55.88	-25.25	23.73
-58.36	-38.24	33.82
1.24	-28.63	46.83
-42.03	-3.28	2.71
44.69	-57.91	15.22
-54.79	-7.91	23.88
0.05	-33.62	1.54
-61.95	-21.69	4.49
-2.33	-6.19	-5.42
61.89	-37.1	22.64
52.97	1.83	17.59
62.92	-41.05	29.32
30.86	-39.21	44.92
-55.05	-12.34	29.94
-.18	4.05	0.17
0.44	19.86	44.89
31.64	25.32	-8.45
-36.23	20.64	1.87
0.82	-29.83	5.12
-61.41	-18.64	5.45
35.45	9.81	49.46
61.89	-31.63	24.64
44.59	-57.55	15.75
-1.14	-20.02	46.81
1.79	20.4	40.82
6.17	-34.85	4.47
-.84	-1.88	8.92
-22.02	25.44	3.53
-10.96	-35.14	-.55
-61.52	-18.07	5.85
4.49	-74.74	47.54
60.61	-37.83	22.94
-59.74	-36.26	34.79
-51.16	-10.52	21.38
-46.66	-4.01	-2.19
49.86	-.88	0.79
-.37	-21.86	47.84
50.27	16.65	19.61
47.01	-46.1	43.87
3.95	-16.65	41.78
-1.8	-45.32	33.54
-5.55	41.76	-1.6

// Drapier D, 2008: Bipolar Patients
// Subjects=20
-25.02	-66.24	48.61
-41.44	10.97	30.06
43.8	41.83	8.65
35.76	-58.36	34.99
-37.6	51.52	-10.19
-29.37	-59.29	42.5
51.17	19.9	-14.13
-37.16	11	30.01
47.12	35.39	21.42
-37.58	47.29	-9.83
-44.84	37.5	15.61
-33.63	-50.43	47.39
43.72	24.52	-8.86
-41.55	30.63	22.84
-32.85	-85.29	-4.34
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-30.27	66.49	-23.79
27.44	66.83	-24.49

// Drapier D, 2008: Healthy Relatives
// Subjects=20
-41.58	38.03	22.22
47.07	34.88	14.77
-37.3	34.89	22.43
47.07	34.88	14.77
-21.82	-66.22	48.57
-41.86	47.27	-9.78
8.66	-5.42	6.32
-13.77	6.59	12.27
1.45	12.68	48.38
-34.37	60.51	-4.29
-33.69	-46.63	41.49
44.32	-46.16	40.56
-30.06	60.97	1.2
47.07	34.88	14.77
-30.09	63.97	-1.28

// Drapier D, 2008: Healthy Controls
// Subjects=20
-41.57	9.6	12.33
-29.32	-49.98	52.87
47.12	35.39	21.42
44.36	-45.73	46.1
-33.63	-50.43	47.39
47.11	38.57	21.15
-33.16	21.4	-1.02
1.42	21.14	47.67
-33.38	55.35	-16.13
-37.44	48.75	9
39.4	24.06	-14.34
-33.63	-50.43	47.39
-37.38	-68.16	-30.26
-29.95	21.42	-1.06
5.63	23.83	40.71
47.14	31.16	21.77
-33.17	48.77	8.95
-30.09	63.97	-1.28
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-30.27	66.49	-23.79
27.44	66.83	-24.49

// Aleman A, 2008: Men
// Subjects=8
-46.76	5.65	30.57
26.77	40.22	16.79
-11.62	30.98	24.69
-53.42	3.04	-2.59
-37.57	17.71	-20.73
-11.91	54.3	-4.02
-33.75	14.21	57.58
40.14	-23.24	62.1
7.48	69.16	21.27
20.64	36.49	51.74
65.23	-12.37	-6.01
23.72	-57.03	-1.79
-21.24	-35.09	-3.11
33.35	-27.13	12.32
-30.71	-13.8	25.32
67.39	-7.69	-.85
47.26	12.64	30.02
31.46	7.2	57.42
32.02	57.97	11.89
8.65	35.16	21.88
-12.29	-3.38	62.15
-12.38	12.14	56.39
-15.04	69.32	11.48
-27.24	-8.84	61.67
-27.66	48.32	30.11
-41.33	-8.78	36.18
-58.72	-2.02	1.24
-27.87	18.63	-9.77

// Aleman A, 2008: Women
// Subjects=8
-46.76	5.65	30.57
26.77	40.22	16.79
-11.62	30.98	24.69
-53.42	3.04	-2.59
-37.57	17.71	-20.73
-11.91	54.3	-4.02
-33.75	14.21	57.58
40.14	-23.24	62.1
7.48	69.16	21.27
20.64	36.49	51.74
65.23	-12.37	-6.01
23.72	-57.03	-1.79
-21.24	-35.09	-3.11
33.35	-27.13	12.32
-30.71	-13.8	25.32
67.39	-7.69	-.85
47.26	12.64	30.02
31.46	7.2	57.42
32.02	57.97	11.89
8.65	35.16	21.88
-12.29	-3.38	62.15
-12.38	12.14	56.39
-15.04	69.32	11.48
-27.24	-8.84	61.67
-27.66	48.32	30.11
-41.33	-8.78	36.18
-58.72	-2.02	1.24
31.1	43.04	25.42
-48.87	-21.48	23.94
34.17	21.89	-.72

// Baliki M N, 2008: Chronic Low Back Pain (CBP) Patients
// Subjects=7
2	48	2
-2	38	20
-16	32	46
16	22	52
6	12	-10
-56	-8	-32
-48	-72	38
-64	-44	-10
6	52	-8
-2	38	20
-16	30	44
-46	-74	44

// Baliki M N, 2008: Knee Osteoarthritis (OA) Patients
// Subjects=5
-36	42	6
-36	28	-8
-8	22	28
50	14	48
2	8	62
-36	6	4
42	6	-4
26	6	-2
-20	-6	-18
14	-18	2
-8	-22	0
-54	-26	24
52	-28	24
44	42	-14
-40	36	32
-4	38	22
6	30	26
40	18	52
-22	14	-2
10	16	62
-40	8	-6
38	18	-8
-18	14	-2
16	-18	4
-16	-16	4
-38	-24	56
-58	-28	26
54	-24	26
0	-52	68
-28	-52	54
-56	-64	4
22	-76	48
-12	-80	-12
-38	52	12
-36	28	-8
-4	24	28
12	-18	0
-6	-22	0

// Bragulat V, 2008: Alcoholic Odor > Non Appetitive Odors
// Bragulat V, 2008: Alcohol Odors > Appetitive Odors
// Subjects=10
6	0	-10
4	12	-18
-4	68	-2
-2	62	0
8	70	2
0	-68	24
-44	-78	40
0	-40	32
-4	-50	20
0	48	-6
34	34	-14
34	36	-20
-10	64	10
0	-40	30
-2	-66	20

// Brewer J A, 2008: Incongruent vs. Congruent Stroop
// Brewer J A, 2008: Stroop Main Effect Correlation with Percent 
// Cocaine-Negative Urine Toxicology
// Brewer J A, 2008: Stroop Main Effect Correlation with Longest Duration of 
// Cocaine Abstinence
// Brewer J A, 2008: Stroop Main Effect Correlation with Weeks in Treatment
// Subjects=20
36	28	-8
-40	8	32
-4	12	52
-16	4	0
12	0	-4
-32	-60	44
52	-48	48
24	0	-4
-24	-36	40
-12	48	-8
24	0	12
-28	40	48

// Chandrasekhar P V, 2008: Activations in Response to Regret
// Chandrasekhar P V, 2008: Activations in Response to Rejoice
// Chandrasekhar P V, 2008: Activations in Response to Regret and Rejoice
// Chandrasekhar P V, 2008: Regions Activated with the Linear Increase of 
// Probability of Shock in the Anticipation Phase
// Subjects=30
9	-81	51
-6	-63	66
-30	-81	39
45	-72	36
-6	-27	12
-54	-66	-18
-21	6	66
3	54	-24
-9	60	-6
0	60	-9
3	-21	72
21	-18	75
45	15	-12
39	-15	-6
-45	6	-6
-30	-12	15
15	-84	3
-18	9	-9
18	9	-9
63	-27	42
-12	-87	0
3	36	3
-21	-27	-3
12	15	0
-9	36	48
3	-15	-12
33	-60	-12
48	45	24
48	21	-18
51	39	-15
-48	18	-12
-6	-75	45
3	-30	27
42	-54	57
-42	-54	57
-3	24	36
63	-39	-6
6	24	63
24	6	-15
51	12	42
9	-3	12
-42	-66	-27
-3	9	39
9	-9	75
15	-48	72
60	3	0
-57	3	0
57	-27	27
-63	-24	21
9	-21	3
-6	-24	-9
45	-3	45
-51	-3	45
-36	48	36
27	36	24
33	24	6
45	6	6
-39	18	6
-21	-60	-27
-9	-42	-30
15	-30	42
-18	-45	72

// Coderre E L, 2008: Kana Words > Kanji Words
// Coderre E L, 2008: Kana Incongruent > Kana Congruent
// Coderre E L, 2008: Kanji Incongruent > Kanji Congruent
// Coderre E L, 2008: (Kana Incongruent > Kana Congruent) > (Kanji Incongruent 
// > Kanji congruent)
// Coderre E L, 2008: Kana Incongruent > Kana Words
// Coderre E L, 2008: Kanji Incongruent > Kanji Words
// Subjects=9
-30.56	-32.06	36.89
-20.65	-55.33	65.49
-19.3	45.26	3.51
49.47	-16.24	27.95
17.78	-65.38	55.86
7.62	37.7	27.25
-14.87	50.25	26.46
14.23	-83.26	3.87
-11.41	-78.93	7.14
-21.21	-61.07	-8.74
10.92	18.94	32.14
-5.06	25.96	41.77
-5.49	51.08	-4.94
42.95	5.67	22.84
-46.5	-44.33	44.79
-5.11	25.45	35.12
10.91	28.72	34.66
-6.51	38.48	-2.76
-4.91	7.7	53.33
-49.98	8.8	30.34
13.97	32.74	17.56
-17.97	28.29	31.68
4.35	27.14	14.8
-37.2	28.17	31.91
46.18	-.65	23.34
13.82	65.26	11.49
-43.63	-57.69	-4.3
8.84	22.79	40.76
39.87	3.68	38.66
-46.47	-50.68	45.32
-46.75	15.68	36.42
-2.86	23.32	48.65
43.18	-48	30.69
14.28	-91.46	7.9
-14.66	6.27	35.72
10.93	9.17	29.61
-9.21	14.02	52.85
47.38	-45.48	21.51
-8.31	-86.54	-8.98
14.23	-85.38	4.04

// Frangou S, 2008: Healthy Controls
// Subjects=7
-52	6	40
-28	-66	56
-30	-66	44
-54	-46	12
-14	-4	16
4	18	54
52	12	40
48	38	24
38	-62	52
42	-50	38
8	-2	12
-50	2	42
36	20	54
36	12	56
8	40	32
36	62	-2
-20	10	68
-34	58	14
-54	8	40
-44	46	16
-54	18	-6
-2	-84	-28
2	30	46
20	62	-6
28	58	-10
50	10	36
34	24	-10
38	-66	56
28	-78	-22
6	-16	8

// Frangou S, 2008: Bipolar Disorder Patients
// Subjects=7
-24	4	60
-40	54	-4
-46	46	16
-42	6	28
-40	22	-8
-44	-56	54
44	-48	42
-58	-60	12
36	2	60
2	14	58
50	10	36
50	38	26
48	20	-4
52	-46	56
58	-46	-14
54	-40	48
-26	-8	70
-64	-20	2
-54	16	-12
-62	-50	8
-30	-66	56
34	0	64
58	-64	-4
28	-76	50
6	-96	16
36	-72	-26
2	-26	10

// Hoeft F, 2008: (Unfixed + Fixed Wall) > Rest, Males + Females
// Subjects=11
0	-11	52
36	37	31
26	7	53
36	42	15
-55	5	22
-51	2	37
44	-7	50
-32	-40	61
-55	-19	40
20	-59	55
-50	-28	27
-16	-59	55
-46	-74	-1
-40	-75	-15
44	-74	-6
46	-59	-7
-22	2	-3
-12	-3	11
-12	-18	-1
18	-13	12

// Hoffman W F, 2008: Delay Discounting vs. Magnitude Estimation, 
// Methamphetamine Users + Healthy Controls
// Hoffman W F, 2008: Significant Clusters for Second Level Linear Regression
// Hoffman W F, 2008: Significant Clusters for Second Level Linear Regression: 
// Effect of Group
// Subjects=20
2.14	-17.55	42.77
-45.96	-61.04	37.93
0.67	34.59	26.26
-33.83	53.35	7.57
49.15	-56.86	39.39
-39.56	-17.26	-.72
-3.52	77.5	26.83
-44.18	-10.59	40.6
-30.01	-51.52	17.77
-36.47	47.94	-4.32
-42.25	-45.86	12.31
-21.85	-.97	-11.88
-42.8	74.02	16.98
-18.52	-53.98	23.53
8.86	63.77	-8.74
-24.44	7.93	1.57
16.69	44.46	0.93
-14.58	12.22	34.22
-12.66	80.88	20.41
-58.18	-12.31	-2.48
-33.11	75.43	27.46
29.18	74.2	23.95
-19.68	3.65	21.5
-10.34	-11.7	34.17
7.79	80.5	-2.88
-11.01	81.79	-.99
-34.58	81.21	4.57
-18.12	16.85	35.21
-8.7	80.55	35.11
-35.34	89.76	-7.29
-25.51	14.32	59.59
-25.76	80.83	-14.9
35.37	20.01	43.81
48.5	76.54	-19.18
-40.1	4.35	35.17
-23.04	96.48	-16.47
-48.52	7.77	25.06

// Hutcherson C A, 2008: Extraversion and Response to Amusing vs. Neutral 
// Films, All Participants
// Hutcherson C A, 2008: Extraversion and Response to Amusing vs. Neutral 
// Films, Attend Subjects
// Hutcherson C A, 2008: Extraversion and Response to Amusing vs. Neutral 
// Films, Watch Subjects
// Hutcherson C A, 2008: Extraversion and Response to Sad vs. Neutral Films, 
// (Attend vs. Watch Subjects)
// Hutcherson C A, 2008: Extraversion and Response to Sad vs. Neutral Films, 
// Attend Subjects
// Hutcherson C A, 2008: Extraversion and Response to Sad vs. Neutral Films, 
// Watch Subjects
// Subjects=14
21.23	69.99	3.2
41.67	42.96	9.69
17.83	-36.26	74.6
12.77	21.42	-4.9
-19.29	12.42	-8.23
21.23	69.99	3.2
41.67	42.96	9.69
17.83	-36.26	74.6
12.77	21.42	-4.9
-19.29	12.42	-8.23
21.23	69.99	3.2
41.67	42.96	9.69
17.83	-36.26	74.6
12.77	21.42	-4.9
-19.29	12.42	-8.23
-19.35	8.56	-16.83
-19.35	8.56	-16.83
-19.35	8.56	-16.83

// Ino T, 2008: Kanji > Kana, Word Recognition
// Ino T, 2008: Word Recognition > Reading Aloud, Kanji
// Ino T, 2008: Word Recognition > Reading Aloud, Kana
// Ino T, 2008: Reading Aloud > Word Recognition, Kanji
// Ino T, 2008: Reading Aloud > Word Recognition, Kana
// Ino T, 2008: Word Recognition (Kanji vs. Kana) > Reading (Kanji vs. Kana)
// Subjects=14
-36	-44	-16
36	-48	-18
32	24	4
-28	22	0
44	6	32
-50	4	36
48	24	30
10	26	38
-4	14	48
2	4	34
24	2	48
36	4	60
32	-76	34
-38	-82	24
42	-76	18
-34	-78	8
34	-60	52
-26	-66	48
34	-54	46
-50	-42	50
-28	-52	38
24	-34	-24
-52	-54	-10
40	-62	-12
56	-46	-12
36	46	30
-44	32	40
-20	-2	0
-18	-78	8
8	-80	6
-36	-64	-30
36	-48	-46
38	-72	-14
10	-6	4
-6	-24	-4
-2	-26	-26
8	-28	-18
14	-50	-20
-24	-36	-40
-30	-12	62
24	-8	60
22	2	48
-42	-24	62
-36	-34	40
54	-20	36
-48	-26	38
36	-42	40
-8	-22	-6
44	-48	62
-16	-64	60
42	30	26
10	-62	54
-10	-4	58
10	-4	48
32	24	4
-26	22	2
2	-24	-32
-6	-24	-28
-30	-4	0
14	6	-6
16	16	-4
-16	22	10
-42	-54	-18
-44	-58	-16
14	-52	-18
-32	-12	60
-40	-28	54
-46	-12	34
44	-12	36
54	-6	46
66	-8	-2
-60	-12	2
-10	-62	-24
-46	-14	36
44	-12	36
56	-4	46
64	-10	0
-58	-12	6
-10	-62	-20
28	24	6
-32	22	2
10	32	28
-2	6	32
32	4	56
-20	-2	58
12	-66	54
-20	0	4
52	-42	58
-46	-44	46
44	30	26
50	40	8
52	-36	60
-50	-46	56
-20	-76	10
8	-74	10
34	-56	64
-26	-66	48
36	-78	36
-24	-64	42
10	-6	0
-30	-56	-36
4	-50	-20
-8	-40	-34
56	-52	-14
16	14	-4

// Ino T, 2008: Word > Color
// Ino T, 2008: Color > Word
// Subjects=18
-42	-86	-8
42	-80	-6
-28	-88	-10
32	-92	-6
-48	-68	-12
46	-80	-10
-24	-94	-2
30	-96	2
-44	-50	-22
50	-60	-16
-54	-58	-12
50	10	26

// Knaus T A, 2008: Autism Spectrum Disorder (ASD) Adolescents
// Subjects=12
-48	23	-10
-62	-47	8
-8	-17	12
-4	7	60
36	-81	-26
-8	-21	-10
-32	-39	-17
62	31	18
62	31	20
72	-57	-6
-54	19	18
-62	-65	-8
-34	3	34
-58	-69	12
-2	5	60
-36	17	-.25
38	13	24
38	39	-14
42	-71	56

// Knaus T A, 2008: Typically Developing Adolescents
// Subjects=12
-50	25	14
-54	-11	-12
-58	-37	6
-32	-37	-16
-32	33	-12
-36	-13	-40
-44	-.5	50
62	31	20
72	-57	-6
-54	19	18
-62	-65	-8
-34	3	34
-58	-69	12
-2	5	60
-36	17	-.25
38	13	24
38	39	-14
42	-71	56

// Knutson B, 2008: Major Depressive Disorder (MDD)
// Subjects=14
-10.44	15.64	32.66
-53.21	-.27	23.33
47.35	-11.68	32.05
-31.7	23.23	50.11
9.5	43.86	-3.39
-32.2	26.89	-12.64
15	11.45	3.72
-19.2	6.85	2.27
-16.59	9.54	64.46
-42.5	-24.16	16.29
-33.58	-28.97	63.43
-48.74	-37.8	33.12
-39.38	-46.92	-3.03
41.79	44.25	26.31
12.76	14.73	-8.79
17.07	12.98	-4.24
18.11	11.59	-8.59
-10.77	8.96	-12.5
-19.07	11.48	20.84
57.69	10.05	-4.46
1.31	11.23	29.55
-23.55	8.17	-7.83
-10.62	7.16	5.49
1.41	9	42
53.7	8.62	32.51
17.6	10.72	62.86
45.22	9.26	41.47
37.86	1.7	54.46
26.2	2.57	66.79
26.2	-5.09	64.09
4.44	-13.65	10.41
-3.03	-15.81	10.67
21.45	-23.29	-5.71
26.2	-21.64	56.55
61.29	-27.54	32.11
-42.16	-30.51	58.08
26.29	-37.16	62.31
-10.04	-46.17	59.03
5.76	-64.85	22.49
-18.57	-62.43	56.03
12.82	67	20.28
32.9	48.34	-16.31
1.06	50.38	12.88
9.61	42.77	10.08
33.04	21.19	-9.57
-42.78	21.34	-.91
5.66	25.23	45.05
-23.56	9.22	-7.92
26.06	14.31	53.54
-9.47	-.78	12.83
-10.53	-1.76	14.04
-3.1	-23.09	-.98
12.94	-26.17	-.91
49.72	-34.53	52.9
0.88	48.49	-11.49
8.52	20.59	-1.43
-19.04	3.02	21.55
-18.96	-8.27	26.95
17.36	-4.88	26.25
-2.97	-41.53	8.37
21.64	3.95	29.92

// Knutson B, 2008: Healthy Controls
// Subjects=12
-10.44	15.64	32.66
-53.21	-.27	23.33
47.35	-11.68	32.05
-31.7	23.23	50.11
9.5	43.86	-3.39
-32.2	26.89	-12.64
15	11.45	3.72
-19.2	6.85	2.27
-16.59	9.54	64.46
-42.5	-24.16	16.29
-33.58	-28.97	63.43
-48.74	-37.8	33.12
-39.38	-46.92	-3.03
9.56	45.6	5.38
-10.74	12.47	-8.34
21.28	12.32	-13.15
7.44	12.75	-6.34
-9.68	11.34	-9.37
8.58	5.79	-.19
-16.08	1.52	-11.82
1.21	-6.26	9.83
21.05	63.79	-21.93
1.09	59.52	21.04
-19.58	55.55	-28.57
41.47	52.97	-12.33
41.72	43.56	17.45
1.39	29.69	48.07
28.73	20.83	-13.95
-35.31	16.9	-3.96
53.41	17.69	-1.7
-58.85	16.41	-8.11
12.75	16.84	-8.97
33.51	14.02	49.02
9.63	10.02	-.56
-9.47	-.78	12.83
1.55	-2.75	55.25
1.22	-9.44	10.09
-42.24	-10.42	56.4
-46.44	-38.28	54.32
49.71	-37.96	49.84
33.79	-41.34	62.58
29.51	-50.17	58.91
29.5	-62.4	52.13
13.48	-66.72	52.67
-22.87	-70.46	48.94
-3.46	64.33	-12.77
-15.02	28.91	-1.86
9.58	21.65	-1.53
-23.55	16.97	-4.1
1.33	12.54	32.78
-15.04	0.13	-16.17
65.31	-1.65	8.7
17.34	-8.4	22.09
-14.7	-12.82	22.83
-26.67	-15.12	-5.84
21.45	-23.29	-5.71
-34.66	-25.89	62.07
-50.77	-31.16	50.43
49.75	-34.18	57.33
-2.45	-57.08	68.77
29.57	-57.23	63.96
32.95	60.92	-5.09
-35.5	59.91	-12.03
-26.75	-3.83	-11.25
-26.57	-6.43	10.16
28.91	-10.21	-2.43
61	-9.76	0.51
1.61	-9.81	60.3
49.55	-15.38	39.03
-62.85	-22.51	11.92
49.66	-18.67	51.57
57.9	-21.78	10.48
65.5	-28.2	23.19
49.51	-27.95	27.82
-51.19	-39.93	-7.94
-38.94	-51.18	51.97
17.85	-56.95	68.53
-25.98	-61.79	64.98
6.05	-78.4	53.74

// Koeneke S, 2008: Anticipation Effect of Losing Trials (Increasing Linearly 
// with Subjective Preference)
// Koeneke S, 2008: Anticipation Effect of Losing Trials (Decreasing Linearly 
// with Subjective Preference)
// Koeneke S, 2008: Outcome of Lost Losing Trials (Increasing Linearly with 
// Subjective Preference)
// Koeneke S, 2008: Outcome of Lost Losing Trials (Decreasing Linearly with 
// Subjective Preference)
// Koeneke S, 2008: Main Effects of the Anticipation Phase of Winning Trials 
// (WA)
// Koeneke S, 2008: Main Effect of the Outcome Phase of Won Winning Trials 
// (WOW)
// Koeneke S, 2008: Preference-Dependent Activation during WA, Increasing 
// Linearly with Subjective Preference
// Koeneke S, 2008: Preference-Dependent Activation during WA, Decreasing 
// Linearly with Subjective Preference
// Koeneke S, 2008: Preference-Dependent Activation during WOW, Increasing 
// Linearly with Subjective Preference
// Subjects=19
10	24	10
-12	18	16
0	-90	14
-10	-100	24
-6	-100	16
12	-62	-2
2	-68	-6
16	-54	-8
60	8	-10
24	8	14
-18	-42	20
-28	22	44
26	-94	-10
-30	-96	8
-24	-30	-4
22	-28	-2
-16	28	-4
-22	-8	32
4	24	2
16	-28	-30
32	22	-26
48	46	-16
-58	16	4
60	22	26
30	4	68
44	-6	22
-22	-8	60
-40	-4	48
38	-10	36
-60	-6	38
12	-78	-46
2	-34	-32
-28	-30	28
-8	-86	-12
-48	-60	30
2	-62	62
-14	0	28
-12	14	22
14	14	20
28	-32	8
-34	-12	-24
-38	8	44
40	26	24
-50	28	0
2	28	62
44	52	-10
42	18	48
-2	62	26
-34	22	-26
-6	64	-2
18	48	48
-10	14	68
38	-20	68
4	-46	34
68	-32	-8
52	16	-22
-54	4	-26
62	-4	-26
-40	16	-34
38	18	-42
-44	-40	-22
64	-2	10
10	-38	74
-12	-42	74
46	-8	18
-26	-30	20
40	-26	26
28	-76	-50
0	-72	-46
10	-56	-36
32	-2	24
-2	24	8
24	-54	36
24	-22	44
6	-30	16
-16	-8	62
16	4	68
44	28	-12
42	-48	14
10	-18	-6
-36	12	60
-4	-30	40
-16	-50	36
-4	-50	8
6	-52	14
-2	-58	26
-2	-72	34
-4	-70	16
-42	-76	34
-52	-74	26
-8	-80	-8
-16	-82	-6
-26	-42	-14
28	-36	-40
18	8	18
16	2	26
24	2	-8
6	-46	6
-2	-42	8
0	-54	-4
16	-60	40
-20	-72	-4
-14	-82	-12
-12	-80	-2
-14	-96	20
-14	-56	0
-6	-66	4
22	-90	-16
34	-22	-16
22	-52	-2
14	-50	-4
16	-82	-28
6	-20	-22
-22	-66	-34
52	-26	16
42	-42	22
46	-28	28
-38	-56	16
-42	-52	22
38	-30	54
28	16	20
18	28	40

// Leff A P, 2008: (Idioms + Rearranged Idioms + Time Reversed Idioms) vs. 
// Fixation
// Leff A P, 2008: (Idioms + Rearranged Idioms) - Time Reversed Idioms
// Subjects=26
-44	-24	8
50	-26	6
-62	-32	14
68	-32	2
-58	0	-8
56	0	-8
40	-18	54
-4	-86	2
8	-86	2
-20	-48	-22
28	-62	-24
-26	-4	8
24	-6	8
-52	-48	8
-54	10	-16
-48	28	-6

// LoPresti M L, 2008: Active Maintenance Analysis, DMS vs. Number 
// Discrimination, Delay
// LoPresti M L, 2008: Face Processing Analysis, DMS vs. Number 
// Discrimination, Stimuli
// Subjects=19
-46	26	-6
-40	56	14
-44	30	8
-26	32	8
54	6	46
-40	2	32
0	20	48
-18	-16	-20
-18	-4	-20
-32	-30	-8
34	-46	-4
-50	-50	52
-42	-54	-28
-2	-82	-30
50	-74	-14
58	-62	-10
28	-82	18
24	-80	-14
50	-36	0
-40	-74	-14
-40	-60	-18
-52	-46	4
40	30	-8
50	38	6
34	28	2
-50	22	-6
-46	16	22
-32	26	0
2	30	44
10	20	36
6	38	18
-16	-36	-6
16	-36	-6
-18	-4	-16
20	2	-20
-36	-52	42
40	-52	48
0	-52	-44
-6	-80	-38

// Merabet L B, 2008: Blindfold > Non Blindfold, Day 5
// Merabet L B, 2008: Non Blindfold > Blindfold, Day 5
// Subjects=16
8.91	-100.55	0.92
57.01	4.21	43.99
40.8	-5.51	16
-28.25	-76.38	41.69
-37.15	-9.78	22.83

// Pierno A C, 2008: Main Effect of Type of Observed Behavior [(GT + GTD) - 
// (GAT + GATD)]
// Pierno A C, 2008: Interaction [(GT - GTD) - (GAT - GATD)]
// Subjects=12
-36	0	45
48	-3	51
27	-6	51
-27	-12	60
60	-36	15
36	-42	51
-30	-42	60
-24	-51	51
42	-48	-18
6	-63	3
-39	-69	9
54	-66	3
50	24	21
9	-78	-3
-3	-75	-3

// Schiller D, 2008: Shock > No Shock
// Subjects=17
-9.55	4.96	4.55
13.96	6.25	5.28
-26.64	-1.57	4.18
26.7	4.32	-6.97
-45.91	7.74	2.5
49.18	9.29	0.16
10.77	-11.21	0.09
6.59	-11.35	12.42
-6.41	-12.17	-10.78
-6.39	-24.05	-13.13
3.53	8.84	39.76
1.6	-2.24	61.9
-9.09	-37.51	47.14
5.97	-54.97	54
16.08	-44.44	-17.25

// Seseke S, 2008: Normal Males
// Subjects=12
7.46	-18.85	-15.95
-4.28	-15.5	-12.76
34.24	-52.07	-21.28
-30.88	-58.38	-14.43
12.94	-11.91	4.59
-11.63	-13.11	4.97
26.75	8.18	1.63
-24.47	-1.3	7.47
61.04	8.27	13.5
-54.38	6.35	12.75
63.4	-34.47	24.86
-47.71	-27.14	33.33
34.24	10.51	3.58
-32.04	17.52	3.75
18.79	-26.45	63.73
-14.35	-24.54	63.95
-1.24	-20.45	-35.79
1.18	-43.93	-9.32
0.34	7.93	42.1
1.57	-2.49	58.57
-8	1.22	66.18
37.36	20.68	-2.89
-34.23	19.19	-1.94
-21.28	5.15	8.01
-.11	-34.1	-33.55
9.61	-18.76	-14.87
-6.41	-17.62	-12.55
15.07	-19.64	0.75
-13.77	-21.93	1.27
8.11	-27.49	65.06
-5.79	-26.6	64.03
21.45	-57.27	-18.47
-13.8	-51.93	-15.17
27.14	-85.5	15.06
-15.57	-83.3	19.82
-6.31	56.99	30.26
-43.45	-60.2	18.21
5.18	-21.47	-35.78
3.26	-52.17	-19.8
2.6	-47.98	34.5
22.48	-75.29	-31.47
17.47	-44.43	23.99
42.2	-38.26	46.61
-46.56	-28.47	43.46
28.87	57.4	18.67
-24.43	49.65	33.31
26.73	14.61	2.21
26.85	-40.26	-5.46
3.74	-63.67	38.03
-24.43	49.65	33.31
48.4	-49.25	14
-46.72	-45.59	14.79

// Seseke S, 2008: Normal Females
// Subjects=11
22.48	-75.29	-31.47
17.47	-44.43	23.99
42.2	-38.26	46.61
-46.56	-28.47	43.46
28.87	57.4	18.67
-24.43	49.65	33.31
26.73	14.61	2.21
26.85	-40.26	-5.46
3.74	-63.67	38.03
-24.43	49.65	33.31
48.4	-49.25	14
-46.72	-45.59	14.79

// Strathearn L, 2008: Own Infant Face vs. Unknown Infant Face
// Subjects=26
2.65	4.2	62.46
4.29	66.06	22.68
52.57	12.33	25.52
49.54	-13.35	37.75
22.98	-22.88	54.46
52.25	3.53	-19.46
43.02	-40.91	12.25
41.84	-55.23	-7.72
24.6	6.94	-.47
26.87	-15.88	6.99
10.77	7.46	7.45
8.65	-19.76	-.28
5.41	-5.87	0.82
16.14	-8.63	5.39
4.27	-7.79	-10.15
46.03	-38.46	-11.41
35.23	-2.4	-12.08
43.84	4.94	-.52
45.99	-19.17	-9.68
2.5	2.66	42.52
2.09	-17.03	-19.39
4.31	-21.62	-10.11
41.67	-51.49	-28.11
-6.35	44.5	20.15
-44.95	25.3	-4.56
-24.49	54.51	27.33
-47.7	-13.93	38.91
-14.75	-58.31	-1.24
-58.65	-39.8	-5.63
-49.26	3.01	-17.14
-40.45	-28.35	3.23
-42.7	-47.08	-18.59
-12.8	7.77	-.11
-23.47	3.48	0.37
-29.86	-11.71	-2.74
-26.58	-8.72	8.12
-13.76	4.56	13.55
-8.47	-8.06	1.17
-10.58	-15.48	1.81
-4.29	-7.92	-11.16
-27.86	-6.46	-17.7
-32.01	-4.15	-1.12
-1.1	41.39	6.97
-1.91	17.64	30.16
-3.91	-53.45	19.42
-7.13	-65.7	12.68
-7.45	-23.97	-12.01
-2.11	-21.74	-11.14
-35.34	-41.63	-31.4
-1.2	-49.77	-43.37

// Thaut M H, 2008: Polyrhythmic vs. No Movement
// Thaut M H, 2008: Isorhythmic vs. No Movement
// Thaut M H, 2008: 3 Hz vs. 2 Hz
// Thaut M H, 2008: Polyrhythmic vs. Isorhythmic
// Thaut M H, 2008: Isorhythmic vs. Polyrhythmic
// Subjects=12
-32	-26	68
-48	-30	62
-30	-20	66
-48	-28	52
-58	-18	50
-56	-12	40
-42	-10	48
-52	8	44
-8	-8	68
2	-6	70
-6	2	68
2	2	68
-8	-4	56
-50	-22	16
-56	-26	24
-56	-16	22
-24	-8	-2
-36	4	0
-52	10	-4
-32	-30	10
16	-24	8
-6	-24	0
16	-48	-22
28	-62	-24
16	-50	-18
30	-62	-24
-28	-28	62
-44	-24	52
-40	-20	62
-34	-12	-6
-28	-4	6
-32	-26	10
-52	-22	16
-16	-28	0
4	-66	-16
30	-42	56
44	-24	10
46	-16	-2
-20	-66	-18
-4	-6	70
4	-4	72
52	-32	50
38	-48	46
-20	-66	-18
-28	-42	-34
18	26	-4
18	14	-4

// Wu Y, 2008: Cerebral Palsy Patients
// Subjects=11
20.26	53.43	-12.46
-28.29	54.84	-6.17
39.56	-5.57	-36.09
-8.1	30.97	47.4
3.86	-3.43	46.11
-17.52	-10.56	62.87
-41.06	37.65	5.83
30.11	-38.6	-21.45
46.83	-55.42	15.79
-37.97	0.49	-12.95
-27.99	-39.16	-1.35
14.39	-75.51	9.36
-11.51	-74.23	13.04

// Wu Y, 2008: Healthy Subjects
// Subjects=10
7.5	14.45	-3.9
-5.55	19.2	-9.75
49.96	-29.99	12.1
-2.11	-19.72	-1.48
14.11	-29.44	-3.03
7.65	-58.81	-6.74
-31.12	-38.35	7.58

// Li C S, 2008: Stop Errors > Stop Successes
// Li C S, 2008: Post-Stop Successes Go > Post-Stop Errors Go
// Subjects=40
-4	16	44
4	8	64
-8	20	36
16	-64	8
28	-48	0
-4	-24	8
-48	8	-8
-44	4	4
-32	24	8
-36	-8	52
-48	-28	24
44	16	0
-4	-8	56
-16	-36	52
-36	-12	52
16	-68	12
24	-64	4
16	-56	-4
-12	12	-8
8	12	-8
12	28	-8
-16	-32	0
-12	-28	8
16	-20	-12
20	12	-16
-16	-52	-4
40	4	12
28	-20	-28
16	-28	8

// Shamosh N A, 2008: 3-Back vs. Fixation, Activations
// Shamosh N A, 2008: 3-Back vs. Fixation, Deactivations
// Shamosh N A, 2008: 3-Back Correlated with Accuracy
// Shamosh N A, 2008: 3-Back Inverse Correlated with Accuracy
// Shamosh N A, 2008: 3-Back Correlated with Intelligence
// Shamosh N A, 2008: 3-Back Inverse Correlated with Intelligence
// Shamosh N A, 2008: 3-Back Inverse Correlated with Delayed Discounting
// Shamosh N A, 2008: 3-Back Correlated with Delayed Discounting
// Subjects=103
10	-70	54
-3	40	7
39	-9	-11
-9	-62	12
-22	61	8
10	-70	54
-3	40	7
-59	-32	22
39	-9	-11
-9	-62	12
-22	61	8
10	-70	54
-3	40	7
-59	-32	22
39	-9	-11
-9	-62	12
-22	61	8
-3	40	7
39	-9	-11

// Deckersbach T, 2008: Bipolar Disorder Patients
// Subjects=9
-10	22	40
12	18	38
-58	10	6
50	6	16
-56	14	18
-32	26	4
36	28	24
32	34	28
-40	-4	52
-26	-2	44
30	2	48
-22	0	-14
-42	4	34
-56	-16	36
-60	0	10
-60	-10	20
20	2	14
-66	-14	-2
60	-16	-2
-62	-18	4
60	12	-12
30	14	6
-12	32	22
-12	20	40
6	20	42
-48	10	14
-30	26	6
42	20	6
36	22	-10
32	36	28
-40	-4	52
-20	-2	-14
-56	-16	36
20	4	14
60	-12	-2
62	-22	0
-62	-20	2
60	10	-12
-38	12	-4
-52	34	16
-50	16	28
50	8	16
32	34	26
28	6	44
-56	-12	34
32	34	26
28	6	44

// Deckersbach T, 2008: Healthy Controls
// Subjects=17
-8	4	-56
-58	6	22
36	18	-6
26	-8	46
12	-6	12
-46	-4	42
-56	-16	28
24	-10	-2
-8	-20	-12
68	-12	-6
-58	-10	-8
-32	18	2
14	8	38
-6	16	44
10	8	58
-2	10	62
60	8	30
48	18	2
36	18	-8
28	14	-18
-48	22	25
-46	-2	42
-24	-10	-18
24	-12	-16
-12	-16	6
-32	-6	50
-56	-16	28
24	-12	-2
-8	-20	-12
60	-16	-10
-56	-14	-12
52	-8	-28
44	14	-38
38	10	-20
14	46	6
38	24	14
-32	24	38
42	4	40
-2	2	8
50	8	16
32	34	26
28	6	44
-56	-12	34
32	34	26
28	6	44

// Fales C L, 2008: Major Depression Patients
// Subjects=27
-18.29	-5.86	-24.55
39.68	32.43	25.1
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34
-21.45	-6.51	-18.89
23.44	-6.07	-17.21
43.97	24.89	23.45
20.4	46.15	25.28
-39.38	20.07	23.7
4.51	26.65	36.02
5.62	22.68	39.69
-40.34	27.78	40.9
-2.31	43.19	-11.01
12.84	44.19	14.38
-20.06	36.45	41.06
-24.3	30.16	42.75
22.68	34.42	38.51
5.42	32.6	16.56
1.36	18.34	38.99
46.07	31.16	21.79
-41.53	28.69	25.23
-0.08	39.74	-.71
-34.25	40.94	4.04
-23.32	41.29	35.12
22.63	40.5	34.65
-39.38	36.53	30.12
40.89	25.09	40.2
-.11	28.48	-8.69
-4.17	43.89	25.76
34.19	35.26	7.08
-26.58	39.69	28.6
30.08	34.75	28.36

// Fales C L, 2008: Healthy Controls
// Subjects=24
-18.29	-5.86	-24.55
39.68	32.43	25.1
-9.76	37.94	-9.37
5.62	22.68	39.69
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34
-21.45	-6.51	-18.89
23.44	-6.07	-17.21
43.97	24.89	23.45
20.4	46.15	25.28
-39.38	20.07	23.7
4.51	26.65	36.02
5.62	22.68	39.69
-40.34	27.78	40.9
-2.31	43.19	-11.01
12.84	44.19	14.38
-20.06	36.45	41.06
-24.3	30.16	42.75
22.68	34.42	38.51
5.42	32.6	16.56
-7.71	38.16	-20.56
1.36	18.34	38.99
46.07	31.16	21.79
-41.53	28.69	25.23
-0.08	39.74	-.71
-34.25	40.94	4.04
-23.32	41.29	35.12
22.63	40.5	34.65
-.11	28.48	-8.69
-4.17	43.89	25.76
34.19	35.26	7.08
-26.58	39.69	28.6
30.08	34.75	28.36

// Fu C H Y, 2008: Patients with Major Depression
// Subjects=19
-18	58	-10
36	54	8
-63	-12	-2
63	-30	26
-48	-74	-16
8	-84	-18
-14	-102	-12
-42	-90	4
38	-82	34
16	-92	16
14	-42	-10
-28	-4	-24
10	-32	4

// Fu C H Y, 2008: Healthy Controls
// Subjects=19
14	36	12
26	52	0
50	20	38
-60	-4	12
42	-4	0
40	-84	-10
-18	-88	-22
26	-80	26
-53	-72	-6
-20	-20	-16
2	2	4
29	-52	-26

// Fu C H Y, 2008: Major Depressed Patients
// Subjects=16
29.83	-7.43	-21.63
14.92	-4.72	-12.76
-11.79	32.44	2.27
-10.45	32.02	37.98
-13.68	1.02	22.77
-12.58	2.43	27.1
24.91	-5.21	35.12
23.94	-8.59	46.56
19.71	-31.25	42.93
-25.41	31.93	38.15
-25.37	32.36	43.69
4.54	36.76	42.98
1.38	36.12	48.65
-10.42	34.56	43.34
-15.72	34.96	48.94
32.59	-45.98	44.02
26.18	-36.07	48.84
12.3	-51.38	44.71
19.8	-32.51	54.19
34.21	18.97	2.87
-19.15	-4.78	3.24
-49.08	20.21	12.64
3.4	38.27	35.06
39.72	27.4	28.86
36.31	8.7	-6.33
34.23	13.68	3.31
-8.24	-60.59	10.03
-.58	-63.06	32.45
-2.89	-25.35	24.86
-4.15	34.2	24.34
-58.58	-56.63	-3.11
-58.54	-57.26	2.52
-49.93	-55.55	10.09
-51.12	-24.9	7.53
-52.04	-37.62	21.99
-45.6	-36.18	26.26
-37.87	-42.37	55.68
0.49	-54.25	36.16
7.01	-53.1	50.49
-14.71	-60.17	2.26
-9.35	-58.83	5.43
-34.27	-62.48	-39.7
-38.32	-82.2	-19.04
37.32	-56.68	-39.89
38.58	-62.37	-17.12
-7.34	-97.51	-27.03
-9.41	-97.89	-18.05
14	-62.51	-16.83
16.19	-66.39	-12.07
-29.71	-89.21	-14.09
-31.81	-89.94	-9.54
35.47	-86.7	-15.05
36.59	-91.64	-10.18
-26.42	-94.85	-4.73
-37.05	-93.26	3.06
30.23	-96.63	-5.23
30.32	-92.43	7.8

// Fu C H Y, 2008: Healthy Controls
// Subjects=16
29.83	-7.43	-21.63
14.92	-4.72	-12.76
-11.79	32.44	2.27
-10.45	32.02	37.98
-13.68	1.02	22.77
-12.58	2.43	27.1
24.91	-5.21	35.12
23.94	-8.59	46.56
19.71	-31.25	42.93
-25.41	31.93	38.15
-25.37	32.36	43.69
4.54	36.76	42.98
1.38	36.12	48.65
-10.42	34.56	43.34
-15.72	34.96	48.94
32.59	-45.98	44.02
26.18	-36.07	48.84
12.3	-51.38	44.71
19.8	-32.51	54.19
-8.24	-60.59	10.03
-.58	-63.06	32.45
-2.89	-25.35	24.86
-4.15	34.2	24.34
-58.58	-56.63	-3.11
-58.54	-57.26	2.52
-49.93	-55.55	10.09
-51.12	-24.9	7.53
-52.04	-37.62	21.99
-45.6	-36.18	26.26
-37.87	-42.37	55.68
0.49	-54.25	36.16
7.01	-53.1	50.49
-14.71	-60.17	2.26
-9.35	-58.83	5.43
-34.27	-62.48	-39.7
-38.32	-82.2	-19.04
37.32	-56.68	-39.89
38.58	-62.37	-17.12
-7.34	-97.51	-27.03
-9.41	-97.89	-18.05
14	-62.51	-16.83
16.19	-66.39	-12.07
-29.71	-89.21	-14.09
-31.81	-89.94	-9.54
35.47	-86.7	-15.05
36.59	-91.64	-10.18
-26.42	-94.85	-4.73
-37.05	-93.26	3.06
30.23	-96.63	-5.23
30.32	-92.43	7.8

// Grimm S, 2008: Major Depressive Disorder Patients
// Subjects=19
-42	10	30
-2	-12	56
28	-78	22
-26	-78	30
-38	-30	50
40	24	42
48	28	0
0	-72	38
56	-56	30
-40	6	30
40	12	10
-2	-12	54
28	-68	24
-26	-74	28
-38	-22	54
-40	10	34
2	-6	58
46	16	48
6	-68	36
56	-54	32
22	12	50
24	10	-12
-26	14	-12
48	-4	44
-38	22	28
36	8	38

// Grimm S, 2008: Healthy Controls
// Subjects=29
-42	10	30
-2	-12	56
28	-78	22
-26	-78	30
-38	-30	50
40	24	42
48	28	0
0	-72	38
56	-56	30
-40	6	30
40	12	10
-2	-12	54
28	-68	24
-26	-74	28
-38	-22	54
-40	10	34
2	-6	58
46	16	48
6	-68	36
56	-54	32
22	12	50
24	10	-12
-26	14	-12
48	-4	44
-38	22	28
-40	6	40

// Taylor Tavares J V, 2008: Major Depressive Disorder (MDD) Patients
// Subjects=13
48.62	50.08	7.56
44.26	30.09	0.65
-50.53	8.88	20.05
-50.4	14.27	31.84
20.58	50.4	12.49
65.09	-48.54	8.07
56.6	-47.43	20.43
-50.53	8.88	20.05
-52.72	8.66	17.87
-15.51	14.55	55.87
-7.43	-44.31	-0.08
-9.47	-57.62	6.88
-22.5	-53.83	2.24
24.95	-50.99	-4.45
48.62	47.96	7.77
50.92	35.83	15.65
21.03	34.06	44.35
63.18	-52.1	27.51
42.7	-38.68	34.37
42.91	-44.78	49.54
48.62	47.96	7.77
50.9	35.72	14.54
40.14	46.94	20.34
48.62	47.96	7.77

// Taylor Tavares J V, 2008: Bipolar Disorder Patients
// Subjects=12
-7.43	-44.31	-0.08
-9.47	-57.62	6.88
-22.5	-53.83	2.24
24.95	-50.99	-4.45
48.62	47.96	7.77
50.92	35.83	15.65
21.03	34.06	44.35
63.18	-52.1	27.51
42.7	-38.68	34.37
42.91	-44.78	49.54
48.62	47.96	7.77
50.9	35.72	14.54
40.14	46.94	20.34
48.62	47.96	7.77

// Taylor Tavares J V, 2008: Healthy Controls
// Subjects=15
48.62	50.08	7.56
44.26	30.09	0.65
-50.53	8.88	20.05
-50.4	14.27	31.84
20.58	50.4	12.49
65.09	-48.54	8.07
56.6	-47.43	20.43
-50.53	8.88	20.05
-52.72	8.66	17.87
-15.51	14.55	55.87

// Wang L, 2008: Attentional Targets, Major Depression Disorder < Healthy 
// Controls
// Wang L, 2008: Sad Distractors vs. Neutral Distractors, Deactivations, Major 
// Depression > Healthy Controls
// Wang L, 2008: Target-After-Neutral > Target-After-Sad, Healthy Controls > 
// Major Depression Disorder
// Wang L, 2008: Target-After-Sad > Target-After-Neutral, Healthy Controls > 
// Major Depression Disorder
// Subjects=19
-42	53	0
46	42	4
49	25	-11
32	14	25
-28	4	39
-42	11	-11
49	11	-11
-7	-67	60
-28	4	-4
25	-11	18
-32	-77	21
-25	-81	-35
-28	28	35
56	-32	25
-7	-63	46
-49	-18	21
-35	-32	11
-39	42	14
35	42	28
39	18	35
49	14	18
-28	18	14
-11	35	11

// D'Ardenne K, 2008: Response to Positive and Negative Reward Prediction 
// Errors from Delivery of Primary Rewards
// Subjects=18
20.37	5.14	4.19
-13.95	2.59	-11.93

// Bjork J M, 2008: Children of Alcoholics
// Subjects=13
8.56	11.07	-.63
8.49	12.59	-8.57
2.24	-6.6	5.38
5.37	-20.64	-11.32
-7.56	10.12	-11.52
11.67	10.15	-12.86
-16.07	-9.39	-15.36
18.11	-7.07	-15.95
0.13	-10.76	6.87
2.97	49.14	-17.14
41.48	53.14	-10.12
-46.1	42.04	-8.18
53.6	-62.73	-9.46
-42.55	-63.05	-4.98
3.51	-54	11.57
11.04	-69.91	11.7
-14.62	-66.89	11.75
-8.49	9.28	5.29
11.84	7.46	7.44
-30.04	19.42	-13.16
40.52	16.84	-11.52
-.94	-27.31	-.65
8.47	45.34	2.07
7.2	49.79	-22.82
-28.85	-3.5	-6.79
28.95	-6.52	3.95

// Bjork J M, 2008: Adolescent Controls
// Subjects=13
-9.68	9.14	-10.3
-17.18	9.98	-12.51
11.69	10.32	-10.64
-18.23	-9.58	-17.55
20.23	-9.43	-19.12
-8.37	-9.24	13.53
2.99	48.25	-14.84
45.94	33.04	4.9
-42.75	28.2	5.21
52.6	-63.2	-1.6
-43.61	-60.86	-4.04
1.43	-36.96	25.78
7.85	-56.55	19.54
-7.13	-59.01	16.58
-8.48	6.11	5.55
12.84	11.18	0.42
-38.53	12.31	-8
36.29	12.93	-6.68
8.67	-27.25	-.77
1.1	-19.52	-10.25
7.39	39.7	-1.91
19.62	-65.11	17.9
-39.77	51.17	-14.59
32.88	59.09	-14.98
-27.71	-5.98	2.33
28.94	-6.61	2.85

// Bokde A L W, 2008: Healthy Controls
// Subjects=19
39.4	-74.21	-12.01
31.05	-59.21	44.73
41.55	-41.19	44.54
47.61	18.57	20.44
51.81	27.15	22.04
9.57	25.17	30.2
-30.23	-96.45	-3.42
-49.28	-90.51	-7.04
-47.34	-54.33	-19.52
-45.31	7.83	30.6
35.28	-83.26	13.05
16.28	-70.18	40.02
18.4	-58.5	58.07
31.05	-56.97	46.8
45.53	14.83	28.47
-36.61	-88.3	-7.27
-32.33	-83.49	19.02
-11.19	-61.19	52.88
-17.54	-70.86	33.6
-38.79	-38.34	33.72
22.57	-77.2	10.49
16.18	-65.77	8.64
18.24	-60.19	-3.96
24.75	-105.38	-2.02
39.41	-72.82	-6.55
41.58	-85.21	-2.39
43.53	-51.34	-18.04
32.73	-7.74	-45.38
34.87	-9.48	-39.72
33.81	-5.94	-33.3
47.49	0.86	-44.94
24.26	8.89	-30.93
1.15	33.8	51.85
9.47	46.69	19.85
7.46	27.38	32.28
40.1	20.28	-19.59
11.55	64.19	29.73
11.52	65.88	22.96
7.53	-16.73	0.89
-11.35	-59.52	-6.06
-15.79	-10.66	-17.14
-20.05	1.07	-14.59
-54.99	28.9	-2.97
-45.45	33.15	13.33
-57.11	37.76	4.2
-41.29	30.3	-16.47
-57.03	30.57	24.67
-49.74	52.09	13.16
-22.28	61.2	20.15
-13.68	24.84	28.14
31.08	-76.83	32.62
12.04	-44.29	67.13
16.31	-67.13	55.35
-9.06	-63.27	53.01
-6.96	-68.07	43.34
-4.8	-66.9	62.11
3.17	51	39.57
0.96	63.63	22.07
5.14	65.93	7.45
-47.61	50.14	15.51
-37.03	50.7	23.17
-34.79	33.16	46.56
-24.4	63.28	20.02
-17.98	50.55	35.28
-9.42	33.71	51.92
-59.11	26.83	32.71
-43.44	59.22	8.2
-39.27	68.17	-1.32
-37.1	50.13	-3.42
-7.35	36.14	39.53
-7.41	47.15	29.9
-7.54	59.05	0.23

// Bokde A L W, 2008: Mild Cognitive Impairment (MCI) Patients
// Subjects=16
37.44	-94.67	16.04
43.64	-78.45	-12.85
54.24	-76.5	0.27
43.75	-51.72	61.9
41.17	33.26	2.82
51.88	15.15	32.85
-36.57	-96.5	-3.37
-47.2	-79.72	-3.35
-51.47	-73.92	-11.49
-47.48	17.91	23.26
58.37	-61.58	-15.2
47.98	-87.02	18.79
37.42	-76.64	34.79
35.29	-51.92	59.74
49.6	41.94	5.51
-17.46	-76.93	55.11
-17.53	-55.58	59.19
-32.28	-85.76	33.6
-17.87	-23.82	-25.11
-32.3	-57.47	64.96
-51.82	28.72	-6.31
-56.05	18.29	-21.11
-32.56	11.93	61.32
3.17	51	39.57
0.96	63.63	22.07
5.14	65.93	7.45
-47.61	50.14	15.51
-37.03	50.7	23.17
-34.79	33.16	46.56
-24.4	63.28	20.02
-17.98	50.55	35.28
-9.42	33.71	51.92
-59.11	26.83	32.71
-43.44	59.22	8.2
-39.27	68.17	-1.32
-37.1	50.13	-3.42
-7.35	36.14	39.53
-7.41	47.15	29.9
-7.54	59.05	0.23

// Bray S, 2008: Pavlovian Training > Transfer Trials
// Subjects=23
27	-3	-3
24	-18	0
-27	-15	-3

// Harenski C L, 2008: Normal Males
// Subjects=14
12	45	-12
-6	-54	9
12	-48	3
-51	-72	24
54	-66	33
21	-33	-18
-24	36	51
-12	-72	60
-21	6	69
0	-12	-15
-6	54	6
-9	-54	9
9	-48	6
-6	-60	36
-3	-36	36
-54	-60	27
21	-36	51
-24	-30	-18
-6	-66	57
-21	6	72
9	-24	-15
0	-15	-15
54	-72	12
-9	-33	-36
6	-51	27
0	51	-15
-45	-75	36
-21	-3	-27
-42	-78	36
-18	-63	33
-33	6	15
-39	-81	33
36	21	3
42	9	27
0	-36	-42
-45	-72	15
36	21	3

// Harenski C L, 2008: Normal Females
// Subjects=14
12	45	-12
-6	-54	9
12	-48	3
-51	-72	24
54	-66	33
21	-33	-18
-24	36	51
-12	-72	60
-21	6	69
0	-12	-15
12	45	-9
-6	-57	24
3	60	6
-51	-72	24
51	-69	36
-24	-36	-18
-12	-72	60
6	-51	27
0	51	-15
-45	-75	36
-21	-3	-27
-3	-57	21
-12	-57	30
-30	6	12
-18	-63	33
-33	6	15
-39	-81	33
36	21	3
42	9	27
0	-36	-42
-45	-72	15
3	18	51

// Hu S H, 2008: Healthy heterosexual males
// Subjects=10
-2	2	26
-30	-90	-26
40	-60	-32
20	-36	-2
-32	-56	48
48	-72	-10
-54	12	24
54	20	10
54	32	30
-54	-70	-8
-40	0	-4
38	6	-10
2	-80	-2
6	-70	2
8	40	-6
-38	58	16
52	42	20
-52	-74	0
28	-92	2
62	-6	-26
14	-14	-20
-60	-16	40
-20	-16	62
48	10	36
-12	-40	4
-20	70	8
32	64	16
28	-66	50
-18	-52	66
-16	-18	12
0	-26	-24
-6	-44	-30

// Hu S H, 2008: Healthy homosexual males
// Subjects=10
-42	-68	48
-8	0	24
-12	-86	-28
-6	-78	-48
60	20	4
54	30	20
44	12	18
-52	-68	-10
56	-66	-6
-50	-62	-18
64	-30	-18
-38	0	6
8	72	12
2	-6	38
4	20	32
-42	56	6
-36	52	2
52	44	16
-28	-84	32
-64	-12	-18
14	0	6
32	-36	66
-64	-10	20
12	-36	6
54	2	30
-22	-42	18
-16	72	6
-26	-78	54
-8	-32	6
12	-10	8
-2	-50	-30

// Jager G, 2008: Recognition, Novel - Recognition, Practiced
// Jager G, 2008: Oddball Detection - Rest
// Jager G, 2008: Associative Learning - Classification
// Subjects=33
34	-63	48
46	5	32
6	6	56
46	-39	-12
-30	-67	44
-46	21	-4
-58	-31	4
60	-23	8
-2	21	44
-26	-47	-16
34	-47	-20
-34	-87	8
50	17	28
-46	29	24
-42	21	-4
2	29	40
30	-91	8
50	21	-4

// Lim H K, 2008: Alzheimer's Disease
// Subjects=12
-21.91	-51.59	49.08
-46.61	48.61	-3
-57.42	24.44	-8.27
-46.43	-24.44	-3.62
25.68	-9.45	60.91
-24.12	-49.78	45.57
-17.55	-57.86	50.74

// Lim H K, 2008: Elderly Normals
// Subjects=12
-2.47	-75.65	43.28
60.84	20.94	28.16
-41.26	-20.32	63.12
-37.33	-29.81	30.38
14.96	-8.87	67.75
-46.61	48.61	-3
-57.42	24.44	-8.27
-46.43	-24.44	-3.62
25.68	-9.45	60.91
-24.12	-49.78	45.57
-17.55	-57.86	50.74

// McClernon F J, 2008: Smoking Cues vs. Control Cues, FTND-Positive 
// Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, FTND-Negative 
// Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Craving-Negative 
// Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Negative 
// Affect-Positive Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Negative 
// Affect-Negative Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Sex-Female Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Sex-Male Correlations
// McClernon F J, 2008: Smoking Cues > Control Cues
// McClernon F J, 2008: Control Cues > Smoking Cues
// Subjects=12
9	42	-6
6	39	-18
-42	-75	-18
-48	-78	-12
-15	-6	0
9	12	9
-36	-45	45
-27	-51	51
21	-12	-21
-33	-48	-6
60	-3	0
-12	21	-6
-51	-78	9
15	3	0
-30	-12	-18
-12	33	-18
-15	-6	78
-15	-3	66
-51	-45	54
-42	24	-9
27	12	3
12	-84	33
-42	15	-27
-45	0	-27
-18	-102	9
-15	-9	75
-30	-12	-18
-12	33	-18
-9	48	-3
18	54	12
-6	-84	36
9	-48	30
12	36	-15
6	-48	-21
21	27	66
18	-69	54
-15	51	30
-15	-72	9
-12	-39	-33
-9	-48	45
42	-30	-3
-6	-33	30
39	-15	60
-15	-69	-12
9	39	12
-45	-66	57
-39	-87	21
45	-75	24

// Piblajamaki M, 2008: AD Patients > Healthy Controls, Repeated Face/Name 
// Pairs vs. Fixation (Activations)
// Piblajamaki M, 2008: AD Patients > Healthy Controls, Repeated Face/Name 
// Pairs vs. Fixation (Deactivations)
// Subjects=15
42	36	26
38	16	28
-36	-50	40
-46	-44	36
-24	-62	42
-22	-4	-26
16	-50	24
6	-68	40
-4	-72	40
-36	-70	36

// Shimomura T, 2008: Nenbutsu > Rest
// Shimomura T, 2008: Sutra > Rest
// Shimomura T, 2008: Shiritori > Rest
// Subjects=8
1.88	13.21	63.55
-6.73	9.03	65.23
-2.32	-.11	70.54
-.5	21.43	48.21
-.44	13.13	51.27
1.5	34.43	37.92
-45.97	20.54	41.23
-58.06	24.47	26.48
-52.39	12.22	44.4
56.85	-50.98	39.83
49.28	-59.82	37.47
67.58	-40.62	35.26
3.79	21.24	45.91
-33.58	39.29	-0.06
-46.7	46.82	-10.66
-36.79	27.47	0.05
-41.52	19.36	51.35
-32.82	19.81	55.64
-28.47	12.38	56.31

// Vannini P, 2008: Normals
// Subjects=13
26.28	-70.25	47.24
-22.92	-62.17	46.02
-20.75	-79.42	42.98
34.73	-47.02	44.08
-32.61	-48.65	42.76
49.41	8.34	29.24
-45.7	8.91	31.4
49.41	8.34	29.24
-32.7	-10.07	46.22
10.05	14.63	42.54
-7.85	10.74	47.54
24.07	-85.29	31.8
-32.74	-85.25	9.93
-22	-95.53	13.68
31.42	-85.47	15.01
-30.49	-86.22	24.7
-46.7	-78.26	5.15
-32.01	21.12	9.03
7.38	-19.74	0.18
1.92	-18.68	0.6
-18.07	4.22	8.05
22.06	-78.48	51.33
-14.27	-79.75	51.85
56	-34.72	36.12
44.27	-47.73	34
31.46	-87.25	19.62
-34.8	-85.53	20.23
-15.65	-81.93	10.01
-45.65	-74.11	3.68
23.67	-31.19	2.07
0.01	-14.21	3.48
-21.76	-73.28	53.63
40.85	-2.59	23.56
-48.9	-.75	27.78
22.81	-15.8	36.03
-25.23	-13.46	43.07
-30.65	-93.36	1.21
30.39	-80.65	22.42
-6.69	-89.62	33.64
29.21	-38.99	24.52
28.99	-24.83	1.14
-.52	-15.24	4.02
28.19	-94.51	8.55
57.95	-54.27	3.27

// Vannini P, 2008: Alzheimer's Disease Patients
// Subjects=13
28.29	-63.86	33.3
-23.93	-78.04	47.36
-22.93	-54.6	47.61
40.04	-36.33	44.24
-36.89	-42.16	44.5
48.35	7.15	30.46
-42.46	3.52	32.93
26.07	-81.19	15.82
-28.45	-80.63	14.17
44.14	-71.12	6.85
38.52	21.62	9.29
14.06	-18.02	7.99
-16.93	-17.12	8.71
-19.13	5.23	10.21
22.06	-78.48	51.33
-14.27	-79.75	51.85
56	-34.72	36.12
44.27	-47.73	34
31.46	-87.25	19.62
-34.8	-85.53	20.23
-15.65	-81.93	10.01
-45.65	-74.11	3.68
23.67	-31.19	2.07
0.01	-14.21	3.48
-21.76	-73.28	53.63
40.85	-2.59	23.56
-48.9	-.75	27.78
22.81	-15.8	36.03
-25.23	-13.46	43.07
-30.65	-93.36	1.21
30.39	-80.65	22.42
-6.69	-89.62	33.64
29.21	-38.99	24.52
28.99	-24.83	1.14
-.52	-15.24	4.02
28.19	-94.51	8.55
57.95	-54.27	3.27

// Vossel S, 2008: Invalid Responses > Valid Responses, Nicotine vs. Placebo
// Subjects=12
15	54	-15
51	15	45
36	60	3
51	0	24
-51	-18	-21
42	-42	15
18	-60	63
54	-54	36
24	-48	3
-15	30	-6
33	-12	-18
30	-27	3
3	9	15

// Wiech K, 2008: Catholics
// Subjects=12
51	-21	27
48	-33	27
36	6	18
39	-21	3
-54	-33	24
18	-102	15
48	-81	-9
24	-9	-9
-27	3	-12
21	0	-15
39	3	-6
-54	-3	12
57	0	9
33	-30	75
9	-15	54
-18	-45	-27
33	9	-21
48	30	6
-6	-21	-27
0	-15	75
18	-12	75
51	-75	9
-15	-24	78

// Wiech K, 2008: Atheists and Agnostics
// Subjects=12
45	-24	21
-60	-24	21
-48	-33	21
57	6	0
48	30	6
-6	-21	-27
0	-15	75
18	-12	75
51	-75	9
-15	-24	78

// Zheng D, 2008: No-Go - Go (Go/No-Go)
// Zheng D, 2008: Stop - Go (Stop Signal)
// Subjects=18
1.4	51.24	34.02
42.9	21.42	-23.12
64.51	5.13	-26.36
-37.88	59.14	5.9
-8.88	-52.54	-30.61
40.37	35.53	36.03
53.22	24.86	24.54
55.27	-76.62	-4.67
50.01	21.76	26.03
67.93	-46.01	-22.48
58.92	-49.47	32.92
-68.9	-28.39	12.84
55.25	-75.66	-5.89
-24.33	-63.35	26.75
-49.94	-33.74	57.87
68.14	-32.44	-3.66
61.63	25.36	6.42
-8.54	38.6	14.15

// Chan S W Y, 2008: Negative Words vs. Control Words
// Chan S W Y, 2008: Positive Words vs. Control Words
// Chan S W Y, 2008: Positive Words vs. Negative Words
// Chan S W Y, 2008: Negative Words vs. Positive Words
// Chan S W Y, 2008: Negative Words > Positive Words, High N Scores vs. Low N 
// Scores
// Chan S W Y, 2008: Positive Correlations with N, Negative Words
// Chan S W Y, 2008: Positive Correlations with N, Positive Words
// Chan S W Y, 2008: Negative Correlations with N, Positive Remembered
// Chan S W Y, 2008: Negative Correlations with N, Negative Remembered
// Chan S W Y, 2008: Correlations with Categorization and Recognition of 
// Negative Words
// Subjects=10
14	-84	6
-4	56	24
-44	28	-10
-2	18	42
14	-82	4
-56	28	-2
66	-18	30
-24	14	66
20	-64	64
-8	-8	52
-20	-28	66
-46	26	-6
48	0	12
-10	8	54
-10	26	46

// Helmchen C, 2008: Thermal Pain > Laser Pain
// Helmchen C, 2008: Thermal Pain = Laser Pain
// Subjects=14
8	-4	42
58	-18	14
48	-22	16
-56	-12	26
-48	-12	12
50	4	4
-54	-20	6
-36	-16	10
0	56	-16
-4	64	4
-4	58	-10
8	-12	54
20	-14	76
26	-44	72
18	-46	66
6	16	36
0	10	48
-8	8	46
32	20	4
34	18	6
40	18	-2
46	8	14
-32	10	8
-38	26	-2
-36	0	0
36	4	4
40	-2	-10
40	0	-10
36	8	-16
32	6	-12
46	-18	20
38	-14	18
62	-30	18
50	-14	22
52	-18	18
52	-20	32
50	-24	22
54	-14	14
34	-16	16
-4	-10	-2
-8	-20	6
6	-10	0
10	-10	-4
10	-20	8
10	-22	10
10	6	2
20	10	-12
18	6	2
-12	6	-4
-18	12	-8
-20	8	0
-20	6	-10
28	-2	52
28	-2	54
-28	-6	50
-30	-2	58
44	-2	56
-50	4	46
36	0	60
-40	48	22
54	6	26
-56	6	38
-60	12	30
-58	8	18
48	-32	48
34	-40	46
36	-48	54
-56	-38	24
22	-52	0
16	-38	-6
-6	-28	-8
-4	-30	-26
8	-30	-6
6	-36	-36
4	-28	-26
-4	-42	-18
14	-78	-24
-10	-70	-24
-44	-50	-38
-36	-50	-36
-36	-46	-44
-20	-38	-30
-14	-46	-24
-28	-56	-32
-58	-18	30
-22	-10	62

// Mohr C, 2008: Pain vs. High Level Baseline
// Mohr C, 2008: Self Administrated Thermal Stimulation vs. Externally 
// Administrated Thermal Stimulation
// Mohr C, 2008: Externally Administrated Thermal Stimulation vs. Self 
// Administrated Thermal Stimulation
// Mohr C, 2008: Externally Administered Thermal Stimulation = Self 
// Administered Thermal Stimulation
// Subjects=17
2	16	56
6	22	40
-4	22	40
40	46	6
-38	36	14
-38	32	24
-42	50	20
36	46	-16
46	-44	48
54	-42	54
42	-48	40
-38	-54	46
-20	-42	76
-60	-24	22
-54	-18	10
-64	-16	12
-44	-22	12
52	-4	8
-52	-4	4
-32	20	-4
34	24	-8
32	16	8
-38	-18	14
14	14	-2
-14	14	-4
-40	-58	-34
-44	-74	-30
38	-74	-28
-8	-80	-32
-10	-74	-46
-20	-72	-46
52	-4	8
-38	-2	-14
60	2	8
36	-20	56
28	-14	60
32	56	30
42	52	8
4	-58	-32
0	-48	-18
0	-46	-6
-6	-62	-32
-8	-50	-16
0	16	44
8	14	44
4	10	54
36	18	4
42	12	-4
38	10	-6
-32	14	6
6	-66	-16
8	-76	-18
-4	-58	-12
26	-60	-24
22	-52	-24
-28	-50	-30
-28	-60	-28
-22	-66	-24

// Plassmann H, 2008: Wine 1 High vs. Low Price, Sampling
// Plassmann H, 2008: Wine 1 High vs. Low Price, Swallowing
// Plassmann H, 2008: Wine 1 Low vs. High Price, Sampling
// Plassmann H, 2008: Wine 1 Low vs. High Price, Swallowing
// Plassmann H, 2008: Wine 2 High vs. Low Price, Sampling
// Plassmann H, 2008: Wine 2 High vs. Low Price, Swallowing
// Plassmann H, 2008: Wine 2 Low vs. High Price, Sampling
// Plassmann H, 2008: Wine 2 Low vs. High Price, Swallowing
// Plassmann H, 2008: Wine 1 and 2 High vs. Low Price, Sampling
// Plassmann H, 2008: Wine 1 and 2 High vs. Low Price, Swallowing
// Plassmann H, 2008: Wine vs. Neutral Solution, Tasting
// Plassmann H, 2008: Wine vs. Neutral Solution, Swallowing
// Plassmann H, 2008: [Wine 1, High Price - Low Price] - [Wine 2, High Price - 
// Low Price]
// Plassmann H, 2008: [Wine 2, High Price - Low Price] - [Wine 1, High Price - 
// Low Price]
// Plassmann H, 2008: Sampling is Modulated by the Liking Ratings
// Subjects=20
-12	-90	-6
30	30	24
-6	0	39
-12	36	-9
15	-93	-3
-42	-24	-6
-18	42	6
-24	30	-4
-4	-10	-9
9	-60	-42
9	-60	15
4	27	-4
21	42	54
-2	27	-2
3	-40	-33
3	-27	-12
9	-42	-1
-6	-49	16
57	18	3
57	12	24
54	12	45
57	16	3
-43	50	3
63	-9	-21
-30	-24	-6
-2	48	-20
3	48	-19
21	0	-18
6	-57	24
39	27	-21
9	39	-9
57	21	33
9	54	-3
-50	2	-27
15	30	57
-54	3	-27
3	33	-21
9	51	-6
3	-24	-21
33	-18	-21
9	-48	12
-1	-45	-12
-27	31	24
24	33	30
36	42	42
51	-27	6
14	-22	38
18	49	-9
-48	25	0
-51	-27	0
52	26	0
-9	3	43
38	-23	19
-60	-39	-3
33	-66	0
-4	43	-16
4	33	-13
-6	-15	-12
5	38	-9
-3	45	-18
4	-39	-38
9	-51	15
-33	-93	-3
-32	24	3
32	24	3
12	24	30
5	24	48
-3	24	47
21	45	36
-27	-51	-33
24	45	15
-6	12	6
10	15	10
-18	-84	0
18	-84	-3
33	30	21
-27	-45	-33
-27	54	30
-54	3	-15
-2	18	-17
-18	5	57
48	27	9
-3	48	-18
1	-39	-33

// Hampton A N, 2008: Expected Reward Signals at the Time of Choice
// Hampton A N, 2008: Influence Signals, Influence Update of Inferred 
// Opponent's Strategy
// Hampton A N, 2008: Influence Signals, Influence On Opponent
// Hampton A N, 2008: Prediction Error signals
// Subjects=30
0	36	-21
-3	63	15
42	15	-39
-3	57	12
-57	-54	0
60	-54	9
-3	51	24
9	6	-18
-9	9	-18
-9	57	6
12	36	18

// Tobler P N, 2008: Covariation Between Modeled and Actual Brain Activation 
// with an Inverted S-Shaped Function
// Tobler P N, 2008: Activations Covarying with an Inverted S-Shaped Function
// Tobler P N, 2008: Independence of Neuronal Probability Coding in Striatum 
// from Behavioral Probability Distortion
// Subjects=16
-32	16	34
54	32	14
-10	4	-4

// Knutson B, 2008: Positive Pictures > Negative Pictures
// Knutson B, 2008: High > Low-Risk Shift
// Knutson B, 2008: Gain vs Loss Outcome
// Subjects=15
-7.71	40.36	-19.63
12.65	24.62	-18.54
-26.87	20.15	-17.72
-3.25	17.09	-4.35
-11.82	12.38	-9.43
8.48	9.16	-11.62
21.3	9.24	-11.78
36.69	4.98	41.93
53.74	8.97	36.94
-58.48	-57.72	10.37
-51.04	-54.85	5.58
-2.84	-56.7	18.56
42.08	-60.41	21.7
-43.34	-85.49	21.44
36.35	25.58	5.64
-7.56	24.38	-6.03
5.34	14.23	-.86
-11.81	4.81	-11.03
13.83	7.08	-11.51
0.87	67.16	-4.13
-14.93	14.45	3.81
20.26	9.49	-8.44
-18.21	9.26	-7.98
49.36	12.23	24.45
-58.73	1.15	0.97
1.41	-53.59	17.14
24.83	-78.51	-4.46

// Hare T, 2008: Parametric Regressor for Goal Values
// Hare T, 2008: Parametric Regressor for Decision Values
// Hare T, 2008: Parametric Regressor for Prediction Errors
// Subjects=16
33	-81	-9
30	27	-12
-24	30	-18
-1	27	-18
1	39	6
51	24	21
45	33	9
21	9	-21
21	-30	-3
6	51	0
-15	-9	-15
-27	36	-6
15	21	-6

// Henderson L A, 2008: Male > Female, Intramuscular Pain
// Henderson L A, 2008: Female > Male, Intramuscular Pain
// Henderson L A, 2008: Male > Female, Subcutaneous Pain
// Henderson L A, 2008: Female > Male, Subcutaneous Pain
// Subjects=11
-24	-50	-48
-24	-60	-20
33	-11	-24
-24	-30	-20
8	8	56
3	-2	40
36	51	20
-33	50	16
-24	-66	-48
9	-47	-48
-18	-33	-20
0	17	44
0	3	28
35	41	24

// Hooker C I, 2008: Fear Learning > Neutral Learning
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlations 
// with Neuroticism
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition, 
// Positive Correlations with Neuroticism
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Extraversion
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Extraversion
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Agreeableness
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Agreeableness
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Conscientiousness
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Openness
// Hooker C I, 2008: Happy Learning > Neutral Learning
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition
// Hooker C I, 2008: Happy Learning > Neutral Learning, Positive Correlation 
// with Extraversion
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation wtih Extraversion
// Hooker C I, 2008: Happy Learning > Neutral Learning, Negative Correlation 
// with Extraversion
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Negative Correlation wtih Extraversion
// Hooker C I, 2008: Happy Learning > Neutral Learning, Positive Correlation 
// with Neuroticism
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Neuroticism
// Hooker C I, 2008: Happy Learning > Neutral Learning, Positive Correlation 
// with Conscientiousness
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Conscientiousnes
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Openness
// Subjects=12
28	8	-24
42	-20	-18
50	32	16
-52	32	4
-56	18	26
-26	-76	46
66	-52	2
-62	-54	4
38	-84	-20
44	-46	-26
30	2	-16
26	-20	-20
-26	-24	-20
24	-2	62
-30	-38	64
-54	-26	44
-46	-68	6
44	-60	-18
-8	-50	22
20	-6	-16
32	-18	-20
-26	-10	-20
38	-52	60
44	-70	28
-36	-76	42
26	62	-6
52	50	10
-36	50	32
6	20	40
60	-46	30
44	-44	58
18	-4	8
-14	0	-8
-44	-6	-18
-40	34	36
16	-78	40
8	-44	44
6	18	50
-22	-86	30
38	-86	20
-36	-50	36
-10	-44	4
52	-30	4
-52	-42	-20
58	-42	-22
36	-10	12
-8	20	68
-12	12	44
-40	-76	12
-54	-34	4
-16	-22	4
-34	-30	12
26	-54	42
22	-20	-2
-36	6	58
-52	-62	2
-52	0	28
36	-50	48
26	32	42
-46	-36	12
-36	-80	-28
46	-50	34
-56	-62	0
30	34	-22
-20	60	-8
36	44	4
8	32	48
26	26	-14
12	-54	40
-12	-64	28
2	-44	-10
46	-56	16
10	56	-8
58	-16	-6
-44	2	-10
-36	-46	-44
28	-22	-14
2	66	2
-10	66	-4
0	58	-8
20	32	32
-28	24	46
44	-18	18
-32	-26	20
8	-22	52
32	-26	52
-46	-12	22
-10	-30	70
54	-22	-6
60	-38	18
-44	-54	-2
-40	-64	24
-18	-36	-16
-10	-56	22
-18	-14	-22
-22	2	-16
24	-12	-14
-16	-40	64
6	-40	58
48	-10	-10
-40	-18	-6
-54	4	-18
6	-10	-10
16	-16	36
40	-70	14
46	-44	-32
-14	-30	-12
18	-28	-6
36	-40	-38
2	-42	34
26	0	-20
22	-6	-10
14	28	62
56	-6	42
60	-34	-4
60	-46	-2
28	16	-36
-14	14	8
-20	-82	22
-14	-92	-4
26	-86	20
28	0	-10
-40	8	14
-56	4	4
28	12	-14
-20	28	-14
-32	40	22
14	-16	48
-14	-2	46
34	-6	42
36	-20	4
-30	-26	18
-52	-28	24
-46	-14	-10
-60	-34	20
44	-66	-4
-44	-66	-8
-28	-44	62
16	-66	10
-20	-76	26
12	-48	66
-26	30	56
32	-36	60
-26	-72	52
-22	-72	-14
-12	-52	4
-12	-2	2
18	-4	64
-34	-40	-34
-46	-64	24
-6	-46	38
28	16	48
10	-58	46
-40	-72	16
-56	-56	0
-48	-38	-20
-30	-22	-20
-48	-48	-40

// McNab F, 2008: Flanker Task, Incongruent > Congruent
// McNab F, 2008: No-Go > Oddball (Go/No-Go)
// McNab F, 2008: No-Go > Go
// McNab F, 2008: Stop > Oddball (Stop Task)
// McNab F, 2008: Stop > Go
// McNab F, 2008: Spatial Working Memory > Spatial Working Memory Control
// McNab F, 2008: Verbal Working Memory > Verbal Working Memory Control
// McNab F, 2008: Spatial and Verbal Working Memory Tasks
// McNab F, 2008: Go/No-Go and Stop Tasks w/ Oddball
// McNab F, 2008: Go/No-Go and Stop Tasks
// McNab F, 2008: Flanker Task and both Working Memory Tasks
// McNab F, 2008: Go/No-Go and both Memory Working Tasks
// McNab F, 2008: Stop Task and both Working Memory Tasks
// McNab F, 2008: Go/No-Go, stop Task and both Working Memory Tasks w/ Oddball
// McNab F, 2008: Go/No-Go, Stop Task and both Working Memory Tasks
// Subjects=11
30	-54	45
39	-45	51
-3	27	18
-24	27	9
-15	27	9
-42	12	-3
45	15	-3
33	24	-6
27	15	-15
12	-75	48
-42	36	36
33	51	33
24	48	33
45	42	30
63	-45	33
51	-42	36
54	-36	42
-45	-45	39
-42	-51	48
-33	-90	-6
6	-36	27
0	-30	30
33	24	-6
33	24	-6
48	15	-9
33	12	3
27	51	30
36	42	27
48	39	27
45	15	-6
36	15	3
36	18	-18
-45	15	-9
-36	21	6
-36	12	12
30	45	36
30	42	24
42	42	27
15	9	69
15	-9	72
12	15	60
9	18	45
9	6	48
6	24	30
54	-45	36
63	-54	30
9	-18	9
9	-24	-6
15	-9	-3
24	-87	-15
42	-84	-9
39	-78	-15
27	-54	51
39	-39	51
48	15	-6
6	9	48
33	24	-6
-45	15	-9
-33	21	6
-30	6	15
-63	-57	6
-45	-81	-12
-57	-54	18
12	-72	45
51	-72	-6
51	-57	12
9	-18	9
6	-24	-6
-3	-18	-6
-3	-27	30
27	-69	51
21	-78	51
39	-42	42
27	-6	60
-24	-6	57
6	15	54
-42	-51	51
-24	-69	54
-33	-54	45
36	21	-6
45	15	-3
-33	21	3
-42	15	-6
48	6	27
48	21	33
57	6	36
-42	3	30
-3	-3	63
-42	-6	51
-30	-60	42
-27	-69	45
-42	-45	42
36	21	-6
30	-69	48
39	-48	48
33	-66	36
45	3	30
51	24	30
45	42	30
33	-3	66
27	-6	60
-48	-51	6
-15	-3	15
-15	9	3
-3	-18	15
-42	-51	51
-33	-54	42
-42	-45	42
-42	-6	51
-6	12	51
6	12	54
30	-69	48
39	-48	48
36	-57	51
36	21	-6
45	15	-3
-33	21	3
-42	15	-6
45	3	30
51	27	33
42	39	21
33	-3	66
27	-6	60
45	15	-3
33	24	-6
36	21	-15
-42	12	-3
24	48	33
45	42	30
39	33	39
33	24	-6
48	15	-9
33	12	3
27	51	30
36	52	27
48	39	27
30	-54	45
39	-45	51
33	24	-6
45	15	-3
33	24	-9
36	18	-3
45	15	-3
6	6	51
9	18	45
12	21	36
-33	24	3
-42	15	-6
-36	21	-6
27	-54	48
33	-57	54
39	-42	48
33	24	-6
45	15	-3
33	24	-6
45	15	-3

// Mulder M J, 2008: Attention Deficit/ Hyperactivity Disorder Patients
// Subjects=12
-37.92	52.24	0.98
23	27.19	28.19
-16.59	-62.42	-44.07

// Mulder M J, 2008: Healthy Siblings
// Subjects=12
27.31	31.46	27.69
35.38	-52.69	-34.71

// Mulder M J, 2008: Healthy Controls
// Subjects=12
44.06	20.99	-16.38
10.1	27.56	32.86
44.28	53.26	7.32
-37.6	51.34	25.71
48.64	-44.94	-9.93
64.87	-18.42	-2.75
-20.96	-59.56	-47.64
39.82	25.95	-8.95
48.64	-23.04	-5.38
1.44	-88.53	8.63
35.38	31.59	-17.28
5.78	36.37	35.42
10.11	45.2	37.83
40.57	26.04	49.3
-57.79	-47.96	32.52
69.67	-43.25	29.88
-37.92	52.24	0.98
27.31	31.46	27.69
-16.59	-62.42	-44.07
35.38	-52.69	-34.71

// Protopopescu X, 2008: Premenstrual vs. Postmenstrual Phases, Negative Go 
// vs. Neutral Go
// Protopopescu X, 2008: Premenstrual vs. Postmenstrual Phases, Positive Go 
// vs. Neutral Go
// Subjects=8
24	3	-27
-21	51	-3
-45	36	-12
30	42	-12
-6	48	-15
9	6	-9

// Shane M S, 2008: Errors > Correct Responses, Performance Go and NoGo
// Shane M S, 2008: Errors > Successful Inhibitions
// Shane M S, 2008: Observed Errors > Observed Correct Responses
// Shane M S, 2008: Observed Errors > Observed Correct Inhibitions
// Shane M S, 2008: Observed Errors vs. Performed Errors
// Subjects=21
-39	15	-15
-63	-45	36
9	21	63
3	-72	45
-39	-51	-27
6	30	33
0	-24	6
45	21	-9
48	12	45
18	-33	-3
9	-3	6
3	-21	-33
-9	39	12
-45	3	-12
3	-93	30
3	-36	0
-15	-24	-39
-57	-21	15
-3	24	27
9	21	66
0	24	30
51	-36	48
-54	-27	51
-39	-54	60
-45	-81	0
39	-42	-36
-39	-57	-36
45	39	30
21	42	-21
54	-63	3
-12	-6	12
57	18	24
-63	-24	18
27	-24	3
12	-69	6
39	6	60
3	27	45
0	15	33
-9	36	18
12	21	-9
6	30	-12
12	57	6
-6	42	-6
3	3	-15
-45	-39	60
-33	-45	-51
0	-81	21
-66	-24	18
12	-66	9
-60	-21	42
-18	-48	63
-54	-27	51
-54	-72	12
-15	-51	-3
6	66	3
63	-18	36
45	-45	60
-9	0	60

// Simmons W K, 2008: Word association > Situation generation
// Simmons W K, 2008: Situation generation > Word association
// Simmons W K, 2008: Early property generation > Late property generation
// Simmons W K, 2008: Late property generation > Early property generation
// Simmons W K, 2008: Early property generation > Late masked by Word 
// association > Situation generation
// Simmons W K, 2008: Late property generation > Early masked by Situation 
// Generation > Word association
// Simmons W K, 2008: Late property generation > Early masked by Word 
// association > Situation generation
// Subjects=10
-39	24	-12
-48	36	-6
-51	18	-3
-51	39	6
-57	12	12
54	12	18
-42	3	30
-9	-69	-42
-27	-60	-30
-9	-54	-12
15	-87	-33
27	-69	-30
-45	-48	-18
-18	15	-15
-33	33	24
21	18	-15
-24	0	9
24	3	9
-15	-9	3
-12	-18	12
18	-15	-3
-24	-96	0
-24	-69	48
-54	6	-6
-9	-15	-18
0	0	69
15	6	72
48	18	-3
12	18	-3
0	-93	6
12	21	39
-9	18	42
-12	-72	24
-21	-69	18
-6	-57	54
-12	-42	57
3	-69	27
39	-12	42
-9	-30	51
-9	-45	21
48	-72	33
48	-60	12
-45	-3	-21
-51	0	-15
-42	-21	-3
-54	-15	9
-54	-30	15
51	-18	9
0	54	-6
-24	51	-3
18	36	39
-24	45	27
-27	27	45
-63	-9	-30
42	-6	-9
-45	36	6
-54	27	12
-39	27	15
-45	33	24
-3	45	-18
-21	30	-18
6	57	3
-15	57	27
-3	42	30
-3	45	51
-18	33	54
6	63	3
-54	-6	42
-30	-15	54
-30	-6	54
27	-72	-33
6	-57	-39
0	-45	-21
-54	-39	-9
-51	-48	-3
-3	-57	18
-12	-51	3
-15	15	0
-3	9	60
-12	33	-15
6	30	-12
-12	-72	33
54	24	-6
54	18	6
45	18	39
33	63	12
18	54	39
3	36	45
27	18	63
24	6	66
27	54	-6
51	-18	9
39	9	-36
-21	-48	-9
-39	-15	-18
-30	-60	-12
-42	-84	12
-24	-84	18
-60	-51	33
-39	-48	42
-51	-48	51
-39	9	-12
6	3	9
27	15	-6
33	6	-6
-15	-27	12
12	-15	18
-45	36	6
-48	6	33
27	-72	-33
-6	-54	54
9	-72	27
6	-69	42
9	-54	51
51	-54	18
9	-15	12

// Tanaka S C, 2008: Contrast of High vs. Low Objective Contingency
// Tanaka S C, 2008: Contrast of Sessions with High vs. Low Causality 
// Judgments
// Subjects=13
6	10	20
-6	52	-10
-2	30	-20
26	-36	-8
-48	14	-18
-10	50	-10
-42	32	-8
-2	18	-18
-12	36	42

// Walter M, 2008: Bodily-Emotional Positive Pictures > Non-Bodily-Emotional 
// Positive Pictures
// Walter M, 2008: (Positive Bodily > Positive Non-Bodily) ^ (Positive > 
// Negative Bodily)
// Walter M, 2008: Signal Correlation with Sexual Intensity
// Walter M, 2008: (Positive Bodily > Positive Non-Bodily) ^ (Negative Bodily 
// > Negative Non-Bodily)
// Walter M, 2008: (Bodily-Emotional > Non-Bodily-Emotional) ^ 
// (Non-Bodily-Emotional > Non-Bodily Neutral)
// Subjects=21
-9	9	3
9	6	6
-3	12	-9
6	0	-12
0	39	6
3	57	3
6	51	30
-51	-78	0
54	-72	0
-36	-60	57
27	-60	60
3	-66	36
42	-45	24
-3	-6	-9
18	-3	-15
0	12	-3
-2	11	-11
0	39	6
3	57	3
54	-72	-6
3	-66	48
-3	15	-3
-6	48	-9
33	-39	48
-9	9	6
9	9	3
-9	3	-13
-6	51	27
-51	-75	-6
54	-66	0
-33	-57	54
33	-57	57
9	-63	39
45	-42	-24
-15	3	-18
18	0	-18
9	0	0
3	-24	0
-48	-81	0
51	-69	0
42	-45	-24
39	33	-9
-6	54	30

// Preuschoff K, 2008: Activation During 1s Epoch After Display of Card 1
// Preuschoff K, 2008: Deactivation During 1s Epoch After Display of Card 1
// Preuschoff K, 2008: Activation During Second, Remaining Epoch Between Cards 
// 1 and 2
// Subjects=19
35.19	16.95	-9.57
-32.12	15.57	-7.68
58.13	-51.34	27.45
52.44	20.82	11.43
-44.35	-59.64	39.36
43.92	-9.68	3.04
62.33	-24.62	28.51
-39.25	-25.83	21.97
-58.68	-10.43	2.61
36.32	24.27	2.4
-9.38	-25.1	14.87
-13.71	-30.1	5.75
-32.07	24.89	2.8
-39.23	-5.64	32.54
-41.27	-8.18	43.93

// Rao H, 2008: Activations Covaried with Voluntary Risk
// Rao H, 2008: Activations Covaried with Involuntary Risk
// Rao H, 2008: Activations Differed Between Voluntary and Involuntary Risk
// Rao H, 2008: Active Inflation vs. Passive Inflation
// Rao H, 2008: Active Loss vs. Passive Loss
// Rao H, 2008: Active Win vs. Passive Win
// Rao H, 2008: Active Loss vs. Active Win
// Subjects=14
38	10	-2
-34	18	-6
0	12	42
-10	2	4
14	2	-2
6	-16	-2
-6	-12	-4
-22	-54	-4
30	-76	24
30	-52	-16
-28	-80	20
30	-46	46
-34	46	16
-52	-36	38
30	36	20
-42	-80	4
28	-50	-10
10	-68	6
30	-50	48
-28	-48	50
12	18	38
-8	0	4
36	16	0
-28	18	6
12	4	4
32	46	26
-32	46	22
30	50	32
-14	10	67
30	54	26
30	22	-6
-8	2	0
8	4	2
32	52	32
10	12	70
-32	18	-6
32	20	-2
4	22	52
-8	2	2
10	4	0

// Kinno R, 2008: Sentence Control > Fixation
// Kinno R, 2008: Canonical/Subject-Initial Active Sentence > Fixation
// Kinno R, 2008: Noncanonical/Subject-Inital Passive Sentence > Fixation
// Kinno R, 2008: Noncanonical/Object-Initial Scrambled Sentence > Fixation
// Kinno R, 2008: Canonical/Subject-Initial Active Sentence - Sentence Control
// Kinno R, 2008: Noncanonical/Object-Initial Scrambled Sentence - 
// Canonical/Subject-Initial Active Sentence
// Kinno R, 2008: (Scrambled Sentence - Active Sentence) vs. (Active Sentence 
// - Sentence Control)
// Kinno R, 2008: Noncanonical/Subject-Initial Passive Sentence  - 
// Canonical/Subject-Initial Active Sentence
// Subjects=14
-36	12	51
45	15	36
-54	18	12
-45	39	9
-3	24	48
-54	-51	6
-48	-60	51
42	-63	36
-45	6	48
48	21	33
-51	18	27
-51	27	6
-3	18	51
-6	3	3
9	3	0
-54	-54	6
51	-54	6
-24	-78	33
45	-78	6
-39	-3	45
45	18	36
-51	21	24
-54	27	3
3	18	51
9	3	3
-54	-54	6
51	-60	9
-39	-57	54
-30	-81	30
42	-78	6
-42	3	48
48	21	33
-51	21	18
-48	18	0
42	21	-6
-3	18	48
-9	0	3
-60	-48	9
54	-36	3
-36	-57	51
-30	-84	30
45	-75	6
-39	0	54
-57	-60	0
54	-60	0
-51	-75	6
-39	0	45
-52	21	21
-54	-54	3
-51	21	18
-51	-51	3
-48	24	21

// Shikata E, 2008: Color Discrimination > Orientation Judgment
// Subjects=11
-39.6	-40.1	44.7
41.2	-40.6	50.2
-15.5	-66.3	58.4
21	-65.7	55.9
-25.6	-57	58.4
26.1	-59.4	57.6

// van Duinen H, 2008: Right Index Finger Abduction > Rest
// van Duinen H, 2008: Left Index Finger Abduction > Rest
// van Duinen H, 2008: Right Finger MVC vs. Right Finger Submaximum
// van Duinen H, 2008: Left Finger MVC vs Left Finger Submaximum
// van Duinen H, 2008: Activity Correlating with "Activation Per Se", Right 
// Contractions
// van Duinen H, 2008: Activity Correlating with "Activation Per Se", Left 
// Contractions
// Subjects=10
-34	-40	56
-40	-28	52
-24	-26	56
-60	2	34
-20	-20	76
22	-10	68
66	-16	32
40	2	16
-10	-10	54
14	-12	48
-12	-26	44
56	12	14
-42	-36	24
52	-36	26
-54	-30	22
66	-34	22
-40	-2	12
40	2	10
34	28	8
30	4	12
-14	10	22
-14	-22	6
-22	0	-10
12	-56	-12
-34	-58	-28
22	-52	-24
-18	-72	-50
18	-66	-44
-44	-60	-30
40	-56	-32
-34	-46	56
-38	-12	66
-26	-30	48
-46	-12	60
-42	-12	44
-48	-8	48
-20	-18	70
54	-16	54
38	-24	64
32	-26	50
40	-12	62
18	-22	74
42	-22	48
-44	-2	2
-6	-6	54
8	-4	50
12	-14	76
-12	-26	44
12	0	44
56	12	20
58	10	32
-50	-42	24
-52	-26	20
54	-22	18
-64	-20	28
56	-20	20
-30	-54	56
38	-48	64
-48	-40	14
66	-30	18
44	2	10
-16	-2	6
26	-2	2
-24	6	0
32	-8	4
-12	2	16
18	0	24
26	0	10
-40	-18	-18
-28	-42	2
12	-34	16
-22	-48	10
-4	-62	-16
-20	-52	-26
30	-54	-26
-20	-64	-50
-44	-26	56
-40	-28	50
-30	-26	64
-38	-24	62
38	-22	64
24	-14	64
-44	-4	10
42	4	12
-10	-12	56
12	-2	52
16	-22	48
16	-30	50
-34	-28	24
-44	-24	18
50	-26	18
58	-30	20
-32	-16	8
-38	6	6
-26	-10	-10
-16	-4	-18
-16	-2	-24
-18	-26	-20
16	-36	-10
-10	-34	-12
8	-64	-8
2	-62	-14
-24	-52	-24
22	-52	-24
-24	-62	-48
18	-56	-46
4	-70	-34
-36	-60	-28
40	-58	-30
-32	-28	60
44	-16	48
42	-22	52
30	-24	48
-46	-10	50
-28	-28	72
-30	-26	72
38	-24	64
50	0	6
-6	-6	56
-4	2	46
8	-20	48
10	0	42
14	38	2
10	14	-14
48	-34	26
-44	-24	16
36	-26	22
52	-28	18
46	-34	16
36	-18	10
28	-6	-2
30	-8	0
30	-20	6
-12	10	20
18	0	24
18	-16	8
-30	-40	0
38	-28	-10
-20	-54	-24
30	-52	-26
-16	-66	-46
-6	-42	-42
6	-44	-48
-40	-38	66
62	-16	30
-38	-30	54
-38	-30	68
-46	-14	60
-36	-16	56
-48	4	8
-14	-8	50
14	0	62
58	10	28
52	12	4
36	30	8
-60	-24	34
58	-40	34
62	-24	46
64	-28	38
-38	-40	42
38	-44	46
-44	-76	-6
-52	-74	-2
36	22	-2
-38	0	4
42	6	0
-26	4	0
-30	-8	0
26	8	0
26	-6	4
16	-52	-26
18	-66	-50
42	-22	46
66	-14	28
34	-26	52
38	-24	58
36	-22	60
-62	6	20
-56	4	32
-56	2	40
4	-8	52
62	12	24
-60	-24	32
-36	-56	62
-34	-54	54
36	-46	50
42	-70	-6
-32	-92	-8
44	-78	-6
-40	-86	0
40	-64	2
-40	0	10
40	2	12
-26	-6	10
32	-4	2
-18	-52	-24
-26	-66	-50

// Cohen M X, 2008: Reward > Loss (p <. 001)
// Cohen M X, 2008: Reward > Loss (FWE p < .05)
// Cohen M X, 2008: Loss > Reward
// Cohen M X, 2008: Loss Switch > Loss Stay
// Cohen M X, 2008: Loss Stay > Loss Switch
// Subjects=15
60	8	-7
63	5	0
65	-30	25
65	-15	8
30	-2	-7
30	8	10
8	-52	23
68	0	20
33	35	-10
8	28	-10
60	-5	-17
48	-55	5
38	5	8
68	-47	-10
50	-47	-15
53	40	10
3	-17	40
13	-35	35
10	-12	45
25	-2	-15
-60	-35	38
-57	-27	10
-12	-87	33
-12	33	55
-17	23	60
-30	-12	10
-2	-55	20
-60	8	38
-47	-17	40
-30	-22	-20
-30	30	-10
-47	-62	23
-47	-5	-22
-52	-60	0
-60	-7	-7
-35	0	10
-40	-40	-15
-45	30	18
-42	33	5
-30	-10	-17
-10	48	48
-5	-35	45
-2	-37	38
-2	33	13
-45	-70	35
-22	0	-12
-22	0	-14
-23	0	-13
25	-3	-15
-45	-70	35
-20	0	-15
40	28	33
35	18	8
45	18	3
10	23	30
10	15	45
-5	3	53
-40	15	8
-27	28	3
-7	10	43
-10	23	33
-17	-7	-2
-15	-20	8
-30	20	-10
38	53	5
-18	-5	-8
35	-12	-17
-7	-25	45
35	-13	-18

// Finger E C, 2008: Successful Extinction > Successful Baseline (Control)
// Finger E C, 2008: Successful Extinction < Successful Baseline (Control)
// Finger E C, 2008: Correct Hits > Correct Avoidance
// Finger E C, 2008: Early Extinction Phase > Late Extinction Phase
// Finger E C, 2008: Extinction > Baseline (Control)
// Finger E C, 2008: Response Type x Phase
// Finger E C, 2008: Response x Pair
// Finger E C, 2008: Response x Phase x Pair
// Subjects=19
15	69	-5
-16	62	-9
-30	42	-11
14	35	-5
12	36	-12
37	-66	58
-27	-70	58
47	4	30
32	40	-19
-32	-28	72
15	5	-17
4	34	42
-35	20	29
42	13	43
-27	20	4
40	-70	47
-41	-62	45
52	18	-7
3	-75	34
9	70	-1
35	33	-17
-37	-2	-10
-51	20	12
-62	-10	7
-43	-6	0

// Mitchell D G V, 2008: Reversal Errors > Constant Reinforcement
// Subjects=13
-47	22	-1
5	27	60
49	18	51
-25	58	28
-6	1	13
13	6	16
2	-22	5

// Xue G, 2008: Regions Activated in the Learning Task
// Xue G, 2008: Full Reversal Learning - No-Reversal Learning
// Xue G, 2008: Outcome Reversal Learning - No-Reversal Learning
// Xue G, 2008: Response Reversal Learning - No-Reversal Learning
// Xue G, 2008: Outcome Reversal Learning > Response Reversal Learning
// Subjects=17
6	18	40
-2	10	50
-28	-10	46
-48	0	30
-34	14	24
40	42	16
40	4	30
46	32	26
-30	-54	50
30	-66	54
-24	2	0
24	2	0
8	-18	10
-14	-8	10
-38	-44	-20
38	-44	-22
8	-74	8
-32	-90	4
12	-94	-6
38	-62	-24
-40	-60	-28
-4	16	46
-2	10	56
-26	6	64
-46	30	16
-50	2	34
-38	14	26
38	8	26
-24	-74	48
18	-70	54
-30	-56	42
-40	-68	-16
34	-60	-18
-6	-96	-14
-28	-78	30
36	-90	0
0	-68	16
34	-66	-26
-4	12	44
0	14	62
-30	-2	66
-48	14	2
-54	14	0
-64	-14	32
36	4	24
58	10	6
34	26	-2
-56	-22	24
-20	-72	50
18	-74	48
-58	-36	0
-24	-30	-6
24	0	-18
-14	4	14
-24	8	2
18	12	-6
-8	-16	12
8	-14	10
2	-72	18
-38	-68	-18
40	-62	-16
-32	-86	20
38	-90	14
-8	-98	-8
40	-82	4
-34	-42	-26
-4	10	40
-4	12	68
-36	54	12
-32	44	14
-30	-2	54
-46	10	22
-54	8	6
46	18	24
-24	-72	54
24	-68	42
-26	-52	38
14	-76	12
-38	-64	-14
30	-48	-14
-30	-88	22
-48	-74	-8
36	-90	2
52	-70	-14
-6	-74	-28
12	-72	-28
18	8	-4
-28	-8	4
20	22	12
18	10	-12
60	8	6

// Fuhrer D, 2008: Hunger > Satiety
// Fuhrer D, 2008: Satiety > Hunger
// Fuhrer D, 2008: Food > Nonfood
// Fuhrer D, 2008: Nonfood > Food
// Fuhrer D, 2008: Increased Interaction between the State of Satiation and 
// the Quaility of Visual Stimulation
// Fuhrer D, 2008: Decreased Interaction between the State of Satiation and 
// the Quality of Visual Stimulation
// Subjects=12
41.13	-67.93	34.61
-16.72	-96.22	4.19
21.16	52.85	-12.09
-26.91	49.39	-11.25
-61.64	-60.57	15.1
-7.45	65.02	24.02
-45.49	-49.41	34.05
63.36	-4.09	32.35
-3.89	-10.33	40.34
-10.19	-52.12	37.22
-4.04	17.71	31.3
-39.59	4.64	-10.69
-16.75	-96.48	0.87
37.58	-8.96	12.98
-4.18	26.2	17.2
-7.22	-31.44	15.38
-32.96	-88.6	-19.68
24.99	9.91	51.69
63.54	-25.27	47.51
34.81	-43.96	56.09
37.95	-80.89	32.39
-48.81	-67.09	12.16
27.59	62.91	-6.32
44.13	-80	2.13
2.01	17.32	-15.58
-13.67	20.82	31.14
28.28	-94.67	20.27
-10.8	40.48	-3.99
18.03	-8.99	-26.94
30.79	-12.85	-36.8
5.21	17.34	-15.62
-20.48	23.28	-19.17

// Malik S, 2008: Male Healthy Controls Who Received Ghrelin (Experiment 1)
// Subjects=12
-36	30	-6
50	6	30
-52	2	32
-50	4	4
20	-10	-8
-18	-10	-16
32	-10	-30
42	8	-6
-34	16	10
42	-6	10
-36	-12	14
-8	-2	12
20	-100	4
42	-70	-12
-50	-66	-10
-16	-36	2
18	-98	-4
-10	-96	-12
-42	-48	58
32	-90	6
-26	-92	14
-26	-76	30
28	-58	56
-20	-66	48
-52	34	18
54	30	18
-28	30	-10
25	28	-12
-34	20	8
48	8	30
0	8	54
34	6	-14
0	4	40
-46	4	32
42	-6	10
-56	-6	42
18	-10	-8
-24	-12	-10
36	-28	-22
-46	-38	50
32	-44	44
-32	-60	58
28	-60	56
-22	-66	50
38	-68	-14
-50	-70	-10
44	-74	-10
-28	-74	28
30	-80	26
40	-82	-8
-40	-86	-8
32	-90	0
-28	-92	12
-34	-94	0
24	-98	2
-16	-98	-8
16	-98	-2
-18	-100	-2
-36	36	-2
-28	16	16
34	8	18
-30	-4	-16
-36	-14	14
10	-26	-14
-14	-38	6
44	-60	-20
-18	-72	-14

// Malik S, 2008: Male Healthy Controls Who Did Not Receive Ghrelin 
// (Experiment 1)
// Subjects=8
48	10	30
-44	4	32
-34	20	8
-16	-100	-2
46	-72	-12
-34	-80	-14
-46	-38	50
38	-84	2
-48	-74	-6
32	-62	56
-32	-58	56
-52	34	18
54	30	18
-28	30	-10
25	28	-12
-34	20	8
48	8	30
0	8	54
34	6	-14
0	4	40
-46	4	32
42	-6	10
-56	-6	42
18	-10	-8
-24	-12	-10
36	-28	-22
-46	-38	50
32	-44	44
-32	-60	58
28	-60	56
-22	-66	50
38	-68	-14
-50	-70	-10
44	-74	-10
-28	-74	28
30	-80	26
40	-82	-8
-40	-86	-8
32	-90	0
-28	-92	12
-34	-94	0
24	-98	2
-16	-98	-8
16	-98	-2
-18	-100	-2
40	-68	-16
-32	-56	-18
-52	8	26
48	-80	-4
-42	-74	-12
-46	-38	48
40	-62	-2
16	-86	-12
48	-64	-8
-30	-60	60
-36	36	-2
-28	16	16
34	8	18
-30	-4	-16
-36	-14	14
10	-26	-14
-14	-38	6
44	-60	-20
-18	-72	-14

// Malik S, 2008: Male Healthy Controls (Experiment 2)
// Subjects=20
-22	30	-14
-46	26	20
50	4	30
38	4	-8
-36	-6	-8
-32	-6	-28
-62	-22	32
-46	-38	42
34	-56	-18
-36	-56	-14
28	-58	50
-24	-60	48
40	-76	-8
-42	-72	-8
42	-82	-4
-24	-86	-4
18	-94	2
-14	-98	2
-20	-30	0
-24	32	-12
-44	22	26
46	2	28
36	4	-10
-38	0	-4
-32	-32	-24
-58	-20	26
-2	-32	30
-44	-40	46
34	-48	-18
-34	-56	-14
30	-58	56
-26	-62	54
44	-68	-10
-40	-74	-8
38	-84	0
-26	-86	-8
16	-94	0
-18	-100	-4
-20	-10	-8
-34	-20	-22
-20	-30	0
20	-30	-4

// Davis M H, 2008: All Words vs. Letter Strings
// Davis M H, 2008: (Complex Noun vs. Simple Noun) vs. (Complex Verb vs. 
// Simple Verb)
// Davis M H, 2008: Verbs (Simple/Complex) vs. Nouns (Simple/Complex)
// Subjects=12
-63	-42	-3
-45	-42	-12
-6	27	-42
-48	30	-15
-33	27	-12
-48	24	18
-18	-9	-15
9	27	42
33	-12	60
-30	-6	18
-27	48	-12
-54	-48	-6
-54	-36	21
-21	-36	3
-3	9	-6

// Knutson B, 2008: Sell vs Buy - Product Preference (Product + Price)
// Knutson B, 2008: Sell vs Buy - Price Percent (Price) - Deactivations
// Knutson B, 2008: Sell vs Buy - Price Percent X Condition (Price) - 
// Activations
// Knutson B, 2008: Sell vs Buy - Price Percent X Condition (Price) - 
// Deactivations
// Knutson B, 2008: Sell vs Buy - Product Choice (Choice)
// Knutson B, 2008: Sell vs Buy - Product Choice X Condition (Choice) - 
// Deactivations
// Knutson B, 2008: Period Regressor - Product Period - Activations
// Knutson B, 2008: Period Regressor - Product Period - Deactivations
// Knutson B, 2008: Period Regressor - Price Period - Activations
// Knutson B, 2008: Period Regressor - Price Period - Deactivations
// Knutson B, 2008: Period Regressor - Price Period X Condition - 
// Deactivations
// Knutson B, 2008: Period Regressor - Choice Period - Activations
// Knutson B, 2008: Period Regressor - Choice Period - Deactivations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Conflict (Price) - 
// Activations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Conflict (Price) - 
// Deactivations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Conflict X 
// Condition (Price)
// Knutson B, 2008: Conflict and Reaction Time Regressor - Reaction Time 
// (Price) - Activations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Reaction Time 
// (Price) - Deactivations
// Knutson B, 2008: Sell vs Choose - Product Preference (Product + Price) - 
// Activations
// Knutson B, 2008: Sell vs Choose - Product Preference (Product + Price) - 
// Deactivations
// Knutson B, 2008: Sell vs Choose - Price Percent (Price) - Deactivations
// Knutson B, 2008: Sell vs Choose - Price Percent X Condition (Price)
// Knutson B, 2008: Sell vs Choose - Product Choice (Choice)
// Subjects=24
28.77	28.91	-5.71
-6.97	-104.65	18.17
37.69	32.82	44.05
-39.22	24.96	45.59
49.3	19.29	19.4
-55.46	18.32	16.22
65.34	-17.85	5.6
-7.61	41.38	-6.34
28.63	31.86	-22.68
-7.35	30.92	23.53
-10.6	18.33	12.36
-15.01	0.47	-11.74
1.2	-14.01	6.01
1.07	-27.52	-17.38
-7.12	-49.07	21.32
-23.18	-82.43	4.23
-55.44	-2.37	10.15
37.86	-6.05	50.65
61.27	-48.66	20.5
33.08	-24.5	-22.47
32.96	57.75	-4.83
12.81	17.44	-1.22
-26.4	-87.02	0.19
45.23	-86.25	3.76
-39.19	-86.75	4.77
33.02	25.42	-9.92
-31	25.98	3.03
-7.29	23.86	28.59
3.55	16.75	45.79
-.73	16.64	44.73
41.91	12.53	28.97
-39.21	4.18	38.41
33.54	5.56	49.73
-26.28	0.97	50.8
5.67	-20.81	27.72
-19.11	-26.36	-.52
21.49	-26.12	-1.01
-3.26	54.33	9.26
-3.31	32.95	-5.68
17.38	-28.83	19.34
21.65	-33.29	16.32
33.35	-38.14	7.67
-18.94	-37.76	17.16
-26.48	-41.67	8.65
-2.75	-48.01	34.56
-42.2	-71.51	36.99
-39.61	58.34	9.34
45.01	31.24	22.91
-10.56	30.9	23.57
33.02	25.42	-9.92
5.67	21	45.41
-1.81	20.95	45.5
-42.79	16.85	-3.87
37.59	15.33	24.33
-42.54	11.68	25.55
29.23	13.99	49.07
12.9	1.92	4.54
-23.09	-3.5	47.79
12.9	-6.88	0.82
-7.31	-13.72	10.55
9.82	-13.27	14.78
1.39	-20.84	27.77
21.52	-25.86	2.31
9.74	-26.19	-.87
-3.09	-26.26	-.71
-19.1	-30.59	-.17
-7.75	59.73	-16.79
-15.01	54.26	9.4
-7.6	28.35	-9.7
33.24	11.19	12.46
17.3	3.23	21.11
53.36	-3.69	-16.64
-23.26	-.9	26.39
-63.14	-4.64	-18.57
-23.49	-7.7	-6.5
-23.56	-8.38	-15.36
9.97	-3.98	38.53
-46.87	-9.72	10.67
-39.34	-13.57	15.37
37.48	-14.39	-2.18
-19.28	-16.01	-18.12
17.05	-15.8	-18.55
-10.3	-11.51	39.39
61.18	-16.59	22.27
-58.75	-19.88	-9.53
21.65	-16.83	22.74
-10.27	-19.97	40.1
-39.24	-33.4	20.37
-23.67	65.15	-.34
1.44	-23.67	32.47
-7.13	-53.55	18.35
32.87	64.55	-13.2
37.11	56.49	-21.5
-26.73	9.55	-3.45
-46.69	12.94	42.22
25.74	6.57	8.47
5.63	-12.35	27.01
-10.55	-14.08	6.16
25.82	-25.49	6.7
-19.09	-26.1	2.8
-26.12	-51.1	51.82
26.28	-53.7	54.78
-18.66	-63.37	43.84
53.99	-67.51	38.89
-7.32	31.27	27.97
-7.09	-56.47	21.94
45.21	-82.02	3.41
48.99	32.58	-15.17
37.51	11.22	12.4
-30.82	2.6	17.26
-2.88	4.4	37.97
42.09	5.61	49.62
13.29	1.55	54.76
-42.96	-5.81	-35.43
-14.54	-11.19	43.88
53.54	-22.75	-1.66
53.73	-24.04	22.98
-42.61	-30.73	0.11
61.21	-40.46	16.47
-58.55	-46.43	4.96
-55.25	-45.38	18.22
-58.29	-48.09	38.55
-55.17	-49.01	26.33
5.89	-47.02	46.65
-25.98	-52.99	68.7
-31.11	53.47	0.73
-35.4	48.88	-3.3
-39.57	54.37	13.02
33.17	55.49	21.01
-26.55	47.61	34.62
28.93	43.83	22.03
-30.86	39.58	27.54
33.04	28.94	-5.76
-42.55	14.85	25.29
37.59	15.33	24.33
37.77	9.56	46
-14.85	2.1	9.31
-10.64	-7.28	-2.22
1.04	-20.12	-18
5.68	-16.24	31.8
42.17	-22.14	48.6
-42.24	-26.88	49.97
1.21	-51.24	-7.59
29.46	-46.28	54.12
17.36	-57.61	5.02
26.24	-58.53	47.38
-2.84	-65.5	14.84
-22.87	-62.71	52.75
29.4	-71.09	36.13
-18.89	-86.63	4.53
25.99	-86.36	3.99
-26.22	-85.14	24.56
-26.12	-84.11	37.86
-14.51	-97.64	13.21
41.8	-1.79	8.98
25.57	-8.34	-19.27
-18.93	-5.81	31.21
-19.27	-20.24	-17.76
69.61	-17.83	5.55
33.08	50.23	8.07
56.98	-52.2	16.38
45.36	-71.67	27.07
56.98	-52.2	16.38
36.55	32.13	35.2
-38.16	23.82	44.56
49.3	19.29	19.4
-54.39	18.32	16.21
65.33	-16.8	5.51
33.41	-61.74	5.19
-6.28	38.59	26.22
0.98	36.41	-2.67
-6.45	17.07	-4.31
-22.14	-73.96	3.5
-33.96	-65.92	-1.5
-14.44	-92.47	25.04
-14.9	42.25	19.32

// Labudda K, 2008: Incentives Presented (Activation) > No Incentives 
// Presented (High-Level Control)
// Labudda K, 2008: Incentives Presented (Activation) > Blank Die (Low-Level 
// Control)
// Subjects=12
2	28	36
50	32	24
-34	10	46
-48	-58	42
6	-90	-14
4	-74	54
46	34	24
-52	18	26
42	-46	38
2	-72	-29

// Lee T M C, 2008: Younger Healthy Control Males
// Subjects=12
-40	-6	-14
-26	-28	-20
-28	-44	-8
16	-26	-24
-30	50	20
38	12	-12
20	-76	6
-16	-24	20

// Lee T M C, 2008: Older Healthy Control Males
// Subjects=8
42	0	-12
52	4	-14
12	-62	10
4	-48	50
-8	-40	18
14	-10	16
-30	50	20
38	12	-12
20	-76	6
-16	-24	20

// Samanez-Larkin G R, 2008: Association between Activation During Loss 
// Anticipation and Subsequent Loss-Avoidance Learning
// Subjects=11
33.08	22.77	-3.01

// Schlagenhauf F, 2008: Healthy Controls
// Subjects=10
-18	6	-9
18	6	-3
18	6	3
24	-3	-18
-24	-60	12
0	-72	0
-27	-90	6
3	-81	-15
9	-93	-9
0	-15	-18
6	-57	-18
-6	-60	-18
-15	6	-3
15	15	-3
-33	-6	-6
-21	-3	6
18	15	0
21	-3	0
-51	-36	15
63	0	12
36	0	3
-15	12	-6
15	9	-3
-12	-3	6
-27	21	0
21	6	3
18	-12	6
18	3	-18
66	-33	9
54	-51	-18
57	0	3
-48	-75	-15
-42	15	-3
-30	-84	12
-51	-30	6
36	-93	-9
6	-42	-6
-6	-60	-18
-15	9	-3
18	6	-3
-6	3	18
-18	-6	3
-30	-3	3

// Schlagenhauf F, 2008: Schizophrenia Patients
// Subjects=10
15	6	-12
-21	9	-6

// Weber B J, 2008: Healthy Controls
// Subjects=23
-20	-90	-7
-56	-67	-8
-28	-57	47
-28	4	52
-45	8	30
-50	33	17
-3	29	35
22	35	-23
26	3	51
28	-54	50
30	-37	-7
31	19	-10
41	51	-10
44	35	17
49	8	25
49	-59	-6
-40	6	6
-8	-56	18
2	32	10
2	34	0
10	60	14
10	8	-2
38	-46	64
50	8	-6
58	38	0
36	6	52

// Weber B J, 2008: Subgroup of Healthy Controls Who Exhibited Consistent 
// Delay Discounting
// Subjects=7
-30	34	40
-23	31	39
-18	-41	7
-9	-62	32
-4	-46	21
18	1	23

// Liljestrom M, 2008: ACT vs. Rest
// Liljestrom M, 2008: OBJACT vs. Rest
// Liljestrom M, 2008: OBJ vs. Rest
// Liljestrom M, 2008: OBJACT vs. ACT
// Liljestrom M, 2008: OBJACT vs. OBJ
// Liljestrom M, 2008: ACT vs. OBJ
// Subjects=15
-34	-50	-26
-28	-34	-28
-34	-20	-24
-48	-72	-2
-46	-62	-12
-50	-22	40
-40	-48	58
-58	-36	18
-66	-38	6
-50	-42	6
-46	14	14
-46	32	-2
-44	34	-16
-30	28	0
-48	4	44
-40	-4	56
-36	6	-4
-36	-14	-14
42	-76	-8
36	-80	6
50	-68	0
50	-74	10
64	-48	8
44	-52	-20
40	-58	-30
50	-6	50
2	6	62
-4	18	46
36	-18	-12
36	-6	-24
-32	-62	48
-48	-72	-2
-34	-50	-26
-46	-64	-12
-48	-34	38
-44	-48	-22
-42	-46	-24
-44	-50	4
-48	34	8
-46	14	12
-56	16	2
-44	12	26
-34	30	-8
-50	4	46
-6	16	50
-8	6	60
40	-74	-4
36	-86	6
50	-74	10
28	-60	50
18	-66	60
38	-48	-20
46	-64	-10
40	-58	-28
-48	-72	-2
-32	-50	-24
-34	-40	-28
-30	-62	46
-48	-36	42
-42	12	12
-34	32	-4
38	-48	-20
40	-84	4
20	-70	46
28	-58	48
34	-88	8
-50	-38	38
-50	-54	48
-30	-66	52
-12	-66	44
42	34	30
48	20	42
34	-64	56
46	-48	54
-44	6	38
-30	8	26
-10	18	50
-44	22	26
10	30	36
-12	2	68
-54	26	2
-30	36	10
-30	26	0
-20	12	8
-14	-74	48
-50	-50	42
-36	-52	42
-26	-76	38
-56	-40	30
-46	-50	6
-62	-48	6
34	56	8
46	30	30
32	0	50
52	14	8
54	28	-10
26	-46	42
40	-50	50
26	-60	60
34	-72	46
62	-52	10
48	-68	0
42	-50	-22
32	-66	-38
-56	-42	26
-62	-50	8
-46	18	-22
-4	18	42
-52	6	44
60	-48	12
54	-66	-4
36	-58	-42
46	8	-8
50	-2	-14

// Siri S, 2008: Main Effect: Infinitive Verb + Inflected Verb + Action Noun
// Siri S, 2008: Action Noun vs. Infinitive Verb
// Siri S, 2008: Action Noun vs. Inflected Verb
// Siri S, 2008: Inflected Verb vs. Infinitive Verb
// Subjects=12
-46	10	24
-54	4	38
-52	-14	-6
-44	2	-10
44	2	-14
26	-34	2
-46	16	26
-48	24	-4
-46	16	26
-48	24	-4
-48	24	-4

// Tyler L K, 2008: Stems (Nouns + Verbs) vs. Baseline
// Tyler L K, 2008: Phrases (Nouns + Verbs) vs. Baseline
// Tyler L K, 2008: Noun Phrases vs. Baseline
// Tyler L K, 2008: Verb Phrases vs. Baseline
// Tyler L K, 2008: [Phrases (Nouns + Verbs) - Baseline] vs. [Stems (Nouns + 
// Verbs) - Baseline]
// Tyler L K, 2008: [Noun Phrases- Baseline] vs. [Stems (Nouns + Verbs) - 
// Baseline]
// Tyler L K, 2008: [Verb Phrases - Baseline] vs. [Stems (Nouns + Verbs) - 
// Baseline]
// Tyler L K, 2008: Verb Phrases vs. Noun Phrases
// Subjects=15
-48	22	28
20	-52	-32
-30	-8	-4
-52	20	28
-28	-2	-6
-52	-44	-4
-50	30	12
-54	-44	-2
-32	4	-4
-52	20	28
-30	-6	-6
-52	-42	-4
18	-54	-28
-46	-36	-6
32	-82	4
-50	-32	-6
30	-88	6
-46	-36	-6
-52	18	28
-12	-48	40
-2	-76	22
-52	-58	6

// Berlingeri M, 2008: Noun vs. Baseline (GCST)
// Berlingeri M, 2008: Verb vs. Baseline (GCST)
// Berlingeri M, 2008: Nouns vs. Verbs (GCST)
// Berlingeri M, 2008: Verbs vs. Noun (GCST)
// Berlingeri M, 2008: Noun vs. Baseline (PNT)
// Berlingeri M, 2008: Verbs vs. Baseline (PNT)
// Berlingeri M, 2008: Verbs vs. Noun (PNT)
// Berlingeri M, 2008: Verb vs. Noun (PNT + GCST) (Inclusive Mask of Baseline)
// Berlingeri M, 2008: Verbs vs. Noun (PNT) + Nouns vs. Verb (GCST) (Inclusive 
// Mask of Baseline)
// Subjects=12
-46	26	32
-48	26	32
-48	28	0
-48	16	30
-46	20	-6
-44	28	-2
-48	4	50
-52	14	-16
-54	-48	-18
-52	-54	-20
-28	-68	42
-22	-78	40
-24	-80	32
-22	-88	18
-24	-86	22
-26	-96	10
-12	-96	-6
-14	-92	-4
-8	-74	-20
56	-40	-18
24	-80	26
36	-86	-12
24	-100	0
24	-90	12
28	-92	-12
24	-100	0
38	-76	-32
-44	4	36
-50	-2	50
-46	-4	38
-8	8	50
-2	-40	56
-4	-8	38
-50	-46	24
-60	-4	-12
-58	-52	-2
-60	-54	-10
-58	-54	-18
-58	-46	26
-42	-48	30
-36	-50	34
-22	-100	-14
-40	-54	-32
-38	-82	-22
-32	-24	-10
-32	-18	-16
34	-14	56
48	8	-22
54	-6	-18
58	0	-14
56	-42	-16
36	-90	-10
26	-94	-14
26	-88	-16
44	-86	-12
24	-102	2
36	-72	-30
34	-68	-28
-52	24	2
-38	36	18
-44	28	-14
-46	-46	62
-8	-72	62
-24	-88	16
-18	-80	42
-38	-72	-28
36	-74	-30
-12	12	54
-26	-18	62
-6	-12	64
-4	-38	46
-2	-40	50
18	-30	66
16	-26	64
4	-20	58
12	-8	54
2	-34	52
16	-34	64
20	-40	64
6	-32	56
4	-38	56
2	-42	56
16	-2	-16
22	-4	4
-32	-24	58
-22	-92	34
-44	-78	-8
-38	-54	-28
50	-64	-18
36	-92	0
48	-82	-2
44	-50	-26
40	-50	-32
-54	30	20
-50	26	32
-24	-88	28
-26	-88	24
-32	-90	16
-34	-94	8
-10	-78	6
-46	-74	-8
-52	-72	-2
-24	-74	-8
-8	-74	6
-12	-62	-2
-42	-62	-22
-44	-54	-26
-18	-34	-8
52	-66	-12
16	-86	46
28	-88	28
36	-92	4
34	-88	16
48	-80	-2
52	-66	-12
10	-58	0
38	-46	-32
40	-64	-22
22	-32	-4
-36	22	2
-32	22	2
-10	-38	72
-12	-46	74
-58	-50	6
-20	-80	28
-50	-72	6
-10	-100	-12
-12	-82	-6
-6	70	6
-34	-36	-32
-46	-54	-26
-28	14	-2
-14	-2	-14
-40	-24	60
-22	-18	62
-32	-24	46
-38	-34	58
-14	-34	74
-8	-22	58
-18	-56	60
-14	-44	66
-12	-40	66
-14	-4	-16
-18	-28	10
38	-26	58
4	-8	58
26	-46	64
16	-30	60
10	-36	64
18	-44	70
16	-42	64
10	-42	64
6	-40	60
32	-46	56
18	0	-14
-52	32	14
-48	24	22
-30	22	-2
-54	-56	-16
-48	-50	-18
-24	-86	28
-26	-88	20
-28	-94	10
-12	-78	-16
-38	-74	-18
26	-80	30
32	-88	14
38	-74	10
10	-70	-34
10	-78	-18

// Filbey F M, 2008: Alcohol Cue > Rest
// Filbey F M, 2008: Control Cue > Rest
// Filbey F M, 2008: Alcohol Cue > Control Cue
// Subjects=37
-26	-28	50
46	10	-12
68	6	-2
74	-24	-4
-22	-58	34
52	28	6
64	30	6
-58	24	12
-5	-22	0
-68	-40	-18
-54	-40	14
-6	30	14
40	2	-40
-36	34	-20
-50	-62	44
-38	2	52
-10	-48	14
-20	-12	-20
48	-18	-24
62	28	10
-18	-50	-2
24	-26	18
-22	-26	16
-40	-38	-14
0	10	-16
-2	-38	-8
30	-40	16
-44	-88	-4

// Gilman J M, 2008: Alcoholism Patients
// Subjects=12
-42.71	-24.1	-10.48
44.75	20.84	-15.25
-19.06	-46.71	-2.16
49.39	-50.01	4.02
44.93	-14.6	-5.59
25.77	-34.81	-3.68
21.7	-73.44	6.3
-35.41	24.59	-14.64
-39.51	-36.23	-16.19
9.64	-7.41	-5.79
-46.77	-66.97	-.14
25.94	-78.16	-0.04
-46.85	-59.02	-7.5
49.31	-55.27	-8.92
-19.06	-46.71	-2.16
-23.13	-89.57	8.17
42.01	-77.55	6.41
12.94	-30.65	-3.88
33.4	-87.09	-6.07
-26.41	-82.7	0.94
37.68	-73.86	-.54
41.78	-55.83	-15.48
-39.44	-39.94	-9.19
49.28	-46.81	-9.63
13.13	-82.47	0.47
-42.48	-71.17	0.16
-35.2	-31.46	-9.95
21.68	-82.42	0.36
-39.51	-36.23	-16.19
21.52	-25.86	2.31
25.9	-82.9	-6.33
37.71	-82.32	0.17
69.54	-35.06	-10.85
-7.19	-78.36	0.36
44.94	-43.12	-16.58
65.3	-30.34	-4.5
32.95	20.25	-21.76
-42.74	-15.64	-11.19
12.83	-3.16	-6.18
-23.67	15.68	-20.72
-42.85	-.29	-19.16
57.85	-38.85	-3.7
9.6	-11.1	-12.17
28.85	-27.36	-17.72

// Gilman J M, 2008: Healthy Controls
// Subjects=12
-30.61	-89.62	8.26
-35.2	-31.46	-9.95
21.68	-82.42	0.36
-39.51	-36.23	-16.19
21.52	-25.86	2.31
25.9	-82.9	-6.33
37.71	-82.32	0.17
69.54	-35.06	-10.85
-7.19	-78.36	0.36
44.94	-43.12	-16.58
65.3	-30.34	-4.5
32.95	20.25	-21.76
-42.74	-15.64	-11.19
12.83	-3.16	-6.18
-23.67	15.68	-20.72
-42.85	-.29	-19.16
57.85	-38.85	-3.7
9.6	-11.1	-12.17
28.85	-27.36	-17.72

// Gilman J M, 2008: Main Effect of Alcohol
// Gilman J M, 2008: Main Effect of Emotion
// Gilman J M, 2008: Interaction between Main Effects of Alcohol and Emotion
// Gilman J M, 2008: Neutral Faces: Alcohol > Placebo
// Gilman J M, 2008: Fearful Faces: Alcohol > Placebo
// Gilman J M, 2008: Fearful Faces: Placebo > Alcohol
// Gilman J M, 2008: Placebo: Fearful > Neutral
// Gilman J M, 2008: Alcohol: Neutral > Fearful
// Subjects=12
25.69	7.12	1.73
-23.5	-0.04	-3.79
25.75	-47.12	-11.56
-14.45	-40.97	44.14
-16.99	29.55	20.41
-59.78	-4.14	1.43
-23.19	-80.4	2.94
19.26	-8.41	-5.81
-12.65	47.87	36.67
19.55	-88.95	-1.29
15.09	51.92	31.55
4.14	33.8	-9.18
-42.64	-29.93	-3.3
32.35	-82.52	-1.98
-29.87	39.88	17.47
21.76	-63.96	18.89
66.42	15.25	20.66
49.24	-18.63	-3.07
34.21	46.43	13.95
-10.35	-58.15	14.31
-8.44	-25.32	-1.85
-29.87	39.88	17.47
-8.64	9.94	-13.72
-23.39	-5.52	7.82
25.64	4.49	-4.74
25.78	41.07	27.88
11.09	-48.53	26.64
-25.43	-68.24	-4.74
-16.95	27.78	25.02
-21.41	3.86	-8.61
53.37	-2.55	-15.62
-12.62	-83.65	-12.52
-42.64	-34.33	-5.16
-21.44	-9.68	-18.62
62.08	27.74	17.43
-21.29	-27.86	-5.95
15.38	-94.46	10.37
-18.87	-88.66	5.81
-38.4	-43.45	-13.37
10.58	14.29	-14.31
44.97	-25.18	-4.7
49.38	0.34	22.1
-21.31	42.21	19.4
-48.87	24.56	41.27
-19.08	-13.96	8.47

// Kemmerer H, 2008: Running Verbs > Wingdings
// Kemmerer H, 2008: Speaking Verbs > Wingdings
// Kemmerer H, 2008: Hitting Verbs > Wingdings
// Kemmerer H, 2008: Cutting Verbs > Wingdings
// Kemmerer H, 2008: Change of State Verbs > Wingdings
// Subjects=16
-28	-32	60
24	-32	62
-60	-36	0
-54	24	28
-54	32	16
-46	16	36
-44	30	-16
-6	44	46
-60	-42	22
-58	-52	18
-60	-4	-12
-50	-22	-10
-46	-14	-30
46	12	-18
58	-6	-12
60	2	-10
24	-48	72
14	-84	26
12	-70	20
10	-40	22
-34	-30	-6
-30	-42	2
-36	-20	24
-54	-38	2
-48	-30	-8
-50	18	20
-50	24	-12
-46	34	-2
-4	56	36
-2	48	-14
34	-40	2
-28	-30	62
14	-26	62
10	-34	68
-54	-38	2
-66	-36	2
-58	-34	-10
-46	40	4
-32	40	-14
-42	46	-14
-58	-4	-14
60	4	-8
24	-48	72
14	-58	32
0	28	-20
-46	28	24
-46	10	40
-54	-40	2
-60	-42	16
60	-58	-8
-44	-60	12
-46	-14	-30
-36	-68	42
-38	-60	38
-52	36	18
-58	16	-12
-28	38	-12
-50	38	-2
-54	26	-4
-4	48	-18
-36	40	18
70	-8	16
54	-72	26
24	-50	72
10	-58	30
16	-66	12
10	-70	20
44	-16	4
-56	-38	0
-44	-16	-28
-52	-26	-22
-46	18	22
-38	30	22
-4	46	50
-58	-6	-14
-58	-44	18
10	-68	18

// Onoda K, 2008: Conjunction Analysis: Anticipation of Affective Pictures
// Onoda K, 2008: Anticipation of Certain Negative > Anticipation of Certain 
// Positive and Uncertain Positive/Negative
// Onoda K, 2008: Conjunction Analysis: Perception of Affective Pictures
// Onoda K, 2008: Positive Pictures > Negative Pictures
// Subjects=18
-4	14	54
-44	8	34
46	10	26
-40	-4	50
-32	22	-2
34	22	-2
-26	-60	44
14	70	-10
-14	-70	44
14	-82	-10
4	22	24
0	16	50
44	14	22
-46	8	32
-34	20	-2
-40	-2	58
-24	-62	46
8	-90	-2
58	-2	26

// De Nil L F, 2008: Stuttering Patients
// Subjects=15
-58	-14	-4
-52	-8	30
2	12	40
6	6	58
-46	-30	18
62	-18	0
-14	0	34
38	-24	22
-32	4	12
-52	-4	6
30	-4	20
58	-30	32
62	-6	-4
-12	-14	16
0	52	38
6	-40	-10
28	-34	18
-64	-22	0
42	2	14
32	22	-2
48	-36	20
54	-2	-14
10	-12	-16
-34	2	-18
0	-20	-22
54	6	24

// De Nil L F, 2008: Healthy Controls
// Subjects=15
-58	-20	4
-54	-16	2
-46	-2	-10
-6	-34	-8
0	16	42
-62	-36	14
-10	-22	-18
-4	-80	-12
24	-18	-18
-12	-14	16
0	52	38
6	-40	-10
28	-34	18
-64	-22	0
42	2	14
32	22	-2
48	-36	20
54	-2	-14
10	-12	-16
-34	2	-18
0	-20	-22
54	6	24

// Giraud A L, 2008: Stuttering Patients, Pre-Therapy
// Subjects=16
-16	18	4
-16	10	16
-8	4	-2
12	20	6
8	26	10
14	36	6
-4	-38	72
-12	-48	72
-32	-42	64
58	-10	-32
-58	-8	-30

// Giraud A L, 2008: Stuttering Patients, Post-Therapy
// Subjects=9
6	16	12
36	-26	-24
8	-60	26
-6	-10	12

// Watkins K E, 2008: Speech Activation Across Feedback Types, Healthy 
// Controls > Stuttering Patients
// Watkins K E, 2008: Speech Activation Across Feedback Types, Stuttering 
// Patients > Healthy Controls
// Subjects=10
-54	2	24
66	2	16
-48	-16	46
44	-10	44
-48	-10	6
-10	28	26
30	16	10
-34	12	14
32	14	-14
-8	-20	-10
6	-18	-12
-6	-68	-48
8	-68	-48

// Strakowski S M, 2008: Correct Stops > Non Targets, Healthy Controls
// Strakowski S M, 2008: Non Targets > Correct Stops, Healthy Controls
// Strakowski S M, 2008: Correct Stops > Non Targets, Bipolar Disorder 
// Patients
// Strakowski S M, 2008: Non Targets > Correct Stops, Bipolar Disorder 
// Patients
// Strakowski S M, 2008: Correct Stops > Non Targets, Healthy Controls > 
// Bipolar Disorder Patients
// Strakowski S M, 2008: Correct Stops > Non Targets, Unmedicated > Medicated 
// Bipolar Disorder Patients
// Strakowski S M, 2008: Correct Stops > Non Targets, Medicated > Unmedicated 
// Bipolar Disorder Patients
// Subjects=8
49.42	7.37	30.43
48.4	5.68	36.16
-4.04	29.85	36.97
7.73	23.5	36.25
0.3	-19.96	25.48
8.88	-23.97	27.95
-2.05	-9	2.29
8.88	-23.97	27.95
-2.05	-9	2.29
8.65	-9.9	3.35
-39.55	16.07	-.5
43.84	13.74	3.2
-57.46	-51.63	6.5
59.69	54.82	-3.77
-31.49	-61.33	43.82
30.5	-65.28	42.32
-2.86	-58.02	15.33
7.81	-55.84	15.02
-48.68	-66.78	29.97
-32.14	49.5	4.42
-26.17	-51.61	45.17
23.02	-72.98	39.71
-6.03	-53.21	22.77
5.74	-44.25	27.46
-48.7	-67.04	26.65
-1.92	29.7	34.73
-.65	-47.37	28.91
3.62	-47.35	28.86
-2.08	-8.28	-2.23
4.36	-7.9	2.12
-12.22	-78.48	40.57
9.17	-77.04	43.55
-54.28	-58.47	0.34
35.17	-6.26	-20.68
43.9	1.14	5.37
-59.44	-29.15	35.86
-34.78	-71.01	29.05
-21.9	-79.14	32.93
28.27	-83.75	23.82

// Lauro L J, 2008: Conjunction Among All Conditions
// Lauro L J, 2008: Idiomatic > Literal
// Lauro L J, 2008: Literal > Idiomatic
// Subjects=22
-46	28	16
-52	16	28
-44	-12	60
-56	2	32
-32	20	0
-34	-30	52
-44	-42	48
-48	-24	16
-34	-52	0
-38	-52	-24
-34	-84	16
-46	-78	-4
-14	-22	8
-32	-68	-20
-4	56	4
-2	-2	56
-2	42	-4
38	-6	64
50	28	16
50	8	28
32	22	-4
10	-50	32
62	-4	0
54	-68	0
44	-52	-20
22	-76	36
44	-70	8
46	-76	-12
10	8	8
12	-16	4
34	-46	-28
-4	54	32
-10	48	48
-50	26	0
-50	-58	24
-52	4	-32
-52	6	-40
52	32	-8
46	12	-36
54	0	-24
52	-48	12
-58	-32	40
42	-46	60
58	-36	52
62	-28	36

// Elliott R, 2008: Responses to B Cue Greater after AB than after BC
// Elliott R, 2008: Responses to B Cue Greater after BC than after AB
// Subjects=12
6	48	-12
15	-6	-15
-24	6	6
-9	9	-6
42	42	-18

// Izuma K, 2008: High Monetary Reward vs. No Monetary Reward
// Izuma K, 2008: Interaction: (Self - Other) x (HSR - NoSR)
// Izuma K, 2008: Main Effect: Self > Other
// Izuma K, 2008: Main Effect: Other > Self
// Subjects=19
50	38	22
-20	36	-18
22	32	-24
10	30	36
-28	18	2
24	12	4
12	10	-4
-14	10	-4
10	10	2
-12	8	2
-24	4	12
16	-2	-6
-20	-6	18
22	-14	18
-14	-14	14
10	-20	16
4	-26	-14
30	-60	-32
-32	-62	-34
50	-34	44
-42	-46	40
14	-66	42
-14	-68	42
-14	52	8
-36	50	10
-6	40	18
-14	24	54
-8	24	32
-52	20	14
-22	20	-2
22	16	-4
-4	-22	30
-44	-32	-8
-62	-18	-10
16	-48	-38
-6	-58	-12
12	2	-2
-6	2	6
-46	-54	-12
-34	-94	-10
50	-56	-16
40	-84	-6
34	28	38
36	-4	-46
28	-24	-26
-32	-6	-42
-20	-14	-22
-36	-16	16
-50	-38	20
10	-72	-4
-6	-88	-12
4	-30	62
6	-56	50
10	-102	16

// Krueger F, 2008: Integration Verification - Font Verification
// Subjects=18
-45.67	-53.8	49.7
-41.64	20.66	42.26
-28.56	21.54	50.92
-50.52	26.52	25.03
-6.49	-67.96	68.36
-36.9	-69.21	56.68
-6.8	-71.31	44.05
45.06	-71.12	43.15
-32.64	-79.49	49.78
1.66	-30	37.57
-2.85	-36.9	21.52
-2.83	-27.97	25.12

// Uddin L Q, 2008: ASD Patients
// Subjects=12
40	-72	-8
30	-82	-14
36	-82	-2
42	-54	-8
38	-50	-14
38	-54	-18
-32	-86	-8
-40	-82	-12
-14	-100	2
-20	-94	2
-38	-64	-18
-34	-48	-20
50	6	26
40	34	14
34	24	0
32	16	8
48	4	40
40	0	40
28	-84	-16
-30	-84	-10
42	-76	-14
-32	-48	-22
40	-74	-8
-18	-88	-14

// Uddin L Q, 2008: Typically Developing Controls
// Subjects=12
40	-72	-10
-30	-86	-14
-42	-82	-12
46	-62	-16
28	-76	26
38	-42	-22
50	6	26
40	34	12
32	18	-8
38	48	10
42	48	10
34	28	4
30	-84	-16
42	-72	-14
-30	-84	-16
-42	-66	-24
22	-88	-12
-36	-58	-18
52	14	30
48	6	28
42	32	10
32	26	6
40	12	6
30	16	2

// Kensinger E A, 2008: Healthy Young Subjects
// Subjects=17
30	54	10
-38	-32	-14
-34	-80	-2
-20	-91	10
14	-67	13
15	-5	-18
30	14	-14
46	-38	36
20	-64	-3
20	66	7
-28	59	21
-52	30	8
16	-47	32
-63	-54	6
-57	-36	11
-21	-18	-11
14	-32	25
-28	-18	-13
26	-14	-12

// Kensinger E A, 2008: Healthy Old Subjects
// Subjects=17
30	54	10
-38	-32	-14
-34	-80	-2
-20	-91	10
14	-67	13
15	-5	-18
30	14	-14
46	-38	36
20	-64	-3
20	66	7
-28	59	21
-52	30	8
16	-47	32
-63	-54	6
-57	-36	11
-21	-18	-11
14	-32	25
-16	64	4
-6	52	20
-2	65	17
8	56	3
-38	54	1
52	25	1
58	-33	5
44	-17	4
0	43	-7
0	33	-10
-8	26	10
10	11	25
-8	-45	26

// Mickley K R, 2008: All Valence Types, Recognized > Forgotten
// Mickley K R, 2008: Positive and Negative Items, Recognized > Forgotten
// Mickley K R, 2008: Negative Items, Remembered > Known
// Mickley K R, 2008: Negative and Positive Items, Remembered > Known
// Mickley K R, 2008: Positive Items,  Known > Remembered
// Mickley K R, 2008: Negative Items, Known > Remembered
// Mickley K R, 2008: Negative and Positive Items, Known > Remembered
// Subjects=20
-13.42	12.98	50.39
43.9	25.27	-28
18	-25	-36.04
59.68	19.25	21.63
-31.7	27.33	-24.68
-48.86	45.74	-10.52
-3.35	3.15	-9.32
14.15	28.9	12.48
18.52	-42.94	1.59
59.43	-57.02	-13.4
-39.52	-51.92	23.64
-50.93	-36.76	-20.25
46.54	-67.49	-9.91
52.87	-44.48	-16.77
34.34	-37.7	56.83
23.43	-75.77	40.61
21.24	-45.37	44.36
22.47	-12.89	-21.62
27.41	-23.61	24.18
57.06	-60.81	-30.92
50.76	-79.15	-20.03
-46.55	-73.53	-23.41
-29.42	41.35	-12.66
-40.01	-35.89	-11.56
46.45	-37.5	-10.63
-12.11	-2.17	-19.85
25.23	-4.06	26.76
24.91	-23.98	-2.64
-7.26	-22.23	17.91
9.52	-39.08	-25.53
40.05	-65.38	-10
-29.37	-30.51	-23.48
50.97	-60.05	0.49
-48.48	-60.82	-2.22
-44.07	-68.9	2.98
-56.03	-62.97	-1.88
25.69	46.01	-11.82
34.09	17.3	48.03
-16.47	29.28	-16.17
6.03	-1.19	46.98
12.36	-31.86	28.61
-55.86	-5.93	22.73
-34.87	-45.05	50.89
-47.87	-33.29	51.07
-62.73	1.03	-5.86
29.26	6.95	6.55
-12.07	23.33	-11.17
27.64	15.35	50.57
1.49	-14.88	27.12
9.63	-18.59	-13
-4.85	51.82	52
34.12	15.38	50.46
27.49	-16.4	32.43
-39.58	-21.72	25.13

// Ritchey M, 2008: Encoding Success Activity (ESA) Emotional > ESA Neutral
// Ritchey M, 2008: ESA Neutral > ESA Emotional
// Ritchey M, 2008: Recollection Persistence for Emotional Stimuli
// Ritchey M, 2008: Recollection Persistence for Emotional and Neutral Stimuli
// Ritchey M, 2008: Emotional > Neutral Encoding (long- vs. short-delay hits)
// Ritchey M, 2008: Emotional > Neutral Encoding (short- vs. long-delay hits)
// Subjects=13
26	3	-23
-19	3	-19
-48	29	6
-56	-48	-17
37	-64	35
30	-33	-2
4	22	-4
-19	-13	39
-11	18	3
15	12	17
-26	-18	4
63	-33	5
45	-54	3
-37	-51	-7
33	-52	-23
-37	-59	-16
30	-76	11
-22	-4	-13
-37	-77	-9
-45	2	35
-37	-77	-9
30	-1	-26
-19	-8	-22
7	38	37
59	-24	36
56	-38	37
-19	44	15

// Sommer T, 2008: Encoding: Arousing > Non and Slightly Arousing
// Sommer T, 2008: Arousal-Dependent Memory Effects
// Subjects=17
-33	-3	-21
30	-6	-12
-30	-18	-27
-24	-39	3
30	-15	-27
-24	-12	-33
27	-12	-33
-15	36	39
15	-12	36
12	18	19
12	-48	63
-45	-39	-6
-33	-3	-15
30	-33	63

// Talmi D, 2008: High Attention (HA) > Low Attention (LA): Scrambled Pictures
// Talmi D, 2008: HA > LA: Neutral Pictures
// Talmi D, 2008: HA > LA: Emotional Pictures
// Talmi D, 2008: Emotional Pictures > Neutral Pictures: LA
// Talmi D, 2008: Spatial Overlap: Content-Indepenent Attention and Emotion
// Talmi D, 2008: Spatial Overlap: Content-Dependent Attention and Emotion
// Talmi D, 2008: Spatial Overlap: HA > LA Neutral Pictures vs Scrambled 
// Pictures
// Talmi D, 2008: Differences due to memory (Dm) Emotional > Dm Neutral: EEM
// Subjects=11
31.61	-56.04	51.57
-26.16	-80.13	34.18
-28.39	-88.83	18.21
-32.02	-48.16	-19.74
50.34	-57.81	-14.3
30.97	-34.12	-22.75
51.48	6.61	20.44
-51.04	5.54	29.51
-26.17	-1.17	64.36
-32.08	14.89	-2.72
38.43	15.14	-5.78
-1.84	23.87	41.91
37.84	-84.21	17.06
31.46	-46.58	36.28
23.56	19.33	8.54
32.48	-5.37	46.19
49.44	3.23	31.9
-27.33	-6.52	50.32
47.29	-42.03	11.18
33.01	-14.27	-27.78
18.69	-58.2	38.52
-30.54	-81.27	19.83
49.35	6.68	21.57
33.57	-4.04	49.42
-47.85	3.19	26.33
-26.15	-6.38	65.91
-6.12	18.3	39.08
-.94	29.82	22.44
20.59	-23.35	21.07
-5.09	-19.36	19.92
10.76	-1.43	2.62
19.42	-29.85	6.02
35.25	21.98	0.38
-36.34	17.23	0.48
2.26	-27.29	-.69
-23.44	20.28	11.23
28.03	2.67	26.61
-47.88	-78.32	-9.22
36.67	-91.84	0.98
-26.21	-83.91	26.69
-19.3	2.48	-12.98
27.4	-81.79	49.31
-57.73	-9.47	-12.65
-38.47	-23.36	-15.05
-39.67	32.39	-9.67
-7.19	-47.55	13.39
25.19	-64.97	46.81
-27.27	-78.37	29.58
-40.33	-83.04	-2.22
-34.86	-87.27	11.46
37.82	-83.32	14.75
42.91	-61.74	-9.42
-34.13	-52.31	-18.25
-44.49	-78.61	14.19
-27.28	-79.6	27.46
-42.49	-59.2	3.62
49.48	-74.33	6.06
37.82	-83.32	14.75
51.38	-50.49	-16.04
25.18	-63.91	46.73
-56.07	-50.48	48.76
51.8	-46.12	40.47
-8.25	-49.76	12.47
36.78	-84.13	18.18
-27.25	-78.2	31.8
-40.16	-82.47	18.92
-33.08	-49.22	-19.63
-40.33	-83.04	-2.22
40.78	-65.01	-10.24
29.96	-45.58	-19.55
-38.96	-47.03	50.51
50.44	6.86	23.77
-27.33	-4.32	51.25
-50.06	-72.24	-13.05
-46.91	-55.22	-13.4
-36.48	1.52	-23.85
39.37	-8.14	-31.72
-22.58	-5.97	-25.61
-64.19	0.98	-14.56

// Janzen J, 2008: Right Ear Vestibular Evoked Myogenic Potential (VEMP) 
// Stimulation > Rest, Deactivations
// Janzen J, 2008: Left Ear VEMP Stimulation > Rest, Deactivations
// Janzen J, 2008: Acoustic Short Tone Bursts (STB) Control Stimulation > 
// Rest, Right Ear (Deactivations)
// Janzen J, 2008: Acoustic STB Control Stimulation > Rest, Left Ear 
// (Deactivations)
// Janzen J, 2008: Acoustic Loudness Control Stimulation > Rest, Right Ear 
// (Deactivations)
// Janzen J, 2008: Acoustic Loudness Control Stimulation > Rest, Left Ear 
// (Deactivations)
// Janzen J, 2008: VEMP Stimulation > Rest, Right Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Rest, Left Ear (Activations)
// Janzen J, 2008: Acoustic STB Control Stimulation > Rest, Right Ear 
// (Activations)
// Janzen J, 2008: Acoustic STB Control Stimulation > Rest, Left Ear 
// (Activations)
// Janzen J, 2008: Right Ear > Left Ear, VEMP Stimulation-Rest (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB Control Stimulation, Right 
// Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB Control Stimulation, Left 
// Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic Loudness Control Stimulation, 
// Right Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic Loudness Control Stimulation, 
// Left Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB + Acoustic Loudness Control 
// Stimulations, Right Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB + Acoustic Loudness Control 
// Stimulations, Left Ear (Activations)
// Subjects=16
-12	-52	66
-6	36	10
-14	16	22
-6	-10	64
-8	-36	48
14	-52	72
4	-12	64
-36	-46	38
-20	-44	50
-10	10	40
-20	-2	54
-18	40	-14
36	-30	40
10	-64	56
6	34	-4
40	-74	28
12	50	-8
22	-40	64
-2	10	34
64	-56	16
44	-2	56
-2	22	24
44	-2	56
6	26	22
16	-32	44
-42	-30	10
-36	-30	18
-58	-24	14
-30	2	-18
-32	-16	6
-42	-8	52
-14	-24	-8
-12	-36	-20
42	-30	10
54	-22	2
58	-24	14
34	-20	-14
32	-22	-4
50	-6	52
52	22	14
-38	-26	8
-48	-26	0
-46	-34	22
-30	-20	8
42	-20	2
42	-26	2
52	-26	20
32	-22	2
-48	-28	4
44	-22	2
-44	-34	20
48	-28	4
44	-22	2
-34	-30	22
-36	-32	24
40	-24	4
36	-26	6
40	-36	30
-32	-12	48
-32	-46	52
-38	-46	38
-26	-16	16
-44	-62	2
-14	-70	38
-4	12	46
40	-46	38
14	-70	-50
16	-70	-26
-36	-30	20
-58	10	14
-44	-34	24
-32	-20	0
-28	2	-20
-34	-6	42
-14	-24	-8
38	-28	10
52	-24	0
48	-28	20
32	-20	0
48	-2	50
46	12	16
-42	32	12
-46	-14	-8
-44	32	20
-32	-22	2
48	-34	10
46	-14	-8
50	-28	20
30	-22	2
-38	-26	-2
-38	-34	20
-48	-34	24
-30	-22	-2
-40	-2	62
42	-20	-4
44	-20	-8
40	-34	22
30	-22	-2
56	2	48
50	20	20
-34	-30	16
-44	-30	6
-40	-28	22
32	-20	2
42	-28	6
68	-20	8
48	-28	24
32	-20	-2
-40	-36	18
-44	-36	24
-54	-10	14
-42	-2	60
38	-34	16
44	-22	-8
40	-34	24
46	2	50
48	6	16
-42	-32	8
-34	-30	16
-38	-30	22
48	-18	-10
44	-12	14
50	-32	20

// Schlindwein P, 2008: Right-Sided 102 dB STB > Rest, Activations
// Schlindwein P, 2008: Right-Sided 102 dB STB > Rest, Deactivations
// Schlindwein P, 2008: Right-Sided 65 dB STB > Rest, Activations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 65 dB STB) > Rest, 
// Activations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 65 dB STB) > Rest, 
// Deactivations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Activations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Deactivations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 65 db STB - 102 dB White 
// Noise Signal) > Rest, Activations
// Schlindwein P, 2008: Left-Sided 102 dB STB > Rest, Activations
// Schlindwein P, 2008: Left-Sided 102 dB STB > Rest, Deactivations
// Schlindwein P, 2008: Left-Sided 65 dB STB > Rest, Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 dB STB) > Rest, 
// Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 dB STB) > Rest, 
// Deactivations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Deactivations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 db STB - 102 dB White 
// Noise Signal) > Rest, Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 db STB - 102 dB White 
// Noise Signal) > Rest, Deactivations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 65 dB STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 65 dB STB > Rest, Deactivations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB - Ipsilateral 65 dB 
// STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB - Ipsilateral 102 dB 
// STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB - Ipsilateral 102 dB 
// STB > Rest, Deactivations
// Subjects=21
50	-24	4
50	4	50
14	-24	-6
8	-74	-24
4	-50	-28
-50	-26	2
-18	-2	42
-50	-2	48
-38	34	-18
8	54	0
36	20	44
66	-10	32
54	-20	48
42	-86	20
18	-36	6
20	-46	-52
-40	-80	30
-52	-12	30
-16	-36	4
-28	-42	-14
58	-26	4
48	2	38
4	-28	-42
-46	-24	2
-36	-28	44
-12	-16	40
42	-34	12
2	-48	-26
-38	-40	12
-48	-14	12
22	38	42
28	50	4
8	12	44
24	-12	60
10	-54	60
34	-46	-32
18	-50	-54
-10	-54	72
-46	-16	30
-40	-34	48
-8	-42	44
-16	-36	4
50	-14	-4
52	2	50
54	40	-6
-56	-28	6
-46	-8	48
-58	32	-2
46	-82	18
50	-12	-6
-44	-36	24
52	-12	-4
-50	-24	-2
-18	-62	62
56	-26	2
-46	-34	6
38	-32	12
-34	-30	8
2	-40	42
42	-76	-28
-10	20	42
46	-28	12
-38	-28	12
40	46	24
36	-76	40
2	26	44
-4	-18	76
-34	-26	10
40	-68	52
2	22	48
-2	22	48
-6	6	12
-14	-38	-48
12	-12	60
4	-80	-34
18	-52	-34
-64	12	10
-46	-12	54
26	44	10
42	-44	28
-8	-22	-12
-58	-12	-6
52	-28	2
58	-20	0
-58	32	8
8	-88	-40
4	-16	28
12	-10	68
44	-86	18

// Wang Z, 2008: Vestibular Vertigo (Activations)
// Wang Z, 2008: Vestibular Vertigo (Deactivations)
// Subjects=17
0	-24	52
42	-62	4
22	-60	-4
10	-48	54
0	0	46
44	-32	14
46	-58	-38
34	-20	4
8	-46	74
2	-16	6
4	-62	6
0	-24	54
44	-70	2
38	28	-22
-16	-36	-2
-6	-72	18

// Brookheimer S Y, 2008: Autism Spectrum Disorder (ASD) Patients
// Subjects=12
-35.59	-61.4	-9.11
-44.39	-51.62	-18.89
33.46	-46.47	-14
27.13	-54.17	-4.17
-24.71	-73.91	-5.82
22.87	-71.2	-2.41
-39.88	-63.33	-6.6
42.17	-48.15	-9.5
35.59	-44.54	-16.47
-32.86	-83.38	31.12
22.87	-71.2	-2.41
35.68	21.76	3.86
33.32	57.5	-4.12
-28.44	-65.11	42.68

// Brookheimer S Y, 2008: Typically Developing (TD) Controls
// Subjects=12
-42.07	-54.83	-7.41
42.18	-59	-10.67
24.9	-52.47	-8.78
-11.69	-75.58	-1.39
29.5	-65.68	10.37
42.48	4.51	25.62
44.42	31.34	13.97
35.53	51.33	-1.31
22.5	2.62	-16.43
-22.83	-10.3	-14.38
-37.84	-53.31	-14.35
-42.07	-63.55	-8.79
42.18	-59	-10.67
33.48	-57.31	-15.17
-24.67	-77.96	-3.18
31.46	-71.59	-7
-48.25	15.24	30.59
38.17	15.55	29.08
50.95	33.91	18.08

// Ischebeck A, 2008: Multiplication, Untrained > Trained
// Ischebeck A, 2008: Multiplication, Trained > Untrained
// Ischebeck A, 2008: Differences, Division > Multiplication
// Subjects=17
-44.04	13.36	21.74
-24.92	20.82	-2.86
-4.67	-9.22	53.56
-30.61	13.64	58.46
33.41	34.1	-1.81
49.7	44.67	6.96
34.2	17.06	57.02
-18.15	0.07	15.89
20.76	6.9	17.91
27.17	-29.73	4.62
-23.95	-53.96	58.31
53.74	-28.16	54.43
28.1	-58.91	71.36
21.48	-66.56	58.78
-21.25	-90.84	8.13
-30.67	-68.93	36.37
-34.41	-72.68	-3.53
-46.67	-67.43	53.31
-8.03	-46.2	37.1
62.69	-50.31	-10.76
-33.75	-77.58	47.37

// Kleinhans N, 2008: Patients with Autism Spectrum Disorder (ASD)
// Subjects=19
-44	-48	-22
42	-54	-22
46	-42	-22
-28	-48	-8
28	-54	-8

// Kleinhans N, 2008: Healthy Controls
// Subjects=21
-42	-50	-24
-28	-66	-12
30	-44	-14

// Kroger J K, 2008: Normals Group 1
// Subjects=16
40.86	26.95	36.7
-52.82	-59.89	50.63
9.74	48.54	29.67
-24.2	10.33	47.76
31.39	5.37	47.54
-38.01	-11.96	49.79
-20.68	-65.53	57.43
-41.62	45.35	20.49
-52.86	-51.6	47.71
-47.82	-15.13	23.4
60.92	30.13	7.2
-20.29	17.59	3.61
-40.73	23.75	-11.17
20.19	17.6	-13.58
-62.85	-25.85	9.97
-19.75	-94.36	28.61
-38	-8.53	52.84
49.22	40.52	18.73
-.67	-35.48	31.26
-48.93	-14.42	18.89

// Kroger J K, 2008: Normals Group 2
// Subjects=12
35.94	-52.16	60.11
-32.45	-52.57	60.93
52.56	-28.42	7.75
32.88	67.89	-11.25

// Marquand A F, 2008: Depressed Patients
// Subjects=20
26.69	67.28	-13.94
-46.56	55.51	1.92
-30.65	28.64	58.1
28.91	43.68	-13.88
-47.8	-5.46	61.76
-63.85	2.94	-8.27
44.08	-6.23	-20.41
-32.39	-42.65	76.39
-19.47	-75.76	65.99
55.03	-66.37	-21.37
3.47	-90.62	-2.4
49.09	-86.47	16.58
40.16	-95.16	-7.06
-16.59	7.62	-29.71
-20.79	-22.17	-26.69
-9.87	22.48	-8.88
7.24	-22.49	-31.62
-37.83	-86.05	-20.08
9.33	49.17	-23.06
44.02	63.3	-11.6
-47.12	-7.74	-54.56
-34.06	-48.53	-55.23
28.67	61.58	-29.1
2.01	8.73	72.96
44.02	63.3	-11.6
52.56	51.65	-21.8
-33.89	57.73	-20.93
-69.86	-30.75	22.06
-70.23	-31.32	-7.01
70.03	2.79	-17.26
-23.89	-72.14	58.99
7.69	-93.57	-11.15
4.89	-17.36	-45.53
-42.08	-89.9	-15.14

// Marquand A F, 2008: Healthy Controls
// Subjects=20
18.87	53.72	48.05
3.28	61.18	13.96
-27.42	44.57	-24.22
-27.28	52.2	-11.53
39.75	57.11	-8.67
44.68	46.39	37.13
61.83	21.39	21.38
60.06	8.98	49.53
68.46	-51.95	17.32
-55.37	-4.86	-23.33
61.23	1.51	-30.43
74.53	-28.69	-9.74
60.07	-58.83	36.07
1.29	-40.46	6.12
6.45	-73.54	65.33
-.63	-104.28	12.47
5.72	-70.23	8.99
38.64	-83.81	45.63
1.1	-87.83	-18.33

// Shafritz K M, 2008: High-Functioning Autism vs Control Group, All Target 
// Trials
// Shafritz K M, 2008: High-Functioning Autism vs Control Group, Target-Shift 
// Trials
// Shafritz K M, 2008: High-Functioning Autism vs Control Group, 
// Target-Maintain Trials
// Shafritz K M, 2008: High-Functioning Autism vs Control Group, All Novel 
// Trials
// Subjects=15
54.31	23.8	24.63
-30.58	-47.47	47.7
-19.49	12.33	-2.11
-43.03	-9.05	11.61
-19.49	-54.41	-15.68
-39.72	35.27	26.22
-1.96	36.05	21.01
-37.05	-45.16	49.82
-23.87	14.03	-6.69
-41.96	-10.21	10.59
52.09	26.67	21.02
47.08	10.96	48.44
-39.16	-38.27	54.78
-21.64	11.26	-1.97
-39.82	-11.47	8.43
-41.88	-8.52	17.14

// Fakra E, 2008: Schizophrenic patients
// Subjects=14
22.33	-4.3	-21.81
-16.14	-2.42	-21.52
-26.51	9.57	24.43
27.92	0.41	11.19
56.89	-42.05	9.96
-30.74	5.66	29.27
-41.41	5.77	31.61
52.44	24.17	13.38
41.43	42.68	-21.51
-3.21	-2.29	-7.18
-43.78	-42.77	-17.82
-36.75	-40.79	62.23
-56.12	-28.02	50.23
-26.03	-40.3	67.64
46.53	-32.18	56.09
28.41	-36.17	61.09
-25.33	34.9	49.06
-22.27	40.06	32.98
-26.72	55.76	16.1
-3.27	66.3	12.71
-11.24	-4.69	58.91
-50.33	-.34	-19.07
3.89	-37.92	68.21

// Fakra E, 2008: Healthy controls
// Subjects=14
22.33	-4.3	-21.81
-16.14	-2.42	-21.52
-26.51	9.57	24.43
27.92	0.41	11.19
56.89	-42.05	9.96
-30.74	5.66	29.27
-41.41	5.77	31.61
52.44	24.17	13.38
41.43	42.68	-21.51
-3.21	-2.29	-7.18
-43.78	-42.77	-17.82
-36.75	-40.79	62.23
-56.12	-28.02	50.23
-26.03	-40.3	67.64
46.53	-32.18	56.09
28.41	-36.17	61.09
-25.33	34.9	49.06
-22.27	40.06	32.98
-26.72	55.76	16.1
-3.27	66.3	12.71
-11.24	-4.69	58.91
-50.33	-.34	-19.07
3.89	-37.92	68.21
22.36	39.88	-.98
26.75	-24.74	-11.22
46.37	-86.53	13.81
-36.87	-61.71	39.45
31.54	4.72	66.55
54.71	-46.98	1.47
50.51	-57.24	6.84
-15.92	26.21	18.45
-28.27	-91.95	32.96
10.08	16.93	61.31
18.76	-71.78	41.88

// Gilbert S J, 2008: Autism Spectrum Disorder (ASD) Patients
// Subjects=15
-38	54	16
48	48	16
-44	42	28
36	26	0
-38	26	2
-6	20	40
-48	16	-6
50	14	10
-52	12	18
56	12	44
30	0	58
60	-24	46
44	-40	60
-46	-42	44
38	-46	-38
-34	-56	-32
16	-58	70
-14	-58	64
20	-66	42
-8	-74	44
6	50	-8
-14	32	6
26	-32	-20
-18	-40	28
-38	-52	26
0	-52	24
-12	-62	30
36	-92	2
-24	-46	-30
-42	-58	-18
-50	44	6
38	42	26
-2	24	50
-36	22	0
30	20	-8
-44	12	26
-36	8	54
-34	6	34
-26	-50	34
-36	-60	54
10	-64	52
-28	-44	-30
20	60	2
12	52	34
10	56	36
-6	56	18
-12	50	0
-14	38	36
52	12	-26
-50	2	-30
2	-2	36
32	-12	-18
-64	-14	-24
-6	-18	44
66	-26	24
-38	-30	62
32	-44	60
20	-44	-20
22	-52	-22
-28	-62	-50
48	-64	-38
34	-72	-40
10	54	36
0	48	2
-16	44	24
-12	36	38
10	30	26
36	22	-32
26	8	-22
-58	4	-24
26	-6	-16
-22	-8	48
8	-28	46
14	-34	66
40	-40	6
28	-42	60
2	-46	16
18	-48	-20
-38	-56	4
12	-62	46
16	-96	16

// Gilbert S J, 2008: Healthy Controls
// Subjects=18
46	54	-4
36	32	24
32	30	-2
-22	28	-6
-32	18	10
-46	6	28
24	-4	42
-24	-8	42
14	-8	-2
24	-38	66
-46	-38	50
16	-44	72
46	-46	40
-40	-48	-46
-26	-48	40
-10	-66	60
14	-72	56
0	50	50
18	48	46
4	46	-10
-32	30	52
2	24	-2
-36	22	-32
38	-10	-36
20	-16	-34
48	-20	-18
-52	-24	-12
40	-32	-26
-32	-32	-26
-12	-40	-26
-6	-54	6
10	-60	14
-42	-62	-16
60	-62	26
-10	-68	18
-52	-70	34
50	-78	20
-24	-46	-30
-42	-58	-18
24	56	4
34	48	22
-36	44	0
-26	38	40
44	38	26
-4	38	38
34	24	-4
2	22	36
28	20	50
-52	18	16
40	6	46
-40	4	42
0	-8	4
-50	-36	50
52	-36	46
38	-56	46
10	-56	-2
-10	-68	54
-28	-70	54
8	-84	-4
-28	-44	-30
20	60	2
12	52	34
4	64	30
-64	-8	26
66	-16	28
26	-92	6
-22	-100	14
10	54	36
0	48	2
-16	44	24
-12	36	38
10	30	26
36	22	-32
26	8	-22
-58	4	-24
26	-6	-16
-22	-8	48
8	-28	46
14	-34	66
40	-40	6
28	-42	60
2	-46	16
18	-48	-20
-38	-56	4
12	-62	46
16	-96	16

// Hall J, 2008: Fear vs Neutral facial expression in control > patients
// Hall J, 2008: Neutral facial expression vs Baseline in control > patients
// Subjects=19
14	-55	-2
33	-39	-11
-22	-1	-12
10	-53	-10
10	-76	-7
-17	-2	-15
10	-53	-10
10	-76	-7
-17	-2	-15

// Kennedy D P, 2008: Autism
// Subjects=13
-4.87	13.67	61.75
-5.34	57.11	17.97
-4.83	-60.63	36.76
-39.54	21.7	3.49
-4.75	-99.38	31.09
-43.45	7.84	44.84
-60.46	-61.65	28.56
-52.3	-21.7	-6.11
13.06	-50.23	4.46
-21.07	29.38	46.12
0.39	-38.82	29.29
-25.61	-26.2	-11.61
-30.53	-74.5	24.83
25.95	29.66	45.56
46.55	-75.93	40.8
0.01	-20.76	-12.36
25.88	-22.69	15.38
16.43	-79.22	14.65
28.94	-29.76	-7.48
-3.9	-79.68	10.47
-39.03	-78.53	28.62
20.68	22.66	51.79
0.02	-21.81	-12.28
24.7	-11.75	5.56
-25.37	-79.7	-1.55
13.15	-83.35	2.77
4.79	-59.52	36.55
16.3	-23.46	20.02

// Kennedy D P, 2008: Healthy Controls
// Subjects=12
-5.09	46.48	45.62
-1.03	57.48	22.35
3.64	-48.23	31.16
-43.75	22.36	12.4
-1.55	-99.36	31.05
-43.42	8.18	49.27
-51.8	-64.8	42.11
-1.18	33.94	-6.9
-44.05	1.67	-34.93
63.55	-64.79	31.86
-52.19	-33.7	3.82
-39.64	30.53	-6.17
3.54	-13	32.67
0.01	57.15	17.9
-.97	24.02	16.23
-4.01	-48.93	9
-21.05	26.29	47.5
4.74	-30.37	41.92
-18.13	-34.87	-14.32
-39	-73.78	34.91
42.04	27.01	51.17
51.77	-68.38	27.84
-39.03	-78.53	28.62
20.68	22.66	51.79
0.02	-21.81	-12.28
24.7	-11.75	5.56
-5.04	-76.06	2.37
24.89	-70.25	6
9.01	-56.75	30.7
-17.95	-46.19	4.47
24.82	-45.67	7.28
20.55	-23.7	16.64

// Killgore W D S, 2008: Bipolar Patients
// Subjects=14
40	-18	-8
-14	-62	-24
-52	-8	22
-8	-46	-6
-14	-64	44
34	28	46
20	-52	18
-18	-30	-18
-40	-8	-22
-34	-36	-6
36	32	8
10	-60	-18
-28	-66	4
-28	-88	14
-6	-70	20
54	14	-18
-16	12	-4
-20	-6	22
-8	34	12
42	24	36
34	14	-32
26	28	-6
-12	48	-6

// Killgore W D S, 2008: Healthy controls
// Subjects=13
-22	14	-18
-10	-2	22
-34	42	-4
-4	-30	24
16	-4	-4
16	-6	-30
20	42	-12
-6	-70	20
54	14	-18
-16	12	-4
-20	-6	22
-8	34	12
42	24	36
34	14	-32
26	28	-6
-12	48	-6

// Michalopoulou P G, 2008: Schizophrenia patients
// Subjects=11
-32.59	-55.08	42.19
-17.72	-18.61	44.54
-13.26	-54.02	54.14
-5.9	-10.2	55.96
27.99	-81.21	-12.08
-48.98	-21.62	8.35
24.51	-7.21	-18.24
27.84	-26.76	-9.95
-52.89	-29.94	52.58
31.9	16.1	-20.28

// Michalopoulou P G, 2008: Control group
// Subjects=9
35.46	-77.99	-12.43
39.78	-77.45	-5.84
46.9	4.56	-19.49
55.4	7.35	-25.39
43.79	5.48	-7.26
-13.96	-7.44	-17.78
27.76	-6.67	-11.63
27.65	-16.59	-29.76
27.99	-81.21	-12.08
-48.98	-21.62	8.35
24.51	-7.21	-18.24
27.84	-26.76	-9.95
-52.89	-29.94	52.58
31.9	16.1	-20.28

// Schmitz N, 2008: Healthy Controls
// Subjects=10
33.76	-20.16	14.76
3.47	19.91	20.28
-3.11	24.58	13.2
28.46	35.28	34.02
-29.91	50.17	35.78
-5.21	38.17	20.86
-24.13	47.13	-20.04

// Schmitz N, 2008: Autism Patients
// Subjects=10
-2.22	47.26	3.1
-23.96	58.26	-4.34
-31.32	55.33	10.64
38.84	-53.87	67.32
-5.21	38.17	20.86
-24.13	47.13	-20.04

// Silani G, 2008: High Functioning Autism and Asperger Syndrome (HFA/AS) 
// Group
// Subjects=15
-4	42	-16
8	56	16
-44	10	48
8	-56	40
36	26	-22
46	10	-42
58	-60	28
24	-94	-18
-12	38	-14
-14	56	32
-12	56	14
-36	28	24
10	38	32
-6	-22	50
-10	-54	38
-50	-2	-34
-56	4	-30
62	-8	34
-6	-50	-30
6	-54	-34
-30	-10	68
10	-58	48
-30	-50	50
8	-40	-6
-20	-78	30
26	-82	30
-26	-96	2
38	-80	32
-2	54	-16
-8	-60	52
58	20	30
-44	48	-12
-42	18	-10
-62	-58	14
-18	-2	-18
-42	-54	38
-22	-80	-10
16	-84	-8
34	-86	10
-44	-74	-6
-12	-86	-20
-28	34	-14
6	-84	-40
34	-88	10
2	-80	-6
-2	24	8
-40	4	0
-18	-8	-20
-32	20	2
44	20	-2
-44	4	-4
-36	14	0
48	0	10
-16	-6	-16
-32	10	2
-20	-10	-16

// Silani G, 2008: Healthy Controls
// Subjects=15
-4	36	-14
-14	54	32
-6	56	16
4	52	28
-24	50	26
-12	40	26
8	42	28
-4	8	70
-4	-46	34
-36	16	-18
30	20	-20
-58	-4	-22
60	-6	-24
-46	8	-38
34	8	-18
-40	14	-36
44	14	-36
-34	6	-36
-36	8	-6
-40	-60	20
30	-8	-28
-26	-30	-24
-22	-76	-32
18	-80	-34
-12	38	-14
-14	56	32
-12	56	14
-36	28	24
10	38	32
-6	-22	50
-10	-54	38
-50	-2	-34
-56	4	-30
62	-8	34
-6	-50	-30
6	-54	-34
-30	-10	68
10	-58	48
-30	-50	50
8	-40	-6
-20	-78	30
26	-82	30
-26	-96	2
38	-80	32
-28	34	-14
-46	-40	-20
-32	-4	-14
-28	34	-14
6	-84	-40
34	-88	10
2	-80	-6
-2	24	8
-34	28	0
-32	20	2
44	20	-2
-32	20	2

// Kramer M E, 2008: Children with Traumatic Brain Injuries
// Subjects=5
46.09	36.87	26.88
-47.96	31.74	23.93
41.73	31.59	13.99
-39.45	31.45	19.4
33.03	56.23	3.1
-39.23	11.67	38.9
3.55	-27.17	28.28
-.8	-6.05	26.56
-21.85	-65.42	45.16
33.82	-45.4	65.15
-21.88	-47.1	48.09
29.41	-46.79	47.47
37.86	-82.98	19.18
-34.81	-83.41	20.06
28.98	-51.25	-10.14
20.37	-51.99	-18.9
-47.52	-20.85	59.56
-47.49	-29.31	60.27
3.22	52.85	17.11
-.98	31.68	18.94
2.89	49.42	-27.2
-1.34	45.51	-22.37
2.94	54.34	-18.7
-1.34	54.31	-18.64
54.43	30.3	-3.89
54.39	29.95	-8.32
-56.37	-6.38	27.23
-56.35	-1.81	31.3
3	46.22	-13.55
-1.27	46.2	-13.5
45.69	15.16	-33.74
-47.63	-57.09	31.38
-47.71	-53.54	22.16
38.06	-45.72	60.66
-17.48	-45.71	65.76
-47.5	-55.71	49.1
20.99	-80.68	50.41
-8.93	-80.86	50.77
20.91	-85.94	37.47
-13.27	-90.38	38.24
25.11	-86.6	28.56
-26.18	-86.91	29.17
29.1	-54.45	3.51
16.03	-35.09	-20.27

// Kramer M E, 2008: Children with Orthopedic Injuries
// Subjects=8
46.09	36.87	26.88
-47.96	31.74	23.93
41.73	31.59	13.99
-39.45	31.45	19.4
33.03	56.23	3.1
-39.23	11.67	38.9
3.55	-27.17	28.28
-.8	-6.05	26.56
-21.85	-65.42	45.16
33.82	-45.4	65.15
-21.88	-47.1	48.09
29.41	-46.79	47.47
37.86	-82.98	19.18
-34.81	-83.41	20.06
28.98	-51.25	-10.14
20.37	-51.99	-18.9
-47.52	-20.85	59.56
-47.49	-29.31	60.27

// Kramer M E, 2008: Children with Orthopedic Injuries with Behavioral Data 
// Available
// Subjects=6
3.22	52.85	17.11
-.98	31.68	18.94
2.89	49.42	-27.2
-1.34	45.51	-22.37
2.94	54.34	-18.7
-1.34	54.31	-18.64
54.43	30.3	-3.89
54.39	29.95	-8.32
-56.37	-6.38	27.23
-56.35	-1.81	31.3
3	46.22	-13.55
-1.27	46.2	-13.5
45.69	15.16	-33.74
-47.63	-57.09	31.38
-47.71	-53.54	22.16
38.06	-45.72	60.66
-17.48	-45.71	65.76
-47.5	-55.71	49.1
20.99	-80.68	50.41
-8.93	-80.86	50.77
20.91	-85.94	37.47
-13.27	-90.38	38.24
25.11	-86.6	28.56
-26.18	-86.91	29.17
29.1	-54.45	3.51
16.03	-35.09	-20.27

// Dichter G S, 2008: Healthy Controls
// Subjects=22
3.57	-28.14	29.48
36.35	-38.06	-19.14
-41.68	33.75	8.08
39.76	11.28	26.87
59.04	-67.22	0.89
-8.27	-94.91	-7.17
-4.5	53.58	-14.09
-16.09	48.71	6.53
51.47	22.99	25.75
-41.4	-52.33	9.72
40.02	-68.45	27.98
-48.62	-10.11	60.91
-18.64	-47.8	52.57
32.59	-59.09	39.55
-29.84	58.79	28.15
31.81	64.54	-13.19

// Dichter G S, 2008: Autistic Patients
// Subjects=12
-56.27	-66.88	15.57
-56.66	33.4	4.93
62	35.68	10.07

// Freitag C M, 2008: Typical Developing (TD) Controls
// Subjects=15
54	-20	30
24	-68	18
64	-20	-20
52	-4	2
42	2	6
4	12	-2
22	12	2
44	30	-10
-56	-26	28
-46	-46	38
-18	-44	34
-32	-10	-38
-40	0	-6
-16	12	8
-28	-8	-2
-8	-2	64
16	-84	10
22	-64	18
38	-16	42
54	-20	30
32	-36	44
62	-26	24
54	-64	6
44	0	4
10	0	46
10	-6	60
28	34	48
-20	-30	70
-54	-26	24
-32	-10	-36
-58	2	2
-38	-12	18
-6	2	48

// Freitag C M, 2008: ASD
// Subjects=15
14	-30	-14
4	-8	2
30	-12	-20
-32	-22	44
-4	-64	36
-12	-38	4
-16	-30	-10
-10	-4	22
-8	64	28
16	-84	10
22	-64	18
38	-16	42
54	-20	30
32	-36	44
62	-26	24
54	-64	6
44	0	4
10	0	46
10	-6	60
28	34	48
-20	-30	70
-54	-26	24
-32	-10	-36
-58	2	2
-38	-12	18
-6	2	48

// Loveland K A, 2008: Healthy Controls
// Subjects=3
32.92	51.86	-12.14
23.27	48.12	-18.41
4.8	-75.81	32.34
4.74	-92.95	17.06
-30.72	-55.61	7.64
-24.35	-49.48	3.71
-5.1	-75.52	-4.37
-11.36	-87.22	10.07
39.41	52.67	-2.25
36.13	51.88	-12.18
-50.17	-18.43	-5.29
20.59	-71.68	1.71
-14.66	-68.46	5.19
26.92	-36.23	5.35
33.33	-42.79	2.48
-33.96	-52.71	4.09
-24.38	-43.14	3.18
11.3	-2.38	72.95
8.06	7.12	72.19
8.01	-75.79	32.31

// Loveland K A, 2008: Autism Spectrum Disorder (ASD) Patients
// Subjects=5
32.92	51.86	-12.14
23.27	48.12	-18.41
4.8	-75.81	32.34
4.74	-92.95	17.06
-30.72	-55.61	7.64
-24.35	-49.48	3.71
-5.1	-75.52	-4.37
-11.36	-87.22	10.07
0.75	67.01	-19.73
10.4	67.33	-16.52
14.15	-78.57	-4.33
-5.12	-75.77	-7.69

// Wicker B, 2008: Emotion vs Age, Controls>ASD
// Subjects=12
73.88	-32.06	23.1
58.32	24.83	0.93
14.16	63.97	20.22

// Pichon S, 2008: Effects of observing body expressions vs scrambled stimuli
// Pichon S, 2008: Main effect of anger vs neutral expressions
// Pichon S, 2008: Brain regions involved during the observation of dynamic 
// expressions, (Ad-As)
// Pichon S, 2008: Brain regions involved during the observatioin of dynamic 
// expressions, (Nd-Ns)
// Pichon S, 2008: Brain regions involved during observation of dynamic anger 
// expressions (Ad-As)-(Nd-Ns)
// Subjects=16
56	30	-8
-34	2	-24
20	-2	-14
24	-24	-6
12	-32	-4
42	-52	-20
-40	-42	-22
50	-76	0
44	-86	0
-44	-86	0
26	-100	-4
-26	-100	-4
10	60	40
60	32	0
-42	30	-8
-54	22	32
-46	10	54
42	2	44
28	0	-26
10	-12	6
-12	-6	42
54	-18	-14
66	-34	36
66	-40	20
-66	-40	20
56	-42	4
-56	-42	4
44	-44	-18
-44	-44	-18
46	-74	0
-46	-74	0
12	-102	2
-12	-102	2
38	30	0
-38	30	0
28	12	-30
-28	12	-30
54	8	-22
-6	0	-14
50	2	48
54	-2	-24
68	-38	22
42	-42	-20
-42	-42	-20
54	-44	12
-54	-44	12
48	-68	4
-48	-68	4
-12	-80	-46
52	16	32
42	-46	62
-42	-46	62
62	-44	16
-62	-44	16
8	-74	56
-8	-74	56
8	-50	50
-34	-62	52
26	-66	66
42	-56	-18
48	-70	2
-48	-70	2
24	-94	24
-24	-94	24
46	-76	-14
-46	-76	-14
6	56	48
2	48	-26
56	-4	52
-6	0	-12
48	-42	8
54	-22	-6
54	-6	-20
54	14	-26
-54	14	-26
-32	12	-30

// Lui F, 2008: conjunction analysis: observation and imagery for all stimuli, 
// MNI coordinates
// Lui F, 2008: conjunction analysis: observation and imagery for all stimuli, 
// Talairach coordinates
// Lui F, 2008: observation > motor imagery for all stimuli, MNI coordinates
// Lui F, 2008: observation > motor imagery for all stimuli, Talairach 
// coordinates
// Lui F, 2008: motor imagery > observation for all stimuli, MNI coordinates
// Lui F, 2008: motor imagery > observation for all stimuli, Talairach 
// coordinates
// Subjects=13
-28	-72	36
-56	8	20
-40	-8	44
-8	4	56
-52	36	20
-56	4	40
-60	-48	12
44	-48	44
56	32	12
44	8	20
52	0	44
60	-52	-12
64	-44	8
-28	-68	36
-55	9	18
-40	-6	41
-8	6	51
-51	36	17
-55	6	37
-59	-46	13
44	-44	43
55	32	9
44	9	18
51	2	40
59	-51	-8
63	-42	9
-64	-16	16
-48	-56	0
40	-72	36
56	-12	20
60	-20	40
48	-40	0
60	-48	-4
-63	-15	15
-48	-54	3
40	-68	37
55	-11	19
59	-18	38
48	-39	2
59	-47	-1
-68	-36	20
-48	8	4
-44	12	-8
-36	40	20
-8	4	48
-12	0	-8
60	-44	28
36	28	-8
44	20	-20
28	44	24
8	12	60
4	16	32
64	-44	20
16	-8	4
-67	-34	20
-48	8	3
-44	11	-7
-36	40	16
-8	6	44
-12	0	-7
59	-41	28
36	27	-8
44	19	-18
28	44	20
8	14	55
4	17	29
63	-42	21
16	-8	4

// Villarreal M, 2008: [(tv > rest) AND (iv > rest) AND (cv > rest)]
// Villarreal M, 2008: (tv > rest)
// Villarreal M, 2008: (iv > rest)
// Villarreal M, 2008: (cv > rest)
// Villarreal M, 2008: [(iv - cv) - (tv - cv)]
// Subjects=17
55.25	-71.3	-5.2
42.52	-87.11	10.03
39.94	-68.34	-18.67
36.46	-77.43	45.04
38.66	-50.86	53.58
-50.61	-75.93	-2.93
-44.27	-68.22	-12.77
-26.61	-98.2	10.07
-26.24	-69.14	45.28
-28.15	-58.57	66.68
-43.5	-38.39	53.74
12.51	21.79	51.32
64.01	-41.95	9.68
40.42	-88.83	14.72
57.44	-71.08	-3.01
40.03	-67.72	-12.01
38.77	-56.62	60.87
59.63	-40.26	5.1
57.44	-49.19	1.54
19.31	-69.87	58.03
-50.57	-77.84	-.5
-37.62	-82.26	-2.53
-41.34	-38.38	53.7
-42.08	-68.01	-10.59
-10.93	-78.69	57.17
-56.92	-68.11	12.09
-34.74	-52.83	59.5
-28.8	-83.11	10.85
-56.95	-44.3	14.21
38.39	10.62	45.26
45.01	5.09	54.65
-28.44	9.29	57.73
-24.03	1.22	62.94
12.58	17.95	56.18
1.69	26	51.08
55.27	42.64	19.39
44.28	32.43	2.66
55.31	-70.88	-.76
50.82	-72.14	-14
-50.61	-75.93	-2.93
-26.19	-73.19	47.93
-26.17	-64.27	51.52
38.35	-88.22	21.42
17.16	-72	58.27
-37.75	-76.71	-12.04
-39.14	-49.01	54.72
-37.63	-80.13	-2.74
32.18	-66.19	50.72
-61.3	-68.54	7.72
38.63	-51.07	51.36
42.86	9.55	56.49
-30.82	-97.39	19.02
59.74	-39.43	13.99
-59.18	-42.59	9.6
-32.89	12.7	48.5
57.41	40.31	17.34
-31.32	47.68	9.16
46.43	41.15	4
5.95	25.6	46.57
-52.38	7.96	44.82
-23.03	20.98	-24.2
-23.02	25.45	-22.4
-35.76	27.06	-4.41
-52.73	31.62	22.32
44.6	21.74	26.12
35.67	23.89	3.65
53.11	-68.97	-3.15
38.28	-86.51	16.77
-44.22	-65.68	-8.54
40.96	-56.4	63.05
35.74	-69.65	-9.51
61.88	-41.75	11.94
36.42	-66.8	43.98
-48.45	-73.79	-3.18
-37.63	-80.13	-2.74
-39.3	-34.95	44.36
-30.85	-97.59	16.8
-26.32	-69.77	38.62
-34.77	-53.04	57.28
12.6	20.28	58.19
-28.48	4.62	53.71
-9.08	17.46	52.11
35.92	3.86	19.07
38.44	6.57	47.9
39.94	27.95	0.93
-50.87	29.34	-2.14
-54.99	22.07	12.1
-52.71	27.37	22.74
44.43	37.93	15.56

// Kim M J, 2008: PTSD
// Subjects=12
-40	18	50
-50	16	44
58	-56	-12
-64	-28	-8
58	-48	-14
40	-58	-20
-50	-50	-22
-46	-50	-24
10	-82	52
-8	64	32
-10	66	26
-6	66	26
-68	-28	-8
-58	-52	2
-38	14	50
6	64	32
12	64	32
32	-84	-20
30	-82	-22
24	-20	-8
-14	44	4
-8	40	6
-10	40	0
12	50	2
16	60	-2
24	-76	48
-50	10	42
54	-40	-18
54	-36	-16
60	-48	-14
56	-38	-14
-66	-48	22

// Kim M J, 2008: Healthy Control
// Subjects=12
-40	26	-26
48	-60	-42
50	-64	-44
-6	64	14
20	62	-2
24	-20	-8
-14	44	4
-8	40	6
-10	40	0
12	50	2
16	60	-2
24	-76	48
-50	10	42
54	-40	-18
54	-36	-16
60	-48	-14
56	-38	-14
-66	-48	22

// Sailer U, 2008: PTSD
// Subjects=13
-38	50	-10
-50	30	36
-48	42	24
-38	26	54
24	-74	52
28	-68	34
-38	-42	46
30	-94	14
38	-94	2
24	-72	-12
0	-98	-8
0	-94	6
-12	-76	-8
46	-72	-6
40	-56	-14
52	-44	-20
60	30	-4
-48	0	2
-61	-18	19
-24	28	60
-54	-54	28
-4	10	-6
6	12	-2
-8	62	-12
-8	-10	2
4	64	-14
-4	10	-4
6	62	-16
4	52	-22
-6	10	-8
16	10	-30
-12	38	34

// Sailer U, 2008: Healthy control
// Subjects=13
-38	50	-10
-50	30	36
-48	42	24
-38	26	54
24	-74	52
28	-68	34
-38	-42	46
30	-94	14
38	-94	2
24	-72	-12
0	-98	-8
0	-94	6
-12	-76	-8
46	-72	-6
40	-56	-14
52	-44	-20
60	30	-4
-48	0	2
-24	24	60
-54	-54	26
-56	-24	16
-18	-44	32
-24	28	60
-54	-54	28
-4	10	-6
6	12	-2
-8	62	-12
-8	-10	2
4	64	-14
-4	10	-4
6	62	-16
4	52	-22
-6	10	-8
16	10	-30
-12	38	34

// Sanchez-Carrion R, 2008: Traumatic Brain Injury Patients
// Subjects=12
36	46	24
6	62	-4
-22	56	-2
32	48	22
6	62	-2
40	44	30
-14	14	18
-34	36	22
-16	58	18
-34	34	18
-18	30	-4
10	50	38
22	52	36
12	48	40
10	42	52

// Sanchez-Carrion R, 2008: Healthy Controls
// Subjects=10
36	46	24
6	62	-4
-22	56	-2
32	48	22
6	62	-2
40	44	30
22	52	36
12	48	40
10	42	52

// Yi D J, 2008: Refresh > Repeat
// Yi D J, 2008: [Novel + Skip] > Repeat
// Yi D J, 2008: Conjunction of [Novel > Repeat] and [Novel > Refresh]
// Subjects=9
-40.36	3.52	54.02
-52.54	10.01	32.3
-62.39	-50.05	10.39
-62.53	-42.37	0.67
-59.3	-65.42	-4.95
-65.39	-50.42	29.53
34.03	14.65	42.69
8.09	24.34	44.41
46.52	48.36	12.25
39.96	56.54	8.19
43.96	-40.62	47.99
-27.42	-94	32.08
21.06	-98.16	19.34
37.31	-91.2	23.97
36.64	-51.34	-20.3
-40.38	-77.57	36.27
27.37	-52.3	15.81
47.09	-84.17	29.83
26.91	-35	-17.27
33.47	-52.96	-14.48

// Abraham A, 2008: Mental state or intentional relations (M) > 
// Non-intentional relations (PO)
// Abraham A, 2008: M > Person-spatial (P) relations
// Abraham A, 2008: P > Object-spatial (O) relations
// Subjects=17
-10.59	53.62	28.36
2.09	58.76	11.05
-43.01	0.19	-40.39
-43	9.17	-34.45
-55.73	-2.03	-26.68
56.47	21.62	-19.91
43.6	4.66	-31.72
63.24	-27.3	7.53
-58.7	-16.11	-2.04
37.87	-80.61	22.33
28.27	-90.44	19.92
47.34	-75.49	5.06
28	-73.46	-8.27
24.73	-57.62	-9.56
37.53	-57.8	-13.03
-39.29	-70.18	-1.08
60.11	-13.34	23.13
-55.37	-8.2	17.33
-45.69	-4.2	26.92
-.55	-11.14	57.09
2.63	-50.98	36.98
-14.02	44.69	-4.31
-10.59	53.62	28.36
2.11	59.02	14.38
-43.01	0.19	-40.39
-49.36	10.7	-27.82
40.4	-1.97	-34.48
63.24	-27.3	7.53
37.88	-83.78	22.6
31.21	-70.01	-5.25
2.46	-95.56	-2.77
66.46	-4.04	18.93
-48.81	-13.22	34.4
-48.92	-4.48	23.63
-39.2	-32.97	25.91
-10.27	-5.62	46.71
47.15	-4.93	9.19
-13.24	-82.29	46.48
44.18	-45.42	22.65
-42.36	-52.28	24.22
-3.89	-52.05	23.76
-.57	-54.18	37.28
-55.6	-7.34	-12.85

// Montojo C A, 2008: NMBR, RULE, BOTH > HOLD
// Montojo C A, 2008: Main effect of Condition (NMBR, RULE, BOTH)
// Montojo C A, 2008: Main effect of Event (CUE, CALC, ANSW)
// Montojo C A, 2008: Interaction of Condition x Event
// Montojo C A, 2008: RULE > NMBR
// Montojo C A, 2008: NMBR > RULE
// Montojo C A, 2008: BOTH > NMBR
// Montojo C A, 2008: BOTH > RULE
// Subjects=16
44.24	3.14	36.76
-47.57	-13.19	29.26
34.04	-8.73	39.65
-10.46	67.03	36.6
-11.6	69.81	1.03
4.02	28.6	14.45
-34.39	54.22	32.71
37.37	62.03	41.94
-12.91	78.11	42.39
-50.23	39.64	38.24
14.21	75.53	38.28
2.23	-.67	61.43
-8.1	-5.38	51.01
-27.25	68.55	35.77
-44.93	-3.77	42.15
2.96	35.86	17.65
-43.42	-45.76	13.65
43.54	60.06	38.01
38.84	44.2	31.48
-2.25	1.23	49.27
-13.57	6.2	66.38
-11.26	65.25	42.56
-25.7	67.49	42.54
2.45	5.53	64.58
-27.24	62.28	34.4
-47.84	0.53	27.77
-17.76	79.75	37.96
37.27	63.63	43.36
3.37	1.54	58.33
-3.99	-12.7	39.98
9.2	83.24	42.15
-8.8	77.83	48.17
-42.88	-35.31	31.73
-39.18	-6.39	39.3
-28.64	60.76	32.76
23.78	77.48	32.43
-36.34	57.26	44.74
-31.11	49.59	26.26
2.81	2.24	55.04
6.04	-9.62	52.76
6.72	83.72	40.36
32.21	61.19	38.5
14.03	85.52	46.37
-45.59	2.93	28.33
-34.4	57.29	32.56
36.08	63.52	42.05
-42.6	2.06	27.81
2.63	-3.77	57.11
-21.91	81.96	40.72
10.79	82.95	41.04
8.29	20.75	37.81
-41.93	-35.53	30.28

// Bryant R, 2008: PTSD (Post traumatic stress disorder)
// Subjects=15
24	2	-12
-26	-2	-12
-8	60	36
-28	-2	-26
26	4	-28
0	36	36
0	50	-12

// Bryant R, 2008: Healthy Controls
// Subjects=15
-16	2	-16
18	4	-16
8	58	-12
-28	-2	-26
26	4	-28
0	36	36
0	50	-12

// Carrion V G, 2008: PTSS/early life trauma
// Subjects=16
39.83	43.49	-5.09
-29.45	22.54	-18.64
22.66	68.39	9.55
44.29	51.13	7.53
7.53	50.8	5.95
24.51	29.97	-22.54
-33.78	24.66	-18.78
52.84	18.76	-6.22
-33.65	21.23	-9.48
33.49	-.35	-2.88
-18.28	13.27	7.86
50.76	-29.94	-10.33
66.95	-33.28	-12.52
46.5	-51.33	-9.26
-42	-63.03	-3.24
-35.25	-90.58	11.7
-35.61	43.51	10.77
-11.4	-78.92	20.23
-48.48	-69.64	-4.71
-46.2	-75.29	3.65
7.68	31.11	13.5
-9.7	39.14	8.52
5.48	33.02	11.1
-5.33	35.11	11.08
31.03	32.43	-19.53
33.34	25.93	-8.84
35.59	16.78	-3.49
35.48	10.42	-14.07

// Carrion V G, 2008: Healthy Controls
// Subjects=14
39.87	32.85	-4.03
-31.59	27.1	-15.69
28.84	32.22	-21.71
-27.3	29.04	-18.2
10	40.01	28.26
10.14	52	41.64
33.59	39.81	13.31
10.28	16.9	45.11
48.48	21.73	-8.68
-42.37	22.81	-15.09
13.94	20.75	-5.76
-16.3	16.29	-5.92
-5.48	12.07	-5.69
24.6	14.23	-18.74
-26.99	10.59	2.67
7.66	-24.8	1.1
7.58	-6.82	-1.8
34.16	14.52	52.79
55.21	-54.07	-4.66
50.64	-25.35	-18.63
60.36	-3.42	-14.24
46.53	-64.3	-10.22
-46.37	-75.47	-9.78
-20.44	-46.89	-4.08
-19.61	-70.21	56.48
51.48	-35.48	45.11
10.46	-58.38	43.59
-5.46	-31.51	-12.58
-22.51	-50.64	1.93
48.78	-69.09	-4.18
-44.17	-78.44	-7.28
-35.61	43.51	10.77
-11.4	-78.92	20.23
-48.48	-69.64	-4.71
-46.2	-75.29	3.65
7.68	31.11	13.5
-9.7	39.14	8.52
5.48	33.02	11.1
-5.33	35.11	11.08

// Geuze E, 2008: PTSD > control, encoding
// Geuze E, 2008: Control > PTSD, encoding
// Geuze E, 2008: Control > PTSD, retrieval
// Subjects=12
49.43	11.94	34.51
13.01	-46.34	-.33
-45.66	-69.79	4.54
46.31	-67.41	13.32
-47.96	-22.05	2.79
-54.46	-1.11	-1.12
60.94	3.9	-1.75
-39.72	49.48	-8.88
54.45	37.15	2.23
-33.76	6.47	53.77
-8.16	29.17	56.03
-37.97	-67.6	32.15
-9.07	-64.71	39.38
66.38	14.9	16.22
64.2	1.17	4.02
-52.14	-11.27	18.67
-10.45	-48.17	5.67
-59.66	-35.86	4.09
48.38	-54.96	8.91
-65.12	-21.69	-4.85
11.02	-94.28	-.75

// Simmons A N, 2008: Negative - positive anticipation, PTSD> control, whole 
// brain
// Subjects=15
39.77	21.32	32.72
46.46	-41.66	43.5
-40.09	-37.78	46.4
7.59	9.98	12.85
35.21	28.15	-2.37
13.17	17.87	45.58
-12.39	2.2	51.65
-32.1	24.58	-1.3
-42.63	17.34	16.16
-14.54	19.62	56.91
55.59	15.93	2.88
11.98	36.47	38.46

// B?lte S, 2008: Healthy Controls
// Subjects=7
23	-72	-7

// Kadosh R C, 2008: Size Congruity Effect
// Kadosh R C, 2008: Comparison X Congruity Interaction
// Kadosh R C, 2008: ComparisonXCongruity - Beta weights of Congruity Effect
// Subjects=16
38.94	-41.08	37.96
37.64	18.04	31.9
35.81	-51.33	43.32
49.65	-30.81	45.9
41.04	-33.75	36.21

// Kleinhans N M, 2008: Autism (ASD) Group
// Subjects=14
-42.59	18.91	22.72
53.44	16.89	1.71
52.33	28.51	0.75
58.79	9.26	-1.06
54.5	13.46	-1.36
50.23	27.78	5.29
-30.96	22.01	6.71
-52.15	13.91	27.71
-2.77	6.65	53.4
-43.53	28.99	43.07
56.55	21.33	-9.85
-57.57	5.44	15.1
-9.13	-10.39	53.78
-43.53	28.99	43.07

// Kleinhans N M, 2008: Typically-Developing (Control) Group
// Subjects=14
-43.58	13.07	29.91
53.44	16.89	1.71
52.33	28.51	0.75
58.79	9.26	-1.06
54.5	13.46	-1.36
50.23	27.78	5.29
-45.79	21.09	23.68
-38.52	28.85	-.47
-4.9	8.93	55.46
-43.53	28.99	43.07
56.55	21.33	-9.85
-57.57	5.44	15.1
-9.13	-10.39	53.78
-43.53	28.99	43.07
-9.38	-92.09	-11.85
-.64	-97.73	10.83
-8.68	57.84	0.1
39.71	-39.75	-0.07
48.32	-47.91	3.86

// Ramirez-Ruiz B, 2008: Parkinson's Disease Patients Without Halluncinations
// Subjects=10
49	7	33
44	-73	9
-49	-66	7
54	28	15
50	25	2
20	18	51
12	-4	46
40	21	36
-16	22	19
-10	23	41
-10	-6	47
-24	9	42
-22	6	53
16	12	44

// Ramirez-Ruiz B, 2008: Parkinson's Disease Patients With Visual 
// Hallucinations
// Subjects=10
51	-60	7
-36	-69	-13
54	28	15
50	25	2
20	18	51
12	-4	46
40	21	36
-16	22	19
-10	23	41
-10	-6	47
-24	9	42
-22	6	53

// Ramirez-Ruiz B, 2008: Healthy Controls
// Subjects=10
-10	45	0
48	-61	25
-49	-57	16
44	-67	-12
16	12	44

// Hooker C I, 2008: Emotion Inference (EI): False Belief (FB) > EI: True 
// Belief (TB)
// Hooker C I, 2008: EI: FB > Emotion Recognition (ER): FB
// Hooker C I, 2008: (EI: FB - ER: FB) > (EI: TB - ER: TB)
// Hooker C I, 2008: ER: TB > ER: FB
// Hooker C I, 2008: ER: FB > ER: TB
// Hooker C I, 2008: EI: FB > EI: TB (correlated with overall empathy)
// Hooker C I, 2008: EI: FB vs. ER: FB (correlated with overall empathy)
// Hooker C I, 2008: ER: TB > ER: FB (correlated with overall empathy)
// Hooker C I, 2008: Personal Distress (PD): EI: FB vs. EI: TB
// Hooker C I, 2008: PD: ER: TB vs. ER: FB
// Hooker C I, 2008: PD: EI: FB vs. ER: FB
// Subjects=22
-44	18	22
-38	32	22
-4	40	16
-10	8	56
-50	-68	14
-60	-46	-2
-48	24	-20
-22	-68	-4
-12	-10	0
-22	-28	-2
-20	6	-10
62	-42	-4
14	-2	10
10	-30	2
22	-64	6
46	24	22
46	-16	42
-42	4	36
-42	24	-10
54	54	8
-42	-2	58
-18	50	38
-10	18	54
2	56	18
-54	-58	16
-58	-14	-16
-12	-54	30
-18	-72	-4
18	-52	8
-8	-18	12
-10	12	-12
38	18	24
32	22	-6
6	-12	12
-40	26	12
-46	14	8
-6	16	46
-4	42	18
-52	-46	-8
-50	24	-22
-24	-62	-6
26	-58	-16
-10	-14	0
-28	14	-4
-12	2	14
42	26	18
14	14	-2
48	-16	48
-42	26	14
0	50	20
4	20	44
-14	58	38
-52	-40	48
20	-52	6
-8	-18	4
-28	6	4
14	12	4
-48	-16	54
-26	52	-4
-44	-80	22
10	-46	36
22	12	54
28	58	2
50	-54	22
-16	-12	4
56	-26	22
64	0	4
4	-32	46
8	22	38
48	-36	46
22	-28	-2
-46	4	4
6	6	40
20	-22	6
54	-32	18
56	-30	30
26	-2	72
-28	-10	14
-46	18	4
-38	-62	-14
-16	-56	62
38	-28	40
48	-24	22
20	-10	56
52	-36	60
32	-58	-20
28	-8	-14
18	-24	4
54	-18	12
-10	-8	0
-8	-74	14
42	-50	8
24	24	38

// Malhi G S, 2008: Healthy controls
// Subjects=20
56.6	51.51	8.81
-56.67	49.78	10.25
52.38	27.88	6.37
-54.33	-19.46	9.34
39.53	23.23	2.45
-34.17	18.73	5.91
65.7	-50.35	39.55
-60.36	-48.48	47.53
52.91	-64.34	38.64
-47.54	-64.95	39.84
63.03	-9.72	-12.9
-56.65	-10.44	-11.46
33.17	-29.02	-12.05
14.09	-16.59	12.77
-7.3	-13.63	11.66
18.23	4.07	4.3

// Wagner G, 2008: MDD Patients
// Subjects=16
-10	-51	22
-12	-59	30

// Wagner G, 2008: Healthy Controls
// Subjects=16
4	-54	19
-8	48	-6
-14	55	32

// Frewen P A, 2008: PTSD
// Subjects=25
4	48	6
2	50	6

// Frewen P A, 2008: Healthy control
// Subjects=15
8	54	2
2	50	6

// Bensafi M, 2008: CO2 > Baseline
// Bensafi M, 2008: H2S > Baseline
// Bensafi M, 2008: CO2 High > CO2 Low
// Bensafi M, 2008: H2S High > H2S Low
// Subjects=8
6	39	15
24	-69	-30
69	-21	6
66	-51	12
3	-63	-27
-51	-12	9
-60	-36	36
-66	-39	15
57	-24	27
57	-42	48
45	33	27
36	-9	21
18	-3	12
36	-27	-9
-9	15	21
-15	-48	9
-3	-21	51
6	-51	-27
0	-87	3
3	0	57
39	-72	48
-39	45	27
-30	9	-33
-12	-66	48
-33	6	57

// Blondin F, 2008: Low Discriminability vs High Discriminability
// Blondin F, 2008: High Discriminability vs Low Discriminability
// Subjects=24
-40	-8	24
-56	-24	48
-36	-30	40
-38	-32	66
-30	-34	52
-16	-54	54
-44	62	-4
-22	-62	52
-44	-66	-18
-22	-66	-26
-12	-70	62
-4	-82	-14
-12	-86	42
-22	-92	0
-22	-96	16
38	32	14
2	-12	40
34	-42	38
44	-50	52
32	-50	-32
34	-64	-18
18	-72	-18
38	-72	-26
18	-74	-6
30	-86	-4
32	-86	-18
6	-86	42
12	-98	6
0	-46	-26
0	-68	-26
0	-68	-6
2	-26	52
-6	60	24
-18	60	16
-38	6	-36
-22	-6	-38
-20	-12	-22
-36	-12	-36
-12	-60	16
8	46	2
4	42	-10
60	24	8
36	8	-40
20	-64	-32

// Gundel H, 2008: Somatoform Disorder Pain Patients
// Subjects=12
30	9	-15
-39	-45	18
33	-27	66
-27	-48	57
21	0	-15
-36	-45	-6
6	54	-15
12	-3	6
-12	-3	6
39	6	9
-42	3	-3
9	3	39
39	-12	6
-36	-18	12
51	-36	18
-42	-39	21
36	-30	66
15	-33	30
51	-45	45
-48	-45	42
-9	18	30
6	-9	39

// Gundel H, 2008: Healthy Volunteers
// Subjects=13
30	9	-15
-39	-45	18
33	-27	66
-27	-48	57
21	0	-15
-36	-45	-6
6	54	-15
21	-21	15
-12	-9	6
27	15	-3
-27	18	9
9	-18	33
-6	-21	30
39	-18	15
57	-36	24
3	24	51
39	39	0
-45	45	-9
45	-48	51
-57	-48	30

// Bolger D J, 2008: Spelling and Rhyming Tasks, Orthographic and Phonological 
// Consistency, Inconsistent Words
// Bolger D J, 2008: Spelling and Rhyming Tasks, Orthographic and Phonological 
// Consistency, Consistent Words
// Bolger D J, 2008: Spelling, Orthographic Consistency, Inconsistent Words
// Bolger D J, 2008: Spelling, Phonological Consistency, Inconsistent Words
// Bolger D J, 2008: Rhyming, Orthographic Consistency, Inconsistent Words
// Bolger D J, 2008: Rhyming, Phonological Consistency, Inconsistent Words
// Bolger D J, 2008: Spelling, Orthographic Consistency, Consistent Words
// Bolger D J, 2008: Rhyming, Orthographic Consistency, Consistent Words
// Bolger D J, 2008: Rhyming, Phonological Consistency, Consistent Words
// Bolger D J, 2008: Rhyming, Inconsistent Words >Spelling, Orthographic And 
// Phonological Consistency
// Bolger D J, 2008: Rhyming, Inconsistent Words > Spelling, Orthographic 
// Consistency
// Bolger D J, 2008: Rhyming, Inconsistent Words > Spelling, Phonological 
// Consistency
// Bolger D J, 2008: Rhyming, Consistent Words > Spelling, Orthographic and 
// Phonological Consistency
// Bolger D J, 2008: Rhyming, Consistent Words > Spelling, Orthographic 
// Consistency
// Bolger D J, 2008: Rhyming, Consistent Words > Spelling, Phonological 
// Consistency
// Bolger D J, 2008: Correlation of Rhyming Accuracy With Orthographic 
// Consistency, Inconsistent Words
// Bolger D J, 2008: Correlation of Rhyming Accuracy With Phonological 
// Consistency, Inconsistent Words
// Bolger D J, 2008: Correlation of Rhyming Accuracy With Phonological 
// Consistency, Consistent Words
// Subjects=46
-6	19	38
6	22	35
-33	23	-1
-50	12	16
46	27	24
45	7	28
-27	-56	42
-36	-45	41
-50	-33	46
-48	-56	-7
-9	-75	12
18	-66	12
18	-55	0
30	-56	44
27	-65	36
-50	-40	8
15	-32	-6
45	-36	46
-9	-22	20
6	-60	27
3	-57	45
-15	-57	27
-48	-63	21
9	-54	69
45	-54	24
60	-54	21
51	-54	12
-3	22	38
-3	30	18
-33	20	-1
-45	41	3
-42	36	15
36	20	-1
45	36	18
30	2	47
11	-8	15
-21	-56	44
24	-59	39
33	-44	44
50	-38	49
6	-22	26
-33	23	-1
-27	23	-11
-12	-38	-1
-48	-53	-5
-27	-59	44
-30	-60	33
-27	-65	39
21	-66	25
27	-60	31
21	-59	44
-6	19	38
6	17	43
9	28	35
-36	23	-1
-50	10	19
-45	4	30
33	26	1
50	27	24
42	2	39
53	-7	42
-24	-52	3
-33	-21	40
-33	-45	41
-39	-36	38
42	-53	44
-3	-22	23
-6	20	43
6	20	40
-3	11	49
-36	26	1
-50	9	11
-45	35	-2
39	20	-1
39	21	13
42	24	21
45	42	23
53	7	30
53	5	38
0	46	-15
6	-57	25
9	-49	63
6	-50	49
-45	-63	20
45	-1	-28
53	-57	17
9	-54	33
3	-51	38
-3	-56	42
-6	22	38
6	37	40
6	25	43
-53	15	19
-56	10	24
-45	26	-1
53	10	27
50	21	18
42	8	38
6	-4	31
56	-10	39
-53	18	13
-56	7	25
-45	21	21
-6	22	38
9	17	43
6	11	49
-56	10	24
-56	18	13
39	14	38
53	10	27
53	5	36
6	-1	33
-45	-24	48
18	-4	3
15	-64	53
9	-63	25
3	-36	40
3	-40	13
48	-69	20
50	11	-21
42	13	-28
15	-64	53
9	-63	28
15	-67	56
0	-50	41
-33	-54	-9
-33	-54	-3
0	-54	42

// Mouras H, 2008: Positive Correlations with Penile Tumescence (Time Lag = 
// 0s) (Activations)
// Mouras H, 2008: Negative Correlations with Penile Tumescence (Time Lag = 
// 0s) (Deactivations)
// Mouras H, 2008: Positive Correlations with Penile Tumescene (Time Lag = 
// -20s) (Activations)
// Mouras H, 2008: Negative Correlations with Penile Tumescence (Time Lag = 
// -20s) (Deactivations)
// Mouras H, 2008: Sexual (Block) > Neutral (Block)
// Mouras H, 2008: Sexual (Onset) > Neutral (Onset)
// Subjects=8
18	9	60
-12	24	45
39	33	36
6	-6	60
0	30	36
27	6	63
36	30	48
-30	36	36
39	33	36
42	48	12
-30	24	-15
36	24	-15
54	9	0
48	3	0
63	6	18
-3	-9	33
3	12	33
0	33	21
12	45	6
-15	-30	36
-33	-18	15
18	-54	18
-15	-30	36
9	-30	39
-51	-27	21
-54	-18	21
66	-12	21
-60	-27	21
57	-39	51
-54	-45	33
-42	3	6
-33	18	0
42	-12	3
63	-18	12
-54	-3	0
60	-6	0
48	15	-9
60	-33	12
6	-78	21
-9	-66	39
15	-51	51
15	-63	30
15	-9	12
18	21	-6
27	3	-9
-36	-12	-6
33	3	9
6	-51	-21
3	-48	18
-45	-12	21
-24	-63	21
-18	-9	60
18	-9	66
9	-9	63
-9	39	45
-30	0	51
33	0	48
39	9	30
42	48	12
48	39	3
-51	12	15
39	9	30
-48	3	3
57	9	39
3	9	30
51	-27	57
-60	-21	27
60	-24	24
60	-12	21
60	-12	21
-21	-60	45
33	-45	66
36	39	69
-51	-33	48
57	-27	48
-39	12	-9
42	6	-6
-42	-6	-6
42	0	9
57	-9	0
-51	-57	-3
51	-63	-6
51	-63	-6
-36	-39	-3
-18	-36	3
-36	-60	-12
21	-72	39
42	-78	-6
15	-81	-3
12	-6	12
-21	-6	24
21	-27	18
-33	0	12
0	15	-6
18	60	24
9	33	57
-9	12	51
51	18	9
-48	27	-3
48	-66	45
-9	36	33
6	-48	12
-42	-72	36
-57	-57	27
60	-57	36
60	-33	0
-57	-39	0
-48	-69	-3
-39	-45	-15
45	-57	-18
45	-72	-9
-24	-3	69
-30	-9	-60
30	-6	57
45	9	24
0	3	33
-33	-51	51
-39	-45	57
-30	15	6
48	-63	-6
48	-60	9
-24	-57	51
-21	-75	33
30	-81	33
-9	-36	-6
-6	-6	9
-6	9	-3
3	-48	-3
33	-51	60

// Paul T, 2008: Healthy heterosexual males
// Subjects=12
18	42	-3
-18	3	30
-15	6	18
36	15	-3
24	51	12
-9	36	-15
36	-81	3
-51	-63	-6
60	-27	24
-69	-30	21
42	-48	-15
-42	-51	-21
21	-66	-51
-12	-72	-48
6	-27	-15
21	0	-18
9	6	0
45	3	0
-36	3	6
-12	9	-3
45	39	9
36	0	60
-54	18	12
-51	6	42
48	-75	-12
45	-75	-9
66	-30	33
-33	-48	57
42	3	-12
-39	9	-18
3	-27	-6
-6	-21	-9

// Paul T, 2008: Healthy homosexual males
// Subjects=12
6	48	-15
-24	33	-9
42	-81	0
-39	-75	3
60	-24	27
-24	-48	39
42	-51	-12
-48	-42	-18
24	-51	-48
-21	-60	-48
-9	15	6
9	57	3
15	57	27
24	27	-15
39	15	-12
-39	15	-12
45	84	6
-54	-72	-6
63	-24	21
-66	-30	24

// Strigo I A, 2008: Pain anticipation; MDD > CON
// Strigo I A, 2008: Pain anticipation; CON > MDD
// Strigo I A, 2008: Pain stimulation; MDD > CON
// Strigo I A, 2008: Pain stimulation; CON > MDD
// Subjects=15
48.08	25.48	3.28
-33.06	23.48	12.19
12.04	22.72	39.61
-17.8	2.54	42.76
49.43	17.4	36.28
-35.09	4.86	19.35
-26.62	38.12	22.04
-34.27	31.96	-1.89
-48.2	18.25	-12.85
-35.86	-26.12	45.37
-55.16	-12.66	42.24
-27.32	-16.3	47.8
48.37	-40.79	13.3
56.79	-39.82	-2.5
27.64	-2.5	-26.48
20.46	-57.56	-8.4
7.44	24.81	-1.77
2.67	-60.41	38.89
-2.76	-71.25	23.13
-29.42	-69.67	32.22
5.26	-14.01	-21.91
-2.82	-49.93	23.57
30.77	-2.11	-35.47
-41.76	-11.03	-20.51
-53.39	-53.74	-21.25
5.22	41.55	-5.38
12.79	45.79	7.56
36.69	17.04	46.5
-45.6	12.14	45.62
-49.24	38.3	-1.14
-17.83	31.86	50.34
-22.12	24	45.47
-56.47	-43.67	-.87
-34.65	-69.73	45.67
-48.66	-50.06	39.72
11.8	-35.75	-14.59
13.85	-40.99	-27.55

// Landgrebe M, 2008: Electrosensitive Patients
// Subjects=15
36	18	0
-33	15	6
-3	21	51
-24	48	9
-27	-66	-33
48	45	21
48	-51	48
57	-39	48
3	15	57
-42	-30	57
51	21	3
-33	27	-3
9	24	39
-3	15	57
42	24	-6
-42	21	-6
54	24	3
-3	21	51
33	30	-3
0	-78	39
36	-42	-18
60	-54	18
39	-51	-18

// Landgrebe M, 2008: Controls
// Subjects=15
36	18	0
-33	15	6
-3	21	51
-24	48	9
36	21	3
-33	15	6
-57	3	42
66	-21	24
48	30	33
48	3	36
6	21	48
42	-48	45
30	6	57
-48	-36	48
54	24	3
-3	21	51
33	30	-3
-18	-66	-24
-54	-57	-3
57	-63	-3
57	-54	6

// Bertolino A, 2008: 2-back, Main effect of diagnosis (controls > patients)
// Subjects=46
-49	21	44
19	13	51
-34	58	1
0	-33	-2
-11	-7	0
8	-67	48
-11	-74	45

// Campbell-Meiklejohn D K, 2008: Chase > Quit
// Campbell-Meiklejohn D K, 2008: Quit > Chase
// Campbell-Meiklejohn D K, 2008: Quit > Ctrl
// Campbell-Meiklejohn D K, 2008: Ctrl > Quit
// Campbell-Meiklejohn D K, 2008: Ctrl > Chase
// Subjects=23
-6	50	-16
-6	38	-18
-2	6	-12
-54	-70	26
-4	22	38
36	18	0
38	30	36
40	8	52
-32	20	2
0	-30	26
-18	18	-4
18	18	-6
44	-52	52
-42	-44	48
8	-74	6
4	-74	44
-2	26	36
-42	-48	52
42	-52	52
-8	-18	6
-30	20	4
0	-30	26
-6	-88	-8
-6	50	-16
4	20	-10
4	-84	-14
36	18	2
52	40	4
12	18	42
10	50	14

// Chen E, 2008: Predicate Metaphors > Literal Motion Sentences
// Chen E, 2008: Literal Motion Sentences < Non-Motive Sentences
// Chen E, 2008: Predicate Metaphors > Non-Motive Sentences
// Chen E, 2008: Positive Correlation between Figurativeness Ratings and 
// Activations Across All Sentences
// Subjects=14
-56.2	21.13	2.12
-53.37	6.01	-33.41
-56.39	-9.87	-19.46
-65.69	-38.47	8.18
-43.64	-55.9	38.67
57.95	-2	-33.39
-56.42	-1.37	-20.3
-24.7	-55.21	-.94
-8.2	-86.88	15.36
58.04	8.51	-24.35
27.12	-48.75	-3.59
11.19	-77.34	12.96
-59.11	-49.73	13.67
-59.53	32.5	-2.31
-53.37	6.01	-33.41
-56.39	-9.87	-19.46
-55.95	-40.46	9.33
-43.61	-54.52	41.89
54.8	1.91	-25.88

// Chen J L, 2008: Experiment 1 Non-musicians
// Subjects=12
-43.61	-32.25	8.06
58.94	-21.06	5.94
48.3	-29.42	9
-6.93	2.37	67.19
-49.77	-3.32	52.54
57.02	3.16	44.08
-52.16	5.02	22.88
54.72	10.23	25.67
50.45	8.09	25.9
-33.06	-68.77	-24.69
13.99	-76.94	-24.54
33.16	-68.71	-29.91
-26.86	-73.07	-53.39
28.71	-77.14	-55.92
-13.75	-1.95	11.87
16.06	5.83	-.28
14.07	2.96	17.83
-30.39	-54.47	49.92
-54.22	-29.34	19.09
-32.94	-27.96	7.58
73.99	-28.75	15.34
44.06	-35.61	11.8
-41.14	-11.21	59.8
-2.67	-2.18	63.06
57.07	1.55	50.91
-60.69	5.14	25.19
63.21	9.77	18.92
50.29	4.26	3.92
-28.79	-68.74	-24.74
13.99	-63.74	-18.96
24.63	-64.19	-25.73
-29	-70.97	-53.54
-31.16	-66.75	-53.87
24.44	-74.88	-53.83
-22.35	-2.52	5.32
22.53	2.15	6.64
-51.86	-33.62	46.19
-41.43	-34.01	12.64
71.81	-24.87	10.58
44.06	-35.61	11.8
-6.93	2.37	67.19
-49.77	-3.32	52.54
57.02	3.16	44.08
-52.16	5.02	22.88
52.55	7.76	21.44
-33.06	-68.77	-24.69
13.99	-76.94	-24.54
33.16	-68.71	-29.91
-26.86	-73.07	-53.39
28.71	-77.14	-55.92

// Chen J L, 2008: Experiment 2 Non-musicians
// Subjects=12
-39.28	-33.83	14.83
48.29	-27.3	8.82
63.25	-22.81	10.5
1.67	0.73	72.8
-51.91	-3.33	52.57
59.2	-.72	48.84
-35.16	-70.55	-20.05
-41.57	-66.19	-18.11
37.49	-65.89	-21.28
-41.42	-36.13	12.82
-62.91	-19.85	5.01
-56.48	-19.64	7.15
52.56	-27.28	8.77
-.55	6.47	64.54
-49.77	1.09	54.4
59.19	3.51	48.49
-56.65	11.57	-2.16
-47.9	13.68	24.33
-41.38	1.71	34.18
-30.93	-66.64	-24.89
-48.02	-68.86	-24.51
37.47	-70.46	-25.35
11.89	-78.73	-19.91
-29.04	-69.2	-58.15
-24.71	-75.17	-53.24
26.6	-79.09	-53.5
-43.55	-33.85	14.88
-58.45	-42.06	20.2
69.7	-28.94	13.17
-.52	0.12	65.07
-43.29	-9.11	59.64
57.08	3.84	52.94
-52.35	9.65	0.19
58.73	11.92	-7.97
-30.96	-62.58	-27.46
33.15	-62.2	-28.23
7.63	-67.67	-14.09
-22.57	-75.16	-53.27
22.32	-74.72	-51.59
-11.62	-17.43	4.22
-15.87	-10.6	10.39
18.29	-1.93	9.27
-41.42	-36.13	12.82
-62.88	-21.79	7.4
-56.48	-19.64	7.15
69.7	-28.94	13.17
1.58	-.21	60.61
-51.9	-1.04	54.61
59.19	3.51	48.49
-35.16	-70.55	-20.05
-30.88	-66.12	-18.24
37.49	-65.89	-21.28

// de Rover M, 2008: Healthy Controls, Experiment 1
// Subjects=6
8.23	-85.16	32.83
-2.78	-93.24	15.89
-4.87	-88.37	22.17
-7	-81.58	26.02
12.14	-75.08	2.64
12.2	-76.79	7.29
16.37	-73.56	-4.31
5.77	-74.27	11.63
-7.14	-73.9	16.29
29.35	-64.59	-.94
27.21	-68.85	-.48
22.93	-64.2	3.62
-9.71	-13.47	-3.09
-9.71	-20.06	-4.68
-7.56	-9.21	-3.55
-5.33	-13.04	1.28
9.77	-6.6	0.38
11.99	-6.18	4.79
7.67	-8.32	5.07
-14.06	-4.98	-3.85
14.07	-.21	-.32
-18.39	-2.87	-3.99
-18.32	-6.7	0.87
31.43	-21.42	1.48
37.91	-19.27	1.16

// de Rover M, 2008: Healthy Controls, Experiment 2
// Subjects=20
16.47	-11.51	16.44
18.52	-3.62	8.9
-15.98	-7.58	14.37
-11.75	-14.77	6.04
22.73	8.75	3.13
-20.48	8.59	3.88
-18.27	2.43	6.69
-22.62	-4.38	2.96
16.45	-13.84	14.43
-11.73	-12.44	8.05
20.54	8.53	0.94
-18.34	6.27	1.83
-13.91	0.52	9.05

// Evans K C, 2008: Angry Faces > Neutral Faces, Social Anxiety Disorder 
// Patients > Healthy Controls
// Evans K C, 2008: Angry Faces > Neutral Faces, Healthy Controls > Social 
// Anxiety Disorder Patients
// Evans K C, 2008: Angry Faces > Happy Faces, Social Anxiety Disorder 
// Patients > Healthy Controls
// Evans K C, 2008: Angry Faces > Happy Faces, Healthy Controls > Social 
// Anxiety Disorder Patients
// Subjects=11
-60	-55	28
-10	0	66
18	26	24
-24	-82	-2
-24	-68	6
-40	-64	0
34	-64	-6
34	-12	48
14	-76	-36
44	-12	14
-16	-26	44
58	-22	-14
44	42	30

// Gentili C, 2008: Emotional Faces > Scrambled Pictures, Social Phobia 
// Patients > Healthy Controls
// Gentili C, 2008: Emotional Faces > Scrambled Pictures, Healthy Controls > 
// Social Phobia Patients
// Subjects=7
0.42	-86.8	14.36
27.13	-40.6	31.37
37.67	-44.28	10.37
-42.53	-34.28	9.33
-26.8	-5.48	-18.91
-33.27	4.88	-21.94
39.08	-50.62	52.14
-35.74	-54.5	49.98
-38.37	-43.19	-10.04
-42.6	31.94	26.08

// Mohr C, 2008: Common Activity During Thermal Stimulation
// Mohr C, 2008: Capsaicin-Treated 43 C vs. Untreated 43 C
// Mohr C, 2008: Capsaicin-Treated 0 C > Untreated 0 C
// Subjects=15
26	-40	76
-46	-40	62
-66	-22	22
40	-12	66
-34	-4	66
-42	-2	60
-50	-2	52
-4	10	34
-58	14	32
-26	-52	72
38	-4	12
58	-14	8
22	16	-22
-50	-24	20
56	6	6
-18	10	-4
28	10	52
12	-26	-22

// Gandini D, 2008: Healthy Young Adults
// Subjects=13
-30.77	-69.65	28.6
-30.3	-60.7	66.93
-34.63	30.78	0.8
43.3	35.38	11.35
36.64	23.06	-5.25
53.69	-25.28	50.79
53.22	-79.09	3.45
-1.34	11.18	64.93
31.26	-59.52	64.64
13.89	25.86	-8.5
-18.32	8.6	3.84
-11.31	-72.78	28.58
33.27	58.25	-7.56
-1.09	-50.4	72.14
-58.87	-33.72	35.61
-24.53	-7.94	22.39
-62.52	-32.39	4.17
-50.21	-53.25	32.91
-53.22	31.18	-16.85
-8.07	-46.51	33.77
21.47	-6.41	70.76
-52.05	-46.51	59.17
14.78	-80.26	38.96
69.14	2.01	-2.6
-52.5	-25.81	28
26.96	4.74	-5.51
-44.08	-21.92	11.78
68.28	-21.52	9.83
11.13	-87.64	6.14
-59.28	-32.37	4.11

// Gandini D, 2008: Healthy Older Adults
// Subjects=12
-62.52	-32.39	4.17
-50.21	-53.25	32.91
-53.22	31.18	-16.85
-8.07	-46.51	33.77
21.47	-6.41	70.76
-52.05	-46.51	59.17
14.78	-80.26	38.96
69.14	2.01	-2.6
-52.5	-25.81	28
26.96	4.74	-5.51
-44.08	-21.92	11.78
68.28	-21.52	9.83
11.13	-87.64	6.14
-59.28	-32.37	4.11

// Kaufmann L, 2008: Healthy Control Adults
// Subjects=12
41.02	-53.76	68.39
37.47	-57.12	44.13
31.05	-53.43	49.48
-30.35	-47.94	65.67
-49.91	-17.06	64.07
53.89	-32.54	64.95
50.38	-25.81	45.29
50.63	-22.78	66.28
43.45	-66.36	2.36
-40.8	-86.21	1.28
53.56	-22.92	41.59
41.02	-53.76	68.39
24.78	-57.32	65.66
65.6	-30.45	52.22
55.91	-11.68	58.37
34.38	-10.07	65.3
14.61	-53.02	31.79
-1.49	-42.47	42.22
-11.2	-70.88	37.36
14.72	-77.38	35.32
21.53	-28.95	70.75
62.42	-26.75	57.51
68.32	-1.55	16.81
71.93	-29.45	39.68

// Kaufmann L, 2008: Healthy Control Children
// Subjects=12
53.75	-20.4	57.03
43.96	-31.9	49.37
43.45	-66.36	2.36
-40.8	-86.21	1.28
53.56	-22.92	41.59
65.6	-30.45	52.22
55.91	-11.68	58.37
34.38	-10.07	65.3
14.61	-53.02	31.79
-1.49	-42.47	42.22
-11.2	-70.88	37.36
14.72	-77.38	35.32
21.53	-28.95	70.75
62.42	-26.75	57.51
68.32	-1.55	16.81
71.93	-29.45	39.68

// Kaufmann L, 2008: MCI > Elderly Controls Congruity effects (collapsed over 
// numerical and physical)
// Kaufmann L, 2008: MCI > Elderly Controls Distance effects (collapsed over 
// numerical and physical)
// Subjects=6
30.22	-43.19	-13.15
39.82	-55.04	-25.59
49.59	-56.82	-22.22
-40.82	-66.66	3.83
49.78	-35.7	-3.02
49.38	46.64	-17.89
47.43	-38.95	65.69
56	-32.85	61.58
-21.28	-19.94	20.16
-50.55	20.78	21.11
53.3	25.48	31.2
1.77	-2.92	51.7
-8.63	-26.64	-6.28
7.62	-36.06	-4.51
49.57	45.86	-3.24
68.48	-22.19	25.58
-50.17	-10.32	44.35
62.1	-43.39	28.9
30.89	-52.44	37.06
11.3	-5.4	36.1
-62.07	-40.01	37.41
-68.88	-30.41	14.16
-7.72	-64.64	57.97
-34.83	1.9	-20.99

// Kucian K, 2008: Children-Adults (Approximate Calculation)
// Kucian K, 2008: Children-Adults (Exact Calculation)
// Kucian K, 2008: Children-Adults (Magnitude Comparison)
// Kucian K, 2008: Adults-Children (Exact Calculation)
// Kucian K, 2008: Adults-Children (Magnitude Comparison)
// Kucian K, 2008: Children-Adults (Approximate Calculation) (ANCOVA with 
// Number of Trials as Covariate)
// Kucian K, 2008: Adults-Children (Approximate Calculation) (ANCOVA with 
// Number of Trials as Covariate)
// Kucian K, 2008: Adults-Children (Exact Calculation) (ANCOVA with Number of 
// Trials as Covariate)
// Kucian K, 2008: Adults-Children (Magnitude Comparison) (ANCOVA with Number 
// of Trials as Covariate)
// Subjects=10
11.46	-64.42	36.33
-8.01	-77.77	32.38
-50.68	-39.24	-.96
58.24	4.54	-9.39
28.05	-27.55	73.86
40.12	-5.77	7.63
-8	-71.18	33.97
1.99	-23.15	64.91
-63.57	-2.63	12.45
-59.48	-2.15	-5.6
-20.6	-37.81	70.1
-14.43	-39.01	45.46
-4.66	-58.33	44.97
65.16	-3.17	22.63
20.59	-84.16	-14.54
14.28	44.08	25.55
14.36	28.23	28.23
-43.62	-39.32	43.75
-46.89	-36.25	42.38
-27.43	-74.34	35.73
-50.47	11.52	25.39
-27.59	-89.83	19.34
20.96	-96.66	12.46
34.26	-53.63	47.2
43.61	-77.23	12.4
46.41	-59.71	-18.52
59.02	-25.78	45.14
40.09	-80.38	-9.64

// Kadosh R C, 2008: Main effect: Inteference
// Kadosh R C, 2008: Main Effect: Interference and Facilitation, Numerical 
// comparison > Physical comparison
// Kadosh R C, 2008: Size congruity effect
// Kadosh R C, 2008: Interference under physical task
// Subjects=14
42.23	-41.26	49.09
-37.96	-34.51	47.22
8.84	13.98	37.04
-3.95	9.94	40.87
31.53	-6.37	60.79
-28.74	46.03	28.09
-48.92	4.32	27.36
37.44	15.99	5.31
28.36	-64.15	43.36
-26.12	-53.39	49.78
37.5	-50.4	-13.65
-39.39	-59.15	-9.81
-26.2	-4.69	60.19
33.24	46.4	27.35
53.61	8.74	20.23
6.81	12.97	51.64
3.54	-18.54	29.79
-36.26	7.09	6.91

// Zarate J M, 2008: Healthy experienced singers
// Subjects=12
-40	-24	0
-40	-36	12
-42	-22	36
-58	4	4
-42	-20	42
58	2	2
40	-34	16
2	-6	58
42	-14	36
62	6	28
38	-2	0
6	-4	4
22	-2	-6
2	-54	-26
-42	-28	6
-60	-16	8
-42	-34	12
-2	0	46
0	-4	58
-44	-14	44
-40	-20	40
-2	-26	8
-26	-64	-24
62	-12	8
40	-34	16
2	-2	52
46	-12	36
54	4	30
38	-2	2
4	-6	4
-10	-62	-20
2	-56	-24
-52	-18	4
-62	-30	10
-50	-32	6
-42	4	24
-54	-36	50
-46	-40	42
-38	-54	50
50	-4	-6
64	-34	8
50	-44	0
38	-4	56
48	8	22
40	20	0
-44	-44	58
-38	-38	22
62	-30	46
-48	-50	54
-62	-44	26
40	-4	54
36	20	-2
52	-46	50
-56	-32	4
-4	24	30
-2	6	52
-44	-4	54
-40	4	26
-36	22	2
-46	16	32
-56	-42	50
-28	2	6
48	-34	0
10	8	60
52	2	46
40	10	28
30	16	6
28	-6	52
46	6	24
42	-50	60
58	-30	42
10	-22	18
26	8	4
20	-4	8
-46	-3	54
-54	-44	54
-60	-40	50
8	6	48
46	-50	62
-56	-28	6
-24	-14	10
54	-20	4
48	-42	0
-42	-10	46
-54	-32	24
-10	20	38
-22	-2	8
50	-38	0
16	-26	66
-34	-14	70
-12	-52	32
-20	-86	40

// Zarate J M, 2008: Healthy non-musicians
// Subjects=12
-54	-18	8
-54	8	0
-38	-34	16
-2	4	42
0	-4	58
-44	-14	44
-38	-20	40
-24	-60	-22
60	-22	10
60	8	-2
54	-30	18
4	-2	52
48	-10	42
48	4	26
38	-16	-6
20	-32	58
0	-22	14
10	-74	-16
0	-48	-4
-42	-28	6
-60	-16	8
-42	-34	12
-2	0	46
0	-4	58
-44	-14	44
-40	-20	40
-2	-26	8
-26	-64	-24
62	-12	8
40	-34	16
2	-2	52
46	-12	36
54	4	30
38	-2	2
4	-6	4
-10	-62	-20
2	-56	-24
-44	26	28
-54	12	28
-48	-50	56
-52	-34	30
8	18	40
42	-4	52
36	20	-2
-48	-50	54
-62	-44	26
40	-4	54
36	20	-2
52	-46	50
-62	-44	20
-34	-14	70
-34	-2	64
-50	-48	58
-54	-40	26
8	6	46
-46	-3	54
-54	-44	54
-60	-40	50
8	6	48
46	-50	62
-56	-28	6
-24	-14	10
54	-20	4
48	-42	0
-42	-10	46
-54	-32	24
-10	20	38
-22	-2	8
50	-38	0
16	-26	66
-34	-14	70
-12	-52	32
-20	-86	40

// Nagano-Saito A, 2008: Balanced Drink (BAL): Receive negative feedback (RNF) 
// > Receive control feedback (RCF), p<.05
// Nagano-Saito A, 2008: Amino Acid deficient drink (APTD): RNF > RCF, p<.05
// Nagano-Saito A, 2008: BAL: RNF < RCF, p<.05
// Nagano-Saito A, 2008: APTD: RNF < RCF, p<.05
// Nagano-Saito A, 2008: BAL: Matching after negative feedback (MNF) > 
// Matching after control feedback (MCF), p<.05
// Nagano-Saito A, 2008: APTD: MNF > MCF, p<.05
// Nagano-Saito A, 2008: BAL: MNF < MCF, p<.05
// Nagano-Saito A, 2008: APTD: MNF < MCF, p<.05
// Nagano-Saito A, 2008: BAL: Positive feedback (RPF) > RCF, p<.05
// Nagano-Saito A, 2008: APTD: RPF > RCF, p<.05
// Nagano-Saito A, 2008: BAL: Matching after positive feedback (MPF) > 
// Matching after control feedback (MCF), p<.05
// Nagano-Saito A, 2008: APTD: MPF > MCF, p<.05
// Nagano-Saito A, 2008: BAL: MPF < MCF, p<.05
// Nagano-Saito A, 2008: Balanced Drink (BAL): Receive negative feedback (RNF) 
// > Receive control feedback (RCF), p<.001
// Nagano-Saito A, 2008: Amino Acid deficient drink (APTD): RNF > RCF, p<.001
// Nagano-Saito A, 2008: BAL: RNF < RCF, p<.001
// Nagano-Saito A, 2008: APTD: RNF < RCF, p<.001
// Nagano-Saito A, 2008: BAL: Matching after negative feedback (MNF) > 
// Matching after control feeback (MCF), p<.001
// Nagano-Saito A, 2008: APTD: MNF > MCF, p<.001
// Nagano-Saito A, 2008: BAL: MNF < MCF, p<.001
// Nagano-Saito A, 2008: BAL: RPF > RCF, p<.001
// Subjects=19
3.52	28.56	47.03
-39.48	34.36	15.81
-47.93	26.54	25.48
37.82	7.78	50.61
-47.85	14.19	30.98
44.04	12.45	27.84
-31.07	28.64	-3.88
37.32	26.76	-6.74
-17.85	-68.22	8.55
14.24	-72.09	10.74
-28.64	-71.6	-6.66
22.68	-79.75	-6.56
-34.85	-89.3	12.74
37.83	-90.98	12.05
-24.01	-74.49	38.14
31.58	-71.7	41.73
-30.35	-56.24	54.53
31.66	-59.93	56.35
-13.91	7.42	-4.53
3.52	28.56	47.03
-41.63	36.46	15.66
-54.35	28.61	25.38
43.86	36.97	14.63
37.84	14.64	56.72
-45.72	14.2	30.95
46.16	12.29	25.6
-31.08	28.47	-6.1
37.32	26.76	-6.74
-11.39	-69.96	13.08
14.24	-69.97	10.56
-32.94	-69.68	-9
26.95	-82.01	-8.65
-32.67	-91.06	17.33
42.05	-87.07	7.21
-28.26	-72.06	42.45
-28.2	-64.86	52.99
46.51	-41.15	50.15
16.01	7.6	-4.89
-7.38	-8.94	3.46
11.84	-11.11	1.19
5.06	57.44	-20.09
-.61	-49.15	33.52
-58.71	-5.19	1.5
-48.4	4.13	-44.01
49.9	8.95	-45.54
-24.69	-15.67	-27
30.82	-4.94	-30.77
39.63	6.66	8.3
2.91	59.54	-20.25
24.47	-17.49	-27.42
3.52	30.67	46.85
-45.88	38.89	19.96
-43.67	37.48	28.98
-30.52	14.58	61.97
46.06	42.07	25.33
-31.1	28.3	-8.31
39.44	26.61	-8.98
-39.68	56.42	-1.65
35.15	61.62	3.74
39.27	57.81	-18.29
-28.26	-72.06	42.45
3.88	-66.61	55
-30.34	-64.87	53.02
3.88	-66.61	55
35.88	-60.42	49.66
-24.26	-100.12	-4.31
35.51	-88.48	-10.44
41.86	-82.44	-15.48
-9.59	-77.77	-33.12
-31.01	-69.61	-35.79
9.72	-83.49	-26.17
43.85	-75.16	-31.72
3.37	42.33	32.49
-48.01	38.88	19.99
-50.02	27.04	32.16
-30.51	16.86	64.01
48.15	41.57	18.66
37.84	14.64	56.72
-45.69	7.86	31.48
-31.09	26.18	-8.14
37.27	28.54	-11.35
-39.59	55.17	9.6
37.31	59.69	6.11
-7.11	-80.85	9.49
-4.64	-70.72	57.68
-30.32	-64.7	55.24
-4.64	-70.72	57.68
33.81	-64.15	56.68
43.98	-82.6	-17.72
-3.09	-83.39	-23.8
-52.23	-68.2	-15.59
9.72	-83.49	-26.17
43.99	-80.31	-15.68
0.77	59.53	-20.22
78.23	-22.55	12.54
-22.51	-15.15	-20.38
28.79	-16.95	-20.82
-5.58	53.49	-15.18
3.75	-21.86	55.71
9.98	-74.23	10.96
46.16	-84.35	-13.14
40.18	-57.93	53.86
16.43	-102.37	4.33
9.99	-74.06	13.18
-26.09	-67.3	48.71
-39.35	-78.52	-12.64
1.43	22.37	49.8
-41.59	36.81	20.09
-28.35	10.53	64.52
-31.03	24.58	-1.31
-9.25	-80.86	9.51
10.34	-70.46	59.71
-6.77	-70.73	57.7
-30.28	-66.47	59.85
-6.77	-70.73	57.7
35.96	-63.96	58.87
44	-78.02	-13.64
-71.38	-21.33	14.15
-26.27	16.54	59.53
50.32	37.53	21.2
16.02	9.89	-2.85
-7.37	-11.06	3.64
11.88	-10.77	5.62
-30.51	16.86	64.01
-13.9	16.22	-.81
-4.91	-3.22	49.79
14.4	-26.54	49.29
-6.99	-44.44	39.89
35.7	21.15	58.43
-45.7	9.97	31.31
-2.83	-78.53	11.47
-28.82	3.45	0.44
35.29	1.54	-2.37
-16	-3.16	-3.62
16.06	-.69	-1.96
50.44	10.21	25.72
-31.01	5.03	-6.36
-11.62	-8.63	7.94
16.1	-2.46	2.64
3.7	-13.57	52.79
-41.38	6.11	36.04
-26.14	-67.82	42.07

// Konishi S, 2008: 1st shift - 2nd shift during the WCST
// Subjects=176
42	-34	34
-48	-30	16
44	-66	36

// Specht K, 2008: Working memory-Rest
// Specht K, 2008: WCST-Rest
// Specht K, 2008: WCST-Working memory
// Subjects=14
33	24	6
-3	3	54
-48	-39	48
45	30	18
45	-45	51
-33	-9	63
-33	-63	-9
30	-3	63
-39	3	33
36	-69	-9
-30	24	3
-6	-75	-21
3	3	54
-48	-39	51
6	27	39
30	21	0
42	-57	45
51	9	33
36	-60	-27
-33	27	-3
-33	-57	-24
-30	-9	54
-36	48	12
9	-12	9
-9	3	9
-6	27	39
42	-60	45
-45	-57	48
30	12	57
-51	18	30
-30	54	-3
42	21	-9
-21	-75	-24
-33	24	-9
-60	-39	-3
9	-6	9
-36	-57	33

// Stice E, 2008: Food reward anticipation: Obese > Lean adolescents
// Stice E, 2008: Food reward consumption: Obese > Lean adolescents
// Stice E, 2008: Positive relationship between Food reward anticipation and 
// BMI: All Participants
// Stice E, 2008: Positive relationship between Food reward consumption and 
// BMI: All Participants
// Stice E, 2008: Negative relationship between Food consumption reward and 
// BMI: All Participants
// Subjects=7
54	-3	27
-54	-9	30
-29	-18	39
51	-12	33
-48	-6	3
51	3	18
-54	-3	18
-60	-42	30
60	-36	42
-36	6	6
-39	-15	18
-6	3	45
54	-6	27
54	-12	33
-48	-12	33
-48	-12	12
51	3	18
45	45	0
-39	30	36
-45	33	30
-54	-3	3
-57	-6	6
-54	-9	12
63	-12	12
-12	3	27

// Rilling J K, 2008: Experiment 1 Participants
// Subjects=30
38.45	13.2	-3.39
-33.22	15.25	-11.66
-15.79	-64.66	-.69
14.01	-10.84	4.49
-10.58	-12.13	3.76
55.73	27.24	25.35
40.53	24.67	-6.6
12.93	-12.08	2.37
-9.52	-12.21	2.64
-21.15	-63.81	-2.93
-33.22	18.6	-9.71

// Rilling J K, 2008: Experiment 2 Participants
// Subjects=20
54.42	13.75	-11.42
41.95	7.41	31.63
29.87	16.06	-6.87
19.71	-63.11	29.99
15.18	-71.25	-6.07
6.36	31.32	-0.08
-8.27	-72.99	1.03
-40.34	7.98	32.53
-30.92	-43.41	-13.45
36.61	-29.94	16.98
31.82	-11.08	-41.42
-8.44	47.21	27.76
-13.7	-31.1	6.5
-36.04	-32.32	20.25
-43.71	31.51	20.56

// Jensen J, 2008: Neutral comparators (CS-), Schizophrenia > Healthy controls
// Subjects=13
-6	-36	39
12	-30	3
36	45	-3
15	-21	-15

// Gu B M, 2008: OCD
// Subjects=21
39.97	57.71	9.19
-37.29	-7.6	38.26
27.54	18.99	43.49
-54.26	22.77	-14.88
21.35	-8.4	60.88
-4.87	-24.92	34.94
21.06	-32.48	33.01
24.49	2.45	-29.9
46.49	-25.18	-5.13
-21.84	-35.77	57.59
27.86	-33.36	57.63
42.64	-65.45	23.58
52.6	7.11	-27.48
1.86	-86.48	42.04
20.93	-81.56	13.21
-21.36	0.26	18.16
-31.08	-33.68	11.6

// Gu B M, 2008: Healthy Controls
// Subjects=21
42.17	59.09	12.38
-30.73	3.99	47.09
32.02	16.85	54.83
-58.46	19.23	-6.61
1.64	19.1	46.16
6.4	-12.63	73.87
20.75	17.74	19.08
-.56	-28.3	32.96
23.18	-39.37	28.05
-41.35	-45.07	51
47.08	-42.61	38.05
34.08	-53.91	32.66
-22.25	-94.58	14.12
16.66	-96.57	13.65
20.34	23.45	-11.73
-19.21	2.4	17.92
39.97	57.71	9.19
-37.29	-7.6	38.26
27.54	18.99	43.49
-54.26	22.77	-14.88
21.35	-8.4	60.88
-4.87	-24.92	34.94
21.06	-32.48	33.01
24.49	2.45	-29.9
46.49	-25.18	-5.13
-21.84	-35.77	57.59
27.86	-33.36	57.63
42.64	-65.45	23.58
52.6	7.11	-27.48
1.86	-86.48	42.04
20.93	-81.56	13.21
-21.36	0.26	18.16
-31.08	-33.68	11.6

// Pessoa L, 2008: Color-cue > Pop-out
// Pessoa L, 2008: Switch > Non-switch
// Pessoa L, 2008: Color-cue (Switch > Non-switch)
// Pessoa L, 2008: Pop-out (Switch > Non-switch)
// Pessoa L, 2008: Pop-out (Non-switch > Switch)
// Subjects=20
-21.01	-98.53	2.21
-42.47	-75.4	0.51
-48.83	-60.66	12.73
-53.15	-41.4	14.51
55.85	-36.34	15.07
-52.02	-33.05	26.07
-48.8	-30.74	28.07
47.43	-37.23	31.97
-38.09	1.44	44.2
38.76	6.51	33.97
-37.04	0.22	42.06
44.21	1.05	45.52
-52.23	10.93	16.8
50.22	30.96	5.03
-18.01	11.31	18.61
17.23	11.35	15.97
-16.86	-22.95	15.89
-37.16	-81.25	-6.86
35.56	-82.42	-.91
-29.77	-59.09	-9.92
-60.78	-46.33	-7.29
-26.17	-67.02	38.65
33.69	-57.69	43.88
-36.11	14.17	29.73
-20.89	5.92	59.24
-35.89	-73.65	22.59
36.63	-87.87	-2.7
-38.25	-83.72	-11.11
38.53	-57.42	-22
-25.08	-66.84	40.86
32.59	-66.84	35.73
-37.18	15.22	29.65
37.79	-4.53	42.72
-23.08	8.65	53.46
24.91	10.19	41.63
-28.31	-67.12	37.57
-43.51	3.9	35.14
-4.33	56.52	10.2
12.69	65.71	3.66
49.09	-2.57	-15.57

// Murray G K, 2008: Psychosis
// Subjects=13
-16	6	-12
12	10	-12
10	-8	-6
-4	-16	-6
8	-22	-8
-10	-22	2
-18	-2	6
-14	-24	4
52	-2	-8
-36	-12	2
2	22	32
-10	-34	42
36	-8	-18
-36	-10	-14
-48	-26	6
50	-16	0
-58	-6	-18
52	-58	4
26	14	-20
10	46	30
36	44	14
-26	40	28
64	-34	38
14	-84	48
6	-48	-20
-20	-64	10
30	-94	14
-44	-80	10

// Murray G K, 2008: Healthy controls
// Subjects=12
-16	6	-12
12	10	-12
10	-8	-6
-4	-16	-6
-8	-20	-8
14	-16	-6
16	18	-10
-20	10	-12
-16	6	-2
-36	10	-4
-10	-42	44
-12	-10	36
42	-76	24
24	-26	72
-20	-16	72
10	46	-8
-10	54	-4
28	38	28
-8	-54	-22
32	-98	-10
-28	-98	-12
8	-22	-8
-10	-22	2
-18	-2	6
-14	-24	4
52	-2	-8
-36	-12	2
2	22	32
-10	-34	42
36	-8	-18
-36	-10	-14
-48	-26	6
50	-16	0
-58	-6	-18
52	-58	4
26	14	-20
10	46	30
36	44	14
-26	40	28
64	-34	38
14	-84	48
6	-48	-20
-20	-64	10
30	-94	14
-44	-80	10

// Park I H, 2008: Schizophrenia patients
// Subjects=14
52	16	38
22	-6	-26
20	-36	6
-12	-34	4
-10	-54	18
36	8	-32
-10	-18	-8
-28	-34	-18
-24	-42	12
14	-46	-42

// Park I H, 2008: Healthy Controls
// Subjects=14
30	-74	32
2	-40	-2
-10	50	0
0	18	-4
-50	0	0
-34	-12	-18
32	-18	-18
10	-38	6
-10	-42	6
-18	14	-6
50	-4	6
-58	-10	36
46	-10	-6
-52	-12	50
20	-32	58
-62	-22	22
-44	-62	14

// Kdia G, 2008: Emotional > Neutral conditions, p<0.05
// Kdia G, 2008: Emotional > Neutral conditions, p<0.001
// Kdia G, 2008: Other agent > Self agent
// Kdia G, 2008: Interaction [(guilt + other-anger) - (self-anger + 
// compassion)]
// Kdia G, 2008: Guilt > Self-anger
// Kdia G, 2008: Other-anger > Self-anger
// Kdia G, 2008: Compassion > Self-anger, p<0.001
// Kdia G, 2008: Compassion > Self-anger, p<0.05
// Kdia G, 2008: Conjunction: (Guilt > Self-anger) + (Other-anger > 
// Self-anger) + (Compassion > Self-anger), p<0.001
// Kdia G, 2008: Conjunction: (Guilt > Self-anger) + (Other-anger > 
// Self-anger) + (Compassion > Self-anger), p<0.05
// Subjects=29
4	44	31
12	23	62
-59	-37	31
-48	4	0
-4	51	20
0	-56	36
-48	-61	29
10	43	13
6	1	7
-22	4	-11
-1	-62	32
-50	-69	10
52	-58	14
6	39	37
24	12	-21
20	1	-14
-15	-3	3
-8	1	7
-47	-69	21
12	23	62
0	-56	36
59	-53	21
-48	-57	21
-4	51	20
0	-56	36
51	-57	21
-48	-57	25
0	51	20
48	-57	21
0	-56	36
-48	-57	25
0	51	20
48	-57	21
0	-57	35
-48	-57	25

// Brunetti M, 2008: Erotic > Sport
// Subjects=18
31.58	-50.84	50.02
-24.06	-46.4	43.59
58.12	-25.02	37.51
-57.28	-27.82	39.07
51.5	8.98	23.58
-47.85	7.59	28.19
53.7	-18.92	20.32
-54.41	26.87	16.61
41.7	31.25	9.56
43.86	0.71	-.17
-42.69	1.33	1.89
1.22	-12.78	8.14
0.12	-10.84	5.76
27.08	-89.44	5.35
-27.41	-92.94	6.27
4.2	27.79	-4.22
-1.13	23.53	-3.8
-51	-59.96	8.24
11.71	-4.83	-13.83
-2.17	-4.82	-12.56
17.12	-20.57	-11.46
-17.09	-17.6	-11.32
48.16	-53.93	-19.06
-45.88	-49.04	-16.16
26.6	-1.11	-22.12
-22.56	-1.4	-21.53

// Buehler M, 2008: Erotic > Neutral, Blocked Design (Activations)
// Buehler M, 2008: Erotic > Neutral, Blocked Design (Deactivations)
// Buehler M, 2008: Erotic > Neutral, Event-Related Design (Activations)
// Buehler M, 2008: Blocked Design > Event-Related Design: Erotic >Neutral 
// (Activations)
// Buehler M, 2008: Blocked Design > Event-Related Design: Erotic > Neutral 
// (Deactivations)
// Subjects=10
33	-3	51
42	15	27
-24	-9	51
36	-48	54
-21	-54	54
54	-63	0
42	-75	-15
-51	-66	3
-3	-72	-27
63	0	6
48	15	33
-9	-15	57
36	18	-15
39	42	-3
-39	18	-12
-27	-18	42
-39	-18	-21
48	-57	-3
48	-72	-3
-54	-66	3
-39	-75	-9
-9	-24	6
6	12	42
-9	-24	6
36	3	51
27	-39	42
-21	-54	54
39	-63	9
-51	-66	3
6	-15	66
-3	-18	63
60	3	0
-42	-15	15

// Morita T, 2008: Self > Other
// Subjects=19
36	10	-4
48	36	4
-38	24	0
52	6	26
8	4	30
48	-70	-8
46	-52	-14
24	-72	42
-42	-74	-2

// Polk T A, 2008: Stroop > Neutral
// Subjects=14
-48.12	44.37	8.38
-52.09	14.51	35.46
-47.96	34.99	24.77
28.93	41.63	21.1
31.62	-58.16	51.75
-38.8	-64.07	64.2
-35.4	30.22	-10.66
41.55	28.56	-11.4
-30.42	-52.53	47.53
-9.12	12.76	64.11

// Berkowitz A L, 2008: Melodic Improvisation > Patterns, Activations
// Berkowitz A L, 2008: Melodic Improvisation > Patterns, Deactivations
// Berkowitz A L, 2008: Rhythmic Improvisation > Metronome
// Subjects=13
0.21	26.28	31.64
0.38	10.48	47.46
-48.98	10.24	21.29
-19.9	7.35	50.19
26.04	0.94	45.74
66.21	47.17	6.83
-19.07	-64.4	-10.72
39.44	49.67	0.24
16.96	68.91	3.34
-4.9	-36.14	36.94
13.3	-33.49	42.08
-60.49	-44.39	31.58
49.57	-44.87	29.24
-1.91	24.24	32.95
-8.22	3.31	38.13
-35.22	33.16	13.63
-16.74	6.86	43.5
-25.22	-10.03	46.13
-19.67	-58.38	53.47
-36.91	-38.02	43.04

// Limb C J, 2008: Improv > Ctrl, Activations
// Limb C J, 2008: Improv > Ctrl, Deactivations
// Subjects=6
-28.38	57.52	-12.03
-28.18	69.92	5.78
13.69	61.5	-17.63
8.39	66.67	-7.96
4.19	69.72	1.89
-54.15	36.67	-3.93
-54.94	11.53	14.26
-56.88	4.37	29.57
-30.42	-7.96	68.44
-1.33	7.99	65.24
-27.32	-8.99	57.28
-67.04	-28.43	-10.72
-54.33	-17.18	-28.85
-50.84	-71.1	-20.22
-55.48	-38.09	46.07
-43.53	-41.89	50.73
-17.39	-73.08	60.09
-37.55	-94.92	-.16
-27.55	-97.17	21.19
-20.86	-95.59	37.72
-3.72	15.04	48.9
56.49	10.84	23.63
34.35	1.73	65.25
5.24	4.28	71.1
30.95	-2.71	52.3
69.36	-32.47	7.53
62.58	-21.59	-13.6
49.47	-16.19	-24
53.63	-37.71	44.17
50.54	-37.74	55.44
24.81	-74.64	64.01
40.49	-76.3	22.44
39.54	-84.09	31.08
23.57	-68.58	-31.82
4.06	-85.54	-39.89
7.56	-71.54	-16.69
-11.62	56.2	30.39
-31.07	48.48	29.25
-43.88	27.68	37.12
-37.22	25.76	50.65
-47.96	44.4	-24.97
14.25	59.17	26.3
56.39	36.36	21.11
43.62	31.18	35.29
46	25.2	51.53
36.27	21.43	-34.22
36.32	41.5	-26.12
-10.95	-5.9	-13.9
-25.14	-.5	-24.28
-24.78	-37.23	-3.84
-38.04	-29.58	-24.54
-1.66	-50.3	27.31
-31.72	2.04	-31.14
-31.45	-12.35	-12.91
-11.83	18.51	6.11
-30.2	-1.22	2.77
-34.83	16.14	-17.92
-34.45	6.94	9.88
-34.39	-23.26	8.39
-53.58	-57.49	22.19
-46.88	-68.98	36.66
10.7	-5.51	-10.95
31.07	-1.16	-22.93
30.06	-25.83	-22.71
17.46	-42.84	2.72
26.74	-29.66	-29
4.93	-56.04	34.49
36.15	-2.47	-48.66
30.06	7.01	-15.88
10.74	17.76	-3.16
30.35	-13.77	2.98
36.8	18.78	6.38
36.86	2.83	7.95
46.56	-9.35	3.39
56.69	-53.29	26.61

// Ettlin D A, 2008: Pain > Baseline
// Ettlin D A, 2008: Pain > Baseline, Correlations with Intensity Rating
// Ettlin D A, 2008: Pain > Baseline, Correlations with Unpleasantness Rating
// Subjects=17
26	-74	-28
-16	-80	-36
-48	16	-6
0	-74	-2
42	38	28
0	24	26
2	-48	44
6	-86	-8
-44	8	26
-26	-68	52
-48	8	-10
62	-54	-8
26	-74	-28
-16	-80	-36
0	-74	-2
0	24	26
16	0	14
8	-84	-8
-26	-68	52
-48	8	-10
62	-54	-8
26	-74	-28
-16	-80	-36
0	-74	-2
0	24	26
16	0	14
8	-84	-8

// Green A C, 2008: Minor - Major
// Subjects=21
-18.12	-44.58	9.1
9.63	37.21	-1.71
-1.19	41.43	-1.94
-14.24	51.7	-6.1

// Iannilli E, 2008: Chemical Stimulation > Baseline
// Iannilli E, 2008: Electrical Stimulation > Baseline
// Iannilli E, 2008: Mechanical Stimulation > Baseline
// Iannilli E, 2008: Positive Effect of Chemical Stimulus on the Electrical
// Iannilli E, 2008: Positive Effect of Chemical Sitmulus on the Mechanical
// Iannilli E, 2008: Positive Effect of the Electrical Stimulus on the 
// Mechanical
// Iannilli E, 2008: Positive Effect of the Mechanical Stimulus on the 
// Electrical
// Iannilli E, 2008: Conjunction Analysis: Chemical and Electrical
// Iannilli E, 2008: Conjunction Analysis: Chemical and Mechanical
// Iannilli E, 2008: Conjunction Analysis: Electrical and Mechanical
// Subjects=18
-44.39	49.03	1.4
49.72	48.06	8.86
43.19	41.14	4.05
-31.62	31.25	-17.23
58.22	17.51	-8.43
-12.2	54.07	-15.33
-27.81	11.4	22.77
43.29	-6.28	2.02
43.2	5.11	-2.47
-41.08	-18.25	-6.56
44.33	17.54	4.13
36.96	-5.16	14.34
-44.26	-14.55	-1.27
-31.25	0.05	4.91
-27.92	-2.51	11.83
17.43	-12.44	6.43
42.95	11.96	-21.07
36.49	5.55	-20.32
-11.63	24.42	23.45
14.24	36.11	20.73
23.64	45.77	-2.79
49.43	51.41	-12.76
-44.59	56.29	-12.76
46.36	29.69	-3.83
49.31	46.12	-23.44
52.96	41.49	7.22
-1.77	38.57	36.45
-43.65	15.21	52.92
47.17	10.52	55.2
43.76	11.49	42.84
58.86	8.05	39.56
58.86	8.05	39.56
58.96	-39.38	37.53
-41.58	-26.01	36.8
-39.27	-20.5	49.66
25.83	-30.2	68.56
59.78	-25.94	20.49
-42.52	-42.4	45.16
55.91	-56.53	49.36
-33.9	-42.58	42.79
-14.63	-30.69	31.2
-11.85	11.82	3.41
10.94	7.2	10.2
51.67	16.97	-13.87
-41.29	11.87	-17.38
-11.65	-24.99	11.53
36.32	31.62	-28.5
-38.05	11.88	-17.44
-53.29	36.18	-20.71
36.79	58.11	13.69
-31.4	59.17	5.78
7.75	55.75	24.5
1.23	48.83	19.7
39.58	62.45	-20.4
46.36	55.94	1.42
55.04	49.69	3.01
-44.43	48.72	-1.93
-44.47	58.29	-2.87
7.78	-2.07	14.54
17.38	5.85	6.87
-11.62	0.4	19.1
-15.24	20.54	-6.36
-8.5	-5.94	8.47
-44.41	17.15	-6.65
46.27	15.88	-13.67
43.17	-11.57	-8.66
36.96	1.43	15.93
36.74	24.96	3.52
44.21	1.3	-8.83
46.36	-5.39	-11.57
-18.25	0.4	8.01
-11.56	17.29	27.52
18.68	20.59	26.68
-13.84	34.95	21.33
7.7	32.38	15.61
-48.05	1.05	-40.85
52.41	4.59	-42.91
-57.66	-4.74	-33.39
43.29	-7.34	2.13
46.2	8.78	-20.81
52.83	52.56	-.6
-44.29	50.92	10.18
-8.32	18.37	27.36
-34.48	-.92	6.18
43.33	38.89	14.36
49.82	32.42	13.77
23.68	51.5	1.12
2	61.85	-1.78
-27.97	55.11	19.57
11.51	58.1	-19.5
3.85	58.41	-27.24
-34.78	-9.8	-19.83
4.49	25.99	16.3
24.81	19.08	-1.29
48.33	9.64	-23.17
-37.95	23.55	-7.39
48.42	51.92	-7.19
-44.43	48.72	-1.93
42.97	5.57	-20.44
50.7	54.99	2.56
50.51	51.41	-12.77
-38.01	12.19	-14.11
46.27	15.88	-13.67

// Schiffer B, 2008: Heterosexual pedophile forensic patients
// Subjects=4
54	15	18
51	39	3
-48	15	45
-36	21	0
-21	9	3
48	-45	-18
39	-48	-18
-42	-54	-21
57	-63	-12
66	-18	24
-57	-27	42
-24	-78	33
-51	-33	60
-24	-3	6
-39	-90	3
-48	-60	-6
45	-81	-9
-36	-87	-15
48	21	27
9	57	12
-12	6	48
33	18	9
48	12	33
15	3	21
30	-3	-12
-3	-6	6
-9	-21	-9
-48	-57	-15
51	-51	-18
-57	-60	-15
-45	-72	9
-60	-60	0
42	-78	9
-21	-39	-12
30	-78	42
33	-57	60
24	-69	48
39	-84	3
45	-75	9
-33	-84	-12
57	21	24
-42	18	15
33	33	42
-3	-21	3
-27	-36	-6
-33	-36	-21
30	-48	-9
-36	-51	54
-45	-84	3
-48	-63	-6
-51	-69	-12
39	-78	-12
48	-45	-18
49	-50	-18
-33	-36	-23
8	55	10
-12	6	48
16	4	19
-48	-57	-19
-3	-21	3
-42	36	-15
-6	24	-15
-21	60	21
18	54	39
-21	60	30
33	18	9
-3	-6	6
39	-84	3
-33	-84	-12
33	33	42
-27	-36	-6
-45	-84	3
-9	12	33
3	36	9
3	15	27
6	21	21
-6	-54	3
-48	15	-9
54	-3	-12
21	-81	30
9	-75	30
-9	-66	30
-12	-57	30
-6	-63	0
24	-78	-18
-33	-27	-12
30	24	-9
-36	-39	-12
51	-60	-21
18	-24	15
-27	-36	-6
30	21	-24
45	33	-12
-30	15	-30
6	57	3
3	-15	39
6	3	42
-3	6	39
-3	38	0
3	42	3
42	-18	63
-30	-15	69
-3	-24	48
48	18	27

// Schiffer B, 2008: Healthy heterosexual volunteers
// Subjects=10
-30	21	-24
36	39	-12
51	39	3
-3	-9	72
-9	21	0
24	3	-18
-24	-3	-27
21	-27	-3
-30	-45	-18
30	-75	-21
-48	-66	0
27	-93	3
-36	-81	-9
45	-75	-12
-21	-99	6
36	-75	27
51	39	-9
-39	0	42
45	-18	63
-3	39	0
-6	6	51
3	39	6
-3	6	39
-3	6	42
6	9	-6
-3	-12	9
6	-15	9
15	-21	-6
32	-36	-10
48	-60	-6
-48	15	-9
51	21	-18
48	-33	39
-45	-30	42
18	-27	-12
-30	-45	-15
30	-78	33
-9	-66	63
-36	-48	54
24	-69	45
-27	-87	-3
42	15	39
24	-3	-3
-6	-15	-9
-24	-99	12
39	-78	-12
-9	-90	3
30	24	-18
51	30	18
48	18	45
12	21	39
-18	-3	0
30	-45	-18
33	-72	-12
-21	-84	-21
-24	-99	12
39	-78	-12
-36	-84	-18
-9	-90	3
35	-31	-11
-11	-62	61
-34	-45	52
32	36	-13
-32	20	-21
-11	23	2
-32	-44	-16
-3	38	0
-44	-30	42
-30	-44	-13
-9	-66	65
21	-2	-5
-9	12	33
3	36	9
3	15	27
6	21	21
-6	-54	3
-48	15	-9
54	-3	-12
21	-81	30
9	-75	30
-9	-66	30
-12	-57	30
-6	-63	0
24	-78	-18
-33	-27	-12
30	24	-9
-36	-39	-12
51	-60	-21
18	-24	15
-27	-36	-6
30	21	-24
45	33	-12
-30	15	-30
6	57	3
3	-15	39
6	3	42
-3	6	39
-3	38	0
3	42	3
42	-18	63
-30	-15	69
-3	-24	48
48	18	27

// Dechaumont-Palacin S, 2008: Subgroup of Ischemic Stroke Patients, Trained 
// group
// Subjects=7
-45.8	-13.18	47.92
-2.55	-21.54	48.01
49.12	-29.29	31.09
-43.84	-34.39	27.58
3.9	4.53	50.93
-20.32	49.17	24.51
57.56	4.25	22.03
62.05	-18.61	29.82
60.04	-41.5	37.72

// Dechaumont-Palacin S, 2008: Subgroup of Ischemic Stroke Patients, Control 
// group
// Subjects=6
-32.79	-25.9	48.96
3.93	-3.98	51.77
47.16	-5.95	51.23
62.07	-44.66	26.79
-48.21	-41.31	22.73
35.98	54.66	34.22

// Li C S, 2008: Stop Success > Stop Error, Long > Short SSRT
// Li C S, 2008: Stop Success > Stop Error, Short > Long SSRT
// Subjects=15
3	-66	-21
9	-48	-24
18	-24	12
-6	-21	-3
-18	-63	-45
12	-33	39
-27	27	27
12	0	48
3	-21	57
30	-69	39
60	6	18
12	-45	69
-9	-42	27
-3	36	51
-9	51	6

// Abler B, 2008: Healthy Controls > Bipolar Manic Disorder (Win > Omission of 
// reward)
// Subjects=12
-3	12	-9

// Tsukiura T, 2008: Face and Name (HSFN) > Face (HSF) and Non-retrieval of 
// Face or Name (HS)
// Tsukiura T, 2008: HSFN and HSF > HS
// Subjects=10
-60.7	-6.49	-17.48
-7.06	-43.73	29
-13.77	-61.89	7.38
-22.94	3.11	-20.19
-3.16	-66.6	-9.15
22.35	9.13	-27.16
2.96	67.51	-10.2
8	31.99	-45.99
44.89	-62.59	31.1
61.03	-34.57	31.41
12.39	-43.66	28.66
10.37	-31.69	42.07
12.17	-74.87	4.86
9.97	-55.43	6.33
1	56.95	3.21
-9.39	-48.28	14.92
-9.73	10.45	0.15
-5.52	-60.41	-23.17
44.6	31.52	27.39
48.84	13.48	17.9
37.36	11.65	-35.51
34.22	-64.88	41.59
49.25	-42.6	38.01
8.25	-76.23	36.43
12.21	-90.93	5.32
37.71	20.84	-6.17
20.29	-7.58	-22.11
26.94	-29.27	-13.35
5.52	-9.4	5.21
7.53	-33.49	-11.49
3.66	-19.13	27.5

// Browndyke J N, 2008: Normal Hits (NH) > Malingered Target Miss (MM)
// Browndyke J N, 2008: MM > NH
// Browndyke J N, 2008: Normal Correct Rejection (NCR) > Malingered False 
// Alarm (MFA)
// Browndyke J N, 2008: MFA > NCR
// Subjects=7
2	-72	-6
26	-48	6
-2	-74	46
-16	-84	34
50	-50	30
46	-44	0
10	-28	34
-4	14	38
-32	-2	-22
-34	-40	32
-34	30	36
28	-78	-4
-26	-76	-10
-16	-84	34
-34	-58	18
-12	-62	14
58	-58	8
46	14	-4
48	-68	28
40	-76	-16
-42	18	-6

// Muller J L, 2008: Controls
// Subjects=12
12.81	58.11	15.45
-58.63	14.33	19.94
-45.98	39.98	6.49
37.17	13.16	-31.25
12.81	58.11	15.45
-58.63	14.33	19.94
-24.67	43.91	0.34
37.17	13.16	-31.25
-45.48	-47.04	37.2
-16.46	-61.62	52.59

// Muller J L, 2008: Criminal Psychopaths
// Subjects=10
12.81	58.11	15.45
-58.63	14.33	19.94
-45.98	39.98	6.49
37.17	13.16	-31.25
33.04	27.8	-6.78
30.94	24.95	-2.05

// Schiffer B, 2008: Pedophiles
// Subjects=11
51	39	15
57	33	12
36	27	-18
-51	15	33
48	-45	-15
-54	-72	9
30	-51	51
33	-54	60
54	-24	54
-42	-87	9
-36	-87	18
48	-72	6
36	-90	0
51	39	6
24	33	-6
51	15	27
24	42	-15
-42	33	18
57	9	42
51	12	36
3	15	-6
-3	12	-6
3	30	-9
6	18	0
18	-6	-9
27	-18	-3
27	3	-6
-9	-21	-12
12	-21	12
30	15	-33
-39	18	-36
51	6	-21
-48	42	12
48	18	27
3	12	-6
-3	12	-6
48	-42	-15
-36	-57	-18
-36	-84	15
39	-60	57
-30	-66	57
-36	-36	-18
-39	-78	6
-36	-87	9
-36	-81	-9
-42	-87	-6

// Schiffer B, 2008: Healthy Controls
// Subjects=12
48	-48	-15
-45	-60	-21
-45	-72	-3
27	-51	48
-21	-60	57
33	-51	54
51	-75	-3
45	-81	3
-39	-90	0
-45	-84	3
42	-75	-9
-36	-87	-9
-45	-84	-6
48	51	12
54	42	12
45	-67	-18
48	-48	-15
-45	-78	-12
-48	-48	-21
36	-81	33
27	-57	54
15	-66	63
21	-69	57
33	-84	15
42	-84	3
-45	-78	-12
-33	-90	3
42	-75	-12
36	-75	27

// Shimada T, 2008: Pre-improvement: Motor task > Rest
// Shimada T, 2008: Post-improvement: Motor task > Rest
// Subjects=1
8	-14	76
-14	-72	-16
16	-70	-16
-2	-12	66

// Lloyd D, 2008: Subgroup of cLBP, High Pain Levels (WS-H)
// Subjects=15
4	-54	18
22	-66	10
14	-76	24
-46	-50	42
-38	-66	38
50	10	6
46	12	2
58	4	4
15	46	65

// Lloyd D, 2008: Subgroup of cLBP, Low Pain Levels (WS-L)
// Subjects=13
-30	-72	42
-40	-80	-16
-40	-60	-10
4	-54	18
22	-66	10
14	-76	24
-46	-50	42
-38	-66	38
52	8	10
60	-30	36
-42	-48	40
48	30	26
46	-34	16
-40	-42	38
-50	-58	42
34	6	-2
-24	-2	4
-6	38	42
4	28	50
-62	-20	18
62	-20	18
40	-2	-2
-12	24	34
30	22	-2
62	-18	24
-62	-18	24

// Lloyd D, 2008: Healthy Controls
// Subjects=17
-30	-72	42
-40	-80	-16
-40	-60	-10
62	-32	38
34	6	4
44	10	-6
54	2	2
62	-20	18
40	-16	-10
62	-18	24
12	-20	-24
4	-34	-30
-20	43	64
18	44	64

// MacSweeney M, 2008: Deaf group: Location task > Baseline
// MacSweeney M, 2008: Deaf group: Rhyme task > Baseline
// MacSweeney M, 2008: Hearing group: Rhyme task > Baseline
// MacSweeney M, 2008: Deaf group: Conjunction of rhyme and location tasks
// MacSweeney M, 2008: Deaf group: Rhyme > Location
// MacSweeney M, 2008: Deaf group: Location > Rhyme
// MacSweeney M, 2008: Native signers > Non-native signers: Rhyme > Location
// MacSweeney M, 2008: Non-native signers > Native signers: Location & Rhyme > 
// Baseline
// MacSweeney M, 2008: Deaf group x Task Interaction
// MacSweeney M, 2008: Native signers > Non-native signers: Rhyme > Baseline
// MacSweeney M, 2008: All groups: Location & Rhyme > Baseline
// MacSweeney M, 2008: Deaf group > Hearing: Location & Rhyme > Baseline
// Subjects=11
-44.68	19.32	28.28
-29.36	-62.55	41.66
5.69	16.77	45.76
-41.41	7.97	32.54
-25.04	-66.41	46.4
1.46	12.85	50.6
-41.48	10.54	24.52
-25.07	-57.95	45.69
1.38	25.2	45.1
44.06	-77.42	-5.89
-41.64	34.09	12.51
-29.32	-66.44	46.45
1.49	6.51	51.13
-53.07	0.04	41.15
1.56	-5.92	55.52
-2.56	-69.19	49.72
-41.49	23.57	27.89
-41.48	19.34	28.24
-41.5	10.28	21.2
-44.7	23.55	27.93
-48.85	3.95	36.31
1.47	17.34	53.57
-41.42	11.14	32.28
-29.28	-61.69	52.74
1.45	17.08	50.24
-41.39	3.74	32.9
-2.8	9.66	50.91

// Redgrave G W, 2008: Patient - Control, Thin - XXXX
// Redgrave G W, 2008: Control - Patient, Fat - XXXX
// Subjects=6
-52	-12	12
-46	-16	16
-18	10	56
-24	14	52
-12	12	52
-50	26	6
-52	26	14
-48	20	34
30	-58	46
20	-58	42

// DeLuca J, 2008: Group x Within-run fatigue
// DeLuca J, 2008: Group x Across-run fatigue
// DeLuca J, 2008: Group x Across x Within-run fatigue
// Subjects=15
-4	31	-19
0	1	65
-36	17	47
-32	53	19
-50	29	17
-40	25	-25
-24	-81	25
0	11	-9
40	31	35
2	-55	59
4	-85	-21
-18	53	27
-58	19	9

// Rubia K, 2008: Healthy Controls (HC) & Conduct Disorder (CD) > ADHD, 
// Successful stop > Failed stop
// Rubia K, 2008: HC > CD & ADHD, Failed stop > Go
// Rubia K, 2008: HC & ADHD > CD, Failed stop > Go
// Subjects=13
-26	65.67	6.17
13.48	-46.85	28.96
-41.53	-29.95	40.55
64.06	-16.45	18.36

// Vasic N, 2008: Developmental Dyslexia
// Subjects=12
-48	3	39
-6	-93	0
-42	-69	48
21	-78	-3
-45	3	39
-33	-60	60
-27	27	51
-42	12	15
57	18	12
-45	33	27
39	21	24
9	30	54

// Vasic N, 2008: Healthy Controls
// Subjects=13
-48	3	39
-6	-93	0
-42	-69	48
21	-78	-3
-45	3	39
-33	-60	60
-27	27	51
-42	12	15
57	18	12

// Conway T, 2008: Healthy controls
// Subjects=11
-44.75	-17.63	4.62
56.76	-19.3	1.36
61.12	-20.54	12.57
4.73	13.47	58.31
-45.67	-33.61	18.23
53.38	5.28	-10.7
53.42	-3.09	-8.88
-65.05	-17.75	4.86
4.55	26.99	40.45
45.12	19.23	32.83
-3.74	-43.91	46.5
-51.2	-7.09	3.81
11.61	42.47	-7.76
-59.51	-38.72	22.17
-59.65	-25.83	9.94
-60.59	-37.67	22.09
-53.22	-28.97	10.12

// Conway T, 2008: Developmental dyslexia
// Subjects=11
-59.51	-38.72	22.17
-59.65	-25.83	9.94
-60.59	-37.67	22.09
-53.22	-28.97	10.12

// Fehr T, 2008: addition (complex > simple)
// Fehr T, 2008: subtraction (complex > simple)
// Fehr T, 2008: division (complex > simple)
// Fehr T, 2008: multiplication (complex > simple)
// Fehr T, 2008: complex > simple
// Subjects=11
8.21	19.75	52.71
23.39	19.15	56.99
-28.43	10.46	58.74
-32.85	3.13	49.45
-33.03	29.2	41.27
44.65	14.4	27.97
51.07	33.67	27.07
32.02	16.85	54.83
29.86	8.12	53.49
-39.25	-44.42	46.42
-34.88	-51.64	49.3
-32.68	-71.09	47.83
34.26	-60.21	45.61
34.25	-69.03	43.12
44.94	-38.15	39.88
17.42	-2.66	7.71
12	16.88	10.35
10.01	-17.91	17.19
-11.85	-2.43	0.34
-1.29	-9.68	-20.41
9.69	-15.94	-7.66
8.2	21.88	52.5
-37.55	51.75	30.15
51.02	37.72	24.43
53.39	31.63	39.56
40.58	4.25	45.85
53.24	11.89	23.59
-37.03	-53.77	49.55
-39.25	-44.42	46.42
42.86	-45.19	45.1
-30.53	-68.95	47.58
34.26	-60.21	45.61
19.27	-65.82	55.39
-9.77	21.08	-.9
14.22	-.13	11.99
-7.65	3.24	-8.14
6.02	19.53	50.53
55.3	35.19	20.12
60.88	14.67	29.9
35.45	25.52	-13.32
-35.79	21.43	-7.22
30.62	-77.82	-73.61
-9.6	-93.63	-10.85
-7.36	-6.59	13
12.02	-4.81	8.01
6.01	21.66	50.32
49.39	0.1	58.44
64.67	19.45	-10.97
-30.36	-57.82	63.28
-13.06	-68.6	61.81
-21.74	-68.95	58.64
32.16	-68.52	48.71
53.04	-61.84	-7.21
-7.28	-63.99	7.47
29.33	-80.11	-6.12
-50.75	-60.59	-11.17
69.1	12.65	-3.65
5.6	-4.41	12.56
-5.3	4.7	7.37
8.21	19.75	52.71
34.3	-62.13	48.04
12.02	-2.68	7.8

// Ragland J D, 2008: Schizophrenia
// Subjects=13
48	4	20
-50	24	23
39	31	36
36	6	55
0	3	59
3	17	44
-53	-11	21
-59	-37	9
-56	3	4
-50	-33	47
53	-35	49
-9	12	62
3	14	44
-12	-14	14
15	-6	0
-50	-52	10
48	-35	5
56	-41	-5
-53	-41	47
-50	-56	-7
-12	-90	-2
15	-84	4
-33	-65	-22
3	-74	-22
45	-60	-26
9	9	13
-42	30	26
-24	0	51
-53	-4	31
-42	-3	52
-42	15	7
3	16	34
-36	-39	26
39	12	7
24	6	0
-45	-50	-7
50	-44	-7
50	-40	12
-45	-21	-6
-53	-52	10
48	-35	5
-53	-41	47
-12	-64	58
-15	-58	-4
-9	-73	4
-15	-90	4
-6	-59	48
0	-74	-22
-45	24	19
0	11	44
-24	2	45
30	-13	38
53	10	34
-48	8	-10
-6	32	-5
18	7	17
-45	-21	-6
50	-40	12
24	-30	-14
-18	-90	4
24	-20	1
15	-76	-15
-24	-59	34
24	-6	52
-15	-28	29
-30	-32	2
18	-23	5
-30	-52	16
50	-41	-5
-42	-40	9
30	-56	40
27	-53	44
24	-67	51
-15	-12	59
12	27	19
9	-90	4
3	32	54
-15	-87	1
21	-79	-15
-30	-55	58

// Ragland J D, 2008: Normals
// Subjects=14
-27	35	2
50	22	34
33	17	41
-53	-42	37
53	-35	49
33	-62	51
-15	-71	-25
-27	47	15
42	34	30
-3	6	59
36	5	35
-33	18	3
33	14	-4
36	-48	-30
9	9	13
-42	30	26
-24	0	51
-53	-4	31
-42	-3	52
-42	15	7
3	16	34
-36	-39	26
39	12	7
24	6	0
-45	-50	-7
50	-44	-7
50	-40	12
-45	-21	-6
-53	-52	10
48	-35	5
-53	-41	47
-12	-64	58
-15	-58	-4
-9	-73	4
-15	-90	4
-6	-59	48
0	-74	-22
-36	17	-8
-39	21	16
-6	22	37
-12	-11	21
21	-2	20
-45	-21	-6
50	-40	12
24	-30	-14
-18	-90	4
24	-6	52
-15	-28	29
-30	-32	2
18	-23	5
-30	-52	16
50	-41	-5
-42	-40	9
30	-56	40
3	-64	55
-15	-12	59

// Wood G, 2008: large range > small range
// Wood G, 2008: small range > large range
// Wood G, 2008: decade crossing > no decade crossing
// Wood G, 2008: no decade crossing > decade crossing
// Wood G, 2008: large sum > small sum
// Wood G, 2008: small sum > large sum
// Wood G, 2008: small distance to the mean > large distance to the mean
// Wood G, 2008: large distance to the mean > small distance to the mean
// Wood G, 2008: multiplicative >non-multiplicative
// Wood G, 2008: non-multiplicative > multiplicative
// Wood G, 2008: impossible > possible
// Subjects=17
55.87	-28.36	52.18
39.8	-51.5	58.1
-7.72	-71.23	56.38
-52.19	-32.24	51.04
34.28	-69.89	45.45
43.57	-93.91	6.2
-27.3	-70.11	46.52
-40.89	-95.66	-7.87
-37.72	-75.34	-8.82
8.4	-66.38	50.02
-1.19	-80.68	58.32
33.98	27.41	41.43
-24.27	24.64	49.42
55.47	20.07	30.58
-47.25	16.85	24.81
46.31	34.8	-6.58
43.07	5.24	-12.56
-31.51	22.2	-10.73
-2.53	49.33	-20.63
21.06	40.86	48.16
-1.56	-42.99	36.67
37.6	-49.59	55.71
37.54	-56.6	49.68
-40.4	-29.63	43.86
-30.41	-62.6	58.15
37.55	-72.97	46.82
-27.31	-73.51	44.61
46.53	-71.95	-11.71
-47.49	-65.9	-10.7
65.06	27.89	21.8
-47.18	8.66	28.98
-47.41	35.37	16.25
7.94	51.68	38.35
-1.59	24.62	47.91
34.02	17.84	42.37
-36.08	-3.37	49.03
43.02	19.06	-13.93
-31.58	21.68	-16.28
62.23	-62.11	35.24
-55.59	-59.65	33.64
65.24	-22.21	25.63
-65.59	-23.5	19.03
24	56.12	27.55
-11.7	58.87	24.53
11.33	-46.76	30.1
0.7	45.95	-22.59
37.02	-94.45	0.77
-8.27	-84.1	10.6
-19.11	-97.53	5.39
4.14	92.37	3.01
-44.4	-57.15	-20.59
-5.4	-79.24	-17.94
-50.42	72.1	41.81
58.9	-69.34	27.04
-40.31	-38.79	49.24
-20.73	-52.99	57.04
18.27	-50.96	65.14
-52.65	14.71	25.11
1.67	18.25	48.49
34.31	8.01	63.51
-40.44	5.13	48.26
-31.52	29.75	-10.35
36.62	26.25	-5.57
-40.8	-78.56	2.76
-46.9	-52.72	38.41
50.4	-57.38	40.57
-14.95	58.86	24.58
21.05	44.05	47.85
71.43	-41.9	-1.66
-52.39	-59.95	30.25
-14.86	56.19	30.45
-50.07	-32.55	47.67
47.32	-39.78	56.81
-33.99	-76.05	29.29
21.54	-63.92	64.12
-47.28	17.71	22.48
61.82	17.99	19.47
-1.69	27.18	40.94
-28.16	24.11	-2.01
42.93	24.93	-20.11
-47.41	-67.51	-4.94
44.12	22.47	-12.04

// Moores K A, 2008: PTSD patients
// Subjects=13
-25	45	15
30	40	25
35	35	20
-40	20	30
45	25	35
0	30	20
-10	25	30
-35	20	15
35	20	15
-45	15	10
35	30	5
-40	-5	40
50	0	30
-60	-25	25
-40	-30	50
50	-25	45
-30	-55	35
30	-50	40
-10	-30	35
5	-35	30
-15	-75	35
15	-70	35
-55	-25	0
40	-30	0
-50	-50	20
45	-40	15
50	-65	10
-40	-65	-5
-35	-80	0
35	-75	10
-30	-15	-10
-30	-25	15
-35	-15	0
-15	-70	0
20	-85	0
-25	-55	-10
40	-55	-10
-30	-40	-25
40	-40	-30
-25	-5	15
25	5	10
-20	5	20
20	0	20
-25	-15	25
25	-10	20
-10	-90	30
15	-80	20
-20	-70	10
0	-20	-30
-40	45	5
35	45	5
-45	30	30
-40	25	25
35	25	30
-35	15	10
35	20	5
-50	10	5
40	20	15
-55	10	30
45	0	40
-5	10	50
5	10	55
-40	-60	45
35	-55	45
-50	-50	50
50	-50	50
-45	-50	35
-55	-25	0
45	-30	0
-55	-50	10
45	-50	10
-55	-45	20
-50	-50	-5
-15	-85	5
-35	-55	-25
30	-45	-25
15	0	20

// Moores K A, 2008: Healthy Controls
// Subjects=12
-25	30	30
35	5	60
-30	45	25
35	40	25
-40	20	30
40	30	35
-45	15	5
-30	20	15
10	25	40
-10	20	40
10	25	40
-5	10	50
-45	0	40
50	0	35
-45	-50	30
55	-35	50
-30	-55	35
35	-50	45
5	-35	25
-10	-65	45
15	-70	35
40	-75	30
-40	-65	-5
50	-50	-5
-15	-70	0
25	-55	-5
40	-55	-10
-10	-60	-10
15	-50	-20
-25	-5	20
20	0	20
0	-20	-30
-25	45	15
30	40	25
35	35	20
-40	20	30
45	25	35
0	30	20
-10	25	30
-35	20	15
35	20	15
-45	15	10
35	30	5
-40	-5	40
50	0	30
-60	-25	25
-40	-30	50
50	-25	45
-30	-55	35
30	-50	40
-10	-30	35
5	-35	30
-15	-75	35
15	-70	35
-55	-25	0
40	-30	0
-50	-50	20
45	-40	15
50	-65	10
-40	-65	-5
-35	-80	0
35	-75	10
-30	-15	-10
-30	-25	15
-35	-15	0
-15	-70	0
20	-85	0
-25	-55	-10
40	-55	-10
-30	-40	-25
40	-40	-30
-25	-5	15
25	5	10
-20	5	20
20	0	20
-25	-15	25
25	-10	20
-10	-90	30
15	-80	20
-20	-70	10
0	-20	-30
40	25	0
-45	0	35
40	0	55
5	10	55
-5	-5	60
35	-55	45

// Spalek K, 2008: Object and Color tasks > Baseline
// Subjects=17
17.21	-86.27	-25.48
39.96	-75.89	-19.05
-34.64	-47.02	-16.15
-59.69	34.55	-14.83
-50.84	40.5	2.36
-27.3	-51.51	50.28
-1.54	22.8	51.45

// Schon K, 2008: Object delay match to sample (ODMS) > Location delay match 
// to sample (LDMS)
// Schon K, 2008: ODMS > OCON, familiar objects
// Schon K, 2008: Saccadic eye movements > Fixation
// Subjects=17
24	34	-16
-2	50	-6
18	16	-12
-34	42	-14
-26	36	-14
-18	20	-6
34	-48	-32
-14	58	4
-34	-36	-32
-2	-54	-12
24	-28	70
-26	58	-4
-38	-88	10
-10	-6	-18
-30	-10	-26
-40	-12	-32
-10	-2	16
-22	50	20
-40	32	2
34	10	-24
12	-34	10
40	-56	-32
-38	-88	10
24	34	-16
-34	42	-14
-2	50	-6
34	-48	-32
48	-62	-30
-34	-36	-32
-32	-48	-28
-40	-52	-28
-2	-54	-12
24	-28	70
-10	-6	-18
-30	-10	-26
-40	-12	-32
-10	-2	16
-40	32	2
34	10	-24
12	-34	10
24	-24	74
26	-32	70
42	-26	64
-32	-48	-26
-40	-60	-16
-46	-66	-20
10	16	42
-4	14	42
4	12	52
24	14	-26
32	26	-26
20	30	-2
-12	28	62
-16	-70	42
-18	-76	52
-28	-74	46
-32	-4	52
50	0	-12
-16	-60	26
-10	0	16
-44	0	30
-40	-4	-24
48	-24	34
42	34	8
-52	36	2
-6	34	58
60	-46	-6
48	-10	12
30	-76	50
34	-2	-18
38	-62	-28
10	-42	54
-6	-74	-40
12	-80	-14
10	-74	-6
-12	-80	-16
22	-2	54
28	-6	50
36	-2	38
-36	-4	42
-56	0	38
-26	-8	54
-24	-30	-4
-4	-28	-18
6	-28	-16
-22	-6	6
-18	-10	-4
-26	-56	46
24	-30	-4
26	18	4
22	4	6
-38	26	-10

// Holsen L M, 2008: Fragile X Syndrome
// Subjects=11
27.72	-20.3	-22.76
-36.33	-33.21	-18.71
-42.74	30.48	7.25
-27.94	13.54	-20.5
-18.21	-9.41	-15.34
41.79	-49.14	-11.58
-38.46	-44.14	-22.23
-46.79	-19.95	15.99
-3.9	-64.28	16.98
15.17	-83.48	-12.85
-38.46	-44.14	-22.23
-4.08	-81.48	-12.8
-20.36	53.08	8.44
-10.54	51.94	34.08
-52.87	-64.81	42.12
-29.84	22.62	14.45
-14.7	-52.34	7.18
-40.34	4.72	31.69
12.58	50.25	-17.35
27.64	55.77	-2.37
-27.64	-40.41	-2.59

// Holsen L M, 2008: Healthy Controls
// Subjects=11
23.61	-36.22	-7.99
-53.5	36.25	0.2
17.28	48.04	36.31
-20.36	53.08	8.44
-10.54	51.94	34.08
-23.39	-11.07	4.94
41.23	-65.84	47.82
30.37	-89.63	16.48
25.87	-54.73	0.22
-16.74	-86.53	5.61
-20.36	53.08	8.44
-10.54	51.94	34.08
-52.87	-64.81	42.12
-29.84	22.62	14.45
-14.7	-52.34	7.18
-40.34	4.72	31.69
12.58	50.25	-17.35
27.64	55.77	-2.37
-27.64	-40.41	-2.59

// Watson C, 2008: Typically Developing (TD)
// Subjects=13
16.41	-39.34	5.75
-3.01	64.74	29.4
42.73	10.74	46.29
18.14	-48.7	54.83
-2.42	-38.03	55.25
18.41	6.5	2.3

// Watson C, 2008: Developmental Delay (DD)
// Subjects=10
44.51	28.67	19.83
37.98	35.99	18.1
28.9	-16.58	-26.97
-2.39	-42.18	56.78
-9.28	26.95	38.85

// Watson C, 2008: Fragile X Syndrome (FraX)
// Subjects=13
-35.68	10.15	-1.62
18.41	6.5	2.3
-9.52	-17.54	10.76

// Cardoso E F, 2008: Subgroup of Parkinson's disease, Active rTMS (+placebo)
// Subjects=9
39.58	-58.73	-25.25
50.43	18.92	28.34
-44.8	13.72	10.91
1.48	2.02	48.16
-2.38	5.17	47.94

// Cardoso E F, 2008: Subgroup of Parkinson's disease, Sham rTMS (+fluoxetine)
// Subjects=9
20.79	-5.81	55.29
47.28	4.1	29.62
-2.38	5.17	47.94

// Andersson F, 2008: 22q11.2 Deletion Syndrome
// Subjects=15
6	39	-3
-33	-45	-27
-57	-21	36
-45	21	-9
-36	-87	9
-36	-33	42
-36	-27	57
-30	-45	-27
-24	-42	51
-24	-39	63
-24	-15	57
-21	-96	3
0	-9	51
6	-30	30
27	-39	-21
30	-9	63
33	-39	57
36	-84	6
36	-84	21
36	-42	42
36	-30	66
39	-60	24
48	-30	42
57	-18	27
63	-36	21
0	-9	51
27	-60	-6
-27	18	57
51	24	0
15	30	0
27	6	60
-6	-6	33
18	-18	36
24	21	24
24	42	27
-36	33	42
-33	0	-45
33	3	-33

// Andersson F, 2008: Healthy Controls
// Subjects=16
-39	-36	-27
-33	-75	6
3	-81	3
48	-75	3
48	-39	-24
-33	-45	-27
-33	-93	9
-24	-45	-12
15	-51	12
24	-51	-12
33	-90	24
33	-78	9
36	-78	18
27	-60	-6
-51	-12	-6
15	30	0
-54	18	0
-39	-66	-21
36	-48	-30
-51	12	-12
-48	-66	24
33	3	-30
-36	33	42
-33	0	-45
33	3	-33

// Chiao J Y, 2008: Own-culture Fear > Other-culture Fear
// Subjects=10
-24	-12	-16
50	18	-18
24	6	22
-4	10	64
12	-36	-8
18	-6	-12
38	36	-16
-30	-8	-20

// Lee K, 2008: Happy > Neutral (Own-race faces), p=0
// Lee K, 2008: Happy > Neutral (Own-race faces), p=0.001
// Lee K, 2008: Neutral > Happy (Own-race faces)
// Lee K, 2008: Sad > Neutral (Own-race faces), p=0
// Lee K, 2008: Sad > Neutral (Own-race faces), p=0.001
// Lee K, 2008: Neutral > Sad (Own-race faces)
// Lee K, 2008: Happy > Neutral (Other-race faces), p=0
// Lee K, 2008: Happy > Neutral (Other-race faces), p=0.001
// Lee K, 2008: Neutral > Happy (Other-race faces), p=0
// Lee K, 2008: Neutral > Happy (Other-race faces), p=0.001
// Lee K, 2008: Sad > Neutral (Other-race faces), p=0
// Lee K, 2008: Sad > Neutral (Other-race faces), p=0.001
// Lee K, 2008: Neutral > Sad (Other-race faces), p=0
// Lee K, 2008: Neutral > Sad (Other-race faces), p=0.001
// Lee K, 2008: Own-race > Other-race neutral face, p=0
// Lee K, 2008: Own-race > Other-race neutral face, p=0.001
// Lee K, 2008: Other-race > Own-race neutral face, p=0
// Lee K, 2008: Other-race > Own-race neutral face, p=0.001
// Lee K, 2008: Own-race > Other-race emotional face (happy and sad), p=0
// Lee K, 2008: Own-race > Other-race emotional face (happy and sad), p=0.001
// Lee K, 2008: Other-race > Own-race emotional face (happy and sad), p=0
// Lee K, 2008: Other-race > Own-race emotional face (happy and sad), p=0.001
// Subjects=13
14	16	-2
42	44	14
6	22	44
-34	-56	48
-12	16	-10
-4	10	52
36	16	-42
6	54	-12
22	34	46
48	-8	32
-44	-8	6
44	-12	2
-24	-56	56
50	-56	32
-58	-56	-8
-22	-10	-16
-6	-76	22
-20	-32	70
10	20	0
-48	-28	58
-42	-14	56
42	-12	50
-8	-38	52
-10	-90	18
46	8	-26
52	-32	-16
-44	-12	-2
0	-72	-32
20	-8	-6
-44	-60	20
6	-42	-26
56	-36	50
52	10	20
6	24	44
36	58	-8
48	36	14
-64	-24	28
12	-44	72
56	-48	-8
8	34	40
54	32	24
0	2	26
-34	24	-4
44	24	0
36	58	-2
-46	28	22
-62	-6	30
6	-70	22
-10	-66	8
38	58	-4
52	2	46
6	26	42
-34	-52	40
34	28	-4
38	-10	66
-26	-86	-14
-30	22	6
-22	-10	-16
-40	32	-14
38	4	-20
-66	-44	2
-42	-28	8
10	-48	56
-28	-80	-16
40	30	30
-52	-32	52
-28	-56	-18
40	-48	52

// Van Bavel J J, 2008: In-group > Out-group
// Van Bavel J J, 2008: Black > White
// Subjects=17
-24	3	-15
-30	39	-6
39	-48	-15
-36	-42	-24
27	-6	15
-54	-57	-6
-36	-54	30
-48	-78	-6
42	-75	-6
33	-93	-9
-30	-96	-9

// Guillot A, 2009: Physical Execution vs. Passive Listening
// Guillot A, 2009: Visual Imagery vs. Passive Listening
// Guillot A, 2009: Kinesthetic Imagery vs. Passive Listening
// Guillot A, 2009: Visual Imagery vs. Kinesthetic Imagery
// Guillot A, 2009: Kinesthetic Imagery vs. Visual Imagery
// Subjects=50
-36	-40	47
62	-22	20
-50	-30	51
46	-29	46
-45	-27	39
39	-21	51
47	-24	43
38	-44	63
41	-17	56
-39	-9	57
27	-12	59
-27	-8	50
-8	-6	61
8	-6	61
-3	-3	53
5	1	55
-5	1	55
-46	-1	8
57	4	19
-2	0	37
18	-24	18
-24	-10	-2
24	-15	4
-25	5	10
23	6	13
-26	-2	-5
30	-14	8
-12	-47	-15
-21	-44	-21
8	-57	-2
-5	-55	-2
-12	-49	-8
-35	-52	-18
35	-51	-20
-5	-59	-15
-20	-67	-14
24	-61	-15
-14	-67	-12
44	-55	-2
-11	-24	2
16	-65	42
-14	-68	-4
20	-72	-9
-12	-62	-6
36	-69	-14
8	-72	23
-51	-30	32
34	-36	49
21	-59	58
36	-15	52
-36	-11	43
24	-11	54
-9	-9	61
9	-6	59
-3	-3	66
5	-3	66
-40	33	12
39	44	26
22	-13	3
-20	-11	3
-20	3	5
20	5	9
-27	-9	12
27	-9	12
-26	-30	-24
-4	-48	0
-28	-36	-26
-34	-46	-25
40	-51	-20
-4	-62	-25
-24	-57	-17
7	-70	-17
-36	-59	-17
-39	-41	41
46	-29	46
-60	-22	26
40	-40	57
-61	0	6
60	-27	40
39	-40	60
-30	-48	49
18	-44	52
36	-15	52
-28	-7	56
27	-8	61
42	-6	57
-9	-9	61
9	-2	63
-4	-5	64
-45	2	8
46	2	9
-61	11	19
-57	4	22
60	7	25
-42	46	23
-40	9	11
-39	12	8
-13	11	-1
20	-26	18
-21	-2	0
24	-9	1
-27	9	12
20	5	9
-28	-5	11
22	-3	0
-11	-49	-18
-4	-49	-5
-10	-55	-2
-15	-51	-20
-15	-66	-8
38	-50	-23
-3	-68	-9
-32	-55	-17
6	-69	-17
-18	-67	-14
-42	-55	-20
38	-63	-36
15	-77	12
8	-72	21
-38	-77	9
27	-80	40
3	-40	57
-18	-54	55
27	-76	45
-32	-7	50
26	-9	53
-63	-30	29
59	-41	32
-53	-5	9
56	1	17
4	9	58
11	-6	67
-58	6	19
56	6	17
-47	21	36
10	5	36
20	-24	21
-29	-12	1
29	-8	11
-32	-51	-20
-23	-65	-17
22	-61	-20
-42	-55	-20
38	-63	-36

// Wilson S M, 2009: Semantic Dementia Patients
// Subjects=5
-52	-6	28
62	2	16
42	-32	6
-38	-90	-6
38	-86	2
-36	-14	38
46	-10	42
-38	-90	-2
38	-84	-4
-50	-6	28
62	-6	18
-40	-84	0
46	-82	0
-38	-14	38
-38	-36	32
-38	-84	-8
18	-100	-2
-36	-14	36
62	0	18
-40	-84	-10
20	-98	-6
-26	-58	44

// Wilson S M, 2009: Normals
// Subjects=9
-54	-8	30
-60	-26	14
60	-2	44
68	-26	18
-32	-94	-6
-28	-62	-18
26	-92	-4
36	-60	-16
-56	-8	28
-50	-28	10
-46	-40	28
56	-8	44
66	-24	18
-30	-94	-8
-36	-50	-16
22	-94	-2
34	-60	-18
-4	-2	38
-62	-4	24
-50	-24	8
58	-10	20
60	-28	12
-28	-96	-8
-36	-46	-18
28	-92	-4
32	-58	-18
-52	-10	28
-40	-36	10
60	-2	44
64	-24	14
-28	-96	-8
-34	-48	-18
28	-94	-4
44	-70	-12
-48	4	20
-68	-30	8
56	-10	20
60	-30	12
-32	-94	-6
-34	-48	-16
22	-94	-4
40	-56	-16
-36	-50	34
-26	-60	48
-48	30	-8
-46	36	12
-32	34	6
-18	8	6

// Ewbank M P, 2009: Attended Anger > Attended Neutral, (Trait Anxiety)
// Ewbank M P, 2009: Attended Anger > Attended Neutral, (State Anxiety)
// Ewbank M P, 2009: Attended Anger > Attended Fear, (Trait Anxiety)
// Ewbank M P, 2009: Attended Anger > Attended Fear, (State Anxiety)
// Ewbank M P, 2009: Attended Anger > Unattended Anger, (Trait Anxiety)
// Ewbank M P, 2009: Attended Anger > Unattended Anger, (State Anxiety)
// Ewbank M P, 2009: Unattended Fear > Unattended Neutral, (Trait Anxiety)
// Ewbank M P, 2009: Unattended Fear > Unattended Anger, (Trait Anxiety)
// Ewbank M P, 2009: Unattended Fear > Unattended Anger, (State Anxiety)
// Subjects=24
14	-38	76
-48	-12	-18
-2	20	-8
52	-42	-12
26	-4	-20
26	-2	-20
-50	-44	-8
-46	-28	-10
16	-4	-26
60	-38	8
18	-80	-34
44	36	2
-28	-28	72
-18	30	-6
28	-8	-22
50	6	-2
16	-2	-24
44	-42	38
-28	0	-24
38	-44	30
38	2	-16
-28	-2	-20
52	-44	6
-12	-82	-44
30	28	-12
-24	-2	-22
42	-86	-6
40	4	-16
-40	0	-14

// Ballard K, 2009: Magnitude
// Ballard K, 2009: Delay
// Ballard K, 2009: Magnitude x Delay Interaction
// Subjects=16
10.64	6.17	-9.17
-10.9	43.77	-16.53
0.33	-51.57	15.87
-19.38	59.89	0.05
-48.71	-57.18	30.28
34.74	-73.25	35.13
60.02	2.18	17.36

// Bickel W K, 2009: Hypothetical Money Gains + Hypothetical Money Losses > 
// Real Money Gains
// Bickel W K, 2009: Real Money Gains - Random Effects
// Bickel W K, 2009: Hypothetical Money Gains - Random Effects
// Bickel W K, 2009: Hypothetical Money Losses - Random Effects
// Bickel W K, 2009: Real Money Gains > Hypothetical Money Gains
// Bickel W K, 2009: Real Money Gains > Hypothetical Money Losses
// Bickel W K, 2009: Hypothetical Money Gains > Real Money Gains
// Bickel W K, 2009: Hypothetical Money Losses > Hypothetical Money Gains
// Bickel W K, 2009: Hypothetical Money Losses > Real Money Gains
// Subjects=30
1.22	-70.53	-5.47
36.95	49.47	24.63
1.68	-79.11	28.99
-15.19	59.22	5.5
-5.47	-73.17	-21.91
-15.03	-87.27	-11.38
-11.52	-97.29	7.48
53.63	-48.65	41.9
46.59	42.3	16.21
30.77	27.61	43.7
-11.74	3.93	10.91
-15.1	14.99	3.15
1.6	-25	33.72
17.39	3.72	7.08
14.02	-1.69	-4.66
23.73	1.54	-5.14
36.75	-29.68	-6.76
30.29	-23.01	-3.95
20.12	-44.96	-43.06
1.33	-36.86	10.24
-21.49	64.91	20.73
-56.1	-32.88	-1.5
-62.72	-35.01	-12.38
-21.28	51.16	34.42
-28.04	-26.4	-2.62
71.1	-19.2	-22.95
-43.85	16.94	37.07
49.83	42.31	16.15
-38	61.5	-3.3
-41.26	-75.4	-32.28
10.83	-85.57	-17.59
14.09	15.3	4.87
17.45	7.43	12.31
4.89	-26.8	37.2
1.4	-42.93	14.2
26.98	-24.6	-9.34
-15.01	10.2	9.23
-18.13	-8.54	15.62
0.9	-61.97	-28.73
7.28	-65.97	-37.4
-24.8	-26.39	-2.67
20.76	-24.88	10.97
30.6	-65.57	11.47
-11.65	-24.99	11.53
7.92	2.26	26.43
23.38	-41.55	-41.21
53.71	-53.56	46.86
39.77	-75.11	-33.69
46.79	35.03	30.37
-37.16	13.1	53.02
-59.7	-18.06	-26.44
-65.78	-42.38	0.73
-52.74	-41.82	6.05
64.6	-22.63	-24.74
-14.98	3.92	10.97
-11.69	-15.42	10.59
1.61	-27.13	33.93
0.83	-55.9	-32.69
-2.55	-41.64	-40.76
17.2	1.2	-8.36
14.27	-11.83	13.15
4.09	-26.24	-25.59
-12.12	-19.71	-23.72
17.43	-55.06	-1.68
-2.22	-41.38	-15.02
-24.77	-26.18	-.45
-27.86	-50.24	6.46
64.89	-45.63	-6.78
-52.93	-56.35	-11.56
-5.64	-36.16	-27.81
-25.15	-69.48	-38.74
40.11	32.49	15.05
-41.44	45.8	-21.86
44.1	-46.17	57.5
-1.39	23.94	63.66
-51.11	11.1	-24.98
17.82	-72.98	24.74
-17.69	-97.16	32.22
-51.08	43.09	-15.82
-27.81	-53.12	10.11
24.13	-70.91	12.1
43.58	32.04	32.96
-8.31	48.02	34.51

// Broome M R, 2009: 1-Back, Healthy Controls > At-risk > Psychosis
// Broome M R, 2009: 2-Back, Healthy Controls > At-risk > Psychosis
// Broome M R, 2009: 'Easy' Verbal Fluency, Psychosis > At-risk > Healthy 
// Controls
// Broome M R, 2009: 'Hard' Verbal Fluency, Healthy Controls > At-risk > 
// Psychosis
// Broome M R, 2009: 'Hard' Verbal Fluency,  Psychosis > At-risk > Healthy 
// Controls
// Subjects=10
35.65	-59.56	19.48
-41.17	-46.67	41.58
32.57	-62.61	35.38
44.36	-45.73	46.1
-21.98	-59.13	30.14
44.34	-41.5	45.74
-21.81	-69.39	48.84
-41.2	-39.27	40.96
32.56	-58.38	35.03
-17.72	-75.74	21.45
35.17	24.46	-8.75
-41.49	14.77	24.17
5.71	16.94	47.98
40.17	-53.7	53.5
1.37	20.63	41.03
-22.02	0.91	49.64
-37.39	33.94	10.24
-41.53	10.03	17.87
-49.12	13.27	5.42
-44.79	13.81	12.02
-33.19	16.65	-7.31

// Camara E, 2009: Gain, Boost Unexpected Trial vs. Fixation
// Camara E, 2009: Loss, Boost Unexpected Trial vs. Fixation
// Camara E, 2009: Gain, Standard Trial vs. Fixation
// Camara E, 2009: Loss, Standard Trial vs. Fixation
// Camara E, 2009: Gain, Standard Trial vs. Loss, Standard Trial
// Camara E, 2009: Gain, Boost Unexpected Trial vs. Loss, Boost Unexpected 
// Trial
// Subjects=17
8	8	4
-4	16	8
20	-72	-28
-24	-72	-24
-4	-50	-4
44	36	28
-36	-56	-12
4	24	52
36	20	-8
36	-56	48
-36	-52	52
-4	-28	-4
4	-16	8
-4	-12	8
8	4	-8
-16	12	-12
8	8	4
-4	16	8
20	-72	-28
-24	-72	-24
-4	-50	-4
44	36	28
4	24	52
-36	-56	-12
36	-56	48
-36	-52	52
36	20	-8
0	-28	-8
4	-16	8
-4	-12	8
8	4	-8
-16	12	-12
8	36	24
8	16	8
-8	8	8
32	-72	-32
-32	-68	-36
12	-88	4
44	36	28
-24	-40	12
-8	-80	-4
32	-56	48
-32	-56	52
36	24	-8
-28	20	4
8	40	40
8	-24	12
-12	-28	12
-16	12	-12
16	12	-8
4	20	52
4	4	12
-4	4	12
12	-68	-28
-28	-64	-36
12	-88	8
-12	-84	12
28	-56	52
-44	-44	52
4	-20	4
36	24	-8
16	12	-12
-16	12	-12
-16	4	-12
16	8	-12
-16	4	-4
16	8	-16

// Clark L, 2009: Winning Outcomes minus Non-Win Outcomes
// Clark L, 2009: Near-Miss Outcome minus Full-Miss Outcome
// Clark L, 2009: Selection Phase Contrast (Participant-Chosen Trials minus 
// Computer-Chosen Trials)
// Subjects=15
28	16	-10
-36	18	-4
16	4	-12
16	6	-4
-14	10	-2
-10	-2	-6
-4	32	6
6	28	20
10	40	2
-6	-20	-14
8	-20	-12
-8	-12	-8
-2	-34	28
2	-14	32
4	-4	34
4	-20	32
30	-66	-26
2	-16	2
-8	4	-2
12	2	-2
32	18	0
18	-44	-24
8	-60	-40
4	-62	-14
-26	-50	-26
-34	-32	52
-30	-46	60
-48	-32	40
48	-30	54
-22	-4	58
-4	-4	54
38	-10	52
-12	-18	4
10	-12	-2
6	22	30
32	14	2
-32	16	4
-38	0	6
44	10	-4
-18	2	12
18	12	0
-56	6	30
24	-10	2

// Engelmann J B, 2009: Expert Message > No Message
// Engelmann J B, 2009: No Message > Expert Message
// Engelmann J B, 2009: Followed Advice > Ignored Advice
// Engelmann J B, 2009: Ignored Advice > Followed Advice
// Engelmann J B, 2009: Correlations with Weighted Value of Lotteries, No 
// Message
// Engelmann J B, 2009: Correlations with Magnitude of Sure Win During No 
// Message
// Engelmann J B, 2009: Correlations with Magnitude of Sure Win During Message
// Subjects=24
3.5	38.4	51.2
-51.7	-57	31.2
50.9	-50.2	31.6
-29.4	18.2	-11.9
35.7	25	-11.3
55.5	25.5	7.5
7.9	9.5	11.4
9	8.4	1.2
-51.6	25.8	9
1.2	-81.6	-3.2
-9	-66	4
10.6	6.7	36.3
-19.7	-69.9	-9.4
12.4	-50.9	10.3
58.5	-35.5	-3.5
-41.4	-13.8	-1.8
49.8	-31.5	28.4
49.2	-7.4	48.7
17.6	-35.1	50.3
8.4	-7.8	60
14.5	-2	69.5
-30.3	20.5	-9
15.5	2	-5.1
-31.4	20.8	-2.1
-6.2	27.7	42.9
-.7	-13	0.6
-37.7	23.6	41.2
28.1	-89.5	-3.5
31.3	-48.5	44.2
-23.9	-95.4	-8.3
32	-92	-1.1
29.7	-64.8	40.5
-11.3	-73	6.4
19.6	-68.8	4.4
59.5	-49.3	-12
-27	-60.6	1.1
28.8	-65.4	7.2
40.8	7.2	30
-9	7.5	-6
-27	-20.1	52.7
-58.4	-35.1	-5.5

// Flaisch T, 2009: Insult > Neutral
// Flaisch T, 2009: OK > Neutral
// Subjects=30
27	-53	55
62	-22	26
62	-10	34
39	-44	57
30	-65	31
-9	-95	24
21	-95	24
30	-71	28
-45	-76	-4
48	-67	-7
-45	-79	-6
45	-76	-6
-48	-78	12
53	-59	-7
-48	-76	-1
48	-73	-1
-48	-68	-12
48	-65	-12
-9	-95	25
6	-89	21
-9	-101	16
9	-95	13

// Goldstein R Z, 2009: Cocaine Use Disorders (CUDs)
// Subjects=15
6	-12	-9
-6	-15	-12
3	-15	-12
-6	-15	-18
3	-18	-21
3	-15	-12
-21	-24	-12
-15	42	-9
0	36	12
3	15	-3

// Goldstein R Z, 2009: Normals
// Subjects=15
3	-15	-12
-6	-15	-18
3	-18	-21
3	-15	-12
-21	-24	-12
-15	42	-9
0	36	12
3	15	-3

// Hauk O, 2009: All Words > Hash Marks
// Hauk O, 2009: Positive Correlation with Imageability
// Hauk O, 2009: Positive Correlation with Action Relatedness
// Hauk O, 2009: Frequency - Action Related Words Only
// Hauk O, 2009: Frequency - Visually Related Words Only
// Hauk O, 2009: Frequency - All Words
// Subjects=21
-42	-46	-22
-56	-50	-4
-54	12	32
-44	24	16
-54	24	0
-36	-24	50
-32	30	-14
-2	18	48
-42	-42	56
-34	-44	-22
28	-44	-22
0	-22	6
2	-12	2
4	58	-4
-62	-52	4
-62	-48	16
-26	-14	64
40	-38	10
4	-14	6
16	-28	12
-12	14	48
-60	-60	10
-46	-56	40
-28	28	-14
8	24	48
-38	-38	-24
18	30	40
-36	-32	-18
-28	-36	-22
-18	-36	-26
-30	28	-12
-20	26	4
-32	24	8
-38	14	30
32	28	-6
30	26	10

// Husain F T, 2009: Identity Discrimination > Category Discrimination
// Husain F T, 2009: Category Discrimination > Identity Discrimination
// Husain F T, 2009: Meaningful (ASL, EMB) > Non-meaningful (pASL, NLNM)
// Husain F T, 2009: Linguistic + Meaningful (ASL) > Nonlinguistic + 
// Non-meaningful (NLNM)
// Subjects=12
-36	-58	56
-34	-52	42
-36	-22	62
24	-74	58
24	-60	44
40	-52	54
-44	-56	-18
-48	-72	-18
-48	-80	-4
-22	-78	2
12	-80	0
-14	-62	-8
10	-46	58
-4	-20	40
0	-34	62
34	18	-26
48	30	-16
46	-20	-6
48	6	48
42	4	58
-56	-66	18
-44	-56	22
48	-66	22
40	-66	16
54	-56	18
-34	56	2
-14	62	18
40	-82	26
56	-56	46
52	-68	24
-58	-64	16
-46	-56	20
-2	-70	-28
16	-66	-36
6	-62	-16
38	-28	66
44	-28	52
40	-26	40
48	-32	-18
42	-38	-20
40	-14	-32

// Janata P, 2009: Summary of Significant Activations Associated with the 
// MusPlay Regressor
// Janata P, 2009: Summary of Loci at which BOLD Signal Correlated Positively 
// with Familiarity
// Janata P, 2009: Loci in which Activity was Positively Correlated with the 
// Degree of Autobiographical Salience
// Janata P, 2009: Loci at which Changes in BOLD Signal were Pos. Correlated 
// w/ the Degree of Postive Affect
// Janata P, 2009: Summary of Tonality Tracking Activation Clusters
// Subjects=13
-40	22	2
-60	-28	16
-46	-2	-10
-66	-34	4
-18	-14	-10
-6	-36	-4
-20	-56	-36
62	-22	6
58	0	-2
28	-56	-22
-44	14	12
-50	12	32
-32	10	58
-48	42	12
-2	34	48
-6	44	36
-4	56	2
0	28	32
-30	18	8
-50	-44	18
-54	-44	26
-52	-24	-12
-4	-50	10
-12	-12	10
-42	-52	-26
2	12	54
50	12	32
56	26	32
56	26	32
10	54	28
58	-62	24
16	-10	22
8	-28	2
20	-76	-28
40	-52	-26
32	-60	-20
34	-72	-36
4	-56	-34
-16	48	40
-4	48	40
-10	32	44
-12	44	30
-32	18	42
-50	20	6
8	52	30
8	50	-16
62	-18	-22
-22	40	22
-2	26	10
-6	34	-6
-2	-20	-6
-14	-12	12
56	-32	22
-10	52	32
-4	28	34
-8	32	48
-8	42	8
-16	62	22
-4	42	50
2	40	32
-46	42	-2
-42	38	6
-40	32	14
-42	42	18
16	48	34
-18	-86	-4
-10	-82	10
42	-62	22
18	32	52
8	-2	50
26	-68	-48

// Keedy S K, 2009: Schizophrenia Patients
// Subjects=9
-44.41	-8.57	52.92
2.61	7.03	57.76
0.43	9.93	54.2
8.47	-50.25	-36.75
-9.71	-53.79	-39.59
2.04	-73.53	-48.11
11.66	21.07	-9.31
-9.65	11.68	-4.94
25.16	-43.31	51.69
-18.61	-43.05	58.86
11.98	-96.53	-16.18
-9.3	-56.11	13.01
60.14	-16.34	25.61
-54.04	-31.86	41.6
21.29	17.95	-9.16
-12.85	5.06	-7.69
47.02	22.22	2.45
-63.93	-14.94	13.53
21.21	40.16	-11.02
-16.16	17.21	-15.36
11.57	46.44	-11.44
-0.09	21	-9.17
40.7	-15.34	-1.02
2.6	1.49	54.88
63.52	-40.93	37.67
-54.04	-45.06	36.02
12.05	18.49	39.97
-6.15	8.09	31.01
15	12.51	3.63
-3.14	12.66	7.17
27.9	-21.76	-.33
-22.46	1.83	-7.31
-2.8	9.66	50.91
50.2	21.98	-.91
-25.71	24.44	-3.59
8.87	25.33	46.12
-2.81	12.83	50.65
24.56	54.84	13.36
-25.51	39.7	28.58
11.99	21.15	33.05
-9.49	23.17	19.75
8.61	-12.53	-3.12
8.57	-3.02	-3.91
34.31	-41.44	-7.68
-18.87	-82.06	8.61
53.48	0.85	0.82
-28.35	-1.62	58.84
-25.8	-64.43	-51.9
24.51	-40.13	-31.09
2.09	-59.81	-35.88
-6.05	22.33	49.89
14.94	48.18	10.68
37.29	-.96	-21.14
-48.22	17.02	-14.98
24.34	52.61	-15.45
-22.62	56.18	-6.29
43.78	31.72	1.69
-44.78	0.78	8.65
44.41	-39.76	54.52
-28.3	-43.88	49.01
60.18	-62.04	12.71
-18.77	-87.63	19.11
60.18	-25.86	26.4
-54.21	-27.06	21.13
-15.72	8.55	37.77
-9.51	6.53	11.11
27.86	-12.25	-1.13
-31.92	39.66	28.66
11.81	35.73	15.1

// Keedy S K, 2009: Normals
// Subjects=9
-44.41	-8.57	52.92
2.61	7.03	57.76
0.43	9.93	54.2
8.47	-50.25	-36.75
-9.71	-53.79	-39.59
2.04	-73.53	-48.11
11.66	21.07	-9.31
-9.65	11.68	-4.94
25.16	-43.31	51.69
-18.61	-43.05	58.86
11.98	-96.53	-16.18
-9.3	-56.11	13.01
60.14	-16.34	25.61
-54.04	-31.86	41.6
21.29	17.95	-9.16
-12.85	5.06	-7.69
47.02	22.22	2.45
-63.93	-14.94	13.53
21.21	40.16	-11.02
-16.16	17.21	-15.36
11.57	46.44	-11.44
-0.09	21	-9.17
40.7	-15.34	-1.02
2.6	1.49	54.88
63.52	-40.93	37.67
-54.04	-45.06	36.02
12.05	18.49	39.97
-6.15	8.09	31.01
15	12.51	3.63
-3.14	12.66	7.17
27.9	-21.76	-.33
-22.46	1.83	-7.31
-2.8	9.66	50.91
50.2	21.98	-.91
-25.71	24.44	-3.59
8.87	25.33	46.12
-2.81	12.83	50.65
24.56	54.84	13.36
-25.51	39.7	28.58
11.99	21.15	33.05
-9.49	23.17	19.75
8.61	-12.53	-3.12
8.57	-3.02	-3.91
34.31	-41.44	-7.68
-18.87	-82.06	8.61
53.48	0.85	0.82

// Nakao T, 2009: Patients with Obsessive-Compulsive Disorder
// Subjects=40
42	18	14
-42	-50	20
-32	-14	18
14	-86	18
40	28	-18
14	-18	10
-24	-34	68

// Nakao T, 2009: Normals
// Subjects=25
42	18	14
-42	-50	20
-32	-14	18
14	-86	18

// Nelles G, 2009: Young Healthy Adults
// Subjects=11
48	2	50
-42	-3	53
3	3	58
0	-52	58
-27	-50	55
15	-88	-6
-12	-90	-1
15	-61	-4
-9	-73	-11
39	2	47
-33	5	47
0	3	61
24	-56	55
-30	-50	52
9	-87	4
-6	-93	2
39	-81	7
-30	-87	4

// Nelles G, 2009: Older Healthy Adults
// Subjects=11
39	2	47
-33	5	47
0	3	61
24	-56	55
-30	-50	52
9	-87	4
-6	-93	2
39	-81	7
-30	-87	4
39	2	47
-33	5	47
0	3	61
24	-56	55
-30	-50	52
9	-87	4
-6	-93	2
39	-81	7
-30	-87	4

// Salo R, 2009: Group Differences Associated w/ Trial to Trial Adjustments in 
// MA Dependent and Normals
// Subjects=12
8	14	44
18	0	72
44	0	46
-14	-6	72
14	44	42
62	12	10
-52	-2	40

// Seifert F, 2009: Normal Pin-prick Pain, Placebo Administration
// Seifert F, 2009: Pin-prick Hyperalgesia, Placebo Administration
// Seifert F, 2009: Normal Pin-prick Pain, Lidocaine Administration
// Seifert F, 2009: Pin-prick Hyperalgesia, Lidocaine Administration
// Seifert F, 2009: Main Effect of Sensitization Across Both Pharmacological 
// Treatments (Hyperalgesia > Normal Pain)
// Seifert F, 2009: Placebo > Lidocaine Administration, Averaged Across Both 
// Sensitization States
// Seifert F, 2009: Interaction of Sensitization and Pharmacological Treatment
// Subjects=12
-56.37	-20.73	20.62
54.77	-25.43	18.62
-42.47	-24.96	19.7
35.26	11.15	-2.06
-53.23	-.45	21.12
56.84	5.67	21.57
-53.18	-18.68	19.3
52.62	-16.82	20.16
-41.57	4.05	9.45
41.76	7.64	7.08
-7.32	26.86	26.1
5.54	22.88	28.52
-10.48	39.42	37.35
7.7	37.41	37.31
-23.32	34.77	33.43
43.95	29.12	23.1
-19.81	-10.45	53.91
36.66	0.32	36.75
-26.14	-56.82	46.72
37.94	-42.6	45.91
-8.44	-12.12	3.74
11.86	-9.89	3.32
-8.49	-18.18	-5.79
-5.03	-41.82	18.46
8.89	-43.69	20.68
-51.01	-25.98	21
16.67	-28.41	66.15
-48.86	-28	22.26
50.54	-26.09	24.3
-41.53	-4.32	11.27
-48.81	-25.28	29.84
51.66	-21.17	32.8
-42.67	-1.75	3.26
44.98	-5.29	4.78
-29.92	27.3	6.25
34.2	21.09	2.69
-4.17	39.49	23.89
7.57	38.33	21.63
-5.23	42.82	25.86
9.87	38.91	42.74
-4.02	43.23	44.77
-34	21.59	29.08
37.64	16.9	30.88
-16.61	-6.12	54.63
17.6	-20	50.94
-26.12	-58.84	48.01
32.66	-55.15	49.25
-10.58	-12.22	2.65
9.71	-9.98	2.23
-10.63	-15.99	-4.83
2.52	-39.95	28.25
-54.2	-17.03	26.98
54.73	-13.8	17.65
-43.82	12.79	-1.29
40.64	6.06	0.53
44.02	-20.64	12.77
-3.03	22.66	26.41
6.63	22	30.81
-12.7	51.67	30.78
12.04	31.52	43.33
-22.29	44.21	31.51
-43.52	2.75	34.12
50.56	-6.11	34.9
-25.03	-56.38	52.25
25.26	-55.39	60.51
15.02	-11.44	-3.28
-9.59	-18.53	-10.21
18.2	-14.93	-7.49
-4.42	50.03	-4.87
18.12	53.4	9.09
3.25	64.11	25.09
-2.86	-49.21	19.05
3.56	-49.09	20.08
-2.94	-48.93	8.99
17.07	22.84	-.6

// Spreckelmeyer K N, 2009: MID, Normal Males and Females, Triangle < One Bar 
// < Two Bars < Three Bars
// Spreckelmeyer K N, 2009: SID, Normal Males and Females, Triangle < One Bar 
// < Two Bars < Three Bars
// Spreckelmeyer K N, 2009: MID, Normal Males > Normal Females
// Spreckelmeyer K N, 2009: SID, Normal Males > Normal Females
// Spreckelmeyer K N, 2009: MID, Normal Females > Normal Males
// Spreckelmeyer K N, 2009: SID, Normal Females > Normal Males
// Subjects=16
9	15	-1
3	-17	12
-9	9	0
24	-89	18
-21	-90	10
33	26	-9
-12	-65	34
27	-90	13
-18	12	-1
-9	6	5
21	9	8
-24	-90	10
30	32	-2
24	-90	16
9	15	-1
15	32	-4
15	-2	17
-9	12	-1
12	-69	15
39	-77	26
-21	2	-10
24	-90	10
-18	12	-1
21	9	8
-3	32	2
3	-17	12
-21	11	-6
-21	-90	10
-6	28	26
0	19	32
15	9	5
18	-2	11
21	-90	10
12	-72	15
3	49	-13
21	-52	5
-18	5	-8
-9	6	5
0	-17	9
27	-87	13
15	-92	16
-24	-90	10
42	-57	25
24	18	2
0	24	18
-6	25	26
6	0	3

// Xu G, 2009: Previously Viewed > Novel Faces, Family History, APOE4
// Xu G, 2009: -APOE4 > APOE4, Previously Viewed vs. Fixation
// Xu G, 2009: -APOE4 > APOE4, Novel Faces vs. Fixation
// Xu G, 2009: No Family History > Family History, Previously Viewed vs. 
// Fixation
// Xu G, 2009: No Family History > Family History, Novel Faces vs. Fixation
// Xu G, 2009: Family History and APOE4 Interaction, Previously Viewed > 
// Fixation
// Xu G, 2009: Family History and APOE4 Interaction, Novel Faces > Fixation
// Xu G, 2009: d' and Previously Viewed > Novel Faces Interaction
// Subjects=15
-16	-46	50
-14	-76	50
-12	42	16
-14	40	16
-8	24	50
44	-60	18
-10	26	46
-10	-82	22
42	-60	-18
30	-8	-42
28	-12	40
-18	-46	2
28	-12	40
-18	-46	2
-24	-38	-2
-24	20	62

// Yoon H W, 2009: Word Encoding > Fixation, Alcoholic Patients > Normals
// Yoon H W, 2009: Word Encoding > Fixation, Normals > Alcoholic Patients
// Yoon H W, 2009: Face Encoding > Fixation, Alcoholic Patients > Normals
// Yoon H W, 2009: Face Encoding > Fixation, Normals > Alcoholic Patients
// Subjects=12
-50	-4	-20
-28	-50	50
-2	46	-8
-30	-52	-8
44	-58	-14
16	-74	2
-12	-76	3
-28	-46	62
28	-35	64
-44	-32	18
-8	36	-8
10	-78	2
-8	-78	2

// Beck A, 2009: Healthy Controls
// Subjects=19
-15	6	-3
15	12	-6
24	-39	12
-6	-24	6
6	-24	6
33	24	3
-18	9	-3
18	12	-6
0	-18	9
21	0	9
-24	0	0
-24	3	-12
15	-12	-15
36	-90	12
27	-27	15
-6	-69	9
60	12	-3
3	-87	15
21	12	-6
-15	-66	21
-12	-78	24
24	-60	24
15	-78	21
36	-45	6
42	-54	9
-51	-30	15
69	-27	9
57	-27	9
66	-27	0
-15	15	-3
-15	-63	21
39	-39	3
36	-24	0
-48	-75	18
69	-27	9
66	-24	0
-30	54	-6
-48	-42	15
-24	3	6
54	-18	12
15	9	3
0	33	-3
12	9	3
0	33	-3
15	9	3
36	-84	27
45	-78	27
-24	-78	24
-3	33	0

// Beck A, 2009: Alcoholics
// Subjects=19
-15	6	-3
18	6	-5
18	3	-6
-33	54	-3
36	51	12
9	-24	3
-51	6	-12
-15	6	-3
18	6	-6
33	45	3
36	33	9
-15	15	-3
-15	-63	21
39	-39	3
36	-24	0
-48	-75	18
69	-27	9
66	-24	0
-30	54	-6
-48	-42	15
-24	3	6
54	-18	12
15	9	3
0	33	-3
12	9	3
0	33	-3
15	9	3
36	-84	27
45	-78	27
-24	-78	24
12	9	3
0	33	-3
12	9	3
0	33	-3
21	15	0
12	0	3
12	0	3

// Xu L, 2009: Loss > Gain
// Xu L, 2009: Gain > Fixation
// Xu L, 2009: Immediate Reward > Delayed Reward, Gain
// Xu L, 2009: Loss > Fixation
// Xu L, 2009: Immediate Loss > Delayed Loss, Loss
// Subjects=20
48	51	21
54	39	21
12	33	-24
54	48	0
-42	33	18
-51	27	27
24	12	51
42	9	57
33	39	24
12	-9	12
30	-18	-6
27	18	-3
-24	-27	3
-12	15	-3
-33	-18	6
54	-42	48
42	-57	45
-24	-72	60
6	-66	0
15	-81	45
54	-60	-12
-51	-63	0
45	57	-9
27	69	-6
51	24	-12
-42	57	-9
-45	48	-15
-60	24	3
21	45	-21
9	57	39
-12	27	57
-6	45	45
33	24	48
-33	24	51
54	-42	48
-51	-57	45
-3	-99	18
15	-108	-3
6	-105	3
60	-36	-18
-60	-36	-18
21	-54	30
3	-42	36
-9	-60	33
6	57	9
-3	57	-6
-3	45	-9
3	48	-15
-6	9	-6
42	-63	42
54	-24	-15
51	0	-30
-54	6	-24
30	66	-6
39	33	27
-57	21	-6
-45	54	-3
6	21	66
-3	27	54
-42	12	48
24	-27	12
21	0	24
-21	-33	9
-12	-6	-6
6	-99	24
54	-45	48
-51	-54	30
63	-27	-18
-63	-33	-24
-45	-36	-6
-54	-63	-21
3	36	15
-6	30	15
9	42	-6
-6	-15	42
9	-21	33
-18	54	27
-27	51	30
-21	30	45
-30	24	60
42	-15	9
42	-21	-6
-36	-24	6
12	-51	36
-3	-54	42
-60	-15	-21
-57	-18	-12
-57	-51	36
-57	-57	21
-63	-48	15
66	-51	21
69	-45	15

// Hamilton L S, 2009: Schizophrenic Patients
// Subjects=20
-30	18	-4
-42	16	-8
-48	18	-16
-46	20	28
-58	14	12
-50	-22	52
-6	-10	52
-42	-18	62
6	-12	52
-16	-14	70

// Hamilton L S, 2009: Bipolar Patients
// Subjects=21
-8	-70	32
10	-76	10
8	-82	2
10	-72	-12
28	-86	-6
-50	-22	52
-6	-10	52
-42	-18	62
6	-12	52
-16	-14	70

// Hamilton L S, 2009: Healthy Controls
// Subjects=38
-30	18	-4
-42	16	-8
-48	18	-16
-46	20	28
-58	14	12
-8	-70	32
10	-76	10
8	-82	2
10	-72	-12
28	-86	-6

// Robinson J L, 2009: Familiarity > Fixation, Bipolar Patients + Healthy 
// Controls
// Robinson J L, 2009: Novelty > Fixation, Bipolar Patients + Healthy Controls
// Robinson J L, 2009: Healthy Controls > Bipolar Patients, Familiarity
// Robinson J L, 2009: Healthy Controls > Bipolar Patients, Novelty
// Robinson J L, 2009: Bipolar Patients > Healthy Controls, Familiarity
// Robinson J L, 2009: Bipolar Patients > Healthy Controls, Novelty
// Subjects=15
37.29	19.91	-12.86
46.06	33.27	21.61
-2.84	11.43	46.31
45.96	36.64	10.17
35.34	34.98	17.13
-39.64	56.94	4.99
-39.32	5.27	24.94
26.78	-59.61	-21.68
35.28	18.98	2.86
37.36	18.48	-3.82
22.59	-30.25	0.44
16.18	-14.8	8.14
16.11	-17.78	-2.76
22.63	-32.03	5.05
24.76	0.91	17.88
22.57	0.38	11.25
9.63	-22.9	-13.41
7.7	27.55	33.68
35.25	34.12	6.05
-41.82	52.01	-3.49
5.68	17.82	45.67
35.67	1.08	46.73
33.61	1.93	57.84
27.13	-5.48	45.15
54.81	6.86	37.11
46.06	33.27	21.61
-2.87	19.89	45.6
-.56	1.89	60.46
1.62	2.42	67.08
45.98	36.82	12.39
-39.65	56.77	2.78
41.89	5.75	23.96
46.28	-1.82	35.7
41.77	43.99	22.99
1.49	9.85	53.08
-35.37	59.08	4.77
20.42	-32.72	-3.79
-22.33	-30.87	-3.45
-33.07	-53.45	-19.28
-7.43	-29.18	-10.46
11.73	-25.52	-19.91
31.61	-64.84	47.85
31.65	-62.21	54.32
33.32	-84.6	-15.2
9.91	-92.52	-5.34
-45.75	-76.27	-10.53
35.21	22.69	-4.14
37.43	19.16	5.05
22.65	-9.85	16.57
22.62	-34.31	3.01
-22.26	-30.18	5.41
-11.58	-19.2	8.83
-15.86	-14.82	10.74
-11.63	-19.71	2.18
24.67	-26.35	-4.37
-18.03	-4.26	9.88
9.64	-25.01	-13.23
-7.45	-22.83	-10.99
-24.65	-32.76	-27.8
-9.55	-18.1	-4.67
37.61	-73.49	-9.49
16.35	-96.54	-2.85
-19.94	-94.13	4.06
20.64	-89.82	1
-11.51	-75.56	-4.29
37.65	-70.86	-3.02
-17.7	-101.89	13.6
27.06	-87.5	2.96
18.78	-58.4	49.68
38.09	-55.32	60.35
-37.27	-63.71	-13.91
35.46	-84.59	-15.22
-15.93	4.21	9.14
-18.04	-30.67	-1.29
-37.28	-55.08	-12.4
44	-64.82	-8.06
-39.54	-36.57	-20.62
-62.96	-51.17	-14.67
-67.18	-52.8	-7.79
-69.34	-33.26	-2.71
-37.37	-45.02	-19.94
-17.69	-95.2	17.5
33.37	-92.89	-12.27
16.35	-96.54	-2.85
-19.95	-92.01	3.88
20.64	-89.82	1
-11.47	-90.53	-5.27
18.44	-83.84	-3.94
-17.73	-99.94	11.21
27.05	-85.39	2.78
-35.33	-30.54	-25.64
31.42	-60.21	25.16
42.24	-49.98	46.48
33.66	-45.97	44.01
-43.76	-42.6	-15.61
59.07	6.71	34.84
59.02	10.6	30.05
-3.25	53.27	9.35
-5.57	36.05	-20.41
-5.56	51.54	-12.79
52.71	7.19	41.56
59.06	0.03	30.94
-1.1	35.85	4.09
-9.66	42.31	5.88

// Kaladjian A, 2009: Bipolar Disorder Patients
// Subjects=10
0	40	45
-6	54	28
-48	20	43
27	10	33
-45	-32	2
57	-4	-15
-24	-10	-15
-42	-57	30
48	-54	22
9	46	39
-23	37	31
-42	14	49
-33	-13	23
-42	-63	28
50	-57	19
-15	-51	36
9	-57	30
-21	-71	45
27	-55	57
-27	-9	-14
25	5	-4
-24	6	-3
15	-51	27
-6	-57	19

// Kaladjian A, 2009: Healthy Controls
// Subjects=10
24	56	14
27	37	40
-45	16	30
48	-1	34
56	0	-5
-27	-6	-18
27	-11	10
27	-33	-18
-42	-62	50
15	-42	38
-42	-70	1
24	-65	47
-12	46	39
-45	19	21
54	-4	-12
-54	-20	-1
-27	-6	-12
21	-32	-6
21	-54	28
27	-72	48
25	5	-4
-24	6	-3
15	-51	27
-6	-57	19

// Kaladjian A, 2009: Bipolar Disorder Patients
// Subjects=20
-40.39	9.9	53.39
4.73	51.88	40.63
-43.73	-63.11	30.42
59.85	-50.61	20.69
47.24	-56.77	47.29
5.18	-66.18	52.3
-21.78	64.96	-1.68
-28.23	-9.26	-14.4
30.06	-3.94	-18.16

// Kaladjian A, 2009: Healthy Controls
// Subjects=20
-40.66	28.65	35.85
30.68	20.4	35.45
-21.77	61.77	-1.36
26.91	56.93	1.65
-44.59	34.4	-17.32
52.59	36.56	-22.55
7.28	44.57	-14.72
-57.17	-42.67	-2.75
54.72	4.58	-31.74
-25.02	-10.52	-16.57
26.87	-9.06	-15.35
-43.58	-60.9	42.52
53.48	-49.8	29.69
4.96	-52.54	37.51
-40.85	-70.16	0.81
18.04	-80.04	41.13
-21.78	64.96	-1.68
-28.23	-9.26	-14.4
30.06	-3.94	-18.16

// Lee T M C, 2009: Intentional Faked Responses > Truthful Accurate Responses
// Lee T M C, 2009: Truthful Accurate Responses > Intentional Faked Responses
// Lee T M C, 2009: Intentional Faked Responses > Truthful Error Responses
// Subjects=10
-26	14	40
8	10	42
40	6	-14
4	-66	46
-42	-60	10
-8	-68	6
10	-56	6
8	-22	-4
-44	20	-4
-34	44	6
8	-40	28
-12	-56	46

// Chikazoe J, 2009: Stop vs. Uncertain-Go
// Chikazoe J, 2009: Uncertain-Go vs. Certain-Go
// Chikazoe J, 2009: Conjunction Analysis, Stop vs. Uncertain-Go + 
// Uncertain-Go vs. Certain-Go
// Chikazoe J, 2009: Disjunction Analysis, Stop vs. Uncertain-Go but not 
// Uncertain-Go vs. Certain-Go
// Subjects=22
38	16	-6
-32	18	2
54	14	26
48	16	18
42	6	32
34	18	14
26	52	26
-44	16	-6
46	36	16
-44	10	32
34	8	58
-40	56	18
-32	36	18
32	-4	50
18	16	58
4	24	36
2	14	46
0	-22	32
6	42	14
6	6	62
-4	4	60
18	-6	68
-8	0	68
64	-40	30
-42	-52	50
52	-38	48
64	-30	38
36	-58	48
-58	-36	36
-50	-42	48
12	-70	38
44	-46	40
24	-62	42
64	-26	24
-26	-66	50
-26	-60	38
14	-36	42
-14	-96	6
64	-40	16
60	-48	8
52	-50	16
52	-20	-6
-54	-40	20
38	-52	-14
50	-30	-2
36	-12	-8
54	-10	-10
10	-10	2
16	2	10
-10	-2	6
12	-18	14
-26	16	-6
6	-28	-22
2	-50	-40
-30	-58	-32
-12	-22	18
10	-56	-36
30	28	2
42	18	4
42	6	40
-40	16	0
-26	26	-6
4	12	52
20	-10	56
-14	-20	8
40	24	4
46	10	44
-32	20	4
-42	6	38
34	58	20
6	22	52
2	-22	32
58	-40	40
-62	-24	34
16	-66	40
30	-56	48
12	-90	4
-16	-92	-2
56	-20	-2
-8	-4	10
14	-14	16
-32	-56	-30
14	2	0
0	-52	-36
46	16	16
28	52	28
-42	12	28
-24	16	2
-34	20	18
-36	16	-10
56	-43	24
-44	-44	52
-54	-36	38
54	-46	56
4	36	26
-2	-24	36
20	4	6
-14	4	6
8	-6	6
-4	0	6

// Fales C L, 2009: Depressed Patients
// Subjects=23
39.68	32.43	25.1
-18.29	-5.86	-24.55
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34

// Fales C L, 2009: Healthy Controls
// Subjects=18
39.68	32.43	25.1
-18.29	-5.86	-24.55
-9.76	37.94	-9.37
5.62	22.68	39.69
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34

// Baillieux H, 2009: Activations in Controls, Absent in Dyslexics
// Baillieux H, 2009: Activations in Dyslexics, Absent in Controls
// Subjects=7
-44.86	29.58	9.58
-30.08	-15.08	-32.57
4.68	29.5	59.2
40.21	-39.02	64.54
-38.45	40.54	13.05
-53.35	-51.11	-14.78
-46.6	-43.25	31.32
-39.36	-79.75	-14.77
-20.42	-12.39	-26.21
68.57	1.17	17.35
20.51	-76.85	-10.13
19.51	-97.03	-9.54

// Bokde A L W, 2009: Face Matching > Control, Before Treatment
// Bokde A L W, 2009: Location Matching > Control, Before Treatment
// Bokde A L W, 2009: Before Treatment > After Treatment, Location Matching
// Subjects=5
-24.35	-102.12	-16.41
-70.55	-34.73	-21.53
-30.41	-52.44	48.63
-42.58	10.19	20.1
-32.89	39.54	40.95
-30.63	26.58	52.05
-9.39	28.68	36.01
-13.78	37.31	24.19
-13.86	-94.26	-39.5
-11.63	-104.22	-30.88
31.39	-107.74	2.38
46.29	-90.73	0.78
48.33	-86.2	-9.66
1.31	39.83	41.65
10.06	11.22	56.21
9.57	54.4	9.1
11.82	58.96	26.54
5.79	22.19	60.92
8.05	1.49	68.2
3.27	41.3	19.2
50.33	23.35	16.81
58.82	30.46	11.66
54.7	22.12	28.02
50.62	-3.31	43.58
58.82	30.46	11.66
43.85	-58.7	-25.3
48.09	-68.88	-33.41
-24.35	-102.12	-16.41
-41.68	-34.38	-19.66
-43.38	-101.24	10.5
-39.33	-73.95	-8.57
-36.88	-76.14	31.74
-34.88	-92.9	7.47
-24.26	-91.32	-.59
-19.76	-65.92	38.49
-54.62	2.72	-20.4
-56.82	19.71	-20.68
-46.17	21.55	-25.42
-24.61	-32.42	-23.37
-21.8	-78.11	46.23
-15.72	-73.84	4.54
-45.6	-30.72	28.03
-36.84	-43.85	50.22
-54.65	31.07	-11.62
-41.58	30.37	19.51
-52.48	46.74	-1.81
-15.65	24.64	53.15
-5.02	17.59	43.58
-.97	41.62	23.68
-4.93	15.19	53.82
-3.18	58.44	21.18
-3.01	37.09	34.12
-34.86	0.66	47.58
-24.01	-19.57	60.3
-21.84	-14.81	66.57
-52.31	-65.71	-24.72
-37.53	-41.18	-39.21
-35.33	-39.43	-30.47
-28.81	-48.14	-19.77
-9.48	-46.99	-6.71
20.61	-102.14	-6.89
25.06	-86.06	21.82
41.97	-73.66	1.63
46.14	-68.07	-8.93
33.74	-71.52	43.92
31.12	-55.64	-12.03
48.27	-73.68	-12.94
52.41	-42.11	-17.87
73.78	-41.98	-18.12
65.33	-56.32	-10.13
41.52	5.24	-23.94
48.37	-57.25	6.87
58.79	-29.12	-15.68
52.84	-60.71	30.53
60.95	6.18	0.29
61.22	-43.71	15.62
35.2	-6	-17.35
44.42	-38.53	56.64
48.63	-47.91	45.11
61.26	-32.28	25.82
12.27	-45.13	43.07
16.73	-65.22	58.08
40.15	-25.27	63.39
42.15	-53.12	33.36
46.4	-43.4	34.73
57.07	-43.51	32.38
1.43	4.85	43.46
20.53	26.57	33.62
50.16	36.96	0.06
58.86	18.75	11.53
39.67	33.4	23.9
43.01	20.53	36.09
41.71	38.99	13.37
41.77	30.87	18.51
35.39	42.1	26.57
3.12	51.82	3.82
12.13	16	49.1
14.22	24.3	46.15
14.1	41.77	37.99
10.27	-22.91	69.11
46.29	-6.14	34.95
11.8	-7.23	-3.6
16.2	-15.69	10.44
13.96	-.36	2.49
33.2	-7.9	-.44
5.29	-32.41	-25.94
26.85	-64.38	-14.59
18.29	-86.52	-24.9
52.43	-71.51	-26.55
65.13	-36.46	-28.52
-19.68	-100.27	34.68
-11.24	-73.87	31.25
-32.63	-78.57	27.43
-41.07	-80.77	41.09
-28.26	-74.26	41.52
-19.58	-69.58	59.98
-15.36	-76.67	50.49
-52.23	-62.74	-13.82
-41.59	-56.5	-16.69
-26.77	-30.4	-24.63
-39.16	-73.21	14.79
-39.74	34.96	-17.7
-39.73	24.13	-20.13
-17.56	-21.3	64.83
-3.13	43.55	21.31
-54.45	-72.32	-27.49
-43.84	-45.65	-27.62
-3.32	-47.32	-39.09
7.75	-79.58	-3.06
31.23	-70.98	-4.05
31.46	-79.59	22.32
65.32	-58.69	-13.28
45.97	-46.8	-22.97
56.7	-53.97	-20.27
20.29	-12.09	-12.21
46.2	-68.52	-1.08
44.31	-62.71	33.02
8.19	-80.5	53.89
14.5	-73.83	43.22
42.16	-52.95	35.57
35.08	28.98	-19.17
37.22	35.68	-15.29
35.32	17.2	7.47
49.22	15.17	7.48
18.2	-.67	-1.99
9.51	-48.3	-39.16
26.87	-64.21	-12.37
39.47	-43.3	-32.12

// Chae Y, 2009: Verum Acupuncture > Sham Acupuncture
// Subjects=10
20	33	30
-20	-1	24
-24	18	18
-18	-57	19
-8	-50	6
30	-49	-8
-30	-38	-15
-4	-64	31
8	-61	27
-10	-67	-12

// Davis N, 2009: Normal Adults
// Subjects=10
52.79	-38.17	33.1
46.06	-57.92	-15.35
46.18	-63.24	-1.53
36.8	-57.55	31.56
47.56	-56.72	41.4
33.71	-53.11	47.95
30.53	-66.08	45.73
-44.26	-49.89	55.27
-36.74	-53.82	58.86
43	6.19	29.49
26.98	2.92	29.95
33.67	-50.2	44.36
30.42	-57.33	34.96
-43.3	-41.14	44.49
-43.54	9.1	33.59
33.29	38.11	30.27
39.72	-70.39	-10.89
-30.43	-10.89	62.99
39.76	9.08	25.94
30.39	-1.61	53.71
43.09	3.79	39.73
46.4	-31.35	39.29
57.09	-24.68	41.95
-40.36	8.86	30.22
-30.76	12.09	29.84
-46.7	9.59	40.27
33.62	-57.31	34.92
30.6	-68.65	53.75
33.64	-70.26	32.66
30.52	-43.1	53.84
4.65	17.02	49.1
14.55	-65.66	52.57
-30.96	52.82	19.74
-24.5	53.37	26.31
-46.56	-41.68	37.88
-39.95	-49.53	59.65
42.98	12.53	28.96
46.29	3.81	39.69
29.96	57.67	21.98
30.45	-1.01	61.46
30.45	-60.25	38.55
43.19	-31.36	39.33
36.87	-53.61	41.27
37	-65.44	53.41
43.2	-41.14	36.8
52.81	-24.71	42.01
-43.47	3.27	40.77
-43.3	-41.14	44.49
-43.38	-35.31	37.31
-27.22	-47.13	48.15
-24.05	-1.33	62.12
-14.32	-69.26	49.86
-46.59	-25.56	39.87
-27.3	-61.11	32.6
4.62	16.76	45.77
46.11	-57.41	-8.7
30.14	-73.36	-7.18
-49.94	-69.9	3.48
-40.33	-80.93	-2.39
-27.55	-76.88	-6.23

// Davis N, 2009: Normal Children
// Subjects=27
36.34	16.78	1.91
33.15	26.79	7.8
4.56	26.02	41.65
7.79	13.09	39.35
-8.28	15.91	35.96
-20.72	-79.07	47.41
4.86	-82.86	37.4
-7.81	-68.2	63.08
-30.47	-50.84	41.81
14.49	-63	45.66
1.43	20.17	48.87
-1.88	25.72	38.4
-17.76	7.37	50.16
27.13	4.46	49.89
7.86	-94.93	4.92
7.94	-97.33	15.16
-14.68	-96.09	-8.11
-1.83	-75.96	3.44
-1.52	-62.84	49.17
8.18	-71.79	56.5
30.56	-68.99	49.32
1.42	23.34	48.6
-5.11	32.05	37.91
4.49	38.45	37.26
-20.94	7.6	53.53
-24.01	-83.29	34.42
-30.46	-54.01	42.07
-24	-73.26	40.27
-36.81	-50.11	51.86
27.42	-78.27	53.48
33.83	-71.63	56.2
27.13	11.06	52.68
23.83	10.02	39.43
-20.68	-75.39	53.79
-30.47	-70.64	33.43
33.67	-63.4	38.78
1.43	20.17	48.87
4.56	26.02	41.65
-1.92	31.81	34.55
-30.42	-63.53	42.87
-27.13	-72.51	50.28
-33.64	-53.77	45.44
43.25	-40.62	43.45
-43.57	2.24	27.47
52.79	-38.17	33.1
46.06	-57.92	-15.35
46.18	-63.24	-1.53
36.8	-57.55	31.56
47.56	-56.72	41.4
33.71	-53.11	47.95
30.53	-66.08	45.73
-44.26	-49.89	55.27
-36.74	-53.82	58.86
43	6.19	29.49
26.98	2.92	29.95
33.67	-50.2	44.36
30.42	-57.33	34.96
-43.3	-41.14	44.49
-43.54	9.1	33.59
33.29	38.11	30.27
39.72	-70.39	-10.89
-30.43	-10.89	62.99
39.76	9.08	25.94
30.39	-1.61	53.71
43.09	3.79	39.73
46.4	-31.35	39.29
57.09	-24.68	41.95
-40.36	8.86	30.22
-30.76	12.09	29.84
-46.7	9.59	40.27
33.62	-57.31	34.92
30.6	-68.65	53.75
33.64	-70.26	32.66
30.52	-43.1	53.84
4.65	17.02	49.1
14.55	-65.66	52.57
-30.96	52.82	19.74
-24.5	53.37	26.31
-46.56	-41.68	37.88
-39.95	-49.53	59.65
42.98	12.53	28.96
46.29	3.81	39.69
29.96	57.67	21.98
30.45	-1.01	61.46
30.45	-60.25	38.55
43.19	-31.36	39.33
36.87	-53.61	41.27
37	-65.44	53.41
43.2	-41.14	36.8
52.81	-24.71	42.01
-43.47	3.27	40.77
-43.3	-41.14	44.49
-43.38	-35.31	37.31
-27.22	-47.13	48.15
-24.05	-1.33	62.12
-14.32	-69.26	49.86
-46.59	-25.56	39.87
-27.3	-61.11	32.6
4.62	16.76	45.77
46.11	-57.41	-8.7
30.14	-73.36	-7.18
-49.94	-69.9	3.48
-40.33	-80.93	-2.39
-27.55	-76.88	-6.23

// Fullam R S, 2009: Lie - Truth
// Fullam R S, 2009: Truth - Lie
// Subjects=24
-30	24	-12
51	24	-15
-6	48	-6
3	48	-3
-9	54	0
6	51	0

// Harada T, 2009: Lie Judgement - Gender Judgment (masked with Lie Judgement)
// Harada T, 2009: Moral Judgement - Gender Judgment (masked with Moral 
// Judgement)
// Harada T, 2009: Lie Judgement - Moral Judgement (masked with the Lie 
// Judgement)
// Subjects=18
-6	46	40
-52	18	14
-48	28	-10
-48	18	38
-54	4	-30
52	18	46
60	30	16
52	30	18
44	30	-12
-50	-60	46
-58	-52	26
-4	-78	40
50	-54	28
-56	-42	0
52	-30	-10
46	6	-44
-28	26	0
-10	8	14
-16	4	0
10	0	18
16	0	0
6	-18	-4
28	-82	-40
-8	44	46
-48	16	-34
-50	16	16
-52	26	-10
-46	6	50
-36	24	44
-56	-42	0
32	-86	-36
14	8	0
-48	-58	40
-50	-54	24
-38	-58	20
54	-52	28
50	-52	40
-46	26	44
54	-28	-12

// Hester R L, 2009: Aware Errors - Unaware Errors, Healthy Controls and 
// Cannabis Users
// Hester R L, 2009: Cannabis Users > Healthy Controls, All Errors
// Subjects=16
2	21	36
41	15	-1
-41	-25	54
47	-34	48
28	-8	57
28	-10	5
29	-92	14
13	-80	-21
-29	44	24
41	15	-1
49	-41	42
-35	15	-6
2	-18	33
5	36	22
58	-28	-1
-39	-51	56
19	6	-4
-29	20	5
6	-19	-2
3	-14	49
1	-27	28
39	49	18
39	40	30

// Janse Van Rensburg K, 2009: Post Sitting > Fixation
// Janse Van Rensburg K, 2009: Post Exercise > Fixation
// Subjects=10
34	-28	72
56	36	4
54	42	-2
-32	38	-20
-64	-36	-14
-12	-16	52
-40	-46	44
40	-54	48
-34	-44	50
-48	-38	32
-38	-60	56
36	-58	60
64	-24	2
58	-30	0
64	-8	12
-38	-20	-12
-12	-16	68
-34	-42	-38
-44	-44	2
18	-4	18
18	-64	-28
-52	-56	-18
-34	32	50
0	48	14
10	46	18
2	62	12
-10	-78	26
48	-20	-16
38	-70	22
2	-62	26
2	16	36
0	46	-2
-2	-54	-44
0	-42	46

// Kato J, 2009: Negative Political Advertisements, Unchanged > Changed
// Kato J, 2009: Negative Political Advertisements, Changed > Unchanged
// Kato J, 2009: Positive Political Advertisements, Unchanged > Changed
// Kato J, 2009: Positive Political Advertisements, Changed > Unchanged
// Kato J, 2009: Negative Cola Advertisements, Unchanged > Changed
// Kato J, 2009: Negative Cola Advertisements, Changed > Unchanged
// Kato J, 2009: Positive Cola Advertisements, Unchanged > Changed
// Kato J, 2009: Positive Cola Advertisements, Changed > Unchanged
// Subjects=40
-43.96	-52.76	14.83
-69.15	-36.85	-8.73
-7.3	-66.33	5.46
32.04	-49.69	43.49
7.98	56.35	42.37
25.58	-75.86	39.46
51.14	-52.22	15.4
-15.8	47.45	40.29
-5.34	-42.69	-5.87
46.69	-35.74	8.24
40.89	-64.58	56.02
-13.42	-85.55	29.88
71.36	-1.93	1.11
-35.58	-87.55	-13.25
44.63	-80.93	7.14
-43.85	22.47	38.76
16.08	-27.6	-17.82
-53.33	13.98	-28.59
58.33	34.71	3.31
-30.62	-89.34	36.15
-23.84	-68.43	64.22
-48.6	34.54	7.39
-66.59	-6.51	28.57
46.05	29.53	-28.46
16.92	-95.66	34.85
58.32	-62.75	-17.3
-38.22	4.04	-32.35
-56	-41.93	5
19.32	-59.98	60.41
14.1	-71.11	-12.36
-15.29	-75.72	54.71
12.13	-42.34	8.36
5.55	-89.01	-8.2
-22.61	-62.31	-8.12
0.78	26.9	-19.59
27.1	-57.67	-7.18
-69.14	-38.97	-8.52
50.78	-62.57	-14.95
48.16	9.46	-36.6
-46.35	-78.56	-8.35
-35.89	-37.33	-27.18
50.67	-14.19	-14.13
53.03	-29.1	-1.49
-31.46	-16.82	-14.71
29.32	-77.98	-6.33
63.09	-49.53	20.53
-41.61	-72.13	25.67
-28.44	-69.46	41.99
-60.69	3.39	-15.09
18.16	67.02	-4.8
-44.06	-26.17	12.2
-33.13	12	29.53
43.07	-52.35	60.37
-50.6	-58.39	0.93
56.28	-15.91	1.63
37.64	-65.03	-29.05
56.12	46.4	2.19
-32.55	-6.6	71.7
22.34	-12.76	-31.72
-28.42	-45.23	48.56
38.23	-77.04	14.71
73.7	-30.12	9.46
-27.3	-48.66	-34.04
46.78	14.2	25.71
25.54	-54.28	40.69
26.68	28.92	-22.47
-16.51	28.97	-19.5
-19.86	-55.71	39.36
8.02	-38.57	25.99
56.37	-43.67	3.26
62.99	23.08	27.92
48.37	-1	-22.12
14.43	53.93	39.14
-48.18	-45.46	24.26
49.12	5.68	37.72
60.4	-16.28	-14.09
-56.23	36.22	2.87
-3.1	66.25	22.53
-48.06	-82.89	25.73
-18.37	-34.44	-8.71
7.82	-90.4	-.26
-41.54	-.51	45.48
24.72	-16.62	-15.69
-7.04	47.24	49.13
17.33	-52.15	75.36
32.1	19.7	62.39
-60.11	12.11	32.22
16.61	-103.47	8.73
18.51	-17.86	5.83
33.77	11.61	21.7
37.67	-60.46	-26.14
-11.39	-105.07	16.09
-22.5	-19.92	8.97
-35.77	-72.53	-24.81
1.41	-50.47	13.83
40.11	26.97	13.35
-68.67	-32.15	30.02
55.71	5.02	-38.53
-8.84	-78.14	51.48
51.05	2.85	18.91
42.53	43.19	37.48
48.82	-79.72	-3.13
-41.61	29.59	45.86
-25.04	14.47	-13.43
-52.57	9.8	30.08
-43.74	-41.32	33.86
-32.81	-20.58	48.43
-33.75	38.04	-13.38
29.9	-69.26	40.98
25.3	-54.98	21.71
55.06	-51.92	-16.07
-6.92	-9.85	46.93
-48.59	-19.03	-3
20.53	-25.48	-6.9
33.11	18.74	-28.3
50.76	25.86	0.96
-7.05	-98.37	18.71
42.89	2.1	57.23
58.15	-3.84	-18.64
-50.95	23.3	-9.39
-50.44	-35.25	18.81
-21.73	-39.3	65.79
-69.17	-16.22	-6.28
40.6	-22.97	41.82

// Langleben D D, 2009: Public Service Announcements (hiMSV + loMSV) > Neutral 
// Video Clips
// Langleben D D, 2009: Neutral Video Clips < Public Service Announcements 
// (hiMSV + loMSV)
// Langleben D D, 2009: High Message Sensation Value > Low Message Sensation 
// Value, Public Service Announcements
// Langleben D D, 2009: Low Message Sensation Value > High Low Message 
// Sensation Value, Public Service Announcements
// Langleben D D, 2009: Positive Correlation Between Frame Recognition Test 
// and Public Service Announcements
// Langleben D D, 2009: Negative Correlation Between Frame Recognition Test 
// and Public Service Announcements
// Subjects=18
-52	-58	16
56	-36	8
-8	44	40
10	-30	-10
-6	-52	32
4	46	-18
46	2	42
24	-96	-6
10	0	10
-18	-78	-34
26	-80	-30
18	-64	54
-30	12	8
40	-2	-2
-30	38	-14
40	28	34
54	-60	-6
-44	-72	10
60	-24	12
-30	-4	46
14	-46	-43
-64	-40	2
48	-36	2
-50	-62	40
50	-62	40
8	24	58
44	12	46
-6	38	46
16	44	42
6	42	-20
-28	-14	66
-46	-24	58
-24	-98	-8
-18	-82	-36
32	-80	-28
-40	20	-28
-60	-46	10
50	-34	0
6	52	-12
-54	-16	-6
2	48	38
56	-18	-10
42	-38	-18
-26	-84	8
38	-56	2
0	-88	-4
-32	-86	0
-32	-64	-12

// Leaver A M, 2009: Musically Trained Subjects
// Subjects=11
59.96	-11.63	4.02
-52.22	-18.64	5.9
4.69	10.93	52.95
34.18	-54.96	-31.08
1.15	-72.79	-24.74
-5.02	-78	4.76
-14.62	-97.61	-.17
-2.1	-24.91	-10.88
-34.21	-55.28	-29.15
-8.18	12.54	47.39
-40.09	-43.24	44.63
-56.53	7.31	11.58
25.66	6.84	-1.81
-49.05	1.9	9.72

// Leaver A M, 2009: Musically Untrained Subjects
// Subjects=9
57.85	-13.61	6.11
-52.2	-20.6	8.18
27.73	-12.47	-17.84
-1.09	-56.26	24.08
-35.24	-30.74	-14.47
55.97	5.45	47.25
6.7	9.28	63.1
53.53	22.14	14.65
37.18	51.71	-14.41
-1.59	-.94	65.17
1.51	8.97	55.38
0.34	-30.53	26.37
-19.15	-3.64	4.26
-14.84	-13.13	5.01
-1.92	-18.63	15.36
-35.82	-50.96	40.76
30.96	-57.26	-33.08

// Liu P, 2009: GB37 Acupuncture vs. Rest
// Liu P, 2009: GB37 Acupuncture vs. Rest (Deactivations)
// Liu P, 2009: KI8 Acupuncture vs. Rest
// Liu P, 2009: KI8 Acupuncture vs. Rest (Deactivations)
// Liu P, 2009: GB37 Acupuncture vs. K18 Acupuncture
// Liu P, 2009: K18 Acupuncture vs. GB37 Acupuncture
// Subjects=28
-15	28	32
6	56	19
-42	-12	-4
42	-12	-4
-27	-10	-20
-50	11	-3
-18	-72	12
3	-78	12
-12	-80	26
21	-55	3
-30	-83	26
12	-86	35
-45	-57	17
56	-57	17
31	-84	4
-3	-80	26
12	-90	16
-42	-60	14
6	-77	37
-3	55	0
3	-18	48
9	41	3
23	26	-10
-3	53	14
6	42	23
-3	-51	30
3	-63	17
-12	-55	3
42	-67	9
-42	-15	-4
42	-14	12
-33	-15	-7
30	-12	-15

// Mazzola-Pomietto P, 2009: Manic Patients
// Subjects=16
27.57	27.91	47.09
-40.45	-56.2	35.28
8.27	-42.12	45.38
46.22	28.65	-14.93
-41.31	24.84	-16.43

// Mazzola-Pomietto P, 2009: Healthy Controls
// Subjects=16
46.17	31.53	-18.58
-38.13	33.15	-19.54
-21.82	64.65	-5.01
64.86	-16.29	-2.96
53.48	-56.39	28.1
-36.89	-60.39	59.17
-1.46	-38.97	45.24
46.22	28.65	-14.93
-41.31	24.84	-16.43

// McCabe C, 2009: Subjects Receiving Aprepitant
// Subjects=12
32	-60	-20
-36	-48	-28
36	-52	-22
-38	-48	-22
0	54	24
-38	-48	-20
58	-64	-10
46	40	24
2	46	0
24	6	0
-18	-100	0
12	-18	6
-22	4	2
14	-96	-2
12	-2	12
-20	-98	0
14	26	-18
2	-72	30

// McCabe C, 2009: Subjects Receiving Placebo
// Subjects=12
30	-58	-20
-38	-20	52
34	-56	-18
2	46	0
24	6	0
-18	-100	0
12	-18	6
-22	4	2
14	-96	-2
12	-2	12
-20	-98	0
14	26	-18
2	-72	30

// Mensebach C, 2009: Borderline Personality Disorder (BPD)
// Subjects=18
43.12	23.09	-5.36
-1.66	30.69	43.95
-37.84	49.57	6.84
-59.54	17.09	-6.38
-30.65	-45.76	43.05
-27.31	-57.03	48.59
-37.2	-39.71	39.2
49.84	49	18.85
36.31	52.35	-24.95
33.17	56.36	-16.33
34.22	-53.94	43.87
21.33	-63.24	48.37
-5.59	-22.67	-21.3
4.7	-22.73	23.36
-5	-9.48	27.81
-62.41	-37.08	11.35
-8.44	-18.6	10.85
24	1.38	16.16
17.45	3.07	11.62
55.35	24.66	22.29
4.24	-54.64	-19.42
-8.12	24.28	44.7
1.47	29.87	35.02
-49.46	17.6	21.41
43.12	23.09	-5.36
49.49	15.69	-15.95
-27.32	-53.84	48.27
-43.65	-36.23	42.32
-37.14	-42.59	42.84
-5.18	-11.9	13.49
-18.24	-9.38	6.74
-12.03	-22.38	-17.86
-50.86	-53.77	-18.57
-44.13	-51.88	1.3
20.81	-8.1	18.27
17.28	-8.06	-4.08
4.39	-45.85	-5.73
1.04	-46.69	-14.55
7.67	-70.71	-7.81
49.84	49	18.85
49.65	46.48	3.42
43.39	-48.17	1.68
36.96	-56.6	3.75
-56.13	-33.09	-3.72
-59.27	-42.15	2.84
-15.15	-59.72	-15.23
11.36	-23.59	36.77
11.23	-42.06	22.92
1.53	-12.34	31.35
-59.68	1.81	-20.56
-62.37	-36.77	14.68
52.87	24.39	-3.42
47.09	-58.98	35.19
4.95	-23.09	42.44
43.4	-50.3	1.89
-33.62	-26.26	68.06
0.27	21.28	23.56

// Mensebach C, 2009: Healthy Controls
// Subjects=18
-1.58	21.43	48.23
-40.78	1.47	20.62
-55.73	13.71	37.59
40	48.03	9.03
-27.46	-49.46	37.75
-14.21	-62.54	57.87
-27.35	-57.35	45.26
11.76	-67.66	59.06
46.27	15.88	-13.67
47.05	-33.04	37.1
4.12	-35.81	-24.65
-34.65	52.46	3.14
-1.58	21.43	48.23
-37.78	18.31	5.45
-44.29	34.45	6.21
4.44	-80.5	-9.02
7.47	-44.85	-18.2
-5.49	-18.64	-12.73
-5.58	-42.23	-23.85
24.02	-11.59	15.2
-27.42	-49.15	41.08
-52.99	-60.06	-16.79
11.36	-23.59	36.77
11.23	-42.06	22.92
1.53	-12.34	31.35
-59.68	1.81	-20.56
-62.37	-36.77	14.68
52.87	24.39	-3.42
47.09	-58.98	35.19
4.95	-23.09	42.44
43.4	-50.3	1.89
-33.62	-26.26	68.06
0.27	21.28	23.56

// Mostofsky S H, 2009: High Functioning Autism (HFA) Patients
// Subjects=13
-53.33	-14.06	50.38
24.86	-56.07	-12.91
-13.95	-22.75	1.26
-31.37	-3.01	-4.87
-6.95	8.54	48.47
12.16	-85.82	2.58
42.95	-12.79	58.7
1.2	-66.27	-5.89
-.3	6.51	60.89
9.82	-16.07	2.44

// Mostofsky S H, 2009: Healthy Controls
// Subjects=13
-39.25	-22.52	50.98
18.27	-54.7	-20.78
-18.13	-26.08	11.75
-9.22	16.42	41.01
22.36	-68.46	-41.9
-22.86	-60.89	-27.31
-.81	-99.04	-.38
55.66	-13.55	38.39
-20.39	-86.97	-7.96
51.53	-11.05	53.9
-16.26	-54.51	-16.85
-4.89	14.31	41.15
-34.81	-1.91	64.55
-41.46	-29.43	46.1
26.99	-62.86	-16.75
14.22	-11.08	9.71
-62.09	-17.16	40.75

// Obermann M, 2009: Pain-Related Responses Using Train Pulse and Single Pulse 
// Stimulation
// Obermann M, 2009: Stimulation Level by Condition Interaction
// Subjects=11
1.41	15.21	27.5
-.57	-27.24	32.86
46.32	0.89	-13.31
51.76	-54.13	63.76
53.78	-32.21	57.08
9.93	-14.18	11.22
57.59	28.48	28.59
5.97	23.58	47.89
22.81	7.14	8.89
-37.92	-73.6	-24.67
7.39	-27.94	-21
1.41	15.21	27.5
10.53	-24.3	-28.13
26.94	-18.32	-11.08

// Onur O A, 2009: (Fear > Neutral) Reboxetine > (Fear > Neutral) Placebo
// Onur O A, 2009: (Happy > Neutral) Reboxetine > (Happy > Neutral) Placebo
// Onur O A, 2009: (Fear > Neutral) Placebo > (Fear > Neutral) Reboxetine
// Onur O A, 2009: (Happy > Neutral) Placebo > (Happy > Neutral) Reboxetine
// Subjects=9
50	-16	8
42	42	-10
32	-60	-14
20	-54	44
18	-86	-4
-36	-56	-8
-22	30	-12
54	-50	30
-48	-44	32
26	6	-32
60	-24	22
-46	-40	30
-18	-4	26
16	-64	-34
14	28	-20
-12	38	28
-8	48	6
12	-16	34
-32	-74	14
12	-56	42
-28	14	-10
-28	-86	42
4	-68	-20
-40	-74	24
-26	-14	16
-12	-28	-6
56	-58	-34
48	-56	-16
-18	54	-10
18	-44	6

// Ramaekers J G, 2009: Effect of MDMA in Go Trials
// Ramaekers J G, 2009: Effect of MDMA in No-Go Trials
// Subjects=12
-7.41	-5.94	0.98
-11.72	7.95	2.09
-20.76	-66.3	47.45
-33.58	-45.52	55.9
61.32	-27.28	35.43
-40.05	-43.95	49.15
36.91	-53.09	47.91

// Schienle A, 2009: Spider-Phobic
// Subjects=10
-39	9	-12
45	15	-12
-24	0	-15
-48	15	-9
48	18	-9
-9	48	-21
0	42	-27
6	51	-6
45	6	-6
-36	30	-18
48	51	-6
0	42	-27
3	42	-21
-33	3	6
0	42	-27
9	39	-9
-15	48	-18
-39	-3	18
-36	30	-15
21	24	-18
-36	-12	12
45	9	-6

// Schienle A, 2009: Healthy Controls
// Subjects=8
-9	45	-6
12	42	-6
-15	18	-12
15	42	-12
-3	57	-15
-33	3	6
0	42	-27
9	39	-9
-30	24	-3
-24	36	-9
36	51	-12
-33	21	-9
33	15	-12

// Small G W, 2009: Internet-Naive Subjects
// Subjects=12
-56	26	-4
-46	18	18
-54	28	14
-38	-2	32
-46	10	44
-56	0	-20
-60	-16	-16
-60	-44	0
60	-4	-20
-44	-66	34
-36	-46	-20
-44	-70	-12
-14	-102	6
26	-90	-6
-20	-24	-20
-2	-60	14
8	-34	66
-54	28	4
-56	20	22
-48	6	38
-46	10	48
-56	10	-26
-56	-16	-12
-56	-44	-2
48	-54	12
-44	-50	-18
-52	-56	-14
-14	-102	4
-28	-74	48
18	-102	10
-2	-54	12

// Small G W, 2009: Internet-Savvy Subjects
// Subjects=12
-54	30	-6
-50	12	20
-46	28	12
-46	0	32
-42	2	42
50	30	14
-52	-8	-26
-62	-28	-6
-56	-38	-4
-34	-74	32
-38	-50	-18
-44	-64	-18
-22	-102	-2
26	-100	4
-22	-30	-6
-4	-56	16
-52	26	-6
-56	20	20
-46	8	22
-42	2	40
-4	44	38
-10	14	64
46	12	28
-56	0	-20
-56	-20	-8
-56	-38	-2
60	-6	-18
-48	-70	20
-28	-36	-22
-34	-54	-18
38	-48	-22
-18	-102	-6
-22	-80	48
16	-92	-6
26	-86	40
-26	-24	-16
24	-18	-18
-4	-56	10
-4	-54	38
-6	26	34
12	-28	66

// Sripada C S, 2009: Social Anxiety Disorder Patients
// Subjects=26
0	-82	-2
48	-76	-8
42	-48	-24
-46	-78	-4
-16	-14	-12
52	-14	24
-24	-86	12
10	50	22
-12	-84	28
48	6	16
52	14	22
-8	18	74
-62	-52	32
44	44	32

// Sripada C S, 2009: Healthy Controls
// Subjects=26
0	-80	0
-46	-80	-6
46	-80	-4
50	26	28
48	-70	8
-14	10	-8
-64	-2	20
-24	-86	12
8	52	24
52	-14	24
-24	-86	12
10	50	22
-12	-84	28
48	6	16
52	14	22
-8	18	74
-62	-52	32
44	44	32

// Summerfield J J, 2009: Brain Regions Activated By All Conditions
// Summerfield J J, 2009: Recall of Real Autobiographical Events > Recall of 
// Imagined Autobiographical Events
// Summerfield J J, 2009: Recall of Autobiographical Events > Recall of Film 
// and News Events
// Summerfield J J, 2009: Recall of Previously Viewed Events > Recall of 
// Previously Imagined Events
// Summerfield J J, 2009: Recall of Film Events > Recall of News Events
// Subjects=18
-9	63	24
0	48	-12
-3	18	-15
-3	6	69
-21	39	48
-36	6	57
-54	21	15
-51	30	0
57	30	9
-15	-15	9
45	15	-33
-57	-3	-21
-51	-42	-3
48	-36	-3
18	-30	-9
-24	-36	-15
30	-36	-18
-3	-54	36
-6	-42	39
12	-54	30
-9	-54	3
-12	-60	12
21	-60	21
-48	-69	30
42	-63	27
0	-69	-3
6	-87	-18
9	-48	-48
-27	-81	-36
27	-84	-33
-9	42	-9
3	33	-3
-21	24	45
39	12	0
30	-33	54
-3	-12	30
12	-66	27
-48	-66	33
42	-72	36
-21	-36	-42
-18	-51	-30
27	-51	-33
-12	54	33
-27	51	27
-18	39	33
-33	36	-12
-6	33	-12
6	33	24
3	18	24
-24	6	60
-51	9	33
-36	-24	39
18	6	21
-9	-15	12
6	-30	36
-6	-54	6
-9	-72	54
-39	-81	27
-6	-96	0
18	-84	-36
-3	-3	63
-3	18	-6
48	-9	54
60	3	-18
-9	-45	0
9	-51	6
3	-51	45
-15	-57	18
-9	-96	6
0	54	27
3	45	-21
48	12	-33
60	-9	-18
48	-33	-6
-57	-60	30
57	-57	24
0	-60	42

// Watson A, 2009: Not Informed Low Intensity (Conditioning-Preconditioning) - 
// Informed (Conditioning-Preconditioning)
// Watson A, 2009: Not Informed (Post Conditioning - Preconditioning) - 
// Informed (Post Conditioning - Preconditioning)
// Subjects=11
4	-22	42
-6	32	24
-26	52	18
-6	44	34
-2	-32	32
-20	-62	2
-8	-48	16
-8	-58	36
12	38	-12
-24	52	18
-6	44	34
-8	42	-10
-6	32	24
-10	40	-12

// Welander-Vatn A S, 2009: Bipolar II Disorder
// Subjects=27
12	0	58
28	-66	44
-10	-76	-26
38	-66	-22
22	2	0
10	-104	8
-34	-58	58
40	16	0
-38	22	-2
-56	2	40
50	14	18
8	-76	-20
-26	6	-8

// Welander-Vatn A S, 2009: Healthy Controls
// Subjects=28
-4	6	50
-48	-68	-8
-26	-64	50
-24	2	-2
12	-98	8
46	4	22
46	-52	50
-50	-2	52
4	-30	-14
44	38	22
-22	-92	18
10	-100	8

// Baglio F, 2009: Healthy Controls
// Subjects=11
-26.25	-21.1	53.98
-50.13	-13.3	46.89
-39.26	-17.1	51.56
18.26	-62.45	-23.37
-41.98	-78.23	-5.1
-46.53	-58.01	-18.22
1.73	0.06	49.17
-.24	2.57	64.64
28.94	-.52	64.45
47.46	-25.56	71.09
31.48	-84.56	-7.96
37.4	82	-17.82
42.14	-54.95	-13.31
-21.78	-59.37	57.69
53.57	-26.11	41.91
10.18	-82.35	16.84
70.59	-30.26	19.62
-11.82	-19.65	-.2
-59.01	9.03	33.63
63.97	12.47	17.74
55.42	-78.77	6.75
-59.6	6.8	-13.21
-48.41	-84.43	-2.13
-44.36	-66.72	-19.64
58.12	-39.74	56.63
-21.9	-58.08	48.6
39	-82.61	-10.52
47.45	-23.43	70.88
-19.58	-61.29	60.08
-28.13	-34.34	73.25
43.88	-4.49	-36.27
9.68	10.2	-3.52
-28.46	-23.65	49.79
40.99	-27.71	71.42
-48.41	-84.43	-2.13
-5.23	-16.67	8.36
7.48	-18.49	-11.85
-59	-43.48	23.13
5.58	3.13	12.94
-31.58	32.63	-14

// Baglio F, 2009: Parkinson's Disease Patients
// Subjects=15
-54.94	-14.72	9.01
-13.45	-68.22	31.53
-34.93	-12.62	53.29
-7.6	-13.88	-7.57
-28.78	-96.08	9.89
11.84	-13.81	-7.9
16.74	-29.2	33.88
22.98	41.23	29.04
-52.29	-13.31	46.93
42.95	-66.36	48.31
51.03	14.76	19.98
48.79	42.61	19.5
6.01	26.02	51.01
-33.06	-88.13	14.78
37.18	-87.78	14.67
47.45	-23.43	70.88
-19.58	-61.29	60.08
-28.13	-34.34	73.25
43.88	-4.49	-36.27
9.68	10.2	-3.52
-28.46	-23.65	49.79
40.99	-27.71	71.42
-48.41	-84.43	-2.13
-5.23	-16.67	8.36
7.48	-18.49	-11.85
-59	-43.48	23.13
5.58	3.13	12.94
-31.58	32.63	-14

// Bennett D S, 2009: Prenatal Tobacco Exposed Subjects
// Subjects=7
-8	26	54
-38	22	49
4	26	52
14	54	36
-30	42	26
-34	57	19
14	13	58
36	5	53
30	39	40
44	10	36
51	0	42
-55	-22	-6
-59	-18	-14
50	-49	-16
20	-54	45
-4	-74	26
-16	-96	23
8	-88	34
-10	-96	25
10	-13	4
6	-41	-6
-6	-51	-3
0	-64	0
-8	-29	-7
-2	-72	-3
-44	18	47
-10	60	28
-12	63	19
-32	18	43
-36	17	25
-54	-59	26
32	-57	27
-53	-59	25
32	-57	30
-50	-51	-15
-50	-51	-13
32	-57	25
-36	-73	46
-40	-74	35
10	-51	34
20	-78	28
20	-78	32

// Bennett D S, 2009: Non-Exposed Subjects
// Subjects=11
2	8	53
0	20	47
18	11	57
18	-5	61
2	8	38
32	-43	63
50	-40	54
-32	-69	-23
6	-41	-6
-6	-51	-3
0	-64	0
-8	-29	-7
-2	-72	-3
-44	18	47
-10	60	28
-12	63	19
-32	18	43
-36	17	25
-54	-59	26
32	-57	27
-53	-59	25
32	-57	30
-50	-51	-15
-50	-51	-13
32	-57	25
-36	-73	46
-40	-74	35
10	-51	34
20	-78	28
20	-78	32

// Lau J Y F, 2009: Fearful Faces > Passive Viewing
// Subjects=31
26	2	-16
22	16	56
26	30	48
-16	-4	-10
36	-68	-22
-6	42	42
4	-20	-14

// Dichter G S, 2009: Healthy Controls
// Subjects=15
6	-76	10
18	-2	66
2	-8	56
-6	52	-4
2	54	22
20	10	18
-44	34	4
48	20	81
-30	34	30
-44	22	38
48	77	55
16	-32	8
-40	-60	-8
38	-66	-10
32	28	-18
-42	40	8
45	97	38
18	-12	24
34	14	8
-40	-8	64
34	40	32
-8	50	20
-42	38	30
0	-56	22
-18	-32	2

// Dichter G S, 2009: Unipolar Major Depressive Disorder Patients
// Subjects=14
6	-76	6
16	20	-2
-18	-18	74
4	22	44
-12	18	2
48	14	30
14	-2	66
-36	22	-14
-44	22	38
48	77	55
16	-32	8
-40	-60	-8
38	-66	-10
32	28	-18
-42	40	8
45	97	38
18	-12	24
34	14	8
-40	-8	64
34	40	32
-8	50	20
-42	38	30
0	-56	22
-18	-32	2
32	63	25

// Glascher J, 2009: Conjunction of Vchosen for Action Response and Stimulus 
// Response
// Glascher J, 2009: Action Response Vchosen > Stimulus Response Vchosen
// Glascher J, 2009: Conjunction of Prediction Error for Action Response and 
// Stimulus Response
// Glascher J, 2009: Action Response Prediction Error > Stimulus Response 
// Prediction Error
// Glascher J, 2009: Conjunction of Action Response Switch > Stay and Stimulus 
// Response Switch > Stay
// Glascher J, 2009: Conjunction of Action Response Stay > Switch and Stimulus 
// Response Stay > Switch
// Glascher J, 2009: (Action Response Switch > Stay) - (Stimulus Response 
// Switch > Stay)
// Subjects=20
-6	24	-21
6	30	-9
9	27	-12
3	54	-3
-27	-18	-18
24	-9	-18
9	-30	51
-3	-9	51
3	-6	51
-36	-60	24
-21	-63	-18
21	-66	-18
-51	-18	54
51	-15	54
-57	-3	-15
63	-15	3
-57	-30	39
63	-30	48
-6	6	45
12	6	36
-18	-6	57
0	3	57
-33	-6	42
48	-3	39
-42	-21	42
-39	-15	15
57	3	12
-15	3	-15
9	9	-12
-24	6	6
24	3	15
30	-6	9
0	33	-12
3	36	21
-42	33	-9
-18	3	-15
18	6	-15
57	-33	33
27	27	-3
24	48	-6
-33	48	21
36	45	30
-3	39	-12
3	-15	42
-33	-30	45

// Hooley J M, 2009: Healthy Controls
// Subjects=12
-18	-2	4
-36	-84	0
46	20	42
-18	-82	16
-22	-50	-12
-14	-66	-8
4	-76	22
24	-46	-6
56	-52	30
-38	12	-2
48	-64	42
12	-62	4
0	50	-6
-4	-60	4
58	16	24
-34	8	-28
-42	-4	6
50	56	14
42	-4	-16
46	22	-6
-52	-24	6
62	-2	-10
16	-80	-44
2	58	18
-18	-78	-30
-16	-48	-10
-52	28	-12
0	-14	0
-2	-50	2
-50	-28	2
6	-78	20
60	-4	-8
26	-84	-36
-26	-80	-34
0	58	8
-58	-20	-4
62	-12	-10
2	-78	-14
-26	-82	-36
-2	-60	8

// Hooley J M, 2009: Recovered Depressed Patients
// Subjects=11
-18	-2	4
-36	-84	0
46	20	42
-18	-82	16
-22	-50	-12
-14	-66	-8
4	-76	22
24	-46	-6
56	-52	30
-38	12	-2
48	-64	42
12	-62	4
0	50	-6
-4	-60	4
58	16	24
-34	8	-28
-42	-4	6
50	56	14
42	-4	-16
46	22	-6
-64	-26	-2
46	14	-46
26	-86	-38
4	-60	-46
-22	-74	-38
62	-24	-12
-64	-26	-2
6	-4	2
-26	-18	-18
4	-72	-20
4	-32	-6
-62	-28	-2
64	-18	-14
54	18	18

// Matthews S C, 2009: Errors - Correct Responses, Healthy Controls > Major 
// Depressive Disorder Patients
// Matthews S C, 2009: Hard - Easy Trials, Major Depressive Disorder Patients 
// > Healthy Controls
// Subjects=15
32.06	29.79	5.33
-12.82	27.41	6.05
-6.33	43.62	22.46
1.97	34.5	-13.67

// Remijnse P L, 2009: Major Depressive Disorder Patients
// Subjects=20
39	15	-30
-36	-15	48
30	-90	15
-27	15	0
12	33	-12
39	15	-30
-27	-87	0
24	0	12
-39	21	3
18	-69	51
-33	18	3
36	-93	3
39	-72	39
-21	-42	54
39	15	-24
-48	15	-18
-21	-45	54
-33	24	9
-18	51	0
45	42	6
33	21	6
-33	48	-6
-24	57	9
48	3	18
-3	36	18
-48	-33	36
9	-15	6

// Remijnse P L, 2009: Obsessive Compulsive Disorder Patients
// Subjects=20
12	33	-12
39	15	-30
-27	-87	0
24	0	12
-33	18	3
39	15	-24
-48	15	-18
-21	-45	54
-33	24	9
-18	51	0
45	42	6

// Remijnse P L, 2009: Healthy Controls
// Subjects=27
39	15	-30
-36	-15	48
30	-90	15
-27	15	0
-39	21	3
18	-69	51
36	-93	3
39	-72	39
-21	-42	54
33	21	6
-33	48	-6
-24	57	9
48	3	18
-3	36	18
-48	-33	36
9	-15	6

// Valentin V V, 2009: Average Prediction Errors, (Juice - Neutral Solution) 
// and (Money - Scrambled Money)
// Valentin V V, 2009: Conjunction Prediction Errors, (Juice - Neutral 
// Solution) and (Money - Scrambled Money)
// Valentin V V, 2009: (Money - Scrambled Money) - (Juice - Neutral Solution), 
// Prediction Errors
// Valentin V V, 2009: Juice > Money, Prediction Errors
// Subjects=17
-9	3	15
15	12	-6
-9	0	6
15	9	-6
-39	-66	-3

// Smoski M, 2009: Selection Phase > Control Wheel, Depressed Patients > 
// Healthy Controls
// Smoski M, 2009: Selection Phase > Control Wheel, Healthy Controls > 
// Depressed Patients
// Smoski M, 2009: Anticipation Phase > Control Wheel, Depressed Patients > 
// Healthy Controls
// Smoski M, 2009: Anticipation Phase > Control Wheel, Healthy Controls > 
// Depressed Patients
// Smoski M, 2009: Feedback > Control Wheel, Depressed Patients > Healthy 
// Controls, Winning Trials
// Smoski M, 2009: Feedback > Control Wheel, Healthy Controls > Depressed 
// Patients, Winning Trials
// Smoski M, 2009: Feedback > Control Wheel, Depressed Patients > Healthy 
// Controls, Non-Winning Trials
// Smoski M, 2009: Feedback > Control Wheel, Healthy Controls > Depressed 
// Patients, Non-Winning Trials
// Subjects=14
48	-10	8
8	-86	26
-34	36	20
24	24	52
26	30	-16
22	48	-20
-16	34	-12
22	-6	-28
56	-72	-8
-4	-62	4
52	-72	14
-40	-64	6
14	-70	56
-14	-72	58
8	-90	14
-8	-90	30
-38	-12	-22
44	-36	32
64	-18	8
6	-50	76
6	-28	80
8	-50	58
-16	-50	54
-50	-28	34
50	-42	44
-44	-24	-14
48	-56	-6
-46	-56	-10
44	-22	-32
-60	-8	0
-52	-54	28
-8	6	6
-48	26	38
-18	26	60
-14	44	48
0	48	2
52	-2	52
-62	-52	38
-70	-14	-22
-52	-28	24
-18	-16	22
-16	36	14
10	-44	12
-10	-30	-38
-28	24	26
34	12	30
-32	12	52
-34	34	12
-34	-26	-14
-10	-76	-4
22	-74	36
-32	-66	46
-34	-80	22
-32	-70	-2
42	-22	48
24	-10	72
-40	-4	54
16	-66	42
-22	-54	22
-2	12	2
-58	-28	-22
-70	-22	-20
-54	14	-34
18	-22	14
-12	-10	14
48	-58	20
6	-88	24
58	14	22
30	-76	2
8	-56	18
-30	10	-24
18	-30	-4
-22	-30	0
-2	-88	42
44	22	42
-18	-66	-8
24	-70	32
-30	-72	34
60	14	22
52	34	22
-24	22	-24
24	2	-18
-16	2	20
-42	-16	12
-6	-34	18
-30	12	16
-16	38	-20
52	-20	6
-28	-18	-18
-32	12	-8
-10	-74	2
-30	-72	6
-34	-72	20
-24	-48	48
36	-36	14
-2	-42	66
20	-56	8
26	-2	-4
-6	6	-12
56	-20	-6
-54	8	-32
18	-18	16

// Werner N S, 2009: Depressed Patients > Healthy Controls, Encoding
// Werner N S, 2009: Healthy Controls > Depressed Patients, Encoding
// Werner N S, 2009: Depressed Patients > Healthy Controls, Retrieval
// Werner N S, 2009: Healthy Controls > Depressed Patients, Retrieval
// Subjects=11
0.42	11.96	52.91
1.38	24.06	44.08
-22.41	-17.38	-7.93
38.53	-45.36	-17.43
40.74	-62.1	-13.83
-42.61	-61.54	-12.92
19.48	-90.77	-11.18
38.65	-74.8	-12.74
-39.34	-78.44	-11.54
1.07	-68.1	-32.94
-14.69	-96.18	-9.22
1.09	-61.33	-27.93
31.23	-88.5	-10.39
-25.38	-94.13	-9.26
1.07	54.95	16.96
0.93	54.55	-1.96
-39.48	-12.82	-2.54
1.05	38.23	7.21
1.01	44.41	4.46
2.5	-1.74	40.66
1.21	26.74	23.79
20.36	-37.73	-13.41
44.79	2.6	-17.07
3.51	-50.66	13.52
0.3	-38.71	17.02
2.58	-15.23	45.13
7.72	-11.8	20.25
2.6	-29.24	42.96
1.46	-48.67	25.65
0.64	-64.77	51.54
1.53	-65.59	27.07
1.54	-80.82	22.77
3.49	-66.24	4.79
-11.55	-74.93	-9.92
0.4	15.13	52.65
29.08	-88.69	-12.58
-1.06	35.22	9.72
-1.21	51.2	-3.89
47.54	-9.71	57.54
-.34	-36.37	74.82
1.61	-25.13	54.9
1.79	-60.65	63.45
0.72	-46.4	68.96

// Cooper J C, 2009: UNC-Only, High Gain > UNC-Only, Low Gain
// Cooper J C, 2009: UNC-Only, High Loss > UNC-Only, Low Loss
// Cooper J C, 2009: UNC-Only, High Gain > UNC-Only, High Loss
// Cooper J C, 2009: CERT/UNC, UNC High Gain > CERT/UNC, UNC Low Gain
// Cooper J C, 2009: CERT/UNC, UNC High Loss > CERT/UNC, UNC Low Loss
// Cooper J C, 2009: CERT/UNC, UNC High Gain >CERT/UNC, UNC High Loss
// Cooper J C, 2009: CERT/UNC, UNC High Loss >CERT/UNC, UNC High Gain
// Cooper J C, 2009: UNC-Only, High Gain > CERT/UNC, UNC High Gain
// Cooper J C, 2009: CERT/UNC, UNC High Gain > UNC-Only, High Gain
// Subjects=12
6	20	30
2	6	48
4	-26	38
-40	-30	66
-8	12	-2
-40	26	0
-30	28	-6
8	-64	26
-40	8	14
-6	-44	18
38	12	-6
-24	44	34
-40	-14	52
8	40	-14
10	-16	10
-28	46	26
-38	2	58
-34	50	14
-18	16	8
-2	-36	60
-30	-44	70
8	-76	48
-4	54	-8
-8	-18	28
14	-10	24
18	-70	38
56	8	-10
14	-38	52
12	10	44
-4	8	50
-6	-20	48
-16	6	4
-34	-44	66
38	-50	20
6	44	10
-4	-10	56
-4	4	66
-58	12	6
28	-58	6
24	-4	8
10	-66	24
-24	-16	54
44	-50	-4
-26	-20	-2
10	6	10
30	34	18
-10	-10	38
14	14	-12
-40	-10	60
-34	-38	66
-32	38	40
52	-8	54
-14	-84	32
-4	14	-14
42	2	52
-28	2	48
14	-48	-4
-44	-50	20
4	-84	32
-4	-8	16
58	-28	30
-16	-54	-2
34	22	2
26	-72	24
30	36	-6
-16	-68	28
36	-4	-22
-10	-38	6
-38	-16	52
34	4	60
50	-36	0
-30	-76	28
12	-20	0
-16	-14	22
-34	2	-8
-2	8	36
22	-52	8
14	2	-2
-46	10	54
4	-34	42
-8	-24	-8
-42	44	0
-28	-70	56
-38	6	40
6	-72	44
-38	-62	56
6	-76	34
12	10	-4
-20	0	6
-10	42	12
-6	-4	60
-2	36	-18
34	-8	-26
24	-20	62
-30	-68	52
-32	28	14
54	30	22
-54	16	26
28	52	18
54	2	-22
30	32	-8

// Bach D R, 2009: Noisy, Ambiguity > Clear, Risk
// Bach D R, 2009: Noisy, Ambiguity > Noisy, Ignorance
// Bach D R, 2009: Conjunction:  (Noisy, Ambiguity > Clear, Risk) & (Noisy, 
// Ambiguity > Noisy, Ignorance)
// Bach D R, 2009: Risky Cues as Opposed to Ignorance Cues
// Subjects=20
32	-56	-8
30	-68	-10
44	-54	-4
-44	-58	0
-52	-60	2
-28	-68	-10
-30	-82	-8
32	-46	-14
10	-88	6
-34	-82	20
-28	-76	38
28	-70	-14
38	-52	-14
30	-56	-8
-28	-68	-10
-20	-74	-12
-26	-80	-8
8	-86	2
-10	-94	2

// Blasi G, 2009: Schizophrenia Patients
// Subjects=12
45	34	16
45	26	26
-4	14	38
-53	15	9
45	23	9
-11	-5	-16
-27	14	-17
45	15	-1
41	32	-18
-11	-5	-16
-11	-3	-16
41	32	-17
41	32	-17
45	22	-14

// Blasi G, 2009: Healthy Controls
// Subjects=12
45	34	16
45	26	26
-4	14	38
-53	15	9
45	23	9
-11	-5	-16
-27	14	-17
45	15	-1
41	32	-18
-11	-5	-16
-11	-3	-16
41	32	-17
41	32	-17
45	22	-14
48	-15	4

// Chae Y, 2009: Verum Acupuncture vs. Covert Placebo
// Chae Y, 2009: Covert Placebo vs. Overt Placebo
// Chae Y, 2009: Vernum Acupuncture vs. Overt Placebo
// Subjects=10
-34	32	21
28	-62	33
26	-15	49
-28	-25	-2
20	0	39
20	13	34
-51	-51	30
-50	-53	19
-46	1	-14
-4	12	49
28	38	26
4	-9	19
36	-12	39
26	-61	27
14	-6	35
-14	6	40
40	-35	4
44	-62	-5
18	18	41
36	-30	18

// Chan S W, 2009: High Neuroticism Score > Low Neuroticism Score, Medium 
// Fearful Face vs. Medium Happy Face
// Chan S W, 2009: High Neuroticism Score > Low Neuroticism Score, Positive 
// Correlation with Fearful Faces
// Subjects=12
0	-64	-26
-30	58	2
-18	-66	60
4	-48	68
26	-66	-14
-56	-32	0

// Chikazoe J, 2009: No-Go vs. Frequent-Go
// Chikazoe J, 2009: No-Go vs. Infrequent-Go
// Chikazoe J, 2009: Infrequent-Go vs. Frequent-Go
// Subjects=25
26	-4	62
42	42	18
48	4	38
40	18	-2
50	10	26
-52	8	20
42	-2	56
32	46	0
40	56	6
56	16	16
-22	-4	58
32	58	-2
-30	58	14
-26	56	24
44	32	32
30	22	-6
-36	-6	58
-40	38	22
-52	6	38
32	18	12
-8	2	58
-2	-4	64
6	10	60
10	20	56
8	0	60
6	30	36
36	-44	42
24	-68	48
66	-14	32
64	-38	28
14	-68	54
-24	-66	48
-20	-62	60
56	-42	48
16	-68	64
40	-62	56
-48	-36	40
-42	-48	52
30	-68	30
52	-22	-2
66	-32	20
52	-46	14
-30	-58	-30
-32	-62	-16
-36	-50	-34
-14	-64	-32
24	4	0
-30	16	8
-18	12	10
18	10	6
-26	2	4
-32	26	-2
42	16	-2
36	40	20
24	-4	62
-24	-4	58
30	24	-6
58	14	16
44	0	56
-50	10	18
38	56	10
-50	6	4
48	10	26
60	10	28
-58	12	10
44	2	44
-46	14	-8
6	-12	32
2	2	50
2	30	36
4	34	26
4	-28	32
12	-32	44
-4	6	36
2	0	62
-6	-6	64
0	12	44
10	16	60
54	-42	48
44	-46	46
38	-56	48
62	-44	36
64	-28	28
12	-70	52
32	-64	50
-14	-66	54
-22	-60	64
-48	-32	40
30	-68	38
62	-40	24
52	-26	0
-60	-34	22
58	-50	-2
60	-18	-2
28	-54	-32
-30	-62	-28
-20	2	-4
22	6	-6
-14	4	12
32	12	-10
-24	10	4
26	0	4
16	4	12
-30	16	-4
32	52	-2
30	52	14
26	-4	64
-50	10	34
42	-4	40
52	0	40
-50	6	46
-4	12	60
-24	-68	46
22	-64	46
28	-74	22
-32	-64	-14
-36	-54	-22

// De Ruiter M B, 2009: Problem Gamblers
// Subjects=19
45	39	3
51	9	18
51	-36	54
30	-90	-6
-3	12	6
3	12	6
-3	-15	-6
33	21	9
48	15	6
-3	-15	-6
39	54	3
36	18	-3
48	12	15
39	36	30
21	9	66
9	36	33
-42	-45	39
48	-42	45
-3	-18	-6
33	42	6
27	-78	36
39	42	3
-30	-66	-30
33	30	-3
54	21	15
-39	33	36
45	36	30
-6	21	48
-12	-63	60
9	-63	51
-39	-45	45
45	-39	45
-9	15	6
18	18	6
3	-42	-15
-42	33	33
39	42	30
0	30	42
-9	-63	57
9	-54	54
-54	-45	48
48	-57	48
-18	3	15
18	6	21

// De Ruiter M B, 2009: Smokers
// Subjects=18
45	39	3
51	9	18
51	-36	54
30	-90	-6
-3	12	6
3	12	6
-3	-15	-6
33	21	9
48	15	6
-3	-15	-6
39	54	3
36	18	-3
48	12	15
39	36	30
21	9	66
9	36	33
-42	-45	39
48	-42	45
-3	-18	-6
33	24	6
54	21	39
27	21	48
12	-18	60
-30	-33	51
33	-57	57
36	42	6
48	3	21
36	39	9
33	30	-3
54	21	15
-39	33	36
45	36	30
-6	21	48
-12	-63	60
9	-63	51
-39	-45	45
45	-39	45
-9	15	6
18	18	6
-42	33	33
39	42	30
0	30	42
-9	-63	57
9	-54	54
-54	-45	48
48	-57	48
-18	3	15
18	6	21
30	-48	39

// De Ruiter M B, 2009: Healthy Controls
// Subjects=19
45	39	3
51	9	18
51	-36	54
30	-90	-6
-3	12	6
3	12	6
-3	-15	-6
33	21	9
48	15	6
-3	-15	-6
39	54	3
36	18	-3
48	12	15
39	36	30
21	9	66
9	36	33
-42	-45	39
48	-42	45
-3	-18	-6
33	42	6
27	-78	36
33	24	6
54	21	39
27	21	48
12	-18	60
-30	-33	51
33	-57	57
39	42	3
36	42	6
48	3	21
-30	-66	-30
36	39	9
33	30	-3
54	21	15
-39	33	36
45	36	30
-6	21	48
-12	-63	60
9	-63	51
-39	-45	45
45	-39	45
-9	15	6
18	18	6
3	-42	-15
-42	33	33
39	42	30
0	30	42
-9	-63	57
9	-54	54
-54	-45	48
48	-57	48
-18	3	15
18	6	21
30	-48	39

// Hsu M, 2009: Regions Significantly Correlated with Probability (p) Term
// Hsu M, 2009: Regions Significantly Correlated with Nonlinear Deviation Term
// Subjects=21
-12	15	60
-15	9	48
-12	-3	-6
30	-51	-27
-9	57	24
12	0	-3
30	-87	-9
6	24	-12
-15	-48	24
-24	-48	27
-9	-75	-24
-9	-66	-27
-42	9	21
51	18	24
18	21	18
27	24	18
21	-45	15
18	-48	24
-18	-6	3
-24	-6	12
-27	3	9
-33	9	-9
-9	9	-3
-21	18	-12
-18	18	-3
33	3	24
15	24	30
27	18	30
3	-3	0
0	-6	-9
0	-15	-3
18	-21	39
-18	-72	-33
-12	12	21
24	-9	18
-30	-9	39
-30	6	39
-15	-3	48
-24	27	48
-18	36	48

// Li C S, 2009: Alcohol Dependence > Healthy Controls, During Stop Error > 
// Stop Success
// Li C S, 2009: Healthy Controls > Alcohol Dependence, Risk-Taking Decisions
// Subjects=24
-56	-72	12
20	-64	36
12	28	56
-4	28	60
36	-84	20
-36	12	44
40	12	44
44	4	20
-12	36	20
-28	44	32
28	-84	-12
52	-52	4
-20	-76	28
-8	-28	32
12	-40	72
40	-60	0
32	40	24
24	12	-12
40	-8	-16
28	36	-12
44	-12	64
4	-88	4
-52	-52	-20
-52	-24	44
68	-20	12
-28	24	-12
-44	-16	60
32	-68	36
-4	16	40

// Li C S, 2009: Increased Reaction Time vs. Decreased Reaction Time, Go-Trial
// Subjects=33
28	-96	-8
-28	-100	-8
-52	16	40
-20	20	48
-4	-44	44
-32	-72	48
-40	-60	40
-60	-48	-12
56	0	-32
56	-8	-16
16	-84	-36
44	-64	-44
48	-72	40
-12	-32	-32
36	36	-16
-56	-24	-28
48	20	48
24	32	48
32	-16	16
0	-8	36

// Mak A K Y, 2009: Males
// Subjects=12
-8	48	24
-40	28	-4
-16	52	32
4	40	4
-36	-4	16
-4	44	36
-40	24	-12
-36	-12	-20

// Mak A K Y, 2009: Females
// Subjects=12
-8	48	24
-16	20	-16
-4	44	36
-36	-12	-20

// Mandzia J, 2009: Healthy Controls > Mild Cognitive Impairment, Encoding 
// Tasks
// Mandzia J, 2009: Healthy Controls > Mild Cognitive Impairment, Deep 
// Retrieval
// Mandzia J, 2009: Mild Cognitive Impairment > Healthy Controls, Shallow 
// Retrieval
// Subjects=14
-44	5.44	-27.44
-27.87	5.51	-14.25
46.71	1.45	-45.99
1.49	28.51	60.44
-19.97	31.84	50.37
-48.22	17.02	-14.98
-35.45	36.22	-15.62
-15.57	-45.89	35.65
11.18	-48.65	38.92
0.5	-90.43	22.47
-11.68	23.7	13.04
29.82	8.94	-16.31
12.78	11.73	-6.31
-34.18	-24.22	-12.8
-54.21	11.41	36.86
-34.37	38.6	-12.49
-17.85	35.03	50.07
23.9	23.9	53.87
4.43	43.4	32.39
31.75	59.63	-21.7
52.37	30	6.2
-42.24	-80.74	27.72
15.24	-5.87	27.47
-11.44	-10	31.47
-20.07	-20.77	16.86
-17.19	4.43	-15.39
-22.28	-58.96	-8.9
-40.6	53.64	17.55
-11.41	22.12	47.74
22.85	-2.25	46.04
-18.1	-36.81	-11.92
-48.99	-67.83	-11.2
57.49	3.6	-32.91
48.15	18.51	9.44
48.06	34.03	3.68
51.72	-27.17	37.76
-30.49	-92.82	21.91
-17.73	-85.68	16.7
-1.15	-59.11	-40.36
27	-18.91	22.86

// Schmidt H, 2009: Males
// Subjects=25
26	12	54
-6	22	46
42	36	32
32	64	8
-34	22	-4
14	-68	52
-28	0	58
-48	-48	50

// Schmidt H, 2009: Females
// Subjects=21
34	4	56
-4	14	54
54	22	30
-56	20	32
-41	32	-8
44	-54	58

// Tricomi E, 2009: Normals, 1-Day Group
// Subjects=16
-12	3	-3
12	3	69
-33	-6	51
39	0	51
6	12	51
-45	-36	39
-45	-3	36
-27	-75	30
6	3	27
3	-24	24
63	-45	15
54	12	9
12	3	6
-27	30	3
24	24	-3
9	-9	-6
45	-54	-18
-30	9	-24
0	-57	-36
-42	-84	30
36	-24	21
45	-84	21
-12	-51	12
-3	-27	-9
-54	-6	-18
-3	45	-18

// Tricomi E, 2009: Normals, 3-Day Group
// Subjects=15
33	-24	0
-66	-45	24
33	-24	0
60	-36	-6
-45	-15	-15
12	15	48
-12	-24	39
42	6	36
12	15	48
9	-24	27
63	-18	27
-63	-18	21
-63	-42	18
-36	-84	6
-27	-24	0
12	-24	-3
-6	6	-6
42	-45	-18
-42	-84	30
36	-24	21
45	-84	21
-12	-51	12
-3	-27	-9
-54	-6	-18
-3	45	-18

// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts- Vhand
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Veye
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Vchosen
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Vunchosen - Vchosen
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Hand Bias
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Eye Bias
// Subjects=23
-21	-90	-18
57	-54	-9
-30	-24	75
39	-78	39
27	15	-3
-39	-36	69
21	-48	60
36	-21	39
-15	-36	45
-48	-15	51
-60	-9	-6
-54	-30	3
-27	24	0
36	24	6
-33	-54	42
-48	12	36
-39	-21	51
21	-45	-30
6	21	66
-39	-66	-39
66	-27	-21
21	-39	60
-39	-66	57
48	-51	54
30	15	45
33	-27	69
-12	-42	30
45	-72	-33
12	-72	12
-27	12	0
24	-42	45

// Yang T T, 2009: Stop - Go, Depressed Adolescents > Healthy Adolescents
// Yang T T, 2009: Stop - Go, Depressed Adolescents < Healthy Adolescents
// Subjects=13
-11.71	37.64	-13.11
0.4	56.34	-.77
-1.05	-73.57	8.03

// Ye Z, 2009: Effects of Plausibility in Sentence Comprehension
// Ye Z, 2009: Effects of Syntax in Sentence Comprehension
// Ye Z, 2009: Effects of Interaction in Sentence Comprehension
// Ye Z, 2009: Effects of Congruency in Stroop Task
// Ye Z, 2009: Effects of Congruency in Flanker Task
// Ye Z, 2009: Plausibility, Stroop Congruency and Flanker Congruency
// Ye Z, 2009: Plausibility, and Stroop Congruency
// Ye Z, 2009: Plausibility vs. Stroop Congruency and Flanker Congruency
// Subjects=19
-6	46	32
-40	22	24
-52	32	-4
-44	-60	30
-12	8	60
-54	22	14
-32	30	-4
34	-88	-10
22	-50	-4
-30	-92	-12
-24	-96	-8
36	-94	-6
0	16	50
-38	28	0
-44	14	22
-40	-46	52
-40	-86	-6
-42	-56	-32
-50	-54	-20
40	22	8
32	30	-14
50	14	2
38	-86	-6
34	-86	4
44	-50	-28
54	-50	-22
-38	-42	46
-46	-58	-10
-44	-68	-8
54	-64	-12
42	-86	-2
28	-56	-32
8	34	42
-44	20	28
-36	26	-14
-32	16	8
-44	-46	46
56	26	14
-8	28	42
10	32	44
-38	22	26
-46	-48	44
-58	-30	-18
46	24	28
40	36	-10
38	-52	28
-8	56	18
-40	-60	28

// van Broeckhoven P C A, 2009: No-Step vs. Dot
// van Broeckhoven P C A, 2009: Random-Step vs. Dot
// Subjects=17
-14	-76	-2
-42	36	-14
-48	-10	42
52	-6	38
20	4	4
42	-64	10
58	-50	38
32	-64	56
-20	16	4
-26	-6	8
50	40	-14
62	-42	10
40	-10	48
18	-44	0
-34	-58	60
12	-16	0
-24	-74	24
22	-84	52
46	-36	34
-56	-8	-28
-50	4	-2
32	-80	10
10	-78	-12
-20	-64	60
68	-36	14
28	-62	54
-48	-2	40
26	6	6
56	-54	42
-64	-34	0
60	-6	46
-30	-4	42
48	-42	30
20	-28	-4
36	-6	-14
50	12	2
-14	4	12
-60	-32	-10
50	2	16
-24	-2	6

// Christopoulos G I, 2009: Normals (Point Gamble)
// Subjects=13
8	30	34
48	32	14

// Hare T, 2009: Food Decision > Taste Rating
// Hare T, 2009: Successful Self-Control Trials:  Successful Self-Controllers 
// > Non-Self-Controllers
// Hare T, 2009: Task Related Functional Connectivity with the Left IFG/BA9
// Hare T, 2009: Positive Task Related Functional Connectivity with the Left 
// IFG/BA46 Region
// Subjects=18
3	51	3
-3	45	6
3	36	-12
-30	42	18
-3	39	21
27	-27	66
60	-36	18
-48	-12	48
12	-18	42
-60	-33	21
-21	-3	-3
-12	-42	60
-21	-21	66
18	0	0
42	-12	45
-27	-60	51
54	30	30
42	-48	-30
9	-90	-3
-45	42	12
-3	-42	-15
-42	-51	-24
3	-54	-33
9	-84	-24
-12	-27	-15
33	-78	-21
-3	24	45
33	-66	45
-54	15	36
-9	-96	-3
-9	-63	6
-3	-27	33
-48	-69	-6
-3	48	12
12	51	0

// Lawrence N S, 2009: Decision Making per SE
// Lawrence N S, 2009: Choices from Risky vs Safe Decks
// Lawrence N S, 2009: Positive Correlation with Score
// Lawrence N S, 2009: Decreases in Activation Over Time (Linear)
// Lawrence N S, 2009: Significant Activation in Response to Wins vs Losses 
// (All Decks)
// Subjects=15
10.57	39.47	-12.03
7.43	23.82	-7.07
-2.39	39.42	-11.81
-66.57	-5.24	30.68
-66.71	-2.98	20.38
-30.82	-96.32	18.92
-2.21	47.36	4.21
4.27	47.39	4.1
-2.37	56	-6.72
-8.63	54.34	10.35
-51.03	22.68	-16.05
-28.47	21.82	-26.43
-37.96	7.08	-11.36
-31.59	12.86	-18.77
56.11	21.11	-4.27
39.86	30.62	-4.93
-2.26	73.2	5.02
4.22	73.22	4.91
7.38	72.61	-1.81
0.71	64.65	-17.72
-1.58	29.08	49.71
-4.65	17.24	61.02
-4.6	27.43	66.74
-57.14	-7.39	7.2
-44.55	22.7	-16.16
-38	16.65	-12.31
-28.3	23.07	-13.11
-44.44	16.94	-8.87
-1.58	29.08	49.71
27.46	-47.32	23.16
4.54	-9.74	13.11
39.61	-82.85	-47.49
-21.19	-18.15	27.83
-18.32	21.78	7.02
13.51	-48.15	-53.84
-24.36	-47.19	27.39
30.67	-8.09	29.31
60.25	-34.52	54.95
-28.46	-70.01	-44.24
-20.85	27.07	63.69
20.4	33.75	-4.91
-27.12	-60.04	62.33

// Xue G, 2009: Foci of Regions Modulated by the Experienced Risk in the 
// Parametric Analysis
// Xue G, 2009: Foci of Regions Modulated by the Experienced Reward in the 
// Parametric Analysis
// Xue G, 2009: Risky Minus Safe Choices Across both Gain and Loss Domains
// Xue G, 2009: Win Minus Loss Domains Across both Risky and Safe Choices
// Xue G, 2009: Negative Correlation Between Individual Risk Preference 
// Activation in Risky vs Safe Contrast
// Xue G, 2009: Positive Correlation Between Individual Risk Preference and 
// Activation in Win vs Loss Contrast
// Subjects=13
4	48	26
2	52	30
4	50	12
-2	-2	4
54	-42	34
54	-50	46
0	58	-6
-34	56	-14
-2	42	8
0	-36	26
-20	12	-12
-16	6	-18
-52	-64	20
-30	-78	44
-26	32	48
-18	28	58
8	18	-4
6	40	38
4	52	28
6	50	48
-4	-2	2
2	-12	10
4	-90	-4
-10	-84	-38
-22	-78	-20
66	-32	-4
-2	40	8
0	48	-14
0	58	-4
-52	42	-4
-22	32	44
-16	54	34
-14	20	54
-20	12	-12
-10	16	-6
8	18	-4
20	12	-10
-44	-78	34
-46	-66	24
-18	-54	68
-46	-56	58
-76	32	44
32	-62	36
-6	-46	30
6	-46	68
4	58	18
-20	-68	40
2	-24	14
-28	-70	-10
-40	-74	6
-30	-86	6
16	-92	6
-52	-32	28
-14	50	-2
-46	-74	32
-40	-60	40
-44	-66	18
26	28	38
-56	-54	46
-50	-54	56

// Ghahremani D G, 2009: 1st Post-Reversal Trial vs 2nd Acquisition Trial, 
// Correct Responses Only
// Ghahremani D G, 2009: 2nd Acquisition Trial vs 1st Post-Reversal Trial, 
// Correct Responses Only
// Ghahremani D G, 2009: 1st Reversal Trial Errors vs 1st Acquisition Trial 
// Errors
// Ghahremani D G, 2009: 1st Acquisition Trial Errors vs 1st Reversal Trial 
// Errors
// Subjects=16
48	36	-18
50	-18	-12
54	-48	28
60	-44	2
46	2	-18
10	-56	22
24	-40	-20
30	-62	-22
28	-60	-30
50	34	-18
34	16	-20
44	30	-6
46	12	44
50	0	-34
8	8	14
-10	0	16
10	-14	10
-14	-28	10
20	-26	10
2	-12	-14
44	-52	34
14	-62	24
36	-42	-22
32	-86	2
56	-76	-6
36	70	-24
-46	-82	0
-50	-70	-30
-40	-88	-2
-56	-58	-28

// Mitchell D G V, 2009: Reward Differential x Block ANOVA
// Mitchell D G V, 2009: Reversal Errors vs. Correct Control Condition 
// Selections
// Subjects=16
-44.59	17.01	39.63
-26.74	53.38	12.95
9.99	22.59	51.91
-6.35	15.98	9.16
-28.3	5.5	68.28
34.89	-64.05	57.78
14.71	-69.49	71.85
-29.31	-67.49	46.54
16.11	11.89	9.25
7.93	22.21	60.89
-37.24	20.08	23.67
53.35	30.2	-4.98
-48.19	29.34	-7.09
-27.79	18.43	1.4
-22.87	-3.47	75.67
-6.62	20.82	-24.7
20.12	46.49	-11.54
65.22	-21.25	-10.84
59.13	-53.07	18.66
-1.81	-80.1	4.9
-35.18	-69.67	-22.36
4.33	-21.36	-6.79
22.67	-79.92	-8.78
-45.52	-58.47	27.01
33.79	-75.32	49.81
-5.3	9.22	4.14
18.23	8.47	6.16
35.51	-43.41	8.09
5.42	-65.11	-22.09

// Peters J, 2009: Positive Correlation with Subjective Value of Delayed 
// Reward, Delay Discounting
// Peters J, 2009: Positive Correlation with Subjective Value of Delayed 
// Reward, Delay > Probabilistic Discounting
// Peters J, 2009: Subjective Valuation during Probabilistic Discounting
// Peters J, 2009: Subjective Valuation during Probabilistic Discounting, 
// Probabilistic Discounting > Delay Discounting
// Peters J, 2009: Correlation between Subjective Value and both Delay 
// Discounting and Probabilistic Discounting
// Peters J, 2009: Correlation with Inverse Delay-to-Reward, Orthogonalized 
// with Respect to Subjective Value
// Peters J, 2009: Correlation with Reward Probability, Orthogonalized with 
// Respect to Subjective Value
// Peters J, 2009: Subjective Value Correlation Delay Discounting
// Peters J, 2009: Correlation with Inverse Delay-to-Reward
// Peters J, 2009: Correlation with Reward Probability
// Peters J, 2009: Correlation with Reward Magnitude, Delay Discounting
// Peters J, 2009: Correlation with Reward Magnitude, Probability Discounting
// Subjects=22
-58	-46	36
-54	-56	46
-50	-54	36
-8	4	-8
-18	-6	-12
54	-42	26
54	40	-4
48	36	-12
70	-36	2
66	-30	-2
58	-40	-2
12	46	6
28	16	-18
-2	-46	32
50	-22	-20
-8	52	16
-2	58	24
-34	32	12
-44	14	12
-52	14	8
36	30	-16
-18	16	12
-66	-30	-6
-64	-32	2
54	6	42
-58	-50	34
12	42	4
64	-42	28
54	-40	26
-10	54	16
-62	-14	-10
-4	-48	32
52	38	-6
42	-38	44
40	-46	42
-36	-52	46
-8	4	-8
-6	-20	10
6	-12	6
-48	-62	-10
-58	-48	-10
-52	-44	-14
0	-34	42
-4	-34	26
6	-20	32
44	8	26
36	4	30
52	10	18
-12	-96	-6
-16	-92	0
-24	-72	-8
-42	-2	30
-48	6	28
-50	6	42
46	36	10
42	30	20
56	-54	-10
48	-56	-10
46	-56	-20
-26	18	0
-18	60	4
-24	56	0
-4	38	-8
4	40	-2
22	-50	-24
-44	42	8
-40	36	14
-38	24	20
-12	-76	-24
26	34	-14
30	18	-6
24	24	-10
-22	34	-18
-14	40	-16
-20	26	-18
-6	-30	-8
10	-80	-26
-14	-38	-2
18	-18	14
12	-80	6
6	-80	18
0	-76	8
26	18	-16
38	-82	-4
54	30	18
4	-28	-16
28	18	44
6	28	-10
48	20	-18
-10	28	30
-26	10	-18
2	2	38
-16	-92	0
-4	-86	-6
42	-38	44
32	-48	44
32	-60	54
38	2	30
44	6	26
-48	-64	-10
-14	-38	-2
22	-56	-2
12	-70	10
16	-60	6
56	-54	-10
48	-56	-10
-26	18	0
-22	-72	50
-32	-76	34
-28	-84	32
24	-50	-26
-18	-56	12
-14	-54	4
8	-72	46
16	-96	8
14	-94	18
-42	-2	30
-20	-26	-2
2	-34	42
44	36	8
48	42	14
-22	-68	-2
44	-78	16
40	-72	20
48	-68	20
-8	28	32
-4	-30	10
-12	-18	12
40	-64	-12
-2	-78	6
-24	34	-18
-4	-74	44
-42	-50	48
-32	-54	48
-14	-64	22
-18	-80	16
-12	-64	54
-8	4	-8
26	18	-16
-50	-52	44
-4	34	-6
-20	38	0
-48	28	-8
44	32	40
52	-60	-14
54	-48	-16
-6	30	34
-4	20	54
6	22	48
44	42	22
52	34	26
44	-52	42
42	-42	50
54	-34	48
-6	-28	60
-12	-34	76
26	-64	42
34	-58	52
22	-56	40
56	-32	-18
-16	30	60
30	-34	52
28	-34	60
60	12	28
38	-12	-30
8	22	34
-22	-66	-34
-28	-60	-34
-46	-38	40
-42	-44	44
48	-16	58
-38	44	2
62	-20	42
20	28	56
32	16	56
20	-16	44
-46	10	-34
-64	-36	40
-58	-42	40
-60	-54	34
60	-40	42
-62	-54	0
52	30	-4
50	38	-16
46	-44	30
52	-56	24
56	-44	26
56	-36	-10
58	-28	-14
46	-6	-36
54	-12	-8
-60	-62	6
64	-22	-24
-34	16	28
24	-8	16
-18	-4	12
-48	26	-10
-50	38	-6
-46	4	46
-30	-18	8
-20	38	0
-58	-62	2
34	-50	18
-64	-30	-4
-64	-20	0
-20	16	10
-54	20	18
44	-50	60
34	-60	58
36	-86	0
-48	-62	-8
-40	-56	-12
-32	-58	-8
-44	-46	50
-36	-52	50
-40	-44	42
56	-56	-12
44	-56	-8
38	-40	-20
46	6	28
46	14	30
36	4	30
44	42	22
48	46	16
52	34	26
-40	-42	-38
-54	8	34
-46	4	46
-42	-2	32
-40	44	4
-44	48	-14
24	36	-14
-18	36	-20
-22	-74	-4
-10	-34	0
-8	-20	-12
-6	-30	-8
-6	30	34
-8	-78	-24
42	32	42
22	2	50
28	20	44
32	12	56
10	-10	10
-30	56	-4
-26	6	60
6	22	48
52	24	14
-2	6	26
-6	12	22
-10	-14	2
-42	34	18
14	12	2
22	-94	-2
8	-40	44
32	16	-2
48	20	-14
-38	-72	-26
-42	-72	-34
0	-32	28
-50	28	26
-16	-6	-8
-8	0	-10
8	8	-6
30	-28	-12
30	18	-14
8	46	8
52	44	-4
56	36	2
10	-26	-20
-14	-92	2
-10	-100	4
-24	-78	-12
-30	-68	-14
28	-58	38
-54	-56	32
-14	-94	-2
-16	-98	8
4	-50	6
-14	-70	24
8	-76	22
0	-78	26
-8	-74	54
0	-94	14
-2	-86	20
8	4	-4
2	-22	12
4	-18	4
-6	4	4
6	-78	48
14	-76	52
-14	-86	18
8	-18	30
-28	22	2
-20	22	6

// Jocham G, 2009: FINREVERR (Final Reversal Errors) - ALLPOS (Positive 
// Feedback), High Probability
// Jocham G, 2009: FINREVERR (Final Reversal Errors) - ALLPOS (Positive 
// Feedback), Low Probability
// Jocham G, 2009: REVERR (Reversal Errors) - ALLPOS (Positive Feedback), High 
// Probability
// Jocham G, 2009: REVERR (Reversal Errors) - ALLPOS (Positive Feedback), Low 
// Probability
// Subjects=21
1	33	29
-52	-37	35
46	-51	35
34	18	28
-55	6	28
-12	50	6
-41	42	27
24	-40	59
-13	-70	33
8	-17	30
-5	-39	63
-2	36	28
46	38	26
-37	33	24
-1	-24	27
-39	4	24
43	-42	29
48	14	33
-39	36	28
3	36	31
47	-42	35
-35	-36	36
14	-57	18
1	-24	33
4	-29	-21
-32	-24	14
24	-35	71
23	37	-19
-34	9	27
-46	8	36
-51	30	7
31	-17	14
28	-80	16
-11	-69	12
9	-76	-19
-4	-23	62
46	-36	35
-39	-40	42
44	9	36
-42	34	32
2	34	31
21	52	32
57	-41	-8
-58	-33	-16
30	17	50
31	-29	52
4	-50	-15

// Mobascher A, 2009: Activation in Response to Laser Stimulation
// Mobascher A, 2009: Electrodermal Activity High vs. Low
// Subjects=12
60	-20	16
58	-42	20
40	4	6
48	-34	60
4	-52	60
24	0	20
46	44	2
28	-6	70
-62	-22	20
-34	-20	14
-62	-40	28
2	10	40
-34	-52	-36
12	-14	8
-8	-12	0
-8	-20	-16
0	-30	-48
60	-20	16
58	-42	20
40	4	6
48	-34	60
4	-52	60
46	44	2
-62	-22	20
-34	-20	14
-62	-40	28
2	10	40
-34	-52	-36

// Vanhaudenhuyse A, 2009: Wakefulness, Non-Painful > Rest
// Vanhaudenhuyse A, 2009: Non-Painful, Wakefulness > Hypnosis
// Vanhaudenhuyse A, 2009: Wakefulness, Painful > Rest
// Vanhaudenhuyse A, 2009: Painful, Wakefulness > Hypnosis
// Vanhaudenhuyse A, 2009: Wakefulness > Hypnosis, Painful > Non-Painful
// Subjects=13
-6	-22	-12
-58	-34	12
46	-16	-4
46	-38	52
0	-22	-16
-54	-42	8
46	-14	-6
48	-36	52
0	-22	-14
6	-18	16
-14	10	8
16	6	-2
-60	-34	10
40	-14	14
48	-34	52
-6	18	44
34	48	12
36	14	60
8	-18	14
10	-18	14
-14	12	10
18	8	2
-54	-40	6
34	-14	12
46	-40	52
-4	24	46
36	50	12
36	6	54
4	-10	12
24	2	-6
-20	8	6
4	12	58

// Freund W, 2009: Right weak - rest
// Freund W, 2009: Left weak - rest
// Freund W, 2009: Right moderate - rest
// Freund W, 2009: Left moderate - rest
// Freund W, 2009: Right pain - rest
// Freund W, 2009: Left pain - rest
// Freund W, 2009: Right increase
// Freund W, 2009: Left increase
// Freund W, 2009: Right tonic pain early - rest
// Freund W, 2009: Left tonic pain early - rest
// Freund W, 2009: Right tonic pain late - rest
// Freund W, 2009: Left tonic pain late - rest
// Freund W, 2009: Right tonic pain early - tonic pain late
// Freund W, 2009: Left tonic pain early - tonic pain late
// Freund W, 2009: Right tonic pain late - tonic pain early
// Freund W, 2009: Left tonic pain late - tonic pain early
// Subjects=15
0	-64	-34
26	-12	70
-14	-78	-26
8	-20	6
26	22	-12
40	50	-10
26	-34	58
34	-24	42
10	8	30
12	4	62
36	18	-12
28	-18	-8
-36	18	-8
18	4	52
-44	-32	6
38	-62	54
48	32	26
42	-2	28
40	52	-12
54	-52	4
-24	-64	48
16	-72	42
-34	-32	50
-38	-22	64
34	-70	40
28	-12	66
46	36	34
36	60	-4
34	24	-6
42	-60	46
2	22	50
-30	18	0
58	12	26
-44	-32	6
38	-62	54
48	32	26
42	-2	28
40	52	-12
16	-66	64
54	-52	4
-24	-64	48
-34	-32	50
14	30	26
-18	-86	18
66	-30	6
14	-78	22
14	-86	10
-36	54	-4
46	-40	46
12	24	58
26	10	-8
-34	26	0
12	24	46
-12	-80	-36
22	-12	68
-10	-8	-10
54	16	0
20	8	58
0	-2	12
-60	10	10
36	48	28
38	54	-2
44	24	-4
50	24	28
42	-62	54
12	24	48
56	-36	44
-36	38	22
-34	-20	64
-32	-44	36
-22	-84	-50
-40	-2	8
-40	52	-6
-38	-68	-50
-52	-24	20
-60	6	4
-8	-82	-34
56	-46	0
12	10	66
42	36	36
36	46	22
22	56	20
-42	-36	38
-32	24	12
18	-10	62
-32	26	-2
34	24	-4
-4	26	42
52	14	-2
-60	10	10
-12	2	8
48	40	18
16	2	6
26	10	-8
44	-62	52
52	24	28
44	24	-4
-20	-86	-48
36	46	22
-28	20	58
-8	-4	0
-42	52	-6
56	-36	46
8	26	54
-14	-82	-28
-44	10	-6
40	36	36
-38	38	26
-36	-68	-48
22	10	-8
44	52	-8
-34	-52	48
12	12	68
-16	22	-14
-30	30	2
-60	-24	8
-46	-34	34
20	6	48
-2	10	52
62	-18	14
10	-20	16
-2	-72	-2
42	2	30
52	24	0
46	16	24
-20	-42	70
2	24	44
-32	42	28
40	16	2
52	20	22
-62	-18	22
10	0	10
-56	-36	46
2	8	-2
38	20	-2
12	2	62
44	-62	-38
32	-10	34
-12	-94	16
10	-64	-34
-20	24	24
-28	14	12
-26	42	12
34	20	-22
-34	36	-4
14	6	44
10	4	64
-2	-74	-42
-26	-54	-44
-52	8	4
38	16	2
-12	10	60
52	20	-6
42	42	-12
58	2	8
-44	-26	-8
6	4	14
-54	-62	-16
-8	22	2
-18	-42	74
-28	-66	48
10	-20	18
-6	12	-12
58	-14	4
-26	-54	46
-8	-70	52
-34	6	-38
-18	-8	70
-12	-34	76
56	-16	2
-50	-24	4
2	12	2
38	-38	54
-26	-68	48
-4	-70	50
-42	-24	-24
0	-48	62
-56	-68	-6
0	-10	58
-4	-30	52
-18	30	32
8	-58	-32
26	18	20
-18	-52	-46
30	16	-30
40	42	-16
-30	-16	26
-34	-56	22
36	-12	18
-8	20	54
14	-74	-38
36	-40	-14
34	-82	-46
30	-10	24
12	-46	-40
-24	-28	-6
32	-26	-14
26	-40	26
-16	-52	-42
-10	-44	24
-20	44	34
14	-72	-42

// Schienle A, 2009: Female Binge-Eating Disorder Patients
// Subjects=17
-15	-96	0
-24	30	-21
-45	-42	-24
36	3	-12

// Schienle A, 2009: Normal Weight Healthy Control Females
// Subjects=19
9	-93	-6
27	27	-18
-36	-6	6
-9	-90	-12
-15	-105	-6
-30	30	-12

// Schienle A, 2009: Female Bulimia Nervosa Patients
// Subjects=14
15	-84	-9
-39	6	-9
-27	-66	-12
30	24	-18

// Schienle A, 2009: Overweight Healthy Control Females
// Subjects=17
-39	-57	-12
-24	3	-24

// Boorman E D, 2009: Relative Chosen Value During the Decide Phase (Chosen - 
// Unchosen Subjective Action Value)
// Boorman E D, 2009: Relative Unchosen Probability During the Entire Trial 
// (Log Unchosen - Log Chosen Action Probability)
// Subjects=18
-6	48	-8
-34	56	-8
36	54	0
42	34	28
50	-46	46
-32	-60	40

// Chib V S, 2009: Common Representation of Decision Value (Willingness to 
// Pay) for Money Category
// Chib V S, 2009: Common Representation of Decision Value (Willingness to 
// Pay) for Trinkets Category
// Chib V S, 2009: Common Representation of Decision Value (Willingness to 
// Pay) for Snacks Category
// Chib V S, 2009: Conjuction Analysis Across All Categories
// Subjects=19
-3	42	-6
6	39	12
3	30	12
-3	42	-6

// Engelmann J B, 2009: Activations During Risky Choice
// Engelmann J B, 2009: Correlations Between Risk Preference and Activations 
// During Risky Choice
// Engelmann J B, 2009: Correlations Between Risk Preference and Deactivations 
// During Risky Choice
// Engelmann J B, 2009: Activations During Anticipation Period After Risky 
// Choice
// Engelmann J B, 2009: Activations During the Outcome Period After (Won vs. 
// Lost)
// Subjects=10
27.66	54.88	27.37
22.48	41.03	42.86
13.34	36.62	-7.85
32.58	34.55	-21.28
14.04	34.03	27.38
-3.17	31.92	25.07
-12.56	12.31	6.2
28.19	8.19	-19.02
-7.11	10.88	18.97
11.96	12.34	67.81
2.29	6.41	71.76
2.23	-10.54	16.31
2.71	-17.31	-7.89
3.38	-22.33	35.91
-17.02	-35.69	3.92
21.46	-36.62	4.89
20.97	-50.81	-23.02
27.23	-50.31	-15.77
-39.54	-59.71	-1.95
-16.93	-64.93	45.51
46.22	-73.01	-1.26
-16.12	-72.96	22.87
-26.54	-75.69	42.17
36.56	-85.21	16.6
-32.37	-86.42	16.71
13.11	47.48	-18.79
6.61	40.28	-19.12
-45.59	33.98	-14.76
46.45	27.85	-14.19
24.64	31.84	55.99
21.88	17.93	-16.42
-49.52	11.76	21.72
27.96	-20.62	-19.95
-34.88	-23.37	-21
-15.52	-27.45	-6.72
35.78	-32.41	-8.01
31.77	-78.91	-6.07
13.18	-83.54	-6.58
-35.29	-83.42	-.57
1.88	-86.61	-5.3
0.81	-86.62	-5.29
2.35	-99.43	-4.57
0.43	-99.44	-4.54
16.34	12.82	11.62
33.62	48.74	-5.75
10.9	36.83	22.61
-2.84	36.01	28.41
21.49	0.46	-4.13
58.23	-26.2	-17.82
-.98	-30.07	35.27
51.33	-61.17	42.63
-10.6	39.07	-7.11
0.22	32.35	22.1
8.91	24.53	-4.22
-17.22	6.39	-5.19
-61.02	-5.37	20.06
62.1	-7.83	19.85
-50.6	-9.58	39.03
-15.99	-15.94	21.1
-34.79	-16.95	49.72
51.62	-18.2	28.54
0.44	-18.22	43.85
2.58	-18.21	43.82
20.62	-21.38	25.93
36.58	-29.76	41.39
4.18	-28.53	67.08
-32.97	-37.54	55.78
-4.59	-40	33.8
-44	-48.65	-34.72
-1.58	-46.17	5.96
4.19	-46.14	5.89
-14.87	-51.82	-42.49
46.38	-51.96	-41.51
-29.82	-56.75	-56.73
34.13	-51.91	62.12
12.85	-54.92	44.33
48.83	-62.83	-46.09
22.55	-61.81	-30.48
-38.62	-64.33	-37.04
-27.26	-58.42	38.39
-40.3	-63.2	-18.15
-28.13	-69.1	-22.6
-2.41	-70.49	-41.51
4.43	-70.45	-41.59
-18.26	-65.43	25.38
39.67	-66.52	25.48
-28.46	-66.42	46.55
-15.7	-73.95	-6.5
49.58	-73.89	-8.81
1.21	-69.93	53.64
2.28	-69.92	53.63
-3.42	-71.89	34.23
-35.85	-85.36	22.46
12.55	-85.3	35.51
26.44	-86.78	34.35
31	-93.81	-.57

// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Main Effect of Person, Self > Other
// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Main Effect of Time, Current > Future
// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Valence, Positive > Negative (Activations)
// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Valence, Positive > Negative (Deactivations)
// Ersner-Hershfield H, 2009: Person x Valence (Deactivations)
// Ersner-Hershfield H, 2009: Time x Valence
// Ersner-Hershfield H, 2009: Person x Time x Valence (Deactivations)
// Subjects=18
-15.17	69.09	-5.23
28.77	54.18	4.44
-3.24	50.1	9.61
4.08	47.46	-11.44
-3.37	41.07	-10.82
-23.34	44.46	34.85
-46.73	12.59	37.79
-3.05	23.55	24.1
9.62	22	2.9
-7.51	17.24	-2.08
7.4	18.93	-9.09
-7.11	16.95	49.24
12.92	6.5	8.62
13	-5.85	14.12
-10.54	2.47	13.69
-3.05	-9.46	10.14
-2.86	-11.81	34.87
-23.43	-23.56	-5.17
-51.17	-26.55	-.14
-7.24	-33.81	12.23
33.72	-34.28	57.53
33.63	-35.22	45.34
-46.78	-41.79	8.9
-2.94	-49.99	9.08
-22.9	-46.59	54.75
-2.57	-53.87	55.12
-18.63	-79.58	40.74
13.49	-53.44	59.36
29.4	-63.43	38.83
33.75	-74.69	44.19
26.22	-79.56	36.87
-51.35	12.23	-7.85
49.55	-15.38	39.03
-39.06	-27.2	45.5
-7.44	-31.55	-13.6
-18.64	-42.34	54.34
5.63	-54.16	9.33
29.5	-62.4	52.13
-39.58	58.6	12.66
-51.18	1.88	9.74
-42.43	-8.07	31.67
69.84	-19.83	34.71
5.75	-69.34	19.52
10.06	-76.72	20.09
-15.01	45.45	5.68
13.24	-81.27	15.98
28.88	-10.55	-6.86
-46.8	7.42	25.96
-35.02	-.97	26.53
33.75	-41.68	58.15
10.32	-53.11	63.83
-14.4	-67.92	39.71
45.42	-67.82	35.67

// Palminteri S, 2009: Correlation with State Value (Expected Reward, Given 
// Displayed Cues, Regardless of Upcoming Action)
// Palminteri S, 2009: Activity Correlated with Reward Prediction Errors at 
// Outcome
// Palminteri S, 2009: Activity Correlated with Right Hand Movement
// Palminteri S, 2009: Activity Correlated with Left Hand Movement
// Palminteri S, 2009: Activity Correlated with the Right Option Value
// Palminteri S, 2009: Activity Correlated with the Left Option Value
// Palminteri S, 2009: Activity Correlated with Prediction Error Following the 
// Chosen Response (Right Symbol)
// Palminteri S, 2009: Activity Correlated with Prediction Error Following the 
// Chosen Response (Left Symbol)
// Subjects=20
-54	32	-4
-12	8	-10
-50	-20	48
38	-18	46
-54	34	0
-28	36	-10
-8	20	-12
6	26	-8
28	36	-12
54	32	-4
-16	8	-10
10	8	-8

// Smith B W, 2009: Greater BOLD for High-Magnitude Rather than Low-Magnitude 
// Selections
// Smith B W, 2009: Greater BOLD for Low vs. High-Probability Selections
// Smith B W, 2009: Greater BOLD for Risky vs. Safe Selections
// Subjects=25
-3.85	-51.71	28.19
0.42	-8.82	45.74
8.48	59.68	8.67
-59.59	-53.84	5.59
-28.64	0.84	21.84
41.67	-6.42	-9.58
25.63	-14.34	-14.31
24.48	-5.26	-20.64
-16.01	-18.57	-10.13
-23.58	-6.44	-17.75
2.44	27.24	43.8
-35.02	35.21	40.22
-2.92	28.17	42.67
-57.18	-44.4	44.92

// Venkatraman V, 2009: Activation Modulated by the Decision:  Magnitude 
// Sensitive > Probability Maximizing
// Venkatraman V, 2009: Activation Modulated by the Decision:  Probability 
// Maximizing > Magnitude Sensitive
// Venkatraman V, 2009: Activation Modulated by the Decision:  Strategy 
// Preference (Mag. Sen. - Prob. Max.)
// Venkatraman V, 2009: Increased Activations to Anticipation and Resolved 
// Gains, Deactivations to Resolved Losses
// Subjects=20
38	28	0
16	21	-23
20	-76	57
3	-72	57
44	44	27
47	42	8
42	25	22
10	22	45
10	42	29
14	16	-10

// Weber B, 2009: High-Price Income Feedback > Low-Price Income Feedback
// Weber B, 2009: Random-Effect Results for Model 1 @ Outcome High > Low
// Weber B, 2009: Random-Effect Results for Model 1 @ Outcome Modulated by 
// Real Income, High > Low
// Subjects=24
12	47	0
12	47	0
27	-6	-12
21	10	1
16	4	14
-31	-7	-3

// Smits M, 2009: 0-Back > Rest
// Smits M, 2009: 0-Back > Rest, Regression Analysis, Increased Activation 
// with Increased Severity of PCS
// Smits M, 2009: 2-Back > 0-Back
// Smits M, 2009: 2-Back > 0-Back, Regression Analysis, Increased Activation 
// with Increased Severity of PCS
// Smits M, 2009: 2-Back > 1-Back
// Smits M, 2009: 2-Back > 1-Back, Regression Analysis, Increased Activation 
// with Increased Severity of PCS
// Smits M, 2009: Stroop Interference > Stroop Neutral
// Smits M, 2009: Stroop Interference > Stroop Neutral, Regression Analysis, 
// Increased Activation with Increased PCS
// Subjects=11
6	8	62
42	14	6
-34	22	12
58	-24	-6
-66	-30	10
42	6	48
8	24	56
6	8	62
30	50	4
20	50	32
12	-12	66
34	38	36
38	30	16
-38	14	24
-10	24	42
-8	38	34
58	-48	-4
50	-32	48
-34	-44	46
-30	-56	62
-42	-48	62
28	0	62
-46	12	34
2	18	52
32	22	4
-34	24	0
46	-44	46
4	-68	50
-32	-64	42
-6	62	24
16	-36	-4
-6	-48	4
12	-68	18
24	-4	54
-4	16	54
30	-54	38
32	-72	38
-36	-56	40
-26	-68	42
40	-24	6
56	-34	16
-58	-30	-6
-54	32	10
-44	-22	4
-54	8	4
6	-50	54
20	-74	22
52	-44	28
6	-56	62
-52	-20	20
18	-16	-12
6	-40	8
42	18	-6
54	20	30
42	16	36
-44	16	32
-8	10	58
30	-66	46
2	-70	54
-30	-78	24
-28	-66	32
-38	8	18
-56	-10	18
-4	44	10
4	32	26
-4	-26	24
-12	-60	-18
10	-80	20
-20	-58	22

// Tomasi D, 2009: Rested Wakefulness, Main Effect
// Tomasi D, 2009: Rested Wakefulness, Main Effect (Deactivations)
// Tomasi D, 2009: Rested Wakefulness, Load, 2 Ball to 4 Ball-Tracking
// Tomasi D, 2009: Rested Wakefulness, Load, 2 Ball to 4 Ball-Tracking 
// (Deactivations)
// Tomasi D, 2009: Sleep Deprived, Main Effect
// Tomasi D, 2009: Sleep Deprived, Main Effect (Deactivations)
// Tomasi D, 2009: Sleep Deprived, Load, 2 Ball to 4 Ball-Tracking
// Tomasi D, 2009: Sleep Deprived, Load, 2 Ball to 4 Ball-Tracking 
// (Deactivations)
// Tomasi D, 2009: Sleep Deprived > Rested Wakefulness, Main Effect
// Tomasi D, 2009: Sleep Deprived > Rested Wakefulness, Main Effect 
// (Deactivations)
// Subjects=14
0	12	51
-27	-3	60
21	0	57
-51	6	39
36	6	33
-15	-15	12
15	-18	15
-36	15	9
27	18	9
0	-21	-9
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
3	-45	-9
12	-57	-30
-3	33	12
-36	-21	18
30	-12	15
-12	-45	-3
18	-45	-3
3	-63	21
-6	-81	18
-6	-9	39
-9	-36	60
36	6	33
-15	-15	12
15	-18	15
0	-21	-9
-30	-51	54
-12	-69	57
3	-45	-9
12	-57	-30
-3	33	12
-36	-21	18
30	-12	15
3	-63	21
-6	-81	18
-6	-9	39
-9	-36	60
0	12	51
-27	-3	60
21	0	57
-51	6	39
36	6	33
-15	-15	12
15	-18	15
-36	15	9
27	18	9
0	-21	-9
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
12	-57	-30
-3	33	12
-36	-21	18
30	-12	15
-12	-45	-3
18	-45	-3
3	-63	21
-6	-81	18
-6	-9	39
-9	-36	60
0	12	51
-27	-3	60
21	0	57
-51	6	39
36	6	33
0	-21	-9
-30	-51	54
21	-69	54
12	-57	-30
-36	-21	18
30	-12	15
-6	-81	18
-15	-15	12
15	-18	15
30	-12	15
3	-63	21
-6	-81	18
-9	-36	60
0	12	51
-27	-3	60
21	0	57
27	18	9
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
-33	-72	-12
33	-72	-12
3	-45	-9

// Volkow N D, 2009: Rested Wakefulness, Main Effect
// Volkow N D, 2009: Rested Wakefulness, Main Effect (Deactivations)
// Volkow N D, 2009: Rested Wakefulness, Load, 4 Ball Tracking > 2 Ball 
// Tracking
// Volkow N D, 2009: Rested Wakefulness, Load, 4 Ball Tracking > 2 Ball 
// Tracking (Deactivations)
// Volkow N D, 2009: Sleep Deprived, Main Effect
// Volkow N D, 2009: Sleep Deprived, Main Effect (Deactivations)
// Volkow N D, 2009: Sleep Deprived, Load, 4 Ball Tracking > 2 Ball Tracking
// Volkow N D, 2009: Sleep Deprived Main > Rested Wakefulness, Main Effect
// Volkow N D, 2009: Sleep Deprived, Positive Correlation between BOLD 
// Activations and Accuracy
// Volkow N D, 2009: Sleep Deprived, Negative Corrrelation between BOLD 
// Activations and Accuracy
// Volkow N D, 2009: Rested Wakefulness, Positive Correlation between BOLD 
// Activations and Main Effect
// Volkow N D, 2009: Rested Wakefulness, Negative Correlation between BOLD 
// Activations and Main Effect
// Volkow N D, 2009: Sleep Deprived, Positive Correlation between BOLD 
// Activations and Main Effect
// Volkow N D, 2009: Sleep Deprived, Negative Correlation between BOLD 
// Activations and Main Effect
// Subjects=14
-27	-3	60
21	0	57
-51	6	39
36	6	33
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
-15	-15	12
15	-18	15
3	-45	-9
12	-57	-30
-3	33	12
-6	-9	39
-36	-21	18
30	-12	15
3	-63	21
12	-81	12
12	-57	-30
-6	-9	39
30	-12	15
-27	-3	60
21	0	57
-51	6	39
36	6	33
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
-15	-15	12
15	-18	15
12	-57	-30
-3	33	12
-6	-9	39
-36	-21	18
30	-12	15
3	-63	21
21	-69	54
-15	-15	12
15	-18	15
3	-81	-6
27	-72	-18
-12	-72	-18
-12	12	36
42	-21	21
-3	-66	42
3	-81	-6
27	-72	-18
-12	-72	-18
42	-21	21
-3	-66	42
3	-81	-6
27	-72	-18
-12	-72	-18
-12	12	36
42	-21	21
-3	-66	42

// Koenigsberg H W, 2009: Borderline Personality Disorder (BPD) Patients
// Subjects=18
26	-80	-2
-26	-64	-8
-58	-24	-16
40	-16	-22
-50	28	16
10	44	36
-18	54	28
-4	-68	-18
56	-34	22
4	-20	46
0	8	46
-6	-56	42
-54	-50	46
-38	-36	22
52	-28	-6
-50	-12	2
-24	-12	-22
8	-8	-22
-8	6	-4
-36	12	-38
-36	30	30
44	30	2
14	64	20
-8	-98	16
-56	-22	44
62	-12	34
42	8	26
-56	4	34
-54	-50	46
46	-52	46
6	-66	44
-62	-38	14
18	-6	-24
38	56	4
26	20	60
-18	58	10
44	12	50
-30	28	52
34	-16	18
14	-96	14
-28	-48	54
-4	-6	54
58	-10	32
40	-76	4
30	-70	20
28	-54	-16
30	-52	44
-40	-50	54
-4	30	36
42	-20	6
50	-18	-14
30	6	-22
26	28	50
16	-16	18
-32	-26	8
54	8	0
-38	12	-2
-16	54	14
32	54	24

// Koenigsberg H W, 2009: Healthy Controls
// Subjects=16
26	-80	-2
-26	-64	-8
-58	-24	-16
40	-16	-22
-50	28	16
10	44	36
-18	54	28
-4	-68	-18
56	-34	22
4	-20	46
0	8	46
-40	-56	38
50	-56	40
-58	-52	-6
62	-36	2
4	-24	36
36	56	4
2	-86	0
-40	-78	14
44	-72	-6
-50	-32	56
-40	-12	62
-54	-50	46
46	-52	46
6	-66	44
-62	-38	14
18	-6	-24
38	56	4
26	20	60
-18	58	10
44	12	50
-30	28	52
34	-16	18
14	-96	14
-28	-48	54
-4	-6	54
58	-10	32
40	-76	4
30	-70	20
28	-54	-16
30	-52	44
-40	-50	54
-4	30	36
42	-20	6
50	-18	-14
30	6	-22
26	28	50
16	-16	18
-32	-26	8
54	8	0
-38	12	-2
-16	54	14
32	54	24

// Koenigsberg H W, 2009: Negative - Rest (Handedness as a Covariate), BPD 
// Patients > HC
// Koenigsberg H W, 2009: Negative - Rest (Handedness as a Covariate), HC > 
// BPD Patients
// Koenigsberg H W, 2009: Positive-rest (Handedness as a Covariate), BPD 
// Patients > HC
// Koenigsberg H W, 2009: Positive - Rest (Handedness as a Covariate), HC > 
// BPD Patients
// Koenigsberg H W, 2009: Negative - Positive (Handedness as a Covariate), BPD 
// Patients > HC
// Koenigsberg H W, 2009: Negative - Positive (Handedness as a Covariate), HC 
// > BPD Patients
// Subjects=17
16	-92	10
32	-86	28
48	-74	-12
30	-76	18
-46	-42	16
18	-68	0
6	-66	18
16	-48	0
46	-44	14
36	-2	48
-44	-28	-10
48	-10	22
40	44	10
16	-76	-28
48	-70	-14
-54	-64	22
4	6	64
-54	22	6
-16	-12	4
0	-62	14
-40	24	2
18	-50	0
48	-40	16
18	28	4
-20	34	6
16	-94	12
-34	-88	14
-26	-84	-2
26	-90	-2
6	-88	22
-38	-54	-18
30	-60	24
30	-48	-22
18	-42	42
44	20	22
-44	-26	-8
30	-20	40
42	-12	16

// McClernon F J, 2009: Smoke > Control, Abstinent
// McClernon F J, 2009: Smoke > Control, Abstinent > Satiated
// McClernon F J, 2009: Positive Correlation between Pre-Scan Craving and 
// Smoking > Control Activation, Abstinent
// McClernon F J, 2009: Smoke > Control
// Subjects=18
-10	-60	18
-6	-34	34
-14	-56	70
20	-62	46
0	-46	56
-28	-26	14
-32	0	-12
32	-4	-4
-14	58	20
-26	40	44
-8	48	26
-22	-60	6
-30	-80	36
-16	-86	40
32	-24	48
0	-32	60
10	-82	-20
-40	-68	-20
12	-18	22
-20	26	60
18	-54	48
8	-38	32
30	-76	22
26	-58	8
-22	-52	10
26	-34	72
20	16	20
20	30	54
4	44	8
12	58	18
14	10	62
-44	-28	42
46	-42	50
20	-76	-12
36	-68	-20
4	-56	-2
4	-34	54
12	-82	36
2	0	-10
-28	-74	30
20	-12	68
26	-8	48
-44	-4	6

// Goldstone A P, 2009: High-Calorie > Low-Calorie, Fasted
// Goldstone A P, 2009: High-Calorie > Low-Calorie, Fed
// Subjects=20
-36	-46	-32
28	-40	-30
-8	-24	50
-36	10	-16
34	2	-24
38	-10	-14
-26	48	34
2	2	70
-24	36	54
-46	4	54
54	-44	12
-38	18	-28
-16	-8	54
-20	-38	2
-34	-40	64
18	-74	-24
-8	-78	0
30	34	-16
62	-4	0
-20	66	6
42	40	-2
54	-24	44
-14	-46	-4
40	16	-36
-14	56	-8
26	34	54
-54	-72	18
-64	-56	16
56	-10	24
12	-54	-52
8	20	30
58	14	34
10	28	62
60	10	-16
-20	-8	74
-32	-20	68
-50	-24	24
-10	14	36
36	-8	18
50	-62	-12
-38	-50	-14
-48	-66	-2

// Janes A C, 2009: Smoking-Related > Neutral Images, Prequit
// Janes A C, 2009: Neutral > Smoking-Related Images, Prequit
// Janes A C, 2009: Smoking-Related > Neutral Images, Smoking Abstinence
// Janes A C, 2009: Neutral > Smoking-Related Images, Smoking Abstinence
// Janes A C, 2009: Smoking-Related > Neutral Images, Smoking Abstinence > 
// Prequit
// Janes A C, 2009: Smoking-Related > Neutral Images, Prequit > Smoking 
// Abstinence
// Subjects=13
-17.94	41.75	40.59
1.65	-3.92	67.62
7.83	39.84	54.95
-27.24	5.42	67.16
10.87	25.03	28.28
20.79	-34.41	43.19
4.62	-45.83	20.91
1.42	-12.84	34.91
49.36	-33.9	6.01
-50	-40.84	7.74
-18.19	-23.41	-17.51
-40.77	-5.28	-28.81
59.16	-28.61	32.22
14.61	-48.51	67.86
8.09	-46.41	54.38
4.96	-32.45	69.97
-30.42	-30.52	56.83
36.52	-77.01	-13.64
-40.47	-71.38	-16.57
27.13	-84.53	13.86
14.32	-94.38	11.49
17.69	-82.79	37.24
8	-77.01	30.18
-40.26	-65.9	13.07
42.76	-52.37	-25.82
-53.31	-55.09	-11.1
-27.35	-68.22	23.16
-33.69	-60.89	36
46.32	-2.54	40.22
-53.29	-5.45	11.5
30.1	41.52	33.37
23.5	42.85	9.91
-4.82	-17.68	55.46
-36.98	10.68	53.45
16.91	70.6	-2.38
-8.09	14.54	59.49
-11.56	51.3	39.72
13.8	38.6	-3
4.58	6.47	36.6
11.1	-2.24	47.29
7.65	21.58	25.26
20.4	27.49	17.93
-30.81	41.15	34.1
4.69	-22.08	38.99
-8.14	-28.76	36.35
-24.12	-28.34	43.19
1.68	-33.24	60.04
45.97	7.07	-.73
-27.87	15.37	-10.61
-30.8	-18	12.29
-34.13	10.27	6.61
39.6	23.92	11.31
-37.49	28.52	-4.91
46.21	-36.57	12.97
-33.87	-33.11	23.63
-43.54	-40.28	14.31
45.77	-1.59	-30.11
-21.21	-51.21	-5.11
63.5	-24.64	41.88
30.57	-49.19	57.7
-7.89	-59.19	55.63
56.05	-60.61	31.6
27.33	-33.09	59.73
-56.3	-43.02	21.38
-59.58	-24	19.82
20.77	-84.05	20.59
-8.05	-87.14	24.52
17.3	-60.49	-4.77
-8.32	-70.16	-3.66
-14.72	-79.98	-6.11
10.77	-15.61	-1.77
7.56	4.18	6.65
-27.59	-11.38	15.05
7.33	11.64	-20.74
33.14	-32.62	-17.33
-24.65	-23.96	-24.08
-43.82	-39.94	-22.52
-17.86	-95.86	-4.75
23.55	49.97	19.35
-1.7	14.41	57.19
20.73	7.85	53.03
-17.69	-11.67	51.76
-43.68	17.59	19.49
-17.76	-61.82	22.51
-30.6	-42.35	27.72
46.44	-27.66	45.67
20.82	-27.56	49.3
17.51	-84.59	13.98
-20.97	-81.64	14.17
-15.04	35.25	-2.39
-14.98	-23.39	-17.55

// Coletta M, 2009: Highly - Moderately Palatable Food, Unrestrained > 
// Restrained Eaters, Fasted
// Coletta M, 2009: Highly - Moderately Palatable Food, Unrestrained > 
// Restrained Eaters, Fed
// Coletta M, 2009: Highly - Moderately Palatable Food, Restrained > 
// Unrestrained Eaters, Fasted
// Coletta M, 2009: Highly - Moderately Palatable Food, Restrained > 
// Unrestrained Eaters, Fed
// Subjects=9
52.85	-1.97	-9.77
-15.46	-21.61	-32.44
-21.67	-.96	-6.36
-44	21.33	26.55
-8.1	-34.71	33.72
43.57	12.27	28.2
14.62	-43.14	34.17
-18.24	-53.16	-2.38
-2.21	-43.51	-14.81
20.41	-86.57	-28.86
-50.82	65.79	8.82
-34.41	58.69	23.81
-31.21	26.61	13.48
-38.32	25.21	-35.56
-43.89	8.98	32.25

// Grahn J A, 2009: Exp. 1: Beat - No Beat
// Grahn J A, 2009: Exp. 2: Beat - No Beat
// Grahn J A, 2009: Exp. 1: All Rhythms - Rest
// Grahn J A, 2009: Exp. 1: Volume Conditions - Duration Conditions
// Grahn J A, 2009: Exp. 1: Volume Nonbeat - Volume Beat
// Grahn J A, 2009: Exp. 1: Beat x Accent Interaction
// Subjects=36
-26	2	6
26	8	8
-32	-18	0
30	-16	8
-8	20	-8
-18	12	-12
0	28	-12
-50	-24	-20
-18	-26	66
-22	6	8
-20	8	-4
-24	-2	8
-18	10	-8
26	8	0
22	6	12
-30	-14	-2
-26	-12	14
30	-12	4
42	38	28
44	22	8
34	28	2
-34	20	2
6	0	66
-6	-4	66
54	0	48
-52	-10	50
-48	-8	54
-50	-20	4
-42	-34	10
56	-14	4
56	-24	6
62	-42	32
46	-50	46
-30	-64	-28
-28	-62	-50
28	-60	-28
24	2	8
20	8	68
-2	24	54
-6	32	46
46	16	42
36	4	62
44	44	18
40	26	26
48	38	28
42	34	40
30	56	30
42	46	-6
-42	22	42
-44	18	44
-50	12	42
-40	46	-2
10	34	36
8	20	66
-44	-6	36
50	28	32
42	22	36
32	14	34
34	8	38
28	12	32
38	6	40
48	46	2
-50	8	32
-38	6	32
-48	38	16
-54	30	16
-48	36	20
64	-14	4
-40	-34	14
-56	-22	6
-66	-36	-4
-52	-60	4
-56	-50	-10
70	-32	2
64	-50	-2
68	-40	-6
62	-34	-16
56	-50	46
42	-50	46
52	-42	54
42	-56	50
34	-62	48
-48	-48	42
-50	-54	50
-42	-62	54
62	-38	42
60	-40	44
56	-44	42
-64	-42	36
-32	-70	-48
-12	-78	-32
-38	-64	-40
10	-78	-32
18	-26	22
22	-32	16
-12	-22	22
-18	-24	-2
-8	24	44
48	44	14
-46	12	26
-46	16	2
-40	26	22
52	10	20
40	12	26
60	18	28
32	26	-6
44	22	12
46	24	24
56	26	26
54	28	24
50	40	14
-34	24	4
34	24	-4
-52	-6	48
54	2	44
40	2	38
56	8	40
-6	14	54
-2	0	66
6	18	48
8	12	60
10	4	70
-54	-40	12
-66	-36	10
-54	-2	-8
-48	-16	-6
56	-24	0
56	-6	-4
-58	-38	10
-66	-26	4
-52	-22	0
-44	-2	-16
70	-36	6
40	-52	44
12	-12	4
-14	-10	0
12	-18	-8
-8	-10	-6
0	-58	-20
-12	-74	-28
-20	-70	-36
-8	-36	-12
-24	-64	-28
-12	-76	-20
-38	-68	-22
20	-70	-26
28	-64	-28
36	-68	-24
16	-58	-28
-16	-74	-40
-28	-62	-50
14	-76	-34
-50	38	6
-46	14	2
-44	14	22
-32	24	4
54	20	28
44	22	12
50	12	16
44	14	26
50	16	2
30	26	-8
42	20	22
-52	-8	48
-46	2	36
54	0	46
40	0	38
38	2	36
-2	0	66
-8	16	52
8	2	66
-54	-2	-8
-54	-6	-6
-44	-10	-10
-36	-34	10
-50	-44	18
-56	-38	12
-42	0	-16
58	-4	-2
56	-34	4
70	-34	4
52	-40	12
56	-26	0
70	-24	0
-66	-26	4
56	4	-6
42	-50	46
-26	-62	-26
-14	-74	-16
30	-62	-26
26	-74	-24
24	4	4
24	2	8
-22	2	4
12	-12	2

// Grahn J A, 2009: All Stimuli - Rest
// Subjects=35
-22	46	-4
-18	42	-12
24	44	-6
-28	48	-6
-22	44	-10
-32	42	26
34	40	20
40	48	10
32	-8	58
-54	4	12
58	6	20
-50	28	30
-42	32	26
42	16	10
40	38	30
12	14	38
-4	-4	68
-6	0	60
6	0	70
-50	-8	54
-28	-10	54
34	-26	56
52	-2	50
26	-6	48
16	-38	78
-36	-30	60
-10	-40	76
-8	-36	68
-12	-30	72
12	-34	72
8	-42	76
-28	22	4
-30	18	10
34	26	6
-54	4	8
-62	-34	14
-62	-28	10
-52	-16	2
-54	-42	20
-42	-34	14
66	-20	6
58	-16	2
68	-32	12
-42	-4	-22
-38	0	-28
-42	-46	44
42	-44	46
32	-8	-22
-22	-40	12
24	-14	-18
22	0	26
-22	4	6
-22	10	6
22	12	6
24	10	16
24	-6	16
-14	-16	6
-4	-14	24
-2	-10	8
16	-14	6
0	-56	-8
2	-62	-20
2	-68	-44
-8	-50	-26
-10	-78	-32
-30	-82	-34
-4	-52	-14
-28	-62	-26
-12	-78	-36
-24	-64	-50
-34	-56	-50
6	-82	-26
20	-82	-38
32	-58	-30
8	-80	-38
6	-78	-36
32	-56	-50
20	-66	-50
8	-76	-34

// Garn C L, 2009: Male Healthy Controls
// Subjects=13
31	-79	-15
-24	-92	-6
12	-88	-6
-8	5	54
-40	-85	-15
-30	-69	55
-7	-26	10
1	2	33
-14	-94	-6
16	-94	-4
-24	-78	50
-66	-42	26
-54	20	22
22	-99	-2
-18	-72	53
-33	-61	51
-29	42	28
-17	-31	-17
-1	27	15
-46	-63	24
50	-24	-4
-59	-23	-2
50	-24	-4
50	-26	6

// Garn C L, 2009: Female Healthy Controls
// Subjects=13
31	-79	-15
-24	-92	-6
12	-88	-6
-8	5	54
-40	-85	-15
-30	-69	55
-7	-26	10
1	2	33
-14	-94	-6
16	-94	-4
-24	-78	50
-66	-42	26
-54	20	22
-27	-95	1
-39	-61	54
-62	-42	28
-44	16	24
-17	-31	-17
-1	27	15
-46	-63	24
50	-24	-4
-59	-23	-2
50	-24	-4
50	-26	6

// Hsieh L, 2009: No Conversation > Fixation
// Hsieh L, 2009: Long Conversation > No Conversation
// Subjects=10
50.42	-26.23	8.7
42.97	9.19	27.01
40.85	-38.98	9.88
35.44	-57.3	-6.36
29.43	-69.69	40.47
28.9	17.08	6.44
27.11	-73.78	15.19
25.76	-7.52	5.19
24.74	-26.73	4.58
20.68	-5.86	40.79
3.4	-61.72	-5.62
-5.97	7.78	54.45
-12.48	4.51	40.31
-19	-71.29	-3.45
-22.03	-75.05	16.98
-22.29	-23.92	3.77
-24	-67.81	42.04
-24.53	18.96	8.01
-26.61	-3.51	6.57
-32.18	32.61	-7.55
-33.89	8.44	37.99
-38.21	-39.28	13.05
-47.93	-20.65	7.14
54.69	-22.95	9.5
50.41	19.72	24.92
43.72	26.72	-7.93
41.73	24.99	11.2
37.94	-40.4	46.84
21.74	-57.61	18.36
15.53	-53.31	47.06
11.13	-73.37	22.03
8	-38.55	45.91
4.65	-26.91	31.59
1.39	-17.58	28.62
-1.84	21.75	42.08
-27.19	-44.59	53.51
-28.91	22.31	-3.38
-44.89	9.52	-2.12
-32.96	13.59	21.94
-39.01	-35.4	49.53
-45.64	8.37	38.13
-50.02	-21.29	12.79

// Meriau K, 2009: Healthy Controls
// Subjects=23
2	58	40
-2	62	24
-16	-4	-14
16	-4	-16
-14	-92	42
10	-88	42
30	-56	58
52	-74	0
-40	0	-4

// Meriau K, 2009: Healthy Controls, Skin Conductance
// Subjects=18
50	52	-4
-36	54	2
42	18	-6
40	24	-18
-12	-32	2
-34	-36	2
38	-70	32
4	-92	22

// Modinos G, 2009: Main Effect of Task: Self > Semantic and Other > Semantic
// Modinos G, 2009: (Self > Semantic) > (Other > Semantic)
// Modinos G, 2009: (Other > Semantic) > (Self > Semantic)
// Subjects=16
-8	28	28
6	28	28
26	54	30
-24	52	32
20	52	36
-24	50	22
4	-62	32
14	-88	0
66	-40	18
8	10	62
-36	20	4
-8	28	28
6	28	28
26	54	30
-24	52	32
20	52	36
66	-40	18
8	10	62
-36	20	4
-24	50	22
4	-62	32
20	-68	50

// Chang S E, 2009: Speech Perception, Healthy Controls > Stuttering Patients
// Chang S E, 2009: Non-Speech Perception, Healthy Controls > Stuttering 
// Patients
// Chang S E, 2009: Speech Planning, Healthy Controls > Stuttering Patients
// Chang S E, 2009: Non-Speech Planning, Healthy Controls > Stuttering 
// Patients
// Chang S E, 2009: Speech Production, Healthy Controls > Stuttering Patients
// Chang S E, 2009: Speech Production, Stuttering Patients > Healthy Controls
// Chang S E, 2009: Non-Speech Production, Healthy Controls > Stuttering 
// Patients
// Chang S E, 2009: Non-Speech Production, Stuttering Patients > Healthy 
// Controls
// Subjects=20
-33.87	-5.65	34.71
45.39	-7.69	56.28
4.91	-6.56	74.49
-38.22	-39.45	10.83
46.2	-36.74	10.75
-47.72	-64.63	16.4
64.28	-42.95	-2.32
49.73	-66.31	41.07
34.77	-79.6	35.66
4.41	-9.59	7.84
17.2	-60.38	-17.04
53.77	8.25	41.46
-31.73	-5.63	34.69
13.5	-12.68	77.14
-38.22	-39.45	10.83
43	-36.68	11.9
-49.85	-63.5	17.44
64.3	-43.92	-1.12
49.73	-66.31	41.07
4.39	-9.76	5.62
20.39	-59.39	-18.28
-36.01	-5.66	34.74
41.11	-7.72	56.33
0.3	5.3	35.63
43.38	-61.26	51.87
-31.44	-68.56	46.65
6.63	-30.72	9.58
23.59	-75.91	-25.85
-12.74	-65.13	-20.76
-18.86	3.76	44.9
43.38	-59.14	51.69
-33.57	-70.69	46.85
51.61	-16.22	27.93
4.41	-9.59	7.84
23.59	-74.86	-25.94
-23.46	-63.42	-25.24
-33.89	-5.82	32.5
30.55	-21.9	66.56
10.99	5.37	35.5
-57.49	-31.11	10.35
-63.98	-33.06	-.56
-40.26	-23.03	30.67
-48.77	-50.12	25.23
19.47	-89.8	-12.37
19.09	-45.33	-42.86
4.41	-55.71	-10.6
-42.35	-13.81	39.95
52.65	-5.47	29.24
-10.4	14.93	37.18
-5.96	2.41	53.79
48.02	16	-9.31
-45.84	-13.49	3.17
40.77	-5.77	12.68
-36.13	-28.86	9.92
47.23	-26.08	10.96
60	-26.6	3.05
55.73	-33.14	1.42
55.88	-29.4	22.29
-8.18	-66.59	14.99
26.79	2.01	4.38
-30.92	-57.75	-20.06
-36.01	-5.66	34.74
9.23	-25.91	71.6
-27.82	54.35	11.77
-33.92	-41.37	13.17
-39.18	-26.2	30.92
49.73	-48.7	48.51
-50.91	-49.07	25.17
-23.21	-80.57	0.73
19.48	-89.63	-10.16
4.41	-9.59	7.84
0.13	-53.62	-10.72
-19.17	-78.54	-28.49
-21.3	-74.15	-26.6
-42.35	-13.81	39.95
65.38	-3.08	17.74
-8.26	18.28	39.1
-40.48	-20.94	2.61
-40.48	-20.94	2.61
68.56	-26.46	4.06
55.74	-35.26	1.59
56.94	-29.48	21.17
49.73	-48.7	48.51
-23.45	2.68	3.78
27.84	4.04	3.08
-31.68	-54.5	22.06

// Kell C A, 2009: Healthy Controls
// Subjects=13
50	26	38
30	20	56
44	16	48
20	34	52
4	46	26
4	32	50
-2	40	8
18	12	-16
-14	6	-18
46	22	10
42	-14	-4
34	-30	12
50	-22	20
0	-32	38
56	-42	30
46	-54	50
46	-52	-36
34	-62	-28
18	12	-16
-14	6	-18
46	-52	-36
34	-62	-28
2	44	26
2	30	48
-6	60	8
32	18	-18
-20	16	-14
46	22	10
40	-14	-8
-44	-32	16
0	-32	38
2	-58	22
-4	-48	24
2	-40	-10
-2	-60	-16
38	-62	-22
-20	16	-14
-2	-60	-16
38	-62	-22
-30	54	10
-44	-16	52
-30	14	-28
48	-28	12
22	-70	-18
28	-64	-28
-24	-74	-22
22	-70	-18
28	-64	-28
-24	-74	-22

// Kell C A, 2009: Recovered Stutterers (RS)
// Subjects=13
-30	54	10
-44	-16	52
-30	14	-28
48	-28	12
22	-70	-18
28	-64	-28
-24	-74	-22
22	-70	-18
28	-64	-28
-24	-74	-22

// Kell C A, 2009: Persistent Stutterers (PS)
// Subjects=13
50	26	38
30	20	56
44	16	48
20	34	52
4	46	26
4	32	50
-2	40	8
18	12	-16
-14	6	-18
46	22	10
42	-14	-4
34	-30	12
50	-22	20
0	-32	38
56	-42	30
46	-54	50
46	-52	-36
34	-62	-28
18	12	-16
-14	6	-18
46	-52	-36
34	-62	-28
2	44	26
2	30	48
-6	60	8
32	18	-18
-20	16	-14
46	22	10
40	-14	-8
-44	-32	16
0	-32	38
2	-58	22
-4	-48	24
2	-40	-10
-2	-60	-16
38	-62	-22
-20	16	-14
-2	-60	-16
38	-62	-22
-26	4	-4
14	8	-4
-34	4	12
-44	-12	-4
46	-12	-6
-44	0	10
-44	0	10
-44	28	32
44	24	36
-50	-40	48
40	-54	50
32	12	-18
32	12	-18

// Lu C, 2009: Healthy Controls
// Subjects=9
-42.58	31.05	28.39
-52.22	6.62	16.05
-48.13	22.28	-2.04
-32.68	-2.16	52.25
-44.36	-35.52	48.49
44.29	-40.96	39.01
32.67	-80.24	41.32
-35.18	-49.86	-13.98
35.56	-78.02	0.95
0.3	17.36	40.2
-32.02	21.03	7.92
44.93	12.86	5.49
-18.1	9.31	6.51
-26.74	66.59	18.54
28.82	52.57	11.27
36.71	1.89	43.31
6.7	31.58	44.51
61.97	32.08	4.8
36.88	-50.18	44.32
-46.7	-44.28	18.03
37.42	23.48	5.8
-24.48	-1.39	6.37
-45.79	38.69	31.13
-51.22	-16.06	-2.13

// Lu C, 2009: Stuttering Patients
// Subjects=10
33.14	54.09	16.67
-49.08	23.56	14.59
-36.02	-.29	35.4
37.76	-4.88	38.29
-31.45	-53.25	52.06
-30.43	-36.15	52.84
39.05	-49.82	48.73
-62.76	-38.11	16.58
44.04	-70.99	-5.31
-33.8	-88.41	10.43
-2.84	8.08	44.36
-38.34	4.42	13.85
34.23	22.49	7.04
-23.39	3.28	11.54
14.95	-76.99	-39.04
-27.75	-44.87	-18.94
26.77	-56.43	-21.95
-10.49	-16.74	13.07
16.19	-7.06	11.95
-26.74	66.59	18.54
28.82	52.57	11.27
36.71	1.89	43.31
6.7	31.58	44.51
61.97	32.08	4.8
36.88	-50.18	44.32
-46.7	-44.28	18.03
37.42	23.48	5.8
-24.48	-1.39	6.37
-45.79	38.69	31.13
-51.22	-16.06	-2.13

// Corbett B A, 2009: Autism Patients
// Subjects=12
-38.21	5.65	53.78
-65.76	-32.4	4.22
-60.16	-58.24	14.53
26.93	-40.32	-16.74
-65.79	-30.48	1.79
-33.73	-5.2	63.74
-64.37	-11.51	32.39
-35.83	-61.65	57.03
-52.48	13.72	37.53
-57.53	-57.38	-33.79
39.91	48.47	2.26
-37.69	11.28	10.63
38.05	-90.4	-1.89

// Corbett B A, 2009: Healthy Controls
// Subjects=15
54.39	17.83	29.7
39.85	-52.6	-22.47
-18.44	-12	-9.81
-21.65	-38.05	-12.78
-18.46	-36.23	-16.38
-49.62	-63.47	-7.55
26.93	-40.32	-16.74
-65.79	-30.48	1.79
-33.73	-5.2	63.74
-64.37	-11.51	32.39
-35.83	-61.65	57.03
-52.48	13.72	37.53
-57.53	-57.38	-33.79
40.43	-55.99	21.56
21.53	-7.5	-9.81
-31.33	-83.69	-18.18
25.96	-92	-18.34

// Mashal N, 2009: Novel Metaphoric Sentences > Nonsensical Sentences
// Mashal N, 2009: Novel Metaphoric Sentences > Literal Sentences
// Subjects=15
-48.71	-59.38	29.35
-48.14	-6.33	-14.14
-56.47	-42.62	-.96
-9.17	-49.28	32.51
-45.76	22.49	28.03

// Freyer T, 2009: Main Effect of Last Reversal Error (Final Reversal Errors 
// vs. Correct Responses), First Visit
// Freyer T, 2009: Main Effect of Last Reversal Error (Final Reversal Errors 
// vs. Correct Responses), Second Visit
// Subjects=10
6	24	29
30	21	0
36	33	33
-34	24	33
39	-48	38
6	24	39
30	21	-6
-33	21	-6
36	30	36
-39	27	33
-36	-54	42

// Schmidt G, 2009: All Sentences (Literal, Easy-Familiar, Easy-Unfamiliar, 
// Difficult-Unfamiliar) > Non-Word Sentences
// Schmidt G, 2009: Metaphors (Easy-Familiar, Easy-Unfamiliar, 
// Difficult-Unfamiliar) > Literal Sentences
// Schmidt G, 2009: Easy-Familiar Metaphors > Literal Sentences
// Schmidt G, 2009: Familiar Metaphors (Easy-Familiar) > Unfamiliar Metaphors 
// (Easy-Unfamiliar)
// Schmidt G, 2009: Unfamiliar Metaphors (Easy-Unfamiliar) > Familiar 
// Metaphors (Easy-Familiar)
// Schmidt G, 2009: Easy Metaphors (Easy-Unfamiliar) > Difficult Metaphors 
// (Difficult-Unfamiliar)
// Schmidt G, 2009: Difficult Metaphors (Difficult-Unfamiliar) > Easy 
// Metaphors (Easy-Unfamiliar)
// Subjects=10
-35.22	21.1	9.07
30.14	0.22	22.33
-35.32	-10.74	-17.26
-67.06	-5.39	27.26
39.63	-2.15	4.58
-59.99	22.24	-15.28
-43.43	-36.97	29.64
15.5	-49.25	44.49
-17.88	-75.17	1.33
8.03	-64.61	39.18
-67.08	-6.7	24.03
-12.32	-79.51	27.28
17.63	-86.73	27.54
-24.2	-66.6	16.29
-31.67	-83.02	11.07
-27.48	-76.11	3.75
65.05	30.82	-11.86
-29.7	-63.86	-2.83
-14.91	-33.62	-12.23
15.78	11.72	-34.23
53.68	23.77	35.7
-29.46	-103.1	12.72
-24.2	-92.92	6.23
28.01	-53.57	1.22
-11.45	-7.97	30.19
-29.79	-37.26	-2.83
-23.95	-51.89	55.2
-48.04	41.88	17.51
2.22	23.86	13.98
-4.24	34.31	12.06
-9.74	43.66	-4.27
-14.98	21.59	-.13
19.12	37.31	-6.3
-28.89	0.47	-10.47
-33.52	-72.29	53.68
-68.14	15.3	33.35

// Aziz-Zadeh L, 2009: Aha Solutions > Search Solutions
// Subjects=12
-54	20	0
40	44	0
-6	26	44
38	12	-14
-48	-52	24
58	-52	36
42	6	-40
-6	-20	-26

// Fink A, 2009: AU > Fixation
// Fink A, 2009: OC > Fixation
// Fink A, 2009: NI > Fixation
// Fink A, 2009: WE > Fixation
// Fink A, 2009: AU > OC
// Fink A, 2009: OC > AU
// Fink A, 2009: NI > WE
// Subjects=68
-20	32	22
36	-66	-26
22	-94	-8
-50	-48	-18
36	-40	0
-20	-94	-12
-24	-68	46
-42	-38	44
28	-70	4
-10	-22	20
-4	16	46
24	-94	-8
-16	-94	-10
-26	-66	44
34	-36	2
-34	-30	-4
-46	16	24
34	-64	-26
26	-92	-8
-38	-88	-6
26	-54	34
-26	-66	46
-44	-40	44
32	44	30
-6	16	46
-52	14	12
50	-8	34
40	-66	-26
-28	-64	46
-42	-88	-8
-28	-34	8
40	-88	-12
-46	-40	44
28	-56	36
-36	-4	60
-48	-74	30
36	-58	48
50	-74	-4

// Kleinhans N, 2009: Healthy Controls
// Subjects=20
22	-6	-14
-22	-10	-14
42	-46	-24
-42	-48	-22
-20	-10	-12
16	-6	-16
-24	-2	-22
42	-52	-22
-44	-70	-16
-22	-4	-28
44	-60	-18
24	-74	-16
22	0	-18
-26	-2	-22

// Kleinhans N, 2009: Patients with Autism Spectrum Disorder
// Subjects=19
24	10	-18
-26	-10	-16
44	-56	-22
24	0	-16
-24	-6	-10
-28	-6	-26
-16	-8	-18
42	-56	-18
-42	-58	-20
16	-6	-16
-22	-4	-28
44	-60	-18
24	-74	-16
22	0	-18
-26	-2	-22

// Mickley K R, 2009: Emotional Items > Neutral Items
// Mickley K R, 2009: Arousing (Remembered - Forgotten) > Non-Arousing 
// (Remembered - Forgotten)
// Mickley K R, 2009: Non-Arousing (Remembered - Forgotten) > Arousing 
// (Remembered - Forgotten)
// Mickley K R, 2009: Negative (Remembered - Forgotten) > Positive (Remembered 
// - Forgotten)
// Mickley K R, 2009: Positive (Remembered - Forgotten) > Negative (Remembered 
// - Forgotten)
// Subjects=19
55	29	6
-4	63	17
8	59	19
40	-82	23
-36	-91	14
-53	-70	7
-22	-91	16
-22	-99	9
-38	-91	3
28	-93	8
22	-99	3
44	-70	-5
30	-90	23
36	-42	11
40	-60	-4
46	-49	-4
40	-73	24
48	-64	0
-55	-68	0
36	-34	-17
48	-45	-11
42	-40	17
-22	-5	-15
32	-13	-18
34	-8	-10
36	-16	-8
-8	8	-4
-30	-44	-16
-28	-34	-18
-55	-35	39
-26	-71	9
36	-3	26
-16	-22	-19
48	5	26
2	-32	59
44	2	44
-36	22	21
-26	-88	34
32	-28	59
55	-31	-3
-28	-51	-3
-24	-58	1
-14	-33	7
-26	56	-11
-40	11	31
24	9	27
38	47	11
34	53	7
50	-52	52
-24	-21	5

// Rasch B, 2009: Negative > Neutral Pictures, Genotype-Independent (G-I)
// Rasch B, 2009: Positive > Neutral Pictures, G-I
// Rasch B, 2009: Neutral > Positive Pictures, G-I
// Rasch B, 2009: Negative > Positive Pictures, G-I
// Rasch B, 2009: Emotional Subsequent Memory (ESM) Analysis, Difference Due 
// to Memory (Dm) Negative > Neutral, G-I
// Rasch B, 2009: ESM Analysis, Dm Positive > Neutral, G-I
// Rasch B, 2009: ADRA2B Deletion (Negative > Neutral) > Non-ADRA2B Deletion 
// (Negative > Neutral)
// Rasch B, 2009: ADRA2B Deletion > Non-ADRA2B Deletion for (Dm Negative > Dm 
// Neutral)
// Rasch B, 2009: Non-ADRA2B Deletion > ADRA2B Deletion for (Dm Negative > Dm 
// Neutral)
// Rasch B, 2009: ADRA2B Deletion > Non-ADRA2B Deletion for (Dm Positive > Dm 
// Neutral)
// Subjects=8
-22	-6	-20
19	0	-20
-52	-69	4
44	-52	-16
-63	-22	28
69	-25	28
39	0	-20
-22	-6	-20
28	-52	60
-6	52	20
52	-17	-24
-8	-17	36
-19	-3	-16
19	-3	-20
-14	-72	-4
-52	-72	8
52	-69	8
-3	47	-20
0	61	16
3	44	0
-33	19	-20
28	-41	-12
39	-83	24
-30	-41	-20
-22	-6	-20
22	0	-20
36	-52	-16
58	-22	40
44	-63	0
-14	-17	-24
-50	-74	-4
66	-14	24
-61	-22	36
-33	19	12
19	0	-20
30	0	-20
19	0	-20
-28	-8	-24
-25	-3	-24
-25	3	-20
-19	-3	-24
22	-3	-24
-22	0	-20
-30	-41	48
39	17	-20
-47	-6	-8
-52	-11	16
-44	-6	12
-19	-102	-8
-47	-6	16

// St. Jacques P, 2009: Subsequent-Memory Activity for Negative > Neutral: 
// Younger > Older
// St. Jacques P, 2009: Subsequent-Memory Activity for Negative > Neutral: 
// Older > Younger
// St. Jacques P, 2009: Functional Connectivity with Amygdala for Subsequent 
// Memory of Negative > Neutral: Younger > Older
// St. Jacques P, 2009: Functional Connectivity with Amygdala for Subsequent 
// Memory of Negative > Neutral: Older > Younger
// Subjects=15
-26.33	3.8	46.1
-14.89	43.48	21.45
13.16	30.99	50.06
17.61	2.09	61.35
40.89	14.18	36.65
21.94	-34.61	54.34
49.39	-11.55	19.75
36.2	15.33	-16.92
-26.67	13.49	6.26
-38.66	-2.27	-31.31
-54.08	-33.35	36.15
49.59	-35.9	35.17
57.07	-49.06	29.5
36.85	-55.98	38.12
-26.67	-27.18	-10.4
-22.48	-12.69	-16.13
-26.52	-57.5	-3.4
8.96	-16.59	40.71
-26.39	-95.65	-1.32
33.4	-68.43	1.29
-19.24	5.28	-4.29
-46.87	39.66	29.95
28.69	2.88	-25.83
-2.5	-72.91	56.72
37.03	-48.64	64.27
-2.97	-81.05	-7.27
-26.58	-86.7	-23.26
-42.81	24.34	-3.39
36.26	29.04	-4.69
-34.23	-15.93	-15.72
-54.37	15.24	17.58
-47.07	36.55	3.44
56.59	37.17	2.2
-34.05	-50.4	-7.26
-53.9	-46.87	54.01
8.64	-71.52	-22.7

// Gentili C, 2009: Normals
// Subjects=7
-42.04	-71.03	57.02
1.56	-39.99	41.65
-25.51	-40.49	-3.72
-32.08	-20.23	-16.5
-43.71	-14.62	2.12
67.29	-15.32	-16.94
50.19	-9.97	-14.96
-3.27	0.37	-14.1
3.06	50.08	-4.96
-22.43	57.1	19.28
59.91	2.12	2.87
21.99	-73.7	44.24
-1.42	-77.22	55.95

// Gentili C, 2009: Social Phobics
// Subjects=8
-8.07	-56.59	34.23
57.05	-52.57	25.34
28.62	-3.35	-37.57
-38.41	-12.81	-2.55
-53.65	22.65	-24.31
33.94	21.69	-30.81
43	-18.02	19.25
11.5	21.55	-30.54
-15.8	45.1	42.52
34.05	20.6	-17.34
21.99	-73.7	44.24
-1.42	-77.22	55.95

// Grabner R H, 2009: Retrieval > Procedural
// Grabner R H, 2009: Procedural > Retrieval
// Subjects=28
-54	-66	36
12	3	0
-9	-72	51
9	15	51
36	-3	63
45	9	27
30	-66	45
-3	-75	12
-51	-63	-12
-15	-42	-3

// Perfetti B, 2009: Activations
// Subjects=8
0.37	16.99	49.15
-29.43	-9.37	55.05
27.2	-5.86	54.1
-47.8	1.59	33.15
49.38	12.49	27.77
-30.99	20.69	3.47
36.34	21.1	2.67
-47.9	-65.37	-6.96
53.53	-55.76	-15.62
-33.62	-51.4	48.58
32.69	-60.26	51.91

// Solomon M, 2009: ASDs
// Subjects=22
55.89	3.08	-24.89
-54.16	11.48	-9.28
-53.27	2.38	-26.33
5.85	-25.5	28.09
27.72	-42.05	45.05
-33.1	-66.55	16.01
-53.23	-25.35	55.98
-29.47	54.11	-13.92
31.09	55.91	-9.53
-24.3	-89.4	23.72
-15.38	-57.74	51.82
24.89	-86.48	-16.62
-20.38	53.11	20.76
26.89	-67.95	-25.21
-58.13	-41.73	7.26
-62.11	-41.38	34.18
-22.53	-84.65	-5.91
-52.32	-32.11	40.94
-28.4	1.95	59.58
27.45	-83.46	15.53
29.82	-40.33	40.36
-52.29	-34.03	43.37
-26.23	-.17	59.75
-6.47	-43.73	74.93
37.77	-31.25	-12.22
44.48	-49.23	1.77
-60.2	13.62	25.35
23.7	-59.55	64.78
-13.12	-59.24	58.65
-22.54	53.1	20.8
-30.94	-68.77	15.07
-46.18	-70.72	6.56
40.33	-34.82	18.34
-15.45	17.2	61.21
19.21	-64.11	50.74
20.98	-79.02	17.44
-39.91	-73.42	-11.21
44.29	-71.41	-17.32
25.91	-26.29	76.01
-46.03	13.54	35.2
-26.87	-87	-7.85
-.21	9.37	68.45
6.42	-32.19	71.33

// Solomon M, 2009: Normals
// Subjects=23
-20.16	-92.96	8.32
-57.69	-40.64	41.88
29.59	-88.02	12.58
60.57	-35.77	-4.32
-31.72	51.25	-21.44
14.42	27.58	32.78
3.91	12.29	53.52
-51.02	13.96	-17.42
31.05	58.89	-12.06
38.68	7.27	66.87
-46.02	7.05	34.72
1.45	-12.96	24.69
-22.53	50.98	21.01
-37.56	37.41	25.97
25.69	17.97	67.16
35.49	28.07	-9.09
27.72	-42.05	45.05
-33.1	-66.55	16.01
-53.23	-25.35	55.98
-29.47	54.11	-13.92
31.09	55.91	-9.53
-24.3	-89.4	23.72
-15.38	-57.74	51.82
24.89	-86.48	-16.62
-20.38	53.11	20.76
26.89	-67.95	-25.21
-58.13	-41.73	7.26
-62.11	-41.38	34.18
-22.53	-84.65	-5.91
-52.32	-32.11	40.94
-28.4	1.95	59.58
27.45	-83.46	15.53
29.82	-40.33	40.36
-52.29	-34.03	43.37
-26.23	-.17	59.75
-6.47	-43.73	74.93
37.77	-31.25	-12.22
44.48	-49.23	1.77
-60.2	13.62	25.35
23.7	-59.55	64.78
-13.12	-59.24	58.65
-22.54	53.1	20.8
-30.94	-68.77	15.07
-46.18	-70.72	6.56
40.33	-34.82	18.34
-15.45	17.2	61.21
19.21	-64.11	50.74
20.98	-79.02	17.44
-39.91	-73.42	-11.21
44.29	-71.41	-17.32
25.91	-26.29	76.01
-46.03	13.54	35.2
-26.87	-87	-7.85
-.21	9.37	68.45
6.42	-32.19	71.33

// Wu S S, 2009: Mental Arithmetic, Roman, Calculation - Identification
// Wu S S, 2009: Mental Arithmetic, Roman, Identification - Calculation
// Wu S S, 2009: Mental Arithmetic, Arabic, Calculation - Identification
// Wu S S, 2009: Mental Arithmetic, Arabic, Identification - Calculation
// Wu S S, 2009: Mental Arithmetic, Arabic - Roman
// Wu S S, 2009: Mental Arithmetic, Roman - Arabic
// Subjects=18
36	-50	42
54	-54	-18
2	-64	-30
36	-88	4
-14	52	34
-54	-66	28
48	-70	28
-52	14	30
-22	-70	42
34	-52	44
-2	54	8
56	-58	12
-46	-72	42
-46	-72	20
-4	56	24
-54	10	8
-26	32	-4
-22	8	58
-2	6	60
38	20	-6
-24	-58	-42

// Kana R K, 2009: Autism Patients
// Subjects=12
52	30	0
-48	38	-14
42	-54	-24
46	8	24
58	-52	6
56	-28	18

// Kana R K, 2009: Healthy Controls
// Subjects=12
-10	56	42
-50	-72	28
-54	20	8
44	-48	18
0	-62	32
-42	18	48
60	-10	-18
44	-46	-22
-54	-12	-24
-42	-56	-14
-54	-34	-10
60	24	22
56	-28	18

// Kraus A, 2009: BPD+PTSD Patients > BPD Only Patients, Deactivations
// Subjects=12
24.5	-6.23	-19.44

// Reske M, 2009: Schizophrenia patients
// Subjects=18
-10	-48	42
-10	-58	22
-32	-78	48
14	-54	16
54	-46	40
-44	-40	48
-28	36	44
36	34	42
-54	-8	44
44	-12	54
20	-32	56
0	-32	42
-52	-56	22
-48	-30	14
66	-14	-2
58	-52	14
-48	-66	-8
40	-12	4
-32	-84	16
-18	-70	6
26	-84	16
10	-46	-2
-4	-64	24
-52	-42	46
-34	28	42
-38	32	-4
12	-54	-6
0	-38	40

// Reske M, 2009: Healthy subjects
// Subjects=18
-14	104	10
40	-50	60
-32	-52	38
16	20	60
-34	10	60
-26	42	24
44	12	54
-42	10	28
-40	30	26
40	42	-2
-28	28	-14
-46	38	-2
52	18	-2
-52	-14	26
6	24	40
54	-68	8
-56	-64	10
46	-60	-20
32	-72	-14
22	-88	38
38	-72	22
6	-64	14
14	10	0
-12	8	0
-4	-64	24
-52	-42	46
-34	28	42
-38	32	-4
12	-54	-6
0	-38	40

// Soulieres I, 2009: Autism (AUT) Group
// Subjects=15
-32	-84	-10
-22	-92	16
-36	-76	-10
-12	-98	2
-46	-28	46
-56	2	32
-38	-4	12
-28	20	4
-32	-4	-4
-14	-18	6
-2	-40	-42
-20	-58	-54
-26	-50	-54
-34	-54	-54
30	-84	16
34	-76	-12
32	-42	46
32	-52	50
24	-60	56
56	6	30
2	4	18
54	8	12
12	-14	0
-36	-58	24
-44	-68	38
-24	-84	-10
-26	-92	16
-30	-76	-10
-28	-66	-14
-12	-98	2
-44	-30	46
-36	-34	50
-32	-44	50
-28	-58	54
-54	4	34
-38	-4	12
-28	20	4
-34	-2	2
-12	-14	6
-28	-2	-4
-8	-14	-4
32	-88	12
30	-68	-12
34	-48	54
28	-56	50
48	8	28
58	8	30
60	8	22
30	-4	52
32	20	4
28	26	0
12	-10	2
8	-18	-4
2	-36	-42
-20	-16	58
-44	-14	42
-32	-14	42
-56	0	20
-50	-6	-34
28	-14	46
42	-16	40
46	-18	32
22	-18	50
22	-16	64
30	-12	70
-28	-88	-4
-38	-82	-6
-24	-92	18
-32	-88	12
-26	-74	32
28	-92	-4
38	-84	-4
34	-88	2
32	-88	10
36	-76	-10
-24	-64	52
-24	-4	56
-42	28	26
-46	2	34
34	-50	50
54	10	30
28	-6	52
44	36	20
-54	-22	-16
-44	-64	28
-56	-60	12
-52	-62	20
-56	-34	16
-64	-44	16
-60	0	0
-48	-64	38
-60	-46	30
-22	-6	32
-20	42	42
-8	-36	10
-8	46	2
60	-14	-20
62	-6	-12
62	-46	20
62	4	-2
40	-36	-6
36	-46	0
2	-66	36
2	-84	36
58	-48	32
22	-2	26
4	52	8
2	-28	42
2	-42	28
6	44	-4
4	34	14
12	34	-2
22	-18	-18
-28	-88	-4
-32	-88	12
-26	-92	16
-26	-74	32
-22	-64	52
-30	-50	50
-24	-2	56
-42	28	26
-46	2	34
28	-92	-4
38	-84	-4
34	-88	2
32	-88	10
32	-74	30
22	-64	58
52	10	28
28	-6	52
44	36	20
-44	-64	28
-60	0	0
-52	-62	20
-58	-32	18
-60	-42	24
-46	-68	38
-22	-6	32
-20	42	42
-6	-44	12
-8	46	2
-10	-36	6
60	-14	-20
58	-8	-14
62	2	2
36	-46	0
40	-38	-6
22	-2	26
4	52	8
2	-28	42
2	-42	28
6	44	-4
2	34	16
12	34	-2
22	-18	-18
40	-30	-12
14	-38	10
-2	-60	40
-42	22	36
-36	34	38
2	-58	54
36	42	34
-22	-92	18
-18	-82	24

// Soulieres I, 2009: Non-Autistic (Non-AUT) Controls
// Subjects=18
-12	-98	4
-14	-92	-2
-20	-86	-8
-28	-70	-12
-36	-38	48
-42	-30	46
-28	-50	54
-18	-66	50
-58	8	30
-50	2	36
-38	-2	12
-28	20	4
-12	-14	6
-8	-14	-4
-24	0	2
-26	-14	0
26	-80	-10
28	-70	-12
26	-62	50
28	-62	38
58	8	30
60	8	22
46	8	26
32	26	-2
38	0	14
32	24	8
12	-10	2
22	-24	-4
8	-18	-4
2	-36	-42
22	4	0
26	-4	0
30	6	-8
-24	-84	-10
-26	-92	16
-30	-76	-10
-28	-66	-14
-12	-98	2
-44	-30	46
-36	-34	50
-32	-44	50
-28	-58	54
-54	4	34
-38	-4	12
-28	20	4
-34	-2	2
-12	-14	6
-28	-2	-4
-8	-14	-4
32	-88	12
30	-68	-12
34	-48	54
28	-56	50
48	8	28
58	8	30
60	8	22
30	-4	52
32	20	4
28	26	0
12	-10	2
8	-18	-4
2	-36	-42
-20	-16	58
-44	-14	42
-32	-14	42
-56	0	20
-50	-6	-34
28	-14	46
42	-16	40
46	-18	32
22	-18	50
22	-16	64
30	-12	70
-30	-88	-8
-30	-92	4
-18	-94	-4
-18	-66	52
-34	-42	46
-26	-74	32
-24	-2	54
-44	14	30
-48	24	28
-6	8	56
-8	18	48
-42	44	-2
-30	24	-2
-4	-74	-24
30	-92	-4
38	-86	-4
32	-74	28
18	-64	58
28	-62	40
26	-62	52
28	-2	54
46	8	26
50	20	36
42	26	24
48	38	16
6	16	52
32	24	-2
8	-74	-24
0	-52	-40
2	-38	-42
-58	-30	20
-58	2	4
-42	6	-12
-50	-12	14
-6	-44	32
-6	-66	-8
2	-82	40
4	-42	26
4	48	0
10	38	-4
0	-22	42
6	-66	-6
-28	-88	-4
-32	-88	12
-26	-92	16
-26	-74	32
-22	-64	52
-30	-50	50
-24	-2	56
-42	28	26
-46	2	34
28	-92	-4
38	-84	-4
34	-88	2
32	-88	10
32	-74	30
22	-64	58
52	10	28
28	-6	52
44	36	20
-44	-64	28
-60	0	0
-52	-62	20
-58	-32	18
-60	-42	24
-46	-68	38
-22	-6	32
-20	42	42
-6	-44	12
-8	46	2
-10	-36	6
60	-14	-20
58	-8	-14
62	2	2
36	-46	0
40	-38	-6
22	-2	26
4	52	8
2	-28	42
2	-42	28
6	44	-4
2	34	16
12	34	-2
22	-18	-18
40	-30	-12
14	-38	10
-2	-60	40
-42	22	36
-36	34	38
2	-58	54
36	42	34
-22	-92	18
-18	-82	24

// Kim Y H, 2009: MPP, Healthy Controls > Traumatic Brain Injury Patients, 
// Activations
// Kim Y H, 2009: MPP, Healthy Controls < Traumatic Brain Injury Patients, 
// Activations
// Kim Y H, 2009: MPP, Posttraining > Pretraining, Subgroup of Traumatic Brain 
// Injury Patients, Training Completion
// Subjects=10
6	2	66
-2	-4	66
0	-12	32
0	14	32
22	28	38
28	8	36
42	40	-8
-26	-10	-28
38	-10	-4
6	24	18
-2	28	18
8	-58	40
-2	-52	48
46	-58	6
4	-58	-6

// Kohl A D, 2009: Group x Within-Run Fatigue
// Kohl A D, 2009: Group x Across-Run Fatigue x Within-Run Fatigue
// Kohl A D, 2009: Fatigue-Interaction Analysis: Group x Within-Run Fatigue
// Kohl A D, 2009: Fatigue-Interaction Analysis: Group x Across-Run Fatigue x 
// Within-Run Fatigue
// Subjects=11
0.6	-7.02	69
-41.72	47.58	8.03
0.12	23.22	19.63
-18.6	-85.83	42.38
-63.9	-21.29	14.06
-57.67	-0.07	-1.17
53.44	19.09	2.64
34.8	-69.4	43.73
2.46	-49.44	15.66
-21.93	1.85	61.83
-12.19	-72.59	47.88
-57.77	-1.01	-13.36
-19.23	-26.42	-15.01
-38.34	-38.45	-3.75
40.7	46.19	23.93
59.92	16.47	9.48
53.95	-40.47	44.43
53.41	-46.04	-27.58
0.6	-7.02	69
-41.72	47.58	8.03
0.12	23.22	19.63
-18.6	-85.83	42.38
-63.9	-21.29	14.06
-57.67	-0.07	-1.17
53.44	19.09	2.64
2.46	-49.44	15.66
-25.59	55.31	23.93
-44.44	-74.84	21.68
-41.54	-38.47	-3.71
-12.8	2.31	-1.88
5.86	-73.77	31.05
15.11	3.77	14.4

// Lee P S, 2009: Regional activation for the NoGo vs Go trials
// Subjects=12
6.74	11.14	41.76
-33.27	19.14	-16.44
34.04	15.06	-20.22
-27.81	39.12	7.47
32.13	31.62	15.22
-12.72	18.57	15.71
-7.4	4	5.72
59.15	-45.24	23.58
-55.13	-23.32	42.01
46.41	-23.52	44.21

// Dormal V, 2009: Numerosity Processing vs. Ref for N
// Dormal V, 2009: Discrete Length vs. Ref for DL
// Dormal V, 2009: Continuous Length vs. Ref for CL
// Dormal V, 2009: Conjunction of Discrete Length and Continuous Length
// Dormal V, 2009: Conjunction of 3 Experimental Tasks (N, DL, CL)
// Dormal V, 2009: Conjunction of N and DL tasks masked exclusively by CL
// Dormal V, 2009: Conjunction of 3 Reference Tasks
// Subjects=14
48	6	26
-48	4	26
30	-2	64
42	32	28
46	-38	50
-32	-52	52
-44	-74	-8
6	16	46
32	26	0
44	-40	50
-38	-46	50
-22	-64	52
48	6	28
34	28	0
-44	-76	-6
-34	-84	14
6	16	46
30	0	60
50	4	26
40	-42	48
-40	-50	64
28	-40	44
50	4	26
40	-42	48
-40	-50	64
-30	-80	24
46	-60	-10
-42	-40	42
58	-66	28
12	-54	36
-52	-62	20
-58	-46	0
-50	-20	18
54	-14	-20
-12	46	34
-16	68	16
-4	62	-8

// Cantlon J F, 2009: Healthy Controls
// Subjects=14
44	-68	8
-48	-68	-4
-24	-60	48
-28	-8	52
-40	-12	68
40	8	16
-32	12	16
-40	-52	-64

// Cantlon J F, 2009: Children
// Subjects=14
-24	-60	-8
16	-52	-12
-20	-48	-4
-47	-72	0
-24	20	12
-32	12	16
48	16	12
40	12	16
40	0	32
-8	0	52
-24	-12	56
-8	-4	64
-40	0	36
8	-16	16
-12	-20	16
-20	-56	48
40	8	16
-32	12	16
-40	-52	-64

// Leroux G, 2009: (INT-REfint) AND (COV-REFcov)
// Leroux G, 2009: (INT-REfint) - (COV-REFcov)
// Leroux G, 2009: (COV-REFcov) - (INT-REfint)
// Subjects=9
60	-50	-10
48	-40	46
62	-28	46
20	-70	54
18	-62	58
6	22	46
6	36	30
54	14	26
44	46	14
38	24	-2
34	-90	-10
-30	-62	52
22	-70	54
34	-66	50
12	-64	60
-12	-64	52
-26	-66	38
34	-64	38
8	22	46
-6	36	42
4	32	50
54	38	30
6	12	26
38	4	14

// Bledowski C, 2009: Selection
// Bledowski C, 2009: Updating
// Subjects=17
-21	-6	51
24	-3	51
-18	-66	57
18	-60	57
42	-36	42
-24	30	36
-21	-30	39
-9	-48	36
6	-45	33
-3	54	-6
18	57	24
18	51	-3
-51	-66	36
-27	0	-21
-24	-3	57
27	-3	54
-18	-66	54
18	-60	57
-33	-39	42
42	-39	54
27	63	12
-21	12	-6

// Nee D E, 2009: Perceptual Selection
// Nee D E, 2009: Memorial selection
// Nee D E, 2009: Perceptual and Memorial Selection
// Nee D E, 2009: Perceptual Selection Unique
// Nee D E, 2009: Memory Selection Unique
// Nee D E, 2009: Forget vs Remember Cues, Memory updates
// Subjects=18
-28	4	56
-42	-4	44
-48	0	56
-46	30	30
14	0	68
48	4	38
24	-2	52
4	20	44
42	46	26
34	46	24
52	-48	26
58	-48	8
-26	-66	56
-14	-66	54
-32	-84	26
22	-66	58
34	-52	46
26	-60	54
50	-34	2
56	-44	2
-52	-36	0
-60	-52	4
20	-100	-8
28	-98	-14
-16	-102	-6
-20	-96	-12
6	-8	0
18	-82	-30
26	-74	-32
20	-14	-14
18	-2	16
-52	20	28
-54	14	22
-48	26	34
-56	10	38
-50	-4	39
-2	18	50
6	28	32
6	8	68
50	8	40
36	4	56
50	36	30
40	46	28
60	14	32
34	26	2
48	14	-4
46	28	2
-30	8	60
-28	8	66
-24	-66	42
-34	-66	50
-36	-50	42
34	-60	42
32	-62	34
36	-44	44
-52	-46	4
-60	-38	0
48	-42	2
52	-34	2
16	-76	-34
-16	-2	4
-40	-70	-36
4	12	20
-6	-84	-26
-25	5	52
-44	32	30
-48	0	48
2	18	44
2	6	60
44	6	44
38	44	26
-56	14	2
-36	28	-4
-38	22	16
36	28	-8
14	30	20
-6	-64	52
-22	-66	52
24	-66	52
-50	-38	42
52	-40	4
-54	-46	2
52	14	-4
-56	16	-14
28	-76	-32
20	2	12
8	-6	2
-14	0	14
-34	-60	-32
-8	-12	0
-18	6	8
16	-2	64
50	-6	54
18	-60	64
-22	-58	66
54	-44	22
-10	-50	54
-20	-98	-10
22	-98	-8
-32	-84	22
-22	6	0
-6	-34	-46
-48	26	12
46	38	18
-2	28	42
38	12	56
34	30	0
10	42	16
-38	-56	44
44	-52	44
0	-74	46
-42	-68	-38
58	-64	-38
46	-58	-38
4	-88	-34
46	-82	-30
6	-30	-22
2	8	20
58	6	36
-50	12	50
-36	28	26
-44	22	36
-8	26	52
-16	6	70
-8	14	66
-4	40	36
-8	42	28
50	26	26
46	10	48
50	16	32
52	16	42
30	56	2
28	60	10
10	10	68
32	34	-4
50	38	8
12	16	36
-46	-58	56
-42	-66	50
-22	-72	50
-50	-48	52
-36	-52	54
28	-64	58
36	-66	54
44	-60	52
54	-36	42
-24	-60	49

// Grezes J, 2009: Dynamic > Static, Controls and ASD
// Grezes J, 2009: Dynamic > Static, Controls > ASD
// Grezes J, 2009: Fearful > Neutral, Controls and ASD
// Grezes J, 2009: Fearful > Neutral, Controls > ASD
// Grezes J, 2009: Fearful > Neutral, ASD > Controls
// Grezes J, 2009: Fearful > Neutral, Dynamic > Static, Controls and ASD
// Grezes J, 2009: Fearful > Neutral, Dynamic > Static, Controls > ASD
// Grezes J, 2009: Fearful > Neutral, Dynamic > Static, ASD > Controls
// Subjects=12
-50	-76	0
-28	-88	24
-52	-56	2
-24	-94	8
-24	-94	30
50	-76	6
48	-58	0
56	-40	16
56	-46	10
44	-68	-16
28	-96	4
32	-50	50
36	-78	24
44	4	54
44	18	24
-68	-46	16
54	-36	18
46	-74	-6
-52	-54	0
14	48	54
48	-32	0
44	-4	50
-64	16	12
10	-68	56
54	14	50
-54	-72	6
42	-42	-26
-48	-76	4
54	-44	10
48	-64	6
-24	-100	-10
-46	-52	10
52	22	0
44	-6	56
46	-16	-24
22	-16	74
36	-4	-20
58	-44	-6
-6	62	10
60	-48	10
18	-54	48
44	-60	20
62	28	20
12	-42	44
16	-60	8
44	0	-20
-34	10	-16
-36	-38	20

// Jung W H, 2009: Activation associated with biological motion vs scrambled 
// motion in OCD and control groups
// Jung W H, 2009: Increases in BOLD response associated with biological 
// motion vs scrambled motion, Control>OCD
// Jung W H, 2009: Increases in BOLD response associated with biological 
// motion vs scrambled motion, OCD>Control
// Subjects=15
60.84	-52.39	13.01
-58.88	-60.08	29.26
-60.08	-47.84	22.46
69.29	-28.63	2.67
-58.07	-27.08	14.77
-41.62	-56.93	27.53
60.68	-51.41	0.59
42.47	-80.94	7.18
58.8	-27.44	27.38
53.76	-67.38	48.23
-62.26	-32.64	24.36
-39.21	-60.47	46.89
-39.38	17.04	49.31
-4.98	54.18	42.81
4.92	46.3	-30.54
-5.86	50.82	-27.44
-14.42	42.7	-22.01
-37.53	-24.67	16.42
-46.29	-9.16	10.56
14.64	-.31	44.5
5.94	-16.06	37.24
-.48	-27.68	39.62
-56.32	34.43	-4.79
-50.81	27.63	2.51
59.68	-35.48	10.23
-58.21	-42.36	0.6
55.37	-50.7	8.45
62.79	-41.93	-1.51
-52.74	-47.24	5.47
65.16	-63.32	10.65
35.97	-99.67	2.42
-54.04	34.21	4.16
-53.94	26.22	10.55
60.33	30.28	-9.73
58.26	33.13	-2.13
51.15	21.12	30.55
48.88	26.87	23.3
55.31	33.07	20.34
-48.42	23.88	19.65
-42.13	-56.31	-11.74
46.37	-46.84	-18.67
-50.88	-34.21	-16.02
56.54	-21.59	21.24
60.62	-44.17	-2.37
56.45	-48.57	8.22
-46.43	-56.22	-10.56
-44.3	-47.71	-11.44
-50.88	-34.21	-16.02
16.08	-65.86	-25.24

// New A S, 2009: PTSD
// Subjects=14
-6	-42	10
14	-42	38
-32	38	-8
20	20	50
-38	2	36
-4	40	44
-36	30	-12
-36	-6	36
-42	-60	40
54	8	2
-52	-58	0
-56	-8	10
54	-2	10
0	-60	2
-18	46	32
-22	32	42
-12	38	40
10	22	50
44	14	36
-42	-62	52
14	-66	60
-58	-30	18
20	-68	-8
-6	12	60
44	16	38
-40	10	44
30	6	-30
32	-22	-18

// New A S, 2009: Non-PTSD
// Subjects=14
4	-24	26
-22	12	48
14	26	48
-34	16	56
-34	-66	48
10	6	16
50	-66	2
56	10	0
18	-84	40
38	-82	-4
0	-60	2
-18	46	32
-22	32	42
-4	2	42
-6	12	60
44	16	38
-40	10	44
30	6	-30
32	-22	-18

// New A S, 2009: Healthy Controls
// Subjects=14
-6	-42	10
14	-42	38
-32	38	-8
20	20	50
-38	2	36
-4	40	44
-36	30	-12
-36	-6	36
-42	-60	40
54	8	2
-52	-58	0
-56	-8	10
54	-2	10
4	-24	26
-22	12	48
14	26	48
-34	16	56
-34	-66	48
10	6	16
50	-66	2
56	10	0
18	-84	40
38	-82	-4
-12	38	40
10	22	50
44	14	36
-42	-62	52
14	-66	60
-58	-30	18
20	-68	-8
-4	2	42

// Strangman G E, 2009: Group (Simple Effect), Directed - Spontaneous, Healthy 
// Controls > TBI Patients
// Strangman G E, 2009: Group x Condition
// Strangman G E, 2009: Group x LBCsem
// Strangman G E, 2009: Condition x LBCsem
// Subjects=20
-52	-61	43
-32	29	29
4	-14	29
-52	-58	39
-14	31	43
29	-8	16
-30	-15	21
-24	-2	5
13	-13	37
29	-5	16
26	-5	-12
6	-19	66
-23	29	30
-33	32	30
26	59	1
-1	-88	21
-52	-61	39

// Chen S, 2009: Post-traumatic stress disorder (PTSD)
// Subjects=12
8.26	24.52	57.84
33.59	57.35	17.18
42.7	19.25	45.45
58.7	29.86	31.8
53.23	33.68	27.03
-52.72	30.56	22.42
-43.97	35.78	31.84
-29.13	-31.93	-4.29
-24.94	-29.66	-14.67
26.96	-34.59	-12.83
-42.18	12.25	-1.72
25.37	23.23	43.11
40.54	19.24	45.49
-53.81	21.73	19.95
58.15	41.01	-9.63
-5.11	2.86	22.11
3.16	1.15	-8.12
6.12	-44.26	45.63
-20.51	-29.88	-5.76
14.23	-41.69	3.78
-18.16	-47.12	4.87
-41.84	-20.22	18.3
12.71	20.05	67.17
-11.85	47.95	11.04
9.35	59.15	-19.56
-62.55	19.91	12.44
18.38	-34.2	-8.24
10.4	19.96	54.89
-39.34	21.71	53.33
26.79	69.18	-5.16
-13.56	-5.6	35.42
25.28	-40.84	23.68
-42.21	-33.98	-13.95
-31.52	-23.82	-20.74
35.42	-19.54	-24.55
-43.95	-32.99	19.6
46.75	-30.86	14.48

// Chen S, 2009: Healthy Controls
// Subjects=12
-64.47	10.72	29.07
58.73	0.52	27.98
35.28	58.18	-19.91
-58.24	35.13	14.22
-56.39	38.27	-9.65
24.46	13.19	-29.84
7.47	3.3	-8.4
-5.11	2.86	22.11
6.12	-44.26	45.63
-29.15	-29.91	-5.61
14.23	-41.69	3.78
-18.16	-47.12	4.87
-46.54	16.28	-4.28
48.54	10.13	-6.42
25.37	23.23	43.11
40.54	19.24	45.49
-53.81	21.73	19.95
58.15	41.01	-9.63
-5.11	2.86	22.11
3.16	1.15	-8.12
6.12	-44.26	45.63
-20.51	-29.88	-5.76
14.23	-41.69	3.78
-18.16	-47.12	4.87
-41.84	-20.22	18.3
29.05	69.91	2.57
-48.85	18.43	-15.66
10.4	19.96	54.89
-13.56	-5.6	35.42
25.28	-40.84	23.68
-42.21	-33.98	-13.95
35.42	-19.54	-24.55
-31.52	-23.82	-20.74
-43.95	-32.99	19.6
46.75	-30.86	14.48
10.4	19.96	54.89
-39.34	21.71	53.33
26.79	69.18	-5.16
-13.56	-5.6	35.42
25.28	-40.84	23.68
-42.21	-33.98	-13.95
-31.52	-23.82	-20.74
35.42	-19.54	-24.55
-43.95	-32.99	19.6
46.75	-30.86	14.48

// Elman I, 2009: PTSD
// Subjects=20
25	2	-1
-2	8	11

// Elman I, 2009: Healthy Controls
// Subjects=26
16	13	-2
25	2	-1
-2	8	11
26	7	-8

// Felmingham K L, 2009: Posttraumatic stress disorder (PTSD)
// Subjects=11
16	40	18
26	-12	-22
-34	-22	-10
64	-20	38
22	18	40
30	-30	-22
-2	-18	2
36	20	38
28	-12	-24
10	-20	54
-8	8	42
44	22	14
8	24	18
50	-24	24
-44	30	42
36	12	28
4	34	-8
-52	12	2
30	6	32
-36	34	26
-46	-38	28

// Felmingham K L, 2009: Healthy Controls
// Subjects=11
16	40	18
26	-12	-22
-34	-22	-10
64	-20	38
22	18	40
30	-30	-22
-2	-18	2
36	20	38
28	-12	-24
10	-20	54
-8	8	42
44	22	14
4	34	-8
-62	-32	42
-52	10	4
4	34	-8
-52	12	2
30	6	32
-36	34	26
-46	-38	28

// Shaw M E, 2009: PTSD
// Subjects=13
-40	-50	61
35	-54	52
50	-38	55
-38	54	-1
27	56	4
-27	31	-24
-38	41	-20
-57	11	29
48	20	29
42	33	12
-37	18	-7
-57	12	-7
-17	7	70
13	17	64
-37	0	60
33	7	60
-2	19	43
-55	-39	-16
-50	-30	-22
-44	-65	-23
12	-78	-26
32	-70	-47
-2	2	70
-13	26	58
-3	32	17
-3	39	-4
17	57	9
49	-70	-23

// Shaw M E, 2009: Healthy Control
// Subjects=12
-29	-61	52
31	-59	52
-45	-41	55
50	-33	55
42	48	16
-52	11	29
48	15	29
-37	0	60
33	7	60
-2	15	49
-1	-7	-14
-5	-37	-16
-2	15	-1
14	-19	13
-34	-61	57
-2	24	43
48	25	-12

// Thomaes K, 2009: PTSD
// Subjects=9
-18	-12	-18
-36	-27	-21
-42	-30	-21
-45	-36	-15
-42	-42	-21
-36	-15	-18
-39	-27	-24
-42	-39	-15
-21	-12	-15
-36	-9	-33
-30	-18	-9
-36	-9	-33
-33	-9	-18
-30	-9	-12

// Thomaes K, 2009: Healthy Control
// Subjects=9
-36	-24	-21
-39	-27	-24
-42	-39	-15
-30	-18	-9
-36	-9	-33

// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Happy
// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Sad
// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Angry
// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Fearful
// Seiferth N Y, 2009: Schizophrenia > Healthy Controls, Happy
// Seiferth N Y, 2009: Schizophrenia > Healthy Controls, Angry
// Seiferth N Y, 2009: Schizophrenia > Healthy Controls, Fearful
// Seiferth N Y, 2009: Conjunction Analysis: Healthy Controls > Schizophrenia, 
// All emotions
// Seiferth N Y, 2009: Conjunction Analysis: Schizophrenia > Healthy Controls, 
// All emotions
// Subjects=12
-36	-70	-10
32	-78	-6
0	-16	2
-34	-72	-8
-2	-22	-18
-14	-14	22
60	-44	20
0	-36	24
16	-34	16
48	-78	18
22	-80	30
44	-62	14
60	-20	16
40	-8	-14
30	-18	20
-16	-40	-20
-38	-38	12
66	-22	-4
20	-36	-20
62	-48	40
50	-24	-6
-36	-70	-10
32	-78	-6
-2	-18	2
-26	-78	-8
32	-78	-8
46	-38	6
8	-82	18
8	-82	18
-4	-54	8
-56	10	32
-8	-66	22
8	-82	14
-36	-70	-10
32	-78	-6
8	-82	14

// Mak A K Y, 2009: Control > Depressed, Gray Matter Concentration
// Mak A K Y, 2009: Control > Depressed, Gray Matter Volume
// Subjects=17
18	42	15
20	5	56
7	28	41
-23	54	15
34	29	-23
70	9	45
31	21	-31
57	-15	-8
-52	-45	-5
24	-41	-16
-1	-71	61
19	43	13
66	11	44
13	-18	59
31	21	-31
-51	-46	-4
-50	-60	36
-1	-67	60

// Milad M R, 2009: TENC > PTSD, extinction learning, blue > yellow
// Milad M R, 2009: PTSD > TENC, extinction learning, blue > yellow
// Milad M R, 2009: TENC > PTSD, extinction recall, blue > red
// Milad M R, 2009: PTSD > TENC, extinction recall, blue > red
// Subjects=15
-15.26	35.23	-30.27
27.62	-7.07	-30.56
-9.87	45.63	-20.05
2.94	47.74	-21.49
35.09	-10.46	-33.7
-1.06	41.82	12.51

// Werner N S, 2009: Encoding test > encoding control, PTSD > control
// Werner N S, 2009: Encoding test > encoding control, control > PTSD
// Werner N S, 2009: Retrieval test > retrieval control, PTSD > control
// Werner N S, 2009: Retrieval test > retrieval control, control > PTSD
// Subjects=12
-47.09	25.29	-4.53
11.06	17.05	49.02
-46.77	22.03	35.88
33.19	17.28	8.6
39.68	24.69	21.29
-1.84	29.41	44.79
-21.1	-10.57	24.94
-14.79	-4.96	14.36
7.8	16.52	42.41
33.67	-63.4	38.78
-37.33	-68.71	-23.53
-45.93	-49.55	-22.8
42.93	-70.37	-10.93
40.63	-42.35	-19.94
20.3	-13.15	-12.12
33.27	-31.33	-.71
-30.95	-19.54	-7.65
-27.2	-60.08	45.89
-66.11	-35.19	-.36
-30.52	-51.35	35.16
-17.86	-95.86	-4.75
-21.15	-93.39	-13.84
10.73	-75.28	-30.22
7.4	61.79	8.51
1.23	24.71	25.07
-24.31	22.42	38.94
-7.95	-49.93	51.51
-62.71	-29.85	27.04
59.03	-26.72	15.34
62.3	-45.74	16.9
58.6	11.69	-24.68
-27.62	-44.64	-2.24
-43.34	-71.23	26.94
20.37	-38.78	-13.32
-54.54	1.44	-9.44
-51.33	1.48	-9.2
-37.46	22.17	-4.38
-5.05	22.79	42.03
36.29	16.27	-4.73
-39.47	-68.72	-23.5
1.73	-19.53	72.27
-2.21	51.96	6.1
-2.07	59.93	26.62
9.72	12.11	12.65
1.79	-61.79	62.43
-23.85	-42.06	72.22
59.19	-34.95	32.76
4.78	-47.46	41.12
49.38	-66.65	-4.62
-1.8	-69.1	9.55
-21.16	-57.29	-1.25
69.63	-11.05	10.56
52.54	-20.93	8.24
7.78	-59.52	8.64
17.6	-86.99	24.21
-17.7	-84.28	21.05
-4.83	-83.69	27.54

// Whalley M G, 2009: Emotional hits > Neutral hits, (PTSD, Depressed, 
// Control)
// Whalley M G, 2009: Negative hits > Neutral hits (PTSD, Depressed, Control)
// Whalley M G, 2009: Positive hits > Neutral hits (PTSD, Depressed, Control)
// Whalley M G, 2009: Negative hits > Positive hits (PTSD, Depressed, Control)
// Whalley M G, 2009: Positive hits > Negative hits (PTSD, Depressed, Control)
// Whalley M G, 2009: PTSD > depressed/control, old > new
// Whalley M G, 2009: PTSD < depressed/control, old > new
// Whalley M G, 2009: PTSD > depressed/control, Emotional > Neutral
// Whalley M G, 2009: PTSD > depressed/control, Negative hits > Neutral hits
// Whalley M G, 2009: PTSD < depressed/control, Negative hits > Neutral hits
// Whalley M G, 2009: PTSD > depressed/control, Positive hits > Neutral hits
// Whalley M G, 2009: PTSD > depressed/control, Postive hits > Negative hits
// Whalley M G, 2009: PTSD < depressed/control, Positive hits > Negative hits
// Subjects=16
-14	46	4
8	28	20
-38	30	28
-30	24	40
-12	48	2
16	-12	38
-30	26	42
-22	-82	-4
42	-54	38
-40	8	8
-30	6	10
-32	10	-12
-14	-50	-14
-18	0	-12
42	-74	6
38	-82	0
40	38	10
14	-4	36
20	-50	14
30	-68	16
-30	0	2
-18	-44	10
20	-50	12
-26	8	40
-22	6	60
-60	-4	-4
44	-64	4
14	-6	38
44	0	4
-26	-16	54
58	4	26
-38	-18	20
-40	-8	-8
30	-70	16
-44	-14	20
-12	-14	-8
-64	-36	22
-20	-64	20

// Albrecht J, 2009: Nicotine Stimulation vs. Audition and Rest
// Subjects=19
8	28	38
10	20	44
-8	16	50
46	38	0
22	4	-16
-30	-60	-30
-54	12	4
-40	16	-8
-62	-28	20
42	36	30
50	4	44
-4	-34	24
24	-64	28
-6	-80	42
20	-26	2
4	-30	-6
-22	-18	56
58	-30	38
58	-12	10
-34	-4	0
-58	-50	-4
-8	-76	-34
-38	-52	52
52	-38	22
2	-92	6
-30	-40	-40
30	-38	38
66	-32	14
26	-72	-32
-10	-12	4
50	-46	58
-12	-76	28
34	-6	12
30	50	-8
12	8	70
-10	-14	62

// Bai L, 2009: Visual, V1 vs BL
// Bai L, 2009: Visual, R1 vs BL
// Bai L, 2009: Visual, V2 vs BL
// Bai L, 2009: Visual, R2 vs BL
// Bai L, 2009: Acupuncture, A1 vs BL
// Bai L, 2009: Acupuncture, A2 vs BL
// Bai L, 2009: Sham, S1 vs BL
// Bai L, 2009: Sham, S2 vs BL
// Subjects=26
-8.23	-96.97	10.75
17.9	-97.55	26.05
-5.03	-97.27	7.37
4.65	-87.66	6.25
-17.78	-101.18	23.66
33.83	-90.75	6.06
-47.11	-42.27	23.93
52.64	8.49	-24.25
-27.22	-49.82	56.84
-40.35	-22.63	49.89
46.11	12.51	-26.78
-1.7	-73.57	19.53
7.96	-93.72	10.15
-44.09	-76.76	-.72
4.66	-90.85	6.57
-44.23	-78.86	-11.72
68.07	-11.07	-4.65
-20.83	-47.23	49.75
46.98	14.59	41.35
69.19	-20.64	-3.72
14.66	-72.37	31.46
20.34	-6.1	-17.78
-29.38	-28.38	-23.69
-5.23	32.54	18.06
5.53	37.79	16.23
-1.62	-15.02	37.27
5.91	-43.69	28.77
-2.32	-2.68	-14.37
5.29	-5.64	-11.96
-41.15	22.79	-3.9
39.89	23.18	-4.2
-44.4	-1.35	-9.3
46.4	-13.79	-9.61
-8.47	-28.69	6.24
7.7	-12.47	6.6
-2.18	-18.11	-7.24
4.3	-18.09	-7.35
-14.05	-26.32	77.82
-52.41	-27.32	34.87
58.86	-24.8	32.72
6.21	-11.86	59.23
-3.57	46.35	-18.08
6.08	43.63	-24.69
-30.54	31.26	-17.24
61.75	17.47	13.92
-57.23	-60.62	-11.06
-58.95	-21.17	32.13
65.34	-22.54	33.51
-1.84	-69.19	9.01
8.24	-70.81	37.02
-2.39	-62.29	-32
7.46	-61.32	-22.18
-15.17	-64.28	-18.14
20.59	-69.92	-11.47
-29.44	-5.84	-23.68
29.94	-7	-27.94
-31.57	-13.29	-22.9
29.02	-28.82	-20.16
7.37	48.49	-7.27
-2.29	-5.77	-12.94
4.17	-3.72	-14.37
-37.9	23.97	-2.95
43.09	21.81	-7.48
-45.41	-.83	-3.73
-44.22	-20.83	0.47
49.75	-12.95	-.79
13.96	-21.77	-12.76
-3.33	-30.65	-14.94
4.28	-29.14	-10.74
-1.56	-37.91	-46.75
2.79	-40.98	-45.4
-65.44	-22.36	31.24
57.59	-25.09	18.21
5.04	-14.71	51.69
-59.33	15.36	9.47
61.78	17.68	16.14
-59.43	-58.71	-13.45
59.46	-56.81	-11.18
-24.1	-71.47	43.24
27.8	-68.85	45.46
-27.97	-74.03	-6.87
20.98	-83.38	16.75
-2.3	-51.79	-22.95
5.18	-62.27	-32.13
-34.61	-67.54	-17.48
23.75	-60.64	-15.8
-28.31	-14.24	-21.74
-31.53	18.8	-12.63
36.79	25.27	6.85
-52.56	-29.52	22.76
44.21	-23.45	70.94
-55.81	-26.34	22.5
67.96	-5.14	242.41
-51	22.88	-13.83
5	43.63	-24.68
-47.24	14.73	25.02
42.98	51.59	-10.42
-52.53	-26.02	25.78
-56.12	-29.69	-1.81
68.04	-24.45	-10.05
-28.19	-41.79	-17.9
13.97	-79.69	-23.83
-24.92	-38.27	-14.94
30.06	-29.13	-23.51
-31.53	18.8	-12.63
40.16	-5.46	10.96
50.51	-23.71	56.29
-62.3	-26.37	22.62
49.68	21.5	0.28
-1.65	20.91	42.68
15.41	34.61	27.59
-31.58	21.68	-16.28
34.36	-43.01	57.35
-31.43	-41.8	-17.84
36.6	-41.76	-21.25
-24.98	-41.98	-20.18
23.71	-43.42	-15.26
-11.89	-62.9	-14.97

// Eger E, 2009: Number Comparison Same List
// Eger E, 2009: Number Comparison Different List
// Subjects=10
32	-75	36
-20	-63	57
-39	-47	57
-33	-42	66
15	-72	39
-8	-69	47
-48	2	51
-5	8	42
32	-63	45
30	-72	50
23	-65	53
-24	-59	47
-42	-53	54
-17	-63	44
-24	-62	60
-5	-68	56
33	-3	65
6	11	57

// Franklin M S, 2009: Magnitude Near>Far (common regions with Order Near>Far)
// Franklin M S, 2009: Order Far>Near (common regions with Magnitude Near>Far)
// Franklin M S, 2009: Magnitude Near>Far (Unique regions)
// Franklin M S, 2009: Order Far>Near (Unique regions)
// Subjects=17
-40	-52	52
-40	-52	52
-42	-44	46
-58	-42	48
-34	-64	52
2	-74	-26

// Roebling R, 2009: JME patients
// Subjects=19
-3	3	66
-51	-3	54
-45	3	27
-30	24	0
36	21	0
-15	-3	15
12	3	0
-27	-63	51
-45	-66	-15
-30	-63	-30
36	-66	-33
30	-3	60
51	36	33
51	9	27
-51	0	42
39	-45	51
-21	-69	60
63	-57	-15
-54	-63	-24
-42	-69	-27
48	-69	-30

// Roebling R, 2009: Healthy controls
// Subjects=20
-3	6	57
-45	-3	54
-51	12	15
-45	39	0
36	27	-3
-18	6	-3
12	6	3
-21	-66	48
-48	-39	-24
-39	-66	-24
39	-57	-33
27	3	60
45	36	30
51	9	30
-48	6	36
45	-42	57
-24	-66	57
60	-45	-18
-51	-63	-15
-42	-42	-33
57	-57	-21

// Costafreda S G, 2009: Patients in clinical remission after CBT-Low 
// intensity
// Costafreda S G, 2009: Patients in clinical remission after CBT- High 
// intensity
// Costafreda S G, 2009: Patients not in clinical remission after CBT-Low 
// intensity
// Costafreda S G, 2009: Patients not in clinical remission after CBT- High 
// intensity
// Subjects=16
-9.35	13.25	30.12
25.48	-10.91	45.36
-24.31	-7.45	39.15
-20.64	64.31	2.85
18.49	55.27	18.77
-6.82	27.01	62.33
37.94	31.32	14.08
-4.55	-22.53	60.47
31.65	-61.42	9.92
-11.11	-53.79	47.99
25.83	-47.74	64.69
38.35	-53.15	29.15
11.58	-4.84	-26.72
-1.27	-41.25	-25.14
9.54	-65.23	-29.67
8.03	18.4	38.28
-11.74	57.5	21.3
-8.98	27	62.37
8.46	-11.22	65.86
-34.68	-32.65	68.71
38.35	-53.15	29.15
43.17	-62.57	65.86
-19.8	-49.77	45.5
46.31	-29.82	-20.35
18.57	-99.5	-6.26
-33.23	-70.78	5.22
16.05	-65	-27.56
16.73	-33.66	32.08
11.7	-36.74	-23.56
7.32	54.66	-10.12
29.09	55.98	2.83
-24.21	2.1	49.41
49.46	1.68	63.88
19.24	-20.11	62.07
-28.72	-58.47	21.86
-65.56	-30.94	19.76
-39.6	-24.05	23.12
50.81	-39.41	-8.28
-15.23	-69.78	60.85
10.02	60.95	34.04
33.85	-96.07	6.58
-48.68	-51.43	-16.6
46.02	-45.08	-45.73
-20.71	-36.86	-23
22.23	-45.37	-47.54
9.3	55.55	-23.69
-26.38	4.22	49.23
46.08	64.81	-18.51
-35.46	0.86	13.86
-63.49	-29.43	12.85
57.83	-74.76	26.48
50.81	-39.41	-8.28
49.33	-45.27	43.88
29.96	-51.31	49.29
-46.52	-51.42	-16.63
29.49	-85.45	5.61
16.22	23.82	3.99
-13.97	22	9.16
-5.62	-41.47	-27.28

// Blickenstorfer A, 2009: Wrist Flexion/Extension, Block vs. Rest, 
// Contralateral
// Blickenstorfer A, 2009: Wrist Flexion/Extension, Block vs. Rest, 
// Ipsilateral
// Blickenstorfer A, 2009: Wrist Flexion/Extension, Event vs. Rest, 
// Contralateral
// Blickenstorfer A, 2009: Wrist Flexion/Extension, Event vs. Rest, 
// Ipsilateral
// Subjects=15
-4.75	-7.13	67.96
-43.24	-24	59.78
-30.35	-19.98	69.33
-27.3	-28.1	46.56
-27.12	-39.5	64.24
1.54	-1.78	54.05
-49.91	-30.03	23.56
-53.32	-2.53	7.91
-27.7	-2.63	4.28
-1.91	-60.35	-1.21
4.83	-4.16	64.25
4.66	7.24	46.57
49.56	1.17	46.56
62.45	-24.39	45.21
36.83	-44.09	40.47
62.33	-32.28	25.8
52.43	1.02	3.05
58.91	5	12.68
42.79	0.7	-.16
39.55	16.8	1.88
49.11	39.32	3.22
14.02	-8.47	7.63
13.95	-52.02	-18.82
-21.29	-65.18	-20.66
-4.72	-10.05	71.55
-23.89	-32.63	70.32
-23.92	-19.68	72.58
-23.93	-42.91	61.14
-52.89	-21.14	56.3
-33.67	-31.05	50.22
-1.73	0.86	47.18
-4.88	-8.42	51.34
-11.17	-40.18	54.08
-53.16	-23.97	19.74
-43.68	-2.22	11.12
-40.56	-13	-4.74
-50.23	6.23	-2.9
-14.81	-21.59	5.72
-27.68	-8.98	4.81
1.27	-60.59	-4.58
11.29	-3.61	70.82
4.5	22.08	31.95
7.79	13.09	39.35
59.15	-32.04	29.17
33.22	7.76	9.4
36.48	-18.11	4.84
55.68	-1.88	6.6
7.64	-14.86	8.24
13.95	-52.02	-18.82

// Kumari V, 2009: Healthy Controls (HC)
// Subjects=14
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
42	-52	-16
28	-44	-6
30	-58	-12
26	-74	18
-20	-78	20
-20	-70	6
24	-66	2
28	-58	-2
26	-74	20
46	16	-2
52	18	6
42	20	-8
60	-46	16
64	-54	8
60	-32	2
64	-2	30
56	-6	32
48	-16	52
-38	-40	68
-42	-80	26
-54	-24	8
38	-82	40
36	-86	24
32	-70	56
-4	-30	8
10	-36	46
52	-16	-4
48	16	0
48	22	-8
-6	50	0
-2	22	40
6	12	54
-62	-52	4
-56	-52	30
-56	-60	32
10	-68	-2
22	-72	12
12	-38	4
-10	-62	60
-26	-46	70
-4	-38	64
0	-54	-10
-8	-40	8
4	-34	-10
-40	-74	30
-46	-82	14
-28	-88	40
44	-16	42
56	-4	36
46	-24	-8
-16	44	46
-26	34	46
-6	44	32
-44	-16	56
-50	-2	54
-38	-22	44

// Kumari V, 2009: Nonviolent Schizophrenia Patients (SZ)
// Subjects=13
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
26	-74	18
-20	-78	20
-20	-70	6
20	32	-14
-6	24	-2
-16	26	-8
42	-60	16
50	-12	-2
26	-74	14
-44	-34	-14
-36	-26	-6
-28	-84	10
-32	-76	24
-20	-66	6
-38	20	-6
-34	22	2
-42	16	-18
38	22	-4
56	14	-14
58	10	0
-46	-76	12
-40	-86	6
-50	-64	26
-2	-26	60
-2	-28	70
0	-38	60

// Kumari V, 2009: Violent Schizophrenia (VSZ) Patients
// Subjects=13
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
42	-52	-16
28	-44	-6
30	-58	-12
26	-74	18
-20	-78	20
-20	-70	6
24	-66	2
28	-58	-2
26	-74	20
20	32	-14
-6	24	-2
-16	26	-8
42	-60	16
50	-12	-2
26	-74	14
-44	-34	-14
-36	-26	-6
-28	-84	10
-32	-76	24
-20	-66	6
16	-10	8
12	20	0
-4	18	60
-2	42	32
4	26	54
40	24	-12
50	22	-18
54	20	-8
-38	-32	54
-42	-26	66
-38	-40	68
52	-76	26
44	-52	16
12	-64	8
-22	-42	-6
-34	-30	-20
-20	-34	-2
30	36	-10
56	22	-6
58	22	-4
66	-46	26
56	-44	16
62	-54	38
-8	50	0
-6	40	28
0	28	48
0	38	44
44	-64	6
50	-64	28
48	-56	-6
-20	-78	20
-22	-76	34
-32	-78	22
-38	-28	-20
-36	-38	-22
-54	-44	-14

// Kumari V, 2009: Antisocial Personality Disorder (APD) Patients
// Subjects=13
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
26	-74	18
-20	-78	20
-20	-70	6
16	-10	8
12	20	0
38	24	-8
52	12	-4
58	22	2
-20	-40	66
-10	-44	68
16	-34	70
48	-64	-8
40	-74	6
48	-72	4
50	-18	52
66	-4	28
44	-8	32
-22	-76	6
-38	-76	0
-32	-70	4
-8	-94	-2
-16	-100	2
-28	-92	12
40	-48	-16
16	-48	6
26	-62	6
-30	-36	-4
-10	-46	8
-18	-40	0
-8	-38	54
-28	-34	68
-14	-38	68
-6	-30	64
10	-32	66
18	-38	70

// Bonnet M, 2009: Healthy Controls
// Subjects=20
-30	-85	-17
-30	-44	-27
41	20	22
22	-85	32
29	-71	42
-42	-67	-20
41	6	28
32	-85	-11
-33	-92	-5
-27	20	34
-20	-75	-23
21	-24	-14
13	-37	-8
-15	-75	-20
4	-51	-6
-24	-17	-26
47	-64	27
4	34	38

// Bonnet M, 2009: Subgroup of Healthy Controls, Performance Data Available
// Subjects=19
38	3	-9
-40	-3	-16
34	-37	44
29	-27	17
-24	24	32
-52	-24	14
22	-10	40
-27	1	3
-42	-27	11
-40	-24	17
7	-89	-23
-20	-58	-19

// Brem S, 2009: Children
// Subjects=19
-63.52	-46.01	7.77
-53.94	25.16	10.65
-8.34	-55.07	11.09
-63.71	5.04	2.72
62.73	-27.04	-2.98
-38.01	-35.96	-23.91
-60.21	-6.15	20.58

// Brem S, 2009: Adolescents
// Subjects=13
-63.56	-46.32	4.44
-50.92	26.8	-6.37
-17.83	28.71	46.66
-57.53	-7	-23.08
52.92	-37.58	-11.85
-46.7	-70.93	50.29
-56.68	-3.96	43.84

// Brem S, 2009: Adults
// Subjects=18
26.68	-13.71	-30.58
62.66	1.99	-2.49
59.23	-15.85	-20.84
-36.88	-73.46	57.1
-60.84	-10.82	-29.37
-1.49	-62.13	38.57
50.32	-59.07	34.02
49.32	31.98	-25.4
66.02	-49.68	-4.16

// Pizzagalli D A, 2009: Healthy controls > MDD; Reward-No incentive
// Pizzagalli D A, 2009: MDD > Healthy controls;  Reward-No incentive
// Pizzagalli D A, 2009: Healthy controls > MDD; Loss-No incentive
// Pizzagalli D A, 2009: MDD > Healthy controls; Loss-No incentive
// Pizzagalli D A, 2009: Healthy controls > MDD; Gain-No change
// Pizzagalli D A, 2009: MDD > Healthy controls; Gain-No change
// Pizzagalli D A, 2009: Healthy controls > MDD; Penalty-No change
// Pizzagalli D A, 2009: MDD > Healthy controls; Penalty-No change
// Subjects=30
-28.81	-12.93	-4.88
33.54	-31.85	33.9
41.95	-67.23	2.2
37.19	-3.13	-35.46
59.69	37.22	-11.22
-47.91	20.19	26.01
26.97	28.01	37.88
33.27	31.34	25.26
-28.61	29.79	38.37
13.7	34.31	-17.14
62.07	-8.61	1.52
-24.68	32.82	-5.42
-24.18	-34.48	32.56
14.14	-52.25	5.73
35.27	-76.62	-35.96
22.53	-59.37	-18.31
-39.55	-6.99	-9.72
3.43	36.33	37.45
-41.34	-14.41	32.19
3.26	26.87	11.48
7.91	-16.43	42.94
-34.9	-66.75	15.31
-28.61	-63.6	0.48
16.07	18.06	6.5
18.33	2.9	16.67
-11.56	-1.34	19.6
-20.03	-25.88	19.52
-7.58	11.01	-13.83
35.22	19.52	-3.88
-32.94	-1.55	18.74
54.61	28.92	19.64
22.33	52.74	0.17
55.81	23.7	34.57
31.34	21.32	47.31
5.41	53.46	24.84
-53.15	0.33	31.09
7.45	32.64	3.15
11.94	22.84	27.34
-.71	-27.11	29.44
55.8	-58.78	0.22
-7.39	-66.16	-20.74
-15.92	-81.35	-23.83
-41.82	-16.03	-30.12
16.04	26.52	5.79
-7.36	0.03	9.4
-17.93	-24.1	14.89
48.15	33.83	14.85
33.43	20.9	41.75
-55.29	0.31	31.11
-.78	-10.28	26.91
54.38	11.12	-17.89
72.86	-40.44	1.83
-63.85	-52.55	8.88
-34.99	-85.3	-4.32
-15.62	-54.15	25.19
33.22	-81.23	-26.63

// Seo Y, 2009: ERO vs. HA
// Seo Y, 2009: Positive association of basal plasma prolactin concentration 
// with brain activity
// Seo Y, 2009: Positive association of basal plasma testosterone 
// concentration with brain activity
// Seo Y, 2009: Correlation between subjective feeling for erotic pictures and 
// brain activation
// Subjects=12
48	12	34
32	-4	60
40	26	42
-28	2	58
-4	36	54
4	42	48
10	24	48
-8	46	50
32	46	-18
30	32	-14
28	-8	46
-24	-10	48
-56	4	36
-36	-6	66
-42	-50	54
24	-60	58
-30	-58	56
54	-30	56
-52	-62	2
-50	-76	4
-38	-78	6
-46	0	-44
48	8	-44
-24	-4	-34
-24	-12	-26
-22	-10	-22
30	-6	-36
24	10	-36
-32	10	-40
-14	2	-4
10	6	10
-16	-8	16
20	-10	0
14	10	-6
34	24	0
8	-18	-14
-6	-80	-30
6	-20	-34
-8	-22	-32
-38	16	54
-6	32	34
40	-54	54
12	-64	40
-4	-56	64
-24	-60	56
38	-72	-38
4	2	48
-38	16	54
-22	20	64
32	14	56
24	10	66
-6	32	34
20	-74	50

// Osuch E A, 2009: Major depressive disorder
// Subjects=16
-14	64	14
56	-54	-10
16	-6	2
-36	-14	-20
-14	64	14
16	-6	2

// Persad C C, 2009: Deep Processing > Shallow Processing, Postmenopausal 
// Subjects
// Persad C C, 2009: Deep Processing > Shallow Processing, Hormones > Placebo
// Subjects=10
-48	24	16
8	14	28
42	22	0
-32	-70	32
-42	-36	48
30	-70	32
50	-36	-6
30	-90	2
-34	-88	-2
-22	4	6
-2	-58	-44
-24	16	50
10	12	48
6	-18	60
-48	-32	22

// Braskie M N, 2009: Encoding > Control
// Braskie M N, 2009: Retrieval > Control
// Braskie M N, 2009: Positive Correlation between Left ERC Thickness and 
// Retrieval Activation
// Subjects=32
-6	18	40
-2	-34	28
-24	-74	34
-28	-56	42
-26	-62	46
-64	-22	2
-64	-32	8
-30	-30	-22
-30	-22	-16
-44	6	34
-46	32	0
-50	-6	50
0	-76	8
-4	18	40
-2	-32	26
-28	-64	36
-28	-60	34
-30	-64	48
60	-18	2
-62	-32	0
-28	-28	-28
-18	-28	-10
-46	12	22
-34	26	-4
-50	-8	52
2	-84	32
-8	-26	-14
-10	0	18
-6	-20	12
-8	-60	-14
6	26	30
-10	66	14

// Mechelli A, 2009: Go/Nogo > Fixation
// Mechelli A, 2009: Nogo > Go
// Mechelli A, 2009: Go > Nogo
// Mechelli A, 2009: Go/Nogo, CT and TT Variants > CC Variant
// Mechelli A, 2009: Go/Nogo, TT Variant > CC Variant
// Mechelli A, 2009: Go/Nogo, CT and TT Variants > CC Variant (Controlling for 
// Teacher Rated Hyperactivity)
// Mechelli A, 2009: Go/Nogo, TT Variant > CC Variant (Controlling for Teacher 
// Rated Hyperactivity)
// Mechelli A, 2009: Effect of twin pairs: Go/Nogo, CT and TT Variants > CC 
// Variant
// Mechelli A, 2009: Effect of twin pairs: Go/Nogo, TT Variants > CC Variants
// Subjects=7
-36	50	28
38	50	32
-46	46	8
38	54	8
50	22	40
50	16	-4
62	-40	-2
4	-26	34
-42	-64	50
36	-60	46
-34	-60	-20
34	-58	-20
-42	-82	-10
38	-84	-12
6	-88	-6
-4	-88	-6
42	22	42
26	-2	48
42	0	38
62	-48	16
48	-30	-8
40	-40	44
28	-64	48
8	-62	50
20	-52	-22
-26	-64	-14
28	-56	-10
-26	-64	-14
6	28	-6
-28	-42	-12
28	-44	-12
-44	-18	14
44	24	-14
44	24	-14
44	24	-14
44	24	-14
44	24	-14
44	24	-14

// Jensen K B, 2009: FMS Patients and Healthy Controls: Painful Stimuli - 
// Sensory Stimuli
// Jensen K B, 2009: Healthy Controls > FMS Patients: Painful Stimuli - 
// Sensory Stimuli
// Subjects=16
48	10	-2
-2	-24	16
-38	-2	-16
-52	-2	2
40	36	32
22	-56	-24
8	46	4
-14	-34	12

// Bertolino A, 2009: Subgroup of Healthy Controls; Working Memory Sample, 
// DRD2
// Subjects=142
59	23	6
30	52	-3
26	7	-6
15	26	19
-38	6	51
-38	26	26
-8	0	7
11	-6	18
26	-72	21
-34	49	33
-38	52	11
-11	24	34
38	-53	24
-45	22	-7
-63	-35	16

// Bertolino A, 2009: Subgroup of Healthy Controls; Working Memory Sample, DAT
// Subjects=142
-41	6	51
-49	20	37
-45	22	-7
-38	6	51
-38	26	26
-8	0	7
11	-6	18
26	-72	21
-34	49	33
-38	52	11
-11	24	34
38	-53	24
-45	22	-7
-63	-35	16

// Bertolino A, 2009: Subgroup of Healthy Controls; Recognition Memory Sample, 
// DRD2
// Subjects=102
-22	5	14
48	22	-1
49	13	41
11	7	17
-8	8	15
-22	10	-16
26	-78	35
-41	-5	42
59	-19	42
4	-21	8
49	19	9
30	14	-10

// Bertolino A, 2009: Subgroup of Healthy Controls; Recognition Memory Sample, 
// DAT
// Subjects=102
-8	-18	11
-55	-2	42
-19	10	-16
41	-46	34
4	-4	8
30	18	-1
49	13	41
11	7	17
-8	8	15
-22	10	-16
26	-78	35
-41	-5	42
59	-19	42
4	-21	8
49	19	9
30	14	-10

// Peck K K, 2009: Comfortable Pitch > Rest
// Peck K K, 2009: High Pitch > Rest
// Peck K K, 2009: Low Pitch > Rest
// Subjects=12
33.47	-54.45	16.84
-20.23	-63.15	-21.96
50.45	-39.09	7.55
-57.47	-39.74	8.85
-29.75	-.65	16.4
40.78	-2.34	15.73
32.01	35.88	1.48
63.34	-5.41	29.11
-47.8	-11.62	27.57
67.52	-6.32	16.88
-54.26	-12.17	21
46.3	-31.23	27.01
-47.71	-38.14	28.67
11.03	-65.59	12.46
-16.74	-67.87	12.97
44.24	-38.13	34.31
-45.53	-36.64	34.1
39.41	53.81	-1.23
32.15	-54.92	-16.56
-10.68	-47.23	-23.4
52.54	-26.39	6.46
-60.68	-39.76	8.89
-32.93	-8.07	17.06
49.33	-.17	15.45
48.07	26.46	2.08
-47.98	9.56	12.41
57.96	5.13	28.29
-49.95	-7.4	27.24
59.07	-26.29	20.88
-53.17	-9.71	25.24
61.26	-29.03	26.66
-46.63	-40.25	28.84
30.31	-55.19	21.4
-22.1	-60.33	14.63
-41.25	-36.53	35.16
34.35	-72.88	-15.08
-7.47	-47.21	-23.44
45.05	-22.2	6.2
-62.74	-35.65	20.83
-37.17	-16.55	17.82
39.74	-22.95	10.78
30.93	37.98	1.31
-52.24	6.36	12.73
63.33	-2.23	28.85
-46.73	-10.55	27.46
60.06	-6.2	19.18
-49.98	-14.26	21.12
64.46	-29.01	26.62
-57.34	-35.02	28.52
17.19	-6.68	2.99
21.63	-4.94	25.09
-17.82	-64.62	13.82
-22.34	1.97	8.29
-3.82	-.84	52.92
-49.79	-39.75	35.52
45.84	48.56	-.86

// Crinion J T, 2009: Native Chinese
// Subjects=31
54	14	-18
46	-2	-16
44	-16	-6
-36	-16	2
-48	-12	16
52	14	-20
46	-4	-16
44	-14	-12
-34	-16	0
-46	-10	16

// Crinion J T, 2009: Europeans
// Subjects=21
54	14	-18
46	-2	-16
44	-16	-6
-36	-16	2
-48	-12	16
52	14	-20
46	-4	-16
44	-14	-12
-34	-16	0
-46	-10	16
54	16	-18
46	2	-20
44	-16	-4
-38	-16	4
-50	-16	18

// Crinion J T, 2009: English-Chinese
// Subjects=7
54	14	-18
46	-2	-16
44	-16	-6
-36	-16	2
-48	-12	16
54	16	-18
46	2	-20
44	-16	-4
-38	-16	4
-50	-16	18

// Crossley N A, 2009: Working Memory, All Groups
// Subjects=10
32	0	56
46	4	38
40	32	40
38	50	38
-36	-50	50
-14	-72	56
38	-42	44
28	-64	58
36	-56	54
-26	0	56
-46	26	38
-40	2	34
-44	44	26
0	14	52
8	20	42
6	4	56
-34	18	2
38	24	-4
-32	-60	-32
16	-4	20
30	-66	-30
-36	56	14
-36	46	30

// Dagher A, 2009: Deactivations during stress
// Dagher A, 2009: Cue-reactivity, stress
// Dagher A, 2009: Cue-reactivity, non-stress
// Dagher A, 2009: Stress response predicts craving response
// Dagher A, 2009: Deactivations due to the stressful MIST
// Dagher A, 2009: Deactivations due to the non-stressful MIST
// Subjects=15
0	60	0
2	40	2
-44	38	-8
-24	42	-20
-46	32	8
-6	18	-6
12	14	-14
-14	14	-12
36	8	-26
-24	-8	-16
-32	-16	4
40	-20	4
-28	-24	-20
32	-24	-16
0	-32	32
-54	-36	4
-8	-58	16
2	-66	28
-46	-74	30
4	-84	28
10	53	20
16	0	18
2	-6	2
18	-34	-12
58	-40	6
-18	-48	-6
2	-58	44
0	-82	0
54	-40	6
-24	-54	2
16	-80	8
10	50	22
-20	36	-2
16	34	38
14	32	4
-16	24	40
20	20	44
18	8	18
14	-6	-26
-2	-8	4
-4	-26	32
-4	-28	60
18	-34	-12
-22	-34	-10
-12	-38	48
58	-44	10
16	-58	14
-28	-60	10
0	-86	0
-8	46	44
-44	42	-14
4	38	-2
20	36	46
-24	36	-20
28	34	-16
54	34	-12
12	14	-14
-12	14	-12
36	6	-20
-46	4	-38
44	2	-34
-12	-6	-24
20	-8	-18
4	-10	42
-40	-10	2
42	-14	-4
-30	-14	2
28	-18	-24
-26	-18	-24
18	-26	70
-42	-30	8
-4	-30	42
-4	-50	28
14	-52	0
-12	-52	0
-52	-62	26
54	-62	28
0	58	-4
-2	66	-2
10	52	40
12	28	56
52	30	-8
-2	-10	48
-50	-8	4
40	-8	-16
-34	-24	12
22	-14	24
-22	-16	-22
-38	-24	54
4	-24	42
8	-52	32
-54	-62	30
52	-58	34

// de Greck M, 2009: Win > Lose
// Subjects=10
18	20	-6
-18	16	-2
6	-28	-32
-4	48	-6
-38	34	-18
12	6	-6
22	-2	16
-58	-54	-8
-42	-16	46
-18	-38	18
6	26	22
-40	-28	36
-28	-38	18
-42	-26	-20
38	-28	10
-64	-40	18
-6	-44	44
68	-30	0
50	-42	-22
-46	34	18
0	18	26
-58	-6	-8
50	-30	-20
52	-38	-14
-18	-42	48
-38	-66	36
-40	52	-4
56	6	-30
26	-40	20
-24	-78	14

// Callan A M, 2009: Driver Occluded View (DO) > Driver Occluded View with 
// Camera (DOC)
// Callan A M, 2009: DOC > DO
// Callan A M, 2009: Driver Non-Occluded View with Camera (DNC) > Driver 
// Non-Occluded View (DN)
// Subjects=14
-13.7	-83.27	8.37
-68.62	-29.6	34.25
-42.08	-9.98	1.6
41.88	5.47	-21.53
-24.94	37.09	-1.11
53.18	-2.77	16.07
-52.68	-6.33	18.23
14.61	-2.75	41.38
-11.59	22.5	25.88
29	-76.01	-31.18
-56.24	-16.38	-8.73
-9.9	56.18	-4.37
-31.51	-10.64	-17.56
41.98	-16.76	-18.21
-26.8	-19.73	11.27
-25.16	0.46	-25.49
26.84	30.16	-9.15
-22.47	15.36	18.93
-29.18	-65.19	-15.57
33.57	-55.52	-7.51
-32.77	5.98	57.01
40.56	-80.14	27.31
-50.42	-75.64	11.6
36.58	-50.24	60.27
-31.98	68.32	46.35
-15.27	-62.44	59
17.16	-68.71	59.07
-28.43	-78.18	40.61
37.45	-73.69	39.05
10.17	-96.59	13.76
-9.41	-74.74	7.45
12.19	-63.72	9.35
48.88	15.92	21.02
14.11	-75.36	-11.94
1.1	-77.95	-15.94
48.84	-77.39	-1.12
40.62	-80.79	31.85
-30.78	-80.71	25.21
10.28	-94.7	22.54
-11.6	-72.73	6.17
33.59	-61.91	-6.88
-20.4	-69.54	-5.2
23.52	-72.91	48.17
44.51	-77.41	-1.05
16.34	-48.58	-1.18
38.68	-48.53	55.59
-.18	-65.89	55.72

// Cao F, 2009: Meaning - Lines, Adults
// Cao F, 2009: Meaning - Lines, Children
// Cao F, 2009: Rhyming - Lines, Adults
// Cao F, 2009: Rhyming - Lines, Children
// Cao F, 2009: Meaning - Lines, Adults - Children
// Cao F, 2009: Rhyming - Lines, Adults - Children
// Cao F, 2009: Rhyming - Meaning, Adults - Children
// Cao F, 2009: Rhyming - Lines, Children - Adults
// Cao F, 2009: Positive Correlation between Differences in Accuracy and 
// Activations, Rhyming - Lines, Children
// Cao F, 2009: Negative Correlation between Differences in Accuracy and 
// Activations, Rhyming - Lines, Children
// Cao F, 2009: Positive Correlation between Differences in Accuracy and 
// Activation, Meaning - Lines, Children
// Cao F, 2009: Meaning - Lines, Adult Accuracy Subgroup > Child Accuracy 
// Subgroup
// Cao F, 2009: Rhyming - Lines, Adult Accuracy Subgroup > Child Accuracy 
// Subgroup
// Cao F, 2009: Meaning - Lines (Accuracy as Covariate), Adults > Children
// Cao F, 2009: Rhyming - Lines (Accuracy as Covariate), Adults > Children
// Cao F, 2009: Rhyming - Meaning (Accuracy as Covariate), Adults > Children
// Subjects=5
27	-90	6
-3	-96	15
-24	-90	-9
-45	27	21
6	-63	-30
-60	-45	0
-3	33	39
-36	-3	-33
30	-69	-36
33	-24	-24
39	30	-3
-39	24	24
-39	-66	-18
33	-84	-12
-57	-39	6
24	-99	0
-6	21	54
-36	-6	-33
21	-69	6
36	27	-6
33	-87	0
-39	27	-12
-54	18	9
-24	-90	-9
-3	30	33
-30	-84	-6
30	-90	-12
-42	36	3
-3	15	57
-48	15	30
27	-90	6
27	-90	9
-45	-36	51
57	-9	21
9	18	24
24	18	6
15	-63	33
-12	-57	42
-39	21	36
-30	-63	-15
27	-84	3
-27	-72	-9
30	-81	3
-36	-51	57
27	-87	6
27	-90	6
-18	-66	60

// Carreiras M, 2009: Low Frequency - High Frequency
// Carreiras M, 2009: Incongruent - Congruent
// Subjects=20
-1.82	22.98	44.21
11.24	-53.51	44.9
-38.54	30.88	-1.75
45.93	19.76	-1.79
4.9	-44.06	57.56
-6.23	-21.28	8.94
11.93	-21.17	8.72
4.18	50.68	2.79

// Chiao J Y, 2009: Individualism > Collectivism
// Chiao J Y, 2009: Collectivism > Individualism
// Chiao J Y, 2009: General Self-description > Contextual Self-description
// Chiao J Y, 2009: Contextual Self-description > General Self-description
// Chiao J Y, 2009: (IND General + COL Contextual) - (IND Contextual + COL 
// General)
// Chiao J Y, 2009: Correlation Analysis [Contextual - General] and [COL score 
// - IND score]
// Subjects=10
10.97	-8.96	9.56
33.45	-5.02	-6.9
-14.89	-15.12	13.97
-1.85	-49.53	12.67
27.1	9.07	6.38
17.73	-86.79	14.9
-37.8	-75.96	-15.48
33.54	-81.98	-14.97
17.13	71.79	0.35
-47.75	-9.84	-19.61
-53.61	-10	-55.35
62.33	-15.37	53.02
-58.83	-13.75	42.6
-12.02	-41.94	-20.4
0.73	36.37	-21.64
61.6	-29.59	-7.19
17.55	-21.39	14.04
-56.48	1.51	-23.94
-18.13	-25.02	11.65
40.04	54.93	13.95
4.82	30.71	43.84
-34.71	15.91	-8.93
8.05	-35.07	29
55.06	27.9	-.44
36.61	-76.73	-27.87
4.53	42.77	23.6
4.63	-75.76	7.31
4.57	14.6	20.79
23.37	55.8	-21.71
46.72	-39.89	9.77
43.7	-2.1	35.22
27.66	13.33	51.89
58.33	-27.68	-9.56
-33.94	-83.39	31.14
-25.06	-26.13	-22.86
4.18	48.89	-2.77
20.3	-29.37	-25.56
4.22	50.26	0.45
-62.33	-36.46	18.01
0.94	48.88	-2.71
-33.93	-87.64	31.56
-25.06	-26.13	-22.86
36.8	-87.29	-14.5
17.54	-46.58	8.69
67.84	-.72	-20.24
17.02	-29.69	-28.83
-40.69	-26.29	22.24

// Clement F, 2009: Mild Cognitive Impairment Patients
// Subjects=10
-36	51	-9
-21	-69	-39

// Clement F, 2009: Healthy Controls
// Subjects=10
18	0	6
-24	0	21
-57	-9	-18
-24	0	21

// Costafreda S G, 2009: Schizophrenia Patients
// Subjects=39
-54	14	0
-56	22	16
56	14	0
-56	32	8
56	28	16

// Costafreda S G, 2009: Unaffected Twins of Schizophrenia Patients
// Subjects=10
56	22	8
56	28	8

// Costafreda S G, 2009: Bipolar Disorder Patients
// Subjects=28
-56	32	8
56	28	16
56	28	8

// Costafreda S G, 2009: Healthy Controls
// Subjects=48
-58	16	8
-54	14	0
-56	22	16
56	14	0
56	22	8

// Dibbets P, 2009: Correct NoGo Trials - Correct Go Trials in All Subjects
// Dibbets P, 2009: Negative - Positive Feedback in All Subjects
// Dibbets P, 2009: ADHD > Healthy Controls (Overall)
// Dibbets P, 2009: Activation During Response Inhibition (NoGo - Go) That 
// Positively Correlates with Number of Errors
// Subjects=13
61	-42	6
50	-51	32
57	-45	32
46	34	19
53	12	12
53	18	19
-63	-33	37
-40	-52	49
-28	-69	57
26	-71	51
44	-52	54
50	-48	50
6	33	43
14	37	48
-34	21	-3
-46	20	21
-46	32	17
18	11	64
16	-2	68
10	21	62
-32	3	55
-50	4	40
-44	-1	48
-46	-26	57
-53	-23	47
-57	-39	41
53	21	-9
57	17	-4
50	41	9
46	-60	51
59	-37	39
61	-48	4
-51	12	5
-48	11	-14
-4	-24	-17
8	-24	-14
38	23	38
-53	35	-7
-57	16	3
55	27	-1
51	14	10
51	33	8

// Diekhof E K, 2009: Regions showing a positive interaction with pOFC during 
// processing of infrequent deviants
// Subjects=10
-56	-60	44
44	-48	56
-8	-28	8
-4	-20	-20
52	-64	-12

// Fang J, 2009: LV3
// Fang J, 2009: LV2
// Fang J, 2009: ST44
// Fang J, 2009: Sham
// Fang J, 2009: LV3, Deactivations
// Fang J, 2009: LV2, Deactivations
// Fang J, 2009: ST44, Deactivations
// Fang J, 2009: Sham, Deactivations
// Fang J, 2009: LV2 vs. Sham
// Fang J, 2009: ST44 vs. Sham
// Subjects=10
-3	7	33
3	9	33
-3	21	45
3	12	48
-9	-12	6
12	-15	6
-42	18	-9
36	12	-9
-59	-14	17
60	-15	15
-63	-24	24
53	-25	29
-54	-18	30
-3	-3	36
6	6	33
-3	12	42
6	12	57
-9	-14	3
9	-14	6
-42	15	-9
36	21	-9
-59	-14	17
54	-12	15
-60	-18	18
63	-27	21
-57	-21	24
-3	30	27
6	24	30
-3	12	48
3	12	48
-9	-15	3
9	-14	2
-34	24	-7
39	24	-3
-60	-12	15
54	-12	12
-60	-18	15
63	-24	24
-3	27	27
3	33	24
-3	6	45
3	6	42
-9	-12	0
9	-12	0
-36	18	-9
33	21	-9
-59	-9	6
51	-9	12
-51	-18	15
63	-24	24
-3	60	0
6	57	-3
-27	-36	-12
30	-39	-9
-24	-42	-15
30	-45	-12
-45	12	-30
48	6	-30
-3	-45	48
6	-39	51
-9	-60	27
6	-54	39
-6	-51	9
12	-51	9
6	-78	33
-6	54	-9
6	51	-12
-6	36	0
9	36	-3
-24	-9	-15
-24	-33	-9
27	-39	-9
-24	-45	-6
24	-45	-9
-6	-58	30
6	-48	30
-12	-50	10
9	-45	9
-9	-84	33
9	-78	21
-9	54	0
6	54	-12
-33	-6	-30
-39	-21	-21
48	9	-24
-6	-60	33
-6	57	24
9	-42	33
-6	-84	27
6	-84	27
-6	45	-6
15	57	-3
-3	39	0
6	36	0
-30	-3	-27
-35	-12	25
33	-33	-15
-27	-36	-18
30	-36	-18
-48	12	-30
45	9	-30
-9	-36	60
9	-36	54
-6	-33	45
6	-54	30
-9	-48	9
12	-48	3
-9	-75	30
9	-72	33
-39	6	-24
-9	30	45
9	-36	39
51	-33	42
-9	-30	45
-9	-33	-3

// Fridriksson J, 2009: Correct Naming > Baseline
// Fridriksson J, 2009: Phonemic Errors > Correct Naming
// Fridriksson J, 2009: Semantic Errors > Correct Naming
// Subjects=11
58	0	40
57	1	32
6	8	68
64	6	-3
57	-31	0
53	-37	45
49	33	9
70	-21	6
-20	-86	42
-24	-90	38
-31	-64	42
-22	-82	46
-26	-73	45
-44	-61	-4
20	-98	6
18	-96	10
40	-80	4
32	-86	6
58	-62	-6

// Friedman D, 2009: Target Tones > Baseline, p<0.001
// Friedman D, 2009: Target Tones > Baseline, p<0.0001
// Friedman D, 2009: Target Tones > Baseline, p<0.00001
// Friedman D, 2009: Target Tones > Baseline, p<0.000001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.0001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.00001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.000001
// Friedman D, 2009: Target Tones > Novel Sounds
// Friedman D, 2009: Environmental Sounds > Target Tones
// Friedman D, 2009: Novel Sounds > Target Tones
// Subjects=15
53	-19	38
12	-39	35
-12	-31	36
-12	-43	37
-40	-34	49
2	-29	-7
-20	-2	-7
14	-19	5
-28	45	13
40	-11	54
-55	-6	-6
53	-17	47
32	24	-4
34	26	8
6	-6	64
-44	-11	48
50	-10	8
2	20	38
58	-44	12
-55	-19	45
-51	-27	36
48	-20	18
32	18	6
-54	4	18
4	-10	66
-52	2	10
-10	-2	42
10	4	36
54	-26	-4
-48	-12	-8
68	-40	20
52	-22	4
-14	-16	-2
-32	2	10
-38	12	2
2	4	48
-42	-25	14
-63	-35	9
-32	23	3
63	-38	11
-48	-34	13
63	-12	-3
65	-27	10
53	-17	3
-55	-18	-1
-57	-30	27
42	-29	38
50	-26	23
-49	26	8
55	-18	-3

// Ge J, 2009: Nonreligious Healthy Controls
// Subjects=14
12.62	-28.82	49.6
40.49	-58.77	26.31
-41.43	-63.13	41.59
31.95	30.57	52.36
-13.65	-50.01	19.64
47.07	-62.38	33.28
-34.83	-64.4	50.56
29.82	30.77	54.61
-11.16	-34.43	48.32
19.44	-42.68	73.26
43.06	-60.11	57.78
29.74	36.74	49.54

// Ge J, 2009: Christian Healthy Controls
// Subjects=14
-2.42	-65.45	49
34.48	-17	71.59
-15.49	-31.26	48.08
40.77	-74.23	44.65
-39.21	-76.95	42.92
-67.86	-25.4	10.29
65.97	-10.66	-.17

// Goldin P R, 2009: Social Anxiety Disorder Patients
// Subjects=15
-7.74	52.16	-18.39
-13.01	26.49	-19.52
-21.31	-28.03	-8.16
21.47	-28.57	-5.26
-57.14	-19.76	60.7
-44.4	-12.89	52.17
-20.59	-51.38	75.2
-41.22	-75.79	22.84
27.04	-93.22	-2.14
11.97	-57.1	-1.65
22.99	-79.84	33.59
9.06	-52.89	39.3
-50.67	-53.19	54.5
65.65	-53.06	31.97
8.42	55.83	0.08
12.14	-1.43	43.87
-24.15	-5.62	47.98
45.01	-19.29	2.61
45.47	-14.58	63.54
-5.79	-90.24	39.25
12.16	-92.45	9.12
-21.11	-63.38	2.61
49.68	-15.15	55.74
16.33	-59.39	9.65
24.3	-62.03	71.11
34.92	-43.99	69.48
-42.17	-33.94	55.02
19.6	-58.77	17.36
-20.59	-43.73	77.9
44.95	-58.35	-20.88
-60.73	-16.15	11.37
67.52	-15.13	13.15
-24.46	-72.52	-18.89
70.63	-11.73	1.68
23.56	55.6	23.34
11.7	4.95	-11.31
-9.64	-3.64	-10.34
63.34	8.85	34.61
-65.05	-19.95	3.93
-54.28	-26.69	12.18
44.94	55.73	23.08
1.06	65.78	19.4
37.56	18.33	21.84
49.44	-85.76	-4.13
-42.57	-79.77	-14.73
60.14	-74.53	2.61
1.4	-17.5	29.72
1.54	-56.71	31.9
45.41	-49.16	43.03
-42.68	-51.22	-17.13
52.68	-62.34	9.48
-17.15	-2.88	-13.67
19.21	-9.01	-13.57
-2	-45.89	-6.89
-34.66	-90.67	36.28
-16.39	-86.19	51.3
-20.78	-87.42	35.84
-20.81	-72.36	37.93
-31.42	-93.57	39.83
16.38	-55.61	17.14
9	-28.23	41.69
-24.48	-43.11	-10.21
30.96	-25.4	-20.14
41.88	15.53	26.49
1.11	58.64	23.34
45.01	30.09	21.89
-57.41	-78.66	0.96
52.64	-74.83	-.63
16.3	-82.79	-4
27.33	-86.87	38.59
-28.29	-80.06	35.31
-16.87	-83.5	-10.25
1.53	-53.45	32.74
-34.51	-44.07	74.74
-42.73	-44.08	-21.07
41.76	-46.14	-14.06
56.57	-5.87	-17.61
-20.35	-3.96	-13.54
16.15	-27.21	-.86
-16.97	-27.4	-.46
44.96	-4.49	1.37
37.61	-7.56	17.32
45.15	-25.49	18.74
37.51	3.47	8.59
-60.76	-8.75	10.75
-68.2	-19.37	11.72
-28.74	-45.16	-8.87
-57.81	33.68	-5.11
59.75	31.21	-6.26
9.02	21.41	64.29
-57.17	-57.43	41.55
-5.82	-64.27	44.88
63.47	-50.16	28.41
-53.87	-59.73	52.86
-60.77	-31.9	0.42
56.74	-27.22	-4.67
67.53	-41.36	4.2
-17.15	4.78	-10.96
37.56	-19.08	6.02
-42.79	1.45	-10.39
24.24	-62.63	63.36
49.71	-22.55	56.36
-38.95	-38.15	55.34
34.87	-40.02	65.8
16.75	-44.1	69.7
-49.63	-27.12	61.23
52.99	-26.16	64.43
-60.75	-11.92	11.01
60.26	-73.33	18.12
-49.97	-68.04	-0.02

// Goldin P R, 2009: Healthy Controls
// Subjects=17
-7.74	52.16	-18.39
-13.01	26.49	-19.52
-21.31	-28.03	-8.16
21.47	-28.57	-5.26
-57.14	-19.76	60.7
-44.4	-12.89	52.17
-20.59	-51.38	75.2
-41.22	-75.79	22.84
27.04	-93.22	-2.14
11.97	-57.1	-1.65
22.99	-79.84	33.59
9.06	-52.89	39.3
-50.67	-53.19	54.5
65.65	-53.06	31.97
8.42	55.83	0.08
12.14	-1.43	43.87
-24.15	-5.62	47.98
45.01	-19.29	2.61
45.47	-14.58	63.54
-5.79	-90.24	39.25
12.16	-92.45	9.12
-21.11	-63.38	2.61
49.68	-15.15	55.74
16.33	-59.39	9.65
24.3	-62.03	71.11
34.92	-43.99	69.48
-42.17	-33.94	55.02
19.6	-58.77	17.36
-20.59	-43.73	77.9
44.95	-58.35	-20.88
-60.73	-16.15	11.37
67.52	-15.13	13.15
-24.46	-72.52	-18.89
70.63	-11.73	1.68
23.56	55.6	23.34
11.7	4.95	-11.31
-9.64	-3.64	-10.34
63.34	8.85	34.61
-65.05	-19.95	3.93
-54.28	-26.69	12.18
49.38	-75.45	-8.34
-46.73	-86.34	-2.98
1.4	-25.15	27.02
52.91	-53.34	43.29
63.56	-60.22	35.94
-46.41	-37.93	58.75
-13.83	5.99	4.51
-17.15	-3.94	-13.58
20.25	-2.66	-14.11
-16.38	-81.71	54.27
27.39	-63.13	56.67
-57.57	-53.88	-8.92
-23.43	-41.07	-11.51
23.62	-45.99	-10.52
4.26	58.06	15.55
4.54	31.31	41.21
4.67	20.53	53.26
49.33	22.97	25.78
59.99	30.44	25.03
-31.66	1.74	47.45
34.11	27.89	-5.68
-32.12	31.01	-.72
52.58	-75.43	-8.38
42.81	-50.71	-18.15
-46.75	-83.17	-3.25
-41.58	-47.61	-11.86
-13.51	-103.78	2.56
31.54	-83.13	31.54
1.45	-47.7	24.45
-28.08	-65.77	68.68
-38.83	-40.2	70.01
44.65	22.01	-27.62
56.5	4.36	-22.93
1.23	-26.95	3.75
16.14	-24.03	-1.12
-20.36	-2.9	-13.63
19.17	-.55	-14.28
-35.15	6.47	12.52
-39.26	-26	19.75
-39.36	-16.02	11.11
-9.04	-11.73	63.93
-42.44	-33.42	20.41
57.04	-5.39	43.68
63.02	13.26	-4.79
-68.23	-11.97	11.1
-31.92	-38.33	-2.72
-46.96	-9.61	-1.61
-60.8	-54.16	-12.21
9.03	13.75	61.59
-1.57	11.38	73.06
-49.85	16.78	50.86
-34.83	-22.14	41.68
-57.76	19.94	-3.96
-54.33	-12.94	11.02
-8.3	19	34.58
52.76	2.24	46.44
-54.05	-1.23	52.42
-64.66	-54.3	41.38
-64.65	-42.07	48.16
-60.76	-35.07	0.69
49.3	-31.24	-.9
-57.91	21.65	-23.06
44.95	-58.35	-20.88

// Grabner R H, 2009: Conjunction (Multiplication, Figural-spatial), Untrained
// Grabner R H, 2009: Multiplication > Figural-spatial, Untrained
// Grabner R H, 2009: Figural-spatial > Multiplication, Untrained
// Grabner R H, 2009: Conjunction (Multiplication, Figural-spatial), Trained
// Grabner R H, 2009: Multiplication > Figural-spatial, Trained
// Grabner R H, 2009: Figural-spatial > Multiplication, Trained
// Grabner R H, 2009: Untrained > Trained, Multiplication
// Grabner R H, 2009: Trained > Untrained, Multiplication
// Grabner R H, 2009: Untrained > Trained, Figural-spatial
// Grabner R H, 2009: Trained > Untrained, Figural-spatial
// Subjects=14
14.29	-84.96	0.21
-43.93	7.6	29.03
27.08	-27.17	-2.36
53.28	14.33	26.71
43.85	3.4	48.12
24.07	-97.69	1.31
-24.45	-100.42	9.13
28	-66.23	62
33.4	-41.46	-17.86
-28.25	-45.5	-23.14
-20.54	-52.7	71.57
31.05	4.6	61.66
63	14.36	26.54
-60.35	-69.58	-3.4
-59.9	-20.23	42.14
14.29	-84.96	0.21
27.08	-27.17	-2.36
8.19	16.35	50.81
-21.53	-30.53	-1.2
-43.93	7.6	29.03
53.29	11.14	27.02
-27.36	0.58	56.33
43.1	20.75	-7.37
23.84	5.66	4.53
37.47	0.81	55.21
-34.56	21.41	3.97
-14.87	-98.13	-1.35
27.44	-99.93	11.56
33.33	-68.24	-28.66
33.32	-42.09	-24.52
59.51	-66.28	-9.13
36.23	-11.73	-44.38
-24.98	-41.98	-20.18
-4.83	19.18	47.39
-47.23	10.47	25.44
-28.19	27.19	-3.43
-5.55	-81.45	-30.05
10.6	-22.71	-22.69
31.24	-66.22	61.94
-28.4	-63.01	-38.21
-27.23	-54.28	55.04
33.39	27.41	-4.51
56.48	14.03	23.32
49.81	38.91	14.25
-37.95	-74.87	-26.79
-57.22	-63.81	-10.74
-21.13	-89.91	18.12
34.31	11.31	64.31
-63.04	-45.77	44.72
63.19	-56.46	26.82
-1.53	-39.48	39.69
47.14	-32.31	44.87
-53.81	35.97	23.03
56.49	10.84	23.63
-8.07	19.17	47.44
53.18	39.85	24.18
27.73	3.97	55.06
33.41	24.22	-4.19
-27.34	7.27	59.03
-28.13	24.31	0.21
59.95	-56.47	26.87
-56.57	-65.52	39.84
-1.61	-63.07	28.58

// Green A, 2009: German, Unrelated > German, Iconic
// Green A, 2009: German, Iconic > Russian, Iconic
// Green A, 2009: German, Unrelated > Russian, Unrelated
// Green A, 2009: German, Iconic > German, No Gestures
// Green A, 2009: German, Unrelated > German, No Gestures
// Green A, 2009: German, Iconic > Russian, Iconic and German, Iconic > 
// German, No Gestures
// Green A, 2009: German, Unrelated > Russian, Unrelated and German, Unrelated 
// > German, No Gestures
// Green A, 2009: [GI > RI and GI > G] and [GU > RU and GU > G]
// Green A, 2009: [GI > RI and GI > G] masked by [GU > RU and GU > G]
// Green A, 2009: [GU > RU and GU > G] masked by [GI > RI and GI > G]
// Subjects=16
-44	-36	40
-60	16	24
52	-36	36
48	32	12
8	20	56
8	-36	56
-60	-60	-4
44	12	48
-20	-12	-16
-40	-72	8
44	12	-28
60	-44	-8
-60	-20	36
12	-8	-16
-56	-8	-20
-44	28	0
56	-52	-8
-32	-44	44
-44	4	48
56	0	-24
36	-52	48
60	-4	36
-48	-76	-4
52	-72	-4
68	-24	8
-20	-28	-8
-48	-76	-4
44	-68	-4
32	-56	44
-48	-68	4
-56	-68	0
56	-64	-4
-32	-44	44
32	-52	44
-52	-68	0
-40	-76	8
-56	-56	0
56	-64	-4
-32	-44	44
32	-52	44

// Habermeyer B, 2009: Deviant Pattern > Silence
// Habermeyer B, 2009: Standard Pattern > Silence
// Habermeyer B, 2009: Musicians vs. Non-musicians, Deviant Pattern > Silence
// Subjects=8
55.69	-13.77	4.25
38.4	-8.18	-18.32
-2.99	6.54	24.41
-12.39	-50.53	30.42
-31.01	42.36	8.35
-45.78	-24.95	6.36
-38.37	24.94	17.7
-44.35	-77.16	33.02
51.28	-5.3	-9.79
-30.48	-71.87	31.31
-49.06	-13.59	2.1
19.08	30.28	-14.63
-43.98	30.88	-15.07
-55.6	-15	-15.55
-60.71	-17.04	13.67

// Haupt S, 2009: Incongruent Phonetic > Congruent Phonetic
// Haupt S, 2009: Incongruent Semantic > Congruent Semantic
// Haupt S, 2009: Incongruent Phonetic > Incongruent Semantic
// Subjects=29
40	16	32
-48	18	10
2	18	46
2	-56	26
-44	4	20
28	8	28
-34	16	14
-6	-6	26
-18	12	0
-6	32	38
48	14	30
-6	-16	8
-2	32	18
-18	-6	46
0	14	48
-18	-8	16
-18	-8	62
0	30	48

// Heim S, 2009: Congruent > Null
// Heim S, 2009: Incongruent > Null
// Heim S, 2009: Incongruent > Congruent
// Heim S, 2009: Congruent > Incongruent
// Heim S, 2009: Onset Latency Difference for 1st Temporal Derivative of the 
// HRF: Congruent > Incongruent
// Subjects=16
-32	-14	-6
26	-4	6
-14	-24	2
10	-14	0
-54	-2	16
-60	-8	2
-36	-20	4
-50	6	2
4	-38	-6
-30	-60	-10
-40	-40	-14
-42	-82	-8
-34	-92	-2
-20	-68	-12
20	-62	0
22	-48	-12
-16	-66	12
6	-64	16
-6	-76	24
20	-64	20
10	14	58
-6	32	32
6	28	32
-18	-76	48
-28	-86	36
-20	-88	26
28	-52	64
28	-40	64
10	-68	-14
22	-82	36
18	-80	26
14	-30	56
12	-26	50
-30	26	6
-12	2	66
10	4	70
-42	4	36
-62	10	14
46	14	14
48	-28	58
-12	-22	2
10	-12	0
-50	4	4
-62	-2	4
-44	4	38
-54	-2	16
-36	10	8
-66	-28	12
-30	-4	-12
2	-40	-2
-34	-60	-10
-26	-92	-12
-38	-86	22
-22	-82	24
22	-80	38
-14	-68	12
6	-66	16
-6	-76	22
6	-82	32
-18	-76	48
-24	-62	-2
10	-86	-4
24	-72	-6
26	-42	-22
10	14	58
-12	4	68
2	24	38
8	-70	-16
-2	-60	2
32	-46	60
22	2	4
28	-88	30
32	-86	30
-40	-44	-14
26	-92	2
24	-94	4
-38	-56	-46
-40	14	30
26	-70	50
-50	-8	46
14	-40	-48
-32	36	38
6	56	-4
-50	-8	46
-46	-32	26
-34	-22	22

// Meehan S K, 2009: Low Synchrony > High Synchrony
// Meehan S K, 2009: High Synchrony > Low Synchrony
// Meehan S K, 2009: High Synchrony > Low Synchrony, Vibrotactile Tracking
// Meehan S K, 2009: Low Synchrony > High Synchrony, Vibrotactile Tracking
// Meehan S K, 2009: High Synchrony > Low Synchrony, Visuospatial Tracking
// Meehan S K, 2009: Low Synchrony > High Synchrony, Visuospatial Tracking
// Subjects=10
-5.86	-.97	65.22
52.51	16.13	19.63
-32.1	27.92	0.65
33.07	29.28	-1.33
-68.15	-37.52	11.01
64.38	-34.26	13.68
37.41	55.25	17.63
19.54	-93.43	-4.26
-23.33	-73.05	-12.17
54.48	-26.23	-19.22
40.67	-70.53	-26.5
29.8	-45.1	-40.78
-36.37	-68.76	-38.03
20.38	-57.36	-19.57
-15.78	39.82	42.96
-1.22	74.17	4.22
-47.64	-71.43	24.77
-44.78	-54.15	-13.51
-44.51	-60.21	18.22
-67.11	-16.9	15.96
-55.15	-29.04	36.92
-65.23	3.52	-9.19
28.48	-35.49	69.95
15.7	-53.8	68.29
56.96	-44.71	16.87

// Nahab F B, 2009: Control vs. Baseline
// Nahab F B, 2009: Cough vs. Baseline
// Nahab F B, 2009: Gape vs. Baseline
// Nahab F B, 2009: Yawn vs. Baseline
// Nahab F B, 2009: Gape vs. Yawn
// Nahab F B, 2009: Yawn vs. Gape
// Subjects=18
-19.4	-95.75	3.63
25.48	-88.88	5.88
-16.69	70.51	6.38
28.18	60.75	-0.01
6.11	8.48	28.05
50.76	29.41	5.71
57.45	-36.91	14.54
-57.9	-40.26	22.83
-38.67	-86.35	3.06
-61.34	23.17	17.56
47.91	-72.37	10.93
53.74	7.32	-32.62
28.71	-95.21	6.37
31.19	29.13	-37.54
2.44	-32.6	-48.76
38.1	-61.28	-9.96
-45.02	-69.24	18.43
47.95	-68.69	17.31
-38.66	-82.92	6.12
54.3	3.2	37.98
63.91	-42.96	18.32
-38.68	-.79	36.03
2.85	-38.26	1.9
-10.17	-13.99	-13.37
9.46	13.22	47.69
47.59	26.48	9.34
60.74	-19.48	33.11
-15.87	-10	80.04
28.91	-53.54	49.72
-38.85	-51.97	-6.51
57.26	-48.74	-14.58
47.9	-75.8	7.87
-41.86	-82.94	6.16
57.54	6.9	44.32
-.37	-35.11	1.67
2.49	30.5	-17.25
-31.91	-29.9	71.85
73.34	-41.52	-5.33
-61.26	-61.62	-5.45
-10.2	-11.07	-16.96
-6.52	-35.75	35.25
15.32	-54.98	-50.37
0.06	-86.72	36.1
-6.45	-67.98	31.26
57.56	-19.25	36.47
-61.05	-19.96	37.9
12.73	-38.81	35.28
-25.7	4.26	58.88
-41.95	-11.35	23.57
-67.78	-33.11	-7.76
-13.42	61.27	10.46
35.01	32.15	42.46
2.72	9.84	4.56
18.92	-83.86	-11.19
2.5	27.33	-16.98

// O'Hare E D, 2009: Healthy Controls
// Subjects=20
32.76	20.59	3.74
49.87	-63.92	-34.97
43.53	-20.4	22.02
-42.93	-64.84	32.23

// O'Hare E D, 2009: Fetal alcohol syndrome (FASDs)
// Subjects=20
1.24	10.83	55.65
30.86	-66.05	-32.49
-47.32	-68.8	-31.85
43.53	-20.4	22.02
-42.93	-64.84	32.23

// Natale E, 2009: Main Effect of Endogenous Invalidity, Invalid > Valid
// Natale E, 2009: Simple Main Effect of Valid Exogenous Cues
// Natale E, 2009: Simple Main Effect of Invalid Exogenous Cues
// Natale E, 2009: Orienting of Endogenous Spatial Attention, Valid > Neutral
// Subjects=14
6	10	68
-10	16	66
24	8	56
-8	-68	54
8	-64	54
56	-42	36
58	-44	20
44	12	32
54	18	2
-58	-48	34
-36	-46	44
0	12	66
-8	14	68
18	16	60
-6	-62	52
8	-62	54
56	-44	34
54	-46	18
42	12	32
54	20	0
-58	-48	32
-38	-46	42
6	8	68
-10	18	64
24	8	56
-10	-68	52
10	-70	54
54	-44	40
58	-44	22
44	10	22
58	20	4
-58	-50	36
-32	-46	46
-2	-2	62
-28	-4	56
-20	-64	60
-30	-52	56
-32	-38	44
28	-2	54
26	-62	64
32	-36	40

// Kaufmann L, 2009: Nonsymbolic Numerical Judgment > Rest (Healthy 
// Dyscalculics > Healthy Controls)
// Kaufmann L, 2009: Spatial Judgment > Rest (Healthy Dyscalculics > Healthy 
// Controls)
// Kaufmann L, 2009: Nonsymbolic Numerical Judgment > Spatial Judgment 
// (Healthy Dyscalculics > Healthy Controls)
// Subjects=9
-40.02	-46.95	51.63
49.3	8.37	15.85
42.77	53.26	18.85
30.52	-36.5	56.63
33.75	-36.22	59.92
-40.01	-56.73	49.1
-1.4	-38.58	73.9
7.99	-21.03	52.25
2.38	38.78	41.72

// Kovas Y, 2009: Nonsymbolic Number Comparison High Ability > Nonsymbolic 
// Number Comparsion Low Ability
// Kovas Y, 2009: Nonsymbolic Number Comparison Low Ability > Nonsymbolic 
// Number Comparsion High Ability
// Subjects=13
1.24	-66.31	-9.67
-34.4	-17.73	-38.99
28.12	-68.92	9.2
-2.93	-85.11	-4.7
20.35	13.77	5.7

// Wood G, 2009: Conjunction all age groups: Interference Control
// Subjects=9
-23.99	3.76	67.17
-27.45	6.44	50.15
-33.85	-42.17	47.23
52.85	-63.29	-22.76

// Chouinard P A, 2009: Object lifting vs. Rest
// Chouinard P A, 2009: Different size > Same size
// Chouinard P A, 2009: Different weight > Same weight
// Chouinard P A, 2009: Different density > Same density
// Chouinard P A, 2009: Same density>Different density
// Chouinard P A, 2009: Different size/same weight/different density (SW 
// illusion) > Same size/weight/density (SS-SW)
// Chouinard P A, 2009: SW illusion>SS-SW in conjunction with effect of 
// density
// Subjects=12
-34	-22	56
-50	-22	54
-48	-20	48
-42	-32	58
-60	10	20
-14	-22	-2
-28	-52	-28
22	-50	-24
4	-56	-18
10	-70	-46
-58	-24	48
-40	-24	42
-42	-32	60
-22	-62	-20
26	-52	-22
-38	-14	50
-58	12	18
-38	-12	50
-34	-20	46
-38	-26	42
-60	8	22
-58	16	20

// Tesink C, 2009: Autism Spectrum Disorder ASD patients
// Subjects=24
-62	-24	8
-56	-32	20
-42	-28	14
-38	-18	54
-46	-28	54
-56	-26	48
56	-22	8
66	-12	4
66	-32	12

// Tesink C, 2009: Healthy controls
// Subjects=24
-36	-38	10
-46	0	28
-42	-28	6
34	-26	14
46	-14	26
42	-22	30
8	-66	26
36	-50	-10
46	-42	-16
2	26	4
16	28	-10
14	46	-2
4	-30	-6
6	-20	4

// Peran P, 2009: Object Naming, Manipulable Biological Objects - Fixation
// Peran P, 2009: Object Naming, Man-Made Objects - Fixation
// Peran P, 2009: Generation of Action Words, Manipulable Biological Objects - 
// Fixation
// Peran P, 2009: Generation of Action Words, Man-Made Objects - Fixation
// Peran P, 2009: [Generation of Action Words - Fixation] > [Object Naming - 
// Fixation]
// Peran P, 2009: Interaction between Task and Object Category
// Peran P, 2009: [GenA, MBO - Fixation] > [ON, MBO - Fixation]
// Peran P, 2009: [GenA, MMO - Fixation] > [ON, MMO - Fixation]
// Peran P, 2009: [GenA, MBO - Fixation] > [ON, MMO - Fixation]
// Peran P, 2009: [ON, MMO - Fixation] > [GenA, MBO - Fixation]
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and ON, MBO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and ON, MMO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and GenA, MBO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and GenA, MMO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between Endogenous Repitition and GenA, 
// MBO BOLD Responses
// Subjects=14
-48	-8	50
-46	-74	-12
-2	-2	62
46	-12	26
34	-96	-2
-40	26	-4
-52	-10	48
-46	-72	-12
-2	0	60
48	-10	26
36	-94	-4
-40	26	-4
-12	-18	0
-2	0	60
-50	-10	36
50	-10	28
38	-68	-28
-46	-74	-10
30	24	0
-24	-68	40
-2	-2	62
-50	-10	36
50	-74	28
-46	-66	-10
40	-50	-28
-40	-44	58
-46	52	-4
32	26	-4
-48	-78	22
-66	-28	22
-2	36	34
-26	8	54
-16	-52	28
-44	54	-2
-2	36	34
-48	-78	22
-16	-52	28
-64	-28	22
-2	38	32
-46	52	-4
32	26	-4
-2	36	34
32	28	-4
-48	-78	22
-44	54	-2
18	42	28
-62	-54	28
-62	8	18
-4	-32	22
-18	-52	30
-30	58	18
-34	18	30
16	-72	30
6	-62	46
-32	-42	70
-58	-26	48
-42	-4	52
-2	-2	58
-44	4	28
50	-24	-8
-42	-6	54
4	0	60
0	6	56
50	-16	-8
-44	16	22
-38	0	52
56	2	30
10	14	32
-40	-2	58
44	10	28
-40	22	-6
-4	12	52
-44	2	38
38	-44	-28
28	-100	8
58	-24	-6
-28	-90	-10
10	10	68
30	24	2
58	6	-10
-52	-60	-16
-56	6	-10
-56	-18	22

// Kim J H, 2009: Healthy Controls
// Subjects=12
-40	38	14
-43	-54	3
-37	-77	36
-1	7	46
53	30	0
34	17	14

// Kim J H, 2009: Subgroup of mTLE patients, Left mTLE
// Subjects=12
-38	18	29
-53	-45	-4
-29	-64	29
51	12	30
8	-2	61
-43	18	29
-66	-36	-2
-29	-63	36
-34	53	19
-31	-3	48
-1	6	53
51	16	26
56	-53	-11
31	-68	32
38	0	42
-42	14	30
-27	-54	33
-19	-97	-3
53	18	22
48	11	30
29	-69	40
35	19	6

// Kim J H, 2009: Subgroup of mTLE, Right mTLE
// Subjects=7
-40	32	8
-63	-51	-7
58	24	17
-47	13	26
-44	-33	-2
-1	5	55
-46	14	30
6	-52	42

// Schlagenhauf F, 2009: Healthy controls
// Subjects=15
15	-6	-18
12	6	-3
-6	-54	-6
9	-21	-12
-24	-6	6
9	-24	12
27	-3	3
12	6	0
27	-63	12

// Page L, 2009: Control > OCD: No-Go > Go
// Page L, 2009: OCD > Control: No-Go > Go
// Page L, 2009: Control > OCD: Incongruent > Congruent
// Page L, 2009: OCD > Control: Incongruent > Congruent
// Page L, 2009: Control > OCD: Switch > Repeat
// Subjects=10
-3.56	42.44	-34.35
-3.28	7.94	-12.5
39.58	-22.46	-10.44
28.07	-52.89	10.08
-17.84	-36.36	21.49
-44.82	-67.78	-24.63
31.93	48.22	-4.02
51.21	-3.87	-18.83
32.51	-6.17	49.61
32.52	-58.81	29.49
55.87	-56.95	10.1
-41.33	-28.58	27.8
-10.14	-70.27	36.51
-22.33	-67.13	-18.25
-33.87	11.96	42.16
-5.83	-41.29	52.99

// Chiu C Y, 2009: Sustained effects of attention: Left-Mag + Left-Par > 
// Right-Mag + Right-Par
// Chiu C Y, 2009: Attention shift (attSh) > Attention hold (attHd)
// Chiu C Y, 2009: Categorization rule switch (rulSw) > Categorization rule 
// hold (rulHd)
// Chiu C Y, 2009: Conjunction: attsh>attHd + rulSw>rulHd
// Subjects=16
29.44	-58.6	46.23
-23.98	-64.29	46.21
37.66	-72.92	-2.07
-33.95	-74.56	-3.11
28.28	0.84	57.99
37.52	42.11	26.54
52.62	11.79	32.26
61.3	-41.71	27.72
10.24	-60.57	49.96
-10.05	-68.18	49.72
-.46	-65.12	47.12
-3.67	-66.28	46.14
4.86	-64.29	43.65
-3.63	-67	50.66
9.16	-59.61	48.78

// Yoshida W, 2009: Rule Switch > Exploitation
// Yoshida W, 2009: Meta-rule Switch > Exploitation
// Yoshida W, 2009: Rule Switch > Meta-switch
// Yoshida W, 2009: Meta-rule Switch > Rule Switch
// Subjects=16
-42.26	18.22	-6.79
7.73	44.6	20
35.42	20.96	-16.23
33.31	60.69	-4.44
-12.02	-14.62	-15.26
7.65	1.35	5.24
1.26	33.73	18.95
-33.6	63.21	3.18
-56.06	37.47	16.19
37.58	61.46	-7.95
-32.72	-62.58	46.99
-5.37	-33.01	-5.71
-57.16	24.19	11.92

// Jamadar S, 2009: Schizophrenia
// Subjects=12
-50.39	11.08	32.15
2.08	-64.09	63.35
-3.27	-76.15	-19.41
-16.01	55.67	24.92
-28.73	24.65	38.29
-15.77	40	41.03
-15.61	-12.43	42.85
-15.62	-43.14	35.81
-11.43	-48.52	23.94
-63.86	-12.47	-12.35
53.4	-61.37	20.75
18.65	57.58	31.98
5.54	59.69	20.79
40.16	-13.11	9.47
53.29	-15.11	21.78
44.02	-1.22	-24.27
48.96	-72.1	9.56
27.14	-23.46	2.88
-16.03	59.92	24.5
-28.85	27.01	29.09
-15.84	40.55	35.37
-3.01	35.19	23.36
-24.76	-47.97	-3.9
-33.35	-60.77	-2.49
-3.27	-24.71	-8.81
14.35	40.24	30.41
5.69	22.57	25.58
5.41	-20.01	-4.94

// Jamadar S, 2009: Healthy Controls
// Subjects=12
-6.55	-8.22	75.9
-33.25	47.2	27.17
-6.73	-62.07	50.98
14.96	-78.91	53.39
-11.66	-77.6	-0.07
-42.2	-67.78	-19.57
-29.3	-63.89	-24.66
18.63	-92.49	-.23
5.36	-71.86	-19.98
44.15	-60.44	-26.25
53.4	-61.37	20.75
-16.03	59.92	24.5
-28.85	27.01	29.09
-15.84	40.55	35.37
-3.01	35.19	23.36
-24.76	-47.97	-3.9
-33.35	-60.77	-2.49
-3.27	-24.71	-8.81
14.35	40.24	30.41
5.69	22.57	25.58
5.41	-20.01	-4.94

// Chechko N, 2009: Healthy Controls
// Subjects=18
-16	-4	34
16	6	-20
2	-28	-14
0	28	20
-46	6	38
38	2	34
-2	8	56
-24	-56	44
-14	-78	-6
-10	48	-8
-14	42	14
-8	-58	2
2	30	22
-8	-36	-24
56	-6	-8
-14	44	24
-28	-24	58
28	-34	-6
-40	12	-20

// Chechko N, 2009: Panic Disorder
// Subjects=18
-34	-10	-22
22	-34	-26
48	-2	-26
34	8	60
46	-50	46
36	50	26
10	-60	42
16	6	-20
2	-28	-14
0	28	20
2	30	22
-8	-36	-24
56	-6	-8
-14	44	24
-26	-12	-18
22	-6	-20
28	-34	-6
-40	12	-20

// Arnow B A, 2009: Healthy Controls
// Subjects=20
-27.57	-84.2	22.14
-53.9	-74.12	-6.42
-46.04	-83.92	14.59
-48.44	-61.68	0.1
-36.24	-86.56	20.28
-49.64	-68.04	-10.46
-26.25	-58.3	46.45
-62.15	-26.39	33.82
-26.28	-68.39	41.85
-64.48	-27.64	20.54
-29.62	-80.08	31.86
-66.36	-22.28	43.57
-40.41	-40.58	41.58
-.16	-68.35	-28.08
-0.06	38.55	1.69
-31.57	30.5	-13.79
-2.2	46.3	4.32
-30.42	-72.48	55.77
-9.95	-86	47.8
-2.03	-20.27	4.18
-14.15	-.18	-9.93
-18.59	53.61	-8.45
-16.31	57.84	2.29
-51.74	7.94	10.08
0.32	21.69	28
-2.09	-28.33	-1.75
-28.5	33.62	-26.48
-39.86	-88.31	-9.74
-39.93	50.08	12.43
-24	-4.44	-20.55
-11.92	10.23	-2.03
-9.86	-25.56	-17.58
-50.36	1.41	31.99
-28.53	1.64	-35.64
-44.32	-32.5	-9.58
26.57	-86.37	30.4
25.6	-62.58	43.75
52.04	-67.81	-2.12
25.57	-70.44	40.05
36.59	-52.37	60.48
23.78	-72.45	-15.75
50.02	-82.08	6.05
32	-79.55	34.12
31.83	-84.09	20
23.54	-63.99	51.77
13.87	-52.04	-26.57
27.93	-56.24	-26.39
37.75	36.45	0.13
4.4	36.31	11.92
21.67	19.79	6.53
16.01	-6.22	-18.81
31.99	-6.32	48.16
20.41	-74.12	58.43
33.57	-35.86	-3.85
28.39	-34.22	14
51.71	-41.82	-22.62
14.27	-16.19	12.46
50.05	7.83	26.28
34.35	-1.56	64.46
16.35	-25.52	4.38
24.47	0.11	-31.91
-3.98	-58.04	13.55
44.58	-15.66	16.37
57.92	-54.37	37.91
-16.58	2.2	-30.29
22.31	0.11	-31.87
-30.37	1.89	-9.86
37.61	22.24	-14.15
6.24	72.19	-6.23
25.91	-.48	-3.86
-51.54	-80.31	7.6
-53.86	-76.04	-3.99
-48.4	-79.96	-.33
-28.36	-96.26	42.4
-15.63	-100.11	23.51
4.22	-81.72	58.34
-38.08	-51.78	-32.43
-19.82	-74.44	-46.19
-4.19	34.46	15.61
-.45	-96.34	28.49
-39.5	-97.73	15.84
-18.42	-71.61	64.44
-7.74	-84.51	52.09
-48.52	58.12	18.5
-23.98	-2.11	-18.54
-19.54	-4.45	-9.42
-9.53	-73.45	-1.64
-47.59	-43.67	-14.02
-64.35	-1.52	35.88
-28.14	-54.1	68.48
-15.87	-14.4	21.76
54.17	-68.01	-4.38
42.31	-77.72	-4.34
37.89	-76.34	-12.25
16.27	-74.29	-12.08
17.94	-98.3	29.49
20.24	-88.54	41.93
46.28	10.46	-14.25
41.98	-53.96	-25.73
32.23	34.44	-9.66
29.8	6.2	-35.96
28.09	30.35	4.26
19.79	-2.16	24.43

// Arnow B A, 2009: Women with Hypoactive Sexual Desire Disorder
// Subjects=16
-52.4	-26.15	35.87
-43.72	-28.04	38.15
-64.43	-19.58	26.46
-54.46	-22.13	44.48
-39.85	-76.2	-6.45
-41.96	-84.61	-4.46
-49.84	-39.94	-19.96
-54.03	-61.98	-14.34
-58.23	-60	-4.38
-44.38	-43.87	-16.3
-22.15	-81.84	24.06
-14.4	-85.89	37.77
-15.61	-85.76	27.7
-29.84	-81.74	14.1
-48.36	5.69	20.33
-32.19	-40.48	7.81
-2.11	-17.59	-1.69
-21.97	-66.25	41.56
-33.86	26.26	-24.54
-52.47	-.42	35.57
-5.65	-75.59	-36.23
-32.41	22.48	3.83
-11.98	-74.47	-23.91
-6.11	-28.29	21.85
-12.27	26.58	57.99
-37.99	-69.76	-29.53
-34.01	-70.11	-56.46
-27.94	47.66	20.31
-24.01	2.04	-20.07
-22.25	-27.83	27.68
-19.87	-17.89	-38.34
-23.92	3.83	-12.4
-8.39	-18.29	14.18
47.61	-64.29	-10.24
42.26	-68.26	-6.4
28.14	-67.76	-11.81
23.54	-76.44	-35.52
35.94	-80.21	3.86
9.63	-4.35	-9.92
23.62	-.36	-13.92
37.6	24.36	-14.36
39.69	11.84	-22.12
-12.03	-3.78	-14.09
62.01	-17.76	27.49
54.54	-18.22	34.39
29.68	-79.64	21.84
30.06	-56	56.47
29.68	-79.64	21.84
24.34	-83.6	25.68
2.3	35.65	16.5
24.15	-28.08	22.43
57.58	7.65	23.93
31.52	48.18	22.61
32.45	48.11	10.27
41.81	-59.57	-39.74
1.92	-65.68	-33.98
25.51	-75.66	-50.2
35.52	-47.91	62.3
7.84	-18.03	16.11
-16.58	2.2	-30.29
22.31	0.11	-31.87
-30.37	1.89	-9.86
37.61	22.24	-14.15
6.24	72.19	-6.23
25.91	-.48	-3.86
22.37	-87.68	39.57
40.16	-89.74	-6.48
44.48	-86.43	-5.76
-31.81	8.35	47.8
-.36	-3.78	54.06
-12.05	-39.57	62.29
-10.17	-9.97	45.88
-29.79	16.03	38.04
-11.69	-48.26	3.75
-17.99	-57.88	16.02
-4.56	21.88	-15.64
-28.36	-19.63	58.35
52.43	-10.16	40.35
20.16	8.3	55.88
52.56	-20.17	48.06
36.34	13.57	53.96
35.91	8.22	19.76
24.38	2.06	46.34
33.98	2.22	36.08
3.92	-13.96	48.28
43.61	-11.54	26.07
16.38	-46.14	1.94
6	-15.64	41.68
-51.57	-66.28	8.45
-50.51	-79.56	4.15
-53.77	-55.65	7.44
-44.01	-64.12	8.11
-39.74	-84.19	-0.06
-60.47	-58.4	-10.1
-43.95	-80.08	9.69
-46.16	-71.68	7.78
-37.61	-74.5	0.06
-49.79	-48.35	-18
-65.48	-21.6	27.8
-53.76	-28.23	13.69
-64.4	-30.32	26.4
0.05	-19.71	-1.52
-26.12	-69.82	-30.85
-4.51	-74.1	-31.91
-31.57	26.14	-14.48
-16.33	-3.58	-11.8
-23.96	2.46	-15.63
-7.6	-74.04	-19.54
-19.66	-67.78	-32.28
-62.44	7.56	18.14
-10.12	-91.6	33.79
-19.47	-58.22	69.86
-17.8	-85.98	25.52
-18.26	22.2	11.46
0.1	37.57	14.11
-62.42	-43.67	9.76
-.2	-67.6	-31.51
-5.46	2.39	-5.85
-25.72	-38.33	7.49
47.76	-81.75	-1.79
49.89	-69.94	-1.88
46.4	-47.7	-16.35
56.36	-75.44	-3.68
54.34	-70.05	8.14
42.22	-69.63	-9.62
47.6	-62.17	-10.45
42.3	-75.6	-4.55
47.7	-87.69	-7.93
10.32	-94.39	25.87
10.2	-89.8	17.57
56.43	6.06	18.51
11.78	-7.74	-11.86
27.77	-87.66	39.47
22.27	-88.4	31.8
32.31	21.88	-6.18
19.7	-27.97	12.41
27.83	2.12	-22.08
26.17	-81.72	-.31
20.29	-86	46.16
38.13	-38.44	14.26
19.61	-10.1	8.41
37.59	12.25	-17.64
60.51	-41.71	-10.45
26.34	-30.1	23.72
28.45	-40.29	17.97
14.34	-15.67	18.01
19.77	-19.8	19.45

// Burnett S, 2009: Adolescents
// Subjects=19
-42	-68	44
-52	-58	34
-10	52	18
-18	42	16
-4	52	-8
-16	48	34
-4	-56	28
-4	-62	40
-38	-66	42
44	-48	28
-40	-6	-26
-16	42	20
-24	-40	52
14	38	44

// Burnett S, 2009: Adults
// Subjects=10
-42	-68	44
-52	-58	34
-14	44	2
4	48	18
-56	-62	28
-36	-30	28
-40	-6	-26
-16	42	20
-42	-66	40
14	42	36

// Bengtsson S L, 2009: Isochronous rhythm sequence (ISO) > Random intervals 
// (RAN)
// Bengtsson S L, 2009: METRIC > RAN
// Bengtsson S L, 2009: NON-METRIC > RAN
// Bengtsson S L, 2009: ISO > METRIC
// Bengtsson S L, 2009: ISO > NON-METRIC
// Bengtsson S L, 2009: METRIC > ISO
// Bengtsson S L, 2009: NON-METRIC > ISO
// Bengtsson S L, 2009: METRIC > NON-METRIC
// Subjects=17
-31.29	57.77	13.76
-24.99	59.73	0.01
-21.2	50.72	41.18
-50.72	31.55	9.96
-40.47	15.87	48.32
-1.5	19.82	53.99
-11.43	18.23	37.51
-1.4	-5.71	56.51
17.61	-81.13	6.5
20.93	-70.61	15.49
21.23	-81.51	36.73
18.3	-51.19	-17.76
-31.29	57.77	13.76
-24.99	59.73	0.01
-21.2	50.72	41.18
-50.72	31.55	9.96
-40.47	15.87	48.32
-1.5	19.82	53.99
-11.43	18.23	37.51
-1.4	-5.71	56.51
17.61	-81.13	6.5
20.93	-70.61	15.49
21.23	-81.51	36.73
18.3	-51.19	-17.76
-31.29	57.77	13.76
-24.99	59.73	0.01
-21.2	50.72	41.18
-50.72	31.55	9.96
-40.47	15.87	48.32
-1.5	19.82	53.99
-11.43	18.23	37.51
-1.4	-5.71	56.51
17.61	-81.13	6.5
20.93	-70.61	15.49
21.23	-81.51	36.73
18.3	-51.19	-17.76
-37.72	54.86	17.52
43.27	54.84	12.78
-34.42	38.92	19.04
-47.66	33.5	-3.73
46.45	37.96	4.31
66.06	6.44	10.46
24.55	20.84	63.53
8.21	23.04	53.51
-1.92	16.7	20.69
14.33	26.95	26.12
-25.31	21.21	-33.15
43.09	10.87	-9.76
43.49	-25.55	14.01
-44.37	10.87	-4.91
-40.98	-17.52	1.21
-53.92	-14.07	4.45
56.28	-13.68	2.53
-63.3	-34.57	26.81
-31.76	-54.07	-45.76
-37.72	54.86	17.52
43.27	54.84	12.78
-34.42	38.92	19.04
-47.66	33.5	-3.73
46.45	37.96	4.31
66.06	6.44	10.46
24.55	20.84	63.53
8.21	23.04	53.51
-1.92	16.7	20.69
14.33	26.95	26.12
-25.31	21.21	-33.15
43.09	10.87	-9.76
43.49	-25.55	14.01
-44.37	10.87	-4.91
-40.98	-17.52	1.21
-53.92	-14.07	4.45
56.28	-13.68	2.53
-63.3	-34.57	26.81
-31.76	-54.07	-45.76
-18.01	53.61	37.48
17.73	54.36	43.52
72.51	-29.89	0.5
52.31	10.35	-50.2
30.84	-85.6	26.89
17.41	-76	-7.45
36.87	-66.04	-5.4
-18.01	53.61	37.48
17.73	54.36	43.52
72.51	-29.89	0.5
52.31	10.35	-50.2
30.84	-85.6	26.89
17.41	-76	-7.45
36.87	-66.04	-5.4
1.22	65.2	22.56

// Dube A A, 2009: Pain > Warm
// Dube A A, 2009: Regression Analysis: SCRwarm and Brain Activation
// Dube A A, 2009: Regression Analysis: SCRpain and Brain Activation
// Dube A A, 2009: Regression Analysis: SCRpain-warm and Brain Activation
// Subjects=12
8	20	68
4	16	56
8	24	60
-56	8	12
52	0	52
-52	16	-12
52	16	-12
52	-48	-4
16	8	20
8	16	8
-20	24	8
-20	12	12
32	8	-8
28	-4	8
28	16	-8
-24	20	-4
-24	-76	-48
-44	-52	-36
-28	-72	-28
-32	-56	-52
20	-72	-24
16	-80	-28
28	-68	-28
-28	-40	-48
36	32	36
52	28	0
52	4	36
32	0	64
52	-40	20
68	-28	4
-48	4	-8
16	-60	4
8	-72	4
44	-56	-32
8	-64	0
-36	-88	-16
8	-76	-4
8	16	60
52	8	48
-16	28	-4
-24	20	-4

// Peretz I, 2009: Familiar - Unfamiliar
// Peretz I, 2009: Familiar - Random
// Subjects=9
48	-24	-10
-48	-18	-16
-24	2	-8
16	4	-8
-8	-72	46
4	-70	46
-60	-40	24
60	-30	10
-56	13	-2
-4	-4	66
-24	2	-5
20	6	0
-8	-72	46
8	-72	36

// Lu H, 2009: Control > Baseline
// Lu H, 2009: Placebo > Baseline
// Lu H, 2009: Control > Placebo
// Subjects=14
-42.47	17.72	-23.55
-4.64	4.16	58.95
-66.53	-27.89	29.56
-62.28	-24.03	24.63
-52.97	-11.81	-5.88
-53.94	-7.69	3.82
-46.78	4.63	-25.54
-37.82	19.06	2.02
-.6	29.42	41.82
-11.83	-9.87	1.07
-18.32	-6.7	0.87
-31.48	-1.61	-12.85
67.03	15.49	3.95
62.93	9.49	20.3
46.57	42.19	15.1
71.92	-38.27	37.2
65.13	-11.03	18.93
76.02	-30.03	21.74
62.7	-4.29	-.75
54.86	18.79	-17.47
39.89	16.59	-5.79
44.22	-7.42	-10.21
14.56	12.25	41.02
16.26	-9.77	0.59
33.43	5.83	-5.73
18.31	10.13	-4.78
13.86	-36.73	-23.6
-54.18	29.88	-7.74
-56.32	8.18	-10.04
-13.99	-8.82	1.01
-22.64	-6.72	0.95
52.98	35.11	7.85
8.2	26.23	53.19
42.17	6.58	1.89
16.26	-8.71	0.48
31.35	4.21	0.07
13.93	-57.05	-22.71
-35.26	0.19	29.61
-41.86	41.96	28.95
-60.01	7.42	39.4
-22.89	5.65	-15.96
-35.9	20.6	-16.1
-60.1	-21.69	26.6
-11	-57.31	56.18
-68.84	-11.5	21.26
-70.94	-11.09	25.73
-52.94	-13.73	-3.45
-51.08	6.95	-23.45
-46.06	-77.54	13.96
-48.44	-6.94	11.49
-16.23	-30.17	-9.17
-29	-9.1	10.26
67.07	9.21	5.69
35.89	33.2	22.89
69.6	-20.82	28.78
53.72	-12.96	56.29
60.29	8.07	-17.62
53.27	-61.24	10.65
40.06	9.12	6.16
14.61	14.79	45.25
14.15	31.03	12.27
18.5	-21.26	3.93
29.01	5.08	-13.43
33.42	12.31	-5.25

// Stankewitz A, 2009: Ammonia > Air Puffs
// Stankewitz A, 2009: Odour > Air Puffs
// Subjects=23
36	18	-9
6	12	42
24	-57	6
42	-12	39
57	-21	27
9	-12	0
9	6	-3
12	-63	-21
51	-48	6
3	-36	-45
24	-3	-12
-39	0	-3
0	-3	42
-15	-66	9
-60	-18	30
-57	3	31
-9	-15	0
-9	-63	-21
-12	0	-3
-51	-60	6
-6	-39	-51
-18	0	-15
-6	36	6
63	12	12
24	-63	-42
12	3	-3
21	6	-9
18	9	15
27	3	-18
69	-18	21
33	15	12
54	3	51
-24	30	-9
-15	-75	-36
-15	6	0
-66	-18	21
-21	-3	-18
-27	18	12
-45	33	36

// Ponseti J, 2009: Pedophiles < Controls (boys <men)
// Ponseti J, 2009: Pedophiles <Controls (girls <women)
// Subjects=24
-38	-62	-24
40	-64	-22
-12	-40	-2
-2	-6	4
22	-32	-4
-34	-76	0
14	-34	0
-38	-74	-16
46	-44	-12
38	-66	44
12	18	-8
-8	14	-8
32	-62	52
-42	-44	-10
-38	-46	-10
-2	4	28
-38	-78	0
-18	0	-12
-26	-56	46
44	-42	-14
54	-56	-8
-32	12	-10
44	24	22
-16	-8	10
28	-48	-30

// Veldhuijzen D S, 2009: Pricking > Burning
// Veldhuijzen D S, 2009: Burning > Pricking
// Subjects=10
-29.93	-16.79	-13.47
-10.57	-35.2	-5.46
22.58	-34.74	-2.53
-37.3	-45.3	-9.88
33.2	-41.96	-14.31
9.68	-70.71	-26.13
9.02	-81.92	21.66
-35.08	32.41	31.53

// Kobayashi Y, 2009: Healthy Controls
// Subjects=8
48.49	12.08	50.12
2.49	-40.29	23.82
2.55	9.77	51.96
33.21	47.11	22.83
39.58	11.6	3.43

// Kobayashi Y, 2009: Patients
// Subjects=8
2.45	-46.18	16.51
2.48	17.8	45.71
51.3	14.67	0.8
36.25	27.9	-5.71
20.93	-28.56	63.88
3.51	-46.26	15.38
3.45	-48	6.61
3.54	18.78	44.5
51.31	13.61	0.89
-52.37	19.34	1.6
35.2	29.12	-3.57
49.4	29.12	36.42
-6.35	19.24	10

// Schiffer B, 2009: Girls > Neutral
// Schiffer B, 2009: Girls > Women
// Subjects=1
-38	49	1
-2	17	-3
-2	5	-7
-26	14	-28
-34	18	-24
28	54	38
30	40	36
32	-64	64
30	-62	48
-36	-52	63
-36	-52	-36

// Chau A C M, 2009: Subgroup of Ischemic Stroke Patients, Treatment Group
// Subjects=10
-50	-32	64
-4	4	74
4	4	74
68	-40	20
42	30	44
48	20	-16
-56	8	-4
-2	-58	70
2	-58	70

// Chau A C M, 2009: Subgroup of Ischemic Stroke Patients, Control Group
// Subjects=8
-4	4	74
4	4	74
68	-40	20
42	30	44
48	20	-16
-56	8	-4
-2	-58	70
2	-58	70

// Chao H H, 2009: Short SSRT > Long SSRT (Within Subjects)
// Subjects=65
28	-4	0
-4	-44	-12
8	-12	40

// Page S J, 2009: Post-testing > Pre-testing: Wrist flexion/extension of the 
// affected hand > Rest
// Subjects=10
47.31	-3.92	44.23
28.48	-61.65	59.1
-30.36	-13.94	70.27
35.48	-45.44	72.72
23.37	-74.83	43.31

// Adamovich S V, 2009: OTI > REST
// Adamovich S V, 2009: WATCH_e > REST
// Adamovich S V, 2009: MOVE_h > REST
// Adamovich S V, 2009: MOVE_e > REST
// Adamovich S V, 2009: OTI > WATCH_e
// Adamovich S V, 2009: MOVE_h > MOVE_e
// Adamovich S V, 2009: WATCH_e > OTI
// Adamovich S V, 2009: MOVE_e > MOVE_h
// Adamovich S V, 2009: OTI block 4>3>2>1
// Subjects=13
34	20	-4
-34	20	2
-44	-32	44
-66	-16	20
14	-76	56
-24	2	50
-52	12	38
46	50	-10
-46	46	-16
-36	64	4
-48	28	12
66	-12	34
52	18	22
-54	18	4
26	-16	-28
38	-24	-12
18	22	42
-8	30	38
-8	12	60
-24	16	12
24	-60	-38
-26	-72	22
46	-68	2
-26	-102	-4
48	-68	2
-44	-70	-16
20	-96	10
-8	-104	-4
-22	-96	6
36	-44	54
-36	-46	38
-34	-44	48
-38	-48	-28
-54	-66	16
-44	-14	52
-8	40	40
28	-38	-50
-22	-4	74
16	2	58
44	-66	-10
-44	-8	4
50	6	4
-6	4	48
46	-26	32
16	-70	52
-46	-74	-20
32	-70	22
24	-2	6
56	6	42
-26	-86	-4
-58	-2	2
56	-20	44
54	16	-6
44	-64	0
-38	-76	-18
44	-56	-40
-27	-70	-38
-14	-54	54
-56	2	44
-32	18	4
18	2	12
22	50	20
16	-68	50
66	-14	24
-34	-80	18
44	-74	12
-32	14	10
-40	18	0
38	18	2
-28	64	6
-20	-4	62
34	4	56
-58	10	34
46	44	26
-44	52	14
-62	4	18
46	20	26
-26	-104	-2
26	-32	2
38	-20	-10
-64	-34	22
-50	-36	26
6	-62	-34
-20	-74	-48
-34	-62	-34
40	-58	-44
20	0	20
-14	20	-4
-26	-70	32
38	-68	38
18	-62	46
-26	-86	-4
26	-86	-6
58	-54	-14
40	-68	-12
-12	-94	20
18	-80	24
6	-62	0
-10	-16	32
-10	-88	34
-16	58	14
62	4	-6
-20	20	50
22	46	16
34	-6	38
-36	56	-4
-46	-16	14

// Pujol J, 2009: Subgroup of [Healthy Controls], Group 1
// Subjects=9
-51	-27	48
-54	-28	26
56	-17	17
-59	-23	15
-36	15	2
36	15	-1
-45	-15	42
-45	-36	30
-59	-28	18
-45	18	7
0	14	38
3	2	44
-27	6	-3
15	14	-6
48	29	4
-51	-44	49
36	20	-4
-27	-39	46
-56	-46	22
-45	18	7
51	29	4

// Pujol J, 2009: Subgroup of [Healthy Controls], Group 2
// Subjects=9
-54	-15	48
-33	-29	62
54	-21	48
-60	-22	26
56	-16	23
-48	-20	18
-33	-2	11
39	-3	-2
-6	-1	36
0	0	55
54	13	35
-30	-62	-17
-42	12	5
38	18	-1
0	-4	44
-27	3	8
30	12	-3

// Pujol J, 2009: Patients
// Subjects=9
-36	-17	59
-48	-28	26
59	-37	21
-59	-28	18
56	-17	17
-39	15	5
36	15	-1
0	14	38
3	2	44
0	0	53
-27	6	-3
15	14	-6
54	-64	6
21	18	18
-45	-15	42
-45	-36	30
-59	-28	18
-45	18	7
0	14	38
3	2	44
-27	6	-3
15	14	-6
48	29	4
-54	-33	43
-45	-25	23
59	-17	20
-39	18	5
36	15	0
-27	-39	46
-56	-46	22
-45	18	7
51	29	4
-45	-15	42
-59	-28	18
-39	15	5
33	12	-1
3	11	38
6	2	44
3	0	55
-33	9	5
18	12	-1
54	-61	3
56	6	3
-51	-27	43
54	-15	48
-48	-20	18
56	-16	23
-33	-3	8
-45	-8	6
39	17	-1
0	-1	44
0	0	55
-27	3	-3
15	12	-1
56	10	16
-42	12	5
38	18	-1
0	-4	44
-27	3	8
30	12	-3

// Whalley H C, 2009: Healthy Controls
// Subjects=14
26	-43	30
-28	-51	23
-40	-7	50
32	-2	-10
-28	-4	-12
-34	-59	20
18	-85	-3
-26	-30	-10
19	-57	-6
12	17	43
-30	4	48

// Whalley H C, 2009: Schizophrenia
// Subjects=15
-28	-46	16
42	-53	32
-20	-10	35
32	-2	-10
-28	-4	-12
-26	-30	-10
19	-57	-6
12	17	43
-30	4	48
12	26	10
-44	40	24
-46	-47	39
57	-18	36

// Whalley H C, 2009: Bipolar Disorder
// Subjects=14
26	-43	30
-28	-51	23
-40	-7	50
-28	-46	16
42	-53	32
-20	-10	35
-34	-59	20
18	-85	-3
-26	-30	-10
19	-57	-6
12	17	43
-30	4	48
12	26	10
-44	40	24
-46	-47	39
57	-18	36

// Scheibel R S, 2009: Moderate Traumatic Brain Injury (mTBI)
// Subjects=9
7.74	-.15	12.11
-7.44	10.33	10.21
-15.85	14.19	29.02
36.04	0.44	28.37
18.67	11.77	24.19
7.75	4.31	13.91
-15.85	14.19	29.02
-11.73	-.43	10.22
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
21.11	-8.04	41.79
-30.94	-36.99	22.01
-33.05	-53.06	22.52
-26.56	-70.47	19.65
-22.33	-88.61	9.04
-11.51	-23.96	22.63
31.74	-3.83	28.87
10.12	-19.31	25.17
58.5	8.64	11.49
23.5	-33.69	54.38
7.72	-2.49	10.1
25.15	-30.93	14.86
21.22	-13.8	49.09
-53.54	-37.52	29.17
-35.18	-54.99	24.99
-13.59	-32.06	27.95
16.75	-38.98	32.6
46.55	-33.48	-2.07
29.77	-53.82	33.85
-26.41	-76.98	30.37
10.68	-43.54	64.53
-41.93	-73.46	0.03
-39.57	-79.65	14.05
36.09	-63.76	19.04
19.19	-66.44	48.73
40.47	-34.85	29.55
-14.01	47.94	11.08
-1	26.41	9.63
16.19	23.61	1.77
3.31	46.09	13.21
-5.1	-28.81	16.28
-11.76	-11.58	5.72
5.5	-5.14	4.79
20.88	7.73	26.79
14.39	-35.02	17.68
-24.42	-43.25	23.64
10.09	-8.57	25.23
7.73	6.33	12.58
-15.85	14.19	29.02
-9.56	4.04	11.99
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
-30.8	-35.96	33.11
-26.56	-70.47	19.65
-33.05	-53.06	22.52
-22.33	-88.61	9.04
-48.54	4.34	5.9
-50.28	-35.17	31.13
-50.07	-29.25	48.47
-50.43	-13.35	23.37
-9.34	-26.08	22.81
-8.22	-22.47	26.91
-23.48	-27.92	15.38
-53.54	-37.52	29.17
-37.35	-50.74	24.6
-13.59	-32.06	27.95
-26.38	-76.77	32.59
1.45	-23.91	22.41
-18.14	-46.91	7.09
16.36	-24.35	5.39
-5.25	-17.94	6.24
3.5	-64.16	5.06
3.61	-23.9	22.37
5.55	-.37	9.92
-7.44	11.39	10.1
14.23	-24.15	7.65
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Scheibel R S, 2009: Severe TBI (sTBI)
// Subjects=8
7.74	-.15	12.11
-7.44	10.33	10.21
-15.85	14.19	29.02
36.04	0.44	28.37
18.67	11.77	24.19
7.75	4.31	13.91
-15.85	14.19	29.02
-11.73	-.43	10.22
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
21.11	-8.04	41.79
-30.94	-36.99	22.01
-33.05	-53.06	22.52
-26.56	-70.47	19.65
-22.33	-88.61	9.04
-11.51	-23.96	22.63
31.74	-3.83	28.87
10.12	-19.31	25.17
58.5	8.64	11.49
23.5	-33.69	54.38
7.72	-2.49	10.1
25.15	-30.93	14.86
21.22	-13.8	49.09
-53.54	-37.52	29.17
-35.18	-54.99	24.99
-13.59	-32.06	27.95
16.75	-38.98	32.6
46.55	-33.48	-2.07
29.77	-53.82	33.85
-26.41	-76.98	30.37
10.68	-43.54	64.53
-41.93	-73.46	0.03
-39.57	-79.65	14.05
36.09	-63.76	19.04
19.19	-66.44	48.73
40.47	-34.85	29.55
-14.01	47.94	11.08
-1	26.41	9.63
16.19	23.61	1.77
3.31	46.09	13.21
-5.1	-28.81	16.28
-11.76	-11.58	5.72
5.5	-5.14	4.79
20.88	7.73	26.79
14.39	-35.02	17.68
-24.42	-43.25	23.64
10.09	-8.57	25.23
7.73	6.33	12.58
-15.85	14.19	29.02
-9.56	4.04	11.99
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
-30.8	-35.96	33.11
-26.56	-70.47	19.65
-33.05	-53.06	22.52
-22.33	-88.61	9.04
-48.54	4.34	5.9
-50.28	-35.17	31.13
-50.07	-29.25	48.47
-50.43	-13.35	23.37
-9.34	-26.08	22.81
-8.22	-22.47	26.91
-23.48	-27.92	15.38
-53.54	-37.52	29.17
-37.35	-50.74	24.6
-13.59	-32.06	27.95
-26.38	-76.77	32.59
-7.19	-23.94	22.56
12.29	-32.38	23.06
-26.63	-21.78	23.8
60.73	-28.03	9.48
-7.39	-50.58	1.67
46.53	-18.28	-.21
48.86	-39.98	8.62
-24.6	-51.19	7.62
33.91	-36.56	23.11
20.82	-48.49	11.06
1.33	-64.17	5.1
1.45	-23.91	22.41
-18.14	-46.91	7.09
16.36	-24.35	5.39
-5.25	-17.94	6.24
3.5	-64.16	5.06
-32.79	1.42	54.1
-26.47	-37	33.14
-55.49	-31.61	46.55
-41.7	7.07	34.64
-34.93	-44.4	46.35
-35.18	-54.99	24.99
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Scheibel R S, 2009: Very Severe TBI (vsTBI)
// Subjects=13
7.74	-.15	12.11
-7.44	10.33	10.21
-15.85	14.19	29.02
36.04	0.44	28.37
18.67	11.77	24.19
7.75	4.31	13.91
-15.85	14.19	29.02
-11.73	-.43	10.22
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
21.11	-8.04	41.79
-30.94	-36.99	22.01
-33.05	-53.06	22.52
-26.56	-70.47	19.65
-22.33	-88.61	9.04
-11.51	-23.96	22.63
31.74	-3.83	28.87
10.12	-19.31	25.17
58.5	8.64	11.49
23.5	-33.69	54.38
7.72	-2.49	10.1
25.15	-30.93	14.86
21.22	-13.8	49.09
-53.54	-37.52	29.17
-35.18	-54.99	24.99
-13.59	-32.06	27.95
16.75	-38.98	32.6
46.55	-33.48	-2.07
29.77	-53.82	33.85
-26.41	-76.98	30.37
10.68	-43.54	64.53
-41.93	-73.46	0.03
-39.57	-79.65	14.05
36.09	-63.76	19.04
19.19	-66.44	48.73
40.47	-34.85	29.55
-14.01	47.94	11.08
-1	26.41	9.63
16.19	23.61	1.77
3.31	46.09	13.21
-5.1	-28.81	16.28
-11.76	-11.58	5.72
5.5	-5.14	4.79
20.88	7.73	26.79
14.39	-35.02	17.68
-24.42	-43.25	23.64
10.09	-8.57	25.23
7.73	6.33	12.58
-15.85	14.19	29.02
-9.56	4.04	11.99
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
-30.8	-35.96	33.11
-26.56	-70.47	19.65
-33.05	-53.06	22.52
-22.33	-88.61	9.04
-48.54	4.34	5.9
-50.28	-35.17	31.13
-50.07	-29.25	48.47
-50.43	-13.35	23.37
-9.34	-26.08	22.81
-8.22	-22.47	26.91
-23.48	-27.92	15.38
-53.54	-37.52	29.17
-37.35	-50.74	24.6
-13.59	-32.06	27.95
-26.38	-76.77	32.59
-7.19	-23.94	22.56
7.74	-.15	12.11
-22.23	-38.68	26.51
-26.63	-21.78	23.8
38.5	5.92	52.44
21.14	-9.96	44.22
-32.72	0.87	59.76
-15.59	15.1	50.21
-44.87	0.99	38.66
46.69	-37.86	8.45
12.78	-41.82	59.85
-32.79	1.42	54.1
-26.47	-37	33.14
-55.49	-31.61	46.55
-41.7	7.07	34.64
-34.93	-44.4	46.35
-35.18	-54.99	24.99
3.61	-23.9	22.37
5.55	-.37	9.92
-7.44	11.39	10.1
14.23	-24.15	7.65
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Scheibel R S, 2009: Orthopedic Controls (OI)
// Subjects=10
-7.19	-23.94	22.56
12.29	-32.38	23.06
-26.63	-21.78	23.8
60.73	-28.03	9.48
-7.39	-50.58	1.67
46.53	-18.28	-.21
48.86	-39.98	8.62
-24.6	-51.19	7.62
33.91	-36.56	23.11
20.82	-48.49	11.06
1.33	-64.17	5.1
-7.19	-23.94	22.56
7.74	-.15	12.11
-22.23	-38.68	26.51
-26.63	-21.78	23.8
38.5	5.92	52.44
21.14	-9.96	44.22
-32.72	0.87	59.76
-15.59	15.1	50.21
-44.87	0.99	38.66
46.69	-37.86	8.45
12.78	-41.82	59.85
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Pollok B, 2009: Auditory Pacing > Rest
// Pollok B, 2009: Visual Pacing > Rest
// Subjects=10
-36.93	-15.85	64.85
-32.81	22.04	56.54
8.44	14.92	69.99
-45.46	-36.94	69.32
-16.01	-16.5	10.77
35.31	-90.41	-47.79
-54.83	-11.76	17.68
66.15	-13.67	13.57
-39.06	-15.65	67.1
-58.97	13.7	37.64
12.8	19.61	73.94
-45.46	-39.07	69.53
-5.23	-10.08	9.95
41.73	-88.68	-52.55
-17.88	-99.67	16.79

// Posner J, 2009: Positive Correlation between Unadjusted Valence and BOLD 
// activity
// Posner J, 2009: Inverse Correlation between Unadjusted Valence and BOLD 
// activity
// Posner J, 2009: Positive Correlation between Unadjusted Arousal and BOLD 
// activity
// Posner J, 2009: Inverse Correlation between Unadjusted Arousal and BOLD 
// activity
// Posner J, 2009: Positive Correlation between Valence Extremes and BOLD 
// activity
// Posner J, 2009: Inverse Correlation between Valence Extremes and BOLD 
// activity
// Subjects=10
-40	3	-15
32	50	25
14	-46	56
-32	-22	-16
2	45	9
-32	5	57
-6	-74	-6
-33	51	1
-10	59	8
5	40	9
-2	-49	39
34	49	18
-61	-33	2
35	1	-20

// Post M, 2009: All Conditions > Rest
// Post M, 2009: Sustained MVC > Brief Maximal Voluntary Isometric 
// Contractions (MVC)
// Subjects=12
-38	-20	62
-30	-22	70
-22	-24	72
-32	-28	56
-24	-26	60
-60	-22	14
-36	-28	48
-36	-32	58
-26	-30	72
-34	-40	60
-50	-24	50
-50	-18	52
-52	-18	16
-4	-12	56
-2	-22	48
4	-14	54
12	-52	-12
20	-54	-22
16	-58	-18
12	-60	-16
30	-58	-26
26	-62	-24
30	-68	-26
16	-74	-20
12	-70	-44
6	-62	-46
6	-58	-12
6	-64	-24
0	-60	-20
4	-72	-32
6	-68	-44
4	-72	-34
-16	-72	-28
-4	-56	-12
-12	-56	-20
-20	-64	-38
-8	-62	-46
28	-6	6
-16	-30	12
-14	-30	6
-12	-26	8
-20	-24	72
-28	-22	70
-38	-22	60
-18	-30	68
-36	-32	58
-28	-42	58
-32	-40	56
-18	-30	64
-52	-20	20
-46	-10	32
-50	-8	22
-2	-16	56
-4	0	44
2	14	34
-58	-22	14
-40	-20	8

// Pulvermuller F, 2009: Normals, Experiment 1
// Subjects=12
-47	22	15
-42	-44	-19
-45	20	8
-53	-49	-1
-49	11	16
-32	-38	58
-44	-29	40
-51	-50	-3
48	22	10
-32	-5	52
-49	-51	-9
27	-17	56
37	21	13
-19	-29	61
0	3	56
-29	-7	-15
-12	-43	-6
28	-19	60
-36	21	8
-46	6	42
-4	20	52
1	-10	61
-32	-28	-17
-33	-67	22
32	-26	53

// Pulvermuller F, 2009: Normals, Experiment 2
// Subjects=9
-49	22	16
-45	-46	-14
-46	18	13
-50	-50	-6
-50	9	10
-38	-34	51
-49	-50	-4
49	21	8
-34	-10	50
-52	-52	-9
36	-8	48
7	-8	58
38	19	12
-20	-26	57
0	2	58
-4	20	48
-35	-8	-11
-11	-38	-10
38	-17	53
-39	26	2
-50	-3	38
-2	20	56
0	-14	61
-28	-19	-16
-28	-66	38
38	-31	52

// Qin J, 2009: Risky Social Situation > Safe Social Situation, Risk 
// Identification
// Qin J, 2009: Risky Physical Situation > Safe Physical Situation, Risk 
// Identification
// Qin J, 2009: Social Risk Identification > Autobiographical Response
// Qin J, 2009: Physical Risk Identification > Autobiographical Response
// Qin J, 2009: Social Risk Identification > Physical Risk Identification
// Subjects=14
-13.93	61.64	19.81
-5.35	63.38	15.01
-2.79	-55.08	22.2
-6.99	-47.57	33.86
-58.58	7.45	-17.77
-47.95	-60.17	39.16
-13.49	-30.27	35.62
-4.99	-54.23	19.91
-5.58	47.48	-5.83
-7.47	65.92	19.27
-50.71	-12.14	1.96
-4.85	-11.64	39.23
-9.24	25.03	41.28
-37.49	-88.98	5.98
-7.5	-20.8	-1.28
9.75	-18.82	-4.01
-41.33	-10.96	59.95
29.05	-55.93	-23.08
27.29	-74.82	4.59
16.84	-76.62	31.84
-35.25	-21.6	26.17
51.02	-10.43	14.63
50.72	-20.37	-11.28
-35.74	-16.52	-11.31
10	37.78	27.36
-9.27	24.82	39.06
-58.27	-34.06	-2.46

// Vilberg K L, 2009: Familiarity > Recollection
// Vilberg K L, 2009: Recollection > Familiarity
// Subjects=20
-6	33	39
-36	51	9
-48	27	33
-54	9	36
-39	21	-12
-27	-3	60
-33	15	0
12	12	0
-12	3	12
-15	3	-3
9	0	9
0	-18	27
48	-30	42
-48	-48	51
45	-48	51
42	-72	45
12	-66	33
-3	-81	42
36	-63	-36
-36	30	-21
-27	27	54
39	-21	57
21	-15	-36
-24	-24	-30
24	-27	-30
-63	-51	-12
-6	-54	18
-51	-75	21

// Wilson S M, 2009: Viewing Pictures or Scrambled Pictures > Fixation
// Wilson S M, 2009: Naming Pictures > Fixation
// Wilson S M, 2009: Positive Correlation between Word Familiarity and 
// Activations
// Wilson S M, 2009: Negative Correlation between Word Frequency and 
// Activations
// Wilson S M, 2009: Positive Correlation between Word Length and Activations
// Wilson S M, 2009: Positive Correlation between Reaction Time and 
// Activations
// Subjects=12
-6	-96	-6
-40	-8	26
-54	12	20
-56	-28	0
-16	-4	14
-4	-12	6
40	-8	30
66	-24	6
-6	6	56
-10	-52	-8
-12	-64	-22
-50	-56	-18
40	-58	-26
36	-46	-28
22	-92	-2
-50	-80	4
-14	-54	-32
-38	-54	-22
-64	-34	24
-44	-68	-10
12	-70	-10
-54	-2	-16
-38	-68	50
-6	2	46
-26	10	60
58	-10	-4
-4	-80	-12
-28	-54	-22
26	-52	-22
-44	-58	-18
-44	-64	-36
28	-66	-32
-56	8	2
-58	18	22
-44	34	-8
-42	4	28
-44	4	48
-6	14	40
-2	14	58
38	18	-2
-32	-86	14
38	-80	8
-2	-6	2
-58	-28	-4
-56	-32	-4

// Dichter G S, 2009: Target Face > Novel, Healthy Controls > Autism
// Dichter G S, 2009: (Target Shape > Novel) > (Target Face > Novel), Healthy 
// Controls > Autism
// Dichter G S, 2009: (Target Face > Novel) > (Target Shape > Novel), Healthy 
// Controls > Autism
// Dichter G S, 2009: Target Shape > Novel, Autism > Healthy Controls
// Dichter G S, 2009: Target Face > Novel, Autism > Healthy Controls
// Dichter G S, 2009: (Target Shape > Novel) > (Target Face > Novel), Autism > 
// Healthy Controls
// Dichter G S, 2009: (Target Face > Novel) > (Target Shape > Novel), Autism > 
// Healthy Controls
// Subjects=15
-12	-56	62
-54	32	18
-6	26	48
-40	26	-10
18	64	4
40	-76	14
-20	2	-18
-4	24	28
-10	4	2
-16	-8	20
-56	-12	12
-12	-20	32
-6	-24	46
-14	4	70
-22	26	-16
-26	48	14
-36	-26	4
-38	6	0
16	-46	-12
10	52	0
0	24	36
50	2	38
24	-18	60
-48	44	10
-12	-56	10
-20	14	-4
4	-12	50
-46	-50	10
-12	-16	-4
-24	-8	-18
44	6	12
-14	34	12
44	22	28
-44	16	36
-36	6	48
-4	26	54
-10	56	-10
-44	12	0
24	22	-8
40	44	12
28	14	10
14	-68	12
6	-78	-12
20	-54	4
-14	-78	-12
-10	46	20
34	-42	40
-52	-20	24
-44	2	30
12	-74	44
-20	-60	14
-46	-46	52
-50	-42	38
-50	-24	-8
-12	-16	0
18	64	4
40	-76	14
-6	26	48
-40	26	-10
-54	32	18

// Baumgartner T, 2009: Promise Stage: Dishonest (D) > Honest (H), (Promise - 
// No Promise)^D - Promise - No Promise)^H
// Baumgartner T, 2009: Anticipation Stage: D>H, (Promise (P) - No Promise 
// (NoP))^D - (P-NoP)^H
// Baumgartner T, 2009: Anticipation Stage: H>D, ((P-NoP)^H - (P-NoP)^D)
// Baumgartner T, 2009: Anticipation Stage: D>H, ((NoP-P)^D - (NoP-P)^H), 
// p<0.0001
// Baumgartner T, 2009: Anticipation Stage: D>H, ((NoP-P)^D - (NoP-P)^H), 
// p<0.0005
// Baumgartner T, 2009: Anticipation Stage: D>H, ((NoP-P)^D - (NoP-P)^H), 
// p<0.005
// Baumgartner T, 2009: Decision Stage A: D>H, ((P-NoP)^D - (P-NoP)^H), 
// p<0.001
// Baumgartner T, 2009: Decision Stage A: D>H, ((P-NoP)^D - (P-NoP)^H), 
// p<0.005
// Baumgartner T, 2009: Decision Stage B: D>H, ((P-NoP)^D - (P-NoP)^H)
// Subjects=26
33	-72	3
-45	-66	36
51	-57	-3
-36	66	6
9	-30	21
21	-72	60
24	-72	52
-33	3	54
6	-6	63
-36	-42	15
21	18	63
24	-33	45

// Greene J D, 2009: Subgroup of Normals, Honest
// Subjects=14
34.18	-20.9	-17.21
-29.96	-14.93	-16.97
-42.17	-25.13	58.75
-13.27	-37.65	59.46
26.18	-15.21	57.13

// Greene J D, 2009: Subgroup of Normals, Dishonest
// Subjects=14
38.91	-45.74	32.78
-29.49	-49.57	30.54
-6.97	-18.92	53.36
-35.93	-30.15	34.56
50.57	-36.75	24.08
8.98	-46	32.03
-39.43	75.54	39.12
43.83	-23.75	-13.73
-45.87	-20.35	-2.95

// Kozel F A, 2009: Subgroup of Normals, Mock-Crime Group
// Subjects=22
-45	30	-9
-42	12	45
-54	30	-3
54	15	-12
33	18	-15
36	27	-6
-42	-51	48
-60	-51	33
-33	-42	51
9	-3	6
15	0	18
9	18	54
-3	18	48
-6	15	57
9	-105	6
6	-93	3
27	-87	-9
12	-84	-18
-6	-81	-18
39	54	12
33	51	21
-27	51	24
-33	60	15
-45	51	6
-18	-102	12
-9	-27	18
-24	-63	60
-15	-69	60
-60	-36	-12
-51	-42	-6

// Kozel F A, 2009: Subgroup of Normals, No Crime Group
// Subjects=26
-3	-24	48
-12	-18	42
9	-54	33
12	54	0
-12	42	-15
-3	48	-18
-45	-78	36
45	-27	63
42	-18	45
30	-30	54
57	-66	18
42	-51	21
30	-12	9
21	-18	-27
27	-12	-27

// Bhatt S, 2009: Unfamiliar: Lie > Truth
// Bhatt S, 2009: Familiar: Lie > Truth
// Bhatt S, 2009: Familiar (Lie > Truth) > Unfamilar (Lie > Truth)
// Subjects=18
-13.16	-46.37	58.5
29.82	15.47	51.65
3.2	-20.43	-9.34
57.19	16.75	-4.98
60.04	-37.14	38.41
3.79	25.59	46.6
38.11	39.15	28.99
8.61	-58.23	68.26
10.63	-43.95	60.09
8.62	-60.36	68.47
-13.16	-46.37	58.5
53.21	45.59	28.1
52.78	16.12	-11.56
26.73	-78.97	-39.81
66.52	-59.01	33.74
29.1	60.44	4.63
45.73	0.89	-59.24

// Antonova E, 2009: Older Normals
// Subjects=10
55.78	7.95	23.62
-32.83	-29.05	21.05
51.38	9.98	9
51.53	8.27	28.1
-25.16	-6.08	55.84
-41.13	-22.04	57.36
28.2	-2.13	47.09
59.06	-12.12	25.27
44.11	-69.16	4.57
-41.38	-69.68	5.6
27.86	-46.31	-15
-48.78	-28.28	32.32
63.3	-16.84	18.92
51.62	-60.06	11.53
-25.25	-71.9	16.75
12.92	-22.02	-2.37
25.15	-66.45	41.36
-5.75	-73.44	50.11
25.15	-74.11	38.66
-25.27	-80.87	10.81
-25.33	-89.13	0.35
32.48	-80.01	16.77
20.58	-93.68	-7.6
-13.55	-93.29	0.57
5.38	-22.67	-10.03
-22.22	-85.74	-11.12
8.45	-69.09	-46.32
-13.74	-13.93	8.41
16.16	-9.52	7.7
-25.51	-2.11	10.9
-13.66	-13.07	19.49
-32.92	7.42	24.68
-32.93	-33.33	6.91
47.24	-17.28	14.68
-2.75	-18.44	45.46
2.57	-6.52	47.75
1.55	-10.41	52.55
-2.68	-14.41	56.28
-29.34	-29.37	57.84
35.77	-38.55	43.36
-29.41	-26.8	49.82
51.43	-54.37	-11.25
-41.36	-72.85	5.86
51.57	-24.31	19.68
35.65	-68.36	15.75
-37.14	-29.41	16.67
-29.3	-33.34	61.52
44.38	-41.16	50.17
40.03	-50.76	36.53
-21.93	-50.87	40.6
1.29	7.71	25.38
16.64	-61.68	48.87
-2.57	-73.68	46.75
-6.55	56.71	-.94
1.37	-52.96	11.51
1.43	-56.68	18.51
39.88	-72.02	9.32
-17.61	-70.14	38.82
-22	-83.51	17.69
20.64	-93.08	0.16
20.58	-93.68	-7.6
-10.3	-92.75	7.17
-17.95	-90.2	-14.14
24.78	-85.71	-15.01
-10.52	-18.14	8.73
32.52	-67.52	26.87
32.49	-51.4	28.87
28.32	-62.46	37.65
32.56	-62.69	34.27
32.51	-70.95	23.81
28.23	-79.78	20.14
32.55	-67.27	30.19
28.27	-67.29	30.25
28.29	-79.18	27.9
32.45	-71.55	16.06
24.99	-75.83	16.5
-25.23	-71.64	20.07
-25.2	-63.64	27.21
-17.57	-74.11	42.5
16.15	76.04	40.67
-13.26	-66.08	49.58
-13.27	-69.51	46.52
-13.22	-61.25	56.98
-13.34	-66.94	38.5
-17.62	-74.63	35.85
-21.88	-70.16	38.87
-17.68	-67.57	30.8
-17.69	-71	27.74
-21.96	-79.74	25.18
-29.51	-76.15	17.16

// Antonova E, 2009: Younger Normals
// Subjects=10
27.8	46.4	14.03
39.61	38.26	17.92
39.63	47.32	24.96
58.86	18.75	11.53
-44.76	2.01	10.78
47.09	14.19	8.7
55.71	10.61	16.71
-21.94	-1.58	58.77
28.25	-6.02	51.87
-41.42	3.48	29.57
27.89	-30.65	-5.16
-37.19	-54.05	0.89
-18.11	-27.04	-9.4
-37.04	-48.1	22.7
47.26	-60.94	0.5
35.36	-46.01	-11.77
-53.09	-40.8	22.27
-60.58	-24.47	27.68
16.54	-41.84	43.86
24.62	-8.21	-3.66
-22.43	1.03	-3.9
-17.52	-69.28	49.9
25.24	-68.77	52.71
-13.28	-78.32	42.8
16.68	-77.79	46.87
-25.33	-89.13	0.35
32.38	-88.78	-.34
-17.85	-97.89	-3.46
-10.46	-94.38	-13.88
20.46	-82.91	-19.65
-17.94	-20.84	15.73
24.73	-30.16	1.52
-22.37	-14.83	-2.57
-13.83	-19.27	-5.64
51.42	38.93	25.53
58.86	18.75	11.53
47.03	17.9	1.7
55.71	10.61	16.71
-25.1	-14.29	59.87
28.25	-6.02	51.87
-36.89	-42.16	44.5
44.31	-38.5	43.26
35.4	-38.01	-4.63
47.18	-45.34	-4.15
-18.11	-27.04	-9.4
35.41	-49.98	-8.09
-53.22	-58.63	-1.89
35.36	-46.01	-11.77
-25.53	-42.95	-7.98
59.19	-30.55	34.62
-32.59	-41.88	47.77
35.74	-70.68	27.1
-32.71	-32.16	35.81
13.34	-41.86	43.9
16.38	-43.55	21.7
-22.36	-19.06	-2.21
25.24	-73.26	49.74
-13.2	-61	60.3
-13.28	-78.32	42.8
28.33	-74.35	35.3
16.38	-97.34	0.56
-25.28	-88.61	7
-10.42	-98.35	-10.2
-10.46	-94.38	-13.88
20.47	-86.08	-19.39
-6.28	-14.14	5
12.97	-18.25	5.12
24.7	-21.7	0.81
32.52	-67.52	26.87
32.49	-51.4	28.87
28.32	-62.46	37.65
32.56	-62.69	34.27
32.51	-70.95	23.81
28.23	-79.78	20.14
32.55	-67.27	30.19
28.27	-67.29	30.25
28.29	-79.18	27.9
32.45	-71.55	16.06
24.99	-75.83	16.5
-25.23	-71.64	20.07
-25.2	-63.64	27.21
-17.57	-74.11	42.5
16.15	76.04	40.67
-13.26	-66.08	49.58
-13.27	-69.51	46.52
-13.22	-61.25	56.98
-13.34	-66.94	38.5
-17.62	-74.63	35.85
-21.88	-70.16	38.87
-17.68	-67.57	30.8
-17.69	-71	27.74
-21.96	-79.74	25.18
-29.51	-76.15	17.16

// Wolf R C, 2009: Attention-Deficit/Hyperactivity Disorder (ADHD)
// Subjects=12
-41.24	26.52	-9.87
43.21	14.99	-0.08
20.96	-99.95	11.67
11.58	10.91	61.37
39.77	-68.53	-32.1
7.21	-63.19	-42.16
43.61	11.42	30.52
-1.54	29.39	53.04
-12.04	-91.35	-32.32
-34.51	-93.07	-14.96
17.42	-10.31	6.22
-25.18	32.03	-20.77
-7.99	-68.85	35.98
-23.87	-63.22	62.59
-40.08	-16.3	71.67
-57.25	44.29	8.82
3.98	-20.48	-32.88
-40.18	-47.64	57.96
-57	-42.48	10.67
-60.27	-46	7.72
-31.24	45	15.03
-53.9	15.58	11.6
-8.39	36.45	25.57
-11.5	24.3	33.55
-18.26	18.9	10.66
-37.82	24.59	3.71
15.22	-58.34	78.25
4.88	35.48	48.97
34.3	-41.3	52.7
26.81	-68.57	-31.88
17.42	-10.31	6.22
8.13	22.42	46.84
53.5	-33.22	34.77
47.04	-39.62	35.51
50.09	10.37	30.51
50.11	5.06	31.04
49.88	32.84	18.21
30.14	30.59	-4.76
34.15	10.06	50.99
24.72	-56.67	61.11
46.7	26.76	22.23
34.29	-70.95	45.55
39.81	33.5	-8.58
11.75	-76.48	56.57
62.94	-58.33	6.84
20.59	8.84	4.27
30.42	-98.6	-8.8
62.49	13.81	-13.74
65.93	-27.34	-6.37

// Wolf R C, 2009: Healthy Controls
// Subjects=12
-41.24	26.52	-9.87
43.21	14.99	-0.08
20.96	-99.95	11.67
11.58	10.91	61.37
39.77	-68.53	-32.1
-21.17	-90.22	14.79
-24.31	-92.8	21.82
-60.2	13.62	25.35
-43.27	-53.09	68.64
-21.21	-67.57	15.91
-31.42	23.99	-3.06
-53.97	-66.99	-10.49
-24.41	-67.27	19.29
-34.37	39.23	22.37
-34.69	20.48	-6.02
-11.52	17.6	30.85
-27.9	-101.99	-7.47
-18.67	58.51	-13.42
-31.48	-71.66	-27.22
-53.22	-28.54	56.29
-60.47	-17.9	-1.78
-47.27	43	28.94
-18.35	-1.49	-.76
-36.86	-1.09	73.47
-63.64	-37.06	0.16
-15.08	-11.05	0.13
-12.17	-23.42	-28.96
27.54	-92.61	20.92
46.35	14.28	-7.91
46.98	-.71	38.39
36.59	-71.42	-28.4
18.17	-72.52	52.71
14.33	26.95	26.12
49.56	-74.56	-28.31
24.41	-75.43	32.72
50.38	-31.23	44.71
59.9	-10.86	32.45
39.89	24.24	-4.3
33.35	27.1	-7.84
24	-12.86	13.09
56.48	14.03	23.32
46.64	42.71	20.65
65.96	-23.84	-3.35
14.77	13.8	57.67
44.11	-53.72	57.13
20.59	8.84	4.27
30.48	52.85	26.64

// Banich M T, 2009: Neutral > Fixation, Healthy Controls > ADHD
// Banich M T, 2009: Neutral > Fixation, ADHD > Healthy Controls
// Banich M T, 2009: Congruent > Fixation, Healthy Controls > ADHD
// Banich M T, 2009: Congruent > Fixation, ADHD > Healthy Controls
// Banich M T, 2009: Incongruent > Fixation, Healthy Controls > ADHD
// Banich M T, 2009: Incongruent > Fixation, ADHD > Healthy Controls
// Banich M T, 2009: Congruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Incongruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Incongruent > Neutral, ADHD > Healthy Controls
// Banich M T, 2009: Incongruent > Congruent, ADHD > Healthy Controls
// Banich M T, 2009: Incongruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Congruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Neutral Frequent (inc) > Neutral Frequent (neut), Healthy 
// Controls > ADHD
// Banich M T, 2009: Neutral Frequent (inc) > Neutral Frequent (cong), Healthy 
// Controls > ADHD
// Banich M T, 2009: Incongruent > Congruent, Healthy Controls > ADHD
// Subjects=23
-42	30	24
-50	4	36
8	-46	20
34	-26	12
60	-10	2
42	-58	12
-46	-26	4
-14	46	46
-2	-94	-4
-34	-82	38
6	54	14
26	16	-28
-46	32	28
-48	6	40
60	-4	-2
-40	-34	8
4	-48	30
-46	32	30
44	-14	6
-40	-22	6
6	-48	6
42	-60	12
-34	0	-28
0	-92	-2
16	-90	-6
-6	-60	32
-58	-50	34
2	-76	30
48	40	20
54	34	18
6	-22	0
-38	-58	46
24	-50	8
-34	-18	-16
14	-14	-12
10	-28	-16

// Lehtonen M, 2009: Finnish inflected real & pseudo words > Swedish inflected 
// real & pseudo words
// Lehtonen M, 2009: Finnish inflected real & pseudo words > Finnish 
// monomorphemic real & pseudo words
// Subjects=16
-54	12	27
-57	9	15
-48	0	36
-33	-90	-12
-36	-75	-21
-51	9	24

// Gougoux F, 2009: Sighted Group
// Subjects=14
63.24	-14.18	12.01
-54.31	-14.88	13.42
37.6	-77.89	-11.35
14.31	-75.8	17.74
48.46	-76.11	10.68
-49.89	-81.45	5.57
-37.27	-72.51	-17.63
67.43	-21.53	-.81
61.14	-37.97	7.34
-60.82	-20.35	-1.66
-65.01	-34.84	4.06
65.28	-27.17	-4.77
-65.07	-31.12	-2.94
37.48	-54.97	-17.73
39.69	-73.99	-16.16
-48.02	-51.25	-17.06

// Gougoux F, 2009: Congenitally Blind Group
// Subjects=5
63.24	-14.18	12.01
-54.31	-14.88	13.42
37.6	-77.89	-11.35
14.31	-75.8	17.74
48.46	-76.11	10.68
-49.89	-81.45	5.57
-37.27	-72.51	-17.63
65.35	-31.94	2.32
-67.18	-28.68	1.34
-48.03	-49.14	-17.24
65.28	-27.17	-4.77
-65.07	-31.12	-2.94
37.48	-54.97	-17.73
39.69	-73.99	-16.16
-48.02	-51.25	-17.06
54.76	-71.64	-.92
63.22	-33.01	2.44
-73.61	-35.4	-2.48
-67.18	-28.68	1.34
37.48	-54.97	-17.73
38.58	-72.22	-20.76
-48.02	-51.25	-17.06
65.38	-44.8	1.17
65.23	-11.31	-6.1
-57.51	-52.23	-1.26

// Gougoux F, 2009: Acquired Blind Group
// Subjects=10
63.24	-14.18	12.01
-54.31	-14.88	13.42
37.6	-77.89	-11.35
14.31	-75.8	17.74
48.46	-76.11	10.68
-49.89	-81.45	5.57
-37.27	-72.51	-17.63
69.5	-11.28	-6.15
58.81	-20.15	-9.74
-60.8	-20.18	0.55
-58.64	-33.03	-.62
54.76	-71.64	-.92
63.22	-33.01	2.44
-73.61	-35.4	-2.48
-67.18	-28.68	1.34
37.48	-54.97	-17.73
38.58	-72.22	-20.76
-48.02	-51.25	-17.06
65.38	-44.8	1.17
65.23	-11.31	-6.1
-57.51	-52.23	-1.26

// Bohon C, 2009: Anticipatory reward: Main effect of mood condition
// Bohon C, 2009: Anticipatory reward: Interaction between emotional eating 
// and mood condition
// Bohon C, 2009: Consummatory reward: Main effect of emotional eating status
// Bohon C, 2009: Consummatory reward: Main effect of mood condition
// Bohon C, 2009: Consummatory reward: Interaction between emotional eating 
// and mood condition
// Subjects=10
-2.35	29.85	-10.86
-14.95	-33.07	5.66
-31.3	-40.76	-6.74
13.98	63.68	5.68
-5.37	47.97	10.93
27.04	-40.55	-7.76
7.62	31.75	8.95
-11.88	11.61	1.19
4.3	41	4.73
-2.02	42.23	18.16
20.5	-1.66	-4.77
-18.2	-20.01	7.79
-24.8	-11.08	0.29
-14.84	-5.99	19.79
4.41	-10.67	3.12
7.66	41.95	14.66

// Frodl T, 2009: Emotional processing, Major Depression>Healthy Controls
// Frodl T, 2009: Explicit Processing, Healthy Controls>Major Depression
// Frodl T, 2009: Implicit Processing, Major Depression>Healthy Controls
// Frodl T, 2009: Implicit>Explicit
// Frodl T, 2009: Explicit>Implicit
// Subjects=12
-6	-4	36
26	-28	42
30	56	18
28	48	22
-24	-68	-44
-8	-76	-32
-42	6	38
-32	58	14
-60	-14	10
-22	-66	-42
30	-58	-24

// Rubia K, 2009: Healthy Controls
// Subjects=16
47.61	-13.92	0.46
47.59	-12.96	-.75
4.46	-51.92	-1.77
20.9	9	28.91
21.07	-13.78	37.88
11.61	35.87	-16.18
-29.89	-48.15	17.5
-29.89	-48.15	17.5
-37.22	-67.24	31.84
-57.19	-34.05	-2.48
-18.08	11.53	23.72
-20.94	-26.17	45.42
-3.46	40.59	-10.78
-3.46	40.59	-10.78
42.9	47.68	-17.88
8.48	65.17	-1.09
-41.84	27.92	28.1
-57.08	-1.44	13.34
-41.5	-58.23	36.62
-41.5	-58.23	36.62
-32.81	-29.4	45.95
1.42	-24.12	20.19
-5.88	-70.32	31.61
-25.69	3.44	17.92
4.78	-54.95	23.18
36.27	-14.27	43.27
-50.1	46.73	-22.92
47.15	43.88	-24.3
39.81	-15.71	-18.28
29.01	-15.75	-18.09
35.44	21.06	-15.12
-2.78	26.01	39.95
39.8	-51.95	-27.02
39.8	-51.95	-27.02
35.55	-71.11	-25.05
-18.47	-66.94	-23.42
20.62	-78.42	-10.62
-45.4	-46.75	-12.63
-10.54	-61.98	6.21
-13.66	-76.36	13.29
-17.49	-39.9	59.05
35.43	40.72	-11.46
-2.86	-52.31	17.45

// Rubia K, 2009: ADHD
// Subjects=18
20.65	-66.21	-6.23
44.29	-55.05	-14.46
-6.37	-86.07	-10.53
20.65	-66.21	-6.23
-30.05	-70.12	0.62
-6.24	-56.65	5.61
-45.12	-41.38	10.36
21.37	-32.32	57.64
20.89	-47.97	16.61
21.01	-18.65	31.64
16.39	39.31	20.38
24.9	50.42	12.41
25.34	17.6	40.3
-10.35	9.51	36.11
32.78	33.06	33.05
32.78	33.06	33.05
20.49	34.37	1.75
39.8	29.04	-10.38
-42.23	49.04	1.37
-42.23	49.04	1.37
-42.31	28.75	-8.95
63.84	-1.64	4.57
63.84	-1.64	4.57
16.2	6.18	-.99
44.52	-11.72	12.62
-45.24	-70.69	-4.66
-37.08	-21.35	51.95
-37.54	-24.77	15.31
-28.71	9.45	36.43
-52.3	-38.5	41.58
-40.4	18.51	53.66
-29.68	-42.23	34.84
-56.39	-16.02	64.07
-21.63	-10.53	-5.42
-50.1	46.73	-22.92
47.15	43.88	-24.3
39.81	-15.71	-18.28
29.01	-15.75	-18.09
35.44	21.06	-15.12
-2.78	26.01	39.95
39.8	-51.95	-27.02
39.8	-51.95	-27.02
35.55	-71.11	-25.05
-18.47	-66.94	-23.42
20.62	-78.42	-10.62
-45.4	-46.75	-12.63
-10.54	-61.98	6.21
-13.66	-76.36	13.29
-17.49	-39.9	59.05
35.43	40.72	-11.46
-2.86	-52.31	17.45

// Rubia K, 2009: Conduct Disorder
// Subjects=14
-3.13	-45.56	-2.27
-2.48	-69.16	43.76
-6.51	-91.46	-22.32
-50.1	46.73	-22.92
47.15	43.88	-24.3
39.81	-15.71	-18.28
29.01	-15.75	-18.09
35.44	21.06	-15.12
-2.78	26.01	39.95
39.8	-51.95	-27.02
39.8	-51.95	-27.02
35.55	-71.11	-25.05
-18.47	-66.94	-23.42
20.62	-78.42	-10.62
-45.4	-46.75	-12.63
-10.54	-61.98	6.21
-13.66	-76.36	13.29
-17.49	-39.9	59.05
35.43	40.72	-11.46
-2.86	-52.31	17.45

// Rubia K, 2009: Healthy Controls (HC) > ADHD & Conduct Disorder (CD), 
// Incongruent > Oddball
// Rubia K, 2009: HC & CD > ADHD, Oddball > Congruent
// Rubia K, 2009: HC > ADHD & CD, Oddball > Congruent
// Subjects=13
59.23	-7.13	-19.46
16.93	-64.95	41.89
-33.77	56.43	-11.84
31.82	41.65	44.54

// Wolf R C, 2009: Healthy Controls (HC) > Huntington's Disease (HD), Load 
// level 2
// Wolf R C, 2009: HC > HD, Load level 3
// Subjects=12
27	-63	-30
-30	33	36
-51	0	39
-51	-45	51
-9	-69	48
3	-53	54
-27	-50	48
-18	9	-3
30	-63	-33
12	-33	-48

// Aarts E, 2009: Incongruent > Congruent + Congruent > Neutral
// Aarts E, 2009: Congruent > Neutral
// Aarts E, 2009: Incongruent > Congruent
// Subjects=12
-6	38	28
-2	26	44
-32	26	-14
36	24	-18
-44	22	24
-36	10	28
44	6	44
-32	-54	44
-6	34	10
-2	26	44
36	24	8
-34	8	30
58	16	28
-40	60	2
32	58	4
26	16	42
38	2	48
-60	-50	8
-32	-54	44
36	-48	44
32	-68	52
12	-64	58
-8	0	4
14	2	6
-8	-14	10
34	-64	-36
-10	42	26
2	30	46
-40	22	-14
34	24	-14
-42	28	6
-42	20	14
-54	4	38
-46	4	30
-28	-60	36
-36	-38	40
-48	-52	30
-32	-64	54
-26	-66	46
-8	10	-2
10	12	6

// Schoning S, 2009: Healthy controls (HC)
// Subjects=28
-2	8	58
-30	26	-2
-32	26	-6
-36	-56	38
-34	-64	38
-30	-64	16
-4	-54	-24
0	-58	-40
-6	-74	-36
-16	0	22
-16	0	10
14	4	-2
16	-2	20
12	-6	0
2	-28	10
38	-66	-36
-12	-8	6
-4	-10	8
-50	-62	-22
-42	-68	-36
-32	-58	38
-26	-68	38
30	-48	24
26	-46	32
-34	-44	0
-50	8	38
-26	0	72
-8	-38	72
8	-24	72
8	-16	74
54	-4	-14
16	-52	70
-4	40	6
0	-20	44
-24	-10	-28
-2	20	36
-12	-26	42
-4	-6	34
-12	-14	46
-42	-24	38
-22	-8	18
-10	-2	2
-14	2	14
34	-20	48
38	-16	40
-6	-24	68
0	-18	62
6	-18	70
-58	-54	34
-58	-44	32
-46	-66	20
46	20	20
12	-48	32

// Schoning S, 2009: Major depressive disorder (MDD) patients
// Subjects=28
4	8	56
-48	8	46
-6	-8	4
36	-56	32
-38	-58	36
-34	-68	36
58	-46	-16
60	-26	-18
24	-36	50
-38	-24	34
4	-74	-6
-28	-18	-28
22	-30	-10
-10	2	62
-6	-2	56
-48	8	20
34	-56	32
-30	-52	30
-28	-62	34
40	-68	-34
30	-70	-30
-38	-26	-38
8	-40	-38
-8	-40	-36
54	-46	-20
-4	-32	14
6	-28	16
-60	-30	-6
-28	46	-4
-28	54	-6
-24	48	-12
32	-54	-40
-12	-80	-34
-12	-70	-36
22	44	-2
-32	-16	-22
-30	-70	-34
36	-72	14
-54	-50	8
0	-32	-22
12	-76	-28
-8	-38	72
8	-24	72
8	-16	74
54	-4	-14
16	-52	70
-4	40	6
0	-20	44
-24	-10	-28
-2	20	36
-12	-26	42
-4	-6	34
-12	-14	46
-42	-24	38
-22	-8	18
-10	-2	2
-14	2	14
34	-20	48
38	-16	40
-6	-24	68
0	-18	62
6	-18	70
-58	-54	34
-58	-44	32
-46	-66	20
46	20	20
12	-48	32

// Rodriguez-Jimenez R, 2009: Conjunction, Auditory and Visual > Control
// Rodriguez-Jimenez R, 2009: Auditory > Visual
// Rodriguez-Jimenez R, 2009: Visual > Auditory
// Subjects=13
-1.48	13.44	54.62
-1.37	7.68	61.91
7.99	34.56	38.92
-53.57	8.19	35.86
-47.27	33.12	26.56
-43.94	10.79	28.71
-27.33	4.08	59.35
-24.2	-0.03	49.62
-43.61	-42.51	44.07
-27.31	-67.98	46.31
-27.37	-52.03	44.73
1.08	-54.03	-12.71
43.44	43.01	24.04
63.02	21.06	29.24
49.94	26.77	22.17
37.43	10.38	54.26
27.72	7.16	54.74
18.22	-63.38	58.52
47.31	-40.95	55.81
50.34	-32.61	41.49
-1.97	62.31	26.26
11.03	65.85	29.05
-54.25	29.36	-13.29
-44.07	-22.98	11.89
65.87	-1.5	-5.56
56.37	-26.13	7.12
-50.54	-81.99	1.03
-44.03	-88.35	1.54
-40.83	-78.77	0.54
-11.57	20.48	27.2
-21.22	-54.5	17.98
-44.33	-67.58	-17.31
-31.48	-58.58	-25.15
-37.71	-46.85	-2.67
7.28	9.49	-22.46
52.93	-63.73	-15.99
43.22	-66.96	-15.51
49.73	-73.31	-14.99
27.65	-42.57	39.5
14.37	-38.42	15.78

// Melcher T, 2009: Response Incongruent (RI) - Semantic Incongruent (SI)
// Melcher T, 2009: RI - Congruent (CO), p<0.005
// Melcher T, 2009: RI - Congruent (CO), p<0.001
// Melcher T, 2009: SI - CO, p<0.005
// Melcher T, 2009: SI - CO, p<0.001
// Melcher T, 2009: RI-CO+RI-SI
// Melcher T, 2009: RI-CO+SI-CO, p<0.005
// Melcher T, 2009: RI-CO+SI-CO, p<0.001
// Subjects=12
-60	3	33
-60	6	36
15	9	42
-45	-21	42
-45	-15	18
-45	3	0
6	-87	39
-39	-15	6
42	6	3
24	-21	12
24	-42	-45
-39	-12	12
42	6	3
30	-66	-21
-15	-6	45
-12	6	42
-51	-21	45
-51	-12	24
-39	15	6
18	-75	42
6	-84	36
21	-21	9
-60	6	36
12	6	42
-36	-12	9
-42	3	0
42	6	3
6	-87	39
24	-21	12
24	-42	-45
-48	-12	45
24	-21	12

// Morey R A, 2009: Main Effect Combat > Scrambled
// Morey R A, 2009: Main Effect of Scrambled > Combat
// Subjects=20
-32.53	-52.75	-13.05
37.19	-49.08	-14.82
-21.09	-6.63	-19.61
25.39	-4.21	-21.16
-43.3	23.64	12.86
50.78	19.72	21.45
2	63.23	15.43
2.44	-48.77	29.75
-41.3	23.19	-29.3
59.21	-8.33	-24.4
-33.93	53.51	-.34
33.69	51.84	-2.85
-49.32	-34.13	52.36
52.13	-40.83	48.9

// Acheson A, 2009: Iowa Gambling Task > Rest, All Participants
// Subjects=15
51.88	2.38	13.75
-34.67	-57.92	-28.23
28.61	-30.48	-37.14
-53.56	-34.3	50.18
-47.23	-36.89	41.44
-28.14	-53.4	44.68
-28.09	-61.4	51.89
-26.01	-64.43	36.54
-26	-61.92	43.03
62.55	-22.48	19.83
-24.14	-29.03	-5.85
-36.98	12.89	-8.64
-30.61	11.38	0.3
34.9	12.06	2.09
37.01	11.81	-2.35
-26.38	9.31	0.42
-23.89	-98.5	-3.31
-11.25	-94.73	-12.52
14.15	-100.55	-7.83
20.49	-100.5	-7.88
-5.02	-76.85	-31.54
24.38	-35.12	-43.45
32.85	-36.88	-38.94

// Hall S S, 2009: Fragile X Syndrome
// Subjects=10
-37.49	2.96	24.89
71.33	17.53	2.55
-41.53	12.67	48.66
-7.1	-21.09	30.12
7.85	35.65	27.61
-53.3	17.48	-25.58
48.25	19.96	-27.55
53.02	-29.2	-2.6
-1.08	-49.68	-11.98
-15.99	2.2	15.64
12.08	2.2	14.04
-5.05	36.12	33.39
-46.69	-5.59	-20.05
-20.62	-56.96	-19.89
-3.56	-27.95	-32.02

// Hall S S, 2009: Healthy Controls
// Subjects=10
-45.81	-29.65	43.95
-9.41	-86.75	5.28
31.09	-65.57	-34.49
11.77	14.05	-8.42
-5.05	36.12	33.39
-46.69	-5.59	-20.05
-20.62	-56.96	-19.89
-3.56	-27.95	-32.02

// Krendl A C, 2009: All Participants: Stigma face > Control
// Krendl A C, 2009: High-Functioning Older Adults > Low-Functioning Older 
// Adults and Young Adults: Stigma face > Control
// Subjects=17
-48	-57	-24
30	24	-6
6	15	48
-57	15	-9
-30	0	51
-21	-42	-51
21	0	-21
-18	0	-21
-54	33	15
30	21	-27
-39	42	0
-33	27	-12
36	24	9
21	-66	-45
-39	-48	-39
24	15	0
-18	-12	12
-48	9	27

// Newman-Norlund R D, 2009: Miss (All) > Goal (All), p<0.001
// Newman-Norlund R D, 2009: Miss (All) > Goal (All), p=0.004
// Newman-Norlund R D, 2009: Miss (All) > Goal (All), p=0.001
// Newman-Norlund R D, 2009: [Miss (Friend) > Goal (Friend)] > [Miss (Foe) > 
// Goal (Foe)]
// Newman-Norlund R D, 2009: Friend (All) > Foe (All)
// Subjects=22
69.66	-36.77	30.36
-45.76	41.42	-22.47
39.64	6	-27.15
-5.48	-11.95	-10.03
12.96	-9.14	-3.9
-5.02	36.33	35.61
11.64	36.07	-13.96
-3.25	-7.07	-3.83
-44.57	-14.71	-25.9
-12.96	38.92	6.35
23.66	-28.53	-16.73
-39.84	-78.33	-6.24
45.43	-57.82	-9.72
44.51	13.36	16.87

// Volz K G, 2009: Mixed trials > in- and out-group trials
// Volz K G, 2009: Mixed trials > in-group trials
// Volz K G, 2009: Mixed trials > out-group trials
// Volz K G, 2009: In-group > out-group trials
// Volz K G, 2009: In-group bias > fair behavior (pooled across strategies)
// Volz K G, 2009: Inter-group behavior (mixed trials > in-group trials)
// Volz K G, 2009: Fair behavior (mixed trials > in-group trials)
// Subjects=20
2.12	56.9	14.56
2.09	43.44	5.65
5.84	-53.08	37.12
-55.14	-54.13	28.99
47.51	-59.43	33.83
-55.44	-30.89	-.84
8.55	57.2	17.8
-1.09	43.68	9.01
5.85	-49.65	40.18
-45.52	-57.33	28.03
57.1	-51.97	33.09
5.32	56.92	14.52
2.16	37.61	12.83
2.73	-58.67	47.66
-61.56	-47.65	30.75
57.13	-52.77	36.5
-29.91	20.79	4.57
27.77	20.88	0.55
-20.01	-55.29	10.84
-10.66	50.74	18.56
2.13	33.92	6.45
8.91	24.62	50.64
-61.61	-48.17	24.1
9.27	-57.35	64.2
-36.32	27.35	7.44
9.68	58.86	25.46
-4.32	50	8.52
5.82	-46.73	36.59
-51.92	-58.43	28.19
9.06	-85.81	26.44
8.88	-84.44	2.91
-7.17	17.4	41.39
-36.06	-75.45	-.67
44.1	-81.4	-2.21

// Xu X, 2009: Chinese Participants
// Subjects=17
-2	28	20
0	20	38
-48	34	-2
-4	38	40

// Xu X, 2009: American Participants
// Subjects=16
2	34	38
-40	42	4
34	46	14
-48	-50	52
4	28	42

// Davis N, 2009: Children with Mathematical calculation difficulties (MD)
// Subjects=24
-40.58	39.56	14.27
-1.69	11.15	56.35
-5.08	25.7	38.44
30.35	7.91	52.91
49.26	34.26	20.37
30.35	7.91	52.91
33.11	16.51	-1.37
1.66	-63.08	45.81
-27.24	-63.77	39.51
43.31	-49.88	47.57
33.71	-66.32	42.37
-14.79	1.64	17.15
-34.02	21.33	25.76
-31.02	48.87	10.03
-24.59	22.76	2.11
-40.69	41.7	0.71
26.55	44.5	-10.34
-1.66	8.23	59.94
-46.66	0.08	41.07
46.06	-1.94	6.72
36.86	-17.43	54.96
-2.22	48.53	3.04
-1.72	-28.72	36.28
-1.88	-50.06	7.96
-21.46	28.61	-5.11
40.09	-66.53	38.97
23.46	32.57	0.74
-46.88	17.57	19.53
33.09	9.65	-7.49

// Davis N, 2009: Typically developing control (TD)
// Subjects=24
33.15	26.79	7.8
10.96	22.63	38.52
20.74	14.45	55.82
1.38	26.26	45.01
8.11	-65.96	49.32
-24.13	11.01	56.62
-27.26	-87	28.08
33.72	-82.69	37.05
39.79	29.15	37.64
-46.66	0.08	41.07
46.06	-1.94	6.72
36.86	-17.43	54.96
-2.22	48.53	3.04
-1.72	-28.72	36.28
-1.88	-50.06	7.96
-21.46	28.61	-5.11
40.09	-66.53	38.97
23.46	32.57	0.74
-46.88	17.57	19.53
33.09	9.65	-7.49

// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract), 
// p=0.609
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract), 
// p=0.039
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract), 
// p=0.339
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract), 
// p=0.009
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract), 
// p=0.042
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract), p=0
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract), 
// p=0.001
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid)
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.901
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.909
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.367
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.288
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.975
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.948
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.936
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.017
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract) 
// (High-vivid with respect to Low-vivid)
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.042
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.001
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.032
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.77
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.78
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.131
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.085
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.005
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.001
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.035
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract) 
// (Regressed onto the vividness ratings)
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract) 
// (Regressed onto the vividness ratings)
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.049
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.05
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.095
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.002
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.004
// Subjects=9
-50.74	-68.14	-11.55
-42.02	-61	-4.56
-47.44	-61.13	-5.57
-58.16	-60.54	1.27
-37.68	-35.7	1.83
-46.36	-27.22	1.14
-37.67	-39.95	2.25
-15.26	-68.92	58.52
-19.75	-62.53	46.76
-15.32	-57.33	56.26
-33.26	-42.61	8.04
-37.79	-27.71	-4.56
-23.83	-30.07	72.75
-36.81	-39.04	69.38
-45.54	-35.33	63.56
-15.54	-7.55	49.09
-25.09	-61.41	-32.82
44.38	-79.51	-12.04
31.21	-34.03	-18.56
44.25	-49.83	-16.1
-42.09	-84.48	-14.56
-54	-67.2	-12.71
-46.54	52.42	3.35
-29.32	69.5	1.36
-37.94	65.21	1.93
31.32	53.21	7.54
31.32	53.21	7.54
-16.39	-47.79	-25.35
-33.84	53.79	-17.18
-33.47	45.54	9.41
53.8	-35.4	57.39
-46.54	52.42	3.35
-33.73	3.18	-18.89
-32.83	-20.79	46.21
-12.2	-45.52	-35.73
18.13	-48.08	-30.39
45.21	-64.56	55.94
32.23	-57.06	56.54
44.87	12.77	44.93
40.23	-90.29	-.82
49.14	21.19	42.91
-28.62	3.59	42.61
-24.85	49.83	8.84
18.54	-86.63	-6.42
53.28	-76.44	8.79
-3.14	39.68	13.95
10.11	-50.03	18.12
18.9	-52.15	29.39
44.84	-38.88	32.11
-41.46	-42.61	42.92
18.39	58.9	11.68
27.06	54.78	13.06
39.76	56.15	-7.46
44.37	19.98	7.25
-28.92	-77.46	2.45
5.76	-28.36	20.53
50.36	-67.47	35.97
73.64	-17.46	7.09
-53.81	4.2	16.09
55.95	42.92	-12.03
36.58	-39.3	62.55
40.25	-24.5	13.96
55.86	20.41	-23.24
-53.72	-15.91	19.19
31.13	-56.55	-29.78
49.3	53.67	-23.06
31.34	62.14	11.14
44.32	58.99	11.23
-41.99	3.82	11.44
-37.63	-4.67	12.21
14.86	-13.95	59.29
-41.61	7.69	41.31
27.63	-85.4	29.17
-57.73	-25.65	41.52
-62.18	-27.66	31.71
27.87	-22.31	61.02
-2.59	-3.25	48.45
14.88	-18.21	59.71
-66.65	-50.71	15.01
-62.59	19.6	9.11

// Gardini S, 2009: General image > Baseline
// Gardini S, 2009: Specific image > Baseline
// Gardini S, 2009: Image generated as first > Image generated as second
// Gardini S, 2009: Image generated as second > Image generated as first
// Gardini S, 2009: Interaction: Image Type x Position
// Subjects=13
21.17	-67.78	34.26
53.31	27.71	32.1
51.4	6.62	47.67
-4.97	-21.29	27.86
-5.6	60.45	-4.87
-5.3	68.16	20.14
1.14	-9.83	0.85
-2.79	-55.08	22.2
-.74	-48.25	14.77
7.97	-56.42	18.79
-16.26	-16.24	-9.43
-22.98	-19.1	-28.08
-35.84	-30.42	-22.26
-22.63	-89.84	-15.48
-46.47	-69.61	-15.96
29.68	-98.24	18.08
33.73	-97	-3.41
22.92	-94.91	-3.43
64.75	1.47	-8.08
58.44	-15.9	1.59
-8.88	-75.15	48.94
21.19	-65.45	36.27
44.61	33.86	29.4

